Citrus Sinensis ID: 042949
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 608 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LP77 | 655 | Probable inactive recepto | yes | no | 0.832 | 0.772 | 0.299 | 3e-61 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.889 | 0.845 | 0.296 | 3e-61 | |
| Q9SH71 | 587 | Putative inactive recepto | no | no | 0.875 | 0.906 | 0.304 | 4e-60 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.870 | 0.817 | 0.293 | 1e-59 | |
| Q9SUQ3 | 638 | Probable inactive recepto | no | no | 0.802 | 0.764 | 0.300 | 4e-59 | |
| Q9FL63 | 614 | Inactive leucine-rich rep | no | no | 0.914 | 0.905 | 0.271 | 7e-58 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.847 | 0.804 | 0.293 | 1e-57 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.875 | 0.794 | 0.297 | 1e-55 | |
| Q9FMD7 | 625 | Probable inactive recepto | no | no | 0.824 | 0.801 | 0.280 | 4e-55 | |
| Q9FK10 | 601 | Probable inactive recepto | no | no | 0.866 | 0.876 | 0.285 | 1e-54 |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 236 bits (603), Expect = 3e-61, Method: Compositional matrix adjust.
Identities = 182/608 (29%), Positives = 281/608 (46%), Gaps = 102/608 (16%)
Query: 54 WNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLI 113
WN PC N G+KC + + +RL + LSG I L LR +SL N +
Sbjct: 54 WNIKQTSPC--NWAGVKC--ESNRVTALRLPGVALSGDIPEGIFGNLTQLRTLSLRLNAL 109
Query: 114 QGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHL---------------------- 151
G +P +S L +L L N SG +P L L HL
Sbjct: 110 SGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRLNLASNSFTGEISSGFTNLT 169
Query: 152 --KTLDISNNHFAATSPD-----------------NFRQEIKYFDK-YVVETS------- 184
KTL + NN + + PD + + ++ F+ ++TS
Sbjct: 170 KLKTLFLENNQLSGSIPDLDLPLVQFNVSNNSLNGSIPKNLQRFESDSFLQTSLCGKPLK 229
Query: 185 --SSEINRASTVEARGLEDTQPPSVHNKSEHGEKRHWFRNWMT--IIPLAAGIGLVVLIA 240
E S + G + PPSV E +K + +I G L+VLI
Sbjct: 230 LCPDEETVPSQPTSGG--NRTPPSVEGSEEKKKKNKLSGGAIAGIVIGCVVGFALIVLIL 287
Query: 241 YCM-GKKSAQIARDREILKALQDSPS-KSPPQVMDIEEVR-------------------- 278
+ KKS + +R +I Q P + +D V
Sbjct: 288 MVLCRKKSNKRSRAVDISTIKQQEPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGN 347
Query: 279 -PEVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ 337
P ++ LVFF N + F L+DLL A+A++ + + + L V AVKRLK +
Sbjct: 348 GPATKK--LVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVM 405
Query: 338 VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEA-YIEGKRD 396
++ EF + + +G + H N++PL Y + +EKLLVY + GSL +LL G+
Sbjct: 406 MADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSP 465
Query: 397 FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456
W +R IA G A+GLD+++ + + HGN+K SNILL ++ D +S+ G ++ +
Sbjct: 466 LNWDVRSRIAIGAARGLDYLHSQGT---STSHGNIKSSNILLTKSHDAKVSDFGLAQLVG 522
Query: 457 PKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKT-----VEKTGIDLPKW 507
T + GY APE K VS++GDV+SFGV+LLEL+TGK + + G+DLP+W
Sbjct: 523 SSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLPRW 582
Query: 508 VKAMVREEWTGEVFDKE---VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564
VK++ R+EW EVFD E +A + ++ + L+C S PD RP M+EV+ ++E +
Sbjct: 583 VKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENL 642
Query: 565 --VNGNDE 570
+G+D+
Sbjct: 643 RPYSGSDQ 650
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (603), Expect = 3e-61, Method: Compositional matrix adjust.
Identities = 185/624 (29%), Positives = 286/624 (45%), Gaps = 83/624 (13%)
Query: 7 FLFLEGLICIAILPRLFTGCVGGEL-SESESFFKFISAVDSQNVLRIGWNGNLPHPCSYN 65
FLFL ++ + C+ ++ S+ ++ +F S V ++ WN +P S+
Sbjct: 8 FLFL-------LVTTFVSRCLSADIESDKQALLEFASLVPHSR--KLNWNSTIPICASWT 58
Query: 66 LKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISN-- 123
GI C+ + + +RL L G + +T KL LR++SL N +QG IP+ I +
Sbjct: 59 --GITCSKNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLP 116
Query: 124 --------------------CRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAA 163
RL L+LS+N LSG +P +L L L L + NN +
Sbjct: 117 FIRSLYFHENNFSGTIPPVLSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSG 176
Query: 164 TSPDNFRQEIKYFDKYVVE-----TSSSEINRASTVEARGL----------EDTQPPS-- 206
P N +KY + SS + AS+ + L E+T PS
Sbjct: 177 PIP-NLPPRLKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPS 235
Query: 207 ---------VHNKSEHGEKRHWFRNWMTIIPLAAGIGLVVLIA---YCMGKKSAQIARDR 254
N K+ + I + + L +++A C KK
Sbjct: 236 PTTPTEGPGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDST 295
Query: 255 EILKALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTIC 314
+ KA P +S + + E +++LVFF F L+DLL A+A++ +
Sbjct: 296 AVPKA---KPGRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSY 352
Query: 315 SSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLL 373
+ + L+ VKRLK++ EF Q M +G + H N+ PL Y + +EKLL
Sbjct: 353 GTTYKAILEEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLL 412
Query: 374 VYKYQSNGSLLSLLEAYIEGKRD-FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
VY Y G+ LL EG R W+ RL I A+G+ ++ S + + HGN+K
Sbjct: 413 VYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAK--LLHGNIK 470
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVIL 488
N+LL + +S+ G + + S GY APE + +++ DV+SFGV+L
Sbjct: 471 SPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLL 530
Query: 489 LELLTGKTVEKTG-----IDLPKWVKAMVREEWTGEVFDKEVAKAGR---QWAFPLLNVA 540
LE+LTGK KT +DLPKWV+++VREEWTGEVFD E+ K + +L +A
Sbjct: 531 LEMLTGKAAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIA 590
Query: 541 LKCVSNSPDDRPTMAEVLERIEEV 564
+ CVS PD RP+M EV+ +EE+
Sbjct: 591 MACVSKHPDSRPSMEEVVNMMEEI 614
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (593), Expect = 4e-60, Method: Compositional matrix adjust.
Identities = 185/608 (30%), Positives = 299/608 (49%), Gaps = 76/608 (12%)
Query: 5 KLFLFLEGLICIAILPRLFTGCVGGELSESE--SFFKFISAVDSQNVLRIGWNGNLPHPC 62
++FLF LI +L + + E + + F+S+ +S R+ WN +
Sbjct: 2 QIFLFFFSLILCFVL-------ISSQTLEDDKKALLHFLSSFNSS---RLHWNQS--SDV 49
Query: 63 SYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSIS 122
++ G+ CN + IV +RL + +G+I T+ +L L+ +SL +N G P+ +
Sbjct: 50 CHSWTGVTCNENGDRIVSVRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFT 109
Query: 123 NCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSP---------------- 166
N + LT+L L N LSG + ++LK+LK LD+SNN F + P
Sbjct: 110 NLKSLTHLYLQHNHLSGPLLAIFSELKNLKVLDLSNNGFNGSIPTSLSGLTSLQVLNLAN 169
Query: 167 DNFRQEIKYFDKYVVETSSSEINRASTVEARGLEDTQPP--SVHNKSEHGEKR---HWFR 221
++F EI + + N+ + L+ Q S +N +E ++R
Sbjct: 170 NSFSGEIPNLHLPKLSQINLSNNKLIGTIPKSLQRFQSSAFSGNNLTERKKQRKTPFGLS 229
Query: 222 NWMTIIPLAAGI-----GLVVLIAYCMGKKSAQIARDREILKALQDSPSKSPPQVMDIEE 276
++ L+A GL ++ C GK I L+ S SPP +
Sbjct: 230 QLAFLLILSAACVLCVSGLSFIMITCFGKT--------RISGKLRKRDSSSPPGNWTSRD 281
Query: 277 VRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKL 336
E +++FF F LDDLL ++A++ + + + V +++ + VKRLK++
Sbjct: 282 DNTE-EGGKIIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDMSTVVVKRLKEV 340
Query: 337 QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRD 396
V EF Q M IG ++H N+ L Y + ++KL VY Y ++GSL +L
Sbjct: 341 VVGRREFEQQMEIIGMIRHENVAELKAYYYSKDDKLAVYSYYNHGSLFEILHGNRGRYHR 400
Query: 397 FP--WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454
P W RL IATG A+GL K +E K I HGN+K SNI L+ I + G +
Sbjct: 401 VPLDWDARLRIATGAARGL----AKIHEGKFI-HGNIKSSNIFLDSQCYGCIGDVGLTTI 455
Query: 455 LD--PKKTCLFSSNGYTAPEKTVSEQ----GDVFSFGVILLELLTGKT------VEKTG- 501
+ P+ TCL ++GY APE T + + DV+SFGV+LLELLTGK+ + TG
Sbjct: 456 MRSLPQTTCL--TSGYHAPEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQAELVPTGG 513
Query: 502 --IDLPKWVKAMVREEWTGEVFDKEV-AKAG--RQWAFPLLNVALKCVSNSPDDRPTMAE 556
+DL W++++V +EWTGEVFD E+ +++G + +L + L CV+ +RP +A+
Sbjct: 514 ENMDLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALKQQERPHIAQ 573
Query: 557 VLERIEEV 564
VL+ IE++
Sbjct: 574 VLKLIEDI 581
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (589), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 185/631 (29%), Positives = 284/631 (45%), Gaps = 102/631 (16%)
Query: 29 GELSESES-FFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMN 87
G+L+ +S F SAV + +L W+ PC N G+ C+ + +RL
Sbjct: 29 GDLAADKSALLSFRSAVGGRTLL---WDVKQTSPC--NWTGVLCD--GGRVTALRLPGET 81
Query: 88 LSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTK 147
LSG I L LR +SL N + G +P + +C L L L N SG +P L
Sbjct: 82 LSGHIPEGIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFS 141
Query: 148 LKHLKTLDISNNHFAATSPDNFRQEIKYFDKYV--------------------------- 180
L +L L+++ N F+ F+ + Y+
Sbjct: 142 LSNLVRLNLAENEFSGEISSGFKNLTRLKTLYLENNKLSGSLLDLDLSLDQFNVSNNLLN 201
Query: 181 --VETSSSEINRASTVEA------------RGLEDTQPPSVHN------KSEHGEKRHWF 220
+ S + + S V G +QP SV N SE +KR
Sbjct: 202 GSIPKSLQKFDSDSFVGTSLCGKPLVVCSNEGTVPSQPISVGNIPGTVEGSEEKKKRKKL 261
Query: 221 RNWMT---IIPLAAGIGLVVLIAYCMGKKSAQIARDREI--------------LKALQDS 263
+I G+ L+V+I + +K R R I KA ++
Sbjct: 262 SGGAIAGIVIGCVVGLSLIVMILMVLFRKKGN-ERTRAIDLATIKHHEVEIPGEKAAVEA 320
Query: 264 PSK-------SPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSS 316
P SP V +E +++ LVFF N + F L+DLL A+A++ + +
Sbjct: 321 PENRSYVNEYSPSAVKAVEVNSSGMKK--LVFFGNATKVFDLEDLLRASAEVLGKGTFGT 378
Query: 317 LFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376
+ L + AVKRLK + ++ EF + + +G + H N++PL Y + +EKLLVY
Sbjct: 379 AYKAVLDAVTLVAVKRLKDVTMADREFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYD 438
Query: 377 YQSNGSLLSLLEA-YIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
+ GSL +LL G+ W++R IA G A+GLD+++ +++ HGN+K SN
Sbjct: 439 FMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLH---SQDPLSSHGNVKSSN 495
Query: 436 ILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKT----VSEQGDVFSFGVILLEL 491
ILL + D +S+ G ++ + T + GY APE T VS++ DV+SFGV+LLEL
Sbjct: 496 ILLTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLEL 555
Query: 492 LTGKT-----VEKTGIDLPKWVKAMVREEWTGEVFDKE------VAKAGRQWAFPLLNVA 540
LTGK + + G+DL +WV ++ REEW EVFD E V + A +L +
Sbjct: 556 LTGKAPSNSVMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMA-EMLQLG 614
Query: 541 LKCVSNSPDDRPTMAEVLERIEEVVNGNDER 571
+ C PD RP M EV+ RI+E+ +R
Sbjct: 615 IDCTEQHPDKRPVMVEVVRRIQELRQSGADR 645
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 229 bits (584), Expect = 4e-59, Method: Compositional matrix adjust.
Identities = 169/562 (30%), Positives = 270/562 (48%), Gaps = 74/562 (13%)
Query: 68 GIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGR----------- 116
G+ CN + I+ +RL + L+G I T+ +L LRV+SL NLI G
Sbjct: 60 GVTCNQDGSRIIAVRLPGVGLNGQIPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDL 119
Query: 117 -------------IPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAA 163
+P S + LT +NLS+N +G +P +L++LK +++L+++NN +
Sbjct: 120 AFLYLQDNNLSGPLPLDFSVWKNLTSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSG 179
Query: 164 TSPD----NFRQEIKYFDKYVVETSSSE-INRASTVEARGLED----------TQPPSVH 208
PD + Q I + Y + + + R G++ T PP
Sbjct: 180 DIPDLSVLSSLQHIDLSNNYDLAGPIPDWLRRFPFSSYTGIDIIPPGGNYTLVTPPPPSE 239
Query: 209 NKSEHGEKRHWFRNWMTIIPLA---------AGIGLVVLIAYCMGK--KSAQIARDREIL 257
+ K + T+ L + V+ + Y K + + D ++
Sbjct: 240 QTHQKPSKARFLGLSETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGDGVISDNKLQ 299
Query: 258 KALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSSL 317
K SP K ++ D+ + L FF F L+DLL A+A++ + +
Sbjct: 300 KKGGMSPEKFVSRMEDVN--------NRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTT 351
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377
+ L+++ AVKRLK + +F Q M IG +KH N++ L Y + +EKL+VY Y
Sbjct: 352 YKAVLEDATSVAVKRLKDVAAGKRDFEQQMEIIGGIKHENVVELKAYYYSKDEKLMVYDY 411
Query: 378 QSNGSLLSLLEAYIEGKRDFP--WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
S GS+ SLL G+ P W+ R+ IA G AKG+ +++++N + + HGN+K SN
Sbjct: 412 FSRGSVASLLHGN-RGENRIPLDWETRMKIAIGAAKGIARIHKENNGK--LVHGNIKSSN 468
Query: 436 ILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKT----VSEQGDVFSFGVILLEL 491
I LN + +S+ G + + P + GY APE T S+ DV+SFGV+LLEL
Sbjct: 469 IFLNSESNGCVSDLGLTAVMSPLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLEL 528
Query: 492 LTGKTVEKTG-----IDLPKWVKAMVREEWTGEVFDKEVAKAG--RQWAFPLLNVALKCV 544
LTGK+ T I L +WV ++VREEWT EVFD E+ + + +L +A+ CV
Sbjct: 529 LTGKSPIHTTAGDEIIHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCV 588
Query: 545 SNSPDDRPTMAEVLERIEEVVN 566
+ D RP M++++ IE V N
Sbjct: 589 VKAADQRPKMSDLVRLIENVGN 610
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FL63|Y5410_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At5g24100 OS=Arabidopsis thaliana GN=At5g24100 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 225 bits (574), Expect = 7e-58, Method: Compositional matrix adjust.
Identities = 171/630 (27%), Positives = 293/630 (46%), Gaps = 74/630 (11%)
Query: 1 MRGSKLFLFLEGLICIAILPRLFTGCVGGELSESESFFKFISAVDSQNVLRIGWNGNLPH 60
M + F+F L L++ G + ++ F++ + L WN + P
Sbjct: 1 MSRGRSFIFYFVLFLFFGSSALYSQVTGDLAGDRQALLDFLNNIIHPRSL--AWNTSSPV 58
Query: 61 PCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKL-------------------- 100
++ G+ C++ T + + L +L G+I T+ +L
Sbjct: 59 CTTW--PGVTCDIDGTRVTALHLPGASLLGVIPPGTISRLSELQILSLRSNGLRGPFPID 116
Query: 101 ----RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156
+ L+ +SL N G +P+ + LT L+L SN +G++P L L +L++
Sbjct: 117 FLQLKKLKAISLGNNRFSGPLPSDYATWTNLTVLDLYSNRFNGSIPAGFANLTGLVSLNL 176
Query: 157 SNNHFAATSPD----NFRQEIKYFDKYVVETSSSEINRASTVEARG----LEDTQPPSVH 208
+ N F+ PD R+ + + + + + + + R G E+ PP+V
Sbjct: 177 AKNSFSGEIPDLNLPGLRR-LNFSNNNLTGSIPNSLKRFGNSAFSGNNLVFENAPPPAVV 235
Query: 209 NKSEHGEKRHWFRNWMTIIPLAAG--------IGLVVLIAYCMGKKSAQIARDREILKAL 260
+ E +K + + I+ +A I +V+++ Y ++ ++ + LK
Sbjct: 236 SFKEQ-KKNGIYISEPAILGIAISVCFVIFFVIAVVIIVCYVKRQRKSETEPKPDKLKLA 294
Query: 261 QDSPSKSPPQVM----DIEEVRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSS 316
+ PS+ + +IE++ + ++++FF F L+DLL A+A+ + +
Sbjct: 295 KKMPSEKEVSKLGKEKNIEDMEDKSEINKVMFFEGSNLAFNLEDLLIASAEFLGKGVFGM 354
Query: 317 LFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376
+ L++S V AVKRLK + VS +F M +GN+KH N+ PL Y + EEKL+VY
Sbjct: 355 TYKAVLEDSKVIAVKRLKDIVVSRKDFKHQMEIVGNIKHENVAPLRAYVCSKEEKLMVYD 414
Query: 377 YQSNGSLLSLLEA--YIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
Y SNGSL L EG W+ RL G+AKGL ++ ++ + HGN+K S
Sbjct: 415 YDSNGSLSLRLHGKNADEGHVPLNWETRLRFMIGVAKGLGHIHTQN-----LAHGNIKSS 469
Query: 435 NILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPEKT----VSEQGDVFSFGVI 487
N+ +N ISE G +P S+ Y APE T + + D++SFG++
Sbjct: 470 NVFMNSEGYGCISEAGLPLLTNPVVRADSSARSVLRYRAPEVTDTRRSTPESDIYSFGIL 529
Query: 488 LLELLTGKTV---EKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA--FPLLNVALK 542
+LE LTG+++ K GIDL WV ++ ++WTGEVFD E+ K A +L +
Sbjct: 530 MLETLTGRSIMDDRKEGIDLVVWVNDVISKQWTGEVFDLELVKTPNVEAKLLQMLQLGTS 589
Query: 543 CVSNSPDDRPTMAEVLERIEEVVNGNDERD 572
C + P RP M +V+E +EE+ ERD
Sbjct: 590 CTAMVPAKRPDMVKVVETLEEI-----ERD 614
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 224 bits (572), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 177/604 (29%), Positives = 285/604 (47%), Gaps = 89/604 (14%)
Query: 32 SESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLH--ATNIVGIRLENMNLS 89
S+ ++ F ++V ++ WN NL S+ GI C+ + +V +RL + L
Sbjct: 31 SDEQALLNFAASVPHPP--KLNWNKNLSLCSSW--IGITCDESNPTSRVVAVRLPGVGLY 86
Query: 90 GIIDAETLCKLRHLRVVSLARNLIQGRIPTSI--------------------------SN 123
G I TL KL L+V+SL N + G +P+ I S
Sbjct: 87 GSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYLQHNNFSGELTTNSLPSI 146
Query: 124 CRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF---------------------- 161
++L L+LS N LSG +P L L + L + NN F
Sbjct: 147 SKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPIDSLDLPSVKVVNLSYNNL 206
Query: 162 AATSPDNFRQEIKYFDKYVVETSSSEINRASTVEARGLEDTQPPSVHNKSEHGEKRHWFR 221
+ P++ ++ +Y +N S + P N H +R +
Sbjct: 207 SGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSSNLPRPLTENL--HPVRRRQSK 264
Query: 222 NWMTIIPLAAGI-----GLVVLIAYCMGKKSAQIARDREILKALQDSPSKSPPQVMDIEE 276
++ I + + G+V L+ C+ KK+ + E ++ + PQ
Sbjct: 265 AYIIAIVVGCSVAVLFLGIVFLV--CLVKKTKKEEGGGEGVRTQMGGVNSKKPQDFGSGV 322
Query: 277 VRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKL 336
PE +++L FF F L+DLL+A+A++ + + + L+++ VKRL+++
Sbjct: 323 QDPE--KNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREV 380
Query: 337 QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKR 395
S EF Q M +G + +H N +PL+ Y + +EKLLVYKY + GSL ++ G R
Sbjct: 381 VASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGN-RGDR 439
Query: 396 DFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455
W+ R+ IATG +K + +++ HG++K SNILL E+ +P +S+
Sbjct: 440 GVDWETRMKIATGTSKAISYLHSLK-----FVHGDIKSSNILLTEDLEPCLSDTSLVTLF 494
Query: 456 D-PKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTV--------EKTGI 502
+ P T + GY APE + VS++ DV+SFGV++LE+LTGKT E+ I
Sbjct: 495 NLPTHTP--RTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVI 552
Query: 503 DLPKWVKAMVREEWTGEVFDKEVAKAG--RQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560
DLP+WV+++VREEWT EVFD E+ K + +L +AL CV+ +P+ RP M EV
Sbjct: 553 DLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARM 612
Query: 561 IEEV 564
IE+V
Sbjct: 613 IEDV 616
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (554), Expect = 1e-55, Method: Compositional matrix adjust.
Identities = 197/663 (29%), Positives = 305/663 (46%), Gaps = 131/663 (19%)
Query: 32 SESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCN--------LHATNIVG--- 80
++SE+ F DS L WN +PC + G+ CN L N+ G
Sbjct: 30 TDSETLLNFKLTADSTGKLN-SWN-TTTNPCQWT--GVSCNRNRVTRLVLEDINLTGSIS 85
Query: 81 ----------IRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130
+ L++ NLSG I L L L+++ L+ N G PTSI++ RL L
Sbjct: 86 SLTSLTSLRVLSLKHNNLSGPI--PNLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRL 143
Query: 131 NLSSNLLSGAVP----------------------LALTKLKHLKTLDISNNHFAATSPDN 168
+LS N SG +P + L L+ ++S N+F P++
Sbjct: 144 DLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNS 203
Query: 169 FRQEIKYFDKYVV----------------------------ETSSSEINRASTVEARGLE 200
Q F + V E +S +N+ TV +
Sbjct: 204 LSQ----FPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPS---- 255
Query: 201 DTQPPSVHNKSEHGEKRHWFRNWMTIIPLAAGIG-------LVVLIAYCM-------GKK 246
P S+H G+K + TI +A +G + +L+ YC KK
Sbjct: 256 --SPTSIHG----GDKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKK 309
Query: 247 SAQIARDREILKALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEATA 306
++I +I+ + P+ + ++V + ++VFF + RF+L+DLL A+A
Sbjct: 310 HSKILEGEKIVYSSNPYPTSTQNNNNQNQQVG---DKGKMVFFEGTR-RFELEDLLRASA 365
Query: 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCY 364
++ + + + L++ AVKRLK EF Q M +G L+H N++ L Y
Sbjct: 366 EMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAY 425
Query: 365 NSTNEEKLLVYKYQSNGSLLSLLEA-YIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEE 423
EEKLLVY Y NGSL LL G+ W RL IA G A+GL F++
Sbjct: 426 YFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTL 485
Query: 424 KTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQG 479
K + HG++K +N+LL+ + + +S+ G S F P +T + SNGY APE + +++
Sbjct: 486 K-LTHGDIKSTNVLLDRSGNARVSDFGLSIFA-PSQT-VAKSNGYRAPELIDGRKHTQKS 542
Query: 480 DVFSFGVILLELLTGK--TVEKTG-----IDLPKWVKAMVREEWTGEVFDKEVA--KAGR 530
DV+SFGV+LLE+LTGK + +TG +DLP+WV+++VREEWT EVFD E+ K
Sbjct: 543 DVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIE 602
Query: 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERD--RDHSNSSFSSMESIPH 588
+ LL +A+ C + + D RP M V++ IE++ G E D NS+ S +
Sbjct: 603 EEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIRGGGSEASPCNDGINSAVDS-PCLSE 661
Query: 589 DSC 591
D+C
Sbjct: 662 DTC 664
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FMD7|Y5659_ARATH Probable inactive receptor kinase At5g16590 OS=Arabidopsis thaliana GN=At5g16590 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (550), Expect = 4e-55, Method: Compositional matrix adjust.
Identities = 162/578 (28%), Positives = 273/578 (47%), Gaps = 77/578 (13%)
Query: 54 WNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLI 113
WN P PC++ G++C + + +RL + LSG + + L L +S N +
Sbjct: 46 WNLTAP-PCTWG--GVQC--ESGRVTALRLPGVGLSGPLPI-AIGNLTKLETLSFRFNAL 99
Query: 114 QGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEI 173
G +P +N L YL L N SG +P L L ++ ++++ N+F PDN
Sbjct: 100 NGPLPPDFANLTLLRYLYLQGNAFSGEIPSFLFTLPNIIRINLAQNNFLGRIPDNVNSAT 159
Query: 174 KYFDKYVVE------------------TSSSEINRASTVEARGLEDT---------QPPS 206
+ Y+ + SS+++N + G+ T +P
Sbjct: 160 RLATLYLQDNQLTGPIPEIKIKLQQFNVSSNQLNGSIPDPLSGMPKTAFLGNLLCGKPLD 219
Query: 207 VH--NKSEHGEKRHWFRNWMTIIPLAAGIGLVV------------LIAYCMGKKSAQIAR 252
N + +G + + A +G+V+ + C KK Q+ +
Sbjct: 220 ACPVNGTGNGTVTPGGKGKSDKLSAGAIVGIVIGCFVLLLVLFLIVFCLCRKKKKEQVVQ 279
Query: 253 DREILKALQDSPSKS-------PPQVM------DIEEVRPEVRRSELVFFVNEKERFKLD 299
R I A + S + PP V+ + P +L FFV F LD
Sbjct: 280 SRSIEAAPVPTSSAAVAKESNGPPAVVANGASENGVSKNPAAVSKDLTFFVKSFGEFDLD 339
Query: 300 DLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNIL 359
LL+A+A++ + S + + V AVKRL+ + V EF + ++ +G++ H N++
Sbjct: 340 GLLKASAEVLGKGTFGSSYKASFDHGLVVAVKRLRDVVVPEKEFREKLQVLGSISHANLV 399
Query: 360 PLVCYNSTNEEKLLVYKYQSNGSLLSLLEA-YIEGKRDFPWKLRLSIATGIAKGLDFMYQ 418
L+ Y + +EKL+V++Y S GSL +LL G+ W+ R +IA G A+ + +++
Sbjct: 400 TLIAYYFSRDEKLVVFEYMSRGSLSALLHGNKGSGRSPLNWETRANIALGAARAISYLHS 459
Query: 419 KSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKT---- 474
+ + T HGN+K SNILL+E+ + +S+ + + P T +GY APE T
Sbjct: 460 R---DATTSHGNIKSSNILLSESFEAKVSDYCLAPMISPTSTP-NRIDGYRAPEVTDARK 515
Query: 475 VSEQGDVFSFGVILLELLTGKT-----VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA- 528
+S++ DV+SFGV++LELLTGK+ + + G+DLP+WV ++ ++ +VFD E+ +
Sbjct: 516 ISQKADVYSFGVLILELLTGKSPTHQQLHEEGVDLPRWVSSITEQQSPSDVFDPELTRYQ 575
Query: 529 --GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564
+ LLN+ + C + PD RPTM EV IEEV
Sbjct: 576 SDSNENMIRLLNIGISCTTQYPDSRPTMPEVTRLIEEV 613
|
Might be involved in early recognition of growth promoting fungi. Appears to be specific for P.indica. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FK10|Y5332_ARATH Probable inactive receptor kinase At5g53320 OS=Arabidopsis thaliana GN=At5g53320 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (547), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 168/589 (28%), Positives = 291/589 (49%), Gaps = 62/589 (10%)
Query: 14 ICIAILPRLFTGCVGGEL--SESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKC 71
+ + ++ +F C+ E + + +F++ ++ + L W+ +L + G+ C
Sbjct: 5 VVLILIVVIFNVCIEAETIKEDKHTLLQFVNNINHSHSLN--WSPSLSICTKWT--GVTC 60
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLN 131
N +++ + L L G I+ + +L +LR + L+ N I G PT++ + LT L
Sbjct: 61 NSDHSSVDALHLAATGLRGDIELSIIARLSNLRFLILSSNNISGTFPTTLQALKNLTELK 120
Query: 132 LSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKY------FDKYVVETSS 185
L N SG +P L+ + L+ LD+SNN F + P + + ++K+ E
Sbjct: 121 LDFNEFSGPLPSDLSSWERLQVLDLSNNRFNGSIPSSIGKLTLLHSLNLAYNKFSGEIPD 180
Query: 186 SEIN--RASTVEARGLEDTQPPS---------VHNKS----EHGEKRHWFRNWMTIIPLA 230
I + + L T P S V NK ++H + ++ +A
Sbjct: 181 LHIPGLKLLNLAHNNLTGTVPQSLQRFPLSAFVGNKVLAPVHSSLRKHTKHHNHVVLGIA 240
Query: 231 AGIGLVVLIAYCMGKKSAQIARDREILKALQDSPSK----SPPQVMDIEEVRPEVRRSEL 286
+ +L + R+ E ++ +D PSK S P V + + +++
Sbjct: 241 LSVCFAILALLAILLVIIIHNRE-EQRRSSKDKPSKRRKDSDPNVGEGD--------NKI 291
Query: 287 VFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQT 346
VFF + F L+DLL A+A++ + + + V L++SA VKR+K++ V EF Q
Sbjct: 292 VFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYKVDLEDSATIVVKRIKEVSVPQREFEQQ 351
Query: 347 MRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRD---FPWKLRL 403
+ IG++KH N+ L Y + +EKL+VY Y +GSL +LL +G RD W+ RL
Sbjct: 352 IENIGSIKHENVATLRGYFYSKDEKLVVYDYYEHGSLSTLLHGQ-KGLRDRKRLEWETRL 410
Query: 404 SIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD--PKKTC 461
++ G A+G+ ++ +S + + HGN+K SNI LN IS G + + P+
Sbjct: 411 NMVYGTARGVAHIHSQSGGK--LVHGNIKSSNIFLNGKGYGCISGTGMATLMHSLPRHAV 468
Query: 462 LFSSNGYTAPEKTVSEQG----DVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT 517
GY APE T + +G DV+SFG+++ E+LTGK+ +L +WV ++VREEWT
Sbjct: 469 -----GYRAPEITDTRKGTQPSDVYSFGILIFEVLTGKS---EVANLVRWVNSVVREEWT 520
Query: 518 GEVFDKEVAKAGR--QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564
GEVFD+E+ + + + +L V + C + P+ RP M EV+ +EE+
Sbjct: 521 GEVFDEELLRCTQVEEEMVEMLQVGMVCTARLPEKRPNMIEVVRMVEEI 569
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 608 | ||||||
| 224114439 | 612 | predicted protein [Populus trichocarpa] | 0.983 | 0.977 | 0.588 | 0.0 | |
| 147783407 | 506 | hypothetical protein VITISV_003520 [Viti | 0.825 | 0.992 | 0.488 | 1e-145 | |
| 357494803 | 575 | Leucine-rich repeat receptor-like protei | 0.878 | 0.928 | 0.497 | 1e-137 | |
| 255576304 | 489 | serine-threonine protein kinase, plant-t | 0.476 | 0.593 | 0.485 | 8e-77 | |
| 359491256 | 976 | PREDICTED: receptor-like protein kinase | 0.888 | 0.553 | 0.332 | 2e-74 | |
| 359494163 | 473 | PREDICTED: probable inactive receptor ki | 0.491 | 0.632 | 0.512 | 2e-73 | |
| 356518991 | 589 | PREDICTED: probable inactive receptor ki | 0.825 | 0.852 | 0.335 | 9e-68 | |
| 302804855 | 606 | hypothetical protein SELMODRAFT_156455 [ | 0.835 | 0.838 | 0.320 | 9e-67 | |
| 302780982 | 580 | hypothetical protein SELMODRAFT_267563 [ | 0.840 | 0.881 | 0.340 | 3e-66 | |
| 359488856 | 610 | PREDICTED: probable inactive receptor ki | 0.855 | 0.852 | 0.321 | 7e-66 |
| >gi|224114439|ref|XP_002316760.1| predicted protein [Populus trichocarpa] gi|222859825|gb|EEE97372.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1837), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/619 (58%), Positives = 457/619 (73%), Gaps = 21/619 (3%)
Query: 2 RGSKLFLFLEGLICIAILPRLFTGCVGGELSESESFFKFISAVDSQNVLRIGWNGNLPHP 61
R +L L+ L I + T C GGELSE+ESFF F+ A+D QNVLRI W+G +PHP
Sbjct: 3 RRRNCYLLLKALAHITVF-FFITACSGGELSETESFFTFMRAIDPQNVLRISWSGIVPHP 61
Query: 62 CSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI 121
CSY +G+KCN I IRL+ N +G IDA++LC L+HL+V+SLA+N IQG IP SI
Sbjct: 62 CSYRWRGVKCNFQPPAITQIRLDRQNFTGTIDADSLCGLQHLQVLSLAKNHIQGNIPHSI 121
Query: 122 SNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYFDKYVV 181
NCR LTYLNLSSN L+G VP+ L KLK+L+TLDISNN+ P E K+ + Y +
Sbjct: 122 LNCRSLTYLNLSSNFLTGRVPVPLFKLKYLRTLDISNNYLTVIIPRP-ELEFKHLNHYSM 180
Query: 182 ETSSSEINRA------------STVEARGLEDTQPPSVHNKSEHGEKRHWFRNWMTIIPL 229
+ S+ ++ ++ +A +E PS +K G KR W+ + ++PL
Sbjct: 181 KHSAVKMYNLQKLAIVADSVALNSTDAGSVEHPADPSNGSKPGSG-KRKWYDKAIYVVPL 239
Query: 230 AAGIGLVVLIAYCMGKKSAQIARDREILKALQDSPSKSPPQVMDIEEVRPEVRRSELVFF 289
A GI + ++AY + K+ + A++REILK+L SP K+PP V E+++P+ R SELVFF
Sbjct: 240 AFGIVFLSVLAYFVNKRFSDSAKEREILKSLAHSPQKTPPPVPQ-EDLKPKERCSELVFF 298
Query: 290 VNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQ 349
V EKERF LDDL EATADL+SQT SSL+ V+L N VYAVKRLKKLQVS +EF QTMRQ
Sbjct: 299 VEEKERFGLDDLFEATADLQSQTPSSSLYKVKLGN-IVYAVKRLKKLQVSFEEFGQTMRQ 357
Query: 350 IGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGI 409
IGNLKHPNILPLV YNST+EEKLL+YKYQS+GSLL+LLE YIEGKR+FPWK RLSIA GI
Sbjct: 358 IGNLKHPNILPLVGYNSTDEEKLLIYKYQSSGSLLNLLEDYIEGKREFPWKHRLSIAIGI 417
Query: 410 AKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYT 469
A+GLDF+Y+ E + PHGN+KLSNILL+EN++PLISE G+S FLDPK+ FSSNGYT
Sbjct: 418 ARGLDFIYRNPIEHEIKPHGNIKLSNILLDENQEPLISEYGFSTFLDPKRVWSFSSNGYT 477
Query: 470 APEKTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529
APEK +SEQGDVFSFG+I+LELLTGKTVEK+GIDLPKWV+++VREEWTGEVFDKE A
Sbjct: 478 APEKILSEQGDVFSFGIIMLELLTGKTVEKSGIDLPKWVRSIVREEWTGEVFDKEFNHAA 537
Query: 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHSNSSFSSMESIPHD 589
RQ+AFPLL ++LKCVS SP++RP M EV+E+IEEVVN N+E + SS S+ S P +
Sbjct: 538 RQYAFPLLIISLKCVSKSPEERPPMGEVMEKIEEVVNANEE----FTISSMGSILSSPPE 593
Query: 590 SCLLHTVIQENWDTPRSSY 608
C+LH+VI E WDTP S+Y
Sbjct: 594 WCILHSVIPETWDTPGSNY 612
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147783407|emb|CAN75219.1| hypothetical protein VITISV_003520 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 521 bits (1342), Expect = e-145, Method: Compositional matrix adjust.
Identities = 298/610 (48%), Positives = 374/610 (61%), Gaps = 108/610 (17%)
Query: 1 MRGSKLF-LFLEGLICIAILPRLFTGCVGGELSESESFFKFISAVDSQNVLRIGWNGNLP 59
M+ + F L + LI + L C GG+L +S+ FF FI AVD +N+L IGWNG+LP
Sbjct: 1 MKSRREFNLVFKMLIWVVFSSLLVMVCEGGQLLKSQFFFNFIQAVDPENILGIGWNGSLP 60
Query: 60 HPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPT 119
HPC KG+KCN A IV IRLEN+NLSGIIDA++LCKL LRVVSLA+NLI G
Sbjct: 61 HPCMLQRKGVKCNSQAEAIVDIRLENLNLSGIIDADSLCKLPFLRVVSLAKNLIPG---- 116
Query: 120 SISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYFDKY 179
KH S H D F E + F+
Sbjct: 117 -----------------------------KH------SRVHITLHKLDLFESEQQSFEWE 141
Query: 180 VVETSSSEINRASTVEARGLEDTQPPSVHNKSEHGEKRH--WFRNWMTIIPLAAGIGLVV 237
S + S Q PS K E E RH R W + P+ IG +
Sbjct: 142 CAWGSDWSLVTMS----------QGPS--PKPETSEARHEKGIRIWASYAPVVICIGFFL 189
Query: 238 LIAYCMGKKSAQIARDREILKALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKERFK 297
L A+ + KK+ + A+++EILK+L SP KSP + +EV+PE SELVFFV E RF+
Sbjct: 190 LFAFFVNKKAVRSAKEKEILKSLGASPLKSP-RTKTTDEVKPEKACSELVFFVGEHARFR 248
Query: 298 LDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPN 357
L+DLLE+ ADL+SQ++C S++Y
Sbjct: 249 LEDLLESAADLQSQSLC----------SSLY----------------------------- 269
Query: 358 ILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMY 417
EEKLL+Y YQ NGSL +LLE YIEG+R+FPW+ RLSIA GIA+GLDF++
Sbjct: 270 ----------KEEKLLIYNYQRNGSLQTLLENYIEGQREFPWRHRLSIACGIARGLDFIH 319
Query: 418 QKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTVSE 477
QK++ ++IPHG +KLSNILLNENE+PLISE GYSKFLDPK L+SSNGYTAPE+ +SE
Sbjct: 320 QKTDHWESIPHGGIKLSNILLNENEEPLISEYGYSKFLDPKTASLYSSNGYTAPERRLSE 379
Query: 478 QGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537
+GDVFSFGVILLELLTGKTVEK+ +DLPKWVK+MVREEWTGEVFDKEV +A +QWAFP+L
Sbjct: 380 EGDVFSFGVILLELLTGKTVEKSALDLPKWVKSMVREEWTGEVFDKEVNRAAKQWAFPML 439
Query: 538 NVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHSNSSFSSMESIPHDSCLLHTVI 597
N++LKCV++ P++RP++AEVLE+IEEVVN + D S SS+ES D CLLHTVI
Sbjct: 440 NISLKCVAHFPENRPSVAEVLEKIEEVVNAQGDIDA----SPDSSIESNYQDGCLLHTVI 495
Query: 598 QENWDTPRSS 607
E WDTP S+
Sbjct: 496 PETWDTPGSN 505
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357494803|ref|XP_003617690.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355519025|gb|AET00649.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1278), Expect = e-137, Method: Compositional matrix adjust.
Identities = 284/571 (49%), Positives = 381/571 (66%), Gaps = 37/571 (6%)
Query: 41 ISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKL 100
+ A+DS NVL I + HPC N G++CN +ATNI+ IRL+NMNLSGI DA++LC+L
Sbjct: 39 LKAIDSNNVLNIS---KISHPCLIN--GVRCNSNATNILEIRLDNMNLSGIFDADSLCRL 93
Query: 101 RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVP-LALTKLKHLKTLDISNN 159
+ L+VVSLA N I+G I SI +C RL YLN+S+N LSG P ALT+LK+L LD+S N
Sbjct: 94 QKLKVVSLANNNIKGTISFSILHCTRLVYLNVSNNQLSGRFPNKALTRLKYLTNLDVSMN 153
Query: 160 HFAATSPDNFRQEIKYFDKYVVETSSSEINRASTVEARGLEDTQPPSVHNKSEHGEKRHW 219
+F+ + Y ++ S+ I + L + P + ++ E
Sbjct: 154 NFSTS----------YMAPISIKLESNTIQPTPS----PLTNKTPKNATSEIE------- 192
Query: 220 FRNWMTIIPLAAGIGLVVLIAYCMGKKSAQIARDREILKALQDSPSKSPPQVMDIEEVRP 279
++ L GIGL++ Y M KKS+++ + E+ K DSP K ++
Sbjct: 193 -----IMVGLVLGIGLLLSSLYFMIKKSSKLMGEIEVKKNNLDSPMKKATSEGRLK--GG 245
Query: 280 EVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS 339
+ SELVFFV + ERFKL+DLL ATADLRS+ SSLF V+ +N+ YAVKRLK LQVS
Sbjct: 246 DNNNSELVFFVEDHERFKLEDLLRATADLRSENFWSSLFKVKFENNVEYAVKRLKNLQVS 305
Query: 340 MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPW 399
DEF + ++QI +KH NIL LV Y ST EEKL++YKYQSNGS+L+LL YI ++DFPW
Sbjct: 306 CDEFREILKQISKVKHQNILSLVGYRSTKEEKLIIYKYQSNGSVLNLLNDYIARRKDFPW 365
Query: 400 KLRLSIATGIAKGLDFMYQK--SNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457
KLRL+IA GIA+GL F+Y+K E +IPHGNLKLSNILL++ + LISE G SKF +P
Sbjct: 366 KLRLNIACGIARGLAFIYKKLEEGEVNSIPHGNLKLSNILLDDKNEALISEHGLSKFFEP 425
Query: 458 KKTCLFSSNGYTAPEKTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT 517
+ FSS+GYTAPEK+++E+GDV+SFGVILLELLTG+++E + IDL +WV++MVREEWT
Sbjct: 426 DRGTFFSSHGYTAPEKSLTEKGDVYSFGVILLELLTGQSIEVSRIDLVRWVRSMVREEWT 485
Query: 518 GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHSN 577
GEVFDKEV + Q AF LLN+AL CVS S ++RP E+LE IE V+N +D++ + S
Sbjct: 486 GEVFDKEVRENDHQGAFSLLNIALMCVSRSQENRPNFGEILETIEGVMNAHDQQQMELSA 545
Query: 578 SSFSSMESIPHDSCLLHTVIQENWDTPRSSY 608
S S S + C LH +I + WD+P S+Y
Sbjct: 546 SKCCSNGS-NQECCSLHQIIPDTWDSPGSNY 575
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255576304|ref|XP_002529045.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223531525|gb|EEF33356.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 294 bits (753), Expect = 8e-77, Method: Compositional matrix adjust.
Identities = 152/313 (48%), Positives = 215/313 (68%), Gaps = 23/313 (7%)
Query: 22 LFTGCVGGELSESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGI 81
L T C+GGELSE+E+FF FI AVD +NVL I NG + +PCSY+ KG+KCNL T I I
Sbjct: 21 LITACLGGELSETEAFFSFIRAVDPENVLGISLNGKVTNPCSYDQKGVKCNLQETTITEI 80
Query: 82 RLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAV 141
RLE++NLSG+IDA++LCKL++L+V+SL++NLI G IP SIS CRRL YL+LS NLLSG V
Sbjct: 81 RLESLNLSGVIDADSLCKLQNLQVLSLSKNLICGNIPDSISTCRRLAYLDLSHNLLSGKV 140
Query: 142 PLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYFDKYVVETSSSEINRA----STVEAR 197
PLALTKLKHL+ LDISNN+F + P + + E ++ D Y ++ +S+ + + S V++
Sbjct: 141 PLALTKLKHLRILDISNNNFTGSIPLS-KLEFEHPDNYSLKETSTRLYKLRKLFSVVDSE 199
Query: 198 GL---------EDTQPPSVHNKSEHGEKRHWFRNWMTIIPLAAGIGLVV---LIAYCMGK 245
E +QPP+ K+ W++ + ++P GI ++ L+ Y +
Sbjct: 200 ATDGSNNNMVEESSQPPTSSEP-----KKEWYKQLIDLLPFIIGIAFIILFFLVVYSVTA 254
Query: 246 KSAQIARDREILKALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEAT 305
K ++A+++E+LK+L SP +PP V EEV+P+ R+ELVFFV E+E FK+DDL EAT
Sbjct: 255 KVTKVAKEKELLKSLARSPQNNPPPVPK-EEVKPDEGRTELVFFVEEQETFKMDDLFEAT 313
Query: 306 ADLRSQTICSSLF 318
ADL+S T+ SSL+
Sbjct: 314 ADLQSHTLYSSLY 326
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491256|ref|XP_003634250.1| PREDICTED: receptor-like protein kinase HSL1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 286 bits (732), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 206/619 (33%), Positives = 312/619 (50%), Gaps = 79/619 (12%)
Query: 36 SFFKFISAVDSQNVLR---IGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGII 92
S +F++ + N R GWN N PC+ +G+ C+ + + + L+ +NL GI+
Sbjct: 30 SLIQFMTNISPGNAGRGSNWGWNMN-SDPCTDKWEGVTCDSQSKFVRKVILDGLNLDGIL 88
Query: 93 DAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLK 152
DA++LCK++ L V+SL N + G++ IS+C+RLT+L S N SG +P +L++L +LK
Sbjct: 89 DAKSLCKVKTLAVLSLNNNSVVGKLSEGISSCKRLTHLYASGNHFSGELPQSLSRLSNLK 148
Query: 153 TLDISNNHFAATSPD---------------NFRQEIKYFD-----KYVVET--------- 183
L ISNN+F+ PD EI FD ++ V
Sbjct: 149 RLHISNNNFSGVLPDLPRISGLISFLAQNNQLSGEIPKFDFSNLQQFNVSNNNFSGPIPD 208
Query: 184 -----SSSEINRASTVEARGLEDTQPPSVHNKSEHGEKRHWFRNWMTIIP-LAAGIGLVV 237
S+S + + L +T PPS+ S++G K + +T + G+ +V+
Sbjct: 209 VDGRFSASSFSGNPGLCGPPLSNTCPPSL--PSKNGSKGFSSKQLLTYSGYIILGLIIVL 266
Query: 238 LIAYCMGKKSAQIARDREILKALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEK---- 293
+ Y + +K E++K S S +++ RSE E
Sbjct: 267 FLFYKLFRKKRPKGEKVEVIKKGVSMESSSNKPSSVSSQLKTSDNRSEYSITSAEAGMTS 326
Query: 294 -----------ERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDE 342
+ +DLL A A+L + SL+ V L+N V AVKR+K +S +
Sbjct: 327 SSLTVLSSPVINGLRFEDLLRAPAELIGRGKHGSLYKVVLENKMVLAVKRIKDWGISSQD 386
Query: 343 FSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLR 402
F + M++I +KHPN+LP + + + +EKLLVY+YQ NGSL LL G+ F W R
Sbjct: 387 FKRRMQKIDQVKHPNVLPPLAFYCSKQEKLLVYEYQQNGSLFKLLYGTQNGEV-FEWGSR 445
Query: 403 LSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCL 462
L +A IA+ L FMY + +++ I HGNLK +NILL ++ DP ISE G D + L
Sbjct: 446 LGVAASIAEALAFMYSELHDD-GIAHGNLKSTNILLGKDMDPCISEYGLMVVEDQDQQFL 504
Query: 463 -----FSSNGYTAPEKTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT 517
SNG + + + DV+ FGVILLELLTGK V+ +G DL +WV +++REEWT
Sbjct: 505 AQAENLKSNGPSGYTAYSTFKVDVYGFGVILLELLTGKLVQNSGFDLARWVHSVLREEWT 564
Query: 518 GEVFDKE--VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDH 575
EVFDK + A + LL VALKC++ SP +RPT+ +V I + +E +R
Sbjct: 565 AEVFDKALILEGASEERMVNLLQVALKCINPSPGERPTINQVAGMINTI---KEEEER-- 619
Query: 576 SNSSFSSMESIPHDSCLLH 594
SI D L+H
Sbjct: 620 ---------SIQKDDILIH 629
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359494163|ref|XP_002276389.2| PREDICTED: probable inactive receptor kinase At2g26730 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 283 bits (724), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 161/314 (51%), Positives = 207/314 (65%), Gaps = 15/314 (4%)
Query: 8 LFLEGLICIAILPRLFTGCVGGELSESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLK 67
L + LI + L C GG+L +S+ FF FI AVD +N+L IGWNG+LPHPC K
Sbjct: 9 LAFKMLIWVVFSSLLVMVCEGGQLLKSQFFFNFIQAVDPENILGIGWNGSLPHPCMLQRK 68
Query: 68 GIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRL 127
G+KCN A IV IRLEN+NLSGIIDA++LCKL LRVVSLA+NLI+G IP SIS C L
Sbjct: 69 GVKCNSQAEAIVDIRLENLNLSGIIDADSLCKLPFLRVVSLAKNLIRGSIPESISLCTSL 128
Query: 128 TYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYFDKYVVETSSSE 187
TYLNLSSNLL+G+VP ALT +K+L++LDIS+NH PD FDK++ + S
Sbjct: 129 TYLNLSSNLLNGSVPGALTGMKNLRSLDISHNHLLGKIPD--------FDKHLYKFSLKS 180
Query: 188 INRASTVEARGLED-TQPPSVHNKSEHGEKRH--WFRNWMTIIPLAAGIGLVVLIAYCMG 244
N E R L +Q PS K E E RH R W + P+ IG +L A+ +
Sbjct: 181 -NEFLVNETRSLVTMSQGPS--PKPETSEARHEKGIRIWASYAPVVICIGFFLLFAFFVN 237
Query: 245 KKSAQIARDREILKALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEA 304
KK+ + A+++EILK+L SP KS P+ +EV+PE SELVFFV E RF+L+DLLE+
Sbjct: 238 KKAVRSAKEKEILKSLGASPLKS-PRTKTTDEVKPEKACSELVFFVGEHARFRLEDLLES 296
Query: 305 TADLRSQTICSSLF 318
ADL+SQ++CSSL+
Sbjct: 297 AADLQSQSLCSSLY 310
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356518991|ref|XP_003528158.1| PREDICTED: probable inactive receptor kinase At2g26730-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 264 bits (675), Expect = 9e-68, Method: Compositional matrix adjust.
Identities = 187/558 (33%), Positives = 275/558 (49%), Gaps = 56/558 (10%)
Query: 53 GWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNL 112
GWN N PC G+KC + + LE N G++DA ++C + LR++ L N+
Sbjct: 16 GWNLN-SDPCIDKWHGVKCYSDNKYVKSVILEKFNFGGVVDASSVCIAKSLRILRLTDNI 74
Query: 113 IQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPD----- 167
+ I I NC+ LT L LS N LSG +P+++ KL ++K L +S+NHF P+
Sbjct: 75 LHDSISEDIGNCQSLTQLFLSGNQLSGDLPISIGKLSNMKRLHVSDNHFTGELPNMVHVS 134
Query: 168 ----------NFRQEIKYFDKYVVETSSSEIN----RASTVEARGLEDT---------QP 204
NF EI FD ++ + N + V+ + ED+ +P
Sbjct: 135 GLISFFAQNNNFTGEIPSFDFSNLDAFNVSNNNLQGQVPDVKGKFHEDSFSGNPNLCGKP 194
Query: 205 PSVHNKSEHGEKRHWFRNWMTIIPLAAGIGLVVLIAYCMG-------KKSAQIARDREIL 257
S + ++ F N ++I +GL+VL+ K+ A +E+
Sbjct: 195 LSQECPPPEKKDQNSFPNDLSIYSGYLVLGLIVLLFLTFKLLSKLKIKEKALDVEKKEMA 254
Query: 258 KALQDSPSKSPPQVMDIEEVRPEVRRSE--------------LVFFVNEKER-FKLDDLL 302
+ K+ I V RSE LV + R + +DLL
Sbjct: 255 EETVSVAGKASEISNSIVSKNGTVIRSECSLTSLESGMTTSGLVLLSSRTLRGLQFEDLL 314
Query: 303 EATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLV 362
A A+L + SL+ V L N + AVKR+K +S +F + M I KHP +LP V
Sbjct: 315 GAPAELIRRGKHGSLYKVMLDNGVLLAVKRIKDWGISKQDFERRMNLIAQAKHPRVLPPV 374
Query: 363 CYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNE 422
Y + +EKLL Y+Y NGSL L G F W+ RL++A IA+ L +M+++
Sbjct: 375 AYYCSQQEKLLAYEYLQNGSLFMFLYGSQSG-HSFDWRSRLNVAANIAEALAYMHEEF-L 432
Query: 423 EKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTVSE-QGDV 481
E I HGNLK SNIL ++N DP ISE G + + + G + + + + DV
Sbjct: 433 ENGIGHGNLKSSNILFDKNMDPCISEYGLMMAENQDQLVPSHNKGLKSKDLIAATFKADV 492
Query: 482 FSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG--RQWAFPLLNV 539
+FG+ILLELLTGK ++ G DL KWV ++VREEWT EVFDK + G + LL V
Sbjct: 493 HAFGMILLELLTGKVIKNDGFDLVKWVNSVVREEWTVEVFDKSLISQGSSEEKMMCLLQV 552
Query: 540 ALKCVSNSPDDRPTMAEV 557
ALKCV+ SP+DRP+M++V
Sbjct: 553 ALKCVNPSPNDRPSMSQV 570
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302804855|ref|XP_002984179.1| hypothetical protein SELMODRAFT_156455 [Selaginella moellendorffii] gi|300148028|gb|EFJ14689.1| hypothetical protein SELMODRAFT_156455 [Selaginella moellendorffii] | Back alignment and taxonomy information |
|---|
Score = 261 bits (666), Expect = 9e-67, Method: Compositional matrix adjust.
Identities = 191/596 (32%), Positives = 289/596 (48%), Gaps = 88/596 (14%)
Query: 40 FISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCK 99
F ++ D N L NG+ PCS N G+KC I + LE + L+G + A L
Sbjct: 3 FKASADVSNRLTSWGNGD---PCSGNWTGVKC--VQGRIRYLILEGLELAGSMQA--LTA 55
Query: 100 LRHLRVVSLARNLIQG-----------------------RIPTSISNCRRLTYLNLSSNL 136
L+ LR+VSL N + G +P S+SN L LNLS N
Sbjct: 56 LQDLRIVSLKGNSLNGTLPDLTNWRYLWSLYLHHNNFSGELPPSLSNLVHLWRLNLSFNG 115
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPD-------------------------NFRQ 171
SG +P + + L TL + NN F+ PD NF
Sbjct: 116 FSGQIPPWINSSRRLLTLRLENNQFSGAIPDLRLVNLTEFNVANNRLSGEIPPSLRNFSG 175
Query: 172 EIKYFDKYVV--ETSSSEINRASTVEARGLEDTQPPSVHNKSEHGEKRHWFRNWMTIIPL 229
+ ++ ++ + A+ + +E+ P + ++ G + II +
Sbjct: 176 TAFLGNPFLCGGPLAACTVIPATPAPSPAVENIIPATPTSRPNEGRRTRSRLGTGAIIAI 235
Query: 230 AAG-------IGLVVLIAYCMGKKSAQIARDREILKALQDSPSKSPPQVMDIEEVRPEVR 282
G I LV L Y + + + I + S+ QV PE
Sbjct: 236 VVGDAAVLALIALVFLFFYWKRYQHMAVPSPKTIDEKTDFPASQYSAQV-------PEAE 288
Query: 283 RSELVFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS-MD 341
RS+LVF ++ F L+DLL A+A++ + + + L++ + AVKRLK + +S
Sbjct: 289 RSKLVFVDSKAVGFDLEDLLRASAEMLGKGSFGTAYKAVLEDGTIVAVKRLKDITISGRK 348
Query: 342 EFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEA-YIEGKRDFPWK 400
EF Q M I +HPN++ L+ Y EEKLLVY + NG+L +LL G++ W
Sbjct: 349 EFEQHMELIAKFRHPNVVKLIAYYYAKEEKLLVYDFMPNGNLYTLLHGNRGPGRKPLDWT 408
Query: 401 LRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT 460
R+ IA G AKGL F++++ +K IPHGN+K SN+LL+++ + I++ G + ++
Sbjct: 409 TRVKIALGAAKGLAFIHRQPGAQK-IPHGNIKSSNVLLDKDGNACIADFGLALLMNTAAA 467
Query: 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGK------TVEKTGIDLPKWVKA 510
GY APE K +S +GDV+SFGV+LLELLTGK T + IDLP+WV++
Sbjct: 468 SRLV--GYRAPEHAESKKISFKGDVYSFGVLLLELLTGKAPAQSHTTQGENIDLPRWVQS 525
Query: 511 MVREEWTGEVFDKEVAKAG--RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564
+VREEWT EVFD E+ K + +L V + CVS SPDDRP M++V++ IE++
Sbjct: 526 VVREEWTAEVFDIELMKYKNIEEEMVAMLQVGMVCVSQSPDDRPKMSQVVKMIEDI 581
|
Source: Selaginella moellendorffii Species: Selaginella moellendorffii Genus: Selaginella Family: Selaginellaceae Order: Selaginellales Class: Isoetopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302780982|ref|XP_002972265.1| hypothetical protein SELMODRAFT_267563 [Selaginella moellendorffii] gi|300159732|gb|EFJ26351.1| hypothetical protein SELMODRAFT_267563 [Selaginella moellendorffii] | Back alignment and taxonomy information |
|---|
Score = 259 bits (662), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 193/567 (34%), Positives = 285/567 (50%), Gaps = 56/567 (9%)
Query: 40 FISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCK 99
F ++ D N L NG+ PCS N G+KC I + LE + L+G + A L
Sbjct: 3 FKASADVSNRLTSWGNGD---PCSGNWTGVKC--VQGRIRYLILEGLELAGSMQA--LTA 55
Query: 100 LRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
L+ LR+VSL N + G +P ++N R L L L N SG +P +L+ L HL L++S N
Sbjct: 56 LQDLRIVSLKGNSLNGTLP-DLTNWRYLWSLYLHHNDFSGELPPSLSNLVHLWRLNLSFN 114
Query: 160 HFAATSPD---------NFRQEIKYFDKYVVETSSSEINRASTVEARGLEDTQPPSVHNK 210
F+ P R E F + + + + R L PPS+ N
Sbjct: 115 DFSGQIPPWINSSRRLLTLRLENNQFSGAIPDLRLVNLTEFNVANNR-LSGEIPPSLRNF 173
Query: 211 SEHGEKRHWFR-----NWMTIIPLAAGIGLVV--LIAYCMGKKSAQIARDREIL------ 257
S + F T+IP V +I + + R R L
Sbjct: 174 SGTAFLGNPFLCGGPLAACTVIPATPAPSPAVENIIPATPTSRPNEGRRTRSRLGTGAII 233
Query: 258 ------KALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQ 311
A D + P + PE RS+LVF ++ F L+DLL A+A++ +
Sbjct: 234 AIVVGDAATIDEKTDFPASQYSAQV--PEAERSKLVFVDSKAVGFDLEDLLRASAEMLGK 291
Query: 312 TICSSLFMVRLKNSAVYAVKRLKKLQVS-MDEFSQTMRQIGNLKHPNILPLVCYNSTNEE 370
+ + L++ + AVKRLK + +S EF Q M I +HPN++ L+ Y EE
Sbjct: 292 GSFGTAYKAVLEDGTIVAVKRLKDITISGRKEFEQHMELIAKFRHPNVVKLIAYYYAKEE 351
Query: 371 KLLVYKYQSNGSLLSLLEA-YIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHG 429
KLLVY + NG+L +LL G++ W R+ IA G AKGL F++++ +K IPHG
Sbjct: 352 KLLVYDFMPNGNLYTLLHGNRGPGRKPLDWTTRVKIALGAAKGLAFIHRQPGAQK-IPHG 410
Query: 430 NLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFG 485
N+K SN+LL+++ + I++ G + ++ GY APE K +S +GDV+SFG
Sbjct: 411 NIKSSNVLLDKDGNACIADFGLALLMNTAAASRLV--GYRAPEHAESKKISFKGDVYSFG 468
Query: 486 VILLELLTGK------TVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG--RQWAFPLL 537
V+LLELLTGK T + IDLP+WV+++VREEWT EVFD E+ K + +L
Sbjct: 469 VLLLELLTGKAPAQSHTTQGENIDLPRWVQSVVREEWTAEVFDIELMKYKNIEEEMVAML 528
Query: 538 NVALKCVSNSPDDRPTMAEVLERIEEV 564
V + CVS SPDDRP M++V++ IE++
Sbjct: 529 QVGMVCVSQSPDDRPKMSQVVKMIEDI 555
|
Source: Selaginella moellendorffii Species: Selaginella moellendorffii Genus: Selaginella Family: Selaginellaceae Order: Selaginellales Class: Isoetopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488856|ref|XP_002275088.2| PREDICTED: probable inactive receptor kinase At2g26730-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 258 bits (659), Expect = 7e-66, Method: Compositional matrix adjust.
Identities = 185/575 (32%), Positives = 279/575 (48%), Gaps = 55/575 (9%)
Query: 36 SFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAE 95
+F +S + Q GWN + PC G+ C+ ++ I L+ ++L+GI+D
Sbjct: 33 NFLGSLSGSNGQAAQAAGWNLD-TDPCLDGWNGVTCDKKNQSVQKISLDGLSLAGILDVG 91
Query: 96 TLCKLRHLRV----VSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHL 151
+LC + L +S+ N I G + I++C++L LN+S N SG +P +L L +L
Sbjct: 92 SLCTKQSLAASLNYLSVGNNSISGDVRKEIADCKQLARLNISGNRFSGKLPDSLPMLNNL 151
Query: 152 KTLDISNNHFAATSPDNFR-----------------------QEIKYFD------KYVVE 182
K LDISNNH + PD R ++ FD + +
Sbjct: 152 KKLDISNNHLSGDLPDLSRISGLTTFLAQNNQLTGKVPKLDFSNLEQFDVSNNLFRGPIP 211
Query: 183 TSSSEINRASTVEARGLEDTQPPSVHNKSEHGEKRHWFRNWMTIIPLAAGIGLVVLIAYC 242
N +S + GL P+ K E+ + + I+ + + + V+ C
Sbjct: 212 DVEDRFNESSFLGNPGLCGDPLPNKCPKKVSKEEFLMYSGYALIVLV---LIMFVVFRLC 268
Query: 243 MGKKSAQIARDREILKALQDSPSKSPPQVMDIEEVRPE----VRRSELVFFVNEK-ERFK 297
+ + + A+ DS K+ D + + V + LV + K
Sbjct: 269 KRRTKEEKVDATNKIVAVDDSGYKTGLSRSDFSVISGDQSALVSSTSLVVLTSPVVNGLK 328
Query: 298 LDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPN 357
+DLL A A+L + SL+ V VKR+K +S DEF + M++I +KHPN
Sbjct: 329 FEDLLTAPAELLGRGKHGSLYKVIFDKRMTLVVKRIKDWAISSDEFKKRMQRIDQVKHPN 388
Query: 358 ILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMY 417
+LP + + + EKLL+Y+YQ NGSL LL G + W RL++A IA+ L FM+
Sbjct: 389 VLPALAFYCSKLEKLLIYEYQQNGSLFQLL----SGDQPLGWSSRLNLAATIAEALAFMH 444
Query: 418 QKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTVSE 477
Q+ + + I HGNLK SNILLN N P ISE G + + L ++N A E+T +
Sbjct: 445 QELHSD-GIAHGNLKSSNILLNRNMVPCISEYGLREADSKELPSLSATNSRRAIEQTGAT 503
Query: 478 ------QGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531
D+++FGVILLELLTGK V+ + DL +WV + VREEWT EVFDK + G
Sbjct: 504 SSNSTFNADIYAFGVILLELLTGKLVQNSEFDLARWVHSAVREEWTVEVFDKRLISHGAS 563
Query: 532 WA--FPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564
A LL A+KCV+ SP+ RPTM +V I +
Sbjct: 564 EARMVDLLQAAIKCVNRSPETRPTMRKVAYMINAI 598
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 608 | ||||||
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.534 | 0.507 | 0.348 | 5.4e-59 | |
| TAIR|locus:2198090 | 655 | RKL1 "receptor-like kinase 1" | 0.465 | 0.432 | 0.375 | 1.4e-58 | |
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.491 | 0.462 | 0.361 | 1.1e-56 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.649 | 0.589 | 0.337 | 4.8e-56 | |
| TAIR|locus:2128156 | 676 | AT4G31250 [Arabidopsis thalian | 0.468 | 0.421 | 0.366 | 7.2e-55 | |
| TAIR|locus:2044913 | 672 | AT2G36570 [Arabidopsis thalian | 0.345 | 0.312 | 0.436 | 4.6e-54 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.796 | 0.756 | 0.290 | 2.4e-53 | |
| TAIR|locus:2063621 | 647 | PRK2A "AT2G07040" [Arabidopsis | 0.768 | 0.721 | 0.259 | 2.8e-52 | |
| TAIR|locus:2154227 | 601 | AT5G53320 [Arabidopsis thalian | 0.868 | 0.878 | 0.282 | 2.4e-51 | |
| TAIR|locus:2128414 | 638 | AT4G23740 [Arabidopsis thalian | 0.764 | 0.728 | 0.316 | 1.1e-50 |
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 497 (180.0 bits), Expect = 5.4e-59, Sum P(2) = 5.4e-59
Identities = 120/344 (34%), Positives = 180/344 (52%)
Query: 235 LVVLIAYCMGKKSAQIARDREILKALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKE 294
++ +I C KK + KA P +S + + E +++LVFF
Sbjct: 276 ILAIITLCCAKKRDGGQDSTAVPKA---KPGRSDNKAEEFGSGVQEAEKNKLVFFEGSSY 332
Query: 295 RFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK 354
F L+DLL A+A++ + + + L+ VKRLK++ EF Q M +G +
Sbjct: 333 NFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVAAGKREFEQQMEAVGRIS 392
Query: 355 -HPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRD-FPWKLRLSIATGIAKG 412
H N+ PL Y + +EKLLVY Y G+ LL EG R W+ RL I A+G
Sbjct: 393 PHVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARG 452
Query: 413 LDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE 472
+ ++ S + + HGN+K N+LL + +S+ G + + S GY APE
Sbjct: 453 ISHIHSASGAK--LLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPE 510
Query: 473 ----KTVSEQGDVFSFGVILLELLTGKTVEKT-G----IDLPKWVKAMVREEWTGEVFDK 523
+ +++ DV+SFGV+LLE+LTGK KT G +DLPKWV+++VREEWTGEVFD
Sbjct: 511 AIETRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDV 570
Query: 524 EVAKAGR---QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564
E+ K + +L +A+ CVS PD RP+M EV+ +EE+
Sbjct: 571 ELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEI 614
|
|
| TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 508 (183.9 bits), Expect = 1.4e-58, Sum P(2) = 1.4e-58
Identities = 113/301 (37%), Positives = 177/301 (58%)
Query: 285 ELVFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFS 344
+LVFF N + F L+DLL A+A++ + + + L V AVKRLK + ++ EF
Sbjct: 353 KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVMMADKEFK 412
Query: 345 QTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYI-EGKRDFPWKLRL 403
+ + +G + H N++PL Y + +EKLLVY + GSL +LL G+ W +R
Sbjct: 413 EKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRS 472
Query: 404 SIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLF 463
IA G A+GLD+++ + HGN+K SNILL ++ D +S+ G ++ + T
Sbjct: 473 RIAIGAARGLDYLHSQGTSTS---HGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPN 529
Query: 464 SSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKT-----VEKTGIDLPKWVKAMVRE 514
+ GY APE K VS++GDV+SFGV+LLEL+TGK + + G+DLP+WVK++ R+
Sbjct: 530 RATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVKSVARD 589
Query: 515 EWTGEVFDKEV---AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV--VNGND 569
EW EVFD E+ A + ++ + L+C S PD RP M+EV+ ++E + +G+D
Sbjct: 590 EWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLRPYSGSD 649
Query: 570 E 570
+
Sbjct: 650 Q 650
|
|
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 487 (176.5 bits), Expect = 1.1e-56, Sum P(2) = 1.1e-56
Identities = 116/321 (36%), Positives = 178/321 (55%)
Query: 267 SPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSA 326
SP V +E +++ LVFF N + F L+DLL A+A++ + + + L
Sbjct: 331 SPSAVKAVEVNSSGMKK--LVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVT 388
Query: 327 VYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386
+ AVKRLK + ++ EF + + +G + H N++PL Y + +EKLLVY + GSL +L
Sbjct: 389 LVAVKRLKDVTMADREFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLSAL 448
Query: 387 LEAYI-EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
L G+ W++R IA G A+GLD+++ +++ HGN+K SNILL + D
Sbjct: 449 LHGNKGAGRPPLNWEVRSGIALGAARGLDYLH---SQDPLSSHGNVKSSNILLTNSHDAR 505
Query: 446 ISECGYSKFLDPKKTCLFSSNGYTAPEKT----VSEQGDVFSFGVILLELLTGKT----- 496
+S+ G ++ + T + GY APE T VS++ DV+SFGV+LLELLTGK
Sbjct: 506 VSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSV 565
Query: 497 VEKTGIDLPKWVKAMVREEWTGEVFDKE------VAKAGRQWAFPLLNVALKCVSNSPDD 550
+ + G+DL +WV ++ REEW EVFD E V + A +L + + C PD
Sbjct: 566 MNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMA-EMLQLGIDCTEQHPDK 624
Query: 551 RPTMAEVLERIEEVVNGNDER 571
RP M EV+ RI+E+ +R
Sbjct: 625 RPVMVEVVRRIQELRQSGADR 645
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 507 (183.5 bits), Expect = 4.8e-56, Sum P(2) = 4.8e-56
Identities = 148/439 (33%), Positives = 232/439 (52%)
Query: 182 ETSSSEINRASTVEARGLEDTQPPSVHNKSEHGEKRHWFRNWMTIIPLAAGIG------- 234
E +S +N+ TV + P S+H G+K + TI +A +G
Sbjct: 241 EAKASPLNKPETVPS------SPTSIHG----GDKSNNTSRISTISLIAIILGDFIILSF 290
Query: 235 LVVLIAYCMGKKSA-QIARDREILKA--LQDSPSKSPPQVMDIEEVRPEVR-RSELVFFV 290
+ +L+ YC ++ A + +IL+ + S + P + +V + ++VFF
Sbjct: 291 VSLLLYYCFWRQYAVNKKKHSKILEGEKIVYSSNPYPTSTQNNNNQNQQVGDKGKMVFFE 350
Query: 291 NEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKK-LQVS-MDEFSQTMR 348
+ RF+L+DLL A+A++ + + + L++ AVKRLK + V+ EF Q M
Sbjct: 351 GTR-RFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQME 409
Query: 349 QIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYI-EGKRDFPWKLRLSIAT 407
+G L+H N++ L Y EEKLLVY Y NGSL LL G+ W RL IA
Sbjct: 410 VLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA 469
Query: 408 GIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG 467
G A+GL F++ K + HG++K +N+LL+ + + +S+ G S F P +T + SNG
Sbjct: 470 GAARGLAFIHGSCKTLK-LTHGDIKSTNVLLDRSGNARVSDFGLSIFA-PSQT-VAKSNG 526
Query: 468 YTAPE----KTVSEQGDVFSFGVILLELLTGK--TVEKTG-----IDLPKWVKAMVREEW 516
Y APE + +++ DV+SFGV+LLE+LTGK + +TG +DLP+WV+++VREEW
Sbjct: 527 YRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSVVREEW 586
Query: 517 TGEVFDKEVA--KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERD-- 572
T EVFD E+ K + LL +A+ C + + D RP M V++ IE++ G E
Sbjct: 587 TAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIRGGGSEASPC 646
Query: 573 RDHSNSSFSSMESIPHDSC 591
D NS+ S + D+C
Sbjct: 647 NDGINSAVDS-PCLSEDTC 664
|
|
| TAIR|locus:2128156 AT4G31250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 452 (164.2 bits), Expect = 7.2e-55, Sum P(2) = 7.2e-55
Identities = 112/306 (36%), Positives = 173/306 (56%)
Query: 275 EEVRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLK 334
E+ R + R+ L F N++ERF L D+L A+A++ S + L + VKR +
Sbjct: 340 EDKRGDQRK--LHFVRNDQERFTLQDMLRASAEVLGSGGFGSSYKAALSSGRAVVVKRFR 397
Query: 335 KLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAY-IE 392
+ + +EF M++IG L HPN+LPL+ + EEKLLV Y SNGSL +LL A
Sbjct: 398 FMSNIGREEFYDHMKKIGRLSHPNLLPLIAFYYRKEEKLLVTNYISNGSLANLLHANRTP 457
Query: 393 GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452
G+ W +RL I G+ +GL ++Y+ + +PHG+LK SN+LL+ N +PL+++
Sbjct: 458 GQVVLDWPIRLKIVRGVTRGLAYLYRVF-PDLNLPHGHLKSSNVLLDPNFEPLLTDYALV 516
Query: 453 KFLDPKKTCLFSSNGYTAPEKT----VSEQGDVFSFGVILLELLTGKTV-----EKTGID 503
++ ++ F Y APE T S + DV+S G+++LE+LTGK + G D
Sbjct: 517 PVVNRDQSQQFMV-AYKAPEFTQQDRTSRRSDVWSLGILILEILTGKFPANYLRQGKGAD 575
Query: 504 --LPKWVKAMVREEWTGEVFDKEVAKAGRQWA---FPLLNVALKCVSNSPDDRPTMAEVL 558
L WV+++ R EWT +VFDKE+ KAG++ LL + L+C + R + E +
Sbjct: 576 DELAAWVESVARTEWTADVFDKEM-KAGKEHEAQMLKLLKIGLRCCDWDIEKRIELHEAV 634
Query: 559 ERIEEV 564
+RIEEV
Sbjct: 635 DRIEEV 640
|
|
| TAIR|locus:2044913 AT2G36570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 383 (139.9 bits), Expect = 4.6e-54, Sum P(3) = 4.6e-54
Identities = 96/220 (43%), Positives = 131/220 (59%)
Query: 283 RSELVFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKN-SAVYAVKRLKKLQ-VSM 340
RS LVFF K+ F+LDDLL+A+A++ + +++ L + S AVKRLK
Sbjct: 338 RSRLVFFERRKQ-FELDDLLKASAEMLGKGSLGTVYKAVLDDGSTTVAVKRLKDANPCPR 396
Query: 341 DEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYI-EGKRDFPW 399
EF Q M IG LKH N++ L Y EEKLLVY+Y NGSL SLL G+ W
Sbjct: 397 KEFEQYMEIIGRLKHQNVVKLRAYYYAKEEKLLVYEYLPNGSLHSLLHGNRGPGRIPLDW 456
Query: 400 KLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459
R+S+ G A+GL ++ + + K IPHGN+K SN+LL+ N LI++ G S L+P
Sbjct: 457 TTRISLMLGAARGLAKIHDEYSISK-IPHGNIKSSNVLLDRNGVALIADFGLSLLLNPVH 515
Query: 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGK 495
+ GY APE K +S++ DV+SFGV+LLE+LTGK
Sbjct: 516 A-IARLGGYRAPEQSEIKRLSQKADVYSFGVLLLEVLTGK 554
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 552 (199.4 bits), Expect = 2.4e-53, P = 2.4e-53
Identities = 152/524 (29%), Positives = 266/524 (50%)
Query: 83 LENMNLSGIIDAETLCKL-RHLRVVSLARNLIQGRIPTSISNCRRLTYXXXXXXXXXGAV 141
L++ N SG + +L + + L V+ L+ N + G IP+ + N ++T G
Sbjct: 129 LQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDG-- 186
Query: 142 PXXXXXXXXXXXXDISNNHFAATSPDNFRQEIKYFDKYVVET--SSSEINRASTVEARGL 199
P ++S N+ + P++ ++ +Y ++ + +N S
Sbjct: 187 PIDSLDLPSVKVVNLSYNNLSGPIPEHLKKSPEY--SFIGNSLLCGPPLNACSGGAISPS 244
Query: 200 EDTQPPSVHNKSEHGEKRHWFRNWMTIIPLAAGIGLVVL-IAY--CMGKKSAQIARDREI 256
+ P N H +R + ++ I + + ++ L I + C+ KK+ + E
Sbjct: 245 SNLPRPLTENL--HPVRRRQSKAYIIAIVVGCSVAVLFLGIVFLVCLVKKTKKEEGGGEG 302
Query: 257 LKALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSS 316
++ + PQ PE +++L FF F L+DLL+A+A++ + +
Sbjct: 303 VRTQMGGVNSKKPQDFGSGVQDPE--KNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGT 360
Query: 317 LFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVY 375
+ L+++ VKRL+++ S EF Q M +G + +H N +PL+ Y + +EKLLVY
Sbjct: 361 AYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVY 420
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
KY + GSL ++ G R W+ R+ IATG +K + +++ K + HG++K SN
Sbjct: 421 KYMTKGSLFGIMHGN-RGDRGVDWETRMKIATGTSKAISYLHSL----KFV-HGDIKSSN 474
Query: 436 ILLNENEDPLISECGYSKFLD-PKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLE 490
ILL E+ +P +S+ + P T + GY APE + VS++ DV+SFGV++LE
Sbjct: 475 ILLTEDLEPCLSDTSLVTLFNLPTHTP--RTIGYNAPEVIETRRVSQRSDVYSFGVVILE 532
Query: 491 LLTGKTV--------EKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR--QWAFPLLNVA 540
+LTGKT E+ IDLP+WV+++VREEWT EVFD E+ K + +L +A
Sbjct: 533 MLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLA 592
Query: 541 LKCVSNSPDDRPTMAEVLERIEEV--VNGNDERDRDHSNSSFSS 582
L CV+ +P+ RP M EV IE+V ++ + + ++ ++S +S
Sbjct: 593 LACVARNPESRPKMEEVARMIEDVRRLDQSQQLQQNRTSSEATS 636
|
|
| TAIR|locus:2063621 PRK2A "AT2G07040" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 438 (159.2 bits), Expect = 2.8e-52, Sum P(2) = 2.8e-52
Identities = 131/505 (25%), Positives = 239/505 (47%)
Query: 103 LRVVSLARNLIQGRIPTSISNCRRLTYXXXXXXXXXGAVPXXXXXXXXXXXXDISNNHFA 162
L+ + L +N G IPTS+ +L G +P ++SNN A
Sbjct: 138 LKKLHLEQNNFIGEIPTSLVKSPKLIELRLDGNRFTGQIPEFRHHPNML---NLSNNALA 194
Query: 163 ATSPDNFRQEIKYFDKYVVETSSSEINRASTVEARGL--EDTQPPSVHNKSEHGEKRHWF 220
P++F D + E + + + ++P S K+ + +
Sbjct: 195 GQIPNSFST----MDPKLFEGNKGLCGKPLDTKCSSPYNHSSEPKSSTKKTS---SKFLY 247
Query: 221 RNWMTIIPLAAG---IGLVVLIAYCMGKKSAQIARDR-----EILKALQDSPSKSPPQVM 272
+ LAA IG+V+ + KK ++ + ++ +Q+S
Sbjct: 248 IVAAAVAALAASLIIIGVVIFLIRRRKKKQPLLSAEPGPSSLQMRAGIQESERGQGSYHS 307
Query: 273 DIEEVRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKR 332
+ + ++L F ++K +F+L DLL+A+A++ + + L N +V VKR
Sbjct: 308 QNRAAKKMIHTTKLSFLRDDKGKFELQDLLKASAEILGSGCFGASYKTLLSNGSVMVVKR 367
Query: 333 LKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYI 391
K + +DEF + M+++G L H N+LP+V Y EEKL V + +NGSL + L +
Sbjct: 368 FKHMNSAGIDEFQEHMKRLGRLNHENLLPIVAYYYKKEEKLFVSDFVANGSLAAHLHGHK 427
Query: 392 E-GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECG 450
G+ W R +I G+ +GL +++ K+ PHG+LK SN+LL+E +PL+ + G
Sbjct: 428 SLGQPSLDWPTRFNIVKGVGRGLLYLH-KNLPSLMAPHGHLKSSNVLLSEKFEPLLMDYG 486
Query: 451 YSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVE-------K 499
++ +++ Y +PE V+++ DV+ GV++LE+LTGK +E +
Sbjct: 487 LIPMIN-EESAQELMVAYKSPEYVKQSRVTKKTDVWGLGVLILEILTGKLLESFSQVDKE 545
Query: 500 TGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA--FPLLNVALKCVSNSPDDRPTMAEV 557
+ DL WV++ + EWT E+FD+E+ K A L+ + L C + R + E
Sbjct: 546 SEEDLASWVRSSFKGEWTQELFDQEMGKTSNCEAHILNLMRIGLSCCEVDVEKRLDIREA 605
Query: 558 LERIEEVVNGNDERDRDHSNSSFSS 582
+E++E+++ ++ D D S+++S
Sbjct: 606 VEKMEDLMKEREQGDDDFY-STYAS 629
|
|
| TAIR|locus:2154227 AT5G53320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 2.4e-51, P = 2.4e-51
Identities = 166/588 (28%), Positives = 287/588 (48%)
Query: 14 ICIAILPRLFTGCVGGEL--SESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKC 71
+ + ++ +F C+ E + + +F++ ++ + L W+ +L C+ G+ C
Sbjct: 5 VVLILIVVIFNVCIEAETIKEDKHTLLQFVNNINHSHSLN--WSPSLSI-CT-KWTGVTC 60
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYXX 131
N +++ + L L G I+ + +L +LR + L+ N I G PT++ + LT
Sbjct: 61 NSDHSSVDALHLAATGLRGDIELSIIARLSNLRFLILSSNNISGTFPTTLQALKNLTELK 120
Query: 132 XXXXXXXGAVPXXXXXXXXXXXXDISNNHFAATSPDNF-RQEIKY-----FDKYVVETSS 185
G +P D+SNN F + P + + + + ++K+ E
Sbjct: 121 LDFNEFSGPLPSDLSSWERLQVLDLSNNRFNGSIPSSIGKLTLLHSLNLAYNKFSGEIPD 180
Query: 186 SEIN--RASTVEARGLEDTQPPS---------VHNK---SEHGE-KRHW-FRNWMTI-IP 228
I + + L T P S V NK H ++H N + + I
Sbjct: 181 LHIPGLKLLNLAHNNLTGTVPQSLQRFPLSAFVGNKVLAPVHSSLRKHTKHHNHVVLGIA 240
Query: 229 LAAGIGLVVLIAYCMGKKSAQIARDREILK-ALQDSPSKSPPQVMDIEEVRPEVRRSE-- 285
L+ ++ L+A + I +RE + + +D PSK ++ P V +
Sbjct: 241 LSVCFAILALLAILL----VIIIHNREEQRRSSKDKPSKRR------KDSDPNVGEGDNK 290
Query: 286 LVFFVNEKERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQ 345
+VFF + F L+DLL A+A++ + + + V L++SA VKR+K++ V EF Q
Sbjct: 291 IVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYKVDLEDSATIVVKRIKEVSVPQREFEQ 350
Query: 346 TMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRD---FPWKLR 402
+ IG++KH N+ L Y + +EKL+VY Y +GSL +LL +G RD W+ R
Sbjct: 351 QIENIGSIKHENVATLRGYFYSKDEKLVVYDYYEHGSLSTLLHGQ-KGLRDRKRLEWETR 409
Query: 403 LSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCL 462
L++ G A+G+ ++ +S + + HGN+K SNI LN IS G + +
Sbjct: 410 LNMVYGTARGVAHIHSQSGGK--LVHGNIKSSNIFLNGKGYGCISGTGMATLMHSLPR-- 465
Query: 463 FSSNGYTAPEKTVSEQG----DVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG 518
+ GY APE T + +G DV+SFG+++ E+LTGK+ E +L +WV ++VREEWTG
Sbjct: 466 -HAVGYRAPEITDTRKGTQPSDVYSFGILIFEVLTGKS-EVA--NLVRWVNSVVREEWTG 521
Query: 519 EVFDKEVAKAGR--QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564
EVFD+E+ + + + +L V + C + P+ RP M EV+ +EE+
Sbjct: 522 EVFDEELLRCTQVEEEMVEMLQVGMVCTARLPEKRPNMIEVVRMVEEI 569
|
|
| TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 527 (190.6 bits), Expect = 1.1e-50, P = 1.1e-50
Identities = 160/506 (31%), Positives = 243/506 (48%)
Query: 83 LENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYXXXXXXXXXGAVP 142
L++ NLSG + + ++L V+L+ N G IP+S+S +R+ G +P
Sbjct: 124 LQDNNLSGPLPLD-FSVWKNLTSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIP 182
Query: 143 XXXXXXXXXXXXDISNNH-FAATSPDNFRQEIKYFDKYVVETSSSEINRASTVEARGLED 201
D+SNN+ A PD R+ F Y T I L
Sbjct: 183 DLSVLSSLQHI-DLSNNYDLAGPIPDWLRRFP--FSSY---TGIDIIPPGGNYT---LVT 233
Query: 202 TQPPS--VHNKSEHGEKRHWFRNWMTIIPLAAGIGLVVLIAY----CMGKKSAQIARDRE 255
PPS H K +I +A I ++ +A+ C ++ ++ R
Sbjct: 234 PPPPSEQTHQKPSKARFLGLSETVFLLIVIAVSIVVITALAFVLTVCYVRR--KLRRGDG 291
Query: 256 ILK--ALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTI 313
++ LQ SP + + R E + L FF F L+DLL A+A++ +
Sbjct: 292 VISDNKLQKKGGMSPEKFVS----RMEDVNNRLSFFEGCNYSFDLEDLLRASAEVLGKGT 347
Query: 314 CSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLL 373
+ + L+++ AVKRLK + +F Q M IG +KH N++ L Y + +EKL+
Sbjct: 348 FGTTYKAVLEDATSVAVKRLKDVAAGKRDFEQQMEIIGGIKHENVVELKAYYYSKDEKLM 407
Query: 374 VYKYQSNGSLLSLLEAYIEGKRDFP--WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
VY Y S GS+ SLL G+ P W+ R+ IA G AKG+ ++ K N K + HGN+
Sbjct: 408 VYDYFSRGSVASLLHGN-RGENRIPLDWETRMKIAIGAAKGIARIH-KENNGKLV-HGNI 464
Query: 432 KLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKT----VSEQGDVFSFGVI 487
K SNI LN + +S+ G + + P + GY APE T S+ DV+SFGV+
Sbjct: 465 KSSNIFLNSESNGCVSDLGLTAVMSPLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVV 524
Query: 488 LLELLTGKT-VEKTG----IDLPKWVKAMVREEWTGEVFDKEVAKAGR--QWAFPLLNVA 540
LLELLTGK+ + T I L +WV ++VREEWT EVFD E+ + + +L +A
Sbjct: 525 LLELLTGKSPIHTTAGDEIIHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIA 584
Query: 541 LKCVSNSPDDRPTMAEVLERIEEVVN 566
+ CV + D RP M++++ IE V N
Sbjct: 585 MSCVVKAADQRPKMSDLVRLIENVGN 610
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XI000589 | hypothetical protein (612 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 608 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-29 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-23 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-22 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-10 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-10 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-09 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-04 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.001 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.001 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.001 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.001 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.001 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.001 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.001 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.001 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 0.001 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 0.002 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.002 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.002 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 0.003 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.003 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 0.003 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.004 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 0.004 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.004 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 64/257 (24%), Positives = 103/257 (40%), Gaps = 62/257 (24%)
Query: 315 SSLFMVRLKNS-AVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEK 371
++++ R K + A+K +KK ++E + + + L HPNI+ L
Sbjct: 7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66
Query: 372 LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
LV +Y GSL LL+ + L I I +GL++++ I H +L
Sbjct: 67 YLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSNG-----IIHRDL 118
Query: 432 KLSNILLNENED-PLISECGYSKFLDPKKTCLFSSNG---YTAPE-----KTVSEQGDVF 482
K NILL+ + +++ G SK L K+ L + G Y APE SE+ D++
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 483 SFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALK 542
S GVIL EL +K ++R K
Sbjct: 179 SLGVILYEL--------------PELKDLIR----------------------------K 196
Query: 543 CVSNSPDDRPTMAEVLE 559
+ P+ RP+ E+LE
Sbjct: 197 MLQKDPEKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 72/254 (28%), Positives = 106/254 (41%), Gaps = 30/254 (11%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYK 376
+ AVK LKK + R+I L HPNI+ L+ + LV +
Sbjct: 19 KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVME 78
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
Y G L Y+ IA I +GL++++ I H +LK NI
Sbjct: 79 YCEGGDLF----DYLSRGGPLSEDEAKKIALQILRGLEYLHSNG-----IIHRDLKPENI 129
Query: 437 LLNENEDPLISECGYSKFL---DPKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVIL 488
LL+EN I++ G +K L T + Y APE + DV+S GVIL
Sbjct: 130 LLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVIL 189
Query: 489 LELLTGKTV--EKTGIDLPKWVKAMVREEWTGEV-FDKEVAKAGRQWAFPLLNVALKCVS 545
ELLTGK + +D ++R + FD+ +G + A L+ KC++
Sbjct: 190 YELLTGKPPFSGENILD----QLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK---KCLN 242
Query: 546 NSPDDRPTMAEVLE 559
P RPT E+L+
Sbjct: 243 KDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 70/261 (26%), Positives = 110/261 (42%), Gaps = 52/261 (19%)
Query: 329 AVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
AVK LK+ + +F + R + L HPN++ L VC + E LV +Y G LL
Sbjct: 27 AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC--TEEEPLYLVLEYMEGGDLL 84
Query: 385 SLL-----EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
L K K LS A IAKG++++ K H +L N L+
Sbjct: 85 DYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL-----ASKKFVHRDLAARNCLVG 139
Query: 440 ENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLE 490
E+ IS+ G S+ + + G + APE + + DV+SFGV+L E
Sbjct: 140 EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWE 199
Query: 491 LLT-GKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVAL 541
+ T G T + ++ +++ + G + P L + L
Sbjct: 200 IFTLGATPYPGLSNEEVLEYL------------------RKGYRLPKPEYCPDELYELML 241
Query: 542 KCVSNSPDDRPTMAEVLERIE 562
C P+DRPT +E++ER+E
Sbjct: 242 SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 68/253 (26%), Positives = 112/253 (44%), Gaps = 46/253 (18%)
Query: 329 AVKRLK--KLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
AVK LK + ++EF + R + L HPNI+ L VC + E ++V +Y G LL
Sbjct: 32 AVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVC--TEEEPLMIVMEYMPGGDLL 89
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
L ++ LS A IA+G++++ E K H +L N L+ EN
Sbjct: 90 DYLRKN--RPKELSLSDLLSFALQIARGMEYL-----ESKNFIHRDLAARNCLVGENLVV 142
Query: 445 LISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLT-G 494
IS+ G S+ L G + APE + + DV+SFGV+L E+ T G
Sbjct: 143 KISDFGLSRDLYDDDY-YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 201
Query: 495 KT--VEKTGIDLPKWVKAMVR----EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
+ + ++ +++K R E++ + L+C + P
Sbjct: 202 EEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELY----------------KLMLQCWAEDP 245
Query: 549 DDRPTMAEVLERI 561
+DRPT +E++E +
Sbjct: 246 EDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 6e-22
Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 47/253 (18%)
Query: 329 AVKRLK--KLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
AVK LK + ++EF + R + L HPN++ L VC + E +V +Y G LL
Sbjct: 32 AVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVC--TEEEPLYIVMEYMEGGDLL 89
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
S L + LS A IA+G++++ E K H +L N L+ EN
Sbjct: 90 SYLRKN---RPKLSLSDLLSFALQIARGMEYL-----ESKNFIHRDLAARNCLVGENLVV 141
Query: 445 LISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLT-G 494
IS+ G S+ L G + APE + + DV+SFGV+L E+ T G
Sbjct: 142 KISDFGLSRDLYDDDYYR-KRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 200
Query: 495 KT--VEKTGIDLPKWVKAMVR----EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
+ + ++ +++K R E++D + L+C + P
Sbjct: 201 EQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYD----------------LMLQCWAEDP 244
Query: 549 DDRPTMAEVLERI 561
+DRPT +E++E +
Sbjct: 245 EDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 63/249 (25%), Positives = 108/249 (43%), Gaps = 26/249 (10%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYK 376
K + A+K +KK ++ + + +R+I LKHPNI+ L ++ LV +
Sbjct: 19 RDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVME 77
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
Y G L LL+ + I L++++ K I H +LK NI
Sbjct: 78 YCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLHSKG-----IVHRDLKPENI 128
Query: 437 LLNENEDPLISECGYSKFLDPKKTC--LFSSNGYTAPE----KTVSEQGDVFSFGVILLE 490
LL+E+ +++ G ++ LDP + + Y APE K + D++S GVIL E
Sbjct: 129 LLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYE 188
Query: 491 LLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDD 550
LLTGK L + K + + + + +++ + L+ K + P+
Sbjct: 189 LLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD----LIR---KLLVKDPEK 241
Query: 551 RPTMAEVLE 559
R T E L+
Sbjct: 242 RLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 2e-19
Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 46/253 (18%)
Query: 329 AVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
AVK LK+ + +EF + + L HPNI+ L VC E +V +Y G LL
Sbjct: 32 AVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLL 89
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
L + K L +A IAKG++++ E K H +L N L+ EN
Sbjct: 90 DFLR---KHGEKLTLKDLLQMALQIAKGMEYL-----ESKNFVHRDLAARNCLVTENLVV 141
Query: 445 LISECGYSKFLDPKKTCLFSSNGY-----TAPE----KTVSEQGDVFSFGVILLELLT-G 494
IS+ G S+ + G APE + + DV+SFGV+L E+ T G
Sbjct: 142 KISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLG 201
Query: 495 KT--VEKTGIDLPKWVKAMVR----EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
+ + ++ + ++ R E E+++ + L+C + P
Sbjct: 202 EQPYPGMSNEEVLELLEDGYRLPRPENCPDELYE----------------LMLQCWAYDP 245
Query: 549 DDRPTMAEVLERI 561
+DRPT +E++E +
Sbjct: 246 EDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-17
Identities = 80/322 (24%), Positives = 143/322 (44%), Gaps = 53/322 (16%)
Query: 270 QVMDIEEVRPEVRRSELVFFVNEKER-FKLDDLLEATAD---LRSQTICSSLFMVRLKNS 325
++++ V E EL FF ++ + ++D+L + + + +S +KN
Sbjct: 656 NNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNG 715
Query: 326 AVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
+ VK + + + E + +G L+HPNI+ L+ + + L+++Y +L
Sbjct: 716 MQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
+L R+ W+ R IA GIAK L F++ + GNL I+++ ++P
Sbjct: 772 EVL-------RNLSWERRRKIAIGIAKALRFLH--CRCSPAVVVGNLSPEKIIIDGKDEP 822
Query: 445 -LISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKT--- 496
L D K F S+ Y APE K ++E+ D++ FG+IL+ELLTGK+
Sbjct: 823 HLRLSLPGLLCTDTKC---FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
Query: 497 ---------VE-----KTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALK 542
VE + L W+ +R + + V E+ + +N+AL
Sbjct: 880 AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS--VNQNEIVEV--------MNLALH 929
Query: 543 CVSNSPDDRPTMAEVLERIEEV 564
C + P RP +VL+ +E
Sbjct: 930 CTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 80.2 bits (196), Expect = 5e-16
Identities = 60/302 (19%), Positives = 110/302 (36%), Gaps = 34/302 (11%)
Query: 323 KNSAVYAVKRL-KKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNSTNEEKLLVYKY 377
++ + A+K L KKL+ E + +R+I L PNI+ L + LV +Y
Sbjct: 20 RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
GSL LL+ L I I L++++ K I H ++K NIL
Sbjct: 80 VDGGSLEDLLKKIGRKGP-LSESEALFILAQILSALEYLHSKG-----IIHRDIKPENIL 133
Query: 438 LNENED----------PLISECGYSKFLDPKKTCLFSSNGYTAPE-------KTVSEQGD 480
L+ + L+ + G + + + + GY APE S D
Sbjct: 134 LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSD 193
Query: 481 VFSFGVILLELLTGKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538
++S G+ L ELLTG + ++ E T + + +
Sbjct: 194 IWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASD 253
Query: 539 VALKCVSNSPDDRPTMAEV----LERIEEVVNGNDERDRDHSNSSFSSMESIPHDSCLLH 594
+ K ++ P +R + + L ++ + +S+ + P L+
Sbjct: 254 LLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALIS 313
Query: 595 TV 596
++
Sbjct: 314 SL 315
|
Length = 384 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 42/121 (34%), Positives = 66/121 (54%), Gaps = 5/121 (4%)
Query: 50 LRIGWNGNLPHPCSYNLKGIKCNLHATN----IVGIRLENMNLSGIIDAETLCKLRHLRV 105
LR GWNG+ P + G C +T I G+ L+N L G I + KLRHL+
Sbjct: 388 LRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFI-PNDISKLRHLQS 446
Query: 106 VSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATS 165
++L+ N I+G IP S+ + L L+LS N +G++P +L +L L+ L+++ N +
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
Query: 166 P 166
P
Sbjct: 507 P 507
|
Length = 623 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 62/257 (24%), Positives = 106/257 (41%), Gaps = 36/257 (14%)
Query: 334 KKLQVSMDEFSQT--MRQIG---NLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLSL 386
K L S +E ++ R+I L H NI+ VC L+ +Y +GSL
Sbjct: 39 KSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD- 97
Query: 387 LEAYIEGKRD-FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
Y++ RD K L ++ I KG+D++ + H +L NIL+ +
Sbjct: 98 ---YLQRHRDQINLKRLLLFSSQICKGMDYL-----GSQRYIHRDLAARNILVESEDLVK 149
Query: 446 ISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLTGK 495
IS+ G +K L K + + APE S DV+SFGV L EL T
Sbjct: 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT-- 207
Query: 496 TVEKTGIDLPKWVKAMVREEWTGEVFD-KEVAKAGRQWAFP------LLNVALKCVSNSP 548
+ + ++++ + + V E+ K G + P + ++ C P
Sbjct: 208 YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEP 267
Query: 549 DDRPTMAEVLERIEEVV 565
DRP+ A+++ ++ +
Sbjct: 268 QDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 52/244 (21%), Positives = 107/244 (43%), Gaps = 31/244 (12%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLSL 386
A+K +++ +S D+F + + + L HPN++ L VC + +V +Y +NG LL+
Sbjct: 32 AIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC--TKQRPIFIVTEYMANGCLLNY 89
Query: 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446
L E K + L + + + + ++++ E H +L N L+ E+ +
Sbjct: 90 LR---ERKGKLGTEWLLDMCSDVCEAMEYL-----ESNGFIHRDLAARNCLVGEDNVVKV 141
Query: 447 SECGYSKF-LDPKKTCLFSSN---GYTAPE----KTVSEQGDVFSFGVILLELLTGKTVE 498
S+ G +++ LD + T + + PE S + DV+SFGV++ E+ +
Sbjct: 142 SDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK-- 199
Query: 499 KTGIDLPKWVKAMVREE-WTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEV 557
+ ++ + V E G + + + + C P+DRP ++
Sbjct: 200 ---MPYERFSNSEVVESVSAGYRLYRP-----KLAPTEVYTIMYSCWHEKPEDRPAFKKL 251
Query: 558 LERI 561
L ++
Sbjct: 252 LSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 323 KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKL-LVYKYQS 379
K S AVK LK+ + ++EF + + +KHPN++ L VC T E ++ ++ +
Sbjct: 29 KYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC---TREPPFYIITEFMT 85
Query: 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
G+LL L +++ + L +AT I+ ++++ E+K H +L N L+
Sbjct: 86 YGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYL-----EKKNFIHRDLAARNCLVG 138
Query: 440 ENEDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILL 489
EN +++ G S+ + + G +TAPE S + DV++FGV+L
Sbjct: 139 ENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 196
Query: 490 ELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP-LLNVALKCVSNSP 548
E+ T GIDL + E+ +K + P + + C +P
Sbjct: 197 EIATYGMSPYPGIDLSQ----------VYELLEKGYRMERPEGCPPKVYELMRACWQWNP 246
Query: 549 DDRPTMAEVLERIE 562
DRP+ AE+ + E
Sbjct: 247 SDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 32/198 (16%)
Query: 315 SSLFMVRLK-NSAVYAVKRLKKLQVSMDEF--SQTMRQIGNL---KHPNILPLVCYNS-- 366
++ VR K +YA LKK+ V DE Q +R++ L + P ++ CY +
Sbjct: 15 GVVYKVRHKPTGKIYA---LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK--CYGAFY 69
Query: 367 TNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRL--SIATGIAKGLDFMYQKSNEEK 424
E +V +Y GSL LL K+ + IA I KGLD+++ K +
Sbjct: 70 KEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTKRH--- 120
Query: 425 TIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPEKTVSEQ--- 478
I H ++K SN+L+N + I++ G SK L+ + G Y +PE+ E
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 479 -GDVFSFGVILLELLTGK 495
D++S G+ LLE GK
Sbjct: 180 AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 66/262 (25%), Positives = 119/262 (45%), Gaps = 44/262 (16%)
Query: 317 LFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376
++M A+K LK+ +S + F + L+HP ++ L T E ++ +
Sbjct: 22 VWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV-VTQEPIYIITE 80
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
Y NGSL+ L+ EG + KL + +A IA+G+ F+ E K H +L+ +NI
Sbjct: 81 YMENGSLVDFLKTP-EGIKLTINKL-IDMAAQIAEGMAFI-----ERKNYIHRDLRAANI 133
Query: 437 LLNENEDPLISECGYSKFLDPKKTCLFSSNG------YTAPEK----TVSEQGDVFSFGV 486
L++E I++ G ++ ++ + + G +TAPE T + + DV+SFG+
Sbjct: 134 LVSETLCCKIADFGLARLIEDNEYT--AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 191
Query: 487 ILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVA 540
+L E++T + G+ P+ ++ + R G + P L +
Sbjct: 192 LLTEIVTYGRIPYPGMTNPEVIQNLER---------------GYRMPRPDNCPEELYELM 236
Query: 541 LKCVSNSPDDRPT---MAEVLE 559
C P++RPT + VLE
Sbjct: 237 RLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 41/177 (23%), Positives = 81/177 (45%), Gaps = 22/177 (12%)
Query: 329 AVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386
A+K L++ + E + ++ HP+++ L+ + + L+ + G LL
Sbjct: 40 AIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGI-CLSSQVQLITQLMPLGCLLD- 97
Query: 387 LEAYIEGKRD-FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
Y+ +D + L+ IAKG+ ++ EEK + H +L N+L+ +
Sbjct: 98 ---YVRNHKDNIGSQYLLNWCVQIAKGMSYL-----EEKRLVHRDLAARNVLVKTPQHVK 149
Query: 446 ISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLT 493
I++ G +K LD + + G + A E + + + DV+S+GV + EL+T
Sbjct: 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 48/218 (22%)
Query: 315 SSLFMVRLK-NSAVYAVKRLKKLQVS----MDEFSQTMRQIGNLK-HPNILPLVCYNST- 367
S++ + + K + YA+K L K Q+ + + L HP I+ L T
Sbjct: 15 STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYY---TF 71
Query: 368 -NEEKL-LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKT 425
+EE L V +Y NG LL + Y G D R A I L++++ K
Sbjct: 72 QDEENLYFVLEYAPNGELLQYIRKY--GSLDEKC-TRFYAAE-ILLALEYLHSKG----- 122
Query: 426 IPHGNLKLSNILLNENEDPLISECGYSKFLDP--------KKTCLFSSNG---------- 467
I H +LK NILL+++ I++ G +K LDP S
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 468 -----YTAPE----KTVSEQGDVFSFGVILLELLTGKT 496
Y +PE K + D+++ G I+ ++LTGK
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 40/255 (15%)
Query: 323 KNSAVYAVKRLKK-LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381
KN A+K LK + +F + ++ + L+H +++ L S E ++ + G
Sbjct: 28 KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
SLL+ L EG + P + +A +A+G+ ++ EE+ H +L NIL+ E+
Sbjct: 88 SLLAFL-RSPEG-QVLPVASLIDMACQVAEGMAYL-----EEQNSIHRDLAARNILVGED 140
Query: 442 EDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELL 492
+++ G ++ + K+ SS+ +TAPE T S + DV+SFG++L E+
Sbjct: 141 LVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF 198
Query: 493 TGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVALKCVSN 546
T V G++ EV+D+ AG + P + + L+C +
Sbjct: 199 TYGQVPYPGMN-------------NHEVYDQ--ITAGYRMPCPAKCPQEIYKIMLECWAA 243
Query: 547 SPDDRPTMAEVLERI 561
P+DRP+ + E +
Sbjct: 244 EPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 77/280 (27%), Positives = 111/280 (39%), Gaps = 81/280 (28%)
Query: 322 LKNSAVYAVKR--LKKLQVSMDEFS---QTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376
L N+ A+KR L+K Q S+DE Q M Q HPN++ +E LV
Sbjct: 23 LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC---NHPNVVKYYTSFVVGDELWLVMP 79
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKL--RLSIAT---GIAKGLDFMYQKSNEEKTIPHGNL 431
Y S GSLL ++ K +P IAT + KGL+ Y SN + H ++
Sbjct: 80 YLSGGSLLDIM------KSSYPRGGLDEAIIATVLKEVLKGLE--YLHSNGQI---HRDI 128
Query: 432 KLSNILLNENEDPLISECGYSKFL----DPKKTCLFSSNG---YTAPEKTVSEQG----- 479
K NILL E+ I++ G S L D + + G + APE G
Sbjct: 129 KAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKA 188
Query: 480 DVFSFGVILLELLTG--------------KTVEK------TGIDLPKWVKAMVREEWTGE 519
D++SFG+ +EL TG T++ TG D K+ K+
Sbjct: 189 DIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS--------- 239
Query: 520 VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559
F K ++ C+ P RPT E+L+
Sbjct: 240 -FRKMIS---------------LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 34/258 (13%)
Query: 315 SSLFMV-RLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYN--STN 368
S++ V RL ++ YA+K + +S E + +I ++ HPNI + Y +
Sbjct: 14 GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---ISYKEAFLD 70
Query: 369 EEKL-LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIP 427
KL +V +Y G L + + ++ P + I + +GL ++ E+ I
Sbjct: 71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL-----QALHEQKIL 125
Query: 428 HGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGD 480
H +LK +NILL N+ I + G SK L KK + G Y APE + S + D
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQIGTPHYMAPEVWKGRPYSYKSD 183
Query: 481 VFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVA 540
++S G +L E+ T P ++M ++ +V + ++ L N
Sbjct: 184 IWSLGCLLYEMATFAP--------PFEARSM--QDLRYKVQRGKYPPIPPIYSQDLQNFI 233
Query: 541 LKCVSNSPDDRPTMAEVL 558
+ P RP ++L
Sbjct: 234 RSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (151), Expect = 1e-10
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 19/187 (10%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLL--VY 375
R + +Y +K + +S E + ++ L HPNI+ Y S E+ L V
Sbjct: 21 RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK--YYESFEEKGKLCIVM 78
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
+Y G L ++ + + FP + L + L +++ + I H ++K N
Sbjct: 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-----SRKILHRDIKPQN 133
Query: 436 ILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSFGVIL 488
I L N + + G SK L + G Y +PE K + + D++S G +L
Sbjct: 134 IFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVL 193
Query: 489 LELLTGK 495
EL T K
Sbjct: 194 YELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 65/264 (24%), Positives = 111/264 (42%), Gaps = 56/264 (21%)
Query: 324 NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKL-LVYKYQSN 380
N+ AVK LK + +F + + L+HP ++ L VC T EE + +V +
Sbjct: 29 NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC---TLEEPIYIVTELMKY 85
Query: 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440
GSLL L+ R + +A +A G+ ++ E + H +L N+L+ E
Sbjct: 86 GSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYL-----EAQNYIHRDLAARNVLVGE 138
Query: 441 NEDPLISECGYSKFLD------------PKKTCLFSSNGYTAPEKTV----SEQGDVFSF 484
N +++ G ++ + P K +TAPE + S + DV+SF
Sbjct: 139 NNICKVADFGLARVIKEDIYEAREGAKFPIK--------WTAPEAALYNRFSIKSDVWSF 190
Query: 485 GVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP-----LLNV 539
G++L E++T + G+ EV + V + R P L ++
Sbjct: 191 GILLTEIVTYGRMPYPGMT-------------NAEVLQQ-VDQGYRMPCPPGCPKELYDI 236
Query: 540 ALKCVSNSPDDRPTMAEVLERIEE 563
L C PDDRPT + ++E+
Sbjct: 237 MLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 61/252 (24%), Positives = 110/252 (43%), Gaps = 45/252 (17%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLE 388
A+K +K+ +S DEF + + + L H ++ L + +V +Y SNG LL+ L
Sbjct: 32 AIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLR 91
Query: 389 AYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448
E + F L + + +G+ ++ E K H +L N L+++ +S+
Sbjct: 92 ---EHGKRFQPSQLLEMCKDVCEGMAYL-----ESKQFIHRDLAARNCLVDDQGCVKVSD 143
Query: 449 CGYSKF-LDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT-GKT 496
G S++ LD + T SS G ++ PE S + DV++FGV++ E+ + GK
Sbjct: 144 FGLSRYVLDDEYT---SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK- 199
Query: 497 VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL------NVALKCVSNSPDD 550
M E + ++V++ G + P L + C ++
Sbjct: 200 --------------MPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMYSCWHEKAEE 244
Query: 551 RPTMAEVLERIE 562
RPT ++L IE
Sbjct: 245 RPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/193 (31%), Positives = 94/193 (48%), Gaps = 22/193 (11%)
Query: 317 LFMVRLKNS-AVYAVKRLKKLQVSMD---EFSQTMRQIGNL--KHPNILPLVCYNSTNEE 370
+F+ LK + +A+K LKK V MD E + +++ +L +HP + L C T E
Sbjct: 11 VFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN 70
Query: 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
V +Y + G L+ +I+ F A I GL F++ K I + +
Sbjct: 71 LFFVMEYLNGGDLM----FHIQSCHKFDLPRATFYAAEIICGLQFLHSKG-----IVYRD 121
Query: 431 LKLSNILLNENEDPLISECGYSK--FLDPKKTCLF-SSNGYTAPEKTVSEQG----DVFS 483
LKL NILL+ + I++ G K L KTC F + Y APE + ++ D +S
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWS 181
Query: 484 FGVILLELLTGKT 496
FGV+L E+L G++
Sbjct: 182 FGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 75/267 (28%), Positives = 117/267 (43%), Gaps = 72/267 (26%)
Query: 329 AVKRLKKLQVSMDEF---SQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSL 383
AVK LK +S + F +Q M++ L+H ++ L VC S E +V +Y S GSL
Sbjct: 34 AVKTLKPGTMSPEAFLQEAQIMKK---LRHDKLVQLYAVC--SEEEPIYIVTEYMSKGSL 88
Query: 384 LSLLEAYIEGKRDFPWKLRLS----IATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
L L++ EGK KLRL +A IA+G+ ++ E + H +L NIL+
Sbjct: 89 LDFLKSG-EGK-----KLRLPQLVDMAAQIAEGMAYL-----ESRNYIHRDLAARNILVG 137
Query: 440 EN--------------EDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDV 481
EN ED + +KF P K +TAPE + + DV
Sbjct: 138 ENLVCKIADFGLARLIEDDEYTAREGAKF--PIK--------WTAPEAANYGRFTIKSDV 187
Query: 482 FSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP-----L 536
+SFG++L E++T + P EV + +V + R P L
Sbjct: 188 WSFGILLTEIVT-----YGRVPYPGMTNR--------EVLE-QVERGYRMPRPPNCPEEL 233
Query: 537 LNVALKCVSNSPDDRPTMAEVLERIEE 563
++ L+C P++RPT + +E+
Sbjct: 234 YDLMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 74/295 (25%), Positives = 122/295 (41%), Gaps = 68/295 (23%)
Query: 318 FMVRLKNSAVY---AVKRLKK------LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN 368
RLK A Y AVK LK+ L+ + EF ++Q+ HP+++ L S +
Sbjct: 20 TAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEF-NLLKQV---NHPHVIKLYGACSQD 75
Query: 369 EEKLLVYKYQSNGSLLSLLE-------AYI-------------EGKRDFPWKLRLSIATG 408
LL+ +Y GSL S L +Y+ +R +S A
Sbjct: 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQ 135
Query: 409 IAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG- 467
I++G+ ++ E + H +L N+L+ E IS+ G S+ + + + + S G
Sbjct: 136 ISRGMQYL-----AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGR 190
Query: 468 ----YTAPEK----TVSEQGDVFSFGVILLELLTGKTVEKTGI------DLPKWVKAMVR 513
+ A E + Q DV+SFGV+L E++T GI +L K M R
Sbjct: 191 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMER 250
Query: 514 EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568
E E + N+ L C PD RPT A++ + +E+++ +
Sbjct: 251 PENCSE---------------EMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 72/257 (28%), Positives = 103/257 (40%), Gaps = 48/257 (18%)
Query: 329 AVKRLK--KLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKL-LVYKYQSNGSLLS 385
AVK LK KL MD+F + + +L H N++ L Y L +V + GSLL
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL--YGVVLTHPLMMVTELAPLGSLLD 84
Query: 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
L + F A IA G+ ++ E K H +L NILL ++
Sbjct: 85 RLRK--DALGHFLISTLCDYAVQIANGMRYL-----ESKRFIHRDLAARNILLASDDKVK 137
Query: 446 ISECGYSKFLDPKKTCLFSSN------GYTAPE----KTVSEQGDVFSFGVILLELLTGK 495
I + G + L + + APE +T S DV+ FGV L E+ T
Sbjct: 138 IGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT-- 195
Query: 496 TVEKTGIDLPKWVKAMVREEWTG-------EVFDKEVAKAGRQWAFP--LLNVALKCVSN 546
E W G + DKE + R A P + NV L+C ++
Sbjct: 196 ---------------YGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAH 240
Query: 547 SPDDRPTMAEVLERIEE 563
+P DRPT A + E + E
Sbjct: 241 NPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 61/252 (24%), Positives = 115/252 (45%), Gaps = 38/252 (15%)
Query: 317 LFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376
++M NS AVK LK +S+ F + + L+H ++ L + E ++ +
Sbjct: 22 VWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
Y + GSLL L++ GK P KL + + IA+G+ ++ E K H +L+ +N+
Sbjct: 82 YMAKGSLLDFLKSDEGGKVLLP-KL-IDFSAQIAEGMAYI-----ERKNYIHRDLRAANV 134
Query: 437 LLNENEDPLISECGYSKFL-DPKKTCLFSSN---GYTAPEK----TVSEQGDVFSFGVIL 488
L++E+ I++ G ++ + D + T + +TAPE + + + DV+SFG++L
Sbjct: 135 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 194
Query: 489 LELLTGKTVEKTGIDLPKWVKAMVR-------EEWTGEVFDKEVAKAGRQWAFPLLNVAL 541
E++T + G+ + A+ R E E++D +
Sbjct: 195 YEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD----------------IMK 238
Query: 542 KCVSNSPDDRPT 553
C ++RPT
Sbjct: 239 TCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 31/192 (16%)
Query: 322 LKNSAVYAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYK-- 376
+ AVK ++ S +E R+I +L+HPNI+ Y S +E+
Sbjct: 22 KDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR--YYGSERDEEKNTLNIF 79
Query: 377 --YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
Y S GSL SLL+ + GK P + I +GL +++ I H ++K +
Sbjct: 80 LEYVSGGSLSSLLKKF--GK--LPEPVIRKYTRQILEGLAYLHSNG-----IVHRDIKGA 130
Query: 435 NILLNENEDPLISECGYSKFLDPKKTCLFSS--NG---YTAPEKTV---SEQG---DVFS 483
NIL++ + +++ G +K L +T + G + APE V E G D++S
Sbjct: 131 NILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE--VIRGEEYGRAADIWS 188
Query: 484 FGVILLELLTGK 495
G ++E+ TGK
Sbjct: 189 LGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 8e-10
Identities = 59/192 (30%), Positives = 90/192 (46%), Gaps = 23/192 (11%)
Query: 318 FMVRLKNSA-VYAVKRLKK---LQVSMDEFSQTMRQI-GNLKHPNILPLVCYNSTNEEKL 372
+VR K++ +YA+K LKK ++ E + T R I + HP I+ L T EEKL
Sbjct: 10 LLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKL 68
Query: 373 -LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
LV +Y G L S L F + A I L++++ I + +L
Sbjct: 69 YLVLEYAPGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSLG-----IIYRDL 119
Query: 432 KLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSF 484
K NILL+ + +++ G +K L + + + G Y APE K + D +S
Sbjct: 120 KPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSL 179
Query: 485 GVILLELLTGKT 496
GV+L E+LTGK
Sbjct: 180 GVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 45/184 (24%), Positives = 88/184 (47%), Gaps = 19/184 (10%)
Query: 322 LKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLLVYKYQ 378
L+ A+K++ ++ + M++I NLKHPNI+ + T++ ++ +Y
Sbjct: 22 LETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
NGSL +++ + G FP L + +GL +++++ + H ++K +NIL
Sbjct: 82 ENGSLRQIIKKF--GP--FPESLVAVYVYQVLQGLAYLHEQG-----VIHRDIKAANILT 132
Query: 439 NENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSFGVILLEL 491
++ +++ G + L+ S G + APE S D++S G ++EL
Sbjct: 133 TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIEL 192
Query: 492 LTGK 495
LTG
Sbjct: 193 LTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 62/277 (22%), Positives = 113/277 (40%), Gaps = 52/277 (18%)
Query: 312 TICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQ--------IGNLKHPNILPLVC 363
+C + K A+K LK S R +G HPNI+ L
Sbjct: 19 EVCRGRLKLPGKKEIDVAIKTLK------AGSSDKQRLDFLTEASIMGQFDHPNIIRLEG 72
Query: 364 YNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEE 423
+ + +++ +Y NGSL L +GK F + + GIA G+ ++ E
Sbjct: 73 VVTKSRPVMIITEYMENGSLDKFLREN-DGK--FTVGQLVGMLRGIASGMKYL-----SE 124
Query: 424 KTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KT 474
H +L NIL+N N +S+ G S+ L+ + + G +TAPE +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 475 VSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533
+ DV+SFG+++ E+++ G + P W + + + K V R
Sbjct: 185 FTSASDVWSFGIVMWEVMSYG--------ERPYW-------DMSNQDVIKAVEDGYRLPP 229
Query: 534 -----FPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565
L + L C ++RPT ++++ +++++
Sbjct: 230 PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 44/250 (17%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLE 388
AVK LK + F + L+HPN++ L+ +V +Y + GSL+ L
Sbjct: 33 AVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR 92
Query: 389 AYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448
+ G+ +L A + +G++++ EEK H +L N+L++E+ +S+
Sbjct: 93 S--RGRAVITLAQQLGFALDVCEGMEYL-----EEKNFVHRDLAARNVLVSEDLVAKVSD 145
Query: 449 CGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLTGKTVEK 499
G +K + +G +TAPE K S + DV+SFG++L E+ + V
Sbjct: 146 FGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
Query: 500 TGIDLPKWVKAMVR-------EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRP 552
I L V + + E EV+ V C P RP
Sbjct: 201 PRIPLKDVVPHVEKGYRMEAPEGCPPEVYK----------------VMKDCWELDPAKRP 244
Query: 553 TMAEVLERIE 562
T ++ E++
Sbjct: 245 TFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 60/244 (24%), Positives = 120/244 (49%), Gaps = 32/244 (13%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLE 388
AVK +K +S++ F + L+H ++ L T E ++ ++ + GSLL L+
Sbjct: 34 AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLK 92
Query: 389 AYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448
+ K+ P KL + + IA+G+ F+ E++ H +L+ +NIL++ + I++
Sbjct: 93 SDEGSKQPLP-KL-IDFSAQIAEGMAFI-----EQRNYIHRDLRAANILVSASLVCKIAD 145
Query: 449 CGYSKFLDPKKTCLFSSNGY----TAPEK----TVSEQGDVFSFGVILLELLTGKTVEKT 500
G ++ ++ + + TAPE + + + DV+SFG++L+E++T +
Sbjct: 146 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 205
Query: 501 GIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP--LLNVALKCVSNSPDDRPT---MA 555
G+ P+ ++A+ R + R P L N+ ++C N P++RPT +
Sbjct: 206 GMSNPEVIRALERG-----------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQ 254
Query: 556 EVLE 559
VL+
Sbjct: 255 SVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 61/245 (24%), Positives = 108/245 (44%), Gaps = 29/245 (11%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKL-LVYKYQSNGSLLSLL 387
A+K LK + + F Q + + L+H ++PL Y +EE + +V ++ GSLL L
Sbjct: 34 AIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAVVSEEPIYIVTEFMGKGSLLDFL 91
Query: 388 EAYIEGK-RDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446
+ EG + + +A IA G+ ++ E H +L+ +NIL+ +N I
Sbjct: 92 K---EGDGKYLKLPQLVDMAAQIADGMAYI-----ERMNYIHRDLRAANILVGDNLVCKI 143
Query: 447 SECGYSKFLDPKKTCLFSSNGY----TAPEKTV----SEQGDVFSFGVILLELLTGKTVE 498
++ G ++ ++ + + TAPE + + + DV+SFG++L EL+T V
Sbjct: 144 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
Query: 499 KTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVL 558
G MV E +V + L + C PD+RPT +
Sbjct: 204 YPG---------MVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQ 254
Query: 559 ERIEE 563
+E+
Sbjct: 255 SFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 66/257 (25%), Positives = 103/257 (40%), Gaps = 55/257 (21%)
Query: 329 AVKRLKK--LQVSMDEF---SQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNG 381
AVK LK+ + EF + M Q L HP I+ L VC E +LV + G
Sbjct: 27 AVKTLKQEHIAAGKKEFLREASVMAQ---LDHPCIVRLIGVC---KGEPLMLVMELAPLG 80
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
LL Y++ +R+ P +A +A G+ ++ E K H +L N+LL
Sbjct: 81 PLLK----YLKKRREIPVSDLKELAHQVAMGMAYL-----ESKHFVHRDLAARNVLLVNR 131
Query: 442 EDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLEL 491
IS+ G S+ L ++ + APE S + DV+S+GV L E
Sbjct: 132 HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEA 191
Query: 492 LT--GKTV-EKTGIDLPKWVKAMVR----EEWTGEVFDKEVAKAGRQWAFPLLNVALKCV 544
+ K E G ++ +++ R EE E++ + L C
Sbjct: 192 FSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYS----------------IMLSCW 235
Query: 545 SNSPDDRPTMAEVLERI 561
P+DRPT +E+
Sbjct: 236 KYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 72/269 (26%), Positives = 114/269 (42%), Gaps = 67/269 (24%)
Query: 322 LKNSAVYAVKRLKKLQVSMDEFSQTMRQ-----------IGNLKHPNILPLVCYNST--N 368
L + +AVK +VS+ + QT ++ + L+HPNI V Y T
Sbjct: 22 LDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI---VQYLGTERE 73
Query: 369 EEKLLVY-KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIP 427
E+ L ++ + GSL LL+ Y FP + I GL++++ + T+
Sbjct: 74 EDNLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR----NTV- 124
Query: 428 HGNLKLSNILLNENEDPLISECGYSK---FLDPKKTCLFSSNGYTAPEKTVSEQG----- 479
H ++K +NIL++ N +++ G +K K+ S + APE + G
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY-WMAPEVIAQQGGYGLAA 183
Query: 480 DVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL-- 537
D++S G +LE+ TGK P W + E VF K GR P +
Sbjct: 184 DIWSLGCTVLEMATGK---------PPWSQ----LEGVAAVF-----KIGRSKELPPIPD 225
Query: 538 -------NVALKCVSNSPDDRPTMAEVLE 559
+ LKC+ P RPT AE+LE
Sbjct: 226 HLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 63/238 (26%), Positives = 106/238 (44%), Gaps = 35/238 (14%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKL-LVYKYQSNGSLLSLL 387
A+K LK +S + F Q + + L+H ++ L Y +EE + +V +Y S GSLL L
Sbjct: 34 AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFL 91
Query: 388 EAYIEGKRDFPWKLRL----SIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443
K + LRL +A IA G+ ++ E H +L+ +NIL+ EN
Sbjct: 92 ------KGEMGKYLRLPQLVDMAAQIASGMAYV-----ERMNYVHRDLRAANILVGENLV 140
Query: 444 PLISECGYSKFLDPKKTCLFSSNGY----TAPEKTV----SEQGDVFSFGVILLELLTGK 495
+++ G ++ ++ + + TAPE + + + DV+SFG++L EL T
Sbjct: 141 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 200
Query: 496 TVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPT 553
V G MV E +V + L ++ +C P++RPT
Sbjct: 201 RVPYPG---------MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 7e-09
Identities = 56/248 (22%), Positives = 107/248 (43%), Gaps = 27/248 (10%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKY 377
+ A+K +K S ++ + + +I KHPNI+ +E +V ++
Sbjct: 21 HKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
S GSL LL++ + + + KGL++++ I H ++K +NIL
Sbjct: 79 CSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLH-----SNGIIHRDIKAANIL 130
Query: 438 LNENEDPLISECGYSKFLDPKKTC--LFSSNGYTAPE----KTVSEQGDVFSFGVILLEL 491
L + + + + G S L K + + + APE K + D++S G+ +EL
Sbjct: 131 LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIEL 190
Query: 492 LTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDR 551
GK +LP +KA+ + G + +W+ + KC+ +P+ R
Sbjct: 191 AEGKPPYS---ELPP-MKALFKIATNGPPGLRN----PEKWSDEFKDFLKKCLQKNPEKR 242
Query: 552 PTMAEVLE 559
PT ++L+
Sbjct: 243 PTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 82 RLENMNLS-----GIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNL 136
RLEN++LS G + L L L + L+ N + G IP +S+C++L L+LS N
Sbjct: 476 RLENLDLSRNQFSGAV-PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPDN 168
LSG +P + +++ L LD+S N + P N
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN 566
|
Length = 968 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 61/257 (23%), Positives = 106/257 (41%), Gaps = 52/257 (20%)
Query: 328 YAVKRLKKLQVSM-DEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386
R Q M + + +L H NI+ + + +T E + +Y GS+ S
Sbjct: 39 TIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSC 98
Query: 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446
L Y G+ F +L + +GL +++ K I H +LK N+L++ + I
Sbjct: 99 LRTY--GR--FEEQLVRFFTEQVLEGLAYLHSKG-----ILHRDLKADNLLVDADGICKI 149
Query: 447 SECGYSK-----FLDPKKTCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGK 495
S+ G SK + + + + S + APE + S + D++S G ++LE+ G+
Sbjct: 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
Query: 496 TVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP---------LLNVALK---- 542
+ EE +F K G + + P L VAL
Sbjct: 210 -------------RPWSDEEAIAAMF-----KLGNKRSAPPIPPDVSMNLSPVALDFLNA 251
Query: 543 CVSNSPDDRPTMAEVLE 559
C + +PD+RPT E+L+
Sbjct: 252 CFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 1/85 (1%)
Query: 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNL 136
N+ + L NL+G I E LC +L + L N ++G IP S+ CR L + L N
Sbjct: 357 NLTVLDLSTNNLTGEI-PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415
Query: 137 LSGAVPLALTKLKHLKTLDISNNHF 161
SG +P TKL + LDISNN+
Sbjct: 416 FSGELPSEFTKLPLVYFLDISNNNL 440
|
Length = 968 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 2e-08
Identities = 17/60 (28%), Positives = 30/60 (50%)
Query: 102 HLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+L+ + L+ N + + L L+LS N L+ P A + L L++LD+S N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 27/191 (14%)
Query: 320 VRLKNSAVYAVKR--LKKLQVSM-DEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLL--V 374
VR + VYA+K+ L K+ +E R + L I+ Y S ++ L V
Sbjct: 20 VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY--YESFLDKGKLNIV 77
Query: 375 YKYQSNGSLLSLLEAYIEGKR---DFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
+Y NG L LL+ G+ D W+ + I G L ++ K I H ++
Sbjct: 78 MEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLG----LAHLHSKK-----ILHRDI 127
Query: 432 KLSNILLNENEDPLISECGYSKFLDPKKT---CLFSSNGYTAPE----KTVSEQGDVFSF 484
K N+ L+ ++ I + G +K L + + Y +PE K +E+ DV++
Sbjct: 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWAL 187
Query: 485 GVILLELLTGK 495
GV+L E TGK
Sbjct: 188 GVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 55/265 (20%), Positives = 101/265 (38%), Gaps = 44/265 (16%)
Query: 317 LFMVRLKNSAVYAVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLV 374
++ LK + AVK + +F Q + HPNI+ L+ + +V
Sbjct: 11 VYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70
Query: 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
+ GSLL+ L + K K L ++ A G++++ E K H +L
Sbjct: 71 MELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYL-----ESKNCIHRDLAAR 122
Query: 435 NILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPEK----TVSEQGDVFSFG 485
N L+ EN IS+ G S+ + + +TAPE + + DV+S+G
Sbjct: 123 NCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYG 182
Query: 486 VILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR--------QWAFPLL 537
++L E + P RE + R + + L+
Sbjct: 183 ILLWETFSLGDTP-----YPGMSNQQTRE---------RIESGYRMPAPQLCPEEIYRLM 228
Query: 538 NVALKCVSNSPDDRPTMAEVLERIE 562
+C + P++RP+ +E+ ++
Sbjct: 229 L---QCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 56/192 (29%), Positives = 87/192 (45%), Gaps = 24/192 (12%)
Query: 318 FMVRLKNS-AVYAVKRLKKLQVSMD---EFSQTMRQIGNL--KHPNILPLVCYNSTNEEK 371
+ LK + +YAVK LKK + D E + T +++ L KHP + L T +
Sbjct: 12 LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71
Query: 372 LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
V +Y + G L+ +I+ F A I GL F++ E+ I + +L
Sbjct: 72 FFVMEYVNGGDLM----FHIQRSGRFDEPRARFYAAEIVLGLQFLH-----ERGIIYRDL 122
Query: 432 KLSNILLNENEDPLISECGYSK--FLDPKKTCLF-SSNGYTAPEKTVSEQG-----DVFS 483
KL N+LL+ I++ G K L T F + Y APE +S Q D ++
Sbjct: 123 KLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPE-ILSYQPYGPAVDWWA 181
Query: 484 FGVILLELLTGK 495
GV+L E+L G+
Sbjct: 182 LGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 22/193 (11%)
Query: 317 LFMVRLKNSA-VYAVKRLKKLQVSMD---EFSQTMRQIGNL--KHPNILPLVCYNSTNEE 370
+ + LK + +A+K LKK V D E + R++ L +HP + L C T E
Sbjct: 11 VMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEH 70
Query: 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
V +Y + G L+ +I+ F A I GL F+++K I + +
Sbjct: 71 LFFVMEYLNGGDLMF----HIQSSGRFDEARARFYAAEIICGLQFLHKKG-----IIYRD 121
Query: 431 LKLSNILLNENEDPLISECGYSK---FLDPKKTCLFSSNGYTAPE----KTVSEQGDVFS 483
LKL N+LL+++ I++ G K + K + + Y APE + +E D +S
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWS 181
Query: 484 FGVILLELLTGKT 496
FGV+L E+L G++
Sbjct: 182 FGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 48/193 (24%), Positives = 91/193 (47%), Gaps = 20/193 (10%)
Query: 313 ICSSLFMVRLKNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEE 370
+CS + K A+K LK + +F +G HPNI+ L + ++
Sbjct: 20 VCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79
Query: 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
++V +Y NGSL + L + +G+ F + + GIA G+ ++ + H +
Sbjct: 80 VMIVTEYMENGSLDAFLRKH-DGQ--FTVIQLVGMLRGIASGMKYL-----SDMGYVHRD 131
Query: 431 LKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGD 480
L NIL+N N +S+ G S+ L+ +++ G +TAPE + + D
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASD 191
Query: 481 VFSFGVILLELLT 493
V+S+G+++ E+++
Sbjct: 192 VWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 27 VGGELSESESFFKFISAVD-SQNVLRIGWNGNLPHPCSYNLKGIK-CNLHATNIVG---- 80
+ G++S + +I ++ S N L +G +P ++ NL N G
Sbjct: 81 ISGKISSAIFRLPYIQTINLSNNQL----SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR 136
Query: 81 --------IRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNL 132
+ L N LSG I + + L+V+ L N++ G+IP S++N L +L L
Sbjct: 137 GSIPNLETLDLSNNMLSGEIPND-IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195
Query: 133 SSNLLSGAVPLALTKLKHLKTLDISNNHFAATSP 166
+SN L G +P L ++K LK + + N+ + P
Sbjct: 196 ASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 1/92 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
++ + L + +LSG I E + +L++L ++ L N G+IP ++++ RL L L SN
Sbjct: 284 QKLISLDLSDNSLSGEI-PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPD 167
SG +P L K +L LD+S N+ P+
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
|
Length = 968 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 71/260 (27%), Positives = 121/260 (46%), Gaps = 46/260 (17%)
Query: 333 LKKLQVS----MDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLSL 386
+KKLQ S + +F + + + +L+H NI+ VCY++ LV +Y GSL
Sbjct: 38 VKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDY 97
Query: 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL- 445
L+ + E + D KL L A+ I KG++++ K H +L NIL+ E+E+ +
Sbjct: 98 LQKHRE-RLDHR-KL-LLYASQICKGMEYL-----GSKRYVHRDLATRNILV-ESENRVK 148
Query: 446 ISECGYSKFL----------DPKKTCLFSSNGYTAPEK----TVSEQGDVFSFGVILLEL 491
I + G +K L +P ++ +F + APE S DV+SFGV+L EL
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPESLTESKFSVASDVWSFGVVLYEL 204
Query: 492 LTGKTVEKTGIDLPKWVKAMVREEWTGE--VFD-KEVAKAGRQWAFP------LLNVALK 542
T + P M+ + G+ V+ E+ K + P + + +
Sbjct: 205 FTYSDKSCSP---PAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKE 261
Query: 543 CVSNSPDDRPTMAEVLERIE 562
C +N P RP+ +E+ ++E
Sbjct: 262 CWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 60/253 (23%), Positives = 116/253 (45%), Gaps = 49/253 (19%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKL-LVYKYQSNGSLLS 385
A+K + + +S ++F + + + L HP ++ L VC T ++ L +V ++ NG LL+
Sbjct: 32 AIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC---TQQKPLYIVTEFMENGCLLN 88
Query: 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
L + + + LS+ + +G++++ E + H +L N L++
Sbjct: 89 YLR---QRQGKLSKDMLLSMCQDVCEGMEYL-----ERNSFIHRDLAARNCLVSSTGVVK 140
Query: 446 ISECGYSKF-LDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT- 493
+S+ G +++ LD + T SS+G ++ PE S + DV+SFGV++ E+ T
Sbjct: 141 VSDFGMTRYVLDDEYT---SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTE 197
Query: 494 GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW-----AFPLLNVALKCVSNSP 548
GK M E+ + + +++ R + + + V C P
Sbjct: 198 GK---------------MPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKP 242
Query: 549 DDRPTMAEVLERI 561
+ RPT AE+L I
Sbjct: 243 EGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 35/198 (17%)
Query: 313 ICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFS------QTMRQIG---NLKHPNILPLV- 362
+CS+ + +N A+ KK+ M FS +T R++ +L+H NI+ L
Sbjct: 26 VCSARDQLTGQNVAI------KKI---MKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 363 CYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNE 422
+ S E+ V + L LL + R + I +GL +++
Sbjct: 77 IFISPLEDIYFVTELLGT-DLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG-- 128
Query: 423 EKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTVSEQG--- 479
+ H +LK SNIL+NEN D I + G ++ DP+ T S+ Y APE ++ Q
Sbjct: 129 ---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDV 185
Query: 480 --DVFSFGVILLELLTGK 495
D++S G I E+L GK
Sbjct: 186 EVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 46/180 (25%), Positives = 89/180 (49%), Gaps = 23/180 (12%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLE 388
A+K +++ +S ++F + + + L HP ++ L + LV+++ +G L L
Sbjct: 32 AIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR 91
Query: 389 AYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448
A + F + L + + +G+ ++ E + H +L N L+ EN+ +S+
Sbjct: 92 AQ---RGKFSQETLLGMCLDVCEGMAYL-----ESSNVIHRDLAARNCLVGENQVVKVSD 143
Query: 449 CGYSKF-LDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT-GKT 496
G ++F LD + T SS G +++PE S + DV+SFGV++ E+ + GKT
Sbjct: 144 FGMTRFVLDDQYT---SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT 200
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 29/80 (36%), Positives = 51/80 (63%), Gaps = 1/80 (1%)
Query: 87 NLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALT 146
NL+G I + +L L++L+ + L +N + G IP SI + ++L L+LS N LSG +P +
Sbjct: 247 NLTGPIPS-SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305
Query: 147 KLKHLKTLDISNNHFAATSP 166
+L++L+ L + +N+F P
Sbjct: 306 QLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 56/280 (20%)
Query: 319 MVRLKNSAVYAVKRLKKLQVSMDEFS------QTMRQIGNLKHPNILPL--VCYNSTNEE 370
+ ++ AVK LK + + S + M+ IG KH NI+ L VC T E
Sbjct: 36 LDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIG--KHKNIINLLGVC---TQEG 89
Query: 371 KL-LVYKYQSNGSLLSLLEAY----IEGKRDFPWKLR--------LSIATGIAKGLDFMY 417
L +V +Y ++G+L L A D P +S A +A+G++F+
Sbjct: 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA 149
Query: 418 QKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK---FLDPKKTCLFSSNG-----YT 469
K K I H +L N+L+ E+ I++ G ++ +D + +NG +
Sbjct: 150 SK----KCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT---TNGRLPVKWM 201
Query: 470 APE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV 525
APE + + Q DV+SFGV+L E+ T GI + + K +++E G +K
Sbjct: 202 APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-LLKE---GYRMEKPQ 257
Query: 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565
L ++ C P RPT +++E ++ ++
Sbjct: 258 NCTQE-----LYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 63/241 (26%), Positives = 112/241 (46%), Gaps = 41/241 (17%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKL-LVYKYQSNGSLLSLL 387
AVK LK +S + F + + + L+H ++ L Y +EE + +V +Y S GSLL L
Sbjct: 34 AVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFL 91
Query: 388 EAYIEGK-RDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446
+ +G+ R + +A +A G+ ++ E H +L+ +NIL+ + I
Sbjct: 92 K---DGEGRALKLPNLVDMAAQVAAGMAYI-----ERMNYIHRDLRSANILVGDGLVCKI 143
Query: 447 SECGYSKFL-DPKKTCLFSSN---GYTAPEKTV----SEQGDVFSFGVILLELLTGKTVE 498
++ G ++ + D + T + +TAPE + + + DV+SFG++L EL+T V
Sbjct: 144 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
Query: 499 KTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVALKCVSNSPDDRP 552
G++ EV E + G + P L + L+C P++RP
Sbjct: 204 YPGMN-------------NREVL--EQVERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248
Query: 553 T 553
T
Sbjct: 249 T 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 48/185 (25%), Positives = 89/185 (48%), Gaps = 25/185 (13%)
Query: 323 KNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380
K AV A+K LK + +F +G H NI+ L + + +++ +Y N
Sbjct: 32 KEVAV-AIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMEN 90
Query: 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440
G+L L + +F + + GIA G+ ++ + H +L NIL+N
Sbjct: 91 GALDKYLR---DHDGEFSSYQLVGMLRGIAAGMKYL-----SDMNYVHRDLAARNILVNS 142
Query: 441 NEDPLISECGYSKFL--DPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVIL 488
N + +S+ G S+ L DP+ T ++++G +TAPE + + DV+SFG+++
Sbjct: 143 NLECKVSDFGLSRVLEDDPEGT--YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVM 200
Query: 489 LELLT 493
E+++
Sbjct: 201 WEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 26/159 (16%)
Query: 350 IGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGI 409
+G HPNI+ L + + +++ ++ NG+L S L +G+ F + + GI
Sbjct: 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN-DGQ--FTVIQLVGMLRGI 115
Query: 410 AKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL-----DPKKTCLFS 464
A G+ ++ E H +L NIL+N N +S+ G S+FL DP T S
Sbjct: 116 AAGMKYL-----SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT---S 167
Query: 465 SNG------YTAPE----KTVSEQGDVFSFGVILLELLT 493
S G +TAPE + + DV+S+G+++ E+++
Sbjct: 168 SLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 59/254 (23%), Positives = 111/254 (43%), Gaps = 39/254 (15%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLL--VY 375
R + + +K++ Q++ DE + LK HPNI+ Y + E+K L V
Sbjct: 21 RKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY--YENFLEDKALMIVM 78
Query: 376 KYQSNGSLLSLLEAYIEGKRD--FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKL 433
+Y G+L YI+ + + L I L ++ K I H +LK
Sbjct: 79 EYAPGGTL----AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-----LILHRDLKT 129
Query: 434 SNILLNENEDPL-ISECGYSKFLDPKKTC--LFSSNGYTAPE----KTVSEQGDVFSFGV 486
NILL++++ + I + G SK L K + + Y +PE K +++ D+++ G
Sbjct: 130 QNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGC 189
Query: 487 ILLELLTGKTVEKTGIDLPKWVKAMVREEWT--GEVFDKEVAKAGRQWAFPLLNVALKCV 544
+L EL + K + +LP V ++ + + + ++ RQ +LN+
Sbjct: 190 VLYELASLKRAFE-AANLPALVLKIMSGTFAPISDRYSPDL----RQLILSMLNL----- 239
Query: 545 SNSPDDRPTMAEVL 558
P RP +++++
Sbjct: 240 --DPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 49/219 (22%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 353 LKHPNILPLVCYNSTNEEKLLV--YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIA 410
L+HPNI+ YN ++ L+ +Y + G+L + + + F ++ L I
Sbjct: 56 LQHPNIIAY--YNHFMDDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIV 111
Query: 411 KGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK----KTCLFSSN 466
+ ++++ I H ++K NI L + + + G SK L + +T + +
Sbjct: 112 SAVSYIHKAG-----ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTP 165
Query: 467 GYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVF 521
Y +PE + + D+++ G +L ELLT +T + T + V +V+ +T V
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--NPLNLVVKIVQGNYTPVV- 222
Query: 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560
++ L+++ + P+ RPT EVL++
Sbjct: 223 --------SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 78 IVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
++ ++L LSG I E L + L + L+ N + G+IP S S L+ L+LS N L
Sbjct: 501 LMQLKLSENKLSGEIPDE-LSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL 559
Query: 138 SGAVPLALTKLKHLKTLDISNNHFAATSP 166
SG +P L ++ L ++IS+NH + P
Sbjct: 560 SGEIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 60/249 (24%), Positives = 101/249 (40%), Gaps = 33/249 (13%)
Query: 322 LKNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379
LK+ AVK K+ Q +F R + HPNI+ L+ + + +V +
Sbjct: 16 LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75
Query: 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
G LS L + K + K + A A G+ ++ E K H +L N L+
Sbjct: 76 GGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYL-----ESKNCIHRDLAARNCLVG 127
Query: 440 ENEDPLISECGYSKFLDPKKTCLFSSNG-------YTAPEK----TVSEQGDVFSFGVIL 488
EN IS+ G S+ D ++SS+G +TAPE S + DV+S+G++L
Sbjct: 128 ENNVLKISDFGMSRQEDDG---IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILL 184
Query: 489 LELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
E + G M ++ +V ++ + V +C P
Sbjct: 185 WETFSLGVCPYPG---------MTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235
Query: 549 DDRPTMAEV 557
++RP +E+
Sbjct: 236 ENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 48/193 (24%), Positives = 82/193 (42%), Gaps = 21/193 (10%)
Query: 315 SSLFMVRLKNSA-VYAVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEE 370
++ R K + + A+K++K S +R+I LK HPNI+ L+ +
Sbjct: 13 GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD 72
Query: 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
LV+++ L L++ +R P L S + +GL F + I H +
Sbjct: 73 LYLVFEFMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG-----ILHRD 123
Query: 431 LKLSNILLNENEDPLISECGYSKFLDPKK---TCLFSSNGYTAPE-----KTVSEQGDVF 482
LK N+L+N +++ G ++ T + Y APE K S D++
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIW 183
Query: 483 SFGVILLELLTGK 495
S G I ELL+ +
Sbjct: 184 SVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 337 QVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGK 394
+ + E + M +G+L H I+ L +C ++ + LV + GSLL ++
Sbjct: 50 RQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQ---LVTQLSPLGSLLD----HVRQH 102
Query: 395 RD-FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453
RD + L+ IAKG+ ++ EE + H NL NILL + I++ G +
Sbjct: 103 RDSLDPQRLLNWCVQIAKGMYYL-----EEHRMVHRNLAARNILLKSDSIVQIADFGVAD 157
Query: 454 FLDPKKTCLFSSNGYTAPEKTVSE---------QGDVFSFGVILLELLT 493
L P F S T + E Q DV+S+GV + E+++
Sbjct: 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 46/230 (20%)
Query: 352 NLKHPNILPLVCYNSTNEEKLLV-YKYQSNGSLLSLLEAYIEGKRDFPWKLR----LSIA 406
L H NILP++ + E V Y Y + G+L L+ G+ + P L + +A
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 407 TGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-TCLFSS 465
IA G+ +++++ + H ++ N +++E I++ S+ L P CL +
Sbjct: 124 IQIACGMSYLHKRG-----VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178
Query: 466 NG----YTAPE----KTVSEQGDVFSFGVILLELLT-GKT--VEKTGIDLPKWVKAMVRE 514
+ A E K S DV+SFGV+L EL+T G+T VE ID P + A +
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE---ID-PFEMAAYL-- 232
Query: 515 EWTGEVFDKEVAKAGRQWAFP------LLNVALKCVSNSPDDRPTMAEVL 558
K G + A P L V C + P++RP+ ++++
Sbjct: 233 ------------KDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 55/274 (20%)
Query: 315 SSLFMVR-LKNSAVYAVKRLKKLQVSMDEFSQTMRQI-------GNLKHPNILPLVCYNS 366
SS + R +K + AVK++ ++ + E + + + L HP+I+ +
Sbjct: 14 SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR--MLGA 71
Query: 367 TNEEKL--LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIA--TGIAKGLDFMYQKSNE 422
T E+ L ++ + GS+ LL Y +K + I + +GL +++
Sbjct: 72 TCEDSHFNLFVEWMAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLH----- 120
Query: 423 EKTIPHGNLKLSNILLNEN-EDPLISECGYSKFLDPKKTC-------LFSSNGYTAPEKT 474
E I H ++K +N+L++ + I++ G + L K T L + + APE
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 475 VSEQ----GDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530
EQ DV+S G +++E+ T K P W A +F ++A A
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAK---------PPW-NAEKHSNHLALIF--KIASATT 228
Query: 531 QWAFP------LLNVALKCVSNSPDDRPTMAEVL 558
+ P L +V L+C+ P+DRP E+L
Sbjct: 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 24/67 (35%), Positives = 36/67 (53%)
Query: 103 LRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFA 162
L + L+RN G +P + + L L LS N LSG +P L+ K L +LD+S+N +
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536
Query: 163 ATSPDNF 169
P +F
Sbjct: 537 GQIPASF 543
|
Length = 968 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 21/181 (11%)
Query: 328 YAVKRLKKLQVSMD---EFSQTMRQIGNL--KHPNILPLVCYNSTNEEKLLVYKYQSNGS 382
+AVK LKK V +D E + +++ L ++P + L C T E V ++ + G
Sbjct: 23 FAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGD 82
Query: 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442
L+ +I+ K F A I GL F++ K I + +LKL N++L+ +
Sbjct: 83 LM----FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG-----IIYRDLKLDNVMLDRDG 133
Query: 443 DPLISECGYSK---FLDPKKTCLFSSNGYTAPEKTVSEQG----DVFSFGVILLELLTGK 495
I++ G K F D + + + Y APE + D +SFGV+L E+L G+
Sbjct: 134 HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
Query: 496 T 496
+
Sbjct: 194 S 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 40/230 (17%)
Query: 339 SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRD-- 396
S E + M Q+ + KH + VC +E ++V +Y GSL + Y++ ++
Sbjct: 45 SFFEAASMMSQLSH-KHLVLNYGVCV--CGDESIMVQEYVKFGSL----DTYLKKNKNLI 97
Query: 397 -FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455
WKL +A +A L F+ E+K + HGN+ N+LL ED + K
Sbjct: 98 NISWKLE--VAKQLAWALHFL-----EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150
Query: 456 DP-------KKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGID 503
DP K L + PE + +S D +SFG L E+ +G + +D
Sbjct: 151 DPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210
Query: 504 LPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPT 553
K K E D+ A + W L N+ +C+ PD RP+
Sbjct: 211 SQK--KLQFYE-------DRHQLPAPK-WT-ELANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 61/265 (23%), Positives = 100/265 (37%), Gaps = 48/265 (18%)
Query: 329 AVKRLKK---LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385
AVK LK+ + D F + + HPNI+ L+ + + L+++Y + G L
Sbjct: 39 AVKMLKEEASADMQAD-FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 386 LLEA------------------YIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIP 427
L +L IA +A G+ ++ E+
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL-----SERKFV 152
Query: 428 HGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPEKTV----SEQ 478
H +L N L+ EN I++ G S+ + S N + PE + +
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 479 GDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538
DV+++GV+L E+ + G+ P + M EE V D V L N
Sbjct: 213 SDVWAYGVVLWEIFS------YGMQ-PYY--GMAHEEVIYYVRDGNVLSCPDNCPLELYN 263
Query: 539 VALKCVSNSPDDRPTMAEV---LER 560
+ C S P DRP+ A + L+R
Sbjct: 264 LMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 409 IAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK--FLDP---KKTCLF 463
+A+G++F+ + K I H +L NILL+EN I + G ++ + DP +K
Sbjct: 183 VARGMEFLASR----KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 464 SSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGE 519
+ APE K + Q DV+SFGV+L E+ + G+ + EE+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ--------INEEFCQR 289
Query: 520 VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568
+ D +A + + L C P +RPT + ++E + +++ N
Sbjct: 290 LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 33/83 (39%), Positives = 46/83 (55%), Gaps = 5/83 (6%)
Query: 87 NLSGIIDAET--LCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLA 144
NLSG I E L L HL L N + G IP+S+ N + L YL L N LSG +P +
Sbjct: 223 NLSGEIPYEIGGLTSLNHL---DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279
Query: 145 LTKLKHLKTLDISNNHFAATSPD 167
+ L+ L +LD+S+N + P+
Sbjct: 280 IFSLQKLISLDLSDNSLSGEIPE 302
|
Length = 968 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 22/180 (12%)
Query: 327 VYAVKRLKKLQVSMDEFSQTMRQIGNL---KHPNILPLVCYNS--TNEEKLLVYKYQSNG 381
+ AVK ++ L+++ Q +R++ L P I+ Y + N + + +Y G
Sbjct: 28 IMAVKTIR-LEINEAIQKQILRELDILHKCNSPYIVG--FYGAFYNNGDISICMEYMDGG 84
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
SL +L+ E + P ++ IA + KGL ++++K I H ++K SNIL+N
Sbjct: 85 SLDKILK---EVQGRIPERILGKIAVAVLKGLTYLHEKHK----IIHRDVKPSNILVNSR 137
Query: 442 EDPLISECGYSKFL--DPKKTCLFSSNGYTAPEKTVSE----QGDVFSFGVILLELLTGK 495
+ + G S L KT + +S+ Y APE+ + D++S G+ L+EL TG+
Sbjct: 138 GQIKLCDFGVSGQLVNSLAKTFVGTSS-YMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 62/249 (24%), Positives = 111/249 (44%), Gaps = 39/249 (15%)
Query: 345 QTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPW----- 399
+ M+ IG KH NI+ L+ + + ++ +Y S G+L L A D+ +
Sbjct: 69 EMMKMIG--KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 400 -------KLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452
K +S A +A+G++++ + K I H +L N+L+ E+ I++ G +
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQ----KCI-HRDLAARNVLVTEDNVMKIADFGLA 181
Query: 453 KFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID 503
+ + ++NG + APE + + Q DV+SFGV+L E+ T GI
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241
Query: 504 LPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563
+ + K +++E G DK L + +C P RPT +++E ++
Sbjct: 242 VEELFK-LLKE---GHRMDKPA-----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292
Query: 564 V--VNGNDE 570
V V DE
Sbjct: 293 VLTVTSTDE 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 3e-06
Identities = 42/192 (21%), Positives = 85/192 (44%), Gaps = 25/192 (13%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQT-MRQIG---NLKHPNILPL--VCYNSTNEEKLLV 374
K + A+K+++ ++ + F T +R+I L+HPNI+ L + + +V
Sbjct: 20 NKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78
Query: 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
++Y + L LL+ + F + +GL +++ I H ++K S
Sbjct: 79 FEYMDH-DLTGLLD---SPEVKFTESQIKCYMKQLLEGLQYLHSNG-----ILHRDIKGS 129
Query: 435 NILLNENEDPLISECGYSKFLDPKKTCLFSSN----GYTAPE-----KTVSEQGDVFSFG 485
NIL+N + +++ G ++ + + +++ Y PE + D++S G
Sbjct: 130 NILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVG 189
Query: 486 VILLELLTGKTV 497
IL EL GK +
Sbjct: 190 CILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 48/196 (24%)
Query: 329 AVKRLK-----KLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383
A+K LK K+Q EF Q + +L+HPNI+ L+ + + ++++Y ++G L
Sbjct: 39 AIKTLKENAEPKVQ---QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL 95
Query: 384 LSLL-----------EAYIEGKRDFPWKLR-LSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
L E+ E + L IA IA G++++ S+ H +L
Sbjct: 96 HEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL--SSHH---FVHRDL 150
Query: 432 KLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTV---------------- 475
N L+ E IS+ G S+ ++S++ Y K++
Sbjct: 151 AARNCLVGEGLTVKISDFGLSRD-------IYSADYYRVQSKSLLPVRWMPPEAILYGKF 203
Query: 476 SEQGDVFSFGVILLEL 491
+ + D++SFGV+L E+
Sbjct: 204 TTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 22/195 (11%)
Query: 315 SSLFMVRLK-NSAVYAVKRLKKLQVSMDE---FSQTMRQIGNL--KHPNILPLVCYNSTN 368
+ + +VRLK N +YA+K +KK V DE + QT + + +P ++ L T
Sbjct: 9 AKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT 68
Query: 369 EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPH 428
LV +Y + G L+ +++ +R P + A I L+F++ E+ I +
Sbjct: 69 SRLFLVIEYVNGGDLM----FHMQRQRKLPEEHARFYAAEICIALNFLH-----ERGIIY 119
Query: 429 GNLKLSNILLNENEDPLISECGYSK-FLDPKKT--CLFSSNGYTAPEKTVSEQG----DV 481
+LKL N+LL+ + +++ G K L P T + Y APE E+ D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 482 FSFGVILLELLTGKT 496
++ GV++ E++ G++
Sbjct: 180 WALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 63/260 (24%), Positives = 116/260 (44%), Gaps = 30/260 (11%)
Query: 317 LFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKH---PNILPLVCYNSTNEEKLL 373
+F V K S + ++L L++ +Q +R++ L P I+ ++ E +
Sbjct: 21 VFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80
Query: 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKL 433
++ GSL +L+ G+ P ++ ++ + KGL ++ E+ I H ++K
Sbjct: 81 CMEHMDGGSLDQVLKK--AGR--IPEQILGKVSIAVIKGLTYL----REKHKIMHRDVKP 132
Query: 434 SNILLNENEDPLISECGYS-KFLDPKKTCLFSSNGYTAPEKT----VSEQGDVFSFGVIL 488
SNIL+N + + + G S + +D + Y +PE+ S Q D++S G+ L
Sbjct: 133 SNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 489 LELLTGKTVEKTGIDLP--KWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSN 546
+E+ G + I P K ++ M G+ + E + R PL S
Sbjct: 193 VEMAIG----RYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL-------SSY 241
Query: 547 SPDDRPTMAEVLERIEEVVN 566
PD RP MA + E ++ +VN
Sbjct: 242 GPDSRPPMA-IFELLDYIVN 260
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 22/156 (14%)
Query: 353 LKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKG 412
L+H NI+ + + + + +Y GS+ +LL Y F L + I KG
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKG 118
Query: 413 LDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT---------CLF 463
L++++ + I H ++K +NIL++ IS+ G SK L+ L
Sbjct: 119 LNYLHNRG-----IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 464 SSNGYTAPE----KTVSEQGDVFSFGVILLELLTGK 495
S + APE + + + D++S G +++E+LTGK
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 27/176 (15%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL---VCYNSTNEEKLLVYKYQSNGSLLS 385
AVK +K V+ F + + L H N++ L + +N +V + S G+L++
Sbjct: 33 AVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLY----IVMELMSKGNLVN 87
Query: 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
L G+ L + +A+G++++ E K + H +L NIL++E+
Sbjct: 88 FLRT--RGRALVSVIQLLQFSLDVAEGMEYL-----ESKKLVHRDLAARNILVSEDGVAK 140
Query: 446 ISECGYSKF----LDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT 493
+S+ G ++ +D K + +TAPE K S + DV+S+GV+L E+ +
Sbjct: 141 VSDFGLARVGSMGVDNSKLPV----KWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 45/178 (25%), Positives = 82/178 (46%), Gaps = 29/178 (16%)
Query: 333 LKKLQV--SMDEFSQT--MRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385
LKK+Q+ MD ++ +++I LK HPN++ + N E +V + G L
Sbjct: 32 LKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSR 91
Query: 386 LLEAYIEGKRDFP----WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
+++ + + KR P WK + + + L+ M+ K I H ++K +N+ +
Sbjct: 92 MIKHFKKQKRLIPERTIWKYFVQLCSA----LEHMHSKR-----IMHRDIKPANVFITAT 142
Query: 442 EDPLISECGYSKFLDPKKTCLFSSNG---YTAPEKTVSEQG-----DVFSFGVILLEL 491
+ + G +F K T S G Y +PE+ + E G D++S G +L E+
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER-IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 62/271 (22%), Positives = 117/271 (43%), Gaps = 42/271 (15%)
Query: 321 RLKNSAVYAVKRLKKLQVSMD-----EFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVY 375
+ K + AVK LK D + M+ IG KH NI+ L+ + + ++
Sbjct: 43 KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIV 100
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLR------------LSIATGIAKGLDFMYQKSNEE 423
+Y S G+L L A ++ + + +S +A+G++++ +
Sbjct: 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL----ASQ 156
Query: 424 KTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KT 474
K I H +L N+L+ EN I++ G ++ ++ ++NG + APE +
Sbjct: 157 KCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV 215
Query: 475 VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534
+ Q DV+SFGV++ E+ T GI + + K +++E G DK
Sbjct: 216 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-LLKE---GHRMDKPANCTNE---- 267
Query: 535 PLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565
L + C P RPT +++E ++ ++
Sbjct: 268 -LYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 22/191 (11%)
Query: 317 LFMVRLKNSA-VYAVKRLKK---LQVSMDEFSQTMRQIGNL--KHPNILPLVCYNSTNEE 370
+ + RLK S +YAVK LKK LQ E + T ++I +L HP + L C T +
Sbjct: 11 VMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR 70
Query: 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
V ++ + G L+ +I+ R F A I L F++ +K I + +
Sbjct: 71 LFFVMEFVNGGDLM----FHIQKSRRFDEARARFYAAEITSALMFLH-----DKGIIYRD 121
Query: 431 LKLSNILLNENEDPLISECGYSK--FLDPKKTCLF-SSNGYTAPEKTVSEQG----DVFS 483
LKL N+LL+ +++ G K + K T F + Y APE D ++
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWA 181
Query: 484 FGVILLELLTG 494
GV+L E+L G
Sbjct: 182 MGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 30/188 (15%)
Query: 322 LKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPL--VCYNSTNEEKLLVY 375
K YA+K +KK S+++ + +R+I L+ HPNIL L V ++ LV+
Sbjct: 21 RKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79
Query: 376 KYQSNGSLLSLLEAYIEG-KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
+ ++L E I+G KR P K S + K LD M++ I H ++K
Sbjct: 80 ELMD----MNLYE-LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-----IFHRDIKPE 129
Query: 435 NILLNENEDPLI---SECG-YSKFLDPKKTCLFSSNGYTAPEKTVSE-----QGDVFSFG 485
NIL+ ++ L S G YSK P T S+ Y APE +++ + D+++ G
Sbjct: 130 NILIKDDILKLADFGSCRGIYSK---PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVG 186
Query: 486 VILLELLT 493
+ E+L+
Sbjct: 187 CVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 30/179 (16%)
Query: 403 LSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK--FLDPKKT 460
+S + +A+G++F+ + K I H +L NILL+EN I + G ++ + DP
Sbjct: 176 ISYSFQVARGMEFLASR----KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPD-- 228
Query: 461 CLFSSNG-------YTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVK 509
+ G + APE K + Q DV+SFGV+L E+ + G+
Sbjct: 229 --YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ------ 280
Query: 510 AMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568
+ EE+ + + +A + ++ L C N+P+DRPT +E++E + +++ N
Sbjct: 281 --IDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 45/184 (24%), Positives = 88/184 (47%), Gaps = 16/184 (8%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKH---PNILPLVCYNSTNEEKLLVYK 376
V+ K S + ++L L++ +Q +R++ L P I+ ++ E + +
Sbjct: 24 VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
+ GSL +L+ E KR P ++ ++ + +GL ++ E+ I H ++K SNI
Sbjct: 84 HMDGGSLDQVLK---EAKR-IPEEILGKVSIAVLRGLAYL----REKHQIMHRDVKPSNI 135
Query: 437 LLNENEDPLISECGYS-KFLDPKKTCLFSSNGYTAPEKT----VSEQGDVFSFGVILLEL 491
L+N + + + G S + +D + Y +PE+ S Q D++S G+ L+EL
Sbjct: 136 LVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 492 LTGK 495
G+
Sbjct: 196 AIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 1e-05
Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 35/183 (19%)
Query: 333 LKKLQVSMDE---FSQTMRQIG---NLKHPNILPL--VCYNSTNEEKL-LVYKYQSNGSL 383
LKK+++ +E S +R+I LKHPNI+ L V + E KL LV++Y
Sbjct: 29 LKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT---ERKLYLVFEYCDMD-- 83
Query: 384 LSLLEAYIEGKR-DFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442
L+ Y++ + L SI + +GL + + I H +LK NIL+N +
Sbjct: 84 ---LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR-----ILHRDLKPQNILINRDG 135
Query: 443 DPLISECGYSKFLDPKKTCLFSSNG-----YTAPE-----KTVSEQGDVFSFGVILLELL 492
+++ G ++ ++ Y APE K S D++S G I E++
Sbjct: 136 VLKLADFGLARAFGIPLRTY--THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI 193
Query: 493 TGK 495
TGK
Sbjct: 194 TGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 58/267 (21%), Positives = 106/267 (39%), Gaps = 54/267 (20%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPL--VCYNSTNEEK----LLVYKYQS 379
AVK +K + E + + +K HPN++ L VC + E +++ +
Sbjct: 30 AVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMK 89
Query: 380 NGSLLSLLEAYIEGKRD--FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+G L S L G P ++ + T IA G++++ KS H +L N +
Sbjct: 90 HGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-----FIHRDLAARNCM 144
Query: 438 LNENEDPLISECGYSKFLD-------------PKKTCLFSSNGYTAPEKTVSEQGDVFSF 484
LNEN + +++ G SK + P K S ++ + + DV+SF
Sbjct: 145 LNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES----LADRVYTTKSDVWSF 200
Query: 485 GVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLN 538
GV + E+ T G++ E++D + G + P L +
Sbjct: 201 GVTMWEIATRGQTPYPGVE-------------NSEIYD--YLRQGNRLKQPPDCLDGLYS 245
Query: 539 VALKCVSNSPDDRPTMAEVLERIEEVV 565
+ C +P DRP+ + +E+ +
Sbjct: 246 LMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 1/89 (1%)
Query: 81 IRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
++L + SG I L K +L V+ L+ N + G IP + + L L L SN L G
Sbjct: 337 LQLWSNKFSGEIPKN-LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395
Query: 141 VPLALTKLKHLKTLDISNNHFAATSPDNF 169
+P +L + L+ + + +N F+ P F
Sbjct: 396 IPKSLGACRSLRRVRLQDNSFSGELPSEF 424
|
Length = 968 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 341 DEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWK 400
+F Q R + HPNI+ L+ + + +V + G L+ L EG R K
Sbjct: 38 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGPR-LKVK 94
Query: 401 LRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT 460
+ + A G++++ E K H +L N L+ E IS+ G S+ ++
Sbjct: 95 ELIQMVENAAAGMEYL-----ESKHCIHRDLAARNCLVTEKNVLKISDFGMSR---EEED 146
Query: 461 CLFSSNG--------YTAPEK----TVSEQGDVFSFGVILLE 490
+++S G +TAPE S + DV+SFG++L E
Sbjct: 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 61/260 (23%), Positives = 110/260 (42%), Gaps = 47/260 (18%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQ---IGNLKHPNILPLVCYNSTNE-EKLLVYKYQSNGSLL 384
AVK L ++ ++E Q +++ + + HPN+L L+ +E L+V Y +G L
Sbjct: 27 AVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLR 85
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
+ + + K + +AKG++++ K H +L N +L+E+
Sbjct: 86 NFIR---SETHNPTVKDLIGFGLQVAKGMEYL-----ASKKFVHRDLAARNCMLDESFTV 137
Query: 445 LISECGYSK-FLDPKKTCLFSSNGYTAPEK----------TVSEQGDVFSFGVILLELLT 493
+++ G ++ D + + + G P K + + DV+SFGV+L EL+T
Sbjct: 138 KVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
Query: 494 GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA-GRQWAFP------LLNVALKCVSN 546
+D FD V GR+ P L V L C
Sbjct: 198 RGAPPYPDVD----------------SFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHP 241
Query: 547 SPDDRPTMAEVLERIEEVVN 566
P+ RPT +E++ RIE++ +
Sbjct: 242 KPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 30/187 (16%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386
AVK L+K + EF + + N HPNI+ L+ NE + ++ + G LLS
Sbjct: 30 AVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSY 89
Query: 387 LEAYIEGKRDFPWKLRLS----IATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442
L +R P L L I +AKG ++ E+ H +L N L++E
Sbjct: 90 LRD-ARVERFGPPLLTLKELLDICLDVAKGCVYL-----EQMHFIHRDLAARNCLVSEKG 143
Query: 443 DPL-----ISECGYSKFLDPKKTCLFSSNG-------YTAPEKTV----SEQGDVFSFGV 486
I + G ++ D K+ + G + APE + + Q DV+SFGV
Sbjct: 144 YDADRVVKIGDFGLAR--DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGV 201
Query: 487 ILLELLT 493
++ E+LT
Sbjct: 202 LMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 54/255 (21%), Positives = 96/255 (37%), Gaps = 47/255 (18%)
Query: 330 VKRLKKLQVSMDEFS-QTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL--LSL 386
++ KK T +I NL+ +S N K+ + L LSL
Sbjct: 48 IRTFKKFHKGHKVLIDITENEIKNLR--------RIDSNNILKIYGFIIDIVDDLPRLSL 99
Query: 387 LEAY---------IEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+ Y ++ ++D +K +L +A KGL +Y+ +N+ P+ NL + L
Sbjct: 100 ILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK----PYKNLTSVSFL 155
Query: 438 LNENEDPLISECGYSKFLD--PKKTCLFSSNGYTAPE------KTVSEQGDVFSFGVILL 489
+ EN I G K L P K F Y + + + + D++S GV+L
Sbjct: 156 VTENYKLKIICHGLEKILSSPPFKNVNFMV--YFSYKMLNDIFSEYTIKDDIYSLGVVLW 213
Query: 490 ELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL--NVALKCVSNS 547
E+ TGK + + + ++ + + PL + C S+
Sbjct: 214 EIFTGK-IPFENLTTKEIYDLIINKN-NSLKLPLDC---------PLEIKCIVEACTSHD 262
Query: 548 PDDRPTMAEVLERIE 562
RP + E+L +
Sbjct: 263 SIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 59/242 (24%), Positives = 108/242 (44%), Gaps = 37/242 (15%)
Query: 345 QTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEA-------YIEGKRDF 397
+ M+ IG KH NI+ L+ + + ++ +Y S G+L L A Y
Sbjct: 75 EMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 398 P-----WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452
P +K +S A +A+G++++ K K I H +L N+L+ E+ I++ G +
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLASK----KCI-HRDLAARNVLVTEDNVMKIADFGLA 187
Query: 453 KFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID 503
+ + ++NG + APE + + Q DV+SFGV+L E+ T G+
Sbjct: 188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247
Query: 504 LPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563
+ + K +++E G DK L + C P RPT +++E ++
Sbjct: 248 VEELFK-LLKE---GHRMDKPSNCTNE-----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 298
Query: 564 VV 565
++
Sbjct: 299 IL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 320 VRLKNSAVYAVK--RLKKLQVSMDEFSQTMRQIGN---LKHPNILPLVCYN-STNEEKLL 373
V L + AVK R++ + ++ LKHPN++ Y + EK+
Sbjct: 20 VNLDTGELMAVKEIRIQDNDPKT--IKEIADEMKVLELLKHPNLVK--YYGVEVHREKVY 75
Query: 374 VY-KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
++ +Y S G+L LLE R + + +GL +++ I H ++K
Sbjct: 76 IFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLH-----SHGIVHRDIK 126
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCLFS-------SNGYTAPE-----KTVSEQG- 479
+NI L+ N + + G + L T + + Y APE K
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRA 186
Query: 480 -DVFSFGVILLELLTGKT 496
D++S G ++LE+ TGK
Sbjct: 187 ADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 44/179 (24%), Positives = 81/179 (45%), Gaps = 26/179 (14%)
Query: 405 IATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS-KFLDPKKTCLF 463
IA + KGL +++ I H ++K SN+L+N + + G S + ++
Sbjct: 100 IAVAVVKGLTYLWSLK-----ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154
Query: 464 SSNGYTAPEKTVSEQ----GDVFSFGVILLELLTG-----KTVEKTGIDLP-KWVKAMVR 513
+N Y APE+ EQ DV+S G+ +EL G + + G +P + ++ +V
Sbjct: 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214
Query: 514 EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVVNGNDE 570
E D V G Q++ ++ +C+ P +RP +++ I + +GN E
Sbjct: 215 E-------DPPVLPVG-QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAE 265
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 56/186 (30%), Positives = 86/186 (46%), Gaps = 29/186 (15%)
Query: 327 VYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVC---YNSTNEEKL-LVYKYQ 378
+YA+K LKK + E ++T RQ+ L+ P + Y + KL L+ Y
Sbjct: 30 LYAMKVLKKATIVQKAKTAEHTRTERQV--LEAVRRCPFLVTLHYAFQTDTKLHLILDYV 87
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
+ G L + L Y ++R+ IA I LD ++Q I + ++KL NILL
Sbjct: 88 NGGELFTHL--YQREHFTES-EVRVYIAE-IVLALDHLHQLG-----IIYRDIKLENILL 138
Query: 439 NENEDPLISECGYSK-FLDPKKTCLFSSNG---YTAPEKTVSEQG------DVFSFGVIL 488
+ ++++ G SK FL ++ +S G Y APE G D +S GV+
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198
Query: 489 LELLTG 494
ELLTG
Sbjct: 199 FELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 59/265 (22%), Positives = 103/265 (38%), Gaps = 52/265 (19%)
Query: 326 AVYAVKRL--KKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383
+ VK L K + EF + + L H N++ L+ E ++ +Y G L
Sbjct: 36 TLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95
Query: 384 LSLLEA---YIEGKRDFPW--KLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
L A E + P K ++++ T IA G+D + H +L N L+
Sbjct: 96 KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-----FVHRDLAARNCLV 150
Query: 439 NENEDPLISECGYSKFLDPKKTCLFSSNGYTAP----------EKTVSEQGDVFSFGVIL 488
+ + +S SK D + + P E S + DV+SFGV++
Sbjct: 151 SSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLM 208
Query: 489 LELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV---AKAGR-QWAFP------LLN 538
E+ T +LP + D+EV +AG+ + P L
Sbjct: 209 WEVFTQG-------ELPF-----------YGLSDEEVLNRLQAGKLELPVPEGCPSRLYK 250
Query: 539 VALKCVSNSPDDRPTMAEVLERIEE 563
+ +C + +P DRP+ +E++ + E
Sbjct: 251 LMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 22/169 (13%)
Query: 409 IAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK--FLDP---KKTCLF 463
+AKG++F+ + K I H +L NILL+EN I + G ++ + DP +K
Sbjct: 188 VAKGMEFLASR----KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 464 SSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGE 519
+ APE + + Q DV+SFGV+L E+ + G+ + EE+
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--------IDEEFCRR 294
Query: 520 VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568
+ + +A + L C P RPT +E++E + ++ N
Sbjct: 295 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 45/217 (20%)
Query: 315 SSLFMVRLKNSA-VYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNIL-----PLVC---YN 365
+F+ + K++ +YA+K +KK + + + L +IL P V Y+
Sbjct: 7 GRVFLAKKKSTGDIYAIKVIKK-----ADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61
Query: 366 STNEEKL-LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEK 424
++ L LV +Y G L SLLE G D R+ IA I L++++
Sbjct: 62 FQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVA-RIYIAE-IVLALEYLHSNG---- 113
Query: 425 TIPHGNLKLSNILLNENEDPLISECGYSKF----------LDPKKTC-LFSSNGYTAPE- 472
I H +LK NIL++ N +++ G SK D K+ + + Y APE
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 473 ---KTVSEQGDVFSFGVILLELLTG------KTVEKT 500
+ S+ D +S G IL E L G +T E+
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI 209
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 53/188 (28%), Positives = 89/188 (47%), Gaps = 30/188 (15%)
Query: 327 VYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVC---YNSTNEEKL-LVYKYQ 378
+YA+K L+K + E ++T R + L+H P + Y E KL L+ Y
Sbjct: 30 LYAMKVLQKAALVQKAKTVEHTRTERNV--LEHVRQSPFLVTLHYAFQTEAKLHLILDYV 87
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATG-IAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
S G + + L +RD + + +G I L+ +++ I + ++KL NIL
Sbjct: 88 SGGEMFTHLY-----QRDNFSEDEVRFYSGEIILALEHLHKLG-----IVYRDIKLENIL 137
Query: 438 LNENEDPLISECGYSK-FLDPKKTCLFSSNG---YTAPEKTVSEQG-----DVFSFGVIL 488
L+ ++++ G SK FL +K +S G Y APE + G D +S G+++
Sbjct: 138 LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILI 197
Query: 489 LELLTGKT 496
ELLTG +
Sbjct: 198 FELLTGAS 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 323 KNSAVYAVKRLKKLQVSM-DEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381
K+ + AVK LK ++ +F + + NL+H +I+ + ++V++Y +G
Sbjct: 33 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG 92
Query: 382 SLLSLLEAY------------IEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHG 429
L L A+ + K + L IA+ IA G+ ++ + H
Sbjct: 93 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL-----ASQHFVHR 147
Query: 430 NLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYT-------APE----KTVSEQ 478
+L N L+ N I + G S+ D T + G+T PE + + +
Sbjct: 148 DLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 205
Query: 479 GDVFSFGVILLELLT 493
DV+SFGVIL E+ T
Sbjct: 206 SDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 54/260 (20%), Positives = 111/260 (42%), Gaps = 52/260 (20%)
Query: 327 VY-AVKRLKKLQVS---MDEFSQTMRQIGN-------LKHPNILPLV-CYNSTNEEKLLV 374
VY A R +V+ M Q I N KHPNI+ Y +E +V
Sbjct: 35 VYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY-LVGDELWVV 93
Query: 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLS------IATGIAKGLDFMYQKSNEEKTIPH 428
+Y GSL ++ +R++ + + +GL++++ ++ + H
Sbjct: 94 MEYMDGGSLTDIITQN---------FVRMNEPQIAYVCREVLQGLEYLHSQN-----VIH 139
Query: 429 GNLKLSNILLNENEDPLISECGYSKFLD---PKKTCLFSSNGYTAPE----KTVSEQGDV 481
++K NILL+++ +++ G++ L K+ + + + APE K + D+
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDI 199
Query: 482 FSFGVILLELLTGKTVEKTGIDLPKWVKAM--VREEWTGEVFDKEVAKAGRQWAFPLLNV 539
+S G++ +E+ G E + P ++A+ + + + K +W+ +
Sbjct: 200 WSLGIMCIEMAEG---EPPYLREPP-LRALFLITTKGIPPL------KNPEKWSPEFKDF 249
Query: 540 ALKCVSNSPDDRPTMAEVLE 559
KC+ P+ RP+ E+L+
Sbjct: 250 LNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 49/195 (25%), Positives = 93/195 (47%), Gaps = 22/195 (11%)
Query: 315 SSLFMVRLKNS-AVYAVKRLKKLQVSMDE---FSQTMRQIGNL--KHPNILPLVCYNSTN 368
+ + +VRLK + +YA+K +KK V+ DE + QT + + HP ++ L T
Sbjct: 9 AKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 68
Query: 369 EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPH 428
V +Y + G L+ +++ +R P + + I+ L++++ E+ I +
Sbjct: 69 SRLFFVIEYVNGGDLM----FHMQRQRKLPEEHARFYSAEISLALNYLH-----ERGIIY 119
Query: 429 GNLKLSNILLNENEDPLISECGYSK-FLDPKKT--CLFSSNGYTAPEKTVSE----QGDV 481
+LKL N+LL+ +++ G K L P T + Y APE E D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 482 FSFGVILLELLTGKT 496
++ GV++ E++ G++
Sbjct: 180 WALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 14/101 (13%)
Query: 405 IATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL--DPKKTCL 462
IA I K L++++ K + + H ++K SN+L+N N + + G S +L KT
Sbjct: 108 IAVSIVKALEYLHSKLS----VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID 163
Query: 463 FSSNGYTAPEKTVSEQ--------GDVFSFGVILLELLTGK 495
Y APE+ E DV+S G+ ++EL TG+
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 8e-05
Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 4/60 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
L++++LS +I L +L+V+ L+ N + P + S L L+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 63/262 (24%), Positives = 108/262 (41%), Gaps = 30/262 (11%)
Query: 316 SLFMVRLKNSA-VYAVKRLKKLQVSMDEFSQTMRQI-------GNLKHPNILPL--VCYN 365
S+ RLKN+ ++A+K ++ D +QI + K P I+ +
Sbjct: 16 SVTKCRLKNTGMIFALK-----TITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD 70
Query: 366 STNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKT 425
++ + +Y GSL S+ + + K+ IA + KGL +++ + K
Sbjct: 71 ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR----KI 126
Query: 426 IPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-YTAPE----KTVSEQGD 480
I H ++K SNILL + + G S L F+ Y APE K S D
Sbjct: 127 I-HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSD 185
Query: 481 VFSFGVILLELLTGK---TVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537
V+S G+ LLE+ + E P + + + E+ D+ G +W+
Sbjct: 186 VWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP--GNGIKWSEEFK 243
Query: 538 NVALKCVSNSPDDRPTMAEVLE 559
+ +C+ P RPT ++LE
Sbjct: 244 DFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 27/158 (17%)
Query: 352 NLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGI 409
NL+HPNI+ L V + LV +Y L SLL+ F + +
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEY-CEQDLASLLDNM---PTPFSESQVKCLMLQL 117
Query: 410 AKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS-------KFLDPKKTCL 462
+GL +++ E I H +LK+SN+LL + I++ G + K + PK L
Sbjct: 118 LRGLQYLH-----ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL 172
Query: 463 FSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGK 495
+ Y APE T + D+++ G IL ELL K
Sbjct: 173 W----YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 45/219 (20%), Positives = 89/219 (40%), Gaps = 33/219 (15%)
Query: 319 MVRLKNSAVY-AVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLL 373
+ + K + Y A+K LKK ++ + +Q + L HP I+ ++C
Sbjct: 36 IAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95
Query: 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKL 433
+ ++ G L + L G+ FP + + ++++ K I + +LK
Sbjct: 96 LLEFVVGGELFTHLRK--AGR--FPNDVAKFYHAELVLAFEYLH-----SKDIIYRDLKP 146
Query: 434 SNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTVSEQG-----DVFSFGVIL 488
N+LL+ +++ G++K + + L + Y APE + +G D ++ GV+L
Sbjct: 147 ENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLL 205
Query: 489 LELLTG----------KTVEKT---GIDLPKWVKAMVRE 514
E + G + EK + P W R+
Sbjct: 206 YEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244
|
Length = 329 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 57/269 (21%), Positives = 112/269 (41%), Gaps = 60/269 (22%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPL--VCYNSTNEEK----LLVYKYQS 379
AVK +K + E + + + +K HPN++ L VC+ +++ +K +++ +
Sbjct: 31 AVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMK 90
Query: 380 NGSLLS-LLEAYIEGK-RDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+G L S LL + + G P + L IA G++++ SN + H +L N +
Sbjct: 91 HGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SN--RNFIHRDLAARNCM 145
Query: 438 LNENEDPLISECGYSKFLDP----KKTCL------------FSSNGYTAPEKTVSEQGDV 481
L E+ +++ G SK + ++ + + YT+ + DV
Sbjct: 146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS-------KSDV 198
Query: 482 FSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------ 535
++FGV + E+ T G++ E++D + G + P
Sbjct: 199 WAFGVTMWEIATRGQTPYPGVE-------------NHEIYD--YLRHGNRLKQPEDCLDE 243
Query: 536 LLNVALKCVSNSPDDRPTMAEVLERIEEV 564
L ++ C P DRPT ++ E +E +
Sbjct: 244 LYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 81 IRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
+RL++ + SG + +E KL + + ++ N +QGRI + + L L+L+ N G
Sbjct: 409 VRLQDNSFSGELPSE-FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467
Query: 141 VPLALTKLKHLKTLDISNNHFAATSPDNFR 170
+P K L+ LD+S N F+ P
Sbjct: 468 LP-DSFGSKRLENLDLSRNQFSGAVPRKLG 496
|
Length = 968 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 350 IGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGI 409
+G H NI+ L + ++V +Y SNG+L S L + EG+ + + G+
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQ--LVAGQLMGMLPGL 116
Query: 410 AKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-- 467
A G+ ++ E H L +L+N + IS G+ + + K ++++
Sbjct: 117 ASGMKYL-----SEMGYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGK 169
Query: 468 ----YTAPEKT----VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGE 519
+ APE S DV+SFG+++ E+++ + P W M ++
Sbjct: 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYG-------ERPYW--DMSGQDVIKA 220
Query: 520 VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEV 557
V D A R L + L C +RP +++
Sbjct: 221 VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 30/80 (37%), Positives = 44/80 (55%), Gaps = 13/80 (16%)
Query: 426 IPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE---------KTVS 476
I H +LK SNI +NE+ + I + G ++ D + T ++ Y APE +TV
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV- 197
Query: 477 EQGDVFSFGVILLELLTGKT 496
D++S G I+ ELLTGKT
Sbjct: 198 ---DIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 54/185 (29%), Positives = 83/185 (44%), Gaps = 29/185 (15%)
Query: 327 VYAVKRLKK-LQVSMDEFSQTM---RQIGNLKHPNIL-PLVCYNSTNEEKLLVYKYQSNG 381
+YA+K LKK + + D+ TM R + P L L T + V +Y + G
Sbjct: 27 LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 86
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
L+ ++ GK F + A IA GL F++ K I + +LKL N++L+
Sbjct: 87 DLMYHIQ--QVGK--FKEPHAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDAE 137
Query: 442 EDPLISECGYSK--FLDPKKTCLF-SSNGYTAPE--------KTVSEQGDVFSFGVILLE 490
I++ G K K T F + Y APE K+V D ++FGV+L E
Sbjct: 138 GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYE 193
Query: 491 LLTGK 495
+L G+
Sbjct: 194 MLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 28/166 (16%)
Query: 342 EFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPW 399
EF + ++ HP+++ L VC + T + LV + +G LL + E K +
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQ---LVTQLMPHGCLLDYVH---EHKDNIGS 108
Query: 400 KLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL--DP 457
+L L+ IAKG+ ++ EE+ + H +L N+L+ I++ G ++ L D
Sbjct: 109 QLLLNWCVQIAKGMMYL-----EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163
Query: 458 KKTCLFSSNGYTAPEK----------TVSEQGDVFSFGVILLELLT 493
K+ ++++G P K + Q DV+S+GV + EL+T
Sbjct: 164 KE---YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 55/259 (21%)
Query: 329 AVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386
AVK L+ + + ++F + ++ + LK+PNI+ L+ +++ ++ +Y NG L
Sbjct: 48 AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQF 107
Query: 387 L-----EAYIEGKRDFPWKLR---LSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
L E+ + P L +A IA G+ ++ H +L N L+
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL-----ASLNFVHRDLATRNCLV 162
Query: 439 NENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTV----------------SEQGDVF 482
+ I++ G S+ L+S + Y + V + DV+
Sbjct: 163 GNHYTIKIADFGMSR-------NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVW 215
Query: 483 SFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF-------- 534
+FGV L E+ T + + + V E TGE F + GRQ
Sbjct: 216 AFGVTLWEMFTLCKEQPYSLLSDEQVI-----ENTGEFFRNQ----GRQIYLSQTPLCPS 266
Query: 535 PLLNVALKCVSNSPDDRPT 553
P+ + ++C S DRPT
Sbjct: 267 PVFKLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 322 LKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLL--VYKYQS 379
LK A+ V RLK+ Q +E + HP I+ L + ++++ L + +Y
Sbjct: 31 LKVMAIPEVIRLKQEQHVHNEKRVLKE----VSHPFIIRLFW--TEHDQRFLYMLMEYVP 84
Query: 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
G L S Y+ F L A+ I L++++ K I + +LK NILL+
Sbjct: 85 GGELFS----YLRNSGRFSNSTGLFYASEIVCALEYLHSKE-----IVYRDLKPENILLD 135
Query: 440 ENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTVSEQG-----DVFSFGVILLELLTG 494
+ +++ G++K L + L + Y APE + +G D ++ G+++ E+L G
Sbjct: 136 KEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVG 194
Query: 495 K 495
Sbjct: 195 Y 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 23/161 (14%)
Query: 352 NLKHPNILPLVCY-----NSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIA 406
LKHPNI V Y + +N+ +V +Y G L L++ + ++ + I
Sbjct: 55 ELKHPNI---VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111
Query: 407 TGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD----PKKTCL 462
T + L + +S+ T+ H +LK +NI L+ N + + + G +K L KT +
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 463 FSSNG---YTAPE----KTVSEQGDVFSFGVILLELLTGKT 496
G Y +PE + E+ D++S G ++ EL
Sbjct: 172 ----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 23/182 (12%)
Query: 327 VYAVKRLKKLQVSMD---EFSQTMRQIGNL--KHPNILPLVCYNSTNEEKLLVYKYQSNG 381
VYA+K LKK + D + + T ++I L KHP + L C T + V +Y + G
Sbjct: 22 VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
L+ I+ R F A + L F+++ + + +LKL NILL+
Sbjct: 82 DLM----FQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG-----VIYRDLKLDNILLDAE 132
Query: 442 EDPLISECGYSK--FLDPKKTCLF-SSNGYTAPEKTVSEQG-----DVFSFGVILLELLT 493
+++ G K L+ T F + Y APE + E D ++ GV++ E++
Sbjct: 133 GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMA 191
Query: 494 GK 495
G+
Sbjct: 192 GQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 409 IAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGY 468
I +GL +++ I H +LK SN+ +NE+ + I + G ++ D + T ++ Y
Sbjct: 129 ILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWY 183
Query: 469 TAPEKTV-----SEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT--GEVF 521
APE + ++ D++S G I+ ELLTG+T+ G D +K ++R T E+
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL-FPGTDHIDQLKLILRLVGTPGAELL 242
Query: 522 DKEVAKAGRQW-----AFPLLNVALKCVSNSP--------------DDRPTMAEVLER-- 560
K +++ R + P +N A + +P D R T A+ L
Sbjct: 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302
Query: 561 IEEVVNGNDERDRDHSNSSFSSME 584
+ + +DE D + SF S +
Sbjct: 303 FAQYHDPDDEPVADPYDQSFESRD 326
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 18/191 (9%)
Query: 317 LFMVRLKNSA-VYAVKRLKKLQVSMDEFSQTM---RQIGNLKH-PNILPLVCYNSTNEEK 371
+ ++K + +YA K+L K ++ + Q ++I I+ L T ++
Sbjct: 9 VCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL 68
Query: 372 LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
LV + G L + Y G+ FP + A I GL+ ++Q+ I + +L
Sbjct: 69 CLVMTLMNGGDLKYHI--YNVGEPGFPEARAIFYAAQIICGLEHLHQRR-----IVYRDL 121
Query: 432 KLSNILLNENEDPLISECGYS-KFLDPKKTCLFS-SNGYTAPE----KTVSEQGDVFSFG 485
K N+LL+++ + IS+ G + + KK + + GY APE + D F+ G
Sbjct: 122 KPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALG 181
Query: 486 VILLELLTGKT 496
L E++ G++
Sbjct: 182 CTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 51/249 (20%)
Query: 345 QTMRQIGNLKHPNILPL--VCYNSTNEEKLLV-YKYQSNGSLLSLLEAYIEGKRDFP--- 398
+ M+ IG KH NI+ L VC T E L V +Y + G+L L A D+
Sbjct: 69 ELMKLIG--KHKNIINLLGVC---TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123
Query: 399 ---------WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC 449
+K +S A +A+G++++ E + H +L N+L+ E+ I++
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYL-----ESRRCIHRDLAARNVLVTEDNVMKIADF 178
Query: 450 GYSKFLDP----KKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLTGKT 496
G ++ + KKT SNG + APE + + Q DV+SFG+++ E+ T
Sbjct: 179 GLARGVHDIDYYKKT----SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234
Query: 497 VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAE 556
GI + + K ++RE G DK L + +C P RPT +
Sbjct: 235 SPYPGIPVEELFK-LLRE---GHRMDKP-----SNCTHELYMLMRECWHAVPTQRPTFKQ 285
Query: 557 VLERIEEVV 565
++E +++V+
Sbjct: 286 LVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 29/177 (16%)
Query: 331 KRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLSLLE 388
K L F +T + L H +++ L VC +E ++V +Y G L +
Sbjct: 36 KVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVC---VRDENIMVEEYVKFGPL----D 88
Query: 389 AYIEGKRDFPWKL-RLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL-----NENE 442
++ +++ +L +A +A L ++ E+K + HGN+ NIL+ NE
Sbjct: 89 VFLHREKNNVSLHWKLDVAKQLASALHYL-----EDKKLVHGNVCGKNILVARYGLNEGY 143
Query: 443 DPLI--SECGYSKFLDPKKTCLFSSNGYTAPE------KTVSEQGDVFSFGVILLEL 491
P I S+ G + ++ + + APE +++ D +SFG LLE+
Sbjct: 144 VPFIKLSDPGIPITVLSREERV-ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 30/181 (16%)
Query: 333 LKKLQVSMDEF--SQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLL 387
LK++ + +E S +R+I LKH NI+ L T + +LV++Y L
Sbjct: 30 LKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKD-----L 84
Query: 388 EAYIE---GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
+ Y++ + S + KG+ F + E + H +LK N+L+N+ +
Sbjct: 85 KKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH-----ENRVLHRDLKPQNLLINKRGEL 139
Query: 445 LISECGYSK-FLDPKKTCLFSSN----GYTAPE-----KTVSEQGDVFSFGVILLELLTG 494
+++ G ++ F P T FS+ Y AP+ +T S D++S G I+ E++TG
Sbjct: 140 KLADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
Query: 495 K 495
+
Sbjct: 198 R 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 26/96 (27%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 405 IATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS-KFLDPKKTCLF 463
IA + +GL ++Y I H ++K SNIL+N + + G S + ++
Sbjct: 108 IAVAVVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163
Query: 464 SSNGYTAPEKTVSEQ----GDVFSFGVILLELLTGK 495
++ Y +PE+ + DV+S G+ ++EL GK
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 16/150 (10%)
Query: 353 LKHPNILPLVCYNST---NEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGI 409
L+HPNI V Y T N+ +V L + E K+ F + +I +
Sbjct: 66 LRHPNI---VRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 410 AKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP--KKTCLFSSNG 467
L ++++ EK I H +L +NI+L E++ I++ G +K P K T + +
Sbjct: 123 VLALRYLHK----EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 468 YTAPEKTVS----EQGDVFSFGVILLELLT 493
Y+ PE + E+ DV++FG IL ++ T
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 24/189 (12%)
Query: 318 FMVRLKNSA-VYAVKRLKKLQ-VSMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEEKL 372
+VR K S YA+K L K + V + + + ++I +++HP ++ L Y S ++
Sbjct: 18 MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL--YGSFQDDSN 75
Query: 373 L--VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
L V +Y G L S L FP + A + L++++ I + +
Sbjct: 76 LYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLD-----IVYRD 126
Query: 431 LKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTVSEQG-----DVFSFG 485
LK N+LL+ + I++ G++K + + L + Y APE + +G D ++ G
Sbjct: 127 LKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEI-ILSKGYGKAVDWWALG 185
Query: 486 VILLELLTG 494
+++ E+L G
Sbjct: 186 ILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 29/184 (15%)
Query: 328 YAVKRLKK-LQVSMDEFSQTM---RQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383
YA+K LKK + V+ DE + T+ R + N +HP + L T++ V +Y + G L
Sbjct: 23 YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL 82
Query: 384 ---LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440
LS + E + F I LD+++ EK + + +LKL N++L++
Sbjct: 83 FFHLSRERVFSEDRARF-------YGAEIVSALDYLHS----EKNVVYRDLKLENLMLDK 131
Query: 441 NEDPLISECGYSK--FLDPKKTCLF-SSNGYTAPEKTVSEQGDV------FSFGVILLEL 491
+ I++ G K D F + Y APE V E D + GV++ E+
Sbjct: 132 DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE--VLEDNDYGRAVDWWGLGVVMYEM 189
Query: 492 LTGK 495
+ G+
Sbjct: 190 MCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 1/84 (1%)
Query: 83 LENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVP 142
L + L G I E L +++ L+ + L N + G IP I L +L+L N L+G +P
Sbjct: 195 LASNQLVGQIPRE-LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253
Query: 143 LALTKLKHLKTLDISNNHFAATSP 166
+L LK+L+ L + N + P
Sbjct: 254 SSLGNLKNLQYLFLYQNKLSGPIP 277
|
Length = 968 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 47/198 (23%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDE---FSQTMRQIGNLKHPNILPLV--CYNSTNEEKLLVY 375
R + A VK L+ + DE F Q ++ L HPN+L + C S LLV
Sbjct: 18 RGMSKARVVVKELRA-SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLLVL 74
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWK-LRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
++ G L + L + K + +A +A GL +++Q H +L L
Sbjct: 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-----FIHSDLALR 129
Query: 435 NILLNENE-----DPLISECGYSKFLDPKKTCLFSSNGYTAPE-----------KTVSEQ 478
N L + D ++ Y + K C + APE K +++
Sbjct: 130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK 189
Query: 479 GDVFSFGVILLELLTGKT 496
+++S GV + EL T
Sbjct: 190 SNIWSLGVTMWELFTAAD 207
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 57/264 (21%), Positives = 120/264 (45%), Gaps = 48/264 (18%)
Query: 318 FMVRLKNSA-VYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLL 373
+V+ K Y +K + ++S E ++ +++ N+KHPNI V Y + EE
Sbjct: 17 ILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI---VQYQESFEE--- 70
Query: 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIA----KGLDFMYQ-----KSNEEK 424
NG+L +++ Y EG + +++ G+ + LD+ Q K ++
Sbjct: 71 ------NGNLYIVMD-YCEGGDLYK---KINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 425 TIPHGNLKLSNILLNENEDPLISECGYSKFLDPK----KTCLFSSNGYTAPE----KTVS 476
I H ++K NI L ++ + + G ++ L+ +TC+ + Y +PE + +
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYN 179
Query: 477 EQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536
+ D+++ G +L E+ T K + G ++ V ++R + +++ L
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIRGSY---------PPVSSHYSYDL 229
Query: 537 LNVALKCVSNSPDDRPTMAEVLER 560
N+ + +P DRP++ +LE+
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 28/167 (16%)
Query: 350 IGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIAT 407
+ ++ +P++ L +C ST + L+ + G LL + E K + + L+
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCV 116
Query: 408 GIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL--DPKKTCLFSS 465
IAKG++++ EE+ + H +L N+L+ + I++ G +K L D K+ + +
Sbjct: 117 QIAKGMNYL-----EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE---YHA 168
Query: 466 NGYTAPEK----------TVSEQGDVFSFGVILLELLTGKTVEKTGI 502
G P K + Q DV+S+GV + EL+T + GI
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 43/196 (21%), Positives = 83/196 (42%), Gaps = 34/196 (17%)
Query: 316 SLFMVRLKNSAVY-AVKRLKKLQVSMDEFSQTMRQIGNLK-----------HPNILPLVC 363
S+++ + +++ Y A+K LKK M Q+ N+K P + L
Sbjct: 11 SVYLAKKRSTGDYFAIKVLKK--SDMI----AKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 364 YNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEE 423
+ + LV +Y + G SL++ G W + + G++ ++Q+
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQY--IAEVVLGVEDLHQRG--- 117
Query: 424 KTIPHGNLKLSNILLNENEDPLISECGYSKF-LDPKKTCLFSSNGYTAPE----KTVSEQ 478
I H ++K N+L+++ +++ G S+ L+ KK + Y APE +
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK--FVGTPDYLAPETILGVGDDKM 173
Query: 479 GDVFSFGVILLELLTG 494
D +S G ++ E L G
Sbjct: 174 SDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 24/69 (34%), Positives = 38/69 (55%)
Query: 100 LRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
L+ L + L+ N + G IP + + L L+L SN +G +P+ALT L L+ L + +N
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 160 HFAATSPDN 168
F+ P N
Sbjct: 343 KFSGEIPKN 351
|
Length = 968 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 46/201 (22%), Positives = 81/201 (40%), Gaps = 29/201 (14%)
Query: 317 LFMVRLKNSAVYAVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLV 374
L++ + ++ + A+K LK + EF Q + L HPNI+ L+ + + ++
Sbjct: 26 LYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85
Query: 375 YKYQSNGSLLSLL-------EAYIEGKRDFPWKLRLS------IATGIAKGLDFMYQKSN 421
++Y + G L L + D K L IA IA G++++
Sbjct: 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL----- 140
Query: 422 EEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPEKTV- 475
H +L NIL+ E IS+ G S+ + + PE +
Sbjct: 141 SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200
Query: 476 ---SEQGDVFSFGVILLELLT 493
S D++SFGV+L E+ +
Sbjct: 201 GKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 342 EFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDF---P 398
E + MRQ+ + KH +L VC + E ++V ++ G L + ++ K D P
Sbjct: 53 ETASMMRQVSH-KHIVLLYGVCVR--DVENIMVEEFVEFGPL----DLFMHRKSDVLTTP 105
Query: 399 WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECG-YSKFLDP 457
WK + +A +A L ++ E+K + HGN+ NILL + + ECG + K DP
Sbjct: 106 WKFK--VAKQLASALSYL-----EDKDLVHGNVCTKNILL--AREGIDGECGPFIKLSDP 156
Query: 458 --------KKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLEL 491
++ C+ + APE K +S D +SFG L E+
Sbjct: 157 GIPITVLSRQECV-ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 16/97 (16%)
Query: 415 FMYQ-----KSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK------TCLF 463
F+YQ K + H +LK SN+LLN N D I + G ++ DP+ T
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 464 SSNGYTAPEKTVSEQG-----DVFSFGVILLELLTGK 495
++ Y APE ++ +G D++S G IL E+L+ +
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 38/114 (33%), Positives = 55/114 (48%), Gaps = 24/114 (21%)
Query: 406 ATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE----CGYSKFLDPKKTC 461
A I GL+ M+ + + + +LK +NILL+E+ IS+ C +SK K
Sbjct: 103 AAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHA 154
Query: 462 LFSSNGYTAPE---KTVS--EQGDVFSFGVILLELLTG-------KTVEKTGID 503
++GY APE K V+ D FS G +L +LL G KT +K ID
Sbjct: 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 31/189 (16%)
Query: 327 VYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVC---YNSTNEEKL-LVYKYQ 378
+YA+K LKK + E ++T RQ+ L+H P + Y + KL L+ Y
Sbjct: 30 LYAMKVLKKATIVQKAKTTEHTRTERQV--LEHIRQSPFLVTLHYAFQTDTKLHLILDYI 87
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATG-IAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+ G L + L K + I +G I L+ +++ I + ++KL NIL
Sbjct: 88 NGGELFTHLSQRERFKEQ-----EVQIYSGEIVLALEHLHKLG-----IIYRDIKLENIL 137
Query: 438 LNENEDPLISECGYSK-FLDPKKTCLFSSNG---YTAPEKTVSEQG------DVFSFGVI 487
L+ N ++++ G SK F + + +S G Y AP+ G D +S GV+
Sbjct: 138 LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197
Query: 488 LLELLTGKT 496
+ ELLTG +
Sbjct: 198 MYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 39/174 (22%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 333 LKKLQV--SMDEFSQT--MRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385
LKK+Q+ MD ++ +++I LK HPN++ + + E +V + G L
Sbjct: 32 LKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQ 91
Query: 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
+++ + + KR P + + ++ M+ + + H ++K +N+ +
Sbjct: 92 MIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-----VMHRDIKPANVFITATGVVK 146
Query: 446 ISECGYSKFLDPKKTCLFSSNG---YTAPEKTVSEQG-----DVFSFGVILLEL 491
+ + G +F K T S G Y +PE+ + E G D++S G +L E+
Sbjct: 147 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPER-IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 27/194 (13%)
Query: 317 LFMVRLKNSA----VYAVKRLKKLQVSMDEFSQTMRQ---IGNLKHPNILPLVCYNSTNE 369
+F+VR +YA+K LKK + + + +T + + + HP I+ L Y E
Sbjct: 12 VFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL-HYAFQTE 70
Query: 370 EKL-LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPH 428
KL L+ + G L + L + + ++ +A +A LD ++ I +
Sbjct: 71 GKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAE-LALALDHLHSLG-----IIY 121
Query: 429 GNLKLSNILLNENEDPLISECGYSK--FLDPKKTCLFSSN-GYTAPEKTVSEQG-----D 480
+LK NILL+E +++ G SK KK F Y APE V+ +G D
Sbjct: 122 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSAD 180
Query: 481 VFSFGVILLELLTG 494
+SFGV++ E+LTG
Sbjct: 181 WWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 59/252 (23%), Positives = 104/252 (41%), Gaps = 50/252 (19%)
Query: 333 LKKLQVSMDEFSQT-MRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLE 388
+K++ + Q +I LKH NI+ + +S N + + GSL +LL
Sbjct: 38 IKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLR 97
Query: 389 AYIEGKRDFPW-KLRLSIAT------GIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
+ W L+ + T I +GL +++ + I H ++K N+L+N
Sbjct: 98 S--------KWGPLKDNEQTIIFYTKQILEGLKYLH-----DNQIVHRDIKGDNVLVNTY 144
Query: 442 EDPL-ISECGYSKFLDPKKTCLFSSNG---YTAPEKTVSEQG--------DVFSFGVILL 489
+ IS+ G SK L C + G Y APE V ++G D++S G ++
Sbjct: 145 SGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE--VIDKGPRGYGAPADIWSLGCTIV 202
Query: 490 ELLTGKTVEKTGIDLPKWVKAMVREEW--TGEVFDKEVAKAGRQWAFPLLNVALKCVSNS 547
E+ TGK I+L + AM + + ++ + N L+C
Sbjct: 203 EMATGK---PPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK-------NFILRCFEPD 252
Query: 548 PDDRPTMAEVLE 559
PD R + ++L+
Sbjct: 253 PDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 52/191 (27%), Positives = 75/191 (39%), Gaps = 40/191 (20%)
Query: 389 AYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448
Y K P ++ IA K L+++ EE I H ++K SNILL+ N + + +
Sbjct: 96 VYEVLKSVIPEEILGKIAVATVKALNYL----KEELKIIHRDVKPSNILLDRNGNIKLCD 151
Query: 449 CGYSKFLDPK--KTCLFSSNGYTAPEKTVSEQG-------DVFSFGVILLELLTGKTVEK 499
G S L KT Y APE+ DV+S G+ L E+ TGK
Sbjct: 152 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK---- 207
Query: 500 TGIDLPKWVKAMVREEWTGEVFDK--EVAKA---------GRQWAFPLLNVALKCVSNSP 548
PKW VFD+ +V K R+++ +N C+
Sbjct: 208 --FPYPKW----------NSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDE 255
Query: 549 DDRPTMAEVLE 559
RP E+LE
Sbjct: 256 SKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 22/195 (11%)
Query: 315 SSLFMVRLK-NSAVYAVKRLKKLQVSMDE---FSQTMRQIGNL--KHPNILPLVCYNSTN 368
+ + +V LK +YA+K +KK V+ DE + QT + + HP ++ L T
Sbjct: 9 AKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE 68
Query: 369 EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPH 428
V ++ S G L+ +++ +R P + + I+ L+F++ E+ I +
Sbjct: 69 SRLFFVIEFVSGGDLM----FHMQRQRKLPEEHARFYSAEISLALNFLH-----ERGIIY 119
Query: 429 GNLKLSNILLNENEDPLISECGYSK--FLDPKKTCLF-SSNGYTAPEKTVSEQG----DV 481
+LKL N+LL+ +++ G K T F + Y APE E D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 482 FSFGVILLELLTGKT 496
++ GV++ E++ G++
Sbjct: 180 WALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 61/261 (23%), Positives = 103/261 (39%), Gaps = 51/261 (19%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQ--IGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386
AVK L + DE M + H NI+ L+ + + ++ + + G L S
Sbjct: 40 AVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSF 99
Query: 387 L-EAYIEGKRDFPWKLR--LSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443
L E +R ++ L A +AKG ++ EE H ++ N LL +
Sbjct: 100 LRENRPRPERPSSLTMKDLLFCARDVAKGCKYL-----EENHFIHRDIAARNCLLT-CKG 153
Query: 444 P----LISECGYSKFLDPKKTCLFSSNG-------YTAPEKTV----SEQGDVFSFGVIL 488
P I++ G ++ D + + G + PE + + + DV+SFGV+L
Sbjct: 154 PGRVAKIADFGMAR--DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211
Query: 489 LELL-------TGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVAL 541
E+ G+T ++ V V G D G P+ +
Sbjct: 212 WEIFSLGYMPYPGRTNQE--------VMEFVTG---GGRLDPPKGCPG-----PVYRIMT 255
Query: 542 KCVSNSPDDRPTMAEVLERIE 562
C ++P+DRP A +LERI+
Sbjct: 256 DCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 14/101 (13%)
Query: 405 IATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL-DPK-KTCL 462
+ I K L ++ +K + H ++K SNILL+ + + + + G S L D K KT
Sbjct: 119 MTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS 174
Query: 463 FSSNGYTAPEKTVSE--------QGDVFSFGVILLELLTGK 495
Y APE+ + DV+S G+ L+EL TG+
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 62/273 (22%), Positives = 107/273 (39%), Gaps = 76/273 (27%)
Query: 329 AVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKL-LVYKYQSNGSL 383
AVK L+ + ++F + ++ + L PNI L VC T + L ++ +Y NG L
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVC---TVDPPLCMIMEYMENGDL 106
Query: 384 LSLLEAYI-------EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
L+ ++ + + L +AT IA G+ ++ E H +L N
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-----ESLNFVHRDLATRNC 161
Query: 437 LLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTV----------------SEQGD 480
L+ +N I++ G S+ L+SS+ Y + + + D
Sbjct: 162 LVGKNYTIKIADFGMSR-------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSD 214
Query: 481 VFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV--------AKAGRQW 532
V++FGV L E+LT + RE+ + D++V GRQ
Sbjct: 215 VWAFGVTLWEILT-----------------LCREQPYEHLTDQQVIENAGHFFRDDGRQI 257
Query: 533 AFP--------LLNVALKCVSNSPDDRPTMAEV 557
P + + L+C +DRPT E+
Sbjct: 258 YLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 31/193 (16%)
Query: 333 LKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIE 392
LK L+ S E+S+ I PN++ L Y + + LV ++ G L S + ++
Sbjct: 23 LKGLRKS-SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN 81
Query: 393 GKRDF--PWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECG 450
+ W + +A LD ++++ I +L +NILL++ I
Sbjct: 82 IPEECVKRWAAEMVVA------LDALHREG-----IVCRDLNPNNILLDDRGH--IQLTY 128
Query: 451 YSKFLDPKKTCLFS--SNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEK----- 499
+S++ + + +C N Y APE +E D +S G IL ELLTGKT+ +
Sbjct: 129 FSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG 188
Query: 500 ----TGIDLPKWV 508
T +++P+WV
Sbjct: 189 INTHTTLNIPEWV 201
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 36/111 (32%), Positives = 52/111 (46%), Gaps = 18/111 (16%)
Query: 406 ATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS-KFLDPKKTCLFS 464
AT I GL+ M+ + + + +LK +NILL+E+ IS+ G + F K
Sbjct: 103 ATEIILGLEHMHNR-----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 157
Query: 465 SNGYTAPE-----KTVSEQGDVFSFGVILLELLTG-------KTVEKTGID 503
++GY APE D FS G +L +LL G KT +K ID
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 20/178 (11%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEK---LLVYKY 377
R AV +K Q + E S M Q L+H N++ L+ EEK +V +Y
Sbjct: 28 RGNKVAVKCIKNDATAQAFLAEAS-VMTQ---LRHSNLVQLL--GVIVEEKGGLYIVTEY 81
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+ GSL+ L + G+ L + + + ++++ E H +L N+L
Sbjct: 82 MAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL-----EANNFVHRDLAARNVL 134
Query: 438 LNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLEL 491
++E+ +S+ G +K + +TAPE K S + DV+SFG++L E+
Sbjct: 135 VSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 65/275 (23%), Positives = 109/275 (39%), Gaps = 66/275 (24%)
Query: 333 LKKLQVSMDE--FSQTMRQIGNLKHPNILPLVC--YNSTNEEKLLVY--KYQSNGSLLSL 386
+K++++ +DE F+Q + ++ L H + P + Y + E + +Y GSL L
Sbjct: 31 MKEIRLELDESKFNQIIMELDIL-HKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKL 89
Query: 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446
+ + LR I + KGL F+ EE I H ++K +N+L+N N +
Sbjct: 90 YAGGVATEGIPEDVLR-RITYAVVKGLKFL----KEEHNIIHRDVKPTNVLVNGNGQVKL 144
Query: 447 SECGYSKFLDPK--KTCLFSSNGYTAPEK----------TVSEQGDVFSFGVILLELLTG 494
+ G S L KT + Y APE+ T + Q DV+S G+ +LE+ G
Sbjct: 145 CDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
Query: 495 K-----------------TVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537
+ V+ LP ++ + D
Sbjct: 204 RYPYPPETYANIFAQLSAIVDGDPPTLP--------SGYSDDAQD--------------- 240
Query: 538 NVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERD 572
KC++ P+ RPT A++LE V N + D
Sbjct: 241 -FVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 26/80 (32%), Positives = 38/80 (47%), Gaps = 1/80 (1%)
Query: 87 NLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALT 146
N +G I L L L+V+ L N G IP ++ LT L+LS+N L+G +P L
Sbjct: 319 NFTGKI-PVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377
Query: 147 KLKHLKTLDISNNHFAATSP 166
+L L + +N P
Sbjct: 378 SSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 29/101 (28%), Positives = 53/101 (52%), Gaps = 15/101 (14%)
Query: 402 RLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS-KFLDPKKT 460
++SIA + +GL ++ E+ I H ++K SNIL+N + + + G S + +D
Sbjct: 103 KISIA--VLRGLTYL----REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156
Query: 461 CLFSSNGYTAPEK------TVSEQGDVFSFGVILLELLTGK 495
+ Y +PE+ TV Q D++S G+ L+E+ G+
Sbjct: 157 SFVGTRSYMSPERLQGTHYTV--QSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 347 MRQI---GNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRL 403
+R+I LKHPN++ L+ + LV++Y + ++L+ LE G P L
Sbjct: 48 LREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRG---VPEHLIK 103
Query: 404 SIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460
I + ++F ++ I H ++K NIL+ + + + G+++ L T
Sbjct: 104 KIIWQTLQAVNFCHK----HNCI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158
Query: 461 CLFSSNGYTAPEKTVSEQG-----DVFSFGVILLELLTG 494
++ Y APE V + DV++ G + ELLTG
Sbjct: 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 28/192 (14%)
Query: 323 KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381
++ + AVK LK + +F + + NL+H +I+ + ++V++Y +G
Sbjct: 33 QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 382 SLLSLLEAY-----IEGKRDFPWKLR----LSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
L L A+ + + + P +L L IA IA G+ ++ + H +L
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL-----ASQHFVHRDLA 147
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYT-------APE----KTVSEQGDV 481
N L+ EN I + G S+ D T + G+T PE + + + DV
Sbjct: 148 TRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 205
Query: 482 FSFGVILLELLT 493
+S GV+L E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 45/203 (22%)
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIAT---GIAKGLDFMYQKSNEEKTIPHG 429
++ +Y GS L LL A G D IAT I KGLD+++ EK I H
Sbjct: 79 IIMEYLGGGSALDLLRA---GPFD-----EFQIATMLKEILKGLDYLHS----EKKI-HR 125
Query: 430 NLKLSNILLNENEDPLISECGYSKFLDP---KKTCLFSSNGYTAPE----KTVSEQGDVF 482
++K +N+LL+E D +++ G + L K+ + + APE + D++
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 483 SFGVILLELLTGKTVE------KTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536
S G+ +EL G+ + +PK + E++ KE A
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPF--KEFIDA-------- 235
Query: 537 LNVALKCVSNSPDDRPTMAEVLE 559
C++ P RPT E+L+
Sbjct: 236 ------CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 10/94 (10%)
Query: 411 KGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTA 470
GL +++ I H +LK N+ +NE+ + I + G ++ D + T + Y A
Sbjct: 128 CGLKYIHSAG-----IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRA 182
Query: 471 PEKTVS-----EQGDVFSFGVILLELLTGKTVEK 499
PE ++ + D++S G I+ E+LTGKT+ K
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 327 VYAVKRLKK-LQVSMDEFSQTM---RQIGNLKHPNILPLV--CYNSTNEEKLLVYKYQSN 380
+YA+K LKK + + D+ TM R + P L + C+ T + V +Y +
Sbjct: 27 LYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-TVDRLYFVMEYVNG 85
Query: 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440
G L+ +I+ F + A I+ GL F++++ I + +LKL N++L+
Sbjct: 86 GDLMY----HIQQVGKFKEPQAVFYAAEISVGLFFLHRRG-----IIYRDLKLDNVMLDS 136
Query: 441 NEDPLISECGYSK--FLDPKKTCLF-SSNGYTAPE----KTVSEQGDVFSFGVILLELLT 493
I++ G K +D T F + Y APE + + D +++GV+L E+L
Sbjct: 137 EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA 196
Query: 494 GK 495
G+
Sbjct: 197 GQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 41/197 (20%)
Query: 320 VRLKNSA-VYAVKRLKKLQ-VSMDEFSQTMRQ---IGNLKHPNILPLVCYNSTNEEKLLV 374
VR +++ +YA+K ++K VS E + T+ + + + P I+PL + E+ LV
Sbjct: 12 VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71
Query: 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
+ + G L L+ EG+ D + R A + L+ ++ + + + +LK
Sbjct: 72 LAFINGGELFHHLQR--EGRFDL-SRARFYTAE-LLCALENLH-----KFNVIYRDLKPE 122
Query: 435 NILLN-----------------ENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTVSE 477
NILL+ +++D + CG ++L P+ L +GYT K V
Sbjct: 123 NILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPE---LLLGHGYT---KAV-- 174
Query: 478 QGDVFSFGVILLELLTG 494
D ++ GV+L E+LTG
Sbjct: 175 --DWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 0.003
Identities = 48/194 (24%), Positives = 89/194 (45%), Gaps = 28/194 (14%)
Query: 317 LFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNSTNEEKL 372
+ + A+K++KK S +E +R++ +L+ HPNI+ L N+E
Sbjct: 16 YLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPNIVKLKEVFRENDELY 74
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHG--- 429
V++Y G+L L++ + F + SI I +GL +++ HG
Sbjct: 75 FVFEYM-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHK---------HGFFH 122
Query: 430 -NLKLSNILLNENEDPLISECGYSKFLDPKK--TCLFSSNGYTAPE-----KTVSEQGDV 481
+LK N+L++ E I++ G ++ + + T S+ Y APE + S D+
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDI 182
Query: 482 FSFGVILLELLTGK 495
++ G I+ EL T +
Sbjct: 183 WALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 29/182 (15%)
Query: 329 AVKRLK------KLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382
AVK LK + + M E + M +GN H NI+ L+ + L++ +Y G
Sbjct: 69 AVKMLKPTAHSSEREALMSEL-KIMSHLGN--HENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442
LL+ L E L LS + +AKG+ F+ K H +L N+LL +
Sbjct: 126 LLNFLRRKRESFLTL-EDL-LSFSYQVAKGMAFL-----ASKNCIHRDLAARNVLLTHGK 178
Query: 443 DPLISECGYSKFLDPKKTCLFSSNGYT-------APEKTV----SEQGDVFSFGVILLEL 491
I + G ++ D + G APE + + DV+S+G++L E+
Sbjct: 179 IVKICDFGLAR--DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
Query: 492 LT 493
+
Sbjct: 237 FS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 41/201 (20%)
Query: 373 LVYKYQSNGSLLSLL------EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTI 426
++ +Y GS L LL E YI +I I KGLD+++ E+ I
Sbjct: 79 IIMEYLGGGSALDLLKPGPLEETYIA-----------TILREILKGLDYLHS----ERKI 123
Query: 427 PHGNLKLSNILLNENEDPLISECGYSKFLDP---KKTCLFSSNGYTAPE----KTVSEQG 479
H ++K +N+LL+E D +++ G + L K+ + + APE +
Sbjct: 124 -HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 480 DVFSFGVILLELLTGKTVEKTGIDL-PKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538
D++S G+ +EL G E DL P V ++ + Q++ P
Sbjct: 183 DIWSLGITAIELAKG---EPPNSDLHPMRVLFLIPK--------NSPPTLEGQYSKPFKE 231
Query: 539 VALKCVSNSPDDRPTMAEVLE 559
C++ P RPT E+L+
Sbjct: 232 FVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 39/175 (22%), Positives = 72/175 (41%), Gaps = 23/175 (13%)
Query: 333 LKKLQVSMDEFSQTMRQ--------IGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
LKK+Q+ D R + L HPN++ + E +V + G L
Sbjct: 32 LKKVQI-FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 90
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
+++ + + KR P K + L+ M+ + + H ++K +N+ +
Sbjct: 91 RMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-----VMHRDIKPANVFITATGVV 145
Query: 445 LISECGYSKFLDPKKTCLFSSNG---YTAPEKTVSEQG-----DVFSFGVILLEL 491
+ + G +F K T S G Y +PE+ + E G D++S G +L E+
Sbjct: 146 KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER-IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 28/166 (16%)
Query: 345 QTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKL 401
Q R+I L+ HPN++ N E ++ ++ GSL EG +
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL--------EGTHIADEQF 169
Query: 402 RLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461
+A I G+ +++++ I H ++K SN+L+N ++ I++ G S+ L
Sbjct: 170 LADVARQILSGIAYLHRRH-----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224
Query: 462 LFSSNG---YTAPEKTVSE---------QGDVFSFGVILLELLTGK 495
SS G Y +PE+ ++ GD++S GV +LE G+
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 608 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.87 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.84 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.45 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.36 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.35 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.27 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.24 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.19 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.18 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.17 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.15 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.94 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.91 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 97.88 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 97.87 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 97.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.85 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.83 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.82 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.8 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.79 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.78 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.77 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.77 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.75 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.73 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.71 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.66 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.62 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.57 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.54 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.52 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.47 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.46 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.45 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.44 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.42 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.4 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.37 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.36 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 97.34 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 97.29 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.24 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.23 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 97.22 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=485.43 Aligned_cols=453 Identities=24% Similarity=0.419 Sum_probs=298.8
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.++..|+|++|.++|.+| ..+.+++.|+.|+|++|.+.|.+|..+.+|++|+.|+|++|.++|.+|..+..+++|+.||
T Consensus 475 ~~L~~L~ls~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVP-RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred ccceEEECcCCccCCccC-hhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 467888888888888886 4688888999999999999999998888999999999999999999998888999999999
Q ss_pred CcCCcCCccCChhHHHh--hhhccccc------ccCCccccccc--cccccC-CCCCCCCCCCCCCCCCCcccccccchh
Q 042949 156 ISNNHFAATSPDNFRQE--IKYFDKYV------VETSSSEINRA--STVEAR-GLEDTQPPSVHNKSEHGEKRHWFRNWM 224 (608)
Q Consensus 156 ls~N~l~g~~p~~~~~~--~~~~~~~~------~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (608)
|++|+++|.+|..+... +..++... ++... .+... +....+ .+.+..++... .+.....+...+++
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~-~~~~~~~~~~~~n~~lc~~~~~~~~--~~c~~~~~~~~~~~ 630 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG-AFLAINASAVAGNIDLCGGDTTSGL--PPCKRVRKTPSWWF 630 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcc-hhcccChhhhcCCccccCCccccCC--CCCccccccceeee
Confidence 99999999999877542 11111110 01000 00000 000000 01000000000 00000101111122
Q ss_pred hHHHHHHHHHHHHHHHh-hhccchhhhhhhHHHHhhhcCCCCCCCCCccccccccccccccceEEee-cCccCcCHHHHH
Q 042949 225 TIIPLAAGIGLVVLIAY-CMGKKSAQIARDREILKALQDSPSKSPPQVMDIEEVRPEVRRSELVFFV-NEKERFKLDDLL 302 (608)
Q Consensus 225 ~ii~~~~~~~l~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 302 (608)
+++++++++++++++++ ++++++++..+. +.. . .... ..+...+. .....++++++.
T Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-~----~~~~------------~~~~~~~~~~~~~~~~~~~~~ 689 (968)
T PLN00113 631 YITCTLGAFLVLALVAFGFVFIRGRNNLEL----KRV-E----NEDG------------TWELQFFDSKVSKSITINDIL 689 (968)
T ss_pred ehhHHHHHHHHHHHHHHHHHHHHhhhcccc----ccc-c----cccc------------cccccccccccchhhhHHHHH
Confidence 22222222222222221 111111111000 000 0 0000 00011111 112345666665
Q ss_pred HHhh--cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 303 EATA--DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 303 ~~~~--~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.... +++|+|+||.||+|+. .++..||||+++..... ...|++.+++++|||||+++++|.+.+..++||||++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 5443 4799999999999987 57899999998743321 2356889999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.++++ .++|.++.+|+.|||+||+|||+.+ .++|+||||||+||+++.++.+++. ||........
T Consensus 767 ~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 767 GKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRC--SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCC--CCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999985 2899999999999999999999653 3569999999999999999998876 6665543322
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCC----CChHHHHHHHHhhhcccccccHHHHH---h
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTG----IDLPKWVKAMVREEWTGEVFDKEVAK---A 528 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 528 (608)
....+|.+|+||| ..++.++|||||||++|||+||+.|+... .....|.+............++.+.. .
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 2346789999999 56789999999999999999999997532 34555655433222222223332211 1
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
......++.+++.+||+.||++||||+||+++|+++.+.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 223455688999999999999999999999999998764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=434.44 Aligned_cols=271 Identities=32% Similarity=0.542 Sum_probs=235.3
Q ss_pred CccCcCHHHHHHHhhc-----ccCCCCCceEEEEEEcCCcEEEEEEecccccC-HHHHHHHHHHHhcCCCCcceeeeeee
Q 042949 292 EKERFKLDDLLEATAD-----LRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS-MDEFSQTMRQIGNLKHPNILPLVCYN 365 (608)
Q Consensus 292 ~~~~~~~~~l~~~~~~-----~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~ 365 (608)
....|+++++.+||++ ++|+|+||.||+|.+.+|..||||++...... ..+|..|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 4567999999999976 48999999999999999999999998864443 66799999999999999999999999
Q ss_pred ecCC-eeEEEEeeccCCCHHHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC
Q 042949 366 STNE-EKLLVYKYQSNGSLLSLLEAYIEGKR-DFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443 (608)
Q Consensus 366 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~ 443 (608)
.+.+ +.+||||||++|+|.++|+.. .. .++|.+|++||.++|+||+|||..+ .++||||||||+|||||++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~---~~~~L~W~~R~kIa~g~A~gL~yLH~~~--~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGK---KGEPLDWETRLKIALGAARGLAYLHEGC--PPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCC---CCCCCCHHHHHHHHHHHHHHHHHHccCC--CCCEecCCCCHHHeeECCCCC
Confidence 9988 599999999999999999852 22 8999999999999999999999987 457999999999999999999
Q ss_pred ceEeccccccccCC-CCccc---cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcC-----CCChHHHHHH
Q 042949 444 PLISECGYSKFLDP-KKTCL---FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKT-----GIDLPKWVKA 510 (608)
Q Consensus 444 ~kl~DFGla~~~~~-~~~~~---~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~-----~~~~~~~~~~ 510 (608)
+||+|||+|+.... ..... .||.+|+||| ...+.|+|||||||+|+|++||+.+... ...+..|++.
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 99999999987664 33222 7999999999 4689999999999999999999976542 3357889888
Q ss_pred HHhhhcccccccHHHH-Hhch--hcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 511 MVREEWTGEVFDKEVA-KAGR--QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 511 ~~~~~~~~~~~~~~~~-~~~~--~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
...+....+++|+.+. .... .....+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 8888788889998875 2222 4566789999999999999999999999999766543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=382.08 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=211.1
Q ss_pred cCHHHHHHHhhcccCCCCCceEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCC-ee
Q 042949 296 FKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNE-EK 371 (608)
Q Consensus 296 ~~~~~l~~~~~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~ 371 (608)
+..+++. ..+.+|+|+||+||+|.+.....||||++.....+ .++|.+|+.+|.+++|||||+++|+|..+. ..
T Consensus 38 i~~~~l~--~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 38 IDPDELP--IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred cChHHhh--hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 3444443 23449999999999999965555999999854433 458999999999999999999999999887 79
Q ss_pred EEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-CceEeccc
Q 042949 372 LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-DPLISECG 450 (608)
Q Consensus 372 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG 450 (608)
++|||||++|+|.++++.. ....+++..+++++.|||+||+|||++. + ||||||||+|||++.++ ++||+|||
T Consensus 116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~---~-iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEG---P-IIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---C-eeecccChhhEEEcCCCCEEEECCCc
Confidence 9999999999999999863 3578999999999999999999999876 1 99999999999999997 99999999
Q ss_pred cccccCC---CCccccccCccccCC--C----CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 451 YSKFLDP---KKTCLFSSNGYTAPE--K----TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 451 la~~~~~---~~~~~~gt~~y~aPE--~----~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
+++.... ..+...||+.||||| . .++.|+|||||||++|||+||+.||..... ......+........
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~-- 266 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPP-- 266 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCC--
Confidence 9987764 234468999999999 2 489999999999999999999999987655 333333332222111
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
.+..+...+..++.+||..||+.||++.+++..|+.+....
T Consensus 267 ------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 267 ------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred ------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 12236667889999999999999999999999999987643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=371.32 Aligned_cols=247 Identities=22% Similarity=0.359 Sum_probs=207.4
Q ss_pred CcCHHHHHHHhhcccCCCCCceEEEEEEc-CCcEEEEEEecc--cccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC-e
Q 042949 295 RFKLDDLLEATADLRSQTICSSLFMVRLK-NSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE-E 370 (608)
Q Consensus 295 ~~~~~~l~~~~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~ 370 (608)
.++..||.+. +.+|+|..|+||+++++ +++.+|+|.+.. .....+++.+|++++++.+||+||+++|.|..++ .
T Consensus 75 ~i~~~dle~~--~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERL--GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhh--hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 4677777644 67999999999999875 789999999952 2334678999999999999999999999999988 5
Q ss_pred eEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccc
Q 042949 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECG 450 (608)
Q Consensus 371 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 450 (608)
..++||||.+|+|.+++.. .+.+++...-+|+.+|++||.|||+.. .||||||||+|||++..|++||+|||
T Consensus 153 isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~----~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEER----KIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred EEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcc----CeeeccCCHHHeeeccCCCEEecccc
Confidence 9999999999999999875 367999999999999999999999632 39999999999999999999999999
Q ss_pred cccccCCCC-ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCC----CChHHHHHHHHhhhcccccc
Q 042949 451 YSKFLDPKK-TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTG----IDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 451 la~~~~~~~-~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~----~~~~~~~~~~~~~~~~~~~~ 521 (608)
.++.+.... .+.+||..||||| ..|+.++||||||++++|+++|+.|+... ....+.+..+..+.
T Consensus 225 VS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p------ 298 (364)
T KOG0581|consen 225 VSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP------ 298 (364)
T ss_pred ccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC------
Confidence 999776553 6789999999999 57899999999999999999999998653 22223233332221
Q ss_pred cHHHHHhch-hcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 DKEVAKAGR-QWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 ~~~~~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+..+. .++.++.+++..||+.||.+|||+.|++++
T Consensus 299 ---pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 ---PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 112223 488889999999999999999999999876
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=373.03 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=212.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
.-||+|-||.|+.|++.....||+|.++....+.++|.+|+++|++|+|+|||+++|+|..++.++||||||+.|+|.++
T Consensus 212 ~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~y 291 (468)
T KOG0197|consen 212 RELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDY 291 (468)
T ss_pred HHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHH
Confidence 45899999999999998888999999998777889999999999999999999999999998899999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc-ccc-
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC-LFS- 464 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~g- 464 (608)
|+. .....+...+.+.++.|||+||+||++++ +|||||.++|||++++..+||+|||+|+...++... ..|
T Consensus 292 Lr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~-----~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~ 364 (468)
T KOG0197|consen 292 LRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN-----YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG 364 (468)
T ss_pred hhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC-----ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence 986 34677899999999999999999999887 999999999999999999999999999965544322 112
Q ss_pred --cCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 465 --SNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 465 --t~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
...|.||| ..++.|||||||||+||||+|-...++.+....+.++.+.+... ...+..++..+.+
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR---------lp~P~~CP~~vY~ 435 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR---------LPRPEGCPDEVYE 435 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc---------CCCCCCCCHHHHH
Confidence 34599999 78999999999999999999965555556666666655544322 2346678899999
Q ss_pred HHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 539 VALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
+|..||+.+|++|||++.+...|+++....
T Consensus 436 lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 436 LMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 999999999999999999999999987643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=346.91 Aligned_cols=250 Identities=19% Similarity=0.310 Sum_probs=207.2
Q ss_pred cccCCCCCceEEEEE-EcCCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeee-eeecCCe-eEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVR-LKNSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVC-YNSTNEE-KLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~-~~lv~e~~~~ 380 (608)
+.||+|.||+||++. +.+|..||.|.++-. ....++...|+.+|++|+|||||++++ .+..+.+ .+||||||..
T Consensus 25 ~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~ 104 (375)
T KOG0591|consen 25 KKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDA 104 (375)
T ss_pred HHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcc
Confidence 568999999999997 579999999999832 234567889999999999999999998 4444444 8999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|||.++++.+...++.++++.+++++.|++.||.++|..- ....|+||||||.||+|+.+|.+||+|||+++++..+.
T Consensus 105 GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t 183 (375)
T KOG0591|consen 105 GDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT 183 (375)
T ss_pred cCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhcchhH
Confidence 9999999988888899999999999999999999999954 23459999999999999999999999999999988764
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
...+||++||+|| ..|+.||||||+||++|||+.-++||.+. ++....+.+...+. ..+. ....+
T Consensus 184 fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~qgd~-~~~p-------~~~YS 254 (375)
T KOG0591|consen 184 FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQGDY-PPLP-------DEHYS 254 (375)
T ss_pred HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHcCCC-CCCc-------HHHhh
Confidence 4578999999999 68999999999999999999999999876 44444443333221 1111 13456
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
..+..|+..|+..||+.||+...++..++.-.+
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~ 287 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDTVPYVQDIQSELD 287 (375)
T ss_pred hHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence 678899999999999999997666666665433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=361.61 Aligned_cols=240 Identities=18% Similarity=0.270 Sum_probs=199.8
Q ss_pred hcccCCCCCceEEEEE-EcCCcEEEEEEeccccc--------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVR-LKNSAVYAVKRLKKLQV--------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~-~~~g~~vavK~l~~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 376 (608)
..-+|+|+||.|-+|. .++|+.||||++++... ....+.+|+++|++|+|||||+++++|...+..|+|||
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE 256 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE 256 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence 4568999999999996 46899999999975322 22346799999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC---CCceEecccccc
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN---EDPLISECGYSK 453 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~ 453 (608)
|+.||+|.+++-. .+.+.+..-..++.|++.|+.|||+.+ |+||||||+|||+..+ ..+||+|||+|+
T Consensus 257 ~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G-----I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 257 YVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG-----IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC-----cccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999865 567888888999999999999999988 9999999999999766 678999999999
Q ss_pred ccCCC--CccccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHH
Q 042949 454 FLDPK--KTCLFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKE 524 (608)
Q Consensus 454 ~~~~~--~~~~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (608)
..... ..+.+||+.|.||| ..+..+.|+||+||+||-+++|.+||.+....+...+++....+...
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~----- 402 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG----- 402 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc-----
Confidence 98644 35689999999999 23456899999999999999999999876655544444444332111
Q ss_pred HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 525 VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 525 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+......+.+.+++|.+||..||++|||++|+++.
T Consensus 403 -p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 403 -PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11223445668999999999999999999999876
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=371.50 Aligned_cols=235 Identities=24% Similarity=0.364 Sum_probs=203.3
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEecc----cccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKK----LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.++|+|+|+.+|.++. .+|+.||+|++.+ .....+.+.+||++.++|+|||||+++++|++.+..|+|.|+|++
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~ 102 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR 102 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence 47899999999999997 8899999999975 345677899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC---C
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD---P 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~---~ 457 (608)
|+|..+++. ...+++..+..++.||+.||.|||+.+ |+|||||-.|+++++++++||+|||+|..+. +
T Consensus 103 ~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~-----IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 103 GSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG-----IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred ccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC-----ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 999998874 678999999999999999999999987 9999999999999999999999999999887 3
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
...+.+||+.|+||| ...+..+||||+||++|-|++|++||+... ..+-...+....+. .+...+
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-vkety~~Ik~~~Y~----------~P~~ls 242 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-VKETYNKIKLNEYS----------MPSHLS 242 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-HHHHHHHHHhcCcc----------cccccC
Confidence 457789999999999 456888999999999999999999997642 22222222222111 122445
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+..+||.++|+.||.+|||+++|+..
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 668899999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=350.67 Aligned_cols=185 Identities=26% Similarity=0.399 Sum_probs=168.4
Q ss_pred cCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 309 RSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
||.|.|++||+|+++ ++..||||.+.+.. ...+....|+.+|+.++|||||.++++++..+..|+|||||.+|||.
T Consensus 18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs 97 (429)
T KOG0595|consen 18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLS 97 (429)
T ss_pred ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHH
Confidence 899999999999975 68999999997543 34566789999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC------CCceEeccccccccCCC
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN------EDPLISECGYSKFLDPK 458 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~------~~~kl~DFGla~~~~~~ 458 (608)
+||+. ...+++..++.++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||+|+.+.+.
T Consensus 98 ~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~-----IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 98 DYIRR----RGRLPEATARHFMQQLASALQFLHENN-----IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred HHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 99986 568999999999999999999999987 9999999999999875 34799999999998866
Q ss_pred C--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Q 042949 459 K--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI 502 (608)
Q Consensus 459 ~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~ 502 (608)
. .+.+|++.||||| ..|+.|+|+||.|+++|||++|+.||....
T Consensus 169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 4 5678999999999 789999999999999999999999997543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.23 Aligned_cols=246 Identities=23% Similarity=0.373 Sum_probs=206.5
Q ss_pred ccCCCCCceEEEEEEc------CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 308 LRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
-+|+|.||+||+|+.. +.+.||||.++... ....+|++|++.++.++|||||+|+|.|..++..++|+|||.
T Consensus 493 eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~ 572 (774)
T KOG1026|consen 493 ELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMD 572 (774)
T ss_pred hhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecc
Confidence 3799999999999863 34789999998533 356789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhc------C----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecc
Q 042949 380 NGSLLSLLEAYIE------G----KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC 449 (608)
Q Consensus 380 ~g~L~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 449 (608)
.|||.+||+.... + ..+|+..+.+.||.|||.||+||-++. +|||||..+|+||.++..+||+||
T Consensus 573 ~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~-----FVHRDLATRNCLVge~l~VKIsDf 647 (774)
T KOG1026|consen 573 HGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH-----FVHRDLATRNCLVGENLVVKISDF 647 (774)
T ss_pred cccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc-----ccccchhhhhceeccceEEEeccc
Confidence 9999999986321 1 223889999999999999999998776 999999999999999999999999
Q ss_pred ccccccCCCCccccc-----cCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccc
Q 042949 450 GYSKFLDPKKTCLFS-----SNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGE 519 (608)
Q Consensus 450 Gla~~~~~~~~~~~g-----t~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 519 (608)
|+++.+...+...++ ...||+|| +.++.+||||||||+|||++| |+.|+.+-.+ .+.+. ..+
T Consensus 648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-~EVIe-~i~------ 719 (774)
T KOG1026|consen 648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-QEVIE-CIR------ 719 (774)
T ss_pred ccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-HHHHH-HHH------
Confidence 999987665544333 45799999 789999999999999999998 7777664332 12221 112
Q ss_pred cccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 520 VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 520 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
+..+...++.++.++.+||..||+..|++||+++||-..|+...+..
T Consensus 720 --~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 720 --AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 22334567889999999999999999999999999999999998654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=327.33 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=197.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..+|+|+||+||+++.+ +|+.||||++..+..+ .+-..+|+++|++++|+|+|.++.+|......++|+|||+. +
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 35799999999999976 6999999999865543 23467999999999999999999999999999999999975 4
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC-CC--
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP-KK-- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~-~~-- 459 (608)
+.+-|+.+ ...++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+.. ..
T Consensus 87 vL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n-----~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 87 VLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN-----CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred HHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC-----eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 44445543 556899999999999999999999987 99999999999999999999999999998873 32
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc----------cccccc--
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW----------TGEVFD-- 522 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~-- 522 (608)
+..+.|.+|+||| ..|+..+||||.||++.||++|.+.|.+..++.+.......-+. ...++.
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 4467899999999 57899999999999999999999999888777665443321110 011111
Q ss_pred -------HH-HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 -------KE-VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 -------~~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+ +.......+..+++++..|++.||++|++.+|++..
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00 111122334458899999999999999999998753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=346.34 Aligned_cols=245 Identities=22% Similarity=0.308 Sum_probs=203.9
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHH--HHHHHHHhcCC-CCcceeeeeeeecCC-eeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEF--SQTMRQIGNLK-HPNILPLVCYNSTNE-EKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~--~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~lv~e~~~~g 381 (608)
.-+|.|.||.||+|+. .+|..||||+|++.-.+.++. .||+..|++++ |||||++..++.+.+ .+++|||||+ .
T Consensus 16 ~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~ 94 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-C 94 (538)
T ss_pred HHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-h
Confidence 3479999999999985 578999999999766666664 58999999998 999999999999888 9999999995 5
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|++++++ ..+.|++..++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+.+....
T Consensus 95 NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G-----fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 95 NLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG-----FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred hHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC-----cccccCChhheEecccceeEecccccccccccCCCc
Confidence 99999986 3678999999999999999999999988 9999999999999999999999999999887654
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHH--hhh----cc-----------
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMV--REE----WT----------- 517 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~--~~~----~~----------- 517 (608)
+..+.|.+|+||| ..|+.+.||||+|||++|+++-++.|.+..++.+..+... ... +.
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 5678999999999 6899999999999999999999999987777665544321 110 00
Q ss_pred --cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 518 --GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 518 --~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+....+..-...++.++.+++.+|+.+||++|||+.|++++
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000011111223467778999999999999999999999876
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=337.08 Aligned_cols=227 Identities=25% Similarity=0.319 Sum_probs=193.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.++|+|+||+||.++.. +++.+|+|++++.. ...+....|..+|.+++||+||+++..|++.+.+|+|+||+.||
T Consensus 31 kviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GG 110 (357)
T KOG0598|consen 31 KVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGG 110 (357)
T ss_pred eeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCc
Confidence 57999999999999865 68999999998543 24566889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---C
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP---K 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~ 458 (608)
.|..+|+. ...+++..+..++.+|+.||.|||+++ ||||||||+|||||++|+++|+|||+++.... .
T Consensus 111 eLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g-----IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 111 ELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG-----IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred cHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC-----eeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence 99999985 678999999999999999999999988 99999999999999999999999999995432 3
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....+||+.||||| ..++..+|+||+||++|||++|.+||... +...+.+.+.... +...+...+.
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-~~~~~~~~I~~~k---------~~~~p~~ls~ 251 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-DVKKMYDKILKGK---------LPLPPGYLSE 251 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-cHHHHHHHHhcCc---------CCCCCccCCH
Confidence 35579999999999 67899999999999999999999999754 3344444444432 1111223455
Q ss_pred HHHHHHHHchhcCCCCCC
Q 042949 535 PLLNVALKCVSNSPDDRP 552 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RP 552 (608)
+..+++.+.+..||++|.
T Consensus 252 ~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 252 EARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHHHHHhccCHHHhc
Confidence 678999999999999995
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=340.65 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=200.4
Q ss_pred cccCCCCCceEEEEE-EcCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVR-LKNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~ 380 (608)
+.||+|.||.||+++ ..+|+.||+|++.... ....-..+||.+|++|+|||||+|.+..... ..+|||+|||++
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 457999999999998 4689999999997432 3455678999999999999999999987765 789999999965
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
||.-++.. ....|++.++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+||+|||+|+++....
T Consensus 203 -DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g-----vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 203 -DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG-----VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred -hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC-----eeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 88888863 4567999999999999999999999987 9999999999999999999999999999886554
Q ss_pred ---ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------ccc-------
Q 042949 460 ---TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------WTG------- 518 (608)
Q Consensus 460 ---~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~------- 518 (608)
+..+-|.+|.||| ..|+...|+||.||||.||++|++.+.+..++.+.-....-.+ |..
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 4456799999999 6799999999999999999999999988776655433321111 110
Q ss_pred -----ccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 519 -----EVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 519 -----~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.-....+.+.....+...++|+..+|..||++|.|+.++++.
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 001112333345566778999999999999999999988754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.99 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=208.2
Q ss_pred ccCcCHHHHHHHhhcccCCCCCceEEEEEEcCCcEEEEEEecccccC----HHHHHHHHHHHhcCCCCcceeeeeeeec-
Q 042949 293 KERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS----MDEFSQTMRQIGNLKHPNILPLVCYNST- 367 (608)
Q Consensus 293 ~~~~~~~~l~~~~~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~- 367 (608)
...++.+|+...+...+++|+++.||+|.. +|+.||||+++..... .+.+.+|+.++.+++||||+++++++.+
T Consensus 12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 12 IKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred ceecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 445677777666567899999999999988 7889999999754332 3567899999999999999999999876
Q ss_pred ---CCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCc
Q 042949 368 ---NEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444 (608)
Q Consensus 368 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~ 444 (608)
....++||||+++|+|.++++. ...+++.....++.|++.||+|||+.. .++||||||+|||+++++.+
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~----~~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT----NKPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC----CCCCCcCChhhEEECCCCcE
Confidence 3567899999999999999975 457899999999999999999999752 27899999999999999999
Q ss_pred eEeccccccccCCCCccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc
Q 042949 445 LISECGYSKFLDPKKTCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG 518 (608)
Q Consensus 445 kl~DFGla~~~~~~~~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 518 (608)
||+|||+++..........++..|+||| ..++.++|||||||++|||++|+.||.... ...............
T Consensus 163 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~ 241 (283)
T PHA02988 163 KIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-TKEIYDLIINKNNSL 241 (283)
T ss_pred EEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhcCCCC
Confidence 9999999987665555567889999999 257889999999999999999999997543 233333322221111
Q ss_pred ccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 519 EVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 519 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
. .+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 242 ~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 K--------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred C--------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0 11234566889999999999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.23 Aligned_cols=244 Identities=20% Similarity=0.345 Sum_probs=201.3
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecc--cccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.||.|..++||+|+. +.+..||||++.- ...+.+.+.+|+..|+.++||||++++..|..+..+|+||.||.+|++
T Consensus 32 e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ 111 (516)
T KOG0582|consen 32 EVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSL 111 (516)
T ss_pred EEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcH
Confidence 5689999999999985 5789999999973 334568899999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---- 459 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---- 459 (608)
.+++..+.. ..+++..+..|.+++++||.|||+++ -||||||+.||||+.+|.+||+|||.+..+....
T Consensus 112 ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G-----~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 112 LDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG-----HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred HHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC-----ceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 999987543 34999999999999999999999987 8999999999999999999999999887654321
Q ss_pred ---ccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccc--cccHHHHHh
Q 042949 460 ---TCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGE--VFDKEVAKA 528 (608)
Q Consensus 460 ---~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 528 (608)
...+||+.||||| .-|+.|+|||||||+..||++|..||..-....-....+........ ..+. ..
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~---d~ 261 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK---DE 261 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh---HH
Confidence 4468999999999 46899999999999999999999999754443333333322221111 1111 12
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.......+.+++..||+.||++|||++++++.
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 23345579999999999999999999999764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=348.09 Aligned_cols=235 Identities=20% Similarity=0.333 Sum_probs=200.7
Q ss_pred ccCCCCCceEEEEE-EcCCcEEEEEEeccccc-CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 308 LRSQTICSSLFMVR-LKNSAVYAVKRLKKLQV-SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 308 ~~g~g~~g~vy~~~-~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
-+|+|..|.||.++ ..+++.||||++..... ..+-+..|+.+|+..+|+|||.+++.|...+++|+|||||++|+|.+
T Consensus 280 kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTD 359 (550)
T KOG0578|consen 280 KIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTD 359 (550)
T ss_pred hhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhh
Confidence 47999999999997 46789999999985544 44557899999999999999999999998999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTCL 462 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~~ 462 (608)
.+.. ..+++.++..|++++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+... ....
T Consensus 360 vVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g-----IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 360 VVTK-----TRMTEGQIAAICREILQGLKFLHARG-----IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred hhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc-----eeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence 9874 56999999999999999999999987 999999999999999999999999999887654 4678
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
+||++||||| ..|+.|.|||||||+.+||+-|++||..+..+.......... ..++ ......+..+.+
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng--~P~l------k~~~klS~~~kd 501 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG--TPKL------KNPEKLSPELKD 501 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC--CCCc------CCccccCHHHHH
Confidence 9999999999 679999999999999999999999998655544333222111 1111 123345666899
Q ss_pred HHHHchhcCCCCCCCHHHHHHH
Q 042949 539 VALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~~ 560 (608)
++.+||+.|+++|+++.|+|+.
T Consensus 502 FL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcC
Confidence 9999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=342.95 Aligned_cols=235 Identities=22% Similarity=0.344 Sum_probs=200.6
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
++.+|.|+|++|++|+. .+++.||||++.+.. ...+-+.+|-++|.+| .||.||+|+..|+++..+|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 45689999999999985 578999999997532 2344567888889999 89999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.++|++ .+.|++...+.++.+|+.||+|||+++ ||||||||+|||+|++|++||+|||.|+.+.+..
T Consensus 158 nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G-----IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 158 NGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG-----IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred CCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC-----ceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999987 467999999999999999999999987 9999999999999999999999999999875321
Q ss_pred ----------------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccc
Q 042949 460 ----------------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGE 519 (608)
Q Consensus 460 ----------------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 519 (608)
..++||-.|.+|| ...+..+|+|+|||+||+|+.|++||.+..+...+-+.+..+...
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f-- 306 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF-- 306 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC--
Confidence 3478999999999 677899999999999999999999999887766555544333222
Q ss_pred cccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 520 VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 520 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
++..+..+.+|+.+.|..||.+|+|..++-+.
T Consensus 307 ---------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 307 ---------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 23344557899999999999999999888664
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=335.72 Aligned_cols=245 Identities=26% Similarity=0.388 Sum_probs=196.4
Q ss_pred hhcccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCC--eeEEEEeeccC
Q 042949 305 TADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE--EKLLVYKYQSN 380 (608)
Q Consensus 305 ~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e~~~~ 380 (608)
..+++|+|.||.||.+... +|...|||.+.... ...+.+.+|+++|.+++|||||+++|...... ..+++|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 3578999999999999876 49999999987432 12566899999999999999999999855544 68999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-CCCceEeccccccccCC--
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-NEDPLISECGYSKFLDP-- 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~-- 457 (608)
|+|.+++..+ +. .|++..++++++||++||+|||+++ ||||||||+|||++. ++.+||+|||+++....
T Consensus 101 GsL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~ylHs~g-----~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 101 GSLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYLHSKG-----IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CcHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999863 22 6999999999999999999999887 999999999999999 79999999999987663
Q ss_pred ----CCccccccCccccCCC---C--CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 458 ----KKTCLFSSNGYTAPEK---T--VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 458 ----~~~~~~gt~~y~aPE~---~--~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
......||+.|||||. . ...++||||+||++.||+||++|+........+.-....+...+ ..
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P--------~i 244 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP--------EI 244 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC--------CC
Confidence 1235789999999992 2 22389999999999999999999875322222222222221111 22
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
+...+.+..+++.+|+..||++|||+.++++..--..
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 3345667889999999999999999999998865443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=344.49 Aligned_cols=243 Identities=25% Similarity=0.392 Sum_probs=203.0
Q ss_pred cCcCHHHHHHHhhcccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEE
Q 042949 294 ERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLL 373 (608)
Q Consensus 294 ~~~~~~~l~~~~~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 373 (608)
.++.+++|.+. +.+|.|..|.||.|++ .++.||||+++... ..+|+.|++|+|||||.+.|+|....-+||
T Consensus 119 WeiPFe~IsEL--eWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 119 WEIPFEEISEL--EWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred ccCCHHHhhhh--hhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 45667776544 6799999999999999 46689999887422 357889999999999999999999999999
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
|||||+.|-|..+|+. ...++......+..+||.||.|||.+. |||||||.-||||..+..+||+|||.++
T Consensus 190 iMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK-----IIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK-----IIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred eeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh-----HhhhccCCCceEeeccceEEeccccchH
Confidence 9999999999999985 677899999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHH-H
Q 042949 454 FLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV-A 526 (608)
Q Consensus 454 ~~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 526 (608)
...+.. ..+.||..||||| ...++|+||||||||||||+||..|+.+-.... .++ .+=...+ .
T Consensus 261 e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-IIw---------GVGsNsL~L 330 (904)
T KOG4721|consen 261 ELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-IIW---------GVGSNSLHL 330 (904)
T ss_pred hhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-eEE---------eccCCcccc
Confidence 876543 4578999999999 578999999999999999999999987532211 000 0000001 1
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
..+..+++.+.-|+++||...|.+||++.+++..|+=.
T Consensus 331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 23556777889999999999999999999999999754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=346.07 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=210.6
Q ss_pred cCcCHHHHHHHhhcccCCCCCceEEEEEEcCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCe
Q 042949 294 ERFKLDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEE 370 (608)
Q Consensus 294 ~~~~~~~l~~~~~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 370 (608)
..+.++|+. ....||+|.||+||+|++.. .||||+++.... ..+.|+.|+.++++-+|.||+-+.|||-.++.
T Consensus 387 WeIp~~ev~--l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 387 WEIPPEEVL--LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccCHHHhh--ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 345666665 34679999999999999864 499999985433 35679999999999999999999999998877
Q ss_pred eEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccc
Q 042949 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECG 450 (608)
Q Consensus 371 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 450 (608)
.||..+|++-+|+.+||.. ...|+..+.+.|+.|||+||.|||.++ |||||||..||++.+++.+||+|||
T Consensus 463 -AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~-----IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN-----IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred -eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh-----hhhhhccccceEEccCCcEEEeccc
Confidence 9999999999999999863 467899999999999999999999987 9999999999999999999999999
Q ss_pred cccccCC-----CCccccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc
Q 042949 451 YSKFLDP-----KKTCLFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG 518 (608)
Q Consensus 451 la~~~~~-----~~~~~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 518 (608)
++..... ......|..-||||| ..|+..+|||||||++|||+||..|+.. ....+.+.. +..
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifm-VGr---- 607 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFM-VGR---- 607 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEE-ecc----
Confidence 9864321 112345677899999 5689999999999999999999999873 221111111 111
Q ss_pred ccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCCCCCCCC
Q 042949 519 EVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHS 576 (608)
Q Consensus 519 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~ 576 (608)
...-+.+......+..++.+|+..||..++++||.+.+|+.+|+++....+.-.|+.+
T Consensus 608 G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S 665 (678)
T KOG0193|consen 608 GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSAS 665 (678)
T ss_pred cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcC
Confidence 1112333344556777899999999999999999999999999999876443334333
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=308.38 Aligned_cols=246 Identities=20% Similarity=0.264 Sum_probs=201.0
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+.+|+|.||.||+|+. .+|+.||||+++..... .....+|++.|+.++|+||+.+++.|...+...+|+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 45789999999999985 58999999999844322 34578999999999999999999999999999999999964
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
||...+++ ....|+..++..++.++++||+|||.+. |+||||||.|+|++.++.+||+|||+|+.+.+..
T Consensus 86 dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~-----IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 86 DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW-----ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh-----hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 89998875 4678999999999999999999999988 9999999999999999999999999999887543
Q ss_pred -ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh------hccc--ccccH-H
Q 042949 460 -TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE------EWTG--EVFDK-E 524 (608)
Q Consensus 460 -~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~------~~~~--~~~~~-~ 524 (608)
...+-|..|.||| +.|+...||||.||++.||+-|.+.|.+..++.+......-- .|.. ...|- +
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 3447899999999 678999999999999999999998888777776654433211 1110 00010 0
Q ss_pred HH--------HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 525 VA--------KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 525 ~~--------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+. ......+...++|+.+++..||.+|+|+.|++++
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00 0112345567999999999999999999998875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=312.82 Aligned_cols=234 Identities=21% Similarity=0.280 Sum_probs=200.2
Q ss_pred cCHHHHHHHhhcccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCe
Q 042949 296 FKLDDLLEATADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEE 370 (608)
Q Consensus 296 ~~~~~l~~~~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 370 (608)
++++|... -..+|.|+||.|..++.+ +|..+|+|++++.. ...+...+|.++|+.+.||+++++++.|.+.+.
T Consensus 41 ~~l~dfe~--~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFER--LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhhh--eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 55666542 256899999999999865 68999999998543 234567889999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccc
Q 042949 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECG 450 (608)
Q Consensus 371 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 450 (608)
.++||||.++|.|.+++++ .+++++..++.++.||+.||+|||+.. |++|||||+|||+|.+|.+||.|||
T Consensus 119 lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~-----iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD-----IIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC-----eeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999999986 678999999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 451 YSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 451 la~~~~~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
+|+.+.....+.+||+.|+||| ..++.++|.|||||++|||+.|.+||.+...+..+-+....+-..
T Consensus 190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~f--------- 260 (355)
T KOG0616|consen 190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKF--------- 260 (355)
T ss_pred ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccC---------
Confidence 9999988888899999999999 678999999999999999999999998876644333322222222
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCC
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDR 551 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~R 551 (608)
+...+..+.+|+.+.++.|-.+|
T Consensus 261 --P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 --PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --CcccCHHHHHHHHHHHhhhhHhh
Confidence 23344457789999999998888
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.23 Aligned_cols=233 Identities=22% Similarity=0.354 Sum_probs=201.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|.||.||||+.+ +.+.||+|.+.+.... .+.+.+|++++++++|||||.++++|++..+.|+|.||+.+ +
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~ 86 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D 86 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence 56899999999999865 6799999999765443 45688999999999999999999999999999999999965 9
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|..+|.. ...++++++..|+.|+..||.|||+.+ |+|||+||.|||++..+.+|++|||+|+.+....
T Consensus 87 L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r-----ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 87 LFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR-----ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred HHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC-----cccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9999986 677999999999999999999999987 9999999999999999999999999999887654
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
+.+.||+.||||| ..|+..+|.||+||++||+++|++||... ++...++.+..+... .+...+..
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-si~~Lv~~I~~d~v~----------~p~~~S~~ 226 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-SITQLVKSILKDPVK----------PPSTASSS 226 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-HHHHHHHHHhcCCCC----------CcccccHH
Confidence 4578999999999 78999999999999999999999999753 344455555444321 12245566
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.+++...+..||.+|.|-.+++..
T Consensus 227 f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 227 FVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHHHhhcChhhcccHHHHhcC
Confidence 8899999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=365.41 Aligned_cols=268 Identities=21% Similarity=0.315 Sum_probs=217.4
Q ss_pred hcccCCCCCceEEEEEEcC--Cc----EEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 306 ADLRSQTICSSLFMVRLKN--SA----VYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~--g~----~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
...+|+|.||.||+|...+ |. .||||.+++. .....+|.+|..+|++++|||||+++|.|.+....++++||
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley 776 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY 776 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence 4679999999999998753 43 5999999854 34567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 378 QSNGSLLSLLEAYIE---GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
|++|||..||++.+. ....|+....+.++.|||+|++||++++ +|||||..+|+||+....+||+|||+|+.
T Consensus 777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~-----fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH-----FVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC-----CcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999987421 1456889999999999999999999887 99999999999999999999999999996
Q ss_pred cCCCCcccc-----ccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHH
Q 042949 455 LDPKKTCLF-----SSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 455 ~~~~~~~~~-----gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (608)
+........ -...||||| ..++.|+|||||||+|||++|...+++...+..+......... .
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---------R 922 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---------R 922 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---------c
Confidence 554432221 124699999 7899999999999999999996554444444333333233322 2
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCCCCCCCCCCCCcccccCC
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHSNSSFSSMESIP 587 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (608)
...+..++.++.++|.+||+.+|++||++..+++.+..+.+.....+..+-..++.+....+
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a~~~~~~~~~ 984 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPADYESVSIRP 984 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccccccccCcccccC
Confidence 24467788999999999999999999999999999999998887777766655554443333
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=339.75 Aligned_cols=248 Identities=20% Similarity=0.297 Sum_probs=194.9
Q ss_pred hcccCCCCCceEEEEEE------cCCcEEEEEEeccccc--CHHHHHHHHHHHhcC-CCCcceeeeeeeecC-CeeEEEE
Q 042949 306 ADLRSQTICSSLFMVRL------KNSAVYAVKRLKKLQV--SMDEFSQTMRQIGNL-KHPNILPLVCYNSTN-EEKLLVY 375 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lv~ 375 (608)
.+.||+|+||.||+|.. .++..||||+++.... ..+.+.+|++++.++ +||||++++++|... +..++||
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 35689999999999974 2357899999974322 245688999999999 899999999988764 4578999
Q ss_pred eeccCCCHHHHHHHHhcC----------------------------------------------------------CCCC
Q 042949 376 KYQSNGSLLSLLEAYIEG----------------------------------------------------------KRDF 397 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~~----------------------------------------------------------~~~l 397 (608)
||+++|+|.+++...... ...+
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 999999999999752110 1348
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-----ccccccCccccCC
Q 042949 398 PWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE 472 (608)
Q Consensus 398 ~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE 472 (608)
++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ....++..|+|||
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC-----EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 88899999999999999999886 9999999999999999999999999998654322 1233567899999
Q ss_pred ----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcC
Q 042949 473 ----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNS 547 (608)
Q Consensus 473 ----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~d 547 (608)
..++.++|||||||++|||++ |..||................. .. ..+...+..+.+++.+||+.|
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~~--------~~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-RM--------RAPENATPEIYRIMLACWQGD 317 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC-CC--------CCCCCCCHHHHHHHHHHccCC
Confidence 567899999999999999997 8888865433222222221111 00 112234566889999999999
Q ss_pred CCCCCCHHHHHHHHHHhhcC
Q 042949 548 PDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 548 P~~RPs~~evl~~L~~~~~~ 567 (608)
|++|||+.|+++.|+++.++
T Consensus 318 p~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 318 PKERPTFSALVEILGDLLQE 337 (338)
T ss_pred hhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=354.04 Aligned_cols=243 Identities=23% Similarity=0.386 Sum_probs=205.3
Q ss_pred hcccCCCCCceEEEEEEc----CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLK----NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+++||.|.||.|++|+++ ....||||.+|.. ...+.+|..|..+|.+++||||++|.|+.......+||.|||+
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME 713 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME 713 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence 357999999999999985 2368999999953 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|..||+.. ...|++.+...+.++||.||.||-+.+ .|||||..+|||++.+..+||+|||+++.+.++.
T Consensus 714 NGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~-----YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 714 NGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred CCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcC-----chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999863 456999999999999999999998876 9999999999999999999999999999887655
Q ss_pred cccccc------CccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 TCLFSS------NGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 ~~~~gt------~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
.....| ..|.||| +.++.+||||||||++||.++ |..|+.+..+ .+.++.+... ...+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~g---------yRLPp 855 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQG---------YRLPP 855 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhc---------cCCCC
Confidence 333333 3599999 789999999999999999776 7777654322 2223322222 12244
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
+..++..+.+||..||+.|-.+||++.+++..|++++.
T Consensus 856 PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 856 PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 67788899999999999999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=333.26 Aligned_cols=232 Identities=22% Similarity=0.296 Sum_probs=194.7
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc----c--cCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL----Q--VSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~----~--~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
..+|+|.||+|+.|.. .+|..||+|++++. . ...+.+.+|+.++++++ ||||++++.++......++||||+
T Consensus 23 ~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~ 102 (370)
T KOG0583|consen 23 RTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYC 102 (370)
T ss_pred eeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEec
Confidence 5689999999999975 57899999977643 1 22445778999999999 999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-CCceEeccccccccC-
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-EDPLISECGYSKFLD- 456 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~- 456 (608)
.+|+|.+++.. ...+.+..+.+++.|++.|++|||+.+ |+||||||+|||+|.+ +++||+|||++....
T Consensus 103 ~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g-----i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 103 SGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG-----IVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred CCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC-----EeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 99999999975 577999999999999999999999987 9999999999999999 999999999999873
Q ss_pred C--CCccccccCccccCC-----C-CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 457 P--KKTCLFSSNGYTAPE-----K-TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 457 ~--~~~~~~gt~~y~aPE-----~-~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
. .....+||+.|+||| . ..+.++||||+||+||.|++|+.||.+. ......+.+....+. .
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-~~~~l~~ki~~~~~~----------~ 242 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-NVPNLYRKIRKGEFK----------I 242 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-cHHHHHHHHhcCCcc----------C
Confidence 2 336678999999999 2 3368899999999999999999999873 333333332222111 1
Q ss_pred chhc-HHHHHHHHHHchhcCCCCCCCHHHHH
Q 042949 529 GRQW-AFPLLNVALKCVSNSPDDRPTMAEVL 558 (608)
Q Consensus 529 ~~~~-~~~l~~li~~Cl~~dP~~RPs~~evl 558 (608)
+... +.++.+++.+|+..||.+|+|+.+++
T Consensus 243 p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 243 PSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1222 56688999999999999999999999
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=306.58 Aligned_cols=253 Identities=22% Similarity=0.234 Sum_probs=200.0
Q ss_pred CHHHHHHHhhcccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeee--cCCe
Q 042949 297 KLDDLLEATADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNS--TNEE 370 (608)
Q Consensus 297 ~~~~l~~~~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~ 370 (608)
+++|.... +-|++|.||.||+|+.+ +++.||+|+++..... .-.-.+||.+|.+++|||||.+..+.. +-+.
T Consensus 74 sv~efe~l--nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 74 SVEEFEKL--NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cHHHHHHH--hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 34444332 56899999999999864 7899999999843321 223579999999999999999977654 4467
Q ss_pred eEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccc
Q 042949 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECG 450 (608)
Q Consensus 371 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 450 (608)
.|+|||||+. ||.++++.. ..++...+...+..|+++|++|||++. |+||||||+|+|+.+.|.+||+|||
T Consensus 152 iy~VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w-----ilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW-----ILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce-----eEecccchhheeeccCCcEEecccc
Confidence 9999999965 899999863 468999999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCC---CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 451 YSKFLDPK---KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 451 la~~~~~~---~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
+|+.+... -+..+-|.+|.||| ..|++..|+||+|||+.||+++++.|.+...+.+.-+....-+...+.+.
T Consensus 223 LAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 223 LAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 99988765 35567899999999 67899999999999999999999999877776655443322211111111
Q ss_pred H-------------------HHHHhchh--cHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 K-------------------EVAKAGRQ--WAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 ~-------------------~~~~~~~~--~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+ .+...... .+..-.+|+...+..||.+|.|++|.++.
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1 11111111 23567899999999999999999998764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.04 Aligned_cols=235 Identities=22% Similarity=0.289 Sum_probs=201.4
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.-+|.|+-|.|-.|++ .+|+.+|||++.+. +.....+.+|+-+|+-+.|||++++++++.++.++|+|.||+++|
T Consensus 18 kTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gG 97 (786)
T KOG0588|consen 18 KTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGG 97 (786)
T ss_pred ccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCc
Confidence 4579999999999986 58999999999754 223456889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
.|++++-. +++|++..+.+++.||..|+.|+|..+ |+|||+||+|+|||.++++||+|||+|.+-.++.
T Consensus 98 ELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~-----icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 98 ELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN-----ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred hhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc-----ceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 99999975 678999999999999999999999987 9999999999999999999999999998765543
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.+.+|++.|.||| ...+.++||||.|||||.|+||+.||.+ .++.....++.+..+ ..+...+.
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f----------~MPs~Is~ 237 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVF----------EMPSNISS 237 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcc----------cCCCcCCH
Confidence 6678999999999 3457899999999999999999999984 344444444433322 12344556
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
++.+|+.+|+..||+.|.|++||++.-
T Consensus 238 eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 238 EAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHHHHHHHHhccCccccccHHHHhhCc
Confidence 688999999999999999999999873
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=323.01 Aligned_cols=234 Identities=20% Similarity=0.261 Sum_probs=194.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||++... +++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 86 (291)
T cd05612 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG 86 (291)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCC
Confidence 56899999999999875 68999999986422 23456889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~ 157 (291)
T cd05612 87 ELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE-----IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT 157 (291)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEEEecCcchhccCCccc
Confidence 99999875 456899999999999999999999987 999999999999999999999999999877665556
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..||+.|+||| ..++.++|||||||++|||++|+.||..... ............ ..+......+.
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~----------~~~~~~~~~~~ 226 (291)
T cd05612 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-FGIYEKILAGKL----------EFPRHLDLYAK 226 (291)
T ss_pred ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCc----------CCCccCCHHHH
Confidence 67899999999 4578899999999999999999999875432 222222222110 01122345678
Q ss_pred HHHHHchhcCCCCCCC-----HHHHHHH
Q 042949 538 NVALKCVSNSPDDRPT-----MAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs-----~~evl~~ 560 (608)
+++.+||+.||.+||+ ++|+++.
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 9999999999999995 7777755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=331.53 Aligned_cols=245 Identities=21% Similarity=0.289 Sum_probs=193.3
Q ss_pred hcccCCCCCceEEEEEE------cCCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRL------KNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~------~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 376 (608)
.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|++++..+ +||||++++++|...+..++|||
T Consensus 40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E 119 (375)
T cd05104 40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITE 119 (375)
T ss_pred hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeeh
Confidence 46799999999999964 245689999997432 2345688999999999 89999999999999999999999
Q ss_pred eccCCCHHHHHHHHhc----------------------------------------------------------------
Q 042949 377 YQSNGSLLSLLEAYIE---------------------------------------------------------------- 392 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~---------------------------------------------------------------- 392 (608)
|+++|+|.++++....
T Consensus 120 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (375)
T cd05104 120 YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDV 199 (375)
T ss_pred hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccccc
Confidence 9999999999964210
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc-----
Q 042949 393 -------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT----- 460 (608)
Q Consensus 393 -------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~----- 460 (608)
....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 200 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 200 TSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 1125789999999999999999999876 99999999999999999999999999986643321
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
...++..|+||| ..++.++|||||||++|||++ |..||..........+.. ....... .+...+.+
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~--------~~~~~~~~ 345 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI-KEGYRML--------SPECAPSE 345 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH-HhCccCC--------CCCCCCHH
Confidence 123456799999 567899999999999999998 777775433222222222 2111100 11223456
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
+.+++.+||+.||++|||+.||++.|++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=326.95 Aligned_cols=233 Identities=21% Similarity=0.282 Sum_probs=191.5
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
++|+|+||.||+++.. +|+.||+|+++... .....+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 5899999999999864 78999999997432 223457789999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---CC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP---KK 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~~ 459 (608)
|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... ..
T Consensus 82 L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~-----ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 82 LFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcc
Confidence 9998875 457899999999999999999999987 99999999999999999999999999985422 22
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
....||+.|+||| ..++.++|||||||++|||+||+.||..... ............ ..+...+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~~~~~~~----------~~p~~~~~~ 221 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI----------RFPRTLSPE 221 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-HHHHHHHHcCCC----------CCCCCCCHH
Confidence 3456899999999 4578899999999999999999999865432 222222211110 112234566
Q ss_pred HHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
+.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 88999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=326.71 Aligned_cols=235 Identities=18% Similarity=0.288 Sum_probs=194.8
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
.+.+|+|+||.||+|+.. +++.||+|+++... ...+.+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 356899999999999875 68999999997432 2345688999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT 460 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 460 (608)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 103 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 103 GELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD-----IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred ChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 999999875 456899999999999999999999987 99999999999999999999999999998766656
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||+.|+||| ..++.++|||||||++|||++|+.||...... ........... ..+...+..+
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~----------~~p~~~~~~~ 242 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-RIYEKILAGRL----------KFPNWFDGRA 242 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCc----------CCCCCCCHHH
Confidence 677999999999 45788999999999999999999998754322 22222221110 0112234557
Q ss_pred HHHHHHchhcCCCCCCC-----HHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPT-----MAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs-----~~evl~~ 560 (608)
.+++.+||+.||.+||+ +.+++..
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 89999999999999996 6777654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.43 Aligned_cols=238 Identities=18% Similarity=0.246 Sum_probs=191.5
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||++.. .+|+.||+|++.... .....+.+|++++.+++|+||+++++++...+..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g 85 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence 5689999999999986 578999999986422 12345778999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 86 DLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER-----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred cHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 999887642 2346899999999999999999999887 9999999999999999999999999998764332
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHH--HHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPK--WVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....||..|+||| ..++.++|||||||++|||++|+.||........ .+....... ........+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~~~~~s 229 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED---------QEEYSEKFS 229 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc---------cccCCccCC
Confidence 3456899999999 5678899999999999999999999875433111 111111000 001122345
Q ss_pred HHHHHHHHHchhcCCCCCCC-----HHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPT-----MAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs-----~~evl~~ 560 (608)
..+.+|+.+||+.||++||+ ++++++.
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 66889999999999999997 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=309.42 Aligned_cols=237 Identities=21% Similarity=0.346 Sum_probs=194.6
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
..+|+|+||.||+++..++..+|+|.++......+++.+|++++++++||||+++++++...+..++||||+++|+|.++
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~ 89 (256)
T cd05114 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY 89 (256)
T ss_pred eEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHH
Confidence 45899999999999998888999999886666677899999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++...... ...
T Consensus 90 ~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05114 90 LRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS-----FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161 (256)
T ss_pred HHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence 8742 345899999999999999999999887 9999999999999999999999999998654322 122
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ..++.++||||||+++|||++ |+.|+.... ....+......... ..+...+..+.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-~~~~~~~i~~~~~~---------~~~~~~~~~~~ 231 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-NYEVVEMISRGFRL---------YRPKLASMTVY 231 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHCCCCC---------CCCCCCCHHHH
Confidence 3456799999 456889999999999999999 888875443 22233322221110 01122345688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
+++.+||+.+|++||++.++++.|
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.14 Aligned_cols=247 Identities=24% Similarity=0.324 Sum_probs=199.6
Q ss_pred cccCCCCCceEEEEEEcC--C--cE-EEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLKN--S--AV-YAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~--g--~~-vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
+.+|+|.||.||+|++.. + .. ||||..+.. .....+|.+|.++|++++|||||+++|++......++|||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 779999999999999753 2 23 899998842 23456899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
|.||+|.++|++. ...++..+++.++.++|.||+|||+++ +|||||-.+|+|++.++.+||+|||+++.-..
T Consensus 243 ~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~-----~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 243 CNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN-----CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred cCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC-----CcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 9999999999863 336999999999999999999999987 99999999999999999999999999886532
Q ss_pred CC---ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 458 KK---TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 458 ~~---~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
.. ....-...|+||| ..++.++|||||||++||+++ |..|+.+... .+....+....+... .+
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-~~v~~kI~~~~~r~~--------~~ 385 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-YEVKAKIVKNGYRMP--------IP 385 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-HHHHHHHHhcCccCC--------CC
Confidence 11 1122345799999 788999999999999999999 6776654332 222222222222111 12
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
...+..+..++.+||..+|++||+|.++.+.|+.+......
T Consensus 386 ~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 386 SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 24455678899999999999999999999999999876543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.88 Aligned_cols=246 Identities=21% Similarity=0.297 Sum_probs=193.8
Q ss_pred hcccCCCCCceEEEEEEc------CCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 376 (608)
.+.+|+|+||.||++... ++..||||+++... ...+.+.+|+++++++ +|+|||+++++|...+..++|||
T Consensus 43 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~e 122 (374)
T cd05106 43 GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITE 122 (374)
T ss_pred hheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHh
Confidence 467899999999998742 34589999997432 2245688999999999 89999999999999999999999
Q ss_pred eccCCCHHHHHHHHhc----------------------------------------------------------------
Q 042949 377 YQSNGSLLSLLEAYIE---------------------------------------------------------------- 392 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~---------------------------------------------------------------- 392 (608)
|+++|+|.++++....
T Consensus 123 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (374)
T cd05106 123 YCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEED 202 (374)
T ss_pred hccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhc
Confidence 9999999999864211
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc-----ccccc
Q 042949 393 --GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT-----CLFSS 465 (608)
Q Consensus 393 --~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-----~~~gt 465 (608)
....+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ...++
T Consensus 203 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 203 TEDSWPLDLDDLLRFSSQVAQGMDFLASKN-----CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred cCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 0134788999999999999999999876 99999999999999999999999999986543321 12345
Q ss_pred CccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHH
Q 042949 466 NGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVA 540 (608)
Q Consensus 466 ~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 540 (608)
..|+||| ..++.++|||||||++|||++ |+.||............ ........ .....+.++.+++
T Consensus 278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~-~~~~~~~~--------~~~~~~~~l~~li 348 (374)
T cd05106 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-VKRGYQMS--------RPDFAPPEIYSIM 348 (374)
T ss_pred cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH-HHcccCcc--------CCCCCCHHHHHHH
Confidence 6799999 567899999999999999997 99998654322222221 11111000 1112345688999
Q ss_pred HHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 541 LKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 541 ~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
.+||+.||++|||+.+|+++|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=323.44 Aligned_cols=235 Identities=20% Similarity=0.311 Sum_probs=197.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecc--cccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
++||+|.||.||+|.. .+++.||+|++.- .....+++.+|+.++.+++++||.++++.+..+..++++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 6789999999999985 5789999999973 334567899999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~ 460 (608)
.+.|+. ...+++..+.-|++++..||.|||.++ .+|||||+.|||+..++.+||+|||++-.+... ..
T Consensus 99 ~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~-----kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 99 LDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK-----KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred hhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc-----eecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 999874 445588888899999999999999987 999999999999999999999999999877543 36
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
.++||+.||||| ..|+.|+||||+||+.+||++|.+|+....... .+ ....+-..+.+ ...++..+
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-vl------flIpk~~PP~L---~~~~S~~~ 239 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-VL------FLIPKSAPPRL---DGDFSPPF 239 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-EE------EeccCCCCCcc---ccccCHHH
Confidence 689999999999 478999999999999999999999976543210 00 00011111111 22677889
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++..||+.||+.||++.++++.
T Consensus 240 kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 240 KEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhh
Confidence 999999999999999999999764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=323.71 Aligned_cols=231 Identities=19% Similarity=0.264 Sum_probs=189.0
Q ss_pred cCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+|+|+||.||+++.. +++.||+|+++.. ......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999999999875 5789999999742 22345678899999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~ 460 (608)
.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN-----VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 999875 456899999999999999999999887 999999999999999999999999999864322 23
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||+.|+||| ..++.++|||||||++|||+||+.||.... .....+....... ..+...+..+
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-~~~~~~~~~~~~~----------~~~~~~~~~~ 220 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYRKILQEPL----------RFPDGFDRDA 220 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-HHHHHHHHHcCCC----------CCCCcCCHHH
Confidence 456899999999 457889999999999999999999987543 2333332222111 1112345568
Q ss_pred HHHHHHchhcCCCCCCC---HHHHHH
Q 042949 537 LNVALKCVSNSPDDRPT---MAEVLE 559 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs---~~evl~ 559 (608)
.+++.+||+.||++||+ +.|++.
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 89999999999999985 556554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.21 Aligned_cols=246 Identities=21% Similarity=0.270 Sum_probs=189.5
Q ss_pred cccCCCCCceEEEEEEcC-----------------CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeec
Q 042949 307 DLRSQTICSSLFMVRLKN-----------------SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNST 367 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-----------------g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 367 (608)
+.+|+|+||.||++...+ +..||+|.++... ....++.+|++++.+++||||+++++++..
T Consensus 11 ~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 90 (304)
T cd05096 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD 90 (304)
T ss_pred eEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEec
Confidence 568999999999997532 3479999987432 234578999999999999999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHHHHHhc---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCC
Q 042949 368 NEEKLLVYKYQSNGSLLSLLEAYIE---------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432 (608)
Q Consensus 368 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlk 432 (608)
.+..++||||+++|+|.+++..... ....+++..+.+++.||+.||+|||+.+ |+|||||
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----ivH~dlk 165 (304)
T cd05096 91 EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-----FVHRDLA 165 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-----ccccCcc
Confidence 9999999999999999999865211 1134788999999999999999999887 9999999
Q ss_pred CCCeecCCCCCceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcC--CCCCcCC
Q 042949 433 LSNILLNENEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTG--KTVEKTG 501 (608)
Q Consensus 433 p~NILl~~~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg--~~p~~~~ 501 (608)
|+|||++.++.+||+|||+++.+.... ....++..|+||| ..++.++|||||||++|||+++ ..|+...
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 999999999999999999998654332 1233467899999 5678999999999999999874 4555432
Q ss_pred CChHHHHHHH---HhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 502 IDLPKWVKAM---VREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 502 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
. ........ ..... ... ....+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 246 ~-~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 246 T-DEQVIENAGEFFRDQG-RQV----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred C-HHHHHHHHHHHhhhcc-ccc----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 2 11111111 11100 000 001123445678999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=320.08 Aligned_cols=240 Identities=20% Similarity=0.268 Sum_probs=196.8
Q ss_pred CcCHHHHHHHhhcccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCC
Q 042949 295 RFKLDDLLEATADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNE 369 (608)
Q Consensus 295 ~~~~~~l~~~~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 369 (608)
+.+++|.. +=..||+|+||.||.++.+ +|..+|+|+++++.. ..+.+..|-.+|...++|+||+|+..|++.+
T Consensus 137 r~~~~DFe--~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 137 RLSLDDFE--LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cCCcccch--hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 44555443 2256999999999999865 699999999986532 3456788999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecc
Q 042949 370 EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC 449 (608)
Q Consensus 370 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 449 (608)
.+||||||.||||+..+|.. ...|++..+..++.+++.|++-||+.+ +|||||||+|+|||..|++||+||
T Consensus 215 ~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g-----yIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG-----YIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred eeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC-----cccccCChhheeecCCCCEeeccc
Confidence 99999999999999999976 678999999999999999999999987 999999999999999999999999
Q ss_pred ccccccCC--------------------------C----C--------------------ccccccCccccCC----CCC
Q 042949 450 GYSKFLDP--------------------------K----K--------------------TCLFSSNGYTAPE----KTV 475 (608)
Q Consensus 450 Gla~~~~~--------------------------~----~--------------------~~~~gt~~y~aPE----~~~ 475 (608)
|++.-+.. . . ...+||+-||||| ..|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 99853211 0 0 1247999999999 568
Q ss_pred CcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCC
Q 042949 476 SEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPT 553 (608)
Q Consensus 476 ~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 553 (608)
+..+|+||+|||+|||+.|-+||........|-+.+........ +.....+.+..+||.+|+. ||++|..
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-------P~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-------PEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-------CCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999999999988777666554433221111 1112234668899999999 9999975
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=315.58 Aligned_cols=238 Identities=29% Similarity=0.435 Sum_probs=188.3
Q ss_pred cccCCCCCceEEEEEEc-----CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-----NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-----~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.||.|.||.||+|.+. .+..|+||.++... ...+++.+|++.+++++||||++++|++...+..++|+||++
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 56899999999999987 25789999996432 235789999999999999999999999998888999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.++|+.. ....+++.++..|+.||++||+|||+.+ |+|+||+++||++++++.+||+|||+++......
T Consensus 85 ~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 85 GGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN-----IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp TEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT-----EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccc--cccccccccccccccccccccccccccc-----cccccccccccccccccccccccccccccccccc
Confidence 99999999862 2467999999999999999999999986 9999999999999999999999999998773221
Q ss_pred -----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 -----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 -----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
........|+||| ..++.++||||||+++|||++ |+.|+... .............. ....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~---------~~~~ 227 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQR---------LPIP 227 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEE---------TTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccc---------ceec
Confidence 2234566799999 568999999999999999999 56676543 44444444422211 1123
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
..++..+.+++.+||+.||++|||+.++++.|
T Consensus 228 ~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 34566788999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=323.24 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=206.9
Q ss_pred hcccCCCCCceEEEEEEcC-CcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 306 ADLRSQTICSSLFMVRLKN-SAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~-g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
++-+|.|-||.||.|.++. .-.||||.++......++|.+|..+|+.++|||+|+|+|+|..+...|||.|||.+|+|.
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLL 351 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLL 351 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHH
Confidence 4568999999999999875 568999999987778899999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc-cc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC-LF 463 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~ 463 (608)
+||++. ....++.-..+.++.||+.||+||..++ +|||||..+|+|+.++..+||+|||+++++..+... ..
T Consensus 352 dYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn-----FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 352 DYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred HHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh-----hhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 999873 3445777788999999999999998876 999999999999999999999999999998766533 33
Q ss_pred c---cCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 464 S---SNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 464 g---t~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
| ...|.||| ..++.|+|||+|||+|||+.|=....+.+.++.+.+.-+ ..++ ....++.|+..+
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-Ekgy--------RM~~PeGCPpkV 495 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-EKGY--------RMDGPEGCPPKV 495 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-hccc--------cccCCCCCCHHH
Confidence 3 34599999 567889999999999999999544444566655544322 2221 123466788889
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
.+||..||++.|.+||++.|+-+.++.+..
T Consensus 496 YeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 999999999999999999999999998754
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=309.24 Aligned_cols=241 Identities=22% Similarity=0.338 Sum_probs=197.4
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|++|.||+|...++..||+|.++......+.+.+|+.++++++|+||+++++++...+..+++|||+++|+|.++
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 91 (261)
T cd05072 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF 91 (261)
T ss_pred eecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHH
Confidence 45899999999999988889999999876555677899999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
++.. ....+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++...... ...
T Consensus 92 l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05072 92 LKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN-----YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 164 (261)
T ss_pred HHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence 9752 2456889999999999999999999876 9999999999999999999999999998765432 123
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ..++.++|||||||++|||+| |+.||..... ......... .... ......+.++.
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~~~~~~~-~~~~--------~~~~~~~~~~~ 234 (261)
T cd05072 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-SDVMSALQR-GYRM--------PRMENCPDELY 234 (261)
T ss_pred ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-HHHHHHHHc-CCCC--------CCCCCCCHHHH
Confidence 3466799999 456789999999999999999 8888754322 222222211 1110 11123456688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
+++.+||..+|++||+++++.+.|+++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.76 Aligned_cols=233 Identities=21% Similarity=0.289 Sum_probs=190.5
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.+|+|+||.||+++.. +|+.||+|+++... .....+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 5899999999999864 78999999997432 233457789999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---C
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---K 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~ 459 (608)
|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 82 LFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcc
Confidence 9988865 457899999999999999999999887 999999999999999999999999998864322 1
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
....||..|+||| ..++.++|||||||++|||++|+.||...... ........... ..+...+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~~~~~----------~~p~~~~~~ 221 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEI----------RFPRTLSPE 221 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCC----------CCCCCCCHH
Confidence 3356899999999 45788999999999999999999998654322 22222211110 012234566
Q ss_pred HHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
+.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 88999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=298.21 Aligned_cols=239 Identities=22% Similarity=0.302 Sum_probs=194.6
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEeccc-----ccC----HHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEE
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKL-----QVS----MDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLV 374 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~-----~~~----~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 374 (608)
++.+|+|..++|-++.. .+|..+|+|++... ... .+.-.+|+.+|+++ .||+|+++.++|+++...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 35679999998888754 57899999999621 111 34467899999998 599999999999999999999
Q ss_pred EeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
+|.|+.|.|.++|.. ...++++...+|++|+..|++|||..+ ||||||||+|||+|++.++||+|||++..
T Consensus 102 Fdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~-----IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN-----IVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh-----hhhcccChhheeeccccceEEeccceeec
Confidence 999999999999975 678999999999999999999999987 99999999999999999999999999998
Q ss_pred cCCCC--ccccccCccccCC----------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 455 LDPKK--TCLFSSNGYTAPE----------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 455 ~~~~~--~~~~gt~~y~aPE----------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
+.+.. ...+||++|.||| ..|+...|+|+.||++|.|+.|.+||.....+. ..+.+. ++... .-
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-MLR~Im-eGkyq-F~- 248 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-MLRMIM-EGKYQ-FR- 248 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-HHHHHH-hcccc-cC-
Confidence 87664 5678999999999 357889999999999999999999986432211 111111 11110 00
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+...+.+..+.+|+.+||+.||.+|.|++|++..
T Consensus 249 ---speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 249 ---SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ---CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11122345568899999999999999999999875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.84 Aligned_cols=242 Identities=16% Similarity=0.160 Sum_probs=196.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|+|+||.||+|+.. +++.||||+++... ...+.+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 86 (333)
T cd05600 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG 86 (333)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999976 58999999997432 23456888999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~ 157 (333)
T cd05600 87 DFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG-----YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS 157 (333)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCCEEEEeCcCCcccccccCC
Confidence 99999975 457899999999999999999999887 999999999999999999999999999877655556
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..||..|+||| ..++.++|||||||++|||++|+.||...... .......... .....+.........+..+.
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~--~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-ETWENLKYWK--ETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-HHHHHHHhcc--ccccCCCCCccccccCHHHH
Confidence 67999999999 56788999999999999999999998754322 2222111110 00000000000123466788
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+++.+||..+|++||++.++++.
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=306.71 Aligned_cols=260 Identities=20% Similarity=0.240 Sum_probs=204.1
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecc---cccCHHHHHHHHHHHhcCCCCcceeeeeeeec-----CCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKK---LQVSMDEFSQTMRQIGNLKHPNILPLVCYNST-----NEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~~~lv~e~ 377 (608)
+.+|+|.||.|..+.. .+|+.||||++.. .....++..+|++.|+.++|+||+.+.+.+.. -...|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 5689999999999986 4789999999973 34456778899999999999999999998765 3578999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
| .-||.+.++. ...|+......++.|+++||.|+|+.+ |+||||||+|+|++.+...||+|||+|+....
T Consensus 108 M-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn-----ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 108 M-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN-----VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred H-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc-----ccccccchhheeeccCCCEEeccccceeeccc
Confidence 9 5689998874 556999999999999999999999987 99999999999999999999999999998853
Q ss_pred -----CCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-----ccccccc
Q 042949 458 -----KKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-----WTGEVFD 522 (608)
Q Consensus 458 -----~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~ 522 (608)
.-+..+.|.+|.||| ..|+...||||.|||+.||++|++.|.+.....+.-..+.--+ ....+-.
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 225677899999999 6789999999999999999999998876554433221111000 0000000
Q ss_pred H---------------HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhhcCCCCCCCCCC
Q 042949 523 K---------------EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVVNGNDERDRDHS 576 (608)
Q Consensus 523 ~---------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~~~~ 576 (608)
. .......+.....++|+.+||..||.+|+|++|.++. |...-+..++...++.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~ 328 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPI 328 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCC
Confidence 0 0011122344558899999999999999999999876 7777666665544443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=315.35 Aligned_cols=239 Identities=19% Similarity=0.270 Sum_probs=189.7
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccccc---------------CHHHHHHHHHHHhcCCCCcceeeeeeeecC--C
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---------------SMDEFSQTMRQIGNLKHPNILPLVCYNSTN--E 369 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---------------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~ 369 (608)
-+|+|.||.|-+++.. +++.||||++.+... ..+...+||.+|++++|||||+|+.+..+. +
T Consensus 104 eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~ 183 (576)
T KOG0585|consen 104 EIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESD 183 (576)
T ss_pred hhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccC
Confidence 3799999999999864 789999999963211 135789999999999999999999997764 6
Q ss_pred eeEEEEeeccCCCHHHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEec
Q 042949 370 EKLLVYKYQSNGSLLSLLEAYIEGKRD-FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448 (608)
Q Consensus 370 ~~~lv~e~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 448 (608)
..|||+|||..|.+... ..... +++.+++++++++..||+|||.++ ||||||||+|+||++++++||+|
T Consensus 184 ~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg-----iiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 184 KLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQG-----IIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred ceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhcC-----eeccccchhheEEcCCCcEEeec
Confidence 78999999999975432 12333 999999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCC--------ccccccCccccCC--------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHH
Q 042949 449 CGYSKFLDPKK--------TCLFSSNGYTAPE--------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMV 512 (608)
Q Consensus 449 FGla~~~~~~~--------~~~~gt~~y~aPE--------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~ 512 (608)
||.+....... ...+||+.|+||| ...+.+.||||+||+||.|+.|+.||.+...+..+ ..+.
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~-~KIv 332 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF-DKIV 332 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH-HHHh
Confidence 99998763221 3468999999999 13467899999999999999999999876544332 2222
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
.+... -+...+....+.+||.++|+.||++|.+..+|.....-..
T Consensus 333 n~pL~--------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 333 NDPLE--------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred cCccc--------CCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 22110 0111234455889999999999999999999977765443
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.56 Aligned_cols=252 Identities=20% Similarity=0.298 Sum_probs=195.3
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC-----eeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE-----EKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~~~ 379 (608)
.+++|.|+||.||+|.+. +++.||||+.-... +.-.+|+++|++++|||||+|.-+|.... ...+||||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCC---CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 368999999999999975 56899999985322 12247999999999999999988776432 3359999997
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-CCceEeccccccccCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-EDPLISECGYSKFLDPK 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 458 (608)
. +|.++++.+...+..++...++-+..||.+||+|||+.+ |+||||||.|+|+|.+ +.+||||||.|+.+...
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~-----IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG-----ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC-----cccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 5 899999877666778888899999999999999999976 9999999999999987 88999999999988655
Q ss_pred C--ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHH--Hhhh-------c---ccc
Q 042949 459 K--TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAM--VREE-------W---TGE 519 (608)
Q Consensus 459 ~--~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~--~~~~-------~---~~~ 519 (608)
+ .....|..|+||| ..|+.+.||||.||++.||+-|++.|.+.....+.+... .... + ..+
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 4 4456789999999 678999999999999999999999998765544433322 1100 0 000
Q ss_pred cccHHHHH------hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhhc
Q 042949 520 VFDKEVAK------AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVVN 566 (608)
Q Consensus 520 ~~~~~~~~------~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~ 566 (608)
...+.+.. .......+..+++.+++..+|.+|.++.|++.. .+++.+
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11111111 122345678999999999999999999998765 444443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=289.57 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=205.1
Q ss_pred cCcCHHHHHHHhhcccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecC
Q 042949 294 ERFKLDDLLEATADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN 368 (608)
Q Consensus 294 ~~~~~~~l~~~~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 368 (608)
..++++|+. .+..+|+|.||.||.|+.+ ++-.||+|++.+++ ....++.+|+++-+.|+||||++++++|.+.
T Consensus 17 ~~~~l~dfe--igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 17 KTWTLDDFE--IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccchhhcc--ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 345566553 4577899999999999864 67899999997554 2356789999999999999999999999999
Q ss_pred CeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEec
Q 042949 369 EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448 (608)
Q Consensus 369 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 448 (608)
...|+++||.++|++...|.. .....+++.....++.|+|.||.|+|.++ ||||||||+|+|++.++..|++|
T Consensus 95 ~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~-----VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR-----VIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred ceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC-----cccCCCCHHHhccCCCCCeeccC
Confidence 999999999999999999985 33567899999999999999999999887 99999999999999999999999
Q ss_pred cccccccC-CCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH
Q 042949 449 CGYSKFLD-PKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 449 FGla~~~~-~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (608)
||.+..-. ....+.+||.-|.+|| ...+...|+|++||+.||++.|.+||.....- +..+.+..- ++.+
T Consensus 168 fGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkrI~k~----~~~~- 241 (281)
T KOG0580|consen 168 FGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKRIRKV----DLKF- 241 (281)
T ss_pred CCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHHHHHc----cccC-
Confidence 99987664 3456788999999999 45788999999999999999999999876532 222222221 1111
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+...+..+.++|.+|+..+|.+|.+..|++..
T Consensus 242 -----p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 -----PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 23345568899999999999999999998765
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.98 Aligned_cols=234 Identities=19% Similarity=0.243 Sum_probs=193.8
Q ss_pred cccCCCCCceEEEEEEcC--CcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKN--SAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~--g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..+|+|+||.||+|...+ +..||+|++... ....+.+.+|++++..++||||+++++++...+..++||||+++
T Consensus 36 ~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~ 115 (340)
T PTZ00426 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIG 115 (340)
T ss_pred EEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCC
Confidence 568999999999998643 368999998642 22345688999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT 460 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 460 (608)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 116 g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~ 186 (340)
T PTZ00426 116 GEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN-----IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY 186 (340)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEccCCCHHHEEECCCCCEEEecCCCCeecCCCcc
Confidence 999999975 457999999999999999999999987 99999999999999999999999999998766556
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||+.|+||| ..++.++|||||||++|||++|+.||...... ........... ..+...+..+
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~~~~----------~~p~~~~~~~ 255 (340)
T PTZ00426 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKILEGII----------YFPKFLDNNC 255 (340)
T ss_pred eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHhcCCC----------CCCCCCCHHH
Confidence 678999999999 45788999999999999999999999754332 12222222110 0112234557
Q ss_pred HHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
.+++.+|++.||++|+ +++++++.
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 8999999999999995 88888765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=306.67 Aligned_cols=241 Identities=23% Similarity=0.341 Sum_probs=197.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+.+|+|++|.||+|... +++.||+|+++......+++.+|++++++++||||+++++++...+..+++|||+++++|.+
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (263)
T cd05052 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 91 (263)
T ss_pred eecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHH
Confidence 56899999999999865 58899999988655556789999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc----c
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT----C 461 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~----~ 461 (608)
++.. .....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....... .
T Consensus 92 ~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 92 YLRE--CNRQEVNAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred HHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence 9875 22356899999999999999999999876 99999999999999999999999999987654321 1
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...+..|+||| ..++.++|||||||++|||++ |..|+... +........... ... ......+..+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~-~~~--------~~~~~~~~~~ 234 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKG-YRM--------ERPEGCPPKV 234 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCC-CCC--------CCCCCCCHHH
Confidence 22356799999 567889999999999999998 88887543 333332222211 100 1123345678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
.+++.+||+.||++|||+.+++++|+++
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 9999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=306.69 Aligned_cols=241 Identities=22% Similarity=0.342 Sum_probs=197.0
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|++|.||+|...+++.||+|.++......+++.+|++++++++||||+++++++...+..+++|||+++++|.++
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 91 (261)
T cd05068 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY 91 (261)
T ss_pred EEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHH
Confidence 56899999999999988888999999986555677899999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc-c---c
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT-C---L 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~---~ 462 (608)
+... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... . .
T Consensus 92 ~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05068 92 LQGG--AGRALKLPQLIDMAAQVASGMAYLEAQN-----YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA 164 (261)
T ss_pred Hhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence 8752 2346899999999999999999999887 99999999999999999999999999987653221 1 1
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..+..|+||| ..++.++||||||+++|||+| |+.|+..... ......+.. .... ......+..+.
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~-~~~~--------~~~~~~~~~~~ 234 (261)
T cd05068 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQ-GYRM--------PCPPGCPKELY 234 (261)
T ss_pred cCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHc-CCCC--------CCCCcCCHHHH
Confidence 2235799999 456889999999999999999 8888754322 222222211 1100 11223456789
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
+++.+||+.+|++||++.++++.|+++
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=307.95 Aligned_cols=241 Identities=20% Similarity=0.257 Sum_probs=193.7
Q ss_pred hcccCCCCCceEEEEEEc----CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLK----NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.+.+|+|+||.||+|... .+..||+|.++... ...+.+.+|+..+.+++||||+++++++...+..++||||++
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS 89 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence 456899999999999763 35789999998532 223568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+.......
T Consensus 90 ~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~-----iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 90 NGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG-----YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred CCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 99999998752 346899999999999999999999876 9999999999999999999999999876543221
Q ss_pred ----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 460 ----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 460 ----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
....++..|+||| ..++.++|||||||++||+++ |+.||..... ........+ .... ..+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-~~~~~~~~~-~~~~--------~~~~ 231 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVED-GFRL--------PAPR 231 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHHC-CCCC--------CCCC
Confidence 1223456899999 567889999999999999775 9888864322 222222211 1110 1123
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
.++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 232 ~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 232 NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 4566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=320.78 Aligned_cols=233 Identities=22% Similarity=0.285 Sum_probs=191.2
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.+|+|+||.||+++.. +|+.||+|+++... .....+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 5899999999999864 68999999997432 234567889999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---C
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---K 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~ 459 (608)
|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 82 LFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK-----IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEecccCHHHeEECCCCcEEEecCcCCccCCCccccc
Confidence 9988864 457999999999999999999999887 999999999999999999999999999864322 2
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
....||..|+||| ..++.++|||||||++|||++|+.||..... ............ ..+...+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~~~~~~~~~~~~----------~~p~~~~~~ 221 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEDI----------KFPRTLSAD 221 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-HHHHHHhccCCc----------cCCCCCCHH
Confidence 3456899999999 4578899999999999999999999865432 222222211110 112234556
Q ss_pred HHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
+.+++.+||+.||++|| ++.|+++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 88999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=312.60 Aligned_cols=243 Identities=18% Similarity=0.198 Sum_probs=189.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|.|+||.||+|+.. ++..||+|+++... .....+.+|++++++++||||+++++++.+.+..++||||++ |+|
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l 89 (288)
T cd07871 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDL 89 (288)
T ss_pred eEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCH
Confidence 56899999999999875 68999999987432 234567899999999999999999999999999999999997 599
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---c
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~ 460 (608)
.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 90 ~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 90 KQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK-----ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 998864 2345789999999999999999999887 9999999999999999999999999998654322 2
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------ccccccc-------
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------WTGEVFD------- 522 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~~~~~------- 522 (608)
...++..|+||| ..++.++||||+||++|||+||+.||...... .......... ....+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 346788999999 24688999999999999999999998654322 2222111100 0000000
Q ss_pred --H-----HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 523 --K-----EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 523 --~-----~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
+ .........+.++.+++.+||..||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 000111234566889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=325.58 Aligned_cols=247 Identities=19% Similarity=0.290 Sum_probs=195.1
Q ss_pred hcccCCCCCceEEEEEEc------CCcEEEEEEecccc--cCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 376 (608)
.++||+|+||.||+|+.. .+..||||+++... ...+.+.+|++++++++ ||||+++++++...+..++|||
T Consensus 42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (400)
T cd05105 42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITE 121 (400)
T ss_pred hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEE
Confidence 367899999999999853 23579999997432 23457899999999996 9999999999999999999999
Q ss_pred eccCCCHHHHHHHHhc----------------------------------------------------------------
Q 042949 377 YQSNGSLLSLLEAYIE---------------------------------------------------------------- 392 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~---------------------------------------------------------------- 392 (608)
||++|+|.++++....
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (400)
T cd05105 122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS 201 (400)
T ss_pred ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence 9999999999875311
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCc
Q 042949 393 ----------------------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444 (608)
Q Consensus 393 ----------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~ 444 (608)
....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN-----CVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChHhEEEeCCCEE
Confidence 0134788899999999999999999876 9999999999999999999
Q ss_pred eEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhh
Q 042949 445 LISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVRE 514 (608)
Q Consensus 445 kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 514 (608)
||+|||+++...... ....++..|+||| ..++.++|||||||++|||++ |..|+...............
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~- 355 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS- 355 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc-
Confidence 999999998654322 2234567899999 457889999999999999997 88887643322222221111
Q ss_pred hcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 515 EWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
.... ......+..+.+++.+||+.||++|||+.+|.+.|+++.+
T Consensus 356 ~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 356 GYRM--------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CCCC--------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1100 1122345668999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=312.96 Aligned_cols=244 Identities=18% Similarity=0.220 Sum_probs=189.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..+|+|+||.||+++.. +++.||+|+++... ...+.+.+|++++++++||||+++++++...+..++||||++++.
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (287)
T cd07848 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86 (287)
T ss_pred EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCH
Confidence 46899999999999985 67899999997432 234568899999999999999999999999999999999999876
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
+..+... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 87 l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 87 LELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND-----IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 6544332 356899999999999999999999876 9999999999999999999999999998764322
Q ss_pred -ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHh--------------hhccccc
Q 042949 460 -TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVR--------------EEWTGEV 520 (608)
Q Consensus 460 -~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~--------------~~~~~~~ 520 (608)
....|+..|+||| ..++.++|||||||++|||++|+.||............... .......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 2346889999999 46788999999999999999999998764432222111100 0000000
Q ss_pred ccHH-------HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 521 FDKE-------VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 521 ~~~~-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
..+. ........+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 00011124566899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.19 Aligned_cols=238 Identities=20% Similarity=0.299 Sum_probs=194.4
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
..+|+|++|.||+++..++..+|+|.++......+++.+|+.++.+++||||+++++++...+..+++|||+++|+|.++
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 89 (256)
T cd05113 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89 (256)
T ss_pred eEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHH
Confidence 45899999999999988877899999986555677899999999999999999999999988899999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc----cc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT----CL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~----~~ 462 (608)
+... ...+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||.++....... ..
T Consensus 90 i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 90 LREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ-----FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred HHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 8752 336899999999999999999999886 99999999999999999999999999986543321 12
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ..++.++|||||||++|||+| |+.|+..... ............. ......+..+.
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~---------~~~~~~~~~~~ 231 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQGLRL---------YRPHLASEKVY 231 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHhcCCCC---------CCCCCCCHHHH
Confidence 3456799999 457889999999999999999 8888754332 2222222211110 01122456689
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
+++.+||+.+|++||++.+++..|+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHhhC
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=311.73 Aligned_cols=240 Identities=18% Similarity=0.215 Sum_probs=190.5
Q ss_pred cCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+|+|+||+||++... +|+.||+|++..... ..+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999864 789999999874321 235677899999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---c
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~ 460 (608)
.+++.........+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.... .
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-----IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 9888653333467999999999999999999999887 9999999999999999999999999998664432 2
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||..|+||| ..++.++|||||||++|||++|+.||.......... .......... .......+..+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~ 228 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQRILNDS------VTYPDKFSPAS 228 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-HHHHhhcccC------CCCcccCCHHH
Confidence 346889999999 567889999999999999999999987543221111 0111000000 01122355668
Q ss_pred HHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
.+++.+||+.||++|| +++++++.
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 8999999999999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=305.45 Aligned_cols=235 Identities=19% Similarity=0.305 Sum_probs=200.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+-+|+|.||+|-++.- ..|+.||||.+++.. .+.-.+.+|+++|+.|+||||+.++.+|++.+...+||||..+|
T Consensus 59 etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~G 138 (668)
T KOG0611|consen 59 ETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGG 138 (668)
T ss_pred HHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCc
Confidence 3479999999999974 789999999998543 23446889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
.|++|+.. .+.|++..+..+++||..|+.|+|+++ ++|||||.+|||+|.++++||+|||++..+..+.
T Consensus 139 eLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr-----VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 139 ELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR-----VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred cHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc-----ceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 99999986 678999999999999999999999887 9999999999999999999999999999887664
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.+++|++-|.+|| ..-++..|.||+||+||-|+.|..||.+. +....++++.+..+.. + ..+.
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-Dhk~lvrQIs~GaYrE----P-------~~PS 277 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-DHKRLVRQISRGAYRE----P-------ETPS 277 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-hHHHHHHHhhcccccC----C-------CCCc
Confidence 6789999999999 23477899999999999999999999754 4444555554433221 1 1122
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
...-||..||..+|++|.|+.||...-.
T Consensus 278 dA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 278 DASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred hHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 3557999999999999999999988754
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=318.36 Aligned_cols=245 Identities=18% Similarity=0.259 Sum_probs=192.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
..+|+|+||.||+++.. +|..||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (331)
T cd06649 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 90 (331)
T ss_pred EeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcH
Confidence 46899999999999875 68899999987432 2345789999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-Cccc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-KTCL 462 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~~~ 462 (608)
.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 91 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 91 DQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH----QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC----CEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence 999875 456899999999999999999999853 3999999999999999999999999999865433 3345
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc-------ccc-----------
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT-------GEV----------- 520 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~----------- 520 (608)
.|+..|+||| ..++.++|||||||++|||+||+.||..... ..... ....... ...
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEA-IFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH-HhcccccccccCCccccCcccccccccc
Confidence 6899999999 4578899999999999999999999854321 11111 1100000 000
Q ss_pred ----cc-----------HHHHHh------chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 521 ----FD-----------KEVAKA------GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 521 ----~~-----------~~~~~~------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
.+ ..+... ....+.++.+++.+||+.||++|||++|+++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00 000000 012456789999999999999999999998763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.90 Aligned_cols=246 Identities=15% Similarity=0.284 Sum_probs=198.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|+.. +++.||||.++... .....+.+|++++++++||||+++++++...+..++++||+++|
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08228 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAG 87 (267)
T ss_pred eeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCC
Confidence 45899999999999864 78999999886322 22346889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.........+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~ 162 (267)
T cd08228 88 DLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred cHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCCHHHEEEcCCCCEEECccccceeccchhHH
Confidence 999998754444556899999999999999999999876 9999999999999999999999999998765432
Q ss_pred -ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC-ChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 -TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI-DLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 -~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....++..|+||| ...+.++||||||+++|||++|+.|+.... +...+........ .... .....+
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~-------~~~~~~ 234 (267)
T cd08228 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD-YPPL-------PTEHYS 234 (267)
T ss_pred HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC-CCCC-------ChhhcC
Confidence 2346788899999 456788999999999999999999986443 2222222221111 1111 011234
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
..+.+++.+||..+|++||++.+|++.++++.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 56889999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=318.56 Aligned_cols=234 Identities=22% Similarity=0.263 Sum_probs=189.8
Q ss_pred cccCCCCCceEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRL----KNSAVYAVKRLKKLQ-----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
+.+|+|+||.||+++. .+++.||+|+++... .....+..|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4689999999999986 357899999997422 2234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG-----IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 999999999875 456888999999999999999999987 99999999999999999999999999875432
Q ss_pred C---CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 458 K---KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 458 ~---~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
. .....||..|+||| ..++.++|||||||++|||++|+.||..... ............ ..+.
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-~~~~~~~~~~~~----------~~~~ 221 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-KKTIDKILKGKL----------NLPP 221 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCC----------CCCC
Confidence 2 23356899999999 3567899999999999999999999875432 222222222110 0122
Q ss_pred hcHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
..+..+.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 3455688999999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=333.92 Aligned_cols=239 Identities=20% Similarity=0.203 Sum_probs=193.5
Q ss_pred hcccCCCCCceEEEEEEc-C-CcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 306 ADLRSQTICSSLFMVRLK-N-SAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~-g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.+.+|+|++|.||++... + +..||+|.+.... .....+.+|++++++++|||||++++++...+..++||||+++|+
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~ 151 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD 151 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence 356899999999999754 4 5788888775322 223457789999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.++++........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 152 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK-----MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred HHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 99998765444567899999999999999999999876 9999999999999999999999999998765432
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....||++|+||| ..++.++|||||||++|||++|+.||.... .............. ..+...+
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-~~~~~~~~~~~~~~---------~~~~~~s 296 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-QREIMQQVLYGKYD---------PFPCPVS 296 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC---------CCCccCC
Confidence 3346899999999 567889999999999999999999986432 22222222211110 1122345
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
..+.+++.+||..||++||++.+++.
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHh
Confidence 66889999999999999999999865
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=312.21 Aligned_cols=243 Identities=20% Similarity=0.319 Sum_probs=194.6
Q ss_pred cccCCCCCceEEEEEEcC------CcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLKN------SAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|++|.||+|.... ...||+|.++.... ...++.+|++.+.+++||||+++++++...+..+++|||+
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 90 (283)
T cd05048 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYL 90 (283)
T ss_pred hcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecC
Confidence 568999999999998643 25799999874322 3456889999999999999999999999989999999999
Q ss_pred cCCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceE
Q 042949 379 SNGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446 (608)
Q Consensus 379 ~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl 446 (608)
++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~-----i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 91 AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred CCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccccceEEEcCCCcEEE
Confidence 99999999975311 0145889999999999999999999886 999999999999999999999
Q ss_pred eccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhc
Q 042949 447 SECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEW 516 (608)
Q Consensus 447 ~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 516 (608)
+|||+++...... ....++..|+||| ..++.++|||||||++|||++ |..||..... .+....+. ...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~~~~i~-~~~ 243 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEVIEMIR-SRQ 243 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHH-cCC
Confidence 9999998654322 2234567899999 567889999999999999998 9888865322 22222211 111
Q ss_pred ccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 517 TGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
.. ......+..+.+|+.+||+.||++||++.||++.|+++
T Consensus 244 ~~--------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 244 LL--------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred cC--------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11 11234567799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.85 Aligned_cols=244 Identities=18% Similarity=0.242 Sum_probs=190.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
..+|+|+||.||+|+.. +++.||||+++... .....+.+|++++++++||||+++++++.+.+..++||||++ ++|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l 89 (303)
T cd07869 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDL 89 (303)
T ss_pred eeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCH
Confidence 46899999999999976 78999999987432 234467889999999999999999999999999999999995 788
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~ 460 (608)
.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ..
T Consensus 90 ~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 90 CQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY-----ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 888764 2356899999999999999999999987 999999999999999999999999998754322 13
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-------ccc----ccc---
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-------WTG----EVF--- 521 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~----~~~--- 521 (608)
...++..|+||| ..++.++||||+||++|||++|+.||....+............ +.. ..+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 346788999999 2467889999999999999999999976555433333221110 000 000
Q ss_pred ------cHHHHH--hchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 522 ------DKEVAK--AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 522 ------~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
...... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 00112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=325.15 Aligned_cols=238 Identities=18% Similarity=0.233 Sum_probs=187.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..||+|+||+||+|+.. +++.||||++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg 86 (381)
T cd05626 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (381)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 46899999999999864 67899999997432 12346889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 87 DMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG-----FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999875 456899999999999999999999887 999999999999999999999999997643100
Q ss_pred -----------------------------------------------CccccccCccccCC----CCCCcchhHHHHHHH
Q 042949 459 -----------------------------------------------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVI 487 (608)
Q Consensus 459 -----------------------------------------------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvv 487 (608)
.....||..|+||| ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 01246899999999 457889999999999
Q ss_pred HHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHH--chhcCCCCCCCHHHHHHH
Q 042949 488 LLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALK--CVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 488 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--Cl~~dP~~RPs~~evl~~ 560 (608)
+|||+||+.||................. .... ......+.++.+++.+ |+..+|..||++.|+++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~------~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWEN-TLHI------PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHcccc-ccCC------CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999976543222221111000 0000 0111234567788887 566677779999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.36 Aligned_cols=237 Identities=22% Similarity=0.353 Sum_probs=202.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCe-eEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEE-KLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lv~e~~~~g 381 (608)
+.+|+|.||.++.++.+ +++.+|+|++.... ..++...+|+.++++++|||||.+.+.+..++. .+|||+||+||
T Consensus 10 ~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg 89 (426)
T KOG0589|consen 10 RQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGG 89 (426)
T ss_pred hhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCC
Confidence 45799999999999865 67899999997432 234467899999999999999999999988887 99999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
++.+.+.... ...++++++..++.|++.|++|||++. |+|||||+.||+++.+..+||+|||+|+.+.+..
T Consensus 90 ~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~-----iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 90 DLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR-----VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred CHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh-----hhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 9999998632 467999999999999999999999765 9999999999999999999999999999987664
Q ss_pred -ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 -TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 -~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
...+||+.||+|| ..|+.|+||||+||++|||++-+++|... +....+..+.... ....+..++.
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-~m~~Li~ki~~~~---------~~Plp~~ys~ 232 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-NMSELILKINRGL---------YSPLPSMYSS 232 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-chHHHHHHHhhcc---------CCCCCccccH
Confidence 5678999999999 78999999999999999999999988753 3444444333322 1223455677
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
++..++..|+..+|+.||++.+++.+
T Consensus 233 el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 233 ELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 78999999999999999999999887
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=303.25 Aligned_cols=237 Identities=19% Similarity=0.348 Sum_probs=193.5
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|++|.||++...++..+|+|.+.......+++.+|++++++++||||+++++++...+..++||||+++++|.++
T Consensus 10 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (256)
T cd05059 10 KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89 (256)
T ss_pred hhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHH
Confidence 56899999999999988888999999876555667899999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc-c---c
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT-C---L 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~---~ 462 (608)
+... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... . .
T Consensus 90 l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 90 LRER---KGKLGTEWLLDMCSDVCEAMEYLESNG-----FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred HHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 8742 346899999999999999999999987 99999999999999999999999999986543321 1 1
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ..++.++||||||+++|||++ |+.|+..... ......... .... ..+...+..+.
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~-~~~~--------~~~~~~~~~~~ 231 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSA-GYRL--------YRPKLAPTEVY 231 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-HHHHHHHHc-CCcC--------CCCCCCCHHHH
Confidence 2334799999 567889999999999999999 7778754332 222221111 1000 11223566789
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
+++.+||..+|++|||+.|+++.|
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=309.86 Aligned_cols=241 Identities=20% Similarity=0.241 Sum_probs=189.6
Q ss_pred cCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+|+|+||.||+++.. +|+.||+|++.... .....+..|++++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999865 68999999986322 1233456799999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--TC 461 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--~~ 461 (608)
.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 81 KYHIYN--VGERGLEMERVIHYSAQITCGILHLHSMD-----IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred HHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHCC-----EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence 988864 23446899999999999999999999876 9999999999999999999999999998765432 23
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|+||| ..++.++||||+||++|||++|+.||......... .......... .........+.++.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~ 227 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRRTLED-----EVKFEHQNFTEESK 227 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHHhhcc-----ccccccccCCHHHH
Confidence 46888999999 45788999999999999999999998653221111 0111110000 00011123456689
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
+++.+||+.||++||++.|+++.+.
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhhhh
Confidence 9999999999999999987764433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=291.90 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=199.3
Q ss_pred cccCCCCCceEEEEE-EcCCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecC-----CeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVR-LKNSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN-----EEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~~ 379 (608)
..+|+|||+.||.++ ..++..+|+|++.-. ..+.+...+|++..++++|||+++++++...+ .+.|++++|..
T Consensus 27 ~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~ 106 (302)
T KOG2345|consen 27 RLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYK 106 (302)
T ss_pred eeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhc
Confidence 457999999999997 678999999999743 46778899999999999999999999886543 35899999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 458 (608)
.|+|.+.++....++..+++.+.+.|+.+|++||++||+.. ++..||||||.|||+.+.+.+++.|||.+....-.
T Consensus 107 ~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~---~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i 183 (302)
T KOG2345|consen 107 RGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE---PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQI 183 (302)
T ss_pred cccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC---CcccccCCCcceeEecCCCceEEEeccCccccceEe
Confidence 99999999876666678999999999999999999999975 46999999999999999999999999998754321
Q ss_pred ---C--------ccccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc-ccc
Q 042949 459 ---K--------TCLFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW-TGE 519 (608)
Q Consensus 459 ---~--------~~~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~ 519 (608)
. .....|..|+||| ...++++|||||||+||+|+.|..||..... ..+. .-.
T Consensus 184 ~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------~GgSlaLA 254 (302)
T KOG2345|consen 184 EGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------QGGSLALA 254 (302)
T ss_pred echHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------cCCeEEEe
Confidence 0 1234688999999 4568999999999999999999999853111 0000 000
Q ss_pred cccHHH-HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 520 VFDKEV-AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 520 ~~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
+....+ .+.....+..+.+++..|++.||.+||++.+++..++.+.
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 0112236777999999999999999999999999998764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=298.64 Aligned_cols=246 Identities=17% Similarity=0.256 Sum_probs=194.2
Q ss_pred cCCCCCceEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCc-ceeeeeeeecCC------eeEEEEee
Q 042949 309 RSQTICSSLFMVRL-KNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPN-ILPLVCYNSTNE------EKLLVYKY 377 (608)
Q Consensus 309 ~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~------~~~lv~e~ 377 (608)
+|+|.||+||+|+. .+|+.||+|+++-... ......+|+.++++++|+| ||++++++.+.+ ..++|+||
T Consensus 19 lGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~ 98 (323)
T KOG0594|consen 19 LGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEF 98 (323)
T ss_pred hCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEe
Confidence 89999999999985 4789999999984322 3455689999999999999 999999998876 78899999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+ .-+|.+++.........++...++.++.||++||+|||+++ |+||||||.||||++++.+||+|||+|+...-
T Consensus 99 ~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~-----IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 99 L-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG-----ILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred e-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 9 46999999864322246788899999999999999999987 99999999999999999999999999996652
Q ss_pred -C--CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh------hcccccccH
Q 042949 458 -K--KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE------EWTGEVFDK 523 (608)
Q Consensus 458 -~--~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~ 523 (608)
. -+..++|..|.||| ..|+...||||+||++.||+++++.|.+..+..+..+...-- .|.....-+
T Consensus 173 p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~ 252 (323)
T KOG0594|consen 173 PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLP 252 (323)
T ss_pred CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccc
Confidence 2 24567899999999 468899999999999999999999888776654443332111 111100000
Q ss_pred -------------HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 524 -------------EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 524 -------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+............+++.+|++.+|.+|.|++.++.+
T Consensus 253 ~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 253 DYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0011111122357899999999999999999999876
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=309.96 Aligned_cols=243 Identities=20% Similarity=0.327 Sum_probs=195.2
Q ss_pred hcccCCCCCceEEEEEEcC------CcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 306 ADLRSQTICSSLFMVRLKN------SAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
.+.+|+|++|.||+|...+ +..||||+++.... ..+.+.+|++++++++|+||+++++++......++||||
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 89 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEY 89 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEec
Confidence 3668999999999998643 47899999975433 346799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHh----------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEe
Q 042949 378 QSNGSLLSLLEAYI----------EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLIS 447 (608)
Q Consensus 378 ~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 447 (608)
+++|+|.++++... .....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-----eeccccccceEEEcCCCeEEEC
Confidence 99999999997531 11245789999999999999999999886 9999999999999999999999
Q ss_pred ccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcc
Q 042949 448 ECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWT 517 (608)
Q Consensus 448 DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 517 (608)
|||+++...... ....++..|+||| ..++.++|||||||++|||++ |+.||..... ........... .
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-~~~~~~~~~~~-~ 242 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECITQGR-L 242 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCC-c
Confidence 999998653322 2233467899999 567889999999999999999 9988764332 22222221111 0
Q ss_pred cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 518 GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
. ......+..+.+++.+||+.||++||++.|+++.|++
T Consensus 243 ~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 243 L--------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred C--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0 1112345668899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.20 Aligned_cols=247 Identities=20% Similarity=0.298 Sum_probs=197.0
Q ss_pred hcccCCCCCceEEEEEEc------CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 306 ADLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
.+.+|+|+||.||++... ++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 89 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 356899999999999752 34679999987432 33557899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHh---------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecc
Q 042949 379 SNGSLLSLLEAYI---------EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC 449 (608)
Q Consensus 379 ~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 449 (608)
++++|.+++.... .....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH-----FVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred CCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccCcceEEEccCCcEEeccC
Confidence 9999999997532 11235899999999999999999999887 999999999999999999999999
Q ss_pred ccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccc
Q 042949 450 GYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGE 519 (608)
Q Consensus 450 Gla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 519 (608)
|+++...... ....++..|+||| ..++.++|||||||++|||+| |..||.... ............. .
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-~~~~~~~i~~~~~-~- 241 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-NNEVIECITQGRV-L- 241 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCc-C-
Confidence 9998654332 1233467899999 457889999999999999999 888775432 2222222211110 0
Q ss_pred cccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 520 VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 520 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
......+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 242 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 242 -------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11223456689999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=319.35 Aligned_cols=233 Identities=21% Similarity=0.282 Sum_probs=189.7
Q ss_pred ccCCCCCceEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 308 LRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.+|+|+||.||+++. .+|+.||+|+++... .....+..|++++.+++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 589999999999986 478999999997432 233567789999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQ-KSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~-----ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 82 LFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC-----EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 9988864 4579999999999999999999997 44 999999999999999999999999998754322
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||..|+||| ..++.++|||||||++|||+||+.||..... ............ ..+...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-~~~~~~i~~~~~----------~~p~~~~~ 221 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI----------RFPRTLSP 221 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-HHHHHHHhcCCC----------CCCCCCCH
Confidence 23456899999999 5678999999999999999999999865432 222222111110 01223455
Q ss_pred HHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
.+.+++.+||+.||++|+ ++.++++.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 688999999999999996 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.12 Aligned_cols=244 Identities=19% Similarity=0.287 Sum_probs=185.3
Q ss_pred cccCCCCCceEEEEEEc--CCcEEEEEEecccc---cCHHHHHHHHHHHhcC---CCCcceeeeeeee-----cCCeeEE
Q 042949 307 DLRSQTICSSLFMVRLK--NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNL---KHPNILPLVCYNS-----TNEEKLL 373 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~--~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l---~H~niv~l~~~~~-----~~~~~~l 373 (608)
..+|+|+||.||+|+.. +++.||+|+++... .....+.+|+.+++++ +||||+++++++. .....++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l 86 (290)
T cd07862 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86 (290)
T ss_pred eEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence 45899999999999863 46889999987322 2234566777777665 6999999999875 2456899
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
||||++ ++|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 v~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~-----iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 87 VFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 999996 699998875 22345899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-------cccc-
Q 042949 454 FLDPK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-------WTGE- 519 (608)
Q Consensus 454 ~~~~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~- 519 (608)
..... .....||..|+||| ..++.++|||||||++|||++|++||....+.... ..+.... +...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHHhCCCChhhchhhh
Confidence 66433 23456889999999 56788999999999999999999998765443222 2221110 0000
Q ss_pred -----ccc----HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 520 -----VFD----KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 520 -----~~~----~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+. ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0001111234556789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.15 Aligned_cols=243 Identities=18% Similarity=0.234 Sum_probs=186.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecC-----CeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN-----EEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~ 377 (608)
+.+|+|+||.||+|... +|+.||||+++.. ......+.+|++++++++||||+++++++... ...++||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~ 85 (338)
T cd07859 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85 (338)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEec
Confidence 56899999999999864 7899999998742 22345688999999999999999999987543 247999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+. ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 86 ME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred CC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 95 789988864 456999999999999999999999987 99999999999999999999999999986432
Q ss_pred CC------ccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc------cc
Q 042949 458 KK------TCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT------GE 519 (608)
Q Consensus 458 ~~------~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~------~~ 519 (608)
.. ....||..|+||| ..++.++|||||||++|||+||+.||........ ...+...... ..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLITDLLGTPSPETISR 234 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHH
Confidence 21 2346889999999 3568899999999999999999999865432211 1111000000 00
Q ss_pred c---------------ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 520 V---------------FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 520 ~---------------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+ ...............+.+++.+||+.||++|||++|+++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0000001112234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.54 Aligned_cols=242 Identities=19% Similarity=0.312 Sum_probs=189.4
Q ss_pred CHHHHHHHhhcccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEE
Q 042949 297 KLDDLLEATADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLL 373 (608)
Q Consensus 297 ~~~~l~~~~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 373 (608)
.++++.. .+.||+|+||.||+++.. +++.||||++.... ...+.+.+|++++++++|+||+++++++...+..++
T Consensus 72 ~~~~~~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELER--VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhh--hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3444432 356899999999999865 68999999986432 224578899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
||||+++|+|.+. ...++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 150 v~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 150 LLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRH-----IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred EEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999997542 33567788899999999999999887 9999999999999999999999999998
Q ss_pred ccCCCC---ccccccCccccCCCC---------CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 454 FLDPKK---TCLFSSNGYTAPEKT---------VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 454 ~~~~~~---~~~~gt~~y~aPE~~---------~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
.+.... ....||..|+|||.. .+.++|||||||++|||++|+.||.... ...|...........
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~~~--- 292 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWASLMCAICMSQ--- 292 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CccHHHHHHHHhccC---
Confidence 765332 345789999999932 2458999999999999999999986322 112221111100000
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
........+.++.+++.+||+.||++|||+.|+++.
T Consensus 293 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122345668999999999999999999999875
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.13 Aligned_cols=233 Identities=20% Similarity=0.297 Sum_probs=189.1
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
++|+|+||.||+|+.. +++.||+|+++.. ....+.+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5899999999999875 5789999999743 22345577888888866 7999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 82 DLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG-----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 99998875 456899999999999999999999987 999999999999999999999999998754322
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||..... ............. .+...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~~~~~~i~~~~~~----------~p~~~~~ 221 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESILHDDVL----------YPVWLSK 221 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCC----------CCCCCCH
Confidence 23456899999999 4678899999999999999999999875432 2222222221110 1112345
Q ss_pred HHHHHHHHchhcCCCCCC-------CHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRP-------TMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RP-------s~~evl~~ 560 (608)
++.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 688999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.05 Aligned_cols=227 Identities=21% Similarity=0.317 Sum_probs=190.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
.++|+|.||+|+.+..+ +++.+|||.+++.. .+.+....|.+++.-. +||.++.+++.|++.+++|+||||+.|
T Consensus 374 ~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~G 453 (694)
T KOG0694|consen 374 AVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAG 453 (694)
T ss_pred EEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCC
Confidence 56899999999999975 67899999998643 3566777888887766 599999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc---CC
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL---DP 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~---~~ 457 (608)
||+..+.+ ...|++..+..++..|+.||+|||+++ ||+||||-+|||||.+|++||+|||++|.- +.
T Consensus 454 gdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~-----IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 454 GDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG-----IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred CcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC-----ceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 99554443 467999999999999999999999987 999999999999999999999999999964 34
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
..++++||+.||||| ..|+..+|.|||||+||||+.|++||.+..+ .+.+..+..++.. .+...+
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-ee~FdsI~~d~~~----------yP~~ls 592 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-EEVFDSIVNDEVR----------YPRFLS 592 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCCC----------CCCccc
Confidence 457889999999999 7899999999999999999999999986543 2333333333211 233456
Q ss_pred HHHHHHHHHchhcCCCCCCCH
Q 042949 534 FPLLNVALKCVSNSPDDRPTM 554 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~ 554 (608)
.+..+++.+++..+|++|..+
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHHHhccCcccccCC
Confidence 668899999999999999865
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=301.49 Aligned_cols=237 Identities=21% Similarity=0.251 Sum_probs=190.4
Q ss_pred ccCCCCCceEEEEEE---cCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRL---KNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~---~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
-+|+|+||.||+|.+ .++..+|+|+++.... ..+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 379999999999965 3578999999874332 2457889999999999999999999886 45678999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc-
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT- 460 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 460 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 99999864 456899999999999999999999886 99999999999999999999999999987654321
Q ss_pred -----cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 461 -----CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 461 -----~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
...++..|+||| ..++.++|||||||++|||+| |+.||..... ....... ...... ..+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~i-~~~~~~--------~~~~ 221 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMI-ESGERM--------ECPQ 221 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH-HCCCCC--------CCCC
Confidence 122346899999 456789999999999999998 8888865322 2222222 211111 1122
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
..+.++.+++.+||+.||++||++.+|.+.|++.
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 3556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=301.59 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=189.8
Q ss_pred cccCCCCCceEEEEEEc----CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeee-cCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK----NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNS-TNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|... ++..||+|++.... ...+.+.+|+.++++++||||+++++++. .++..++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 35899999999999864 24579999986322 23467889999999999999999999775 4556789999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.++++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK-----FVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999999752 345678888999999999999999876 9999999999999999999999999998654321
Q ss_pred -------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 -------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 -------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
....++..|+||| ..++.++|||||||++|||++|..|+....+.............. ..
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 223 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL---------LQ 223 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC---------CC
Confidence 1233466799999 457889999999999999999765544333333333322221100 01
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
....+..+.+++.+||..+|++||++.|+++.|+++..
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 12234568899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=301.64 Aligned_cols=241 Identities=23% Similarity=0.342 Sum_probs=193.9
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
..+|+|++|.||+|+..++..||+|+++......+++.+|++++++++||||+++++++.. +..++||||+++|+|.++
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 90 (262)
T cd05071 12 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 90 (262)
T ss_pred eecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHH
Confidence 4579999999999998777789999998655567789999999999999999999998754 567999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc----cc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT----CL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~----~~ 462 (608)
+... ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.++.+..... ..
T Consensus 91 ~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 163 (262)
T cd05071 91 LKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163 (262)
T ss_pred Hhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence 9752 2345899999999999999999999876 99999999999999999999999999986654321 23
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ..++.++|||||||++|||+| |..||...... ........ .... ......+..+.
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-~~~~~~~~-~~~~--------~~~~~~~~~l~ 233 (262)
T cd05071 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVER-GYRM--------PCPPECPESLH 233 (262)
T ss_pred cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-HHHHHHhc-CCCC--------CCccccCHHHH
Confidence 3556799999 457889999999999999999 77777543321 11111111 1000 01123456688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
+++.+||+.||++||++.++++.|++..
T Consensus 234 ~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 234 DLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=303.31 Aligned_cols=242 Identities=21% Similarity=0.351 Sum_probs=198.4
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEeccccc-CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV-SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
.+.+|.|++|.||+|...++..+|+|.++.... ..+++..|+.++++++|+||+++++++...+..++||||+++|+|.
T Consensus 11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (261)
T cd05148 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90 (261)
T ss_pred hhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHH
Confidence 356799999999999998899999999985443 4677899999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---cc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~ 461 (608)
+++... ....+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....... ..
T Consensus 91 ~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~ 163 (261)
T cd05148 91 AFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN-----SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD 163 (261)
T ss_pred HHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccCcceEEEcCCceEEEccccchhhcCCccccccC
Confidence 999752 3456899999999999999999999876 9999999999999999999999999998764332 12
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
..++..|+||| ..++.++||||||+++|+|++ |+.|+.... ........... ... ......+..+
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~-~~~--------~~~~~~~~~~ 233 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAG-YRM--------PCPAKCPQEI 233 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHHhC-CcC--------CCCCCCCHHH
Confidence 23456799999 567889999999999999999 788875433 22222222211 000 1123445668
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
.+++.+||+.||++|||++++++.|+.+
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 8999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.90 Aligned_cols=232 Identities=23% Similarity=0.334 Sum_probs=196.3
Q ss_pred cCCCCCceEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRL-KNSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
||.|+||.||.++. .+.++||||+|..+. ....++.+|++.|.+++|||+|.+.|+|..+...||||||| -|+-
T Consensus 34 IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSA 112 (948)
T KOG0577|consen 34 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSA 112 (948)
T ss_pred hcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccH
Confidence 69999999999985 578999999997432 23567899999999999999999999999999999999999 5788
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcccc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLF 463 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 463 (608)
.+++... ++++-+-.+..|+.+.+.||+|||+++ .||||||.-|||+++.+.+||+|||.|....+. ..++
T Consensus 113 sDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~-----~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-nsFv 183 (948)
T KOG0577|consen 113 SDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN-----RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-NSFV 183 (948)
T ss_pred HHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhh-----HHhhhccccceEecCCCeeeeccccchhhcCch-hccc
Confidence 8888753 577899999999999999999999987 999999999999999999999999999876544 4678
Q ss_pred ccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 464 SSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 464 gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
||++||||| +.|+-|+||||+||+..||...++|.....-....+....++... -...+|+..+
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt---------Lqs~eWS~~F 254 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------LQSNEWSDYF 254 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC---------CCCchhHHHH
Confidence 999999999 689999999999999999999999876544333333333222111 1135678889
Q ss_pred HHHHHHchhcCCCCCCCHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
..++..||+.-|++|||.++++.
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhh
Confidence 99999999999999999887754
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.53 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=193.4
Q ss_pred hcccCCCCCceEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHhcC-CCCcceeeeeeeecC-CeeEEEE
Q 042949 306 ADLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQV--SMDEFSQTMRQIGNL-KHPNILPLVCYNSTN-EEKLLVY 375 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lv~ 375 (608)
.+.+|+|+||.||+|... +++.||+|+++.... ..+.+.+|+.++.++ +|+||++++++|... ...++++
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ 91 (337)
T cd05054 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (337)
T ss_pred hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence 367899999999999642 357899999874322 234577899999999 799999999988654 5678999
Q ss_pred eeccCCCHHHHHHHHhc---------------------------------------------------------CCCCCC
Q 042949 376 KYQSNGSLLSLLEAYIE---------------------------------------------------------GKRDFP 398 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~---------------------------------------------------------~~~~l~ 398 (608)
||+++|+|.+++..... ....++
T Consensus 92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (337)
T cd05054 92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT 171 (337)
T ss_pred ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence 99999999999864211 013689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-----ccccccCccccCC-
Q 042949 399 WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE- 472 (608)
Q Consensus 399 ~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE- 472 (608)
+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.... ....++..|+|||
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~~~-----ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 172 LEDLISYSFQVARGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC-----eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 9999999999999999999876 9999999999999999999999999998764322 2234567899999
Q ss_pred ---CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCC
Q 042949 473 ---KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548 (608)
Q Consensus 473 ---~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP 548 (608)
..++.++|||||||++|||++ |..||............+ ...... ..+.....++.+++.+||+.+|
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL-KEGTRM--------RAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH-hccCCC--------CCCccCCHHHHHHHHHHccCCh
Confidence 567889999999999999998 988886433222222221 111100 0122345568899999999999
Q ss_pred CCCCCHHHHHHHHHHhhcC
Q 042949 549 DDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 549 ~~RPs~~evl~~L~~~~~~ 567 (608)
++||++.|+++.|+++++.
T Consensus 318 ~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 318 EDRPTFSELVEILGDLLQE 336 (337)
T ss_pred hhCcCHHHHHHHHHHHHhc
Confidence 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.35 Aligned_cols=235 Identities=19% Similarity=0.308 Sum_probs=188.4
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||.||+++.. +++.||+|+++... ...+.+.+|..++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 5799999999999875 68899999997432 2334578899999888 6999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---C
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP---K 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~ 458 (608)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 82 DLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG-----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence 99988864 457999999999999999999999887 99999999999999999999999999975321 2
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC-------ChHHHHHHHHhhhcccccccHHHHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI-------DLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
.....||..|+||| ..++.++|||||||++|||+||+.||.... ....+.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------R 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------C
Confidence 23457899999999 467889999999999999999999985311 111222211111100 1
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCC------HHHHHHH
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPT------MAEVLER 560 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs------~~evl~~ 560 (608)
.+...+..+.+++.+||+.||.+||+ +.++++.
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 12334566889999999999999997 5676543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.12 Aligned_cols=227 Identities=22% Similarity=0.292 Sum_probs=185.6
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||.||+++.. +++.||||+++.. ....+.+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 5899999999999875 6889999999742 22345677888888876 6999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---C
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP---K 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~ 458 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 82 ~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~-----ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 82 DLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG-----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred hHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence 99998875 456999999999999999999999887 99999999999999999999999999875422 2
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||+.|+||| ..++.++|||||||++|||++|+.||..... ............ ..+...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-~~~~~~i~~~~~----------~~~~~~~~ 221 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDEV----------VYPTWLSQ 221 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCCC----------CCCCCCCH
Confidence 23456899999999 4578899999999999999999999875432 222222222111 01122455
Q ss_pred HHHHHHHHchhcCCCCCCCH
Q 042949 535 PLLNVALKCVSNSPDDRPTM 554 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~ 554 (608)
.+.+++.+||+.||++||++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHcccCHHHCCCC
Confidence 68899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=300.68 Aligned_cols=246 Identities=18% Similarity=0.305 Sum_probs=199.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|++|.||+|... +|+.||+|.++.. ....+.+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (267)
T cd08224 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAG 87 (267)
T ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCC
Confidence 46899999999999876 8899999988632 123567889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.........+++.+++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 162 (267)
T cd08224 88 DLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-----IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred CHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC-----EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc
Confidence 999999764444566899999999999999999999876 9999999999999999999999999988654332
Q ss_pred -ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC-ChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 -TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI-DLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 -~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....++..|+||| ..++.++|||||||++|||++|+.|+.... +........... ...... ....+
T Consensus 163 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~-------~~~~~ 234 (267)
T cd08224 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYPPLP-------ADHYS 234 (267)
T ss_pred cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC-CCCCCC-------hhhcC
Confidence 2346788899999 457789999999999999999999985432 222222221111 111110 11345
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
..+.+++.+||..+|++|||+.+|+++|+++.
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 56889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=303.60 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=191.8
Q ss_pred cccCCCCCceEEEEEEcC-Cc--EEEEEEeccc--ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKN-SA--VYAVKRLKKL--QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-g~--~vavK~l~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+++|+|+||.||+|...+ +. .+|+|.++.. ....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 43 5788888742 22345788999999999 799999999999999999999999999
Q ss_pred CCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEec
Q 042949 381 GSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448 (608)
Q Consensus 381 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 448 (608)
|+|.+++..... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~-----i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccccceEEEcCCCeEEECC
Confidence 999999975321 1235889999999999999999999876 99999999999999999999999
Q ss_pred cccccccCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 449 CGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 449 FGla~~~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
||+++...... .....+..|+||| ..++.++|||||||++|||++ |..||... +............ ..
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~-~~--- 230 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGY-RL--- 230 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc-CHHHHHHHHhCCC-CC---
Confidence 99986432211 1122355799999 457889999999999999997 88887543 2222222221111 00
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
......+..+.+++.+||..+|.+|||+.++++.|+++.+
T Consensus 231 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 231 -----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred -----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 0112344568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=299.73 Aligned_cols=237 Identities=21% Similarity=0.302 Sum_probs=189.0
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
.+|+|+||.||+|... +++.||+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5899999999999875 78999999886432 23457899999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc---
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC--- 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 461 (608)
+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 82 TFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH-----CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99864 2346899999999999999999999876 999999999999999999999999999865432211
Q ss_pred --ccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 462 --LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 462 --~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
...+..|+||| ..++.++|||||||++|||++ |..|+..... .. ........... ......+.
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-~~-~~~~~~~~~~~--------~~~~~~~~ 223 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-QQ-TREAIEQGVRL--------PCPELCPD 223 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-HH-HHHHHHcCCCC--------CCcccCCH
Confidence 12234699999 457889999999999999998 7777653321 11 11111111000 11223455
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
.+.+++.+||+.+|++|||+.+++++|+
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 6889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.75 Aligned_cols=232 Identities=24% Similarity=0.337 Sum_probs=186.7
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhc-CCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGN-LKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||.||+|+.. +++.||||+++.. ....+.+..|..++.. ++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 5799999999999875 5789999999743 2234456678888876 48999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---C
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP---K 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~ 458 (608)
+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~-----ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 82 DLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG-----IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 99999875 456899999999999999999999886 99999999999999999999999999875322 2
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||..... ....+...... .. .+...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~i~~~~---~~-------~~~~~~~ 221 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIRMDN---PC-------YPRWLTR 221 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC---CC-------CCccCCH
Confidence 23456899999999 4678899999999999999999999865432 22222211110 00 1122445
Q ss_pred HHHHHHHHchhcCCCCCCCHH-HHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMA-EVLE 559 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~-evl~ 559 (608)
++.+++.+||+.||++||++. ++.+
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 678999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.41 Aligned_cols=231 Identities=22% Similarity=0.288 Sum_probs=186.5
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||.||+++.. +|+.||+|+++.. ....+.+..|.+++... +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 5899999999999875 6889999999743 22345567788888754 8999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC---CC
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD---PK 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~---~~ 458 (608)
+|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++... ..
T Consensus 82 ~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 82 DLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG-----IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152 (316)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence 99998875 456899999999999999999999987 9999999999999999999999999987532 12
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||..... ............ ..+...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-~~~~~~~~~~~~----------~~~~~~~~ 221 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRVDTP----------HYPRWITK 221 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC----------CCCCCCCH
Confidence 23456899999999 5678899999999999999999999865432 222222211100 01122455
Q ss_pred HHHHHHHHchhcCCCCCCCHH-HHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMA-EVL 558 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~-evl 558 (608)
++.+++.+||+.||++||++. +++
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 688999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=306.56 Aligned_cols=245 Identities=20% Similarity=0.246 Sum_probs=191.0
Q ss_pred cccCCCCCceEEEEEE-----cCCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRL-----KNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-----~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~ 377 (608)
..+|+|+||+||++.. .++..||+|.++... .....+.+|++++++++||||+++++++... ...+++|||
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (283)
T cd05080 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89 (283)
T ss_pred eecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecC
Confidence 5689999999988653 367899999987532 2456788999999999999999999987653 467899999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+++|+|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 90 ~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 90 VPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999874 35999999999999999999999887 99999999999999999999999999987654
Q ss_pred CCc------cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHH--
Q 042949 458 KKT------CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV-- 525 (608)
Q Consensus 458 ~~~------~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 525 (608)
... ...++..|+||| ..++.++||||||+++|||+||..|+...... +........ ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~-~~~~~~~~~~ 235 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQ-GQMTVVRLIE 235 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcccc-cccchhhhhh
Confidence 321 123456799999 45788999999999999999999887532211 111100000 00000000
Q ss_pred -------HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 526 -------AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 526 -------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
.......+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0112345677999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.05 Aligned_cols=243 Identities=20% Similarity=0.310 Sum_probs=198.5
Q ss_pred hcccCCCCCceEEEEEEcCC-cEEEEEEeccc-ccCHHHHHHHHHHHhcCC-CCcceeeeee-eec------CCeeEEEE
Q 042949 306 ADLRSQTICSSLFMVRLKNS-AVYAVKRLKKL-QVSMDEFSQTMRQIGNLK-HPNILPLVCY-NST------NEEKLLVY 375 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g-~~vavK~l~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~-~~~------~~~~~lv~ 375 (608)
++.|.+|||+.||.|....+ ..||+|++-.. ....+.+.+||++|++|+ |+|||.+++. ... .-+.+|.|
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm 121 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM 121 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence 46789999999999998766 99999998633 345677899999999997 9999999993 221 24678999
Q ss_pred eeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
|||++|.|.+++..... ..|++.++++|+.|+++|+++||... ++|||||||-+||||+.+++.||||||.+.-.
T Consensus 122 EyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~---pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 122 EYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK---PPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred hhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC---CccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 99999999999987443 34999999999999999999999875 67999999999999999999999999998632
Q ss_pred C--CCC----------ccccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc
Q 042949 456 D--PKK----------TCLFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW 516 (608)
Q Consensus 456 ~--~~~----------~~~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 516 (608)
. ... -..+.|+-|+||| ...++|+|||++||+||-|+....||.....+.
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----------- 265 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----------- 265 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----------
Confidence 2 211 1235788999999 357899999999999999999999998654321
Q ss_pred ccccccHHHH-HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 517 TGEVFDKEVA-KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 517 ~~~~~~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+++.... +.....+..+.+||..||+.||++||++-+|+..+.++.+.
T Consensus 266 ---Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 ---ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1111111 11245667799999999999999999999999999998754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=309.96 Aligned_cols=242 Identities=18% Similarity=0.266 Sum_probs=192.4
Q ss_pred cccCCCCCceEEEEEEc-CCc----EEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSA----VYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
..+|+|+||.||+|.+. ++. .||+|.++... ...+++.+|+.+++.++||||++++++|... ..++++||++
T Consensus 13 ~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~ 91 (316)
T cd05108 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 91 (316)
T ss_pred eeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCC
Confidence 56899999999999864 343 48999987432 2356788999999999999999999998764 5779999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 92 ~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~-----iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 92 FGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred CCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC-----eeccccchhheEecCCCcEEEccccccccccCCC
Confidence 99999999752 346899999999999999999999886 9999999999999999999999999999765432
Q ss_pred c-----cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 T-----CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 ~-----~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
. ...++..|+||| ..++.++|||||||++|||++ |+.|+... ....... ........ ...
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~-~~~~~~~-~~~~~~~~--------~~~ 233 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISS-ILEKGERL--------PQP 233 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-CHHHHHH-HHhCCCCC--------CCC
Confidence 2 122356799999 567889999999999999998 88887543 2222221 11111100 112
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
..+...+.+++.+||..+|++||++.+++..+.++.+.
T Consensus 234 ~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 234 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 23456688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=299.50 Aligned_cols=239 Identities=23% Similarity=0.359 Sum_probs=194.4
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
..+|+|++|.||++...++..+|+|.++......+.+.+|+.++++++|+|++++++++. .+..+++|||+++++|.++
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 90 (260)
T cd05070 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDF 90 (260)
T ss_pred heeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHH
Confidence 568999999999999888889999999865556778999999999999999999999875 4568999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
++. .....+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....... ...
T Consensus 91 ~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05070 91 LKD--GEGRALKLPNLVDMAAQVAAGMAYIERMN-----YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence 875 22346899999999999999999999886 9999999999999999999999999998764332 122
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ..++.++||||||+++|||++ |..||.... ........... ... ......+..+.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~-~~~--------~~~~~~~~~~~ 233 (260)
T cd05070 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQVERG-YRM--------PCPQDCPISLH 233 (260)
T ss_pred CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcC-CCC--------CCCCcCCHHHH
Confidence 3456799999 457889999999999999999 777775432 22222222111 000 11223456689
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
+++.+||..+|++|||+.++.+.|++
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.58 Aligned_cols=232 Identities=23% Similarity=0.314 Sum_probs=185.5
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhc-CCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGN-LKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||.||+|+.. +++.||+|.++... ...+.+..|.+++.. .+||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999875 57899999997432 233455667777765 48999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~-----ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 82 DLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG-----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence 99998875 456899999999999999999999986 999999999999999999999999999864322
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||..... ......+..... ..+...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~~~----------~~~~~~~~ 221 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSILNDRP----------HFPRWISK 221 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC----------CCCCCCCH
Confidence 23456899999999 4578899999999999999999999875432 222222211110 01123455
Q ss_pred HHHHHHHHchhcCCCCCCCHH-HHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMA-EVLE 559 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~-evl~ 559 (608)
++.+++.+||+.||++||++. ++++
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 678999999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.60 Aligned_cols=235 Identities=20% Similarity=0.319 Sum_probs=187.0
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||.||+++.. +++.||+|+++... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 5899999999999875 67899999997432 2234577888888776 7999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---C
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP---K 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~ 458 (608)
+|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.... .
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 82 DLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence 99988864 457999999999999999999999987 99999999999999999999999999975422 2
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC-------ChHHHHHHHHhhhcccccccHHHHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI-------DLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||.... ....+.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~ 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------R 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------C
Confidence 23457899999999 457889999999999999999999985211 111222111111100 1
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCC------HHHHHHH
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPT------MAEVLER 560 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs------~~evl~~ 560 (608)
.+...+..+.+++.+||+.||++||+ +.++++.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 12334566889999999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=300.42 Aligned_cols=237 Identities=22% Similarity=0.279 Sum_probs=189.0
Q ss_pred cCCCCCceEEEEEEc---CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRLK---NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+|+|+||.||+|.+. ++..||+|++.... ...+++.+|+.++++++||||+++++++.. +..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 799999999999764 45679999987432 234568999999999999999999998864 568999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc---
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT--- 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--- 460 (608)
.+++.. ....+++..+++++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 82 NKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN-----FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC-----eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 999864 2456899999999999999999999876 99999999999999999999999999986543321
Q ss_pred ---cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 461 ---CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 461 ---~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
...++..|+||| ..++.++|||||||++||+++ |+.|+..... ......... .... ..+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~-~~~~--------~~~~~~ 223 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-PEVMSFIEQ-GKRL--------DCPAEC 223 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHHC-CCCC--------CCCCCC
Confidence 112246799999 467889999999999999996 8888865432 222222111 1100 112334
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
+.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 56788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=299.52 Aligned_cols=239 Identities=23% Similarity=0.356 Sum_probs=193.2
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
..+|+|++|.||++...++..+|+|++.......+.+.+|++++++++|+|++++++++. .+..+++|||+++|+|.++
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05069 12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDF 90 (260)
T ss_pred eeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHH
Confidence 458999999999999888778999998765555678899999999999999999998875 4568899999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++...... ...
T Consensus 91 ~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 91 LKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN-----YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 9752 2345899999999999999999999876 9999999999999999999999999998664322 122
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ...+.++|||||||++|||+| |+.|+....+. ......... ... ......+..+.
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~-~~~--------~~~~~~~~~~~ 233 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLEQVERG-YRM--------PCPQGCPESLH 233 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcC-CCC--------CCCcccCHHHH
Confidence 3566799999 457889999999999999999 88887654332 222222111 110 01123456688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
+++.+||..||++||++++|++.|++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=324.40 Aligned_cols=250 Identities=19% Similarity=0.233 Sum_probs=189.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecC--------CeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN--------EEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~~lv~e~ 377 (608)
+.+|+|+||.||+|... +++.||||++.... ....+|+.++++++|||||++++++... ...++||||
T Consensus 72 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~ 148 (440)
T PTZ00036 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEF 148 (440)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEec
Confidence 56899999999999874 68899999886432 2345799999999999999998876432 246799999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-CceEeccccccccC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-DPLISECGYSKFLD 456 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 456 (608)
++ ++|.+++.........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+.
T Consensus 149 ~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~-----IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 149 IP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF-----ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred CC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 97 5788887765445677999999999999999999999987 99999999999999665 69999999998764
Q ss_pred CC--CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-------------c
Q 042949 457 PK--KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-------------W 516 (608)
Q Consensus 457 ~~--~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------------~ 516 (608)
.. .....+|+.|+||| ..++.++|||||||++|||+||.+||..........+...... +
T Consensus 223 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 302 (440)
T PTZ00036 223 AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY 302 (440)
T ss_pred CCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhh
Confidence 33 23456899999999 2578899999999999999999999976544332222211000 0
Q ss_pred ----ccccccHHHHH-hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhh
Q 042949 517 ----TGEVFDKEVAK-AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVV 565 (608)
Q Consensus 517 ----~~~~~~~~~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~ 565 (608)
...+....+.. .+...+.++.+|+.+||..||.+|||+.|+++. ++++.
T Consensus 303 ~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 303 ADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00000011111 122345678999999999999999999999865 44443
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=301.18 Aligned_cols=242 Identities=23% Similarity=0.352 Sum_probs=194.4
Q ss_pred hcccCCCCCceEEEEEEcC----CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLKN----SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.+.+|+|+||+||+|.... ...||||+++... ....++.+|+.++++++||||+++++++...+..+++|||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 3568999999999998742 4689999987432 234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 89 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~-----i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 89 NGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 99999998752 347899999999999999999999876 9999999999999999999999999999775221
Q ss_pred c-----cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 T-----CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 ~-----~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
. ...++..|+||| ..++.++||||||+++|||++ |..|+..... ......... .... ...
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~-~~~~--------~~~ 230 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVED-GYRL--------PPP 230 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-HHHHHHHHc-CCCC--------CCC
Confidence 1 123456799999 457889999999999999998 8888754322 222222211 1100 112
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
...+..+.+++.+||+.+|++||++.|+++.|++++
T Consensus 231 ~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 231 MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 234566889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=298.27 Aligned_cols=241 Identities=23% Similarity=0.350 Sum_probs=196.9
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
.+.+|.|++|.||++... |+.||+|.++......+++.+|+.++++++|+||+++++++...+..++||||+++++|.+
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 89 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD 89 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHH
Confidence 366899999999999874 7889999998654456788999999999999999999999998999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcccccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSS 465 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt 465 (608)
++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++...........+
T Consensus 90 ~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 162 (256)
T cd05039 90 YLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN-----FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP 162 (256)
T ss_pred HHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence 99752 2236899999999999999999999887 9999999999999999999999999998775444444456
Q ss_pred CccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHH
Q 042949 466 NGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVA 540 (608)
Q Consensus 466 ~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 540 (608)
..|+||| ..++.++||||||+++||+++ |..|+... ....... ........ ......+..+.+++
T Consensus 163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~-~~~~~~~~--------~~~~~~~~~~~~li 232 (256)
T cd05039 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVP-HVEKGYRM--------EAPEGCPPEVYKVM 232 (256)
T ss_pred ccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHH-HHhcCCCC--------CCccCCCHHHHHHH
Confidence 6799999 456789999999999999997 88887543 2222211 11111111 11223456688999
Q ss_pred HHchhcCCCCCCCHHHHHHHHHHh
Q 042949 541 LKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 541 ~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
.+||..+|++|||++|++++|+.+
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhcC
Confidence 999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=314.06 Aligned_cols=249 Identities=20% Similarity=0.262 Sum_probs=198.4
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
.+-||+|-||.|..+....+..||||+++... ..+.+|.+|+++|.+++|||||+++|+|..++.+++|+|||++|+|
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDL 622 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDL 622 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcH
Confidence 45689999999999999888999999998432 2457899999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCccc-
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCL- 462 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 462 (608)
.+|+.... ...+.-....+|+.|||.||+||.+.+ +||||+.++|+|+|.++++||+|||+++.+.......
T Consensus 623 nqFl~ahe--apt~~t~~~vsi~tqiasgmaYLes~n-----fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 623 NQFLSAHE--LPTAETAPGVSICTQIASGMAYLESLN-----FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHHHHhcc--CcccccchhHHHHHHHHHHHHHHHhhc-----hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99998632 122455677889999999999998776 9999999999999999999999999999776554332
Q ss_pred ----cccCccccCC----CCCCcchhHHHHHHHHHHHHc--CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 463 ----FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT--GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 463 ----~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
+-...|||+| ..++.++|||+||+++||+++ ...|+..-.+ .+.++.. .......-.......+.-+
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~--~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENA--GEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhh--hhhcCCCCcceeccCCCcC
Confidence 2346799999 789999999999999999866 4456543221 1111110 0011111111222345567
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
+..+.+++.+||..|.++||+++++...|++.
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 78899999999999999999999999998875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=317.34 Aligned_cols=230 Identities=21% Similarity=0.252 Sum_probs=187.7
Q ss_pred cccCCCCCceEEEEEE----cCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRL----KNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~----~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+++. .+|+.||+|+++... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 3589999999999875 367899999997432 233457789999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 458 (608)
+|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG-----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 9999999865 456899999999999999999999987 999999999999999999999999999865433
Q ss_pred --CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 459 --KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 459 --~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
.....|+..|+||| ..++.++|||||||++|||++|+.||..... ............ ..+...
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~i~~~~~----------~~p~~~ 221 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-KETMTMILKAKL----------GMPQFL 221 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-HHHHHHHHcCCC----------CCCCCC
Confidence 23456899999999 4568899999999999999999999875432 222222221111 011234
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAE 556 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~e 556 (608)
+..+.+++.+||+.||++||++.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 456789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=305.10 Aligned_cols=246 Identities=21% Similarity=0.328 Sum_probs=197.0
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEeccccc-CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQV-SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
..+|+|++|.||+++.. ++..+++|.++.... ..+.+.+|++.+++++|+||+++++++...+..++||||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (291)
T cd05094 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMK 90 (291)
T ss_pred eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCC
Confidence 56899999999999753 356799999874332 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEe
Q 042949 380 NGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLIS 447 (608)
Q Consensus 380 ~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 447 (608)
+++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccCcceEEEccCCcEEEC
Confidence 9999999975311 1234899999999999999999999887 9999999999999999999999
Q ss_pred ccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcc
Q 042949 448 ECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWT 517 (608)
Q Consensus 448 DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 517 (608)
|||+++...... ....++..|+||| ..++.++|||||||++|||+| |+.|+..... ........... .
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~-~ 243 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIECITQGR-V 243 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhCCC-C
Confidence 999998654322 2334567899999 567889999999999999999 8888754322 22222221111 1
Q ss_pred cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 518 GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
. ......+..+.+++.+||+.||++|||+.+|+++|+++.+.
T Consensus 244 ~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 244 L--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred C--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 11223456688999999999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.92 Aligned_cols=233 Identities=21% Similarity=0.297 Sum_probs=189.5
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||+||+++.. +++.||||+++.. ....+.+.+|.+++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999875 5789999999743 22345677888888877 6999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 82 DLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG-----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 99998875 457999999999999999999999887 999999999999999999999999998753221
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....|+..|+||| ..++.++|||||||++|||++|+.||.... ............. ..+...+.
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-~~~~~~~i~~~~~----------~~~~~~~~ 221 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-EDELFQSILEDEV----------RYPRWLSK 221 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCC----------CCCCcCCH
Confidence 23346899999999 567889999999999999999999986543 2222222221110 01123456
Q ss_pred HHHHHHHHchhcCCCCCCCH-----HHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTM-----AEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~-----~evl~~ 560 (608)
.+.+++.+||+.||++||++ .++++.
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 68899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=301.40 Aligned_cols=244 Identities=22% Similarity=0.288 Sum_probs=189.9
Q ss_pred hcccCCCCCceEEEEEEcCC-c--EEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEE
Q 042949 306 ADLRSQTICSSLFMVRLKNS-A--VYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLL 373 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g-~--~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~l 373 (608)
...+|+|+||.||+|...+. . .||+|.++... ...+.+.+|++++++++|+||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 35689999999999987543 2 69999887432 2345688899999999999999999987432 24689
Q ss_pred EEeeccCCCHHHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccc
Q 042949 374 VYKYQSNGSLLSLLEAYIE--GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGY 451 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 451 (608)
++||+++|+|.+++..... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-----FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhheEEcCCCCEEECCCCc
Confidence 9999999999998853221 2345899999999999999999999876 99999999999999999999999999
Q ss_pred ccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 452 SKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 452 a~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
++...... ....++..|+||| ..++.++|||||||++|||++ |+.||.... ..............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~---- 233 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-NSEIYDYLRQGNRL---- 233 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCCC----
Confidence 98765432 1223566799999 457889999999999999999 777775432 22222222211100
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
......+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 234 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 -----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=310.62 Aligned_cols=247 Identities=18% Similarity=0.282 Sum_probs=182.6
Q ss_pred hcccCCCCCceEEEEEEc---CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeec--CCeeEEEEeeccC
Q 042949 306 ADLRSQTICSSLFMVRLK---NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNST--NEEKLLVYKYQSN 380 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~~ 380 (608)
+..+|+|+||+||+|+.. +++.||+|.++... ....+.+|++++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 456899999999999865 46789999997543 23457899999999999999999998854 456889999995
Q ss_pred CCHHHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec----CCCCCceEecccc
Q 042949 381 GSLLSLLEAYIE-----GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL----NENEDPLISECGY 451 (608)
Q Consensus 381 g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGl 451 (608)
++|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 588888764211 1235899999999999999999999987 9999999999999 4567899999999
Q ss_pred ccccCCCC------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh--------HHHHHHHH
Q 042949 452 SKFLDPKK------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL--------PKWVKAMV 512 (608)
Q Consensus 452 a~~~~~~~------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~--------~~~~~~~~ 512 (608)
++...... ....+|..|+||| ..++.++||||+||++|||++|++||...... ......+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98764321 2356789999999 24688999999999999999999998543210 00111110
Q ss_pred hhh-------c-----ccc--ccc--------------HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 513 REE-------W-----TGE--VFD--------------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 513 ~~~-------~-----~~~--~~~--------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
... + ..+ ... .............+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0 000 000 0000001112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=297.77 Aligned_cols=238 Identities=23% Similarity=0.314 Sum_probs=192.2
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+++|+|++|.||+|...++..+|+|.++.... ....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999874322 2346889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc----
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT---- 460 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 460 (608)
+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN-----CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 98864 2346899999999999999999999876 99999999999999999999999999976543221
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
...++..|+||| ..++.++||||||+++||+++ |..||..... ....... ...... ......+..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-~~~~~~~-~~~~~~--------~~~~~~~~~ 222 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-QQAREQV-EKGYRM--------SCPQKCPDD 222 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHH-HcCCCC--------CCCCCCCHH
Confidence 123356799999 457889999999999999998 8888864422 2111111 111110 112234567
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
+.+++.+||..+|++||++.|+++.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=312.60 Aligned_cols=244 Identities=19% Similarity=0.272 Sum_probs=190.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
..+|+|+||.||++... ++..+|+|+++... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 11 ~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (333)
T cd06650 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 90 (333)
T ss_pred ccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcH
Confidence 56899999999999876 68899999887432 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-Cccc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-KTCL 462 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~~~ 462 (608)
.+++.. ...+++..+..++.|++.||+|||+.+ +|+||||||+|||+++++.+||+|||++...... ....
T Consensus 91 ~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 162 (333)
T cd06650 91 DQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (333)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence 999975 456899999999999999999999753 3999999999999999999999999999865432 2345
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh----hcccc---------------
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE----EWTGE--------------- 519 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~--------------- 519 (608)
.++..|+||| ..++.++|||||||++|||++|+.||...... . ....... .....
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (333)
T cd06650 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK-E-LELMFGCPVEGDPAESETSPRPRPPGRPLSS 240 (333)
T ss_pred CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh-H-HHHHhcCcccCCccccccCcccCCccchhhh
Confidence 6889999999 45788999999999999999999998643210 0 1100000 00000
Q ss_pred -------------cccHHHHHh-----chhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 520 -------------VFDKEVAKA-----GRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 520 -------------~~~~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+...... ....+.++.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000000 01134568899999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=301.24 Aligned_cols=246 Identities=16% Similarity=0.287 Sum_probs=198.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|+|++|.||++.. .++..+|||.+.... ....++.+|++++++++||||+++++++...+..+++|||++++
T Consensus 8 ~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08229 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 87 (267)
T ss_pred hhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCC
Confidence 5689999999999985 588999999886422 12357889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.........+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd08229 88 DLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred CHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc
Confidence 999998754444567899999999999999999999876 9999999999999999999999999988765432
Q ss_pred -ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC-hHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 -TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID-LPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 -~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....++..|+||| ...+.++||||||+++|||++|..|+..... .....+...... .... .....+
T Consensus 163 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~-------~~~~~~ 234 (267)
T cd08229 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPL-------PSDHYS 234 (267)
T ss_pred cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC-CCCC-------Cccccc
Confidence 2346788999999 4567889999999999999999999854321 122221111100 0000 112345
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
..+.+++.+||+.||++|||+.+|++.++++.
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 56889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=317.86 Aligned_cols=247 Identities=18% Similarity=0.270 Sum_probs=194.5
Q ss_pred hhcccCCCCCceEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEE
Q 042949 305 TADLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVY 375 (608)
Q Consensus 305 ~~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 375 (608)
..+.+|+|+||.||+|+.. .+..||+|+++.... ..+.+.+|++++.++. |||||++++++...+..++|+
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 3578999999999999863 346899999975322 2346889999999997 999999999999999999999
Q ss_pred eeccCCCHHHHHHHHhc---------------------------------------------------------------
Q 042949 376 KYQSNGSLLSLLEAYIE--------------------------------------------------------------- 392 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~--------------------------------------------------------------- 392 (608)
||+++|+|.++++....
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 99999999999975311
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC
Q 042949 393 -------------------------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441 (608)
Q Consensus 393 -------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~ 441 (608)
....+++..++.++.|++.||+|||+.+ |+||||||+|||++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN-----CVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----cCcccCCcceEEEeCC
Confidence 1124678889999999999999999876 9999999999999999
Q ss_pred CCceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHH
Q 042949 442 EDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAM 511 (608)
Q Consensus 442 ~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~ 511 (608)
+.+||+|||+++...... ....++..|+||| ..++.++|||||||++|||++ |..|+............
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~- 354 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA- 354 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH-
Confidence 999999999998653221 2234677899999 456889999999999999998 77777543222211111
Q ss_pred HhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 512 VREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
....... ..+...+..+.+++.+||..+|++||+++||++.|++++
T Consensus 355 ~~~~~~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 355 IKRGYRM--------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHcCCCC--------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111100 012234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=299.72 Aligned_cols=239 Identities=23% Similarity=0.367 Sum_probs=196.1
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
..+|+|+||.||+|...+++.||+|.+.......+++.+|+.++++++|+||+++++++. .+..+++|||+++|+|.++
T Consensus 12 ~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05067 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDF 90 (260)
T ss_pred eeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHH
Confidence 468999999999999989999999999876667788999999999999999999999874 4578999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
+.. .....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... ...
T Consensus 91 ~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05067 91 LKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN-----YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA 163 (260)
T ss_pred HHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCC
Confidence 865 23456899999999999999999999876 9999999999999999999999999998765322 123
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ..++.++||||||+++||+++ |+.||.... .......+... ... ......+..+.
T Consensus 164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~-~~~--------~~~~~~~~~~~ 233 (260)
T cd05067 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-NPEVIQNLERG-YRM--------PRPDNCPEELY 233 (260)
T ss_pred cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHcC-CCC--------CCCCCCCHHHH
Confidence 3456799999 456889999999999999999 888886443 22333222111 110 11223455689
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
+++.+||..+|++||+++++++.|+.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHHHhhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=317.80 Aligned_cols=239 Identities=18% Similarity=0.186 Sum_probs=184.7
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+.+|+|+||.||++.. .+++.||+|... ...+.+|++++++++|||||++++++......++|+|++. ++|.+
T Consensus 98 ~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~ 171 (391)
T PHA03212 98 ETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYC 171 (391)
T ss_pred EEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHH
Confidence 4589999999999986 468899999754 2456789999999999999999999999999999999994 78988
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC----Ccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK----KTC 461 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~----~~~ 461 (608)
++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 172 ~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~-----IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 172 YLAA----KRNIAICDILAIERSVLRAIQYLHENR-----IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 8864 456899999999999999999999987 999999999999999999999999999754321 233
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC------hHHHHHHHHhhh-ccccc--cc------
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID------LPKWVKAMVREE-WTGEV--FD------ 522 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~------~~~~~~~~~~~~-~~~~~--~~------ 522 (608)
..||+.|+||| ..++.++|||||||++|||+||+.|+..... .......+.... ..... .+
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 57899999999 4678999999999999999999987643211 111111111100 00000 00
Q ss_pred HHH----------------HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 KEV----------------AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 ~~~----------------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
... .......+.++.+++.+||+.||++|||+.|+++.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 00011234568899999999999999999999863
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=307.02 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=194.4
Q ss_pred hcccCCCCCceEEEEEEcC-C--cEEEEEEeccc--ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLKN-S--AVYAVKRLKKL--QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~-g--~~vavK~l~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.+.+|+|+||.||+|...+ + ..+++|.++.. ....+.+.+|++++.++ +||||+++++++...+..++++||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 3568999999999998754 3 34788888742 22345788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEe
Q 042949 380 NGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLIS 447 (608)
Q Consensus 380 ~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 447 (608)
+|+|.++++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-----FIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCcCCcceEEECCCCeEEEC
Confidence 9999999975211 1135889999999999999999999876 9999999999999999999999
Q ss_pred ccccccccCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccc
Q 042949 448 ECGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEV 520 (608)
Q Consensus 448 DFGla~~~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 520 (608)
|||++....... .....+..|+||| ..++.++|||||||++|||+| |..||..... .......... ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-~~~~~~~~~~-~~~-- 237 (297)
T cd05089 162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG-YRM-- 237 (297)
T ss_pred CcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhcC-CCC--
Confidence 999987543221 1122345699999 457889999999999999998 8888864322 2222222111 000
Q ss_pred ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 521 FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 521 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
......+..+.+++.+||+.+|.+||+++++++.|+++.+..
T Consensus 238 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 238 ------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 112235566889999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.81 Aligned_cols=237 Identities=21% Similarity=0.299 Sum_probs=193.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +|+.||||+++... .....+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (350)
T cd05573 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGG 86 (350)
T ss_pred EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCC
Confidence 56899999999999875 78999999997432 23456889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g-----iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 87 DLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG-----FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999975 357999999999999999999999976 9999999999999999999999999998654322
Q ss_pred ------------------------------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChH
Q 042949 460 ------------------------------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLP 505 (608)
Q Consensus 460 ------------------------------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~ 505 (608)
....||..|+||| ..++.++|||||||++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2346899999999 567889999999999999999999987654322
Q ss_pred HHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCC-HHHHHHH
Q 042949 506 KWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPT-MAEVLER 560 (608)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~ 560 (608)
.+ ..+... ..... . ......+..+.+++.+|+. ||.+||+ ++++++.
T Consensus 238 ~~-~~i~~~--~~~~~---~-p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TY-NKIINW--KESLR---F-PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH-HHHhcc--CCccc---C-CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 22 222110 00000 0 0111245668899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=311.64 Aligned_cols=233 Identities=19% Similarity=0.311 Sum_probs=185.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHH---hcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l---~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|++|.||++... +++.||||+++... ...+.+.+|++++ ++++||||+++++++...+..++||||+
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 84 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA 84 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCC
Confidence 56899999999999865 68999999997432 2234566666654 5678999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC-
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP- 457 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~- 457 (608)
++|+|..+++ ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 85 AGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK-----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999998875 346999999999999999999999887 99999999999999999999999999875432
Q ss_pred --CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 458 --KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 458 --~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
......|+..|+||| ..++.++|||||||++|||++|+.||..... ............ ..+..
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-~~~~~~i~~~~~----------~~p~~ 223 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVFDSIVNDEV----------RYPRF 223 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC----------CCCCC
Confidence 223456899999999 4678899999999999999999999865432 222222222111 01223
Q ss_pred cHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 532 WAFPLLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
.+..+.+++.+||+.||++|| ++.++++.
T Consensus 224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 455678999999999999999 46666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.18 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=194.3
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHh--cCCCCcceeeeeeeecCC----eeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG--NLKHPNILPLVCYNSTNE----EKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~~----~~~lv~e~~~~ 380 (608)
+++|+|.||.||+|.+. ++.||||++... ..+.|..|-++.+ .++|+||++++++-.... +.+||+||.+.
T Consensus 216 eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred HHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 56799999999999995 489999999742 3456777777655 568999999999876655 88999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKS----NEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+|.+||.. ..++|....+|+.-+++||+|||+.. +++++|+|||||++|||+..|+.+.|+|||+|..+.
T Consensus 293 GsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 293 GSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred CcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 999999984 57999999999999999999999853 467899999999999999999999999999999876
Q ss_pred CCC-----ccccccCccccCC---CCC--C-----cchhHHHHHHHHHHHHcCCCCCcC------------C----CChH
Q 042949 457 PKK-----TCLFSSNGYTAPE---KTV--S-----EQGDVFSFGVILLELLTGKTVEKT------------G----IDLP 505 (608)
Q Consensus 457 ~~~-----~~~~gt~~y~aPE---~~~--~-----~ksDVwSfGvvl~elltg~~p~~~------------~----~~~~ 505 (608)
... ...+||..||||| +.. . .+.||||+|.|||||+++-...+. . ..+.
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 442 3468999999999 111 1 358999999999999997643221 1 1111
Q ss_pred HHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 506 KWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
+....+++++..+.+.+.-.. ...+.-+.+.+..||+.||+.|.|+.-|.+++.++....+
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 111122222222222221111 1344558899999999999999999999999999976544
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=298.74 Aligned_cols=233 Identities=20% Similarity=0.253 Sum_probs=184.9
Q ss_pred ccCCCCCceEEEEEEcCCc-----------EEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEe
Q 042949 308 LRSQTICSSLFMVRLKNSA-----------VYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 376 (608)
.+|+|+||.||+|...+.. .+++|.++........+.+|+.++++++||||+++++++.. +..++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEE
Confidence 5899999999999986433 57888776444336788999999999999999999999988 77899999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-------CceEecc
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-------DPLISEC 449 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-------~~kl~DF 449 (608)
|+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 81 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 81 YVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK-----LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred cCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC-----eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999752 236899999999999999999999876 99999999999999888 7999999
Q ss_pred ccccccCCCCccccccCccccCC----C--CCCcchhHHHHHHHHHHHHcC-CCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 450 GYSKFLDPKKTCLFSSNGYTAPE----K--TVSEQGDVFSFGVILLELLTG-KTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 450 Gla~~~~~~~~~~~gt~~y~aPE----~--~~~~ksDVwSfGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
|+++.... .....++..|+||| . .++.++|||||||++|||++| ..|+.... ...+..........
T Consensus 153 g~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~~~~----- 225 (259)
T cd05037 153 GIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQHRL----- 225 (259)
T ss_pred Cccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcCCCC-----
Confidence 99987654 23345677899999 2 467899999999999999995 55554332 22221111111000
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
.......+.+++.+||..+|++|||+.|+++.|+
T Consensus 226 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 226 ------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111256889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.19 Aligned_cols=237 Identities=16% Similarity=0.225 Sum_probs=189.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||.||+++.. +|+.||||+++... .....+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (364)
T cd05599 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGG 86 (364)
T ss_pred EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCc
Confidence 56899999999999875 68999999997432 22345788999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 87 DMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG-----YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred HHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999875 456999999999999999999999987 9999999999999999999999999987543210
Q ss_pred ---------------------------------------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCC
Q 042949 460 ---------------------------------------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKT 496 (608)
Q Consensus 460 ---------------------------------------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~ 496 (608)
....||+.|+||| ..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 1235899999999 567899999999999999999999
Q ss_pred CCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCC---HHHHHHH
Q 042949 497 VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPT---MAEVLER 560 (608)
Q Consensus 497 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~~ 560 (608)
||...... .......... .... . ......+..+.+++.+|+. +|.+|++ +.|+++.
T Consensus 238 Pf~~~~~~-~~~~~i~~~~--~~~~---~-~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQ-ETYRKIINWK--ETLQ---F-PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHH-HHHHHHHcCC--CccC---C-CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99754432 2222221110 0000 0 0111345568899999996 9999997 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=304.68 Aligned_cols=247 Identities=22% Similarity=0.320 Sum_probs=195.5
Q ss_pred hcccCCCCCceEEEEEEc------CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 306 ADLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
...+|+|+||.||+|... ....+|+|.+.... ...+++.+|+.++++++||||+++++.+...+..++++||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 356899999999999853 23578999886432 2345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHhc--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCee
Q 042949 378 QSNGSLLSLLEAYIE--------------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NIL 437 (608)
+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----ivH~dikp~nil 159 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK-----LVHRDLAARNVL 159 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC-----eehhhhhhheEE
Confidence 999999999875211 1235889999999999999999999876 999999999999
Q ss_pred cCCCCCceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHH
Q 042949 438 LNENEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKW 507 (608)
Q Consensus 438 l~~~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~ 507 (608)
+++++.+||+|||+++...... ....++..|+||| ..++.++||||||++++||+| |..|+.... ....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~ 238 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-PERL 238 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-HHHH
Confidence 9999999999999998654322 1223466899999 457889999999999999999 888875432 2222
Q ss_pred HHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 508 VKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
. ......... ......+.++.+++.+||+.+|++||++.|+++.|+++...
T Consensus 239 ~-~~~~~~~~~--------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 239 F-NLLKTGYRM--------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred H-HHHhCCCCC--------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 2 222211110 11233456788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.83 Aligned_cols=238 Identities=24% Similarity=0.319 Sum_probs=190.8
Q ss_pred ccCCCCCceEEEEEEc--C--CcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK--N--SAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~--~--g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||.||+|... + +..+|+|.+..... ..+++.+|++++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 80 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG 80 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence 5899999999999753 2 26899999875433 4567889999999999999999999876 45679999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 81 PLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH-----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC-----eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 99999975 347899999999999999999999876 999999999999999999999999999866433221
Q ss_pred ------ccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 462 ------LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 462 ------~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
..++..|+||| ..++.++|||||||++|||++ |+.||..... ........... .. ....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~~~~~~~-~~--------~~~~ 221 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLESGE-RL--------PRPE 221 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHHcCC-cC--------CCCC
Confidence 12245799999 567889999999999999998 8888764432 22222221111 00 1123
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
..+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 34567889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.07 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=196.8
Q ss_pred hcccCCCCCceEEEEEEcC-----CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeec-CCeeEEEEee
Q 042949 306 ADLRSQTICSSLFMVRLKN-----SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNST-NEEKLLVYKY 377 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~-----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~ 377 (608)
.+++|+|+||.||+|...+ +..|++|+++... ...+.+.+|+.++++++||||+++++++.. +...++++||
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 4678999999999999865 7889999987432 234568899999999999999999998765 5678999999
Q ss_pred ccCCCHHHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 378 QSNGSLLSLLEAYIEG----KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
+++|+|.+++...... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG-----VIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 9999999999763221 156899999999999999999999876 9999999999999999999999999998
Q ss_pred ccCCCCc-----cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccH
Q 042949 454 FLDPKKT-----CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 454 ~~~~~~~-----~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (608)
.+..... ...++..|+||| ..++.++|||||||++||+++ |+.|+.... ...+..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~------ 238 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-PFEMAAYLKDGYRL------ 238 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-HHHHHHHHHcCCCC------
Confidence 6543321 233566799999 557889999999999999999 888886542 22222222111100
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
.....++..+.+++.+||..||++|||+.++++.|+++.+.
T Consensus 239 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 239 ---AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 01122345688999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.75 Aligned_cols=241 Identities=21% Similarity=0.286 Sum_probs=189.6
Q ss_pred cccCCCCCceEEEEEEc-CCc----EEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSA----VYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|... ++. .+++|.+.... ....++..|+..+++++||||+++++++.. ...++++||++
T Consensus 13 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~ 91 (279)
T cd05111 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSP 91 (279)
T ss_pred cccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCC
Confidence 67999999999999864 444 47788775322 223567788889999999999999998864 45788999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++......
T Consensus 92 ~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 92 LGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR-----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred CCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC-----EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999975 2456899999999999999999999876 9999999999999999999999999998654322
Q ss_pred -----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 -----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 -----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....++..|+||| ..++.++|||||||++||++| |+.|+..... .. .......... . ...
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~-~~~~~~~~~~--~------~~~ 233 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HE-VPDLLEKGER--L------AQP 233 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HH-HHHHHHCCCc--C------CCC
Confidence 2234567899999 467889999999999999998 8888764321 11 1111111110 0 011
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
..+...+.+++.+||..||++|||+.|+++.|..+.+
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 234 QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 2244567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.01 Aligned_cols=243 Identities=21% Similarity=0.293 Sum_probs=192.5
Q ss_pred cccCCCCCceEEEEEEcC----CcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCe------eEE
Q 042949 307 DLRSQTICSSLFMVRLKN----SAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEE------KLL 373 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~----g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~l 373 (608)
+.+|+|+||.||+|.... +..||+|+++.... ..+.+.+|++.+++++||||+++++++..... .++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05035 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV 84 (273)
T ss_pred cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence 568999999999998742 36899999974332 24578899999999999999999998866544 789
Q ss_pred EEeeccCCCHHHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccc
Q 042949 374 VYKYQSNGSLLSLLEAYIE--GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGY 451 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 451 (608)
++||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-----FIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccchheEEECCCCeEEECCccc
Confidence 9999999999999865322 2346899999999999999999999876 99999999999999999999999999
Q ss_pred ccccCCCCc-----cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 452 SKFLDPKKT-----CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 452 a~~~~~~~~-----~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
++....... ....+..|+||| ..++.++|||||||++|||++ |..|+.... ..............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~---- 234 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-NHEIYDYLRHGNRL---- 234 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC----
Confidence 986643321 123456799999 457889999999999999999 777775432 22332222221110
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
..+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 235 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 -----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11234566789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.91 Aligned_cols=243 Identities=20% Similarity=0.282 Sum_probs=193.5
Q ss_pred hcccCCCCCceEEEEEEc------CCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 376 (608)
.+.+|+|+||.||++... ++..||||+++... ...+.+.+|+++++++ +||||+++++++...+..+++||
T Consensus 40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 119 (302)
T cd05055 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119 (302)
T ss_pred cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence 457899999999999742 34589999987432 2245688999999999 79999999999999999999999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+++|+|.++++.. ....+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.++++|||+++...
T Consensus 120 ~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 120 YCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred cCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eehhhhccceEEEcCCCeEEECCCccccccc
Confidence 99999999999752 2234899999999999999999999886 9999999999999999999999999998654
Q ss_pred CCCc-----cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 457 PKKT-----CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 457 ~~~~-----~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
.... ...++..|+||| ..++.++|||||||++|||+| |..|+........... ........
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~-------- 263 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK-LIKEGYRM-------- 263 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH-HHHcCCcC--------
Confidence 3321 223567799999 456889999999999999998 8888765433222222 11111110
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
......+..+.+++.+||..+|++|||+.|+++.|+++
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.62 Aligned_cols=235 Identities=20% Similarity=0.277 Sum_probs=187.9
Q ss_pred cccCCCCCceEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL----KNSAVYAVKRLKKLQ-----VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 376 (608)
+.||+|+||.||+++. .+++.||+|+++... ...+.+..|+.++.++ +||||+++++++...+..++|||
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (332)
T cd05614 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILD 85 (332)
T ss_pred EEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEe
Confidence 5689999999999976 367899999986421 2345678899999999 49999999999999999999999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 86 YVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG-----IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999875 456999999999999999999999887 9999999999999999999999999998653
Q ss_pred CC----CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC--hH-HHHHHHHhhhcccccccHH
Q 042949 457 PK----KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGID--LP-KWVKAMVREEWTGEVFDKE 524 (608)
Q Consensus 457 ~~----~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~--~~-~~~~~~~~~~~~~~~~~~~ 524 (608)
.. .....||..|+||| ..++.++|||||||++|||+||+.||..... .. .......... .
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~----- 228 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD---P----- 228 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC---C-----
Confidence 32 12356899999999 2367889999999999999999999864321 11 1111111110 0
Q ss_pred HHHhchhcHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 525 VAKAGRQWAFPLLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 525 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
......+..+.+++.+||+.||++|| +++++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 --PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01123445678999999999999999 67777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=313.23 Aligned_cols=228 Identities=20% Similarity=0.258 Sum_probs=183.4
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHH-HHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMR-QIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||+||+++.. +|+.||+|++.... ....++..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 5899999999999875 78999999997432 12234445544 457899999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g-----ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN-----IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc
Confidence 99998875 457899999999999999999999887 999999999999999999999999998754222
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||+.|+||| ..++.++|||||||++|||++|+.||.... ............. ......+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~----------~~~~~~~~ 221 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYDNILNKPL----------RLKPNISV 221 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-HHHHHHHHHcCCC----------CCCCCCCH
Confidence 23456899999999 467889999999999999999999987542 2233332222110 01123355
Q ss_pred HHHHHHHHchhcCCCCCCCHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMA 555 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~ 555 (608)
.+.+++.+||+.||++||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.08 Aligned_cols=242 Identities=19% Similarity=0.277 Sum_probs=192.7
Q ss_pred cccCCCCCceEEEEEEcC------CcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLKN------SAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||+|+..+ ++.||+|+++.... ..+.+.+|+.++.+++||||+++++++...+..++++||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~ 90 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcC
Confidence 457999999999998642 47899999974332 2356889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHh------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceE
Q 042949 379 SNGSLLSLLEAYI------------EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446 (608)
Q Consensus 379 ~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl 446 (608)
++++|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 91 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g-----i~H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 91 SHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred CCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC-----ccccccchhheEecCCCceEe
Confidence 9999999986311 01235889999999999999999999876 999999999999999999999
Q ss_pred eccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhc
Q 042949 447 SECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEW 516 (608)
Q Consensus 447 ~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 516 (608)
+|||+++...... ....+++.|+||| ..++.++|||||||++|||++ |..|+... ..............
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~i~~~~~ 244 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-SNQDVIEMIRNRQV 244 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCc
Confidence 9999988654322 2234567899999 567889999999999999998 77676543 22333333222111
Q ss_pred ccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 517 TGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
......++..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 245 ---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 245 ---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 01123456668899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.33 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=196.9
Q ss_pred hcccCCCCCceEEEEEEc--------CCcEEEEEEeccc--ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEE
Q 042949 306 ADLRSQTICSSLFMVRLK--------NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLV 374 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~--------~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 374 (608)
...+|+|+||.||+++.. ++..||+|.++.. ....+++.+|+.+++++ +||||+++++++......+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 99 (304)
T cd05101 20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 99 (304)
T ss_pred cceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEE
Confidence 367899999999999741 3457999998743 23346788999999999 899999999999999999999
Q ss_pred EeeccCCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC
Q 042949 375 YKYQSNGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~ 442 (608)
|||+++|+|.+++..... ....+++.+++.++.||++||+|||+++ |+||||||+||++++++
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-----ivH~dlkp~Nili~~~~ 174 (304)
T cd05101 100 VEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-----CIHRDLAARNVLVTENN 174 (304)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC-----eeecccccceEEEcCCC
Confidence 999999999999975311 1235788999999999999999999886 99999999999999999
Q ss_pred CceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHH
Q 042949 443 DPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMV 512 (608)
Q Consensus 443 ~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 512 (608)
.+||+|||+++...... ....++..|+||| ..++.++||||||+++|||++ |..|+.. ...........
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~ 253 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 253 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHH
Confidence 99999999998764322 1223456799999 457889999999999999999 6666643 33333333322
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
.... . ......+..+.+++.+||..+|++|||+.|+++.|+++.....
T Consensus 254 ~~~~-~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 254 EGHR-M--------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred cCCc-C--------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 2110 0 1122455678899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.08 Aligned_cols=242 Identities=18% Similarity=0.232 Sum_probs=190.5
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
..+|+|++|.||+|... ++..||+|+++... ....++.+|+.++++++||||+++++++......++||||+
T Consensus 12 ~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 91 (277)
T cd05062 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 91 (277)
T ss_pred eeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecC
Confidence 45799999999998753 34679999986422 23456889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccc
Q 042949 379 SNGSLLSLLEAYIEG------KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 452 (608)
++|+|.++++..... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 92 TRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred CCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCcchheEEEcCCCCEEECCCCCc
Confidence 999999999753211 234678899999999999999999876 999999999999999999999999999
Q ss_pred cccCCCCc-----cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 453 KFLDPKKT-----CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 453 ~~~~~~~~-----~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
+....... ...++..|+||| ..++.++|||||||++|||++ |..|+... .............. .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-~~~~~~~~~~~~~~-~---- 240 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-SNEQVLRFVMEGGL-L---- 240 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCc-C----
Confidence 86543221 223467799999 467889999999999999999 57776543 22232222222111 0
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
......+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 241 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 241 ----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1122345668999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=316.01 Aligned_cols=238 Identities=17% Similarity=0.199 Sum_probs=186.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||+||+++.. +++.||+|+++... .....+.+|+.++.+++|+||+++++.+.+....++||||+++|
T Consensus 7 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (363)
T cd05628 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG 86 (363)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCC
Confidence 46899999999999865 68999999997432 22356788999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g-----ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 87 DMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG-----FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999975 467999999999999999999999987 9999999999999999999999999987543210
Q ss_pred ------------------------------------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCc
Q 042949 460 ------------------------------------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEK 499 (608)
Q Consensus 460 ------------------------------------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~ 499 (608)
....||+.|+||| ..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 1246899999999 467889999999999999999999997
Q ss_pred CCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchh--cCCCCCCCHHHHHHH
Q 042949 500 TGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVS--NSPDDRPTMAEVLER 560 (608)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~--~dP~~RPs~~evl~~ 560 (608)
....... ......... ...+.+ ....+..+.+++.+++. .++..||+++|+++.
T Consensus 238 ~~~~~~~-~~~i~~~~~-~~~~p~-----~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQET-YKKVMNWKE-TLIFPP-----EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHH-HHHHHcCcC-cccCCC-----cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 6543222 222221100 000100 11234456777776443 334456899999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=304.28 Aligned_cols=240 Identities=18% Similarity=0.230 Sum_probs=190.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|+|+||.||++... +++.||+|++.... .....+.+|++++++++||||+++++.+..++..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCC
Confidence 56899999999999864 68999999997432 12345678999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 86 ~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 86 DLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRER-----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred cHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 99988864 22356899999999999999999999987 9999999999999999999999999998764332
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
....|+..|+||| ..++.++|||||||++|||++|+.||......... ....... . ..........+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~-~-----~~~~~~~~~~~~~ 231 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEVERRV-K-----EDQEEYSEKFSEA 231 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHHHHHh-h-----hcccccCcccCHH
Confidence 2346889999999 45788999999999999999999998754321111 1111000 0 0000112234566
Q ss_pred HHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
+.+++.+||..||++|| +++++++.
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 88999999999999999 78787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=326.82 Aligned_cols=240 Identities=19% Similarity=0.245 Sum_probs=192.9
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCC--------eeEE
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNE--------EKLL 373 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------~~~l 373 (608)
.+.||+|+||+||+++. .+|+.||||++..... ....+.+|+..+..++|+||+++...+...+ ..++
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l 116 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence 35689999999999985 4789999999974332 2346788999999999999999987664322 3679
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
||||+++|+|.++++........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 117 V~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~-----IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 117 VLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH-----MIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 99999999999999764444567999999999999999999999886 9999999999999999999999999998
Q ss_pred ccCCC-----CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHH
Q 042949 454 FLDPK-----KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKE 524 (608)
Q Consensus 454 ~~~~~-----~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (608)
.+... .....||+.|+||| ..++.++|||||||++|||++|+.||... .....+.........
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-~~~~~~~~~~~~~~~------- 263 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-NMEEVMHKTLAGRYD------- 263 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcCCCC-------
Confidence 65432 23456899999999 46789999999999999999999998643 333333322221110
Q ss_pred HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 525 VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 525 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+...+..+.+++.+||..||++||++.++++.
T Consensus 264 --~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 --PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1123345668899999999999999999999864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.98 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=189.5
Q ss_pred cccCCCCCceEEEEEEc-----CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeec--CCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-----NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNST--NEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~ 378 (608)
..+|+|+||.||++... ++..||+|+++... ...+.+.+|++++++++||||+++++++.. ....++|+||+
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 89 (284)
T cd05081 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89 (284)
T ss_pred eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEec
Confidence 56899999999999753 57899999987433 234678899999999999999999998754 34688999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~-----i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 90 PYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR-----YVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred CCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 999999998742 346899999999999999999999886 999999999999999999999999999876543
Q ss_pred Ccc------ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHH--
Q 042949 459 KTC------LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA-- 526 (608)
Q Consensus 459 ~~~------~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 526 (608)
... ..++..|+||| ..++.++|||||||++|||++|..++.... ..+...+ ............+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP--AEFMRMM-GNDKQGQMIVYHLIEL 238 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc--hhhhhhc-ccccccccchHHHHHH
Confidence 221 12334599999 467889999999999999999876543211 1111111 11000000000000
Q ss_pred -------HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 527 -------KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 527 -------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
......+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11223456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=301.62 Aligned_cols=240 Identities=18% Similarity=0.264 Sum_probs=190.9
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|+|+||.||+|+. .+++.||+|+++... .....+.+|+.++.+++||||+++++++...+..++|+||+++++|.
T Consensus 15 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~ 94 (267)
T cd06646 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQ 94 (267)
T ss_pred heeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHH
Confidence 4579999999999986 578899999987432 34456889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Ccc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~ 461 (608)
++++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ...
T Consensus 95 ~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 95 DIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG-----KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence 98874 456899999999999999999999876 999999999999999999999999999866432 233
Q ss_pred ccccCccccCCC-------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 462 LFSSNGYTAPEK-------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 462 ~~gt~~y~aPE~-------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
..++..|+|||. .++.++|||||||++|||++|+.|+.......... .+..... ..+.. .....++.
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~~~~~~----~~~~~-~~~~~~~~ 239 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSKSNF----QPPKL-KDKTKWSS 239 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-eeecCCC----CCCCC-ccccccCH
Confidence 467889999992 25678999999999999999999875432211110 0000000 00000 11123456
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
.+.+++.+||..+|++|||++++++.|
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 789999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=295.96 Aligned_cols=239 Identities=20% Similarity=0.319 Sum_probs=192.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeee-cCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNS-TNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~ 385 (608)
+.+|+|++|.||++.. .|..||+|.++.. ...+.+.+|+.++++++|+|++++++++. ..+..++++||+++|+|.+
T Consensus 12 ~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (256)
T cd05082 12 QTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 89 (256)
T ss_pred eeecccCCCeEEEEEE-cCCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHH
Confidence 5689999999999976 4778999998743 34567899999999999999999999764 4567899999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcccccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSS 465 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt 465 (608)
++.. .....+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++...........+
T Consensus 90 ~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 162 (256)
T cd05082 90 YLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEANN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 162 (256)
T ss_pred HHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeccccchheEEEcCCCcEEecCCccceeccccCCCCccc
Confidence 9875 22345899999999999999999999876 9999999999999999999999999998765544444556
Q ss_pred CccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHH
Q 042949 466 NGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVA 540 (608)
Q Consensus 466 ~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 540 (608)
..|+||| ..++.++|||||||++|||++ |+.|+... ............ .... .....+..+.+++
T Consensus 163 ~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~li 232 (256)
T cd05082 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKG-YKMD--------APDGCPPVVYDVM 232 (256)
T ss_pred eeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcC-CCCC--------CCCCCCHHHHHHH
Confidence 7899999 457889999999999999998 88877532 333332222111 1111 1123456688999
Q ss_pred HHchhcCCCCCCCHHHHHHHHHHh
Q 042949 541 LKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 541 ~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
.+||+.+|++|||+.++++.|+++
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 233 KQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=311.34 Aligned_cols=243 Identities=20% Similarity=0.312 Sum_probs=204.1
Q ss_pred hhcccCCCCCceEEEEEEcC---C--cEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 305 TADLRSQTICSSLFMVRLKN---S--AVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 305 ~~~~~g~g~~g~vy~~~~~~---g--~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
.+.+||+|-||.||+|...+ | -.||||.-+.. ..+.+.|..|.-+|++++|||||+++|.|... ..|+|||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence 35679999999999998632 3 36899988853 34577899999999999999999999999754 58999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
++.|.|..||+. .+..|+......++.||+.||+|||+.. +|||||..+|||+.....+||+|||+++.+.+
T Consensus 472 ~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr-----fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 472 APLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR-----FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc-----hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999985 3567999999999999999999999987 99999999999999999999999999999876
Q ss_pred CCccc--cc--cCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 458 KKTCL--FS--SNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 458 ~~~~~--~g--t~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
+.... .| ...||||| +.++.+||||-|||.+||++. |..||.+-.+ ......+...+..+.
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------sDVI~~iEnGeRlP~ 613 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------SDVIGHIENGERLPC 613 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------cceEEEecCCCCCCC
Confidence 65322 22 34599999 778999999999999999876 7788864322 122333444445566
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
+.+|+..+..|+.+||++||.+||.+.++...|.++.+
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 78889999999999999999999999999999999876
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=306.82 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=193.8
Q ss_pred hcccCCCCCceEEEEEEc-CCc--EEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLK-NSA--VYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~--~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.+.+|+|+||.||+|... ++. .+|+|.++... ...+.+.+|++++.++ +||||+++++++...+..++|+||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 366899999999999874 454 46888776422 2345788999999999 89999999999999999999999999
Q ss_pred CCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEe
Q 042949 380 NGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLIS 447 (608)
Q Consensus 380 ~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 447 (608)
+|+|.++++.... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-----i~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchheEEecCCCcEEeC
Confidence 9999999975321 1235889999999999999999999876 9999999999999999999999
Q ss_pred ccccccccCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccc
Q 042949 448 ECGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEV 520 (608)
Q Consensus 448 DFGla~~~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 520 (608)
|||+++...... .....+..|+||| ..++.++|||||||++|||+| |..||..... .......... ...
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~-~~~-- 242 (303)
T cd05088 167 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG-YRL-- 242 (303)
T ss_pred ccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HHHHHHHhcC-CcC--
Confidence 999987433211 1122356799999 457889999999999999998 8888754322 2222222111 000
Q ss_pred ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 521 FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 521 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
......+..+.+++.+||+.+|++||++.++++.|+++.+..
T Consensus 243 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 243 ------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 011224456889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.30 Aligned_cols=248 Identities=22% Similarity=0.320 Sum_probs=195.7
Q ss_pred hcccCCCCCceEEEEEEc--------CCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEE
Q 042949 306 ADLRSQTICSSLFMVRLK--------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLV 374 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~--------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 374 (608)
.+.+|+|+||.||+++.. ++..+|+|.++... ....++.+|++++.++ +||||+++++++...+..++|
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (307)
T cd05098 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 102 (307)
T ss_pred eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 356899999999999752 23579999997432 2345688899999999 799999999999999999999
Q ss_pred EeeccCCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC
Q 042949 375 YKYQSNGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~ 442 (608)
|||+++|+|.+++..... ....+++.++++++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-----i~H~dlkp~Nill~~~~ 177 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDN 177 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccHHheEEcCCC
Confidence 999999999999975321 1235899999999999999999999876 99999999999999999
Q ss_pred CceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHH
Q 042949 443 DPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMV 512 (608)
Q Consensus 443 ~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 512 (608)
.+||+|||+++...... ....++..|+||| ..++.++|||||||++|||++ |..|+.. ...........
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~ 256 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHH
Confidence 99999999998654321 1122346799999 457889999999999999998 7777643 33333333222
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
. .... ......+..+.+++.+||..+|++|||+.+|++.|+++....
T Consensus 257 ~-~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 257 E-GHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred c-CCCC--------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1 1110 112234567889999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=308.08 Aligned_cols=248 Identities=18% Similarity=0.295 Sum_probs=182.8
Q ss_pred hhcccCCCCCceEEEEEEc---CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeec--CCeeEEEEeecc
Q 042949 305 TADLRSQTICSSLFMVRLK---NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNST--NEEKLLVYKYQS 379 (608)
Q Consensus 305 ~~~~~g~g~~g~vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 379 (608)
.+..+|+|+||.||+|+.. ++..||+|.++... ....+.+|++++++++||||+++++++.. ....++|+||+.
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3456899999999999875 34789999987543 23467899999999999999999998853 567899999986
Q ss_pred CCCHHHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec----CCCCCceEeccc
Q 042949 380 NGSLLSLLEAYIE-----GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL----NENEDPLISECG 450 (608)
Q Consensus 380 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFG 450 (608)
++|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-----EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 588888754211 1235889999999999999999999887 9999999999999 566789999999
Q ss_pred cccccCCCC------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh--------HHHHHHH
Q 042949 451 YSKFLDPKK------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL--------PKWVKAM 511 (608)
Q Consensus 451 la~~~~~~~------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~--------~~~~~~~ 511 (608)
+++...... ....+|..|+||| ..++.++|||||||++|||+||++||...... .......
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 998764322 2346788999999 24688999999999999999999998643210 0001100
Q ss_pred Hhh-------hc-----ccc------------cccHHH----HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 512 VRE-------EW-----TGE------------VFDKEV----AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 512 ~~~-------~~-----~~~------------~~~~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
... .+ ... ...... ..........+.+++.+|++.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000 00 000 000000 0011122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=296.87 Aligned_cols=244 Identities=22% Similarity=0.248 Sum_probs=184.8
Q ss_pred ccCCCCCceEEEEEEcCC---cEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 308 LRSQTICSSLFMVRLKNS---AVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g---~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.+|+|+||.||+++..++ ..+++|.++... ...+.+.+|+..+++++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 479999999999986544 356667665322 235678999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC----
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---- 458 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---- 458 (608)
|.++++........+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-----eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999763222345677888999999999999999876 999999999999999999999999998643221
Q ss_pred -CccccccCccccCCC-----------CCCcchhHHHHHHHHHHHHcC-CCCCcCCCChHHHHHHHHhhhcccccccHHH
Q 042949 459 -KTCLFSSNGYTAPEK-----------TVSEQGDVFSFGVILLELLTG-KTVEKTGIDLPKWVKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 459 -~~~~~gt~~y~aPE~-----------~~~~ksDVwSfGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (608)
.....++..|+|||. .++.++|||||||++|||+++ ..|+... ...........+.. ....++..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~ 234 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-SDREVLNHVIKDQQ-VKLFKPQL 234 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhhcc-cccCCCcc
Confidence 123457788999992 236789999999999999985 4555433 32333333222211 11111111
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
.......+.+++..|| .+|++||++++|++.|.
T Consensus 235 ---~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 ---ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1224456788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=317.57 Aligned_cols=237 Identities=18% Similarity=0.225 Sum_probs=191.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +++.||+|+++... .....+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 49 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg 128 (370)
T cd05596 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGG 128 (370)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCC
Confidence 56899999999999875 68899999996422 23345778999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 129 DLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 99999864 35888999999999999999999987 9999999999999999999999999998764322
Q ss_pred --ccccccCccccCCC--------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 --TCLFSSNGYTAPEK--------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 --~~~~gt~~y~aPE~--------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....||+.|+|||. .++.++|||||||++|||++|+.||....... .............. ...
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~~~------~~~ 271 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMDHKNSLTF------PDD 271 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHHHcCCCcCCC------CCc
Confidence 34568999999992 36789999999999999999999997654322 22222221100000 011
Q ss_pred hhcHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 042949 530 RQWAFPLLNVALKCVSNSPDD--RPTMAEVLER 560 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 560 (608)
...+..+.+++.+||..+|++ ||++.|+++.
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 234567889999999999987 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.32 Aligned_cols=244 Identities=21% Similarity=0.224 Sum_probs=186.6
Q ss_pred ccCCCCCceEEEEEEcC---CcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 308 LRSQTICSSLFMVRLKN---SAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~---g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.+|+|+||.||+|...+ +..+|+|.++.... ....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 47999999999998653 36799998874332 23468889999999999999999999999899999999999999
Q ss_pred HHHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 383 LLSLLEAYIE-GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 383 L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
|.++++.... .....++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-----FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-----EeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999975322 2235678888899999999999999886 9999999999999999999999999997543322
Q ss_pred ---ccccccCccccCCC-----------CCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHH
Q 042949 460 ---TCLFSSNGYTAPEK-----------TVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKE 524 (608)
Q Consensus 460 ---~~~~gt~~y~aPE~-----------~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (608)
....++..|+|||. .++.++||||||+++|||++ |+.||............ .... ......+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~-~~~~~~~~ 234 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VREQ-QLKLPKPR 234 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-hhcc-cCCCCCCc
Confidence 22346778999992 13679999999999999996 99888654332211111 1110 01111111
Q ss_pred HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 525 VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 525 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
. .......+.+++.+|| .+|++|||++||+..|+
T Consensus 235 ~---~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 L---KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred c---CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 1123445788999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.40 Aligned_cols=244 Identities=22% Similarity=0.325 Sum_probs=194.4
Q ss_pred cccCCCCCceEEEEEEcC------CcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLKN------SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~------g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
+.+|+|++|.||++...+ ...+|+|.++... ....++.+|++++.++ +|+||+++++++...+..+++|||
T Consensus 18 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~ 97 (293)
T cd05053 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEY 97 (293)
T ss_pred eEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEe
Confidence 568999999999998642 3689999987432 2234688999999999 899999999999999999999999
Q ss_pred ccCCCHHHHHHHHh------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCce
Q 042949 378 QSNGSLLSLLEAYI------------EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445 (608)
Q Consensus 378 ~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~k 445 (608)
+++|+|.++++... .....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+|
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivH~dlkp~Nil~~~~~~~k 172 (293)
T cd05053 98 AAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK-----CIHRDLAARNVLVTEDHVMK 172 (293)
T ss_pred CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-----ccccccceeeEEEcCCCeEE
Confidence 99999999997521 22356899999999999999999999876 99999999999999999999
Q ss_pred EeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhh
Q 042949 446 ISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREE 515 (608)
Q Consensus 446 l~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 515 (608)
|+|||+++.+.... ....++..|+||| ..++.++|||||||++|||++ |..|+... .............
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~ 251 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEGY 251 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC-CHHHHHHHHHcCC
Confidence 99999998765432 1123456799999 467889999999999999998 87777543 2222222221111
Q ss_pred cccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 516 WTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
.. ......+..+.+++.+||..||++|||+.|+++.|++++
T Consensus 252 -~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 252 -RM--------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -cC--------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 00 112234566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=296.82 Aligned_cols=238 Identities=26% Similarity=0.309 Sum_probs=191.8
Q ss_pred ccCCCCCceEEEEEEcC--C--cEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLKN--S--AVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~--g--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|++|.||+|...+ + ..||+|.+..... ..+++.+|++.+++++||||+++++++.. ...++|+||+++|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 57999999999998743 3 3699999985433 35678999999999999999999999888 8899999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 81 SLLDRLRKD--ALGHFLISTLCDYAVQIANGMRYLESKR-----FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cHHHHHHhc--ccccCcHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 999999752 1146899999999999999999999886 9999999999999999999999999998765421
Q ss_pred ----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 460 ----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 460 ----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
....++..|+||| ..++.++|||||||++|||+| |+.|+.... ..+..+......... ....
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~--------~~~~ 224 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-GSQILKKIDKEGERL--------ERPE 224 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCcC--------CCCc
Confidence 2234677899999 467889999999999999999 998875432 222222222111000 1112
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
..+..+.+++.+||+.+|++||++.++++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 34566889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.68 Aligned_cols=242 Identities=21% Similarity=0.342 Sum_probs=191.7
Q ss_pred cccCCCCCceEEEEEE-----cCCcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRL-----KNSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-----~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
..+|+|+||.||+|.. .++..||+|.++.... ...++.+|++++++++||||+++++++...+..+++|||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 90 (283)
T cd05090 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90 (283)
T ss_pred eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCC
Confidence 5689999999999984 3568999999974322 23578899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhc-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceE
Q 042949 380 NGSLLSLLEAYIE-------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446 (608)
Q Consensus 380 ~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl 446 (608)
+|+|.+++..... ....+++.+.+.++.|++.||+|||+++ |+||||||+|||+++++.+||
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC-----eehhccccceEEEcCCCcEEe
Confidence 9999999863210 1235789999999999999999999886 999999999999999999999
Q ss_pred eccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhc
Q 042949 447 SECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEW 516 (608)
Q Consensus 447 ~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 516 (608)
+|||+++...... ....++..|+||| ..++.++|||||||++|||++ |..||..... ....... ....
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~~~~-~~~~ 243 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVIEMV-RKRQ 243 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH-HcCC
Confidence 9999998654322 2233466799999 457889999999999999999 8888754322 1222211 1111
Q ss_pred ccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 517 TGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
.. ......+..+.+++.+||+.||++||++.+++++|+.
T Consensus 244 ~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 244 LL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cC--------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00 1122345668899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.38 Aligned_cols=244 Identities=16% Similarity=0.210 Sum_probs=188.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||+|+.. ++..||+|+++... .....+.+|++++++++||||+++++++...+..++||||++ ++|
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 90 (309)
T cd07872 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDL 90 (309)
T ss_pred EEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCH
Confidence 56899999999999875 67899999987432 234467889999999999999999999999999999999997 588
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---c
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~ 460 (608)
.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 91 ~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 91 KQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK-----VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 888764 2345889999999999999999999887 9999999999999999999999999998653322 2
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------cccccc--------
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------WTGEVF-------- 521 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~~~~-------- 521 (608)
...++..|+||| ..++.++|||||||++|||+||+.||...... +......... ....+.
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 345788999999 24678999999999999999999998654322 1111111100 000000
Q ss_pred ------cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 ------DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 ------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
...........+..+.+++.+||..||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000001112345668899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=296.06 Aligned_cols=240 Identities=24% Similarity=0.358 Sum_probs=197.3
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|++|.||++...+++.||||.+.......+++.+|+..+++++|+||+++++++......++||||+++++|.++
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 91 (261)
T cd05034 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDF 91 (261)
T ss_pred eeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHH
Confidence 56899999999999988888999999987666778899999999999999999999999988899999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
+.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...... ...
T Consensus 92 i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~~-----i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (261)
T cd05034 92 LKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN-----YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164 (261)
T ss_pred Hhc--cccCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence 975 22346899999999999999999999887 9999999999999999999999999998765321 122
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..+..|+||| ...+.++||||||+++||++| |+.||..... ........... .. ......+..+.
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~~-~~--------~~~~~~~~~~~ 234 (261)
T cd05034 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQVERGY-RM--------PRPPNCPEELY 234 (261)
T ss_pred CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCC-CC--------CCCCCCCHHHH
Confidence 3456799999 457889999999999999999 8888754332 22222221110 00 01122355688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
+++.+|+..+|++||+++++.+.|+.
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 235 DLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHcccCcccCCCHHHHHHHHhc
Confidence 99999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=297.44 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=194.1
Q ss_pred hcccCCCCCceEEEEEEc-CC---cEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLK-NS---AVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g---~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.+.+|+|++|.||+|+.. ++ ..+|+|.++... ...+++..|++++++++||||+++++++...+..++||||++
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 467999999999999875 33 379999987432 234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+++|.+++.. ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 90 NGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN-----YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999874 2356899999999999999999999886 9999999999999999999999999998664322
Q ss_pred cc------ccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 TC------LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 ~~------~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
.. ...+..|+||| ..++.++|||||||++|||++ |+.|+..... ....+.+...... ..
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i~~~~~~---------~~ 231 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRL---------PA 231 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHhcCCCC---------CC
Confidence 11 12234699999 456889999999999999998 9988854332 2233322211100 11
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
....+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 232 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 232 PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1234566889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=297.22 Aligned_cols=233 Identities=19% Similarity=0.251 Sum_probs=181.9
Q ss_pred ccCCCCCceEEEEEEcC-------------CcEEEEEEeccccc-CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEE
Q 042949 308 LRSQTICSSLFMVRLKN-------------SAVYAVKRLKKLQV-SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLL 373 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~-------------g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 373 (608)
.+|+|+||.||+|...+ ...||+|.+..... ....+.+|+.++++++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 47999999999998532 23588898764332 33467889999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC-------ceE
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED-------PLI 446 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~-------~kl 446 (608)
||||+++|+|..++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +++
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 82 VEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD-----LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC-----eECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999988864 2356899999999999999999999876 999999999999987664 799
Q ss_pred eccccccccCCCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHH-cCCCCCcCCCChHHHHHHHHhhhccccc
Q 042949 447 SECGYSKFLDPKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELL-TGKTVEKTGIDLPKWVKAMVREEWTGEV 520 (608)
Q Consensus 447 ~DFGla~~~~~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 520 (608)
+|||++...... ....++..|+||| ..++.++|||||||++|||+ +|..|+.... .... ........ .
T Consensus 154 ~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~-~~~~~~~~--~- 227 (262)
T cd05077 154 SDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAEK-ERFYEGQC--M- 227 (262)
T ss_pred CCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-hhHH-HHHHhcCc--c-
Confidence 999998765432 2345788899999 24678899999999999998 5776664322 1111 11111100 0
Q ss_pred ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 521 FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 521 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
.......++.+++.+||+.||++||++.++++.|
T Consensus 228 -------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 228 -------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0112234578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=319.47 Aligned_cols=237 Identities=22% Similarity=0.279 Sum_probs=195.1
Q ss_pred ccCCCCCceEEEEEEcC-CcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 308 LRSQTICSSLFMVRLKN-SAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
++|+|.||+||.|+..+ ...+|||-+... ....+-+..|+..-++++|.|||+++|.+..+++.-+.||..|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 68999999999999654 567999998733 3334557789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-CCCceEeccccccccC---CCC
Q 042949 386 LLEAYIEGKRDF--PWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-NEDPLISECGYSKFLD---PKK 459 (608)
Q Consensus 386 ~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~---~~~ 459 (608)
+|+.. -+++ ++..+-.+.+||++||.|||++. |||||||-+|||++. .|.+||+|||.++.+. +-.
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen~-----IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHENK-----IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhcc-----eeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 99863 3455 78889999999999999999886 999999999999964 6889999999998653 445
Q ss_pred ccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 TCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 ~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.++.||.-||||| +.|+.++|||||||++.||.||++||..-.+.... +.+-++. +.-++.+...+
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---MFkVGmy-----KvHP~iPeels 805 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---MFKVGMY-----KVHPPIPEELS 805 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---hhhhcce-----ecCCCCcHHHH
Confidence 6788999999999 56899999999999999999999999754432211 1111111 11123345566
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+...+|.+|..+||.+||++.++++.
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccC
Confidence 778899999999999999999999864
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=300.02 Aligned_cols=235 Identities=23% Similarity=0.331 Sum_probs=183.8
Q ss_pred ccCCCCCceEEEEEEcC--------CcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 308 LRSQTICSSLFMVRLKN--------SAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
.+|+|+||.||+|.... ...+|+|.+.... ...+++..|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999998642 2358888876432 23457888999999999999999999999989999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC--------ceEeccc
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED--------PLISECG 450 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DFG 450 (608)
++|+|.++++. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||
T Consensus 82 ~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 82 KFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDKG-----LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999974 2346899999999999999999999887 999999999999988766 4899999
Q ss_pred cccccCCCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHH
Q 042949 451 YSKFLDPKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 451 la~~~~~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (608)
++...... ....++..|+||| ..++.++|||||||++|||++|..++....+....... .... .
T Consensus 154 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~--~------- 222 (258)
T cd05078 154 ISITVLPK-EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDR--H------- 222 (258)
T ss_pred cccccCCc-hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHcc--c-------
Confidence 98765432 3356788999999 23678899999999999999996443322222211111 1110 0
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
..+.....++.+++.+||+.||++|||++++++.|+
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 -QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011123345889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.96 Aligned_cols=238 Identities=20% Similarity=0.269 Sum_probs=192.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +|+.||+|+++.... ..+.+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (330)
T cd05601 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGG 86 (330)
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCC
Confidence 56899999999999865 789999999974322 3456888999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~-----i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 87 DLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG-----YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999752 356999999999999999999999987 9999999999999999999999999998765432
Q ss_pred --ccccccCccccCCC----------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 460 --TCLFSSNGYTAPEK----------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 460 --~~~~gt~~y~aPE~----------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
....||..|+|||. .++.++|||||||++|||++|+.||........ ...+......... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~------~ 231 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-YNNIMNFQRFLKF------P 231 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-HHHHHcCCCccCC------C
Confidence 22468899999992 246789999999999999999999976543322 2222211100000 0
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.....+..+.+++.+|+. +|++||++.++++.
T Consensus 232 ~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 232 EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 112345668899999998 99999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=297.85 Aligned_cols=244 Identities=22% Similarity=0.245 Sum_probs=184.0
Q ss_pred ccCCCCCceEEEEEEcC---CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 308 LRSQTICSSLFMVRLKN---SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~---g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
-+|+|+||.||+|...+ ...+|+|.+.... .....+.+|++.++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 37999999999997654 3578888776332 223567899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 383 LLSLLEAYIEG-KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 383 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
|.+++...... ....++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC-----EecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999763221 233568888999999999999999886 9999999999999999999999999987543221
Q ss_pred ---ccccccCccccCCC-----------CCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHH
Q 042949 460 ---TCLFSSNGYTAPEK-----------TVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKE 524 (608)
Q Consensus 460 ---~~~~gt~~y~aPE~-----------~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (608)
....++..|+|||. .++.++|||||||++|||++ |..|+....+.. .......... .....+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~-~~~~~~- 233 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQD-IKLPKP- 233 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccC-ccCCCC-
Confidence 22334667999991 35778999999999999999 666665433222 2222211111 011111
Q ss_pred HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 525 VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 525 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
......+..+.+++..|| .||++|||++||++.|.
T Consensus 234 --~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 234 --QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 112234555778899999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=294.34 Aligned_cols=241 Identities=29% Similarity=0.373 Sum_probs=196.7
Q ss_pred cccCCCCCceEEEEEEcC----CcEEEEEEecccccC--HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKN----SAVYAVKRLKKLQVS--MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~----g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.+|+|+||.||++.... +..||+|.++..... .+.+.+|++.+.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 358999999999998764 789999999854333 57889999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 381 GSLLSLLEAYIEG-----KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 381 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
++|.+++...... ...+++.++..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-----FVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC-----cccCccCcceEEECCCCcEEEccccccccc
Confidence 9999999763111 367999999999999999999999976 999999999999999999999999999877
Q ss_pred CCC-----CccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHH
Q 042949 456 DPK-----KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 456 ~~~-----~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (608)
... .....++..|+||| ..++.++||||+|+++|||++ |..|+... ............. .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~-~-------- 225 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGY-R-------- 225 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCC-C--------
Confidence 543 23345678899999 467889999999999999999 57887654 2222222222211 0
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
.......+..+.+++.+||..+|++|||+.|+++.|+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0112234566889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.43 Aligned_cols=228 Identities=20% Similarity=0.260 Sum_probs=184.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCC-cceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHP-NILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.+|+|+||.||+|+.. +++.||||+++.. ....+.+..|.+++..++|+ +|+++++++...+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (324)
T cd05587 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (324)
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence 56899999999999875 5789999999742 22345678899999999765 588899999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP--- 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~--- 457 (608)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 86 GDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999998875 456899999999999999999999987 99999999999999999999999999875321
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
......||..|+||| ..++.++|||||||++|||+||+.||..... ............ ..+...+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~~~----------~~~~~~~ 225 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSIMEHNV----------SYPKSLS 225 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC----------CCCCCCC
Confidence 123456899999999 4578899999999999999999999865432 222222221110 0112345
Q ss_pred HHHHHHHHHchhcCCCCCCCH
Q 042949 534 FPLLNVALKCVSNSPDDRPTM 554 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~ 554 (608)
.++.+++.+||..||++|++.
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 226 KEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHHHHHHhhcCHHHcCCC
Confidence 568899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=311.29 Aligned_cols=232 Identities=19% Similarity=0.232 Sum_probs=184.6
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHH-HHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMR-QIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||.||+++.. +++.||+|++.... ....++..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5899999999999875 67889999997432 12233444444 467789999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g-----iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 82 ELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC
Confidence 99998875 456888899999999999999999987 999999999999999999999999999854321
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||..... ............ ......+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~----------~~~~~~~~ 221 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKPL----------QLKPNITN 221 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-HHHHHHHHhCCc----------CCCCCCCH
Confidence 23456899999999 5678899999999999999999999875432 222222222110 01123455
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+.+++.+|++.||.+||++.+.+.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHH
Confidence 6889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=310.69 Aligned_cols=228 Identities=19% Similarity=0.248 Sum_probs=182.7
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHH-HHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMR-QIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.||+|+||.||+++.. +++.||+|++.... ....++.+|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999875 68899999987432 12334555554 578899999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 82 ELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN-----IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc
Confidence 99988864 456889999999999999999999876 999999999999999999999999998753221
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||.... ............. ..+...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~----------~~~~~~~~ 221 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPL----------QLPGGKTV 221 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-HHHHHHHHhcCCC----------CCCCCCCH
Confidence 23456899999999 467889999999999999999999987542 2222222222110 11123455
Q ss_pred HHHHHHHHchhcCCCCCCCHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMA 555 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~ 555 (608)
.+.+++.+||+.||++||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=309.63 Aligned_cols=229 Identities=21% Similarity=0.313 Sum_probs=184.4
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||.||+++.. +++.||+|+++... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 5899999999999875 67899999997432 2234578899999888 6999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---C
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP---K 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~ 458 (608)
+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 82 DLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG-----IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 99988864 457999999999999999999999987 99999999999999999999999999975321 2
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC-----ChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI-----DLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||.... ....+.......... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~p 223 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---------RIP 223 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---------CCC
Confidence 23456899999999 567889999999999999999999985321 111222211111100 112
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCH
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTM 554 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~ 554 (608)
...+..+.+++.+||+.||++|+++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2344567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.41 Aligned_cols=243 Identities=18% Similarity=0.224 Sum_probs=188.5
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCC-----eeEEEEee
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE-----EKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~ 377 (608)
+.+|+|+||.||++.. .+|+.||||++.... ...+++.+|+++++.++||||+++++++...+ ..++|+||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 85 (372)
T cd07853 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTEL 85 (372)
T ss_pred ceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeec
Confidence 5689999999999986 478999999986432 23457889999999999999999999998776 78999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 86 MQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG-----ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred cc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 96 678887753 467999999999999999999999987 99999999999999999999999999986543
Q ss_pred CC----ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-------------
Q 042949 458 KK----TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------------- 515 (608)
Q Consensus 458 ~~----~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------------- 515 (608)
.. ....++..|+||| ..++.++|||||||++|||++|+.||........ ...+....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-LDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHHhhH
Confidence 22 2345788999999 2468899999999999999999999875433211 11111000
Q ss_pred -----ccccc----ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 516 -----WTGEV----FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 516 -----~~~~~----~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..... ............+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 0000001112335668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=295.09 Aligned_cols=237 Identities=18% Similarity=0.229 Sum_probs=191.8
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccccc------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
.+.+|+|++|.||++... +++.||+|.+..... ....+.+|++++++++||||+++++++...+..++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 467899999999999864 689999999863321 2346888999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.....
T Consensus 87 ~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 87 PGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred CCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999875 356899999999999999999999887 999999999999999999999999999865432
Q ss_pred C------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 459 K------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 459 ~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
. ....++..|+||| ..++.++||||||+++|||++|+.||..........+ ........ ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~--------~~ 228 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNP--------QL 228 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-HhccCCCC--------CC
Confidence 1 2245678899999 4577899999999999999999999865433222211 11111100 11
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.......+.+++.+||..+|++|||+.|+++.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 229 PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 22345568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=305.88 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=196.7
Q ss_pred hcccCCCCCceEEEEEEc--------CCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEE
Q 042949 306 ADLRSQTICSSLFMVRLK--------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLV 374 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~--------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 374 (608)
...+|+|+||.||+++.. .+..||+|.++... ...+++.+|++++.++ +||||+++++++...+..+++
T Consensus 17 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (334)
T cd05100 17 GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVL 96 (334)
T ss_pred cceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEE
Confidence 457899999999999742 12479999887432 2346788999999999 799999999999999999999
Q ss_pred EeeccCCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC
Q 042949 375 YKYQSNGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~ 442 (608)
+||+++|+|.+++..... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 97 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-----ivH~dlkp~Nill~~~~ 171 (334)
T cd05100 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-----CIHRDLAARNVLVTEDN 171 (334)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccccceEEEcCCC
Confidence 999999999999975311 1235889999999999999999999876 99999999999999999
Q ss_pred CceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHH
Q 042949 443 DPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMV 512 (608)
Q Consensus 443 ~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 512 (608)
.+||+|||+++...... ....++..|+||| ..++.++|||||||++|||++ |..|+.. .+.........
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~ 250 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLK 250 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHH
Confidence 99999999998664322 1122345799999 457889999999999999999 6777643 33344433332
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
... ... .....+..+.+++.+||+.+|++|||+.|+++.|+++......
T Consensus 251 ~~~-~~~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 251 EGH-RMD--------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred cCC-CCC--------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 211 111 1223455688999999999999999999999999999865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=300.00 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=191.0
Q ss_pred hcccCCCCCceEEEEEE-----cCCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRL-----KNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-----~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 376 (608)
-..+|+|+||.||+++. .++..||+|.++... ...+.+.+|++++++++||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEE
Confidence 35689999999999974 357899999987432 2346789999999999999999999998765 56889999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 89 ~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g-----i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 89 FLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999864 2346899999999999999999999886 9999999999999999999999999998765
Q ss_pred CCC------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh--------------HHHHHHHH
Q 042949 457 PKK------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL--------------PKWVKAMV 512 (608)
Q Consensus 457 ~~~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~--------------~~~~~~~~ 512 (608)
... ....++..|+||| ..++.++|||||||++|||+|++.|....... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL- 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH-
Confidence 432 1234566799999 45788999999999999999987654321110 0011000
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
.... ........+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 240 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGK--------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCc--------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 0011233567799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=311.64 Aligned_cols=233 Identities=20% Similarity=0.252 Sum_probs=185.5
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHH-HHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMR-QIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|+|+||.||+++.. +|+.||+|++.... ....++..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5899999999999864 78999999997431 12334555655 467789999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---C
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP---K 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~ 458 (608)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g-----ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN-----IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence 99988864 467999999999999999999999887 99999999999999999999999999875422 2
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||.... .....+....... ......+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-~~~~~~~~~~~~~----------~~~~~~~~ 221 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEMYDNILHKPL----------VLRPGASL 221 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-HHHHHHHHHcCCc----------cCCCCCCH
Confidence 23456899999999 467889999999999999999999987543 2222222222110 01123455
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.+++.+|++.+|.+||++.+.++.
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 67899999999999999988644333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=293.72 Aligned_cols=237 Identities=22% Similarity=0.319 Sum_probs=193.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|++|.||++... +++.|++|.+... ....+++.+|++++++++||||+++++++...+..++||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence 45899999999999875 6899999998632 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.++++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++......
T Consensus 86 L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~-----i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 86 LHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK-----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 99999863 2356899999999999999999999876 9999999999999999999999999998765432
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
....++..|+||| ..++.++|||||||+++||++|+.|+.... ............ ... .....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~-~~~--------~~~~~~~~ 228 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-QGALILKIIRGV-FPP--------VSQMYSQQ 228 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCC-CCC--------CccccCHH
Confidence 2346788899999 456789999999999999999999986543 222222221111 111 11134556
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.+++.+||+.+|++||++.++++.
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHhhC
Confidence 8899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=318.01 Aligned_cols=237 Identities=15% Similarity=0.217 Sum_probs=187.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +++.||||++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg 86 (377)
T cd05629 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGG 86 (377)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCC
Confidence 56899999999999864 78999999986422 12356788999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 87 DLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG-----FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999875 456899999999999999999999987 999999999999999999999999998632110
Q ss_pred -----------------------------------------------CccccccCccccCC----CCCCcchhHHHHHHH
Q 042949 459 -----------------------------------------------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVI 487 (608)
Q Consensus 459 -----------------------------------------------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvv 487 (608)
.....||+.|+||| ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 00235899999999 467899999999999
Q ss_pred HHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCC---CCHHHHHHH
Q 042949 488 LLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDR---PTMAEVLER 560 (608)
Q Consensus 488 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~evl~~ 560 (608)
+|||+||+.||...... .......... ..... ......+.++.+++.+|+. +|.+| +++.|+++.
T Consensus 238 l~elltG~~Pf~~~~~~-~~~~~i~~~~--~~~~~----p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 238 MFECLIGWPPFCSENSH-ETYRKIINWR--ETLYF----PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhcCCCCCCCCCHH-HHHHHHHccC--CccCC----CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999754432 2222222110 00000 0111345668899999997 67765 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=287.18 Aligned_cols=239 Identities=18% Similarity=0.218 Sum_probs=194.2
Q ss_pred hcccCCCCCceEEEEE-EcCCcEEEEEEecc---cccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 306 ADLRSQTICSSLFMVR-LKNSAVYAVKRLKK---LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~-~~~g~~vavK~l~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+.||+|.|+.||++. .++|+.+|+|++.. ...+.+++.+|+++-+.|+|||||++.+.+......++|+|+|.||
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~ 95 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 95 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccch
Confidence 4568999999999985 46899999999862 2346788999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC---CCceEeccccccccCCC
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN---EDPLISECGYSKFLDPK 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~ 458 (608)
+|..-+-. ...+++..+-..+.||+++|.|+|.++ |||||+||+|+|+... --+||+|||+|..+...
T Consensus 96 dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~-----IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 96 ELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG-----IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred HHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC-----ceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99765543 245788889999999999999999987 9999999999999644 34799999999988744
Q ss_pred C--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 459 K--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 459 ~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
. ....||++||||| ..|+..+|||+.||+||-|+.|.+||.+.. ....++.+....+. ++. ......
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-~~rlye~I~~g~yd---~~~---~~w~~i 239 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-QHRLYEQIKAGAYD---YPS---PEWDTV 239 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhccccC---CCC---cccCcC
Confidence 3 3468999999999 679999999999999999999999998643 23333333332211 000 112334
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.+..+|+.+||..||.+|.|+.|.++.
T Consensus 240 s~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 240 TPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 5668899999999999999999887653
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=300.04 Aligned_cols=242 Identities=19% Similarity=0.296 Sum_probs=192.0
Q ss_pred hcccCCCCCceEEEEEEc------CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 306 ADLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
...+|+|+||.||++... ++..+|+|.++... ...+.+.+|++++++++|+||+++++++...+..++++||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 356899999999999742 45689999887433 34567999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhc-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEe
Q 042949 379 SNGSLLSLLEAYIE-----------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLIS 447 (608)
Q Consensus 379 ~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 447 (608)
++|+|.+++..... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-----i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH-----FVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-----eecccccHhhEEEcCCCCEEEC
Confidence 99999999975311 0135899999999999999999999876 9999999999999999999999
Q ss_pred ccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcc
Q 042949 448 ECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWT 517 (608)
Q Consensus 448 DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 517 (608)
|||+++...... ....++..|+||| ..++.++|||||||++|||++ |+.||..... ............
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~- 242 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-TEAIECITQGRE- 242 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-HHHHHHHHcCcc-
Confidence 999997654322 1223467899999 567889999999999999999 8888754332 222222211100
Q ss_pred cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 518 GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
. ......+..+.+++.+||+.||++||+++||++.|+
T Consensus 243 ~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 243 L--------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred C--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 111234566889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=297.60 Aligned_cols=234 Identities=21% Similarity=0.274 Sum_probs=182.0
Q ss_pred ccCCCCCceEEEEEEcC-------------------------CcEEEEEEeccccc-CHHHHHHHHHHHhcCCCCcceee
Q 042949 308 LRSQTICSSLFMVRLKN-------------------------SAVYAVKRLKKLQV-SMDEFSQTMRQIGNLKHPNILPL 361 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~-------------------------g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~H~niv~l 361 (608)
.||+|+||.||+|.+.. ...||+|.++.... ...++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 13589998874322 23568889999999999999999
Q ss_pred eeeeecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC
Q 042949 362 VCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441 (608)
Q Consensus 362 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~ 441 (608)
++++......++||||+++|+|..++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++..
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN-----LVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC-----ccCCCCCcccEEEecc
Confidence 9999999999999999999999998864 2456899999999999999999999876 9999999999999765
Q ss_pred C-------CceEeccccccccCCCCccccccCccccCC-----CCCCcchhHHHHHHHHHHH-HcCCCCCcCCCChHHHH
Q 042949 442 E-------DPLISECGYSKFLDPKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLEL-LTGKTVEKTGIDLPKWV 508 (608)
Q Consensus 442 ~-------~~kl~DFGla~~~~~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~el-ltg~~p~~~~~~~~~~~ 508 (608)
+ .+|++|||++...... ....++..|+||| ..++.++|||||||++||| ++|+.|+....... .
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K 230 (274)
T ss_pred CcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence 4 3799999998654322 2345678899999 2467899999999999998 47888876433211 1
Q ss_pred HHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 509 KAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
......... ........+.+++.+||+.+|++|||+.++++.|.
T Consensus 231 ~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFYEKKHR----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHhccC----------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111111100 01112345789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.18 Aligned_cols=242 Identities=18% Similarity=0.208 Sum_probs=185.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCC------eeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE------EKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~e 376 (608)
+.+|+|+||.||++... +|..||||++.... .....+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 106 (359)
T cd07876 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 106 (359)
T ss_pred EEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEe
Confidence 56899999999999864 68999999997432 23456789999999999999999999886443 4799999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+. ++|.+.++ ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 107 ~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 107 LMD-ANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred CCC-cCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 996 46766664 24888999999999999999999987 9999999999999999999999999998654
Q ss_pred CC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc--------------
Q 042949 457 PK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW-------------- 516 (608)
Q Consensus 457 ~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-------------- 516 (608)
.. .....+|..|+||| ..++.++|||||||++|||+||+.||........+.........
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 32 23456889999999 46788999999999999999999999765443332211100000
Q ss_pred --------cccc-ccHH--------HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 517 --------TGEV-FDKE--------VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 517 --------~~~~-~~~~--------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.... +... ...........+.+++.+||..||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0000 000011123557899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=297.25 Aligned_cols=237 Identities=19% Similarity=0.289 Sum_probs=189.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecC------CeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTN------EEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~------~~~~lv~e~~ 378 (608)
..+|+|+||.||+|... +++.||+|++........++.+|+.++.++ +||||+++++++... ...+++|||+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~ 91 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 91 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcC
Confidence 45899999999999865 678999999986555667889999999998 699999999998652 4688999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 92 ~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~-----ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 92 GAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 999999998752 2346899999999999999999999986 999999999999999999999999999865432
Q ss_pred ---CccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 459 ---KTCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 459 ---~~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
.....|+..|+|||. .++.++|||||||++|||++|+.|+............ .. ......
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-~~-~~~~~~------ 236 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-PR-NPAPRL------ 236 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-hc-CCCCCC------
Confidence 234568889999992 3567899999999999999999998654332222111 11 000000
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.....+..+.+++.+||..+|.+|||+.|+++
T Consensus 237 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 237 -KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11234556889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=295.62 Aligned_cols=237 Identities=16% Similarity=0.262 Sum_probs=191.5
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEeccccc-------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV-------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
...+|+|+||.||+|...+|+.+|+|.++.... ....+.+|++++++++|+||+++++++...+..++++||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 456899999999999988999999999873321 1245788999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+++.....
T Consensus 85 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 85 PGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC-----VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999975 356899999999999999999999876 999999999999999999999999998764311
Q ss_pred ---------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHH
Q 042949 459 ---------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 459 ---------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (608)
.....++..|+||| ..++.++|||||||++|||++|+.||....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 228 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP------- 228 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-------
Confidence 12345788999999 4567899999999999999999999865433222211111100000
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
......+..+.+++.+||+.+|++||++.|+++
T Consensus 229 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 -RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112234566889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.93 Aligned_cols=248 Identities=20% Similarity=0.277 Sum_probs=191.0
Q ss_pred hcccCCCCCceEEEEEE------cCCcEEEEEEeccccc--CHHHHHHHHHHHhcC-CCCcceeeeeeeecC-CeeEEEE
Q 042949 306 ADLRSQTICSSLFMVRL------KNSAVYAVKRLKKLQV--SMDEFSQTMRQIGNL-KHPNILPLVCYNSTN-EEKLLVY 375 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lv~ 375 (608)
.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.++.++ +||||+++++++... ...+++|
T Consensus 12 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (343)
T cd05103 12 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (343)
T ss_pred cccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEE
Confidence 46789999999999973 3578999999974322 235688999999999 689999999987654 4678999
Q ss_pred eeccCCCHHHHHHHHhc---------------------------------------------------------------
Q 042949 376 KYQSNGSLLSLLEAYIE--------------------------------------------------------------- 392 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~--------------------------------------------------------------- 392 (608)
||+++|+|.++++....
T Consensus 92 ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (343)
T cd05103 92 EFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDL 171 (343)
T ss_pred eccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhh
Confidence 99999999999875210
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-----ccccccCc
Q 042949 393 GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-----TCLFSSNG 467 (608)
Q Consensus 393 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-----~~~~gt~~ 467 (608)
....+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ....++..
T Consensus 172 ~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 172 YKKVLTLEDLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhccCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 0124788899999999999999999886 9999999999999999999999999998653321 12234567
Q ss_pred cccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHH
Q 042949 468 YTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALK 542 (608)
Q Consensus 468 y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 542 (608)
|+||| ..++.++||||||+++|||++ |..|+............. ...... ..+...+..+.+++.+
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~~ 317 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRM--------RAPDYTTPEMYQTMLD 317 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH-hccCCC--------CCCCCCCHHHHHHHHH
Confidence 99999 457889999999999999997 888875432222222211 111100 0011233458899999
Q ss_pred chhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 543 CVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 543 Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
||+.||++|||+.|+++.|+.+.+.
T Consensus 318 cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 318 CWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=297.88 Aligned_cols=241 Identities=23% Similarity=0.319 Sum_probs=191.0
Q ss_pred ccCCCCCceEEEEEEcC-------CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 308 LRSQTICSSLFMVRLKN-------SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~-------g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
.+|+|++|.||+|+..+ ++.+|+|.+.... ....++.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998643 2579999886432 34567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-----CceEeccc
Q 042949 379 SNGSLLSLLEAYIE---GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-----DPLISECG 450 (608)
Q Consensus 379 ~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFG 450 (608)
++|+|.+++..... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++++|||
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999975322 1245889999999999999999999876 99999999999999877 89999999
Q ss_pred cccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccc
Q 042949 451 YSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEV 520 (608)
Q Consensus 451 la~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 520 (608)
+++...... ....++..|+||| ..++.++|||||||++|||+| |+.|+..... ........... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~-~--- 231 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAGG-R--- 231 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-HHHHHHHhcCC-c---
Confidence 998654321 1223467899999 567889999999999999998 8888764332 22221111110 0
Q ss_pred ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 521 FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 521 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
.......+..+.+++.+||..+|++||+++++++.|++
T Consensus 232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 -----LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -----cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01122345568899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=297.64 Aligned_cols=246 Identities=18% Similarity=0.217 Sum_probs=190.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|++|.||+|+.. +++.||+|+++... ...+.+.+|+.++.+++||||+++++++..++..++||||++ ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (285)
T cd07861 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD 84 (285)
T ss_pred eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence 45799999999999875 68999999987432 234678899999999999999999999999999999999997 68
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++.... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 85 LKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR-----VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred HHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 988886422 2356899999999999999999999886 9999999999999999999999999998654322
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh------hc------------
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE------EW------------ 516 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~------~~------------ 516 (608)
....++..|+||| ..++.++|||||||++|||+||+.||...............- .+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 2235678899999 235788999999999999999999987544322221111000 00
Q ss_pred ccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 517 TGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
................+.++.+++.+||+.||++|||+.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000001111112234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=314.78 Aligned_cols=237 Identities=19% Similarity=0.257 Sum_probs=188.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +++.||+|.+++.. ...+.+.+|+.+++.++||||+++++++.+++..++||||+++|
T Consensus 49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg 128 (370)
T cd05621 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG 128 (370)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCC
Confidence 46899999999999875 57899999986421 23445788999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 129 ~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~-----IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 129 DLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG-----LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 99999864 35889999999999999999999987 9999999999999999999999999998764332
Q ss_pred --ccccccCccccCCC--------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 --TCLFSSNGYTAPEK--------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 --~~~~gt~~y~aPE~--------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....||..|+|||. .++.++||||+||++|||++|+.||....... .............. ...
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~------p~~ 271 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSKIMDHKNSLNF------PED 271 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCcccCC------CCc
Confidence 34568999999991 26789999999999999999999997654322 22222221110000 011
Q ss_pred hhcHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 042949 530 RQWAFPLLNVALKCVSNSPDD--RPTMAEVLER 560 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 560 (608)
...+..+.+++.+|+..++.+ ||++.|+++.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 123555788999999755543 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.94 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=191.1
Q ss_pred cccCCCCCceEEEEEEcC-----------------CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeec
Q 042949 307 DLRSQTICSSLFMVRLKN-----------------SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNST 367 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-----------------g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 367 (608)
+.+|+|+||.||++...+ +..||+|.+.... ...+++.+|++++++++||||+++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (296)
T cd05051 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV 90 (296)
T ss_pred ccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 568999999999987643 2468999987432 235678899999999999999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC
Q 042949 368 NEEKLLVYKYQSNGSLLSLLEAYIE-------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440 (608)
Q Consensus 368 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~ 440 (608)
.+..++++||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-----i~H~dlkp~Nili~~ 165 (296)
T cd05051 91 DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-----FVHRDLATRNCLVGK 165 (296)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccccchhceeecC
Confidence 9999999999999999999976321 1236899999999999999999999876 999999999999999
Q ss_pred CCCceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc--CCCCCcCCCChHHHHH
Q 042949 441 NEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT--GKTVEKTGIDLPKWVK 509 (608)
Q Consensus 441 ~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt--g~~p~~~~~~~~~~~~ 509 (608)
++.++|+|||+++...... ....++..|+||| ..++.++|||||||++|||++ |..|+..... ....+
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-~~~~~ 244 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-QQVIE 244 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-HHHHH
Confidence 9999999999998654322 2234567899999 467899999999999999998 5566643322 22111
Q ss_pred HHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 510 AMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
..... .... -...........+.++.+++.+||+.||++|||+.||++.|++
T Consensus 245 ~~~~~-~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 245 NAGHF-FRDD-GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHhc-cccc-cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11110 0000 0000001122345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=301.05 Aligned_cols=236 Identities=17% Similarity=0.279 Sum_probs=192.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|+|++|.||+|.. .+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (296)
T cd06654 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (296)
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHH
Confidence 4579999999999985 478999999987433 34567889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---cc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~ 461 (608)
+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 106 ~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g-----i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 106 DVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred HHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 99863 45899999999999999999999887 9999999999999999999999999988654332 23
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|+||| ..++.++|||||||++|||++|+.||........+....... .... .........+.
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~------~~~~~~~~~l~ 247 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG--TPEL------QNPEKLSAIFR 247 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC--CCCC------CCccccCHHHH
Confidence 46788999999 456789999999999999999999987654332222211111 0000 01123445588
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+++.+||..+|++|||+.|+++.
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhC
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=296.60 Aligned_cols=246 Identities=16% Similarity=0.262 Sum_probs=194.2
Q ss_pred HHHHHHHhhcccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEE
Q 042949 298 LDDLLEATADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVY 375 (608)
Q Consensus 298 ~~~l~~~~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 375 (608)
.+|.++.. ..+|+|+||.||++... ++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++|+
T Consensus 3 ~~~~~~i~-~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 3 PEEFWEII-GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHHHHH-hhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence 34555443 55899999999999876 57889999886432 34567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
||+++|+|..++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 82 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 82 EFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK-----IIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCcccEEEccCCCEEEccccccccc
Confidence 99999999988764 2456899999999999999999999986 999999999999999999999999998765
Q ss_pred CCC---CccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH
Q 042949 456 DPK---KTCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 456 ~~~---~~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (608)
... .....++..|+|||. .++.++|||||||++|||++|++||........ +......... ..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~-~~--- 228 (282)
T cd06643 154 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSEPP-TL--- 228 (282)
T ss_pred cccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhhcCCC-CC---
Confidence 332 233467889999992 245689999999999999999999865432221 1111111100 00
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+...+.++.+++.+||+.||++||++.++++.
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 ---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0122345678999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=292.33 Aligned_cols=244 Identities=16% Similarity=0.273 Sum_probs=202.3
Q ss_pred HHHHHHhhcccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 299 DDLLEATADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 299 ~~l~~~~~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
+|++... +-+|+|+||.||++.+ ..|+++|||++.. ..+.+++.+|+.+|.+.+.|++|+++|.|..+..+|+||||
T Consensus 32 EEVFDi~-~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 32 EEVFDIV-GKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHH-HHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 4444433 3479999999999975 4799999999874 34678899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
|..|++.+.++. ..++|++..+..++.+.++||+|||... -||||||.-|||++.++.+||+|||.|-.+.+
T Consensus 110 CGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~-----KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 110 CGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK-----KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred cCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH-----HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 999999999975 3678999999999999999999999876 79999999999999999999999999987754
Q ss_pred ---CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 458 ---KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 458 ---~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
+.....||+.||||| .-|+.++||||+|++..||..|++|+.+-...... +......+..-..++
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------FMIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------FMIPTKPPPTFKKPE 253 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------EeccCCCCCCCCChH
Confidence 346788999999999 56899999999999999999999998653321110 000001111113456
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.|+.++-+++.+||...|++|-|+-++++.
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 788899999999999999999998887653
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=297.06 Aligned_cols=242 Identities=19% Similarity=0.272 Sum_probs=190.9
Q ss_pred cccCCCCCceEEEEEEcC------CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLKN------SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~------g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|++|.||+|...+ +..||+|.+.... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 91 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELM 91 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecC
Confidence 568999999999998754 5789999886432 23456899999999999999999999999888999999999
Q ss_pred cCCCHHHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC---CceEeccccc
Q 042949 379 SNGSLLSLLEAYIE---GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE---DPLISECGYS 452 (608)
Q Consensus 379 ~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla 452 (608)
++|+|.++++.... ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||+|||++
T Consensus 92 ~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 92 AGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH-----FIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred CCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccchheEEEeccCCCcceEeccCccc
Confidence 99999999976421 1235899999999999999999999886 99999999999998754 5899999999
Q ss_pred cccCCCCc-----cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 453 KFLDPKKT-----CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 453 ~~~~~~~~-----~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
+....... ....+..|+||| ..++.++|||||||++|||++ |..||.... ............. .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~-~~~~~~~~~~~~~-~---- 240 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-NQEVMEFVTGGGR-L---- 240 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCc-C----
Confidence 87643221 122345799999 568899999999999999997 888876432 2222222211110 0
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
..+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 241 ----~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 241 ----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1123345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=301.47 Aligned_cols=249 Identities=19% Similarity=0.262 Sum_probs=188.1
Q ss_pred cccCCCCCceEEEEEEcC---------------CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCC
Q 042949 307 DLRSQTICSSLFMVRLKN---------------SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE 369 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~---------------g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 369 (608)
+.+|+|+||.||+++..+ ...||+|+++... ...+.+.+|++++++++|+||+++++++...+
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 90 (295)
T cd05097 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD 90 (295)
T ss_pred hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence 458999999999987642 2358999987432 23456889999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC
Q 042949 370 EKLLVYKYQSNGSLLSLLEAYIE--------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441 (608)
Q Consensus 370 ~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~ 441 (608)
..++||||+++++|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp~Nill~~~ 165 (295)
T cd05097 91 PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-----FVHRDLATRNCLVGNH 165 (295)
T ss_pred ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-----eeccccChhhEEEcCC
Confidence 99999999999999999965210 1124789999999999999999999887 9999999999999999
Q ss_pred CCceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc--CCCCCcCCCChHHHHHH
Q 042949 442 EDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT--GKTVEKTGIDLPKWVKA 510 (608)
Q Consensus 442 ~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt--g~~p~~~~~~~~~~~~~ 510 (608)
+.+||+|||+++...... ....++..|+||| ..++.++|||||||++|||++ |..|+..... ......
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~~~~~~ 244 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-EQVIEN 244 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-HHHHHH
Confidence 999999999998654322 1123456899999 467899999999999999998 4456543221 121111
Q ss_pred HHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 511 MVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
.... . ...............+..+.+++.+||+.||++|||+++|++.|++
T Consensus 245 ~~~~-~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 245 TGEF-F-RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHh-h-hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1100 0 0000000001122345679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=296.13 Aligned_cols=242 Identities=18% Similarity=0.241 Sum_probs=190.5
Q ss_pred cccCCCCCceEEEEEE-cCCc----EEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRL-KNSA----VYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|+||+||+|+. .+|. .||+|.++... ...+++.+|+.++..++||||+++++++... ..++++||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~ 91 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMP 91 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCC
Confidence 5689999999999985 3554 48999987432 2345788999999999999999999998754 5789999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.++++. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 92 ~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~-----iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 92 YGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred CCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 9999999874 2346899999999999999999999886 9999999999999999999999999998765332
Q ss_pred cc-----ccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 TC-----LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 ~~-----~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
.. ..++..|+||| ..++.++|||||||++|||++ |..|+..... .... ......... ...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~-~~~~~~~~~--------~~~ 233 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REIP-DLLEKGERL--------PQP 233 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHH-HHHHCCCcC--------CCC
Confidence 21 22356799999 457889999999999999998 8888754321 1111 111111100 111
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 234 PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 23456688999999999999999999999999888644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.27 Aligned_cols=235 Identities=20% Similarity=0.287 Sum_probs=196.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEec-----ccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCe--eEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLK-----KLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEE--KLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~-----~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~--~~lv~e~~ 378 (608)
..+|+|.|-+||+|-.. +|..||=-.++ +.....+.|..|+++|+.|+|||||+++.++.+... ..+|.|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 45799999999999764 57677633222 222344789999999999999999999999887654 77899999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-CCceEeccccccccCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-EDPLISECGYSKFLDP 457 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 457 (608)
..|+|..|+.+ .+.++.+..+.+++||++||.|||++. ++|||||||-+||+|+.+ |.+||+|+|+|.....
T Consensus 126 TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~---PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 126 TSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQD---PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCC---CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999987 466888999999999999999999975 689999999999999765 8999999999998876
Q ss_pred CC-ccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc---ccccccHHHHHhch
Q 042949 458 KK-TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW---TGEVFDKEVAKAGR 530 (608)
Q Consensus 458 ~~-~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 530 (608)
.. ..+.||+.||||| ..|++..||||||+.++||+|+.+|+..+....+.++.+..... ...+-
T Consensus 199 s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~--------- 269 (632)
T KOG0584|consen 199 SHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK--------- 269 (632)
T ss_pred cccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC---------
Confidence 54 4468999999999 67999999999999999999999999999888887777654321 11122
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..++.++|.+|+.. .++|||+.|+++.
T Consensus 270 --dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 --DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred --CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 23367899999999 9999999999875
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=295.05 Aligned_cols=241 Identities=23% Similarity=0.356 Sum_probs=192.7
Q ss_pred hcccCCCCCceEEEEEEc----CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLK----NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.+.+|+|+||.||+|... ++..+|+|.++... ...+.+.+|+.++.+++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 357899999999999864 23479999987432 234578999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||+++.+....
T Consensus 89 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 89 NGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999752 346899999999999999999999876 9999999999999999999999999998765432
Q ss_pred cc------ccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 TC------LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 ~~------~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
.. ..++..|+||| ..++.++|||||||++||+++ |..|+..... .......... ... ..
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-~~~~~~~~~~-~~~--------~~ 230 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEG-YRL--------PA 230 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-HHHHHHHhCC-CcC--------CC
Confidence 11 12245799999 467889999999999999887 9988764332 1222222111 100 11
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 231 PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 123455688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.61 Aligned_cols=249 Identities=19% Similarity=0.261 Sum_probs=190.1
Q ss_pred cccCCCCCceEEEEEEc-----------------CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeec
Q 042949 307 DLRSQTICSSLFMVRLK-----------------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNST 367 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-----------------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 367 (608)
+.+|+|+||.||+++.. ++..||+|+++... ....++.+|++++++++|+||+++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 90 (296)
T cd05095 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT 90 (296)
T ss_pred eeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 45899999999998642 23579999987432 234678999999999999999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC
Q 042949 368 NEEKLLVYKYQSNGSLLSLLEAYIEG-------KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440 (608)
Q Consensus 368 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~ 440 (608)
.+..+++|||+++|+|.+++...... ...+++.++..++.|++.||+|||+.+ |+||||||+|||+++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dlkp~Nili~~ 165 (296)
T cd05095 91 SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-----FVHRDLATRNCLVGK 165 (296)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-----eecccCChheEEEcC
Confidence 99999999999999999999763211 134788899999999999999999887 999999999999999
Q ss_pred CCCceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc--CCCCCcCCCChHHHHH
Q 042949 441 NEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT--GKTVEKTGIDLPKWVK 509 (608)
Q Consensus 441 ~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt--g~~p~~~~~~~~~~~~ 509 (608)
++.++|+|||+++.+.... ....++..|++|| ..++.++|||||||++|||++ |..|+.... ......
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~-~~~~~~ 244 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS-DEQVIE 244 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC-hHHHHH
Confidence 9999999999998654322 1123356799999 567889999999999999998 566765332 222222
Q ss_pred HHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 510 AMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
..... .... ...........++..+.+++.+||+.||++||++.||++.|++
T Consensus 245 ~~~~~-~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 245 NTGEF-FRDQ-GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHH-Hhhc-cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11100 0000 0000001122345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=316.89 Aligned_cols=237 Identities=18% Similarity=0.244 Sum_probs=185.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..||+|+||.||+|+.. +++.||+|++.... ...+.+.+|++++++++|||||++++.+.+.+..++||||+++|
T Consensus 7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (382)
T cd05625 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 86 (382)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCC
Confidence 46899999999999864 68899999997432 12356888999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~-----ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 87 DMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999875 356899999999999999999999987 999999999999999999999999997532100
Q ss_pred -----------------------------------------------CccccccCccccCC----CCCCcchhHHHHHHH
Q 042949 459 -----------------------------------------------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVI 487 (608)
Q Consensus 459 -----------------------------------------------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvv 487 (608)
.....||+.|+||| ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 01246899999999 467889999999999
Q ss_pred HHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCC---HHHHHHH
Q 042949 488 LLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPT---MAEVLER 560 (608)
Q Consensus 488 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~~ 560 (608)
+|||++|+.||.......... ...... ..... ......+..+.+++.+++ .+|++|++ +.++++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~-~i~~~~--~~~~~----p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQM-KVINWQ--TSLHI----PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHH-HHHccC--CCcCC----CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999997654322211 111100 00000 011223455778887765 59999987 8877653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.20 Aligned_cols=228 Identities=21% Similarity=0.260 Sum_probs=184.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..+|+|+||.||+|+.. +++.||+|+++... ...+.+..|.+++..+ +|++|+++++++...+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (323)
T cd05616 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (323)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCC
Confidence 56899999999999875 57899999987432 2234566788888777 589999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-- 458 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 458 (608)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 86 g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 86 GDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999998865 456899999999999999999999886 999999999999999999999999999854321
Q ss_pred -CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 459 -KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 459 -~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.....||+.|+||| ..++.++|||||||++|||+||+.||..... ............ ..+...+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~----------~~p~~~s 225 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEHNV----------AYPKSMS 225 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC----------CCCCcCC
Confidence 23456899999999 5678999999999999999999999875432 222222222110 0122345
Q ss_pred HHHHHHHHHchhcCCCCCCCH
Q 042949 534 FPLLNVALKCVSNSPDDRPTM 554 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~ 554 (608)
.++.+++.+|++.||++|++.
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 226 KEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHHHHHHcccCHHhcCCC
Confidence 668899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=291.01 Aligned_cols=237 Identities=20% Similarity=0.365 Sum_probs=193.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|++|.||++...++..+|+|.++.......++.+|++++++++|||++++++++......++|+||+++++|.++
T Consensus 10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 89 (256)
T cd05112 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDY 89 (256)
T ss_pred eeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHH
Confidence 56899999999999987788999999986666677899999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc----cc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT----CL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~----~~ 462 (608)
+.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....... ..
T Consensus 90 ~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 90 LRA---QRGKFSQETLLGMCLDVCEGMAYLESSN-----VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred HHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 874 2346899999999999999999999876 99999999999999999999999999886543221 22
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++.+|+||| ..++.++||||||+++|||++ |+.|+.... ........... . ... .+...+..+.
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~-~--~~~------~~~~~~~~~~ 231 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-NSEVVETINAG-F--RLY------KPRLASQSVY 231 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHhCC-C--CCC------CCCCCCHHHH
Confidence 3456899999 567789999999999999998 888875432 22222222111 0 000 0122345688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
+++.+||+.+|++|||+.|+++.|
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=305.68 Aligned_cols=245 Identities=17% Similarity=0.223 Sum_probs=185.6
Q ss_pred cccCCC--CCceEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQT--ICSSLFMVRL-KNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g--~~g~vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
++||+| ++++||++.. .+|+.||+|+++.... ..+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 467888 6789999976 5789999999974322 234577899999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-- 458 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 458 (608)
|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+........
T Consensus 84 ~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 84 GSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG-----YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999998652 2345899999999999999999999887 999999999999999999999999865433211
Q ss_pred --------CccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH-
Q 042949 459 --------KTCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK- 523 (608)
Q Consensus 459 --------~~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 523 (608)
.....++..|+||| ..++.++|||||||++|||++|+.||....... ......... .....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~-~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGT-VPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcCC-cccccccc
Confidence 11234567799999 236789999999999999999999986432211 111111000 0000000
Q ss_pred -----H-------------------------------HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 524 -----E-------------------------------VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 524 -----~-------------------------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. ........+..+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 000111234568899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.99 Aligned_cols=244 Identities=17% Similarity=0.209 Sum_probs=182.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCC------CcceeeeeeeecC-CeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKH------PNILPLVCYNSTN-EEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H------~niv~l~~~~~~~-~~~~lv~e~~ 378 (608)
+.||+|+||+||++... +++.||||+++......+++..|++++.+++| .+++++++++... ...++|||++
T Consensus 135 ~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~ 214 (467)
T PTZ00284 135 SLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY 214 (467)
T ss_pred EEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc
Confidence 46899999999999864 67899999997543344556677777776654 4588888888764 5788999988
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCceecCCCCCCeecCCCC---------------
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQK-SNEEKTIPHGNLKLSNILLNENE--------------- 442 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivHrDlkp~NILl~~~~--------------- 442 (608)
+++|.+++.. ...+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 215 -g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g-----IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 215 -GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH-----LMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred -CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC-----eecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 7889998875 45799999999999999999999974 5 99999999999998765
Q ss_pred -CceEeccccccccCCCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHH--HHHh--
Q 042949 443 -DPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVK--AMVR-- 513 (608)
Q Consensus 443 -~~kl~DFGla~~~~~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~--~~~~-- 513 (608)
.+||+|||.+...........||..|+||| ..++.++|||||||++|||++|+.||........... ....
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 489999999876555556678999999999 4688999999999999999999999975443221111 0000
Q ss_pred -hhcc------------------cccccHH-HHHh-------chhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 514 -EEWT------------------GEVFDKE-VAKA-------GRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 514 -~~~~------------------~~~~~~~-~~~~-------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+. ....++. +... .......+.+|+.+||..||++|||++|+++.
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 0000 0000000 0000 00112347799999999999999999999974
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=308.33 Aligned_cols=242 Identities=20% Similarity=0.239 Sum_probs=187.8
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 376 (608)
..+|+|+||.||++.. .+++.||||+++... ...+.+.+|++++++++||||+++++++... ...++++|
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 100 (343)
T cd07878 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100 (343)
T ss_pred eecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEee
Confidence 5689999999999986 477899999987432 2345677899999999999999999887532 35689999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
++ +++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 101 LM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG-----IIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecccCChhhEEECCCCCEEEcCCccceecC
Confidence 88 789988775 356999999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-cc-----ccc-----
Q 042949 457 PKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-WT-----GEV----- 520 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~-----~~~----- 520 (608)
.......+|..|+||| ..++.++|||||||++|||++|+.||......... ....... .. ..+
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07878 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL-KRIMEVVGTPSPEVLKKISSEHA 248 (343)
T ss_pred CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHhcchhhH
Confidence 6656667899999999 24688999999999999999999998654332211 1111100 00 000
Q ss_pred ----------ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 521 ----------FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 521 ----------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
...............+.+++.+|+..||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000011111233457899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=294.80 Aligned_cols=238 Identities=16% Similarity=0.253 Sum_probs=190.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|+|++|.||+++.. +++.||+|.++... .....+.+|+.+++.++||||+++++++...+..++|+||+++++|.
T Consensus 15 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (267)
T cd06645 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQ 94 (267)
T ss_pred HHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHH
Confidence 45799999999999864 68999999987432 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Ccc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~ 461 (608)
+++.. ...+++.+++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++...... ...
T Consensus 95 ~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 95 DIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG-----KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 99875 457899999999999999999999987 999999999999999999999999998765432 234
Q ss_pred ccccCccccCCC-------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 462 LFSSNGYTAPEK-------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 462 ~~gt~~y~aPE~-------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
..|+..|+|||. .++.++|||||||++|||++|+.|+........... ........... .....++.
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~ 239 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-MTKSNFQPPKL-----KDKMKWSN 239 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-hhccCCCCCcc-----cccCCCCH
Confidence 568899999992 256789999999999999999998764432221111 11111111100 01112445
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+.+++.+||+.+|++||+++++++
T Consensus 240 ~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 240 SFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhc
Confidence 6889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=296.93 Aligned_cols=241 Identities=20% Similarity=0.233 Sum_probs=192.7
Q ss_pred cccCCCCCceEEEEEEcC------CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLKN------SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~------g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
..+|+|+||.||+|...+ +..||+|.+.... .....+.+|+.++.+++||||+++++++......++||||+
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 91 (277)
T cd05032 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELM 91 (277)
T ss_pred eEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecC
Confidence 568999999999998642 3689999987432 22456889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccc
Q 042949 379 SNGSLLSLLEAYIEG------KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 452 (608)
++|+|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 92 AKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK-----FVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred CCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccChheEEEcCCCCEEECCcccc
Confidence 999999999753211 234789999999999999999999876 999999999999999999999999999
Q ss_pred cccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 453 KFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 453 ~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
+.+.... ....++..|+||| ..++.++|||||||++||++| |+.|+.... .....+... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~~~-~~~~~---- 240 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEVLKFVI-DGGHL---- 240 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHHHHHHh-cCCCC----
Confidence 8654322 2234567899999 567889999999999999998 888875432 222222222 11110
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
..+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 241 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 241 ----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 112234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=298.28 Aligned_cols=242 Identities=21% Similarity=0.298 Sum_probs=191.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeee-----cCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNS-----TNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~-----~~~~~~lv~e~~~ 379 (608)
..+|+|+||.||++... +++.+|+|+++......+++..|+.++.++ +||||+++++++. ..+..++||||++
T Consensus 24 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~ 103 (286)
T cd06638 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCN 103 (286)
T ss_pred eeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecC
Confidence 45899999999999864 678999998875444456788999999999 6999999999874 3456899999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 458 (608)
+|+|.++++........+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 104 GGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK-----TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred CCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 99999998754444567899999999999999999999876 999999999999999999999999999865432
Q ss_pred --CccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 459 --KTCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 459 --~~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
.....|+..|+|||. .++.++|||||||++|||++|+.|+........... ... ...... .
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~-~~~~~~------~ 250 (286)
T cd06638 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPR-NPPPTL------H 250 (286)
T ss_pred CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-ccc-cCCCcc------c
Confidence 233468899999992 257799999999999999999999865433222111 000 000000 0
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
........+.+++.+||+.||++|||+.|+++.+
T Consensus 251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1122345688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.70 Aligned_cols=247 Identities=17% Similarity=0.296 Sum_probs=201.5
Q ss_pred cCHHHHHHHhhcccCCCCCceEEEEEEcC-CcEEEEEEec-ccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEE
Q 042949 296 FKLDDLLEATADLRSQTICSSLFMVRLKN-SAVYAVKRLK-KLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLL 373 (608)
Q Consensus 296 ~~~~~l~~~~~~~~g~g~~g~vy~~~~~~-g~~vavK~l~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 373 (608)
+..+|..+..++ +|.|.||.||++..++ +...|.|.|. +.....++|.-||++|...+||+||+|++.|...+.+++
T Consensus 28 lnP~d~WeIiGE-LGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 28 LNPRDHWEIIGE-LGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred CCHHHHHHHHhh-hcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence 455666655554 5899999999998764 5567778887 344567789999999999999999999999998999999
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
+.|||.||-...++-.. ...|++.++..+++|++.||.|||++. |||||||.-|||++-+|.++|+|||.+.
T Consensus 107 liEFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~-----iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQN-----IIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred EEeecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcc-----hhhhhccccceEEEecCcEeeecccccc
Confidence 99999999988877543 567999999999999999999999987 9999999999999999999999999986
Q ss_pred ccCC---CCccccccCccccCC---------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 454 FLDP---KKTCLFSSNGYTAPE---------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 454 ~~~~---~~~~~~gt~~y~aPE---------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
.... ....+.||++||||| ..|+.++|||||||+|.||..+.+|-..-....-.++....+
T Consensus 179 Kn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe------- 251 (1187)
T KOG0579|consen 179 KNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE------- 251 (1187)
T ss_pred cchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-------
Confidence 4432 346789999999999 578999999999999999999998865433222222211111
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
+.....+..|+..+.+++.+||..+|..||++.++++
T Consensus 252 -PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 252 -PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1122345678888999999999999999999999875
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=296.78 Aligned_cols=244 Identities=17% Similarity=0.252 Sum_probs=191.8
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||+|... .+..||+|.++.... ...++.+|+.++++++||||+++++++...+..++||||+
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 91 (288)
T cd05061 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELM 91 (288)
T ss_pred eeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCC
Confidence 56899999999999754 245899998874332 2346788999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccc
Q 042949 379 SNGSLLSLLEAYIE------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452 (608)
Q Consensus 379 ~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 452 (608)
++|+|.++++.... ....+++..+..++.|++.||+|||+++ |+||||||+||++++++.++|+|||++
T Consensus 92 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 92 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred CCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcCCCCChheEEEcCCCcEEECcCCcc
Confidence 99999999975321 1234567888999999999999999886 999999999999999999999999999
Q ss_pred cccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 453 KFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 453 ~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
+...... ....++..|+||| ..++.++|||||||++|||++ |..|+.. ....+...........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~----- 240 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMDGGYL----- 240 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-----
Confidence 8654322 1223456799999 467889999999999999999 6767653 2323322222211110
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
......+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 241 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 241 ----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111233566899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=295.35 Aligned_cols=241 Identities=22% Similarity=0.380 Sum_probs=191.9
Q ss_pred hcccCCCCCceEEEEEEcC-C---cEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLKN-S---AVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~-g---~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.+.+|+|+||.||+|.... + ..||||.++.. .....+|..|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 4578999999999998753 3 36999998743 2234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~g-----~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 89 NGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred CCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999875 2356899999999999999999999876 9999999999999999999999999988654322
Q ss_pred cc-----cc---ccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 460 TC-----LF---SSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 460 ~~-----~~---gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
.. .. .+..|+||| ..++.++|||||||++||+++ |..||..... ......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-~~~~~~i~~-~~~~-------- 230 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQ-DYRL-------- 230 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-HHHHHHHHc-CCcC--------
Confidence 11 11 134699999 456889999999999999887 8888764322 222222211 1100
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
......+..+.+++.+||+.+|++||++.+++..|+++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11223456688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=316.06 Aligned_cols=237 Identities=17% Similarity=0.215 Sum_probs=187.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..||+|+||.||+++.. +++.||||++.... .....+.+|++++.+++||||+++++.+..++..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (376)
T cd05598 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (376)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCC
Confidence 45899999999999864 68999999996422 23456889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 87 ~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 87 DMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999975 456899999999999999999999987 999999999999999999999999997532100
Q ss_pred -------------------------------------------CccccccCccccCC----CCCCcchhHHHHHHHHHHH
Q 042949 459 -------------------------------------------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLEL 491 (608)
Q Consensus 459 -------------------------------------------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~el 491 (608)
.....||+.|+||| ..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 01246899999999 4578899999999999999
Q ss_pred HcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCC---CHHHHHHH
Q 042949 492 LTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRP---TMAEVLER 560 (608)
Q Consensus 492 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP---s~~evl~~ 560 (608)
++|+.||........ ....... ...... ......+..+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 238 l~G~~Pf~~~~~~~~-~~~i~~~--~~~~~~----~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAET-QLKVINW--ETTLHI----PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHH-HHHHhcc--CccccC----CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999976543222 1111110 000000 011234556778888876 5999999 88998866
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=328.91 Aligned_cols=250 Identities=21% Similarity=0.273 Sum_probs=196.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|... +|+.||+|+++.... ..+++.+|++++++++||||+++++++.+.+..+++|||+++|
T Consensus 8 ~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGG 87 (932)
T PRK13184 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGY 87 (932)
T ss_pred EEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCC
Confidence 56899999999999875 689999999974321 2456889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 382 SLLSLLEAYIEG-------KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 382 ~L~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
+|.+++...... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 SL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-----IIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 88 TLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-----VLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchheEEEcCCCCEEEEecCccee
Confidence 999998753211 234667888999999999999999886 99999999999999999999999999986
Q ss_pred cCCC---------------------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHH
Q 042949 455 LDPK---------------------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVK 509 (608)
Q Consensus 455 ~~~~---------------------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~ 509 (608)
.... .....||+.|+||| ..++.++|||||||++|||+||+.||...........
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~ 242 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh
Confidence 5211 01246899999999 4678899999999999999999999865322111110
Q ss_pred HHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHhhcCCC
Q 042949 510 AMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRP-TMAEVLERIEEVVNGND 569 (608)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~~~~~~ 569 (608)
. ....+.........+..+.+++.+|++.||++|| +++++.+.|+...+...
T Consensus 243 ----~----~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 243 ----D----VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred ----h----hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 0 0011110011123455688999999999999995 78888899999876543
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=298.09 Aligned_cols=240 Identities=18% Similarity=0.225 Sum_probs=190.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||+||++... +++.||+|.+.... .....+.+|++++++++|+||+++.+++..++..+++|||+++|
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence 46899999999999874 78999999986432 12345778999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 86 ~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~~-----iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 86 DLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHREN-----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred cHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99988864 22346999999999999999999999887 9999999999999999999999999997654322
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
....|+..|+||| ..++.++|||||||++|||++|+.||........ ............ .......+..
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~~ 231 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLETE------EVYSAKFSEE 231 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhccc------cccCccCCHH
Confidence 3356889999999 4578899999999999999999999875433211 111111000000 0112234556
Q ss_pred HHHHHHHchhcCCCCCCC-----HHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPT-----MAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs-----~~evl~~ 560 (608)
+.+++.+||+.||++||+ +.+++..
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 789999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.08 Aligned_cols=232 Identities=20% Similarity=0.227 Sum_probs=182.4
Q ss_pred cCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcC---CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 309 RSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNL---KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+|+|+||+||+|+.. +++.||||++..... ....+..|..++.+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 689999999964221 223345566666655 699999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-- 458 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 458 (608)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~-----ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD-----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 999998875 457899999999999999999999987 999999999999999999999999999754322
Q ss_pred -CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 459 -KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 459 -~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
.....||..|+||| ..++.++|||||||++|||+||+.||..... ....+....... .. .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~--~~-------~~~~~ 221 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-QQMYRNIAFGKV--RF-------PKNVL 221 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-HHHHHHHHcCCC--CC-------CCccC
Confidence 23456899999999 2368899999999999999999999865432 222222211110 00 01123
Q ss_pred HHHHHHHHHHchhcCCCCCC----CHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRP----TMAEVLE 559 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RP----s~~evl~ 559 (608)
+..+.+++.+||..||++|| ++.++++
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 45678999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=298.29 Aligned_cols=242 Identities=21% Similarity=0.301 Sum_probs=192.3
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
..+|+|+||.||+++.. ++..||+|++.... ....++.+|+.++++++||||+++++++...+..++++||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (288)
T cd05050 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYM 90 (288)
T ss_pred ccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecC
Confidence 45799999999999864 46789999987432 23456889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHh------------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC
Q 042949 379 SNGSLLSLLEAYI------------------EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440 (608)
Q Consensus 379 ~~g~L~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~ 440 (608)
++|+|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~-----i~H~dl~p~nil~~~ 165 (288)
T cd05050 91 AYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK-----FVHRDLATRNCLVGE 165 (288)
T ss_pred CCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-----eecccccHhheEecC
Confidence 9999999997521 11235789999999999999999999876 999999999999999
Q ss_pred CCCceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHH
Q 042949 441 NEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKA 510 (608)
Q Consensus 441 ~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~ 510 (608)
++.++|+|||+++.+.... .....+..|+||| ..++.++|||||||++|||++ |..|+... ........
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~-~~~~~~~~ 244 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM-AHEEVIYY 244 (288)
T ss_pred CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHH
Confidence 9999999999988654321 1223456799999 567889999999999999998 77776532 22333322
Q ss_pred HHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 511 MVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
...... .......+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 245 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 245 VRDGNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HhcCCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 221111 01122345678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=291.74 Aligned_cols=239 Identities=22% Similarity=0.389 Sum_probs=193.4
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|+||.||++...++..+|+|.++......+.+.+|++++++++|+||+++++++.. ...+++|||+++|+|.++
T Consensus 12 ~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05073 12 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 90 (260)
T ss_pred eEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHH
Confidence 5689999999999998888889999987655556789999999999999999999999887 778999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
+... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+....... ...
T Consensus 91 ~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 163 (260)
T cd05073 91 LKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN-----YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 163 (260)
T ss_pred HHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence 9752 2356889999999999999999999876 9999999999999999999999999998664322 122
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ..++.++|||||||++||++| |+.|+..... ........ ..... ......+..+.
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~~~~~~-~~~~~--------~~~~~~~~~~~ 233 (260)
T cd05073 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALE-RGYRM--------PRPENCPEELY 233 (260)
T ss_pred cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHh-CCCCC--------CCcccCCHHHH
Confidence 3456799999 456889999999999999999 8888764322 22222111 11110 11123455688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
+++.+||+.+|++||++.++.+.|+.
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=296.76 Aligned_cols=244 Identities=20% Similarity=0.266 Sum_probs=184.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcC---CCCcceeeeeeeec-----CCeeEEE
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNL---KHPNILPLVCYNST-----NEEKLLV 374 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~~~~lv 374 (608)
..+|+|+||.||+++.. +++.||+|.++... .....+.+|+++++++ +||||+++++++.. ....+++
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 45799999999999875 68999999987422 1234556777776655 79999999998764 3457899
Q ss_pred EeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
|||++ ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 86 FEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC-----IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred Ecccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 99997 5898888752 2345899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh-------hccccc-
Q 042949 455 LDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE-------EWTGEV- 520 (608)
Q Consensus 455 ~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~- 520 (608)
..... ....++..|+||| ..++.++||||+||++|||++|++||..........+ .... .+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK-IFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH-HHHHhCCCChhhCccccc
Confidence 65332 3456788999999 4678899999999999999999999865433222111 1110 000000
Q ss_pred -----c----cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 521 -----F----DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 521 -----~----~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
+ ..............+.+++.+||+.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00011112234566889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=331.19 Aligned_cols=243 Identities=17% Similarity=0.247 Sum_probs=192.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeec--CCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNST--NEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~~ 380 (608)
..||+|+||+||+++.. ++..||+|.+..... ....+..|+.++.+++|||||+++++|.. ....++||||+++
T Consensus 19 ~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g 98 (1021)
T PTZ00266 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA 98 (1021)
T ss_pred EEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence 46899999999999875 577899999874322 34568899999999999999999998754 4578999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--CCCCceecCCCCCCeecCCC-----------------
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSN--EEKTIPHGNLKLSNILLNEN----------------- 441 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--~~~~ivHrDlkp~NILl~~~----------------- 441 (608)
|+|.++|.........+++..++.|+.||+.||+|||+.+. ...+||||||||+||||+.+
T Consensus 99 GSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~ 178 (1021)
T PTZ00266 99 GDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178 (1021)
T ss_pred CcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCC
Confidence 99999998654444679999999999999999999998541 12359999999999999642
Q ss_pred CCceEeccccccccCCCC--ccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHh
Q 042949 442 EDPLISECGYSKFLDPKK--TCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVR 513 (608)
Q Consensus 442 ~~~kl~DFGla~~~~~~~--~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 513 (608)
..+||+|||+++.+.... ....||+.|+||| ..++.++|||||||++|||+||+.||.........+..+..
T Consensus 179 ~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~ 258 (1021)
T PTZ00266 179 PIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKR 258 (1021)
T ss_pred CceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhc
Confidence 348999999998764332 3457899999999 23688999999999999999999999766554444333222
Q ss_pred hhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 514 EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
... . .....+..+.+||..||..+|.+||++.|++.
T Consensus 259 ~p~---l-------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 259 GPD---L-------PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCC---C-------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 110 0 01123456889999999999999999999984
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=300.33 Aligned_cols=248 Identities=20% Similarity=0.309 Sum_probs=195.2
Q ss_pred hcccCCCCCceEEEEEEc--------CCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEE
Q 042949 306 ADLRSQTICSSLFMVRLK--------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLV 374 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~--------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 374 (608)
.+.+|+|+||.||+++.. ....+|+|.++... ....++.+|++++.++ +||||+++++++...+..+++
T Consensus 17 ~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (314)
T cd05099 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVI 96 (314)
T ss_pred eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEE
Confidence 467899999999999742 24579999987432 2345688999999999 699999999999998999999
Q ss_pred EeeccCCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC
Q 042949 375 YKYQSNGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~ 442 (608)
|||+++|+|.+++..... ....+++.++.+++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-----i~H~dlkp~Nill~~~~ 171 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-----CIHRDLAARNVLVTEDN 171 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC-----eeeccccceeEEEcCCC
Confidence 999999999999975321 1245899999999999999999999876 99999999999999999
Q ss_pred CceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHH
Q 042949 443 DPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMV 512 (608)
Q Consensus 443 ~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 512 (608)
.+||+|||+++...... ....++..|+||| ..++.++|||||||++|||++ |..||... ..........
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~-~~~~~~~~~~ 250 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLLR 250 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHH
Confidence 99999999998664321 1122345799999 567889999999999999999 77777432 3222222222
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
.. ... ......+.++.+++.+||..+|++|||+.|+++.|+++....
T Consensus 251 ~~-~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 251 EG-HRM--------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred cC-CCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11 110 112334556889999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=298.44 Aligned_cols=238 Identities=20% Similarity=0.259 Sum_probs=190.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||++... +++.||+|.+..... ....+.+|+.++++++|+||+++++.+...+..++||||+++|
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 85 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence 56899999999999865 689999999864321 2345678999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 86 DLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER-----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred cHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 999988642 2346899999999999999999999876 9999999999999999999999999997654332
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHH--HHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKW--VKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....|+..|+||| ..++.++|||||||++|||++|+.||......... ....... ..........
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 229 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---------VQEEYSEKFS 229 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---------hhhhcCccCC
Confidence 2346889999999 56788999999999999999999998754321111 1111110 0001122345
Q ss_pred HHHHHHHHHchhcCCCCCCC-----HHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPT-----MAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs-----~~evl~~ 560 (608)
..+.+++.+||+.||++||| +.|+++.
T Consensus 230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 56889999999999999999 7888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=292.31 Aligned_cols=237 Identities=19% Similarity=0.329 Sum_probs=192.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
..+|+|++|.||++... +++.+|+|.++.. ....+.+.+|+.++++++|+||+++++.+...+..+++|||+++|+|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 85 (255)
T cd08219 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL 85 (255)
T ss_pred EEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcH
Confidence 56899999999999865 6899999998632 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---c
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~ 460 (608)
.+++.. .....+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.++++|||.+....... .
T Consensus 86 ~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 86 MQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEKR-----VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred HHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 998864 22346899999999999999999999887 9999999999999999999999999998664322 2
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...++..|+||| ...+.++||||||+++|+|++|+.||.... ............ ... .....+..+
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-~~~~~~~~~~~~-~~~--------~~~~~~~~~ 228 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-WKNLILKVCQGS-YKP--------LPSHYSYEL 228 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-HHHHHHHHhcCC-CCC--------CCcccCHHH
Confidence 356788899999 457889999999999999999999986532 222222221111 110 112234568
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+||+.||++|||+.+++..
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.72 Aligned_cols=237 Identities=22% Similarity=0.324 Sum_probs=191.2
Q ss_pred ccCCCCCceEEEEEEcCCcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 308 LRSQTICSSLFMVRLKNSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
.+|+|++|.||++...+++.||+|+++.... ..+.+.+|++++++++|+||+++++++......++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 5899999999999987799999999874332 34678999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc-----
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT----- 460 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~----- 460 (608)
++... ...+++..+..++.+++.||+|||+++ ++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~-----i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 82 FLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN-----CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 98742 346889999999999999999999887 99999999999999999999999999986543221
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
....+..|+||| ..++.++|||||||++|||+| |..|+..... ...... ...... . ......+..
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-~~~~~~-~~~~~~--~------~~~~~~~~~ 223 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTRER-IESGYR--M------PAPQLCPEE 223 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-HHHHHH-HhcCCC--C------CCCccCCHH
Confidence 122345699999 567889999999999999999 6777654322 111111 111100 0 012234556
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
+.+++.+||..+|++|||+.|+++.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.41 Aligned_cols=244 Identities=17% Similarity=0.200 Sum_probs=189.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|.|+||.||+++.. +++.||+|.++.. ......+.+|++++++++||||+++++++...+..++||||++ ++|
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l 90 (301)
T cd07873 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 90 (301)
T ss_pred eEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCH
Confidence 45899999999999875 6789999998732 2234567889999999999999999999999999999999996 689
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---c
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~ 460 (608)
.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 91 ~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 91 KQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK-----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 988864 2456899999999999999999999887 9999999999999999999999999998654322 2
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh------hcccc----------
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE------EWTGE---------- 519 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~------~~~~~---------- 519 (608)
...++..|+||| ..++.++|||||||++|||+||+.||..... .......... .....
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 345688899999 2367899999999999999999999865432 2221111110 00000
Q ss_pred ----cccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 520 ----VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 520 ----~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.............+..+.+++.+|+..||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000111122345568899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=303.45 Aligned_cols=237 Identities=20% Similarity=0.305 Sum_probs=199.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..+|+|.||.||++..+ +|+.+|+|.+.+... +.+.+.+|+.+|+++. |||||.+.+.|++....++|||++.+
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G 120 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG 120 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence 56899999999999876 499999999974332 4578999999999998 99999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC----CCceEeccccccccC
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN----EDPLISECGYSKFLD 456 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~~~ 456 (608)
|.|.+.+... .+++..+..++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||+++...
T Consensus 121 GeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g-----vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 121 GELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG-----VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred chHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999752 3999999999999999999999987 9999999999999654 469999999999887
Q ss_pred CC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 457 PK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 457 ~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
.. ....+||++|+||| ..++..+||||.||++|.|++|.+||............ ....+ ++. .....
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-~~~~~--~f~----~~~w~ 263 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-LRGDF--DFT----SEPWD 263 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-HcCCC--CCC----CCCcc
Confidence 63 35678999999999 57899999999999999999999999887655444422 22211 000 01122
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+..+.+++.+|+..||.+|+|+.++++.
T Consensus 264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 264 DISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 345668899999999999999999999995
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=295.72 Aligned_cols=245 Identities=22% Similarity=0.285 Sum_probs=192.6
Q ss_pred cccCCCCCceEEEEEEc-----CCcEEEEEEecccccC--HHHHHHHHHHHhcCCCCcceeeeeeeec--CCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLK-----NSAVYAVKRLKKLQVS--MDEFSQTMRQIGNLKHPNILPLVCYNST--NEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-----~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 377 (608)
+.+|+|+||.||+++.. ++..+|||.++..... .+++.+|++.+++++||||+++++++.. ....+++|||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 56899999999999864 3689999999855443 6689999999999999999999999877 5678999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 90 ~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 90 LPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR-----YIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred CCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999752 335999999999999999999999876 99999999999999999999999999987753
Q ss_pred CCc------cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChH-H---------HHHHHHhhhcc
Q 042949 458 KKT------CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLP-K---------WVKAMVREEWT 517 (608)
Q Consensus 458 ~~~------~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~-~---------~~~~~~~~~~~ 517 (608)
... ...++..|++|| ..++.++||||||++++||+||+.|+....... . ......... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL-K 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH-H
Confidence 321 123345699999 557788999999999999999998865422110 0 000000000 0
Q ss_pred cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 518 GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
... .......++..+.+++.+||..+|++|||+.||+++|+++
T Consensus 241 ~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGE----RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCC----cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000 0001123456789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.61 Aligned_cols=243 Identities=18% Similarity=0.264 Sum_probs=193.1
Q ss_pred hcccCCCCCceEEEEEEcCC----cEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLKNS----AVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g----~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
...+|+|++|.||+|...+. ..||||...... ...+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~ 89 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP 89 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence 35789999999999986432 479999887432 234578999999999999999999998875 45789999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~-----~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 90 LGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR-----FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred CCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 99999999752 346899999999999999999999876 9999999999999999999999999998664432
Q ss_pred c----cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 460 T----CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 460 ~----~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
. ...++..|+||| ..++.++||||||+++||+++ |..||....... ........... ....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~~---------~~~~ 231 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-VIGRIENGERL---------PMPP 231 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHcCCcC---------CCCC
Confidence 1 122345799999 457889999999999999986 999986543322 12211111100 1123
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
..+..+.+++.+|+..+|++|||+.++++.|++++++
T Consensus 232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=302.41 Aligned_cols=228 Identities=19% Similarity=0.266 Sum_probs=184.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..+|+|+||.||+++.. +|+.||+|+++.. ....+.+..|.+++..+. |++|+++++++...+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~ 85 (323)
T cd05615 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG 85 (323)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence 56899999999999865 6899999999742 123455778888888885 57788899999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-- 458 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 458 (608)
|+|.+++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~-----ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 86 GDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999998875 456999999999999999999999887 999999999999999999999999999864322
Q ss_pred -CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 459 -KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 459 -~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.....||..|+||| ..++.++|||||||++|||+||+.||..... ............ ..+...+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~~~----------~~p~~~~ 225 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSIMEHNV----------SYPKSLS 225 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC----------CCCccCC
Confidence 23456899999999 5578899999999999999999999865432 222222222111 0112345
Q ss_pred HHHHHHHHHchhcCCCCCCCH
Q 042949 534 FPLLNVALKCVSNSPDDRPTM 554 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~ 554 (608)
..+.+++.+||+.+|++|++.
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 226 KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHHHHcccCHhhCCCC
Confidence 567899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=307.84 Aligned_cols=242 Identities=17% Similarity=0.178 Sum_probs=185.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 376 (608)
+.+|+|+||.||++... .++.||||++.... .....+.+|+.+++.++||||+++++++... ...++|||
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T cd07874 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102 (355)
T ss_pred EEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhh
Confidence 56899999999999864 68899999997432 2345677899999999999999999987643 35699999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|++ ++|.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~-~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 103 LMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred hhc-ccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 996 46777664 24889999999999999999999887 9999999999999999999999999998765
Q ss_pred CCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh---------------
Q 042949 457 PKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE--------------- 515 (608)
Q Consensus 457 ~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------------- 515 (608)
... ....+|..|+||| ..++.++|||||||++|||++|+.||........+......-.
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 432 3456899999999 4578899999999999999999999875543322221111000
Q ss_pred -------cccccccHHH---------HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 516 -------WTGEVFDKEV---------AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 516 -------~~~~~~~~~~---------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.......+.. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 00011123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=292.01 Aligned_cols=242 Identities=19% Similarity=0.283 Sum_probs=193.7
Q ss_pred cccCCCCCceEEEEEEc-CCc----EEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSA----VYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|... +|. .+|+|.++.... ...++.+|+..+++++||||+++++++.. ...++|+||++
T Consensus 13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 91 (279)
T cd05057 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMP 91 (279)
T ss_pred ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCC
Confidence 67899999999999864 333 689998874432 34578899999999999999999999987 78899999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 92 ~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 92 LGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999875 2345899999999999999999999876 9999999999999999999999999998765432
Q ss_pred cc-----ccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 TC-----LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 ~~-----~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
.. ..++..|+||| ..++.++||||||+++||+++ |+.|+... .............. ...+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~---------~~~~ 233 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGER---------LPQP 233 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCC---------CCCC
Confidence 21 12345799999 467889999999999999999 99887643 22222222221110 0112
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
..++..+.+++.+||..+|++||++.++++.|+++.+.
T Consensus 234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 234 PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 23445688999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.29 Aligned_cols=247 Identities=22% Similarity=0.267 Sum_probs=196.5
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCC-C-----CcceeeeeeeecCCeeEEEEeec
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-H-----PNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
-++||+|.||.|.++.. .+++.||||+++....-..+-..|+++|..|+ | -|+|+++++|...++.|||+|.+
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL 270 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL 270 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh
Confidence 36899999999999975 57999999999976555667778999999887 4 38999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC--CCceEeccccccccC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN--EDPLISECGYSKFLD 456 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~ 456 (608)
.-+|+++|+. +....|+...++.|+.||+.||.+||..+ |||+||||+||||.+. ..+||+|||.+....
T Consensus 271 -~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l~-----IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 271 -STNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHELG-----IIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred -hhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCChhheeeccCCcCceeEEecccccccC
Confidence 5699999986 44567999999999999999999999877 9999999999999754 468999999999888
Q ss_pred CCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHH----------hhhc-ccccc
Q 042949 457 PKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMV----------REEW-TGEVF 521 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~----------~~~~-~~~~~ 521 (608)
........+..|+||| ..|+.+.||||||||+.||++|.+.|.+..+..+....+. +... ....+
T Consensus 343 q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff 422 (586)
T KOG0667|consen 343 QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFF 422 (586)
T ss_pred CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceeh
Confidence 7777778899999999 6799999999999999999999887766544333322210 0000 00000
Q ss_pred cH--------------------HH--------H----H--------hch-hcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 DK--------------------EV--------A----K--------AGR-QWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 ~~--------------------~~--------~----~--------~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+. .. . . ... .....+.+++.+|+++||.+|+|..++++.
T Consensus 423 ~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 423 TSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred hccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 00 0 0 001 233458999999999999999999999876
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=288.83 Aligned_cols=236 Identities=19% Similarity=0.307 Sum_probs=192.3
Q ss_pred cccCCCCCceEEEEEEcC-CcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLKN-SAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+.+|+|++|.||++...+ ++.+|+|.++.... .+++.+|++++++++||||+++++++......++++||+++++|.+
T Consensus 9 ~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 87 (256)
T cd06612 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD 87 (256)
T ss_pred hhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHH
Confidence 457999999999999865 78999999875432 6789999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---ccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TCL 462 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~~ 462 (608)
++.. ....+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||++....... ...
T Consensus 88 ~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~-----i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (256)
T cd06612 88 IMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK-----KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV 159 (256)
T ss_pred HHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence 9864 2457899999999999999999999886 9999999999999999999999999998765432 334
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
.++..|+||| ..++.++|||||||++|||++|+.|+........... . ........ .........+.+
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-~-~~~~~~~~------~~~~~~~~~~~~ 231 (256)
T cd06612 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-I-PNKPPPTL------SDPEKWSPEFND 231 (256)
T ss_pred cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-h-ccCCCCCC------CchhhcCHHHHH
Confidence 5788999999 4678899999999999999999999865432211111 0 00000000 011223456889
Q ss_pred HHHHchhcCCCCCCCHHHHHH
Q 042949 539 VALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~ 559 (608)
++.+||+.||++|||+.|+++
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhc
Confidence 999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=306.75 Aligned_cols=242 Identities=16% Similarity=0.174 Sum_probs=185.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 376 (608)
..+|+|+||.||++... .++.||||++.... .....+.+|+.+++.++||||+++++++... ...++|||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e 109 (364)
T cd07875 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109 (364)
T ss_pred EEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEe
Confidence 56899999999999864 68899999997432 2345678899999999999999999887543 35799999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|++ ++|.+++. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 110 LMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred CCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC-----eecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 996 57777764 24889999999999999999999886 9999999999999999999999999998765
Q ss_pred CCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc--------------
Q 042949 457 PKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW-------------- 516 (608)
Q Consensus 457 ~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-------------- 516 (608)
... ....+|..|+||| ..++.++|||||||++|||++|+.||........+......-..
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 432 3456889999999 56788999999999999999999998755433222211110000
Q ss_pred --------ccccccHHH---------HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 517 --------TGEVFDKEV---------AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 517 --------~~~~~~~~~---------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
......... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 00001123467899999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=288.67 Aligned_cols=238 Identities=21% Similarity=0.332 Sum_probs=190.8
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
...+|+|+||.||++.. +++.||+|+++.. ...+.+.+|+.++++++||||+++++++... ..+++|||+++|+|.+
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~ 87 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVN 87 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHH
Confidence 36789999999999975 7788999998643 2456789999999999999999999998654 5799999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcccccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSS 465 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt 465 (608)
++.. .....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...........+
T Consensus 88 ~l~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (254)
T cd05083 88 FLRT--RGRALVSVIQLLQFSLDVAEGMEYLESKK-----LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160 (254)
T ss_pred HHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence 9975 22346899999999999999999999876 9999999999999999999999999998654433333445
Q ss_pred CccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHH
Q 042949 466 NGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVA 540 (608)
Q Consensus 466 ~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 540 (608)
..|+||| ..++.++|||||||++|||++ |+.|+.... .......... .... ......+..+.+++
T Consensus 161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~-~~~~--------~~~~~~~~~~~~li 230 (254)
T cd05083 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEK-GYRM--------EPPEGCPADVYVLM 230 (254)
T ss_pred ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-HHHHHHHHhC-CCCC--------CCCCcCCHHHHHHH
Confidence 6799999 567889999999999999998 888875432 2222222211 1110 01223456688999
Q ss_pred HHchhcCCCCCCCHHHHHHHHHH
Q 042949 541 LKCVSNSPDDRPTMAEVLERIEE 563 (608)
Q Consensus 541 ~~Cl~~dP~~RPs~~evl~~L~~ 563 (608)
.+||+.+|++||+++++++.|++
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 231 TSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHcCCChhhCcCHHHHHHHHcc
Confidence 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=291.48 Aligned_cols=238 Identities=20% Similarity=0.231 Sum_probs=187.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|+|+||.||+|+.. ++..||+|.+.... ...+.+.+|++++++++|+||+++++++...+..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 46899999999999865 67889999887433 24567889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-CCCceEeccccccccCCC---
Q 042949 385 SLLEAYIEGKRDF--PWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-NEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 385 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~--- 458 (608)
+++... ...+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++......
T Consensus 94 ~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 94 ALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ-----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred HHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 999752 2334 78889999999999999999876 999999999999976 678999999998765432
Q ss_pred CccccccCccccCCC------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 459 KTCLFSSNGYTAPEK------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 459 ~~~~~gt~~y~aPE~------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
.....++..|+|||. .++.++||||||+++|||++|+.|+................... ...+...
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 237 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH--------PEIPESL 237 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccC--------CCCCccc
Confidence 223457889999992 26789999999999999999999986433211111110000000 0112234
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
...+.+++.+||+.+|++|||+.|++..
T Consensus 238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 238 SAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 4568899999999999999999998763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.34 Aligned_cols=244 Identities=20% Similarity=0.289 Sum_probs=190.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|++|.||++... +++.||+|++..... ..+.+.+|++++++++||||+++++++...+..++|+||+++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence 56899999999999986 589999999864322 24568899999999999999999999999999999999999998
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|..+... ...+++.+++.++.||++||+|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 87 l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 87 LDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 8876653 345899999999999999999999876 9999999999999999999999999998654332
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc-----------------
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT----------------- 517 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----------------- 517 (608)
....++..|+||| ..++.++|||||||++|||++|++|+........+.+........
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 2345788899999 235788999999999999999998886544332222211100000
Q ss_pred --cccc-cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 518 --GEVF-DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 518 --~~~~-~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.... ...........+..+.+++.+||..+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 00011112244667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=293.21 Aligned_cols=244 Identities=21% Similarity=0.311 Sum_probs=189.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..+|+|++|.||+++.. +|+.||+|++.... ...+.+.+|++++++++||||+++++++......++||||++++.
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV 86 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence 45799999999999876 68999999986432 233567899999999999999999999999999999999999988
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|..++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 87 l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 87 LNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN-----CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 8776643 446899999999999999999999976 9999999999999999999999999998765432
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHH--hh------------hccccc
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMV--RE------------EWTGEV 520 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~--~~------------~~~~~~ 520 (608)
....++..|+||| ..++.++|||||||++|||++|+.||.............. .. .+....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 2345778899999 2367899999999999999999999875443222111100 00 000000
Q ss_pred --cc----HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 521 --FD----KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 521 --~~----~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+ ..........+..+.+++.+||+.+|++||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 0001111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.48 Aligned_cols=234 Identities=19% Similarity=0.295 Sum_probs=189.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|++|.||+|... ++..||+|.++... ...+.+.+|++++++++||||+++++++...+..++|+||+++++|
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcH
Confidence 45899999999999864 67899999987332 2345788999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---c
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~ 460 (608)
.+++. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||+++.+.... .
T Consensus 90 ~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-----ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 90 LDLLK-----PGPLEETYIATILREILKGLDYLHSER-----KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred HHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCC-----eeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 99886 346899999999999999999999876 9999999999999999999999999998765432 2
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...++..|+||| ..++.++|||||||++|||+||+.|+....... .... ....... ......+.++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~-~~~~~~~--------~~~~~~~~~~ 229 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VLFL-IPKNSPP--------TLEGQYSKPF 229 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-HHhh-hhcCCCC--------CCCcccCHHH
Confidence 345788899999 456789999999999999999999875432211 1111 1111000 0112345568
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+||+.+|++||++.++++.
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHHh
Confidence 899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.31 Aligned_cols=244 Identities=19% Similarity=0.246 Sum_probs=190.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..+|+|++|.||+|+.. +|+.||+|+++... .....+.+|++++++++||||+++++++.+....++++||++ ++
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 84 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QD 84 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CC
Confidence 45799999999999875 68999999987422 223567889999999999999999999999999999999996 58
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~-----i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 85 LKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 8887764 2356899999999999999999999887 9999999999999999999999999998654322
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc---------cc-----
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG---------EV----- 520 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~~----- 520 (608)
....++..|+||| ..++.++|||||||++|||+||..|+....+.....+......... ..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 2345678899999 2368899999999999999999988765554433333221110000 00
Q ss_pred ---ccH--HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 521 ---FDK--EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 521 ---~~~--~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
... .........+..+.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 001111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.17 Aligned_cols=236 Identities=17% Similarity=0.289 Sum_probs=192.1
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|.|++|.||++.. .+++.||+|.+.... ...+.+.+|+..+++++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (296)
T cd06655 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT 104 (296)
T ss_pred EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHH
Confidence 3579999999999975 578999999987432 34567889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---cc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~ 461 (608)
+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 105 ~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~-----i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 105 DVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ-----VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred HHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 98863 45899999999999999999999987 9999999999999999999999999988654432 23
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|+||| ..++.++|||||||++|||++|+.||............. ... .... ......+..+.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~-~~~-~~~~------~~~~~~~~~~~ 246 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNG-TPEL------QNPEKLSPIFR 246 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcC-Cccc------CCcccCCHHHH
Confidence 46788999999 456789999999999999999999987654332221111 110 0000 11223445688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+++.+||..||++||++.++++.
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.65 Aligned_cols=241 Identities=20% Similarity=0.282 Sum_probs=191.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecC-----CeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTN-----EEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-----~~~~lv~e~~~ 379 (608)
..+|+|++|.||++... +++.+|+|.+.......+.+.+|+.++.++ +|||++++++++... +..++|+||++
T Consensus 28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~ 107 (291)
T cd06639 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCN 107 (291)
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECC
Confidence 35799999999999874 688999999975544556788999999998 799999999998653 35899999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.++++........+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 108 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 108 GGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR-----IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred CCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 99999998754334567899999999999999999999876 9999999999999999999999999998654322
Q ss_pred ---ccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 460 ---TCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 460 ---~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
....++..|+|||. .++.++|||||||++|||++|+.|+........... .... ......
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~~-~~~~~~------ 254 (291)
T cd06639 183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRN-PPPTLL------ 254 (291)
T ss_pred ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH-HhcC-CCCCCC------
Confidence 33467888999992 157899999999999999999999865433222111 1111 011111
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
........+.+++.+||+.+|++||++.|+++.
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 112234568899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=292.96 Aligned_cols=245 Identities=19% Similarity=0.252 Sum_probs=189.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|.|++|.||+|+.. +|+.||||+++... .....+.+|++++++++||||+++++++.+.+..++||||+. ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD 84 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence 45799999999999875 68999999987432 223578899999999999999999999999999999999995 68
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++.. .....+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||+++......
T Consensus 85 l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-----i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 85 LKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred HHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 9988864 23456899999999999999999999876 9999999999999999999999999988654322
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccc---------------
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGE--------------- 519 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 519 (608)
....++..|+||| ..++.++|||||||++|||+||+.||..........+..........
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 2234678899999 23578899999999999999999998755433222221111000000
Q ss_pred ---cccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 520 ---VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 520 ---~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
................+.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000011111233456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=278.25 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=196.5
Q ss_pred cCHHHHHHHhhcccCCCCCceEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHhcCC-CCcceeeeeeeecCCee
Q 042949 296 FKLDDLLEATADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEK 371 (608)
Q Consensus 296 ~~~~~l~~~~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~ 371 (608)
..+.||... ..+|.|.+|.|++.+.. +|..+|||.+.+... ..+++...++++.+-+ .|.||+.+|||..+...
T Consensus 89 ~dindl~~l--~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENL--GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhH--HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 445555432 45799999999999875 689999999986443 3345667777776654 89999999999999999
Q ss_pred EEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccc
Q 042949 372 LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGY 451 (608)
Q Consensus 372 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 451 (608)
++.||.|. -.+..+++.. ..++++..+-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|++|||.
T Consensus 167 ~IcMelMs-~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH----~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 167 FICMELMS-TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH----GVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred HHHHHHHH-HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc----ceeecccCccceEEccCCCEEeecccc
Confidence 99999984 3566666542 567999999999999999999998875 599999999999999999999999999
Q ss_pred ccccCCCC--ccccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 452 SKFLDPKK--TCLFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 452 a~~~~~~~--~~~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
+-.+.+.. +...|.+.||||| ..|+.++|||||||+++||+||+.|+.....-.+....+.+++. ..+
T Consensus 239 sGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP--P~L- 315 (391)
T KOG0983|consen 239 SGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP--PLL- 315 (391)
T ss_pred cceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--CCC-
Confidence 98776543 4567889999999 35788999999999999999999999876544444444444321 111
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.....++..+.+++..||..|+.+||...++++.
T Consensus 316 ----~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 ----PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ----CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1122367779999999999999999999988764
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.87 Aligned_cols=246 Identities=18% Similarity=0.243 Sum_probs=190.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
..+|+|+||.||++... ++..+|+|.++... ...+++.+|++++.+++||||+++++++..++..++|+||+++++|
T Consensus 7 ~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L 86 (308)
T cd06615 7 GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 86 (308)
T ss_pred eeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcH
Confidence 45899999999999865 67889999887432 1235688999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-Cccc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-KTCL 462 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~~~ 462 (608)
.++++. ...+++..+..++.|+++||+|||+.. +++||||||+|||++.++.+||+|||++...... ....
T Consensus 87 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (308)
T cd06615 87 DQVLKK----AGRIPENILGKISIAVLRGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158 (308)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC----CEEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence 999975 356899999999999999999999742 3999999999999999999999999998765432 2345
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc-ccc------------------
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW-TGE------------------ 519 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~------------------ 519 (608)
.++..|+||| ..++.++|||||||++|||++|+.|+.... ............. ...
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 6788999999 457789999999999999999999975432 1111111100000 000
Q ss_pred ----cccHHHHH-----hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 520 ----VFDKEVAK-----AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 520 ----~~~~~~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
..+..... .....+..+.+++.+||..+|++|||+.++++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000 0012345688999999999999999999998874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=290.54 Aligned_cols=234 Identities=24% Similarity=0.337 Sum_probs=189.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC----------HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEE
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS----------MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVY 375 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 375 (608)
..+|+|++|.||+|... +++.||+|.+...... .+.+.+|+.++++++||||+++++++...+..++++
T Consensus 6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (267)
T cd06628 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL 85 (267)
T ss_pred ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence 57899999999999864 6789999988643211 245788999999999999999999999999999999
Q ss_pred eeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++..
T Consensus 86 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~-----ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 86 EYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG-----IIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC-----cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999975 456899999999999999999999876 999999999999999999999999999876
Q ss_pred CCCC---------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 456 DPKK---------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 456 ~~~~---------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
.... ....++..|+||| ..++.++|||||||++|||++|+.||......... ..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-~~~~---- 230 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGE-NASP---- 230 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhc-cCCC----
Confidence 5211 1234778899999 45678899999999999999999998754332211 11111 0000
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
..+...+..+.+++.+||+.||++||++.|+++
T Consensus 231 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 ----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 112234566889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=308.78 Aligned_cols=238 Identities=18% Similarity=0.234 Sum_probs=188.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +++.||+|++.... .....+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus 49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg 128 (371)
T cd05622 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 128 (371)
T ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCC
Confidence 56899999999999875 67899999986422 22345778999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 129 DLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC-----EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 99999864 35889999999999999999999987 9999999999999999999999999998765322
Q ss_pred --ccccccCccccCCC--------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 --TCLFSSNGYTAPEK--------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 --~~~~gt~~y~aPE~--------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....||+.|+|||. .++.++|||||||++|||++|+.||...... .....+......... ...
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~------~~~ 271 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKNSLTF------PDD 271 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCcccC------CCc
Confidence 34568999999991 2678999999999999999999999754332 222222221110000 111
Q ss_pred hhcHHHHHHHHHHchhcCCCC--CCCHHHHHHHH
Q 042949 530 RQWAFPLLNVALKCVSNSPDD--RPTMAEVLERI 561 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~L 561 (608)
...+..+.+++.+|+..++.+ ||++.|+++..
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 234566889999999843332 67899888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=295.73 Aligned_cols=233 Identities=19% Similarity=0.297 Sum_probs=186.5
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|++|.||++.. .+++.||+|.+.... ....++.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 86 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL 86 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCCh
Confidence 5689999999999986 578999999986432 2345688999999999999999999999999999999999999998
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-Cccc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-KTCL 462 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~~~ 462 (608)
..+ ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++...... ....
T Consensus 87 ~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (279)
T cd06619 87 DVY--------RKIPEHVLGRIAVAVVKGLTYLWSLK-----ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY 153 (279)
T ss_pred HHh--------hcCCHHHHHHHHHHHHHHHHHHHHCC-----EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCC
Confidence 653 24788899999999999999999887 999999999999999999999999999865443 3445
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChH------HHHHHHHhhhcccccccHHHHHhchhc
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLP------KWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
.++..|+||| ..++.++||||||+++|||++|+.||....... .......... .... .....
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~-------~~~~~ 225 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPVL-------PVGQF 225 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-CCCC-------CCCcC
Confidence 7889999999 457889999999999999999999985422110 1111111000 0000 01223
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||+.+|++||+++|+++.
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 4568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=309.42 Aligned_cols=237 Identities=16% Similarity=0.217 Sum_probs=187.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|+|+||.||+++.. +++.||+|+++.. ......+.+|+.++.+++||||+++++.+.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG 86 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence 56899999999999875 6899999999742 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g-----ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 87 DMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG-----FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999875 457899999999999999999999987 999999999999999999999999998754321
Q ss_pred -----------------------------------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCc
Q 042949 459 -----------------------------------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEK 499 (608)
Q Consensus 459 -----------------------------------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~ 499 (608)
.....||..|+||| ..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 01246899999999 567889999999999999999999997
Q ss_pred CCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCC---HHHHHHH
Q 042949 500 TGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPT---MAEVLER 560 (608)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~~ 560 (608)
....... ......... ...+. .....+..+.+++.+++ .||.+|++ +.|+++.
T Consensus 238 ~~~~~~~-~~~i~~~~~-~~~~p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQET-YRKVMNWKE-TLVFP-----PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHH-HHHHHcCCC-ceecC-----CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 6543222 222211100 00000 01123456788888876 49999985 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=289.68 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=192.9
Q ss_pred cccCCCCCceEEEEEEcC--CcEEEEEEeccc-----------ccCHHHHHHHHHHHhc-CCCCcceeeeeeeecCCeeE
Q 042949 307 DLRSQTICSSLFMVRLKN--SAVYAVKRLKKL-----------QVSMDEFSQTMRQIGN-LKHPNILPLVCYNSTNEEKL 372 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~--g~~vavK~l~~~-----------~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~ 372 (608)
+.+|+|++|.||+|.... ++.+|+|.+... .....++.+|+.++.+ ++||||+++++++...+..+
T Consensus 6 ~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 85 (269)
T cd08528 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY 85 (269)
T ss_pred hhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEE
Confidence 458999999999999765 689999988521 1123456778888865 79999999999999999999
Q ss_pred EEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccc
Q 042949 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452 (608)
Q Consensus 373 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 452 (608)
++|||+++++|.+++.........+++..++.++.|++.||+|||+.. +|+|+||||+||+++.++.+||+|||++
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK----RIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC----ceeecCCCHHHEEECCCCcEEEecccce
Confidence 999999999999998654444567999999999999999999999632 3999999999999999999999999999
Q ss_pred cccCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 453 KFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 453 ~~~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
....... ....++..|+||| ..++.++||||||+++|||++|+.|+.... ............. ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~-~~~------ 233 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-MLSLATKIVEAVY-EPL------ 233 (269)
T ss_pred eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-HHHHHHHHhhccC-CcC------
Confidence 8765432 3456788899999 456889999999999999999999986432 2222222221111 000
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
.....+..+.+++.+||+.||++||++.|+..+++
T Consensus 234 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 234 -PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01134456889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.01 Aligned_cols=240 Identities=18% Similarity=0.203 Sum_probs=188.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +++.+|+|++.+.. .....+..|+.++..++|+||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g 86 (332)
T cd05623 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGG 86 (332)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCC
Confidence 56899999999999876 57889999986421 22345788999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.++++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~-----iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 87 DLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred cHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999752 346899999999999999999999987 9999999999999999999999999997654322
Q ss_pred --ccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 --TCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 --~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
....||..|+|||. .++.++|||||||++|||++|+.||..... .............. .....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~~~~-----~~p~~ 232 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKERF-----QFPAQ 232 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-HHHHHHHhCCCccc-----cCCCc
Confidence 23468999999991 367899999999999999999999975432 22233222211000 01111
Q ss_pred chhcHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDD--RPTMAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 560 (608)
....+..+.+++.+|+..+++. |+++.|+++.
T Consensus 233 ~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 233 VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1234566888999988654443 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=286.87 Aligned_cols=237 Identities=19% Similarity=0.281 Sum_probs=193.3
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|.|.||.||.++. .+++.+++|.+... .....++.+|++++++++|+||+++++++...+..+++|||+++|+
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (256)
T cd08221 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85 (256)
T ss_pred eEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCc
Confidence 5689999999999885 46889999998643 2334578899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 86 L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 86 LYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAG-----ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred HHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 99998752 2356899999999999999999999876 9999999999999999999999999998764433
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
....++..|+||| ...+.++||||||++++||++|+.|+.... .............. ......+..
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~ 228 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-PLNLVVKIVQGNYT---------PVVSVYSSE 228 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHcCCCC---------CCccccCHH
Confidence 3456788999999 346788999999999999999999886533 22223222221111 011234556
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.+++.+||..+|++||++.|+++.
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHHHHcccCcccCCCHHHHhhC
Confidence 8899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=302.67 Aligned_cols=240 Identities=18% Similarity=0.213 Sum_probs=187.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +++.||+|++++.. ...+.+.+|+.++..++|+||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (331)
T cd05597 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGG 86 (331)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCC
Confidence 56899999999999875 68999999997421 23445888999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 87 ~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 87 DLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG-----YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999742 356899999999999999999999987 9999999999999999999999999987654332
Q ss_pred --ccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 --TCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 --~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
....||+.|+|||. .++.++|||||||++|||++|+.||...... .............. ....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~-----~~~~ 232 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHKEHFQ-----FPPD 232 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-HHHHHHHcCCCccc-----CCCc
Confidence 22468999999992 2577899999999999999999998754322 22222221110000 0111
Q ss_pred chhcHHHHHHHHHHchhcCC--CCCCCHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSP--DDRPTMAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP--~~RPs~~evl~~ 560 (608)
....+..+.+++.+|+..++ ..||++.++++.
T Consensus 233 ~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 12345668889988775533 347899998877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=294.36 Aligned_cols=244 Identities=19% Similarity=0.233 Sum_probs=190.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|++|.||+|... +|+.||||+++.... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 84 (298)
T cd07841 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM- 84 (298)
T ss_pred eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-
Confidence 46899999999999865 689999999974322 2345678999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ....+++..+..++.||++||+|||+++ |+|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 85 ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSNW-----ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999999874 1236999999999999999999999987 9999999999999999999999999998765432
Q ss_pred ---ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-------c-----ccc
Q 042949 460 ---TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-------W-----TGE 519 (608)
Q Consensus 460 ---~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------~-----~~~ 519 (608)
....++..|+||| ..++.++|||||||++|||++|.+++....+.....+ ..... + ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK-IFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH-HHHHcCCCchhhhhhcccccc
Confidence 2234677899999 2467889999999999999999777765444322211 11100 0 000
Q ss_pred c------ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 520 V------FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 520 ~------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. ............+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0000011112345678899999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=292.71 Aligned_cols=240 Identities=19% Similarity=0.247 Sum_probs=192.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|++|+||++... +|+.||+|++... ....+.+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (284)
T cd06620 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL 90 (284)
T ss_pred HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCH
Confidence 56799999999999865 6899999988643 22356789999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-Cccc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-KTCL 462 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~~~ 462 (608)
.+++.. ...+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++...... ....
T Consensus 91 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~----~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~ 162 (284)
T cd06620 91 DRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH----RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF 162 (284)
T ss_pred HHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc----CeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCcc
Confidence 998875 356899999999999999999999742 3999999999999999999999999998755322 2345
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh----------HHHHHHHHhhhcccccccHHHHHh
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL----------PKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
.++..|+||| ...+.++|||||||++||++||+.||...... ..+......+.. ... .
T Consensus 163 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-------~ 234 (284)
T cd06620 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-PRL-------P 234 (284)
T ss_pred ccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-CCC-------C
Confidence 6889999999 45678999999999999999999998643321 111111111100 000 0
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
....+..+.+++.+||+.||++|||+.|++++..
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0124456889999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=287.05 Aligned_cols=239 Identities=18% Similarity=0.303 Sum_probs=192.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|.|++|.||++... +++.+|+|.+.... ...+.+.+|++++++++||||+++++++...+..+++|||+++++|.
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~ 88 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ 88 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHH
Confidence 45799999999999875 57899999987432 24567899999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Ccc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~ 461 (608)
+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++...... ...
T Consensus 89 ~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 89 DIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG-----KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred HHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 988752 256899999999999999999999876 999999999999999999999999999865432 233
Q ss_pred ccccCccccCC----C---CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 462 LFSSNGYTAPE----K---TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 462 ~~gt~~y~aPE----~---~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
..++..|+||| . .++.++||||||+++|||+||+.|+........... .......... .......+.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~ 234 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-ISKSNFPPPK-----LKDKEKWSP 234 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhccCCCcc-----ccchhhhhH
Confidence 46788899999 3 567789999999999999999999865433222111 1111000000 011123445
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
++.+++.+||..+|++|||+.+++.
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhc
Confidence 6889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.78 Aligned_cols=240 Identities=15% Similarity=0.202 Sum_probs=186.3
Q ss_pred cccCCCCCceEEEEEEc---CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK---NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
..+|+|+||.||++... .+..||+|.+... ....+|++++++++|||||++++++......+++|||+. ++|
T Consensus 98 ~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 172 (392)
T PHA03207 98 SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDL 172 (392)
T ss_pred EeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCH
Confidence 45899999999999753 3578999988642 345689999999999999999999999999999999995 789
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---- 459 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---- 459 (608)
.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+++......
T Consensus 173 ~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g-----ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 173 FTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG-----IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 888853 467999999999999999999999987 9999999999999999999999999998654332
Q ss_pred -ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC--hHHHHHHHHhhhcc-ccccc--------H
Q 042949 460 -TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID--LPKWVKAMVREEWT-GEVFD--------K 523 (608)
Q Consensus 460 -~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~-~~~~~--------~ 523 (608)
....||..|+||| ..++.++|||||||++|||++|+.||..... ....+..+...... ...+. .
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 2356899999999 4578899999999999999999999865321 11111111111000 00000 0
Q ss_pred HHH-------------H--hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 524 EVA-------------K--AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 524 ~~~-------------~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
... . ........+.+++.+||..||++|||+.|++..
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0 001234567889999999999999999999876
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.00 Aligned_cols=238 Identities=20% Similarity=0.321 Sum_probs=191.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|.|++|.||++... ++..+|+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (280)
T cd06611 11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALD 90 (280)
T ss_pred HHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHH
Confidence 34799999999999875 68999999987432 23457889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Ccc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~ 461 (608)
+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++...... ...
T Consensus 91 ~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 91 SIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK-----VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 998752 356999999999999999999999987 999999999999999999999999998755332 233
Q ss_pred ccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 462 LFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 462 ~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
..++..|+|||. .++.++|||||||++|||++|+.|+...... ........... .. + ..+..+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~-~-----~~~~~~ 234 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKSEP-PT-L-----DQPSKW 234 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcCCC-CC-c-----CCcccC
Confidence 567889999992 2466899999999999999999998654322 21211111100 00 0 112234
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||+.+|++||++.++++.
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 235 SSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 5668899999999999999999999775
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=289.98 Aligned_cols=240 Identities=20% Similarity=0.338 Sum_probs=191.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCC------eeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNE------EKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~------~~~lv~e~~ 378 (608)
..+|+|++|.||+|... +++.+++|++.......+++.+|+.+++++ +|+||+++++++.... ..++||||+
T Consensus 12 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~ 91 (275)
T cd06608 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELC 91 (275)
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcC
Confidence 56899999999999975 678999999886555567899999999999 6999999999987544 489999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++++|.+++.........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~-----i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 92 GGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK-----VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred CCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 999999998764333467999999999999999999999886 999999999999999999999999998765432
Q ss_pred ---CccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 459 ---KTCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 459 ---~~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
.....++..|+|||. .++.++|||||||++|||++|+.||.......... ...... ....
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~-~~~~------ 238 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF-KIPRNP-PPTL------ 238 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH-HhhccC-CCCC------
Confidence 234567889999992 35678999999999999999999986543222211 111110 0111
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.....++..+.+++.+||..||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 011224556889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=285.12 Aligned_cols=237 Identities=21% Similarity=0.253 Sum_probs=194.0
Q ss_pred cccCCCCCceEEEEEEcC-CcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLKN-SAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|.|--|+||.++..+ +..+|+|+|.+... ...+...|-++|+.++||.+..|++.+++....|++||||+||
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG 162 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG 162 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence 458999999999999875 58999999975432 3345678999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC-----
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD----- 456 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~----- 456 (608)
+|....+. +....+++..+..++.+|+.||+|||-.+ ||.|||||+||||-++|++-|+||.++....
T Consensus 163 dL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG-----ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 163 DLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG-----IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred cHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc-----eeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 99998875 55678999999999999999999999987 9999999999999999999999998753210
Q ss_pred -----------------------------C-C------------------------CccccccCccccCC----CCCCcc
Q 042949 457 -----------------------------P-K------------------------KTCLFSSNGYTAPE----KTVSEQ 478 (608)
Q Consensus 457 -----------------------------~-~------------------------~~~~~gt~~y~aPE----~~~~~k 478 (608)
. . ...++||-.|.||| .-.+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 0 01246888999999 446789
Q ss_pred hhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCC----H
Q 042949 479 GDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPT----M 554 (608)
Q Consensus 479 sDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~ 554 (608)
+|+|+|||++|||+.|..||++...-..+...+.++....+ ....+..+.+||.+.|..||++|.- +
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~---------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE---------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC---------CCcchhHHHHHHHHHhccChhhhhccccch
Confidence 99999999999999999999987765555444433221111 1244566889999999999999987 5
Q ss_pred HHHHH
Q 042949 555 AEVLE 559 (608)
Q Consensus 555 ~evl~ 559 (608)
.||-+
T Consensus 387 ~eIK~ 391 (459)
T KOG0610|consen 387 AEIKR 391 (459)
T ss_pred HHhhc
Confidence 55543
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=287.91 Aligned_cols=235 Identities=23% Similarity=0.317 Sum_probs=191.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc------cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ------VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|++|.||+|... ++..||+|.+.... ...+.+.+|++++++++|+||+++++++...+..++++||++
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVP 85 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecC
Confidence 56899999999999876 78999999986432 134568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+++|.+++.. ...+++..+..++.|+++||+|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 86 ~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 86 GGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN-----TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999875 346899999999999999999999886 9999999999999999999999999988654432
Q ss_pred --ccccccCccccCC----CC-CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 460 --TCLFSSNGYTAPE----KT-VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~-~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
....++..|++|| .. ++.++|+|||||++|||++|+.||........ ........... ......
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~--------~~~~~~ 227 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-VFKIGRSKELP--------PIPDHL 227 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-HHHHHhcccCC--------CcCCCc
Confidence 3456788899999 23 67889999999999999999999865442221 11111100010 112234
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
...+.+++.+||..+|++||++.+++.
T Consensus 228 ~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 228 SDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 456789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.80 Aligned_cols=236 Identities=15% Similarity=0.249 Sum_probs=190.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|+|+||.||++... ++..||||.+.... ...+.+.+|+..+++++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 45899999999999864 68899999986432 33456889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---cc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~ 461 (608)
+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++....... ..
T Consensus 108 ~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 108 DIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG-----VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 98753 45899999999999999999999886 9999999999999999999999999987654322 23
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|+||| ..++.++||||||+++|||++|+.|+........ ...... ...... ......+..+.
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~-~~~~~~------~~~~~~~~~~~ 249 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MRRIRD-NLPPRV------KDSHKVSSVLR 249 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh-cCCCcc------ccccccCHHHH
Confidence 46788999999 4678899999999999999999999875433221 111111 110000 01112345578
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+++.+||..||++|||++|+++.
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhC
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=289.96 Aligned_cols=242 Identities=21% Similarity=0.318 Sum_probs=190.6
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
..+|+|+||.||+++.. +.+.||+|.+..... ..+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (275)
T cd05046 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT 90 (275)
T ss_pred eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEec
Confidence 35899999999999864 346899998864332 2467899999999999999999999999989999999999
Q ss_pred cCCCHHHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 379 SNGSLLSLLEAYIEG-----KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
++|+|.++++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||+++
T Consensus 91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC-----cccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999753211 126899999999999999999999887 9999999999999999999999999987
Q ss_pred ccCCCC----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHH
Q 042949 454 FLDPKK----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKE 524 (608)
Q Consensus 454 ~~~~~~----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (608)
...... ....++..|+||| ...+.++||||||+++|||++ |..||..... ...+..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-~~~~~~~~~~~~~~------ 238 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRLQAGKLEL------ 238 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-HHHHHHHHcCCcCC------
Confidence 543221 2234567799999 346788999999999999999 6677754322 22222221111100
Q ss_pred HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 525 VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 525 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
......+..+.+++.+||..+|++|||+.|++..|+
T Consensus 239 --~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 --PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 012234566889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.29 Aligned_cols=236 Identities=18% Similarity=0.284 Sum_probs=191.1
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|++|.||++.. .+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (297)
T cd06656 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (297)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHH
Confidence 5689999999999986 578999999997433 34566889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---cc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~ 461 (608)
+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ..
T Consensus 105 ~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~-----i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 105 DVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred HHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 99863 45899999999999999999999876 9999999999999999999999999998654432 23
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|+||| ..++.++|||||||++|+|++|+.||............ .... .... ......+..+.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-~~~~-~~~~------~~~~~~~~~~~ 246 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNG-TPEL------QNPERLSAVFR 246 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-ccCC-CCCC------CCccccCHHHH
Confidence 46788899999 45678999999999999999999998654332111110 0000 0000 01123345578
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+++.+||..+|++||+++++++.
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=295.51 Aligned_cols=235 Identities=16% Similarity=0.267 Sum_probs=191.2
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
.+|+|+||.||++... +++.||+|.++.. ....+.+.+|+.++.+++||||+++++++...+..++++||+++++|.+
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 5899999999999864 7899999998642 3345678899999999999999999999999999999999999999998
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTCL 462 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~~ 462 (608)
++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 108 ~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 108 IVSQ-----TRLNEEQIATVCESVLQALCYLHSQG-----VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred HHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 7753 46899999999999999999999887 999999999999999999999999998765432 2335
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
.++..|+||| ..++.++|||||||++|||++|+.||........ ....... .... ..........+.+
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~-~~~~------~~~~~~~~~~l~~ 249 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRLRDS-PPPK------LKNAHKISPVLRD 249 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcc-CCCC------ccccCCCCHHHHH
Confidence 6888999999 4578899999999999999999999875433221 1111111 0000 0111233456889
Q ss_pred HHHHchhcCCCCCCCHHHHHHH
Q 042949 539 VALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~~ 560 (608)
++.+||+.+|++||++.++++.
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 250 FLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhC
Confidence 9999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=289.54 Aligned_cols=245 Identities=18% Similarity=0.246 Sum_probs=192.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|++|.||+|... +|+.||+|++.... ...+.+.+|+.++++++||||+++++++......++|+||+ +++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~ 84 (286)
T cd07832 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSD 84 (286)
T ss_pred eecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCC
Confidence 45799999999999874 78999999997432 23467899999999999999999999999999999999999 999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++... ...+++.++..++.||++||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 85 L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 85 LSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG-----IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 99998752 356999999999999999999999886 9999999999999999999999999998765432
Q ss_pred -ccccccCccccCCC-----CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc--------------cc
Q 042949 460 -TCLFSSNGYTAPEK-----TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT--------------GE 519 (608)
Q Consensus 460 -~~~~gt~~y~aPE~-----~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--------------~~ 519 (608)
....++..|+|||. .++.++||||+|++++||+||++++....+...+.+....-... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 33567889999992 35789999999999999999987776544333222211100000 00
Q ss_pred c-c----cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 520 V-F----DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 520 ~-~----~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+ + ..............+.+++.+||..+|++|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0 000111112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=285.07 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=191.9
Q ss_pred cccCCCCCceEEEEEEcC-----CcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLKN-----SAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|.|+||.||+++..+ +..||+|+++.... ..+.+..|++.+.+++|+||+++++++...+..+++|||++
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~ 84 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME 84 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence 568999999999998754 48899999975433 45688999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+++|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 85 ~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~-----~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 85 GGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN-----FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred CCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC-----eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999987521 122899999999999999999999886 9999999999999999999999999998765432
Q ss_pred c----cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 460 T----CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 460 ~----~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
. ...++..|+||| ..++.++||||+|++++||++ |..|+.. ................ ....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~---------~~~~ 227 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRL---------PKPE 227 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC---------CCCC
Confidence 1 123567899999 567889999999999999999 6666654 3333333322221110 1112
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
..+..+.+++.+|+..||++|||+.|+++.|
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 2456688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=291.54 Aligned_cols=238 Identities=16% Similarity=0.282 Sum_probs=189.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|+|++|.||+|+.. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 18 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 97 (292)
T cd06644 18 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVD 97 (292)
T ss_pred heecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHH
Confidence 45799999999999875 58999999987432 23567889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Ccc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~ 461 (608)
.++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 98 ~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 169 (292)
T cd06644 98 AIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK-----IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS 169 (292)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC-----eeecCCCcceEEEcCCCCEEEccCccceeccccccccce
Confidence 887642 356899999999999999999999876 999999999999999999999999998754322 233
Q ss_pred ccccCccccCCCC---------CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 462 LFSSNGYTAPEKT---------VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 462 ~~gt~~y~aPE~~---------~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
..++..|+|||.. ++.++|||||||++|||++|+.|+...... ........... ... ......
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~-~~~------~~~~~~ 241 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEP-PTL------SQPSKW 241 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCCC-ccC------CCCccc
Confidence 4578899999922 466899999999999999999998654321 11111111110 000 112234
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||..+|++||+++|+++.
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 5568899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.64 Aligned_cols=240 Identities=17% Similarity=0.199 Sum_probs=183.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
..+|+|+||.||++... +++.||||... ...+.+|++++++++|+|||++++++...+..++|||++ .++|.+
T Consensus 175 ~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~ 248 (461)
T PHA03211 175 RALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYT 248 (461)
T ss_pred EEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHH
Confidence 56899999999999876 57889999643 234678999999999999999999999999999999999 578998
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-----c
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-----T 460 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-----~ 460 (608)
++.. ....+++.+++.|+.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 249 ~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 249 YLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG-----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 8864 2346999999999999999999999887 9999999999999999999999999998664321 2
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC------ChHHHHHHHHhhh-cccccc----cHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI------DLPKWVKAMVREE-WTGEVF----DKEV 525 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~------~~~~~~~~~~~~~-~~~~~~----~~~~ 525 (608)
...||..|+||| ..++.++|||||||++|||++|..++.... .....+..+.... .....+ ...+
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 346899999999 467889999999999999999886543211 1111111111111 000000 0000
Q ss_pred HH--------------------hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 526 AK--------------------AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 526 ~~--------------------~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.. ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000123357899999999999999999999874
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=291.23 Aligned_cols=241 Identities=20% Similarity=0.279 Sum_probs=187.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHH-HhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV--SMDEFSQTMRQ-IGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||.||++... +|+.||+|+++.... ...++..|+.. ++.++||||+++++++...+..+++|||++ |+
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (283)
T cd06617 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS 85 (283)
T ss_pred EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence 45799999999999875 689999999875332 23455666665 566789999999999999999999999996 78
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--c
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--T 460 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--~ 460 (608)
|.+++.........+++..++.++.||+.||+|||++. +++||||||+||+++.++.+||+|||+++...... .
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (283)
T cd06617 86 LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL----SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT 161 (283)
T ss_pred HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC----CeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 99888764444567999999999999999999999862 29999999999999999999999999998664322 2
Q ss_pred cccccCccccCCC--------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 461 CLFSSNGYTAPEK--------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 461 ~~~gt~~y~aPE~--------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
...++..|+|||. .++.++|||||||++|||++|+.|+................. ..... ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-------~~~~ 233 (283)
T cd06617 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-SPQLP-------AEKF 233 (283)
T ss_pred cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC-CCCCC-------cccc
Confidence 3467888999992 247889999999999999999999864332222222221110 00000 1124
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||..+|++||++.++++.
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5668899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.03 Aligned_cols=248 Identities=21% Similarity=0.298 Sum_probs=199.7
Q ss_pred HHHHHhhcccCCCCCceEEEEEE-cCC----cEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeE
Q 042949 300 DLLEATADLRSQTICSSLFMVRL-KNS----AVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKL 372 (608)
Q Consensus 300 ~l~~~~~~~~g~g~~g~vy~~~~-~~g----~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 372 (608)
|.+..-...+|+|.||+||+|.+ +.| ..||+|++... .....++.+|+-+|.+++|||+++|+|+|.... ..
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 33334456899999999999975 444 47999988743 345788999999999999999999999998766 88
Q ss_pred EEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccc
Q 042949 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452 (608)
Q Consensus 373 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 452 (608)
||.+|||.|+|.+|++.. +..+..+..+.|..|||+||.|||.+. +|||||..+|||+..-..+||.|||++
T Consensus 774 lvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~qr-----lVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQR-----LVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhcc-----hhhhhhhhhheeecCCCeEEEEecchh
Confidence 999999999999999863 567888999999999999999999776 999999999999999999999999999
Q ss_pred cccCCCCcccc-----ccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 453 KFLDPKKTCLF-----SSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 453 ~~~~~~~~~~~-----gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
+.+........ -.+.|||-| ..++.++|||||||++||++| |..|+.. .... .+...++.
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~-eI~dlle~-------- 915 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAE-EIPDLLEK-------- 915 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHH-HhhHHHhc--------
Confidence 98876543221 233477777 678999999999999999998 5566543 2211 12222211
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
.+....++.+..++..++.+||..|+..||+++++...+.++.+
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 12234566788889999999999999999999999999988753
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=290.42 Aligned_cols=244 Identities=18% Similarity=0.230 Sum_probs=187.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|++|.||+|... +++.||+|.+.... .....+.+|++++++++|+||+++++++...+..++||||++ ++|
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L 89 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDL 89 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCH
Confidence 56899999999999875 68999999987422 223456789999999999999999999999999999999997 599
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---c
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~ 460 (608)
.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 90 ~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (291)
T cd07844 90 KQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR-----VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161 (291)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence 9988742 346899999999999999999999886 9999999999999999999999999987543211 2
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc--c---------------
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT--G--------------- 518 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~--------------- 518 (608)
...++..|+||| ..++.++||||+||++|||++|+.||.........+....+.... .
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence 234677899999 236788999999999999999999986554332222222110000 0
Q ss_pred ---ccccHHHHHhchhcH--HHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 519 ---EVFDKEVAKAGRQWA--FPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 519 ---~~~~~~~~~~~~~~~--~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
......+........ ..+.+++.+||+.+|++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000011111111222 56789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=290.25 Aligned_cols=241 Identities=22% Similarity=0.322 Sum_probs=191.0
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccccc-----------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEE
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV-----------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLL 373 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~-----------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 373 (608)
.+.+|+|++|.||+|... +|+.||+|.++.... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 357899999999999764 689999998863110 12457889999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
||||+++|+|.++++. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 86 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 86 FLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG-----ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC-----eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999975 356899999999999999999999876 9999999999999999999999999998
Q ss_pred ccCCC-----CccccccCccccCC----C--CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 454 FLDPK-----KTCLFSSNGYTAPE----K--TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 454 ~~~~~-----~~~~~gt~~y~aPE----~--~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
..... .....++..|+||| . .++.++||||||+++||+++|+.|+............... . ....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~-~~~~~~ 234 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK-R-SAPPIP 234 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc-c-cCCcCC
Confidence 65432 12345788899999 2 3678899999999999999999998654433222221111 0 011111
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. ......+..+.+++.+||..+|++|||+++|++.
T Consensus 235 ~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 235 P---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 1112345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=288.69 Aligned_cols=234 Identities=19% Similarity=0.305 Sum_probs=190.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
..+|.|++|.||+|... ++..||+|.++... .....+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcH
Confidence 45899999999999875 68899999987432 2345788999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---c
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~ 460 (608)
.+++.. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 90 ~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~-----ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 90 LDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK-----KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 998863 46889999999999999999999876 9999999999999999999999999997664432 2
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...++..|+||| ...+.++|||||||++|||+||+.|+...... ...... ...... ......+.++
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~-~~~~~~--------~~~~~~~~~~ 229 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-RVLFLI-PKNNPP--------TLTGEFSKPF 229 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-hHhhhh-hcCCCC--------CCchhhhHHH
Confidence 345778899999 45688999999999999999999998654321 111111 100000 1112345568
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+||+.+|++||++.++++.
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 230 KEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHcccCcccCcCHHHHHhC
Confidence 899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=293.99 Aligned_cols=235 Identities=20% Similarity=0.269 Sum_probs=198.1
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+-+|+|-|.+|-.+++ -+|..||||++.+.. .+...+.+|++-|+-++|||||+||.+..++..+|||+|.-.+|+
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD 103 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD 103 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence 3479999999999975 489999999998644 345678899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-CCCceEeccccccccCCCC--
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-NEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~-- 459 (608)
|++||-++ ...+.+..+.+++.||..|+.|+|+.+ ||||||||+||.+-+ -|-+||.|||++..+.+..
T Consensus 104 l~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH-----VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 104 LFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH-----VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred HHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh-----hhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence 99999763 456999999999999999999999987 999999999987754 5789999999998776653
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
...+|+..|-||| ....++.||||+|||||.|+.|++||+...+....... ++..+. .+...+.
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI-mDCKYt----------vPshvS~ 244 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI-MDCKYT----------VPSHVSK 244 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh-hccccc----------CchhhhH
Confidence 6788999999999 23457899999999999999999999877665444332 222221 1334566
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
++.+||..||..||++|.+.+|+...
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhcc
Confidence 78999999999999999999988764
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=300.87 Aligned_cols=240 Identities=18% Similarity=0.215 Sum_probs=181.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
..+|+|+||.||+|+.. ++..||+|+.... ....|+.++++++||||+++++++...+..++|+||+ .|+|.+
T Consensus 72 ~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~ 145 (357)
T PHA03209 72 KTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYT 145 (357)
T ss_pred EEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHH
Confidence 46899999999999875 5678999975432 2356899999999999999999999999999999999 578988
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--Ccccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--KTCLF 463 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--~~~~~ 463 (608)
++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 146 ~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 146 YLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR-----IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred HHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence 8864 2457999999999999999999999987 999999999999999999999999999854322 23456
Q ss_pred ccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC-h-HHH-------HHHHHhh-hccccccc----HHH
Q 042949 464 SSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID-L-PKW-------VKAMVRE-EWTGEVFD----KEV 525 (608)
Q Consensus 464 gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~-~-~~~-------~~~~~~~-~~~~~~~~----~~~ 525 (608)
||..|+||| ..++.++|||||||++|||+++..++..... . ... ....... ......+. ...
T Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 297 (357)
T PHA03209 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRL 297 (357)
T ss_pred ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHH
Confidence 899999999 4678999999999999999997655432211 1 011 1111100 00000000 000
Q ss_pred H-------------------HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 526 A-------------------KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 526 ~-------------------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 298 VRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 0011234456779999999999999999999864
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=286.07 Aligned_cols=244 Identities=19% Similarity=0.272 Sum_probs=193.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeec--CCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNST--NEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~~ 380 (608)
+.+|.|++|.||++.. .+++.||+|.++.... ..+.+..|++++++++||||+++++++.. ....+++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 4579999999999975 4788999999874332 34567889999999999999999997754 4567899999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
++|.+++.........+++..++.++.|++.||+|||..+....+++|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 165 (265)
T cd08217 86 GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165 (265)
T ss_pred CCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc
Confidence 9999999765444567999999999999999999999332112349999999999999999999999999998765433
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....++..|+||| ..++.++||||||+++++|++|+.|+.... .....+.... ... .......+
T Consensus 166 ~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~-~~~--------~~~~~~~~ 235 (265)
T cd08217 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKIKE-GKF--------RRIPYRYS 235 (265)
T ss_pred cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHHHHhc-CCC--------CCCccccC
Confidence 2346788999999 456788999999999999999999986543 2222222211 111 01123445
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.+++.+|++.+|++||++.+|+++
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=284.19 Aligned_cols=237 Identities=20% Similarity=0.312 Sum_probs=189.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeec-CCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNST-NEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~~g 381 (608)
+.+|.|++|.||++... +++.||+|++.... ...+.+.+|++++++++|+|++++++.+.. ....+++|||++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (257)
T cd08223 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG 85 (257)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCC
Confidence 46799999999999865 57899999987432 234568899999999999999999988764 44678999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|.+++... ....+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.....
T Consensus 86 ~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~-----i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 86 DLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH-----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred cHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 999999752 2346899999999999999999999887 999999999999999999999999999866432
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....++..|+||| ..++.++||||||++++||++|+.||... +........... .... .....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~-~~~~--------~~~~~~~ 228 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEG-KLPP--------MPKDYSP 228 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhc-CCCC--------CccccCH
Confidence 23345788999999 45678999999999999999999988643 222222222211 1111 1123445
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.+++.+||+.+|++|||+.++++.
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcC
Confidence 68899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=292.57 Aligned_cols=237 Identities=25% Similarity=0.374 Sum_probs=189.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHH---HHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMD---EFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~---~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||+||+++.. +++.||+|++........ ...+|+.++++++||||+++++++......++||||+++++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~ 84 (260)
T PF00069_consen 5 KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGS 84 (260)
T ss_dssp EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEB
T ss_pred EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccc
Confidence 56899999999999986 456899999986543322 23459999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC---CCC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD---PKK 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~---~~~ 459 (608)
|.+++.. ...+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.++|+|||.+.... ...
T Consensus 85 L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~-----i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 85 LQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG-----IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp HHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT-----EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred ccccccc----ccccccccccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccc
Confidence 9999983 466899999999999999999999987 9999999999999999999999999997532 223
Q ss_pred ccccccCccccCC--C---CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh---chh
Q 042949 460 TCLFSSNGYTAPE--K---TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA---GRQ 531 (608)
Q Consensus 460 ~~~~gt~~y~aPE--~---~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 531 (608)
....++..|+||| . ..+.++||||+|+++++|++|..|+.... ............ . ...... ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-~~~~~~~~~~~~-~-----~~~~~~~~~~~~ 228 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-SDDQLEIIEKIL-K-----RPLPSSSQQSRE 228 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-HHHHHHHHHHHH-H-----THHHHHTTSHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc-chhhhhhhhhcc-c-----ccccccccccch
Confidence 4456788999999 3 57889999999999999999999987541 111111111100 0 000011 111
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
....+.+++.+||+.||++||++.++++
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2367899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=288.29 Aligned_cols=235 Identities=19% Similarity=0.326 Sum_probs=191.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
..+|.|++|.||+|+.. +++.||+|.+.... .....+.+|++++++++|+||+++++++......++|+||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (274)
T cd06609 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC 86 (274)
T ss_pred hhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcH
Confidence 45799999999999875 68899999987432 2345788999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~ 460 (608)
.++++. ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++..... ..
T Consensus 87 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 87 LDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG-----KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 999874 37899999999999999999999876 999999999999999999999999999876543 23
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...++..|+||| ..++.++|||||||++|||+||+.|+...... ........ ....... ....+..+
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~-~~~~~~~-------~~~~~~~~ 227 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-RVLFLIPK-NNPPSLE-------GNKFSKPF 227 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-HHHHHhhh-cCCCCCc-------ccccCHHH
Confidence 456788899999 45788999999999999999999998643321 11111111 1111110 00145568
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+||..+|++|||++++++.
T Consensus 228 ~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 228 KDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhC
Confidence 899999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.45 Aligned_cols=240 Identities=17% Similarity=0.207 Sum_probs=188.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +++.||+|+++... .....+.+|+.++.+++|+||+++++++...+..++||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg 86 (331)
T cd05624 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGG 86 (331)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCC
Confidence 56899999999999875 67899999987421 22345788999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~-----iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 87 DLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH-----YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred cHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999752 346899999999999999999999887 9999999999999999999999999998765432
Q ss_pred --ccccccCccccCC---------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 --TCLFSSNGYTAPE---------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 --~~~~gt~~y~aPE---------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
....||..|+||| ..++.++|||||||++|||++|+.||...... ............. .....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~-----~~p~~ 232 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHEERF-----QFPSH 232 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-HHHHHHHcCCCcc-----cCCCc
Confidence 2346899999999 23678999999999999999999999754332 2222222111000 00111
Q ss_pred chhcHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDD--RPTMAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 560 (608)
....+..+.+++.+|+..++++ |++++++++.
T Consensus 233 ~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 233 ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1234566889999999865544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=279.88 Aligned_cols=251 Identities=23% Similarity=0.276 Sum_probs=201.7
Q ss_pred cCHHHHHHHhhcccCCCCCceEEEEE-EcCCcEEEEEEecccc-cCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeE
Q 042949 296 FKLDDLLEATADLRSQTICSSLFMVR-LKNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKL 372 (608)
Q Consensus 296 ~~~~~l~~~~~~~~g~g~~g~vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~ 372 (608)
-+++|+++.|.+++|+|.|+.|--+. +.+|..||||++.+.. ..+.++.+|++++.+.+ |+||++|+.+|+++...|
T Consensus 73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY 152 (463)
T KOG0607|consen 73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY 152 (463)
T ss_pred chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence 46799999999999999999998875 7899999999998643 46678899999999985 999999999999999999
Q ss_pred EEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC---ceEecc
Q 042949 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED---PLISEC 449 (608)
Q Consensus 373 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DF 449 (608)
||||-|.||.|.++|++ ...+++..+.++..+|+.||.|||+++ |.|||+||+|||-.+... +||+||
T Consensus 153 LVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg-----IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG-----IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred EEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC-----cccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999986 678999999999999999999999987 999999999999976654 699999
Q ss_pred ccccccCCC----------CccccccCccccCC---------CCCCcchhHHHHHHHHHHHHcCCCCCcCC---------
Q 042949 450 GYSKFLDPK----------KTCLFSSNGYTAPE---------KTVSEQGDVFSFGVILLELLTGKTVEKTG--------- 501 (608)
Q Consensus 450 Gla~~~~~~----------~~~~~gt~~y~aPE---------~~~~~ksDVwSfGvvl~elltg~~p~~~~--------- 501 (608)
.+..-+... ..+-+|+..||||| ..|+.++|.||+|||||-|++|.+||.+.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 887543211 12346777899999 46889999999999999999999998642
Q ss_pred CChHHHHHHHHhhhcc---cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 502 IDLPKWVKAMVREEWT---GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 502 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.......+..+-+... -+.-+. .....+.+..+++...+..|+.+|.++.++++
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYeFPdk----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYEFPDK----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCCcCChh----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111112211111100 011111 11234556789999999999999999999987
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=299.59 Aligned_cols=237 Identities=23% Similarity=0.304 Sum_probs=187.2
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccc---ccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.||.||.+.||++...+.+.||+|++... ......|..|+..|.+|+ |.+||+|++|-..++.+|+||||= .-|
T Consensus 367 k~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~D 445 (677)
T KOG0596|consen 367 KQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DID 445 (677)
T ss_pred HhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-ccc
Confidence 568999999999999999999999988632 334567999999999996 999999999999999999999987 569
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc--
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT-- 460 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 460 (608)
|.++|++. ...++.-.++.+..|++.++.++|+++ |||.||||.|+|+ -.|.+||+|||.|..+..+.+
T Consensus 446 L~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g-----IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 446 LNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG-----IVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred HHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc-----eeecCCCcccEEE-EeeeEEeeeechhcccCccccce
Confidence 99999863 223332278889999999999999987 9999999999999 468899999999998877653
Q ss_pred ---cccccCccccCC---------------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 461 ---CLFSSNGYTAPE---------------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 461 ---~~~gt~~y~aPE---------------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
..+||+.||+|| ...+.++||||+|||||+|+-|++||..-.....-+..+.+. -.++.-
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P--~~~Ief 594 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP--NHEIEF 594 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC--Cccccc
Confidence 457999999999 125778999999999999999999986432211111111111 011111
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.+ ....++++++..||+.||++|||+.++++.
T Consensus 595 p~~-----~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 595 PDI-----PENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cCC-----CCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 111 112238899999999999999999999864
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=290.72 Aligned_cols=242 Identities=21% Similarity=0.298 Sum_probs=190.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||++... ++..||+|.++... .....+.+|++++.+++||||+++++++...+..++||||+++++|
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (286)
T cd06622 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL 86 (286)
T ss_pred hhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCH
Confidence 45799999999999876 78999999887422 2345788999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-Cccc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-KTCL 462 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~~~ 462 (608)
.++++.. .....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++..+... ....
T Consensus 87 ~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (286)
T cd06622 87 DKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN 161 (286)
T ss_pred HHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC----CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccC
Confidence 9988742 11347899999999999999999999742 3999999999999999999999999999865432 2334
Q ss_pred cccCccccCCC----------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 463 FSSNGYTAPEK----------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 463 ~gt~~y~aPE~----------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
.++..|+|||. .++.++|||||||++|||++|+.||..... ........... ...........
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~------~~~~~~~~~~~ 234 (286)
T cd06622 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-ANIFAQLSAIV------DGDPPTLPSGY 234 (286)
T ss_pred CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-hhHHHHHHHHh------hcCCCCCCccc
Confidence 57889999992 237789999999999999999999865432 11111111000 00000112234
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||+.+|++||++.++++.
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 5668899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=285.48 Aligned_cols=237 Identities=21% Similarity=0.368 Sum_probs=193.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..+|+|+||.+|+++.. +|+.||+|.+... ....+++.+|++++++++||||+++++++...+..++|+||+++++
T Consensus 6 ~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08218 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGD 85 (256)
T ss_pred EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCc
Confidence 56899999999999864 6899999998632 2234578899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++.. .....+++.+++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 86 LYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDRK-----ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred HHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 9998875 22345889999999999999999999876 9999999999999999999999999998664432
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
....++..|+||| ...+.++|||||||+++||++|+.|+.... ....+........ . ......+..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-~~~~~~~~~~~~~-~--------~~~~~~~~~ 228 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-MKNLVLKIIRGSY-P--------PVSSHYSYD 228 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-HHHHHHHHhcCCC-C--------CCcccCCHH
Confidence 2345788899999 456789999999999999999999986542 2222322222111 0 112234566
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.+++.+||+.+|++||++.||++.
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhhC
Confidence 8899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=289.22 Aligned_cols=246 Identities=22% Similarity=0.272 Sum_probs=191.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~g 381 (608)
+.+|.|.+|.||++... +++.+|+|.+..... ..+++.+|++++++++||||+++++++... +..++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 86 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG 86 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence 45799999999999975 678999999874322 346789999999999999999999988653 4689999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-c
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-T 460 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 460 (608)
+|.+++.........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 87 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-----i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 161 (287)
T cd06621 87 SLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK-----IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG 161 (287)
T ss_pred CHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEecCCeEEEeeccccccccccccc
Confidence 999988754444567899999999999999999999887 9999999999999999999999999987654332 3
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC----ChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI----DLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
...++..|+||| ..++.++||||+||++|||++|+.|+.... ............. ...+... ......+
T Consensus 162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~ 238 (287)
T cd06621 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--NPELKDE-PGNGIKW 238 (287)
T ss_pred cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC--chhhccC-CCCCCch
Confidence 345778899999 467889999999999999999999986542 1112211111100 0000000 0001224
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||+.+|++|||+.|+++.
T Consensus 239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred HHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 5668899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=290.68 Aligned_cols=237 Identities=18% Similarity=0.285 Sum_probs=188.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeec------CCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNST------NEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~------~~~~~lv~e~~ 378 (608)
..+|+|+||.||+|+. .+++.+|+|.+........++..|+.++.++ +|+||+++++++.. .+..+++|||+
T Consensus 22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~ 101 (282)
T cd06636 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFC 101 (282)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeC
Confidence 4689999999999987 4688999999875544556788999999998 69999999998853 45789999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 102 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~-----ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 102 GAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred CCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence 999999998752 2345889999999999999999999887 999999999999999999999999998865422
Q ss_pred ---CccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 459 ---KTCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 459 ---~~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
.....++..|+|||. .++.++|||||||++|||++|+.||........... .... ....
T Consensus 175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~~-~~~~------- 245 (282)
T cd06636 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRN-PPPK------- 245 (282)
T ss_pred ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-HhhC-CCCC-------
Confidence 234568889999992 356789999999999999999999865432211111 1000 0000
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.....++..+.+++.+||..||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 011235567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=294.41 Aligned_cols=244 Identities=20% Similarity=0.242 Sum_probs=184.2
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 309 RSQTICSSLFMVRLKNSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
.|+|+++.||+++. +++.||||+++.. ....+.+.+|++.+++++|+||+++++++...+..+++|||+++|+|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 34455555555444 7899999998743 2345678999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC------
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK------ 459 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~------ 459 (608)
+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+.......
T Consensus 89 ~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~-----ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 89 LLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG-----FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99753 2345889999999999999999999887 9999999999999999999999999887543211
Q ss_pred ----ccccccCccccCCC------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc-------------
Q 042949 460 ----TCLFSSNGYTAPEK------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW------------- 516 (608)
Q Consensus 460 ----~~~~gt~~y~aPE~------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------------- 516 (608)
....++..|+|||. .++.++|||||||++|||++|+.||..................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 22346678999992 3678999999999999999999998764433222221110000
Q ss_pred -ccc----cccHHH-----HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 517 -TGE----VFDKEV-----AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 517 -~~~----~~~~~~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
... ..+... .......+..+.+++.+||..||++|||++++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 000000 00112234568899999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=291.69 Aligned_cols=242 Identities=19% Similarity=0.284 Sum_probs=189.6
Q ss_pred cccCCCCCceEEEEEEc-CCc----EEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSA----VYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|... +|. .||+|.+..... ...++.+|+.++++++||||+++++++... ..++++||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~ 91 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMP 91 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcC
Confidence 57999999999999863 444 578888874322 234688999999999999999999998754 4679999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 92 ~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 92 HGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred CCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC-----eeccccccceeeecCCCceEEccccccccccCcc
Confidence 9999999874 2346899999999999999999999876 9999999999999999999999999998764322
Q ss_pred c-----cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 T-----CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 ~-----~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
. ...++..|+||| ..++.++|||||||++|||++ |+.|+.... ... .......... . ...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~-~~~~~~~~~~---~-----~~~ 233 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TRE-IPDLLEKGER---L-----PQP 233 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHH-HHHHHHCCCC---C-----CCC
Confidence 1 223466899999 457889999999999999998 888875432 111 1112111110 0 011
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
..++..+.+++.+||..+|++||+++++++.|+++.+.
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 234 PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 23455688999999999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=290.35 Aligned_cols=233 Identities=19% Similarity=0.282 Sum_probs=191.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|++|.||++... +++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (290)
T cd05580 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG 86 (290)
T ss_pred EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCC
Confidence 56899999999999875 68999999986432 23456889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||+++........
T Consensus 87 ~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~-----i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 157 (290)
T cd05580 87 ELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD-----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT 157 (290)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCC
Confidence 99999875 467899999999999999999999976 999999999999999999999999999987666556
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|+||| ...+.++||||||+++|||++|+.|+...... ........... ..+......+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~l~ 226 (290)
T cd05580 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEGKV----------RFPSFFSPDAK 226 (290)
T ss_pred CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCc----------cCCccCCHHHH
Confidence 67889999999 44678899999999999999999998654421 11111111110 01122345688
Q ss_pred HHHHHchhcCCCCCC-----CHHHHHH
Q 042949 538 NVALKCVSNSPDDRP-----TMAEVLE 559 (608)
Q Consensus 538 ~li~~Cl~~dP~~RP-----s~~evl~ 559 (608)
+++.+||..||++|| +++|+++
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHc
Confidence 999999999999998 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=285.82 Aligned_cols=243 Identities=21% Similarity=0.307 Sum_probs=188.5
Q ss_pred cccCCCCCceEEEEEEc----CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCC------eeEE
Q 042949 307 DLRSQTICSSLFMVRLK----NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE------EKLL 373 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~l 373 (608)
+.+|+|+||.||+|... +++.||||+++... ...+++.+|++++++++||||+++++++.... ..++
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence 46899999999999863 46899999987432 23456889999999999999999999876432 2478
Q ss_pred EEeeccCCCHHHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccc
Q 042949 374 VYKYQSNGSLLSLLEAYIE--GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGY 451 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 451 (608)
++||+++|+|.+++..... ....+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-----FIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccchhhEEEcCCCCEEECcccc
Confidence 8999999999988754221 1235789999999999999999999876 99999999999999999999999999
Q ss_pred ccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 452 SKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 452 a~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
++...... ....++..|++|| ..++.++|||||||++|||++ |+.|+... +..............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~---- 234 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-ENSEIYNYLIKGNRL---- 234 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC-CHHHHHHHHHcCCcC----
Confidence 98664322 1223456799999 456889999999999999999 77776533 222222222211110
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
......+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 235 -----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 -----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01123455688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=303.64 Aligned_cols=239 Identities=21% Similarity=0.291 Sum_probs=196.3
Q ss_pred hcccCCCCCceEEEEEEc--CC--cEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLK--NS--AVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~--~g--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
-+++|+|.||+|++|.+. .| ..||||.++.... ..++|.+|+.+|.+|+|||+|+|||...+ ...++|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 367899999999999875 34 5799999985432 57899999999999999999999999987 67889999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
.|+|.+.|++ .....|-......++.|||.||+||..++ +|||||..+|+|+-....+||+|||+.+.+....
T Consensus 194 lGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr-----lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 194 LGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR-----LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh-----hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999987 34566888888999999999999998776 9999999999999999999999999999887665
Q ss_pred ccccc------cCccccCC----CCCCcchhHHHHHHHHHHHHcCC-CCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 TCLFS------SNGYTAPE----KTVSEQGDVFSFGVILLELLTGK-TVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 ~~~~g------t~~y~aPE----~~~~~ksDVwSfGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
....- ...|.||| ..++.++|||+|||++|||+|+. .|+.+.... ..++.+ -+.+....
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-qIL~~i---------D~~erLpR 336 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-QILKNI---------DAGERLPR 336 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-HHHHhc---------cccccCCC
Confidence 43322 34699999 67899999999999999999954 566543221 111111 12333445
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
+..++..+++++..||...|++|||+.++.+.+-
T Consensus 337 Pk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred CCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 6778999999999999999999999999985543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=293.17 Aligned_cols=237 Identities=24% Similarity=0.325 Sum_probs=189.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|+|++|.||++... +++.||+|.+..... ..+.+..|++++.+++||||+++++.+......++||||+.++
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG 86 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence 46899999999999876 489999999975332 3456889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. .....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 87 ELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLLG-----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred CHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99999874 22356899999999999999999999876 9999999999999999999999999987543211
Q ss_pred ------------------------------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChH
Q 042949 460 ------------------------------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLP 505 (608)
Q Consensus 460 ------------------------------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~ 505 (608)
....|+..|+||| ..++.++||||||+++|||++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1235788899999 456889999999999999999999986554332
Q ss_pred HHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCC----HHHHHH
Q 042949 506 KWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPT----MAEVLE 559 (608)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~~evl~ 559 (608)
.+.. ....... . ......+..+.+++.+||+.||++||| ++|+++
T Consensus 240 ~~~~-~~~~~~~---~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 TFSN-ILKKEVT---F-----PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHH-HhcCCcc---C-----CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2222 1111100 0 001114566899999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.40 Aligned_cols=236 Identities=16% Similarity=0.182 Sum_probs=184.9
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccc---c---CHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---V---SMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 376 (608)
.+.+|+|+||.||++... +|..||+|.+.... . ..+.+.+|++++++++||||+++++++.+. ...+++||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 467899999999999864 68999999885321 1 234678899999999999999999988763 46789999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++...
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 87 HMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM-----IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred ecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999875 345889999999999999999999887 9999999999999999999999999998653
Q ss_pred CC------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 457 PK------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 457 ~~------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
.. .....++..|+||| ..++.++|||||||++|||++|+.|+.......... ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~-~~------- 228 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPT-NP------- 228 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HHhcCCC-CC-------
Confidence 21 12345788999999 456789999999999999999999986543222211 1111110 00
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+......+.+++.+|+. +|++||+++|+++.
T Consensus 229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1122334557789999995 99999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.08 Aligned_cols=244 Identities=17% Similarity=0.239 Sum_probs=189.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|.|.+|.||+|... +|..||+|++.... ...+.+.+|++++++++|||++++++++.+.+..+++|||++ ++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~ 83 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LD 83 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cC
Confidence 46799999999999864 79999999987432 223568899999999999999999999999999999999994 78
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++... ....+++..++.++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++......
T Consensus 84 l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~-----~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 84 LKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSHR-----VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred HHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 99988752 2246899999999999999999999876 9999999999999999999999999998654322
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc-----------------
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT----------------- 517 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----------------- 517 (608)
....++..|+||| ..++.++||||||+++|||++|+.||..........+ ..+....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR-IFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChHHhhhhhhchhhhh
Confidence 2334678899999 2357889999999999999999999865443322222 1111000
Q ss_pred --cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 518 --GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 518 --~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
...............+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000111112334567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=285.44 Aligned_cols=243 Identities=22% Similarity=0.254 Sum_probs=186.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCC-CCcceeeeeeeecC--CeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLK-HPNILPLVCYNSTN--EEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e~~~~ 380 (608)
+.+|+|++|.||++... +++.||+|+++... .......+|+..+.++. |+||+++++++.+. +..++|+||++
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 83 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD- 83 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-
Confidence 45799999999999864 68999999987432 22334457888999885 99999999999887 88999999996
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|+|.+++.. ....+++.++..++.|++.||+|||+.+ |+||||||+||+++. +.+||+|||+++......
T Consensus 84 ~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 84 MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG-----IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 688888764 2356899999999999999999999887 999999999999999 999999999998764332
Q ss_pred -ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh---------------hcc-
Q 042949 460 -TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE---------------EWT- 517 (608)
Q Consensus 460 -~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~---------------~~~- 517 (608)
....++..|+||| ...+.++|||||||++|||++|+.||....... .+...... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHHHHcCCCCHHHHHhhccccccc
Confidence 3345788999999 235789999999999999999999886543221 11111100 000
Q ss_pred ---cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 518 ---GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 518 ---~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.......+.......+..+.+++.+||..+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000011112223456779999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=282.37 Aligned_cols=236 Identities=24% Similarity=0.358 Sum_probs=196.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|++|.||++... +++.||+|++.... ...+.+.+|++.+.+++|+||+++++++...+..++|+||+++++|
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (264)
T cd06623 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSL 86 (264)
T ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcH
Confidence 57899999999999876 58999999987543 2456799999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc--
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQ-KSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT-- 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 460 (608)
.+++.. ...+++..++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||++........
T Consensus 87 ~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~-----~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 87 ADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH-----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC-----CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 999975 3678999999999999999999998 76 99999999999999999999999999987654332
Q ss_pred -cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC--ChHHHHHHHHhhhcccccccHHHHHhchh-c
Q 042949 461 -CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI--DLPKWVKAMVREEWTGEVFDKEVAKAGRQ-W 532 (608)
Q Consensus 461 -~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 532 (608)
...++..|+||| ..++.++||||||+++|||+||+.|+.... .............. ...... .
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 228 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---------PSLPAEEF 228 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---------CCCCcccC
Confidence 345788899999 456789999999999999999999986654 32222222221110 011122 5
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||..+|++||++.++++.
T Consensus 229 ~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 229 SPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 6678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=285.73 Aligned_cols=238 Identities=21% Similarity=0.305 Sum_probs=192.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|.|++|.||++... +++.+|+|++.... ...+++.+|++.+++++||||+++++++...+..++++||+++++|
T Consensus 7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (265)
T cd06605 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL 86 (265)
T ss_pred HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcH
Confidence 45899999999999876 68999999987542 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQ-KSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-TC 461 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~ 461 (608)
.+++... ...+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+....... ..
T Consensus 87 ~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~-----i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 87 DKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK-----IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred HHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC-----eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 9998752 2678999999999999999999998 65 9999999999999999999999999987654321 22
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC----ChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI----DLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
..++..|+||| ..++.++||||||+++|+|++|+.|+.... ......+....... .... ....+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~-------~~~~~ 230 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-PRLP-------SGKFS 230 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-CCCC-------hhhcC
Confidence 56788999999 567889999999999999999999986542 22222222211110 0000 01145
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.+++.+||..||++|||+.+++..
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 668899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=285.38 Aligned_cols=235 Identities=17% Similarity=0.226 Sum_probs=183.3
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccccc------CHHHHHHHHHHHhcCCCCcceeeeeeeec--CCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV------SMDEFSQTMRQIGNLKHPNILPLVCYNST--NEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e 376 (608)
.+.+|+|++|.||++... ++..||+|++..... ..+.+.+|+.++++++||||+++++++.. ....++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 467899999999999864 689999999863211 23457889999999999999999998875 356789999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+++++|.+++.. ...+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~-----i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 87 YMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999875 346899999999999999999999876 9999999999999999999999999998653
Q ss_pred CC------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 457 PK------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 457 ~~------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
.. .....++..|+||| ..++.++|||||||++|||++|+.||......... ......... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~-~~~~~~~~~-----~~-- 229 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-FKIATQPTN-----PQ-- 229 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH-HHHhcCCCC-----CC--
Confidence 21 12245788899999 44678999999999999999999998754332221 111111100 00
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+......+.+++ +||..+|++||+++||++
T Consensus 230 -~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 -LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0112234456676 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=282.29 Aligned_cols=237 Identities=21% Similarity=0.316 Sum_probs=191.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|++|.||++... +++.+|+|.+.... ...+.+.+|++++++++||||+++++.+...+..++|+||+++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08220 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85 (256)
T ss_pred EEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCC
Confidence 56899999999999864 67899999987432 234578899999999999999999999998999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-CceEeccccccccCCCC--
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-DPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~-- 459 (608)
|.+++... ....+++..+..++.|+++||+|||+++ |+|+||||+||++++++ .+||+|||+++......
T Consensus 86 L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 86 LAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL-----ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred HHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 99999752 2345899999999999999999999886 99999999999998654 57999999998765432
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
....++..|+||| ...+.++||||||+++|+|++|+.|+.... ............. .. .....+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~-~~--------~~~~~~~~ 228 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-LPALVLKIMSGTF-AP--------ISDRYSPD 228 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-hHHHHHHHHhcCC-CC--------CCCCcCHH
Confidence 3356788999999 456789999999999999999999986543 2222222221110 00 11234556
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.+++.+||..+|++|||+.|+++.
T Consensus 229 l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 229 LRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHHccCChhhCCCHHHHhhC
Confidence 8899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.86 Aligned_cols=235 Identities=21% Similarity=0.339 Sum_probs=187.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|++|.||+|... +++.||+|.+..... ..+++.+|++++++++||||+++++++...+..++|+||++ |
T Consensus 21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g 99 (307)
T cd06607 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 99 (307)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-C
Confidence 55899999999999875 689999999863221 23468899999999999999999999999999999999996 6
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
++.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++...... ..
T Consensus 100 ~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~-----i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-~~ 170 (307)
T cd06607 100 SASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE-----RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-NS 170 (307)
T ss_pred CHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcccEEECCCCCEEEeecCcceecCCC-CC
Confidence 787777532 346899999999999999999999876 999999999999999999999999999865433 34
Q ss_pred ccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 462 LFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 462 ~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
..++..|+||| ..++.++||||||+++|||+||+.|+........ ........ .... ....++.
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~~~~~~~-~~~~-------~~~~~~~ 241 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQND-SPTL-------SSNDWSD 241 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HHHHhcCC-CCCC-------CchhhCH
Confidence 56788999999 2367799999999999999999999864432221 11111110 0000 0122455
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.+++.+||..+|++||++.+++..
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 68999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.94 Aligned_cols=235 Identities=22% Similarity=0.230 Sum_probs=182.0
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHH---hcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l---~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
++|+|+||.||+++.. +++.+|+|.+..... ....+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4799999999999874 689999998864321 122334444333 34479999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~-----ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 9999998875 456999999999999999999999987 9999999999999999999999999987654322
Q ss_pred -ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC-hHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 460 -TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGID-LPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 460 -~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
....|+..|+||| ..++.++|||||||++|||++|..||..... ........... .. . ......
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~----~---~~~~~~ 222 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VN----V---ELPDSF 222 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc--CC----c---CCcccc
Confidence 3346889999999 2367889999999999999999999864322 11111111100 00 0 112234
Q ss_pred HHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
+.++.+++.+||..||++|| ++.|+++.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 56688999999999999999 58888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.55 Aligned_cols=243 Identities=21% Similarity=0.223 Sum_probs=187.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~ 380 (608)
+.+|+|++|.||+|... +++.+|+|.++.... ....+.+|+.++.+++||||+++++++... +..++|+||++
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~- 89 (293)
T cd07843 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE- 89 (293)
T ss_pred hhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-
Confidence 56899999999999976 688999999974322 233567899999999999999999998876 88999999996
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++......
T Consensus 90 ~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 90 HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW-----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 5999988752 346899999999999999999999887 9999999999999999999999999998765431
Q ss_pred --ccccccCccccCCC-----CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-----------------
Q 042949 460 --TCLFSSNGYTAPEK-----TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE----------------- 515 (608)
Q Consensus 460 --~~~~gt~~y~aPE~-----~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------------- 515 (608)
....++..|+|||. ..+.++||||||+++|||++|..||........ ........
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhccchh
Confidence 23456788999992 357889999999999999999999875443221 11111100
Q ss_pred ---cccccccHHHHHhchh--cHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 516 ---WTGEVFDKEVAKAGRQ--WAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 516 ---~~~~~~~~~~~~~~~~--~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.........+...... .+..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000111111111 3566889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.59 Aligned_cols=244 Identities=20% Similarity=0.288 Sum_probs=189.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|++|.||+|... +++.||+|+++... ...+.+.+|++++++++|+||+++++++...+..+++|||++++.
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 86 (288)
T cd07833 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL 86 (288)
T ss_pred EEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCH
Confidence 46899999999999876 57899999987432 234678999999999999999999999999999999999999876
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
+..+... ...+++..+..++.||+.||+|||+.+ |+||||+|+||++++++.+||+|||++.......
T Consensus 87 l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 87 LELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN-----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 6655542 456899999999999999999999886 9999999999999999999999999998765432
Q ss_pred -ccccccCccccCC----C-CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHh--------------hh-c--
Q 042949 460 -TCLFSSNGYTAPE----K-TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVR--------------EE-W-- 516 (608)
Q Consensus 460 -~~~~gt~~y~aPE----~-~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~--------------~~-~-- 516 (608)
....++..|+||| . .++.++||||||+++|||++|+.|+............... .. .
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 2345678899999 3 5678999999999999999999988654332211111000 00 0
Q ss_pred --ccccccHH-HH-HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 517 --TGEVFDKE-VA-KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 517 --~~~~~~~~-~~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.....+.. .. ......+.++.+++.+||..+|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 00 111223677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=287.35 Aligned_cols=247 Identities=19% Similarity=0.216 Sum_probs=188.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCe-----eEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEE-----KLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~-----~~lv~e 376 (608)
..+|+|++|.||+|... +++.||+|+++... .....+.+|+.++++++ ||||+++++++...+. .++|||
T Consensus 7 ~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e 86 (295)
T cd07837 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFE 86 (295)
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEee
Confidence 56899999999999875 68999999886432 12356888999999995 6999999998877655 799999
Q ss_pred eccCCCHHHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-CCCceEeccccccc
Q 042949 377 YQSNGSLLSLLEAYIEG-KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-NEDPLISECGYSKF 454 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 454 (608)
|+++ +|.+++...... ...+++..++.++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||+++.
T Consensus 87 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 87 YLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-----VMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred ccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChHHEEEecCCCeEEEeeccccee
Confidence 9975 899988753222 356899999999999999999999886 999999999999998 88999999999986
Q ss_pred cCCCC---ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc-cccc-----
Q 042949 455 LDPKK---TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW-TGEV----- 520 (608)
Q Consensus 455 ~~~~~---~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~----- 520 (608)
..... ....+++.|+||| ..++.++||||||+++|||++|..||.................. ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 53321 2234677899999 24578999999999999999999998765444333221110000 0000
Q ss_pred -----------ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 521 -----------FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 521 -----------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
............+.++.+++.+||..||++||+++|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 001111112235667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=282.18 Aligned_cols=237 Identities=22% Similarity=0.305 Sum_probs=190.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|++|.||++... +++.||+|.++.... ..+.+.+|++++++++|+||+++++++...+..++|+||+++++
T Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06626 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85 (264)
T ss_pred eEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCc
Confidence 56899999999999865 789999999975433 45678999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc--
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT-- 460 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 460 (608)
|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 86 L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 86 LEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG-----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred HHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999874 345889999999999999999999887 99999999999999999999999999987654321
Q ss_pred -----cccccCccccCC----CC---CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 461 -----CLFSSNGYTAPE----KT---VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 461 -----~~~gt~~y~aPE----~~---~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
...++..|+||| .. .+.++||||||++++|+++|+.||............... . ....+. .
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~-~~~~~~-----~ 229 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-G-HKPPIP-----D 229 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-C-CCCCCC-----c
Confidence 235678899999 22 678899999999999999999998654322221111111 0 000000 1
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.......+.+++.+||+.+|++|||+.|++.
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1123456789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=282.73 Aligned_cols=242 Identities=21% Similarity=0.348 Sum_probs=192.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|.|++|.||+|... ++..+|+|++.... ...+.+.+|++.++.++|+||+++++.+...+..++++||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l 86 (267)
T cd06610 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL 86 (267)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcH
Confidence 45799999999999864 67899999987432 2456789999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---- 459 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---- 459 (608)
.++++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..+....
T Consensus 87 ~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~~-----i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 87 LDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNG-----QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred HHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99997521 1246899999999999999999999876 9999999999999999999999999988665432
Q ss_pred ---ccccccCccccCC----C-CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 460 ---TCLFSSNGYTAPE----K-TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 460 ---~~~~gt~~y~aPE----~-~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....++..|+||| . ..+.++|||||||+++||++|+.|+..........+ ...... ...... .....
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~-~~~~~~--~~~~~~--~~~~~ 235 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML-TLQNDP--PSLETG--ADYKK 235 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH-HhcCCC--CCcCCc--ccccc
Confidence 2345788999999 2 578899999999999999999999865433222211 111110 000000 00123
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+..+.+++.+||..||++||++.++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 4566889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=282.49 Aligned_cols=234 Identities=18% Similarity=0.228 Sum_probs=189.7
Q ss_pred cCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+|.|++|.||+++.. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 589999999999975 48999999987432 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--Ccc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--KTC 461 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--~~~ 461 (608)
.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||+++..... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~-----~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG-----IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence 999975 356899999999999999999999876 999999999999999999999999999877543 233
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC-hHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID-LPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
..++..|++|| ..++.++|+||||+++|||++|+.|+..... ............... ..+...+..+
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 223 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL--------EFPNYIDKAA 223 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC--------CCCcccCHHH
Confidence 46788999999 4568899999999999999999999865442 222222222111000 1112224568
Q ss_pred HHHHHHchhcCCCCCCC-----HHHHHH
Q 042949 537 LNVALKCVSNSPDDRPT-----MAEVLE 559 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs-----~~evl~ 559 (608)
.+++.+||..+|++||+ ++|+++
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 89999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=283.90 Aligned_cols=234 Identities=20% Similarity=0.303 Sum_probs=189.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
..+|.|+||.||+|... ++..||+|.+.... .....+.+|+.++.+++||||+++++++...+..++||||+++++|
T Consensus 10 ~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 89 (277)
T cd06641 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 89 (277)
T ss_pred eeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcH
Confidence 35899999999999864 68899999886432 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---c
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~ 460 (608)
.+++.. ..+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||+++.+.... .
T Consensus 90 ~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 90 LDLLEP-----GPLDETQIATILREILKGLDYLHSEK-----KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC-----eecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 998863 46899999999999999999999876 9999999999999999999999999988664432 2
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...++..|+||| ...+.++|||||||++|||++|..|+..... .......... ... ......+.++
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~-~~~--------~~~~~~~~~~ 229 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-MKVLFLIPKN-NPP--------TLEGNYSKPL 229 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-HHHHHHHhcC-CCC--------CCCcccCHHH
Confidence 345788899999 4567789999999999999999999864322 1111111111 000 0112345568
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+||+.+|++||++.++++.
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 230 KEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHccCChhhCcCHHHHHhC
Confidence 899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=289.29 Aligned_cols=241 Identities=17% Similarity=0.245 Sum_probs=191.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||++... +++.||+|.+.... ...+.+.+|++++++++||||+++++.+..++..++||||++++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (305)
T cd05609 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG 86 (305)
T ss_pred eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 56899999999999875 57899999987432 22456789999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 87 DCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999975 356899999999999999999999876 999999999999999999999999998742110
Q ss_pred ---------------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccc
Q 042949 459 ---------------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGE 519 (608)
Q Consensus 459 ---------------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 519 (608)
.....++..|+||| ..++.++|||||||++|||++|+.||.... .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-~~~~~~~~~~~~~--- 233 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDDI--- 233 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccc---
Confidence 01234677899999 467889999999999999999999986432 2222222221110
Q ss_pred cccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 520 VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 520 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
..+ ......+..+.+++.+||+.||++||++.++.+.|+.-
T Consensus 234 -~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 234 -EWP---EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred -CCC---CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 000 01113456688999999999999999977777766653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=286.52 Aligned_cols=235 Identities=17% Similarity=0.263 Sum_probs=190.9
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|+|++|.||++.. .+++.+|+|+++... ...+.+.+|+.++++++||||+++++++...+..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 5789999999999986 478899999986432 23456889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---cc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~ 461 (608)
+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ..
T Consensus 105 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 105 DIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG-----VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred HHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 98864 45899999999999999999999887 9999999999999999999999999887654322 23
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|+||| ..++.++|||||||++|||++|+.|+...... ......... ..... ......+..+.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~~~~~-~~~~~------~~~~~~~~~l~ 246 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKRIRDN-LPPKL------KNLHKVSPRLR 246 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHhc-CCCCC------cccccCCHHHH
Confidence 45788999999 45788999999999999999999998654322 222222111 00000 01122445689
Q ss_pred HHHHHchhcCCCCCCCHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~ 559 (608)
+++.+||..+|++||++.++++
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 247 SFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHcccChhhCcCHHHHcc
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=287.35 Aligned_cols=244 Identities=21% Similarity=0.235 Sum_probs=187.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..+|+|+||.||++... +++.||+|++.... .....+.+|+.++.++. |+||+++++++..++..+++|||+. ++
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~ 88 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-IS 88 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CC
Confidence 56899999999999864 68999999987432 23456889999999996 9999999999999899999999985 46
Q ss_pred HHHHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--C
Q 042949 383 LLSLLEAY-IEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--K 459 (608)
Q Consensus 383 L~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--~ 459 (608)
+.++.... ......+++..+..++.|+++||+|||+.. +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 89 l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 89 LDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL----KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred HHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC----CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 65544321 122467999999999999999999999752 3999999999999999999999999999765432 2
Q ss_pred ccccccCccccCC----C---CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 460 TCLFSSNGYTAPE----K---TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~---~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
....++..|+||| . .++.++|||||||++|||++|+.||................. ... .. .......
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~-~~---~~~~~~~ 239 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD-PPI-LS---NSEEREF 239 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC-CCc-CC---CcCCCcc
Confidence 3346788999999 2 467899999999999999999999865432211111111100 000 00 0111235
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.++.+++.+||+.||++|||+++|+..
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 6678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=284.28 Aligned_cols=244 Identities=16% Similarity=0.164 Sum_probs=185.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
..+|+|++|.||+|... +|..||+|++.... .....+.+|++++++++|+||+++++++...+..++|+||+. ++|
T Consensus 11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l 89 (291)
T cd07870 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDL 89 (291)
T ss_pred EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCH
Confidence 45899999999999864 68999999987432 223467889999999999999999999999999999999995 788
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~ 460 (608)
.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ..
T Consensus 90 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 90 AQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH-----ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 777653 2345788899999999999999999886 999999999999999999999999999764322 12
Q ss_pred cccccCccccCCC-----CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh----------------cccc
Q 042949 461 CLFSSNGYTAPEK-----TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE----------------WTGE 519 (608)
Q Consensus 461 ~~~gt~~y~aPE~-----~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------------~~~~ 519 (608)
...++..|+|||. .++.++|||||||++|||++|+.||................. +...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 3356888999992 357789999999999999999999875443322222211100 0000
Q ss_pred cc----cHHHHHh--chhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 520 VF----DKEVAKA--GRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 520 ~~----~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.. ....... .......+.+++.+|++.||++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 0000000 0112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.51 Aligned_cols=245 Identities=19% Similarity=0.199 Sum_probs=190.0
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccccCH---------------HHHHHHHHHHhcCCCCcceeeeeeeecCC
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSM---------------DEFSQTMRQIGNLKHPNILPLVCYNSTNE 369 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~---------------~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 369 (608)
..++|.|++|.||++... +++.||||+++...... ..+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467899999999999865 68999999986432211 24678999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecc
Q 042949 370 EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC 449 (608)
Q Consensus 370 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 449 (608)
..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~-----i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY-----FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred cEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccccHHHeEECCCCCEEECCc
Confidence 9999999996 689988864 456899999999999999999999877 999999999999999999999999
Q ss_pred ccccccCCC-----------------CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHH
Q 042949 450 GYSKFLDPK-----------------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKW 507 (608)
Q Consensus 450 Gla~~~~~~-----------------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~ 507 (608)
|+++..... .....++..|+||| ..++.++|||||||++|||+||+.|+.........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999865411 11234577899999 23578999999999999999999998765443222
Q ss_pred HHHHH--hhh----cc-----------cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 508 VKAMV--REE----WT-----------GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 508 ~~~~~--~~~----~~-----------~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..... ... +. ...............+..+.+++.+||+.+|++|||++|++..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11110 000 00 0000111112223446678899999999999999999999863
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=289.31 Aligned_cols=247 Identities=19% Similarity=0.277 Sum_probs=186.8
Q ss_pred cccCCCCCceEEEEEEc---CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLK---NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~---~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~ 377 (608)
..+|+|++|.||+|... ++..||+|.+.... ...+.+.+|+.++.+++||||+++++++... +..++||||
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 85 (316)
T cd07842 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY 85 (316)
T ss_pred EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence 45899999999999875 47899999997522 2245678899999999999999999999987 889999999
Q ss_pred ccCCCHHHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC----CCCceEeccccc
Q 042949 378 QSNGSLLSLLEAYIEG-KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE----NEDPLISECGYS 452 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFGla 452 (608)
++ ++|.+++...... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++
T Consensus 86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 86 AE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW-----VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred CC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC-----EeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 96 5787777643322 237899999999999999999999887 999999999999999 899999999999
Q ss_pred cccCCCC------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChH--------HHHHHHHh
Q 042949 453 KFLDPKK------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLP--------KWVKAMVR 513 (608)
Q Consensus 453 ~~~~~~~------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~--------~~~~~~~~ 513 (608)
+...... ....++..|+||| ..++.++|||||||+++||++|+.|+....... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 8764322 2345678899999 346789999999999999999999986432211 00000000
Q ss_pred h-----------------------hccccccc-HHHHH---hchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 514 E-----------------------EWTGEVFD-KEVAK---AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 514 ~-----------------------~~~~~~~~-~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
. ........ ..+.. ........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 00000000 00000 00134566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=280.68 Aligned_cols=237 Identities=21% Similarity=0.331 Sum_probs=191.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|++|.||++... +|..+|+|.+... ....+.+.+|++++++++|+||+++++.+...+..++|+||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (257)
T cd08225 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGD 85 (257)
T ss_pred EEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCc
Confidence 56899999999999875 5889999998643 2344578899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-CceEeccccccccCCCC--
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-DPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~-- 459 (608)
|.+++.. .....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++ .+||+|||.+.......
T Consensus 86 L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 86 LMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDRK-----ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred HHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 9999875 22345899999999999999999999876 99999999999999885 46999999998765432
Q ss_pred -ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 -TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 -~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....|+..|+||| ..++.++||||||++++||++|+.|+... .............. . ......+.
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~--------~~~~~~~~ 228 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYF-A--------PISPNFSR 228 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccC-C--------CCCCCCCH
Confidence 2345788899999 45788999999999999999999998643 22333332222111 0 11123445
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.+++.+||..+|++|||+.|+++.
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 229 DLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhC
Confidence 68899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=284.23 Aligned_cols=238 Identities=18% Similarity=0.327 Sum_probs=193.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
..+|+|++|.||++... ++..||+|+++......+.+.+|++.+++++|+|++++++++...+..++++||+++++|.+
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 104 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD 104 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHH
Confidence 45799999999999886 68899999998544356778999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---ccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TCL 462 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~~ 462 (608)
++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++....... ...
T Consensus 105 ~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~g-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 105 IITQN---FVRMNEPQIAYVCREVLQGLEYLHSQN-----VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred HHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 99862 237999999999999999999999876 9999999999999999999999999987654322 234
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
.++..|++|| ..++.++|||||||++|||++|+.|+........ ........ ..... ....++..+.+
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~~~~------~~~~~~~~l~~ 248 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LFLITTKG-IPPLK------NPEKWSPEFKD 248 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcC-CCCCc------chhhCCHHHHH
Confidence 5778899999 4568899999999999999999999865433221 11111111 11100 11224556889
Q ss_pred HHHHchhcCCCCCCCHHHHHHH
Q 042949 539 VALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~~ 560 (608)
++.+||+.+|.+||++.++++.
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=282.45 Aligned_cols=245 Identities=17% Similarity=0.229 Sum_probs=189.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|.|++|.||+|+.. +|..||||+++... ...+.+.+|++++++++||||+++++++...+..++||||++ |+|
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l 84 (284)
T cd07836 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDL 84 (284)
T ss_pred eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccH
Confidence 45799999999999975 68999999987432 234667889999999999999999999999999999999997 589
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---c
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~ 460 (608)
.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++...... .
T Consensus 85 ~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 85 KKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR-----VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred HHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 88886521 2346899999999999999999999886 9999999999999999999999999998654321 2
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh----------------cc--
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE----------------WT-- 517 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------------~~-- 517 (608)
...++..|++|| ..++.++|||||||++|||++|+.||........ ........ ..
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 345678899999 2357899999999999999999999875543221 11111100 00
Q ss_pred -cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 518 -GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 518 -~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
....+..........+..+.+++.+|++.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000001111111233556889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=281.95 Aligned_cols=237 Identities=21% Similarity=0.347 Sum_probs=188.8
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEeccccc-------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV-------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
...+|+|++|.||+++. .+++.||+|.++.... ..+.+.+|++.+++++|+||+++++++...+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 35689999999999985 5789999999873221 235688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-CceEeccccccccC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-DPLISECGYSKFLD 456 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 456 (608)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||.+....
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~-----i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 85 MAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ-----IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred cCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999875 356899999999999999999999987 99999999999998776 58999999988664
Q ss_pred CCC-------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh--HHHHHHHHhhhcccccccH
Q 042949 457 PKK-------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL--PKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 457 ~~~-------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 523 (608)
... ....++..|+||| ..++.++||||+|++++||++|..|+...... ............. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~---- 230 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA-P---- 230 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC-C----
Confidence 321 2345788999999 46688999999999999999999998643221 1111111000000 0
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
........++.+++.+|+..+|++||++.|+++
T Consensus 231 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 ---SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111223456889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=277.56 Aligned_cols=255 Identities=21% Similarity=0.255 Sum_probs=197.6
Q ss_pred CcCHHHHHHHhhcccCCCCCceEEEEEE-cCCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCe
Q 042949 295 RFKLDDLLEATADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEE 370 (608)
Q Consensus 295 ~~~~~~l~~~~~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 370 (608)
.|+-++|... ..+|.|.||+|++-.+ +.|+..|||+++... ....++..|.+...+- +.||||+++|.+..++.
T Consensus 60 ~F~~~~Lqdl--g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQDL--GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHHHH--HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 4555566543 4589999999999765 579999999998432 3556788888876554 69999999999999999
Q ss_pred eEEEEeeccCCCHHHHHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecc
Q 042949 371 KLLVYKYQSNGSLLSLLEA-YIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC 449 (608)
Q Consensus 371 ~~lv~e~~~~g~L~~~l~~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 449 (608)
.|+.||.| .-+|..+-.. +...+..+++...-+|+.-...||+||-... .|||||+||+|||+|..|.+||+||
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l----kiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL----KIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh----hhhhccCChhheEEecCCCEeeecc
Confidence 99999999 4566554322 2234567999999999999999999997654 5999999999999999999999999
Q ss_pred ccccccCCC--CccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 450 GYSKFLDPK--KTCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 450 Gla~~~~~~--~~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
|.+-.+..+ .+...|...||||| .-|+.+|||||+||+|+|+.||+.|+..-.+..+.+.+........-..
T Consensus 213 GIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 213 GICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred cchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 999876543 34567889999999 2378899999999999999999999876554444444443322111111
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.....+.+.++..++..|+..|-++||+..++.++
T Consensus 293 ----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 ----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11223467789999999999999999999998765
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=284.11 Aligned_cols=235 Identities=17% Similarity=0.291 Sum_probs=189.5
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc--ccCHHHHHHHHHHHhcCC---CCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.+|+|++|.||+|.. .+++.||+|.++.. .....++.+|+.++++++ |||++++++++......++||||+++
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEG 86 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCC
Confidence 4589999999999986 57899999998643 234567889999999986 99999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
++|.++++. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 87 ~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 87 GSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG-----VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999998863 36899999999999999999999887 9999999999999999999999999998765432
Q ss_pred --ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 460 --TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 460 --~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
....|+..|+||| ..++.++|||||||++|||++|+.|+..... .......... .. +.+. ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~-~~-----~~~~--~~~~ 227 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-FRAMMLIPKS-KP-----PRLE--DNGY 227 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-hhhhhccccC-CC-----CCCC--cccC
Confidence 3346788899999 2357899999999999999999999864322 1111111000 00 0000 1124
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||+.||++||++.|++..
T Consensus 228 ~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 228 SKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 5668899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=283.41 Aligned_cols=234 Identities=22% Similarity=0.276 Sum_probs=191.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|.|+||.||+++.. +++.||+|.+.... ...+.+.+|++++++++||||+++++++......++|+||++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (258)
T cd05578 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG 85 (258)
T ss_pred EEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCC
Confidence 56899999999999876 58999999997432 23567889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--C
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--K 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--~ 459 (608)
+|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||++...... .
T Consensus 86 ~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 86 DLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG-----IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred CHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence 99999875 357899999999999999999999876 999999999999999999999999998876543 2
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh-HHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL-PKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....++..|+||| ...+.++||||||+++|+|++|+.|+...... ...+...... .. ...+...+.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~-------~~~~~~~~~ 227 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--AD-------VLYPATWST 227 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--cc-------ccCcccCcH
Confidence 3355778899999 45688999999999999999999998754431 1111111110 00 011223456
Q ss_pred HHHHHHHHchhcCCCCCCCH--HHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTM--AEVL 558 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~--~evl 558 (608)
.+.+++.+||..||++||++ +|++
T Consensus 228 ~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 228 EAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHHHHHccCChhHcCCccHHHHh
Confidence 78899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=280.54 Aligned_cols=237 Identities=16% Similarity=0.219 Sum_probs=183.3
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHH-hcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQI-GNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+|.|++|.||+|... +|+.||+|.++.... ....+..|...+ ...+|+|++++++++...+..++|+||++++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 4799999999999874 689999999874321 112344454443 4558999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.... ...
T Consensus 83 ~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~ 152 (260)
T cd05611 83 DCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG-----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-NKK 152 (260)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCcEEEeecccceeccc-ccc
Confidence 99999875 356899999999999999999999876 99999999999999999999999999886543 234
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|+||| ..++.++||||||+++|||+||..|+...... ............ ... ......+..+.
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~---~~~---~~~~~~~~~~~ 225 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNILSRRIN---WPE---EVKEFCSPEAV 225 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcccC---CCC---cccccCCHHHH
Confidence 46788999999 34688999999999999999999998654332 222211111100 000 01123456689
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
+++.+||+.+|++||++.++.+.|
T Consensus 226 ~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 226 DLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHHccCCHHHccCCCcHHHHH
Confidence 999999999999999876554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=283.18 Aligned_cols=237 Identities=21% Similarity=0.254 Sum_probs=185.9
Q ss_pred cCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+|+|+||+||++... +|+.||+|.+.... .....+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 589999999999764 68999999986422 2244567899999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--TC 461 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--~~ 461 (608)
.+++... ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR-----IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 9998752 2346899999999999999999999887 9999999999999999999999999988654322 23
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|+||| ..++.++|||||||++|+|++|+.||.......... ..... ... .........+..+.
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~-~~~-----~~~~~~~~~~~~~~ 226 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-ELKRR-TLE-----MAVEYPDKFSPEAK 226 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-HHHhc-ccc-----ccccCCccCCHHHH
Confidence 45678899999 457789999999999999999999986543211100 00000 000 00011223456688
Q ss_pred HHHHHchhcCCCCCC-----CHHHHHH
Q 042949 538 NVALKCVSNSPDDRP-----TMAEVLE 559 (608)
Q Consensus 538 ~li~~Cl~~dP~~RP-----s~~evl~ 559 (608)
+++.+||+.||++|| ++.++++
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHh
Confidence 999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=284.24 Aligned_cols=246 Identities=17% Similarity=0.209 Sum_probs=187.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|.+|.||+|+.. +|+.||+|++.... ...+.+.+|++++++++||||+++++++...+..++||||++ ++
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 86 (294)
T PLN00009 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LD 86 (294)
T ss_pred EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-cc
Confidence 45799999999999875 78999999986432 223568899999999999999999999999999999999995 68
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-CCCceEeccccccccCCCC--
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-NEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~-- 459 (608)
|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||+++......
T Consensus 87 l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-----i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 87 LKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred HHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 8887754 22334688889999999999999999876 999999999999985 4568999999998654321
Q ss_pred -ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-ccccc------------
Q 042949 460 -TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-WTGEV------------ 520 (608)
Q Consensus 460 -~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~------------ 520 (608)
....++..|+||| ..++.++|||||||++|||+||+.||..........+...... .....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 2345678899999 2467899999999999999999999876543322222111000 00000
Q ss_pred -----ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 521 -----FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 521 -----~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
............+..+.+++.+|++.+|++||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111123345668899999999999999999999863
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.83 Aligned_cols=236 Identities=17% Similarity=0.291 Sum_probs=189.8
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|+||.||++.. .++..||+|.+... ....+.+.+|+.++++++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (293)
T cd06647 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (293)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHH
Confidence 4579999999999985 46889999998643 334567889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---cc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~ 461 (608)
+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ..
T Consensus 105 ~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g-----i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 105 DVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred HHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC-----EeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 99864 35889999999999999999999887 9999999999999999999999999987654332 23
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|+||| ..++.++|||||||++||+++|+.||.......... ...... ... + ......+..+.
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~~~-~~~-~-----~~~~~~~~~l~ 246 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNG-TPE-L-----QNPEKLSAIFR 246 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehhcCC-CCC-C-----CCccccCHHHH
Confidence 45788899999 456789999999999999999999986543321111 110000 000 0 01112344578
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+++.+||+.+|++||++.+++.+
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=281.90 Aligned_cols=236 Identities=21% Similarity=0.285 Sum_probs=189.0
Q ss_pred cCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+|.|++|.||+++.. +|+.+|+|.+.... ...+.+.+|++++.+++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 588999999999986 48999999987432 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-----
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK----- 458 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~----- 458 (608)
.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~-----i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG-----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 999975 347899999999999999999999876 999999999999999999999999998754322
Q ss_pred ------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 459 ------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 459 ------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
.....++..|++|| ...+.++||||||+++||+++|+.|+..... .............. ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~--------~~ 222 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-EEIFQNILNGKIEW--------PE 222 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCcCC--------Cc
Confidence 12345778899999 4467899999999999999999999865432 22222222111000 00
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
....+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1113566889999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=282.24 Aligned_cols=244 Identities=19% Similarity=0.296 Sum_probs=190.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~ 380 (608)
..+|.|++|.||+|+.. +++.+|+|++... ......+.+|++++++++|+|++++++++... +..++|+||++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~- 83 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD- 83 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-
Confidence 45799999999999876 5899999999854 22345688999999999999999999999887 88999999997
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
++|.+++.. ....+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~-----~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 84 HDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG-----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 588888763 2257899999999999999999999886 9999999999999999999999999998765432
Q ss_pred ---ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-------c--------
Q 042949 460 ---TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-------W-------- 516 (608)
Q Consensus 460 ---~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------~-------- 516 (608)
....++..|+||| ..++.++||||||+++|||+||+.|+..... ........... +
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccchh
Confidence 2345677899999 2467899999999999999999999865443 22222211100 0
Q ss_pred -----ccccccHHHHHhchh-cHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 517 -----TGEVFDKEVAKAGRQ-WAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 517 -----~~~~~~~~~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
........+...... ++..+.+++.+||..+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000111111122 36778999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=291.53 Aligned_cols=249 Identities=20% Similarity=0.243 Sum_probs=189.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 376 (608)
..+|+|++|.||+|... +|+.||||+++... .....+.+|++++++++||||+++++++... ...++|+|
T Consensus 21 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 100 (342)
T cd07879 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP 100 (342)
T ss_pred EEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEec
Confidence 56899999999999864 78999999987422 2235678999999999999999999988654 34689999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+. .+|.+++ ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~-----i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 101 YMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG-----IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred ccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 996 4666654 235899999999999999999999887 9999999999999999999999999998765
Q ss_pred CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh-hcc-------------
Q 042949 457 PKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE-EWT------------- 517 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~------------- 517 (608)
.......++..|+||| ..++.++|||||||++|||++|+.||......... ...... ...
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL-TQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCCHHHHHHhcccch
Confidence 5545556788899999 23678999999999999999999998754332222 111110 000
Q ss_pred -------cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhhcCC
Q 042949 518 -------GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVVNGN 568 (608)
Q Consensus 518 -------~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~~~ 568 (608)
..................+.+++.+||+.||++||++++++.. ++...+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 0000001111112344568899999999999999999999965 77765433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=288.71 Aligned_cols=251 Identities=18% Similarity=0.258 Sum_probs=187.4
Q ss_pred cCCC--CCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 309 RSQT--ICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 309 ~g~g--~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+|+| ++|+||+++.. +|+.||+|++..... ..+.+.+|+.+++.++||||+++++++..++..++|+||+.+|+
T Consensus 6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~ 85 (328)
T cd08226 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85 (328)
T ss_pred hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCC
Confidence 4555 88999999864 789999999874332 23567889999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC----
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---- 458 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---- 458 (608)
|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+......
T Consensus 86 l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 86 ANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQNG-----YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred HHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99998763 2345899999999999999999999876 999999999999999999999999865432111
Q ss_pred ------CccccccCccccCCC------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc--------
Q 042949 459 ------KTCLFSSNGYTAPEK------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG-------- 518 (608)
Q Consensus 459 ------~~~~~gt~~y~aPE~------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 518 (608)
.....++..|+|||. .++.++|||||||++|||++|+.||....................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 011234567999992 257899999999999999999999865433222211111100000
Q ss_pred ---------------------------ccccHHH-HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhhc
Q 042949 519 ---------------------------EVFDKEV-AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVVN 566 (608)
Q Consensus 519 ---------------------------~~~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~ 566 (608)
....... ......++..+.+++.+||+.||++|||++|+++. ++.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000000 01112345678999999999999999999999865 555544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=286.11 Aligned_cols=240 Identities=21% Similarity=0.315 Sum_probs=191.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. ++..||+|++..... ...++.+|++++++++|||++++++++...+..++||||++ |
T Consensus 31 ~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g 109 (317)
T cd06635 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-G 109 (317)
T ss_pred heeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-C
Confidence 45899999999999864 689999999864321 23468889999999999999999999999999999999996 5
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.+++.. ....+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++..... ...
T Consensus 110 ~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-~~~ 180 (317)
T cd06635 110 SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASIASP-ANS 180 (317)
T ss_pred CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcccEEECCCCCEEEecCCCccccCC-ccc
Confidence 88887753 2456899999999999999999999887 99999999999999999999999999876543 234
Q ss_pred ccccCccccCCC-------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 462 LFSSNGYTAPEK-------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 462 ~~gt~~y~aPE~-------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
..++..|+|||. .++.++|||||||++|||++|+.|+.......... ......... .....++.
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~ 251 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPT--------LQSNEWSD 251 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH-HHHhccCCC--------CCCccccH
Confidence 567889999992 46778999999999999999999986543222221 111111100 01123445
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
.+.+++.+||+.+|++||++.++++.+....
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 5889999999999999999999998766544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=275.45 Aligned_cols=238 Identities=22% Similarity=0.349 Sum_probs=194.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc-CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV-SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|++|.||++... +++.+++|++..... ....+.+|++.+++++|+|++++++++......++++||+++++|.
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 85 (253)
T cd05122 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK 85 (253)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHH
Confidence 46899999999999976 789999999975433 5577899999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--ccc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--TCL 462 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--~~~ 462 (608)
+++... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||.+....... ...
T Consensus 86 ~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 86 DLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred HHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC-----EecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 998752 257899999999999999999999876 9999999999999999999999999998776543 456
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
.++..|++|| ...+.++||||||+++++|++|+.|+........... ... ....... .....+..+.+
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~-~~~~~~~------~~~~~~~~~~~ 229 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-IAT-NGPPGLR------NPEKWSDEFKD 229 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HHh-cCCCCcC------cccccCHHHHH
Confidence 6788999999 4568899999999999999999999865432221111 111 1111110 11123566889
Q ss_pred HHHHchhcCCCCCCCHHHHHHH
Q 042949 539 VALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~~ 560 (608)
++.+||+.||++|||+.|+++.
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=280.84 Aligned_cols=234 Identities=21% Similarity=0.213 Sum_probs=181.9
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHH---HHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMR---QIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~---~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
++|+|+||.||++... +++.||+|.+..... ....+..|.. .++..+||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999999864 688999999864321 1122334433 3445679999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 458 (608)
+|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 9999988864 457999999999999999999999876 999999999999999999999999998865432
Q ss_pred CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChH-HHHHHHHhhhcccccccHHHHHhchhc
Q 042949 459 KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLP-KWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 459 ~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
.....|+..|+||| ..++.++||||+||++|||++|+.||....... ......... . .. ......
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-----~~---~~~~~~ 222 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-M-----AV---ELPDSF 222 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-c-----CC---CCCCcC
Confidence 23456889999999 146788999999999999999999986542211 111110000 0 00 111234
Q ss_pred HHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRP-----TMAEVLE 559 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 559 (608)
+..+.+++.+|+..+|++|| ++.++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 56788999999999999999 8988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.65 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=192.7
Q ss_pred hcccCCCCCceEEEEE-EcCCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVR-LKNSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 376 (608)
.+.+|+|+||.||+|+ ..+|..||||.++.. ....+...+|+++|++++|+|||++++.-.+. ....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4678999999999999 468999999999842 34567788999999999999999999875543 46789999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC--CCC--CceEeccccc
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN--ENE--DPLISECGYS 452 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~--~~~--~~kl~DFGla 452 (608)
||.+|||...|+.- .....|++.+.+.+..+++.||.|||+++ |+||||||.||++- .++ .-||+|||.|
T Consensus 98 yC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn~-----IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRENG-----IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999863 33567999999999999999999999877 99999999999983 223 3699999999
Q ss_pred cccCCCC--ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHH---HHHHHHhhhcccccc-
Q 042949 453 KFLDPKK--TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPK---WVKAMVREEWTGEVF- 521 (608)
Q Consensus 453 ~~~~~~~--~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~- 521 (608)
|.+++.. ...+||..|.+|| ..++..+|.|||||++||++||..||........ ............-++
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 9988765 5678999999999 5688899999999999999999999865433211 111111111000000
Q ss_pred -cH---------HHHHhc----hhcHHHHHHHHHHchhcCCCCCC--CHHHHHHHHHHhhc
Q 042949 522 -DK---------EVAKAG----RQWAFPLLNVALKCVSNSPDDRP--TMAEVLERIEEVVN 566 (608)
Q Consensus 522 -~~---------~~~~~~----~~~~~~l~~li~~Cl~~dP~~RP--s~~evl~~L~~~~~ 566 (608)
.+ ...+.+ ......+-.++..++..+|.+|- ...+....+..|++
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 00 000001 11222345677778888888888 77777777777654
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=276.46 Aligned_cols=237 Identities=22% Similarity=0.313 Sum_probs=194.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~ 380 (608)
+.+|+|++|.||+|... +++.|++|++.... ...+.+.+|++.+++++||||+++++.+... +..++++||+++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 85 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence 56899999999999876 78999999987543 3456788999999999999999999999888 889999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 86 ~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~-----~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 86 GSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG-----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999875 337999999999999999999999976 9999999999999999999999999998765442
Q ss_pred ----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 460 ----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 460 ----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....++..|++|| ...+.++||||||+++++|++|+.|+................... ...+..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 228 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP--------PEIPEH 228 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCC--------cCCCcc
Confidence 3456788899999 347889999999999999999999987654322222221110000 011223
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+..+.+++.+|++.+|++||++.|+++.
T Consensus 229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 229 LSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 35668899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=282.31 Aligned_cols=246 Identities=22% Similarity=0.306 Sum_probs=189.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|++|+||+|... +++.||||++..... ......+|+..+++++ |+||+++++++...+..++||||+ +|+
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 83 (283)
T cd07830 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGN 83 (283)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCC
Confidence 45899999999999986 578999999874332 2334567999999999 999999999999999999999999 889
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--c
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--T 460 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--~ 460 (608)
|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++...... .
T Consensus 84 l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~-----i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 84 LYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG-----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred HHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence 99988752 2246899999999999999999999887 9999999999999999999999999998765432 3
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHH---------------Hhhhccc--
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAM---------------VREEWTG-- 518 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~---------------~~~~~~~-- 518 (608)
...++..|+||| ...+.++||||||++++||++|+.|+..........+.. .......
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 356788899999 235789999999999999999998886543322111100 0000000
Q ss_pred --ccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 519 --EVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 519 --~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.................+.+++.+||+.||++|||++|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000001111112235668899999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=272.93 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=193.7
Q ss_pred cCcCHHHHHHHh-hcccCCCCCceEEEEEEcC-----CcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeee
Q 042949 294 ERFKLDDLLEAT-ADLRSQTICSSLFMVRLKN-----SAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVC 363 (608)
Q Consensus 294 ~~~~~~~l~~~~-~~~~g~g~~g~vy~~~~~~-----g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~ 363 (608)
++..++++.+.. -..||+|.||.||++...+ .+.+|+|+++.. ..+ ....+|+..++.++|||+|.+..
T Consensus 16 er~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~h~nvi~Lv~ 94 (438)
T KOG0666|consen 16 ERERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELKHPNVISLVK 94 (438)
T ss_pred hhhhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhcCCcchhHHH
Confidence 344556666543 2468999999999996432 247999999854 223 34568999999999999999999
Q ss_pred eeec-CCeeEEEEeeccCCCHHHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC
Q 042949 364 YNST-NEEKLLVYKYQSNGSLLSLLEAYIE-GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441 (608)
Q Consensus 364 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~ 441 (608)
++.+ +...++++||++. ||.+.++-... ....++......|+.||+.|+.|||++. |+||||||.|||+..+
T Consensus 95 Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-----vlHRDLKPaNIlvmgd 168 (438)
T KOG0666|consen 95 VFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-----VLHRDLKPANILVMGD 168 (438)
T ss_pred HHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh-----eeeccCCcceEEEecc
Confidence 8877 6788999999975 89998875432 2357899999999999999999999998 9999999999999877
Q ss_pred ----CCceEeccccccccCCC------CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh--
Q 042949 442 ----EDPLISECGYSKFLDPK------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL-- 504 (608)
Q Consensus 442 ----~~~kl~DFGla~~~~~~------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~-- 504 (608)
|.+||+|||+++.+... ....+-|..|.||| ..|+.+.|||+.|||+.||+|-++.|......
T Consensus 169 gperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~ 248 (438)
T KOG0666|consen 169 GPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIK 248 (438)
T ss_pred CCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcc
Confidence 89999999999987643 23456789999999 67999999999999999999999877543210
Q ss_pred ------HHHHHHHHhh-hcccccccHH-----------------------HHH---hchhcHHHHHHHHHHchhcCCCCC
Q 042949 505 ------PKWVKAMVRE-EWTGEVFDKE-----------------------VAK---AGRQWAFPLLNVALKCVSNSPDDR 551 (608)
Q Consensus 505 ------~~~~~~~~~~-~~~~~~~~~~-----------------------~~~---~~~~~~~~l~~li~~Cl~~dP~~R 551 (608)
.+.+..+..- +...+...+. +.. ....-+...++|+.++|..||.+|
T Consensus 249 ~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kR 328 (438)
T KOG0666|consen 249 TKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKR 328 (438)
T ss_pred cCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhh
Confidence 0111111100 0000000000 000 001112237899999999999999
Q ss_pred CCHHHHHHHHH
Q 042949 552 PTMAEVLERIE 562 (608)
Q Consensus 552 Ps~~evl~~L~ 562 (608)
.|+++.++..=
T Consensus 329 Ita~qAleh~y 339 (438)
T KOG0666|consen 329 ITAEQALEHPY 339 (438)
T ss_pred ccHHHHhcccc
Confidence 99998877643
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=283.80 Aligned_cols=236 Identities=17% Similarity=0.268 Sum_probs=189.7
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|+|++|.||++.. .++..||||++.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4589999999999987 478999999986322 23456889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---cc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~ 461 (608)
+++. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 106 ~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~g-----ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 106 DIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 8775 245899999999999999999999886 9999999999999999999999999987654322 23
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|+||| ..++.++||||||+++|||++|+.|+...... ...... ........ ......+..+.
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~~~-~~~~~~~~------~~~~~~~~~l~ 247 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMI-RDNLPPKL------KNLHKVSPSLK 247 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-HhhCCccc------CCcccCCHHHH
Confidence 45788999999 45688999999999999999999998654322 222211 11110000 01122345578
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+++.+||+.+|.+||++.++++.
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhcC
Confidence 89999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=285.75 Aligned_cols=244 Identities=21% Similarity=0.237 Sum_probs=186.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~ 380 (608)
+.+|+|.+|.||+|... +|+.||+|+++.... ....+.+|+.++++++|+||+++++++... +..++||||+.
T Consensus 13 ~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 91 (309)
T cd07845 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE- 91 (309)
T ss_pred eeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-
Confidence 45899999999999875 689999999873221 233567899999999999999999998754 56899999996
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
++|.+++... ...+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 92 ~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 92 QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF-----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 5898888742 356899999999999999999999987 9999999999999999999999999998765432
Q ss_pred --ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc--cccc----------
Q 042949 460 --TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW--TGEV---------- 520 (608)
Q Consensus 460 --~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~---------- 520 (608)
....++..|+||| ..++.++||||+||++|||++|+.||...... ..+........ ....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChhhchhhhccccc
Confidence 2234577899999 23578999999999999999999998754332 22222211000 0000
Q ss_pred --------ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 521 --------FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 521 --------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
............+..+.+++.+|++.||++|||+.|++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000011111235668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=281.78 Aligned_cols=243 Identities=21% Similarity=0.269 Sum_probs=191.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..+|+|++|.||++... +++.+|+|+++.... ....+.+|++++++++|+||+++++++..++..++|+||++ ++
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TD 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CC
Confidence 45899999999999875 789999999874332 35678899999999999999999999999999999999996 48
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 84 l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 84 LYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG-----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred HHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence 88888652 357899999999999999999999887 9999999999999999999999999998765432
Q ss_pred ccccccCccccCC----C-CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------cccccc-------
Q 042949 460 TCLFSSNGYTAPE----K-TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------WTGEVF------- 521 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~-~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~~~~------- 521 (608)
....++..|+||| . ..+.++||||||+++|+|+||+.||......... ....... ......
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL-FKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCchHhcccchhhhhhhh
Confidence 2345778899999 2 5788999999999999999999888654432221 1111100 000000
Q ss_pred -------cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 522 -------DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 522 -------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
...........+.++.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00011112234667899999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.66 Aligned_cols=246 Identities=22% Similarity=0.280 Sum_probs=187.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecC--CeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTN--EEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~~lv~e~~~ 379 (608)
+.+|+|++|.||+|... +++.+|+|++... ......+.+|+.+++++ +||||+++++++... ...++||||++
T Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 92 (337)
T cd07852 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME 92 (337)
T ss_pred HhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc
Confidence 56899999999999875 6889999988532 22345677899999999 999999999988653 46899999996
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 93 -~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~-----i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 93 -TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN-----VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred -cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 699888863 27899999999999999999999876 9999999999999999999999999998654322
Q ss_pred --------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-c---------
Q 042949 460 --------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-W--------- 516 (608)
Q Consensus 460 --------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~--------- 516 (608)
....++..|+||| ...+.++||||||+++|||+||+.||......... ....... .
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL-EKIIEVIGPPSAEDIESI 240 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHHHH
Confidence 2345788999999 24578899999999999999999988644332211 1111000 0
Q ss_pred ----cccccc-------HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHh
Q 042949 517 ----TGEVFD-------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEV 564 (608)
Q Consensus 517 ----~~~~~~-------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~ 564 (608)
.....+ ..........+..+.+++.+||+.||++|||+.++++. +++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000000 00011112246678999999999999999999999986 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=289.86 Aligned_cols=248 Identities=20% Similarity=0.266 Sum_probs=188.0
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecC-----CeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN-----EEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~ 378 (608)
+.+|+|++|.||+|.. .+|+.||+|+++.. ......+.+|+.++++++||||+++++++... ...++++||+
T Consensus 11 ~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 90 (336)
T cd07849 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM 90 (336)
T ss_pred EEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhc
Confidence 5689999999999985 47899999998632 22345678899999999999999999876543 3579999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
. ++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 91 E-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred c-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 6 58887775 356999999999999999999999987 999999999999999999999999999865432
Q ss_pred C------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHh---hhc---ccccc
Q 042949 459 K------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVR---EEW---TGEVF 521 (608)
Q Consensus 459 ~------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~---~~~~~ 521 (608)
. ....++..|+||| ..++.++|||||||++|||++|+.||........ ...+.. ... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHHhh
Confidence 1 2245788899999 2467899999999999999999999865432211 111110 000 00000
Q ss_pred cH---------------HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhhc
Q 042949 522 DK---------------EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVVN 566 (608)
Q Consensus 522 ~~---------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~ 566 (608)
.. .........+..+.+++.+||+.||++|||+.|+++. ++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00 0000112235568899999999999999999999987 665543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=282.49 Aligned_cols=243 Identities=23% Similarity=0.299 Sum_probs=186.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC----------eeE
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE----------EKL 372 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----------~~~ 372 (608)
+.+|.|++|.||+|... +|+.||+|+++.. ......+.+|++++++++||||+++++++.... ..+
T Consensus 13 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 92 (302)
T cd07864 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFY 92 (302)
T ss_pred eeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEE
Confidence 56899999999999975 5899999999742 223456788999999999999999999887654 789
Q ss_pred EEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccc
Q 042949 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452 (608)
Q Consensus 373 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 452 (608)
+|+||+++ ++.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 93 LVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN-----FLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred EEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCcEEeCccccc
Confidence 99999975 77777653 2346899999999999999999999886 999999999999999999999999999
Q ss_pred cccCCCC----ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------cc
Q 042949 453 KFLDPKK----TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------WT 517 (608)
Q Consensus 453 ~~~~~~~----~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~ 517 (608)
....... ....++..|+||| ...+.++|||||||+++||++|++|+....... ....+.... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELISRLCGSPCPAVW 242 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhc
Confidence 8765432 2234577899999 235788999999999999999999887544322 221111110 00
Q ss_pred cccc--------------cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 518 GEVF--------------DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 518 ~~~~--------------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
..+. ...........+..+.+++.+||..||++||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 00111112234667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=280.64 Aligned_cols=250 Identities=20% Similarity=0.254 Sum_probs=189.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHh--cCCCCcceeeeeeeecC----CeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG--NLKHPNILPLVCYNSTN----EEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~----~~~~lv~e~~~~ 380 (608)
+.+|+|.||.||+|++ .|..||||++... +.+.+.+|.+++. .|+|+||+.+++..... .++|||.+|.+.
T Consensus 217 e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~ 293 (513)
T KOG2052|consen 217 EIIGKGRFGEVWRGRW-RGEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEH 293 (513)
T ss_pred EEecCccccceeeccc-cCCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccC
Confidence 5689999999999999 5788999999743 3456778888876 46999999999876543 367999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKS---NEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
|+|+|||.. ..++....++++.-+|.||+|||..- +..+.|.|||||+.|||+..++.+-|+|+|+|-....
T Consensus 294 GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 294 GSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 368 (513)
T ss_pred CcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence 999999974 67999999999999999999999632 2467899999999999999999999999999976544
Q ss_pred C-------CccccccCccccCCC---CC-------CcchhHHHHHHHHHHHHcCC----------CCCcCCCChHH---H
Q 042949 458 K-------KTCLFSSNGYTAPEK---TV-------SEQGDVFSFGVILLELLTGK----------TVEKTGIDLPK---W 507 (608)
Q Consensus 458 ~-------~~~~~gt~~y~aPE~---~~-------~~ksDVwSfGvvl~elltg~----------~p~~~~~~~~~---~ 507 (608)
. ....+||..|||||. .. -..+||||||.|+||++-+- .||.+-.+... .
T Consensus 369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ee 448 (513)
T KOG2052|consen 369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEE 448 (513)
T ss_pred cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHH
Confidence 3 245689999999991 11 13589999999999987642 35544332211 1
Q ss_pred HHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 508 VKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
++..+........++... ........+.++|..||..+|..|-|+--+-+.|.++.+
T Consensus 449 MrkVVCv~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 449 MRKVVCVQKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HhcceeecccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 222221111111111110 112344557899999999999999999999999999875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=282.72 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=186.4
Q ss_pred hcccCCCCCceEEEEEEcC-CcEEEEEEeccccc--CHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 306 ADLRSQTICSSLFMVRLKN-SAVYAVKRLKKLQV--SMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+.+|+|.+|.||+|...+ ++.||||+++.... ...++..|+.++.+.. ||||+++++++......+++|||++ +
T Consensus 20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 98 (296)
T cd06618 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-T 98 (296)
T ss_pred eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-c
Confidence 4678999999999999865 89999999975332 3345677887777765 9999999999999999999999984 5
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++... ...+++..+..++.|+++||+|||+.. +|+||||+|+||++++++.+||+|||++..+....
T Consensus 99 ~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~----~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 99 CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC----CEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 777776542 347899999999999999999999742 39999999999999999999999999998664322
Q ss_pred ccccccCccccCCC--------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 460 TCLFSSNGYTAPEK--------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 460 ~~~~gt~~y~aPE~--------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....++..|+|||. .++.++||||||+++|||++|+.||.................. ... .....
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~------~~~~~ 244 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-PSL------PPNEG 244 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC-CCC------CCCCC
Confidence 23356788999992 1567899999999999999999998653322222222222110 000 01113
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.++.+++.+||..||++||++.++++.
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 45678999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=278.57 Aligned_cols=244 Identities=18% Similarity=0.230 Sum_probs=185.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcC---CCCcceeeeeeeecCCe-----eEEE
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNL---KHPNILPLVCYNSTNEE-----KLLV 374 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~-----~~lv 374 (608)
..+|+|++|.||+|+.. +++.||+|+++.... ....+.+|+.++.++ +||||+++++++...+. .+++
T Consensus 5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence 46799999999999986 489999999973221 234566787776655 69999999999988776 8999
Q ss_pred EeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
|||+. ++|.+++... ....+++.+++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 85 ~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~-----i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 85 FEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSHR-----IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred ehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCChhhEEEccCCCEEEeccCccee
Confidence 99996 5899988752 2346899999999999999999999986 99999999999999999999999999987
Q ss_pred cCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc-------cccc-
Q 042949 455 LDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW-------TGEV- 520 (608)
Q Consensus 455 ~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~- 520 (608)
..... ....++..|+||| ..++.++|||||||++|||++|++|+...... +.......... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCCCcc
Confidence 64332 2345778899999 55788999999999999999998887654332 22222221100 0000
Q ss_pred ---------ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 521 ---------FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 521 ---------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
...............+.+++.+||+.||++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000001111223456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=274.09 Aligned_cols=235 Identities=21% Similarity=0.358 Sum_probs=193.3
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+.+|+|.+|.||++... +++.||+|.+..... ..+.+.+|++++++++|+|++++++++...+..++++||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 356899999999999865 678999999975442 4567899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc-
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT- 460 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 460 (608)
+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 85 ~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 85 SLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG-----VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999875 357899999999999999999999886 99999999999999999999999999987654432
Q ss_pred --cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 461 --CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 461 --~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
...++..|+||| ...+.++||||+|+++++|++|+.|+............. ... .. ......+.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~-~~--------~~~~~~~~ 225 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDD-HP--------PLPEGISP 225 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccC-CC--------CCCCCCCH
Confidence 346788899999 346788999999999999999999986544322222211 100 00 11223455
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+.+++.+||..+|++|||+.+++.
T Consensus 226 ~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 226 ELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHHHhCChhhCcCHHHHhc
Confidence 6889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.72 Aligned_cols=242 Identities=17% Similarity=0.206 Sum_probs=185.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 376 (608)
..+|+|++|.||+++.. +|+.||+|++.... ...+++.+|+.++++++||||+++++++... ...++|||
T Consensus 22 ~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 101 (353)
T cd07850 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101 (353)
T ss_pred EEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEe
Confidence 56899999999999864 78999999986422 2345677899999999999999999987643 35699999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g-----i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 102 LMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 995 588887753 2889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc-------------
Q 042949 457 PKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT------------- 517 (608)
Q Consensus 457 ~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~------------- 517 (608)
... ....++..|+||| ..++.++|||||||++|+|++|+.||........+......-...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 432 2345788999999 567889999999999999999999986544322222111000000
Q ss_pred ------c----ccccHHHH---------HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 518 ------G----EVFDKEVA---------KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 518 ------~----~~~~~~~~---------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. ..+..... .........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000000 0011234557899999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=286.22 Aligned_cols=233 Identities=20% Similarity=0.253 Sum_probs=191.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.++|+|+||.||-+... +|+.+|.|++.+.. ....-...|-.+|.+++.+.||.+-..|++.+.+|+|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 46899999999999865 79999999886322 23344678999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
||.-+|.. .+...+++..++.++.+|+.||++||... ||.||+||+|||+|+.|+++|+|.|+|..+....
T Consensus 271 DLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~~~-----iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 271 DLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHRRR-----IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred ceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHhcc-----eeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99988865 34568999999999999999999999886 9999999999999999999999999999887654
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHH--HHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKW--VKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
...+||.+||||| ..|+...|.||+||++|||+.|+.||........+ +.....+. ..+....++
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~---------~~ey~~kFS 414 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED---------PEEYSDKFS 414 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc---------hhhcccccC
Confidence 3458999999999 56999999999999999999999999765443332 11111110 011234566
Q ss_pred HHHHHHHHHchhcCCCCCCCHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMA 555 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~ 555 (608)
.+..++....|+.||.+|.-..
T Consensus 415 ~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHHHHHccCHHHhccCC
Confidence 7788999999999999997543
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.74 Aligned_cols=250 Identities=19% Similarity=0.240 Sum_probs=191.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecC-----CeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN-----EEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~ 377 (608)
..+|+|++|+||+++. .+++.||||.++.. ......+.+|+.++++++|+||+++++++... ...++|+||
T Consensus 11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07858 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL 90 (337)
T ss_pred EEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeC
Confidence 4689999999999986 46899999998742 22345677899999999999999999987654 357999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+. ++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 91 ~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 91 MD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 95 788888764 457999999999999999999999886 99999999999999999999999999987644
Q ss_pred CC---ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHh---h---hcccccc--
Q 042949 458 KK---TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVR---E---EWTGEVF-- 521 (608)
Q Consensus 458 ~~---~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~---~---~~~~~~~-- 521 (608)
.. ....++..|+||| ..++.++|||||||++|||++|+.||....... ....... . .....+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhcCch
Confidence 31 2345788899999 246789999999999999999999986432211 1110000 0 0000000
Q ss_pred -------------cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhhcC
Q 042949 522 -------------DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVVNG 567 (608)
Q Consensus 522 -------------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~~ 567 (608)
...........+..+.+++.+||+.+|++|||++|+++. ++.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 000111122456678999999999999999999999988 7666444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=305.45 Aligned_cols=248 Identities=19% Similarity=0.219 Sum_probs=176.0
Q ss_pred cccCCCCCceEEEEEEcC--CcEEEEE------------------EecccccCHHHHHHHHHHHhcCCCCcceeeeeeee
Q 042949 307 DLRSQTICSSLFMVRLKN--SAVYAVK------------------RLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNS 366 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 366 (608)
+.||+|+||+||++..+. +...++| .++........+.+|++++++++|||||++++++.
T Consensus 154 ~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 233 (501)
T PHA03210 154 DDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILR 233 (501)
T ss_pred eEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEEE
Confidence 458999999999987542 2222222 11111222456789999999999999999999999
Q ss_pred cCCeeEEEEeeccCCCHHHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCce
Q 042949 367 TNEEKLLVYKYQSNGSLLSLLEAYI-EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445 (608)
Q Consensus 367 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~k 445 (608)
..+..++|+|++ .++|.+++.... .........++..|+.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 234 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g-----IiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 234 SEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-----LIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred ECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEE
Confidence 999999999998 467888775421 11222345677889999999999999887 99999999999999999999
Q ss_pred EeccccccccCCCC----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcC-CC-ChHHHHHHHHhhh
Q 042949 446 ISECGYSKFLDPKK----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKT-GI-DLPKWVKAMVREE 515 (608)
Q Consensus 446 l~DFGla~~~~~~~----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~-~~-~~~~~~~~~~~~~ 515 (608)
|+|||+++.+.... ....||..|+||| ..++.++|||||||++|||++|..++.. .. .............
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~ 387 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence 99999998765432 2356899999999 4578899999999999999999865432 21 1111111111100
Q ss_pred -cc-cccccH------------------HHHH--hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 516 -WT-GEVFDK------------------EVAK--AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 516 -~~-~~~~~~------------------~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.. .+..+. .+.. ........+.+++.+||+.||++|||+.|++..
T Consensus 388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 000000 0000 001233457788999999999999999999874
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=281.43 Aligned_cols=242 Identities=14% Similarity=0.130 Sum_probs=174.5
Q ss_pred cccCCCCCceEEEEEEcC----CcEEEEEEecccccC--H----------HHHHHHHHHHhcCCCCcceeeeeeeecCC-
Q 042949 307 DLRSQTICSSLFMVRLKN----SAVYAVKRLKKLQVS--M----------DEFSQTMRQIGNLKHPNILPLVCYNSTNE- 369 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~----g~~vavK~l~~~~~~--~----------~~~~~e~~~l~~l~H~niv~l~~~~~~~~- 369 (608)
+.+|+|+||.||+|...+ +..+|+|........ . .....+...+..++|+|++++++++....
T Consensus 18 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 97 (294)
T PHA02882 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRC 97 (294)
T ss_pred eEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecC
Confidence 568999999999998754 356666654321111 1 11223344566778999999998765433
Q ss_pred ---eeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceE
Q 042949 370 ---EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446 (608)
Q Consensus 370 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl 446 (608)
..++++|++. .++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.++.++|
T Consensus 98 ~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-----iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 98 RMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG-----ISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred CceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCcEEE
Confidence 4467788774 466666653 234678889999999999999999886 999999999999999999999
Q ss_pred eccccccccCCC----------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHH
Q 042949 447 SECGYSKFLDPK----------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMV 512 (608)
Q Consensus 447 ~DFGla~~~~~~----------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~ 512 (608)
+|||+++.+... .....||+.|+||| ..++.++|||||||++|||++|+.||.........+....
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999999865321 12346899999999 5678999999999999999999999976533222222211
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
.+ ....+..... .....+..+.+++..|+..+|++||++.++++.+
T Consensus 248 ~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 CD-FIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HH-HHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11 1111111111 1233456788999999999999999999999876
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=289.12 Aligned_cols=244 Identities=16% Similarity=0.185 Sum_probs=186.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeec----CCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNST----NEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~ 378 (608)
+.+|+|++|.||++... +|+.||+|++.... .....+.+|+.++++++||||+++++++.. ....++|+||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 90 (334)
T cd07855 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM 90 (334)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh
Confidence 45899999999999864 68999999987432 234567789999999999999999988753 35689999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
. |+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 91 E-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred h-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 5 688888763 455999999999999999999999876 999999999999999999999999999865432
Q ss_pred C-------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-----cccccc
Q 042949 459 K-------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-----WTGEVF 521 (608)
Q Consensus 459 ~-------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~ 521 (608)
. ....++..|+||| ..++.++|||||||++|||++|+.||................. ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 1 2346788899999 3467899999999999999999999865443221111000000 000000
Q ss_pred cHH---------------HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 DKE---------------VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 ~~~---------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
... ........+..+.+++.+||+.+|++||++.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 001112346678999999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=275.50 Aligned_cols=230 Identities=18% Similarity=0.252 Sum_probs=178.1
Q ss_pred cCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 309 RSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+|+|+||.||+++.. ++..+|+|.+........ |+.....+ +||||+++++++...+..++||||+++|+|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 699999999999864 678999999875332221 22222212 699999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-CceEeccccccccCCCCcccccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-DPLISECGYSKFLDPKKTCLFSS 465 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~gt 465 (608)
+.. ...+++.++..++.|+++||+|||+.+ ++||||||+||+++.++ .++|+|||+++..... ....++
T Consensus 100 l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~ 169 (267)
T PHA03390 100 LKK----EGKLSEAEVKKIIRQLVEALNDLHKHN-----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-SCYDGT 169 (267)
T ss_pred HHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-ccCCCC
Confidence 975 347999999999999999999999887 99999999999999998 9999999999866533 334678
Q ss_pred CccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHH
Q 042949 466 NGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVAL 541 (608)
Q Consensus 466 ~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 541 (608)
..|+||| ..++.++|||||||++|||++|+.|+................. .... ......+..+.+++.
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~~~~li~ 242 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL------PFIKNVSKNANDFVQ 242 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC------CcccccCHHHHHHHH
Confidence 8999999 4678899999999999999999999864322110001111100 0000 111235566889999
Q ss_pred HchhcCCCCCCC-HHHHHH
Q 042949 542 KCVSNSPDDRPT-MAEVLE 559 (608)
Q Consensus 542 ~Cl~~dP~~RPs-~~evl~ 559 (608)
+||+.+|.+||+ ++|+++
T Consensus 243 ~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 243 SMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHhccChhhCCchHHHHhc
Confidence 999999999996 688874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=322.07 Aligned_cols=235 Identities=22% Similarity=0.323 Sum_probs=188.1
Q ss_pred cccCCCCCceEEEEE-EcCCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVR-LKNSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.++|+|.||.||.+. ..+|...|+|-++-. ......+.+|+.++..++|||+|+++|+-.+.+..+|.||||.+|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 579999999999986 568999999988732 2334567899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+.++. .+..++....-+..|++.|++|||+++ ||||||||.||+++.++.+|++|||.|..+....
T Consensus 1321 La~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g-----IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1321 LASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG-----IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC-----ceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999874 455777888889999999999999987 9999999999999999999999999998776543
Q ss_pred ----ccccccCccccCCCC-------CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 ----TCLFSSNGYTAPEKT-------VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 ----~~~~gt~~y~aPE~~-------~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
....||+.|||||.. -.-+.||||+|||+.||+||+.|+..-.+ +|. .|..-.. + ..+..
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~a-IMy~V~~-g-----h~Pq~ 1462 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWA-IMYHVAA-G-----HKPQI 1462 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhH-HHhHHhc-c-----CCCCC
Confidence 346799999999922 34568999999999999999999854322 221 1111100 0 00111
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
++..+..-.+++.+|++.||++|.++.|+++
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2234455678999999999999988876654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=286.00 Aligned_cols=248 Identities=22% Similarity=0.233 Sum_probs=190.8
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCC------eeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNE------EKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~e 376 (608)
+.+|+|++|.||++.. .+|..||||+++.... ..+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07880 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP 100 (343)
T ss_pred EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEe
Confidence 4589999999999975 4789999999864322 2346789999999999999999999887543 4589999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+ +++|.+++. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 101 ~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g-----i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 101 FM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG-----IIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 99 779988775 346899999999999999999999877 9999999999999999999999999998776
Q ss_pred CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc---------------
Q 042949 457 PKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW--------------- 516 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--------------- 516 (608)
.......++..|+||| ..++.++|||||||++|++++|+.||............+.....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 5555566788999999 24678999999999999999999998755432221111110000
Q ss_pred -----ccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhh
Q 042949 517 -----TGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVV 565 (608)
Q Consensus 517 -----~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~ 565 (608)
...................+.+++.+|++.||++|||+.+++.. ++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00000011111123345568899999999999999999999853 44443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=281.11 Aligned_cols=245 Identities=20% Similarity=0.306 Sum_probs=191.1
Q ss_pred cCHHHHHHHhhcccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCe
Q 042949 296 FKLDDLLEATADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEE 370 (608)
Q Consensus 296 ~~~~~l~~~~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 370 (608)
.+.+++... .+.+|+|++|+||+|+.. ++..||+|++..... ....+.+|++++++++|||++++++++.+.+.
T Consensus 17 ~~~~~~~~~-~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 17 DDPEEIFVG-LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT 95 (313)
T ss_pred CCHHHHhhc-ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 344444322 244899999999999864 688999999864221 23467889999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccc
Q 042949 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECG 450 (608)
Q Consensus 371 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 450 (608)
.++||||+. |++.+++.. ....+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 96 ~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g-----i~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred EEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCChhhEEECCCCCEEEeecC
Confidence 999999995 688887764 2456899999999999999999999886 9999999999999999999999999
Q ss_pred cccccCCCCccccccCccccCCC-------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH
Q 042949 451 YSKFLDPKKTCLFSSNGYTAPEK-------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 451 la~~~~~~~~~~~gt~~y~aPE~-------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (608)
++..... .....++..|+|||. .++.++|||||||++|||++|..|+......... ........ ...
T Consensus 167 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~-~~~--- 240 (313)
T cd06633 167 SASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNDS-PTL--- 240 (313)
T ss_pred CCcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCC-CCC---
Confidence 9875432 234568889999993 3567899999999999999999998654332222 21111111 000
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.....+..+.+++.+||+.+|++||++.+++..
T Consensus 241 ----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011234558899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=270.21 Aligned_cols=250 Identities=18% Similarity=0.240 Sum_probs=194.9
Q ss_pred CcCHHHHHHHhhcccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeec----C
Q 042949 295 RFKLDDLLEATADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNST----N 368 (608)
Q Consensus 295 ~~~~~~l~~~~~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~ 368 (608)
+..+-|-+..+..++|-|..|.|..+.. .+|+.+|+|++..++ ..++|++.--+. .|||||.++++|.+ .
T Consensus 56 ~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 56 EYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred cccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3444555666678899999999999875 478999999987543 345677664444 59999999998765 3
Q ss_pred CeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC---CCCce
Q 042949 369 EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE---NEDPL 445 (608)
Q Consensus 369 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~---~~~~k 445 (608)
.-+.+|||+|+||.|++.+.+ .+...+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|... +-..|
T Consensus 132 kcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n-----IAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN-----IAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred eeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc-----hhhccCChhheeeecCCCCcceE
Confidence 456799999999999999986 45677999999999999999999999987 999999999999965 45689
Q ss_pred EeccccccccCCC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC--ChHHHHHHHHhhhcc
Q 042949 446 ISECGYSKFLDPK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI--DLPKWVKAMVREEWT 517 (608)
Q Consensus 446 l~DFGla~~~~~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~ 517 (608)
|+|||+|+..... ..+-+-|++|.||| ..|+..+|+||+||++|-|+.|.+||+... .+..-++.....+..
T Consensus 205 LtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 205 LTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 9999999976532 24456789999999 578999999999999999999999997533 222333322222211
Q ss_pred cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 518 GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. .-+ +...+.+....++|+.+|..+|.+|.|+.++++.
T Consensus 285 ~-FP~----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 E-FPE----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c-CCC----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1 011 1223456678899999999999999999999865
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=291.64 Aligned_cols=234 Identities=23% Similarity=0.315 Sum_probs=194.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..||+|.|++|..++.. ++..||||.+++.+.. ...+.+|+++|..++|||||+++.+...+..+|+||||+.+|.
T Consensus 62 ~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge 141 (596)
T KOG0586|consen 62 KTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGE 141 (596)
T ss_pred eeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCch
Confidence 45899999999999865 6899999999876543 3458899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--Cc
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--KT 460 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--~~ 460 (608)
+++++.. ...+.+..+..++.|+..|++|||+++ |||||||++||||+.++++||+|||++..+... ..
T Consensus 142 ~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~-----ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 142 LFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN-----IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred hHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc-----eeccccchhhcccccccceeeeccccceeeccccccc
Confidence 9999986 455667889999999999999999988 999999999999999999999999999988754 35
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
..+|++.|.||| ...++.+|+||+|+++|-|+.|..||.+..- ...-...+...+ ..+.-.+.+
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-k~Lr~rvl~gk~----------rIp~~ms~d 281 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-KELRPRVLRGKY----------RIPFYMSCD 281 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-ccccchheeeee----------cccceeech
Confidence 678999999999 4567899999999999999999999975421 111111111100 011223445
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.+++.+++..+|.+|++++++.+.
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhh
Confidence 7789999999999999999998765
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=279.64 Aligned_cols=234 Identities=20% Similarity=0.300 Sum_probs=185.3
Q ss_pred cccCCCCCceEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL----KNSAVYAVKRLKKLQ-----VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 376 (608)
..+|+|+||.||.++. .+|..||+|+++... ...+.+.+|++++.++ +|+||+++++++......++|+|
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILD 85 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEe
Confidence 5689999999999986 378999999987421 2346688899999999 59999999999999899999999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 86 YINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999875 456889999999999999999999876 9999999999999999999999999998764
Q ss_pred CCC----ccccccCccccCCC------CCCcchhHHHHHHHHHHHHcCCCCCcCCCC---hHHHHHHHHhhhcccccccH
Q 042949 457 PKK----TCLFSSNGYTAPEK------TVSEQGDVFSFGVILLELLTGKTVEKTGID---LPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 457 ~~~----~~~~gt~~y~aPE~------~~~~ksDVwSfGvvl~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~ 523 (608)
... ....++..|+|||. ..+.++||||||+++|||++|+.|+..... .............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 229 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------- 229 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC-------
Confidence 422 23457889999992 346789999999999999999999853222 1111111111100
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRP-----TMAEVLE 559 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 559 (608)
.........+.+++.+||+.||++|| ++.+++.
T Consensus 230 ---~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 ---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01122345578999999999999997 5555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=281.35 Aligned_cols=244 Identities=18% Similarity=0.220 Sum_probs=182.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCC--------eeEEE
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE--------EKLLV 374 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------~~~lv 374 (608)
..+|+|++|.||++... +++.||||++.... .....+.+|++++++++||||+++++++...+ ..++|
T Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 97 (310)
T cd07865 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLV 97 (310)
T ss_pred EEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEE
Confidence 46899999999999875 68999999986322 22345678999999999999999999887654 34999
Q ss_pred EeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
|||+. ++|.+++.. ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 98 ~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 98 FEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK-----ILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred EcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 99996 588887764 2346899999999999999999999886 99999999999999999999999999986
Q ss_pred cCCCC-------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHH--HHHHHhh---hcc
Q 042949 455 LDPKK-------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKW--VKAMVRE---EWT 517 (608)
Q Consensus 455 ~~~~~-------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~--~~~~~~~---~~~ 517 (608)
..... ....++..|+||| ..++.++||||||+++|||+||..|+......... ...+... ...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 54321 2235677899999 23578999999999999999999888654332111 1111000 000
Q ss_pred ccc--------------ccHHHHH--hchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 518 GEV--------------FDKEVAK--AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 518 ~~~--------------~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
... ....... ........+.+++.+||..||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 0000000 01112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=271.58 Aligned_cols=239 Identities=21% Similarity=0.337 Sum_probs=195.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..+|.|++|.||++... ++..+|+|++.... ....++.+|++++++++|||++++++.+...+..++|+||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 85 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence 46899999999999875 68999999997432 345678899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++.........+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 86 LSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred HHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC-----EecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 99999864333467999999999999999999999886 9999999999999999999999999998765432
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
....++..|+||| ..++.++||||+|+++++|++|+.|+.... ............ .. ......+..
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~~-~~--------~~~~~~~~~ 230 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKILKGQ-YP--------PIPSQYSSE 230 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHHhcCC-CC--------CCCCCCCHH
Confidence 2345778899999 457889999999999999999999985443 222222222211 11 112245567
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.+++.+||..+|++|||+.++++.
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 8899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=272.98 Aligned_cols=239 Identities=21% Similarity=0.267 Sum_probs=193.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|++|.||++... +++.+|+|.+.... ....++.+|++++++++|+||+++++++......++|+||+++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd08530 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD 85 (256)
T ss_pred eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCC
Confidence 56899999999999754 78899999987432 234567889999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-cc
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-TC 461 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~ 461 (608)
|.+++.........+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++...... ..
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~-----i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 160 (256)
T cd08530 86 LSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK-----ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160 (256)
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence 99998764444567899999999999999999999887 9999999999999999999999999998765432 23
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..++..|++|| ..++.++|+||||++++||++|+.|+.... ........ ....... ........+.
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~--------~~~~~~~~~~ 230 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLRYKV-QRGKYPP--------IPPIYSQDLQ 230 (256)
T ss_pred ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH-hcCCCCC--------CchhhCHHHH
Confidence 45778899999 456779999999999999999999986543 22222111 1111111 1123455688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+++.+|+..+|++||++.|+++.
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcC
Confidence 99999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=280.64 Aligned_cols=240 Identities=22% Similarity=0.302 Sum_probs=189.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|+|++|.||+|+.. ++..+|+|.+.... ...+++.+|++++++++|+|++++++++......++|+||+. |
T Consensus 21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 99 (308)
T cd06634 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 99 (308)
T ss_pred HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-C
Confidence 45899999999999865 67899999986321 223467889999999999999999999999999999999996 6
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
++.+++.. ....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 100 ~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~~ 170 (308)
T cd06634 100 SASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NX 170 (308)
T ss_pred CHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHhEEECCCCcEEECCcccceeecCc-cc
Confidence 88887753 2456899999999999999999999876 999999999999999999999999998865433 34
Q ss_pred ccccCccccCCC-------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 462 LFSSNGYTAPEK-------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 462 ~~gt~~y~aPE~-------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
..++..|+|||. .++.++|||||||++|||++|+.|+...... ........... .. ......+.
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~-~~-------~~~~~~~~ 241 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNES-PA-------LQSGHWSE 241 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCC-CC-------cCcccccH
Confidence 567889999992 3577899999999999999999987643221 11111111110 00 01123455
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
.+.+++.+||..+|++||++.++++.-....
T Consensus 242 ~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 6889999999999999999999987744443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=284.07 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=196.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC-----eeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE-----EKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~ 377 (608)
..+|.|++|.||+|+.. +++.||+|++... ....+.+.+|++++++++|+||+++++++...+ ..+++|||
T Consensus 6 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 85 (330)
T cd07834 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL 85 (330)
T ss_pred eeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecc
Confidence 56899999999999975 5899999998743 234567889999999999999999999988765 78999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
++ ++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 86 ~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g-----i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 86 ME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred hh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 97 588888864 347999999999999999999999987 99999999999999999999999999987654
Q ss_pred CC------ccccccCccccCC----C-CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc--c------
Q 042949 458 KK------TCLFSSNGYTAPE----K-TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT--G------ 518 (608)
Q Consensus 458 ~~------~~~~gt~~y~aPE----~-~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~------ 518 (608)
.. ....++..|+||| . ..+.++||||||+++|+|++|+.||....... ..+........ .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcCCCChhHhhhc
Confidence 32 2345788899999 2 57789999999999999999999986544321 12211111000 0
Q ss_pred --ccc-----------cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhhcCCCC
Q 042949 519 --EVF-----------DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVVNGNDE 570 (608)
Q Consensus 519 --~~~-----------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~~~~~ 570 (608)
... ...........+..+.+++.+||+.+|++|||+.++++. ++++.....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence 000 000011112345668899999999999999999999986 6666554433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=270.92 Aligned_cols=228 Identities=23% Similarity=0.311 Sum_probs=187.5
Q ss_pred cCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+|+|++|.||++... +++.+|+|.+..... ..+.+..|++++++++||||+++++.+...+..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 589999999999875 589999999874332 345788999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~ 460 (608)
.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~-----~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG-----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence 999975 346899999999999999999999876 999999999999999999999999999876543 33
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...++..|++|| ...+.++|+||||+++||+++|+.|+..... ....+....... ..+...+..+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~l 220 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILKDPL----------RFPEFLSPEA 220 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhcCCC----------CCCCCCCHHH
Confidence 456788999999 3467889999999999999999999864432 222222221110 1112235568
Q ss_pred HHHHHHchhcCCCCCCCHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAE 556 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~e 556 (608)
.+++.+||..||++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 89999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=278.68 Aligned_cols=239 Identities=21% Similarity=0.266 Sum_probs=189.9
Q ss_pred cccCCCCCceEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL----KNSAVYAVKRLKKLQ-----VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 376 (608)
+.+|+|++|.||+++. .++..||||.++... ...+.+.+|++++.++ +||||+++++.+......++|||
T Consensus 6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e 85 (288)
T cd05583 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILD 85 (288)
T ss_pred EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEe
Confidence 5689999999999875 357889999987421 2345688999999999 59999999999999999999999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 86 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~-----~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 86 YVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG-----IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred cCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999998864 356899999999999999999999876 9999999999999999999999999988654
Q ss_pred CCC----ccccccCccccCCC------CCCcchhHHHHHHHHHHHHcCCCCCcCCCCh---HHHHHHHHhhhcccccccH
Q 042949 457 PKK----TCLFSSNGYTAPEK------TVSEQGDVFSFGVILLELLTGKTVEKTGIDL---PKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 457 ~~~----~~~~gt~~y~aPE~------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 523 (608)
... ....++..|+|||. ..+.++||||||+++|||++|..|+...... ....+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------- 228 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-------- 228 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--------
Confidence 332 22457889999992 2577899999999999999999998543221 11111111110
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
..........+.+++.+||+.||++|||+.++.+.|+..
T Consensus 229 --~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 011222445688999999999999999998887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=275.16 Aligned_cols=243 Identities=22% Similarity=0.286 Sum_probs=189.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|.+|.||+|+.. +++.||+|.+... ....+.+..|+.++++++|+||+++++++...+..++|+||++ ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 45799999999999876 5899999999853 2234677889999999999999999999999999999999997 59
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++... ...+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||+++......
T Consensus 84 l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 84 LKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR-----ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred HHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 99999752 246999999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccCccccCC----C-CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-------c-----------
Q 042949 460 TCLFSSNGYTAPE----K-TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-------W----------- 516 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~-~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------~----------- 516 (608)
....++..|+||| . .++.++|||||||+++||++|+.|+........ ........ +
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2234567799999 2 678899999999999999999988865433221 11111100 0
Q ss_pred -ccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 517 -TGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 517 -~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
...................+.+++.+||+.||++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000011111223566899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=286.78 Aligned_cols=242 Identities=21% Similarity=0.252 Sum_probs=188.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCe------eEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEE------KLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~lv~e 376 (608)
..+|+|++|.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++...+. .++|+|
T Consensus 21 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07851 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100 (343)
T ss_pred EEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEe
Confidence 56899999999999875 67899999987432 233567789999999999999999988766554 899999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 101 ~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g-----i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 101 LM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG-----IIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 99 6799998863 46999999999999999999999886 9999999999999999999999999998776
Q ss_pred CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------ccccccc---
Q 042949 457 PKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------WTGEVFD--- 522 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~~~~~--- 522 (608)
.......++..|+||| ...+.++|||||||++|||+||+.||....... .+....... ....+..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhccchhH
Confidence 5555567788899999 246789999999999999999999986543322 222111100 0000000
Q ss_pred ------------HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 ------------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 ------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..........+..+.+++.+||..||++|||+.||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00011112346678999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=285.05 Aligned_cols=242 Identities=21% Similarity=0.247 Sum_probs=186.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 376 (608)
..+|+|+||.||++.. .+++.||+|+++... ...+.+.+|++++.+++||||+++++++... ...+++++
T Consensus 23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~ 102 (345)
T cd07877 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 102 (345)
T ss_pred EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence 3589999999999985 578999999997432 2245678899999999999999999987543 34678888
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 103 ~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 103 LM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred hc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 77 7899887752 46899999999999999999999887 9999999999999999999999999998766
Q ss_pred CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------cccccccHH-
Q 042949 457 PKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------WTGEVFDKE- 524 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~- 524 (608)
.......++..|+||| ..++.++|||||||++|||++|+.||....... ......... ....+.+..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T cd07877 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISSESA 250 (345)
T ss_pred ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhcccHhH
Confidence 5555567888999999 346789999999999999999999986443322 111111100 000000000
Q ss_pred --------------HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 525 --------------VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 525 --------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
........+..+.+++.+|++.||++||++.+++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000011235568899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=280.12 Aligned_cols=243 Identities=22% Similarity=0.291 Sum_probs=187.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeec-CCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNST-NEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~~g 381 (608)
..+|.|+||.||++... ++..||+|++... ....+.+.+|++++.+++||||+++++++.. ....++++||+ ++
T Consensus 16 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~ 94 (328)
T cd07856 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GT 94 (328)
T ss_pred EeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-cc
Confidence 56899999999999865 7899999988632 2234678899999999999999999998865 55788999998 57
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.++++ ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||++.........
T Consensus 95 ~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~-----iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 164 (328)
T cd07856 95 DLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAG-----VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG 164 (328)
T ss_pred CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEeECCCCCEEeCccccccccCCCcCC
Confidence 8988876 345888999999999999999999987 999999999999999999999999999876555455
Q ss_pred ccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHH--HHHh---hhcccccccH--------
Q 042949 462 LFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVK--AMVR---EEWTGEVFDK-------- 523 (608)
Q Consensus 462 ~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~--~~~~---~~~~~~~~~~-------- 523 (608)
..++..|+||| ..++.++|||||||++|||+||+.||........+.. .... +.+.....+.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd07856 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244 (328)
T ss_pred CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence 56788999999 2468899999999999999999998865432111100 0000 0000000000
Q ss_pred -------HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 524 -------EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 524 -------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.........+..+.+++.+||+.+|++|||+.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001112345678999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=276.62 Aligned_cols=233 Identities=24% Similarity=0.370 Sum_probs=189.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.+|+|++|.||++... +|+.||+|++.... ...+.+.+|++++.+++ ||||+++++++...+..++||||+++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd05581 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPN 86 (280)
T ss_pred eeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCC
Confidence 45899999999999875 78999999987422 23456888999999998 99999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~-----~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 87 GELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG-----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999975 347999999999999999999999887 9999999999999999999999999988654322
Q ss_pred ----------------------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHh
Q 042949 460 ----------------------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVR 513 (608)
Q Consensus 460 ----------------------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 513 (608)
....++..|+||| ...+.++||||||++++|+++|+.|+........ .+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~ 236 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQKILK 236 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHh
Confidence 1234678899999 4567899999999999999999999875542211 111111
Q ss_pred hhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCH----HHHHH
Q 042949 514 EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTM----AEVLE 559 (608)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~----~evl~ 559 (608)
..+ ..+...+..+.+++.+||+.+|++||++ +++++
T Consensus 237 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 237 LEY----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred cCC----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 110 0112234568899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=278.93 Aligned_cols=243 Identities=19% Similarity=0.257 Sum_probs=182.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecC--------CeeEEE
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN--------EEKLLV 374 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~~lv 374 (608)
..+|+|++|.||+|... +++.+|+|++.... .....+.+|++++++++||||+++++++... ...++|
T Consensus 14 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv 93 (311)
T cd07866 14 GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMV 93 (311)
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEE
Confidence 45899999999999865 68999999986322 1234577899999999999999999887543 346999
Q ss_pred EeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
+||+. ++|...+.. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||+++.
T Consensus 94 ~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 94 TPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH-----ILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred EecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECcCccchh
Confidence 99996 477776653 2457999999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCC--------------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh
Q 042949 455 LDPKK--------------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE 515 (608)
Q Consensus 455 ~~~~~--------------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 515 (608)
..... ....++..|+||| ..++.++|||||||++|||++|++||....... .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 54221 1234577899999 246789999999999999999999986544322 111111100
Q ss_pred c------------cc--------ccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 516 W------------TG--------EVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 516 ~------------~~--------~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
. .. .................+.+++.+||+.||++|||+.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 00 00001111111223456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=271.97 Aligned_cols=235 Identities=16% Similarity=0.188 Sum_probs=185.0
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccc------ccCHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKL------QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 376 (608)
.+.+|+|++|.||++... ++..||+|.+... ......+.+|++++++++|+||+++++++.+. ...++++|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 357899999999999864 6899999987521 11234688999999999999999999998764 45789999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++...
T Consensus 87 ~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 87 YMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred eCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999874 345889999999999999999999887 9999999999999999999999999998653
Q ss_pred CC------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 457 PK------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 457 ~~------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
.. .....++..|+||| ...+.++|||||||++|||++|+.||.......... ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~-~~------- 228 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-KIATQPT-KP------- 228 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH-HHHcCCC-CC-------
Confidence 21 12345788999999 346788999999999999999999986543322211 1111100 01
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
..+......+.+++.+||. +|..||++.+++.
T Consensus 229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1122344568899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=303.22 Aligned_cols=246 Identities=23% Similarity=0.349 Sum_probs=197.8
Q ss_pred cccCCCCCceEEEEEEc----C----CcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEE
Q 042949 307 DLRSQTICSSLFMVRLK----N----SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVY 375 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~----~----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 375 (608)
..+|.|.||.|++|... . ...||||.++... ...+.+..|+++|..+ +|+||+.++|+|...+..++|.
T Consensus 302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~ 381 (609)
T KOG0200|consen 302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIV 381 (609)
T ss_pred ceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEE
Confidence 48999999999999853 1 4579999998433 3467799999999998 5999999999999999999999
Q ss_pred eeccCCCHHHHHHHHh---c--CC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC
Q 042949 376 KYQSNGSLLSLLEAYI---E--GK-------RDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~---~--~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~ 443 (608)
||+..|+|.++|+..+ . .. ..++....+.++.|||.||+||++.. +|||||-.+|||+.++..
T Consensus 382 Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-----~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 382 EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-----CVHRDLAARNVLITKNKV 456 (609)
T ss_pred EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-----ccchhhhhhhEEecCCCE
Confidence 9999999999998744 0 00 23889999999999999999998876 999999999999999999
Q ss_pred ceEeccccccccCCCCccc-c---c--cCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC-hHHHHHHHH
Q 042949 444 PLISECGYSKFLDPKKTCL-F---S--SNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID-LPKWVKAMV 512 (608)
Q Consensus 444 ~kl~DFGla~~~~~~~~~~-~---g--t~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~-~~~~~~~~~ 512 (608)
+||+|||+++......... . + ...||||| ..++.|+|||||||+|||++|...+++.+.. ..+.++ ..
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-~l 535 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-FL 535 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-HH
Confidence 9999999999765543221 2 2 23499999 6789999999999999999996544333333 333322 33
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
+++. ....+..+..++.++|..||+.+|++||++.++.+.++..+.
T Consensus 536 ~~G~--------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 536 KEGN--------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred hcCC--------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 3322 123455678889999999999999999999999999999654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=305.91 Aligned_cols=235 Identities=20% Similarity=0.257 Sum_probs=178.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeec----------------
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNST---------------- 367 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~---------------- 367 (608)
.++|+|+||.||+++.+ ||+.||||+|.-. ......+.+|++.+++|+|||||+++..+..
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 47999999999999976 9999999999743 3344568899999999999999998742100
Q ss_pred --------------------------------------------------------------------------------
Q 042949 368 -------------------------------------------------------------------------------- 367 (608)
Q Consensus 368 -------------------------------------------------------------------------------- 367 (608)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------C--------CeeEEEEeeccCCCHHHHHHHHhcCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCC
Q 042949 368 ---------------N--------EEKLLVYKYQSNGSLLSLLEAYIEGKRDF-PWKLRLSIATGIAKGLDFMYQKSNEE 423 (608)
Q Consensus 368 ---------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l-~~~~~~~i~~~ia~gL~yLH~~~~~~ 423 (608)
+ ..+||-||||+.-.+.++++.. ... .....++++++|++||.|+|+.+
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGLaYIH~~g--- 717 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGLAYIHDQG--- 717 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHHHHHHhCc---
Confidence 0 1247889999988888888752 111 36678999999999999999987
Q ss_pred CCceecCCCCCCeecCCCCCceEeccccccccC----C-----------------CCccccccCccccCC-------CCC
Q 042949 424 KTIPHGNLKLSNILLNENEDPLISECGYSKFLD----P-----------------KKTCLFSSNGYTAPE-------KTV 475 (608)
Q Consensus 424 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~----~-----------------~~~~~~gt~~y~aPE-------~~~ 475 (608)
||||||||.||++|++..+||+|||+|+... . ..+..+||.-|+||| ..|
T Consensus 718 --iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred --eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 9999999999999999999999999998721 0 124567899999999 268
Q ss_pred CcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHH
Q 042949 476 SEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMA 555 (608)
Q Consensus 476 ~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 555 (608)
+.|+|+||+|||++||+. ||....+-........ ....+.. ..........-..+|.++++.||++|||+.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~-----~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEP-----ADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCC-----cccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 999999999999999985 6766655444433332 2212111 000111222245799999999999999999
Q ss_pred HHHH
Q 042949 556 EVLE 559 (608)
Q Consensus 556 evl~ 559 (608)
|+++
T Consensus 867 eLL~ 870 (1351)
T KOG1035|consen 867 ELLN 870 (1351)
T ss_pred HHhh
Confidence 9875
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=272.68 Aligned_cols=238 Identities=21% Similarity=0.248 Sum_probs=185.8
Q ss_pred cccCCCCCceEEEEEEcC-CcEEEEEEeccc------ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLKN-SAVYAVKRLKKL------QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-g~~vavK~l~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
..+|+|++|.||+++... +..+++|.++.. .....++.+|+.++++++||||+++++++......++|+||++
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (260)
T cd08222 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85 (260)
T ss_pred eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence 458999999999998653 445555655421 1223457789999999999999999999999899999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+++|.+++.........+++..++.++.|+++||+|||+.+ ++|+||||+||++++ +.+||+|||+++......
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR-----ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred CCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 99999999765444567999999999999999999999876 999999999999975 569999999998764332
Q ss_pred ---ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 460 ---TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 460 ---~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
....++..|+||| ..++.++||||||+++|+|++|..|+..... ........... .. ......
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~-~~--------~~~~~~ 229 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-LSVVLRIVEGP-TP--------SLPETY 229 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHcCC-CC--------CCcchh
Confidence 2345788899999 4567789999999999999999999864332 22222211110 00 011234
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||..+|++||++.|+++.
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 4568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=271.22 Aligned_cols=217 Identities=21% Similarity=0.221 Sum_probs=173.8
Q ss_pred CCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHHHHHH
Q 042949 312 TICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAY 390 (608)
Q Consensus 312 g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 390 (608)
|.+|.||+++.. +++.||+|+++... .+.+|...+....||||+++++++...+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK- 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence 789999999864 78999999997532 334555566666799999999999999999999999999999999875
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCccccccCcccc
Q 042949 391 IEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTA 470 (608)
Q Consensus 391 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~a 470 (608)
...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+...........++..|+|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~a 150 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG-----IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCA 150 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccC
Confidence 345899999999999999999999876 999999999999999999999999988766554444556778999
Q ss_pred CC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhc
Q 042949 471 PE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSN 546 (608)
Q Consensus 471 PE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~ 546 (608)
|| ..++.++||||+|+++|||++|+.++....... ... ... ..+...+..+.+++.+|++.
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~~~--~~~------~~~~~~~~~~~~li~~~l~~ 215 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------NTH--TTL------NIPEWVSEEARSLLQQLLQF 215 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------ccc--ccc------CCcccCCHHHHHHHHHHccC
Confidence 99 346789999999999999999997754321100 000 000 01122445688999999999
Q ss_pred CCCCCCCHHH
Q 042949 547 SPDDRPTMAE 556 (608)
Q Consensus 547 dP~~RPs~~e 556 (608)
||++||++.+
T Consensus 216 dp~~R~~~~~ 225 (237)
T cd05576 216 NPTERLGAGV 225 (237)
T ss_pred CHHHhcCCCc
Confidence 9999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=282.91 Aligned_cols=242 Identities=19% Similarity=0.225 Sum_probs=182.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecC--------------Ce
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN--------------EE 370 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------------~~ 370 (608)
..+|.|++|.||+|... +|+.||+|++.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 11 ~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (342)
T cd07854 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS 90 (342)
T ss_pred EEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccce
Confidence 45799999999999864 68999999987433 3456788999999999999999998766543 35
Q ss_pred eEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-CCCceEecc
Q 042949 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-NEDPLISEC 449 (608)
Q Consensus 371 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DF 449 (608)
.++|+||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++. +..+|++||
T Consensus 91 ~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 91 VYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN-----VLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred EEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEcCCCceEEECCc
Confidence 789999996 588887752 46899999999999999999999886 999999999999974 557899999
Q ss_pred ccccccCCCC------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc
Q 042949 450 GYSKFLDPKK------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG 518 (608)
Q Consensus 450 Gla~~~~~~~------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 518 (608)
|+++...... ....++..|+||| ..++.++|||||||++|||++|+.||........... ........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~-~~~~~~~~ 238 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL-ILESVPVV 238 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCC
Confidence 9998654321 2235678899999 3467899999999999999999999965543222111 11100000
Q ss_pred ------cc---c-----------cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 519 ------EV---F-----------DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 519 ------~~---~-----------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.. . .............++.+++.+||..||++|||+.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 0 000001112345668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=278.52 Aligned_cols=243 Identities=20% Similarity=0.218 Sum_probs=183.1
Q ss_pred cccCCCCCceEEEEEEc-C--CcEEEEEEecccc---cCHHHHHHHHHHHhcC-CCCcceeeeeeeec----CCeeEEEE
Q 042949 307 DLRSQTICSSLFMVRLK-N--SAVYAVKRLKKLQ---VSMDEFSQTMRQIGNL-KHPNILPLVCYNST----NEEKLLVY 375 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~--g~~vavK~l~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~~~lv~ 375 (608)
..+|+|+||.||+++.. + +..||+|++.... ...+.+.+|++++.++ +||||+++++++.. ....++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 85 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence 56899999999999875 3 7899999987421 2245678899999999 59999999987532 24568888
Q ss_pred eeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
||+. ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 86 e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g-----ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 86 ELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN-----VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred eccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 8885 689888863 467999999999999999999999887 999999999999999999999999999865
Q ss_pred CCC-------CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh------hcc
Q 042949 456 DPK-------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE------EWT 517 (608)
Q Consensus 456 ~~~-------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~------~~~ 517 (608)
... .....|+..|+||| ..++.++|||||||++|+|++|+.||........ ....... ...
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ-LNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence 422 12346888999999 2468899999999999999999998865432211 1111100 000
Q ss_pred cccc---------------cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 518 GEVF---------------DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 518 ~~~~---------------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+. ..............+.+++.+|++.||++|||+.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 000111112235668899999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=261.94 Aligned_cols=237 Identities=20% Similarity=0.281 Sum_probs=192.0
Q ss_pred cCcCHHHHHHHhhcccCCCCCceEEEEEE-cCCcEEEEEEecccc-cCHH---HHHHHHHHHhcCCCCcceeeeeeeecC
Q 042949 294 ERFKLDDLLEATADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ-VSMD---EFSQTMRQIGNLKHPNILPLVCYNSTN 368 (608)
Q Consensus 294 ~~~~~~~l~~~~~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~-~~~~---~~~~e~~~l~~l~H~niv~l~~~~~~~ 368 (608)
.+++.+|..-. .++|+|.||+|-.++- .+|+.+|+|++++.- ...+ .-..|-++|...+||.+..+-..|+++
T Consensus 163 ~kvTm~dFdfL--KvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 163 NKVTMEDFDFL--KVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ceeccchhhHH--HHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 34555544221 5689999999999975 479999999998542 2223 346788999999999999999899999
Q ss_pred CeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEec
Q 042949 369 EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448 (608)
Q Consensus 369 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 448 (608)
+.+|+||||..||.|.-+|.. .+.+++.....+-.+|..||.|||+.+ ||.||+|.+|.|+|.+|++||+|
T Consensus 241 drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~-----ivYRDlKLENLlLDkDGHIKitD 311 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN-----IVYRDLKLENLLLDKDGHIKITD 311 (516)
T ss_pred ceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC-----eeeeechhhhheeccCCceEeee
Confidence 999999999999999988875 577999999999999999999999987 99999999999999999999999
Q ss_pred ccccccc---CCCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 449 CGYSKFL---DPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 449 FGla~~~---~~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
||+++.- .......+||+.|.||| ..|+...|.|.+||++|||++|+.||+....-. .+.-+..+..
T Consensus 312 FGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-LFeLIl~ed~----- 385 (516)
T KOG0690|consen 312 FGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-LFELILMEDL----- 385 (516)
T ss_pred cccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-HHHHHHhhhc-----
Confidence 9999853 33456789999999999 678999999999999999999999997654322 2222211110
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCC
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRP 552 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 552 (608)
..+...+.+...|+...|..||.+|.
T Consensus 386 -----kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 -----KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -----cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 12344455677899999999999995
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=288.94 Aligned_cols=238 Identities=18% Similarity=0.286 Sum_probs=198.9
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeec-----CCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNST-----NEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~-----~~~~~lv~e~~~ 379 (608)
+.+|.|.+|.||+++. ++|+..|+|++.......++++.|.++++.+ +|||++.++|++.. ++.+|||||||.
T Consensus 25 evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~ 104 (953)
T KOG0587|consen 25 EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCG 104 (953)
T ss_pred EEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccC
Confidence 5689999999999984 6899999999987666678889999999887 59999999998763 578999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 458 (608)
+|+..++++... ...+.|..+..|+++++.||++||.+. ++|||||-.|||++.++.+|+.|||++..+...
T Consensus 105 gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk-----viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 105 GGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred CccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc-----eeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence 999999998754 567999999999999999999999876 999999999999999999999999999887653
Q ss_pred --CccccccCccccCC---------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 459 --KTCLFSSNGYTAPE---------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 459 --~~~~~gt~~y~aPE---------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
..+..||+.||||| ..|+..+|+||+||+..||.-|.+|+-+-......+. ...-- +.-..
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-------IpRNP-PPkLk 249 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------IPRNP-PPKLK 249 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-------CCCCC-Ccccc
Confidence 35678999999999 3467789999999999999999998765433221111 00000 11112
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+..|+.++.++|..||..|-.+||++.++++
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 35678899999999999999999999988865
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=276.37 Aligned_cols=245 Identities=20% Similarity=0.300 Sum_probs=198.4
Q ss_pred HHHHHHH-hhcccCCCCCceEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeE
Q 042949 298 LDDLLEA-TADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKL 372 (608)
Q Consensus 298 ~~~l~~~-~~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 372 (608)
+..+++. ..+.+|.|-||+||-|++ ++|+.||||++.+.. ...+.++.|+.+|.+++||.||.+...|++.+..+
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 3344433 246899999999999986 589999999997532 34567899999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC---CCceEecc
Q 042949 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN---EDPLISEC 449 (608)
Q Consensus 373 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DF 449 (608)
+|||-+ +||..+++-. ..+.+|++.....++.||+.||.|||.++ |+|+||||+|||+... -.+||+||
T Consensus 640 VVMEKl-~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn-----IvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN-----IVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred EEehhh-cchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc-----eeeccCCchheeeccCCCCCceeeccc
Confidence 999999 5676666543 24678999999999999999999999988 9999999999999654 45899999
Q ss_pred ccccccCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH
Q 042949 450 GYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 450 Gla~~~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (608)
|+|+++.++. ...+||+.|.||| .-|+..-|+||.||++|--++|..||..+.++.+.++...- +.+.
T Consensus 712 GfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF--MyPp---- 785 (888)
T KOG4236|consen 712 GFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF--MYPP---- 785 (888)
T ss_pred cceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc--ccCC----
Confidence 9999998764 5678999999999 67889999999999999999999999888776555432211 0000
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
....+.+...++||...|+..-.+|.|.+..+.
T Consensus 786 ---~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 ---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 111234455789999999999999998876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=282.13 Aligned_cols=227 Identities=21% Similarity=0.216 Sum_probs=183.8
Q ss_pred cCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 309 RSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 309 ~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+|.|+|+.|-++.. .+++..+||++.+. ..+-.+|+.++.+. +||||+++.+.+.+..+.++|||++.+|-+.+.
T Consensus 330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~r 406 (612)
T KOG0603|consen 330 LGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRR 406 (612)
T ss_pred cCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHH
Confidence 79999999988875 57899999999864 23345677666665 699999999999999999999999999988887
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec-CCCCCceEeccccccccCCCCcccccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL-NENEDPLISECGYSKFLDPKKTCLFSS 465 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~~~~~~gt 465 (608)
+.. ...+. ..+..|+.+|+.|+.|||.++ ||||||||+|||+ ++.++++|+|||.++........-.-|
T Consensus 407 i~~----~~~~~-~e~~~w~~~lv~Av~~LH~~g-----vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~t 476 (612)
T KOG0603|consen 407 IRS----KPEFC-SEASQWAAELVSAVDYLHEQG-----VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPALT 476 (612)
T ss_pred HHh----cchhH-HHHHHHHHHHHHHHHHHHhcC-----eeecCCChhheeecCCCCcEEEEEechhhhCchhhcccchh
Confidence 764 23333 777889999999999999987 9999999999999 588999999999999887763344557
Q ss_pred CccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHH
Q 042949 466 NGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVAL 541 (608)
Q Consensus 466 ~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 541 (608)
..|.||| ..+++++||||||++||+|++|+.|+.....-.+....+ ... ......+.+..+|+.
T Consensus 477 ~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i-~~~-----------~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 477 LQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI-QMP-----------KFSECVSDEAKDLLQ 544 (612)
T ss_pred hcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh-cCC-----------ccccccCHHHHHHHH
Confidence 8899999 678999999999999999999999987654431111111 110 011445677899999
Q ss_pred HchhcCCCCCCCHHHHHHH
Q 042949 542 KCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 542 ~Cl~~dP~~RPs~~evl~~ 560 (608)
+||+.||.+||+|.++...
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HhccCChhhCcChhhhccC
Confidence 9999999999999998765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=240.14 Aligned_cols=203 Identities=20% Similarity=0.234 Sum_probs=170.8
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc--cCHHHHHHHHHHHhc-CCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGN-LKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.=+|+|++|.|-+-++ ++|+..|+|+++..- ....+..+|+.+..+ ..+|.+|.++|.+......++.||.| .-+
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tS 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTS 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhh
Confidence 4479999999988775 589999999998533 234556778887655 47999999999999999999999999 458
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--c
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--T 460 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--~ 460 (608)
|..+-++.......+++...-+|+..|.+||.|||++- .|||||+||+|||++.+|++|++|||.+-.+.++- +
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL----~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt 206 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL----SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT 206 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh----hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH
Confidence 88887776666788999999999999999999999875 49999999999999999999999999998876653 3
Q ss_pred cccccCccccCC--------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh
Q 042949 461 CLFSSNGYTAPE--------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE 514 (608)
Q Consensus 461 ~~~gt~~y~aPE--------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 514 (608)
...|...||||| ..|+.|+||||+|+++.||.+++.|+.......+..++.+.+
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 356788999999 357889999999999999999999988766655555555543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=295.65 Aligned_cols=237 Identities=20% Similarity=0.245 Sum_probs=193.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
.+||+|+||.|..++++ ++++||+|++++. ......|..|-.+|..-+.+.||.+.-.|++..++|+|||||+||
T Consensus 81 KvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGG 160 (1317)
T KOG0612|consen 81 KVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGG 160 (1317)
T ss_pred HHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCc
Confidence 57999999999999875 6899999999852 234556888999999889999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
||..++.++ ..+++..+..++..|..||.-||+.+ .|||||||+|||||..|++||+|||.+-.+..+.
T Consensus 161 DlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mg-----yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 161 DLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMG-----YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred hHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhcc-----ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 999999863 36999999999999999999999987 9999999999999999999999999988776443
Q ss_pred --ccccccCccccCC---------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 --TCLFSSNGYTAPE---------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 --~~~~gt~~y~aPE---------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
...+|||-|++|| +.|+..+|.||+||++|||+.|..||+...-...+-+.+....... +. .
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~--FP-----~ 304 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS--FP-----D 304 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC--CC-----c
Confidence 4568999999999 4689999999999999999999999986544333333332211110 10 1
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCC---HHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPT---MAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~~ 560 (608)
....+....+||.+.+. +|+.|.. ++|+-..
T Consensus 305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 12356668889988775 6888887 6666443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=267.13 Aligned_cols=246 Identities=19% Similarity=0.255 Sum_probs=194.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCC-C-C----cceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-H-P----NILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H-~----niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|.||.|-.+... .+..||||+++......+...-|++++.++. + | -+|.+.+||.-.++.|+|+|.+
T Consensus 95 ~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell- 173 (415)
T KOG0671|consen 95 DLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL- 173 (415)
T ss_pred hhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-
Confidence 45799999999998754 5789999999976667778889999999994 2 2 3778889999999999999998
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-------------------
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE------------------- 440 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~------------------- 440 (608)
|-++.++|.. ++-.+++...+..++.|++++++|||+.. ++|-||||+|||+.+
T Consensus 174 G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k-----l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 174 GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK-----LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc-----eeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 6799999975 45678999999999999999999999987 999999999999942
Q ss_pred -CCCceEeccccccccCCCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHH--HHHHh
Q 042949 441 -NEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWV--KAMVR 513 (608)
Q Consensus 441 -~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~--~~~~~ 513 (608)
+..+||+|||.|.......+.++.|..|.||| -.++.++||||+||||+|++||...|+...+..... +.++.
T Consensus 247 ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG 326 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG 326 (415)
T ss_pred CCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC
Confidence 23478999999999888888899999999999 467999999999999999999999998776544331 11111
Q ss_pred h--------h-----ccccccc-------H---H----------HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 514 E--------E-----WTGEVFD-------K---E----------VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 514 ~--------~-----~~~~~~~-------~---~----------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. . .....+| . . .......+..++++|+.++|..||.+|+|+.|++..
T Consensus 327 p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 327 PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 0 0 0000011 0 0 000112345569999999999999999999998764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=293.65 Aligned_cols=138 Identities=25% Similarity=0.351 Sum_probs=123.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..||+|+||.||+|... +++.||||+++.... ....+.+|+.++..++||||+++++++...+..++||||++++
T Consensus 10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~ 89 (669)
T cd05610 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGG 89 (669)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCC
Confidence 46899999999999876 689999999974322 2356888999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
+|.+++.. ...+++..++.|+.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g-----IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 90 DVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG-----IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999975 346889999999999999999999876 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=254.92 Aligned_cols=231 Identities=27% Similarity=0.374 Sum_probs=188.9
Q ss_pred CCceEEEEEEc-CCcEEEEEEeccccc-C-HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHHHHH
Q 042949 313 ICSSLFMVRLK-NSAVYAVKRLKKLQV-S-MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEA 389 (608)
Q Consensus 313 ~~g~vy~~~~~-~g~~vavK~l~~~~~-~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 389 (608)
+||.||++... +|+.+|+|++..... . .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57899999986 489999999974332 2 57899999999999999999999999998999999999999999999875
Q ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--CccccccCc
Q 042949 390 YIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--KTCLFSSNG 467 (608)
Q Consensus 390 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--~~~~~gt~~ 467 (608)
...+++..+..++.+++++++|||+.+ ++|+||+|+||+++.++.++|+|||.+...... .....++..
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG-----IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC-----eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 233899999999999999999999886 999999999999999999999999999877653 344567888
Q ss_pred cccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHc
Q 042949 468 YTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKC 543 (608)
Q Consensus 468 y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~C 543 (608)
|++|| ...+.++||||||++++++++|..|+....+................ ......+.++.+++.+|
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-------PPEWKISPEAKDLIRKL 224 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------cccccCCHHHHHHHHHH
Confidence 99999 45788999999999999999999998664443333332222111100 00001456688999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 042949 544 VSNSPDDRPTMAEVLE 559 (608)
Q Consensus 544 l~~dP~~RPs~~evl~ 559 (608)
+..+|++||++.++++
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 9999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=231.98 Aligned_cols=244 Identities=19% Similarity=0.266 Sum_probs=187.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+-||+|.||+||+++.. +++.||+|+++-.. .-.....+|+-+++.++|+|||++++....+....+|+|||. .+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HH
Confidence 34799999999999865 67999999987322 234567899999999999999999999999999999999994 57
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|..+... -...++.+....++.|+++||.|+|+++ +.|||+||.|.||+.+++.|++|||+++.+.-..
T Consensus 87 lkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn-----vlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 87 LKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN-----VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh-----hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 8777764 2567899999999999999999999987 9999999999999999999999999999876443
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh-------hccc--ccccHHH
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE-------EWTG--EVFDKEV 525 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~--~~~~~~~ 525 (608)
+..+-|..|.+|+ ..|+...|+||-||++.|+.....|...+.+..+..+.+... .|.. ...|-..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 3345688999999 578899999999999999988666655555555544443321 1110 0000000
Q ss_pred ----------HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 526 ----------AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 526 ----------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
..........-.+++++.+.-+|.+|.++++.++
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0000111122358889999999999999988765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=256.11 Aligned_cols=244 Identities=18% Similarity=0.260 Sum_probs=196.7
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEecc--cccCHHHHHHHHHHHhcCCCCcceeeeeeeec-CCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNST-NEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~ 377 (608)
.++-+|.||.||+|.+. +.+.|-+|.++. ++.....+..|-..+..+.|||+..+.+.+.. ....+.+|.+
T Consensus 290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~ 369 (563)
T KOG1024|consen 290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA 369 (563)
T ss_pred hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence 45789999999999654 346677888874 33345678889999999999999999998765 4567899999
Q ss_pred ccCCCHHHHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 378 QSNGSLLSLLEAYI----EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 378 ~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
+.-|+|..||...+ ...+.++..+...++.|++.|++|||.++ |||.||..+|.+||+...+||+|-.+++
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~-----ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG-----VIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC-----cccchhhhhcceehhheeEEeccchhcc
Confidence 99999999998432 12356778889999999999999999987 9999999999999999999999999999
Q ss_pred ccCCCCcccccc-----CccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccH
Q 042949 454 FLDPKKTCLFSS-----NGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 454 ~~~~~~~~~~gt-----~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (608)
.+-+......|. ..||+|| ..++..+|||||||+||||+| |+.|+. +.+..+ +..+..++
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya-eIDPfE-m~~ylkdG-------- 514 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA-EIDPFE-MEHYLKDG-------- 514 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc-ccCHHH-HHHHHhcc--------
Confidence 877766655553 4599999 678999999999999999998 555543 333222 23333322
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
.....+.+++++++.+|.-||+.+|++||+++++...|.+..
T Consensus 515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 222456788999999999999999999999999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=254.02 Aligned_cols=247 Identities=19% Similarity=0.228 Sum_probs=186.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecc---cccCHHHHHHHHHHHhcCCCCcceeeeeeeec--------CCeeEEE
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKK---LQVSMDEFSQTMRQIGNLKHPNILPLVCYNST--------NEEKLLV 374 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~~~~~lv 374 (608)
..+|+|.||.||+++.+ +|+.||+|++-. ...-.....+|+++|..++|+|++.++..|.. ....++|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 45899999999999875 577889987642 12234556799999999999999999988754 2357999
Q ss_pred EeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
|++|+. +|..+|.. ....++...+.+++.++..||.|+|... |+|||+||+|+||+.++..||+|||+++.
T Consensus 103 f~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k-----ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK-----ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred HHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh-----HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 999965 88888863 3467999999999999999999999886 99999999999999999999999999986
Q ss_pred cCCCC-------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHH-Hhhhcccccc
Q 042949 455 LDPKK-------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAM-VREEWTGEVF 521 (608)
Q Consensus 455 ~~~~~-------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 521 (608)
+.... +..+-|..|.+|| +.++++.|||.-||++.||+||.+.+++..+..+..... +......++.
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 64332 2345588999999 678999999999999999999999887665543322111 1111111111
Q ss_pred cH--------HH-------------HHh--chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 522 DK--------EV-------------AKA--GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 522 ~~--------~~-------------~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
.. .+ ... +........+|+.+++..||.+|++++++++.--
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 00 00 000 0011235789999999999999999999876543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=262.92 Aligned_cols=240 Identities=22% Similarity=0.220 Sum_probs=186.0
Q ss_pred ccCCCCCceEEEEE-EcCCcEEEEEEecccccC--------HHHHHHHHHHHhcCCCCcceeeeeeee-cCCeeEEEEee
Q 042949 308 LRSQTICSSLFMVR-LKNSAVYAVKRLKKLQVS--------MDEFSQTMRQIGNLKHPNILPLVCYNS-TNEEKLLVYKY 377 (608)
Q Consensus 308 ~~g~g~~g~vy~~~-~~~g~~vavK~l~~~~~~--------~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~ 377 (608)
++|+|+|+.||++- +...+.||||+-...... .+...+|.++-+.|+||.||++++|+. +.+..|-|+||
T Consensus 470 LLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEY 549 (775)
T KOG1151|consen 470 LLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEY 549 (775)
T ss_pred HhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeee
Confidence 58999999999996 456788999976422111 223568999999999999999999986 56788999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC---CCCceEeccccccc
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE---NEDPLISECGYSKF 454 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~ 454 (608)
|+|.+|.-||+. .+.++++.+..|+.||+.||.||.... ++|||-||||.|||+.. .|.+||.|||++++
T Consensus 550 ceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEik---pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 550 CEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIK---PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred cCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccC---CCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999976 567999999999999999999998764 67999999999999953 57899999999999
Q ss_pred cCCCC----------ccccccCccccCC--------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc
Q 042949 455 LDPKK----------TCLFSSNGYTAPE--------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW 516 (608)
Q Consensus 455 ~~~~~----------~~~~gt~~y~aPE--------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 516 (608)
++.+. +...||.+|.+|| ...+.|+||||.|||+|.++-|+.||.......+.+. +..
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq----eNT 698 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ----ENT 698 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh----hhc
Confidence 87543 2356899999999 3568899999999999999999999986654332221 111
Q ss_pred ccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 517 TGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.-....... +.....+.+..++|.+||++.-++|....++..
T Consensus 699 IlkAtEVqF-P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 699 ILKATEVQF-PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhcceeccC-CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 000000000 111234455789999999999999987766643
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=259.59 Aligned_cols=226 Identities=21% Similarity=0.281 Sum_probs=184.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
.++|+|+||+|..+..+ +.+.+|||++++.- .+.+--..|-++|.-- +-|.++++..+|++-+.+|+||||+.+
T Consensus 355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnG 434 (683)
T KOG0696|consen 355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNG 434 (683)
T ss_pred EEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecC
Confidence 35899999999999765 56899999998532 2344455677777655 578999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC--C-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD--P- 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~--~- 457 (608)
|+|.-++++ -..+.+..+..+|.+||-||-|||+++ ||.||||..||++|.++++||+|||+++.-- .
T Consensus 435 GDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg-----IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 435 GDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred chhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC-----eeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 999998886 356888899999999999999999987 9999999999999999999999999998532 2
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
...+..||+.|+||| ..|+..+|.|||||+||||+.|++||.+..+ .+.++.+.+... ..+...+
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-~elF~aI~ehnv----------syPKslS 574 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQAIMEHNV----------SYPKSLS 574 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHccC----------cCccccc
Confidence 234678999999999 6789999999999999999999999976544 333443333221 1233455
Q ss_pred HHHHHHHHHchhcCCCCCC
Q 042949 534 FPLLNVALKCVSNSPDDRP 552 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RP 552 (608)
.+..++....+...|.+|.
T Consensus 575 kEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 575 KEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHHHHhhcCCcccc
Confidence 6677888889999999995
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=266.66 Aligned_cols=239 Identities=17% Similarity=0.209 Sum_probs=194.6
Q ss_pred CcCHHHHHHHhhcccCCCCCceEEEEEEcCCc-EEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCC
Q 042949 295 RFKLDDLLEATADLRSQTICSSLFMVRLKNSA-VYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE 369 (608)
Q Consensus 295 ~~~~~~l~~~~~~~~g~g~~g~vy~~~~~~g~-~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 369 (608)
...+.|+... .-+|-|+||.|-.++..... .+|+|++++.. ...+.+..|-++|...+.|.||+++..|.+..
T Consensus 416 ~v~l~dl~~i--aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 416 QVKLSDLKRI--ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred ccchhhhhhh--hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 3445555433 24799999999999875443 58999997432 23456888999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecc
Q 042949 370 EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC 449 (608)
Q Consensus 370 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 449 (608)
..|+.||-|-||.|...|++ ...|+......++..+.+|++|||.++ ||.|||||+|.++|.+|-+||.||
T Consensus 494 yvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~-----iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG-----IIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred hhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC-----ceeccCChhheeeccCCceEEeeh
Confidence 99999999999999999986 678999999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH
Q 042949 450 GYSKFLDPK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 450 Gla~~~~~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (608)
|+|+.+... .-+++||+.|.||| .-.+.++|.||+||++|||+||.+||..-..+..+......-+
T Consensus 565 GFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-------- 636 (732)
T KOG0614|consen 565 GFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-------- 636 (732)
T ss_pred hhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh--------
Confidence 999988654 45689999999999 4457789999999999999999999987655444332221111
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCC
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPT 553 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 553 (608)
....+........+++.+.+..+|.+|.-
T Consensus 637 -~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 -KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 11223334455778999999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=277.17 Aligned_cols=245 Identities=15% Similarity=0.194 Sum_probs=159.7
Q ss_pred hcccCCCCCceEEEEEEc-C----CcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeee------eecCCeeEEE
Q 042949 306 ADLRSQTICSSLFMVRLK-N----SAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCY------NSTNEEKLLV 374 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~------~~~~~~~~lv 374 (608)
.+.+|+|+||.||+|+.. + +..||||+++.... .+....| .+.+..+.+++.++.. .......++|
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV 213 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLV 213 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEE
Confidence 367999999999999975 4 68999999864321 1111111 1222223333333221 2456688999
Q ss_pred EeeccCCCHHHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec
Q 042949 375 YKYQSNGSLLSLLEAYIEG----------------KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl 438 (608)
+||+++++|.+++...... ........+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-----IiHRDLKP~NILl 288 (566)
T PLN03225 214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-----IVHRDVKPQNIIF 288 (566)
T ss_pred EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC-----EEeCcCCHHHEEE
Confidence 9999999999998642100 001123446689999999999999876 9999999999999
Q ss_pred CC-CCCceEeccccccccCCC----CccccccCccccCCCC--------------------------CCcchhHHHHHHH
Q 042949 439 NE-NEDPLISECGYSKFLDPK----KTCLFSSNGYTAPEKT--------------------------VSEQGDVFSFGVI 487 (608)
Q Consensus 439 ~~-~~~~kl~DFGla~~~~~~----~~~~~gt~~y~aPE~~--------------------------~~~ksDVwSfGvv 487 (608)
+. ++.+||+|||+++.+... .....+++.|+|||.. ++.++|||||||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 86 578999999999865432 2345688999999911 2345699999999
Q ss_pred HHHHHcCCCCCcCCCChHHHHHHHHhhhc-----c---cccccHHHHH---hchhcHHHHHHHHHHchhcCCCCCCCHHH
Q 042949 488 LLELLTGKTVEKTGIDLPKWVKAMVREEW-----T---GEVFDKEVAK---AGRQWAFPLLNVALKCVSNSPDDRPTMAE 556 (608)
Q Consensus 488 l~elltg~~p~~~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 556 (608)
+|||+++..++.. ....+.+.+..... . .......... ..........+|+.+||+.||++|||+.|
T Consensus 369 L~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e 446 (566)
T PLN03225 369 FLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA 446 (566)
T ss_pred HHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence 9999997655332 22222222111100 0 0000000000 00111223558999999999999999999
Q ss_pred HHHH
Q 042949 557 VLER 560 (608)
Q Consensus 557 vl~~ 560 (608)
+++.
T Consensus 447 ~L~H 450 (566)
T PLN03225 447 ALAH 450 (566)
T ss_pred HhCC
Confidence 9885
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=263.08 Aligned_cols=186 Identities=20% Similarity=0.289 Sum_probs=160.8
Q ss_pred cCCCCCceEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRL-KNSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
||-|.||.|..++. .+...||+|.+++.+. ....+..|-.+|...+.+.||+|+-.|++.+.+|+||||++|||+
T Consensus 637 iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDm 716 (1034)
T KOG0608|consen 637 IGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDM 716 (1034)
T ss_pred ecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccH
Confidence 79999999999875 4568999999975433 233567899999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC-------
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD------- 456 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~------- 456 (608)
.++|-. ..-|++..+..++.++..|+++.|..+ +|||||||+|||||.+|++||.|||++.-+.
T Consensus 717 MSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG-----FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 717 MSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred HHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc-----ceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999875 467899999999999999999999988 9999999999999999999999999985331
Q ss_pred --CCC------------------------------------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcC
Q 042949 457 --PKK------------------------------------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTG 494 (608)
Q Consensus 457 --~~~------------------------------------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg 494 (608)
... ...+||..|+||| .-++..+|.||.|||||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 000 0246899999999 4678899999999999999999
Q ss_pred CCCCcCCCC
Q 042949 495 KTVEKTGID 503 (608)
Q Consensus 495 ~~p~~~~~~ 503 (608)
+.||.....
T Consensus 868 ~~pf~~~tp 876 (1034)
T KOG0608|consen 868 QPPFLADTP 876 (1034)
T ss_pred CCCccCCCC
Confidence 999976544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=265.83 Aligned_cols=247 Identities=15% Similarity=0.164 Sum_probs=168.9
Q ss_pred hcccCCCCCceEEEEEE-----------------cCCcEEEEEEeccccc-CHHH--------------HHHHHHHHhcC
Q 042949 306 ADLRSQTICSSLFMVRL-----------------KNSAVYAVKRLKKLQV-SMDE--------------FSQTMRQIGNL 353 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-----------------~~g~~vavK~l~~~~~-~~~~--------------~~~e~~~l~~l 353 (608)
.+.||+|+||+||+|.. .+++.||||+++.... ..++ ...|+..+.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 36789999999999964 2456899999874221 1222 33466777777
Q ss_pred CCCcc-----eeeeeeeec--------CCeeEEEEeeccCCCHHHHHHHHhc--------------------CCCCCCHH
Q 042949 354 KHPNI-----LPLVCYNST--------NEEKLLVYKYQSNGSLLSLLEAYIE--------------------GKRDFPWK 400 (608)
Q Consensus 354 ~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~ 400 (608)
+|.++ ++++++|.. .+..++||||+++|+|.++++.... ....+++.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 76654 677777653 3568999999999999999874211 01235678
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccccccCccccCCCCC-
Q 042949 401 LRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCLFSSNGYTAPEKTV- 475 (608)
Q Consensus 401 ~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~~gt~~y~aPE~~~- 475 (608)
.+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....+++.|+|||...
T Consensus 310 ~~~~i~~ql~~aL~~lH~~~-----ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHRIG-----IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred HHHHHHHHHHHHHHHHHHCC-----eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 89999999999999999876 9999999999999999999999999997654322 1123478899999211
Q ss_pred -----------------------C--cchhHHHHHHHHHHHHcCCC-CCcCCCChHHHHHHHHh--hhc---ccccccHH
Q 042949 476 -----------------------S--EQGDVFSFGVILLELLTGKT-VEKTGIDLPKWVKAMVR--EEW---TGEVFDKE 524 (608)
Q Consensus 476 -----------------------~--~ksDVwSfGvvl~elltg~~-p~~~~~~~~~~~~~~~~--~~~---~~~~~~~~ 524 (608)
+ .+.||||+||+++||++|.. |+..........+.... ..+ .....+-
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~- 463 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF- 463 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc-
Confidence 1 24699999999999999875 44321111110100000 000 0000000
Q ss_pred HHHhchhcHHHHHHHHHHchhcCC---CCCCCHHHHHHH
Q 042949 525 VAKAGRQWAFPLLNVALKCVSNSP---DDRPTMAEVLER 560 (608)
Q Consensus 525 ~~~~~~~~~~~l~~li~~Cl~~dP---~~RPs~~evl~~ 560 (608)
......+....+++.+++..+| .+|+|+.|++++
T Consensus 464 --~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 464 --SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0112234567899999999766 689999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=236.22 Aligned_cols=255 Identities=19% Similarity=0.242 Sum_probs=193.1
Q ss_pred CccCcCHHHHHHHhhcccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeee-eeecC
Q 042949 292 EKERFKLDDLLEATADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVC-YNSTN 368 (608)
Q Consensus 292 ~~~~~~~~~l~~~~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~-~~~~~ 368 (608)
+.+.++++|.+.. +..+|+|.||.+..++++ ..+.+++|.+........+|.+|..---.| .|.||+.-++ .|++.
T Consensus 16 el~kv~l~d~y~I-~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 16 ELKKVDLEDVYTI-NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred cccccchhhhhhH-HHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 3456777776644 467899999999999876 567899999998888899999999876566 4999998765 57788
Q ss_pred CeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC--CCCCceE
Q 042949 369 EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN--ENEDPLI 446 (608)
Q Consensus 369 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~--~~~~~kl 446 (608)
+..++++||+|.|+|.+-+. ...+.+....+++.|++.|++|||+++ +||||||.+||||- +..++||
T Consensus 95 d~YvF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHskn-----lVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSKN-----LVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred ceEEEeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhccc-----hhhcccccceEEEecCCccEEEe
Confidence 88999999999999998775 356888999999999999999999998 99999999999993 3458999
Q ss_pred eccccccccCCCCccccccCccccCC---------CCCCcchhHHHHHHHHHHHHcCCCCCcCCC--ChHHHHHHHHhhh
Q 042949 447 SECGYSKFLDPKKTCLFSSNGYTAPE---------KTVSEQGDVFSFGVILLELLTGKTVEKTGI--DLPKWVKAMVREE 515 (608)
Q Consensus 447 ~DFGla~~~~~~~~~~~gt~~y~aPE---------~~~~~ksDVwSfGvvl~elltg~~p~~~~~--~~~~~~~~~~~~~ 515 (608)
+|||..+..+.......-+..|.+|| ....+.+|||.|||++|.++||+.|++... +.+-|-...+...
T Consensus 165 cDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 165 CDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred eecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 99999987665444444566789998 235678999999999999999999987422 1111111111111
Q ss_pred cccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 516 WTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
.. ..++......+..+..+..+-+..+|++|=...++-++-.
T Consensus 245 k~-----~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 245 KN-----PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cC-----ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 11 1222233445566788889999999999955555554433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=271.22 Aligned_cols=236 Identities=22% Similarity=0.268 Sum_probs=175.4
Q ss_pred hhcccCCCCCc-eEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 305 TADLRSQTICS-SLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 305 ~~~~~g~g~~g-~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+++++|.|+.| .||+|.. +|+.||||++-.. ..+-..+|+..|..- +|||||++++.-.+....|+..|.| ..+
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 45667888877 5788988 7889999998532 234567899999877 5999999999999999999999999 469
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC---C--CCceEeccccccccCC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE---N--EDPLISECGYSKFLDP 457 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~---~--~~~kl~DFGla~~~~~ 457 (608)
|.++++..............+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+..
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~-----iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK-----IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc-----cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 99999862011111111345678899999999999976 999999999999976 2 5689999999998875
Q ss_pred CC------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcC-CCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 458 KK------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTG-KTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 458 ~~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
+. ....||.||+||| ..-+.++||+|+||++|..++| ..||.+... ...... .....-. .+.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl-~~~~~L~----~L~ 736 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANIL-TGNYTLV----HLE 736 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhh-cCcccee----eec
Confidence 43 3457899999999 3446689999999999999998 678865422 111111 1111000 000
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
...++ ...+||.+|+.+||..||++.+|+.
T Consensus 737 -~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 737 -PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00111 5789999999999999999999964
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=226.53 Aligned_cols=239 Identities=19% Similarity=0.254 Sum_probs=186.1
Q ss_pred ccCCCCCceEEEEE-EcCCcEEEEEEecccccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCC--eeEEEEeeccCCCH
Q 042949 308 LRSQTICSSLFMVR-LKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNE--EKLLVYKYQSNGSL 383 (608)
Q Consensus 308 ~~g~g~~g~vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~lv~e~~~~g~L 383 (608)
-+|+|.++.||.|. ..+.+.++||+++. .....+.+|+.+|..|+ |||||++++...++. ...+|+||..+-+.
T Consensus 45 k~GRGKYSEVFeg~~~~~~eK~ViKiLKP--VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Df 122 (338)
T KOG0668|consen 45 KVGRGKYSEVFEGINITNNEKCVIKILKP--VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDF 122 (338)
T ss_pred HHcCccHhhHhcccccCCCceEEEeeech--HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccH
Confidence 36999999999997 45778999999983 34577899999999997 999999999987754 45699999999887
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-CCceEeccccccccCCCCc--
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-EDPLISECGYSKFLDPKKT-- 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~-- 460 (608)
..+- ..|+...+..++.++++||.|+|+.+ |+|||+||.|++||.. ...+|+|+|+|.+..+...
T Consensus 123 k~ly-------~tl~d~dIryY~~elLkALdyCHS~G-----ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 123 KQLY-------PTLTDYDIRYYIYELLKALDYCHSMG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred HHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC-----cccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence 7654 34777888999999999999999998 9999999999999975 5689999999999887653
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC-hHHHHHHH--Hhhh-------cccccccHHH
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGID-LPKWVKAM--VREE-------WTGEVFDKEV 525 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~-~~~~~~~~--~~~~-------~~~~~~~~~~ 525 (608)
..+.+..|.-|| ..++..-|+|||||++..|+..+.||..+.+ ..+.++.. +... ...-.+++..
T Consensus 191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~ 270 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF 270 (338)
T ss_pred eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence 346788899999 5678889999999999999999999865544 33333322 1100 0011122222
Q ss_pred HH----------------hch-hcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 526 AK----------------AGR-QWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 526 ~~----------------~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.. ..+ -...++++++.+.|..|.++|+|++|.+..
T Consensus 271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11 001 123668999999999999999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=226.83 Aligned_cols=202 Identities=31% Similarity=0.467 Sum_probs=177.2
Q ss_pred cCCCCCceEEEEEEcC-CcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 309 RSQTICSSLFMVRLKN-SAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+|+|.+|.||++...+ ++.+++|++..... ..+.+.+|++.+++++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 5899999999999864 89999999985433 25679999999999999999999999999899999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-CCCceEeccccccccCCC---Ccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-NEDPLISECGYSKFLDPK---KTC 461 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~---~~~ 461 (608)
++... ...+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+...... ...
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~-----~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG-----IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 98752 146899999999999999999999987 999999999999999 899999999999876654 334
Q ss_pred ccccCccccCC----C-CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 462 LFSSNGYTAPE----K-TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 462 ~~gt~~y~aPE----~-~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
..+...|++|| . ..+.++|+|++|+++++| ..+
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------~~~ 190 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------PEL 190 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------HHH
Confidence 55778899999 2 667889999999999998 236
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+|++.+|++||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=233.85 Aligned_cols=228 Identities=20% Similarity=0.332 Sum_probs=182.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
.+||+|+|.+|..+++. +.+.+|+|++++.- .+.+=.+.|-.+..+. +||.+|.+..+|+++..+++|.||.++
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g 335 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG 335 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence 46899999999999865 67899999998532 2333355666666555 699999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc-C--C
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL-D--P 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~-~--~ 457 (608)
|+|.-+++. ++.|+++.+..+..+|..||.|||+.+ ||.||||..|+|+|..+++||.|+|+++.- . +
T Consensus 336 gdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg-----iiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 336 GDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG-----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred cceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC-----eeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 999877764 567999999999999999999999887 999999999999999999999999999853 2 2
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcC------CCChHHHHHHHHhhhcccccccHHHHH
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKT------GIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
..++++||+.|+||| ..|+...|.|++||+++||+.|+.||.. ..+..++.-++.-+.. ..
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq---------ir 477 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ---------IR 477 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc---------cc
Confidence 346789999999999 5789999999999999999999999863 1222233222222111 12
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCC
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRP 552 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RP 552 (608)
.++..+.....++..-+..||.+|.
T Consensus 478 iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccceeehhhHHHHHHhhcCCcHHhc
Confidence 2344455566788889999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=233.55 Aligned_cols=239 Identities=19% Similarity=0.228 Sum_probs=181.2
Q ss_pred cCCCCCceEEEEEE-cCCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEEEEeec
Q 042949 309 RSQTICSSLFMVRL-KNSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLLVYKYQ 378 (608)
Q Consensus 309 ~g~g~~g~vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e~~ 378 (608)
+|.|.- .|-.+-. -.++.||+|++... ....+...+|...+..++|+||++++.++.-. .+.|+|||||
T Consensus 25 ~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m 103 (369)
T KOG0665|consen 25 IGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM 103 (369)
T ss_pred cCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh
Confidence 444544 3333332 35789999988632 33456678999999999999999999987543 3579999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
.++|.+.+. ..++...+.+|..|++.|++|||+.+ |+||||||+||++..+...||.|||+|+.-...
T Consensus 104 -~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~-----IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 104 -DANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG-----IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred -hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc-----eeecccCcccceecchhheeeccchhhcccCcc
Confidence 578998886 34778899999999999999999987 999999999999999999999999999865544
Q ss_pred --CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHH-------
Q 042949 459 --KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV------- 525 (608)
Q Consensus 459 --~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 525 (608)
.+..+.|..|.||| ..+.+.+||||.||++.||++|+-.|.+...+.+|.+....-+...+-+-..+
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 34567788999999 34788899999999999999999888777777777654322111110000000
Q ss_pred ------------------------HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 526 ------------------------AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 526 ------------------------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+........+.+++.+||..+|++|.+++++++.
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00011123336799999999999999999999876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-29 Score=236.25 Aligned_cols=245 Identities=18% Similarity=0.244 Sum_probs=182.3
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecC-----CeeEEEEeec
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN-----EEKLLVYKYQ 378 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~ 378 (608)
-||-|.||+||.+..+ +|+.||.|++... -.+.+.+.+|+++|..++|.|++..++..+-. .+.|++.|.|
T Consensus 60 PIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm 139 (449)
T KOG0664|consen 60 PIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM 139 (449)
T ss_pred cccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH
Confidence 4799999999999864 8999999998643 23567788999999999999999998876543 2567788877
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
..+|...+ .+...++...++-+..||++||.|||+.+ |.||||||-|.|++.+-..||+|||+++..+.+
T Consensus 140 -QSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~-----ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 140 -QSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN-----ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred -Hhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc-----hhhccCCCccEEeccCceEEecccccccccchh
Confidence 34666655 34678998899999999999999999987 999999999999999999999999999976654
Q ss_pred C----ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHH--HHHHhh-----------hc
Q 042949 459 K----TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWV--KAMVRE-----------EW 516 (608)
Q Consensus 459 ~----~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~--~~~~~~-----------~~ 516 (608)
. +..+-|.+|.||| +.|+...||||.||++.|++.++..|+....+.+.- -..+.. +.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 3 3345688999999 678999999999999999999888887655443221 111110 00
Q ss_pred cccccc-----HHHH-----HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 517 TGEVFD-----KEVA-----KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 517 ~~~~~~-----~~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
...++. +... ........+...+..+++..||++|.+..+.+..+.
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000000 0000 000111223567888899999999999888876643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-29 Score=258.52 Aligned_cols=238 Identities=18% Similarity=0.276 Sum_probs=194.9
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecc-cccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKK-LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|.|.||.|||++. ..++..|+|.++- ...+..-..+|+-+++..+|||||.++|.+...+..++.||||.+|+|.
T Consensus 21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ 100 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ 100 (829)
T ss_pred eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence 3479999999999986 4789999999984 3345566788999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---CCcc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP---KKTC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~~~~ 461 (608)
+.-+. -.++++.++..+++..++||+|||+.+ =+|||||-.|||+++.+.+|++|||.+..+.. +...
T Consensus 101 diy~~----TgplselqiayvcRetl~gl~ylhs~g-----k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 101 DIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG-----KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred ceeee----cccchhHHHHHHHhhhhccchhhhcCC-----cccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 87653 568999999999999999999999987 79999999999999999999999999887654 3456
Q ss_pred ccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 462 LFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 462 ~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
+.||++||||| ..|+.++|||+.|++..|+-.-++|..+-......+ .+ ....+++.-.+....+..
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-Lm-----TkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-LM-----TKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH-Hh-----hccCCCCCcccCCccchH
Confidence 78999999999 568999999999999999988887754322221111 11 112222323334456777
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+.++++.|+..+|++||++..++.
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhhee
Confidence 8999999999999999999887654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=218.33 Aligned_cols=185 Identities=29% Similarity=0.385 Sum_probs=162.7
Q ss_pred cccCCCCCceEEEEEEcC-CcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLKN-SAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|.|++|.||++...+ ++.+|+|.+..... ..+.+.+|++.+.+++|+|++++++++......++++||+++++|
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 84 (225)
T smart00221 5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDL 84 (225)
T ss_pred eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCH
Confidence 467999999999999875 88999999985433 467889999999999999999999999988999999999999999
Q ss_pred HHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 384 LSLLEAYIEGKRD-FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 384 ~~~l~~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
.+++.. ... +++.....++.+++.++.|||+.+ ++|+|++|+||+++.++.++|+|||.+.......
T Consensus 85 ~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 85 FDYLRK----KGGKLSEEEARFYLRQILEALEYLHSLG-----IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred HHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999875 223 899999999999999999999886 9999999999999999999999999998776543
Q ss_pred -ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcC
Q 042949 460 -TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKT 500 (608)
Q Consensus 460 -~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~ 500 (608)
....++..|++|| ..++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4456778899999 3346689999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=237.93 Aligned_cols=190 Identities=22% Similarity=0.230 Sum_probs=161.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCC------CCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK------HPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~------H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
...|+|.|++|.+|+.. .|+.||||+|.........=.+|+++|++|+ --|+++|+..|...+++|||+|-+
T Consensus 438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L- 516 (752)
T KOG0670|consen 438 GYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL- 516 (752)
T ss_pred eccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-
Confidence 35799999999999864 5789999999976666666679999999995 348999999999999999999988
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-CCceEeccccccccCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-EDPLISECGYSKFLDPK 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 458 (608)
.-+|.++|.++. ....|.......++.|+.-||..|-..+ |+|.||||.|||+++. ...||||||.|......
T Consensus 517 slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~-----vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 517 SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG-----VLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC-----eeecccCccceEeccCcceeeeccCccccccccc
Confidence 568999998863 3456888899999999999999998776 9999999999999876 45799999999887654
Q ss_pred C-ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC
Q 042949 459 K-TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID 503 (608)
Q Consensus 459 ~-~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~ 503 (608)
. +...-+..|.||| ..|+...|+||.||+||||+||+..|.+..+
T Consensus 591 eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 591 EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 4 3344567799999 5678899999999999999999988765543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=238.60 Aligned_cols=183 Identities=16% Similarity=0.257 Sum_probs=159.3
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CH-----HHHHHHHHHHhcCC---CCcceeeeeeeecCCeeEEE
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SM-----DEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLLV 374 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~-----~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv 374 (608)
-+|.|.||.|+.+.++ +...|+||.+.+... .. ..+-.|+.+|..++ |+||++++++|++++..||+
T Consensus 568 ~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~ 647 (772)
T KOG1152|consen 568 PLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLE 647 (772)
T ss_pred eccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEE
Confidence 4799999999999875 567899999875432 11 23567999999997 99999999999999999999
Q ss_pred Eeec-cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 375 YKYQ-SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 375 ~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
+|-. ++-+|+++++. +..+++..+..|+.||+.|+++||+.+ |||||||-+||.++.+|-+||+|||.+.
T Consensus 648 te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~-----ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 648 TEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG-----IVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC-----ceecccccccEEEecCCeEEEeeccchh
Confidence 9964 56799999975 678999999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCC-ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCc
Q 042949 454 FLDPKK-TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEK 499 (608)
Q Consensus 454 ~~~~~~-~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~ 499 (608)
...... ..++||.+|.||| ...+..-|||++||+||.++....|++
T Consensus 719 ~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 776554 5678999999999 345777999999999999998887765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=226.09 Aligned_cols=126 Identities=19% Similarity=0.263 Sum_probs=109.1
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCC-----C---Ccceeeeeeeec----CCeeEE
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-----H---PNILPLVCYNST----NEEKLL 373 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~~~~~~----~~~~~l 373 (608)
.-+|-|-|++||.+.. .+.+.||+|+.+..+...+....||++|++++ | .+||+|++.|.. +.+.||
T Consensus 84 rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCM 163 (590)
T KOG1290|consen 84 RKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCM 163 (590)
T ss_pred EeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEE
Confidence 3479999999999975 56789999999977777788889999999874 3 379999999874 568999
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~ 439 (608)
|+|++ |.+|..+|..+ ..+.++...+..|+.||+.||.|||.++ +|||-||||+|||+.
T Consensus 164 VfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec----gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 164 VFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC----GIIHTDLKPENVLLC 222 (590)
T ss_pred Eehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc----CccccCCCcceeeee
Confidence 99999 77999999763 3567999999999999999999999988 599999999999993
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=207.01 Aligned_cols=165 Identities=19% Similarity=0.216 Sum_probs=125.5
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT 460 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 460 (608)
|+|.++++.. ...+++.+++.++.||++||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~-----------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA-----------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC-----------CcccEeEcCccceee--ccceEeecccc-
Confidence 7899999752 456999999999999999999999752 999999999999999 99998765433
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH--H
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA--F 534 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 534 (608)
..||..||||| ..++.++|||||||++|||+||+.|+.......................+ ........ .
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 139 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD---RSNLESVSAAR 139 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc---cccHHHHHhhh
Confidence 36889999999 56788999999999999999999998655443333333322211110000 00011122 2
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
.+.+++.+||..+|++||++.|+++.+..+..
T Consensus 140 ~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 140 SFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 58899999999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-26 Score=261.17 Aligned_cols=188 Identities=18% Similarity=0.212 Sum_probs=135.2
Q ss_pred cCCC-Ccceeeeeeee-------cCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 042949 352 NLKH-PNILPLVCYNS-------TNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEE 423 (608)
Q Consensus 352 ~l~H-~niv~l~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 423 (608)
.++| +||++++++|. .....+.++||+ +++|.++|+. ....+++..++.++.||++||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4456 68888888872 234567788887 6799999963 2456999999999999999999999887
Q ss_pred CCceecCCCCCCeecCC-------------------CCCceEeccccccccCCC-------------------Ccccccc
Q 042949 424 KTIPHGNLKLSNILLNE-------------------NEDPLISECGYSKFLDPK-------------------KTCLFSS 465 (608)
Q Consensus 424 ~~ivHrDlkp~NILl~~-------------------~~~~kl~DFGla~~~~~~-------------------~~~~~gt 465 (608)
|+||||||+||||+. ++.+|++|||+++..... .....||
T Consensus 101 --IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 101 --IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred --eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 999999999999954 456777788877643210 0113578
Q ss_pred CccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHH
Q 042949 466 NGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVAL 541 (608)
Q Consensus 466 ~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 541 (608)
+.||||| ..++.++|||||||+||||++|.+|+..... ........ ...+.. ........+++.
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~-----~~~~~~----~~~~~~~~~~~~ 246 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHR-----VLPPQI----LLNWPKEASFCL 246 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHh-----hcChhh----hhcCHHHHHHHH
Confidence 8899999 4578999999999999999998877542211 11111110 111111 011233567889
Q ss_pred HchhcCCCCCCCHHHHHHH
Q 042949 542 KCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 542 ~Cl~~dP~~RPs~~evl~~ 560 (608)
+||+.+|.+||+|.|+++.
T Consensus 247 ~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HhCCCChhhCcChHHHhhc
Confidence 9999999999999999764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=217.90 Aligned_cols=181 Identities=21% Similarity=0.263 Sum_probs=153.9
Q ss_pred cccCCCCCceEEEEEEc----CCcEEEEEEecccccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK----NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|.|.|++||++... ....||+|.+... ..+..+..|++.|..+. +.||+++.+++..++...+|+||++.-
T Consensus 42 ~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~ 120 (418)
T KOG1167|consen 42 NKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHD 120 (418)
T ss_pred ccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCcc
Confidence 56899999999999864 3578999999753 35677899999999985 999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-CCceEeccccccccC----
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-EDPLISECGYSKFLD---- 456 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~---- 456 (608)
+..++... ++...+..+++.+.+||+|+|+++ ||||||||+|+|.+.. +.-.|.|||+|...+
T Consensus 121 ~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G-----IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 121 RFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG-----IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred CHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC-----ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 98888753 678899999999999999999988 9999999999999865 556899999987210
Q ss_pred -------------C-C-----------------------------CccccccCccccCC-----CCCCcchhHHHHHHHH
Q 042949 457 -------------P-K-----------------------------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVIL 488 (608)
Q Consensus 457 -------------~-~-----------------------------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl 488 (608)
+ . .....||+||.||| ...+++.||||.|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0 01135899999999 4568899999999999
Q ss_pred HHHHcCCCCCcC
Q 042949 489 LELLTGKTVEKT 500 (608)
Q Consensus 489 ~elltg~~p~~~ 500 (608)
+-+++++.||..
T Consensus 269 Lslls~~~PFf~ 280 (418)
T KOG1167|consen 269 LSLLSRRYPFFK 280 (418)
T ss_pred ehhhcccccccc
Confidence 999999999754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-24 Score=202.07 Aligned_cols=240 Identities=19% Similarity=0.280 Sum_probs=181.5
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 309 RSQTICSSLFMVRLKNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+.+...|..|+|+++.. .+++|+++..+. ..++|..|.-.|+-+.||||+.++|.|..+....++..||+.|+|+.
T Consensus 198 l~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslyn 276 (448)
T KOG0195|consen 198 LAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYN 276 (448)
T ss_pred hccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHH
Confidence 56678899999999654 455688774433 24579999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcccccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSS 465 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt 465 (608)
.|++ ......+..++.+++.+||+|++|||+.. +-|..--|.+..+++|++.+++|+ .+-+++.-. ......+
T Consensus 277 vlhe--~t~vvvd~sqav~faldiargmaflhsle---p~ipr~~lns~hvmidedltaris-mad~kfsfq-e~gr~y~ 349 (448)
T KOG0195|consen 277 VLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE---PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ-EVGRAYS 349 (448)
T ss_pred HHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc---hhhhhhhcccceEEecchhhhhee-cccceeeee-ccccccC
Confidence 9986 33456788899999999999999999975 335556789999999999999875 111221111 1122346
Q ss_pred CccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 466 NGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 466 ~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
+.||+|| ...-..+|+|||.|++||+.|...||.+-....--.+..+.. .. ...+...+..+.+
T Consensus 350 pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg-lr--------v~ippgis~hm~k 420 (448)
T KOG0195|consen 350 PAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG-LR--------VHIPPGISRHMNK 420 (448)
T ss_pred cccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc-cc--------ccCCCCccHHHHH
Confidence 7899999 123357999999999999999999987654433333222221 10 1123334455788
Q ss_pred HHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 539 VALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
|+.-|+..||.+||.++.++-.|+++.
T Consensus 421 lm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 421 LMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 999999999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.4e-22 Score=203.69 Aligned_cols=147 Identities=14% Similarity=0.176 Sum_probs=115.8
Q ss_pred hcccCCCCCceEEEEEEc--CCcEEEEEEeccc------ccCHHHHHHHHHHHhcCCCCccee-eeeeeecCCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLK--NSAVYAVKRLKKL------QVSMDEFSQTMRQIGNLKHPNILP-LVCYNSTNEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~--~g~~vavK~l~~~------~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~~~~lv~e 376 (608)
...+|+|+||+||+|... +++.||||++... ....+.+.+|++++++++|+|+++ ++++ +..++|||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE 98 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRG 98 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEE
Confidence 356899999999999865 5788899987522 112456899999999999999985 4432 45799999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCC-CCCCeecCCCCCceEecccccccc
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL-KLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~ 455 (608)
|+++++|.. +. . .. ...++.++++||+|||+.+ |+|||| ||+|||++.++.+||+|||+++.+
T Consensus 99 ~~~G~~L~~-~~-----~--~~---~~~~~~~i~~aL~~lH~~g-----IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 99 WTEGVPLHL-AR-----P--HG---DPAWFRSAHRALRDLHRAG-----ITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred ccCCCCHHH-hC-----c--cc---hHHHHHHHHHHHHHHHHCC-----CeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 999999963 11 1 11 1467889999999999987 999999 999999999999999999999976
Q ss_pred CCCC-----------ccccccCccccCC
Q 042949 456 DPKK-----------TCLFSSNGYTAPE 472 (608)
Q Consensus 456 ~~~~-----------~~~~gt~~y~aPE 472 (608)
.... ....++..|+|||
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe 190 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPD 190 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcc
Confidence 5432 2345677789998
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-19 Score=185.45 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=185.3
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCC-cceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHP-NILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|.|.|+.||++... ..+++|.+..... ....+.+|+..+..+.|+ +|+++.+.+......+++++|+.++
T Consensus 6 ~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 83 (384)
T COG0515 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG 83 (384)
T ss_pred EeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence 34679999999999887 8899999874322 366799999999999988 7999999997777789999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-CceEeccccccccCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-DPLISECGYSKFLDPK-- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~-- 458 (608)
++.+++...... ..++......+..|++.+++|+|..+ ++|||+||+||+++... .+++.|||.++.....
T Consensus 84 ~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~-----~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 84 SLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG-----IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999776641100 26889999999999999999999987 99999999999999988 7999999999865432
Q ss_pred -------CccccccCccccCC---C----CCCcchhHHHHHHHHHHHHcCCCCCcCCCC---hHHHHHHHHhhhcc--cc
Q 042949 459 -------KTCLFSSNGYTAPE---K----TVSEQGDVFSFGVILLELLTGKTVEKTGID---LPKWVKAMVREEWT--GE 519 (608)
Q Consensus 459 -------~~~~~gt~~y~aPE---~----~~~~ksDVwSfGvvl~elltg~~p~~~~~~---~~~~~~~~~~~~~~--~~ 519 (608)
.....++..|++|| . ..+...|+||+|++++++++|..|+..... .............. ..
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 24567899999999 2 467789999999999999999999655443 12222222111100 00
Q ss_pred cccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 520 VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 520 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
....... ......+.+++..|+..+|..|.++.+....
T Consensus 238 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 1112357789999999999999998887764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=198.30 Aligned_cols=208 Identities=22% Similarity=0.393 Sum_probs=160.2
Q ss_pred HhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceec
Q 042949 350 IGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHG 429 (608)
Q Consensus 350 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHr 429 (608)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++|.....++++|++||+|||+.. ...|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~----i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP----IGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc----ceeee
Confidence 4568899999999999999999999999999999999974 4677999999999999999999999754 23999
Q ss_pred CCCCCCeecCCCCCceEeccccccccCCC-----CccccccCccccCC--C---------CCCcchhHHHHHHHHHHHHc
Q 042949 430 NLKLSNILLNENEDPLISECGYSKFLDPK-----KTCLFSSNGYTAPE--K---------TVSEQGDVFSFGVILLELLT 493 (608)
Q Consensus 430 Dlkp~NILl~~~~~~kl~DFGla~~~~~~-----~~~~~gt~~y~aPE--~---------~~~~ksDVwSfGvvl~ellt 493 (608)
.++++|.++|....+||+|||+....... .....-..-|.||| . ..+.++||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999999877431 11122334589999 1 14678999999999999999
Q ss_pred CCCCCcCCCChH---HHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 494 GKTVEKTGIDLP---KWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 494 g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
.+.||....... +.+..... .....+-+.+.... +....+..++.+||..+|.+||++++|-..++.+...
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccCccccccccCChHHHHHHHHh--cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999987533222 12222111 11111222222111 3333688999999999999999999999999988654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=177.48 Aligned_cols=138 Identities=13% Similarity=0.062 Sum_probs=107.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccccc---C-------HHH-----------------HHHHHHHHhcCCCCcce
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---S-------MDE-----------------FSQTMRQIGNLKHPNIL 359 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---~-------~~~-----------------~~~e~~~l~~l~H~niv 359 (608)
..||+|++|.||+|...+|+.||||+++.... . ... ..+|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 56899999999999988999999999974321 1 011 23499999999888775
Q ss_pred eeeeeeecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCCceecCCCCCCeec
Q 042949 360 PLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFM-YQKSNEEKTIPHGNLKLSNILL 438 (608)
Q Consensus 360 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~~ivHrDlkp~NILl 438 (608)
....+... ..++||||++++++...... ...+++.....++.|++.+|+|+ |+.+ |+||||||+|||+
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g-----iiHrDlkP~NIli 151 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR-----LVHADLSEYNLLY 151 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEE
Confidence 44333222 23899999998877654322 35689999999999999999999 5665 9999999999999
Q ss_pred CCCCCceEeccccccccC
Q 042949 439 NENEDPLISECGYSKFLD 456 (608)
Q Consensus 439 ~~~~~~kl~DFGla~~~~ 456 (608)
+ ++.++|+|||++....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.7e-21 Score=210.57 Aligned_cols=245 Identities=17% Similarity=0.204 Sum_probs=174.7
Q ss_pred HhhcccCCCCCceEEEEEEc-CCcEEEEEEecc---cccCHH----HHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEE
Q 042949 304 ATADLRSQTICSSLFMVRLK-NSAVYAVKRLKK---LQVSMD----EFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVY 375 (608)
Q Consensus 304 ~~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~---~~~~~~----~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 375 (608)
....++|.|.+|.|+..... .....+.|.... ...... .+..|+.+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34567899999977776543 344444443321 111111 1556777778899999998887777666666669
Q ss_pred eeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
|||++ ||..++.. ...++...+-.++.|+..|++|+|+.+ |.|||+|++|++++.++.+||+|||.+...
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G-----iahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG-----LAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC-----ceeccCccccEEEecCCceEEeecCcceee
Confidence 99999 99999874 346888899999999999999999988 999999999999999999999999998765
Q ss_pred CCC-------CccccccCccccCC----CCC-CcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH
Q 042949 456 DPK-------KTCLFSSNGYTAPE----KTV-SEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 456 ~~~-------~~~~~gt~~y~aPE----~~~-~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (608)
... .....|+.+|+||| ..| ....||||.||++..|++|+.|+.......+.........+. ....
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~--~~~~ 548 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQR--NIFE 548 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccc--cccc
Confidence 322 13467899999999 233 456899999999999999999986432211111111000000 0001
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.........+.....++.++++.||.+|.|+++|++.
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 1111123345557789999999999999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-19 Score=182.60 Aligned_cols=247 Identities=18% Similarity=0.147 Sum_probs=183.3
Q ss_pred hcccCCCCCceEEEEEEcCC--cEEEEEEecccc-cCHHHHHHHHHHHhcCCC----Ccceeeeeee-ecCCeeEEEEee
Q 042949 306 ADLRSQTICSSLFMVRLKNS--AVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKH----PNILPLVCYN-STNEEKLLVYKY 377 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g--~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~~lv~e~ 377 (608)
...+|+|+||.||.+..... ..+|+|...... .....+..|+.++..+.. +++..+++.. ..+...++||+.
T Consensus 23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l 102 (322)
T KOG1164|consen 23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSL 102 (322)
T ss_pred eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEec
Confidence 35689999999999987653 578888876432 222267788888888863 5888888888 477889999998
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-----CCceEeccccc
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-----EDPLISECGYS 452 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGla 452 (608)
+ +.+|.++.... ....++..+...|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||++
T Consensus 103 ~-G~sL~dl~~~~--~~~~fs~~T~l~ia~q~l~~l~~lH~~G-----~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 103 L-GPSLEDLRKRN--PPGRFSRKTVLRIAIQNLNALEDLHSKG-----FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred c-CccHHHHHHhC--CCCCcCHhHHHHHHHHHHHHHHHHHhcC-----cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 8 88999977653 2467999999999999999999999987 9999999999999865 35889999999
Q ss_pred c--ccC-CC----------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHH--HHHHHHh
Q 042949 453 K--FLD-PK----------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPK--WVKAMVR 513 (608)
Q Consensus 453 ~--~~~-~~----------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~--~~~~~~~ 513 (608)
+ ... .. .....||..|+++. ...+.+.|+||++-++.|+..|..|+........ -+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 321 11 12345999999998 5678899999999999999999988754332211 1111111
Q ss_pred hhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 514 EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
...... .....+..+.++...+-..+..++|....+...+++.....
T Consensus 255 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 KLLTDR--------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhcccc--------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 110000 11122344666666666689999999999999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=172.68 Aligned_cols=138 Identities=17% Similarity=0.188 Sum_probs=110.3
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccC---------------------------HHHHHHHHHHHhcCCCCcce
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS---------------------------MDEFSQTMRQIGNLKHPNIL 359 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~H~niv 359 (608)
..+|+|++|.||+|+..+|+.||||+++..... ...+..|.+.+.+++|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 468999999999999889999999998743210 11235788999999999886
Q ss_pred eeeeeeecCCeeEEEEeeccCCCHHHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCceecCCCCCCee
Q 042949 360 PLVCYNSTNEEKLLVYKYQSNGSLLSL-LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQ-KSNEEKTIPHGNLKLSNIL 437 (608)
Q Consensus 360 ~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivHrDlkp~NIL 437 (608)
....+... ..++||||++++++... +. ...++......++.|++.++.|+|+ .+ |+||||||+||+
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g-----ivHrDlkP~NIl 150 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG-----LVHGDLSEYNIL 150 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC-----EecCCCChhhEE
Confidence 55444333 24899999998865443 33 2457888999999999999999999 76 999999999999
Q ss_pred cCCCCCceEeccccccccCC
Q 042949 438 LNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 438 l~~~~~~kl~DFGla~~~~~ 457 (608)
++ ++.++|+|||+++....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 98 88999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-19 Score=196.66 Aligned_cols=138 Identities=30% Similarity=0.530 Sum_probs=118.4
Q ss_pred cChHHHHHHhHhcCCCccccccCCCCCCCCCCCCCCCCeeecCC----CCcEEEEEecCCCceeecChhhhcCCcCCcEE
Q 042949 31 LSESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLH----ATNIVGIRLENMNLSGIIDAETLCKLRHLRVV 106 (608)
Q Consensus 31 ~~~~~~l~~~~~~~~~~~~~~~~W~~~~~~~c~~~w~gv~c~~~----~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L 106 (608)
..|..||+++|+++..... .+|+++.+.|+.+.|.||.|... ...|+.|+|++|+|+|.+| ..+++|++|+.|
T Consensus 371 ~~~~~aL~~~k~~~~~~~~--~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip-~~i~~L~~L~~L 447 (623)
T PLN03150 371 LEEVSALQTLKSSLGLPLR--FGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIP-NDISKLRHLQSI 447 (623)
T ss_pred chHHHHHHHHHHhcCCccc--CCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCC-HHHhCCCCCCEE
Confidence 3688999999998853322 37986422222346999999532 1259999999999999998 479999999999
Q ss_pred EcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHHH
Q 042949 107 SLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171 (608)
Q Consensus 107 ~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~~ 171 (608)
+|++|.|+|.+|..++.|++|+.|||++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..+..
T Consensus 448 ~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~ 512 (623)
T PLN03150 448 NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512 (623)
T ss_pred ECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence 99999999999999999999999999999999999999999999999999999999999998764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=164.63 Aligned_cols=172 Identities=13% Similarity=0.161 Sum_probs=133.4
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHH-----HHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMD-----EFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~-----~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..+++|+||+||.+.. ++..++.+.++......+ .+.+|+++|++++ |+++.+++++ +..+++|||+.+
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 4689999999997766 777888887775443222 5789999999995 5889999886 346999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCC-CCCCeecCCCCCceEeccccccccCCCC
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL-KLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
.+|.+.+.. ....++.|++++|+|+|+.+ |+|||| ||+|||++.++.++|+|||++.......
T Consensus 83 ~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G-----IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 83 AAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG-----VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc-----CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 998654321 11357789999999999987 999999 7999999999999999999998654332
Q ss_pred c----------------cccccCccccCC--C---CCC-cchhHHHHHHHHHHHHcCCCCCc
Q 042949 460 T----------------CLFSSNGYTAPE--K---TVS-EQGDVFSFGVILLELLTGKTVEK 499 (608)
Q Consensus 460 ~----------------~~~gt~~y~aPE--~---~~~-~ksDVwSfGvvl~elltg~~p~~ 499 (608)
. -...++.|++|+ . ..+ ...+.++-|.-+|.++|+..+..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 1 012467788887 2 222 45788899999999999997753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-20 Score=196.14 Aligned_cols=221 Identities=23% Similarity=0.271 Sum_probs=175.1
Q ss_pred cCCCCCceEEEEEE----cCCcEEEEEEeccccc---CHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccC
Q 042949 309 RSQTICSSLFMVRL----KNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 309 ~g~g~~g~vy~~~~----~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+|+|.+|.|+.++. ..|..+|+|.+++... .......|..++...+ ||.+|++...++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999998763 3467899998874221 1224556777888887 99999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT 460 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 460 (608)
|+|...+.. ...+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-..+.
T Consensus 82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~-----iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG-----IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH-----HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999988764 566778888888899999999999887 99999999999999999999999999997655443
Q ss_pred cccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 461 CLFSSNGYTAPE--KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 461 ~~~gt~~y~aPE--~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
. +||..||||| ......+|.||||++++||+||..||.. +..+.+...+. ..++.....+.+
T Consensus 153 ~-cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~----------~~p~~l~~~a~~ 216 (612)
T KOG0603|consen 153 A-CGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAEL----------EMPRELSAEARS 216 (612)
T ss_pred c-ccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhcc----------CCchhhhHHHHH
Confidence 3 8999999999 4467889999999999999999999876 22333332111 112233344667
Q ss_pred HHHHchhcCCCCCCCH
Q 042949 539 VALKCVSNSPDDRPTM 554 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~ 554 (608)
++..++..+|.+|--.
T Consensus 217 ~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 217 LFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHhhCHHHHhcc
Confidence 8888888889888644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.9e-19 Score=171.53 Aligned_cols=162 Identities=11% Similarity=0.143 Sum_probs=123.5
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHH----------HHHHHHHHhcCCCCcceeeeeeeecC--------
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDE----------FSQTMRQIGNLKHPNILPLVCYNSTN-------- 368 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~----------~~~e~~~l~~l~H~niv~l~~~~~~~-------- 368 (608)
.++|+|+||.||.... ++..+|||.++......+. +.+|++.+.+++|++|..+.+++...
T Consensus 37 ~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~ 115 (232)
T PRK10359 37 KVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYA 115 (232)
T ss_pred EEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccccc
Confidence 4689999999999766 5778999999743222222 68999999999999999998875533
Q ss_pred CeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEec
Q 042949 369 EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448 (608)
Q Consensus 369 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 448 (608)
...+++|||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||+++.++ ++|+|
T Consensus 116 ~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g-----i~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 116 HTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG-----MVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred CCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC-----CccCCCChHHEEEeCCC-EEEEE
Confidence 35789999999999977632 222 24569999999999987 99999999999999888 99999
Q ss_pred cccccccCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHH
Q 042949 449 CGYSKFLDPKKTCLFSSNGYTAPEKTVSEQGDVFSFGVILLELL 492 (608)
Q Consensus 449 FGla~~~~~~~~~~~gt~~y~aPE~~~~~ksDVwSfGvvl~ell 492 (608)
||..+.......... .--|..++.++|+||||+++....
T Consensus 178 fg~~~~~~e~~a~d~-----~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAKDR-----IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhHHH-----HHHHhHhcccccccceeEeehHHH
Confidence 998875533221100 112234567899999999887654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=165.82 Aligned_cols=133 Identities=12% Similarity=0.093 Sum_probs=104.1
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEeccc-ccCHHHHHHHHHHHhcC-----CCCcceeeeeeeecCC---e-eEEEE
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKL-QVSMDEFSQTMRQIGNL-----KHPNILPLVCYNSTNE---E-KLLVY 375 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~-~~lv~ 375 (608)
..+||+|+++.||. ...++. .+||++... ....+.+.+|+++++++ +||||++++|++.+.. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36799999999996 333444 479988743 23456799999999999 5799999999998863 3 33789
Q ss_pred ee--ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCCCceecCCCCCCeecCCC----CCceEec
Q 042949 376 KY--QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGL-DFMYQKSNEEKTIPHGNLKLSNILLNEN----EDPLISE 448 (608)
Q Consensus 376 e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~~~ivHrDlkp~NILl~~~----~~~kl~D 448 (608)
|| +++|+|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++.. ..++|+|
T Consensus 85 e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~-----IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR-----IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred cCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 99 668999999964 236655 35678888888 9999987 9999999999999743 4799999
Q ss_pred cccc
Q 042949 449 CGYS 452 (608)
Q Consensus 449 FGla 452 (608)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-17 Score=154.26 Aligned_cols=242 Identities=13% Similarity=0.150 Sum_probs=175.5
Q ss_pred ccCCCCCceEEEEE-EcCCcEEEEEEecccccCHHHHHHHHHHHhcCCC-CcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 308 LRSQTICSSLFMVR-LKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKH-PNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 308 ~~g~g~~g~vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
-||.|+||.+|.|. ..+|..||||.-+... ...++..|.++...|+| ..|..+.-|..+.....+|||.. +.+|.+
T Consensus 22 kiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEd 99 (341)
T KOG1163|consen 22 KIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLED 99 (341)
T ss_pred eecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHH
Confidence 48999999999997 5789999999765322 22356678888888875 45666677777888899999998 889999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC---CCceEeccccccccCCCC---
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN---EDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~--- 459 (608)
+..- ..+.++.++.+-++-|++.-++|+|.++ +|||||||+|.|+.-. ..+.++|||+|+.+.+..
T Consensus 100 Lfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~-----fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~ 171 (341)
T KOG1163|consen 100 LFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN-----FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ 171 (341)
T ss_pred HHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc-----cccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence 8764 2567999999999999999999999987 9999999999999644 557799999999764322
Q ss_pred -------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChH--HHHHHHHhhhcccccccHHHH
Q 042949 460 -------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLP--KWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 460 -------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 526 (608)
....||..|.+-. ...+.+.|+=|+|-+|...--|..|+++-.... +-...+.... ..-.+.
T Consensus 172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK-----~s~~ie 246 (341)
T KOG1163|consen 172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK-----MSTPIE 246 (341)
T ss_pred cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh-----cCCCHH
Confidence 2346788887765 234667899999999999999999987532211 1111111111 111111
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
.-....+.++...+.-|-..--++-|.-.-+.+..+-+
T Consensus 247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 247 VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 22334566677777778777777888766665555444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-16 Score=155.91 Aligned_cols=247 Identities=15% Similarity=0.143 Sum_probs=178.8
Q ss_pred hcccCCCCCceEEEEE-EcCCcEEEEEEecccccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 306 ADLRSQTICSSLFMVR-LKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.-||.|.||+++.|+ +-+++.||||.-... ...-++..|.+..+.|. .+.|...+-+-..+-+..||+|.+ |.+|
T Consensus 33 GkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSL 110 (449)
T KOG1165|consen 33 GKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSL 110 (449)
T ss_pred ccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCH
Confidence 4568999999999997 578999999975432 23345677888887774 688888887777788889999988 8899
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-----CceEeccccccccCCC
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-----DPLISECGYSKFLDPK 458 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFGla~~~~~~ 458 (608)
.++..- ..+.|+.++..-||.|+..-++|+|++. +|.|||||+|+||...+ .+.++|||+|+.+.+.
T Consensus 111 EDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~-----LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 111 EDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD-----LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred HHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc-----eeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 997763 3577999999999999999999999987 99999999999997543 4789999999987543
Q ss_pred C----------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC--ChHHHHHHHHhhhccccccc
Q 042949 459 K----------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI--DLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 459 ~----------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 522 (608)
. ....||..||+-. +.-+.+-|.=|+|-++...+-|..|+++-. ....-.+.+-+.. ....
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K---r~T~ 259 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK---RSTP 259 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc---ccCC
Confidence 2 2356899999876 445778999999999999999999987521 1111111111111 1111
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+..-....+.++..-+.-.-..+-.+-|.-+-+...+.++.+.
T Consensus 260 --i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 260 --IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred --HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 1111223444454444444445667778877777776666543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=166.42 Aligned_cols=225 Identities=16% Similarity=0.212 Sum_probs=143.7
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCC----------Ccceeeeee------
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKH----------PNILPLVCY------ 364 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H----------~niv~l~~~------ 364 (608)
+..||.|+++.||.+... +|+.+|||+..... ...+++.+|.-....+.+ -.++..++.
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 367899999999999986 58999999885222 235566666655554332 112211121
Q ss_pred ---eecC---C-----eeEEEEeeccCCCHHHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecC
Q 042949 365 ---NSTN---E-----EKLLVYKYQSNGSLLSLLEAYIEGK---RDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430 (608)
Q Consensus 365 ---~~~~---~-----~~~lv~e~~~~g~L~~~l~~~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrD 430 (608)
+... . ..+++|+-+ .+||.+++....... ..+....++.+..|+.+.+++||+.+ |+|+|
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G-----lVHgd 170 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG-----LVHGD 170 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-----EEEST
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-----eEecc
Confidence 1111 1 236777777 679988876432211 22445667888899999999999988 99999
Q ss_pred CCCCCeecCCCCCceEeccccccccCCCCccccccCccccCC-----C-------CCCcchhHHHHHHHHHHHHcCCCCC
Q 042949 431 LKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE-----K-------TVSEQGDVFSFGVILLELLTGKTVE 498 (608)
Q Consensus 431 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE-----~-------~~~~ksDVwSfGvvl~elltg~~p~ 498 (608)
|||+|++++.+|.++|+||+.....+........+..|.+|| . .++.+.|.|++|+++|.|++|..||
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf 250 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF 250 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence 999999999999999999988776554333334456788888 1 3688899999999999999999998
Q ss_pred cCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCC
Q 042949 499 KTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDR 551 (608)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R 551 (608)
....... . .+....... +.+..+..||..+|+.+|++|
T Consensus 251 ~~~~~~~-----------~---~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 251 GLSSPEA-----------D---PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCCGGGS-----------T---SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCccc-----------c---ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 6432100 0 000122222 667779999999999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-16 Score=154.51 Aligned_cols=132 Identities=15% Similarity=0.234 Sum_probs=111.5
Q ss_pred ccCCCCCceEEEEEEcCCcEEEEEEeccccc---------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 308 LRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
.+|+|++|.||+|.. +|..+++|+...... ....+.+|++++.+++|+++.....++...+..+++|||+
T Consensus 3 ~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 3 LIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred ccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 579999999999987 777899997653211 1235778999999999999988877777777889999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
++++|.+++.. . .+ .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||.++.
T Consensus 82 ~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~~~-----i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINS----N---GM-EELELSREIGRLVGKLHSAG-----IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHhCC-----cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999998864 1 12 78899999999999999987 99999999999999 78899999999874
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=163.46 Aligned_cols=189 Identities=17% Similarity=0.207 Sum_probs=134.2
Q ss_pred CCCcceeeeeeeec---------------------------CCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHH
Q 042949 354 KHPNILPLVCYNST---------------------------NEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIA 406 (608)
Q Consensus 354 ~H~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 406 (608)
+|||||++.++|.+ +...|+||.-++ .+|.+++.. ...+...+.-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999876543 235689998774 488888863 456667777899
Q ss_pred HHHHHHHHHHhcCCCCCCCceecCCCCCCeec--CCCCC--ceEeccccccccCCC---------CccccccCccccCC-
Q 042949 407 TGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL--NENED--PLISECGYSKFLDPK---------KTCLFSSNGYTAPE- 472 (608)
Q Consensus 407 ~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl--~~~~~--~kl~DFGla~~~~~~---------~~~~~gt~~y~aPE- 472 (608)
.|+++|+.|||+++ |.|||+|++|||+ |+|.. ..|+|||++-.-+.. .-..-|.-.-||||
T Consensus 348 aQlLEav~hL~~hg-----vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG-----VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHcc-----chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 99999999999987 9999999999999 44444 468999987533221 11123445589999
Q ss_pred ---------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHc
Q 042949 473 ---------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKC 543 (608)
Q Consensus 473 ---------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~C 543 (608)
...-.|+|.|+.|-+.||+++...||+......-..+.+ ++ ..++.-+..++..+.+++...
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y-qe--------~qLPalp~~vpp~~rqlV~~l 493 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY-QE--------SQLPALPSRVPPVARQLVFDL 493 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh-hh--------hhCCCCcccCChHHHHHHHHH
Confidence 122458999999999999999999998644322111111 11 122223344555578899999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 042949 544 VSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 544 l~~dP~~RPs~~evl~~L~ 562 (608)
++.||++|++..-..+.|.
T Consensus 494 L~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hcCCccccCCccHHHhHHH
Confidence 9999999998776655544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.5e-18 Score=185.83 Aligned_cols=232 Identities=22% Similarity=0.284 Sum_probs=167.2
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccc--ccCHHHHHHHHHHHh--cCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKL--QVSMDEFSQTMRQIG--NLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~--~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+-+|.+.|=+|.+++.+.|. |+||++-+. ..+.+.|.++++.++ -++|||.+++.-+-.+....|||=+|.. -+
T Consensus 29 ~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hn 106 (1431)
T KOG1240|consen 29 ENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HN 106 (1431)
T ss_pred cccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh-hh
Confidence 45799999999999999998 888987532 345666666655544 3489999998777666777788888884 48
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc--CCCC-
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL--DPKK- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~--~~~~- 459 (608)
|+|.|.. +.-+...+.+-|+.|++.||.-+|..+ |+|+|||.+||||+.-+-+.|+||.--|.. ..+.
T Consensus 107 LyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g-----VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 107 LYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG-----VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC-----ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 8888864 444667778889999999999999987 999999999999999999999999776632 2221
Q ss_pred ---ccccccC----ccccCCC---------------CCCcchhHHHHHHHHHHHHcC-CCCCcCCCChHHHHHHHHhhhc
Q 042949 460 ---TCLFSSN----GYTAPEK---------------TVSEQGDVFSFGVILLELLTG-KTVEKTGIDLPKWVKAMVREEW 516 (608)
Q Consensus 460 ---~~~~gt~----~y~aPE~---------------~~~~ksDVwSfGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~ 516 (608)
..++.|. -|.|||+ ..+++-||||.||++.||++- +++|. +.+...- ..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aY-r~--- 249 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAY-RS--- 249 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhH-hc---
Confidence 1223333 4999992 145678999999999999885 55553 1111110 00
Q ss_pred ccccccHH-HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 517 TGEVFDKE-VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 517 ~~~~~~~~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..-.+++ +.+.. +...+.+++..|++.||++|.++++.++.
T Consensus 250 -~~~~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 -GNADDPEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -cCccCHHHHHHhC--cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0011111 11111 12247789999999999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=156.37 Aligned_cols=138 Identities=15% Similarity=0.165 Sum_probs=106.1
Q ss_pred hcccCCCCCceEEEEE--EcCCcEEEEEEeccccc--------------------C-----HHHHHHHHHHHhcCCCCc-
Q 042949 306 ADLRSQTICSSLFMVR--LKNSAVYAVKRLKKLQV--------------------S-----MDEFSQTMRQIGNLKHPN- 357 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~--~~~g~~vavK~l~~~~~--------------------~-----~~~~~~e~~~l~~l~H~n- 357 (608)
.+.+|+|++|.||+|. ..+|+.||+|+++.... . ...+.+|++.+.++.+..
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i 112 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGV 112 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3579999999999998 56899999999874321 0 123568999999997533
Q ss_pred -ceeeeeeeecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCe
Q 042949 358 -ILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436 (608)
Q Consensus 358 -iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NI 436 (608)
+.+++++ ...++||||+++++|...... ...+.......++.|++.+|+|||+.+ .|+||||||+||
T Consensus 113 ~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g----~iiH~Dikp~NI 180 (237)
T smart00090 113 PVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEG----ELVHGDLSEYNI 180 (237)
T ss_pred CCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcC----CEEeCCCChhhE
Confidence 3344433 235899999999887765421 234566677899999999999999865 399999999999
Q ss_pred ecCCCCCceEeccccccccC
Q 042949 437 LLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 437 Ll~~~~~~kl~DFGla~~~~ 456 (608)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-16 Score=150.98 Aligned_cols=129 Identities=16% Similarity=0.284 Sum_probs=105.7
Q ss_pred ccCCCCCceEEEEEEcCCcEEEEEEecccc--c-------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 308 LRSQTICSSLFMVRLKNSAVYAVKRLKKLQ--V-------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~~vavK~l~~~~--~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
++|+|.+|.||+|.. +|..+++|+..... . ..+++.+|++++.+++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 479999999999985 67889999864211 1 1245678999999999888766655566666779999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
++++|.+++.. ... .++.+++++|++||+.+ ++|+|++|.||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~g-----i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEE----GND-------ELLREIGRLVGKLHKAG-----IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHCC-----eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988753 110 78999999999999987 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.6e-16 Score=173.02 Aligned_cols=132 Identities=17% Similarity=0.239 Sum_probs=107.8
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccc--------cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ--------VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
.+.+|+|+||+||++...+...++.+++.+.. ...+.+.+|++++.+++|++++....++......++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 57799999999999987655433333232211 1124578999999999999999888887777788999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
+++++|.+++. ....++.+++++|+|||+.+ |+|||+||+|||+ +++.++|+|||+++..
T Consensus 418 ~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g-----iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 418 IGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG-----IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred cCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC-----CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999998875 24678999999999999987 9999999999999 6789999999999853
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.3e-16 Score=149.18 Aligned_cols=133 Identities=15% Similarity=0.121 Sum_probs=104.5
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEeccccc-----------------------CHHHHHHHHHHHhcCCCCc--cee
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV-----------------------SMDEFSQTMRQIGNLKHPN--ILP 360 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~-----------------------~~~~~~~e~~~l~~l~H~n--iv~ 360 (608)
.+.+|+|++|.||++...+|+.||||++..... ....+..|+..+.++.|++ +.+
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~ 99 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK 99 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence 467999999999999988999999998763211 0123567888888888774 344
Q ss_pred eeeeeecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC
Q 042949 361 LVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440 (608)
Q Consensus 361 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~ 440 (608)
.++. ...++||||+++++|...... .....++.+++.++.++|+.+ |+||||||+||++++
T Consensus 100 ~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g-----i~H~Dl~p~Nill~~ 160 (198)
T cd05144 100 PIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG-----IIHGDLSEFNILVDD 160 (198)
T ss_pred eeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC-----CCcCCCCcccEEEcC
Confidence 4432 345899999999998764320 234678899999999999976 999999999999999
Q ss_pred CCCceEeccccccccCC
Q 042949 441 NEDPLISECGYSKFLDP 457 (608)
Q Consensus 441 ~~~~kl~DFGla~~~~~ 457 (608)
++.++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=172.11 Aligned_cols=180 Identities=19% Similarity=0.273 Sum_probs=142.9
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCC---CCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
..+|+|+||+||+|...+|+.||+|.-+.... =+|.--.+++.||+ -+-|+.+...+.-.+.-++|+||.+.|+|
T Consensus 704 ~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtl 781 (974)
T KOG1166|consen 704 KEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTL 781 (974)
T ss_pred eeeccccceEEEEeecCCCcEEEEEeecCCCc--eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccH
Confidence 35899999999999998999999998764322 23333444555555 24455555555667778999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-------CCCceEeccccccccC
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-------NEDPLISECGYSKFLD 456 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-------~~~~kl~DFGla~~~~ 456 (608)
.+++. ..+.++|...+.++.|+++-++.||..+ |||+||||+|.||.. ...++|+|||.+-.+.
T Consensus 782 ld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~-----IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 782 LDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG-----IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred HHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc-----eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99986 3678999999999999999999999987 999999999999943 3457999999986432
Q ss_pred ---CCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCC
Q 042949 457 ---PKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTV 497 (608)
Q Consensus 457 ---~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p 497 (608)
+.. ....+|-.+-++| +.++...|.|.+.-+++-|+.|+..
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 221 3345788888999 6788899999999999999999853
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.6e-16 Score=160.60 Aligned_cols=167 Identities=23% Similarity=0.303 Sum_probs=120.8
Q ss_pred eeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecc
Q 042949 370 EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC 449 (608)
Q Consensus 370 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 449 (608)
..++.|++|...+|.+||.... .....++...+.++.|++.|++| ++ .+|||+||.||....+...||.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~-----~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG-----LIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc-----chhhhccccccccccchhhhhhhh
Confidence 5789999999999999997422 23456788899999999999999 44 899999999999999999999999
Q ss_pred ccccccCCCC---------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc
Q 042949 450 GYSKFLDPKK---------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW 516 (608)
Q Consensus 450 Gla~~~~~~~---------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 516 (608)
|+........ +...||..||+|| ..|+.|+||||+|++|+|+++ +|.....-..... ..
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~-----d~ 472 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLT-----DI 472 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhh-----hh
Confidence 9987654322 4467899999999 678999999999999999987 1111111111111 11
Q ss_pred ccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHH
Q 042949 517 TGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEV 557 (608)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 557 (608)
...++++...... ..-..|+.+++...|.+||++.++
T Consensus 473 r~g~ip~~~~~d~----p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGIIPPEFLQDY----PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCCCChHHhhcC----cHHHHHHHHhcCCCcccCchHHHH
Confidence 1122222211111 112478999999999999955444
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-14 Score=142.22 Aligned_cols=139 Identities=10% Similarity=0.147 Sum_probs=107.0
Q ss_pred HHHHhhcccC-CCCCceEEEEEEcCCcEEEEEEecccc--------------cCHHHHHHHHHHHhcCCCCcc--eeeee
Q 042949 301 LLEATADLRS-QTICSSLFMVRLKNSAVYAVKRLKKLQ--------------VSMDEFSQTMRQIGNLKHPNI--LPLVC 363 (608)
Q Consensus 301 l~~~~~~~~g-~g~~g~vy~~~~~~g~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~H~ni--v~l~~ 363 (608)
-.......+| .|+.|+||.+... +..++||++.... .....+.+|++++.+++|++| ++.++
T Consensus 31 ~~~~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~ 109 (239)
T PRK01723 31 FWQQQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA 109 (239)
T ss_pred HHhhcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence 3344456787 8999999999885 6778999875311 123457889999999998885 66676
Q ss_pred eeecCC----eeEEEEeeccC-CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec
Q 042949 364 YNSTNE----EKLLVYKYQSN-GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438 (608)
Q Consensus 364 ~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl 438 (608)
+..... ..++|+||+++ .+|.+++.. ..++.. .+.+++++|.+||+.+ |+||||||.|||+
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G-----I~HrDlkp~NILv 175 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG-----VYHADLNAHNILL 175 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC-----CCCCCCCchhEEE
Confidence 644322 23599999997 699888753 345544 3578999999999987 9999999999999
Q ss_pred CCCCCceEeccccccc
Q 042949 439 NENEDPLISECGYSKF 454 (608)
Q Consensus 439 ~~~~~~kl~DFGla~~ 454 (608)
+.++.++|+|||.+..
T Consensus 176 ~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 176 DPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCCCCEEEEECCCccc
Confidence 9989999999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.6e-15 Score=166.00 Aligned_cols=206 Identities=17% Similarity=0.238 Sum_probs=138.2
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
-.++..|.||.||.++++ +.+.+|+ ++++... +.+- ++.....|.+| ||-.
T Consensus 88 IklisngAygavylvrh~~trqrfa~-kiNkq~l----ilRn--ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL----ILRN--ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhh-cccccch----hhhc--cccccCCccee---------------------chhh
Confidence 357889999999999876 4678888 4443211 1110 22222333333 4444
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC------
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK------ 458 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~------ 458 (608)
..+.. ...++. +++.+++|||+.+ |+|||+||+|.+|+.-+++|+.|||+++..-..
T Consensus 140 tllk~----~g~lPv--------dmvla~Eylh~yg-----ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 140 TLLKN----IGPLPV--------DMVLAVEYLHSYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhccc----CCCCcc--------hhhHHhHhhccCC-----eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 44432 233332 2378999999987 999999999999999999999999998753110
Q ss_pred ------------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 459 ------------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 459 ------------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
....+||+.|+||| +-|+..+|+|++|+++||.+.|+.||..... .+.+..++.+....
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i~w---- 277 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIEW---- 277 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhccc----
Confidence 12357999999999 5689999999999999999999999876532 33344443332111
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHh
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRP-TMAEVLERIEEV 564 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~ 564 (608)
.+.......++.+++.+.|+.+|.+|- |..+..-+-+.+
T Consensus 278 ---pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~f 317 (1205)
T KOG0606|consen 278 ---PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGF 317 (1205)
T ss_pred ---cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccc
Confidence 111233445578999999999999994 444443333333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.7e-15 Score=140.53 Aligned_cols=134 Identities=14% Similarity=0.203 Sum_probs=95.4
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHH---H----------------------HHHHHHHhcCCCCc--ce
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDE---F----------------------SQTMRQIGNLKHPN--IL 359 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~---~----------------------~~e~~~l~~l~H~n--iv 359 (608)
+.+|+|++|.||++...+|+.||||+++........ + ..|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 468999999999999888999999998743221111 1 24555555554332 33
Q ss_pred eeeeeeecCCeeEEEEeeccCCCHHH-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCceecCCCCCCee
Q 042949 360 PLVCYNSTNEEKLLVYKYQSNGSLLS-LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQ-KSNEEKTIPHGNLKLSNIL 437 (608)
Q Consensus 360 ~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivHrDlkp~NIL 437 (608)
+.+++ ...++||||++++.+.. .+... ... .....++.+++.++.++|. .+ |+||||||+||+
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~-----ivH~Dl~p~Nil 147 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG-----LVHGDLSEYNIL 147 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC-----cCcCCCChhhEE
Confidence 33332 23589999999855432 12210 011 5678899999999999998 65 999999999999
Q ss_pred cCCCCCceEeccccccccC
Q 042949 438 LNENEDPLISECGYSKFLD 456 (608)
Q Consensus 438 l~~~~~~kl~DFGla~~~~ 456 (608)
++ ++.++++|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8999999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-14 Score=130.18 Aligned_cols=133 Identities=15% Similarity=0.183 Sum_probs=111.5
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCC--CcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKH--PNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..+|+|.++.||+++..+ ..+++|....... ...+.+|+..+..++| .++.+++++....+..++++||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 357999999999999855 7899999875433 5678999999999976 58999998888888899999999887654
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
.+ +......++.+++++|+++|... ..+++|+|++|+||+++..+.+++.|||.++.
T Consensus 82 ~~-----------~~~~~~~~~~~~~~~l~~lh~~~--~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV-----------SEEEKEDIAEQLAELLAKLHQLP--LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC-----------CHHHHHHHHHHHHHHHHHHhCCC--ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 32 55677788999999999999863 34599999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.3e-14 Score=170.45 Aligned_cols=134 Identities=31% Similarity=0.584 Sum_probs=99.1
Q ss_pred cChHHHHHHhHhcCC-CccccccCCCCCCCCCCCCCCCCeeecCCCCcEEEEEecCCCceeecChhhhcCCcCCcEEEcc
Q 042949 31 LSESESFFKFISAVD-SQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLA 109 (608)
Q Consensus 31 ~~~~~~l~~~~~~~~-~~~~~~~~W~~~~~~~c~~~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~ 109 (608)
..|..||++||+++. +.+.+ .+|+.. .++| .|.||+|+. .++|+.|+|++|+++|.++ ..+..+++|+.|+|+
T Consensus 28 ~~~~~~l~~~~~~~~~~~~~~-~~w~~~-~~~c--~w~gv~c~~-~~~v~~L~L~~~~i~~~~~-~~~~~l~~L~~L~Ls 101 (968)
T PLN00113 28 AEELELLLSFKSSINDPLKYL-SNWNSS-ADVC--LWQGITCNN-SSRVVSIDLSGKNISGKIS-SAIFRLPYIQTINLS 101 (968)
T ss_pred HHHHHHHHHHHHhCCCCcccC-CCCCCC-CCCC--cCcceecCC-CCcEEEEEecCCCccccCC-hHHhCCCCCCEEECC
Confidence 368899999999984 44444 589754 4778 689999985 4589999999999999886 468889999999999
Q ss_pred cCcCCccCccccc-CCCCcceeeccCeecccc----------------------CChhhcCCCCCCEEeCcCCcCCccCC
Q 042949 110 RNLIQGRIPTSIS-NCRRLTYLNLSSNLLSGA----------------------VPLALTKLKHLKTLDISNNHFAATSP 166 (608)
Q Consensus 110 ~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~----------------------lP~~l~~l~~L~~L~ls~N~l~g~~p 166 (608)
+|.++|.+|..+. .+++|++|+|++|+++|. +|..++.+++|++|+|++|.+++.+|
T Consensus 102 ~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 181 (968)
T PLN00113 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181 (968)
T ss_pred CCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCC
Confidence 9999888887654 667777777666666554 44455555556666666666665555
Q ss_pred hhHH
Q 042949 167 DNFR 170 (608)
Q Consensus 167 ~~~~ 170 (608)
..+.
T Consensus 182 ~~~~ 185 (968)
T PLN00113 182 NSLT 185 (968)
T ss_pred hhhh
Confidence 5544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-14 Score=161.01 Aligned_cols=236 Identities=19% Similarity=0.193 Sum_probs=171.1
Q ss_pred cCCCCCceEEEEEEcC--CcEEEEEEeccccc---CHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 309 RSQTICSSLFMVRLKN--SAVYAVKRLKKLQV---SMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~--g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+|+|.++.|-...... ...+|+|.+..... ..+....|..+-.++. |+|++++++.....+..+++.+|..+|+
T Consensus 28 ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~ 107 (601)
T KOG0590|consen 28 IGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGS 107 (601)
T ss_pred ccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccc
Confidence 6899999888876543 45677777664332 2334445676666666 9999999999999999999999999999
Q ss_pred HHHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCCCceecCCCCCCeecCCCC-CceEeccccccccCC-C
Q 042949 383 LLSLL-EAYIEGKRDFPWKLRLSIATGIAKGLDFMY-QKSNEEKTIPHGNLKLSNILLNENE-DPLISECGYSKFLDP-K 458 (608)
Q Consensus 383 L~~~l-~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~-~ 458 (608)
+.+.+ +. .....+......++.|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||+|..+.. .
T Consensus 108 ~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~~-----~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 108 LFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPENG-----VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cccccccC---CccCCCCcchhhhhhhhccCccccCcccc-----cccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 98877 32 2225666777889999999999999 655 99999999999999999 999999999987655 2
Q ss_pred C-----ccccc-cCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-cccccccHHHH
Q 042949 459 K-----TCLFS-SNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-WTGEVFDKEVA 526 (608)
Q Consensus 459 ~-----~~~~g-t~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 526 (608)
. ....| ++.|+||| ....+..|+||.|+++.-+++|..|+................. ... .
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~ 252 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT-------Q 252 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc-------c
Confidence 2 23467 99999999 2457789999999999999999988653222110000000000 000 0
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
...........++..+++..+|..|.+.+++-.
T Consensus 253 ~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 253 LPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred CccccCChhhhhcccccccCCchhccccccccc
Confidence 011223344677888999999999999887643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.8e-13 Score=131.43 Aligned_cols=199 Identities=20% Similarity=0.278 Sum_probs=137.5
Q ss_pred HHHHHhcCCCCcceeeeeeeecC-----CeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 042949 346 TMRQIGNLKHPNILPLVCYNSTN-----EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKS 420 (608)
Q Consensus 346 e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 420 (608)
-+.-|-++.|.|||+++.|+.+. ....++.|||..|++.++|++.......+....-.+++.||..||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34456667799999999887653 3567899999999999999887666677888888999999999999999864
Q ss_pred CCCCCceecCCCCCCeecCCCCCceEecccccccc-------CCCCccccccCccccCC----CCCCcchhHHHHHHHHH
Q 042949 421 NEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL-------DPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILL 489 (608)
Q Consensus 421 ~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~-------~~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ 489 (608)
++|+|+++.-+-|++..++-+|+.---....- ....+...+-++|.+|| ...+..+|||+||...+
T Consensus 197 ---PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 197 ---PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred ---CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 68999999999999998888886421111100 01122344667899999 34566899999999999
Q ss_pred HHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 490 ELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 490 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
||..+..-.....+....-....+ .....-+ .+ -.+++.+|++..|..||+|++++-.
T Consensus 274 emailEiq~tnseS~~~~ee~ia~--~i~~len-~l----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIAN--VIIGLEN-GL----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhh--heeeccC-cc----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 998876432111110000000000 0000000 00 1257889999999999999998654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.3e-12 Score=136.12 Aligned_cols=140 Identities=15% Similarity=0.129 Sum_probs=98.2
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccccc---------------------------CH--------------HHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---------------------------SM--------------DEFSQ 345 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---------------------------~~--------------~~~~~ 345 (608)
+-+|.|++|.||+|++.+|+.||||+.+..-. .. -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 45899999999999999999999999863210 00 02344
Q ss_pred HHHHHhcC----CCCcceeeeeeee-cCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHhcC
Q 042949 346 TMRQIGNL----KHPNILPLVCYNS-TNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAK-GLDFMYQK 419 (608)
Q Consensus 346 e~~~l~~l----~H~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 419 (608)
|.+.+.++ +|.+-+.+-..+. .....++||||++|++|.++.... .... .+..++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 55555444 2333333333332 234579999999999998876531 1122 23456666665 46788877
Q ss_pred CCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 420 SNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 420 ~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+ ++|+|+||.||+++.++.+++.|||++..+.+
T Consensus 277 g-----~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 G-----FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C-----ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-11 Score=115.61 Aligned_cols=131 Identities=16% Similarity=0.149 Sum_probs=96.2
Q ss_pred ccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcce-eeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 308 LRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNIL-PLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
.+++|.++.||+++.. +..|++|...........+.+|++.+..+.+.+++ +++.+.. ...++||||+++.++.+.
T Consensus 5 ~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 5 PLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE 81 (170)
T ss_pred ecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc
Confidence 4678889999999875 77899998764432334567899999888665554 4444433 345799999999876532
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
.. ....++.+++++|+.||........++|+|++|.||+++ ++.++++|||.+..
T Consensus 82 ---------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 ---------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ---------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 01 113456789999999998763234569999999999998 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.8e-12 Score=132.10 Aligned_cols=234 Identities=18% Similarity=0.181 Sum_probs=170.6
Q ss_pred cccCC--CCCceEEEEEE---cCCcEEEEEEeccc---ccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEee
Q 042949 307 DLRSQ--TICSSLFMVRL---KNSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~--g~~g~vy~~~~---~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
.-+|. |.+|.+|.++. .++..+|+|+-+.. ......=.+|+..-.+++ |+|.++....+...+..++-.|+
T Consensus 120 ~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~ 199 (524)
T KOG0601|consen 120 SRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTEL 199 (524)
T ss_pred cccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecc
Confidence 44678 99999999987 46789999985421 122223345666666665 99999988888889999999998
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCCCceecCCCCCCeecCCC-CCceEeccccc
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAK----GLDFMYQKSNEEKTIPHGNLKLSNILLNEN-EDPLISECGYS 452 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla 452 (608)
+ +.+|.++.+.. ...++....+.+..+..+ ||.++|... |+|-|+||.||++..+ ...++.|||+.
T Consensus 200 ~-~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~-----~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 200 C-GESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN-----IVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred c-cchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCc-----ccccccchhheecccccceeecCCccee
Confidence 8 57888887752 344778888889999998 999999887 9999999999999999 88999999999
Q ss_pred cccCCCCcc--------ccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 453 KFLDPKKTC--------LFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 453 ~~~~~~~~~--------~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
..+.+..-. ..|..-|++|| ..++..+|||++|.+..|..++...+..+.. ..|.. .+..+ +
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~--~r~~~----i 343 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQ--LRQGY----I 343 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC-CCccc--ccccc----C
Confidence 887654311 14556699999 6789999999999999999998876544311 11211 11111 1
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
..+. .......+...+..+++.+|-.|++.+++..
T Consensus 344 p~e~---~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 344 PLEF---CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred chhh---hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111 1112223445888899999999998776644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.5e-10 Score=122.21 Aligned_cols=162 Identities=18% Similarity=0.239 Sum_probs=123.9
Q ss_pred EEcCCcEEEEEEeccccc-CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCH
Q 042949 321 RLKNSAVYAVKRLKKLQV-SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPW 399 (608)
Q Consensus 321 ~~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~ 399 (608)
+..++..|.|...+.... ..+...+-++.|+.+|||||++++..+...+..|+|.|-+. .|..++.+ +..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~ 103 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGK 103 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHH
Confidence 455788899988875433 23456778889999999999999999999999999999874 47777764 334
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---ccccccCccccCCCC--
Q 042949 400 KLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TCLFSSNGYTAPEKT-- 474 (608)
Q Consensus 400 ~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~~~gt~~y~aPE~~-- 474 (608)
......+.||+.||.|||+.+ .++|++|.-..|+++..|+.||++|-++....... ....--..|..|+..
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~----~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC----NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC----CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 555667899999999999876 39999999999999999999999998875433221 111112235666622
Q ss_pred CCcchhHHHHHHHHHHHHcCC
Q 042949 475 VSEQGDVFSFGVILLELLTGK 495 (608)
Q Consensus 475 ~~~ksDVwSfGvvl~elltg~ 495 (608)
.+-..|.|-|||+++|++.|.
T Consensus 180 s~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SEWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cccchhhhhHHHHHHHHhCcc
Confidence 223579999999999999993
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.7e-10 Score=123.86 Aligned_cols=139 Identities=12% Similarity=0.106 Sum_probs=89.5
Q ss_pred cccCCCCCceEEEEEEcC-CcEEEEEEeccccc---------------------------CHH--------------HHH
Q 042949 307 DLRSQTICSSLFMVRLKN-SAVYAVKRLKKLQV---------------------------SMD--------------EFS 344 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-g~~vavK~l~~~~~---------------------------~~~--------------~~~ 344 (608)
.-+|.|++|.||+|++++ |+.||||+++..-. ... ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 358999999999999987 99999999863210 000 133
Q ss_pred HHHHHHhcC----CCCcceeeeeeeec-CCeeEEEEeeccCCCHHHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHh
Q 042949 345 QTMRQIGNL----KHPNILPLVCYNST-NEEKLLVYKYQSNGSLLSLLEAYIEG--KRDFPWKLRLSIATGIAKGLDFMY 417 (608)
Q Consensus 345 ~e~~~l~~l----~H~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH 417 (608)
+|...+.++ .+.+.+.+-.++.+ ....++||||+.|+.+.++-.-...+ ...+.......++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 444444444 24444444333332 34678999999999998743210011 01122333333444443
Q ss_pred cCCCCCCCceecCCCCCCeecCCCC----CceEeccccccccCC
Q 042949 418 QKSNEEKTIPHGNLKLSNILLNENE----DPLISECGYSKFLDP 457 (608)
Q Consensus 418 ~~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~~ 457 (608)
..+ ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 278 ~~G-----ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDG-----FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCC-----eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 333 99999999999999888 899999999886643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.1e-10 Score=108.62 Aligned_cols=142 Identities=12% Similarity=0.155 Sum_probs=109.4
Q ss_pred ccCCCCCceEEEEEEcCCcEEEEEEeccccc--CHHHHHHHHHHHhcCCCC--cceeeeeeeecC---CeeEEEEeeccC
Q 042949 308 LRSQTICSSLFMVRLKNSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHP--NILPLVCYNSTN---EEKLLVYKYQSN 380 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~--niv~l~~~~~~~---~~~~lv~e~~~~ 380 (608)
.++.|..+.+|+++..+|..+++|....... ....+.+|++++..+++. ++.+++.+.... +..++||||+++
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G 84 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG 84 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence 4688999999999987778999998764332 456788999999998753 456677776653 256899999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC---------------------------------------
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSN--------------------------------------- 421 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--------------------------------------- 421 (608)
.++.+.+. ...++..++..++.+++++|.+||+...
T Consensus 85 ~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 85 RVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 88765432 1347778888889999999999986421
Q ss_pred ------------CCCCceecCCCCCCeecCC--CCCceEeccccccc
Q 042949 422 ------------EEKTIPHGNLKLSNILLNE--NEDPLISECGYSKF 454 (608)
Q Consensus 422 ------------~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~ 454 (608)
....++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246799999999999998 56678999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1e-10 Score=124.13 Aligned_cols=233 Identities=18% Similarity=0.142 Sum_probs=161.5
Q ss_pred cCCCCCceEEEEEEc--CCcEEEEEEeccccc-CHHH--HHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 309 RSQTICSSLFMVRLK--NSAVYAVKRLKKLQV-SMDE--FSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~--~g~~vavK~l~~~~~-~~~~--~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+|.+.|+.|+....+ ++..|++|-+.+.-. ...+ -..|+-+...+ -|.+++.++..+......++-.|||.+++
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s 352 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGS 352 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcc
Confidence 788999999998754 678999998764321 1111 23455444444 48888888776666667779999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-CCceEeccccccccCCCCcc
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-EDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~ 461 (608)
+...+.- ...+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||++..+.-....
T Consensus 353 ~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~-----~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~ 423 (524)
T KOG0601|consen 353 SSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL-----FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV 423 (524)
T ss_pred hhhhhHH----HHhcCcchhhhhHHHHHhccccccchh-----hhcccccccceeeccchhhhhccccccccccceeccc
Confidence 8766532 456788889999999999999999876 9999999999999886 78889999998753322222
Q ss_pred ccccCccc--cCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 462 LFSSNGYT--APE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 462 ~~gt~~y~--aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
......++ +++ ..+..+.|++|||..+.|.+++......... |... ....+. ........
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i--~~~~~p---------~~~~~~~~ 489 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTI--RSGDTP---------NLPGLKLQ 489 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceee--eccccc---------CCCchHHh
Confidence 22333333 333 5678899999999999999999865432221 1110 001010 11111234
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
+..+...+...++..||.+.++....+..
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 56778888899999999988877665543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.5e-09 Score=101.29 Aligned_cols=135 Identities=11% Similarity=0.082 Sum_probs=96.1
Q ss_pred cccCCCCCceEEEEEEcC-------CcEEEEEEecccc----------------------cC-HHHHH----HHHHHHhc
Q 042949 307 DLRSQTICSSLFMVRLKN-------SAVYAVKRLKKLQ----------------------VS-MDEFS----QTMRQIGN 352 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-------g~~vavK~l~~~~----------------------~~-~~~~~----~e~~~l~~ 352 (608)
..+|.|.=+.||.|.-.+ +..+|||+.+... .+ ...+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 457888889999997653 4789999875210 01 11222 78888888
Q ss_pred CCC--CcceeeeeeeecCCeeEEEEeeccCCCHHH-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCCcee
Q 042949 353 LKH--PNILPLVCYNSTNEEKLLVYKYQSNGSLLS-LLEAYIEGKRDFPWKLRLSIATGIAKGLDFM-YQKSNEEKTIPH 428 (608)
Q Consensus 353 l~H--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~~ivH 428 (608)
+.. -++.+++++ ...++||||+.++.+.. .++ ...++..+...+..+++.+|.+| |+.+ |||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g-----lVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN-----LVH 148 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC-----eec
Confidence 853 345555554 45689999997654422 232 22355566778889999999999 6665 999
Q ss_pred cCCCCCCeecCCCCCceEeccccccccC
Q 042949 429 GNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 429 rDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
+||++.|||++ ++.+.|+|||.+-...
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999996 4679999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1e-08 Score=94.03 Aligned_cols=131 Identities=19% Similarity=0.293 Sum_probs=97.9
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEE-eccccc--------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKR-LKKLQV--------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~-l~~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
.++++|.=+.+|.+.+.+.. +++|. +++... ..+...+|.+++.+++--.|....=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35678888899998774444 55553 332211 133567899999988766665555566777888999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
+++-.|.+.+.. . ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||+++.-
T Consensus 81 I~G~~lkd~l~~----~-------~~~~~r~vG~~vg~lH~~g-----ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEE----A-------RPDLLREVGRLVGKLHKAG-----IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHh----c-------chHHHHHHHHHHHHHHhcC-----eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999988888874 1 2456677777778899987 99999999999997655 999999999853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.4e-08 Score=102.95 Aligned_cols=169 Identities=23% Similarity=0.298 Sum_probs=127.6
Q ss_pred CCceEEEEEE-cCCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeec----CCeeEEEEeeccC-CCHHH
Q 042949 313 ICSSLFMVRL-KNSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNST----NEEKLLVYKYQSN-GSLLS 385 (608)
Q Consensus 313 ~~g~vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~ 385 (608)
...+.|++.. .||..|++|+++.. .........-++.++++.|+|+|++..++.+ ...+++||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 4467899874 58999999999532 2233344566788999999999999887763 4578999999985 56665
Q ss_pred HHHHH-----------hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 386 LLEAY-----------IEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 386 ~l~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
+--.. .......++...+.++.|+..||.++|+.+ ..-+-|.+.+||++.+.+++|+-.|....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG-----LAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG-----LACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC-----ceeecccHhHeEeeCcceEEEecccceee
Confidence 43211 011334678999999999999999999987 77799999999999999999998888876
Q ss_pred cCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCC
Q 042949 455 LDPKKTCLFSSNGYTAPEKTVSEQGDVFSFGVILLELLTGKT 496 (608)
Q Consensus 455 ~~~~~~~~~gt~~y~aPE~~~~~ksDVwSfGvvl~elltg~~ 496 (608)
+..+... | ...-.+-|.=-||.+++.|.||..
T Consensus 443 l~~d~~~---------~-le~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDPTE---------P-LESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecCCCCc---------c-hhHHhhhhHHHHHHHHHHHhhccc
Confidence 6544310 0 012246799999999999999953
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.6e-08 Score=98.65 Aligned_cols=148 Identities=11% Similarity=0.118 Sum_probs=103.3
Q ss_pred HHHHHHhhcccCCCCCceEEEEEEcCCcEEEEEEecccc------------cCHHHHHHHHHHHhcCCCCcc--eeeeee
Q 042949 299 DDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ------------VSMDEFSQTMRQIGNLKHPNI--LPLVCY 364 (608)
Q Consensus 299 ~~l~~~~~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~------------~~~~~~~~e~~~l~~l~H~ni--v~l~~~ 364 (608)
+.+...-.+++-.-....|+++.+ +|+.|.||+..... .....+.+|.+.+.++...+| .+++++
T Consensus 20 ~~~~~~~~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~ 98 (268)
T PRK15123 20 EEVKTLQGEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAF 98 (268)
T ss_pred HHHHhcCCcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEE
Confidence 344333334444444455677766 67789999774322 111247789988888754443 334555
Q ss_pred eec-----CCeeEEEEeeccCC-CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec
Q 042949 365 NST-----NEEKLLVYKYQSNG-SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438 (608)
Q Consensus 365 ~~~-----~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl 438 (608)
... ....++|+|++++- +|.+++..+. ....+...+..++.+++..+.-||+.+ |+|+|++++|||+
T Consensus 99 ~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G-----i~HgDL~~~NiLl 171 (268)
T PRK15123 99 GERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG-----INHRDCYICHFLL 171 (268)
T ss_pred EEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc-----CccCCCChhhEEE
Confidence 432 23578999999875 8999886432 234566777899999999999999988 9999999999999
Q ss_pred CC-------CCCceEeccccccc
Q 042949 439 NE-------NEDPLISECGYSKF 454 (608)
Q Consensus 439 ~~-------~~~~kl~DFGla~~ 454 (608)
+. +..+.++||+.++.
T Consensus 172 ~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 172 HLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eccccCCCCCceEEEEECCcccc
Confidence 75 46788999998864
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.8e-10 Score=101.72 Aligned_cols=92 Identities=30% Similarity=0.521 Sum_probs=83.5
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|.|+.|.|+-. || .+..|.+|++|++++|++. .+|.+++++++|++|+++-|+|. .+|..|+.++.|++|
T Consensus 32 ~s~ITrLtLSHNKl~~v-pp-nia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLTVV-PP-NIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred hhhhhhhhcccCceeec-CC-cHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 45799999999999864 43 6999999999999999999 78999999999999999999998 899999999999999
Q ss_pred eCcCCcCCc-cCChhHH
Q 042949 155 DISNNHFAA-TSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g-~~p~~~~ 170 (608)
||++|+++. .+|..|.
T Consensus 108 dltynnl~e~~lpgnff 124 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFF 124 (264)
T ss_pred hccccccccccCCcchh
Confidence 999999984 6887764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.2e-08 Score=91.38 Aligned_cols=140 Identities=16% Similarity=0.181 Sum_probs=101.4
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEE-eccc--------ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKR-LKKL--------QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~-l~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
.++.||.=+.|+++.. .|+...||. ..+. +....+..+|++.+.+++--.|.-..-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4677888889999988 566666663 3221 12355678999999988755555555556666777899999
Q ss_pred ccC-CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC---ceEecccccc
Q 042949 378 QSN-GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED---PLISECGYSK 453 (608)
Q Consensus 378 ~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~ 453 (608)
.++ -++.+++..... ..........++..|-+.+.-||.++ |||+||..+||++..++. +.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd-----iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND-----IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC-----eecccccccceEEecCCCcCceEEEeecchh
Confidence 965 378888865322 22222333678889999999999987 999999999999976554 4799999986
Q ss_pred c
Q 042949 454 F 454 (608)
Q Consensus 454 ~ 454 (608)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.1e-09 Score=117.02 Aligned_cols=90 Identities=31% Similarity=0.445 Sum_probs=80.3
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCC-CCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKL-KHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l-~~L~~L 154 (608)
.+++.|+|++|+|+|.+| ..++.+++|+.|+|++|.|+|.+|..+++|++|+.|+|++|+|+|.+|..+..+ .++..+
T Consensus 442 ~~L~~L~Ls~N~l~g~iP-~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIP-PSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCEEECCCCcccCcCC-hHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 579999999999999998 479999999999999999999999999999999999999999999999988764 567888
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
++.+|...+..|
T Consensus 521 ~~~~N~~lc~~p 532 (623)
T PLN03150 521 NFTDNAGLCGIP 532 (623)
T ss_pred EecCCccccCCC
Confidence 888886544333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.6e-09 Score=116.66 Aligned_cols=231 Identities=15% Similarity=0.135 Sum_probs=152.0
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
-+-+|.++.++.++-. .|...++|...... ...+....+-.++-..+||-++...--+......+++++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 4566777777766532 34444444433211 112222222222222345666655544555677899999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC-----
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP----- 457 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~----- 457 (608)
|...|+. ....+..-.......+.++++|||... ++|||++|.|+|+..++..+++|||.......
T Consensus 891 ~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~-----r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 891 LPSKLHN----SGCLSAEPARSPILERVQSLESLHSSL-----RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred chhhhhc----CCCcccccccchhHHHHhhhhccccch-----hhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999885 335665556667778889999999865 89999999999999999999999984332110
Q ss_pred -C----------------------------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh
Q 042949 458 -K----------------------------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL 504 (608)
Q Consensus 458 -~----------------------------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~ 504 (608)
. .....+|+.|.+|| ...+..+|+|++|++++|.++|.+||......
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 01246788999999 45677899999999999999999998765432
Q ss_pred HHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHH
Q 042949 505 PKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMA 555 (608)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 555 (608)
.. ++.+.... +- ........+....+++.+.+..+|.+|-.+.
T Consensus 1042 ~~-f~ni~~~~----~~---~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QI-FENILNRD----IP---WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hh-hhccccCC----CC---CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 11 12111111 00 1112234455577889999999999997665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.9e-08 Score=91.13 Aligned_cols=125 Identities=19% Similarity=0.202 Sum_probs=81.7
Q ss_pred eEEEEEEcCCcEEEEEEeccccc----------------------C-----HHHHHHHHHHHhcCCCC--cceeeeeeee
Q 042949 316 SLFMVRLKNSAVYAVKRLKKLQV----------------------S-----MDEFSQTMRQIGNLKHP--NILPLVCYNS 366 (608)
Q Consensus 316 ~vy~~~~~~g~~vavK~l~~~~~----------------------~-----~~~~~~e~~~l~~l~H~--niv~l~~~~~ 366 (608)
.||.|...+|..+|||+.+.... . .....+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999999999999998752110 0 12356899999999765 455555443
Q ss_pred cCCeeEEEEeecc--CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCCceecCCCCCCeecCCCCC
Q 042949 367 TNEEKLLVYKYQS--NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFM-YQKSNEEKTIPHGNLKLSNILLNENED 443 (608)
Q Consensus 367 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~~ivHrDlkp~NILl~~~~~ 443 (608)
...+||||++ +..+.. |.. ..++......++.+++..+..+ |..+ |+|+|+.+.|||++++ .
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~-----~~~~~~~~~~~~~~il~~~~~~~~~~g-----ivHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKD-----VDLSPEEPKELLEEILEEIIKMLHKAG-----IVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHH-----CGGGGSTHHHHHHHHHHHHHHHHHCTT-----EEESS-STTSEEEETT-C
T ss_pred ---CCEEEEEecCCCccchhh-HHh-----ccccchhHHHHHHHHHHHHHHHHHhcC-----ceecCCChhhEEeecc-e
Confidence 3579999998 544444 332 1122344567778888866665 5655 9999999999999887 9
Q ss_pred ceEeccccccccC
Q 042949 444 PLISECGYSKFLD 456 (608)
Q Consensus 444 ~kl~DFGla~~~~ 456 (608)
+.++|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.64 E-value=2e-08 Score=76.61 Aligned_cols=61 Identities=36% Similarity=0.484 Sum_probs=50.3
Q ss_pred cCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcCCcC
Q 042949 101 RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161 (608)
Q Consensus 101 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l 161 (608)
++|+.|++++|.++...+..+..+++|++|++++|.++..-|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4678888888888865556788899999999999999866666788899999999998875
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1e-06 Score=85.81 Aligned_cols=138 Identities=18% Similarity=0.177 Sum_probs=97.4
Q ss_pred HHHHHHHhhcccCCCCCceEEEEEEcCCcEEEEEEecccc-----------------------cCHHHHHHHHHHHhcCC
Q 042949 298 LDDLLEATADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ-----------------------VSMDEFSQTMRQIGNLK 354 (608)
Q Consensus 298 ~~~l~~~~~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~-----------------------~~~~~~~~e~~~l~~l~ 354 (608)
-.++.++.++.||-|.=+.||.|..+.|..+|||.-+... .+.....+|.+.|.+|.
T Consensus 88 ~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~ 167 (304)
T COG0478 88 KRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY 167 (304)
T ss_pred HcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence 3445567778899999999999999999999999653110 11334678999999886
Q ss_pred CC--cceeeeeeeecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCC
Q 042949 355 HP--NILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432 (608)
Q Consensus 355 H~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlk 432 (608)
-. .+.+.+++ +.-.+||||+++-.|... +++....-.++..|++-+.-....+ |||+|+.
T Consensus 168 ~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~G-----iVHGDlS 229 (304)
T COG0478 168 PEGVKVPKPIAW----NRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRRG-----IVHGDLS 229 (304)
T ss_pred hcCCCCCCcccc----ccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHcC-----ccccCCc
Confidence 44 56665554 445799999987654431 2223333444555555554444444 9999999
Q ss_pred CCCeecCCCCCceEecccccc
Q 042949 433 LSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 433 p~NILl~~~~~~kl~DFGla~ 453 (608)
+=||++++++.+.++||--+.
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred hheEEEecCCCEEEEeCcccc
Confidence 999999999999999996544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.4e-07 Score=69.72 Aligned_cols=60 Identities=32% Similarity=0.491 Sum_probs=54.4
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeec
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 137 (608)
+++.|+|++|+++. +|+..+.++++|++|++++|.+....|..|..+++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~-i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTE-IPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESE-ECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCc-cCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 68899999999995 5667899999999999999999977777899999999999999986
|
... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.5e-06 Score=82.42 Aligned_cols=107 Identities=18% Similarity=0.268 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHhcCCCCc--ceeeeeeeecC----CeeEEEEeeccCC-CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q 042949 340 MDEFSQTMRQIGNLKHPN--ILPLVCYNSTN----EEKLLVYKYQSNG-SLLSLLEAYIEGKRDFPWKLRLSIATGIAKG 412 (608)
Q Consensus 340 ~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~g 412 (608)
.....+|.+.+.++.... ..+.+++.... ...++|+|++++- +|.+++... ...+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence 446778888877775333 44556665542 2458999999874 799888752 226677788999999999
Q ss_pred HHHHhcCCCCCCCceecCCCCCCeecCCCC---CceEecccccccc
Q 042949 413 LDFMYQKSNEEKTIPHGNLKLSNILLNENE---DPLISECGYSKFL 455 (608)
Q Consensus 413 L~yLH~~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~ 455 (608)
++-||+.+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 131 i~~lH~~g-----i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAG-----IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCc-----CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999987 99999999999999887 7889999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.4e-05 Score=76.18 Aligned_cols=136 Identities=14% Similarity=0.134 Sum_probs=99.8
Q ss_pred CCCCCceEEEEEEcCCcEEEEEEeccc-------ccCHHHHHHHHHHHhcCCCCc--ceeeeeeeec-----CCeeEEEE
Q 042949 310 SQTICSSLFMVRLKNSAVYAVKRLKKL-------QVSMDEFSQTMRQIGNLKHPN--ILPLVCYNST-----NEEKLLVY 375 (608)
Q Consensus 310 g~g~~g~vy~~~~~~g~~vavK~l~~~-------~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~-----~~~~~lv~ 375 (608)
|+||-+.|++..+.+. .+=+|+-... ......|.+|+..+.++...+ +.+++ ++.. ....+||+
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 5678888998877444 6778876511 234567999999999886433 33444 3321 22467999
Q ss_pred eeccC-CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC--ceEeccccc
Q 042949 376 KYQSN-GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED--PLISECGYS 452 (608)
Q Consensus 376 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla 452 (608)
|-+++ -+|.+++.+. ...+.+..++..+..+|++.+.-||+.+ +.|+|+-+.||+++.++. ++++||.-+
T Consensus 105 e~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G-----v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 105 EDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN-----RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 97753 5888887641 2235677888899999999999999987 999999999999986666 899999876
Q ss_pred cc
Q 042949 453 KF 454 (608)
Q Consensus 453 ~~ 454 (608)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 63
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.8e-07 Score=98.67 Aligned_cols=141 Identities=22% Similarity=0.326 Sum_probs=94.5
Q ss_pred HHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc------------cccccCccccCC--
Q 042949 407 TGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT------------CLFSSNGYTAPE-- 472 (608)
Q Consensus 407 ~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~------------~~~gt~~y~aPE-- 472 (608)
.+++.||.|+|..- .+||++|.|++|.++..+..||+.|+++........ ...-...|.|||
T Consensus 106 ~~v~dgl~flh~sA----k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA----KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hcccchhhhhccCc----ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34559999999764 599999999999999999999999998765543211 112234699999
Q ss_pred --CCCCcchhHHHHHHHHHHHH-cCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCC
Q 042949 473 --KTVSEQGDVFSFGVILLELL-TGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPD 549 (608)
Q Consensus 473 --~~~~~ksDVwSfGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~ 549 (608)
...+.++|+||+||++|-+. .|+..+.........-.... ..+........+.+.++.+=+.+.+..++.
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-------~~~~~~~~~s~~~p~el~~~l~k~l~~~~~ 254 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-------LLNAGAFGYSNNLPSELRESLKKLLNGDSA 254 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-------ccccccccccccCcHHHHHHHHHHhcCCcc
Confidence 45678999999999999999 55554432221111110000 001111112234556677888899999999
Q ss_pred CCCCHHHHH
Q 042949 550 DRPTMAEVL 558 (608)
Q Consensus 550 ~RPs~~evl 558 (608)
.||++.++.
T Consensus 255 ~rp~~~~l~ 263 (700)
T KOG2137|consen 255 VRPTLDLLL 263 (700)
T ss_pred cCcchhhhh
Confidence 999776664
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-06 Score=89.01 Aligned_cols=84 Identities=29% Similarity=0.457 Sum_probs=60.8
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCC----------------------ccCccc-ccCCCCcceeec
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQ----------------------GRIPTS-ISNCRRLTYLNL 132 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~----------------------g~~p~~-~~~l~~L~~L~L 132 (608)
++++-|+|++|-|.. +| ..++.+..|+.||+|.|+|. |.++++ +.++.+|..|||
T Consensus 435 ~kLt~L~L~NN~Ln~-LP-~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL 512 (565)
T KOG0472|consen 435 QKLTFLDLSNNLLND-LP-EEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDL 512 (565)
T ss_pred hcceeeecccchhhh-cc-hhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceecc
Confidence 467777777766553 44 46777777888888877773 334444 677777888888
Q ss_pred cCeeccccCChhhcCCCCCCEEeCcCCcCC
Q 042949 133 SSNLLSGAVPLALTKLKHLKTLDISNNHFA 162 (608)
Q Consensus 133 s~N~l~g~lP~~l~~l~~L~~L~ls~N~l~ 162 (608)
.+|.+. .+|+.+++|++|++|+|++|+|.
T Consensus 513 ~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 513 QNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred CCCchh-hCChhhccccceeEEEecCCccC
Confidence 888887 77778888888888888888886
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-06 Score=60.32 Aligned_cols=39 Identities=18% Similarity=0.635 Sum_probs=26.9
Q ss_pred ChHHHHHHhHhcCC-CccccccCCCCCC-CCCCCCCCCCeeec
Q 042949 32 SESESFFKFISAVD-SQNVLRIGWNGNL-PHPCSYNLKGIKCN 72 (608)
Q Consensus 32 ~~~~~l~~~~~~~~-~~~~~~~~W~~~~-~~~c~~~w~gv~c~ 72 (608)
.|++||++||+++. +....+.+|+.+. ++|| +|.||+|+
T Consensus 3 ~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C--~W~GV~Cd 43 (43)
T PF08263_consen 3 QDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC--SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC--CSTTEEE-
T ss_pred HHHHHHHHHHHhcccccCcccccCCCcCCCCCe--eeccEEeC
Confidence 58899999999996 3434456998763 6899 58999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=8.8e-06 Score=88.30 Aligned_cols=151 Identities=14% Similarity=0.178 Sum_probs=93.7
Q ss_pred CHHHHHHHhh-cccCCCCCceEEEEEEcCCcEEEEEEecccc---------------------------cCH----H---
Q 042949 297 KLDDLLEATA-DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ---------------------------VSM----D--- 341 (608)
Q Consensus 297 ~~~~l~~~~~-~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~---------------------------~~~----~--- 341 (608)
+++|++...+ +-++.++-|.||+|++++|+.||||+.+..- .+. +
T Consensus 120 ~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 120 PIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred CHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 3444443333 3467888999999999999999999975210 000 1
Q ss_pred -------HHHHHHHHHhcC----CCCcceeeeeeee-cCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHH
Q 042949 342 -------EFSQTMRQIGNL----KHPNILPLVCYNS-TNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGI 409 (608)
Q Consensus 342 -------~~~~e~~~l~~l----~H~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i 409 (608)
++.+|..-+.++ +..--+++-..|. -.....|+|||++|-.+.+...-. ...++.+. ++..+
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~---ia~~~ 273 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKE---LAELL 273 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHH---HHHHH
Confidence 133444444443 2222233323333 345678999999998888874321 23344332 33333
Q ss_pred HHH-HHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 410 AKG-LDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 410 a~g-L~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
+++ +.-+-..+ ++|.|..|-||+++.+++.-+.|||+...+.+.
T Consensus 274 ~~~f~~q~~~dg-----ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 274 VRAFLRQLLRDG-----FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHHHHHHhcC-----ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 322 12222233 999999999999999999999999998877653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.1e-05 Score=75.79 Aligned_cols=141 Identities=8% Similarity=0.093 Sum_probs=84.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcc--eeeeeeeecCCeeEEEEeeccCCC-H
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNI--LPLVCYNSTNEEKLLVYKYQSNGS-L 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~~~~~lv~e~~~~g~-L 383 (608)
..+|+|..+.||+. .|..+++|.... ........+|.+++..+..-.+ .+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 35799999999983 244577887764 3345667899999988864433 566777777777889999998863 2
Q ss_pred HHHH--------------HHH---hcC--CCCCCHHHHH-HHHH----------HHHH-HHHHHhcCCCCCCCceecCCC
Q 042949 384 LSLL--------------EAY---IEG--KRDFPWKLRL-SIAT----------GIAK-GLDFMYQKSNEEKTIPHGNLK 432 (608)
Q Consensus 384 ~~~l--------------~~~---~~~--~~~l~~~~~~-~i~~----------~ia~-gL~yLH~~~~~~~~ivHrDlk 432 (608)
...+ -.. ... ....+..... .+.. .+.+ ..++|... .....++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~-~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEV-PDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhC-CCCCceEecCCC
Confidence 1111 100 000 0111111100 0000 1111 12333322 123457899999
Q ss_pred CCCeecCCCCCceEecccccc
Q 042949 433 LSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 433 p~NILl~~~~~~kl~DFGla~ 453 (608)
|.||++++++ +.|.||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.6e-05 Score=81.35 Aligned_cols=251 Identities=12% Similarity=0.170 Sum_probs=145.0
Q ss_pred ccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeee------eecCCe-eEEEEeecc
Q 042949 308 LRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCY------NSTNEE-KLLVYKYQS 379 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~------~~~~~~-~~lv~e~~~ 379 (608)
-+|+|+-+.+|-..--.+ -+.|+......... .+.+..|.+. .||-+-.=+.+ -.+.+. .-+.|..++
T Consensus 18 ~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~ 93 (637)
T COG4248 18 PLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVS 93 (637)
T ss_pred cccCCccceeeecchhhc--hhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCC
Confidence 368999998887432112 23466654322211 2333444444 46654331221 111222 556777665
Q ss_pred CC-CHHHHHHH--HhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 380 NG-SLLSLLEA--YIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 380 ~g-~L~~~l~~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
+. -+..++.- .+.+....+|...+++++.+|.+-+-||..+ -+-+|+.++|+|+.+++.+.|.|-..-..-.
T Consensus 94 g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G-----h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 94 GKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG-----HVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred CccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC-----CcccccCccceeeecCceEEEEcccceeecc
Confidence 53 22222211 1123455789999999999999999999987 6679999999999999999998754433322
Q ss_pred CCC--ccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcC-CCCCcCCC---ChHHHHHHHHhhhcccccc
Q 042949 457 PKK--TCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTG-KTVEKTGI---DLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 457 ~~~--~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg-~~p~~~~~---~~~~~~~~~~~~~~~~~~~ 521 (608)
... .+-+|...|.+||. ..+...|-|.+||++++++.| +.||.+-. +-+.-.+..+.........
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~ 248 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYAS 248 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeech
Confidence 222 33467888999991 235679999999999999888 66764311 1000000000000000000
Q ss_pred cH--HHHHhch-----hcHHHHHHHHHHchhcC--CCCCCCHHHHHHHHHHhhcC
Q 042949 522 DK--EVAKAGR-----QWAFPLLNVALKCVSNS--PDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 522 ~~--~~~~~~~-----~~~~~l~~li~~Cl~~d--P~~RPs~~evl~~L~~~~~~ 567 (608)
+. .....+. -.+..+..+..+|.... +.-|||++.-+..|..+.++
T Consensus 249 ~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 249 DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 00 0001111 12334667888888653 56899999887777776543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.4e-06 Score=77.69 Aligned_cols=82 Identities=26% Similarity=0.349 Sum_probs=29.3
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccc-cCCCCcceeeccCeeccccC-ChhhcCCCCCCEE
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNLLSGAV-PLALTKLKHLKTL 154 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~l-P~~l~~l~~L~~L 154 (608)
++..|+|++|.++. ++ .+..|+.|++|++++|.++. ++..+ ..+++|+.|+|++|++...- =..+..+++|++|
T Consensus 43 ~L~~L~Ls~N~I~~-l~--~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 43 KLEVLDLSNNQITK-LE--GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL 118 (175)
T ss_dssp T--EEE-TTS--S---T--T----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred CCCEEECCCCCCcc-cc--CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence 56667777777664 22 35566777777777777763 43333 34667777777777765211 0245566777777
Q ss_pred eCcCCcCC
Q 042949 155 DISNNHFA 162 (608)
Q Consensus 155 ~ls~N~l~ 162 (608)
+|.+|.++
T Consensus 119 ~L~~NPv~ 126 (175)
T PF14580_consen 119 SLEGNPVC 126 (175)
T ss_dssp E-TT-GGG
T ss_pred eccCCccc
Confidence 77777665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.97 E-value=4.4e-06 Score=77.72 Aligned_cols=81 Identities=31% Similarity=0.470 Sum_probs=29.8
Q ss_pred cEEEEEecCCCceeecChhhhc-CCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhh-cCCCCCCEE
Q 042949 77 NIVGIRLENMNLSGIIDAETLC-KLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLAL-TKLKHLKTL 154 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l-~~l~~L~~L 154 (608)
++..|+|++|.++- | +.++ .|.+|+.|+|++|.++ .++ .+..|+.|+.|+|++|+++ .++..+ ..+++|+.|
T Consensus 20 ~~~~L~L~~n~I~~-I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccc-c--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 57889999999885 3 2466 5889999999999999 454 5888999999999999999 565555 468999999
Q ss_pred eCcCCcCCc
Q 042949 155 DISNNHFAA 163 (608)
Q Consensus 155 ~ls~N~l~g 163 (608)
+|++|++..
T Consensus 94 ~L~~N~I~~ 102 (175)
T PF14580_consen 94 YLSNNKISD 102 (175)
T ss_dssp E-TTS---S
T ss_pred ECcCCcCCC
Confidence 999999964
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=1.4e-06 Score=96.58 Aligned_cols=98 Identities=32% Similarity=0.496 Sum_probs=76.0
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.++..|+|+.|.|. .+|...+.+|..|+.|+||+|.++ .+|..+.+|+.|+.|...+|++. .+| ++..++.|+++|
T Consensus 383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD 458 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD 458 (1081)
T ss_pred cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence 46888999998876 456667888999999999999998 78888888888888888888887 677 788888889999
Q ss_pred CcCCcCC-ccCChhHH-Hhhhhcc
Q 042949 156 ISNNHFA-ATSPDNFR-QEIKYFD 177 (608)
Q Consensus 156 ls~N~l~-g~~p~~~~-~~~~~~~ 177 (608)
||.|+++ +.+|.... ..+++++
T Consensus 459 lS~N~L~~~~l~~~~p~p~LkyLd 482 (1081)
T KOG0618|consen 459 LSCNNLSEVTLPEALPSPNLKYLD 482 (1081)
T ss_pred cccchhhhhhhhhhCCCcccceee
Confidence 9988887 45555443 3344433
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=8.7e-06 Score=92.28 Aligned_cols=64 Identities=20% Similarity=0.330 Sum_probs=40.5
Q ss_pred CCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 102 HLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 102 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+|+.|++++|.|++ +|.. ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+|.+|..+.
T Consensus 403 ~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~ 466 (788)
T PRK15387 403 ELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 466 (788)
T ss_pred CCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHH
Confidence 44445555555542 4432 234566677777776 6777777777788888888888877776653
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.88 E-value=3e-06 Score=90.02 Aligned_cols=83 Identities=30% Similarity=0.434 Sum_probs=67.5
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCccc-ccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTS-ISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..++.|+|+.|+|.-. | ..+..-.++-+|+||+|+|. +||.. +.+|+.|-+||||+|+|. .+|+.+..|..|++|
T Consensus 103 ~dLt~lDLShNqL~Ev-P-~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL 178 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLREV-P-TNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTL 178 (1255)
T ss_pred ccceeeecchhhhhhc-c-hhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhh
Confidence 4688888898888753 3 46777888888899999888 66654 578888999999999998 788888888889999
Q ss_pred eCcCCcCC
Q 042949 155 DISNNHFA 162 (608)
Q Consensus 155 ~ls~N~l~ 162 (608)
+||+|.+.
T Consensus 179 ~Ls~NPL~ 186 (1255)
T KOG0444|consen 179 KLSNNPLN 186 (1255)
T ss_pred hcCCChhh
Confidence 99988773
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=9e-07 Score=79.56 Aligned_cols=83 Identities=22% Similarity=0.410 Sum_probs=58.2
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeecc-ccCChhhcCCCCCCEEe
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS-GAVPLALTKLKHLKTLD 155 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-g~lP~~l~~l~~L~~L~ 155 (608)
++..|++.+|++.. +| .++++|+.|+.|+++-|.+. .+|..|++++.|+.|||+.|+|+ -.+|..|..|+.|+.|.
T Consensus 57 nlevln~~nnqie~-lp-~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 57 NLEVLNLSNNQIEE-LP-TSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhcccchhhh-cC-hhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 56677777777664 33 35777777777777777777 67777777777777777777775 34666666666666666
Q ss_pred CcCCcCC
Q 042949 156 ISNNHFA 162 (608)
Q Consensus 156 ls~N~l~ 162 (608)
|+.|.|.
T Consensus 134 l~dndfe 140 (264)
T KOG0617|consen 134 LGDNDFE 140 (264)
T ss_pred hcCCCcc
Confidence 6666665
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.87 E-value=3.4e-06 Score=89.60 Aligned_cols=87 Identities=26% Similarity=0.468 Sum_probs=57.8
Q ss_pred cEEEEEecCCCcee-ecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChh-hcCCCCCCEE
Q 042949 77 NIVGIRLENMNLSG-IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLA-LTKLKHLKTL 154 (608)
Q Consensus 77 ~v~~l~l~~~~l~g-~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~-l~~l~~L~~L 154 (608)
++.++.+..|+|.. .|| ..+..|..|+.||||+|++. ..|..+.+-+++-.||||+|++. .||.. +.+|+.|-+|
T Consensus 79 ~LRsv~~R~N~LKnsGiP-~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfL 155 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIP-TDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFL 155 (1255)
T ss_pred hhHHHhhhccccccCCCC-chhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhh
Confidence 45556666666653 254 35777777777777777777 66777777777777777777776 66654 4567777777
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
|||+|.+....|
T Consensus 156 DLS~NrLe~LPP 167 (1255)
T KOG0444|consen 156 DLSNNRLEMLPP 167 (1255)
T ss_pred ccccchhhhcCH
Confidence 777777764333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=3.1e-06 Score=90.67 Aligned_cols=172 Identities=13% Similarity=0.043 Sum_probs=125.3
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCc-ceeeeeeeecCCeeEEEEeeccCC-CHHHH
Q 042949 309 RSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPN-ILPLVCYNSTNEEKLLVYKYQSNG-SLLSL 386 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~~~~g-~L~~~ 386 (608)
.+++.++++||.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..+++++|+..| +-..-
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~ 325 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALE 325 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccccc
Confidence 3577889999987544444446665432 44567889999999999 777778888888999999999877 21111
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--Cccccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--KTCLFS 464 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--~~~~~g 464 (608)
.. .....+..-+...+.+.-.++++|+|+.. =+||| ||+..+ ...|..||+....+... .....+
T Consensus 326 ~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~-----~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~ 392 (829)
T KOG0576|consen 326 MT---VSEIALEQYQFAYPLRKETRPLAELHSSY-----KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIG 392 (829)
T ss_pred CC---hhhHhhhhhhhhhhhhhhccccccccccc-----ccCcc----cccccc-cccccccccCCcccCcccccccCCC
Confidence 10 01122334455566777788999999753 48998 887755 77899999998877765 456778
Q ss_pred cCccccCC----CCCCcchhHHHHHHHHHHHHcCCCC
Q 042949 465 SNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTV 497 (608)
Q Consensus 465 t~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p 497 (608)
++.++||| ..+..+.|+|+.|+--.++.-|-+|
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 99999999 4567789999999877788777765
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00015 Score=71.98 Aligned_cols=138 Identities=14% Similarity=0.126 Sum_probs=81.2
Q ss_pred CCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCCCHHHHHH---
Q 042949 313 ICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLE--- 388 (608)
Q Consensus 313 ~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~--- 388 (608)
....||+.... +..+.||+..... ..++.+|++++..+. +--+.+++++....+..++|||+++|.++.+...
T Consensus 11 ~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~ 87 (244)
T cd05150 11 SGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELE 87 (244)
T ss_pred CcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccC
Confidence 44789998764 4678888776432 345678888888774 3334566777766667899999999877764310
Q ss_pred -------------HHhc-C--CCCCCHH--HHHHHHH--------------------HHHHHHHHHhcC--CCCCCCcee
Q 042949 389 -------------AYIE-G--KRDFPWK--LRLSIAT--------------------GIAKGLDFMYQK--SNEEKTIPH 428 (608)
Q Consensus 389 -------------~~~~-~--~~~l~~~--~~~~i~~--------------------~ia~gL~yLH~~--~~~~~~ivH 428 (608)
.... . ...+... ....... .+...++.|=.. ....+.++|
T Consensus 88 ~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H 167 (244)
T cd05150 88 PERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTH 167 (244)
T ss_pred HHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEEC
Confidence 0000 0 0011100 0000000 011111222111 112346899
Q ss_pred cCCCCCCeecCCCCCceEecccccc
Q 042949 429 GNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 429 rDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
+|+.|.|||++++....|+||+.+.
T Consensus 168 gD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 168 GDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCCCccEEEeCCcEEEEEEccccc
Confidence 9999999999997777899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.82 E-value=1.4e-05 Score=56.16 Aligned_cols=36 Identities=39% Similarity=0.616 Sum_probs=16.8
Q ss_pred CcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCC
Q 042949 126 RLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFA 162 (608)
Q Consensus 126 ~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~ 162 (608)
+|++|+|++|+++ .+|..+..|++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 3445555555554 34444455555555555555444
|
... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=9e-05 Score=71.71 Aligned_cols=135 Identities=13% Similarity=0.228 Sum_probs=90.8
Q ss_pred ccCCCCCceEEEEEEcCCcEEEEEEecccccC--------------------HHH-----HHHHHHHHhcCC--CCccee
Q 042949 308 LRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS--------------------MDE-----FSQTMRQIGNLK--HPNILP 360 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~--------------------~~~-----~~~e~~~l~~l~--H~niv~ 360 (608)
.+.+|.-+.||+|.-.++..+|||+.+..... .++ ..+|+.-|.++. +=.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 46788888999999989999999998643211 111 235666666553 223333
Q ss_pred eeeeeecCCeeEEEEeeccCCC-HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC
Q 042949 361 LVCYNSTNEEKLLVYKYQSNGS-LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439 (608)
Q Consensus 361 l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~ 439 (608)
.+++. ...|||||+.... -.-.|. ..++.......+..++.+++.-|.... ++||+||..=|||+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~a----~LVHgDLSEyNiL~~ 201 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKEA----GLVHGDLSEYNILVH 201 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHhc----CcccccchhhheEEE
Confidence 34333 3579999985431 111121 123333367778888999998887743 399999999999998
Q ss_pred CCCCceEeccccccccC
Q 042949 440 ENEDPLISECGYSKFLD 456 (608)
Q Consensus 440 ~~~~~kl~DFGla~~~~ 456 (608)
++.+.++|+|-|....
T Consensus 202 -~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CCeEEEEECccccccC
Confidence 8999999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00021 Score=83.51 Aligned_cols=148 Identities=12% Similarity=0.222 Sum_probs=89.9
Q ss_pred ccCCCCCceEEEEEEcCC---cEEEEEEecccc--cCHHHHHHHHHHHhcCC-CCcc--eeeeeeeecC---CeeEEEEe
Q 042949 308 LRSQTICSSLFMVRLKNS---AVYAVKRLKKLQ--VSMDEFSQTMRQIGNLK-HPNI--LPLVCYNSTN---EEKLLVYK 376 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g---~~vavK~l~~~~--~~~~~~~~e~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lv~e 376 (608)
.++.|.+..+|+....++ ..+++|+..... .....+.+|+++++.+. |.++ .+++.+|.+. +..++|||
T Consensus 45 ~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME 124 (822)
T PLN02876 45 QFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIME 124 (822)
T ss_pred EeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEE
Confidence 357788889999887654 467778764322 23457889999999995 6765 6777777654 45789999
Q ss_pred eccCCCHHH--------------------HH---HHHhcCC-------CCCCH--HHHHHHH---------------HHH
Q 042949 377 YQSNGSLLS--------------------LL---EAYIEGK-------RDFPW--KLRLSIA---------------TGI 409 (608)
Q Consensus 377 ~~~~g~L~~--------------------~l---~~~~~~~-------~~l~~--~~~~~i~---------------~~i 409 (608)
|+++..+.+ .| |...... .+..+ .+...+. -.+
T Consensus 125 ~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~ 204 (822)
T PLN02876 125 YLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKM 204 (822)
T ss_pred ecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhH
Confidence 998754211 11 1100000 01111 1111111 123
Q ss_pred HHHHHHHhcCCCC------CCCceecCCCCCCeecCCC-CC-ceEecccccccc
Q 042949 410 AKGLDFMYQKSNE------EKTIPHGNLKLSNILLNEN-ED-PLISECGYSKFL 455 (608)
Q Consensus 410 a~gL~yLH~~~~~------~~~ivHrDlkp~NILl~~~-~~-~kl~DFGla~~~ 455 (608)
...+++|..+.+. ...+||+|+++.||+++.+ .. .-|.||.++..-
T Consensus 205 ~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 205 LELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred HHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 3345677554322 2459999999999999853 33 468999987653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.78 E-value=7e-05 Score=73.28 Aligned_cols=144 Identities=14% Similarity=0.115 Sum_probs=82.2
Q ss_pred ccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCC--cceeeeeeee---cCCeeEEEEeeccCCC
Q 042949 308 LRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHP--NILPLVCYNS---TNEEKLLVYKYQSNGS 382 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~---~~~~~~lv~e~~~~g~ 382 (608)
.+++|..+.||++...+ ..+++|..... .....+.+|..++..+... .+.+++.+.. .....+++|+++++..
T Consensus 4 ~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 4 PLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred cCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 46778889999999987 58999987654 3456778888888877533 2445565432 2345789999999988
Q ss_pred HHH----------------HHHHHhc---CCCCCCHHH---------HHHH------------HHHHHH-HHHHHhcCC-
Q 042949 383 LLS----------------LLEAYIE---GKRDFPWKL---------RLSI------------ATGIAK-GLDFMYQKS- 420 (608)
Q Consensus 383 L~~----------------~l~~~~~---~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~~~- 420 (608)
+.. .+..... ....+.+.. .... ...+.+ .++.++...
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (239)
T PF01636_consen 82 LDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLP 161 (239)
T ss_dssp HHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhc
Confidence 777 1111101 111111110 0000 112222 233333211
Q ss_pred -CCCCCceecCCCCCCeecC-CCCCceEecccccc
Q 042949 421 -NEEKTIPHGNLKLSNILLN-ENEDPLISECGYSK 453 (608)
Q Consensus 421 -~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~ 453 (608)
.....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus 162 ~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 162 KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1245699999999999999 55555799998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.77 E-value=1.8e-05 Score=55.65 Aligned_cols=37 Identities=38% Similarity=0.548 Sum_probs=30.6
Q ss_pred cCCcEEEcccCcCCccCcccccCCCCcceeeccCeecc
Q 042949 101 RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS 138 (608)
Q Consensus 101 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 138 (608)
++|++|++++|+|+ .+|+.+++|++|+.|+|++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 46889999999999 67878899999999999999988
|
... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00037 Score=66.41 Aligned_cols=127 Identities=14% Similarity=0.155 Sum_probs=88.8
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccc-----------------cCHHHHHHHHHHHhcCC------CCcceeee
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ-----------------VSMDEFSQTMRQIGNLK------HPNILPLV 362 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~-----------------~~~~~~~~e~~~l~~l~------H~niv~l~ 362 (608)
..++|+|+.=.||. +++.....||++.... ...++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35789999998988 6666778889887433 23456777777766555 88999999
Q ss_pred eeeecCCeeEEEEeeccC--C----CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCe
Q 042949 363 CYNSTNEEKLLVYKYQSN--G----SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436 (608)
Q Consensus 363 ~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NI 436 (608)
|+.++....-+|+|.+.+ | +|.+++. ...++. ...+.+.+. -+||-+++ |+.+|++|.||
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~~f---~~~l~~~~-----Iv~~dl~~~NI 149 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALDEF---KRYLLDHH-----IVIRDLNPHNI 149 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHHHH---HHHHHHcC-----CeecCCCcccE
Confidence 999999888999997643 3 4666664 234555 333344444 35665554 99999999999
Q ss_pred ecCCCC----CceEec
Q 042949 437 LLNENE----DPLISE 448 (608)
Q Consensus 437 Ll~~~~----~~kl~D 448 (608)
++.... .+.|+|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 996542 355665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00024 Score=77.11 Aligned_cols=141 Identities=17% Similarity=0.143 Sum_probs=87.5
Q ss_pred ccCCCCCceEEEEEEcCCcEEEEEEecccccC----------------------------HH----------HHHHHHHH
Q 042949 308 LRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS----------------------------MD----------EFSQTMRQ 349 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~----------------------------~~----------~~~~e~~~ 349 (608)
-++.-+.|.||++++++|+.||||+-+..-.. .+ +|.+|.+-
T Consensus 168 piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~N 247 (538)
T KOG1235|consen 168 PIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKN 247 (538)
T ss_pred hhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHh
Confidence 36777889999999999999999986522110 01 13444443
Q ss_pred Hhc----CCCCc---ceeeeeeeec-CCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 042949 350 IGN----LKHPN---ILPLVCYNST-NEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSN 421 (608)
Q Consensus 350 l~~----l~H~n---iv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 421 (608)
..+ ++|-+ -|.+-.++.+ .....|+||||+|..+.+.-.- ....++...+..-+.++..-+-+- .
T Consensus 248 ae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~--~-- 320 (538)
T KOG1235|consen 248 AERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFK--T-- 320 (538)
T ss_pred HHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHh--c--
Confidence 332 34555 1223233332 3467899999999877665321 123455554433333332222222 2
Q ss_pred CCCCceecCCCCCCeecCC----CCCceEeccccccccCCC
Q 042949 422 EEKTIPHGNLKLSNILLNE----NEDPLISECGYSKFLDPK 458 (608)
Q Consensus 422 ~~~~ivHrDlkp~NILl~~----~~~~kl~DFGla~~~~~~ 458 (608)
+++|.|-.|-||++.. +.++.+-|||+...+...
T Consensus 321 ---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 ---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 3999999999999984 677899999998876544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=5.9e-06 Score=87.36 Aligned_cols=85 Identities=27% Similarity=0.282 Sum_probs=57.7
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
.+..|+|+.|+++..-. ..+.+|+.|+.|+||+|.|...-+..+.-+++|+.|+||+|+++---|..|..|..|+.|+|
T Consensus 270 kme~l~L~~N~l~~vn~-g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNE-GWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred ccceeecccchhhhhhc-ccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 56777777777775432 45777777777788877777666666777777777777777777333335666666666666
Q ss_pred cCCcCC
Q 042949 157 SNNHFA 162 (608)
Q Consensus 157 s~N~l~ 162 (608)
+.|.++
T Consensus 349 s~Nsi~ 354 (873)
T KOG4194|consen 349 SHNSID 354 (873)
T ss_pred cccchH
Confidence 666554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.71 E-value=9.9e-05 Score=69.95 Aligned_cols=101 Identities=16% Similarity=0.135 Sum_probs=80.3
Q ss_pred HHHHHHhcCCC-CcceeeeeeeecCCeeEEEEeeccCCCHHHH---HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 042949 345 QTMRQIGNLKH-PNILPLVCYNSTNEEKLLVYKYQSNGSLLSL---LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKS 420 (608)
Q Consensus 345 ~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 420 (608)
.|.-++..+.+ +++.+++|+|- .+++.||...+++... +.. -..-+|..|.+||.++++.++++++..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 57778888876 69999999994 4679999987765421 111 234689999999999999999998865
Q ss_pred CCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 421 NEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 421 ~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
. ..+.-.|++++|+-+++++++|+.|...+...
T Consensus 80 ~--~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 L--GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred C--CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 2 23888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=1e-05 Score=81.96 Aligned_cols=110 Identities=27% Similarity=0.416 Sum_probs=87.2
Q ss_pred CCCCCCCC---CCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCC
Q 042949 59 PHPCSYNL---KGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRR 126 (608)
Q Consensus 59 ~~~c~~~w---~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 126 (608)
+.||.++- .-|.|+.. ....+.|+|+.|+++- ||+..++.+.+|+.||||+|+|+-.-|..|..|++
T Consensus 38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~-iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~ 116 (498)
T KOG4237|consen 38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISS-IPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLAS 116 (498)
T ss_pred CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCccc-CChhhccchhhhceecccccchhhcChHhhhhhHh
Confidence 35665432 12788642 1356899999999885 66788999999999999999999888999999998
Q ss_pred cceeecc-CeeccccCCh-hhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 127 LTYLNLS-SNLLSGAVPL-ALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 127 L~~L~Ls-~N~l~g~lP~-~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
|..|-|- +|+++ .+|. .|.+|..|+-|.+.-|++.-.....|.
T Consensus 117 l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~ 161 (498)
T KOG4237|consen 117 LLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALR 161 (498)
T ss_pred hhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHH
Confidence 8876554 49999 6775 689999999999999999877666664
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.62 E-value=4e-05 Score=81.26 Aligned_cols=95 Identities=26% Similarity=0.339 Sum_probs=76.8
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
++++.|+|.+|.++..- .+++.-++.|++||||.|.++-.--+.+..-.++++|+|++|+++-.--..|..+.+|.+|.
T Consensus 125 ghl~~L~L~~N~I~sv~-se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 125 GHLEKLDLRHNLISSVT-SEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred cceeEEeeecccccccc-HHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 57888899888877543 46789999999999999999843335677778899999999999854445788888999999
Q ss_pred CcCCcCCccCChhHHH
Q 042949 156 ISNNHFAATSPDNFRQ 171 (608)
Q Consensus 156 ls~N~l~g~~p~~~~~ 171 (608)
|+.|.++...+..|.+
T Consensus 204 LsrNrittLp~r~Fk~ 219 (873)
T KOG4194|consen 204 LSRNRITTLPQRSFKR 219 (873)
T ss_pred cccCcccccCHHHhhh
Confidence 9999999777777753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=1.7e-05 Score=88.28 Aligned_cols=87 Identities=39% Similarity=0.623 Sum_probs=77.2
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
++..|+|++|.++. .| ..+..+.+|+.|+++.|.+. ..|.+++++.+|++|+|.+|+++ .+|.++..+.+|+.||+
T Consensus 46 ~L~~l~lsnn~~~~-fp-~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~Ldl 121 (1081)
T KOG0618|consen 46 KLKSLDLSNNQISS-FP-IQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDL 121 (1081)
T ss_pred eeEEeecccccccc-CC-chhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhccccccc
Confidence 48999999988664 44 46899999999999999999 78899999999999999999999 89999999999999999
Q ss_pred cCCcCCccCChh
Q 042949 157 SNNHFAATSPDN 168 (608)
Q Consensus 157 s~N~l~g~~p~~ 168 (608)
|+|+|. .+|.-
T Consensus 122 S~N~f~-~~Pl~ 132 (1081)
T KOG0618|consen 122 SFNHFG-PIPLV 132 (1081)
T ss_pred chhccC-CCchh
Confidence 999996 55543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00042 Score=66.43 Aligned_cols=68 Identities=15% Similarity=0.228 Sum_probs=52.7
Q ss_pred CeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEec
Q 042949 369 EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448 (608)
Q Consensus 369 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 448 (608)
...+++|||++|..|.++.. ++. .++..+.+++.-||+.+ +.|+|..|.|+++++ +.+++.|
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G-----~~HGD~hpgNFlv~~-~~i~iID 177 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG-----FYHGDPHPGNFLVSN-NGIRIID 177 (229)
T ss_pred eEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC-----CccCCCCcCcEEEEC-CcEEEEE
Confidence 45579999999988766432 222 24456778899999987 999999999999985 4599999
Q ss_pred cccccc
Q 042949 449 CGYSKF 454 (608)
Q Consensus 449 FGla~~ 454 (608)
|+..+.
T Consensus 178 ~~~k~~ 183 (229)
T PF06176_consen 178 TQGKRM 183 (229)
T ss_pred Cccccc
Confidence 987663
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0003 Score=80.78 Aligned_cols=191 Identities=19% Similarity=0.219 Sum_probs=129.0
Q ss_pred HHHHHHHHhcCCCCcceeeeeeeecCCee----EEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 042949 343 FSQTMRQIGNLKHPNILPLVCYNSTNEEK----LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQ 418 (608)
Q Consensus 343 ~~~e~~~l~~l~H~niv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 418 (608)
...|++.+.++.|+|++.++.|-...... .+..||+..-++.+.+.. ...++....+.+..+..+||+|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34567778899999999999886544322 244578888888887764 4667888888899999999999998
Q ss_pred CCCCCCCceecCCCCC---CeecCCCCCceEe--ccccccccCCCCc--cccccCccccCC----C--CCCcchhHHHHH
Q 042949 419 KSNEEKTIPHGNLKLS---NILLNENEDPLIS--ECGYSKFLDPKKT--CLFSSNGYTAPE----K--TVSEQGDVFSFG 485 (608)
Q Consensus 419 ~~~~~~~ivHrDlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~--~~~gt~~y~aPE----~--~~~~ksDVwSfG 485 (608)
.. ..|.-+..+ +--.+.++....+ ||+..+....... ....+..+.++| . ......|+|.+|
T Consensus 305 ~~-----l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 LS-----LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred hc-----cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHH
Confidence 75 555544444 4455566666666 8888887654432 223345567777 1 223347999999
Q ss_pred HHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 486 VILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 486 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
.....+..|..+..-....... .. ........+...+|+..++++|+++.+++...-
T Consensus 380 ll~~~~~~~~~i~~~~~~~~~~----l~----------------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVPVSL----LD----------------VLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred HHHhhhhhcCcccccccchhhh----hc----------------cccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 9999999887653211111000 00 001113567788999999999999999987644
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00014 Score=82.86 Aligned_cols=79 Identities=23% Similarity=0.388 Sum_probs=43.2
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccC-------------------CCCcceeeccCeec
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISN-------------------CRRLTYLNLSSNLL 137 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~-------------------l~~L~~L~Ls~N~l 137 (608)
.++.|+|++|+|+. +|. .+. .+|+.|++++|.|+ .+|..+.. .++|+.|+|++|+|
T Consensus 200 ~L~~L~Ls~N~Lts-LP~-~l~--~nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N~L~~LP~~l~s~L~~L~Ls~N~L 274 (754)
T PRK15370 200 QITTLILDNNELKS-LPE-NLQ--GNIKTLYANSNQLT-SIPATLPDTIQEMELSINRITELPERLPSALQSLDLFHNKI 274 (754)
T ss_pred CCcEEEecCCCCCc-CCh-hhc--cCCCEEECCCCccc-cCChhhhccccEEECcCCccCcCChhHhCCCCEEECcCCcc
Confidence 46677777777773 442 222 35666666666655 34433221 12456666666666
Q ss_pred cccCChhhcCCCCCCEEeCcCCcCCc
Q 042949 138 SGAVPLALTKLKHLKTLDISNNHFAA 163 (608)
Q Consensus 138 ~g~lP~~l~~l~~L~~L~ls~N~l~g 163 (608)
+ .+|..+. ++|+.|+|++|+|++
T Consensus 275 ~-~LP~~l~--~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 275 S-CLPENLP--EELRYLSVYDNSIRT 297 (754)
T ss_pred C-ccccccC--CCCcEEECCCCcccc
Confidence 5 3555442 356666666666663
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=2.1e-05 Score=68.47 Aligned_cols=90 Identities=24% Similarity=0.281 Sum_probs=65.7
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
...++.++|++|.|.. +|+..-.+++.++.|+|++|.++ .+|.++..++.|+.||++.|.|. ..|..+..|.+|-.|
T Consensus 52 ~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 52 GYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 3567888888888774 33333345567888888888888 67888888888888888888887 567767778888888
Q ss_pred eCcCCcCCccCChh
Q 042949 155 DISNNHFAATSPDN 168 (608)
Q Consensus 155 ~ls~N~l~g~~p~~ 168 (608)
|.-+|... +||..
T Consensus 129 ds~~na~~-eid~d 141 (177)
T KOG4579|consen 129 DSPENARA-EIDVD 141 (177)
T ss_pred cCCCCccc-cCcHH
Confidence 88777664 45533
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0019 Score=65.99 Aligned_cols=75 Identities=8% Similarity=-0.013 Sum_probs=54.5
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCC---Ccceeeeeeeec---CCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKH---PNILPLVCYNST---NEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H---~niv~l~~~~~~---~~~~~lv~e~~~~ 380 (608)
.-+|+|..+.||+....+++ +.+|..+. ......+..|.+.++.+.- -.+.++++++.. .+..++|||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 35799999999999876664 56666432 2245688999999988753 356677777654 3568999999988
Q ss_pred CCH
Q 042949 381 GSL 383 (608)
Q Consensus 381 g~L 383 (608)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0014 Score=62.04 Aligned_cols=118 Identities=15% Similarity=0.228 Sum_probs=83.0
Q ss_pred cccCCCCC-ceEEEEEEcCCcEEEEEEecc-----c----------c-------cCHHHHHHHHHHHhcCC---CCcc--
Q 042949 307 DLRSQTIC-SSLFMVRLKNSAVYAVKRLKK-----L----------Q-------VSMDEFSQTMRQIGNLK---HPNI-- 358 (608)
Q Consensus 307 ~~~g~g~~-g~vy~~~~~~g~~vavK~l~~-----~----------~-------~~~~~~~~e~~~l~~l~---H~ni-- 358 (608)
+++|.|.. |.||+++. +|+.+|+|..+. . . ...+-|..|.+..++|+ +.++
T Consensus 43 efLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~A 121 (207)
T PF13095_consen 43 EFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWA 121 (207)
T ss_pred eecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceE
Confidence 57899999 99999999 677999999321 0 0 01224788999988875 4566
Q ss_pred eeeeeeeecC------------------CeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 042949 359 LPLVCYNSTN------------------EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKS 420 (608)
Q Consensus 359 v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 420 (608)
|+.+||..-. ....||.||.+... .+. .+-+.+|.+-|..+|..+
T Consensus 122 vkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~~~~k~g 184 (207)
T PF13095_consen 122 VKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLKILHKLG 184 (207)
T ss_pred EEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHHHHHHCC
Confidence 8888886321 12357888776532 122 223456777788899887
Q ss_pred CCCCCceecCCCCCCeecCCCCCceEeccccc
Q 042949 421 NEEKTIPHGNLKLSNILLNENEDPLISECGYS 452 (608)
Q Consensus 421 ~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 452 (608)
|+-+|+|+.|.. .-||+|||.+
T Consensus 185 -----I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 185 -----IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -----eeeccCcccccc-----CCEEEecccC
Confidence 999999999975 3589999864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00017 Score=82.20 Aligned_cols=84 Identities=21% Similarity=0.424 Sum_probs=62.7
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+.+.|+|++++|+. +|. .+. ..|+.|+|++|.|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+
T Consensus 178 ~~~~~L~L~~~~Lts-LP~-~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILGLTT-IPA-CIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEME 247 (754)
T ss_pred cCceEEEeCCCCcCc-CCc-ccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEE
Confidence 357899999999885 552 343 57999999999999 5777654 58999999999998 6776553 3577777
Q ss_pred CcCCcCCccCChhHH
Q 042949 156 ISNNHFAATSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g~~p~~~~ 170 (608)
|++|++. .+|..+.
T Consensus 248 Ls~N~L~-~LP~~l~ 261 (754)
T PRK15370 248 LSINRIT-ELPERLP 261 (754)
T ss_pred CcCCccC-cCChhHh
Confidence 7777766 5565544
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00022 Score=86.43 Aligned_cols=91 Identities=23% Similarity=0.296 Sum_probs=64.4
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|+++.+.- ++ ..+..+++|+.|+|++|...+.+| .++.+++|+.|+|++|.....+|..+..+++|+.|+
T Consensus 611 ~~L~~L~L~~s~l~~-L~-~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 611 ENLVKLQMQGSKLEK-LW-DGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred cCCcEEECcCccccc-cc-cccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 467778888777663 33 346677788888887766555666 477777888888877666667777777778888888
Q ss_pred CcCCcCCccCChhH
Q 042949 156 ISNNHFAATSPDNF 169 (608)
Q Consensus 156 ls~N~l~g~~p~~~ 169 (608)
+++|...+.+|..+
T Consensus 688 L~~c~~L~~Lp~~i 701 (1153)
T PLN03210 688 MSRCENLEILPTGI 701 (1153)
T ss_pred CCCCCCcCccCCcC
Confidence 87776666666543
|
syringae 6; Provisional |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0015 Score=64.41 Aligned_cols=32 Identities=19% Similarity=0.291 Sum_probs=26.3
Q ss_pred CCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 423 EKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 423 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
...++|+|+.+.||+++++...-|.||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 34589999999999998765567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0036 Score=61.55 Aligned_cols=71 Identities=15% Similarity=0.123 Sum_probs=45.7
Q ss_pred cCCCCCceEEEEEEcC--CcEEEEEEecccccCHHHHHHHHHHHhcCCCCcc-eeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRLKN--SAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNI-LPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~--g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|-...+|+....+ +..|++|+.........+..+|+.++..+....+ .++++.+. ..++|||+++.++
T Consensus 6 l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 6 FTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred cCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 5677778999998764 6788899765322222233578888887753333 44444332 2479999988665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=97.34 E-value=9.2e-05 Score=76.35 Aligned_cols=94 Identities=24% Similarity=0.375 Sum_probs=67.9
Q ss_pred CcEEEEEecCCCceee----cChhhhcCC-cCCcEEEcccCcCCcc----CcccccCCCCcceeeccCeecccc----CC
Q 042949 76 TNIVGIRLENMNLSGI----IDAETLCKL-RHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLSGA----VP 142 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~----~~~~~l~~l-~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----lP 142 (608)
.+++.|++++|.+++. +. ..+..+ ++|+.|++++|.+++. ++..+..++.|+.|+|++|.+++. ++
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~-~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~ 186 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLA-KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALA 186 (319)
T ss_pred CcccEEEeeCCccchHHHHHHH-HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHH
Confidence 3588999999888742 21 245566 8889999999998854 334566778899999999988853 44
Q ss_pred hhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 143 LALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 143 ~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
..+..+++|+.|+|++|.+++.....+.
T Consensus 187 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 214 (319)
T cd00116 187 EGLKANCNLEVLDLNNNGLTDEGASALA 214 (319)
T ss_pred HHHHhCCCCCEEeccCCccChHHHHHHH
Confidence 4566677899999999988765444443
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.29 E-value=8.4e-05 Score=75.59 Aligned_cols=86 Identities=22% Similarity=0.291 Sum_probs=64.3
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCccccc-CCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSIS-NCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
.++.-|+|..|.+.- +| ++.++..|.+|.++.|++. .+|.+.. .|++|..|||.+|++. ++|+++..+.+|..|
T Consensus 206 ~~L~~LyL~~Nki~~-lP--ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rL 280 (565)
T KOG0472|consen 206 ESLELLYLRRNKIRF-LP--EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERL 280 (565)
T ss_pred hhhHHHHhhhccccc-CC--CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhh
Confidence 356667788888764 33 5777888888888888887 6676654 7888888888888887 778888778888888
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
|+|+|.+++-.+
T Consensus 281 DlSNN~is~Lp~ 292 (565)
T KOG0472|consen 281 DLSNNDISSLPY 292 (565)
T ss_pred cccCCccccCCc
Confidence 888888876544
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0033 Score=62.82 Aligned_cols=140 Identities=9% Similarity=0.045 Sum_probs=76.6
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEEecccccCH-HHHHHHHHHHhcCCCCcc-eeeeeeeecCCeeEEEEeeccCCCHHH-
Q 042949 309 RSQTICSSLFMVRLKNSAVYAVKRLKKLQVSM-DEFSQTMRQIGNLKHPNI-LPLVCYNSTNEEKLLVYKYQSNGSLLS- 385 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~-~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~- 385 (608)
+.+|-...+|+.. .++..+++|......... -+..+|.++++.+....+ .+++..+. .++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 3467778899987 456678888765322111 135678888887754333 23343332 368999998866431
Q ss_pred -------------HHHHHhc---CCCCCCHHHH-HHHHHHH---------HHHHHHHhcCC---CCCCCceecCCCCCCe
Q 042949 386 -------------LLEAYIE---GKRDFPWKLR-LSIATGI---------AKGLDFMYQKS---NEEKTIPHGNLKLSNI 436 (608)
Q Consensus 386 -------------~l~~~~~---~~~~l~~~~~-~~i~~~i---------a~gL~yLH~~~---~~~~~ivHrDlkp~NI 436 (608)
.+.+... ...+++.... ..+..++ ..-+..+-... .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1111100 1112222111 1111111 11122221111 1133589999999999
Q ss_pred ecCCCCCceEeccccccc
Q 042949 437 LLNENEDPLISECGYSKF 454 (608)
Q Consensus 437 Ll~~~~~~kl~DFGla~~ 454 (608)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 998876 78999988763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0028 Score=58.24 Aligned_cols=127 Identities=18% Similarity=0.208 Sum_probs=84.1
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCccee-eeeeeecCCeeEEEEeeccCCCHH
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILP-LVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
..++++|.+|.||.+.+..+ .+|+|+-+ .+.....+..|.++|..+.-.++.+ ++.|. ..++.|||+.|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGG-EVALKVRR-RDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeeccCc-eEEEEEec-CCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence 45789999999999998555 77888654 3446778999999999887666543 33332 334569999887877
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCC-CCCeecCCCCCceEeccccccc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK-LSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlk-p~NILl~~~~~~kl~DFGla~~ 454 (608)
+.-.. .+.....+++-. |..|+-+ +|-|..|. |..+++..+..+.|+||.-|+.
T Consensus 101 ~~~~~-------~~rk~l~~vlE~-a~~LD~~--------GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIG-------GDRKHLLRVLEK-AYKLDRL--------GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhc-------ccHHHHHHHHHH-HHHHHHh--------ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 65431 123333333222 3333333 48888876 4445555566999999998874
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00014 Score=75.02 Aligned_cols=89 Identities=24% Similarity=0.261 Sum_probs=64.5
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcC---CcEEEcccCcCCc----cCcccccCC-CCcceeeccCeecccc----CC
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRH---LRVVSLARNLIQG----RIPTSISNC-RRLTYLNLSSNLLSGA----VP 142 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~---L~~L~l~~N~l~g----~~p~~~~~l-~~L~~L~Ls~N~l~g~----lP 142 (608)
..+++.|+|++|.+.+..+ ..+..+.. |+.|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++
T Consensus 80 ~~~L~~L~l~~~~~~~~~~-~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 80 GCGLQELDLSDNALGPDGC-GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred cCceeEEEccCCCCChhHH-HHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 3478889998888876543 34555554 8899999888873 233455666 8889999999988853 33
Q ss_pred hhhcCCCCCCEEeCcCCcCCcc
Q 042949 143 LALTKLKHLKTLDISNNHFAAT 164 (608)
Q Consensus 143 ~~l~~l~~L~~L~ls~N~l~g~ 164 (608)
..+..+++|+.|++++|++++.
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~ 180 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDA 180 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchH
Confidence 4566677889999999888863
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 608 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-27 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-19 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 91/296 (30%), Positives = 146/296 (49%), Gaps = 41/296 (13%)
Query: 295 RFKLDDLLEATADLRSQTIC-----SSLFMVRLKNSAVYAVKRLK--KLQVSMDEFSQTM 347
RF L +L A+ + ++ I ++ RL + + AVKRLK + Q +F +
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 348 RQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIAT 407
I H N+L L + T E+LLVY Y +NGS+ S L E + W R IA
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 408 GIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCLF 463
G A+GL +++ + + I H ++K +NILL+E + ++ + G +K +D K T +
Sbjct: 139 GSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 464 SSNGYTAPE----KTVSEQGDVFSFGVILLELLTGK-------TVEKTGIDLPKWVKAMV 512
+ G+ APE SE+ DVF +GV+LLEL+TG+ + L WVK ++
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 513 REEWTGEVFD---------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559
+E+ + D +EV + + VAL C +SP +RP M+EV+
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQL--------IQVALLCTQSSPMERPKMSEVVR 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-42
Identities = 76/299 (25%), Positives = 142/299 (47%), Gaps = 35/299 (11%)
Query: 295 RFKLDDLLEATADLRSQTICSSLFMV-----------RLKNSAVYAVKRLKKLQVS---- 339
F +L T + + I + + N+ V AVK+L +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEE 72
Query: 340 -MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFP 398
+F Q ++ + +H N++ L+ ++S ++ LVY Y NGSLL L + ++G
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLS 131
Query: 399 WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458
W +R IA G A G++F+++ + I H ++K +NILL+E IS+ G ++ +
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH----I-HRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 459 KTCLFSSN-----GYTAPEKT---VSEQGDVFSFGVILLELLTG-KTVEKT--GIDLPKW 507
+ +S Y APE ++ + D++SFGV+LLE++TG V++ L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 508 VKAMVREEWT-GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565
+ + EE T + DK++ A + +VA +C+ + RP + +V + ++E+
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 83/306 (27%), Positives = 144/306 (47%), Gaps = 52/306 (16%)
Query: 295 RFKLDDLLEATADLRSQTICSSL----F-MV---RLKNSAVYAVKRLKK--LQVSMDEFS 344
R L DL EAT + + + + F V L++ A A+KR Q ++EF
Sbjct: 28 RVPLVDLEEATNNFDHKFL---IGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-GIEEFE 83
Query: 345 QTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLS 404
+ + +HP+++ L+ + E +L+YKY NG+L L W+ RL
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 405 IATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK-FLDPKKTCLF 463
I G A+GL +++ + I H ++K NILL+EN P I++ G SK + +T L
Sbjct: 144 ICIGAARGLHYLH-----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL- 197
Query: 464 SSN-----GYTAPE--KT--VSEQGDVFSFGVILLELLTGK-----TVEKTGIDLPKWVK 509
S+ GY PE ++E+ DV+SFGV+L E+L + ++ + ++L +W
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 510 AMVREEWTGEVFD---------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560
++ D + + K + A+KC++ S +DRP+M +VL +
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKF--------GDTAVKCLALSSEDRPSMGDVLWK 309
Query: 561 IEEVVN 566
+E +
Sbjct: 310 LEYALR 315
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-40
Identities = 57/309 (18%), Positives = 109/309 (35%), Gaps = 46/309 (14%)
Query: 296 FKLDDLLEATADLRSQTI-----CSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI 350
++L + L+ + ++ +L N V AVK + + +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSWQNEYEVYSL 72
Query: 351 GNLKHPNILPLVCY----NSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIA 406
+KH NIL + S + + L+ + GSL L+ W IA
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIA 127
Query: 407 TGIAKGL-----DFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461
+A+GL D K + I H ++K N+LL N I++ G + + K+
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 462 LFSSN-----GYTAPE---------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPK- 506
+ Y APE + + D+++ G++L EL + T +D
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 507 WVKAMVREEWTGEVFDKEVAKAGRQWAFP-----------LLNVALKCVSNSPDDRPTMA 555
+ + + + E + V ++ L +C + + R +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 556 EVLERIEEV 564
V ERI ++
Sbjct: 308 CVGERITQM 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 66/284 (23%), Positives = 114/284 (40%), Gaps = 33/284 (11%)
Query: 314 CSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLL 373
+ + + V A+K+++ + F +RQ+ + HPNI+ L Y + L
Sbjct: 21 FGVVCKAKWRAKDV-AIKQIES-ESERKAFIVELRQLSRVNHPNIVKL--YGACLNPVCL 76
Query: 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKL 433
V +Y GSL ++L E + +S ++G+ +++ S + K + H +LK
Sbjct: 77 VMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLH--SMQPKALIHRDLKP 133
Query: 434 SNILLNENEDPL-ISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVIL 488
N+LL L I + G + + T S + APE SE+ DVFS+G+IL
Sbjct: 134 PNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193
Query: 489 LELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR-----QWAFPLLNVALKC 543
E++T + I P + V R P+ ++ +C
Sbjct: 194 WEVITRRKPFD-EIGGPAFRIMWA------------VHNGTRPPLIKNLPKPIESLMTRC 240
Query: 544 VSNSPDDRPTMAEV---LERIEEVVNGNDERDRDHSNSSFSSME 584
S P RP+M E+ + + G DE + S E
Sbjct: 241 WSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGE 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 59/291 (20%), Positives = 99/291 (34%), Gaps = 56/291 (19%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQ--TMRQIGNLKHPNILPLVCY-----NSTNEEKLL 373
L V AVK + F + ++ ++H NI + E LL
Sbjct: 33 SLDERPV-AVKVFSF--ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89
Query: 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDF----MYQKSNEEKTIPHG 429
V +Y NGSL L W +A + +GL + + + + + I H
Sbjct: 90 VMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR 144
Query: 430 NLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSN-----------GYTAPE------ 472
+L N+L+ + +IS+ G S L + Y APE
Sbjct: 145 DLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAV 204
Query: 473 -----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKA---MVREEWTGEVFDKE 524
++ +Q D+++ G+I E+ T G +P++ A V T E
Sbjct: 205 NLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVL 264
Query: 525 VAKAGRQWAFP------------LLNVALKCVSNSPDDRPTMAEVLERIEE 563
V++ ++ FP L C + R T ER+ E
Sbjct: 265 VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 66/263 (25%), Positives = 116/263 (44%), Gaps = 42/263 (15%)
Query: 323 KNSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKL-LVYK 376
S V AVK L + ++EF + + + L+HPNI+ T L +V +
Sbjct: 59 HGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV---TQPPNLSIVTE 114
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
Y S GSL LL + + RLS+A +AKG+++++ ++ I H NLK N+
Sbjct: 115 YLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNRNP---PIVHRNLKSPNL 170
Query: 437 LLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSFGVILL 489
L+++ + + G S+ S+ G + APE + +E+ DV+SFGVIL
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 490 ELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVALKC 543
EL T + ++ + V A V ++ P + + C
Sbjct: 231 ELATLQQPWG-NLNPAQVVAA--------------VGFKCKRLEIPRNLNPQVAAIIEGC 275
Query: 544 VSNSPDDRPTMAEVLERIEEVVN 566
+N P RP+ A +++ + ++
Sbjct: 276 WTNEPWKRPSFATIMDLLRPLIK 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 50/253 (19%), Positives = 95/253 (37%), Gaps = 40/253 (15%)
Query: 329 AVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSL 383
VK LK S +F++ ++ HPN+LP+ C + L+ + GSL
Sbjct: 37 VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96
Query: 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443
++L + A +A+G+ F++ E IP L +++++E+
Sbjct: 97 YNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMT 151
Query: 444 PLISECGYSKFLDPKKTCLFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKT 496
IS + + APE T D++SF V+L EL+T +
Sbjct: 152 ARISMADVKFSFQSPGRM--YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE- 208
Query: 497 VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVALKCVSNSPDD 550
+P + + + +VA G + P + + C++ P
Sbjct: 209 -------VP-F------ADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAK 254
Query: 551 RPTMAEVLERIEE 563
RP ++ +E+
Sbjct: 255 RPKFDMIVPILEK 267
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 65/280 (23%), Positives = 112/280 (40%), Gaps = 57/280 (20%)
Query: 314 CSSLFMVRLKNSAVYAVKRLKK-----LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNS 366
++ V AVK + + +++ Q + LKHPNI+ L VC
Sbjct: 20 FGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC--- 75
Query: 367 TNEEKL-LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKT 425
E L LV ++ G L +L + P + ++ A IA+G+++++
Sbjct: 76 LKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLH--DEAIVP 128
Query: 426 IPHGNLKLSNILLNENEDPL--------ISECGYSKFLDPKKTCLFSSNG---YTAPE-- 472
I H +LK SNIL+ + + I++ G ++ +T S+ G + APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAWMAPEVI 186
Query: 473 --KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530
S+ DV+S+GV+L ELLTG+ + GID VA
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVAYG--------------VAMNKL 231
Query: 531 QWAFP------LLNVALKCVSNSPDDRPTMAEVLERIEEV 564
P + C + P RP+ +L+++ +
Sbjct: 232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 53/283 (18%), Positives = 104/283 (36%), Gaps = 59/283 (20%)
Query: 314 CSSLFMVRLKNSAVY-AVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNE 369
V + + +K L + + + F + ++ + L+HPN+L V +
Sbjct: 23 FGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL---YKD 79
Query: 370 EKL-LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPH 428
++L + +Y G+L +++ +PW R+S A IA G+ ++ I H
Sbjct: 80 KRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYL-----HSMNIIH 131
Query: 429 GNLKLSNILLNEN--------------EDPLISECGYSKFLDPKKTCLFSSNG---YTAP 471
+L N L+ EN D G P + ++ G + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 472 E----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG--EVFDKEV 525
E ++ E+ DVFSFG++L E++ ++ F V
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRV---------------NADPDYLPRTMDFGLNV 236
Query: 526 AKAGRQWAFP-----LLNVALKCVSNSPDDRPTMAEVLERIEE 563
++ P + ++C P+ RP+ ++ +E
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 50/285 (17%), Positives = 99/285 (34%), Gaps = 41/285 (14%)
Query: 314 CSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVC----YNSTNE 369
++ + + V AVK + + Q L+H NIL + N T
Sbjct: 55 FGEVWRGKWRGEEV-AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113
Query: 370 EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIP-- 427
+ LV Y +GSL L + + + +A A GL ++ + + P
Sbjct: 114 QLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168
Query: 428 -HGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-------YTAPE------- 472
H +LK NIL+ +N I++ G + D + + Y APE
Sbjct: 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 228
Query: 473 ---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529
++ D+++ G++ E+ ++ D +V + + E K V +
Sbjct: 229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288
Query: 530 RQWAFP-----------LLNVALKCVSNSPDDRPTMAEVLERIEE 563
+ P + + +C + R T + + + +
Sbjct: 289 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 53/285 (18%), Positives = 97/285 (34%), Gaps = 41/285 (14%)
Query: 314 CSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLV--CYNSTNEEK 371
++M + + V AVK + + + Q ++H NIL + T
Sbjct: 50 YGEVWMGKWRGEKV-AVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108
Query: 372 --LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIP-- 427
L+ Y NGSL L+ K L +A GL ++ + + P
Sbjct: 109 QLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163
Query: 428 -HGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-------YTAPE------- 472
H +LK NIL+ +N I++ G + + Y PE
Sbjct: 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223
Query: 473 ---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529
D++SFG+IL E+ + +V + + E + V
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283
Query: 530 RQWAFP-----------LLNVALKCVSNSPDDRPTMAEVLERIEE 563
+ +FP + + +C +++P R T V + + +
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 53/261 (20%), Positives = 103/261 (39%), Gaps = 48/261 (18%)
Query: 329 AVKRLKK--------LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQ 378
A+K L + EF + + + NL HPNI+ L + +N +V ++
Sbjct: 48 AIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFV 103
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
G L L + W ++L + IA G+++M ++ I H +L+ NI L
Sbjct: 104 PCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQNP---PIVHRDLRSPNIFL 157
Query: 439 NENEDPLISEC-----GYSKFLDPKKTCLFSSNGYTAPE------KTVSEQGDVFSFGVI 487
++ G S+ + L + + APE ++ +E+ D +SF +I
Sbjct: 158 QSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 488 LLELLTGKT--VEKTGIDLPKWVKAMVREEWTGEV---FDKEVAKAGRQWAFPLLNVALK 542
L +LTG+ E + + K++ + E + + ++
Sbjct: 218 LYTILTGEGPFDEYSYGKI-KFINMIREEGLRPTIPEDCPPRLRN--------VIE---L 265
Query: 543 CVSNSPDDRPTMAEVLERIEE 563
C S P RP + +++ + E
Sbjct: 266 CWSGDPKKRPHFSYIVKELSE 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 60/255 (23%), Positives = 102/255 (40%), Gaps = 39/255 (15%)
Query: 329 AVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSL 383
AVK L + + F + + +H NIL T + +V ++ SL
Sbjct: 50 AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS---TAPQLAIVTQWCEGSSL 106
Query: 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443
L + F K + IA A+G+D++ K+I H +LK +NI L+E+
Sbjct: 107 YHHLH---ASETKFEMKKLIDIARQTARGMDYL-----HAKSIIHRDLKSNNIFLHEDNT 158
Query: 444 PLISECGYSKFLDPKKTCLFSSNG--------YTAPE-------KTVSEQGDVFSFGVIL 488
I + G + K S + APE S Q DV++FG++L
Sbjct: 159 VKIGDFGLATE---KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215
Query: 489 LELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
EL+TG+ + + I+ + MV K + ++ + +C+
Sbjct: 216 YELMTGQ-LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK----RLMAECLKKKR 270
Query: 549 DDRPTMAEVLERIEE 563
D+RP+ +L IEE
Sbjct: 271 DERPSFPRILAEIEE 285
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 54/285 (18%), Positives = 93/285 (32%), Gaps = 41/285 (14%)
Query: 314 CSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLV--CYNSTNEEK 371
++ + V AVK + L+H NIL + S +
Sbjct: 21 YGEVWRGSWQGENV-AVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79
Query: 372 --LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIP-- 427
L+ Y GSL L+ L I IA GL ++ + + P
Sbjct: 80 QLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI 134
Query: 428 -HGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-------YTAPE------- 472
H +LK NIL+ +N I++ G + L N Y APE
Sbjct: 135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ 194
Query: 473 ---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529
++ D+++FG++L E+ D +V + + E K V
Sbjct: 195 VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ 254
Query: 530 R------QWAF-----PLLNVALKCVSNSPDDRPTMAEVLERIEE 563
+ +W L + +C +P R T + + + +
Sbjct: 255 QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 44/265 (16%), Positives = 98/265 (36%), Gaps = 52/265 (19%)
Query: 329 AVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKL-LVYKYQSNGS 382
A++ + + + + F + + +H N++ C + L ++ +
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC---MSPPHLAIITSLCKGRT 115
Query: 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442
L S++ + K IA I KG+ +++ K I H +LK N+ +
Sbjct: 116 LYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHAKG-----ILHKDLKSKNVFYDNG- 166
Query: 443 DPLISECGYSK-----FLDPKKTCLFSSNG---YTAPE-------------KTVSEQGDV 481
+I++ G ++ L NG + APE S+ DV
Sbjct: 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226
Query: 482 FSFGVILLELLTGKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNV 539
F+ G I EL + + + + ++ + KE++ ++
Sbjct: 227 FALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEIS-----------DI 275
Query: 540 ALKCVSNSPDDRPTMAEVLERIEEV 564
L C + ++RPT ++++ +E++
Sbjct: 276 LLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 27/151 (17%), Positives = 50/151 (33%), Gaps = 30/151 (19%)
Query: 39 KFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNL--HATNIVGIRLENMNLSG--IIDA 94
+ + + L W C+ G+ C+ + + L +NL I +
Sbjct: 13 QIKKDLGNPTTLS-SWLPTTDC-CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS 70
Query: 95 E------------------------TLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130
+ KL L + + + G IP +S + L L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+ S N LSG +P +++ L +L + N
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 24/87 (27%), Positives = 42/87 (48%), Gaps = 2/87 (2%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
T + + + + N+SG I L +++ L + + N + G +P SIS+ L + N
Sbjct: 101 TQLHYLYITHTNVSGAIPDF-LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 136 LLSGAVPLALTKLKHLKT-LDISNNHF 161
+SGA+P + L T + IS N
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRL 186
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 21/85 (24%), Positives = 42/85 (49%), Gaps = 2/85 (2%)
Query: 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNL 136
N+ + L L G + ++ + + LA+N + + + + L L+L +N
Sbjct: 198 NLAFVDLSRNMLEGDA-SVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNR 255
Query: 137 LSGAVPLALTKLKHLKTLDISNNHF 161
+ G +P LT+LK L +L++S N+
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNL 280
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 3/87 (3%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRL-TYLNLSS 134
+V + LSG + + L +L ++ N I G IP S + +L T + +S
Sbjct: 125 KTLVTLDFSYNALSGTLPPS-ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 135 NLLSGAVPLALTKLKHLKTLDISNNHF 161
N L+G +P L L +D+S N
Sbjct: 184 NRLTGKIPPTFANLN-LAFVDLSRNML 209
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 21/84 (25%), Positives = 36/84 (42%), Gaps = 3/84 (3%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
N I L +L+ + + ++L + L N I G +P ++ + L LN+S N
Sbjct: 221 KNTQKIHLAKNSLAFDL--GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 136 LLSGAVPLALTKLKHLKTLDISNN 159
L G +P L+ +NN
Sbjct: 279 NLCGEIP-QGGNLQRFDVSAYANN 301
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-19
Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 1/91 (1%)
Query: 71 CNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130
C + + L+N +G I L L + L+ N + G IP+S+ + +L L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPT-LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447
Query: 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
L N+L G +P L +K L+TL + N
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-17
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 1/87 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
++ + L +G I L + L+ N G +P +C L L LSSN
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 136 LLSGAVPL-ALTKLKHLKTLDISNNHF 161
SG +P+ L K++ LK LD+S N F
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEF 355
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 3/91 (3%)
Query: 71 CNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130
N + +V + L LSG I + L L LR + L N+++G IP + + L L
Sbjct: 415 SNC--SELVSLHLSFNYLSGTIPSS-LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETL 471
Query: 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
L N L+G +P L+ +L + +SNN
Sbjct: 472 ILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-17
Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 1/95 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAE-TLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSS 134
+++ + L + N SG I L+ + L N G+IP ++SNC L L+LS
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 135 NLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
N LSG +P +L L L+ L + N P
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-16
Identities = 25/86 (29%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
N+ + + + N S I L L+ + ++ N + G +IS C L LN+SSN
Sbjct: 200 VNLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHF 161
G +P LK L+ L ++ N F
Sbjct: 258 QFVGPIPPL--PLKSLQYLSLAENKF 281
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-16
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 1/86 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ + + G T + + ++ N++ G IP I + L LNL N
Sbjct: 608 STRNPCNITSRVYGGHTS-PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHF 161
+SG++P + L+ L LD+S+N
Sbjct: 667 DISGSIPDEVGDLRGLNILDLSSNKL 692
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-16
Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 1/75 (1%)
Query: 87 NLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALT 146
L G I + L ++ L + L N + G IP+ +SNC L +++LS+N L+G +P +
Sbjct: 453 MLEGEIP-QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 511
Query: 147 KLKHLKTLDISNNHF 161
+L++L L +SNN F
Sbjct: 512 RLENLAILKLSNNSF 526
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-16
Identities = 28/86 (32%), Positives = 49/86 (56%), Gaps = 1/86 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+++ + + LSG I + + + +L +++L N I G IP + + R L L+LSSN
Sbjct: 632 GSMMFLDMSYNMLSGYI-PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHF 161
L G +P A++ L L +D+SNN+
Sbjct: 691 KLDGRIPQAMSALTMLTEIDLSNNNL 716
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-16
Identities = 36/166 (21%), Positives = 61/166 (36%), Gaps = 34/166 (20%)
Query: 32 SESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGI 91
E F + +N+L W+ N +PC++ G+ C + I L + L+
Sbjct: 12 REIHQLISFKDVLPDKNLLP-DWSSN-KNPCTF--DGVTCRDD--KVTSIDLSSKPLNVG 65
Query: 92 IDA-------------------------ETLCKLRHLRVVSLARNLIQGRIPT--SISNC 124
A L + L+RN + G + T S+ +C
Sbjct: 66 FSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSC 125
Query: 125 RRLTYLNLSSNLLSGAVPL-ALTKLKHLKTLDISNNHFAATSPDNF 169
L +LN+SSN L + KL L+ LD+S N + + +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW 171
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-16
Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 3/91 (3%)
Query: 71 CNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130
+ + + L+ +L+G I L +L +SL+ N + G IP I L L
Sbjct: 463 MYV--KTLETLILDFNDLTGEIP-SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519
Query: 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
LS+N SG +P L + L LD++ N F
Sbjct: 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-15
Identities = 17/91 (18%), Positives = 36/91 (39%), Gaps = 1/91 (1%)
Query: 71 CNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130
N + GI + L +L ++ + G + N + +L
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQ-LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637
Query: 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
++S N+LSG +P + + +L L++ +N
Sbjct: 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 9e-15
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 5/89 (5%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI---SNCRRLTYLNL 132
+ + + + + L KL L V+ L+ N I G C L +L +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185
Query: 133 SSNLLSGAVPLALTKLKHLKTLDISNNHF 161
S N +SG V ++ + +L+ LD+S+N+F
Sbjct: 186 SGNKISGDVDVS--RCVNLEFLDVSSNNF 212
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-14
Identities = 26/118 (22%), Positives = 44/118 (37%), Gaps = 17/118 (14%)
Query: 49 VLRIGWN---GNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAE--TLCKLRHL 103
L + N L ++ + L ++SG L
Sbjct: 130 FLNVSSNTLDFPGKVSGGLKL---------NSLEVLDLSANSISGANVVGWVLSDGCGEL 180
Query: 104 RVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+ ++++ N I G + +S C L +L++SSN S +P L L+ LDIS N
Sbjct: 181 KHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKL 235
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-13
Identities = 29/105 (27%), Positives = 53/105 (50%), Gaps = 5/105 (4%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
TN+ I L N L+G I + + +L +L ++ L+ N G IP + +CR L +L+L++N
Sbjct: 490 TNLNWISLSNNRLTGEI-PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYFDKYV 180
L +G +P A+ K + I+ N A + + + +
Sbjct: 549 LFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHG 589
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 30/147 (20%), Positives = 48/147 (32%), Gaps = 36/147 (24%)
Query: 49 VLRIGWN---GNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRV 105
+ + N G +P I L N+ ++L N + SG I AE L R L
Sbjct: 494 WISLSNNRLTGEIPK-------WI-GRL--ENLAILKLSNNSFSGNIPAE-LGDCRSLIW 542
Query: 106 VSLARNLIQGRIPTSI--------------------SNCRRLTYLNLSSNL--LSGAVPL 143
+ L NL G IP ++ N + + NL G
Sbjct: 543 LDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602
Query: 144 ALTKLKHLKTLDISNNHFAATSPDNFR 170
L +L +I++ + + F
Sbjct: 603 QLNRLSTRNPCNITSRVYGGHTSPTFD 629
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 25/80 (31%), Positives = 42/80 (52%), Gaps = 10/80 (12%)
Query: 83 LENMNLS-----GIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
L +NL G I + + LR L ++ L+ N + GRIP ++S LT ++LS+N L
Sbjct: 658 LFILNLGHNDISGSIP-DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716
Query: 138 SGAVPLALTKLKHLKTLDIS 157
SG +P ++ +T +
Sbjct: 717 SGPIP----EMGQFETFPPA 732
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 41/273 (15%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQ 378
+ A+K LK +S + F Q + + L+H ++ L V + E +V +Y
Sbjct: 287 TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV---SEEPIYIVTEYM 343
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
S GSLL L+ E + + +A IA G+ ++ E H +L+ +NIL+
Sbjct: 344 SKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYV-----ERMNYVHRDLRAANILV 396
Query: 439 NENEDPLISECGYSKFLD-----PKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILL 489
EN +++ G ++ ++ ++ F +TAPE + + DV+SFG++L
Sbjct: 397 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFGILLT 455
Query: 490 ELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA-----FPLLNVALKCV 544
EL T V G+ EV D+ V + R L ++ +C
Sbjct: 456 ELTTKGRVPYPGMVNR-------------EVLDQ-VERGYRMPCPPECPESLHDLMCQCW 501
Query: 545 SNSPDDRPTMAEVLERIEEVVNGNDERDRDHSN 577
P++RPT + +E+ + + + N
Sbjct: 502 RKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 534
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 63/265 (23%), Positives = 114/265 (43%), Gaps = 41/265 (15%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLSL 386
A+K LK +S + F Q + + L+H ++ L V + E +V +Y S GSLL
Sbjct: 212 AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDF 268
Query: 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446
L+ E + + +A IA G+ ++ E H +L+ +NIL+ EN +
Sbjct: 269 LKG--ETGKYLRLPQLVDMAAQIASGMAYV-----ERMNYVHRDLRAANILVGENLVCKV 321
Query: 447 SECGYSKFLD-----PKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTV 497
++ G ++ ++ ++ F +TAPE + + DV+SFG++L EL T V
Sbjct: 322 ADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 498 EKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA-----FPLLNVALKCVSNSPDDRP 552
G+ EV D+ V + R L ++ +C P++RP
Sbjct: 381 PYPGMVNR-------------EVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEERP 426
Query: 553 TMAEVLERIEEVVNGNDERDRDHSN 577
T + +E+ + + + N
Sbjct: 427 TFEYLQAFLEDYFTSTEPQYQPGEN 451
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 49/255 (19%), Positives = 100/255 (39%), Gaps = 47/255 (18%)
Query: 329 AVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
A+K L++ + E + ++ +P++ L +C L+ + G LL
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLL 104
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
+ E K + + L+ IAKG++++ E++ + H +L N+L+ +
Sbjct: 105 DYVR---EHKDNIGSQYLLNWCVQIAKGMNYL-----EDRRLVHRDLAARNVLVKTPQHV 156
Query: 445 LISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLT-G 494
I++ G +K L ++ + G + A E + + Q DV+S+GV + EL+T G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 495 KT--VEKTGIDLPKWVKAMVR----EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
++ ++ R T +V+ + KC
Sbjct: 217 SKPYDGIPASEISSILEKGERLPQPPICTIDVY----------------MIMRKCWMIDA 260
Query: 549 DDRPTMAEVLERIEE 563
D RP E++ +
Sbjct: 261 DSRPKFRELIIEFSK 275
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 56/305 (18%), Positives = 118/305 (38%), Gaps = 55/305 (18%)
Query: 329 AVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
A+K L++ + E + ++ +P++ L +C L+ + G LL
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLL 104
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
+ E K + + L+ IAKG++++ E++ + H +L N+L+ +
Sbjct: 105 DYVR---EHKDNIGSQYLLNWCVQIAKGMNYL-----EDRRLVHRDLAARNVLVKTPQHV 156
Query: 445 LISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLT-G 494
I++ G +K L ++ + G + A E + + Q DV+S+GV + EL+T G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 495 KT--VEKTGIDLPKWVKAMVR----EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
++ ++ R T +V+ + +KC
Sbjct: 217 SKPYDGIPASEISSILEKGERLPQPPICTIDVY----------------MIMVKCWMIDA 260
Query: 549 DDRPTMAEVLERIEE--------VVNGNDERDRDHSNSSFSSMESIPHDSCLLHTVIQEN 600
D RP E++ + +V DER S + + ++ + + V +
Sbjct: 261 DSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADE 320
Query: 601 WDTPR 605
+ P+
Sbjct: 321 YLIPQ 325
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 50/257 (19%), Positives = 105/257 (40%), Gaps = 32/257 (12%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCY-----NSTNEEKL 372
R + + K L ++ E + ++ LKHPNI V Y + TN
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI---VRYYDRIIDRTNTTLY 83
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
+V +Y G L S++ + ++ + L + T + L +++S+ T+ H +LK
Sbjct: 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSFG 485
+N+ L+ ++ + + G ++ L+ + + G Y +PE + +E+ D++S G
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203
Query: 486 VILLELLTGKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKC 543
+L EL + +L ++ + E L + +
Sbjct: 204 CLLYELCALMPPFTAFSQKELAGKIREGKFRRI-PYRYSDE-----------LNEIITRM 251
Query: 544 VSNSPDDRPTMAEVLER 560
++ RP++ E+LE
Sbjct: 252 LNLKDYHRPSVEEILEN 268
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 55/273 (20%), Positives = 95/273 (34%), Gaps = 50/273 (18%)
Query: 329 AVKRLKKLQVSM-DEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLS 385
+K L K + + F + + L H +++ VC +E +LV ++ GSL +
Sbjct: 44 LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC--VCGDENILVQEFVKFGSLDT 101
Query: 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
L+ + K +L +A +A + F+ EE T+ HGN+ NILL ED
Sbjct: 102 YLK---KNKNCINILWKLEVAKQLAAAMHFL-----EENTLIHGNVCAKNILLIREEDRK 153
Query: 446 ISECGYSKFLDPKKTCLFSSNGY-------TAPE-----KTVSEQGDVFSFGVILLELLT 493
+ K DP + PE K ++ D +SFG L E+ +
Sbjct: 154 TGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
Query: 494 -GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGR----QWAFPLLNVALKCVSNS 547
G P + + A L N+ C+
Sbjct: 214 GGDK--------PLS-------ALDSQRKLQF-YEDRHQLPAPKAA-ELANLINNCMDYE 256
Query: 548 PDDRPTMAEVLERIEEVVNGNDERDRDHSNSSF 580
PD RP+ ++ + + + S+
Sbjct: 257 PDHRPSFRAIIRDLNSLF--TPDLVPRGSHHHH 287
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 63/291 (21%), Positives = 108/291 (37%), Gaps = 48/291 (16%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
+K ++ + M IG+L H +I+ L +C LV +Y GSLL
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC---PGSSLQLVTQYLPLGSLL 102
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
+ + + +L L+ IAKG+ ++ EE + H NL N+LL
Sbjct: 103 DHVR---QHRGALGPQLLLNWGVQIAKGMYYL-----EEHGMVHRNLAARNVLLKSPSQV 154
Query: 445 LISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLT-G 494
+++ G + L P L S + A E + Q DV+S+GV + EL+T G
Sbjct: 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214
Query: 495 KT--VEKTGIDLPKWVKAMVR----EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
++P ++ R + T +V+ V +KC
Sbjct: 215 AEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY----------------MVMVKCWMIDE 258
Query: 549 DDRPTMAEVLERIEEVVNGNDERDRDHSNSSFSSMESIPHDSCLLHTVIQE 599
+ RPT E+ + + R S + P L + ++E
Sbjct: 259 NIRPTFKELANEFTRMAR-DPPRYLVIKRESGPGIAPGPEPHGLTNKKLEE 308
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 18/95 (18%), Positives = 40/95 (42%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+++ +++ + + +LR+L + L++ ++ PT+ ++ L LN+S N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L L+ LD S NH + +
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 22/112 (19%), Positives = 43/112 (38%), Gaps = 3/112 (2%)
Query: 63 SYN-LKGIKCN-LHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTS 120
S+N + + N L + + ++ NL + + LR+L + ++ +
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 121 ISNCRRLTYLNLSSNLLSGAV-PLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
+ L L ++ N P T+L++L LD+S SP F
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 20/122 (16%), Positives = 37/122 (30%), Gaps = 12/122 (9%)
Query: 61 PCSYNLKGIKCNLHA-----------TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLA 109
PC + I + + L L + + L+V+ L+
Sbjct: 2 PCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGS-YSFFSFPELQVLDLS 60
Query: 110 RNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
R IQ + + L+ L L+ N + A + L L+ L + A+
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 170 RQ 171
Sbjct: 121 GH 122
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 20/94 (21%), Positives = 33/94 (35%), Gaps = 1/94 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ + L + I D L HL + L N IQ + S L L
Sbjct: 52 PELQVLDLSRCEIQTIED-GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
L+ + LK LK L++++N + +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 24/102 (23%), Positives = 45/102 (44%), Gaps = 4/102 (3%)
Query: 71 CNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRI-PTSISNCRRLTY 129
+L N++ + + + + + L L V+ +A N Q P + R LT+
Sbjct: 418 LSL--RNLIYLDISHTHTRVAFN-GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 130 LNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
L+LS L P A L L+ L++S+N+F + ++
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQG-RIPTSISNCRRLTYLNLSS 134
+++ + NL+ + + + L+ L+ +++A NLIQ ++P SN L +L+LSS
Sbjct: 100 SSLQKLVAVETNLASLEN-FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 135 NLLSGAVPLALTKLKHLK----TLDISNNHFAATSPDNFRQ 171
N + L L + +LD+S N P F++
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 16/87 (18%), Positives = 30/87 (34%), Gaps = 2/87 (2%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
N+ + L L + L L+V++++ N L L+ S N
Sbjct: 470 RNLTFLDLSQCQLEQLS-PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
Query: 136 LLSGAVPLALTKL-KHLKTLDISNNHF 161
+ + L L L+++ N F
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 18/87 (20%), Positives = 33/87 (37%), Gaps = 5/87 (5%)
Query: 87 NLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTY----LNLSSNLLSGAVP 142
+ E L +L + L+ N IQ T + ++ L+LS N ++ P
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
Query: 143 LALTKLKHLKTLDISNNHFAATSPDNF 169
A +++ L L + NN +
Sbjct: 195 GAFKEIR-LHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 19/87 (21%), Positives = 34/87 (39%), Gaps = 3/87 (3%)
Query: 85 NMNLSGIIDAETLCKLRHLRVVSLARNLIQ--GRIPTSISNCRRLTYLNLSSNLLSGAVP 142
+ +A + L L + L+RN + G S L YL+LS N + +
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MS 389
Query: 143 LALTKLKHLKTLDISNNHFAATSPDNF 169
L+ L+ LD +++ S +
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSV 416
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 16/121 (13%), Positives = 31/121 (25%), Gaps = 9/121 (7%)
Query: 54 WNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARN-- 111
+ N+ C L L +V N D L L +L +
Sbjct: 212 DSLNVMKTCIQGL----AGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 112 -LIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
I + ++ +L S + + + L++ N F +
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLK 325
Query: 171 Q 171
Sbjct: 326 S 326
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 22/141 (15%), Positives = 49/141 (34%), Gaps = 19/141 (13%)
Query: 46 SQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGI---------RLENMNLSG----II 92
+ N + + ++ NL + +L + + L+ +N+S +
Sbjct: 453 AGNSFQENFLPDIFTELR-NLTFL--DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509
Query: 93 DAETLCKLRHLRVVSLARNLIQGRIPTSISNCRR-LTYLNLSSNLLSGAVPLA--LTKLK 149
D L L+V+ + N I + + L +LNL+ N + L +K
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 569
Query: 150 HLKTLDISNNHFAATSPDNFR 170
+ L + +P + +
Sbjct: 570 DQRQLLVEVERMECATPSDKQ 590
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 20/110 (18%), Positives = 30/110 (27%), Gaps = 6/110 (5%)
Query: 51 RIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLAR 110
GNL L+ L I RL ++ + L ++ SL
Sbjct: 236 EFRNEGNLEKFDKSALE----GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 111 NLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
I+ S +L L + L L LK L +
Sbjct: 292 VTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 15/126 (11%), Positives = 35/126 (27%), Gaps = 11/126 (8%)
Query: 63 SYN-LKGIKCN-LHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRI--- 117
S N + I+ + + L N S + + L L V L +
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 118 PTSISNCRRLTYLNLSSNLLS------GAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
S L L + L+ + L ++ + + + ++
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 172 EIKYFD 177
++ +
Sbjct: 305 GWQHLE 310
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 56/264 (21%), Positives = 115/264 (43%), Gaps = 45/264 (17%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVY 375
+M AVK +K +S++ F + L+H ++ L V T E ++
Sbjct: 205 WMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV---TKEPIYIIT 261
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
++ + GSLL L++ + P + + IA+G+ F+ E++ H +L+ +N
Sbjct: 262 EFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFI-----EQRNYIHRDLRAAN 314
Query: 436 ILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGV 486
IL++ + I++ G ++ ++ +TAPE + + + DV+SFG+
Sbjct: 315 ILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 373
Query: 487 ILLELLT-GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWA-----FPLLNV 539
+L+E++T G+ P + EV + + R L N+
Sbjct: 374 LLMEIVTYGRI--------PYP-------GMSNPEVIRA-LERGYRMPRPENCPEELYNI 417
Query: 540 ALKCVSNSPDDRPTMAEVLERIEE 563
++C N P++RPT + +++
Sbjct: 418 MMRCWKNRPEERPTFEYIQSVLDD 441
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 57/257 (22%), Positives = 108/257 (42%), Gaps = 33/257 (12%)
Query: 329 AVKRLKKLQVS-MDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLS 385
AVK+L+ + +F + + + +L+H NI+ VCY++ L+ +Y GSL
Sbjct: 43 AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 102
Query: 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
L+ + K L + I KG++++ K H +L NIL+
Sbjct: 103 YLQ---KHKERIDHIKLLQYTSQICKGMEYL-----GTKRYIHRDLATRNILVENENRVK 154
Query: 446 ISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLTGK 495
I + G +K L K + APE S DV+SFGV+L EL T
Sbjct: 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214
Query: 496 TVEKTGIDLPKWVKAMVREEWTG----EVFDKEVAKAGR-----QWAFPLLNVALKCVSN 546
EK+ ++++ + ++ + + + GR + + +C +N
Sbjct: 215 --EKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-LKNNGRLPRPDGCPDEIYMIMTECWNN 271
Query: 547 SPDDRPTMAEVLERIEE 563
+ + RP+ ++ R+++
Sbjct: 272 NVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 58/258 (22%), Positives = 110/258 (42%), Gaps = 35/258 (13%)
Query: 329 AVKRLKK-LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLS 385
AVK+L+ + + +F + + + +L+H NI+ VCY++ L+ +Y GSL
Sbjct: 74 AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133
Query: 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
L+ + K L + I KG++++ K H +L NIL+
Sbjct: 134 YLQ---KHKERIDHIKLLQYTSQICKGMEYL-----GTKRYIHRDLATRNILVENENRVK 185
Query: 446 ISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLTGK 495
I + G +K L K + APE S DV+SFGV+L EL T
Sbjct: 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245
Query: 496 TVEKTGIDLPKWVKAMVREEWTG----EVFDKEVAKAGRQWAFP------LLNVALKCVS 545
EK+ ++++ + ++ + E+ K + P + + +C +
Sbjct: 246 --EKSKSPPAEFMRMIGNDKQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWN 301
Query: 546 NSPDDRPTMAEVLERIEE 563
N+ + RP+ ++ R+++
Sbjct: 302 NNVNQRPSFRDLALRVDQ 319
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 52/278 (18%), Positives = 102/278 (36%), Gaps = 29/278 (10%)
Query: 329 AVKRLKK-LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLS 385
AVK+L+ +F + ++ + L I+ V Y + LV +Y +G L
Sbjct: 56 AVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD 115
Query: 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
L+ + L ++ I KG++++ + H +L NIL+
Sbjct: 116 FLQ---RHRARLDASRLLLYSSQICKGMEYL-----GSRRCVHRDLAARNILVESEAHVK 167
Query: 446 ISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT-G 494
I++ G +K L K + APE S Q DV+SFGV+L EL T
Sbjct: 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC 227
Query: 495 KTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR-----QWAFPLLNVALKCVSNSPD 549
+ + + + + + + R + + C + SP
Sbjct: 228 DKSCSPSAEFLRMMGCERDVPALSRLLEL-LEEGQRLPAPPACPAEVHELMKLCWAPSPQ 286
Query: 550 DRPTMAEVLERIEEVVNGNDERDRDHSNSSFSSMESIP 587
DRP+ + + +++ + + H+ ++ +
Sbjct: 287 DRPSFSALGPQLDMLWS-GSRGCETHAFTAHPEGKHHS 323
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 41/269 (15%), Positives = 90/269 (33%), Gaps = 41/269 (15%)
Query: 322 LKNSAVYAVKRLKKLQVSMDE-FSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380
KN + +K K +Q M ++ + + +LV + S
Sbjct: 92 AKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151
Query: 381 GSLLSLLEAY-IEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
G+LL+ + Y ++ P L +S A + ++ ++ I HG++K N +L
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE-----IIHGDIKPDNFILG 206
Query: 440 ENEDPLISEC-----------GYSKFLD--PKKTCLFSSNG---YTAPE----KTVSEQG 479
E G S + PK T + + E K + Q
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266
Query: 480 DVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNV 539
D F + +L G ++ + + R +++++ +LN+
Sbjct: 267 DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHV--------MLNI 318
Query: 540 ALKCVSNSPDDRPTMAEVLERIEEVVNGN 568
P++ + +++++V +
Sbjct: 319 ------PDCHHLPSLDLLRQKLKKVFQQH 341
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 61/250 (24%), Positives = 110/250 (44%), Gaps = 38/250 (15%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLSL 386
AVK LK+ + ++EF + + +KHPN++ L VC + ++ ++ + G+LL
Sbjct: 249 AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDY 306
Query: 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446
L +++ + L +AT I+ ++++ E+K H NL N L+ EN +
Sbjct: 307 LRE--CNRQEVSAVVLLYMATQISSAMEYL-----EKKNFIHRNLAARNCLVGENHLVKV 359
Query: 447 SECGYSKFLD----PKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVE 498
++ G S+ + +TAPE S + DV++FGV+L E+ T
Sbjct: 360 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
Query: 499 KTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA-----FPLLNVALKCVSNSPDDRPT 553
GIDL +V++ + K R + + C +P DRP+
Sbjct: 420 YPGIDLS-------------QVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 465
Query: 554 MAEVLERIEE 563
AE+ + E
Sbjct: 466 FAEIHQAFET 475
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 56/278 (20%), Positives = 100/278 (35%), Gaps = 57/278 (20%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCY----NSTNEEKLL 373
L + YA+KR+ + + R+ HPNIL LV Y E L
Sbjct: 50 GLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107
Query: 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKL 433
+ + G+L + +E + L + GI +GL+ ++ K H +LK
Sbjct: 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-----YAHRDLKP 162
Query: 434 SNILLNENEDPLI----SECGYSKFLDPKKTCLF-----SSNG---YTAPE-------KT 474
+NILL + P++ S ++ + L + Y APE
Sbjct: 163 TNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222
Query: 475 VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534
+ E+ DV+S G +L ++ G+ P + + D Q +
Sbjct: 223 IDERTDVWSLGCVLYAMMFGEG--------PY--------DMVFQKGDSVALAVQNQLSI 266
Query: 535 P--------LLNVALKCVSNSPDDRPTMAEVLERIEEV 564
P L + ++ P RP + +L ++E +
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 50/256 (19%), Positives = 89/256 (34%), Gaps = 33/256 (12%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
AVK LK + Q + + L H +I+ C ++ LV +Y GSL
Sbjct: 64 AVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
L + L A I +G+ ++ + H +L N+LL+ +
Sbjct: 124 DYLP-----RHSIGLAQLLLFAQQICEGMAYL-----HAQHYIHRDLAARNVLLDNDRLV 173
Query: 445 LISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT- 493
I + G +K + + APE DV+SFGV L ELLT
Sbjct: 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233
Query: 494 GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVALKCVSNS 547
+ + + + + + E+ + G + P + ++ C
Sbjct: 234 CDSSQSPPTKFLELIGIAQGQMTVLRLT--ELLERGERLPRPDKCPAEVYHLMKNCWETE 291
Query: 548 PDDRPTMAEVLERIEE 563
RPT ++ ++
Sbjct: 292 ASFRPTFENLIPILKT 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 57/258 (22%), Positives = 98/258 (37%), Gaps = 31/258 (12%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
AVK LK + + + + NL H NI+ +C L+ ++ +GSL
Sbjct: 54 AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
L K K +L A I KG+D++ + H +L N+L+
Sbjct: 114 EYLPKN---KNKINLKQQLKYAVQICKGMDYL-----GSRQYVHRDLAARNVLVESEHQV 165
Query: 445 LISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLTG 494
I + G +K ++ K + + APE DV+SFGV L ELLT
Sbjct: 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225
Query: 495 KTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWAFP------LLNVALKCVSNS 547
+ + + L + + T + K G++ P + + KC
Sbjct: 226 CDSDSSPMALFLKMIGPTHGQMTVTRLV--NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQ 283
Query: 548 PDDRPTMAEVLERIEEVV 565
P +R + ++E E ++
Sbjct: 284 PSNRTSFQNLIEGFEALL 301
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-15
Identities = 19/98 (19%), Positives = 36/98 (36%), Gaps = 2/98 (2%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
++ + L + + + L ++ + L+ N S + L L L
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 136 LLSG--AVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
L + P L++L LD+SNN+ A + D
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 25/96 (26%), Positives = 44/96 (45%), Gaps = 1/96 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ + + + +S + E KL L+V++L N + + + C LT L+L SN
Sbjct: 49 SQLTSLDVGFNTISKLEP-ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN 107
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
+ K K+L TLD+S+N ++T Q
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 25/110 (22%), Positives = 38/110 (34%), Gaps = 3/110 (2%)
Query: 62 CSYN-LKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTS 120
CS+ L + +L TNI + L + L + A + L + + N I P
Sbjct: 11 CSHLKLTQVPDDL-PTNITVLNLTHNQLRRLP-AANFTRYSQLTSLDVGFNTISKLEPEL 68
Query: 121 ISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L LNL N LS +L L + +N + F
Sbjct: 69 CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 24/108 (22%), Positives = 40/108 (37%), Gaps = 10/108 (9%)
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLN 131
L TN+ + L NL+ + + ++ L L L N IQ S+ + YLN
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGN-DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 132 LSSNL---------LSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L + L + LK L+ L++ +N + F
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT 350
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 1/89 (1%)
Query: 81 IRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
+ L++ LS + D +T +L + L N IQ + L L+LS N LS
Sbjct: 78 LNLQHNELSQLSD-KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 141 VPLALTKLKHLKTLDISNNHFAATSPDNF 169
+L++L+ L +SNN A +
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEEL 165
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 24/103 (23%), Positives = 41/103 (39%), Gaps = 3/103 (2%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQG--RIPTSISNCRRLTYLNLS 133
NI I L + + + L+ + L R ++ P+ R LT L+LS
Sbjct: 430 ENIFEIYLSYNKYLQLTR-NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488
Query: 134 SNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYF 176
+N ++ L L+ L+ LD+ +N+ A YF
Sbjct: 489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 8/117 (6%)
Query: 46 SQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRV 105
N L W P Y LKG+ +++ + LE+ I E L L++
Sbjct: 512 QHNNLARLWKHANPGGPIYFLKGL------SHLHILNLESNGFDEIP-VEVFKDLFELKI 564
Query: 106 VSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLAL-TKLKHLKTLDISNNHF 161
+ L N + + +N L LNL NL++ ++L LD+ N F
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 24/114 (21%), Positives = 43/114 (37%), Gaps = 6/114 (5%)
Query: 63 SYN-LKGIKCNL--HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPT 119
+N L + TN+ + L + ++ I + K ++L + L+ N +
Sbjct: 81 QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN-NPFVKQKNLITLDLSHNGLSSTKLG 139
Query: 120 SISNCRRLTYLNLSSNLLSGAVPLALT--KLKHLKTLDISNNHFAATSPDNFRQ 171
+ L L LS+N + L LK L++S+N SP F
Sbjct: 140 TQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHA 193
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 26/117 (22%), Positives = 45/117 (38%), Gaps = 11/117 (9%)
Query: 63 SYN-LKGIK----CNLHATNIVGIRLENMNLSGIIDAE-TLCKLRHLRVVSLARNLIQGR 116
S+N L K L N+ + L N + + E + L+ + L+ N I+
Sbjct: 129 SHNGLSSTKLGTQVQL--ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEF 186
Query: 117 IPTSISNCRRLTYLNLSSNLLSGAVPLALT---KLKHLKTLDISNNHFAATSPDNFR 170
P RL L L++ L ++ L ++ L +SN+ + TS F
Sbjct: 187 SPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 20/108 (18%), Positives = 42/108 (38%), Gaps = 1/108 (0%)
Query: 67 KGIKCNLHATNIVGIRLENMNLSGIIDAE-TLCKLRHLRVVSLARNLIQGRIPTSISNCR 125
+ + L T+I + L N LS + K +L ++ L+ N + S +
Sbjct: 213 EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLP 272
Query: 126 RLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEI 173
+L Y L N + +L L +++ L++ + + +I
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-12
Identities = 22/101 (21%), Positives = 39/101 (38%), Gaps = 3/101 (2%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSIS--NCRRLTYLNLS 133
N++ + L + LS T +L +L+ + L+ N IQ + L L LS
Sbjct: 121 KNLITLDLSHNGLSSTKL-GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 134 SNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIK 174
SN + P + L L ++N + + E+
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELA 220
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 15/76 (19%), Positives = 26/76 (34%)
Query: 95 ETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154
L L HL +++L N + L ++L N L+ LK+L
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSL 589
Query: 155 DISNNHFAATSPDNFR 170
++ N + F
Sbjct: 590 NLQKNLITSVEKKVFG 605
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 24/104 (23%), Positives = 36/104 (34%), Gaps = 9/104 (8%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQ--------GRIPTSISNCRRL 127
N+ + L N N++ I D + L L L ++ L N + G + L
Sbjct: 480 RNLTILDLSNNNIANIND-DMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538
Query: 128 TYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
LNL SN L LK +D+ N+ F
Sbjct: 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 26/118 (22%), Positives = 47/118 (39%), Gaps = 13/118 (11%)
Query: 63 SYN-LKGIKCNL--HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNL------- 112
SYN L + + + LE N+ + +L L ++R ++L R+
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH-SLHGLFNVRYLNLKRSFTKQSISL 314
Query: 113 --IQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDN 168
+ S + L +LN+ N + G T L +LK L +SN+ + + N
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTN 372
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 20/99 (20%), Positives = 41/99 (41%), Gaps = 9/99 (9%)
Query: 82 RLENMNLSG------IIDAETLCKLRH--LRVVSLARNLIQGRIPTSISNCRRLTYLNLS 133
L+ ++LS + ET L H L +++L +N I + S L L+L
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413
Query: 134 SNLLSGAVP-LALTKLKHLKTLDISNNHFAATSPDNFRQ 171
N + + L+++ + +S N + + ++F
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL 452
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 56/262 (21%), Positives = 107/262 (40%), Gaps = 47/262 (17%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQ 378
N A+K +++ +S ++F + + L HP ++ L VC LV ++
Sbjct: 28 YWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAPICLVTEFM 85
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
+G L L + F + L + + +G+ ++ EE + H +L N L+
Sbjct: 86 EHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYL-----EEACVIHRDLAARNCLV 137
Query: 439 NENEDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVIL 488
EN+ +S+ G ++F+ SS G + +PE S + DV+SFGV++
Sbjct: 138 GENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 195
Query: 489 LELLT-GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWA-----FPLLNVAL 541
E+ + GK P + EV + ++ R + + +
Sbjct: 196 WEVFSEGKI--------PYE-------NRSNSEVVED-ISTGFRLYKPRLASTHVYQIMN 239
Query: 542 KCVSNSPDDRPTMAEVLERIEE 563
C P+DRP + +L ++ E
Sbjct: 240 HCWRERPEDRPAFSRLLRQLAE 261
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 61/259 (23%), Positives = 101/259 (38%), Gaps = 51/259 (19%)
Query: 329 AVKRLKK----LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGS 382
AVK LK +MD+F + + + +L H N++ L V +V + GS
Sbjct: 50 AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV---LTPPMKMVTELAPLGS 106
Query: 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442
LL L + + F A +A+G+ ++ E K H +L N+LL +
Sbjct: 107 LLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYL-----ESKRFIHRDLAARNLLLATRD 158
Query: 443 DPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELL 492
I + G + L + APE +T S D + FGV L E+
Sbjct: 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
Query: 493 T-GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWAFP------LLNVALKCV 544
T G+ P G ++ K + K G + P + NV ++C
Sbjct: 219 TYGQE--------PWI-------GLNGSQILHK-IDKEGERLPRPEDCPQDIYNVMVQCW 262
Query: 545 SNSPDDRPTMAEVLERIEE 563
++ P+DRPT + + + E
Sbjct: 263 AHKPEDRPTFVALRDFLLE 281
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 56/262 (21%), Positives = 99/262 (37%), Gaps = 58/262 (22%)
Query: 329 AVKRLKKLQVSMD--EF---SQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNG 381
AVK ++ +F ++ ++Q HPNI+ L VC + + +V + G
Sbjct: 143 AVKSCRETLPPDLKAKFLQEARILKQ---YSHPNIVRLIGVC--TQKQPIYIVMELVQGG 197
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
L+ L K L + A G++++ E K H +L N L+ E
Sbjct: 198 DFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYL-----ESKCCIHRDLAARNCLVTEK 249
Query: 442 EDPLISECGYSKFLDPKKTCLFSSNGY-------TAPE----KTVSEQGDVFSFGVILLE 490
IS+ G S+ +S G TAPE S + DV+SFG++L E
Sbjct: 250 NVLKISDFGMSREEA--DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307
Query: 491 LLT-GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWAFP------LLNVALK 542
+ G + P + + + V K GR P + + +
Sbjct: 308 TFSLGAS--------PYP-------NLSNQQTREF-VEKGGRL-PCPELCPDAVFRLMEQ 350
Query: 543 CVSNSPDDRPTMAEVLERIEEV 564
C + P RP+ + + + ++ +
Sbjct: 351 CWAYEPGQRPSFSTIYQELQSI 372
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 58/265 (21%), Positives = 114/265 (43%), Gaps = 47/265 (17%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQ 378
+ + A+K +K+ +S DEF + + + NL H ++ L VC + ++ +Y
Sbjct: 44 KWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC--TKQRPIFIITEYM 101
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
+NG LL+ L E + F + L + + + ++++ E K H +L N L+
Sbjct: 102 ANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYL-----ESKQFLHRDLAARNCLV 153
Query: 439 NENEDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVIL 488
N+ +S+ G S+++ SS G ++ PE S + D+++FGV++
Sbjct: 154 NDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
Query: 489 LELLT-GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWA-----FPLLNVAL 541
E+ + GK P +T E + +A+ R + + +
Sbjct: 212 WEIYSLGKM--------PYE-------RFTNSETAEH-IAQGLRLYRPHLASEKVYTIMY 255
Query: 542 KCVSNSPDDRPTMAEVLERIEEVVN 566
C D+RPT +L I +V++
Sbjct: 256 SCWHEKADERPTFKILLSNILDVMD 280
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 47/252 (18%), Positives = 104/252 (41%), Gaps = 45/252 (17%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLV-CYNSTNEEKLLVY---KYQSNG 381
A L+ +++ E + + LK HPNI+ + ST + K + + ++G
Sbjct: 55 AWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSG 114
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
+L + L+ + + K+ S I KGL F++ ++ I H +LK NI +
Sbjct: 115 TLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGP 167
Query: 442 EDPL-ISECGYSKFLDPKKTCLFSSNG---YTAPEKTVSEQG-----DVFSFGVILLELL 492
+ I + G + + + + G + APE + E+ DV++FG+ +LE+
Sbjct: 168 TGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPE--MYEEKYDESVDVYAFGMCMLEMA 223
Query: 493 TGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALK-----CVSNS 547
T + + + + +++ + + + +K C+ +
Sbjct: 224 TSE---------YPYSE----CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQN 270
Query: 548 PDDRPTMAEVLE 559
D+R ++ ++L
Sbjct: 271 KDERYSIKDLLN 282
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 63/262 (24%), Positives = 109/262 (41%), Gaps = 47/262 (17%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQ 378
+ K AVK +K+ +S DEF Q + + L HP ++ VC S +V +Y
Sbjct: 28 KWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC--SKEYPIYIVTEYI 85
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
SNG LL+ L + L + + +G+ F+ E H +L N L+
Sbjct: 86 SNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFL-----ESHQFIHRDLAARNCLV 137
Query: 439 NENEDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVIL 488
+ + +S+ G ++++ SS G ++APE S + DV++FG+++
Sbjct: 138 DRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195
Query: 489 LELLT-GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWA-----FPLLNVAL 541
E+ + GK P +T EV K V++ R + + +
Sbjct: 196 WEVFSLGKM--------PYD-------LYTNSEVVLK-VSQGHRLYRPHLASDTIYQIMY 239
Query: 542 KCVSNSPDDRPTMAEVLERIEE 563
C P+ RPT ++L IE
Sbjct: 240 SCWHELPEKRPTFQQLLSSIEP 261
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 30/190 (15%)
Query: 322 LKNSAVYAVKRLKKLQV-SMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLLVYKY 377
++ + A+K L K Q+ Q R++ +L+HPNIL L Y L+ +Y
Sbjct: 31 KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
G++ L+ K F + + T +A L + + K + H ++K N+L
Sbjct: 91 APLGTVYRELQK--LSK--FDEQRTATYITELANALSYCHSKR-----VIHRDIKPENLL 141
Query: 438 LNENEDPLISECGYSKFLDPKK---TCLFSSNG---YTAPEKTVSEQG-----DVFSFGV 486
L + I++ G+S + C G Y PE + + D++S GV
Sbjct: 142 LGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPPE-MIEGRMHDEKVDLWSLGV 195
Query: 487 ILLELLTGKT 496
+ E L GK
Sbjct: 196 LCYEFLVGKP 205
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 58/259 (22%), Positives = 96/259 (37%), Gaps = 54/259 (20%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
A+K LK+ D E + + + L +P I+ L VC E +LV + G L
Sbjct: 41 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLH 97
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
L + + P + ++ G+ ++ EEK H +L N+LL
Sbjct: 98 KFLV---GKREEIPVSNVAELLHQVSMGMKYL-----EEKNFVHRDLAARNVLLVNRHYA 149
Query: 445 LISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT- 493
IS+ G SK L + + + + APE + S + DV+S+GV + E L+
Sbjct: 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 209
Query: 494 GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWAFP--------LLNVALKCV 544
G+ P + G EV + + R L + C
Sbjct: 210 GQK--------PYK-------KMKGPEVMAF-IEQGKR---MECPPECPPELYALMSDCW 250
Query: 545 SNSPDDRPTMAEVLERIEE 563
+DRP V +R+
Sbjct: 251 IYKWEDRPDFLTVEQRMRA 269
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 47/276 (17%), Positives = 107/276 (38%), Gaps = 37/276 (13%)
Query: 321 RLKNSAVYAVKRLKKL-QVSMDEFSQTMRQI---GNLKHPNILPLVCY-NSTNEEKLL-- 373
L + A+K+++ + + +++I L HPN+ + Y S E+ L
Sbjct: 53 CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV---IKYYASFIEDNELNI 109
Query: 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKL 433
V + G L +++ + + KR P + + L+ M+ + + H ++K
Sbjct: 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-----VMHRDIKP 164
Query: 434 SNILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSFGV 486
+N+ + + + G +F K T S G Y +PE + + D++S G
Sbjct: 165 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 224
Query: 487 ILLELLTGKTV-EKTGIDLPKWVKAMVREEWT---GEVFDKEVAKAGRQWAFPLLNVALK 542
+L E+ ++ ++L K + + ++ + + +E L +
Sbjct: 225 LLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE-----------LRQLVNM 273
Query: 543 CVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHSNS 578
C++ P+ RP + V + + + H +
Sbjct: 274 CINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 64/265 (24%), Positives = 110/265 (41%), Gaps = 47/265 (17%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVY 375
+M AVK LK+ +S D F + L+H ++ L V T E ++
Sbjct: 30 WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV---TQEPIYIIT 86
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
+Y NGSL+ L+ L +A IA+G+ F+ EE+ H +L+ +N
Sbjct: 87 EYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFI-----EERNYIHRDLRAAN 139
Query: 436 ILLNENEDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFG 485
IL+++ I++ G ++ + + + G +TAPE T + + DV+SFG
Sbjct: 140 ILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197
Query: 486 VILLELLT-GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGR-----QWAFPLLN 538
++L E++T G+ P T EV + + R L
Sbjct: 198 ILLTEIVTHGRI--------PYP-------GMTNPEVIQN-LERGYRMVRPDNCPEELYQ 241
Query: 539 VALKCVSNSPDDRPTMAEVLERIEE 563
+ C P+DRPT + +E+
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLED 266
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 40/270 (14%), Positives = 93/270 (34%), Gaps = 51/270 (18%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL----KHPNILPLVCYNSTNEEKLLVY 375
V+ + +YA+KR KK + +R++ +H ++ V Y S E +
Sbjct: 31 VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV---VRYFSAWAEDDHML 87
Query: 376 ---KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
+Y + GSL + F + + +GL +++ S + H ++K
Sbjct: 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-----LVHMDIK 142
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCLF----------SSNGYT--------APE-- 472
SNI ++ P + + +F S+ A E
Sbjct: 143 PSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVL 202
Query: 473 ---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529
T + D+F+ + ++ + + + G ++W E+ + +
Sbjct: 203 QENYTHLPKADIFALALTVVCAAGAEPLPRNG------------DQWH-EIRQGRLPRIP 249
Query: 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559
+ + + + P+ RP+ +++
Sbjct: 250 QVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 18/93 (19%), Positives = 36/93 (38%), Gaps = 4/93 (4%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS 138
L ++L+ I +T L + L N + T++S + L +L +S
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 139 GAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
+ L K L++L + +NH ++
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 17/98 (17%), Positives = 31/98 (31%), Gaps = 2/98 (2%)
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLN 131
L ++ I L+ I + T L+ + L + +P+ + L L
Sbjct: 250 GLCEMSVESINLQKHYFFNIS-SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLV 307
Query: 132 LSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
LS+N ++ + L L I N
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-13
Identities = 24/123 (19%), Positives = 36/123 (29%), Gaps = 10/123 (8%)
Query: 59 PHPCSYNLKGIKCNLHATNIVGI------RLENMNLSG----IIDAETLCKLRHLRVVSL 108
C N + I E + S I T +L +L + L
Sbjct: 5 DQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDL 64
Query: 109 ARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDN 168
R I + + RL L L++N L AL+ K LK L ++
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124
Query: 169 FRQ 171
Sbjct: 125 LHN 127
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 4/93 (4%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
RL+ + L+ + L + L+ + + I + N + L L L SN +
Sbjct: 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141
Query: 138 SGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
S + LK LD NN S ++
Sbjct: 142 SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMS 174
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 22/99 (22%), Positives = 38/99 (38%), Gaps = 4/99 (4%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRI---PTSISNCRRLTYLNL 132
+ + L + L + + L L+ ++L N S+ RL L L
Sbjct: 425 HLLKVLNLSHSLLDISSE-QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 133 SSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
S LS A T LK + +D+S+N ++S +
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 19/100 (19%), Positives = 35/100 (35%), Gaps = 2/100 (2%)
Query: 72 NLHATNIVGIRLENMNLSGII-DAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130
N ++ E+M+ I + ++L ++ + L L
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL 283
Query: 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
+L++ LS +P L L LK L +S N F +
Sbjct: 284 DLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 18/98 (18%), Positives = 32/98 (32%), Gaps = 3/98 (3%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ + L L L L+V++L+ +L+ L +LNL N
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN 459
Query: 136 LLSGAVPL---ALTKLKHLKTLDISNNHFAATSPDNFR 170
+L L L+ L +S ++ F
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT 497
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 17/96 (17%), Positives = 34/96 (35%), Gaps = 2/96 (2%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQ--GRIPTSISNCRRLTYLNLS 133
++ + ++ + L L +LR + L+ + I+ + N L LNLS
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 134 SNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
N A + L+ LD++ +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 16/97 (16%), Positives = 32/97 (32%), Gaps = 3/97 (3%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ + +S I L + L + L N I +L L+ +N
Sbjct: 105 KALKHLFFIQTGISSIDF-IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 136 LLSGAVPLALTKLKHLK--TLDISNNHFAATSPDNFR 170
+ ++ L+ +L+++ N A P F
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD 200
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 21/95 (22%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 83 LENMNLSG-------IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
L+++NL G I +L L L ++ L+ + + ++ + + +++LS N
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L+ + AL+ LK + L++++NH + P
Sbjct: 511 RLTSSSIEALSHLKGI-YLNLASNHISIILPSLLP 544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 27/130 (20%), Positives = 54/130 (41%), Gaps = 16/130 (12%)
Query: 57 NLPHPCSYNLKGIKC-NLHATNIVGI--------RLENMNLSG----IIDAETLCKLRHL 103
N+ + G++ +L AT++ + L+ + LS + + L
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327
Query: 104 RVVSLARNLIQGRIPT-SISNCRRLTYLNLSSNLL--SGAVPLALTKLKHLKTLDISNNH 160
+S+ N + + T + N L L+LS + + S L L L HL++L++S N
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 161 FAATSPDNFR 170
+ + F+
Sbjct: 388 PLSLKTEAFK 397
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
RLE + LS ID L+ + V L+ N + ++S+ + + YLNL+SN +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535
Query: 138 SGAVPLALTKLKHLKTLDISNNHF 161
S +P L L +T+++ N
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 12/103 (11%), Positives = 32/103 (31%), Gaps = 6/103 (5%)
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNC--RRLTY 129
+L + + L +++GI + ++ I + N + L
Sbjct: 175 SLQQATNLSLNLNGNDIAGIEP--GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWL 232
Query: 130 LNLSSNLLSGAVPLALTKLK--HLKTLDISNNHFAATSPDNFR 170
P L ++++++ ++F S + F
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFH 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 59/283 (20%), Positives = 114/283 (40%), Gaps = 48/283 (16%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
A+K LK +F +G H NI+ L V S + +++ +Y NG+L
Sbjct: 77 AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI--SKYKPMMIITEYMENGALD 134
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
L E +F + + GIA G+ ++ H +L NIL+N N
Sbjct: 135 KFLR---EKDGEFSVLQLVGMLRGIAAGMKYL-----ANMNYVHRDLAARNILVNSNLVC 186
Query: 445 LISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT- 493
+S+ G S+ L+ ++++G +TAPE + + DV+SFG+++ E++T
Sbjct: 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 246
Query: 494 GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWA-----FPLLNVALKCVSNS 547
G+ P W E + EV + R + + ++C
Sbjct: 247 GER--------PYW-------ELSNHEVMKA-INDGFRLPTPMDCPSAIYQLMMQCWQQE 290
Query: 548 PDDRPTMAEVLERIEEVVNGNDERDRDHSNSSFSSMESIPHDS 590
RP A+++ +++++ + + ++ +P S
Sbjct: 291 RARRPKFADIVSILDKLIR-APDSLKTLADFDPRVSIRLPSTS 332
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 57/260 (21%), Positives = 93/260 (35%), Gaps = 56/260 (21%)
Query: 329 AVKRLKK---LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSL 383
AVK LK DE + L +P I+ + +C E +LV + G L
Sbjct: 48 AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPL 104
Query: 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443
Y++ R K + + ++ G+ ++ EE H +L N+LL
Sbjct: 105 NK----YLQQNRHVKDKNIIELVHQVSMGMKYL-----EESNFVHRDLAARNVLLVTQHY 155
Query: 444 PLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT 493
IS+ G SK L + + + APE S + DV+SFGV++ E +
Sbjct: 156 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
Query: 494 -GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWAFP--------LLNVALKC 543
G+ P G EV + K R + ++ C
Sbjct: 216 YGQK--------PYR-------GMKGSEVTAM-LEKGER---MGCPAGCPREMYDLMNLC 256
Query: 544 VSNSPDDRPTMAEVLERIEE 563
+ ++RP A V R+
Sbjct: 257 WTYDVENRPGFAAVELRLRN 276
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 56/262 (21%), Positives = 103/262 (39%), Gaps = 51/262 (19%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKL-LVYKY 377
+ + V AVK +K + F + L+H N++ L V + L +V +Y
Sbjct: 213 DYRGNKV-AVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLYIVTEY 268
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+ GSL+ L + G+ L + + + ++++ E H +L N+L
Sbjct: 269 MAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL-----EGNNFVHRDLAARNVL 321
Query: 438 LNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVIL 488
++E+ +S+ G +K G +TAPE K S + DV+SFG++L
Sbjct: 322 VSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 376
Query: 489 LELLT-GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWA-----FPLLNVAL 541
E+ + G+ P +V + V K + A + +V
Sbjct: 377 WEIYSFGRV--------PYP-------RIPLKDVVPR-VEKGYKMDAPDGCPPAVYDVMK 420
Query: 542 KCVSNSPDDRPTMAEVLERIEE 563
C RPT ++ E++E
Sbjct: 421 NCWHLDAATRPTFLQLREQLEH 442
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 21/121 (17%), Positives = 37/121 (30%), Gaps = 11/121 (9%)
Query: 49 VLRIGWN--GNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVV 106
+ + N ++P G N + I L L+ + D L +L +
Sbjct: 701 TIILSNNLMTSIPENSLKPKDGNYKNT--YLLTTIDLRFNKLTSLSDDFRATTLPYLSNM 758
Query: 107 SLARNLIQGRIPTSISNCRRLTYLNLSSNL------LSGAVPLALTKLKHLKTLDISNNH 160
++ N PT N +L + + P +T L L I +N
Sbjct: 759 DVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 161 F 161
Sbjct: 818 I 818
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 17/104 (16%), Positives = 34/104 (32%), Gaps = 13/104 (12%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQG---------RIPTSISNCRR 126
++ + L N + + L L L+ +++A N R+ +
Sbjct: 491 KDLTDVELYNCPNMTQLP-DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 127 LTYLNLSSNLLSG-AVPLALTKLKHLKTLDISNNHFAATSPDNF 169
+ + N L +L K+ L LD +N + F
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAF 591
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 11/99 (11%)
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQ-------GRIPTSISNC 124
+ N + L + E + + L+ NL+ + N
Sbjct: 669 DYKGINASTVTLSYNEIQKFP-TELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNT 727
Query: 125 RRLTYLNLSSNLLSGAVP--LALTKLKHLKTLDISNNHF 161
LT ++L N L+ + T L +L +D+S N F
Sbjct: 728 YLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCF 765
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 18/125 (14%), Positives = 41/125 (32%), Gaps = 10/125 (8%)
Query: 63 SYN-LKGIKCNL--HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPT 119
YN ++ I + + G+ + L I + + + V + N I
Sbjct: 603 DYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS-EGR 661
Query: 120 SIS------NCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEI 173
+IS + + LS N + + T+ +SNN + ++ + +
Sbjct: 662 NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKD 721
Query: 174 KYFDK 178
+
Sbjct: 722 GNYKN 726
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 17/86 (19%), Positives = 28/86 (32%), Gaps = 6/86 (6%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
T + I N + A + S SN + LT + L +
Sbjct: 448 TKLQIIYFANSPFTYDNIAV------DWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHF 161
+P L L L++L+I+ N
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRG 527
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 20/110 (18%), Positives = 34/110 (30%), Gaps = 13/110 (11%)
Query: 71 CNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNL------IQGRIPTSISNC 124
L + + + S L+ + I + PT I+ C
Sbjct: 750 TTL--PYLSNMDVSYNCFSSF--PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTC 805
Query: 125 RRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIK 174
L L + SN + V L L LDI++N + + I+
Sbjct: 806 PSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIE 852
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 16/86 (18%), Positives = 29/86 (33%), Gaps = 2/86 (2%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
I + NL + +L K+ L ++ N + R + +LT L L N
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYN 605
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHF 161
+ ++ L S+N
Sbjct: 606 QIEEIPEDFCAFTDQVEGLGFSHNKL 631
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 10/88 (11%), Positives = 25/88 (28%), Gaps = 10/88 (11%)
Query: 83 LENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG--- 139
+ + + L+ L V L ++P + + L LN++ N
Sbjct: 474 SDYAKQYENEE-LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 140 ------AVPLALTKLKHLKTLDISNNHF 161
+ ++ + N+
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNL 560
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 14/63 (22%), Positives = 27/63 (42%)
Query: 111 NLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
++ + + N R+T L+L+ G VP A+ +L LK L + +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 171 QEI 173
+E+
Sbjct: 369 EEL 371
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 15/134 (11%), Positives = 39/134 (29%), Gaps = 21/134 (15%)
Query: 55 NGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQ 114
+ L+ ++++ + I ++ L+ ++ N I
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQI-GNLTNRIT 438
Query: 115 GRIPTSISNCRRLTYLNLSSNLLSG-------------------AVPLALTKLKHLKTLD 155
I +I +L + +++ + L+ + LK L ++
Sbjct: 439 F-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497
Query: 156 ISNNHFAATSPDNF 169
+ N PD
Sbjct: 498 LYNCPNMTQLPDFL 511
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 13/85 (15%), Positives = 29/85 (34%)
Query: 85 NMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLA 144
+++ G L + +SLA +GR+P +I L L+ ++ + + L
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 145 LTKLKHLKTLDISNNHFAATSPDNF 169
+ + + F
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMF 391
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 20/188 (10%), Positives = 53/188 (28%), Gaps = 55/188 (29%)
Query: 39 KFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLC 98
++ S + + + WN N + G+ + + + G+ L G + +
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD-NNGRVTGLSLAGFGAKGRVPDA-IG 344
Query: 99 KLRHLRVVSLARNLIQG-------------------------RIPTSISNCRRLTYLNLS 133
+L L+V+S + + +RL +L
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404
Query: 134 SNLLSG----------------------------AVPLALTKLKHLKTLDISNNHFAATS 165
+ ++ + A+ +L L+ + +N+ F +
Sbjct: 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDN 464
Query: 166 PDNFRQEI 173
++
Sbjct: 465 IAVDWEDA 472
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 10/80 (12%), Positives = 26/80 (32%), Gaps = 6/80 (7%)
Query: 83 LENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN-LLSGAV 141
E + + L + + N I+ + ++ +L L+++ N +S V
Sbjct: 789 AEGNRILRQW-PTGITTCPSLIQLQIGSNDIRK-VDEKLTP--QLYILDIADNPNISIDV 844
Query: 142 PLALTKLK-HLKTLDISNNH 160
++ + L
Sbjct: 845 TSVCPYIEAGMYVLLYDKTQ 864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 50/258 (19%), Positives = 87/258 (33%), Gaps = 43/258 (16%)
Query: 318 FMVRLKNS-AVYAVKRLKKLQVSMDEFSQTMRQIGNL----KHPNILPLVCYNSTNEEKL 372
F VR K +YAVKR + ++ + ++G+ +HP V EE
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC---VRLEQAWEEGG 130
Query: 373 LVY---KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHG 429
++Y + SL EA+ P L ++ + + H
Sbjct: 131 ILYLQTEL-CGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG-----LVHL 181
Query: 430 NLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPEKTVSEQG-----DV 481
++K +NI L + + G L G Y APE + + DV
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGDPRYMAPE--LLQGSYGTAADV 238
Query: 482 FSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVAL 541
FS G+ +LE+ + G + + + E+T + L +V +
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTA------------GLSSELRSVLV 286
Query: 542 KCVSNSPDDRPTMAEVLE 559
+ P R T +L
Sbjct: 287 MMLEPDPKLRATAEALLA 304
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 43/194 (22%), Positives = 80/194 (41%), Gaps = 31/194 (15%)
Query: 319 MVRLKNS-AVYAVKRLKKLQV-SMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLL 373
+ R K + + A+K L K Q+ Q R+I +L+HPNIL + Y + L
Sbjct: 32 LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91
Query: 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKL 433
+ ++ G L L+ G+ F + + +A L + +++ + H ++K
Sbjct: 92 MLEFAPRGELYKELQK--HGR--FDEQRSATFMEELADALHYCHERK-----VIHRDIKP 142
Query: 434 SNILLNENEDPLISECGYSKFLDPKKT---CLFSSNG---YTAPEKTVSEQG-----DVF 482
N+L+ + I++ G+S + C G Y PE + + D++
Sbjct: 143 ENLLMGYKGELKIADFGWSVHAPSLRRRTMC-----GTLDYLPPE-MIEGKTHDEKVDLW 196
Query: 483 SFGVILLELLTGKT 496
GV+ E L G
Sbjct: 197 CAGVLCYEFLVGMP 210
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 21/123 (17%), Positives = 43/123 (34%), Gaps = 10/123 (8%)
Query: 59 PHPCSYNLKGIKCNLHATNIVGI------RLENMNLSG----IIDAETLCKLRHLRVVSL 108
+PC + I + + +N++LS I+ + + L+ + L
Sbjct: 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDL 63
Query: 109 ARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDN 168
+R I+ + L+ L L+ N + P + + L L+ L A+
Sbjct: 64 SRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFP 123
Query: 169 FRQ 171
Q
Sbjct: 124 IGQ 126
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 12/100 (12%), Positives = 27/100 (27%), Gaps = 1/100 (1%)
Query: 73 LHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNL 132
+ + + ++ L + + L L + ++ + L L +
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455
Query: 133 SSNLLSGAVP-LALTKLKHLKTLDISNNHFAATSPDNFRQ 171
+ N +L LD+S S F
Sbjct: 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT 495
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 17/95 (17%), Positives = 33/95 (34%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
T++ +++ + + +L + L++ ++ RL LN+S N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L +L L TLD S N +
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 21/94 (22%), Positives = 36/94 (38%), Gaps = 1/94 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ + + L + I D + L HL + L N IQ P S S L L
Sbjct: 56 SELQWLDLSRCEIETIED-KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
L+ + +L LK L++++N + +
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 14/97 (14%), Positives = 34/97 (35%), Gaps = 2/97 (2%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
++ + L + + L L + + I L LN++ N
Sbjct: 80 HHLSNLILTGNPIQSFSP-GSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN 138
Query: 136 LLSGA-VPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
+ +P + L +L +D+S N+ + ++ +
Sbjct: 139 FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 19/113 (16%), Positives = 41/113 (36%), Gaps = 7/113 (6%)
Query: 49 VLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSL 108
L++ N + S TN+ + L L I L L+++++
Sbjct: 452 TLKMAGNSFKDNTLSNVFANT------TNLTFLDLSKCQLEQI-SWGVFDTLHRLQLLNM 504
Query: 109 ARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+ N + + + L+ L+ S N + + + K L +++NN
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 21/100 (21%), Positives = 42/100 (42%), Gaps = 6/100 (6%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQG-RIPTSISNCRRLTYLNLSS 134
T++ + L+ + + +L L+ +++A N I ++P SN L +++LS
Sbjct: 104 TSLENLVAVETKLASLES-FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 135 NLLSGAVPLALTKLKHLK----TLDISNNHFAATSPDNFR 170
N + L L+ +LD+S N F+
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQ 202
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 18/95 (18%), Positives = 31/95 (32%), Gaps = 8/95 (8%)
Query: 82 RLENMNLSG------IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
L ++LS + + LR + L+ N + + L +L+ +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHS 409
Query: 136 LLSGAVPL-ALTKLKHLKTLDISNNHFAATSPDNF 169
L A L+ L LDIS + F
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 13/125 (10%), Positives = 35/125 (28%), Gaps = 5/125 (4%)
Query: 49 VLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRV--V 106
L + N N + L+ + LH ++ ++ I + + L + +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLA-GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266
Query: 107 SLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSP 166
L ++ ++L+ + + K ++L I
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP--KHFKWQSLSIIRCQLKQFPT 324
Query: 167 DNFRQ 171
+
Sbjct: 325 LDLPF 329
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 17/92 (18%), Positives = 29/92 (31%), Gaps = 5/92 (5%)
Query: 87 NLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLT----YLNLSSNLLSGAVP 142
+ L +L V L+ N IQ + R L++S N +
Sbjct: 139 FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQD 198
Query: 143 LALTKLKHLKTLDISNNHFAATSPDNFRQEIK 174
A +K L L + N ++ Q +
Sbjct: 199 QAFQGIK-LHELTLRGNFNSSNIMKTCLQNLA 229
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 21/99 (21%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 65 NLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNC 124
++K ++ + + L L L+ ++L N I
Sbjct: 296 SIKYLEDVPKHFKWQSLSIIRCQLKQF----PTLDLPFLKSLTLTMNKGS--ISFKKVAL 349
Query: 125 RRLTYLNLSSNLLSGAVPLALTKLK--HLKTLDISNNHF 161
L+YL+LS N LS + + + L L+ LD+S N
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 11/113 (9%), Positives = 24/113 (21%), Gaps = 8/113 (7%)
Query: 73 LHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCR------- 125
+ + L S I L L L V L + I
Sbjct: 201 FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD 260
Query: 126 -RLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYFD 177
+ L+ + L ++ + ++ + +
Sbjct: 261 VTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLS 313
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 13/61 (21%), Positives = 28/61 (45%), Gaps = 4/61 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
RL+ +N+S +D+ +L L + + N I+ + L + NL++N +
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
Query: 138 S 138
+
Sbjct: 558 A 558
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 63/268 (23%), Positives = 115/268 (42%), Gaps = 56/268 (20%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLLSL 386
AVK LK+ + ++EF + + +KHPN++ L VC + ++ ++ + G+LL
Sbjct: 42 AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDY 99
Query: 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446
L +++ + L +AT I+ ++++ E+K H +L N L+ EN +
Sbjct: 100 LRE--CNRQEVSAVVLLYMATQISSAMEYL-----EKKNFIHRDLAARNCLVGENHLVKV 152
Query: 447 SECGYSKFLDPKKTCLFSSNGY------------TAPE----KTVSEQGDVFSFGVILLE 490
++ G S+ + + Y TAPE S + DV++FGV+L E
Sbjct: 153 ADFGLSRLMT--------GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 491 LLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVALKCV 544
+ T GIDL +V++ + K R P + + C
Sbjct: 205 IATYGMSPYPGIDLS-------------QVYEL-LEKDYRMER-PEGCPEKVYELMRACW 249
Query: 545 SNSPDDRPTMAEVLERIEEVVNGNDERD 572
+P DRP+ AE+ + E + + D
Sbjct: 250 QWNPSDRPSFAEIHQAFETMFQESSISD 277
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 15/99 (15%), Positives = 31/99 (31%), Gaps = 13/99 (13%)
Query: 76 TNIVGIRLENMNLSGIIDA------ETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTY 129
+ + I + + T K ++ ++L+ N I S L+
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461
Query: 130 LNLSSNLLSG-------AVPLALTKLKHLKTLDISNNHF 161
+NL N+L+ L ++D+ N
Sbjct: 462 INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL 500
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 20/109 (18%), Positives = 31/109 (28%), Gaps = 10/109 (9%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ I L L+ + D L +L + L+ N PT N L + +
Sbjct: 488 YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 136 L------LSGAVPLALTKLKHLKTLDISNNHFAATS-PDNFRQEIKYFD 177
P +T L L I +N + I D
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI--RKVNEKITPNISVLD 593
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 15/109 (13%), Positives = 37/109 (33%), Gaps = 10/109 (9%)
Query: 63 SYN-LKGIKCNL--HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQG---- 115
+YN + I N + + + L I + + + + + N I
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGK 420
Query: 116 ---RIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+ + ++ +NLS+N +S + L ++++ N
Sbjct: 421 NFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 15/100 (15%), Positives = 35/100 (35%), Gaps = 10/100 (10%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLI--------QGRIPTSISNCRRL 127
++ + + N + L L ++++++A N + ++
Sbjct: 249 KDLTDVEVYNCPNLTKLPTF-LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
Query: 128 TYLNLSSN-LLSGAVPLALTKLKHLKTLDISNNHFAATSP 166
+ + N L + V +L K+K L L+ N P
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 22/119 (18%), Positives = 36/119 (30%), Gaps = 19/119 (15%)
Query: 63 SYN-LKGI-----KCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNL---- 112
+N L + L +VGI L + S L+ +
Sbjct: 496 RFNKLTKLSDDFRATTL--PYLVGIDLSYNSFSKFP--TQPLNSSTLKGFGIRNQRDAQG 551
Query: 113 --IQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
P I+ C LT L + SN + V + ++ LDI +N +
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 17/85 (20%), Positives = 29/85 (34%), Gaps = 5/85 (5%)
Query: 87 NLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVP--LA 144
L G + A L ++LA N I ++ L+ + N L +P
Sbjct: 341 QLEGKLPA--FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFD 397
Query: 145 LTKLKHLKTLDISNNHFAATSPDNF 169
+ + +D S N + NF
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNF 422
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 17/86 (19%), Positives = 38/86 (44%), Gaps = 1/86 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
I I + NL +L K++ L ++ N ++G++P + + +L LNL+ N
Sbjct: 305 EKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYN 363
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHF 161
++ + ++ L ++N
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKL 389
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 11/87 (12%), Positives = 26/87 (29%), Gaps = 9/87 (10%)
Query: 83 LENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL----- 137
E D + L+ L V + ++PT + + +N++ N
Sbjct: 232 SEYAQQYKTEDLK-WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 138 ---SGAVPLALTKLKHLKTLDISNNHF 161
+ ++ + I N+
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNL 317
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 15/150 (10%), Positives = 43/150 (28%), Gaps = 23/150 (15%)
Query: 31 LSESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSG 90
F+ ++ + + P ++K I + N++
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT--LKDTQIGQLSNNITF 197
Query: 91 IIDAETLCKLRHLRVVSLARNLIQG-------------------RIPTSISNCRRLTYLN 131
+ ++ + +L LR + + N + LT +
Sbjct: 198 V--SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255
Query: 132 LSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+ + +P L L ++ ++++ N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRG 285
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 26/166 (15%), Positives = 47/166 (28%), Gaps = 55/166 (33%)
Query: 54 WNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLI 113
WN N G+ N + G+ LE SG + + +L L V++L +
Sbjct: 60 WNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDA-IGQLTELEVLALGSHGE 117
Query: 114 QG----RIPTSISNCR---------------------RLTYLNLSSNLLSG--------- 139
+ P IS R + +L + ++
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 140 -------------------AVPLALTKLKHLKTLDISNNHFAATSP 166
V A+ +L L+ + N+ F A +
Sbjct: 178 SSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENI 223
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 22/132 (16%), Positives = 39/132 (29%), Gaps = 11/132 (8%)
Query: 42 SAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHAT-NIVGIRLENMNLSGIIDAETLCKL 100
+ L+ W+ S G A N + +++ G +L
Sbjct: 27 EYIKDYLALKEIWDALNGKNWSQQ--GFGTQPGANWN----FNKELDMWGAQPGVSLNSN 80
Query: 101 RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG----AVPLALTKLKHLKTLDI 156
+ +SL GR+P +I L L L S+ P ++ +
Sbjct: 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQK 140
Query: 157 SNNHFAATSPDN 168
H+ T D
Sbjct: 141 MRMHYQKTFVDY 152
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 14/54 (25%), Positives = 26/54 (48%)
Query: 120 SISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEI 173
S+++ R+T L+L SG VP A+ +L L+ L + ++ + I
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 11/119 (9%), Positives = 31/119 (26%), Gaps = 21/119 (17%)
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLN 131
++++ + + I + L+ + N I + ++ +L
Sbjct: 155 REDFSDLIKDCINSDPQQKSIKKSSRITLK-DTQIGQLSNNITF-VSKAVMRLTKLRQFY 212
Query: 132 LSSNLLSG-------------------AVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
+ ++ L LK L +++ N P +
Sbjct: 213 MGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 7/78 (8%), Positives = 20/78 (25%), Gaps = 4/78 (5%)
Query: 83 LENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVP 142
+ E + L + + N I+ + I ++ L++ N
Sbjct: 549 AQGNRTLREW-PEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDL 604
Query: 143 LALTKLKHLKTLDISNNH 160
+ + +
Sbjct: 605 SYVCPYIEAGMYMLFYDK 622
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 62/259 (23%), Positives = 99/259 (38%), Gaps = 54/259 (20%)
Query: 329 AVKRLKK--LQVSMDEF---SQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNG 381
A+K LK+ + +E +Q M Q L +P I+ L VC E +LV + G
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQ---LDNPYIVRLIGVC---QAEALMLVMEMAGGG 420
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
L L + + P + ++ G+ ++ EEK H NL N+LL
Sbjct: 421 PLHKFLV---GKREEIPVSNVAELLHQVSMGMKYL-----EEKNFVHRNLAARNVLLVNR 472
Query: 442 EDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLEL 491
IS+ G SK L + + + + APE + S + DV+S+GV + E
Sbjct: 473 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 532
Query: 492 LT-GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWAFP-----LLNVALKCV 544
L+ G+ P + G EV + + R P L + C
Sbjct: 533 LSYGQK--------PYK-------KMKGPEVMAF-IEQGKRMECPPECPPELYALMSDCW 576
Query: 545 SNSPDDRPTMAEVLERIEE 563
+DRP V +R+
Sbjct: 577 IYKWEDRPDFLTVEQRMRA 595
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 48/272 (17%)
Query: 329 AVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
A+K LK + +F +G HPNI+ L V + ++V +Y NGSL
Sbjct: 81 AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV--TRGRLAMIVTEYMENGSLD 138
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
+ L F + + G+ G+ ++ + H +L N+L++ N
Sbjct: 139 TFLR---THDGQFTIMQLVGMLRGVGAGMRYL-----SDLGYVHRDLAARNVLVDSNLVC 190
Query: 445 LISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT- 493
+S+ G S+ L+ +++ G +TAPE +T S DV+SFGV++ E+L
Sbjct: 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAY 250
Query: 494 GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWA-----FPLLNVALKCVSNS 547
G+ P W T +V V + R A L + L C
Sbjct: 251 GER--------PYW-------NMTNRDVISS-VEEGYRLPAPMGCPHALHQLMLDCWHKD 294
Query: 548 PDDRPTMAEVLERIEEVVNGNDERDRDHSNSS 579
RP ++++ ++ ++ + E R + S
Sbjct: 295 RAQRPRFSQIVSVLDALIR-SPESLRATATVS 325
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 52/255 (20%), Positives = 103/255 (40%), Gaps = 37/255 (14%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLLVY-- 375
++ Y +K + ++S E ++ R++ N+KHPNI V Y + EE +Y
Sbjct: 45 STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI---VQYRESFEENGSLYIV 101
Query: 376 -KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
Y G L + A + F L I L ++ ++ I H ++K
Sbjct: 102 MDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVH-----DRKILHRDIKSQ 154
Query: 435 NILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSFGVI 487
NI L ++ + + G ++ L+ + G Y +PE K + + D+++ G +
Sbjct: 155 NIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCV 214
Query: 488 LLELLTGKTVEKTGIDLPKWVKAMVREEWT--GEVFDKEVAKAGRQWAFPLLNVALKCVS 545
L EL T K + + V ++ + + + L ++ +
Sbjct: 215 LYELCTLKHAFE-AGSMKNLVLKIISGSFPPVSLHYSYD-----------LRSLVSQLFK 262
Query: 546 NSPDDRPTMAEVLER 560
+P DRP++ +LE+
Sbjct: 263 RNPRDRPSVNSILEK 277
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 58/282 (20%), Positives = 111/282 (39%), Gaps = 55/282 (19%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEEK--LLVYKYQSNGS 382
AVK L ++ + +F + + HPN+L L +C E L+V Y +G
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC---LRSEGSPLVVLPYMKHGD 177
Query: 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442
L + + + K + +AKG+ F+ K H +L N +L+E
Sbjct: 178 LRNFIR---NETHNPTVKDLIGFGLQVAKGMKFL-----ASKKFVHRDLAARNCMLDEKF 229
Query: 443 DPLISECGYSKFLDPKKTCLFSSNG-------YTAPE----KTVSEQGDVFSFGVILLEL 491
+++ G ++ + K+ + + A E + + + DV+SFGV+L EL
Sbjct: 230 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289
Query: 492 LT-GKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVALK 542
+T G + D+ ++ G + P L V LK
Sbjct: 290 MTRGAPPYPDVNTFDITVYLL-------QGRRLLQ-----------PEYCPDPLYEVMLK 331
Query: 543 CVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHSNSSFSSME 584
C + RP+ +E++ RI + + H N+++ +++
Sbjct: 332 CWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK 373
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 48/281 (17%), Positives = 101/281 (35%), Gaps = 50/281 (17%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPL--VCYNSTNEEKLLVYKYQSNGS 382
+A+K + + MR+ LK H NI+ L + +T K+L+ ++ GS
Sbjct: 37 FAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS 95
Query: 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442
L ++LE P L + + G++ + + I H N+K NI+ E
Sbjct: 96 LYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRENG-----IVHRNIKPGNIMRVIGE 149
Query: 443 DPL----ISECGYSKFLDPKKTCLFSSNG---YTAPE------------KTVSEQGDVFS 483
D +++ G ++ L+ + S G Y P+ K D++S
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS 208
Query: 484 FGVILLELLTGK---TVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR-QWAFPL--- 536
GV TG + + + ++ + +G + + A+ G W+ +
Sbjct: 209 IGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS 268
Query: 537 --LNVALKCVSNS---------PDDRPTMAEVLERIEEVVN 566
L+ L+ + + + ++++
Sbjct: 269 CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 42/193 (21%), Positives = 75/193 (38%), Gaps = 32/193 (16%)
Query: 327 VYAVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPL--VCYNSTNEEKLLVYKYQSNG 381
++A+K + + MR+ LK H NI+ L + +T K+L+ ++ G
Sbjct: 36 LFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
SL ++LE P L + + G++ + + I H N+K NI+
Sbjct: 95 SLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRENG-----IVHRNIKPGNIMRVIG 148
Query: 442 EDPL----ISECGYSKFLDPKKTCLFSSNG---YTAPE------------KTVSEQGDVF 482
ED +++ G ++ L+ + S G Y P+ K D++
Sbjct: 149 EDGQSVYKLTDFGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 483 SFGVILLELLTGK 495
S GV TG
Sbjct: 208 SIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 40/185 (21%), Positives = 73/185 (39%), Gaps = 20/185 (10%)
Query: 322 LKNSAVYAVKRLKKLQV-SMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKY 377
V+A K + K + + + +I +L H +++ + N+ +V +
Sbjct: 37 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
SLL + ++ I G ++++ + H +LKL N+
Sbjct: 97 CRRRSLLE----LHKRRKALTEPEARYYLRQIVLGCQYLHRNR-----VIHRDLKLGNLF 147
Query: 438 LNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSFGVILLE 490
LNE+ + I + G + ++ G Y APE K S + DV+S G I+
Sbjct: 148 LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 207
Query: 491 LLTGK 495
LL GK
Sbjct: 208 LLVGK 212
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 21/239 (8%), Positives = 68/239 (28%), Gaps = 66/239 (27%)
Query: 353 LKHPNILPLVCYNSTNEEKLLVYKY----QSNGSLLSLLEAYIEGKRDFPWKLRLSIATG 408
+ ++ + + Y + + +L ++ + RL +
Sbjct: 155 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQ 214
Query: 409 IAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGY 468
+ + L ++ + H L+ +I+L++ ++ + + S +
Sbjct: 215 VIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRG-F 268
Query: 469 TAPE---------------KTVSEQGDVFSFGVILLELLTGKT-------------VEKT 500
PE ++ D ++ G+++ + + ++
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS 328
Query: 501 GIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559
++P+ V+A++ L +DR + +E
Sbjct: 329 CKNIPQPVRALLEG---------------------FLRY-------PKEDRLLPLQAME 359
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 42/191 (21%), Positives = 75/191 (39%), Gaps = 32/191 (16%)
Query: 322 LKNSAVYAVKRLKKLQV-SMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKY 377
V+A K + K + + + +I +L H +++ + N+ +V +
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLS------IATGIAKGLDFMYQKSNEEKTIPHGNL 431
SLL L + + L+ I G ++++ + H +L
Sbjct: 123 CRRRSLLELHKR----------RKALTEPEARYYLRQIVLGCQYLHRNR-----VIHRDL 167
Query: 432 KLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSF 484
KL N+ LNE+ + I + G + ++ G Y APE K S + DV+S
Sbjct: 168 KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227
Query: 485 GVILLELLTGK 495
G I+ LL GK
Sbjct: 228 GCIMYTLLVGK 238
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 50/291 (17%), Positives = 107/291 (36%), Gaps = 53/291 (18%)
Query: 329 AVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPL--VCY----NSTNEEKLLVYKYQS 379
AVK LK ++ ++EF + + HP++ L V +++ +
Sbjct: 55 AVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMK 114
Query: 380 NGSLLSLLEAYIEGKRDFPWKLR--LSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+G L + L A G+ F L+ + IA G++++ + H +L N +
Sbjct: 115 HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL-----SSRNFIHRDLAARNCM 169
Query: 438 LNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVIL 488
L E+ +++ G S+ + + A E + DV++FGV +
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229
Query: 489 LELLT-GKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNV 539
E++T G+T ++ ++ G + P + ++
Sbjct: 230 WEIMTRGQTPYAGIENAEIYNYLIG-------GNRLKQ-----------PPECMEEVYDL 271
Query: 540 ALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHSNSSFSSMESIPHDS 590
+C S P RP+ + +E ++ G+ + + ++E H
Sbjct: 272 MYQCWSADPKQRPSFTCLRMELENIL-GHLSVLSTSQDPLYINIERAHHHH 321
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 55/271 (20%), Positives = 104/271 (38%), Gaps = 55/271 (20%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEE--KLLVYKYQSNGS 382
A+K L ++ F + + L HPN+L L + E ++ Y +G
Sbjct: 53 AIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIM---LPPEGLPHVLLPYMCHGD 109
Query: 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442
LL + +R+ K +S +A+G++++ E+ H +L N +L+E+
Sbjct: 110 LLQFIR---SPQRNPTVKDLISFGLQVARGMEYL-----AEQKFVHRDLAARNCMLDESF 161
Query: 443 DPLISECGYSKFLDPKKTCLFSSNG-------YTAPE----KTVSEQGDVFSFGVILLEL 491
+++ G ++ + ++ + +TA E + + DV+SFGV+L EL
Sbjct: 162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWEL 221
Query: 492 LT-GKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVALK 542
LT G DL ++ G + P L V +
Sbjct: 222 LTRGAPPYRHIDPFDLTHFLA-------QGRRLPQ-----------PEYCPDSLYQVMQQ 263
Query: 543 CVSNSPDDRPTMAEVLERIEEVVNGNDERDR 573
C P RPT ++ +E++V+
Sbjct: 264 CWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 60/293 (20%), Positives = 114/293 (38%), Gaps = 60/293 (20%)
Query: 329 AVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
A+K LK + +F +G HPNI+ L V + ++ ++V +Y NGSL
Sbjct: 77 AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSLD 134
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
S L + F + + GIA G+ ++ + H +L NIL+N N
Sbjct: 135 SFLR---KHDAQFTVIQLVGMLRGIASGMKYL-----SDMGYVHRDLAARNILINSNLVC 186
Query: 445 LISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT- 493
+S+ G + L+ +++ G +T+PE + + DV+S+G++L E+++
Sbjct: 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 494 GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWA-----FPLLNVALKCVSNS 547
G+ P W E + +V V + R L + L C
Sbjct: 247 GER--------PYW-------EMSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKD 290
Query: 548 PDDRPTMAEVLERIEE-------------VVNGNDERDRDHSNSSFSSMESIP 587
++RP +++ +++ D SN ++ +
Sbjct: 291 RNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTG 343
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 56/263 (21%), Positives = 103/263 (39%), Gaps = 53/263 (20%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKL-LVYKY 377
+ + V AVK +K + F + L+H N++ L V + L +V +Y
Sbjct: 41 DYRGNKV-AVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLYIVTEY 96
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+ GSL+ L + G+ L + + + ++++ E H +L N+L
Sbjct: 97 MAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL-----EGNNFVHRDLAARNVL 149
Query: 438 LNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVIL 488
++E+ +S+ G +K G +TAPE K S + DV+SFG++L
Sbjct: 150 VSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 204
Query: 489 LELLT-GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWAFP------LLNVA 540
E+ + G+ P +V + V K + A P + V
Sbjct: 205 WEIYSFGRV--------PYP-------RIPLKDVVPR-VEKGYKMDA-PDGCPPAVYEVM 247
Query: 541 LKCVSNSPDDRPTMAEVLERIEE 563
C RP+ ++ E++E
Sbjct: 248 KNCWHLDAAMRPSFLQLREQLEH 270
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 56/265 (21%), Positives = 92/265 (34%), Gaps = 59/265 (22%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
AVK L ++ D +F I H NI+ V + + ++ + + G L
Sbjct: 64 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS--LQSLPRFILMELMAGGDLK 121
Query: 385 S-LLEAYIEGKRDFPWKLR--LSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
S L E + + L +A IA G ++ EE H ++ N LL
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL-----EENHFIHRDIAARNCLLTCP 176
Query: 442 EDPL---ISECGYSKFLDPKKTCLFSSNGY-----TAPE----KTVSEQGDVFSFGVILL 489
I + G ++ + PE + + D +SFGV+L
Sbjct: 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 236
Query: 490 ELLT-------GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA-----FPLL 537
E+ + K+ + EV + V GR P+
Sbjct: 237 EIFSLGYMPYPSKSNQ--------------------EVLEF-VTSGGRMDPPKNCPGPVY 275
Query: 538 NVALKCVSNSPDDRPTMAEVLERIE 562
+ +C + P+DRP A +LERIE
Sbjct: 276 RIMTQCWQHQPEDRPNFAIILERIE 300
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 25/273 (9%), Positives = 64/273 (23%), Gaps = 49/273 (17%)
Query: 327 VYAVKRLKKLQVSMDEFSQTMRQ----IGNLKHPNILPLV-------------------- 362
+A+K + + + + L +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 363 --------CYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLD 414
Y N L+ L S L+ + D + + +
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA 208
Query: 415 FMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE-- 472
+ K + HG+ N+ + + ++ + + + Y E
Sbjct: 209 NLQSKG-----LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFL 263
Query: 473 ----KTVSEQGDVFSFGVILLELLTGKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526
T + + + G+ + + T W + +R T +
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCT 323
Query: 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559
+ + + ++ R E +E
Sbjct: 324 PLPD----FVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 47/260 (18%), Positives = 97/260 (37%), Gaps = 55/260 (21%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNSTNEEKLLVYKYQSNGSL 383
AVKR+ + FS R++ L+ HPN++ C + + + + +L
Sbjct: 51 VAVKRILP-----ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL-CAATL 104
Query: 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443
+E + +++ GL ++ + I H +LK NIL++
Sbjct: 105 QEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHSLN-----IVHRDLKPHNILISMPNA 156
Query: 444 -----PLISECGYSKFLDP------KKTCLFSSNGYTAPE-------KTVSEQGDVFSFG 485
+IS+ G K L +++ + + G+ APE + + D+FS G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 486 VILLELLT------GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNV 539
+ +++ GK++++ L + +A+ L+
Sbjct: 217 CVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH---EDVIARE-------LIE- 265
Query: 540 ALKCVSNSPDDRPTMAEVLE 559
K ++ P RP+ VL+
Sbjct: 266 --KMIAMDPQKRPSAKHVLK 283
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 9e-12
Identities = 49/259 (18%), Positives = 95/259 (36%), Gaps = 56/259 (21%)
Query: 329 AVKRLKK--LQVSMDEF---SQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNG 381
AVK KK + ++F + M+ L HP+I+ L + E ++ + G
Sbjct: 44 AVKTCKKDCTLDNKEKFMSEAVIMKN---LDHPHIVKLIGII---EEEPTWIIMELYPYG 97
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
L LE K + + I K + ++ E H ++ + NIL+
Sbjct: 98 ELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYL-----ESINCVHRDIAVRNILVASP 149
Query: 442 EDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLEL 491
E + + G S++++ + ++ + +PE + + DV+ F V + E+
Sbjct: 150 ECVKLGDFGLSRYIE--DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEI 207
Query: 492 LT-GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGR-----QWAFPLLNVALKCV 544
L+ GK P + +V + K R L + +C
Sbjct: 208 LSFGKQ--------PFF-------WLENKDVIGV-LEKGDRLPKPDLCPPVLYTLMTRCW 251
Query: 545 SNSPDDRPTMAEVLERIEE 563
P DRP E++ + +
Sbjct: 252 DYDPSDRPRFTELVCSLSD 270
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 46/313 (14%), Positives = 103/313 (32%), Gaps = 72/313 (23%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNS-------TNE 369
+ + YA+KRL ++ ++++ +K HPNI+ S T +
Sbjct: 49 DVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106
Query: 370 EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHG 429
+ L+ G L+ L+ L I + + M+++ I H
Sbjct: 107 AEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHRQK---PPIIHR 162
Query: 430 NLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG---------------YTAPE-- 472
+LK+ N+LL+ + + G + + +S+ Y PE
Sbjct: 163 DLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222
Query: 473 -----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527
+ E+ D+++ G IL L + P F+
Sbjct: 223 DLYSNFPIGEKQDIWALGCILYLLCFRQH--------P---------------FEDGAKL 259
Query: 528 A--GRQWAFP--------LLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHSN 577
+++ P ++ + +P++R ++AEV+ +++E+ + +
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
Query: 578 SSFSSMESIPHDS 590
+
Sbjct: 320 ELLEQNGGYGSAT 332
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 47/256 (18%), Positives = 94/256 (36%), Gaps = 50/256 (19%)
Query: 329 AVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
A+K K ++F Q + HP+I+ L V T ++ + + G L
Sbjct: 47 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI---TENPVWIIMELCTLGELR 103
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
S L+ K + A ++ L ++ E K H ++ N+L++ N+
Sbjct: 104 SFLQ---VRKYSLDLASLILYAYQLSTALAYL-----ESKRFVHRDIAARNVLVSSNDCV 155
Query: 445 LISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT- 493
+ + G S++++ + + ++ + APE + + DV+ FGV + E+L
Sbjct: 156 KLGDFGLSRYME--DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 213
Query: 494 GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGRQWA-----FPLLNVALKCVSNS 547
G P +V + + R L ++ KC +
Sbjct: 214 GVK--------PFQ-------GVKNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYD 257
Query: 548 PDDRPTMAEVLERIEE 563
P RP E+ ++
Sbjct: 258 PSRRPRFTELKAQLST 273
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 68/304 (22%), Positives = 121/304 (39%), Gaps = 70/304 (23%)
Query: 329 AVKRLKKLQVSMDEFS------QTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSN 380
AVK LK + + S + M+ IG KH NI+ L C + + ++ +Y S
Sbjct: 105 AVKMLKS-DATEKDLSDLISEMEMMKMIG--KHKNIINLLGAC--TQDGPLYVIVEYASK 159
Query: 381 GSLLSLL--------EAYIEGKRDFPWKLR----LSIATGIAKGLDFMYQKSNEEKTIPH 428
G+L L E + +L +S A +A+G++++ K H
Sbjct: 160 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-----ASKKCIH 214
Query: 429 GNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQG 479
+L N+L+ E+ I++ G ++ + ++NG + APE + + Q
Sbjct: 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274
Query: 480 DVFSFGVILLELLT-------GKTVEKTGIDLPKWVKA---MVR-EEWTGEVFDKEVAKA 528
DV+SFGV+L E+ T G VE +L K +K M + T E++
Sbjct: 275 DVWSFGVLLWEIFTLGGSPYPGVPVE----ELFKLLKEGHRMDKPSNCTNELY------- 323
Query: 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHSNSSFSSMESIPH 588
+ C P RPT +++E ++ +V ++ + + IP
Sbjct: 324 ---------MMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPT 374
Query: 589 DSCL 592
L
Sbjct: 375 TENL 378
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 56/281 (19%), Positives = 109/281 (38%), Gaps = 54/281 (19%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNI-------------LPLVCYNST 367
+ Y +KR+K + ++ + ++ + L H NI NS+
Sbjct: 32 HRIDGKTYVIKRVKY---NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88
Query: 368 NEEKLLVY---KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEK 424
+ ++ ++ G+L +E L L + I KG+D+++ K
Sbjct: 89 RSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---- 142
Query: 425 TIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSN-G---YTAPE----KTVS 476
+ + +LK SNI L + + I + G L + + G Y +PE +
Sbjct: 143 -LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDGKRTRSKGTLRYMSPEQISSQDYG 199
Query: 477 EQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535
++ D+++ G+IL ELL T +T ++ + + +
Sbjct: 200 KEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKT------------- 246
Query: 536 LLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHS 576
LL K +S P+DRP +E+L R V + E++ H+
Sbjct: 247 LLQ---KLLSKKPEDRPNTSEIL-RTLTVWKKSPEKNERHT 283
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 56/269 (20%), Positives = 92/269 (34%), Gaps = 59/269 (21%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
AVK L ++ D +F I H NI+ V + + ++ + + G L
Sbjct: 105 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS--LQSLPRFILLELMAGGDLK 162
Query: 385 S-LLEAYIEGKRDFPWKLR--LSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
S L E + + L +A IA G ++ EE H ++ N LL
Sbjct: 163 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL-----EENHFIHRDIAARNCLLTCP 217
Query: 442 EDPL---ISECGYSKFLDPKKTCLFSSNGY-----TAPE----KTVSEQGDVFSFGVILL 489
I + G ++ + PE + + D +SFGV+L
Sbjct: 218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 277
Query: 490 ELLT-------GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA-----FPLL 537
E+ + K+ + EV + V GR P+
Sbjct: 278 EIFSLGYMPYPSKSNQ--------------------EVLEF-VTSGGRMDPPKNCPGPVY 316
Query: 538 NVALKCVSNSPDDRPTMAEVLERIEEVVN 566
+ +C + P+DRP A +LERIE
Sbjct: 317 RIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 37/210 (17%), Positives = 85/210 (40%), Gaps = 39/210 (18%)
Query: 320 VRL--KNSAVYAVKRLKKLQV---------------SMDEFSQTMRQIGNLK---HPNIL 359
+ L K++ YA+K+ +K + ++ ++ + + L
Sbjct: 47 IILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106
Query: 360 PLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIA----TGIAKGLDF 415
+ +E ++Y+Y N S+L E + +++ + + + + +
Sbjct: 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166
Query: 416 MYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE 472
++ + K I H ++K SNIL+++N +S+ G S+++ KK + S G + PE
Sbjct: 167 IHNE----KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--IKGSRGTYEFMPPE 220
Query: 473 KTVSEQG------DVFSFGVILLELLTGKT 496
+E D++S G+ L +
Sbjct: 221 FFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 25/186 (13%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLV------CYNSTNEEKLLVYKYQ 378
A+K+ ++ ++S + +I +K HPN++ + N+ LL +Y
Sbjct: 42 VAIKQCRQ-ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC 100
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
G L L + E ++ + I+ L ++++ I H +LK NI+L
Sbjct: 101 EGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHENR-----IIHRDLKPENIVL 154
Query: 439 NENEDPL---ISECGYSKFLDPKKTC--LFSSNGYTAPE----KTVSEQGDVFSFGVILL 489
L I + GY+K LD + C + Y APE K + D +SFG +
Sbjct: 155 QPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 214
Query: 490 ELLTGK 495
E +TG
Sbjct: 215 ECITGF 220
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 24/95 (25%), Positives = 49/95 (51%), Gaps = 2/95 (2%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
++ + L+ ++ +DA +L L +L + L+ N I S++N L L+L++N
Sbjct: 192 PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L VP L K+++ + + NN+ +A ++F
Sbjct: 251 KLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 26/121 (21%), Positives = 45/121 (37%), Gaps = 13/121 (10%)
Query: 59 PHPCSYNLKGIKC---NLHA------TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLA 109
P C +L+ ++C L + + L+N ++ I L++L + L
Sbjct: 26 PFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILI 84
Query: 110 RNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
N I P + + +L L LS N L +P + K L+ L + N F
Sbjct: 85 NNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVF 141
Query: 170 R 170
Sbjct: 142 N 142
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 17/97 (17%), Positives = 37/97 (38%), Gaps = 11/97 (11%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
+LE + LS + + L+ LR + N I ++ S+ + ++ + L +N
Sbjct: 101 KLERLYLSKNQLKELPEKMPKTLQELR---VHENEIT-KVRKSVFNGLNQMIVVELGTNP 156
Query: 137 LSGAV--PLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
L + A +K L + I++ +
Sbjct: 157 LKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS 193
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 14/94 (14%), Positives = 33/94 (35%), Gaps = 9/94 (9%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQ-GRIPTSI-SNCRRLTYLNLSSNL 136
L+ + + + L + VV L N ++ I ++L+Y+ ++
Sbjct: 123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
++ +P L L L + N + +
Sbjct: 183 IT-TIPQGL--PPSLTELHLDGNKITKVDAASLK 213
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 13/83 (15%), Positives = 29/83 (34%), Gaps = 7/83 (8%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
L + L I L L + L++N ++ +P + + L L + N +
Sbjct: 77 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEI 133
Query: 138 SGAVPLALTKLKHLKTLDISNNH 160
+ L + +++ N
Sbjct: 134 TKVRKSVFNGLNQMIVVELGTNP 156
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 15/94 (15%), Positives = 32/94 (34%), Gaps = 10/94 (10%)
Query: 74 HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQG------RIPTSISNCRRL 127
+ ++ + L N L + L ++++VV L N I P +
Sbjct: 238 NTPHLRELHLNNNKLVKV--PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 295
Query: 128 TYLNLSSNLLSGAV--PLALTKLKHLKTLDISNN 159
+ ++L SN + P + + + N
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 43/180 (23%), Positives = 71/180 (39%), Gaps = 19/180 (10%)
Query: 327 VYAVKRLKKLQV-SMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382
A+K + K + + ++ LKHP+IL L Y + LV + NG
Sbjct: 38 EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGE 97
Query: 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442
+ L+ K F I G+ +++ I H +L LSN+LL N
Sbjct: 98 MNRYLKN--RVKP-FSENEARHFMHQIITGMLYLHSHG-----ILHRDLTLSNLLLTRNM 149
Query: 443 DPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSFGVILLELLTGK 495
+ I++ G + L ++ G Y +PE + DV+S G + LL G+
Sbjct: 150 NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 55/262 (20%), Positives = 104/262 (39%), Gaps = 51/262 (19%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
AVK L ++ + +F + + HPN+L L +C S L+V Y +G L
Sbjct: 57 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLR 115
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
+ + + K + +AKG+ ++ K H +L N +L+E
Sbjct: 116 NFIR---NETHNPTVKDLIGFGLQVAKGMKYL-----ASKKFVHRDLAARNCMLDEKFTV 167
Query: 445 LISECGYSKFLDPKK--TCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLT 493
+++ G ++ + K+ + + + A E + + + DV+SFGV+L EL+T
Sbjct: 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
Query: 494 -GKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVALKCV 544
G + D+ ++ G + P L V LKC
Sbjct: 228 RGAPPYPDVNTFDITVYLL-------QGRRLLQ-----------PEYCPDPLYEVMLKCW 269
Query: 545 SNSPDDRPTMAEVLERIEEVVN 566
+ RP+ +E++ RI + +
Sbjct: 270 HPKAEMRPSFSELVSRISAIFS 291
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 43/204 (21%), Positives = 78/204 (38%), Gaps = 36/204 (17%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG---NLKHPN--ILPLVCYNSTNEEKL 372
F V + +YA+K + + +I L+ + I+ L Y T++
Sbjct: 26 FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
+V + N L S +++ K+ R S + + + ++Q I H +LK
Sbjct: 86 MVMEC-GNIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLK 135
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCLF--SSNG---YTAPE--------------- 472
+N L+ + + + G + + P T + S G Y PE
Sbjct: 136 PANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 194
Query: 473 KTVSEQGDVFSFGVILLELLTGKT 496
+S + DV+S G IL + GKT
Sbjct: 195 SKISPKSDVWSLGCILYYMTYGKT 218
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 23/121 (19%), Positives = 42/121 (34%), Gaps = 10/121 (8%)
Query: 61 PCSYNLKGIKCNLHATNIVGI------RLENMNLSG----IIDAETLCKLRHLRVVSLAR 110
PC + I N I +N++LS + + + L+V+ L+R
Sbjct: 2 PCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 111 NLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
IQ + + L+ L L+ N + A + L L+ L + A+
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 171 Q 171
Sbjct: 122 H 122
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 20/95 (21%), Positives = 39/95 (41%), Gaps = 5/95 (5%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
L + L+G + L L+ + + I + + L LN++ NL+
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 138 -SGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
S +P + L +L+ LD+S+N + + R
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 21/92 (22%), Positives = 35/92 (38%), Gaps = 4/92 (4%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
L+ ++LS I+ L HL + L N IQ + S L L L
Sbjct: 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
Query: 138 SGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
+ + LK LK L++++N + +
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQ-GRIPTSISNCRRLTYLNLSS 134
+++ + NL+ + + + L+ L+ +++A NLIQ ++P SN L +L+LSS
Sbjct: 100 SSLQKLVAVETNLASLEN-FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 135 NLLSGAVPLALTKLKHLK----TLDISNNHFAATSPDNFRQ 171
N + L L + +LD+S N P F++
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 21/109 (19%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 83 LENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVP 142
+ + + +LR+L + L++ ++ PT+ ++ L LN++SN L
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPD 511
Query: 143 LALTKLKHLKTLDISNNHFAATSPDNFRQEIKYFDKYVVETSSSEINRA 191
+L L+ + + N + + P I Y +++ + S E A
Sbjct: 512 GIFDRLTSLQKIWLHTNPWDCSCPR-----IDYLSRWLNKNSQKEQGSA 555
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 25/147 (17%), Positives = 57/147 (38%), Gaps = 9/147 (6%)
Query: 31 LSESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKC-NLHATNIVGIRLENM--- 86
L + F ++ V S +++ + ++ + ++ N ++L+++
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL 330
Query: 87 NLSG--IIDAETLCKLRHLRVVSLARNLIQ--GRIPTSISNCRRLTYLNLSSNLLSGAVP 142
+ +A + L L + L+RN + G S L YL+LS N + +
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS 389
Query: 143 LALTKLKHLKTLDISNNHFAATSPDNF 169
L+ L+ LD +++ S +
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSV 416
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 16/95 (16%), Positives = 33/95 (34%), Gaps = 3/95 (3%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSS 134
T++ + L + + L L + + ++ S+ + R L YL++S
Sbjct: 373 TSLKYLDLSFNGVITMSS--NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 135 NLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
A L L+ L ++ N F +
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 18/98 (18%), Positives = 37/98 (37%), Gaps = 5/98 (5%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTY----LN 131
+ + + + + E L +L + L+ N IQ T + ++ L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 132 LSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
LS N ++ P A +++ L L + NN +
Sbjct: 184 LSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTC 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 48/187 (25%), Positives = 75/187 (40%), Gaps = 20/187 (10%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYK 376
A+K ++K VS S+ + ++ L HPNI+ L + LV +
Sbjct: 57 RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
G L I + F I + G+ ++++ + I H +LK N+
Sbjct: 117 CYKGGELFD----EIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN-----IVHRDLKPENL 167
Query: 437 LLNENED--PL-ISECGYSKFLDPKKTC--LFSSNGYTAPE---KTVSEQGDVFSFGVIL 488
LL E + I + G S + +K + Y APE K E+ DV+S GVIL
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVIL 227
Query: 489 LELLTGK 495
LL G
Sbjct: 228 FILLAGY 234
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 49/265 (18%), Positives = 95/265 (35%), Gaps = 51/265 (19%)
Query: 329 AVKRLKKLQVSMDE---FSQTMRQIGNLKHPNILPL--VCYNS---TNEEKLLVYKYQSN 380
AVK +K S E F + + HPN++ L VC + +++ +
Sbjct: 66 AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125
Query: 381 GSLLSLLEAYIEGKRDFPWKLR--LSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
G L + L L+ L IA G++++ + H +L N +L
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL-----SNRNFLHRDLAARNCML 180
Query: 439 NENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILL 489
++ +++ G SK + + A E + + + DV++FGV +
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240
Query: 490 ELLT-GKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------LLNVA 540
E+ T G T ++ ++ G + P L +
Sbjct: 241 EIATRGMTPYPGVQNHEMYDYLL-------HGHRLKQ-----------PEDCLDELYEIM 282
Query: 541 LKCVSNSPDDRPTMAEVLERIEEVV 565
C P DRPT + + ++E+++
Sbjct: 283 YSCWRTDPLDRPTFSVLRLQLEKLL 307
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 45/204 (22%), Positives = 79/204 (38%), Gaps = 36/204 (17%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG---NLKHPN--ILPLVCYNSTNEEKL 372
F V + +YA+K + + +I L+ + I+ L Y T++
Sbjct: 73 FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
+V + N L S +++ K+ R S + + + ++Q I H +LK
Sbjct: 133 MVMEC-GNIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLK 182
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCLF--SSNG---YTAPE--------------- 472
+N L+ + LI + G + + P T + S G Y PE
Sbjct: 183 PANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSK 241
Query: 473 KTVSEQGDVFSFGVILLELLTGKT 496
+S + DV+S G IL + GKT
Sbjct: 242 SKISPKSDVWSLGCILYYMTYGKT 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 30/284 (10%), Positives = 80/284 (28%), Gaps = 61/284 (21%)
Query: 308 LRSQTICSSLFMVRLKNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVC-- 363
S + ++K V ++ L+ ++ + + +K P ++
Sbjct: 111 PYFTERPPSNAIKQMKE-EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 169
Query: 364 -----YNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQ 418
+ L + + +L ++ + RL + + + L ++
Sbjct: 170 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229
Query: 419 KSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE------ 472
+ H L+ +I+L++ ++ + G+ PE
Sbjct: 230 YG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGR-GFAPPETTAERM 283
Query: 473 --------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKE 524
++ D ++ G+ + + LP +
Sbjct: 284 LPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--------LP---------------NTDD 320
Query: 525 VAKAGRQWAF--------PLLNVALKCVSNSPDDRPTMAEVLER 560
A G +W F P+ + + +DR + +E
Sbjct: 321 AALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 64/300 (21%), Positives = 117/300 (39%), Gaps = 72/300 (24%)
Query: 329 AVKRLKKLQVSMD--EFSQ---TMRQIGNLKHPNILPL--VCYNSTNEEKL-LVYKYQSN 380
A+KR+K+ D +F+ + ++G HPNI+ L C + L L +Y +
Sbjct: 56 AIKRMKEYASKDDHRDFAGELEVLCKLG--HHPNIINLLGAC---EHRGYLYLAIEYAPH 110
Query: 381 GSLLSLL------------EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPH 428
G+LL L + L A +A+G+D++ +K H
Sbjct: 111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL-----SQKQFIH 165
Query: 429 GNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQG 479
+L NIL+ EN I++ G S+ + + G + A E +
Sbjct: 166 RDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNS 222
Query: 480 DVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP--- 535
DV+S+GV+L E+++ G T P M E+++K G + P
Sbjct: 223 DVWSYGVLLWEIVSLGGT--------PYC--GMTCA----ELYEK--LPQGYRLEKPLNC 266
Query: 536 ---LLNVALKCVSNSPDDRPTMAEVLERIEEV-------VNGNDERDRDHSNSSFSSMES 585
+ ++ +C P +RP+ A++L + + VN ++ S+ E+
Sbjct: 267 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEA 326
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 44/205 (21%), Positives = 78/205 (38%), Gaps = 38/205 (18%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG---NLKHPN--ILPLVCYNSTNEEKL 372
F V + +YA+K + + +I L+ + I+ L Y T++
Sbjct: 45 FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
+V + N L S +++ K+ R S + + + ++Q I H +LK
Sbjct: 105 MVMEC-GNIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLK 154
Query: 433 LSNILLNENEDPL-ISECGYSKFLDPKKT--CLFSSNG---YTAPE-------------- 472
+N L+ + L + + G + + P T S G Y PE
Sbjct: 155 PANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212
Query: 473 -KTVSEQGDVFSFGVILLELLTGKT 496
+S + DV+S G IL + GKT
Sbjct: 213 KSKISPKSDVWSLGCILYYMTYGKT 237
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 41/243 (16%), Positives = 86/243 (35%), Gaps = 40/243 (16%)
Query: 339 SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVY---KYQSNGSLLSLLEAYIEGKR 395
S +I + + V + K+ +Y + +L +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLE 159
Query: 396 DFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455
D + L I IA+ ++F++ K + H +LK SNI ++ + + G +
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHSKG-----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 456 ----DPKKTCLFSSNG-----------YTAPE----KTVSEQGDVFSFGVILLELLTGKT 496
+ + Y +PE S + D+FS G+IL ELL
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF- 273
Query: 497 VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAE 556
T ++ + + + ++ +F ++ + + +S SP +RP +
Sbjct: 274 --STQMERVRIITDVRNLKFP-LLFTQKYPQ--------EHMMVQDMLSPSPTERPEATD 322
Query: 557 VLE 559
++E
Sbjct: 323 IIE 325
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 54/277 (19%), Positives = 105/277 (37%), Gaps = 68/277 (24%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNSTNEEKLLVYKYQSNGSL 383
AVKR+ D + +I L HPN++ C +T+ + + N +L
Sbjct: 42 VAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL-CNLNL 95
Query: 384 LSLLEA---YIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440
L+E+ E + +S+ IA G+ ++ I H +LK NIL++
Sbjct: 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-----IIHRDLKPQNILVST 150
Query: 441 NEDP-------------LISECGYSKFLDPKKTCLFS-------SNGYTAPE-------- 472
+ LIS+ G K LD ++ + ++G+ APE
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210
Query: 473 ---KTVSEQGDVFSFGVILLELLTG-------KTVEKTGIDLPKWVKAMVREEWTGEVFD 522
+ ++ D+FS G + +L+ K ++ I ++ + + + D
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI-----IRGIFSLDEMKCLHD 265
Query: 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559
+ + L++ + + + P RPT +VL
Sbjct: 266 RSLIAEATD----LIS---QMIDHDPLKRPTAMKVLR 295
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 47/275 (17%), Positives = 96/275 (34%), Gaps = 55/275 (20%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQ----IGNLKHPNIL---------PLVCYNST 367
+ YA+KR++ + + + + + + L+HP I+
Sbjct: 26 NKVDDCNYAIKRIRLP--NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83
Query: 368 NEEKLLVY---KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEK 424
+ K+ +Y + +L + + + L I IA+ ++F++ K
Sbjct: 84 SSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSKG---- 138
Query: 425 TIPHGNLKLSNILLNENEDPLISECGYSKFLD----PKKTCLFSSNG-----------YT 469
+ H +LK SNI ++ + + G +D + Y
Sbjct: 139 -LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYM 197
Query: 470 APE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV 525
+PE + S + D+FS G+IL ELL + + + VR +F ++
Sbjct: 198 SPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLT----DVRNLKFPPLFTQKY 253
Query: 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560
+ +S SP +RP ++E
Sbjct: 254 PC--------EYVMVQDMLSPSPMERPEAINIIEN 280
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 47/256 (18%), Positives = 94/256 (36%), Gaps = 50/256 (19%)
Query: 329 AVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
A+K K ++F Q + HP+I+ L V T ++ + + G L
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI---TENPVWIIMELCTLGELR 478
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
S L+ K + A ++ L ++ E K H ++ N+L++ N+
Sbjct: 479 SFLQ---VRKFSLDLASLILYAYQLSTALAYL-----ESKRFVHRDIAARNVLVSSNDCV 530
Query: 445 LISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLELLT- 493
+ + G S++++ + + ++ + APE + + DV+ FGV + E+L
Sbjct: 531 KLGDFGLSRYME--DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 588
Query: 494 GKTVEKTGIDLPKWVKAMVREEWTG-EVFDKEVAKAGR-----QWAFPLLNVALKCVSNS 547
G P +V + + R L ++ KC +
Sbjct: 589 GVK--------PFQ-------GVKNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYD 632
Query: 548 PDDRPTMAEVLERIEE 563
P RP E+ ++
Sbjct: 633 PSRRPRFTELKAQLST 648
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 24/108 (22%), Positives = 46/108 (42%), Gaps = 3/108 (2%)
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLN 131
L +++ + L + + + ++ L+ L+V++LA N I + L LN
Sbjct: 262 GLARSSVRHLDLSHGFVFSL-NSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLN 320
Query: 132 LSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR--QEIKYFD 177
LS NLL L + +D+ NH A F+ ++++ D
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLD 368
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 29/171 (16%), Positives = 62/171 (36%), Gaps = 18/171 (10%)
Query: 13 LICIAILPRLFTGCVGGELSESESFFKFISAVD-SQNVLRIGWNGNLPHPCSYNLKGIKC 71
L I +P + ++ S + + ++ + N++ + N NL +
Sbjct: 374 LTTIHFIPSIP------DIFLSGNKLVTLPKINLTANLIHLSENRL------ENLDILYF 421
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI-----SNCRR 126
L ++ + L S +T + L + L N++Q T +
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 127 LTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYFD 177
L L L+ N L+ P + L L+ L +++N S ++ ++ D
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILD 532
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 24/96 (25%), Positives = 34/96 (35%), Gaps = 2/96 (2%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ + L + ID E L +LR++ L + I P + L L L
Sbjct: 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107
Query: 136 LLSGAV--PLALTKLKHLKTLDISNNHFAATSPDNF 169
LS AV LK L LD+S N +
Sbjct: 108 GLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS 143
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 18/88 (20%), Positives = 41/88 (46%), Gaps = 1/88 (1%)
Query: 74 HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLS 133
++ + L ++ I E L +L+V++L+ NL+ ++ ++ Y++L
Sbjct: 288 TLKDLKVLNLAYNKINKI-ADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346
Query: 134 SNLLSGAVPLALTKLKHLKTLDISNNHF 161
N ++ L+ L+TLD+ +N
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 18/104 (17%), Positives = 37/104 (35%), Gaps = 9/104 (8%)
Query: 82 RLENMNLSG------IIDAETLCKLRHLRVVSLARNLIQG-RIPTSISNCRRLTYLNLSS 134
L + L ++ L+ L + L++N I+ + S L ++ SS
Sbjct: 98 HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157
Query: 135 NLLSGAVPLALTKL--KHLKTLDISNNHFAATSPDNFRQEIKYF 176
N + L L K L ++ N + ++ + + F
Sbjct: 158 NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 85 NMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAV-PL 143
NL+ + L + L+ N I+ +S +L L L S +
Sbjct: 13 FCNLTQVPQV-----LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67
Query: 144 ALTKLKHLKTLDISNNHFAATSPDNFR 170
A L +L+ LD+ ++ PD F+
Sbjct: 68 AFRNLPNLRILDLGSSKIYFLHPDAFQ 94
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 23/123 (18%), Positives = 41/123 (33%), Gaps = 19/123 (15%)
Query: 65 NLKGIKC-NLHATNIVGI---------RLENMNLSG----IIDAETLCKLRHLRVVSLAR 110
LK +K NL I I L+ +NLS + + L + + L +
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 111 NLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
N I + +L L+L N L+ + + + + +S N N
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLT 402
Query: 171 QEI 173
+
Sbjct: 403 ANL 405
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 20/108 (18%), Positives = 40/108 (37%), Gaps = 8/108 (7%)
Query: 74 HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCR--RLTYLN 131
+ + + L + + + KL L+ + + N I + + L++ +
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFS 180
Query: 132 LSSNLLSGAVPLALTKL------KHLKTLDISNNHFAATSPDNFRQEI 173
L++N L V + K L+ LD+S N + NF I
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAI 228
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 25/146 (17%), Positives = 46/146 (31%), Gaps = 24/146 (16%)
Query: 46 SQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSG----IIDAETLCKLR 101
+N+L++ W L L L+ + L+ + L
Sbjct: 459 GENMLQLAWETELCWDVFEGLS--------------HLQVLYLNHNYLNSLPPGVFSHLT 504
Query: 102 HLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
LR +SL N + + + L L++S N L L LDI++N F
Sbjct: 505 ALRGLSLNSNRLT-VLSHN-DLPANLEILDISRNQLLA---PNPDVFVSLSVLDITHNKF 559
Query: 162 AAT-SPDNFRQEIKYFDKYVVETSSS 186
F + + + + +
Sbjct: 560 ICECELSTFINWLNHTNVTIAGPPAD 585
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 63/291 (21%), Positives = 106/291 (36%), Gaps = 56/291 (19%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMR---QI-GNLKHPNILPLVCYNSTNEEKLLVY 375
AVK + K QV +++ Q+ L HPNI+ L + LV
Sbjct: 46 KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
+ + G L I ++ F I + G+ +M++ I H +LK N
Sbjct: 106 EVYTGGELFD----EIISRKRFSEVDAARIIRQVLSGITYMHKNK-----IVHRDLKPEN 156
Query: 436 ILLNENED--PL-ISECGYSKFLDPKKTC--LFSSNGYTAPE---KTVSEQGDVFSFGVI 487
+LL + I + G S + K + Y APE T E+ DV+S GVI
Sbjct: 157 LLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVI 216
Query: 488 LLELLTG-------------KTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534
L LL+G K VEK +W K+V+++ +
Sbjct: 217 LYILLSGCPPFNGANEYDILKKVEKGKYTFE-------LPQW------KKVSESAKD--- 260
Query: 535 PLLNVALKCVSNSPDDRPTMAEVLER--IEEVVNGNDERDRDHSNSSFSSM 583
L+ K ++ P R + + L+ I+ D +++ ++
Sbjct: 261 -LIR---KMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNI 307
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 44/193 (22%), Positives = 75/193 (38%), Gaps = 23/193 (11%)
Query: 318 FMVRLKNSA-VYAVKRLKKLQ-VSMDEFSQTM--RQI----GNLKHPNILPLVCYNSTNE 369
+ R ++ +YA+K L K + + + R + P I+ + T +
Sbjct: 206 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265
Query: 370 EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHG 429
+ + + G L L F A I GL+ M+ + + +
Sbjct: 266 KLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF-----VVYR 316
Query: 430 NLKLSNILLNENEDPLISECGYSKFLDPKKTCLF-SSNGYTAPEKTVSEQG-----DVFS 483
+LK +NILL+E+ IS+ G + KK ++GY APE D FS
Sbjct: 317 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 376
Query: 484 FGVILLELLTGKT 496
G +L +LL G +
Sbjct: 377 LGCMLFKLLRGHS 389
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 24/95 (25%), Positives = 43/95 (45%), Gaps = 5/95 (5%)
Query: 66 LKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCR 125
+ IK N ++ + +L A +++ + L+ N + ++
Sbjct: 2 IHEIKQNG--NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFT 58
Query: 126 RLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
+L LNLSSN+L L L L L+TLD++NN+
Sbjct: 59 KLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNY 91
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 20/91 (21%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
LE++NL I D + L+ + L+ N + + + +T+++L +N L
Sbjct: 170 TLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 140 AVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
+ AL ++L+ D+ N F + +F
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 18/83 (21%), Positives = 32/83 (38%), Gaps = 7/83 (8%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQG-RIPTSISNCRRLTYLNLSSNLL 137
+N+ L+ ++ ++ + L N I ++ L +LNL N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 138 SGAVPLALTKLKHLKTLDISNNH 160
V LKTLD+S+N
Sbjct: 182 Y-DVK-GQVVFAKLKTLDLSSNK 202
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 11/72 (15%), Positives = 27/72 (37%), Gaps = 2/72 (2%)
Query: 100 LRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
++ + + ++ + + + + L+LS N LS L L+ L++S+N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 160 HFAATSPDNFRQ 171
+
Sbjct: 69 VL--YETLDLES 78
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 17/92 (18%), Positives = 38/92 (41%), Gaps = 10/92 (10%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
+LE +NLS + + L L LR + L N + + + L+ ++N +S
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 140 AVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
++ ++ + K + ++NN +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGC 142
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 14/90 (15%), Positives = 32/90 (35%), Gaps = 8/90 (8%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
L ++L+ + + L + + A N I R+ S + + L++N ++
Sbjct: 81 TLRTLDLNNNYV---QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITM 134
Query: 140 AVPLALTKLKHLKTLDISNNHFAATSPDNF 169
L ++ LD+ N +
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 16/103 (15%), Positives = 32/103 (31%), Gaps = 8/103 (7%)
Query: 80 GIRLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
G +E ++ + + +++ LA N I R+ YL+L N
Sbjct: 98 GPSIETLHAANNNISRVSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLN 154
Query: 136 LLSG-AVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYFD 177
+ L+ L++ N ++K D
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLD 197
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 11/55 (20%), Positives = 20/55 (36%)
Query: 117 IPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
I N R ++ + L A+ ++K LD+S N + S +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAP 56
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 61/283 (21%), Positives = 107/283 (37%), Gaps = 66/283 (23%)
Query: 329 AVKRLKKLQVSMDEFS------QTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSN 380
AVK LK DE + M +G +H NI+ L C + L++ +Y
Sbjct: 80 AVKMLKS-TAHADEKEALMSELKIMSHLG--QHENIVNLLGAC--THGGPVLVITEYCCY 134
Query: 381 GSLLSLL----------EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
G LL+ L A+ + L ++ +A+G+ F+ K H +
Sbjct: 135 GDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL-----ASKNCIHRD 189
Query: 431 LKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDV 481
+ N+LL I + G ++ + + N + APE + Q DV
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 482 FSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA---KAGRQWAFP-- 535
+S+G++L E+ + G P + G + + + K G Q A P
Sbjct: 250 WSYGILLWEIFSLGLN--------P----------YPGILVNSKFYKLVKDGYQMAQPAF 291
Query: 536 ----LLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRD 574
+ ++ C + P RPT ++ ++E D R+RD
Sbjct: 292 APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ-EDRRERD 333
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 16/97 (16%), Positives = 43/97 (44%), Gaps = 10/97 (10%)
Query: 65 NLKGIKCNLHATNIVGIRLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSIS 122
+L GI+ +A N ++++ ++ + + L +L + + + ++S
Sbjct: 58 DLTGIE---YAHN-----IKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLS 109
Query: 123 NCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
LT L++S + ++ + L + ++D+S N
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 18/82 (21%), Positives = 34/82 (41%), Gaps = 5/82 (6%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS 138
LE + + G L L L ++ ++ + I T I+ ++ ++LS N
Sbjct: 90 LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
Query: 139 GAVPLALTKLKHLKTLDISNNH 160
+ L L LK+L+I +
Sbjct: 150 TDIM-PLKTLPELKSLNIQFDG 170
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 14/89 (15%), Positives = 31/89 (34%), Gaps = 4/89 (4%)
Query: 83 LENMNLS--GIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
L + L+ + D + +++ +++ IS L L + ++
Sbjct: 46 LTYITLANINVTDLTGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSD 103
Query: 141 VPLALTKLKHLKTLDISNNHFAATSPDNF 169
L+ L L LDIS++ +
Sbjct: 104 KIPNLSGLTSLTLLDISHSAHDDSILTKI 132
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 10/82 (12%), Positives = 23/82 (28%), Gaps = 7/82 (8%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS 138
L +++S + L + + L+ N + L LN+ + +
Sbjct: 114 LTLLDISHSAHDDSILTKINTLPKVNSIDLSYN-GAITDIMPLKTLPELKSLNIQFDGVH 172
Query: 139 GAVPLALTKLKHLKTLDISNNH 160
+ L L +
Sbjct: 173 DYRGIE--DFPKLNQLYAFSQT 192
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 53/280 (18%), Positives = 96/280 (34%), Gaps = 69/280 (24%)
Query: 329 AVKRLKKLQVSMDE---FSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSL 383
AVK LK+ S F + + L+H +I+ VC + L+V++Y +G L
Sbjct: 75 AVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVC--TEGRPLLMVFEYMRHGDL 130
Query: 384 LSLL-------EAYIEGKRDFPWKLR----LSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
L + G+ P L L++A+ +A G+ ++ H +L
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL-----AGLHFVHRDLA 185
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFS 483
N L+ + I + G S+ + + PE + + + DV+S
Sbjct: 186 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245
Query: 484 FGVILLELLT-------GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP- 535
FGV+L E+ T + E D GR+ P
Sbjct: 246 FGVVLWEIFTYGKQPWYQLSNT--------------------EAIDC--ITQGRELERPR 283
Query: 536 -----LLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570
+ + C P R ++ +V R++ +
Sbjct: 284 ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 5e-10
Identities = 22/80 (27%), Positives = 32/80 (40%), Gaps = 4/80 (5%)
Query: 83 LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
L+ +N+ I D L L L + L N + I LT L LS N ++
Sbjct: 267 LKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326
Query: 141 VPLALTKLKHLKTLDISNNH 160
PLA L + + D +N
Sbjct: 327 RPLA--SLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 11/104 (10%)
Query: 72 NLHATNIVGI-------RLENMNLS--GIIDAETLCKLRHLRVVSLARNLIQGRIPTSIS 122
+ I + +L + + I D + L L+++++ N I + ++
Sbjct: 227 KIGNNKITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISD--ISVLN 284
Query: 123 NCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSP 166
N +L L L++N L + L +L TL +S NH P
Sbjct: 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 22/96 (22%), Positives = 41/96 (42%), Gaps = 7/96 (7%)
Query: 65 NLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNC 124
+ I+ + TN+ + L ++ I L L L + + N I +++ N
Sbjct: 55 KVASIQGIEYLTNLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKIT--DISALQNL 109
Query: 125 RRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
L L L+ + +S PLA L + +L++ NH
Sbjct: 110 TNLRELYLNEDNISDISPLA--NLTKMYSLNLGANH 143
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 23/109 (21%), Positives = 42/109 (38%), Gaps = 15/109 (13%)
Query: 72 NLHATNIVGI-------RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSIS 122
+ + + + L +++L+ I D L L L + N I P ++
Sbjct: 161 TVTESKVKDVTPIANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VA 218
Query: 123 NCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
N RL L + +N ++ PLA L L L+I N + + +
Sbjct: 219 NMTRLNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQI--SDINAVKD 263
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 23/109 (21%), Positives = 39/109 (35%), Gaps = 13/109 (11%)
Query: 72 NLHATNIVGI-------RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSIS 122
+ I I RL ++ + I D L L L + + N I ++
Sbjct: 205 TAYVNQITDITPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISD--INAVK 262
Query: 123 NCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
+ +L LN+ SN +S L L L +L ++NN +
Sbjct: 263 DLTKLKMLNVGSNQISDISVLN--NLSQLNSLFLNNNQLGNEDMEVIGG 309
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 1e-07
Identities = 21/85 (24%), Positives = 37/85 (43%), Gaps = 6/85 (7%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
TN+ + L N+S I L L + ++L N + +SN L YL ++ +
Sbjct: 110 TNLRELYLNEDNISDISP---LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTES 165
Query: 136 LLSGAVPLALTKLKHLKTLDISNNH 160
+ P+A L L +L ++ N
Sbjct: 166 KVKDVTPIA--NLTDLYSLSLNYNQ 188
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 2e-07
Identities = 18/85 (21%), Positives = 34/85 (40%), Gaps = 7/85 (8%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ L+ +++ ++ T +L + + +A + I L YLNL+ N
Sbjct: 22 AEGIRAVLQKASVTDVV---TQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGN 76
Query: 136 LLSGAVPLALTKLKHLKTLDISNNH 160
++ PL+ L L L I N
Sbjct: 77 QITDISPLS--NLVKLTNLYIGTNK 99
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 10/60 (16%), Positives = 28/60 (46%), Gaps = 6/60 (10%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS 138
L ++ L+ D E + L +L + L++N I P +++ ++ + ++ ++
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 21/83 (25%), Positives = 38/83 (45%), Gaps = 6/83 (7%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
R + ++ A +++ + L+ N + ++ +L LNLSSN+L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 138 SGAVPLALTKLKHLKTLDISNNH 160
L L L L+TLD++NN+
Sbjct: 71 YE--TLDLESLSTLRTLDLNNNY 91
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 20/90 (22%), Positives = 41/90 (45%), Gaps = 4/90 (4%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
LE++NL I D + L+ + L+ N + + + +T+++L +N L
Sbjct: 170 TLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 140 AVPLALTKLKHLKTLDISNNHFAATSPDNF 169
+ AL ++L+ D+ N F + +F
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 20/90 (22%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQG-RIPTSISNCRRLTYLNLSSNLL 137
+N+ L+ ++ ++ + L N I ++ L +LNL N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 138 SGAVPLALTKLKHLKTLDISNNHFAATSPD 167
V LKTLD+S+N A P+
Sbjct: 182 Y-DVK-GQVVFAKLKTLDLSSNKLAFMGPE 209
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 12/67 (17%), Positives = 27/67 (40%)
Query: 100 LRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
++ + + ++ + + + + L+LS N LS L L+ L++S+N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 160 HFAATSP 166
T
Sbjct: 69 VLYETLD 75
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 14/90 (15%), Positives = 32/90 (35%), Gaps = 8/90 (8%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
L ++L+ + + L + + A N I R+ S + + L++N ++
Sbjct: 81 TLRTLDLNNNYV---QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITM 134
Query: 140 AVPLALTKLKHLKTLDISNNHFAATSPDNF 169
L ++ LD+ N +
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 16/103 (15%), Positives = 32/103 (31%), Gaps = 8/103 (7%)
Query: 80 GIRLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
G +E ++ + + +++ LA N I R+ YL+L N
Sbjct: 98 GPSIETLHAANNNISRVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLN 154
Query: 136 LLSG-AVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYFD 177
+ L+ L++ N ++K D
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLD 197
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 11/55 (20%), Positives = 20/55 (36%)
Query: 117 IPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
I N R ++ + L A+ ++K LD+S N + S +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAP 56
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 24/89 (26%), Positives = 40/89 (44%), Gaps = 2/89 (2%)
Query: 82 RLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAV 141
L++ + I+ E L + L + L N I+ S+S L L+L +N LS V
Sbjct: 199 HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RV 256
Query: 142 PLALTKLKHLKTLDISNNHFAATSPDNFR 170
P L LK L+ + + N+ ++F
Sbjct: 257 PAGLPDLKLLQVVYLHTNNITKVGVNDFC 285
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 30/131 (22%), Positives = 50/131 (38%), Gaps = 13/131 (9%)
Query: 50 LRIGWNGNLPHPCSYNLKGIKC---NLHA------TNIVGIRLENMNLSGIIDAETLCKL 100
L ++ P C +L+ ++C L A + + L+N ++S + + L
Sbjct: 19 LPPTYSAMCPFGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGL 77
Query: 101 RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
+HL + L N I + S R+L L +S N L +P L L L I +N
Sbjct: 78 QHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNR 134
Query: 161 FAATSPDNFRQ 171
F
Sbjct: 135 IRKVPKGVFSG 145
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 21/85 (24%), Positives = 33/85 (38%), Gaps = 9/85 (10%)
Query: 80 GIRLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPT-SISNCRRLTYLNLSS 134
G++L + +S I + L L L N IQ I + +L L L
Sbjct: 171 GLKLNYLRISEAKLTGIPKDLPETLNELH---LDHNKIQ-AIELEDLLRYSKLYRLGLGH 226
Query: 135 NLLSGAVPLALTKLKHLKTLDISNN 159
N + +L+ L L+ L + NN
Sbjct: 227 NQIRMIENGSLSFLPTLRELHLDNN 251
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 15/93 (16%), Positives = 34/93 (36%), Gaps = 8/93 (8%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQ-GRIPTSISNCRRLTYLNLSSNLL 137
L + + + LR++ + + N ++ + +L YL +S L
Sbjct: 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184
Query: 138 SGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
+ +P L + L L + +N A ++
Sbjct: 185 T-GIPKDL--PETLNELHLDHNKIQAIELEDLL 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 61/286 (21%), Positives = 112/286 (39%), Gaps = 74/286 (25%)
Query: 329 AVKRLKKLQVSMDEFS------QTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSN 380
AVK LK + + S + M+ IG KH NI+ L C + + ++ +Y S
Sbjct: 71 AVKMLKD-DATEKDLSDLVSEMEMMKMIG--KHKNIINLLGAC--TQDGPLYVIVEYASK 125
Query: 381 GSLLSLL------------EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPH 428
G+L L + + +K +S +A+G++++ + H
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL-----ASQKCIH 180
Query: 429 GNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQG 479
+L N+L+ EN I++ G ++ ++ ++NG + APE + + Q
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 480 DVFSFGVILLELLT-------GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532
DV+SFGV++ E+ T G VE E+F K G +
Sbjct: 241 DVWSFGVLMWEIFTLGGSPYPGIPVE--------------------ELFKL--LKEGHRM 278
Query: 533 AFP------LLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERD 572
P L + C P RPT +++E ++ ++ +
Sbjct: 279 DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 52/294 (17%), Positives = 96/294 (32%), Gaps = 66/294 (22%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
A+K + + + EF + +++ L V S + L++ + + G L
Sbjct: 59 AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--SQGQPTLVIMELMTRGDLK 116
Query: 385 SLLEAYIEGKRDFPWKLRLS------IATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
S L + + P S +A IA G+ ++ H +L N ++
Sbjct: 117 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL-----NANKFVHRDLAARNCMV 171
Query: 439 NENEDPLISECGYSKFLDPKKTCLFSSNGY-----TAPE----KTVSEQGDVFSFGVILL 489
E+ I + G ++ + G +PE + DV+SFGV+L
Sbjct: 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 231
Query: 490 ELLT-------GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP------L 536
E+ T G + E +V G P L
Sbjct: 232 EIATLAEQPYQGLSNE--------------------QVLRF--VMEGGLLDKPDNCPDML 269
Query: 537 LNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHSNSSFSSMESIPHDS 590
+ C +P RP+ E++ I+E + S + S E+ +
Sbjct: 270 FELMRMCWQYNPKMRPSFLEIISSIKEEM-----EPGFREVSFYYSEENKLPEP 318
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 17/94 (18%), Positives = 31/94 (32%), Gaps = 6/94 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
L ++LS I K++ L + ++ N + + L L+LS N L
Sbjct: 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307
Query: 138 SGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
V + L+ L + +N
Sbjct: 308 L-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHT 340
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 23/81 (28%), Positives = 36/81 (44%), Gaps = 3/81 (3%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
L + L + D L L V L+ N ++ + +RL L +S+N L
Sbjct: 227 ELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV- 285
Query: 140 AVPLALTKLKHLKTLDISNNH 160
A+ L + LK LD+S+NH
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNH 306
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 18/95 (18%), Positives = 34/95 (35%), Gaps = 6/95 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
++ + + + + L V+ L RN + +P I N +LT L++S+N
Sbjct: 94 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 152
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
L L+ L +S+N
Sbjct: 153 LERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS 187
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 19/129 (14%), Positives = 43/129 (33%), Gaps = 13/129 (10%)
Query: 54 WNGNLPHPCSY----------NLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHL 103
+ NL + C + ++ ++ N + +N + + A L R +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL-PAALLDSFRQV 71
Query: 104 RVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFA 162
+++L I+ I T + + L + N + P + L L + N +
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 163 ATSPDNFRQ 171
+ F
Sbjct: 131 SLPRGIFHN 139
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 18/86 (20%), Positives = 34/86 (39%), Gaps = 6/86 (6%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ + + N L + + L+V+ L+ N + + + RL L L N
Sbjct: 272 QRLERLYISNNRLVAL--NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 328
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHF 161
+ L L+ LK L +S+N +
Sbjct: 329 SIV---TLKLSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 18/85 (21%), Positives = 31/85 (36%), Gaps = 9/85 (10%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
L + L + L +S++ N ++ RI L L LSSN
Sbjct: 118 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 176
Query: 137 LSGAVPLALTKLKHLKTLDISNNHF 161
L+ + L+ + L ++S N
Sbjct: 177 LTH---VDLSLIPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 20/84 (23%), Positives = 34/84 (40%), Gaps = 9/84 (10%)
Query: 81 IRLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNL 136
I +E ++ S ++ +L L L N + + N L ++LS N
Sbjct: 205 IAVEELDASHNSINVVRGPVNVELTIL---KLQHNNLT-DTAW-LLNYPGLVEVDLSYNE 259
Query: 137 LSGAVPLALTKLKHLKTLDISNNH 160
L + K++ L+ L ISNN
Sbjct: 260 LEKIMYHPFVKMQRLERLYISNNR 283
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 15/111 (13%), Positives = 38/111 (34%), Gaps = 27/111 (24%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIP-----------------TS 120
+L +++S I+ +T L+ + L+ N + + ++
Sbjct: 142 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLST 200
Query: 121 ISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
++ + L+ S N ++ V + L L + +N+ T
Sbjct: 201 LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLN 246
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 44/286 (15%), Positives = 93/286 (32%), Gaps = 74/286 (25%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNI------------LPLVCYNST 367
+S YA+K+++ + + + + +L H +
Sbjct: 26 RNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85
Query: 368 NEEKL-LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTI 426
+ L + +Y NG+L L+ + + I + L +++ + I
Sbjct: 86 KKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWRLFRQILEALSYIHSQG-----I 137
Query: 427 PHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----------------YT 469
H +LK NI ++E+ + I + G +K + L + Y
Sbjct: 138 IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYV 197
Query: 470 APE-----KTVSEQGDVFSFGVILLELLTG-----------KTVEKTGIDLPKWVKAMVR 513
A E +E+ D++S G+I E++ K + I+ P
Sbjct: 198 ATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPD------ 251
Query: 514 EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559
FD K ++ ++ + + P+ RP +L
Sbjct: 252 -------FDDNKMKVEKK----IIR---LLIDHDPNKRPGARTLLN 283
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 57/271 (21%), Positives = 98/271 (36%), Gaps = 59/271 (21%)
Query: 329 AVKRLKKLQVSMD--EFS---QTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNG 381
AVK LK + + + +G H NI+ L C + L++ +Y G
Sbjct: 57 AVKMLKPSAHLTEREALMSELKVLSYLG--NHMNIVNLLGAC--TIGGPTLVITEYCCYG 112
Query: 382 SLLSLL------------EAYIEGKRDFPWKLR--LSIATGIAKGLDFMYQKSNEEKTIP 427
LL+ L I + L LS + +AKG+ F+ K
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-----ASKNCI 167
Query: 428 HGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQ 478
H +L NILL I + G ++ + + N + APE + +
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227
Query: 479 GDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP--- 535
DV+S+G+ L EL + + G+ + M++E G P
Sbjct: 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE---GFRMLS-----------PEHA 273
Query: 536 ---LLNVALKCVSNSPDDRPTMAEVLERIEE 563
+ ++ C P RPT ++++ IE+
Sbjct: 274 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 17/94 (18%), Positives = 31/94 (32%), Gaps = 6/94 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
L ++LS I K++ L + ++ N + + L L+LS N L
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313
Query: 138 SGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
V + L+ L + +N
Sbjct: 314 L-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHT 346
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 23/90 (25%), Positives = 37/90 (41%), Gaps = 3/90 (3%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
L + L + D L L V L+ N ++ + +RL L +S+N L
Sbjct: 233 ELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV- 291
Query: 140 AVPLALTKLKHLKTLDISNNHFAATSPDNF 169
A+ L + LK LD+S+NH +
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLHVERNQP 321
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 18/95 (18%), Positives = 34/95 (35%), Gaps = 6/95 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
++ + + + + L V+ L RN + +P I N +LT L++S+N
Sbjct: 100 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 158
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
L L+ L +S+N
Sbjct: 159 LERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS 193
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 19/129 (14%), Positives = 43/129 (33%), Gaps = 13/129 (10%)
Query: 54 WNGNLPHPCSY----------NLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHL 103
+ NL + C + ++ ++ N + +N + + A L R +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 104 RVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFA 162
+++L I+ I T + + L + N + P + L L + N +
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 163 ATSPDNFRQ 171
+ F
Sbjct: 137 SLPRGIFHN 145
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 6/94 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
++E +NL+ ID ++ + + N I+ +P + N LT L L N
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
LS L TL +SNN+ D F+
Sbjct: 135 LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 168
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 9/97 (9%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
L + L + L +S++ N ++ RI L L LSSN
Sbjct: 124 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 182
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEI 173
L+ + L+ + L ++S N + + +E+
Sbjct: 183 LTH---VDLSLIPSLFHANVSYNLLSTLAIPIAVEEL 216
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 9e-07
Identities = 18/86 (20%), Positives = 34/86 (39%), Gaps = 6/86 (6%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ + + N L + + L+V+ L+ N + + + RL L L N
Sbjct: 278 QRLERLYISNNRLVAL--NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 334
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHF 161
+ L L+ LK L +S+N +
Sbjct: 335 SIV---TLKLSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 20/84 (23%), Positives = 35/84 (41%), Gaps = 9/84 (10%)
Query: 81 IRLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNL 136
I +E ++ S ++ +L L+ L N + + N L ++LS N
Sbjct: 211 IAVEELDASHNSINVVRGPVNVELTILK---LQHNNLT-DTAW-LLNYPGLVEVDLSYNE 265
Query: 137 LSGAVPLALTKLKHLKTLDISNNH 160
L + K++ L+ L ISNN
Sbjct: 266 LEKIMYHPFVKMQRLERLYISNNR 289
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 15/111 (13%), Positives = 38/111 (34%), Gaps = 27/111 (24%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIP-----------------TS 120
+L +++S I+ +T L+ + L+ N + + ++
Sbjct: 148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLST 206
Query: 121 ISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
++ + L+ S N ++ V + L L + +N+ T
Sbjct: 207 LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLN 252
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 16/77 (20%), Positives = 25/77 (32%), Gaps = 5/77 (6%)
Query: 95 ETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154
TL + + + N I + + LT L L N L+ L L +
Sbjct: 205 STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEV 259
Query: 155 DISNNHFAATSPDNFRQ 171
D+S N F +
Sbjct: 260 DLSYNELEKIMYHPFVK 276
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 47/183 (25%), Positives = 75/183 (40%), Gaps = 31/183 (16%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385
A+K + K Q++ + R++ +K HPNI+ L T + L+ +Y S G +
Sbjct: 44 AIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD 103
Query: 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
Y+ K S I + + +QK I H +LK N+LL+ + +
Sbjct: 104 ----YLVAHGRMKEKEARSKFRQIVSAVQYCHQKR-----IVHRDLKAENLLLDADMNIK 154
Query: 446 ISECGYSKFLDP----KKTC---------LFSSNGYTAPEKTVSEQGDVFSFGVILLELL 492
I++ G+S C LF Y PE DV+S GVIL L+
Sbjct: 155 IADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE------VDVWSLGVILYTLV 208
Query: 493 TGK 495
+G
Sbjct: 209 SGS 211
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 19/97 (19%), Positives = 44/97 (45%), Gaps = 1/97 (1%)
Query: 74 HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLS 133
H ++ +RL ++N++ I + +L L+V+ ++ + + LT L+++
Sbjct: 174 HLHGLIVLRLRHLNINAI-RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT 232
Query: 134 SNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L+ LA+ L +L+ L++S N +
Sbjct: 233 HCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLH 269
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 23/95 (24%), Positives = 35/95 (36%), Gaps = 1/95 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
T + L + ++ + HL + L N++ P + +N L L L SN
Sbjct: 32 TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L T L +L LDIS N F+
Sbjct: 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQ 125
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 19/94 (20%), Positives = 35/94 (37%), Gaps = 6/94 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
L +++S I+ L +L+ + + N + I S L L L
Sbjct: 105 NLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCN 163
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L+ AL+ L L L + + + A +F+
Sbjct: 164 LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFK 197
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 24/100 (24%), Positives = 43/100 (43%), Gaps = 3/100 (3%)
Query: 73 LHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLN 131
L+ N+ + + + NL+ + + L +LR ++L+ N I I S+ RL +
Sbjct: 221 LYGLNLTSLSITHCNLTAV-PYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQ 278
Query: 132 LSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
L L+ P A L +L+ L++S N F
Sbjct: 279 LVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHS 318
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 22/95 (23%), Positives = 34/95 (35%), Gaps = 1/95 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
++ + LE NL+ I E L L L V+ L I S RL L +S
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
+ +L +L I++ + A R
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 20/93 (21%), Positives = 38/93 (40%), Gaps = 6/93 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPT-SISNCRRLTYLNLSSNL 136
L+++ + I L L ++L + + IPT ++S+ L L L
Sbjct: 129 NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLN 187
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
++ + +L LK L+IS+ + T N
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC 220
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 15/93 (16%), Positives = 30/93 (32%), Gaps = 4/93 (4%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
L + L +I L +L + ++ N I + + L L + N L
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 138 SGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
A + L L+ L + + + +
Sbjct: 141 VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALS 173
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 21/103 (20%), Positives = 39/103 (37%), Gaps = 13/103 (12%)
Query: 72 NLHATNIVGI---------RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIP 118
++ N+ + L +NLS I+ L +L L+ + L + P
Sbjct: 230 SITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP 289
Query: 119 TSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+ L LN+S N L+ + +L+TL + +N
Sbjct: 290 YAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 20/186 (10%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYK 376
YAVK + K + S +R++ L HPNI+ L + +V +
Sbjct: 42 KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
+ G L I ++ F I + G+ +M++ + I H +LK NI
Sbjct: 102 LYTGGELFD----EIIKRKRFSEHDAARIIKQVFSGITYMHKHN-----IVHRDLKPENI 152
Query: 437 LL-NENEDPLISEC--GYSKFLDPKKTC--LFSSNGYTAPE---KTVSEQGDVFSFGVIL 488
LL ++ +D I G S + Y APE T E+ DV+S GVIL
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVIL 212
Query: 489 LELLTG 494
LL+G
Sbjct: 213 YILLSG 218
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 61/277 (22%), Positives = 109/277 (39%), Gaps = 74/277 (26%)
Query: 329 AVKRLKKLQVSMDEFS------QTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSN 380
AVK LK + + S + M+ IG KH NI+ L C + + ++ +Y S
Sbjct: 117 AVKMLKD-DATEKDLSDLVSEMEMMKMIG--KHKNIINLLGAC--TQDGPLYVIVEYASK 171
Query: 381 GSLLSLL------------EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPH 428
G+L L + + +K +S +A+G++++ + H
Sbjct: 172 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL-----ASQKCIH 226
Query: 429 GNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQG 479
+L N+L+ EN I++ G ++ ++ ++NG + APE + + Q
Sbjct: 227 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 286
Query: 480 DVFSFGVILLELLT-------GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532
DV+SFGV++ E+ T G VE E+F K G +
Sbjct: 287 DVWSFGVLMWEIFTLGGSPYPGIPVE--------------------ELFKL--LKEGHRM 324
Query: 533 AFP------LLNVALKCVSNSPDDRPTMAEVLERIEE 563
P L + C P RPT +++E ++
Sbjct: 325 DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 52/276 (18%), Positives = 98/276 (35%), Gaps = 67/276 (24%)
Query: 329 AVKRLKKLQVSMD--EFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
A+K LK EF L+HPN++ L V + ++ +++ Y S+G L
Sbjct: 43 AIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV--TKDQPLSMIFSYCSHGDLH 100
Query: 385 SLL--------EAYIEGKRDFPWKLR----LSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
L + R L + + IA G++++ + H +L
Sbjct: 101 EFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL-----SSHHVVHKDLA 155
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFS 483
N+L+ + + IS+ G + + N + APE S D++S
Sbjct: 156 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 215
Query: 484 FGVILLELLT-------GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP- 535
+GV+L E+ + G + + V M+R +V P
Sbjct: 216 YGVVLWEVFSYGLQPYCGYSNQD--------VVEMIRN---RQVLPC-----------PD 253
Query: 536 -----LLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566
+ + ++C + P RP ++ R+ N
Sbjct: 254 DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 289
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 39/208 (18%)
Query: 309 RSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLVC-Y 364
+ + I + F R E Q ++I LK HPN++ LV
Sbjct: 48 KKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE--QVYQEIAILKKLDHPNVVKLVEVL 105
Query: 365 NSTNEEKL-LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATG------IAKGLDFMY 417
+ NE+ L +V++ + G ++ + P LS + KG+++++
Sbjct: 106 DDPNEDHLYMVFELVNQGPVM-----------EVPTLKPLSEDQARFYFQDLIKGIEYLH 154
Query: 418 QKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPEKT 474
+ I H ++K SN+L+ E+ I++ G S L ++ G + APE
Sbjct: 155 YQK-----IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESL 209
Query: 475 VSEQG-------DVFSFGVILLELLTGK 495
+ DV++ GV L + G+
Sbjct: 210 SETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 22/95 (23%), Positives = 40/95 (42%), Gaps = 2/95 (2%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
++ + L + I L +LR ++LA ++ IP ++ +L L+LS N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGN 217
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
LS P + L HL+ L + + + F
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD 252
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 31/118 (26%), Positives = 44/118 (37%), Gaps = 10/118 (8%)
Query: 62 CSYNLKGIKC---NLHA------TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNL 112
CS + C NL TN + L + II + LRHL ++ L+RN
Sbjct: 41 CSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99
Query: 113 IQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
I+ + + L L L N L+ A L LK L + NN + F
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 18/90 (20%), Positives = 35/90 (38%), Gaps = 2/90 (2%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
L +NL+ + + L L L + L+ N + P S L L + + +
Sbjct: 186 NLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245
Query: 140 AVPLALTKLKHLKTLDISNNHFAATSPDNF 169
A L+ L +++++N+ D F
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLTLLPHDLF 275
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 25/99 (25%), Positives = 45/99 (45%), Gaps = 11/99 (11%)
Query: 72 NLHATNIVGI-------RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTS 120
NL N+ I +L+ ++LSG I + L HL+ + + ++ IQ +
Sbjct: 191 NLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNA 250
Query: 121 ISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
N + L +NL+ N L+ T L HL+ + + +N
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 21/95 (22%), Positives = 34/95 (35%), Gaps = 7/95 (7%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
LE + LS I+ L +L + L N + IP +L L L +N
Sbjct: 89 HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNP 147
Query: 137 LSGAVPLALTKLKHLKTLDIS-NNHFAATSPDNFR 170
+ A ++ L+ LD+ + S F
Sbjct: 148 IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 55/278 (19%), Positives = 96/278 (34%), Gaps = 70/278 (25%)
Query: 329 AVKRLKKLQVSMDE---FSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSL 383
AVK LK ++ F + + NL+H +I+ VC + ++V++Y +G L
Sbjct: 49 AVKALK--DPTLAARKDFQREAELLTNLQHEHIVKFYGVC--GDGDPLIMVFEYMKHGDL 104
Query: 384 LSLL------------EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
L + K + L IA+ IA G+ ++ + H +L
Sbjct: 105 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL-----ASQHFVHRDL 159
Query: 432 KLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVF 482
N L+ N I + G S+ + + + PE + + + DV+
Sbjct: 160 ATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 219
Query: 483 SFGVILLELLT-------GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535
SFGVIL E+ T + EV + GR P
Sbjct: 220 SFGVILWEIFTYGKQPWFQLSNT--------------------EVIEC--ITQGRVLERP 257
Query: 536 ------LLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567
+ +V L C P R + E+ + + +
Sbjct: 258 RVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 42/190 (22%), Positives = 84/190 (44%), Gaps = 20/190 (10%)
Query: 318 FMVRLKNSA-VYAVKRLKKLQV-SMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEEKL 372
+++ + +YA K+L+K ++ + + +QI + ++ L T +
Sbjct: 201 CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
LV + G L + Y G+ FP + A I GL+ ++++ I + +LK
Sbjct: 261 LVLTLMNGGDLKFHI--YHMGQAGFPEARAVFYAAEICCGLEDLHRER-----IVYRDLK 313
Query: 433 LSNILLNENEDPLISECGYSK-FLDPKKTCLF-SSNGYTAPEKTVSEQG-----DVFSFG 485
NILL+++ IS+ G + + + + GY APE V + D ++ G
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE-VVKNERYTFSPDWWALG 372
Query: 486 VILLELLTGK 495
+L E++ G+
Sbjct: 373 CLLYEMIAGQ 382
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 56/281 (19%), Positives = 108/281 (38%), Gaps = 62/281 (22%)
Query: 329 AVKRLKKL--QVSMDEF---SQTMRQIGNLKHPNILPL--VCYNSTNEEK--LLVYKYQS 379
AVK LK+ + + IG H N++ L C T +++ ++
Sbjct: 61 AVKMLKEGATHSEHRALMSELKILIHIG--HHLNVVNLLGAC---TKPGGPLMVIVEFCK 115
Query: 380 NGSLLSLL--------EAYIEGKRDFPWKLR----LSIATGIAKGLDFMYQKSNEEKTIP 427
G+L + L + + + L + + +AKG++F+ +
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL-----ASRKCI 170
Query: 428 HGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQ 478
H +L NILL+E I + G ++ + + + + APE + + Q
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 230
Query: 479 GDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP-- 535
DV+SFGV+L E+ + G + G+ + + ++E G P
Sbjct: 231 SDVWSFGVLLWEIFSLGAS-PYPGVKIDEEFCRRLKE---GTRMRA-----------PDY 275
Query: 536 ----LLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERD 572
+ L C P RPT +E++E + ++ N ++D
Sbjct: 276 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 47/190 (24%), Positives = 80/190 (42%), Gaps = 36/190 (18%)
Query: 329 AVKRLKK--LQVSMDEFSQTMRQIGNLK---HPNILPL--VCYNSTNEEKLLVYKYQSNG 381
AVK LKK L+ + + ++I L+ H N++ L V YN ++ +V +Y G
Sbjct: 34 AVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG 93
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATG----IAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+ +L+ + KR + A G + GL++++ + I H ++K N+L
Sbjct: 94 -MQEMLD-SVPEKR-----FPVCQAHGYFCQLIDGLEYLHSQG-----IVHKDIKPGNLL 141
Query: 438 LNENEDPLISECGYSKFLDPK------KTCLFSSNGYTAPEKTVSEQG------DVFSFG 485
L IS G ++ L P +T S + PE D++S G
Sbjct: 142 LTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA-FQPPEIANGLDTFSGFKVDIWSAG 200
Query: 486 VILLELLTGK 495
V L + TG
Sbjct: 201 VTLYNITTGL 210
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 27/109 (24%), Positives = 44/109 (40%), Gaps = 10/109 (9%)
Query: 62 CSYN-LKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTS 120
+ N + + T + ++L +S I L L L + L N ++ P
Sbjct: 250 LANNQISNLAPLSGLTKLTELKLGANQISNISP---LAGLTALTNLELNENQLEDISP-- 304
Query: 121 ISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
ISN + LTYL L N +S P++ L L+ L NN + +
Sbjct: 305 ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKV--SDVSSL 349
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 17/96 (17%), Positives = 41/96 (42%), Gaps = 7/96 (7%)
Query: 65 NLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNC 124
N+ + ++ + + + I + + L +L ++ + N + P + N
Sbjct: 35 NVTDTVSQTDLDQVTTLQADRLGIKSI---DGVEYLNNLTQINFSNNQLTDITP--LKNL 89
Query: 125 RRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
+L + +++N ++ PLA L +L L + NN
Sbjct: 90 TKLVDILMNNNQIADITPLA--NLTNLTGLTLFNNQ 123
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 17/85 (20%), Positives = 32/85 (37%), Gaps = 7/85 (8%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ L N++ + + L + + R I+ + LT +N S+N
Sbjct: 24 AEKMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNN 78
Query: 136 LLSGAVPLALTKLKHLKTLDISNNH 160
L+ PL L L + ++NN
Sbjct: 79 QLTDITPLK--NLTKLVDILMNNNQ 101
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 24/79 (30%), Positives = 35/79 (44%), Gaps = 6/79 (7%)
Query: 83 LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
L ++ ++ I D L L +L ++L N I P + N L L LSSN +S
Sbjct: 92 LVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD- 148
Query: 141 VPLALTKLKHLKTLDISNN 159
AL+ L L+ L N
Sbjct: 149 -ISALSGLTSLQQLSFGNQ 166
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 25/101 (24%), Positives = 43/101 (42%), Gaps = 9/101 (8%)
Query: 62 CSYN-LKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTS 120
N + I + TN+ + L + +S I L L L+ +S +
Sbjct: 119 LFNNQITDIDPLKNLTNLNRLELSSNTISDI---SALSGLTSLQQLSFGNQVTD---LKP 172
Query: 121 ISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
++N L L++SSN +S L KL +L++L +NN
Sbjct: 173 LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI 211
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 25/104 (24%), Positives = 47/104 (45%), Gaps = 13/104 (12%)
Query: 72 NLHATNIVGI-------RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSIS 122
++ + + I LE++ + I D L L +L +SL N ++ +++
Sbjct: 183 DISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLA 240
Query: 123 NCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSP 166
+ LT L+L++N +S PL+ L L L + N + SP
Sbjct: 241 SLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 15/79 (18%), Positives = 29/79 (36%), Gaps = 4/79 (5%)
Query: 83 LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
L+ + + D +L L ++ +S N I P ++N R+T L L+ + A
Sbjct: 333 LQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390
Query: 141 VPLALTKLKHLKTLDISNN 159
+ T+
Sbjct: 391 PVNYKANVSIPNTVKNVTG 409
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 24/94 (25%), Positives = 41/94 (43%), Gaps = 5/94 (5%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
L +++S + L L V+ +A N Q I + R LT+L+LS
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L P A L L+ L++S+N+F + ++
Sbjct: 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 17/91 (18%), Positives = 36/91 (39%), Gaps = 2/91 (2%)
Query: 81 IRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNC-RRLTYLNLSSNLLSG 139
+++ + + +LR+L + L++ ++ ++ + N L LN+S N
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS 213
Query: 140 AVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L L+ LD S NH + +
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 17/96 (17%), Positives = 37/96 (38%), Gaps = 8/96 (8%)
Query: 82 RLENMNLSG------IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+L ++LS +++ L+ + L+ N + + ++ +L +L+ +
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 111
Query: 136 LLSGAVPL-ALTKLKHLKTLDISNNHFAATSPDNFR 170
L L++L LDIS+ H F
Sbjct: 112 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 16/95 (16%), Positives = 34/95 (35%), Gaps = 3/95 (3%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSS 134
T++ + L + + + L L + + ++ S+ + R L YL++S
Sbjct: 78 TSLKYLDLSFNGVITM--SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135
Query: 135 NLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
A L L+ L ++ N F +
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 17/86 (19%), Positives = 31/86 (36%), Gaps = 5/86 (5%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
L ++LS + L L+V++++ N L L+ S N +
Sbjct: 176 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235
Query: 138 SGAVPLALTKL-KHLKTLDISNNHFA 162
+ L L L+++ N FA
Sbjct: 236 MTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 22/71 (30%), Positives = 28/71 (39%), Gaps = 3/71 (4%)
Query: 102 HLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS--GAVPLALTKLKHLKTLDISNN 159
+ L N +Q +LT L+LSSN LS G + LK LD+S N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 160 HFAATSPDNFR 170
T NF
Sbjct: 89 GV-ITMSSNFL 98
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 15/54 (27%), Positives = 20/54 (37%), Gaps = 2/54 (3%)
Query: 116 RIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
+PT I T L L SN L KL L L +S+N + +
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 64/301 (21%), Positives = 107/301 (35%), Gaps = 66/301 (21%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG--------------NLKHPNILPLVCYN 365
+ A+K +KK Q +S + I +L HPNI+ L
Sbjct: 56 KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115
Query: 366 STNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKT 425
+ LV ++ G L I + F +I I G+ ++++ +
Sbjct: 116 EDKKYFYLVTEFYEGGELFE----QIINRHKFDECDAANIMKQILSGICYLHKHN----- 166
Query: 426 IPHGNLKLSNILLNENED--PL-ISECGYSKFLDPKKTC--LFSSNGYTAPE---KTVSE 477
I H ++K NILL + I + G S F + Y APE K +E
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNE 226
Query: 478 QGDVFSFGVILLELLTG-------------KTVEKTGIDLPKWVKAMVREEWTGEVFDKE 524
+ DV+S GVI+ LL G K VEK +W K
Sbjct: 227 KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD-------FNDW------KN 273
Query: 525 VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVVNGNDERDRDHSNSSFSS 582
++ ++ L+ ++ + R T E L I++ N ++ D+ + S+
Sbjct: 274 ISDEAKE----LIK---LMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSN 326
Query: 583 M 583
M
Sbjct: 327 M 327
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 23/95 (24%), Positives = 34/95 (35%), Gaps = 7/95 (7%)
Query: 82 RLENMNLSG-----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSN 135
LE ++LS +D T L L + L R +Q + + L YL L N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L L +L L + N ++ FR
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 21/82 (25%), Positives = 35/82 (42%), Gaps = 4/82 (4%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
L ++ L G + L L + L +N + P + + RL L L +N L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 138 SGAVPLALTKLKHLKTLDISNN 159
S AL L+ L+ L +++N
Sbjct: 214 SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 1/89 (1%)
Query: 82 RLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAV 141
L++ L + +T L +L + L N I + L L L N ++
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 142 PLALTKLKHLKTLDISNNHFAATSPDNFR 170
P A L L TL + N+ +A +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALA 222
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 23/94 (24%), Positives = 32/94 (34%), Gaps = 5/94 (5%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
L + L IDA L L + L+ N + + RL L+L
Sbjct: 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
L P L L+ L + +N A D FR
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 21/57 (36%), Positives = 28/57 (49%)
Query: 103 LRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
+ + L N I S CR LT L L SN+L+ A T L L+ LD+S+N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 14/96 (14%), Positives = 37/96 (38%)
Query: 74 HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLS 133
+ TN+ +R+ N+ I L L + + ++ S+ + R + +L L
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 134 SNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
+ + + + L ++ L++ + + A
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 13/111 (11%), Positives = 33/111 (29%), Gaps = 4/111 (3%)
Query: 63 SYN-LKGIKCNL--HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIP- 118
S N L + + +++ + L + L +L+ + + I
Sbjct: 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
Query: 119 TSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
+ L L + + L +L ++ + L + + A
Sbjct: 142 IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 15/93 (16%), Positives = 34/93 (36%), Gaps = 4/93 (4%)
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLN 131
+ I + + L + L ++ +++ + + + + + L +L+
Sbjct: 282 KVETVTIRRLHIPQFYLFYD-LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLD 340
Query: 132 LSSNLLSGAV---PLALTKLKHLKTLDISNNHF 161
LS NL+ L+TL +S NH
Sbjct: 341 LSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 4/83 (4%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS 138
+++++LS I L +L+V+ L + I + + L +L+LS N LS
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 139 GAVPLALTKLKHLKTLDISNNHF 161
L LK L++ N +
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPY 110
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 21/96 (21%), Positives = 33/96 (34%), Gaps = 6/96 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
L+ + L I+ + L L + L+ N + + L YLNL N
Sbjct: 51 NLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110
Query: 138 SG-AVPLALTKLKHLKTLDIS-NNHFAATSPDNFRQ 171
V L +L+TL I F+ +F
Sbjct: 111 QTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 23/98 (23%), Positives = 38/98 (38%), Gaps = 10/98 (10%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRI---PTSISNCRRLTYLNLSS 134
+++ + + ++ L+ L + L+ NL+ L L LS
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 135 NLLS--GAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
N L L LK+L +LDIS N F PD+ +
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQ 407
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 18/72 (25%), Positives = 31/72 (43%)
Query: 100 LRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
++ + L+ N I + C L L L S+ ++ A L L+ LD+S+N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 160 HFAATSPDNFRQ 171
H ++ S F
Sbjct: 85 HLSSLSSSWFGP 96
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 15/98 (15%), Positives = 40/98 (40%), Gaps = 10/98 (10%)
Query: 82 RLENMNLSG-------IIDAETLCKLRHLRVVSLARNLIQ--GRIPTSISNCRRLTYLNL 132
LE ++LS + ++ L+ + L++N ++ + + + LT L++
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394
Query: 133 SSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
S N +P + + ++ L++S+ +
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQ 431
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 16/118 (13%), Positives = 37/118 (31%), Gaps = 5/118 (4%)
Query: 57 NLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLAR-----N 111
+ L L L + +++ + +L + V++ R
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 112 LIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
+ + T S ++ + + ++ + LK L+ LD+S N N
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 17/96 (17%), Positives = 33/96 (34%), Gaps = 6/96 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQG-RIPTSISNCRRLTYLNLSS-N 135
LE+++LS + + L L+ ++L N Q + + N L L + +
Sbjct: 75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
S + L L L+I + +
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 13/62 (20%), Positives = 27/62 (43%), Gaps = 2/62 (3%)
Query: 100 LRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
L L+ + ++RN ++ +P S L + +S N L +L L+ + + N
Sbjct: 450 LPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 160 HF 161
+
Sbjct: 508 PW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 19/115 (16%)
Query: 81 IRLENMNLSGI-IDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS- 138
+ L +L + E L L++L + ++RN +P S ++ +LNLSS +
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV 424
Query: 139 --GAVPLALTKLK--------------HLKTLDISNNHFAATSPDNFRQEIKYFD 177
+P L L L+ L IS N + +
Sbjct: 425 VKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMK 479
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 19/90 (21%), Positives = 33/90 (36%), Gaps = 7/90 (7%)
Query: 82 RLENMNLSG-IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
++ +NLS I C + L V+ ++ N + + L L +S N L
Sbjct: 411 KMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-T 465
Query: 141 VPLALTKLKHLKTLDISNNHFAATSPDNFR 170
+P + L + IS N + F
Sbjct: 466 LP-DASLFPVLLVMKISRNQLKSVPDGIFD 494
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 32/133 (24%), Positives = 59/133 (44%), Gaps = 20/133 (15%)
Query: 65 NLKGIKCNLHATNIVGIR--------LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQ 114
++K + + +N + LE ++ + L KL L+ + L+ N +
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVS 77
Query: 115 GRIPTSISNCRRLTYLNLSSNLLSG-AVPLALTKLKHLKTLDISNNHFAATSPDNFRQEI 173
G + C LT+LNLS N + + L KL++LK+LD+ N T+ +++R+ +
Sbjct: 78 GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV--TNLNDYRENV 135
Query: 174 -------KYFDKY 179
Y D Y
Sbjct: 136 FKLLPQLTYLDGY 148
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-08
Identities = 21/94 (22%), Positives = 38/94 (40%), Gaps = 8/94 (8%)
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISN---CRRLT 128
N +++ + L+N + + L +S + TSI+N +L
Sbjct: 13 NRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLK 67
Query: 129 YLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFA 162
L LS N +SG + + K +L L++S N
Sbjct: 68 KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 38/200 (19%)
Query: 322 LKNSAVYAVKR--LKKLQVSMDEFSQ---TMRQIGNLKHPNILPLVCYNS-TNEEKL-LV 374
A+KR L+K Q SMDE + M Q HPNI+ Y S +++L LV
Sbjct: 37 APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ---CHHPNIVS--YYTSFVVKDELWLV 91
Query: 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLR-LSIAT---GIAKGLDFMYQKSNEEKTIPHGN 430
K S GS+L +++ + L +IAT + +GL++++ + I H +
Sbjct: 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH----KNGQI-HRD 146
Query: 431 LKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYT--------APEKTVSEQG--- 479
+K NILL E+ I++ G S FL + T APE V EQ
Sbjct: 147 VKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE--VMEQVRGY 204
Query: 480 ----DVFSFGVILLELLTGK 495
D++SFG+ +EL TG
Sbjct: 205 DFKADIWSFGITAIELATGA 224
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 40/178 (22%), Positives = 74/178 (41%), Gaps = 21/178 (11%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
+A K + + ++I L+HP ++ L + E +++Y++ S G L
Sbjct: 185 FAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL-NENED 443
E + + + KGL M++ + H +LK NI+ + +
Sbjct: 243 ---EKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSN 294
Query: 444 PL-ISECGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTG 494
L + + G + LDPK+ + + APE K V D++S GV+ LL+G
Sbjct: 295 ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 37/185 (20%), Positives = 68/185 (36%), Gaps = 36/185 (19%)
Query: 329 AVKRLKKLQVSMDEFSQT-MRQIGNLKHPNILPLVCY--NSTNEEKLLVY-KYQSNGSLL 384
AVK +V ++ F + L P I V + ++ + GSL
Sbjct: 87 AVK-----KVRLEVFRVEELVACAGLSSPRI---VPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
L++ P L +GL++++ + I HG++K N+LL+ +
Sbjct: 139 QLIKQM----GCLPEDRALYYLGQALEGLEYLHTRR-----ILHGDVKADNVLLSSDGSR 189
Query: 445 L-ISECGYSKFLDPKKTCLFSSNGYT--------APEKTVSEQG-----DVFSFGVILLE 490
+ + G++ L P G APE V + D++S ++L
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLH 248
Query: 491 LLTGK 495
+L G
Sbjct: 249 MLNGC 253
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 35/110 (31%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 83 LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
LE ++L +I L KL L+ + L+ N I G + LT+LNLS N L
Sbjct: 51 LEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110
Query: 141 VPLA-LTKLKHLKTLDISNNHFAATSPDNFRQEI-------KYFDKYVVE 182
L L KL+ LK+LD+ N T+ +++R+ + Y D Y E
Sbjct: 111 STLEPLKKLECLKSLDLFNCEV--TNLNDYRESVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 8e-07
Identities = 17/82 (20%), Positives = 35/82 (42%), Gaps = 2/82 (2%)
Query: 81 IRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
+ L+N + + +L +SL + + +++ +L L LS N + G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGG 86
Query: 141 VPLALTKLKHLKTLDISNNHFA 162
+ + KL +L L++S N
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLK 108
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 35/203 (17%), Positives = 71/203 (34%), Gaps = 46/203 (22%)
Query: 322 LKNSAVYAVKRLKKLQVSMDEFS------QTMRQIGNLKHPNILPLVCYNS-TNEEKL-L 373
V+R+ S + + + HPNI+P + + +L +
Sbjct: 49 KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL---FNHPNIVP--YRATFIADNELWV 103
Query: 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIAT---GIAKGLDFMYQKSNEEKTIPHGN 430
V + + GS L+ + + IA G+ K LD+++ + H +
Sbjct: 104 VTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVLKALDYIHH----MGYV-HRS 153
Query: 431 LKLSNILLNENEDPLISECGYSKFLDP----KKTCLFSSNGYT------APEKTVSEQG- 479
+K S+IL++ + +S + + ++ +PE V +Q
Sbjct: 154 VKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE--VLQQNL 211
Query: 480 -------DVFSFGVILLELLTGK 495
D++S G+ EL G
Sbjct: 212 QGYDAKSDIYSVGITACELANGH 234
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 2/89 (2%)
Query: 82 RLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAV 141
L + I L +L+ ++L I+ +P ++ L L +S N
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIR 234
Query: 142 PLALTKLKHLKTLDISNNHFAATSPDNFR 170
P + L LK L + N+ + + F
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFD 263
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 31/119 (26%), Positives = 45/119 (37%), Gaps = 12/119 (10%)
Query: 62 CSYNLKGIKC---NLHA------TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNL 112
CS + C L +N + L N+ +I A+T L HL V+ L RN
Sbjct: 52 CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110
Query: 113 IQGRIPTSI-SNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
I+ +I + L L L N L+ A L L+ L + NN + F
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 21/90 (23%), Positives = 37/90 (41%), Gaps = 2/90 (2%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
L+ +NL I D L L L + ++ N P S L L + ++ +S
Sbjct: 197 NLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256
Query: 140 AVPLALTKLKHLKTLDISNNHFAATSPDNF 169
A L L L++++N+ ++ D F
Sbjct: 257 IERNAFDGLASLVELNLAHNNLSSLPHDLF 286
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 19/82 (23%), Positives = 33/82 (40%), Gaps = 4/82 (4%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
LE + +SG I + L L+ + + + + + L LNL+ N L
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
Query: 138 SGAVPLALTKLKHLKTLDISNN 159
S T L++L L + +N
Sbjct: 279 SSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 20/95 (21%), Positives = 31/95 (32%), Gaps = 7/95 (7%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
LE + L I+ L L + L N + IP+ +L L L +N
Sbjct: 100 HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNP 158
Query: 137 LSGAVPLALTKLKHLKTLDIS-NNHFAATSPDNFR 170
+ A ++ L LD+ S F
Sbjct: 159 IESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 29/122 (23%), Positives = 46/122 (37%), Gaps = 11/122 (9%)
Query: 59 PHPCSYNLKGIKC---NLHA------TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLA 109
P C + C L + + L + NLS + T +L +L + L+
Sbjct: 13 PANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLS 72
Query: 110 RNLIQGRIPTSI-SNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDN 168
N + I + L YL+LSSN L + L+ L+ L + NNH +
Sbjct: 73 HNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNA 131
Query: 169 FR 170
F
Sbjct: 132 FE 133
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 19/94 (20%), Positives = 39/94 (41%), Gaps = 6/94 (6%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
L ++ LS I +E + +LR + L+ N + + + S+ + L L L +N
Sbjct: 65 NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNH 123
Query: 137 LSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
+ A + L+ L +S N + + +
Sbjct: 124 IVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIK 157
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 24/96 (25%), Positives = 37/96 (38%), Gaps = 11/96 (11%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNLL 137
L ++LS +D L+ L V+ L N I + + + +L L LS N +
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI 148
Query: 138 SGAVP----LALTKLKHLKTLDISNNHFAATSPDNF 169
S P KL L LD+S+N +
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 53/186 (28%), Positives = 83/186 (44%), Gaps = 36/186 (19%)
Query: 329 AVKRLKKLQV-SMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
AVK L + ++ S+D + R+I NLK HP+I+ L ST + +V +Y S G L
Sbjct: 40 AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF 99
Query: 385 SLLEAYIEGKRDFPWKLRLSIATG------IAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
YI R+ I +D+ ++ + H +LK N+LL
Sbjct: 100 ----DYICKHG------RVEEMEARRLFQQILSAVDYCHRHM-----VVHRDLKPENVLL 144
Query: 439 NENEDPLISECGYSKFLDPK---KTCLFSSNGYTAPEKTVSEQG------DVFSFGVILL 489
+ + + I++ G S + +T S N Y APE +S + D++S GVIL
Sbjct: 145 DAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-YAAPE-VISGRLYAGPEVDIWSCGVILY 202
Query: 490 ELLTGK 495
LL G
Sbjct: 203 ALLCGT 208
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 2e-08
Identities = 74/555 (13%), Positives = 153/555 (27%), Gaps = 168/555 (30%)
Query: 21 RLFTGCVGGELSESESFFKFISAVDSQN----VLRIGWNGNLPHPCSYNLKGIKCNLHAT 76
RLF + + E KF+ V N + I P + + L+
Sbjct: 66 RLF-WTL--LSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 77 NIVGI-----RLENMNLSGIIDAETLCKLRHLRVVSL---------------ARNL-IQG 115
N V RL+ + A L +LR + V + + +Q
Sbjct: 123 NQVFAKYNVSRLQPYL--KLRQA--LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQC 178
Query: 116 RIPT-----SISNCRR---------LTYLNLSSNLLSGA-----VPLALTKLK-HLKTLD 155
++ ++ NC + N S + + L + ++ L+ L
Sbjct: 179 KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL 238
Query: 156 ISNNHFAATSP------DNFR--QEIKYFD---KYVVETSSSEINRASTVEARGLEDTQP 204
S + N + + F+ K ++ T ++ + T
Sbjct: 239 KSKPY-----ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT----THI 289
Query: 205 PSVHNKS--EHGEKRHWFRNWM------------TIIPLA-AGIGLVVLIAYCMGKKSAQ 249
H+ E + ++ T P + I +
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH 349
Query: 250 IARDREILKALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEATADLR 309
+ D+ + ++ S + + P E ++ F + +A +
Sbjct: 350 VNCDK-LTTIIESS----------LNVLEPA----EY------RKMFDRLSVFPPSAHIP 388
Query: 310 SQTIC----------SSLFMVRLKNSAVYAVKRLKKLQVSM----DEFSQTMRQIGNLKH 355
+ + + + +L ++ K+ K+ +S+ E + L H
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSL-VEKQPKESTISIPSIYLELKVKLENEYAL-H 446
Query: 356 PNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYI--------------EGKRDFPWKL 401
+I+ YN + + S+ + L+ Y E F +
Sbjct: 447 RSIVD--HYN-------IPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR-MV 496
Query: 402 RLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN---------ENEDPLISE--CG 450
L F+ QK + T + + + N L +N DP
Sbjct: 497 FLD--------FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN-DPKYERLVNA 547
Query: 451 YSKFLDPKKTCLFSS 465
FL + L S
Sbjct: 548 ILDFLPKIEENLICS 562
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 21/99 (21%), Positives = 38/99 (38%), Gaps = 4/99 (4%)
Query: 74 HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNL 132
++ +++E +I T L L ++ L N ++ T + L L L
Sbjct: 52 RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTL 110
Query: 133 SSNLLSGAV--PLALTKLKHLKTLDISNNHFAATSPDNF 169
+ L GAV L L+ L + +N+ P +F
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 32/145 (22%), Positives = 52/145 (35%), Gaps = 9/145 (6%)
Query: 32 SESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNL-----KGIKCNLHATNIVGIRLENM 86
S ++ FF I+ Q+ L + + N+ + L A+ + L
Sbjct: 227 SMAKRFFDAIAGTKIQS-LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKS 285
Query: 87 NLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNLLSGAVPLAL 145
+ + L ++LA+N I +I + L LNLS N L
Sbjct: 286 KIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMF 343
Query: 146 TKLKHLKTLDISNNHFAATSPDNFR 170
L L+ LD+S NH A +F
Sbjct: 344 ENLDKLEVLDLSYNHIRALGDQSFL 368
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 22/83 (26%), Positives = 37/83 (44%), Gaps = 6/83 (7%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNL 136
LE + L+ ID L HL ++L++N + I + + N +L L+LS N
Sbjct: 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNH 358
Query: 137 LSGAVPLALTKLKHLKTLDISNN 159
+ + L +LK L + N
Sbjct: 359 IRALGDQSFLGLPNLKELALDTN 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 11/114 (9%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNLL 137
L +NLS ID+ L L V+ L+ N I+ + L L L +N L
Sbjct: 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQL 383
Query: 138 SGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYFDKYVVETSSSEINRA 191
+L L+ + + N + + P I Y +++ + S E A
Sbjct: 384 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPR-----IDYLSRWLNKNSQKEQGSA 432
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 16/69 (23%), Positives = 23/69 (33%), Gaps = 1/69 (1%)
Query: 102 HLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPL-ALTKLKHLKTLDISNNH 160
H+ V L+ N I TS S + L +L + + L L L + N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 161 FAATSPDNF 169
F F
Sbjct: 91 FLQLETGAF 99
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 22/104 (21%), Positives = 39/104 (37%), Gaps = 5/104 (4%)
Query: 71 CNLHATNIVGIRLENMNLSGIIDAETLCKLR--HLRVVSLARNLIQGRIPTSI-SNCRRL 127
L + +G + N D T L ++ L+++ I + S+ S+ L
Sbjct: 244 LILSNSYNMGSSFGHTNFKDP-DNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDL 301
Query: 128 TYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
L L+ N ++ A L HL L++S N + F
Sbjct: 302 EQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFEN 345
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 25/109 (22%), Positives = 38/109 (34%), Gaps = 12/109 (11%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI---SNCRRLTYLNL 132
T++ + L + N+ I A +R V+ L N ++ I + T L L
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRL 187
Query: 133 SSNLL--------SGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEI 173
SS L K + TLD+S N F + F I
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAI 236
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 38/178 (21%), Positives = 70/178 (39%), Gaps = 22/178 (12%)
Query: 328 YAVKRLKKLQVSMDEFS---QTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
Y K +K + +H NIL L + EE ++++++ S +
Sbjct: 33 YMAKFVKVKGTDQVLVKKEISILNI---ARHRNILHLHESFESMEELVMIFEFISGLDIF 89
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
E + + +S + + L F++ + I H +++ NI+
Sbjct: 90 ---ERINTSAFELNEREIVSYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQTRRSS 141
Query: 445 L--ISECGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTG 494
I E G ++ L P LF++ Y APE VS D++S G ++ LL+G
Sbjct: 142 TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 24/112 (21%), Positives = 43/112 (38%), Gaps = 7/112 (6%)
Query: 50 LRIGWNGNLPHPCSYNLKGIKCNLH-ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSL 108
+ L S L ++ + L + +L+ + E L + HL L
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHL---DL 470
Query: 109 ARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
+ N ++ +P +++ R L L S N L +A L L+ L + NN
Sbjct: 471 SHNRLR-ALPPALAALRCLEVLQASDNALENVDGVA--NLPRLQELLLCNNR 519
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 3e-06
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 8/99 (8%)
Query: 82 RLENMNLSG--IIDAET-LCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS 138
+ +++LS + L LR L V+ + N ++ + ++N RL L L +N L
Sbjct: 464 LVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
Query: 139 G-AVPLALTKLKHLKTLDISNNHFAATSPDNFRQEIKYF 176
A L L L++ N + ++ +
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSL--CQEEGIQERLAEM 558
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 53/262 (20%), Positives = 91/262 (34%), Gaps = 60/262 (22%)
Query: 328 YAVKRLKKLQVSM--DEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385
+AVK + K + E ++ HPNI+ L LV + + G L
Sbjct: 39 FAVKIISKRMEANTQKEI-TALKLCEG--HPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95
Query: 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL-NENEDP 444
I+ K+ F I + + M+ + H +LK N+L +EN++
Sbjct: 96 ----RIKKKKHFSETEASYIMRKLVSAVSHMHDVG-----VVHRDLKPENLLFTDENDNL 146
Query: 445 LISEC--GYSKFLDPKKTCLFS---SNGYTAPE----KTVSEQGDVFSFGVILLELLTGK 495
I G+++ P L + + Y APE E D++S GVIL +L+G+
Sbjct: 147 EIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206
Query: 496 T-----VEKTGIDLPKWVKAMVREEWTGEV-FDKEVAKAGRQWAFPLLNVALKCVSNS-- 547
+ +++ G+ F+ E W K VS
Sbjct: 207 VPFQSHDRSLTCTSAVEIMKKIKK---GDFSFEGE------AW---------KNVSQEAK 248
Query: 548 ----------PDDRPTMAEVLE 559
P+ R M+ +
Sbjct: 249 DLIQGLLTVDPNKRLKMSGLRY 270
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 25/113 (22%), Positives = 49/113 (43%), Gaps = 13/113 (11%)
Query: 57 NLPHPCSYNLKGIKCNLHATNIVGI--------RLENMNLSG--IIDAETLCKLRHLRVV 106
+ + ++ + I + +++ LS I +L + +LR++
Sbjct: 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLSGMENLRIL 75
Query: 107 SLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
SL RNLI+ +I + L L +S N ++ + KL +L+ L +SNN
Sbjct: 76 SLGRNLIK-KIENLDAVADTLEELWISYNQIASLSGIE--KLVNLRVLYMSNN 125
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 7/94 (7%)
Query: 69 IKCNLHATNIVGIRLENMNLSGI--IDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRR 126
+ ++ AT + L + I +D TL L+ + ++L+ N I+ +I +S+S
Sbjct: 16 ERKSVVATEAEKVELHG-MIPPIEKMD-ATLSTLKACKHLALSTNNIE-KI-SSLSGMEN 71
Query: 127 LTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
L L+L NL+ L L+ L IS N
Sbjct: 72 LRILSLGRNLIKKIENLD-AVADTLEELWISYNQ 104
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 8e-08
Identities = 15/65 (23%), Positives = 30/65 (46%), Gaps = 2/65 (3%)
Query: 95 ETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154
+ +L HL+ +++ + +P ++ L L L+ N L A+P ++ L L+ L
Sbjct: 98 DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155
Query: 155 DISNN 159
I
Sbjct: 156 SIRAC 160
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 11/79 (13%), Positives = 24/79 (30%), Gaps = 2/79 (2%)
Query: 83 LENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVP 142
L D + L + + P L ++ + + L +P
Sbjct: 63 RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP 120
Query: 143 LALTKLKHLKTLDISNNHF 161
+ + L+TL ++ N
Sbjct: 121 DTMQQFAGLETLTLARNPL 139
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 9/66 (13%), Positives = 23/66 (34%), Gaps = 2/66 (3%)
Query: 95 ETLCKLRHLRVVSLA-RNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKT 153
L+ + L + + +P I +L L+L + +P + +L
Sbjct: 247 PIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305
Query: 154 LDISNN 159
+ + +
Sbjct: 306 ILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 9e-07
Identities = 10/65 (15%), Positives = 26/65 (40%), Gaps = 1/65 (1%)
Query: 95 ETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154
++ L++L+ + + + + + +I + +L L+L P LK L
Sbjct: 200 ASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 155 DISNN 159
+ +
Sbjct: 259 ILKDC 263
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 17/76 (22%), Positives = 34/76 (44%), Gaps = 10/76 (13%)
Query: 95 ETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN---------LLSGAVPLAL 145
+T+ + L ++LARN ++ +P SI++ RL L++ + L S
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 146 TKLKHLKTLDISNNHF 161
L +L++L +
Sbjct: 180 QGLVNLQSLRLEWTGI 195
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 16/78 (20%), Positives = 25/78 (32%), Gaps = 2/78 (2%)
Query: 95 ETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSS-NLLSGAVPLALTKLKHLKT 153
+ L L + L P L L L + L +PL + +L L+
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEK 281
Query: 154 LDISNNHFAATSPDNFRQ 171
LD+ + P Q
Sbjct: 282 LDLRGCVNLSRLPSLIAQ 299
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 15/75 (20%), Positives = 32/75 (42%), Gaps = 10/75 (13%)
Query: 95 ETLCKLRHLRVVSLARNLIQGRIPTSISNC---------RRLTYLNLSSNLLSGAVPLAL 145
++ L LR +S+ +P +++ L L L + ++P ++
Sbjct: 144 ASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202
Query: 146 TKLKHLKTLDISNNH 160
L++LK+L I N+
Sbjct: 203 ANLQNLKSLKIRNSP 217
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 55/280 (19%), Positives = 107/280 (38%), Gaps = 54/280 (19%)
Query: 329 AVKRLKKL--QVSMDEFS---QTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNG 381
AVK LK+ + + M Q+G H NI+ L C + + L+++Y G
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLG--SHENIVNLLGAC--TLSGPIYLIFEYCCYG 134
Query: 382 SLLSLL----EAYIEGKRDFPWKLR---------------LSIATGIAKGLDFMYQKSNE 422
LL+ L E + E + ++ + R L A +AKG++F+ E
Sbjct: 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL-----E 189
Query: 423 EKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----K 473
K+ H +L N+L+ + I + G ++ + + N + APE
Sbjct: 190 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 249
Query: 474 TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK-EVAKAGRQW 532
+ + DV+S+G++L E+ + GI + +++ G D+ A
Sbjct: 250 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN---GFKMDQPFYATE---- 302
Query: 533 AFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERD 572
+ + C + RP+ + + + +E
Sbjct: 303 --EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 9e-08
Identities = 57/262 (21%), Positives = 106/262 (40%), Gaps = 46/262 (17%)
Query: 329 AVKRLKKLQVSMDE-----FSQTMRQIGNLKHPNILPLVCYNSTNEEKL--LVYKYQSNG 381
A+K + + E F + + L H NI+ + + E+ LV +Y G
Sbjct: 40 AIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIVSM--IDVDEEDDCYYLVMEY-IEG 95
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
LS YIE ++ I G+ + I H ++K NIL++ N
Sbjct: 96 PTLS---EYIESHGPLSVDTAINFTNQILDGIKHAHDMR-----IVHRDIKPQNILIDSN 147
Query: 442 EDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLEL 491
+ I + G +K L +T L +N Y +PE + E D++S G++L E+
Sbjct: 148 KTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEM 205
Query: 492 LTGKTVEKTGIDLPKWVKAM--VREEWTG--EVFDKEVAKAGRQWAFPLLNVALKCVSNS 547
L G+ G + + A+ +++ K++ ++ L NV L+
Sbjct: 206 LVGE-PPFNG-ETAVSI-AIKHIQDSVPNVTTDVRKDIPQS-------LSNVILRATEKD 255
Query: 548 PDDRP-TMAEVLERIEEVVNGN 568
+R T+ E+ + + V++ N
Sbjct: 256 KANRYKTIQEMKDDLSSVLHEN 277
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 43/191 (22%), Positives = 78/191 (40%), Gaps = 40/191 (20%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGN-------LKHPNILPLVCYNSTNEEKLLVYKYQSN 380
YA K +KK Q + +I + H N++ L + +L+ + S
Sbjct: 40 YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 381 GSLLSLL---EAYIEGKRDFPWKLRLSIATGIAK----GLDFMYQKSNEEKTIPHGNLKL 433
G L L E+ E + AT K G+++++ K I H +LK
Sbjct: 100 GELFDFLAQKESLSEEE-----------ATSFIKQILDGVNYLHTKK-----IAHFDLKP 143
Query: 434 SNILLNENEDPL----ISECGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFS 483
NI+L + P+ + + G + ++ +F + + APE + + + D++S
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203
Query: 484 FGVILLELLTG 494
GVI LL+G
Sbjct: 204 IGVITYILLSG 214
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 51/198 (25%), Positives = 81/198 (40%), Gaps = 33/198 (16%)
Query: 318 FMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEEKL 372
+ R S YA+K L+K + ++ R + L HP + L +EKL
Sbjct: 47 VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKL 105
Query: 373 -LVYKYQSNGSLLSLLEAYIEGKRDFPWKL-RLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
Y NG LL + F R A I L++++ K I H +
Sbjct: 106 YFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSALEYLHGKG-----IIHRD 155
Query: 431 LKLSNILLNENEDPLISECGYSKFL----DPKKTCLFSSNG---YTAPEKTVSEQG---- 479
LK NILLNE+ I++ G +K L + F G Y +PE ++E+
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV--GTAQYVSPE-LLTEKSACKS 212
Query: 480 -DVFSFGVILLELLTGKT 496
D+++ G I+ +L+ G
Sbjct: 213 SDLWALGCIIYQLVAGLP 230
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 26/120 (21%), Positives = 41/120 (34%), Gaps = 14/120 (11%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
+ + ++ S I + LR L+ + + N I LT L L++N L
Sbjct: 43 QFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 102
Query: 140 -AVPLALTKLKHLKTLDISNNHFAATSPDNFRQEI-------KYFDKYVVETSSSEINRA 191
L LK L L I N T+ ++R + + D V E A
Sbjct: 103 LGDLDPLASLKSLTYLCILRNPV--TNKKHYRLYVIYKVPQVRVLDFQKV--KLKERQEA 158
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 81 IRLENMNLSG--IIDAETLCK-LRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLL 137
+R ++L G I E L L + + N I+ ++ RRL L +++N +
Sbjct: 19 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRI 76
Query: 138 SGAVPLALTKLKHLKTLDISNNHFA 162
L L L ++NN
Sbjct: 77 CRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 17/78 (21%), Positives = 28/78 (35%), Gaps = 7/78 (8%)
Query: 86 MNLS--GIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPL 143
+ L+ I A R + L I I + + ++ S N + L
Sbjct: 2 VKLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KL 57
Query: 144 A-LTKLKHLKTLDISNNH 160
L+ LKTL ++NN
Sbjct: 58 DGFPLLRRLKTLLVNNNR 75
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 10/91 (10%)
Query: 76 TNIVGI----RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTY 129
++ + +L++++L I D L L L + L N I T +S +L
Sbjct: 100 KDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDT 157
Query: 130 LNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
L+L N +S VPLA L L+ L +S NH
Sbjct: 158 LSLEDNQISDIVPLA--GLTKLQNLYLSKNH 186
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 21/79 (26%), Positives = 36/79 (45%), Gaps = 6/79 (7%)
Query: 83 LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
L + L I D +L L+ L+ +SL N I + + +L L L +N ++
Sbjct: 89 LGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKITDI 146
Query: 141 VPLALTKLKHLKTLDISNN 159
L+ +L L TL + +N
Sbjct: 147 TVLS--RLTKLDTLSLEDN 163
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 20/80 (25%), Positives = 32/80 (40%), Gaps = 6/80 (7%)
Query: 83 LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
NL + DA T +L + + + I+ + I +T L L+ N L+
Sbjct: 23 TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDI 80
Query: 141 VPLALTKLKHLKTLDISNNH 160
PL LK+L L + N
Sbjct: 81 KPLT--NLKNLGWLFLDENK 98
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 21/101 (20%), Positives = 41/101 (40%), Gaps = 13/101 (12%)
Query: 69 IKCNLHATNIVGI-------RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPT 119
IK NL ++ ++ + + I + + L ++ + L N + I
Sbjct: 24 IKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DI-K 81
Query: 120 SISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
++N + L +L L N + L LK LK+L + +N
Sbjct: 82 PLTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNG 120
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 10/95 (10%)
Query: 65 NLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNC 124
+++GI+ + N+ + L L+ I L L L L N I+ + +S+ +
Sbjct: 57 SVQGIQ---YLPNVTKLFLNGNKLTDIKPLTNLKNLGWL---FLDENKIK-DL-SSLKDL 108
Query: 125 RRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
++L L+L N +S L L L++L + NN
Sbjct: 109 KKLKSLSLEHNGISDINGLV--HLPQLESLYLGNN 141
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 46/197 (23%), Positives = 85/197 (43%), Gaps = 30/197 (15%)
Query: 314 CSSLFMVRLKNS-AVYAVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLVCYNS--T 367
+F V K S V A K + L++ +Q +R++ L P I+ Y + +
Sbjct: 46 GGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSPYIV--GFYGAFYS 102
Query: 368 NEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIP 427
+ E + ++ GSL +L+ P ++ ++ + KGL ++ E+ I
Sbjct: 103 DGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR----EKHKIM 154
Query: 428 HGNLKLSNILLNENEDPLISECGYSKFLDP--KKT---CLFSSNGYTAPE----KTVSEQ 478
H ++K SNIL+N + + + G S L + Y +PE S Q
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS----YMSPERLQGTHYSVQ 210
Query: 479 GDVFSFGVILLELLTGK 495
D++S G+ L+E+ G+
Sbjct: 211 SDIWSMGLSLVEMAVGR 227
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 50/261 (19%), Positives = 95/261 (36%), Gaps = 59/261 (22%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLV-CYNSTNEEKLLVY---KYQSNGSL 383
A+K L + E Q P+I+ ++ Y + + K + + G L
Sbjct: 57 CALKLLYDSPKARQEV-DHHWQA--SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113
Query: 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL-NENE 442
S ++ G + F + I I + F++ + I H ++K N+L ++ +
Sbjct: 114 FSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSHN-----IAHRDVKPENLLYTSKEK 166
Query: 443 DPLISEC--GYSKFLDPK--KTCLFSSNGYTAPEKTVSEQG-----DVFSFGVILLELLT 493
D ++ G++K +T ++ Y APE + + D++S GVI+ LL
Sbjct: 167 DAVLKLTDFGFAKETTQNALQTPCYTP-YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLC 224
Query: 494 GKT--VEKTGIDLPKWVKAMVREEWTGEV-FDKEVAKAGRQWAFPLLNVALKCVSNS--- 547
G TG + +K +R G+ F +W VS
Sbjct: 225 GFPPFYSNTGQAISPGMKRRIRL---GQYGFPNP------EW---------SEVSEDAKQ 266
Query: 548 ---------PDDRPTMAEVLE 559
P +R T+ + +
Sbjct: 267 LIRLLLKTDPTERLTITQFMN 287
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 44/179 (24%), Positives = 83/179 (46%), Gaps = 24/179 (13%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLL 387
+AVK + K + E + + + +HPNI+ L + +V + G LL
Sbjct: 50 FAVKIIDKSKRDPTEEIEILLRY--GQHPNIITLKDVYDDGKYVYVVTELMKGGELLD-- 105
Query: 388 EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL---NENEDP 444
I ++ F + ++ I K +++++ + + H +LK SNIL + N +
Sbjct: 106 --KILRQKFFSEREASAVLFTITKTVEYLHAQG-----VVHRDLKPSNILYVDESGNPES 158
Query: 445 L-ISECGYSKFLDPKKTCLFS---SNGYTAPEKTVSEQG-----DVFSFGVILLELLTG 494
+ I + G++K L + L + + + APE + QG D++S GV+L +LTG
Sbjct: 159 IRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 42/191 (21%), Positives = 82/191 (42%), Gaps = 19/191 (9%)
Query: 318 FMVRLKNSA-VYAVKRLKKLQV-SMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEEKL 372
F ++K + +YA K+L K ++ + M ++I + I+ L T +
Sbjct: 202 FACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
LV + G + + E F + I GL+ ++Q++ I + +LK
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-----IIYRDLK 316
Query: 433 LSNILLNENEDPLISECGYSK--FLDPKKTCLF-SSNGYTAPEKTVSEQG-----DVFSF 484
N+LL+++ + IS+ G + KT + + G+ APE + + D F+
Sbjct: 317 PENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE-LLLGEEYDFSVDYFAL 375
Query: 485 GVILLELLTGK 495
GV L E++ +
Sbjct: 376 GVTLYEMIAAR 386
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 37/181 (20%), Positives = 70/181 (38%), Gaps = 25/181 (13%)
Query: 327 VYAVKRLKKLQVS-----MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381
V+ K + +E M Q L HP ++ L E +L+ ++ S G
Sbjct: 78 VFVAKFINTPYPLDKYTVKNEI-SIMNQ---LHHPKLINLHDAFEDKYEMVLILEFLSGG 133
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL-NE 440
L + ++ +GL M++ S I H ++K NI+ +
Sbjct: 134 ELF---DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETK 185
Query: 441 NEDPL-ISECGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT 493
+ I + G + L+P + ++ + APE + V D+++ GV+ LL+
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
Query: 494 G 494
G
Sbjct: 246 G 246
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 21/179 (11%)
Query: 327 VYAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383
A K +K M + + +I L H N++ L + + +LV +Y G L
Sbjct: 116 KLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL-NENE 442
+ I+ + + I +G+ M+Q I H +LK NIL N +
Sbjct: 174 F---DRIIDESYNLTELDTILFMKQICEGIRHMHQMY-----ILHLDLKPENILCVNRDA 225
Query: 443 DPL-ISECGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTG 494
+ I + G ++ P++ F + + APE VS D++S GVI LL+G
Sbjct: 226 KQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 49/178 (27%), Positives = 75/178 (42%), Gaps = 20/178 (11%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
YAVK + K + S +R++ L HPNI+ L + +V + + G L
Sbjct: 50 YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF 109
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL---NEN 441
I ++ F I + G+ +M++ + I H +LK NILL ++
Sbjct: 110 D----EIIKRKRFSEHDAARIIKQVFSGITYMHKHN-----IVHRDLKPENILLESKEKD 160
Query: 442 EDPLISECGYSKFLDPKK--TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTG 494
D I + G S + Y APE T E+ DV+S GVIL LL+G
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG 218
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 63/285 (22%), Positives = 104/285 (36%), Gaps = 67/285 (23%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFS----QTMRQIGNLKHPNILPLVCYNSTNEEKLLVY 375
+ L S YAVK ++K + + + Q H N+L L+ + + LV+
Sbjct: 33 INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG--HRNVLELIEFFEEEDRFYLVF 90
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
+ GS+LS +I +R F + +A LDF++ K I H +LK N
Sbjct: 91 EKMRGGSILS----HIHKRRHFNELEASVVVQDVASALDFLHNKG-----IAHRDLKPEN 141
Query: 436 ILL-NENEDPLISEC--GYSKFLDPKKTCLFSSN----------GYTAPE--KTVSEQG- 479
IL + N+ + C + C S Y APE + SE+
Sbjct: 142 ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS 201
Query: 480 ------DVFSFGVILLELLTGKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA--- 528
D++S GVIL LL+G V + G D W + +F+ + +
Sbjct: 202 IYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG-WDRGEACPACQNMLFES-IQEGKYE 259
Query: 529 --GRQWAFPLLNVALKCVSNS------------PDDRPTMAEVLE 559
+ W +S + R + A+VL+
Sbjct: 260 FPDKDW---------AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 43/187 (22%), Positives = 78/187 (41%), Gaps = 32/187 (17%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGN-------LKHPNILPLVCYNSTNEEKLLVYKYQSN 380
YA K +KK Q +I + HPNI+ L + +L+ + S
Sbjct: 40 YAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSG 99
Query: 381 GSLLSLL---EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
G L L E+ E + ++ I G+++++ K I H +LK NI+
Sbjct: 100 GELFDFLAQKESLSE--EEATSFIKQ-----ILDGVNYLHTKK-----IAHFDLKPENIM 147
Query: 438 LNENEDPL----ISECGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVI 487
L + P+ + + G + ++ +F + + APE + + + D++S GVI
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
Query: 488 LLELLTG 494
LL+G
Sbjct: 208 TYILLSG 214
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 14/92 (15%), Positives = 33/92 (35%), Gaps = 3/92 (3%)
Query: 72 NLHATNIVGIRLENMNLSGI--IDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTY 129
++ + L+ + S + + +L K R V + + ++ ++ L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281
Query: 130 LNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
L S N L +L L+ + + N +
Sbjct: 282 LEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 21/95 (22%), Positives = 36/95 (37%), Gaps = 3/95 (3%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSS 134
+ + L N ++ I L + +L+ + L N I I S+ L +L+LS
Sbjct: 52 EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSY 109
Query: 135 NLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
N LS L L L++ N + +
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSL 144
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 10/96 (10%), Positives = 31/96 (32%), Gaps = 1/96 (1%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSS 134
+++ + L + + L L+++ + +I + L L + +
Sbjct: 124 SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183
Query: 135 NLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
+ L P +L ++++ L +
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 17/68 (25%), Positives = 33/68 (48%)
Query: 103 LRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFA 162
++ + L+ N I + + C L L L+SN ++ + + L L+ LD+S N+ +
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 163 ATSPDNFR 170
S F+
Sbjct: 114 NLSSSWFK 121
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 13/85 (15%), Positives = 36/85 (42%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
T + +R+ NM+ I + L L + + + +Q P S+ + + +++L L
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208
Query: 136 LLSGAVPLALTKLKHLKTLDISNNH 160
+ + + ++ L++ +
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTD 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 49/194 (25%), Positives = 91/194 (46%), Gaps = 28/194 (14%)
Query: 318 FMVRLKNSA-VYAVKRLKK-LQVSMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEEKL 372
+V+ K + YA+K LKK + V+ DE + T+ ++ N +HP + L T++
Sbjct: 165 ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFP-WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
V +Y + G L ++ +R F + R A I LD+++ + N + + +L
Sbjct: 225 FVMEYANGGELFF----HLSRERVFSEDRARFYGAE-IVSALDYLHSEKN----VVYRDL 275
Query: 432 KLSNILLNENEDPLISECGYSK--FLDPKKTCLFSSNG---YTAPEKTVSEQG-----DV 481
KL N++L+++ I++ G K D F G Y APE + + D
Sbjct: 276 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPE-VLEDNDYGRAVDW 332
Query: 482 FSFGVILLELLTGK 495
+ GV++ E++ G+
Sbjct: 333 WGLGVVMYEMMCGR 346
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 41/191 (21%), Positives = 74/191 (38%), Gaps = 37/191 (19%)
Query: 328 YAVKRLKKLQVSMDEFSQT------MRQIG---NLKHPNILPLVCYNSTNEEKL-LVYKY 377
A++ + K + ++ + +I L HP I+ + N + E +V +
Sbjct: 163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI--KNFFDAEDYYIVLEL 220
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
G L + G + + + ++++ I H +LK N+L
Sbjct: 221 MEGGELFD----KVVGNKRLKEATCKLYFYQMLLAVQYLHENG-----IIHRDLKPENVL 271
Query: 438 LNENEDPL---ISECGYSKFLDP----KKTCLFSSNGYTAPE--KTVSEQG-----DVFS 483
L+ E+ I++ G+SK L + C + Y APE +V G D +S
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLAPEVLVSVGTAGYNRAVDCWS 329
Query: 484 FGVILLELLTG 494
GVIL L+G
Sbjct: 330 LGVILFICLSG 340
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 17/97 (17%), Positives = 32/97 (32%), Gaps = 7/97 (7%)
Query: 72 NLHATNIVGIRLENMNLSGIIDAETL---CKLRHLRVVSLARNLIQGRIPTSISNCRRLT 128
++ + L N++ + L+V+S+A+ + L+
Sbjct: 117 EATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALS 176
Query: 129 YLNLSSNLLSGAVPLALT----KLKHLKTLDISNNHF 161
L+LS N G L K L+ L + N
Sbjct: 177 TLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 17/105 (16%), Positives = 29/105 (27%), Gaps = 8/105 (7%)
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNC----RRL 127
+ + + S E + L + L+ N G + C L
Sbjct: 145 QWLKPGLKVLSIAQ-AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203
Query: 128 TYLNLSSNL---LSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
L L + SG L+ LD+S+N +
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 16/75 (21%), Positives = 32/75 (42%), Gaps = 5/75 (6%)
Query: 87 NLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALT 146
+L A + L ++L+ ++ ++P + +L+ L+LS N L P
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPS-PD 293
Query: 147 KLKHLKTLDISNNHF 161
+L + L + N F
Sbjct: 294 ELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 6/94 (6%)
Query: 71 CNLHATNIVGIRLENMNLSGI--IDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRL 127
C L + + L N + + + L+ + L+ N ++ +L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 128 TYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
LNLS L VP L L LD+S N
Sbjct: 256 NSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRL 286
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 58/273 (21%), Positives = 104/273 (38%), Gaps = 61/273 (22%)
Query: 329 AVKRLKKLQVSMDE-----FSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY-QSNGS 382
AVK L+ ++ D F + + L HP I+ VY ++
Sbjct: 41 AVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVA-------------VYDTGEAETP 86
Query: 383 LLSL------------LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
L L + + K + + + L+F +Q I H +
Sbjct: 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG-----IIHRD 141
Query: 431 LKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGD 480
+K +NI+++ + + G ++ + + + Y +PE +V + D
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 481 VFSFGVILLELLTGKTVEKTGIDLPKWVKAM--VREEWTG-EVFDKEVAKAGRQWAFPLL 537
V+S G +L E+LTG+ TG D P V A VRE+ + ++ L
Sbjct: 202 VYSLGCVLYEVLTGE-PPFTG-DSPVSV-AYQHVREDPIPPSARHEGLSAD-------LD 251
Query: 538 NVALKCVSNSPDDRP-TMAEVLERIEEVVNGND 569
V LK ++ +P++R T AE+ + V NG
Sbjct: 252 AVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 36/186 (19%)
Query: 329 AVKRLKKLQV-SMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
AVK L + ++ S+D + R+I NLK HP+I+ L ST + +V +Y S G L
Sbjct: 45 AVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELF 104
Query: 385 SLLEAYIEGKRDFPWKLRLSIATG------IAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
YI RL I G+D+ ++ + H +LK N+LL
Sbjct: 105 D----YICKNG------RLDEKESRRLFQQILSGVDYCHRHM-----VVHRDLKPENVLL 149
Query: 439 NENEDPLISECGYSKFLDPK---KTCLFSSNGYTAPEKTVSEQG------DVFSFGVILL 489
+ + + I++ G S + +T S N Y APE +S + D++S GVIL
Sbjct: 150 DAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-YAAPE-VISGRLYAGPEVDIWSSGVILY 207
Query: 490 ELLTGK 495
LL G
Sbjct: 208 ALLCGT 213
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 19/80 (23%), Positives = 34/80 (42%), Gaps = 6/80 (7%)
Query: 83 LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
+ + LSG + + + L+ ++ + L I T ++ L L L N ++
Sbjct: 87 ITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNI 144
Query: 141 VPLALTKLKHLKTLDISNNH 160
PLA L +L+ L I N
Sbjct: 145 SPLA--GLTNLQYLSIGNAQ 162
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 23/80 (28%), Positives = 38/80 (47%), Gaps = 6/80 (7%)
Query: 83 LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
++ ++L+ I D L L +L+V+ L N I I ++ L YL++ + +S
Sbjct: 109 IKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDL 166
Query: 141 VPLALTKLKHLKTLDISNNH 160
PLA L L TL +N
Sbjct: 167 TPLA--NLSKLTTLKADDNK 184
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 7/84 (8%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
N + I N++ T L + +S + I + L L L N
Sbjct: 19 ANAIKIAAGKSNVTDT---VTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN 73
Query: 136 LLSGAVPLALTKLKHLKTLDISNN 159
++ PL L + L++S N
Sbjct: 74 QITDLAPLK--NLTKITELELSGN 95
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 8/72 (11%), Positives = 27/72 (37%), Gaps = 4/72 (5%)
Query: 89 SGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKL 148
+ I L + ++ ++ + + ++ +T L+ ++ + L
Sbjct: 7 TAINVIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEGVQ--YL 62
Query: 149 KHLKTLDISNNH 160
+L L++ +N
Sbjct: 63 NNLIGLELKDNQ 74
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 43/190 (22%), Positives = 74/190 (38%), Gaps = 38/190 (20%)
Query: 327 VYAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNSTNEEKLLVYKYQSNGS 382
YA K LKK + D ++ + +I L+ P ++ L E +L+ +Y + G
Sbjct: 56 EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115
Query: 383 LL-----SLLEAYIEGKRDFPWKLRLSIATGIAK----GLDFMYQKSNEEKTIPHGNLKL 433
+ L E E D + K G+ +++Q + I H +LK
Sbjct: 116 IFSLCLPELAEMVSE--ND---------VIRLIKQILEGVYYLHQNN-----IVHLDLKP 159
Query: 434 SNILL-NENEDPLISEC--GYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSF 484
NILL + I G S+ + + + Y APE ++ D+++
Sbjct: 160 QNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNI 219
Query: 485 GVILLELLTG 494
G+I LLT
Sbjct: 220 GIIAYMLLTH 229
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 6e-07
Identities = 36/178 (20%), Positives = 70/178 (39%), Gaps = 17/178 (9%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
+K + K + + Q +I +L HPNI+ + +V + G LL
Sbjct: 50 RVIKTINKDRSQVPM-EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELL 108
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL---NEN 441
+ + + + + L + + + + H +LK NIL + +
Sbjct: 109 ERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH-----VVHKDLKPENILFQDTSPH 163
Query: 442 EDPLISECGYSKFLDPKK--TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTG 494
I + G ++ + T + Y APE + V+ + D++S GV++ LLTG
Sbjct: 164 SPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 34/243 (13%), Positives = 72/243 (29%), Gaps = 43/243 (17%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQ----IGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
A+ + V D+ Q + + P + ++ T L+V ++ GSL
Sbjct: 60 ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ 119
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444
+ + + +A D ++ + S + ++ +
Sbjct: 120 EVADTSPSPVG------AIRAMQSLAAAADAAHRAG-----VALSIDHPSRVRVSID--- 165
Query: 445 LISECGYSKFLDPKKTCLFSSNGYTAPEKTVSEQGDVFSFGVILLELLTGKT-VEKTGID 503
G P + Q D+ G L LL + + + G+
Sbjct: 166 -----GDVVLAYP---------ATMPD---ANPQDDIRGIGASLYALLVNRWPLPEAGVR 208
Query: 504 LPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRP--TMAEVLERI 561
+ R+ + E A R F + VA + V R T+ ++++
Sbjct: 209 SG--LAPAERDTAGQPI---EPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQA 263
Query: 562 EEV 564
V
Sbjct: 264 TAV 266
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 10/91 (10%)
Query: 76 TNIVGI----RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTY 129
++ + +L++++L I D L L L + L N I T +S +L
Sbjct: 103 KDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDT 160
Query: 130 LNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
L+L N +S VPLA L L+ L +S NH
Sbjct: 161 LSLEDNQISDIVPLA--GLTKLQNLYLSKNH 189
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 20/79 (25%), Positives = 36/79 (45%), Gaps = 6/79 (7%)
Query: 83 LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
L + L + D +L L+ L+ +SL N I + + +L L L +N ++
Sbjct: 92 LGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKITDI 149
Query: 141 VPLALTKLKHLKTLDISNN 159
L+ +L L TL + +N
Sbjct: 150 TVLS--RLTKLDTLSLEDN 166
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 20/84 (23%), Positives = 34/84 (40%), Gaps = 4/84 (4%)
Query: 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNL 136
+N+ + DA T +L + + + I+ + I +T L L+ N
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNK 79
Query: 137 LSGAVPLALTKLKHLKTLDISNNH 160
L+ PLA LK+L L + N
Sbjct: 80 LTDIKPLA--NLKNLGWLFLDENK 101
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 17/80 (21%), Positives = 35/80 (43%), Gaps = 6/80 (7%)
Query: 83 LENMNLS--GIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
++ + + I + + L ++ + L N + I ++N + L +L L N +
Sbjct: 48 IDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDL 105
Query: 141 VPLALTKLKHLKTLDISNNH 160
L LK LK+L + +N
Sbjct: 106 SSLK--DLKKLKSLSLEHNG 123
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 22/96 (22%), Positives = 43/96 (44%), Gaps = 7/96 (7%)
Query: 65 NLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNC 124
++K ++ + N+ + L L+ I L L L L N ++ + +S+ +
Sbjct: 57 DIKSVQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWL---FLDENKVK-DL-SSLKDL 111
Query: 125 RRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
++L L+L N +S L L L++L + NN
Sbjct: 112 KKLKSLSLEHNGISDINGLV--HLPQLESLYLGNNK 145
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 318 FMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEEKL 372
+V+ +YA+K + K + V +E QI L+HP ++ L Y+ +EE +
Sbjct: 32 CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDM 90
Query: 373 -LVYKYQSNGSLLSLLEAYIEGKRDFP-WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
+V G L L+ F ++L I + LD++ + I H +
Sbjct: 91 FMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICE-LVMALDYLQNQR-----IIHRD 140
Query: 431 LKLSNILLNENEDPLISECGYSK-FLDPKKTCLFS-SNGYTAPEKTVSEQG-------DV 481
+K NILL+E+ I++ + + + + Y APE S +G D
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200
Query: 482 FSFGVILLELLTGKT 496
+S GV ELL G+
Sbjct: 201 WSLGVTAYELLRGRR 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 44/196 (22%), Positives = 81/196 (41%), Gaps = 27/196 (13%)
Query: 318 FMVRLKNSA-VYAVKRLKKLQ-VSMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEEKL 372
+VR K++ VYA+K L K + + + + R I P ++ L +
Sbjct: 86 QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
+V +Y G L++L+ D P K + LD ++ H ++K
Sbjct: 146 MVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSMG-----FIHRDVK 195
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCL-FSSNG---YTAPEKTVSEQGDVF------ 482
N+LL+++ +++ G ++ + ++ G Y +PE S+ GD +
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 483 --SFGVILLELLTGKT 496
S GV L E+L G T
Sbjct: 256 WWSVGVFLYEMLVGDT 271
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 53/191 (27%), Positives = 75/191 (39%), Gaps = 48/191 (25%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPL--VCYNSTNEEKL-LVYKYQSNG 381
AVK +++ +DE R+I N + HPNI+ V T L ++ +Y S G
Sbjct: 48 VAVKYIERGAA-IDE--NVQREIINHRSLRHPNIVRFKEVILTPT---HLAIIMEYASGG 101
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATG------IAKGLDFMYQKSNEEKTIPHGNLKLSN 435
L I R S + G+ + + I H +LKL N
Sbjct: 102 ELYE----RICNAG------RFSEDEARFFFQQLLSGVSYCHSMQ-----ICHRDLKLEN 146
Query: 436 ILLNENEDPL--ISECGYSKFLD----PKKTCLFSSNGYTAPEKTVSEQG------DVFS 483
LL+ + P I + GYSK PK T + Y APE + Q DV+S
Sbjct: 147 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPE-VLLRQEYDGKIADVWS 203
Query: 484 FGVILLELLTG 494
GV L +L G
Sbjct: 204 CGVTLYVMLVG 214
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 13/71 (18%), Positives = 29/71 (40%)
Query: 101 RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
+ ++++++N I + I + +L L +S N + + L+ LD+S+N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 161 FAATSPDNFRQ 171
S
Sbjct: 81 LVKISCHPTVN 91
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 20/70 (28%), Positives = 33/70 (47%), Gaps = 3/70 (4%)
Query: 92 IDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHL 151
+ + L LR++ ++ N IQ + + L YL+LS N L ++ +L
Sbjct: 36 LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNL 92
Query: 152 KTLDISNNHF 161
K LD+S N F
Sbjct: 93 KHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 6/82 (7%)
Query: 92 IDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLA--LTKLK 149
+D + L + L+ N + S L +L+LS N A+P+ +
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMS 115
Query: 150 HLKTLDISNNHFAATSPDNFRQ 171
LK L +S H +S
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAH 137
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 20/81 (24%), Positives = 36/81 (44%), Gaps = 3/81 (3%)
Query: 83 LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
L ++N+S + D C ++V+ L N I+ IP + L LN++SN L
Sbjct: 401 LLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSV 459
Query: 141 VPLALTKLKHLKTLDISNNHF 161
+L L+ + + N +
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 15/73 (20%), Positives = 34/73 (46%), Gaps = 3/73 (4%)
Query: 99 KLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDIS 157
+++ L+ + +++N + S + L LN+SSN+L+ + L +K LD+
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLH 429
Query: 158 NNHFAATSPDNFR 170
+N + +
Sbjct: 430 SNKIKSIPKQVVK 442
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 21/129 (16%), Positives = 42/129 (32%), Gaps = 5/129 (3%)
Query: 35 ESFFKFISAVDSQNV--LRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGII 92
SF + + V V I + +L A +I + ++ G
Sbjct: 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS---DVFGFP 291
Query: 93 DAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLK 152
+ ++ + + + + S +L+ S+NLL+ V L L+
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE 351
Query: 153 TLDISNNHF 161
TL + N
Sbjct: 352 TLILQMNQL 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 25/135 (18%), Positives = 48/135 (35%), Gaps = 15/135 (11%)
Query: 48 NVLRIGWNGN--LPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRV 105
N+ +G + C + + + + N L+ + E L L
Sbjct: 303 NIKNFTVSGTRMVHMLCPSKI---------SPFLHLDFSNNLLTDTV-FENCGHLTELET 352
Query: 106 VSLARNLIQ--GRIPTSISNCRRLTYLNLSSNLLSGAVP-LALTKLKHLKTLDISNNHFA 162
+ L N ++ +I + + L L++S N +S + K L +L++S+N
Sbjct: 353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412
Query: 163 ATSPDNFRQEIKYFD 177
T IK D
Sbjct: 413 DTIFRCLPPRIKVLD 427
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 59/282 (20%), Positives = 108/282 (38%), Gaps = 75/282 (26%)
Query: 329 AVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
AVK LK+ + + + + HP+++ L C S + LL+ +Y GSL
Sbjct: 57 AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC--SQDGPLLLIVEYAKYGSLR 114
Query: 385 SLL-------EAYIEGKRDFPWKLR-------------LSIATGIAKGLDFMYQKSNEEK 424
L Y+ +S A I++G+ ++ E
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-----AEM 169
Query: 425 TIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTV 475
+ H +L NIL+ E IS+ G S+ + + + + S G + A E
Sbjct: 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229
Query: 476 SEQGDVFSFGVILLELLT-------GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528
+ Q DV+SFGV+L E++T G E+ + +++ G ++
Sbjct: 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--------LFNLLKT---GHRMER----- 273
Query: 529 GRQWAFP------LLNVALKCVSNSPDDRPTMAEVLERIEEV 564
P + + L+C PD RP A++ + +E++
Sbjct: 274 ------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 31/185 (16%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCY--NSTNEEKLLVY-KYQSNGS 382
A+K + + +I +LKH NI V Y + + + ++ + GS
Sbjct: 51 AIKEIPER--DSRYSQPLHEEIALHKHLKHKNI---VQYLGSFSENGFIKIFMEQVPGGS 105
Query: 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442
L +LL + G + I +GL +++ I H ++K N+L+N
Sbjct: 106 LSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDNQ-----IVHRDIKGDNVLINTYS 159
Query: 443 DPL-ISECGYSKFLDPKKTCLFSSNG---YTAPEKTVSEQG--------DVFSFGVILLE 490
L IS+ G SK L C + G Y APE + ++G D++S G ++E
Sbjct: 160 GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE--IIDKGPRGYGKAADIWSLGCTIIE 217
Query: 491 LLTGK 495
+ TGK
Sbjct: 218 MATGK 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 8e-07
Identities = 47/196 (23%), Positives = 90/196 (45%), Gaps = 32/196 (16%)
Query: 318 FMVRLKNSA-VYAVKRLKK-LQVSMDEFSQTM--RQI--GNLKHPNILPLVCYNSTNEEK 371
+VRLK + +YA+K +KK L ++ + + HP ++ L T E +
Sbjct: 26 LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESR 84
Query: 372 L-LVYKYQSNGSLLSLLEAYIEGKRDFPWKL-RLSIATGIAKGLDFMYQKSNEEKTIPHG 429
L V +Y + G L+ +++ +R P + R A I+ L++++++ I +
Sbjct: 85 LFFVIEYVNGGDLMF----HMQRQRKLPEEHARFYSAE-ISLALNYLHERG-----IIYR 134
Query: 430 NLKLSNILLNENEDPLISECGYSK--FLDPKKTCLFSSNG---YTAPEKTVSEQG----- 479
+LKL N+LL+ +++ G K T F G Y APE + +
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GTPNYIAPE-ILRGEDYGFSV 191
Query: 480 DVFSFGVILLELLTGK 495
D ++ GV++ E++ G+
Sbjct: 192 DWWALGVLMFEMMAGR 207
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 38/183 (20%), Positives = 74/183 (40%), Gaps = 34/183 (18%)
Query: 403 LSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCL 462
+ + +AKG++F+ + H +L NILL+E I + G ++ + +
Sbjct: 196 ICYSFQVAKGMEFL-----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250
Query: 463 FSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVR 513
+ + APE + + Q DV+SFGV+L E+ + G+ + + ++
Sbjct: 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 310
Query: 514 EEWTGEVFDKEVAKAGRQWAFP------LLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567
E G + P + L C P RPT +E++E + ++
Sbjct: 311 E--------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
Query: 568 NDE 570
N +
Sbjct: 357 NAQ 359
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 40/191 (20%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGN-------LKHPNILPLVCYNSTNEEKLLVYKYQSN 380
YA K +KK ++S + +I ++HPNI+ L + +L+ + S
Sbjct: 33 YAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSG 92
Query: 381 GSLLSLL---EAYIEGKRDFPWKLRLSIATGIAK----GLDFMYQKSNEEKTIPHGNLKL 433
G L L E+ E + AT K G+ +++ K I H +LK
Sbjct: 93 GELFDFLAEKESLTE--DE---------ATQFLKQILDGVHYLHSKR-----IAHFDLKP 136
Query: 434 SNILLNENEDPL----ISECGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFS 483
NI+L + P + + G + ++ +F + + APE + + + D++S
Sbjct: 137 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 196
Query: 484 FGVILLELLTG 494
GVI LL+G
Sbjct: 197 IGVITYILLSG 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 46/196 (23%), Positives = 90/196 (45%), Gaps = 32/196 (16%)
Query: 318 FMVRLKNSA-VYAVKRLKK-LQVSMDEFSQTM--RQI--GNLKHPNILPLVCYNSTNEEK 371
+VRLK + +YA++ +KK L ++ + + HP ++ L T E +
Sbjct: 69 LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESR 127
Query: 372 L-LVYKYQSNGSLLSLLEAYIEGKRDFPWKL-RLSIATGIAKGLDFMYQKSNEEKTIPHG 429
L V +Y + G L+ +++ +R P + R A I+ L++++++ I +
Sbjct: 128 LFFVIEYVNGGDLMF----HMQRQRKLPEEHARFYSAE-ISLALNYLHERG-----IIYR 177
Query: 430 NLKLSNILLNENEDPLISECGYSK--FLDPKKTCLFSSNG---YTAPEKTVSEQG----- 479
+LKL N+LL+ +++ G K T F G Y APE + +
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GTPNYIAPE-ILRGEDYGFSV 234
Query: 480 DVFSFGVILLELLTGK 495
D ++ GV++ E++ G+
Sbjct: 235 DWWALGVLMFEMMAGR 250
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 58/281 (20%), Positives = 97/281 (34%), Gaps = 75/281 (26%)
Query: 329 AVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQSNGSLL 384
AVK LK+ +F + + +PNI+ L VC + + L+++Y + G L
Sbjct: 81 AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC--AVGKPMCLLFEYMAYGDLN 138
Query: 385 SLL----------------EAYIEGKRDFPWKLR----LSIATGIAKGLDFMYQKSNEEK 424
L P L L IA +A G+ ++ E+
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-----SER 193
Query: 425 TIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGY-----TAPE----KTV 475
H +L N L+ EN I++ G S+ + N PE
Sbjct: 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 253
Query: 476 SEQGDVFSFGVILLELLT-------GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528
+ + DV+++GV+L E+ + G E+ V VR+ G +
Sbjct: 254 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--------VIYYVRD---GNILAC----- 297
Query: 529 GRQWAFP------LLNVALKCVSNSPDDRPTMAEVLERIEE 563
P L N+ C S P DRP+ + ++
Sbjct: 298 ------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 39/188 (20%), Positives = 70/188 (37%), Gaps = 41/188 (21%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385
AVK + + +D ++I K H N++ + + L +Y S G L
Sbjct: 36 AVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF- 93
Query: 386 LLEAYIEGKRDFPWKLRLSIATG------IAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
IE + + G+ +++ I H ++K N+LL+
Sbjct: 94 ---DRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLD 139
Query: 440 ENEDPLISECGYSKFLDP-------KKTCLFSSNGYTAPEKTVSEQG------DVFSFGV 486
E ++ IS+ G + K C + Y APE + + DV+S G+
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPE-LLKRREFHAEPVDVWSCGI 196
Query: 487 ILLELLTG 494
+L +L G
Sbjct: 197 VLTAMLAG 204
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 28/194 (14%)
Query: 318 FMVRLKNSA-VYAVKRLKK-LQVSMDEFSQTM--RQI--GNLKHPNILPLVCYNSTNEEK 371
+ K + +YAVK LKK + + D+ TM +++ K P + L T +
Sbjct: 358 MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417
Query: 372 LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
V +Y + G L+ +I+ F + A IA GL F+ + K I + +L
Sbjct: 418 YFVMEYVNGGDLMY----HIQQVGRFKEPHAVFYAAEIAIGLFFL-----QSKGIIYRDL 468
Query: 432 KLSNILLNENEDPLISECGYSK--FLDPKKTCLFSSNG---YTAPEKTVSEQG-----DV 481
KL N++L+ I++ G K D T F G Y APE ++ Q D
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC--GTPDYIAPE-IIAYQPYGKSVDW 525
Query: 482 FSFGVILLELLTGK 495
++FGV+L E+L G+
Sbjct: 526 WAFGVLLYEMLAGQ 539
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 43/191 (22%), Positives = 76/191 (39%), Gaps = 40/191 (20%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGN-------LKHPNILPLVCYNSTNEEKLLVYKYQSN 380
YA K +KK + + I ++HPN++ L + +L+ + +
Sbjct: 39 YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 381 GSLLSLL---EAYIEGKRDFPWKLRLSIATGIAK----GLDFMYQKSNEEKTIPHGNLKL 433
G L L E+ E + AT K G+ +++ I H +LK
Sbjct: 99 GELFDFLAEKESLTE--EE---------ATEFLKQILNGVYYLHSLQ-----IAHFDLKP 142
Query: 434 SNILLNENEDPL----ISECGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFS 483
NI+L + P I + G + +D +F + + APE + + + D++S
Sbjct: 143 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 202
Query: 484 FGVILLELLTG 494
GVI LL+G
Sbjct: 203 IGVITYILLSG 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 37/186 (19%)
Query: 329 AVKRLKKLQV-SMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
A+K + + + D + R+I LK HP+I+ L +T + ++V +Y + G L
Sbjct: 38 ALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELF 96
Query: 385 SLLEAYIEGKRDFPWKLRLSIATG------IAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
YI K+ R++ G I +++ ++ I H +LK N+LL
Sbjct: 97 D----YIVEKK------RMTEDEGRRFFQQIICAIEYCHRHK-----IVHRDLKPENLLL 141
Query: 439 NENEDPLISECGYSKFLDPK---KTCLFSSNGYTAPEKTVSEQG------DVFSFGVILL 489
++N + I++ G S + KT S N Y APE ++ + DV+S G++L
Sbjct: 142 DDNLNVKIADFGLSNIMTDGNFLKTSCGSPN-YAAPE-VINGKLYAGPEVDVWSCGIVLY 199
Query: 490 ELLTGK 495
+L G+
Sbjct: 200 VMLVGR 205
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 42/197 (21%), Positives = 83/197 (42%), Gaps = 32/197 (16%)
Query: 319 MVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG-NLK---HPNILPLVCYNS-TNEEKL- 372
M + + + AVKR++ V+ E + + + +++ P + Y + E +
Sbjct: 26 MRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTV--TFYGALFREGDVW 82
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
+ + + SL + I+ + P + IA I K L+ ++ K + + H ++K
Sbjct: 83 ICMEL-MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS----VIHRDVK 137
Query: 433 LSNILLNENEDPLISECGYSKFLD---PKKT---CLFSSNGYTAPE--------KTVSEQ 478
SN+L+N + + G S +L K C Y APE K S +
Sbjct: 138 PSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP----YMAPERINPELNQKGYSVK 193
Query: 479 GDVFSFGVILLELLTGK 495
D++S G+ ++EL +
Sbjct: 194 SDIWSLGITMIELAILR 210
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 24/118 (20%), Positives = 45/118 (38%), Gaps = 16/118 (13%)
Query: 50 LRIGWNGNLPHPCSYN-LKGIKCNLHATNIVGIRLENMNLSGIIDAETL-----CKLRHL 103
L I N +L YN + G + + + E L G E + C +
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWD---KWEKQALPGENRNEAVSLLKECLINQF 61
Query: 104 RVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+ L R + +P ++ ++T L ++ N L ++P L++ LD +N
Sbjct: 62 SELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPASLEY---LDACDNRL 112
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 12/71 (16%), Positives = 21/71 (29%), Gaps = 5/71 (7%)
Query: 95 ETLCKLRHLR----VVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKH 150
+ H N I IP +I + + L N LS + +L++
Sbjct: 197 AVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255
Query: 151 LKTLDISNNHF 161
+F
Sbjct: 256 QPDYHGPRIYF 266
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 39/186 (20%), Positives = 69/186 (37%), Gaps = 37/186 (19%)
Query: 329 AVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385
AVK + + +D ++I K H N++ + + L +Y S G L
Sbjct: 36 AVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF- 93
Query: 386 LLEAYIEGKRDFPWKLRLSIATG------IAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
IE + + G+ +++ I H ++K N+LL+
Sbjct: 94 ---DRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLD 139
Query: 440 ENEDPLISECGYSKFLDPKKT--CLFSSNG---YTAPEKTVSEQG------DVFSFGVIL 488
E ++ IS+ G + L G Y APE + + DV+S G++L
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVL 198
Query: 489 LELLTG 494
+L G
Sbjct: 199 TAMLAG 204
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 28/198 (14%)
Query: 318 FMVRLKNSA-VYAVKRLKKLQ-VSMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEEKL 372
+V+LKN+ V+A+K L K + + E + R + N I L Y ++ L
Sbjct: 91 AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL-HYAFQDDNNL 149
Query: 373 -LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
LV Y G LL+LL + E + R +A + +D ++Q H ++
Sbjct: 150 YLVMDYYVGGDLLTLLSKF-EDRLPEEM-ARFYLAE-MVIAIDSVHQLH-----YVHRDI 201
Query: 432 KLSNILLNENEDPLISECGYSKFLDPKKTCLFSSN-G---YTAPE----KTVSEQG---- 479
K NIL++ N +++ G L T S G Y +PE +
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPE 261
Query: 480 -DVFSFGVILLELLTGKT 496
D +S GV + E+L G+T
Sbjct: 262 CDWWSLGVCMYEMLYGET 279
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 23/113 (20%), Positives = 42/113 (37%), Gaps = 5/113 (4%)
Query: 62 CSYN-LKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTS 120
C + + I +L N + +R L +I L + +++N + I
Sbjct: 16 CQESKVTEIPSDLP-RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 121 I-SNCRRLTYLNLS-SNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
+ SN +L + + +N L P A L +L+ L ISN +
Sbjct: 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 17/89 (19%), Positives = 28/89 (31%), Gaps = 4/89 (4%)
Query: 84 ENMNLSGIIDAETLCKLRH-LRVVSLARNLIQGRIPTSISN-CRRLTYLNLSSNLLSGAV 141
+N+N+ I+ + L ++ L +N IQ I S N + +N L
Sbjct: 137 DNINIH-TIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 142 PLALTKLKHLKTLDISNNHFAATSPDNFR 170
LDIS +
Sbjct: 195 NDVFHGASGPVILDISRTRIHSLPSYGLE 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 50/261 (19%), Positives = 97/261 (37%), Gaps = 58/261 (22%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEK--LLVYKYQSNGSL 383
+A+K L+ + E + + + P+I+ + V N K L+V + G L
Sbjct: 90 FALKMLQDCPKARRE-VELHWRA--SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 146
Query: 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL-NENE 442
S ++ G + F + I I + + +++ + I H ++K N+L ++
Sbjct: 147 FSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRP 199
Query: 443 DPLISEC--GYSKFLDPK---KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT 493
+ ++ G++K T ++ Y APE + + D++S GVI+ LL
Sbjct: 200 NAILKLTDFGFAKETTSHNSLTTPCYTP-YYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258
Query: 494 GKT--VEKTGIDLPKWVKAMVREEWTGEV-FDKEVAKAGRQWAFPLLNVALKCVSNS--- 547
G G+ + +K +R G+ F +W VS
Sbjct: 259 GYPPFYSNHGLAISPGMKTRIRM---GQYEFPNP------EW---------SEVSEEVKM 300
Query: 548 ---------PDDRPTMAEVLE 559
P R T+ E +
Sbjct: 301 LIRNLLKTEPTQRMTITEFMN 321
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 39/220 (17%), Positives = 70/220 (31%), Gaps = 52/220 (23%)
Query: 328 YAVKRLKK---LQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381
A+K + K Q++ + + ++ L HPNI L + LV + G
Sbjct: 54 RAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGG 113
Query: 382 SLL-------------SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKT--- 425
LL ++ P +I I + + E+
Sbjct: 114 HLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173
Query: 426 ---------------IPHGNLKLSNILLNENED-PL-ISECGYSKFLDPKKTCLFS---- 464
I H ++K N L + N+ + + + G SK +
Sbjct: 174 MRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
Query: 465 ---SNGYTAPE------KTVSEQGDVFSFGVILLELLTGK 495
+ + APE ++ + D +S GV+L LL G
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 17/82 (20%), Positives = 30/82 (36%), Gaps = 8/82 (9%)
Query: 82 RLENMNLSGI--IDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
+L G I + L ++ I + +S +L YL L++ L+
Sbjct: 276 QLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE 332
Query: 140 AVPLALTKLKHLKTLDISNNHF 161
L ++ LK+L N H
Sbjct: 333 ---LDVSHNTKLKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 17/80 (21%), Positives = 30/80 (37%), Gaps = 8/80 (10%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
+L ++ I + L + + N I +S + L LN +N ++
Sbjct: 149 QLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK 205
Query: 140 AVPLALTKLKHLKTLDISNN 159
L L + L LD S+N
Sbjct: 206 ---LDLNQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 17/100 (17%), Positives = 42/100 (42%), Gaps = 11/100 (11%)
Query: 62 CSYN-LKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTS 120
C + + + T + + + N++ + L + +L ++ N + +
Sbjct: 49 CHNSSITDMTGIEKLTGLTKLICTSNNITTL----DLSQNTNLTYLACDSNKLT-NLD-- 101
Query: 121 ISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
++ +LTYLN +N L+ L +++ L L+ + N
Sbjct: 102 VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 19/77 (24%), Positives = 28/77 (36%), Gaps = 8/77 (10%)
Query: 85 NMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLA 144
M + I E L L L + I T I LT L +SN ++ L
Sbjct: 29 EMQATDTISEEQLATLTSL---DCHNSSITD--MTGIEKLTGLTKLICTSNNITT---LD 80
Query: 145 LTKLKHLKTLDISNNHF 161
L++ +L L +N
Sbjct: 81 LSQNTNLTYLACDSNKL 97
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 9/94 (9%), Positives = 30/94 (31%), Gaps = 9/94 (9%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
T + + + ++ + L + L + L + + +S+ +L L+ +
Sbjct: 297 TQLYLLDCQAAGITEL----DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNA 349
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
+ ++ K+ L + +
Sbjct: 350 HIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETL 381
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 16/86 (18%), Positives = 33/86 (38%), Gaps = 10/86 (11%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ + + N++ + L + L + + N + I ++ +LTY + S N
Sbjct: 191 KLLNRLNCDTNNITKL----DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVN 243
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHF 161
L+ L ++ L L TL
Sbjct: 244 PLT---ELDVSTLSKLTTLHCIQTDL 266
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 9/85 (10%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+ + L+ I + L + N ++ ++ +LT L+ S N
Sbjct: 127 PLLTYLNCARNTLTEI----DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180
Query: 136 LLSGAVPLALTKLKHLKTLDISNNH 160
++ L +++ K L L+ N+
Sbjct: 181 KITE---LDVSQNKLLNRLNCDTNN 202
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 5e-06
Identities = 40/190 (21%), Positives = 74/190 (38%), Gaps = 41/190 (21%)
Query: 329 AVKRLKKLQVSMD-EFSQTMRQ----IGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383
A+K + +S D F M++ G L+ P+++P ++ +
Sbjct: 63 ALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVP-------------IHDFGEIDGQ 108
Query: 384 LSLLEAYIEG-------KRDFPWKLR--LSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
L + I G +R P ++I I LD + H ++K
Sbjct: 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG-----ATHRDVKPE 163
Query: 435 NILLNENEDPLISECGYSKFL-DPKKTCLFSSNG---YTAPE----KTVSEQGDVFSFGV 486
NIL++ ++ + + G + D K T L ++ G Y APE + + D+++
Sbjct: 164 NILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTC 223
Query: 487 ILLELLTGKT 496
+L E LTG
Sbjct: 224 VLYECLTGSP 233
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 5e-06
Identities = 15/81 (18%), Positives = 33/81 (40%), Gaps = 10/81 (12%)
Query: 88 LSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCR---RLTYLNLSSNLLS--GAVP 142
+ + L+ L + Q + +L +++S+ +L+ GA
Sbjct: 242 FRPLFSKDRFPNLKWLG---IVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARL 298
Query: 143 LA--LTKLKHLKTLDISNNHF 161
L + K+KHLK +++ N+
Sbjct: 299 LLDHVDKIKHLKFINMKYNYL 319
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 45/194 (23%), Positives = 74/194 (38%), Gaps = 25/194 (12%)
Query: 319 MVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNS-TNEEKL- 372
MV + + AVKR++ V E Q + + + P I+ Y + E
Sbjct: 41 MVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSDCPYIV--QFYGALFREGDCW 97
Query: 373 LVYKYQSNGSLLSLL-EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
+ + + S Y P ++ I K L+ + + I H ++
Sbjct: 98 ICMEL-MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK----IIHRDI 152
Query: 432 KLSNILLNENEDPLISECGYSKFLDP--KKTCLFSSNGYTAPE--------KTVSEQGDV 481
K SNILL+ + + + + G S L KT Y APE + + DV
Sbjct: 153 KPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDV 212
Query: 482 FSFGVILLELLTGK 495
+S G+ L EL TG+
Sbjct: 213 WSLGITLYELATGR 226
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 29/125 (23%), Positives = 54/125 (43%), Gaps = 16/125 (12%)
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
+LL+L++ Y R P I+ + GLD+M+++ I H ++K N+L+
Sbjct: 115 NLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG----IIHTDIKPENVLMEIV 168
Query: 442 EDPLISEC------GYSKFLDPKKTCLFSSNGYTAPEKTV----SEQGDVFSFGVILLEL 491
+ P G + + D T + Y +PE + D++S ++ EL
Sbjct: 169 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 228
Query: 492 LTGKT 496
+TG
Sbjct: 229 ITGDF 233
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 39/179 (21%), Positives = 71/179 (39%), Gaps = 21/179 (11%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
+A K + ++S +F + R+ L+HPNI+ L LV+ + G L
Sbjct: 34 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 93
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL-NENED 443
I + + I + + + + I H NLK N+LL ++ +
Sbjct: 94 E----DIVAREFYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKG 144
Query: 444 PLISEC--GYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTG 494
+ G + ++ + + GY +PE S+ D+++ GVIL LL G
Sbjct: 145 AAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 32/106 (30%), Positives = 42/106 (39%), Gaps = 11/106 (10%)
Query: 397 FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC--GYSKF 454
F L A I + LD +++ I H +LK NILL + I G S +
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNR-----IIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251
Query: 455 LDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKT 496
+ S Y APE D++S G IL ELLTG
Sbjct: 252 EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 39/180 (21%), Positives = 71/180 (39%), Gaps = 22/180 (12%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
YA + ++S + + R+ LKHPNI+ L S L++ + G L
Sbjct: 39 YAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF 98
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED- 443
I + + I + + +Q + H NLK N+LL
Sbjct: 99 E----DIVAREYYSEADASHCIQQILEAVLHCHQMG-----VVHRNLKPENLLLASKLKG 149
Query: 444 -PL-ISECGYSKFLDPKKTCLFS---SNGYTAPE----KTVSEQGDVFSFGVILLELLTG 494
+ +++ G + ++ ++ F + GY +PE + D+++ GVIL LL G
Sbjct: 150 AAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 41/200 (20%), Positives = 75/200 (37%), Gaps = 40/200 (20%)
Query: 319 MVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNSTNEEKLLV 374
M K V AVK+++ + +E + + + + P I+ C+ +
Sbjct: 44 MRFRKTGHVIAVKQMR-RSGNKEENKRILMDLDVVLKSHDCPYIV--QCFGT-------- 92
Query: 375 YKYQSNGSL--------LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTI 426
+ +N + + + P ++ + I K L ++ E+ +
Sbjct: 93 --FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK----EKHGV 146
Query: 427 PHGNLKLSNILLNENEDPLISECGYSKFLDP--KKTCLFSSNGYTAPE---------KTV 475
H ++K SNILL+E + + G S L K Y APE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 476 SEQGDVFSFGVILLELLTGK 495
+ DV+S G+ L+EL TG+
Sbjct: 207 DIRADVWSLGISLVELATGQ 226
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 17/90 (18%), Positives = 36/90 (40%), Gaps = 11/90 (12%)
Query: 76 TNIVGI----RLENMNLS--GIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTY 129
T++V ++N N I + +L+ + L+ N I + + + + +L
Sbjct: 32 TDLVSQKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEE 89
Query: 130 LNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
L+++ N L + L L + NN
Sbjct: 90 LSVNRNRLKNLNGIPSACLSR---LFLDNN 116
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 6/80 (7%)
Query: 83 LENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
NL + D + +L ++ + + IQ + + L L+LS N +S
Sbjct: 21 AVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISDL 78
Query: 141 VPLALTKLKHLKTLDISNNH 160
PL L L+ L ++ N
Sbjct: 79 SPLK--DLTKLEELSVNRNR 96
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 17/81 (20%), Positives = 36/81 (44%), Gaps = 7/81 (8%)
Query: 82 RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG 139
+LE ++++ + + + L + L N ++ S+ + + L L++ +N L
Sbjct: 86 KLEELSVNRNRLKNLNGIPSA-CLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKS 142
Query: 140 AVPLALTKLKHLKTLDISNNH 160
V L L L+ LD+ N
Sbjct: 143 IVMLG--FLSKLEVLDLHGNE 161
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 42/209 (20%), Positives = 75/209 (35%), Gaps = 43/209 (20%)
Query: 329 AVKRLKKLQVSMDEF------SQTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQS 379
VK +KK +V D + + +I L H NI+ ++ LV +
Sbjct: 53 VVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHG 112
Query: 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
+G L A+I+ L I + + ++ K I H ++K NI++
Sbjct: 113 SGLDLF---AFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD-----IIHRDIKDENIVIA 164
Query: 440 ENEDPLISECGYSKFLDPKK----TC---------LFSSNGYTAPEKTVSEQGDVFSFGV 486
E+ + + G + +L+ K C + N Y PE +++S GV
Sbjct: 165 EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPEL------EMWSLGV 218
Query: 487 ILLELLTG-------KTVEKTGIDLPKWV 508
L L+ + + I P V
Sbjct: 219 TLYTLVFEENPFCELEETVEAAIHPPYLV 247
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 45/247 (18%), Positives = 101/247 (40%), Gaps = 31/247 (12%)
Query: 263 SPSKSPPQVMDIEEVRPEVRRSELVFFVN-EKERFKLDDLLEATADLRSQTICSSLF--- 318
+ +K + ++E + + L + + +LD R +T+ + F
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFD------RIKTLGTGSFGRV 57
Query: 319 -MVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEEKL 372
+V+ K + YA+K L K + V + + T+ ++I + P ++ L N
Sbjct: 58 MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
+V +Y + G + S L F A I ++++ + + +LK
Sbjct: 118 MVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD-----LIYRDLK 168
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTVSEQG-----DVFSFGVI 487
N+L+++ +++ G++K + + L + APE + +G D ++ GV+
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPE-IILSKGYNKAVDWWALGVL 227
Query: 488 LLELLTG 494
+ E+ G
Sbjct: 228 IYEMAAG 234
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 59/194 (30%), Positives = 89/194 (45%), Gaps = 30/194 (15%)
Query: 318 FMVRLKNSA-VYAVKRLKKLQV-SMDEFSQTM--RQI--GNLKHPNILPLVCYNSTNEEK 371
F+ K + +A+K LKK V D+ TM +++ +HP + + C T +E
Sbjct: 34 FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KEN 92
Query: 372 L-LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
L V +Y + G L+ +I+ F A I GL F++ K I + +
Sbjct: 93 LFFVMEYLNGGDLMY----HIQSCHKFDLSRATFYAAEIILGLQFLH-----SKGIVYRD 143
Query: 431 LKLSNILLNENEDPLISECGYSK--FLDPKKTCLFSSNG---YTAPEKTVSEQG-----D 480
LKL NILL+++ I++ G K L KT F G Y APE + Q D
Sbjct: 144 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPE-ILLGQKYNHSVD 200
Query: 481 VFSFGVILLELLTG 494
+SFGV+L E+L G
Sbjct: 201 WWSFGVLLYEMLIG 214
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 19/102 (18%), Positives = 41/102 (40%), Gaps = 11/102 (10%)
Query: 65 NLKGIKC-NLHATNIVGI--RLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPT 119
+LK + N + + + LE + +S + L L+++ + N ++ ++P
Sbjct: 112 SLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPD 170
Query: 120 SISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+ L ++ +N L +P L L L + NN
Sbjct: 171 LPPS---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSL 207
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 20/106 (18%), Positives = 35/106 (33%), Gaps = 23/106 (21%)
Query: 72 NLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLN 131
+ + L N+ LS + + HL + + N + +P + + L N
Sbjct: 67 DCLDRQAHELELNNLGLSSLPEL-----PPHLESLVASCNSLT-ELPELPQSLKSLLVDN 120
Query: 132 LSSNLLSGAVPLALTKL----------------KHLKTLDISNNHF 161
+ LS +P L L LK +D+ NN
Sbjct: 121 NNLKALSD-LPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL 165
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 18/101 (17%), Positives = 37/101 (36%), Gaps = 12/101 (11%)
Query: 62 CSYN-LKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTS 120
N L+ + + + I +N +L + D L + N++
Sbjct: 180 AGNNQLEELPELQNLPFLTAIYADNNSLKKLPD--LPLSLESI---VAGNNIL--EELPE 232
Query: 121 ISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+ N LT + +NLL +P L+ L++ +N+
Sbjct: 233 LQNLPFLTTIYADNNLLK-TLP---DLPPSLEALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 13/86 (15%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
N+ + + + + D L ++++ N + +P L L S N
Sbjct: 297 PNLYYLNASSNEIRSLCD-----LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFN 347
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHF 161
L+ VP ++LK L + N
Sbjct: 348 HLA-EVP---ELPQNLKQLHVEYNPL 369
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 37/178 (20%), Positives = 69/178 (38%), Gaps = 22/178 (12%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
A K++ K V + + ++I +L HPNI+ L N + LV + + G L
Sbjct: 37 RAAKKIPKYFVEDVD--RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELF 94
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL---NEN 441
+ KR F I + + + ++ + + H +LK N L + +
Sbjct: 95 E----RVVHKRVFRESDAARIMKDVLSAVAYCHKLN-----VAHRDLKPENFLFLTDSPD 145
Query: 442 EDPLISECGYSKFLDPKK--TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTG 494
+ + G + P K + Y +P+ + D +S GV++ LL G
Sbjct: 146 SPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 39/179 (21%), Positives = 71/179 (39%), Gaps = 21/179 (11%)
Query: 328 YAVKRLKKLQVSMDEFSQTMRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384
+A K + ++S +F + R+ L+HPNI+ L LV+ + G L
Sbjct: 57 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116
Query: 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED- 443
I + + I + + + + I H NLK N+LL
Sbjct: 117 E----DIVAREFYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKG 167
Query: 444 -PL-ISECGYSKFLDPKKTC--LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTG 494
+ +++ G + ++ + + GY +PE S+ D+++ GVIL LL G
Sbjct: 168 AAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 47/190 (24%), Positives = 80/190 (42%), Gaps = 32/190 (16%)
Query: 328 YAVKRLKKLQVSM-------DEFSQTMRQIGNLK----HPNILPLVCYNSTNEEKLLVYK 376
YAVK + + T++++ L+ HPNI+ L TN LV+
Sbjct: 45 YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD 104
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
G L Y+ K K I + + + +++ + I H +LK NI
Sbjct: 105 LMKKGELFD----YLTEKVTLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENI 155
Query: 437 LLNENEDPLISECGYSKFLDPKK--TCLFSSNGYTAPE-----KTVSEQG-----DVFSF 484
LL+++ + +++ G+S LDP + + + Y APE + G D++S
Sbjct: 156 LLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 485 GVILLELLTG 494
GVI+ LL G
Sbjct: 216 GVIMYTLLAG 225
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 16/113 (14%), Positives = 30/113 (26%), Gaps = 16/113 (14%)
Query: 59 PHPCS-YNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRI 117
P C + G++C + L +L + + +
Sbjct: 2 PDACCPHGSSGLRCT------------RDGALDSLHH--LPGAENLTELYIENQQHLQHL 47
Query: 118 PT-SISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169
+ L L + + L P A L L++S N + S
Sbjct: 48 ELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTV 100
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 12/67 (17%), Positives = 21/67 (31%), Gaps = 3/67 (4%)
Query: 105 VVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPL-ALTKLKHLKTLDISNNHFAA 163
+ + + LT L + + + L L L L+ L I +
Sbjct: 13 LRCTRDGAL--DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70
Query: 164 TSPDNFR 170
+PD F
Sbjct: 71 VAPDAFH 77
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 33/121 (27%), Positives = 46/121 (38%), Gaps = 11/121 (9%)
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441
+L LL R L A + L F+ E +I H +LK NILL
Sbjct: 141 NLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLA---TPELSIIHCDLKPENILLCNP 195
Query: 442 EDPLISEC--GYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGK 495
+ I G S L + S Y +PE D++S G IL+E+ TG+
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
Query: 496 T 496
Sbjct: 256 P 256
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 18/122 (14%), Positives = 46/122 (37%), Gaps = 12/122 (9%)
Query: 59 PHPCS-YNLKGIKC---NLHA-----TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLA 109
PC + + + ++ + ++L +L I + L ++ + ++
Sbjct: 5 SPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVS 63
Query: 110 RNLIQGRIPTSI-SNCRRLTYLNLSSN-LLSGAVPLALTKLKHLKTLDISNNHFAATSPD 167
++ ++ + N ++T++ + + L+ P AL +L LK L I N
Sbjct: 64 IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDL 123
Query: 168 NF 169
Sbjct: 124 TK 125
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 5/94 (5%)
Query: 81 IRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIP--TSISNCRRLTYLNLSSNLLS 138
I + N ID + L +L L+ + + ++ P T + + L ++ N
Sbjct: 85 IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM 143
Query: 139 GAVPL-ALTKL-KHLKTLDISNNHFAATSPDNFR 170
++P+ A L TL + NN F + F
Sbjct: 144 TSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFN 177
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 46/195 (23%), Positives = 91/195 (46%), Gaps = 31/195 (15%)
Query: 318 FMVRLKNSA-VYAVKRLKK-LQVSMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEEKL 372
+VR K + YA+K L+K + ++ DE + T+ ++ N +HP + L T ++L
Sbjct: 22 ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRL 80
Query: 373 -LVYKYQSNGSLLSLLEAYIEGKRDFPWKL-RLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
V +Y + G L ++ +R F + R A I L++++ + + + +
Sbjct: 81 CFVMEYANGGELFF----HLSRERVFTEERARFYGAE-IVSALEYLH-----SRDVVYRD 130
Query: 431 LKLSNILLNENEDPLISECGYSK--FLDPKKTCLFSSNG---YTAPEKTVSEQG-----D 480
+KL N++L+++ I++ G K D F G Y APE + + D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPE-VLEDNDYGRAVD 187
Query: 481 VFSFGVILLELLTGK 495
+ GV++ E++ G+
Sbjct: 188 WWGLGVVMYEMMCGR 202
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 56/270 (20%), Positives = 102/270 (37%), Gaps = 48/270 (17%)
Query: 255 EILKALQDSPSKSPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDD--LLEATADLRSQT 312
++L + ++ + V ++ +E + ++ R + DD +L +
Sbjct: 19 DLLLGVHQELGA--SELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEIL--------KV 68
Query: 313 ICSSLF----MVRLKNSA-VYAVKRLKKLQ-VSMDEFSQTM--RQI-GNLKHPNILPLVC 363
I F +V++K + VYA+K + K + E S R + N I L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 364 YNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKL-RLSIATGIAKGLDFMYQKSNE 422
LV +Y G LL+LL + G+R P ++ R +A I +D +++
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKF--GER-IPAEMARFYLAE-IVMAIDSVHRLG-- 182
Query: 423 EKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCL-FSSNG---YTAPEKTVSEQ 478
H ++K NILL+ +++ G L T + G Y +PE +
Sbjct: 183 ---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE-ILQAV 238
Query: 479 GDVF------------SFGVILLELLTGKT 496
G + GV E+ G+T
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 37/189 (19%), Positives = 76/189 (40%), Gaps = 43/189 (22%)
Query: 333 LKKLQVSMDE--FSQT-MRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386
+K++++ +E T +R++ L+H NI+ L N L+++Y +
Sbjct: 64 IKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-----AEND 118
Query: 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL- 445
L+ Y++ D ++ S + G++F + + H +LK N+LL+ ++
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR-----RCLHRDLKPQNLLLSVSDASET 173
Query: 446 ----ISECGYSK-FLDPKKTCLFSSNGYT---------APE-----KTVSEQGDVFSFGV 486
I + G ++ F P + +T PE + S D++S
Sbjct: 174 PVLKIGDFGLARAFGIPIRQ-------FTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226
Query: 487 ILLELLTGK 495
I E+L
Sbjct: 227 IWAEMLMKT 235
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 55/195 (28%), Positives = 88/195 (45%), Gaps = 30/195 (15%)
Query: 318 FMVRLKNSA-VYAVKRLKK-LQVSMDEFSQTM--RQI--GNLKHPNILPLVCYNSTNEEK 371
+ K + +YAVK LKK + + D+ TM +++ K P + L T ++
Sbjct: 37 MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDR 95
Query: 372 L-LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
L V +Y + G L+ +I+ F + A IA GL F+ K I + +
Sbjct: 96 LYFVMEYVNGGDLMY----HIQQVGRFKEPHAVFYAAEIAIGLFFLQ-----SKGIIYRD 146
Query: 431 LKLSNILLNENEDPLISECGYSK--FLDPKKTCLFSSNG---YTAPEKTVSEQG-----D 480
LKL N++L+ I++ G K D T F G Y APE ++ Q D
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC--GTPDYIAPE-IIAYQPYGKSVD 203
Query: 481 VFSFGVILLELLTGK 495
++FGV+L E+L G+
Sbjct: 204 WWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 32/196 (16%)
Query: 318 FMVRLKNSA-VYAVKRLKK-LQVSMDEFSQTM--RQI--GNLKHPNILPLVCYNSTNEEK 371
+ R+K + +YAVK LKK + + D+ TM ++I HP + L C T ++
Sbjct: 40 MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PDR 98
Query: 372 L-LVYKYQSNGSLLSLLEAYIEGKRDFPWKL-RLSIATGIAKGLDFMYQKSNEEKTIPHG 429
L V ++ + G L+ +I+ R F R A I L F+ +K I +
Sbjct: 99 LFFVMEFVNGGDLMF----HIQKSRRFDEARARFYAAE-IISALMFL-----HDKGIIYR 148
Query: 430 NLKLSNILLNENEDPLISECGYSK--FLDPKKTCLFSSNG---YTAPEKTVSEQG----- 479
+LKL N+LL+ +++ G K + T F G Y APE + E
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC--GTPDYIAPE-ILQEMLYGPAV 205
Query: 480 DVFSFGVILLELLTGK 495
D ++ GV+L E+L G
Sbjct: 206 DWWAMGVLLYEMLCGH 221
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 17/83 (20%), Positives = 30/83 (36%), Gaps = 16/83 (19%)
Query: 94 AETLCKLRHLRVVSLARNLIQGRIPT-----------SISNCRRLTYLNLSSNLLS--GA 140
+E + + L + + GR+ ++ C +L + LS N
Sbjct: 53 SENIASKKDLEIAEFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111
Query: 141 VPLA--LTKLKHLKTLDISNNHF 161
PL L+K L+ L + NN
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGL 134
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 18/79 (22%), Positives = 28/79 (35%), Gaps = 11/79 (13%)
Query: 94 AETLCKLRHLRVVSLARNLIQGR----IPTSISNC--RRLTYLNLSSNLLS--GAVPLA- 144
A L +LR + L L+ R + + S L L L N + L
Sbjct: 237 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 296
Query: 145 --LTKLKHLKTLDISNNHF 161
K+ L L+++ N F
Sbjct: 297 VIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 21/78 (26%), Positives = 35/78 (44%), Gaps = 10/78 (12%)
Query: 94 AETLCKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLS--GAVPL--AL 145
E L + L+V+ L N + ++ + L L L+ LLS GA + A
Sbjct: 209 LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 268
Query: 146 TKLKH--LKTLDISNNHF 161
+KL++ L+TL + N
Sbjct: 269 SKLENIGLQTLRLQYNEI 286
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 17/83 (20%), Positives = 30/83 (36%), Gaps = 9/83 (10%)
Query: 88 LSGIIDAETLCKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLS--GAV 141
L + + LR + RN ++ + + R L + + N + G
Sbjct: 146 LQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE 205
Query: 142 PL---ALTKLKHLKTLDISNNHF 161
L L + LK LD+ +N F
Sbjct: 206 HLLLEGLAYCQELKVLDLQDNTF 228
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 19/72 (26%), Positives = 28/72 (38%), Gaps = 1/72 (1%)
Query: 99 KLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISN 158
L L + L+ N +Q +P LT L++S N L+ AL L L+ L +
Sbjct: 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133
Query: 159 NHFAATSPDNFR 170
N P
Sbjct: 134 NELKTLPPGLLT 145
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 22/87 (25%), Positives = 33/87 (37%), Gaps = 3/87 (3%)
Query: 85 NMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLA 144
+ NL TL L ++L R + ++ L L+LS N L ++PL
Sbjct: 39 SENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLL 95
Query: 145 LTKLKHLKTLDISNNHFAATSPDNFRQ 171
L L LD+S N + R
Sbjct: 96 GQTLPALTVLDVSFNRLTSLPLGALRG 122
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 17/70 (24%), Positives = 26/70 (37%)
Query: 102 HLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+ +SL++N I IS L L LS N + + L+ LD+S+N
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 162 AATSPDNFRQ 171
S
Sbjct: 113 QNISCCPMAS 122
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 14/67 (20%), Positives = 37/67 (55%), Gaps = 4/67 (5%)
Query: 94 AETLCKL-RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLK 152
+ C + V++L+ N++ G + + ++ L+L +N + ++P +T L+ L+
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQ 476
Query: 153 TLDISNN 159
L++++N
Sbjct: 477 ELNVASN 483
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 44.4 bits (106), Expect = 6e-05
Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 48/201 (23%)
Query: 318 FMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEEKL 372
++R + N YA+K LKK V + + T R + + HP I+ + ++
Sbjct: 23 HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKL-RLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
++ Y G L SLL + FP + + A + L++++ K I + +L
Sbjct: 83 MIMDYIEGGELFSLLRK--SQR--FPNPVAKFYAAE-VCLALEYLHSKD-----IIYRDL 132
Query: 432 KLSNILLNENEDPLISECGYSKFLD-------PKKT---CLFSSNG---YTAPEKTVSEQ 478
K NILL++N G+ K D P T C G Y APE VS +
Sbjct: 133 KPENILLDKN--------GHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPE-VVSTK 178
Query: 479 G-----DVFSFGVILLELLTG 494
D +SFG+++ E+L G
Sbjct: 179 PYNKSIDWWSFGILIYEMLAG 199
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 19/100 (19%), Positives = 36/100 (36%), Gaps = 21/100 (21%)
Query: 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135
+I + + + NL+ + +LR L ++ N + +P L+ +
Sbjct: 61 AHITTLVIPDNNLTSL--PALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLT 114
Query: 136 LLSGAVPLALTKL--------------KHLKTLDISNNHF 161
L A+P L KL L+ L +S+N
Sbjct: 115 HLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQL 153
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 12/97 (12%)
Query: 76 TNIVGIRLENMNLSGIID----AETLCKLRHLRVVSLARNLIQGRIPTSISNC----RRL 127
++ + L N+ + AE L +++ S+ + +++ L
Sbjct: 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTL 95
Query: 128 TYLNLSSNLLS--GAVPLA--LTKLKHLKTLDISNNH 160
LN+ SN +S G + L L L L I N
Sbjct: 96 KSLNVESNFISGSGILALVEALQSNTSLIELRIDNQS 132
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 44/266 (16%), Positives = 90/266 (33%), Gaps = 77/266 (28%)
Query: 329 AVKRLKKLQVS----MDEFSQTMRQIGNLK-------HPNILPLVCYNSTNEEKLLVYKY 377
A+K + + +V + + ++ L HP ++ L+ + T E +LV +
Sbjct: 60 AIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLER 119
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
L YI K + + + + + H ++K NIL
Sbjct: 120 PLPAQDLF---DYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG-----VVHRDIKDENIL 171
Query: 438 LNENEDPL-ISECGYSKFLDPKK---TC---------LFSSNGYTAPEKTVSEQGDVFSF 484
++ + + G L + S + Y A V+S
Sbjct: 172 IDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPA------TVWSL 225
Query: 485 GVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD--KEVAKAGRQWAFP------- 535
G++L +++ G D+P F+ +E+ +A + FP
Sbjct: 226 GILLYDMVCG--------DIP---------------FERDQEILEA--ELHFPAHVSPDC 260
Query: 536 --LLNVALKCVSNSPDDRPTMAEVLE 559
L+ +C++ P RP++ E+L
Sbjct: 261 CALIR---RCLAPKPSSRPSLEEILL 283
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 17/77 (22%), Positives = 29/77 (37%), Gaps = 9/77 (11%)
Query: 94 AETLCKLRHLRVVSLARNLIQGRIPTSIS-----NCRRLTYLNLSSNLLS--GAVPLA-- 144
+ L + R L + ++ N ++ + L L L+ +S LA
Sbjct: 334 SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 393
Query: 145 LTKLKHLKTLDISNNHF 161
L L+ LD+SNN
Sbjct: 394 LLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 25/105 (23%), Positives = 37/105 (35%), Gaps = 11/105 (10%)
Query: 66 LKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSIS--- 122
L+ C + ++ L + + TL L L+ + L+ NL+ +
Sbjct: 80 LQTPSCKIQKLSLQNCCLTGAGCGVL--SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGL 137
Query: 123 --NCRRLTYLNLSSNLLS--GAVPLA--LTKLKHLKTLDISNNHF 161
RL L L LS PLA L K L +SNN
Sbjct: 138 LDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 12/77 (15%), Positives = 26/77 (33%), Gaps = 9/77 (11%)
Query: 94 AETLCKLRHLRVVSLARNLIQGRIPTSIS-----NCRRLTYLNLSSNLLS--GAVPLA-- 144
A L + ++++ N I + + +L L L S ++ L
Sbjct: 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222
Query: 145 LTKLKHLKTLDISNNHF 161
+ L+ L + +N
Sbjct: 223 VASKASLRELALGSNKL 239
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 23/108 (21%), Positives = 39/108 (36%), Gaps = 17/108 (15%)
Query: 66 LKGIKCNLHATNIVGIRLENMNLS--GIID-AETLCKLRHLRVVSLARNLIQGR-----I 117
LK C L A ++LE+ ++ D + LR ++L N +
Sbjct: 194 LKDSPCQLEA-----LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELC 248
Query: 118 PTSISNCRRLTYLNLSSNLLS--GAVPLA--LTKLKHLKTLDISNNHF 161
P + RL L + ++ G L L + LK L ++ N
Sbjct: 249 PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 16/77 (20%), Positives = 26/77 (33%), Gaps = 9/77 (11%)
Query: 94 AETLCKLRHLRVVSLARNLIQGRIPTSIS-----NCRRLTYLNLSSNLLS--GAVPLA-- 144
L L+ +SLA N + + +L L + S + +
Sbjct: 277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 336
Query: 145 LTKLKHLKTLDISNNHF 161
L + + L L ISNN
Sbjct: 337 LAQNRFLLELQISNNRL 353
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 43/179 (24%), Positives = 73/179 (40%), Gaps = 24/179 (13%)
Query: 328 YAVKRLKKLQVSMDEFSQT----MRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383
+A+K +KK D + +++ +KH NI+ L + LV + S G L
Sbjct: 37 FALKCIKKSPAFRDSSLENEIAVLKK---IKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93
Query: 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443
I + + K + + + ++++ I H +LK N+L E+
Sbjct: 94 FD----RILERGVYTEKDASLVIQQVLSAVKYLHENG-----IVHRDLKPENLLYLTPEE 144
Query: 444 --PL-ISECGYSKFLDPKK-TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTG 494
+ I++ G SK + + GY APE K S+ D +S GVI LL G
Sbjct: 145 NSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 47/204 (23%)
Query: 323 KNSAVYAVKRLKKLQVSMDEFSQT-MRQIG---NLKHPNILPL--VCYNSTNEEKLLVYK 376
K+ YA+K+++ S + R+I LKHPN++ L V + + + L++
Sbjct: 46 KDDKDYALKQIEG-----TGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100
Query: 377 YQSNGSLLSLLEAYIEGKRD-----FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
Y + L +++ + K + P + S+ I G+ +++ + H +L
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-----VLHRDL 154
Query: 432 KLSNILLNENEDPLISECGYSK---------FLDPKKTCLFSSNG------YTAPE---- 472
K +NIL+ E G K F P K L + Y APE
Sbjct: 155 KPANILVMGEGP----ERGRVKIADMGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLG 209
Query: 473 -KTVSEQGDVFSFGVILLELLTGK 495
+ ++ D+++ G I ELLT +
Sbjct: 210 ARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 42/191 (21%), Positives = 74/191 (38%), Gaps = 37/191 (19%)
Query: 328 YAVKRLKKLQVSMDEFSQT------MRQIG---NLKHPNILPLVCYNSTNEEKL-LVYKY 377
A+K + K + ++ + +I L HP I+ + N + E +V +
Sbjct: 38 VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI--KNFFDAEDYYIVLEL 95
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
G L + G + + + ++++ I H +LK N+L
Sbjct: 96 MEGGELFD----KVVGNKRLKEATCKLYFYQMLLAVQYLHENG-----IIHRDLKPENVL 146
Query: 438 LNENEDPL---ISECGYSKFLDP----KKTCLFSSNGYTAPE--KTVSEQG-----DVFS 483
L+ E+ I++ G+SK L + C + Y APE +V G D +S
Sbjct: 147 LSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 484 FGVILLELLTG 494
GVIL L+G
Sbjct: 205 LGVILFICLSG 215
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 6/83 (7%)
Query: 83 LENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNLL 137
L+ ++LS I+ L HL + L N IQ + S L L L
Sbjct: 54 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL 112
Query: 138 SGAVPLALTKLKHLKTLDISNNH 160
+ + LK LK L++++N
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNL 135
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 15/70 (21%), Positives = 28/70 (40%), Gaps = 2/70 (2%)
Query: 92 IDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNLLSGAVPLALTKLKH 150
+ + + L+V+ L+R IQ I + L+ L L+ N + A + L
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 151 LKTLDISNNH 160
L+ L +
Sbjct: 102 LQKLVAVETN 111
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 15/69 (21%), Positives = 27/69 (39%)
Query: 103 LRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFA 162
+ + L+ N ++ S + L L+LS + A L HL TL ++ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 163 ATSPDNFRQ 171
+ + F
Sbjct: 90 SLALGAFSG 98
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 18/95 (18%), Positives = 38/95 (40%), Gaps = 7/95 (7%)
Query: 82 RLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSN- 135
L + L+G + L L+ + + + + + L LN++ N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170
+ S +P + L +L+ LD+S+N + + R
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 36/261 (13%), Positives = 87/261 (33%), Gaps = 69/261 (26%)
Query: 329 AVKRLKKLQVS----MDEFSQTMRQIGNLK-----HPNILPLVCYNSTNEEKLLVYKY-Q 378
A+K ++K ++S + ++ ++ LK ++ L+ + + +L+ + +
Sbjct: 72 AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
L +I + +L S + + + + + H ++K NIL+
Sbjct: 132 PVQDLFD----FITERGALQEELARSFFWQVLEAVRHCHNCG-----VLHRDIKDENILI 182
Query: 439 NENEDPL-ISECGYSKFLDPK--KTC----------LFSSNGYTAPEKTVSEQGDVFSFG 485
+ N L + + G L + Y V+S G
Sbjct: 183 DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS------AAVWSLG 236
Query: 486 VILLELLTG-------KTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538
++L +++ G + + + + + V + + L+
Sbjct: 237 ILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH---------------------LIR 275
Query: 539 VALKCVSNSPDDRPTMAEVLE 559
C++ P DRPT E+
Sbjct: 276 ---WCLALRPSDRPTFEEIQN 293
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 58/256 (22%), Positives = 93/256 (36%), Gaps = 50/256 (19%)
Query: 266 KSPPQVMDIEEVRPEVRRSELVFFVNEKERFKLDDLLEATADLRSQTICSSL-------- 317
P++M+ P ++ + K D +
Sbjct: 5 PQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDF----------HFLKVIGKGSFGKV 54
Query: 318 FMVRLKNSA-VYAVKRLKK-LQVSMDEFSQTM--RQI--GNLKHPNILPLVCYNSTNEEK 371
+ R K YAVK L+K + E M R + N+KHP ++ L T +K
Sbjct: 55 LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADK 113
Query: 372 L-LVYKYQSNGSLLSLLEAYIEGKRDFPWKL-RLSIATGIAKGLDFMYQKSNEEKTIPHG 429
L V Y + G L +++ +R F R A IA L +++ I +
Sbjct: 114 LYFVLDYINGGELFY----HLQRERCFLEPRARFYAAE-IASALGYLH-----SLNIVYR 163
Query: 430 NLKLSNILLNENEDPLISECGYSK--FLDPKKTCLFSSNG---YTAPEKTVSEQG----- 479
+LK NILL+ ++++ G K T F G Y APE + +Q
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC--GTPEYLAPE-VLHKQPYDRTV 220
Query: 480 DVFSFGVILLELLTGK 495
D + G +L E+L G
Sbjct: 221 DWWCLGAVLYEMLYGL 236
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 26/122 (21%), Positives = 41/122 (33%), Gaps = 11/122 (9%)
Query: 59 PHPCSYNLKGIKC---NLHA------TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLA 109
P C + C L+ +RL N + + KL LR ++ +
Sbjct: 6 PEKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFS 65
Query: 110 RNLIQGRIPTSI-SNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDN 168
N I I + + L+SN L L+ LKTL + +N D+
Sbjct: 66 NNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDS 124
Query: 169 FR 170
F
Sbjct: 125 FI 126
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 35/191 (18%)
Query: 328 YAVKRLKK------LQVSMDEFSQTMRQIGNLK----HPNILPLVCYNSTNEEKLLVYKY 377
+AVK ++ + + T R+ L+ HP+I+ L+ ++ LV+
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
G L Y+ K K SI + + + F++ + I H +LK NIL
Sbjct: 182 MRKGELFD----YLTEKVALSEKETRSIMRSLLEAVSFLHANN-----IVHRDLKPENIL 232
Query: 438 LNENEDPLISECGYSKFLDP----KKTCLFSSNGYTAPE-----KTVSEQG-----DVFS 483
L++N +S+ G+S L+P ++ C + GY APE + G D+++
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPEILKCSMDETHPGYGKEVDLWA 290
Query: 484 FGVILLELLTG 494
GVIL LL G
Sbjct: 291 CGVILFTLLAG 301
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 37/172 (21%), Positives = 69/172 (40%), Gaps = 37/172 (21%)
Query: 345 QTMRQIGNLKHPNILPLVCY-----NSTNEEKL-LVYKYQSNGSLLSLLEAYIEGKRDFP 398
Q MR +KHPN++ L + + +E L LV +Y ++ Y + K+ P
Sbjct: 84 QIMRI---VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP 139
Query: 399 WKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL-ISECGYSKFLDP 457
L + + L +++ I H ++K N+LL+ L + + G +K L
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIG-----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 458 KKT--------------CLFSSNGYTAPEKTVSEQGDVFSFGVILLELLTGK 495
+ +F + YT D++S G ++ EL+ G+
Sbjct: 195 GEPNVSYICSRYYRAPELIFGATNYTTNI-------DIWSTGCVMAELMQGQ 239
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 36/183 (19%), Positives = 72/183 (39%), Gaps = 21/183 (11%)
Query: 328 YAVKRLKKLQVSMDEFSQT---MRQIG---NLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381
+AVK + + + T R+ LKHP+I+ L+ S++ +V+++
Sbjct: 52 FAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA 111
Query: 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL-NE 440
L + + + + I + L + + + I H ++K +LL ++
Sbjct: 112 DLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN-----IIHRDVKPHCVLLASK 166
Query: 441 NED-PL-ISECGYSKFLDPKKTCLFS---SNGYTAPE----KTVSEQGDVFSFGVILLEL 491
P+ + G + L + + APE + + DV+ GVIL L
Sbjct: 167 ENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFIL 226
Query: 492 LTG 494
L+G
Sbjct: 227 LSG 229
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 15/72 (20%), Positives = 31/72 (43%), Gaps = 11/72 (15%)
Query: 98 CKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLS--GAVPL--ALTKLK 149
C++ LR L+ N + + ++ +T+L+L L G L L + +
Sbjct: 155 CQITTLR---LSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR 211
Query: 150 HLKTLDISNNHF 161
L+ L+++ N
Sbjct: 212 QLQELNVAYNGA 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 7e-04
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 33/197 (16%)
Query: 318 FMVRLKNSA----VYAVKRLKKLQVSMDEFSQTM--RQI-GNLKHPNILPLVCYNSTNEE 370
F+V+ + + +YA+K LKK + + + +T R I + HP I+ L T E
Sbjct: 41 FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EG 99
Query: 371 KL-LVYKYQSNGSLLSLLEAYIEGKRDFPWKL-RLSIATGIAKGLDFMYQKSNEEKTIPH 428
KL L+ + G L + L E F + + +A +A LD ++ I +
Sbjct: 100 KLYLILDFLRGGDLFTRLSK--EVM--FTEEDVKFYLAE-LALALDHLHSLG-----IIY 149
Query: 429 GNLKLSNILLNENEDPLISECGYSK--FLDPKKTCLFSSNG---YTAPEKTVSEQG---- 479
+LK NILL+E +++ G SK KK F G Y APE V+ +G
Sbjct: 150 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTVEYMAPE-VVNRRGHTQS 206
Query: 480 -DVFSFGVILLELLTGK 495
D +SFGV++ E+LTG
Sbjct: 207 ADWWSFGVLMFEMLTGT 223
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 608 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.66 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.65 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.54 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.47 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.37 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.34 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.3 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.3 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.27 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.25 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.24 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.24 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.23 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.18 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.17 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.17 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.13 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.1 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.06 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.01 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.0 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 98.99 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.98 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 98.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.97 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.97 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.96 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.95 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.94 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 98.94 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.93 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.93 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 98.92 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.92 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.92 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.92 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.92 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.91 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.9 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.88 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.88 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.88 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.87 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.87 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.86 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.85 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.84 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.83 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.83 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.83 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.83 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.81 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.81 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.8 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.78 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.78 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.78 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.77 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.77 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.76 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.75 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.75 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.75 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.75 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.74 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.73 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.73 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.73 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.72 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.72 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.72 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.71 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.68 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.67 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.67 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.67 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.66 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.66 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.65 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.64 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.64 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.64 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.64 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.64 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.63 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.62 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.62 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.61 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.61 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.59 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.59 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.59 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.59 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.57 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.57 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.51 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.49 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.46 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.45 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.45 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.41 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.4 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.37 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.37 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.37 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.36 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.36 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.35 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.35 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.35 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.35 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.34 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.32 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.3 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.29 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.29 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.29 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.28 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.27 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.26 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.25 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.24 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.22 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.22 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.21 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.2 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.1 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.08 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.99 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 97.92 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.9 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.79 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.76 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.73 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.65 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.53 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.48 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.46 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.35 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.3 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.23 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.2 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.19 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.11 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.99 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.97 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.92 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.85 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.82 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.69 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.6 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.55 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.53 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.43 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.38 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.24 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.17 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.78 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.61 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 95.45 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.44 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 94.77 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 94.51 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.26 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 94.07 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.19 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 92.31 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 90.82 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 90.32 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 84.51 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 82.4 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.2 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 80.32 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=424.43 Aligned_cols=247 Identities=22% Similarity=0.321 Sum_probs=200.3
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.+.||+|+||+||+|++.+ .||||+++.... ..++|.+|++++++++|||||+++|++.. +..++|||||++|+
T Consensus 41 ~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs 117 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS 117 (307)
T ss_dssp EEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred eeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence 3569999999999998753 599999974333 34579999999999999999999998864 56899999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC----
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---- 458 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---- 458 (608)
|.++|+. ....++|.+++.|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 118 L~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~-----IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 118 LYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN-----IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp HHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred HHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999974 2457999999999999999999999986 999999999999999999999999999876432
Q ss_pred -CccccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 459 -KTCLFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 459 -~~~~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
.....||+.||||| ..++.++|||||||++|||+||+.||............. ..... .+.......
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~-~~~~~----~p~~~~~~~ 264 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV-GRGYA----SPDLSKLYK 264 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-HTTCC----CCCSTTSCT
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH-hcCCC----CCCcccccc
Confidence 23457999999999 247899999999999999999999997655443333222 22211 111222334
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
.++..+.+|+.+||+.||++||||.||++.|+.+....
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 56778999999999999999999999999999886554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=425.99 Aligned_cols=247 Identities=20% Similarity=0.296 Sum_probs=204.4
Q ss_pred hcccCCCCCceEEEEEEc------CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 306 ADLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
.+.||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++|||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 356899999999999874 47899999998532 34567999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHh---------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecc
Q 042949 379 SNGSLLSLLEAYI---------EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC 449 (608)
Q Consensus 379 ~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 449 (608)
++|+|.++|+... .....++|.+++.|+.|||+||+|||+++ ||||||||+|||+++++.+||+||
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-----FVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCC
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCccCHhhEEECCCCcEEECCc
Confidence 9999999997631 12457999999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccc
Q 042949 450 GYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGE 519 (608)
Q Consensus 450 Gla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 519 (608)
|+|+...... ....||+.||||| ..++.++|||||||++|||+| |+.||... +..+....+..... .
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~-~~~~~~~~i~~~~~-~- 249 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECITQGRV-L- 249 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHHHTCC-C-
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCC-C-
Confidence 9998765432 2346899999999 789999999999999999999 89998654 33333333322211 1
Q ss_pred cccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 520 VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 520 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
..+..++.++.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 250 -------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 250 -------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 12345677799999999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=427.51 Aligned_cols=246 Identities=19% Similarity=0.283 Sum_probs=199.1
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+.+..++|||||+
T Consensus 47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~ 126 (329)
T 4aoj_A 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMR 126 (329)
T ss_dssp EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 45899999999999874 47899999998533 345679999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhc-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEec
Q 042949 380 NGSLLSLLEAYIE-----------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISE 448 (608)
Q Consensus 380 ~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 448 (608)
+|+|.++++.... ....++|.+++.|+.|||+||+|||+++ ||||||||+|||+++++.+||+|
T Consensus 127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEETTTEEEECC
T ss_pred CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC-----eecccccHhhEEECCCCcEEEcc
Confidence 9999999975311 1346999999999999999999999987 99999999999999999999999
Q ss_pred cccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccc
Q 042949 449 CGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTG 518 (608)
Q Consensus 449 FGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 518 (608)
||+++.+.... ....||+.||||| ..++.++|||||||++|||+| |+.||.... ..+.+..+..... .
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~-~~~~~~~i~~g~~-~ 279 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-NTEAIDCITQGRE-L 279 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-HHHHHHHHHHTCC-C
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCC-C
Confidence 99999764332 3456899999999 678999999999999999999 899987543 2333333322111 1
Q ss_pred ccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 519 EVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 519 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
..+..++.++.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus 280 --------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 280 --------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 12345667799999999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=420.62 Aligned_cols=244 Identities=18% Similarity=0.263 Sum_probs=202.5
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.||+|+||+||+|++. +++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+.+..++|||||
T Consensus 32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~ 111 (308)
T 4gt4_A 32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC 111 (308)
T ss_dssp EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence 45899999999999863 5689999999743 334678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceE
Q 042949 379 SNGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446 (608)
Q Consensus 379 ~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl 446 (608)
++|+|.++|..... ....++|.++++|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEE
T ss_pred CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCCccccceEECCCCCEEE
Confidence 99999999974211 1246999999999999999999999987 999999999999999999999
Q ss_pred eccccccccCCC-----CccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhc
Q 042949 447 SECGYSKFLDPK-----KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEW 516 (608)
Q Consensus 447 ~DFGla~~~~~~-----~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 516 (608)
+|||+++.+... .....||+.||||| ..++.++|||||||++|||+| |+.||... ...+.+..+....
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~-~~~~~~~~i~~~~- 264 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-SNQDVVEMIRNRQ- 264 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC-CHHHHHHHHHTTC-
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCC-
Confidence 999999876432 23457899999999 789999999999999999999 88888654 3333333332211
Q ss_pred ccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 517 TGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
.. +.+..++..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 265 ~~--------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 265 VL--------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CC--------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 11 123456777999999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=407.19 Aligned_cols=238 Identities=18% Similarity=0.266 Sum_probs=197.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeec----CCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNST----NEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~ 378 (608)
..||+|+||+||+|... ++..||+|++..... ..+.|.+|++++++++|||||+++++|.+ ++..++|||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 35899999999999875 689999999974432 34578999999999999999999999864 34679999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-CCCceEeccccccccCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-NEDPLISECGYSKFLDP 457 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 457 (608)
++|+|.++++. ...+++..+..++.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+....
T Consensus 112 ~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~---~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 112 TSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999986 457999999999999999999999875 35999999999999985 78999999999987654
Q ss_pred C-CccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 458 K-KTCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 458 ~-~~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
. ....+||+.||||| ..++.++|||||||++|||+||+.||..........+.+.... ... ......+
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~-~~~-------~~~~~~~ 256 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPA-------SFDKVAI 256 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CCG-------GGGGCCC
T ss_pred CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC-CCC-------CCCccCC
Confidence 3 34568999999999 6789999999999999999999999976655544444333221 111 1122344
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.++.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 56889999999999999999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=413.55 Aligned_cols=242 Identities=17% Similarity=0.211 Sum_probs=200.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+.||+|+||+||+|+.. +|+.||||+++.... ..+|++++++++|||||++++++.+.+..|||||||++|+|.+
T Consensus 64 ~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~ 139 (336)
T 4g3f_A 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred cEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence 45899999999999975 689999999975332 2479999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-CceEeccccccccCCCC-----
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-DPLISECGYSKFLDPKK----- 459 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~----- 459 (608)
+|+. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+|+.+....
T Consensus 140 ~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 140 LIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR-----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp HHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred HHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 9986 357999999999999999999999987 99999999999999987 69999999999775431
Q ss_pred ---ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 460 ---TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 460 ---~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
...+||+.||||| ..++.++|||||||++|||+||+.||....... ....+..... .....+...
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~-------~~~~~~~~~ 282 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEPP-------PIREIPPSC 282 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSCC-------GGGGSCTTS
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCCC-------CchhcCccC
Confidence 2357999999999 568999999999999999999999997543321 1222222111 011223456
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
+..+.+++.+||+.||++|||+.|+++.|..+.+...
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 6778999999999999999999999999999886543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=412.93 Aligned_cols=235 Identities=16% Similarity=0.258 Sum_probs=198.6
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
.||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+++|++++|||||++++++.+.+..|||||||++|+|.+
T Consensus 81 ~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~ 160 (346)
T 4fih_A 81 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 160 (346)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHH
T ss_pred EeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHH
Confidence 4899999999999875 7999999999743 3345678999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTCL 462 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~~ 462 (608)
++.. ..+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+... ....
T Consensus 161 ~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 161 IVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp HHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred HHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence 9874 46999999999999999999999987 999999999999999999999999999977543 2457
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
+||+.||||| ..|+.++||||+||++|||++|+.||..... ...+..+... ..... ......+.++.+
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~-~~~~~------~~~~~~s~~~~d 302 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDN-LPPRL------KNLHKVSPSLKG 302 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHS-SCCCC------SCGGGSCHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHcC-CCCCC------CccccCCHHHHH
Confidence 8999999999 5689999999999999999999999976533 2223322221 11111 112345667899
Q ss_pred HHHHchhcCCCCCCCHHHHHHH
Q 042949 539 VALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~~ 560 (608)
|+.+||+.||++|||+.|+++.
T Consensus 303 li~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999998763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=413.40 Aligned_cols=237 Identities=20% Similarity=0.359 Sum_probs=195.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|++++++++|||||++++++.+++..|+|||||++|+
T Consensus 30 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~ 109 (350)
T 4b9d_A 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGD 109 (350)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 56899999999999874 799999999975433 34578999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.++|.. .....+++.+++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 110 L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 110 LFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRK-----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp HHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred HHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 9999975 23456899999999999999999999987 9999999999999999999999999999876432
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
...+||+.||||| ..++.++||||+||++|||+||+.||... +....+..+...... ......+.+
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~~~---------~~~~~~s~~ 252 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-SMKNLVLKIISGSFP---------PVSLHYSYD 252 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHTCCC---------CCCTTSCHH
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHcCCCC---------CCCccCCHH
Confidence 3467999999999 56899999999999999999999999754 333334433332211 112345667
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.+|+.+||+.||++|||+.|+++.
T Consensus 253 ~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 8999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=409.35 Aligned_cols=252 Identities=17% Similarity=0.229 Sum_probs=192.5
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC----eeEEEEeeccCC
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE----EKLLVYKYQSNG 381 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~e~~~~g 381 (608)
.+.||+|+||+||+|++ +|+.||||+++........++.|+..+.+++|||||+++++|...+ ..+||||||++|
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g 86 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence 35689999999999988 6899999999754332333445666678899999999999997653 579999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC---CCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSN---EEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~---~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
+|.++|+. ..++|..+.+++.|+++||+|||++.. +.++||||||||+|||+|.++++||+|||+++.....
T Consensus 87 sL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 87 SLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp BHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred cHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 99999985 469999999999999999999998621 2346999999999999999999999999999876543
Q ss_pred C-------ccccccCccccCCC----------CCCcchhHHHHHHHHHHHHcCCCCCcCCCC-------------hHHHH
Q 042949 459 K-------TCLFSSNGYTAPEK----------TVSEQGDVFSFGVILLELLTGKTVEKTGID-------------LPKWV 508 (608)
Q Consensus 459 ~-------~~~~gt~~y~aPE~----------~~~~ksDVwSfGvvl~elltg~~p~~~~~~-------------~~~~~ 508 (608)
. ....||+.|||||. .++.++|||||||++|||+||++|+..... .....
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 2 23479999999991 246789999999999999999876532111 11111
Q ss_pred HHHHhhhcccccccHHHHHh--chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 509 KAMVREEWTGEVFDKEVAKA--GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
.....+. ...+.++.. ....+..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 242 ~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 242 RKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1111111 111111111 123445688999999999999999999999999999765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=416.17 Aligned_cols=250 Identities=20% Similarity=0.268 Sum_probs=204.6
Q ss_pred hcccCCCCCceEEEEEEcC------CcEEEEEEecccc--cCHHHHHHHHHHHhcCCC-CcceeeeeeeecC-CeeEEEE
Q 042949 306 ADLRSQTICSSLFMVRLKN------SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKH-PNILPLVCYNSTN-EEKLLVY 375 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~------g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~-~~~~lv~ 375 (608)
.+.||+|+||+||+|+... ++.||||+++... ...++|.+|+++|.+++| ||||+++|+|... +..++||
T Consensus 69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence 3569999999999998643 3689999997533 234679999999999965 8999999998764 5689999
Q ss_pred eeccCCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC
Q 042949 376 KYQSNGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~ 443 (608)
|||++|+|.++|+.... ....+++..++.++.|||+||+|||+++ ||||||||+|||+++++.
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~-----iiHRDLK~~NILl~~~~~ 223 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNV 223 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGC
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC-----eecCccCccceeeCCCCC
Confidence 99999999999986422 1345899999999999999999999987 999999999999999999
Q ss_pred ceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHh
Q 042949 444 PLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVR 513 (608)
Q Consensus 444 ~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 513 (608)
+||+|||+|+.+.... ....||+.||||| ..++.++|||||||++|||+| |+.||..........+.+ .
T Consensus 224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i-~ 302 (353)
T 4ase_A 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-K 302 (353)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH-H
T ss_pred EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH-H
Confidence 9999999999765432 2356889999999 789999999999999999998 899987644333333332 2
Q ss_pred hhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 514 EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
+.... ..+..++.++.+++.+||+.||++|||+.||++.|+++++.+.
T Consensus 303 ~g~~~--------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 303 EGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp HTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred cCCCC--------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 22111 1233456678999999999999999999999999999987644
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=402.00 Aligned_cols=234 Identities=22% Similarity=0.318 Sum_probs=199.7
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
.+.||+|+||+||+|+.. +|+.||||++++. ....+.+.+|+++|++++|||||++++++.+++..|+|||||++
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~g 116 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 357999999999999874 7899999999742 33567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-- 458 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 458 (608)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 117 G~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~-----IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 117 GELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999986 357999999999999999999999987 999999999999999999999999999977532
Q ss_pred ---CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 459 ---KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 459 ---~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....+||+.||||| ..++.++||||+||++|||+||+.||.... .......+...... .+..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~~~~----------~p~~ 256 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-EGLIFAKIIKLEYD----------FPEK 256 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCC----------CCTT
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCC----------CCcc
Confidence 23568999999999 678999999999999999999999997543 33333333332211 1234
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+.++.+|+.+||+.||++|||++|++.
T Consensus 257 ~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 257 FFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred cCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 5566889999999999999999998743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=392.05 Aligned_cols=233 Identities=19% Similarity=0.273 Sum_probs=185.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|++++++++|||||++++++.+++..++||||+ +|
T Consensus 19 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g 97 (275)
T 3hyh_A 19 KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GN 97 (275)
T ss_dssp EEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CC
Confidence 5689999999999986 479999999997432 23567899999999999999999999999999999999999 78
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 98 ~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~-----IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 98 ELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 99999975 467999999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccCccccCC----CC-CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 TCLFSSNGYTAPE----KT-VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~-~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....||+.||||| .. ++.++||||+||++|||+||+.||... +.....+........ .+...+.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-~~~~~~~~i~~~~~~----------~p~~~s~ 237 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-SIPVLFKNISNGVYT----------LPKFLSP 237 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC----------CCTTSCH
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHcCCCC----------CCCCCCH
Confidence 4568999999999 23 468999999999999999999999754 333444433332211 1223456
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
++.+|+.+||+.||++|||++|+++.
T Consensus 238 ~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 238 GAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHcC
Confidence 68899999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=414.08 Aligned_cols=236 Identities=16% Similarity=0.260 Sum_probs=198.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+++|++++|||||+++++|.+.+..|||||||++|+|.
T Consensus 157 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~ 236 (423)
T 4fie_A 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 236 (423)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred eEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHH
Confidence 34899999999999875 6999999999743 334567899999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Ccc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~ 461 (608)
++++. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+... ...
T Consensus 237 ~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~-----IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 237 DIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp HHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred HHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC-----eecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 99874 45999999999999999999999987 999999999999999999999999999977543 345
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.+||+.||||| ..|+.++|||||||++|||++|+.||...... ..+..+... ..... ......+..+.
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~-~~~~~------~~~~~~s~~~~ 378 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDN-LPPRL------KNLHKVSPSLK 378 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHS-CCCCC------SCTTSSCHHHH
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcC-CCCCC------cccccCCHHHH
Confidence 78999999999 56899999999999999999999999765432 222222221 11111 11234566789
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+|+.+||+.||++|||+.|+++.
T Consensus 379 dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 379 GFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999998763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=396.29 Aligned_cols=228 Identities=21% Similarity=0.237 Sum_probs=185.7
Q ss_pred cccCCCCCceEEEEEEc----CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK----NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.||+|+||+||+|+.. +++.||||++++.. .....+.+|++++++++|||||++++++.+++..|+|||||+
T Consensus 30 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 109 (304)
T 3ubd_A 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLR 109 (304)
T ss_dssp EEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCT
T ss_pred EEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCC
Confidence 56899999999999863 46899999997432 233468899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 458 (608)
+|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 110 gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 110 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG-----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp TCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999986 457999999999999999999999987 999999999999999999999999999865432
Q ss_pred --CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 459 --KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 459 --~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
.....||+.||||| ..++.++||||+||++|||+||+.||.... .......+..... ..+...
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~~----------~~p~~~ 249 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMILKAKL----------GMPQFL 249 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCC----------CCCTTS
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-HHHHHHHHHcCCC----------CCCCcC
Confidence 24568999999999 678999999999999999999999997543 3333333333211 112345
Q ss_pred HHHHHHHHHHchhcCCCCCCCH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTM 554 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~ 554 (608)
+.++.+|+.+||+.||++|||+
T Consensus 250 s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 250 SPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTC
T ss_pred CHHHHHHHHHHcccCHHHCCCC
Confidence 6678899999999999999984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=386.06 Aligned_cols=235 Identities=20% Similarity=0.279 Sum_probs=176.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCC------------ee
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE------------EK 371 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------------~~ 371 (608)
+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++|++++|||||++++++.+.+ ..
T Consensus 11 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l 90 (299)
T 4g31_A 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL 90 (299)
T ss_dssp EEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEE
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEE
Confidence 46899999999999875 78999999997432 23467899999999999999999999886543 36
Q ss_pred EEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccc
Q 042949 372 LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGY 451 (608)
Q Consensus 372 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 451 (608)
|+|||||++|+|.+++... ......++..++.|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 91 ~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~~~-----IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 91 YIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSKG-----LMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHHCc-----CccccCcHHHeEECCCCcEEEccCcc
Confidence 8999999999999999742 11123567778999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCC---------------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHH
Q 042949 452 SKFLDPKK---------------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMV 512 (608)
Q Consensus 452 a~~~~~~~---------------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~ 512 (608)
|+.+.... ...+||+.||||| ..++.++|||||||++|||++ ||....+.........
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~ 241 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR 241 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHh
Confidence 99765421 2346999999999 578999999999999999997 6543211111111111
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
. ..+.+.. ......+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~-----~~~p~~~----~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 242 N-----LKFPPLF----TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp T-----TCCCHHH----HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-----CCCCCCC----cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1111111 122334678999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=386.61 Aligned_cols=243 Identities=17% Similarity=0.198 Sum_probs=192.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeec------CCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNST------NEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~~lv~e 376 (608)
+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++|++++|||||++++++.. .+..|+|||
T Consensus 60 ~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE 139 (398)
T 4b99_A 60 ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD 139 (398)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEE
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEe
Confidence 56899999999999874 799999999975433 24568899999999999999999998754 367899999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
||+ |+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+.
T Consensus 140 ~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~-----iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 140 LME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ-----VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc-----CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 995 789998864 567999999999999999999999987 9999999999999999999999999998764
Q ss_pred CC-------CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc--cccc
Q 042949 457 PK-------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG--EVFD 522 (608)
Q Consensus 457 ~~-------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 522 (608)
.. ....+||+.||||| ..++.++||||+||++|||++|++||.+...... +..+....... ....
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCGGGTC
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCChHHhh
Confidence 32 23568999999999 3568999999999999999999999976544332 22222211100 0000
Q ss_pred -------------------HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 -------------------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 -------------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..........+..+.+|+.+||..||++|||+.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00011112345678999999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=374.94 Aligned_cols=240 Identities=20% Similarity=0.209 Sum_probs=190.0
Q ss_pred cccCCCCCceEEEEEEc----CCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK----NSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||+||+|+.+ +++.||||++... ....++.+|+++|.++ +|||||++++++.+.+..++||||+++|
T Consensus 27 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~ 105 (361)
T 4f9c_A 27 DKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHE 105 (361)
T ss_dssp EEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCC
T ss_pred EEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcc
Confidence 46899999999999863 4689999998753 3456788999999998 6999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-CCceEeccccccccCCCC-
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-EDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~- 459 (608)
+|.++++ .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+......
T Consensus 106 ~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g-----IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 106 SFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG-----IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred cHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999873 3899999999999999999999987 9999999999999877 789999999998654321
Q ss_pred ------------------------------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh
Q 042949 460 ------------------------------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL 504 (608)
Q Consensus 460 ------------------------------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~ 504 (608)
...+||+.||||| ..++.++||||+||++|||+||+.||..+.+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 2246999999999 34789999999999999999999999766554
Q ss_pred HHHHHHHHhhh----------cc-------cccc--------------c---HHH----------HHhchhcHHHHHHHH
Q 042949 505 PKWVKAMVREE----------WT-------GEVF--------------D---KEV----------AKAGRQWAFPLLNVA 540 (608)
Q Consensus 505 ~~~~~~~~~~~----------~~-------~~~~--------------~---~~~----------~~~~~~~~~~l~~li 540 (608)
......+..-. .. .... + +.. .......+.++.+|+
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 33322221100 00 0000 0 000 001123456789999
Q ss_pred HHchhcCCCCCCCHHHHHH
Q 042949 541 LKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 541 ~~Cl~~dP~~RPs~~evl~ 559 (608)
.+||+.||++|||++|+++
T Consensus 334 ~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHT
T ss_pred HHHCcCChhHCcCHHHHhc
Confidence 9999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=387.55 Aligned_cols=235 Identities=20% Similarity=0.210 Sum_probs=192.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHH---HHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFS---QTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~---~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
..||+|+||+||+|+.. +|+.||||++++. ......+. .++.+++.++|||||++++++.+.+..|+|||||
T Consensus 195 k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~ 274 (689)
T 3v5w_A 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 274 (689)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecC
Confidence 56899999999999875 6899999999742 12233333 3466778889999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
+||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+...
T Consensus 275 ~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g-----IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 275 NGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp CSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 99999999986 357999999999999999999999987 999999999999999999999999999977544
Q ss_pred -CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC--ChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 459 -KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGI--DLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 459 -~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
....+||+.||||| ..|+.++||||+||++|||++|++||.... +.....+....... ..+.
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~----------~~p~ 415 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----------ELPD 415 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC----------CCCT
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC----------CCCc
Confidence 35578999999999 258999999999999999999999996532 22222222222110 1123
Q ss_pred hcHHHHHHHHHHchhcCCCCCCC-----HHHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPT-----MAEVLER 560 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~ 560 (608)
..+.++.+|+.+||+.||++|++ ++||++.
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 45667899999999999999998 6777654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=388.13 Aligned_cols=239 Identities=20% Similarity=0.302 Sum_probs=199.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.||+|+||+||+|+.. +|+.||+|+++... ...+.+.+|+++|++++|||||++++++.+.+..++|||||++|+|.
T Consensus 163 ~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~ 242 (573)
T 3uto_A 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242 (573)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHH
Confidence 56899999999999875 78999999997533 34567889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC--CCceEeccccccccCCCC--c
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN--EDPLISECGYSKFLDPKK--T 460 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~--~ 460 (608)
++|.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+.... .
T Consensus 243 ~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~-----iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 243 EKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp HHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred HHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 98853 2457999999999999999999999987 9999999999999854 889999999999876554 3
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
..+||+.||||| ..++.++||||+||++|||++|+.||..... ......+....+. +.. ......+..+
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-~~~~~~i~~~~~~---~~~---~~~~~~s~~~ 387 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDWN---MDD---SAFSGISEDG 387 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHTTCCC---CCS---GGGTTSCHHH
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHhCCCC---CCc---ccccCCCHHH
Confidence 467999999999 5689999999999999999999999976543 2333333222111 000 1123456678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+|+.+||+.||++|||+.|+++.
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=358.42 Aligned_cols=270 Identities=33% Similarity=0.511 Sum_probs=214.7
Q ss_pred ccCcCHHHHHHHhhc-----ccCCCCCceEEEEEEcCCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeee
Q 042949 293 KERFKLDDLLEATAD-----LRSQTICSSLFMVRLKNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYN 365 (608)
Q Consensus 293 ~~~~~~~~l~~~~~~-----~~g~g~~g~vy~~~~~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~ 365 (608)
...+++.++...+++ .+|+|+||.||+|+..+|+.||||+++... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 345777777766653 589999999999998889999999997432 2334689999999999999999999999
Q ss_pred ecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCce
Q 042949 366 STNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445 (608)
Q Consensus 366 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~k 445 (608)
...+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.. ..+|+||||||+|||++.++.+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS--SSCEECCCCSGGGEEECTTCCEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999864334456999999999999999999999982 12399999999999999999999
Q ss_pred EeccccccccCCCC----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcC-------CCChHHHHHH
Q 042949 446 ISECGYSKFLDPKK----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKT-------GIDLPKWVKA 510 (608)
Q Consensus 446 l~DFGla~~~~~~~----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~-------~~~~~~~~~~ 510 (608)
|+|||+++...... ....||..|+||| ..++.++|||||||++|||+||+.||.. ......|+..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999998765332 2345899999999 5679999999999999999999999841 2223334333
Q ss_pred HHhhhcccccccHHHH-HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 511 MVREEWTGEVFDKEVA-KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 511 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
...........+.... ......+..+.+++.+||+.||++|||+.||+++|+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 3222222222222221 11234556799999999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=353.48 Aligned_cols=258 Identities=28% Similarity=0.474 Sum_probs=209.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
..+|+|+||.||+|+..+|+.||||++.... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 45 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 124 (321)
T 2qkw_B 45 FLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124 (321)
T ss_dssp CCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGG
T ss_pred ceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHH
Confidence 4689999999999998889999999987433 345779999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-----Cc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-----KT 460 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-----~~ 460 (608)
++.........+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..... ..
T Consensus 125 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 199 (321)
T 2qkw_B 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-----IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199 (321)
T ss_dssp GSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred HHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC-----eecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 88642222346999999999999999999999987 999999999999999999999999999865432 12
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC-----ChHHHHHHHHhhhcccccccHHHH-Hhch
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI-----DLPKWVKAMVREEWTGEVFDKEVA-KAGR 530 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 530 (608)
...||..|+||| ..++.++|||||||++|||+||+.||.... ....|..............++... ....
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (321)
T 2qkw_B 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP 279 (321)
T ss_dssp CCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCH
T ss_pred ccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCH
Confidence 345899999999 678999999999999999999999986432 233343333332222333332221 1123
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
..+..+.+++.+||+.||++|||+.|+++.|+.+.+..+
T Consensus 280 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 456678999999999999999999999999999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=346.59 Aligned_cols=249 Identities=24% Similarity=0.329 Sum_probs=193.3
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||+|+. +|+.||||++...... .+++.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 43 ~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 121 (309)
T 3p86_A 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121 (309)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBH
T ss_pred eEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcH
Confidence 5789999999999987 6889999999754433 35688999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~ 460 (608)
.+++.... ....+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 122 ~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 197 (309)
T 3p86_A 122 YRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN---PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK 197 (309)
T ss_dssp HHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS---SCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred HHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC---CCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccc
Confidence 99997410 0123899999999999999999999875 34999999999999999999999999999865443 23
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||..|+||| ..++.++|||||||++|||+||+.||..... .............. ..+...+..+
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~~~~~~~~~--------~~~~~~~~~l 268 (309)
T 3p86_A 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-AQVVAAVGFKCKRL--------EIPRNLNPQV 268 (309)
T ss_dssp ----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-HHHHHHHHHSCCCC--------CCCTTSCHHH
T ss_pred cCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCC--------CCCccCCHHH
Confidence 457899999999 5678999999999999999999999865432 22222221111110 1123455668
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus 269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 899999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=338.03 Aligned_cols=243 Identities=20% Similarity=0.323 Sum_probs=205.5
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|+||.||+++..+++.||+|+++......+++.+|++++++++||||+++++++.+.+..++||||+++|+|.++
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 95 (269)
T 4hcu_A 16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 95 (269)
T ss_dssp EEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred heecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHH
Confidence 56899999999999998999999999987777788999999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
+.. ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 96 l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (269)
T 4hcu_A 96 LRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167 (269)
T ss_dssp HHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred HHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC-----eecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence 964 2456999999999999999999999987 9999999999999999999999999998765432 234
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.+|..|+||| ..++.++||||+|+++|||++ |+.||.... ............. . ..+...+..+.
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-~~~~~~~~~~~~~--~-------~~~~~~~~~~~ 237 (269)
T 4hcu_A 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFR--L-------YKPRLASTHVY 237 (269)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTTCC--C-------CCCTTSCHHHH
T ss_pred ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHhcCcc--C-------CCCCcCCHHHH
Confidence 5677899999 678999999999999999999 888886533 2222222222110 0 01223456688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 999999999999999999999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=345.12 Aligned_cols=245 Identities=20% Similarity=0.394 Sum_probs=200.4
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
.+.+|+|+||.||++... +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 367899999999999975 6899999998643 33456789999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc---
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT--- 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--- 460 (608)
.+++.. ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 95 ~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 95 RGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN-----IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp HHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999975 2457999999999999999999999987 99999999999999999999999999987643221
Q ss_pred --------------cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 461 --------------CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 461 --------------~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
...||+.|+||| ..++.++|||||||++|||++|..|+......... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~---------~~~~~~ 237 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---------FGLNVR 237 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT---------SSBCHH
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH---------Hhhhhh
Confidence 456899999999 56789999999999999999999887542211000 000000
Q ss_pred HHH-HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 523 KEV-AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 523 ~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
... ......++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 238 GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000 011234455688999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=348.99 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=195.6
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC----eeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE----EKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~e~~~~g~ 382 (608)
+.+|+|+||.||+|+.. ++.||||+++........+.+|+.++++++||||+++++++.... ..++||||+++|+
T Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~ 108 (322)
T 3soc_A 30 EVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGS 108 (322)
T ss_dssp EEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCB
T ss_pred heecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCC
Confidence 57899999999999875 789999999865545556778999999999999999999988744 4699999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKS-----NEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
|.++++. ..+++..++.++.|++.||+|||+.. .+..+|+||||||+|||++.++.+||+|||+++....
T Consensus 109 L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~ 183 (322)
T 3soc_A 109 LSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183 (322)
T ss_dssp HHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECT
T ss_pred HHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccc
Confidence 9999975 45999999999999999999999870 0011399999999999999999999999999987654
Q ss_pred CC-----ccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCC---------------hHHHH
Q 042949 458 KK-----TCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGID---------------LPKWV 508 (608)
Q Consensus 458 ~~-----~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~---------------~~~~~ 508 (608)
.. ....||..|+|||. .++.++|||||||++|||+||+.||....+ ...+.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (322)
T 3soc_A 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ 263 (322)
T ss_dssp TSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH
T ss_pred ccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh
Confidence 32 23568999999991 234578999999999999999999864321 11111
Q ss_pred HHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 509 KAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
....... ........ ......+..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 264 ~~~~~~~-~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 264 EVVVHKK-KRPVLRDY--WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHTTSC-CCCCCCGG--GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhccc-CCCCcccc--ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111110 11111100 01122345689999999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=340.68 Aligned_cols=236 Identities=16% Similarity=0.276 Sum_probs=197.3
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|+||.||+|.. .+|+.||||++... ....+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 26 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (297)
T 3fxz_A 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (297)
T ss_dssp EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHH
Confidence 4689999999999985 57899999999743 345677899999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---cc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---TC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~~ 461 (608)
+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 106 DVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp HHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred HHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 99975 36999999999999999999999987 9999999999999999999999999998765432 34
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..||+.|+||| ..++.++|||||||++|||+||+.||........... ...... ... ......+..+.
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~-~~~------~~~~~~~~~~~ 247 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGT-PEL------QNPEKLSAIFR 247 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHHCS-CCC------SCGGGSCHHHH
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhCCC-CCC------CCccccCHHHH
Confidence 57899999999 5689999999999999999999999976543322222 111111 111 01234556688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+++.+||+.||++|||+.|+++.
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhHCcCHHHHhhC
Confidence 99999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.72 Aligned_cols=249 Identities=15% Similarity=0.238 Sum_probs=205.1
Q ss_pred cCcCHHHHHHHhhc---------------ccCCCCCceEEEEEEc-CCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCC
Q 042949 294 ERFKLDDLLEATAD---------------LRSQTICSSLFMVRLK-NSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHP 356 (608)
Q Consensus 294 ~~~~~~~l~~~~~~---------------~~g~g~~g~vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~ 356 (608)
..++.+++.++++. .+|+|+||.||+|+.. +|+.||||+++.. ....+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888887753 4899999999999986 7999999999743 34567799999999999999
Q ss_pred cceeeeeeeecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCe
Q 042949 357 NILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436 (608)
Q Consensus 357 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NI 436 (608)
||+++++++...+..++||||+++|+|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NI 172 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG-----VIHRDIKSDSI 172 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHE
Confidence 99999999999999999999999999999885 356999999999999999999999987 99999999999
Q ss_pred ecCCCCCceEeccccccccCCC---CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHH
Q 042949 437 LLNENEDPLISECGYSKFLDPK---KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVK 509 (608)
Q Consensus 437 Ll~~~~~~kl~DFGla~~~~~~---~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~ 509 (608)
|++.++.+||+|||+++..... .....||..|+||| ..++.++|||||||++|||++|+.||..... .....
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-~~~~~ 251 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-VQAMK 251 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHH
T ss_pred EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH
Confidence 9999999999999999876543 23457899999999 5678999999999999999999999875432 22222
Q ss_pred HHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 510 AMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..... ..... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~-~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 RLRDS-PPPKL------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHS-SCCCC------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhcC-CCCCc------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22211 11111 0122345668899999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=362.94 Aligned_cols=245 Identities=22% Similarity=0.384 Sum_probs=205.0
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|+||.||+|...++..||||+++......++|.+|++++++++|||||++++++. .+..++||||+++|+|.++
T Consensus 194 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~ 272 (454)
T 1qcf_A 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDF 272 (454)
T ss_dssp EEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHH
T ss_pred EEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHH
Confidence 578999999999999988999999999876677889999999999999999999999986 5678999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 273 l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 345 (454)
T 1qcf_A 273 LKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN-----YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 345 (454)
T ss_dssp HHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSS
T ss_pred HHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCC
Confidence 97421 235889999999999999999999987 9999999999999999999999999999765432 223
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ..++.++|||||||++|||+| |+.||... ........+... ... ..+..++..+.
T Consensus 346 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~-~~~--------~~~~~~~~~l~ 415 (454)
T 1qcf_A 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERG-YRM--------PRPENCPEELY 415 (454)
T ss_dssp SSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHHT-CCC--------CCCTTSCHHHH
T ss_pred cccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcC-CCC--------CCCCCCCHHHH
Confidence 4567899999 678999999999999999999 89888643 333333322221 110 11234567789
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
+++.+||+.||++|||+.+|++.|+++.....
T Consensus 416 ~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 416 NIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 99999999999999999999999999876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=336.34 Aligned_cols=243 Identities=21% Similarity=0.305 Sum_probs=203.5
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
..+|+|+||.||+++..++..||+|+++......+++.+|++++.+++||||+++++++...+..++||||+++|+|.++
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 93 (268)
T 3sxs_A 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93 (268)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred eeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHH
Confidence 56899999999999999888999999987777788899999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
+... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 94 l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 94 LRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp HHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT-----EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred HHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 9763 345999999999999999999999987 9999999999999999999999999998765443 223
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.+|..|+||| ..++.++||||||+++|||+| |+.||..... ............ . ..+...+..+.
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~---~------~~~~~~~~~l~ 235 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQGHR---L------YRPHLASDTIY 235 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHTTCC---C------CCCTTSCHHHH
T ss_pred CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-HHHHHHHHcCCC---C------CCCCcChHHHH
Confidence 4566799999 567899999999999999999 8888864432 222222221110 0 01122355688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 236 QIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.28 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=201.9
Q ss_pred hcccCCCCCceEEEEEEc--------CCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEE
Q 042949 306 ADLRSQTICSSLFMVRLK--------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLV 374 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~--------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 374 (608)
.+.||+|+||.||+|+.. ++..||||+++... ...+++.+|+++++++ +||||+++++++...+..++|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 356999999999999863 35689999997532 2346789999999999 899999999999999999999
Q ss_pred EeeccCCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC
Q 042949 375 YKYQSNGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~ 442 (608)
|||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENN 240 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTC
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccchhhEEECCCC
Confidence 999999999999986321 1245899999999999999999999987 99999999999999999
Q ss_pred CceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHH
Q 042949 443 DPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMV 512 (608)
Q Consensus 443 ~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 512 (608)
.+||+|||+++...... ....+|+.|+||| ..++.++|||||||++|||+| |+.||.... .........
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-~~~~~~~~~ 319 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLK 319 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHHHHHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHh
Confidence 99999999998665422 2345677899999 678999999999999999999 888886532 222222222
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
.. ... ..+..++..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 320 ~~-~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 320 EG-HRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp TT-CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cC-CCC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11 111 112345667899999999999999999999999999988643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.87 Aligned_cols=234 Identities=24% Similarity=0.315 Sum_probs=196.3
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||.||+|+. .+|+.||||++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 21 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~ 100 (328)
T 3fe3_A 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100 (328)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCc
Confidence 5689999999999987 5899999999975433 34568899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--Cc
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--KT 460 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--~~ 460 (608)
|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 101 L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 101 VFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR-----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp HHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence 9999976 356999999999999999999999987 999999999999999999999999999876543 24
Q ss_pred cccccCccccCC----CC-CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 461 CLFSSNGYTAPE----KT-VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~-~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
...||+.|+||| .. .+.++||||+||++|||++|+.||... +.............. .+...+..
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~----------~p~~~s~~ 240 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-NLKELRERVLRGKYR----------IPFYMSTD 240 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCC----------CCTTSCHH
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCC----------CCCCCCHH
Confidence 567999999999 33 358999999999999999999999654 333333333222111 12234566
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.+++.+||..||++|||+.|+++.
T Consensus 241 ~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 241 CENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 8899999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=335.42 Aligned_cols=243 Identities=19% Similarity=0.310 Sum_probs=202.0
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|+||.||+++..++..||||+++......+++.+|++++.+++||||+++++++.+.+..++||||+++|+|.++
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 109 (283)
T 3gen_A 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109 (283)
T ss_dssp EECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHH
T ss_pred hhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHH
Confidence 56899999999999999999999999997777788999999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
+... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 110 l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (283)
T 3gen_A 110 LREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181 (283)
T ss_dssp HHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred HHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence 9742 346999999999999999999999987 9999999999999999999999999998765432 233
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.+|..|+||| ..++.++||||||+++|||+| |+.||..... ............ . ......+..+.
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-~~~~~~~~~~~~--~-------~~~~~~~~~l~ 251 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQGLR--L-------YRPHLASEKVY 251 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHTTCC--C-------CCCTTCCHHHH
T ss_pred ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-hHHHHHHhcccC--C-------CCCCcCCHHHH
Confidence 4567899999 678999999999999999999 9988865432 222222221110 0 01223455688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 252 ~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 252 TIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 999999999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.52 Aligned_cols=267 Identities=26% Similarity=0.460 Sum_probs=212.6
Q ss_pred ccCcCHHHHHHHhhc-----------ccCCCCCceEEEEEEcCCcEEEEEEecccc-----cCHHHHHHHHHHHhcCCCC
Q 042949 293 KERFKLDDLLEATAD-----------LRSQTICSSLFMVRLKNSAVYAVKRLKKLQ-----VSMDEFSQTMRQIGNLKHP 356 (608)
Q Consensus 293 ~~~~~~~~l~~~~~~-----------~~g~g~~g~vy~~~~~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~H~ 356 (608)
...|+++++.+++.+ .+|+|+||.||+|.. +++.||||++.... ...+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 356888999888864 489999999999986 68899999987421 2256789999999999999
Q ss_pred cceeeeeeeecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCe
Q 042949 357 NILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436 (608)
Q Consensus 357 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NI 436 (608)
||+++++++...+..++||||+++|+|.+++... .....+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dlkp~Ni 164 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENH-----HIHRDIKSANI 164 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----eecCCCCHHHE
Confidence 9999999999999999999999999999999753 22456999999999999999999999987 99999999999
Q ss_pred ecCCCCCceEeccccccccCCCC-----ccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC---hH
Q 042949 437 LLNENEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGID---LP 505 (608)
Q Consensus 437 Ll~~~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~---~~ 505 (608)
+++.++.+||+|||+++...... ....||..|+||| ..++.++||||||+++|||++|+.||..... ..
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 99999999999999998765422 2346899999999 5578899999999999999999999865322 12
Q ss_pred HHHHHHHhhhc-ccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 506 KWVKAMVREEW-TGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 506 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
.+......... ....++..........+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22222111100 01111111112233455678999999999999999999999999998853
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.46 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=199.9
Q ss_pred cccCCCCCceEEEEEEc----CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK----NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.+|+|+||.||+|+.. .+..||||+++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 55 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 134 (325)
T 3kul_A 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134 (325)
T ss_dssp EEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTT
T ss_pred eEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCC
Confidence 57899999999999984 44569999998532 2346789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|+|.++++. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 135 ~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 135 GSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp CBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred CcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999964 2457999999999999999999999987 9999999999999999999999999998765432
Q ss_pred -----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 -----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 -----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....+|..|+||| ..++.++|||||||++|||++ |+.||..... ............. ...
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-~~~~~~~~~~~~~---------~~~ 276 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRL---------PAP 276 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-HHHHHHHHTTCCC---------CCC
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHHcCCCC---------CCC
Confidence 1223566799999 678899999999999999999 9988865432 2222222221110 112
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
..++..+.+++.+||+.||++|||+.|+++.|+.+.+...
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 3456678999999999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.91 Aligned_cols=248 Identities=19% Similarity=0.317 Sum_probs=200.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 96 (294)
T 4eqm_A 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP 96 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCC
Confidence 56899999999999865 68999999986322 22457889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 97 TLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR-----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp BHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999976 356999999999999999999999987 9999999999999999999999999998765432
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....||+.|+||| ..++.++|||||||++|||+||+.||..........+.. .. .............+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~ 241 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-QD-----SVPNVTTDVRKDIP 241 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH-SS-----CCCCHHHHSCTTSC
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-hc-----cCCCcchhcccCCC
Confidence 3356899999999 567899999999999999999999997654322222211 11 11111122234566
Q ss_pred HHHHHHHHHchhcCCCCCC-CHHHHHHHHHHhhcCCC
Q 042949 534 FPLLNVALKCVSNSPDDRP-TMAEVLERIEEVVNGND 569 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~~~~~~ 569 (608)
..+.+++.+||+.||++|| +++++.+.|+.+.....
T Consensus 242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 242 QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 7789999999999999998 99999999998876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=356.36 Aligned_cols=242 Identities=20% Similarity=0.300 Sum_probs=199.1
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC-eeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE-EKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~~g~L~~ 385 (608)
+.||+|+||.||+|... |+.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||||+++|+|.+
T Consensus 199 ~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~ 276 (450)
T 1k9a_A 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 276 (450)
T ss_dssp EEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHH
T ss_pred eeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHH
Confidence 56899999999999884 7899999998543 5678999999999999999999999987655 7899999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcccccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSS 465 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt 465 (608)
+++.. +...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..........++
T Consensus 277 ~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 349 (450)
T 1k9a_A 277 YLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 349 (450)
T ss_dssp HHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTSCEEECCCTTCEECC------CCC
T ss_pred HHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCC
Confidence 99863 3345899999999999999999999987 9999999999999999999999999998765444445678
Q ss_pred CccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHH
Q 042949 466 NGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVA 540 (608)
Q Consensus 466 ~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 540 (608)
..|+||| ..++.++|||||||++|||+| |+.||..... ......+.. .... ..+..++..+.+++
T Consensus 350 ~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~~-~~~~--------~~p~~~~~~l~~li 419 (450)
T 1k9a_A 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEK-GYKM--------DAPDGCPPAVYDVM 419 (450)
T ss_dssp TTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-TTHHHHHHT-TCCC--------CCCTTCCHHHHHHH
T ss_pred cceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc-CCCC--------CCCCcCCHHHHHHH
Confidence 8999999 678999999999999999999 9988864332 222222211 1110 12234567789999
Q ss_pred HHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 541 LKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 541 ~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
.+||+.||++|||+.++++.|+++...
T Consensus 420 ~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 420 KNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=346.84 Aligned_cols=253 Identities=16% Similarity=0.178 Sum_probs=197.2
Q ss_pred cccCCCCCceEEEEEEcC------CcEEEEEEeccccc------------CHHHHHHHHHHHhcCCCCcceeeeeeeecC
Q 042949 307 DLRSQTICSSLFMVRLKN------SAVYAVKRLKKLQV------------SMDEFSQTMRQIGNLKHPNILPLVCYNSTN 368 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~------g~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 368 (608)
+.||+|+||.||+|...+ ++.||||++..... ....+..|+..+.+++||||+++++++...
T Consensus 41 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 120 (364)
T 3op5_A 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120 (364)
T ss_dssp EECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEE
T ss_pred EEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeec
Confidence 578999999999998865 47899999864321 112344566677888999999999998764
Q ss_pred ----CeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC--CCC
Q 042949 369 ----EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN--ENE 442 (608)
Q Consensus 369 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~--~~~ 442 (608)
...++||||+ +|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++
T Consensus 121 ~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~-----iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 121 KNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE-----YVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp ETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEESSCTT
T ss_pred cCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEEecCCHHHEEEecCCCC
Confidence 4589999999 9999999975 2467999999999999999999999987 99999999999999 889
Q ss_pred CceEeccccccccCCCC----------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHH
Q 042949 443 DPLISECGYSKFLDPKK----------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWV 508 (608)
Q Consensus 443 ~~kl~DFGla~~~~~~~----------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~ 508 (608)
.+||+|||+++.+.... ....||..|+||| ..++.++|||||||++|||+||+.||........+.
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 99999999998664321 2345899999999 568999999999999999999999998644433333
Q ss_pred HHHHhhhcccccccHHHHHh--chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 509 KAMVREEWTGEVFDKEVAKA--GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
....... .. .+....... ....+..+.+++..||+.||++||++.++++.|+++.+....
T Consensus 272 ~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 272 RDSKIRY-RE-NIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HHHHHHH-HH-CHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHh-hh-hHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 3222111 00 010111111 134577799999999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=337.11 Aligned_cols=244 Identities=19% Similarity=0.249 Sum_probs=193.0
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||+||+++..+|+.||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||++ |+|
T Consensus 27 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l 105 (311)
T 3niz_A 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDL 105 (311)
T ss_dssp EEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEH
T ss_pred hhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCH
Confidence 56899999999999998999999999974322 24678899999999999999999999999999999999997 588
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~ 460 (608)
.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 177 (311)
T 3niz_A 106 KKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR-----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177 (311)
T ss_dssp HHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred HHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence 888764 3456999999999999999999999987 999999999999999999999999999876532 23
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHH--Hhhhcccc--------------
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAM--VREEWTGE-------------- 519 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~-------------- 519 (608)
...+|..|+||| ..++.++|||||||++|||++|+.||............. ........
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcc
Confidence 457899999999 357899999999999999999999987544332222211 11100000
Q ss_pred --cc-cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 520 --VF-DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 520 --~~-~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.. ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 00011122335567899999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.76 Aligned_cols=242 Identities=23% Similarity=0.348 Sum_probs=197.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc--------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV--------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
+.+|+|+||.||+|+.. +++.||||++..... ..+.+.+|++++++++||||+++++++.+.. ++||||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~ 102 (287)
T 4f0f_A 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEF 102 (287)
T ss_dssp EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEEC
T ss_pred hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEe
Confidence 56899999999999874 789999999863221 1267899999999999999999999987665 699999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC-----ceEeccccc
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED-----PLISECGYS 452 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla 452 (608)
+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|||++
T Consensus 103 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 103 VPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN---PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp CTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS---SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred cCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC---CCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 999999998863 3457999999999999999999999865 34999999999999988776 999999999
Q ss_pred cccCCCCccccccCccccCCC------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHH-HHHHHHhhhcccccccHHH
Q 042949 453 KFLDPKKTCLFSSNGYTAPEK------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPK-WVKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 453 ~~~~~~~~~~~gt~~y~aPE~------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 525 (608)
+..........||..|+|||. .++.++|||||||++|||++|+.||........ .............
T Consensus 177 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------ 250 (287)
T 4f0f_A 177 QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT------ 250 (287)
T ss_dssp BCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC------
T ss_pred ccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC------
Confidence 877666666789999999992 257789999999999999999999875443222 2222222211111
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
.....+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 251 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 --IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1234556789999999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=360.93 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=205.1
Q ss_pred hcccCCCCCceEEEEEEcC-CcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 306 ADLRSQTICSSLFMVRLKN-SAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~-g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
.+.||+|+||.||+|.... +..||||+++......++|.+|++++++++|||||+++++|...+..++||||+++|+|.
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~ 304 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHH
Confidence 3579999999999999874 889999999876667889999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----c
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----T 460 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~ 460 (608)
++++. .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 305 ~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 305 DYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN-----FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp HHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred HHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 99975 23456999999999999999999999987 9999999999999999999999999999765432 2
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (608)
...++..|+||| ..++.++|||||||++|||+| |+.||.... .......+.. .... ..+..++..
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-~~~~~~~~~~-~~~~--------~~~~~~~~~ 447 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK-DYRM--------ERPEGCPEK 447 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHHHHHHT-TCCC--------CCCTTCCHH
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHc-CCCC--------CCCCCCCHH
Confidence 234567899999 668999999999999999999 888876432 2222222211 1110 112345677
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 536 LLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 536 l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 448 l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 89999999999999999999999999988643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.95 Aligned_cols=234 Identities=21% Similarity=0.293 Sum_probs=196.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +|+.||+|++++. ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg 90 (337)
T 1o6l_A 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90 (337)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 56899999999999875 6899999999742 335677899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---C
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP---K 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~ 458 (608)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 91 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 91 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp BHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 99999975 356999999999999999999999987 99999999999999999999999999986432 2
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||+.|+||| ..++.++|||||||++|||++|+.||.... ............. ..+...+.
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~----------~~p~~~s~ 230 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEI----------RFPRTLSP 230 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCC----------CCCTTSCH
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-HHHHHHHHHcCCC----------CCCCCCCH
Confidence 34567999999999 467899999999999999999999997543 2233333222211 01224556
Q ss_pred HHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
.+.+++.+||+.||++|| ++.|+++.
T Consensus 231 ~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 688999999999999999 89999765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=349.60 Aligned_cols=244 Identities=22% Similarity=0.344 Sum_probs=190.8
Q ss_pred hcccCCCCCceEEEEEEc----CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLK----NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.+.+|+|+||.||+|+.. ++..||||+++... ...+++.+|++++++++||||+++++++...+..++||||++
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 357899999999999875 57789999997432 234679999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.++++. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 130 ~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 130 NGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp TCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999974 2456999999999999999999999987 9999999999999999999999999998765432
Q ss_pred c------cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 T------CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 ~------~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
. ...++..|+||| ..++.++|||||||++|||++ |+.||.... .......... .... ..
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-~~~~~~~i~~-~~~~--------~~ 271 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAVDE-GYRL--------PP 271 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-HHHHHHHHHT-TEEC--------CC
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHc-CCCC--------CC
Confidence 1 123466899999 678999999999999999998 999886543 2222222221 1110 11
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
...++..+.+++.+||+.||++||++.+|++.|+++++.
T Consensus 272 ~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 234566789999999999999999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=343.87 Aligned_cols=237 Identities=22% Similarity=0.297 Sum_probs=197.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc-------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV-------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||+++.. +|+.||+|+++.... ..+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 18 ~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 97 (361)
T 2yab_A 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV 97 (361)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcC
Confidence 56899999999999875 689999999974322 3578999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC----CceEeccccccc
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE----DPLISECGYSKF 454 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~ 454 (608)
++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.
T Consensus 98 ~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 98 SGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp CSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999864 567999999999999999999999987 99999999999998877 799999999987
Q ss_pred cCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 455 LDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 455 ~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
..... ....||+.|+||| ..++.++|||||||++|||++|..||..... ......+..... .++.. .
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~---~~~~~---~ 241 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANITAVSY---DFDEE---F 241 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHTTCC---CCCHH---H
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCC---CCCch---h
Confidence 75432 4567999999999 5689999999999999999999999976432 222322222111 11111 1
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
....+..+.+++.+||..||++|||+.|+++
T Consensus 242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2345667899999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=336.53 Aligned_cols=234 Identities=22% Similarity=0.324 Sum_probs=199.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +|+.||+|+++.. ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 12 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg 91 (318)
T 1fot_A 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 91 (318)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCC
Confidence 56899999999999875 7899999999742 235677889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 92 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~ 162 (318)
T 1fot_A 92 ELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162 (318)
T ss_dssp BHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChheEEEcCCCCEEEeecCcceecCCcccc
Confidence 99999976 457999999999999999999999887 999999999999999999999999999987766667
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..||+.|+||| ..++.++|||||||++|||++|+.||..... ......+..... ..+...+..+.
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~----------~~p~~~~~~~~ 231 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNAEL----------RFPPFFNEDVK 231 (318)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHCCC----------CCCTTSCHHHH
T ss_pred ccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC----------CCCCCCCHHHH
Confidence 78999999999 5678999999999999999999999976433 222333322211 01223456688
Q ss_pred HHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 538 NVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
+++.+||..||++|| +++|+++.
T Consensus 232 ~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 999999999999999 88888754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=356.10 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=201.2
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
.+.+|+|+||.||+|...++..||||+++......++|.+|++++++++||||+++++++.. +..++||||+++|+|.+
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~ 267 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 267 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHH
Confidence 35689999999999999888899999998766677899999999999999999999999876 67899999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----cc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TC 461 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~ 461 (608)
++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 268 ~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 268 FLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp HHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred HHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 997521 245899999999999999999999987 9999999999999999999999999998765432 22
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
..++..|+||| ..++.++|||||||++|||+| |+.||.... .......+... ... ..+..++..+
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~-~~~--------~~~~~~~~~l 410 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERG-YRM--------PCPPECPESL 410 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTT-CCC--------CCCTTSCHHH
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcC-CCC--------CCCCCCCHHH
Confidence 34567899999 678999999999999999999 888886433 22222222221 110 1123456678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
.+++.+||+.||++|||+.++++.|+++......
T Consensus 411 ~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 9999999999999999999999999999865443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=340.41 Aligned_cols=239 Identities=19% Similarity=0.285 Sum_probs=199.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+.+|+|+||.||++... +++.||+|.++......+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.+
T Consensus 11 ~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~ 90 (321)
T 1tki_A 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHH
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHH
Confidence 56899999999999875 68899999998655556678999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC--CCCceEeccccccccCCCC--cc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE--NEDPLISECGYSKFLDPKK--TC 461 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~--~~ 461 (608)
++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...... ..
T Consensus 91 ~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g-----ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 162 (321)
T 1tki_A 91 RINT---SAFELNEREIVSYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp HHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence 9863 2357999999999999999999999987 999999999999987 7899999999999875543 34
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..||+.|+||| ..++.++|||||||++|||++|..||..... ............. ++. ......+..+.
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~---~~~---~~~~~~s~~~~ 235 (321)
T 1tki_A 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYT---FDE---EAFKEISIEAM 235 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC---CCH---HHHTTSCHHHH
T ss_pred ccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-HHHHHHHHcCCCC---CCh---hhhccCCHHHH
Confidence 57899999999 4468899999999999999999999975432 2333333322111 111 11234566789
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+++.+||..||++|||+.|+++.
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999885
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.01 Aligned_cols=242 Identities=17% Similarity=0.221 Sum_probs=198.2
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccc------ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKL------QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
.+.||+|+||.||++... +|+.||||+++.. ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 108 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 357899999999999875 6899999998632 225678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC---ceEecccccccc
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED---PLISECGYSKFL 455 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~ 455 (608)
++|+|.+++.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++..
T Consensus 109 ~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN-----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp SSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999988765444567999999999999999999999987 999999999999987655 999999999877
Q ss_pred CCCC---ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 456 DPKK---TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 456 ~~~~---~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
.... ....||+.|+||| ..++.++|||||||++|||++|+.||... ............. ...+ ..
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~~~---~~~~---~~ 255 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKGKY---KMNP---RQ 255 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHTCC---CCCH---HH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcCCC---CCCc---cc
Confidence 5432 3457899999999 56789999999999999999999999753 2222222222111 1111 11
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
....+..+.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 23456678999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.13 Aligned_cols=244 Identities=20% Similarity=0.300 Sum_probs=200.0
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.+.+|+|+||.||+|+.. +++.||||+++... ...+++.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 198 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence 357899999999999986 78999999987432 123468899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc--
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT-- 460 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 460 (608)
|.++++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 199 L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 199 FLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC-----CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp HHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 99999753 345899999999999999999999987 99999999999999999999999999986544321
Q ss_pred ---cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 461 ---CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 461 ---~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
...++..|+||| ..++.++|||||||++|||+| |..|+..... ... .......... ..+..+
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-~~~-~~~~~~~~~~--------~~~~~~ 340 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQT-REFVEKGGRL--------PCPELC 340 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-HHH-HHHHHTTCCC--------CCCTTC
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHH-HHHHHcCCCC--------CCCCCC
Confidence 123466799999 668899999999999999999 8888765322 222 2222211110 112345
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 66789999999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.00 Aligned_cols=247 Identities=19% Similarity=0.272 Sum_probs=199.0
Q ss_pred cccCCCCCceEEEEEE------cCCcEEEEEEeccccc--CHHHHHHHHHHHhcC-CCCcceeeeeeeecCC-eeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL------KNSAVYAVKRLKKLQV--SMDEFSQTMRQIGNL-KHPNILPLVCYNSTNE-EKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~-~~~lv~e 376 (608)
+.+|+|+||.||+|+. .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++...+ ..++|||
T Consensus 28 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e 107 (359)
T 3vhe_A 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 107 (359)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEE
T ss_pred eeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEE
Confidence 5689999999999974 2458999999975322 345689999999999 7999999999988755 4899999
Q ss_pred eccCCCHHHHHHHHhcC--------------------------------------------------------------C
Q 042949 377 YQSNGSLLSLLEAYIEG--------------------------------------------------------------K 394 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~--------------------------------------------------------------~ 394 (608)
|+++|+|.++++..... .
T Consensus 108 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3vhe_A 108 FCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187 (359)
T ss_dssp CCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTTT
T ss_pred ecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhc
Confidence 99999999999753210 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-----ccccccCccc
Q 042949 395 RDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-----TCLFSSNGYT 469 (608)
Q Consensus 395 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~ 469 (608)
..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....+|..|+
T Consensus 188 ~~l~~~~~~~~~~ql~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~ 262 (359)
T 3vhe_A 188 DFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262 (359)
T ss_dssp TCBCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGC
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeE
Confidence 12899999999999999999999987 9999999999999999999999999998764322 2346788899
Q ss_pred cCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHch
Q 042949 470 APE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCV 544 (608)
Q Consensus 470 aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl 544 (608)
||| ..++.++|||||||++|||+| |+.||................. .. ..+...+..+.+++.+||
T Consensus 263 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~--------~~~~~~~~~l~~li~~~l 333 (359)
T 3vhe_A 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RM--------RAPDYTTPEMYQTMLDCW 333 (359)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC-CC--------CCCTTCCHHHHHHHHHHT
T ss_pred ChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC-CC--------CCCCCCCHHHHHHHHHHc
Confidence 999 678999999999999999999 9999876544333332222211 11 112234566889999999
Q ss_pred hcCCCCCCCHHHHHHHHHHhhcC
Q 042949 545 SNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 545 ~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+.||++|||+.|+++.|+++++.
T Consensus 334 ~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 334 HGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999999998864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=339.18 Aligned_cols=243 Identities=19% Similarity=0.251 Sum_probs=187.6
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhc--CCCCcceeeeeeeec----CCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGN--LKHPNILPLVCYNST----NEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~----~~~~~lv~e~~~~ 380 (608)
+.+|+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....++||||+++
T Consensus 14 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~ 90 (301)
T 3q4u_A 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM 90 (301)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTT
T ss_pred EeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccC
Confidence 5689999999999988 7899999999753 34555666666655 899999999998654 3468999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCCCceecCCCCCCeecCCCCCceEeccccc
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMY--------QKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 452 (608)
|+|.++++ ...+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 91 GSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA-----IAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp CBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE-----EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-----eecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999995 357999999999999999999999 554 999999999999999999999999999
Q ss_pred cccCCCC-------ccccccCccccCC----C------CCCcchhHHHHHHHHHHHHcC----------CCCCcCCCC--
Q 042949 453 KFLDPKK-------TCLFSSNGYTAPE----K------TVSEQGDVFSFGVILLELLTG----------KTVEKTGID-- 503 (608)
Q Consensus 453 ~~~~~~~-------~~~~gt~~y~aPE----~------~~~~ksDVwSfGvvl~elltg----------~~p~~~~~~-- 503 (608)
+...... ....||+.|+||| . .++.++|||||||++|||+|| +.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8654332 2247899999999 1 234689999999999999999 777754221
Q ss_pred -hHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 504 -LPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 504 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
..................... ......+..+.+++.+||+.||++|||+.||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRPNIPNR--WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGG--GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCCCCCChh--hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 112222222111111111110 11223456789999999999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.26 Aligned_cols=239 Identities=20% Similarity=0.283 Sum_probs=197.6
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccc-------cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-------VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
.+.+|+|+||.||+++.. +|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 95 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEc
Confidence 356899999999999875 68999999997432 2467899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC----CceEecccccc
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE----DPLISECGYSK 453 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~ 453 (608)
+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 96 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 96 VAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp CCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC-----eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999863 467999999999999999999999987 99999999999999887 79999999998
Q ss_pred ccCCC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 454 FLDPK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 454 ~~~~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
..... .....||+.|+||| ..++.++|||||||++|||++|+.||..... ........... ..+.. .
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~---~~~~~---~ 239 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANVSAVN---YEFED---E 239 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHHTC---CCCCH---H
T ss_pred ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-HHHHHHHHhcC---CCcCc---c
Confidence 76533 24467999999999 5688999999999999999999999865432 22222222111 11111 1
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 123455668899999999999999999999873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.73 Aligned_cols=248 Identities=22% Similarity=0.294 Sum_probs=191.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|+||.||+++. .++.||||+++.. ...+.+.+|++++++++||||+++++++.+ ..++||||+++|+|.++
T Consensus 14 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~ 89 (307)
T 2eva_A 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNV 89 (307)
T ss_dssp EEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHH
T ss_pred eEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHH
Confidence 5789999999999987 4788999999743 345678999999999999999999998874 47999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC-ceEeccccccccCCCCcccccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED-PLISECGYSKFLDPKKTCLFSS 465 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~~~~~~~~~~gt 465 (608)
++.. .....+++..++.++.|+++||+|||+.+ ..+|+||||||+|||++.++. +||+|||+++..........||
T Consensus 90 l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt 166 (307)
T 2eva_A 90 LHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQ--PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGS 166 (307)
T ss_dssp HHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCS--SSCCCCCCCSGGGEEEETTTTEEEECCCCC------------CC
T ss_pred Hhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCC--CCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCCC
Confidence 9741 11224789999999999999999999842 134999999999999998887 7999999998776555566799
Q ss_pred CccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChH-HHHHHHHhhhcccccccHHHHHhchhcHHHHHHHH
Q 042949 466 NGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLP-KWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVA 540 (608)
Q Consensus 466 ~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 540 (608)
..|+||| ..++.++|||||||++|||+||+.||....... ........ .... ......+..+.+++
T Consensus 167 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~~~l~~li 237 (307)
T 2eva_A 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GTRP--------PLIKNLPKPIESLM 237 (307)
T ss_dssp TTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TCCC--------CCBTTCCHHHHHHH
T ss_pred CceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CCCC--------CcccccCHHHHHHH
Confidence 9999999 567899999999999999999999987543222 11111111 1111 11234556788999
Q ss_pred HHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 541 LKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 541 ~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
.+||+.||++|||+.|+++.|+.+.+....
T Consensus 238 ~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 238 TRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 999999999999999999999999876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.27 Aligned_cols=243 Identities=20% Similarity=0.313 Sum_probs=205.0
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|+||.||+++..++..||+|+++......+++.+|++++++++||||+++++++...+..++||||+++|+|.++
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 93 (267)
T 3t9t_A 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY 93 (267)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHH
T ss_pred eEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHH
Confidence 56899999999999998899999999987666778899999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 94 ~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 94 LRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp HHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred Hhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence 975 2356899999999999999999999987 9999999999999999999999999998765432 234
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ..++.++||||||+++|||++ |+.||.... ............ .. ..+...+..+.
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~i~~~~-~~--------~~~~~~~~~l~ 235 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGF-RL--------YKPRLASTHVY 235 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTTC-CC--------CCCTTSCHHHH
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-HHHHHHHHhcCC-cC--------CCCccCcHHHH
Confidence 5677899999 678999999999999999999 788876532 222232222211 00 01223456688
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+++.+||+.||++|||+.++++.|+++.+.
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=334.96 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=194.6
Q ss_pred cccCCCCCceEEEEEE-----cCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeec--CCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRL-----KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNST--NEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~ 378 (608)
+.+|+|+||.||++++ .+++.||||+++... ...+.+.+|++++++++||||+++++++.. ....++||||+
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 95 (295)
T 3ugc_A 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95 (295)
T ss_dssp EEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECC
T ss_pred heeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeC
Confidence 5689999999999985 368899999997533 234678999999999999999999999864 35689999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 96 PYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp TTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred CCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 999999999762 345999999999999999999999987 999999999999999999999999999876543
Q ss_pred C------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHH----
Q 042949 459 K------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKE---- 524 (608)
Q Consensus 459 ~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 524 (608)
. ....++..|+||| ..++.++||||||+++|||+||..|+... ...+.. ..............
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP--PAEFMR-MIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH--HHHHHH-HHCTTCCTHHHHHHHHHH
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC--hHHHHh-hhcCccccchhHHHHHHH
Confidence 2 2234667799999 67899999999999999999999886431 111111 11100000000000
Q ss_pred H-----HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 525 V-----AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 525 ~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
. ...+..++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0 0112346677999999999999999999999999999998654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=336.70 Aligned_cols=247 Identities=13% Similarity=0.114 Sum_probs=200.4
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|+||.||+|+. .+|+.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++||||+ +|+|.
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~ 92 (330)
T 2izr_A 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLE 92 (330)
T ss_dssp EECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHH
Confidence 5689999999999986 578999999987432 234688999999999 8999999999999999999999999 99999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC-----ceEeccccccccCCCC
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED-----PLISECGYSKFLDPKK 459 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~~~~~ 459 (608)
+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++......
T Consensus 93 ~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~-----iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 93 DLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN-----LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp HHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred HHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 999752 457999999999999999999999987 999999999999998887 9999999998754322
Q ss_pred ----------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC--ChHHHHHHHHhhhcccccccH
Q 042949 460 ----------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI--DLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 460 ----------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 523 (608)
....||..|+||| ..++.++|||||||++|||++|+.||.... ................ ..
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~---~~ 241 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT---PI 241 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS---CH
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC---CH
Confidence 3457899999999 567899999999999999999999997532 2222222222111100 00
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
.......+ .+.+++.+||+.||.+||++++|.+.|+++.+...
T Consensus 242 --~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 242 --EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp --HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 01112234 78999999999999999999999999999886543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.07 Aligned_cols=247 Identities=20% Similarity=0.238 Sum_probs=189.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||+|... +|+.||+|+++.. ....+.+.+|++++++++||||+++++++...+..++||||++ |+|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L 89 (317)
T 2pmi_A 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDL 89 (317)
T ss_dssp --------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBH
T ss_pred eEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCH
Confidence 46899999999999865 6899999999743 2345678899999999999999999999999999999999997 699
Q ss_pred HHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 384 LSLLEAYIE--GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 384 ~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (317)
T 2pmi_A 90 KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-----ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164 (317)
T ss_dssp HHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC
T ss_pred HHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCChHHeEEcCCCCEEECcCccceecCCCccc
Confidence 999976432 2245899999999999999999999987 999999999999999999999999999876532
Q ss_pred CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-cccccc-----------
Q 042949 459 KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-WTGEVF----------- 521 (608)
Q Consensus 459 ~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~----------- 521 (608)
.....+|..|+||| ..++.++|||||||++|||+||+.||....... ....+.... ......
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T 2pmi_A 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSVTKLPKYN 243 (317)
T ss_dssp CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGGGGCTTCC
T ss_pred CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhhhhhhhcc
Confidence 23457899999999 357899999999999999999999987554322 222222110 000000
Q ss_pred -----------cHHHH-HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 -----------DKEVA-KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 -----------~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000 1112356679999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.24 Aligned_cols=243 Identities=18% Similarity=0.241 Sum_probs=191.9
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||+|+..+|+.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++ +|
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 86 (288)
T 1ob3_A 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DL 86 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EH
T ss_pred hhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CH
Confidence 4689999999999999889999999997432 2346788999999999999999999999999999999999974 99
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~ 460 (608)
.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 87 ~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 87 KKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR-----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp HHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred HHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 998864 2457999999999999999999999987 999999999999999999999999999876532 23
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-cccc----------cccHH
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-WTGE----------VFDKE 524 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~----------~~~~~ 524 (608)
...+|..|+||| ..++.++|||||||++|||++|+.||........ ...+.... .... ..++.
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCCCChhhchhhhcccccccc
Confidence 456899999999 3478999999999999999999999876543222 22221110 0000 00000
Q ss_pred --------HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 525 --------VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 525 --------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
........+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00111235667899999999999999999999976
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=341.38 Aligned_cols=247 Identities=20% Similarity=0.298 Sum_probs=200.8
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 53 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 132 (343)
T 1luf_A 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 132 (343)
T ss_dssp EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecC
Confidence 56899999999999975 34899999997432 23467899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhc--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec
Q 042949 379 SNGSLLSLLEAYIE--------------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438 (608)
Q Consensus 379 ~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl 438 (608)
++|+|.+++..... ....+++.+++.++.||++||+|||+++ |+||||||+|||+
T Consensus 133 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLV 207 (343)
T ss_dssp TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEE
T ss_pred CCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCcceEEE
Confidence 99999999986311 1257999999999999999999999987 9999999999999
Q ss_pred CCCCCceEeccccccccCCC-----CccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHH
Q 042949 439 NENEDPLISECGYSKFLDPK-----KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWV 508 (608)
Q Consensus 439 ~~~~~~kl~DFGla~~~~~~-----~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~ 508 (608)
+.++.+||+|||+++..... .....+|..|+||| ..++.++|||||||++|||+| |..||.... .....
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~ 286 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-HEEVI 286 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHH
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC-hHHHH
Confidence 99999999999999865432 22345788899999 678999999999999999999 888886533 22222
Q ss_pred HHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 509 KAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
........ . ..+..++..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 287 ~~~~~~~~-~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 287 YYVRDGNI-L--------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHHTTCC-C--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HHHhCCCc-C--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 22222111 0 112345667899999999999999999999999999998654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.55 Aligned_cols=246 Identities=20% Similarity=0.290 Sum_probs=199.9
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
..+|+|+||.||+|+.. +++.||||+++.. .....++.+|+.++++++||||+++++++......++||||+
T Consensus 77 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 156 (367)
T 3l9p_A 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELM 156 (367)
T ss_dssp EECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeC
Confidence 56899999999999853 4678999999743 223456889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC---CceEeccccc
Q 042949 379 SNGSLLSLLEAYIE---GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE---DPLISECGYS 452 (608)
Q Consensus 379 ~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla 452 (608)
++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 157 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 157 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp TTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred CCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 99999999987432 1246999999999999999999999987 99999999999999554 5999999999
Q ss_pred cccCC-----CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 453 KFLDP-----KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 453 ~~~~~-----~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
+.... ......+|+.|+||| ..++.++|||||||++|||+| |..||.... ..............
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-~~~~~~~i~~~~~~----- 305 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTSGGRM----- 305 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCCC-----
T ss_pred cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-----
Confidence 85421 223456788999999 678999999999999999998 888886543 22333222221110
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
.....++..+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 306 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 306 ----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11234556688999999999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.84 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=190.9
Q ss_pred cccCCCCCceEEEEEEc--CC--cEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeec-CCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK--NS--AVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNST-NEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~--~g--~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|... ++ ..||||.++... ...+++.+|+.++++++||||+++++++.. .+..++||||++
T Consensus 95 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~ 174 (373)
T 3c1x_A 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 174 (373)
T ss_dssp EEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCT
T ss_pred cEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCC
Confidence 57999999999999864 22 468999987432 235678999999999999999999998754 567899999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.++++. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 175 ~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 175 HGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp TCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999973 3456899999999999999999999987 9999999999999999999999999998664322
Q ss_pred -------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 460 -------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 460 -------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
....+|..|+||| ..++.++|||||||++|||+| |.+||..... ............. .
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-~~~~~~~~~~~~~---------~ 316 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRL---------L 316 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-SCHHHHHHTTCCC---------C
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-HHHHHHHHcCCCC---------C
Confidence 2235677899999 678999999999999999999 5556543322 1122222111100 1
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDR 573 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 573 (608)
.+..++..+.+++.+||+.||++|||+.|+++.|+++.........
T Consensus 317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~ 362 (373)
T 3c1x_A 317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362 (373)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence 1234566789999999999999999999999999999987665443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=329.26 Aligned_cols=243 Identities=19% Similarity=0.270 Sum_probs=196.9
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|+. +++.||||+++.... ..+.+.+|++++++++||||+++++++.+. +..++||||+++|
T Consensus 16 ~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 94 (271)
T 3kmu_A 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG 94 (271)
T ss_dssp EEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTC
T ss_pred HHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCC
Confidence 5789999999999998 488999999985432 345689999999999999999999999887 7889999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.++++. .....+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++.++|+|||++..... ..
T Consensus 95 ~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--~~ 167 (271)
T 3kmu_A 95 SLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTLE---PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--PG 167 (271)
T ss_dssp BHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTSS---SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--TT
T ss_pred cHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcCC---CceecCCCccceEEEcCCcceeEEeccceeeecc--cC
Confidence 99999974 22336999999999999999999999864 3499999999999999999999999998765432 34
Q ss_pred ccccCccccCC----C---CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 462 LFSSNGYTAPE----K---TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 462 ~~gt~~y~aPE----~---~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
..+|+.|+||| . .++.++|||||||++|||++|+.||...... .............. .+...+.
T Consensus 168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--------~~~~~~~ 238 (271)
T 3kmu_A 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-EIGMKVALEGLRPT--------IPPGISP 238 (271)
T ss_dssp CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-HHHHHHHHSCCCCC--------CCTTCCH
T ss_pred ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-HHHHHHHhcCCCCC--------CCCCCCH
Confidence 56899999999 2 2234799999999999999999998754332 22222222211111 1234566
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
.+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 78999999999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=336.27 Aligned_cols=246 Identities=21% Similarity=0.299 Sum_probs=200.4
Q ss_pred cccCCCCCceEEEEEE------cCCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRL------KNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~------~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||++.. .++..||||+++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (314)
T 2ivs_A 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYA 108 (314)
T ss_dssp EEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeec
Confidence 5689999999999986 245899999997432 23467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhc--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec
Q 042949 379 SNGSLLSLLEAYIE--------------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438 (608)
Q Consensus 379 ~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl 438 (608)
++|+|.+++..... ....+++..++.++.||++||+|||+++ |+||||||+||++
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dikp~NIli 183 (314)
T 2ivs_A 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILV 183 (314)
T ss_dssp TTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEE
T ss_pred CCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-----CcccccchheEEE
Confidence 99999999986321 1234899999999999999999999987 9999999999999
Q ss_pred CCCCCceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHH
Q 042949 439 NENEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWV 508 (608)
Q Consensus 439 ~~~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~ 508 (608)
+.++.+||+|||+++...... ....++..|+||| ..++.++|||||||++|||+| |+.||..... ....
T Consensus 184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~ 262 (314)
T 2ivs_A 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLF 262 (314)
T ss_dssp ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHH
Confidence 999999999999998765432 2335677899999 568899999999999999999 9888865432 2222
Q ss_pred HHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 509 KAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
..... .... ......+..+.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 263 ~~~~~-~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 263 NLLKT-GHRM--------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHT-TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHhhc-CCcC--------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 22211 1110 11234566789999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.92 Aligned_cols=234 Identities=16% Similarity=0.212 Sum_probs=199.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|+|+||.||+++.. +|+.||||+++.. ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 47 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg 126 (350)
T 1rdq_E 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCC
Confidence 56899999999999975 6899999999642 235677899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 127 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~ 197 (350)
T 1rdq_E 127 EMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp BHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCccceEEECCCCCEEEcccccceeccCCccc
Confidence 99999986 356999999999999999999999987 999999999999999999999999999988766667
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..||+.|+||| ..++.++|||||||++|||++|+.||.... .......+..... ..+...+..+.
T Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~----------~~p~~~~~~~~ 266 (350)
T 1rdq_E 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKV----------RFPSHFSSDLK 266 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCC----------CCCTTCCHHHH
T ss_pred ccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-HHHHHHHHHcCCC----------CCCCCCCHHHH
Confidence 78999999999 567899999999999999999999997543 2233333322211 01234566788
Q ss_pred HHHHHchhcCCCCCCC-----HHHHHHH
Q 042949 538 NVALKCVSNSPDDRPT-----MAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs-----~~evl~~ 560 (608)
+++.+||+.||++||+ ++|+++.
T Consensus 267 ~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 9999999999999998 8888764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=328.93 Aligned_cols=241 Identities=22% Similarity=0.335 Sum_probs=187.0
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccc-----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ-----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||++.. .|+.||||+++... ...+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 13 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (271)
T 3dtc_A 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91 (271)
T ss_dssp EEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTE
T ss_pred eeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCC
Confidence 5789999999999987 48899999987432 23467899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC--------CCCceEecccccc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE--------NEDPLISECGYSK 453 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~--------~~~~kl~DFGla~ 453 (608)
+|.+++. ...+++..++.++.|++.||+|||+++ ..+|+||||||+||+++. ++.+||+|||+++
T Consensus 92 ~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~--~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 92 PLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEA--IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSS--SSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred CHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9999885 457999999999999999999999975 224899999999999986 6779999999998
Q ss_pred ccCCCC-ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 454 FLDPKK-TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 454 ~~~~~~-~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
...... ....||..|+||| ..++.++||||||+++|||++|+.||....... ............ ..
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~--------~~ 235 (271)
T 3dtc_A 165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-VAYGVAMNKLAL--------PI 235 (271)
T ss_dssp -----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-HHHHHHTSCCCC--------CC
T ss_pred ccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHhhhcCCCCC--------CC
Confidence 765432 3457899999999 678999999999999999999999987543322 111111111111 11
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
....+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 234556789999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.76 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=203.9
Q ss_pred cccCCCCCceEEEEEEc--------CCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEE
Q 042949 307 DLRSQTICSSLFMVRLK--------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVY 375 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~--------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 375 (608)
+.||+|+||.||+|+.. ++..||||+++... ...+++.+|+++++++ +||||+++++++...+..++||
T Consensus 75 ~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~ 154 (382)
T 3tt0_A 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 154 (382)
T ss_dssp EEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEE
Confidence 56899999999999863 23689999997532 2346788999999999 8999999999999999999999
Q ss_pred eeccCCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC
Q 042949 376 KYQSNGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~ 443 (608)
||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 155 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~ 229 (382)
T 3tt0_A 155 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNV 229 (382)
T ss_dssp ECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCC
T ss_pred EecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCcceEEEcCCCc
Confidence 99999999999986321 1245999999999999999999999987 999999999999999999
Q ss_pred ceEeccccccccCCC-----CccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHh
Q 042949 444 PLISECGYSKFLDPK-----KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVR 513 (608)
Q Consensus 444 ~kl~DFGla~~~~~~-----~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 513 (608)
+||+|||+++..... .....+|..|+||| ..++.++|||||||++|||+| |+.|+... ...........
T Consensus 230 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~-~~~~~~~~~~~ 308 (382)
T 3tt0_A 230 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKE 308 (382)
T ss_dssp EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHT
T ss_pred EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHc
Confidence 999999999876532 23345678899999 678999999999999999999 88887643 33333332222
Q ss_pred hhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 042949 514 EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERD 572 (608)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 572 (608)
.. .. .....++..+.+++.+||+.||++|||+.||++.|+++......++
T Consensus 309 ~~-~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 309 GH-RM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp TC-CC--------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred CC-CC--------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 11 11 1123456678999999999999999999999999999987654433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=328.11 Aligned_cols=248 Identities=15% Similarity=0.131 Sum_probs=201.8
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|+||.||+|.. .+|+.||||++.... ..+.+.+|++++.++ +|+|++++++++......++||||+ +++|.
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~ 93 (298)
T 1csn_A 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE 93 (298)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHH
Confidence 5689999999999986 578999999986432 345678999999999 7999999999999999999999999 99999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC-----ceEeccccccccCCC-
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED-----PLISECGYSKFLDPK- 458 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~~~~- 458 (608)
+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 94 ~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 94 DLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS-----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp HHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 999752 346999999999999999999999887 999999999999987776 999999999876432
Q ss_pred ---------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC--ChHHHHHHHHhhhcccccccH
Q 042949 459 ---------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI--DLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 459 ---------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 523 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||.... ................
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 240 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST----- 240 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-----
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc-----
Confidence 13456899999999 567899999999999999999999987643 2222222221111100
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
.........+..+.+++.+||+.||++|||+++|++.|+++.+...
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 0111223456779999999999999999999999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=340.00 Aligned_cols=251 Identities=19% Similarity=0.251 Sum_probs=199.0
Q ss_pred hcccCCCCCceEEEEEEc------CCcEEEEEEeccc--ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLK------NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 376 (608)
.+.+|+|+||.||+|+.. ++..||||+++.. ....+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 129 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence 357999999999999862 4568999999743 23456789999999999 89999999999999999999999
Q ss_pred eccCCCHHHHHHHHhcC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCee
Q 042949 377 YQSNGSLLSLLEAYIEG-------------------KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NIL 437 (608)
|+++|+|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl 204 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVL 204 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-----EEETTCSGGGEE
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChhhEE
Confidence 99999999999752110 134899999999999999999999987 999999999999
Q ss_pred cCCCCCceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHH
Q 042949 438 LNENEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKW 507 (608)
Q Consensus 438 l~~~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~ 507 (608)
++.++.+||+|||+++...... ....+|..|+||| ..++.++|||||||++|||+| |..||.........
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 284 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH
Confidence 9999999999999998664332 2345677899999 678999999999999999998 99998765443332
Q ss_pred HHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 508 VKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
.. ........ ..+...+..+.+++.+||+.||++|||+.|+++.|+.+.....+
T Consensus 285 ~~-~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 285 YK-LIQNGFKM--------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp HH-HHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred HH-HHhcCCCC--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 22 22221111 11233456788999999999999999999999999999876544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.01 Aligned_cols=237 Identities=19% Similarity=0.236 Sum_probs=186.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+.+|+|+||+||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+
T Consensus 26 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~ 105 (361)
T 3uc3_A 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE 105 (361)
T ss_dssp EEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHH
Confidence 56899999999999986 78999999998665566789999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC--ceEeccccccccCC--CCcc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED--PLISECGYSKFLDP--KKTC 461 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~~~--~~~~ 461 (608)
++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++.... ....
T Consensus 106 ~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~-----ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 176 (361)
T 3uc3_A 106 RICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ-----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176 (361)
T ss_dssp HHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCC
Confidence 9975 356999999999999999999999987 999999999999987765 99999999985432 2345
Q ss_pred ccccCccccCC----CCCC-cchhHHHHHHHHHHHHcCCCCCcCCCCh---HHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 462 LFSSNGYTAPE----KTVS-EQGDVFSFGVILLELLTGKTVEKTGIDL---PKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~-~ksDVwSfGvvl~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
..||+.|+||| ..++ .++|||||||++|||++|+.||...... ............. + ......+
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~s 248 (361)
T 3uc3_A 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS---I-----PDDIRIS 248 (361)
T ss_dssp ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC---C-----CTTSCCC
T ss_pred CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC---C-----CCcCCCC
Confidence 67999999999 3344 4499999999999999999998754322 2222222211110 0 0112345
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 668899999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.22 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=203.5
Q ss_pred hcccCCCCCceEEEEEE------cCCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRL------KNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~------~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 376 (608)
.+.+|+|+||.||+|+. .+++.||||+++... ...+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 35789999999999985 356899999997433 2346789999999999 89999999999999999999999
Q ss_pred eccCCCHHHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC
Q 042949 377 YQSNGSLLSLLEAYIE--------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~ 442 (608)
|+++|+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGR 182 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEETTT
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCccceEEEcCCC
Confidence 9999999999986321 1225899999999999999999999987 99999999999999999
Q ss_pred CceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHH
Q 042949 443 DPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMV 512 (608)
Q Consensus 443 ~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 512 (608)
.+||+|||+++...... ....+|..|+||| ..++.++||||||+++|||+| |+.||........... ..
T Consensus 183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~ 261 (313)
T 1t46_A 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK-MI 261 (313)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH-HH
T ss_pred CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH-Hh
Confidence 99999999998765443 2234677899999 678999999999999999999 8888865543332222 22
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
...... ......+..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 262 ~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 262 KEGFRM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHTCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ccCCCC--------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 221111 0123345668899999999999999999999999999986543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=329.74 Aligned_cols=244 Identities=19% Similarity=0.243 Sum_probs=195.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||+||+|+.. +|+.||||+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+++ +
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 86 (292)
T 3o0g_A 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-C
Confidence 46899999999999975 689999999974322 246788999999999999999999999999999999999974 6
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---C
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---K 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~ 459 (608)
+.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 87 l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~-----ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 87 LKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp HHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 7666654 2467999999999999999999999987 999999999999999999999999999876533 2
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc--ccccH---------
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG--EVFDK--------- 523 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~--------- 523 (608)
....+|..|+||| ..++.++|||||||++|||++|..|+....+.......+....... .....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 3457899999999 2379999999999999999999998776666555554443321100 00000
Q ss_pred --------HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 524 --------EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 524 --------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.........+..+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000111235667889999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=327.10 Aligned_cols=241 Identities=20% Similarity=0.281 Sum_probs=193.1
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.+.+|+|+||.||+++.. ++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 106 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence 367899999999999875 6899999999743 3456889999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec---CCCCCceEeccccccccCCC-
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL---NENEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~- 458 (608)
|.+++.........+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++.....
T Consensus 107 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 107 LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH-----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred HHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-----EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 99999765444567999999999999999999999987 9999999999999 45678999999999876543
Q ss_pred -CccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 -KTCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 -~~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||..|+||| ..++.++||||||+++|||++|+.||.... .............. .. ......+.
T Consensus 182 ~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~---~~----~~~~~~~~ 253 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-LEEVQQKATYKEPN---YA----VECRPLTP 253 (285)
T ss_dssp -----CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC---CC----C--CCCCH
T ss_pred cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCC-HHHHHhhhccCCcc---cc----cccCcCCH
Confidence 24457899999999 678899999999999999999999986543 22222211111100 00 01122455
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 254 QAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 6889999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.79 Aligned_cols=248 Identities=20% Similarity=0.303 Sum_probs=189.6
Q ss_pred hcccCCCCCceEEEEEEcCC----cEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCee------E
Q 042949 306 ADLRSQTICSSLFMVRLKNS----AVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEK------L 372 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g----~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~------~ 372 (608)
.+.+|+|+||.||+|+.... ..||||+++.. ....+++.+|++++++++||||+++++++...... +
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 107 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence 35789999999999986543 37999999743 23456789999999999999999999999877655 9
Q ss_pred EEEeeccCCCHHHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccc
Q 042949 373 LVYKYQSNGSLLSLLEAYIEG--KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECG 450 (608)
Q Consensus 373 lv~e~~~~g~L~~~l~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 450 (608)
+||||+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-----cccCCCCcceEEEcCCCCEEEeecc
Confidence 999999999999999764322 236999999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccc
Q 042949 451 YSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEV 520 (608)
Q Consensus 451 la~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 520 (608)
+++...... ....++..|+||| ..++.++|||||||++|||++ |+.||...... ............
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~~~~~--- 258 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-EIYNYLIGGNRL--- 258 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTCCC---
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-HHHHHHhcCCCC---
Confidence 998764432 2334677899999 678999999999999999999 88888654332 222222221110
Q ss_pred ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 521 FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 521 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
......+..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 259 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 259 ------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 112345567899999999999999999999999999998653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=329.22 Aligned_cols=249 Identities=20% Similarity=0.302 Sum_probs=201.5
Q ss_pred hcccCCCCCceEEEEEEcC-C---cEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCee-EEEEeec
Q 042949 306 ADLRSQTICSSLFMVRLKN-S---AVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEK-LLVYKYQ 378 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~-g---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~lv~e~~ 378 (608)
.+.+|+|+||.||+|+..+ + ..||+|+++.... ..+.+.+|++++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 3679999999999998643 2 3799999975332 346788999999999999999999999876655 9999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
.+|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 106 ~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 106 CHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999974 3467899999999999999999999987 999999999999999999999999999865432
Q ss_pred -------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 459 -------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 459 -------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
.....++..|+||| ..++.++||||||+++|||++|..|+....+.............. .
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---------~ 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL---------P 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC---------C
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC---------C
Confidence 12345678899999 567899999999999999999777665554443333322221110 1
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCCC
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDER 571 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 571 (608)
.....+..+.+++.+||+.||++|||+.++++.|+++.+.....
T Consensus 249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 12334566889999999999999999999999999998765543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.10 Aligned_cols=233 Identities=21% Similarity=0.282 Sum_probs=192.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..||+|+||.||+++.. +|+.||||++++. ....+.+.+|.+++.++ +||||+++++++.+.+..++||||+++
T Consensus 29 ~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 108 (353)
T 3txo_A 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG 108 (353)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCC
Confidence 56899999999999875 6899999999742 23456788999999988 699999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-- 458 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 458 (608)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 109 g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~ 179 (353)
T 3txo_A 109 GDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG-----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179 (353)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence 999999976 356999999999999999999999987 999999999999999999999999999864322
Q ss_pred -CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 459 -KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 459 -~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.....||+.|+||| ..++.++|||||||++|||++|+.||..... ......+...... .+...+
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~~~~----------~p~~~~ 248 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDEVV----------YPTWLH 248 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC----------CCTTSC
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC----------CCCCCC
Confidence 24567999999999 4689999999999999999999999975432 3333333322110 122345
Q ss_pred HHHHHHHHHchhcCCCCCCCH------HHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTM------AEVLE 559 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~------~evl~ 559 (608)
..+.+++.+||+.||++||++ .|+++
T Consensus 249 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 568899999999999999998 67765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.28 Aligned_cols=239 Identities=20% Similarity=0.241 Sum_probs=192.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.||+|+||.||+|... +|+.||+|+++... ...+++.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 56999999999999874 68999999998533 34567999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec--CCCCCceEeccccccccCCCC--c
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL--NENEDPLISECGYSKFLDPKK--T 460 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~--~ 460 (608)
+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...... .
T Consensus 175 ~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 175 DRIID---ESYNLTELDTILFMKQICEGIRHMHQMY-----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp HHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 98875 2346899999999999999999999987 9999999999999 567889999999999775443 3
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||+.|+||| ..++.++|||||||++|||++|+.||..... ......+....+.. .. ......+..+
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~--~~----~~~~~~~~~~ 319 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWDL--ED----EEFQDISEEA 319 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCCS--CS----GGGTTSCHHH
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCC--Ch----hhhccCCHHH
Confidence 456899999999 5678899999999999999999999875533 23333333322110 00 1123456678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+||+.||++|||+.|+++.
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHcCCChhhCCCHHHHhcC
Confidence 999999999999999999999873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=331.48 Aligned_cols=251 Identities=16% Similarity=0.283 Sum_probs=194.4
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|.. .+|+.||||+++... ...+++.+|++++++++||||+++++++...+..++||||+++|
T Consensus 38 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (310)
T 2wqm_A 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117 (310)
T ss_dssp EEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSC
T ss_pred EeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCC
Confidence 5689999999999987 478999999997422 23456889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.........+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 118 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 192 (310)
T 2wqm_A 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 192 (310)
T ss_dssp BHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred CHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc
Confidence 999999876555677999999999999999999999987 9999999999999999999999999998765432
Q ss_pred -ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC-ChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 -TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI-DLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 -~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....++..|+||| ..++.++||||||+++|||++|+.||.... ............. .... .....+
T Consensus 193 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~-------~~~~~~ 264 (310)
T 2wqm_A 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPL-------PSDHYS 264 (310)
T ss_dssp ------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-SCCC-------CTTTSC
T ss_pred ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-CCCC-------cccccC
Confidence 3356889999999 567899999999999999999999986543 2222222222111 1110 012345
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
..+.+++.+||+.||++|||+.++++.|+++.....+
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 6688999999999999999999999999999865444
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=346.66 Aligned_cols=238 Identities=19% Similarity=0.197 Sum_probs=194.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||.||++... +|+.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 17 ~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~ 96 (444)
T 3soa_A 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 96 (444)
T ss_dssp EEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCB
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCC
Confidence 56899999999999864 789999999975432 34568899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC---CCCCceEeccccccccCCCC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN---ENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~~ 459 (608)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++......
T Consensus 97 L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g-----ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 97 LFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG-----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 9999876 467999999999999999999999987 99999999999998 45789999999998765433
Q ss_pred ---ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 460 ---TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 460 ---~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
....||+.|+||| ..++.++||||+||++|||++|..||..... .............. .. ......
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~--~~----~~~~~~ 240 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKAGAYDF--PS----PEWDTV 240 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTCCCC--CT----TTTTTS
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhCCCCC--Cc----cccccC
Confidence 3457999999999 4689999999999999999999999875432 22233322221110 00 111244
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 5678899999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=332.04 Aligned_cols=254 Identities=18% Similarity=0.295 Sum_probs=200.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC--eeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE--EKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|+.. +|+.||||+++.. ....+.+.+|++++++++||||+++++++...+ ..++||||+++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 94 (319)
T 4euu_A 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94 (319)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTC
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCC
Confidence 57899999999999986 5899999999743 235677889999999999999999999987655 779999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec----CCCCCceEeccccccccCC
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL----NENEDPLISECGYSKFLDP 457 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~~~~ 457 (608)
+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 95 ~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 95 SLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp BHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 9999997532 2334999999999999999999999987 9999999999999 7888899999999987654
Q ss_pred CC--ccccccCccccCC------------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC---hHHHHHHHHhhhccccc
Q 042949 458 KK--TCLFSSNGYTAPE------------KTVSEQGDVFSFGVILLELLTGKTVEKTGID---LPKWVKAMVREEWTGEV 520 (608)
Q Consensus 458 ~~--~~~~gt~~y~aPE------------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~ 520 (608)
.. ....||..|+||| ..++.++|||||||++|||+||+.||..... .................
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (319)
T 4euu_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (319)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC
T ss_pred CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc
Confidence 43 3457899999999 3467899999999999999999999864332 22223333222110000
Q ss_pred ----------c--cHHHH---HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 521 ----------F--DKEVA---KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 521 ----------~--~~~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
+ ..... .........+.+++.+||+.||++|||++|+++...+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred hhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 0 00000 1112345568899999999999999999999999987754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=339.63 Aligned_cols=238 Identities=18% Similarity=0.208 Sum_probs=195.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||.||++... +|+.||+|+++..... .+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~ 114 (362)
T 2bdw_A 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 114 (362)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCC
Confidence 56899999999999875 6899999999754332 3568899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC---CceEeccccccccCCCC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE---DPLISECGYSKFLDPKK 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~~ 459 (608)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 115 L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 115 LFEDIVA----REFYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp HHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 9998863 467999999999999999999999987 99999999999998654 59999999998776433
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....||+.|+||| ..++.++|||||||++|||++|+.||..... .............. .. ......+
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~~--~~----~~~~~~~ 258 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDY--PS----PEWDTVT 258 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCC--CT----TGGGGSC
T ss_pred ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhCCCCC--Cc----ccccCCC
Confidence 3457999999999 4689999999999999999999999875432 22222222221110 00 1112345
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 678899999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=339.67 Aligned_cols=234 Identities=21% Similarity=0.290 Sum_probs=194.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..||+|+||.||+++.. +++.||+|++... ....+.+.+|++++++++|||||++++++.+.+..++||||+++|
T Consensus 21 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg 100 (384)
T 4fr4_A 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG 100 (384)
T ss_dssp EEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCC
Confidence 57899999999999875 5889999999632 235678899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--C
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--K 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--~ 459 (608)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+... .
T Consensus 101 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 171 (384)
T 4fr4_A 101 DLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR-----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171 (384)
T ss_dssp EHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence 99999874 567999999999999999999999987 999999999999999999999999999976543 3
Q ss_pred ccccccCccccCCC-------CCCcchhHHHHHHHHHHHHcCCCCCcCCC--ChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 460 TCLFSSNGYTAPEK-------TVSEQGDVFSFGVILLELLTGKTVEKTGI--DLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 460 ~~~~gt~~y~aPE~-------~~~~ksDVwSfGvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
....||+.|+|||. .++.++|||||||++|||++|+.||.... .............. ..+.
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------~~p~ 241 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV----------TYPS 241 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC----------CCCT
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc----------CCCC
Confidence 45679999999992 26889999999999999999999996432 22222222211110 1123
Q ss_pred hcHHHHHHHHHHchhcCCCCCCC-HHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPT-MAEVLE 559 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs-~~evl~ 559 (608)
.++..+.+++.+||+.||++||+ ++++.+
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 45667899999999999999998 666654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.29 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=202.4
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.+|+|+||.||+|+..++..||||+++......+.+.+|++++++++||||+++++++.. +..++||||+++++|.++
T Consensus 19 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~ 97 (279)
T 1qpc_A 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97 (279)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHH
T ss_pred eeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHH
Confidence 5689999999999999888899999998766678899999999999999999999999864 568999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
+.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 98 l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 170 (279)
T 1qpc_A 98 LKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN-----YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (279)
T ss_dssp TTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred HhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCC
Confidence 86321 236899999999999999999999987 9999999999999999999999999998765432 223
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.++..|+||| ..++.++||||||+++|||++ |+.||.... ........... ... ......+..+.
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~-~~~--------~~~~~~~~~l~ 240 (279)
T 1qpc_A 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERG-YRM--------VRPDNCPEELY 240 (279)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTT-CCC--------CCCTTCCHHHH
T ss_pred CCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC-HHHHHHHHhcc-cCC--------CCcccccHHHH
Confidence 4677899999 567899999999999999999 888876432 22333222221 100 11234556789
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
+++.+||+.||++|||+.++++.|+++......
T Consensus 241 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 999999999999999999999999999865443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.58 Aligned_cols=242 Identities=22% Similarity=0.317 Sum_probs=196.6
Q ss_pred cccCCCCCceEEEEEEcC-C-------cEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLKN-S-------AVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-g-------~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
+.+|+|+||.||+|+... + ..||+|+++.. ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (289)
T 4fvq_A 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEF 93 (289)
T ss_dssp EEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred eeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEEC
Confidence 568999999999998653 3 47999999743 34567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC--------ceEecc
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED--------PLISEC 449 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DF 449 (608)
+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 94 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 94 VKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC-----eECCCcCcceEEEecCCcccccccceeeeccC
Confidence 9999999999862 334899999999999999999999987 999999999999998887 999999
Q ss_pred ccccccCCCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHH
Q 042949 450 GYSKFLDPKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKE 524 (608)
Q Consensus 450 Gla~~~~~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (608)
|+++..... ....+|..|+||| ..++.++|||||||++|||++|..++...................
T Consensus 166 g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~------- 237 (289)
T 4fvq_A 166 GISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL------- 237 (289)
T ss_dssp CSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------
T ss_pred cccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC-------
Confidence 999765433 3345788999999 457899999999999999999776665554433332222211111
Q ss_pred HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 525 VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 525 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
....+..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 238 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 238 ----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp ----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1122344788999999999999999999999999997643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=328.20 Aligned_cols=243 Identities=17% Similarity=0.268 Sum_probs=188.5
Q ss_pred hcccCCCCCceEEEEEEcC----CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLKN----SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.+.+|+|+||.||+|.... +..||+|+++... ...+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~ 98 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 98 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCC
Confidence 3568999999999998743 4679999987432 23467889999999999999999999984 567899999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 99 LGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp TEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999975 2446999999999999999999999987 9999999999999999999999999998765432
Q ss_pred ----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 460 ----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 460 ----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
....++..|+||| ..++.++|||||||++|||++ |..||...... .....+...... ....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-~~~~~i~~~~~~---------~~~~ 240 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERL---------PMPP 240 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTCCC---------CCCT
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-HHHHHHHcCCCC---------CCCC
Confidence 2334677899999 678999999999999999997 88888654322 222222221110 1123
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
..+..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 4566788999999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=338.99 Aligned_cols=233 Identities=19% Similarity=0.237 Sum_probs=192.5
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|.. .+++.||||++... ......+.+|++++++++||||+++++++.+.+..++||||+ +|
T Consensus 15 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g 93 (336)
T 3h4j_B 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GG 93 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CC
Confidence 5689999999999997 57899999998632 223467899999999999999999999999999999999999 78
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 94 ELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK-----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp EHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT-----CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence 99998875 356999999999999999999999987 9999999999999999999999999998765443
Q ss_pred ccccccCccccCCC----C-CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 TCLFSSNGYTAPEK----T-VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 ~~~~gt~~y~aPE~----~-~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....||+.|+|||. . .+.++|||||||++|||++|+.||....... ....+. ......+...+.
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------~~~~i~-~~~~~~p~~~s~ 233 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------LFKKVN-SCVYVMPDFLSP 233 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------CBCCCC-SSCCCCCTTSCH
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------HHHHHH-cCCCCCcccCCH
Confidence 44578999999992 2 3678999999999999999999986532110 000000 000011233556
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.+++.+||+.||.+|||+.|+++.
T Consensus 234 ~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 234 GAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 68899999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.67 Aligned_cols=241 Identities=18% Similarity=0.275 Sum_probs=192.2
Q ss_pred cccCCCCCceEEEEEEc-CCc----EEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSA----VYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~----~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|+.. +++ .||+|.++.. ....+++.+|+.++++++||||+++++++.... .++|+||++
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~ 99 (327)
T 3poz_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 99 (327)
T ss_dssp EEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecC
Confidence 57899999999999864 444 3688888632 245678999999999999999999999998754 789999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 100 FGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp TCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999975 2456999999999999999999999987 9999999999999999999999999998765432
Q ss_pred -----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 -----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 -----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....+|..|+||| ..++.++|||||||++|||+| |+.||..... ............. ...
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~~---------~~~ 241 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERL---------PQP 241 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHHTTCCC---------CCC
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-HHHHHHHHcCCCC---------CCC
Confidence 2234577899999 678999999999999999999 9988865332 1222211111100 112
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
..++..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 3456678899999999999999999999999999865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.47 Aligned_cols=238 Identities=21% Similarity=0.248 Sum_probs=182.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+.+|+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 59 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 137 (349)
T 2w4o_A 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFD 137 (349)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred eEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHH
Confidence 56899999999999986 57899999997532 45678899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC---CCCceEeccccccccCCCC--c
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE---NEDPLISECGYSKFLDPKK--T 460 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~--~ 460 (608)
++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...... .
T Consensus 138 ~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 138 RIVE----KGYYSERDAADAVKQILEAVAYLHENG-----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp HHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 8864 456999999999999999999999987 999999999999975 8899999999998765432 3
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||+.|+||| ..++.++|||||||++|||++|+.||.................... . .......+..+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~--~----~~~~~~~~~~~ 282 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF--I----SPWWDEVSLNA 282 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC--C----TTTTTTSCHHH
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc--C----CchhhhCCHHH
Confidence 457899999999 4689999999999999999999999976655443333333322110 0 01123455678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+||+.||++|||+.|+++.
T Consensus 283 ~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 283 KDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 899999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=328.22 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=196.1
Q ss_pred cccCCCCCceEEEEEEcC----CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeee-cCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLKN----SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNS-TNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|+..+ +..||+|.++... ...+.+.+|++++++++||||+++++++. ..+..++||||++
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~ 110 (298)
T 3f66_A 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 110 (298)
T ss_dssp EEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCT
T ss_pred ceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCC
Confidence 578999999999998643 2468999987532 23467889999999999999999999864 4567899999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 111 ~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 111 HGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp TCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred CCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 9999999963 3456899999999999999999999987 9999999999999999999999999998764432
Q ss_pred -------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 -------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 -------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
....+|..|+||| ..++.++||||||+++|||++|..|+................... ..
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 253 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---------LQ 253 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC---------CC
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC---------CC
Confidence 2345677899999 678999999999999999999655443333322222222221110 01
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
+...+..+.+++.+||+.||++|||+.|+++.|+++......
T Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 254 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 223456688999999999999999999999999999876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.43 Aligned_cols=253 Identities=19% Similarity=0.262 Sum_probs=190.9
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhc--CCCCcceeeeeeeecC----CeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGN--LKHPNILPLVCYNSTN----EEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~----~~~~lv~e~~~~ 380 (608)
+.+|+|+||.||+|+.. ++.||||++.... ...+.+|.+++.. ++||||+++++++... ...++||||+++
T Consensus 43 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 119 (337)
T 3mdy_A 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHEN 119 (337)
T ss_dssp EEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTT
T ss_pred eEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCC
Confidence 56899999999999875 8999999986433 3445556666554 4899999999998876 788999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKS---NEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
|+|.++++. ..+++..++.++.|++.||+|||+.. .+.++|+||||||+|||++.++.+||+|||+++....
T Consensus 120 g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 194 (337)
T 3mdy_A 120 GSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194 (337)
T ss_dssp CBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred CcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecc
Confidence 999999974 46999999999999999999999871 0112499999999999999999999999999986643
Q ss_pred CC-------ccccccCccccCC----CCCCc------chhHHHHHHHHHHHHcC----------CCCCcCCCC---hHHH
Q 042949 458 KK-------TCLFSSNGYTAPE----KTVSE------QGDVFSFGVILLELLTG----------KTVEKTGID---LPKW 507 (608)
Q Consensus 458 ~~-------~~~~gt~~y~aPE----~~~~~------ksDVwSfGvvl~elltg----------~~p~~~~~~---~~~~ 507 (608)
.. ....||..|+||| ...+. ++|||||||++|||+|| +.|+..... ....
T Consensus 195 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 274 (337)
T 3mdy_A 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274 (337)
T ss_dssp --------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred ccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhh
Confidence 32 2347899999999 23333 49999999999999999 555543211 1111
Q ss_pred HHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 508 VKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
.............+... .....++..+.+++.+||+.||++|||+.|+++.|+++.+..+
T Consensus 275 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 275 MREIVCIKKLRPSFPNR--WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp HHHHHTTSCCCCCCCGG--GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hHHHHhhhccCcccccc--chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 22221111111111111 1123456678999999999999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=327.20 Aligned_cols=244 Identities=22% Similarity=0.335 Sum_probs=204.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
..+|+|+||.||+|... ++..||+|+++......+.+.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 98 (288)
T 3kfa_A 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 98 (288)
T ss_dssp EESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHH
T ss_pred eecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence 56899999999999986 48899999998766667889999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----cc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TC 461 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~ 461 (608)
++.. .....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 99 ~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 171 (288)
T 3kfa_A 99 YLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171 (288)
T ss_dssp HHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHHT-----CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETT
T ss_pred HHHh--cccCCccHhHHHHHHHHHHHHHHHHHHCC-----ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccC
Confidence 9975 33456999999999999999999999987 9999999999999999999999999998776443 22
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
..+|..|+||| ..++.++||||||+++|||++ |..|+.... ........... ... ......+..+
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~-~~~~~~~~~~~-~~~--------~~~~~~~~~l 241 (288)
T 3kfa_A 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKD-YRM--------ERPEGCPEKV 241 (288)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHHHHHHTT-CCC--------CCCTTCCHHH
T ss_pred CccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhcc-CCC--------CCCCCCCHHH
Confidence 34677899999 678999999999999999999 888876432 22222222111 110 1123455678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=358.70 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=205.3
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
.+.||+|+||.||+|...++..||||+++......++|.+|+++|++++|||||++++++.. +..++||||+++|+|.+
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~ 350 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 350 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHH
Confidence 35689999999999999888899999998766677899999999999999999999999876 67899999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----cc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TC 461 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~ 461 (608)
+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 351 ~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 351 FLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp HHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred HHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 997521 245899999999999999999999987 9999999999999999999999999998765422 23
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
..++..|+||| ..++.++|||||||++|||+| |+.||.... .......+... ... .....++..+
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~-~~~~~~~i~~~-~~~--------~~~~~~~~~l 493 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERG-YRM--------PCPPECPESL 493 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-HHHHHHHHHTT-CCC--------CCCTTCCHHH
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcC-CCC--------CCCCCCCHHH
Confidence 34567899999 678999999999999999999 888886432 22222222211 110 1123456678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
.+|+.+||+.||++|||+.+|++.|+++......
T Consensus 494 ~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 9999999999999999999999999998765443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.56 Aligned_cols=242 Identities=19% Similarity=0.234 Sum_probs=195.0
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCC-----CCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-----HPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.+|+|+||.||+|+. .+++.||||+++......+.+..|++++.+++ ||||+++++++...+..++||||+ +
T Consensus 41 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~ 119 (360)
T 3llt_A 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-G 119 (360)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-C
T ss_pred EEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-C
Confidence 5689999999999987 47899999999865555667888999999886 999999999999999999999999 9
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC--------------------
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-------------------- 440 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-------------------- 440 (608)
++|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 120 ~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 120 PSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLRKMS-----LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred CCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCcccEEEccccccccccchhccccccccc
Confidence 999999986 23346999999999999999999999987 999999999999975
Q ss_pred -----CCCceEeccccccccCCCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHH
Q 042949 441 -----NEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAM 511 (608)
Q Consensus 441 -----~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~ 511 (608)
++.+||+|||+++..........||+.|+||| ..++.++|||||||++|||+||+.||....... ....+
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~ 271 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME-HLAMM 271 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHH-HHHHH
Confidence 78899999999998776666778999999999 568999999999999999999999997543322 12111
Q ss_pred HhhhcccccccHHH-------------------------------H-------HhchhcHHHHHHHHHHchhcCCCCCCC
Q 042949 512 VREEWTGEVFDKEV-------------------------------A-------KAGRQWAFPLLNVALKCVSNSPDDRPT 553 (608)
Q Consensus 512 ~~~~~~~~~~~~~~-------------------------------~-------~~~~~~~~~l~~li~~Cl~~dP~~RPs 553 (608)
.... ........ . .........+.+|+.+||+.||++|||
T Consensus 272 ~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 349 (360)
T 3llt_A 272 ESII--QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349 (360)
T ss_dssp HHHT--CCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHhc--CCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC
Confidence 1100 00000000 0 000112255789999999999999999
Q ss_pred HHHHHH
Q 042949 554 MAEVLE 559 (608)
Q Consensus 554 ~~evl~ 559 (608)
+.|+++
T Consensus 350 a~elL~ 355 (360)
T 3llt_A 350 PAELLK 355 (360)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=339.46 Aligned_cols=237 Identities=18% Similarity=0.233 Sum_probs=192.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 13 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 92 (323)
T 3tki_A 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92 (323)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEG
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcH
Confidence 56899999999999876 78999999986432 2346688999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-----
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK----- 458 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~----- 458 (608)
.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 93 ~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 93 FDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp GGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 988753 456999999999999999999999987 999999999999999999999999999865322
Q ss_pred CccccccCccccCC----CC-CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 459 KTCLFSSNGYTAPE----KT-VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~-~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.....||+.|+||| .. .+.++|||||||++|||++|+.||................... . ......+
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~ 235 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---L-----NPWKKID 235 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT---S-----TTGGGSC
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc---C-----CccccCC
Confidence 23457899999999 22 4778999999999999999999997654432322222221110 0 1123345
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 236 SAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 668899999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=340.10 Aligned_cols=229 Identities=19% Similarity=0.328 Sum_probs=187.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..||+|+||+||+++.. +++.||+|++++... ..+.+.+|..++.++ +|||||++++++.+.+..++||||+++
T Consensus 58 ~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~g 137 (396)
T 4dc2_A 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 137 (396)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCC
Confidence 57899999999999976 578999999975332 234578899999876 899999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP--- 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~--- 457 (608)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 138 g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 138 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 999999976 356999999999999999999999987 99999999999999999999999999986322
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh-------HHHH-HHHHhhhcccccccHHH
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL-------PKWV-KAMVREEWTGEVFDKEV 525 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~-------~~~~-~~~~~~~~~~~~~~~~~ 525 (608)
......||+.|+||| ..++.++|||||||++|||++|+.||...... .... ........
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------- 279 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------- 279 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---------
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---------
Confidence 234567999999999 56789999999999999999999999643211 1111 11111110
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCH
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTM 554 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 554 (608)
..+...+..+.+|+.+||+.||++||++
T Consensus 280 -~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1123456678899999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.50 Aligned_cols=233 Identities=23% Similarity=0.331 Sum_probs=194.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.+|+|+||.||+|+.. +|+.||||+++.. ....+.+..|.+++.++ +||||+++++++.+.+..++||||+++
T Consensus 23 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 102 (345)
T 1xjd_A 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 102 (345)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence 56899999999999985 6899999999743 33566788899999876 899999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP--- 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~--- 457 (608)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 103 g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 103 GDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG-----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 999999976 356999999999999999999999987 99999999999999999999999999986432
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
......||+.|+||| ..++.++|||||||++|||++|+.||..... ......+..... . .+...+
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~---~-------~p~~~s 242 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMDNP---F-------YPRWLE 242 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC---C-------CCTTSC
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHhCCC---C-------CCcccC
Confidence 234567999999999 5678999999999999999999999975432 223332222111 0 112345
Q ss_pred HHHHHHHHHchhcCCCCCCCHH-HHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMA-EVLE 559 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~-evl~ 559 (608)
..+.+++.+||..||++||++. |+++
T Consensus 243 ~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 243 KEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 6688999999999999999997 6653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=337.92 Aligned_cols=238 Identities=19% Similarity=0.271 Sum_probs=180.6
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
++.||+|+||.||++... +++.||||++... ....+.+|+.++.+++ ||||+++++++.+....++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 357999999999999885 6899999999743 3567889999999997 99999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC---CceEeccccccccCCCC-
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE---DPLISECGYSKFLDPKK- 459 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~~- 459 (608)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG-----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 999976 467999999999999999999999987 99999999999997765 79999999998765432
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC------hHHHHHHHHhhhcccccccHHHHH
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID------LPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
....+|..|+||| ..++.++|||||||++|||++|+.||..... ............. .+.. .
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~---~~~~---~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF---SFEG---E 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC---CCCS---H
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC---CCCc---c
Confidence 3456799999999 5678999999999999999999999865322 1222222211111 0000 1
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 112356678999999999999999999998753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.15 Aligned_cols=248 Identities=15% Similarity=0.128 Sum_probs=191.3
Q ss_pred cccCCCCCceEEEEEEc----CCcEEEEEEeccccc------------CHHHHHHHHHHHhcCCCCcceeeeeeeec---
Q 042949 307 DLRSQTICSSLFMVRLK----NSAVYAVKRLKKLQV------------SMDEFSQTMRQIGNLKHPNILPLVCYNST--- 367 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~H~niv~l~~~~~~--- 367 (608)
+.+|+|+||.||+|... ++..||||++..... ....+.+|+..+..++||||+++++++..
T Consensus 43 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~ 122 (345)
T 2v62_A 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFK 122 (345)
T ss_dssp EEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESS
T ss_pred eeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccC
Confidence 57899999999999986 578999999874321 22346678889999999999999999887
Q ss_pred -CCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC--Cc
Q 042949 368 -NEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE--DP 444 (608)
Q Consensus 368 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~--~~ 444 (608)
....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 123 ~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 123 GRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE-----YVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp SCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEESSSTTSE
T ss_pred CCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCcCHHHEEEccCCCCcE
Confidence 67899999999 9999998864 337999999999999999999999987 99999999999999887 99
Q ss_pred eEeccccccccCCCC----------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHH
Q 042949 445 LISECGYSKFLDPKK----------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKA 510 (608)
Q Consensus 445 kl~DFGla~~~~~~~----------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~ 510 (608)
||+|||+++.+.... ....||..|+||| ..++.++|||||||++|||+||+.||............
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999998664221 3456899999999 56899999999999999999999999653332222222
Q ss_pred HHhhhcccccccHHHHHhc--hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 511 MVREEWTGEVFDKEVAKAG--RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
.... .. ..+........ ...+..+.+++.+||+.||++|||+.+|++.|+++.-
T Consensus 273 ~~~~-~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 273 AKTN-LL-DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHH-HH-HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHh-hc-ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111 11 11112221111 1566789999999999999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.66 Aligned_cols=241 Identities=21% Similarity=0.292 Sum_probs=192.1
Q ss_pred cccCCCCCceEEEEEEc-CCcE----EEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAV----YAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~----vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|+.. +++. ||+|.+... ....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 19 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 97 (325)
T 3kex_A 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLP 97 (325)
T ss_dssp EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCT
T ss_pred eeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCC
Confidence 57899999999999864 4443 888887532 223456788999999999999999999986 456889999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 98 LGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp TCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT-----CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred CCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999874 2346899999999999999999999987 9999999999999999999999999999775432
Q ss_pred -----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 -----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 -----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....++..|+||| ..++.++|||||||++|||+| |+.||..... ............. ...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~---------~~~ 239 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVPDLLEKGERL---------AQP 239 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-THHHHHHHTTCBC---------CCC
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-HHHHHHHHcCCCC---------CCC
Confidence 2345777899999 678999999999999999999 9999865432 1222222111100 011
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
..++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 240 QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2234457789999999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=328.92 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=196.1
Q ss_pred cccCCCCCceEEEEEE-----cCCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecC--CeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRL-----KNSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN--EEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-----~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~ 377 (608)
+.+|+|+||.||++++ .+++.||||+++.. ....+.+.+|++++++++||||+++++++... ...++||||
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 106 (302)
T 4e5w_A 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106 (302)
T ss_dssp EEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEEC
T ss_pred hccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEe
Confidence 5689999999999984 46899999999743 23557899999999999999999999999876 668999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 107 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 107 LPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC-----cccCCCchheEEEcCCCCEEECcccccccccC
Confidence 9999999999653 456999999999999999999999987 99999999999999999999999999987754
Q ss_pred CC------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHH---
Q 042949 458 KK------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKE--- 524 (608)
Q Consensus 458 ~~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 524 (608)
.. ....+|..|+||| ..++.++||||||+++|||+||..|+.... .......... ........
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~-~~~~~~~~~~~ 254 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM---ALFLKMIGPT-HGQMTVTRLVN 254 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH---HHHHHHHCSC-CGGGHHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh---hHHhhccCCc-ccccCHHHHHH
Confidence 32 2345777899999 567889999999999999999998754211 0011100000 00000000
Q ss_pred -H-----HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 525 -V-----AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 525 -~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
. .......+..+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 0 01123456779999999999999999999999999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=328.50 Aligned_cols=244 Identities=25% Similarity=0.364 Sum_probs=189.8
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||+|+..+ .||||+++.... ..+.+.+|++++++++||||+++++++ ..+..++||||+++++|
T Consensus 30 ~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L 106 (289)
T 3og7_A 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSL 106 (289)
T ss_dssp EEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEH
T ss_pred eEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcH
Confidence 568999999999997643 599999974433 245689999999999999999999976 45568999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-----
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK----- 458 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~----- 458 (608)
.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 107 ~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 107 YHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS-----IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp HHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred HHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 999863 2456999999999999999999999987 999999999999999999999999999865432
Q ss_pred CccccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 459 KTCLFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 459 ~~~~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
.....||..|+||| ..++.++||||||+++|||++|+.||.................... ........
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 253 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-----DLSKVRSN 253 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-----CTTSSCTT
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-----chhhcccc
Confidence 13356899999999 2467799999999999999999999987655544443333322111 11112234
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
++..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 56778999999999999999999999999999865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=359.30 Aligned_cols=242 Identities=21% Similarity=0.271 Sum_probs=197.8
Q ss_pred ccCCCCCceEEEEEEc---CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 308 LRSQTICSSLFMVRLK---NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~---~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.||+|+||.||+|... ++..||||+++.. ....+++.+|++++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 5899999999999874 4578999999853 3356889999999999999999999999986 56899999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 9999863 2456999999999999999999999987 9999999999999999999999999999765332
Q ss_pred ---ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 460 ---TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 460 ---~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....++..|+||| ..++.++|||||||++|||+| |+.||..... ......+... ... ..+..
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~~~~~i~~~-~~~--------~~p~~ 563 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQG-KRM--------ECPPE 563 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-HHHHHHHHTT-CCC--------CCCTT
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcC-CCC--------CCCCc
Confidence 1223457899999 678999999999999999998 9999876443 2222222221 110 12234
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
++..+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 6677999999999999999999999999999987543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=339.84 Aligned_cols=250 Identities=17% Similarity=0.226 Sum_probs=194.6
Q ss_pred cccCCC--CCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQT--ICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g--~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.+|+| +||.||+++.. +|+.||||+++..... .+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 31 ~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 110 (389)
T 3gni_B 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 110 (389)
T ss_dssp EEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCC
Confidence 568999 99999999986 7899999999754332 35678899999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-- 458 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 458 (608)
|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+......
T Consensus 111 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 111 GSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG-----YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp CBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred CCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 9999999762 2356999999999999999999999987 999999999999999999999999998644211
Q ss_pred --------CccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc--
Q 042949 459 --------KTCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD-- 522 (608)
Q Consensus 459 --------~~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 522 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||................ . ....+
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~ 261 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT-V-PCLLDTS 261 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-C-Ccccccc
Confidence 12346888999999 247889999999999999999999997644332222111000 0 00000
Q ss_pred -----------------------------------HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhh
Q 042949 523 -----------------------------------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVV 565 (608)
Q Consensus 523 -----------------------------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~ 565 (608)
..........+..+.+|+.+||+.||++|||+.|+++. ++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 00001123345668999999999999999999999865 54443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.29 Aligned_cols=234 Identities=18% Similarity=0.262 Sum_probs=186.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---------------------------CHHHHHHHHHHHhcCCCCcc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---------------------------SMDEFSQTMRQIGNLKHPNI 358 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---------------------------~~~~~~~e~~~l~~l~H~ni 358 (608)
+.+|+|+||.||+|+.. +++.||||++..... ..+.+.+|++++++++||||
T Consensus 19 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 98 (298)
T 2zv2_A 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNV 98 (298)
T ss_dssp EEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTB
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 56899999999999875 689999999864321 12468899999999999999
Q ss_pred eeeeeeeec--CCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCe
Q 042949 359 LPLVCYNST--NEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436 (608)
Q Consensus 359 v~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NI 436 (608)
+++++++.. .+..++||||+++|+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 99 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Ni 168 (298)
T 2zv2_A 99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK-----IIHRDIKPSNL 168 (298)
T ss_dssp CCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGE
T ss_pred CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHE
Confidence 999999986 568899999999999887543 457999999999999999999999987 99999999999
Q ss_pred ecCCCCCceEeccccccccCCCC---ccccccCccccCCCC-------CCcchhHHHHHHHHHHHHcCCCCCcCCCChHH
Q 042949 437 LLNENEDPLISECGYSKFLDPKK---TCLFSSNGYTAPEKT-------VSEQGDVFSFGVILLELLTGKTVEKTGIDLPK 506 (608)
Q Consensus 437 Ll~~~~~~kl~DFGla~~~~~~~---~~~~gt~~y~aPE~~-------~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~ 506 (608)
|++.++.+||+|||+++...... ....||+.|+|||.. ++.++|||||||++|||++|+.||.... ...
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~ 247 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMC 247 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS-HHH
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc-HHH
Confidence 99999999999999998765432 345789999999921 3678999999999999999999987543 222
Q ss_pred HHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 507 WVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
............ ......+..+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 LHSKIKSQALEF--------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHCCCCC--------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhcccCCC--------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 222222111100 011235566889999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=334.44 Aligned_cols=236 Identities=21% Similarity=0.296 Sum_probs=185.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC--------------
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE-------------- 369 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-------------- 369 (608)
+.+|+|+||.||+|+.. +|+.||||+++.. ....+.+.+|++++++++||||+++++++.+..
T Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~ 91 (332)
T 3qd2_B 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLK 91 (332)
T ss_dssp EEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC----
T ss_pred eEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhc
Confidence 56899999999999986 7899999999743 234567999999999999999999999885543
Q ss_pred -------------------------------------------eeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHH
Q 042949 370 -------------------------------------------EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIA 406 (608)
Q Consensus 370 -------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 406 (608)
..++||||+++|+|.+++... ......++..++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~ 170 (332)
T 3qd2_B 92 DESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDREHGVCLHIF 170 (332)
T ss_dssp ----------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSCHHHHHHHH
T ss_pred cccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchhhHHHHHHH
Confidence 379999999999999999752 122345777899999
Q ss_pred HHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---------------ccccccCccccC
Q 042949 407 TGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---------------TCLFSSNGYTAP 471 (608)
Q Consensus 407 ~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---------------~~~~gt~~y~aP 471 (608)
.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ....||+.|+||
T Consensus 171 ~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 171 IQIAEAVEFLHSKG-----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHhCC-----eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 99999999999987 9999999999999999999999999998765432 234689999999
Q ss_pred C----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcC
Q 042949 472 E----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNS 547 (608)
Q Consensus 472 E----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~d 547 (608)
| ..++.++|||||||++|||++|..++... ....... .. ..... ........+.+++.+||+.|
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---~~~~~~~-~~----~~~~~----~~~~~~~~~~~li~~~l~~~ 313 (332)
T 3qd2_B 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---VRIITDV-RN----LKFPL----LFTQKYPQEHMMVQDMLSPS 313 (332)
T ss_dssp HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---HHHHHHH-HT----TCCCH----HHHHHCHHHHHHHHHHHCSS
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---HHHHHHh-hc----cCCCc----ccccCChhHHHHHHHHccCC
Confidence 9 57899999999999999999987664211 0111111 10 01111 11223345789999999999
Q ss_pred CCCCCCHHHHHHH
Q 042949 548 PDDRPTMAEVLER 560 (608)
Q Consensus 548 P~~RPs~~evl~~ 560 (608)
|++|||+.|+++.
T Consensus 314 p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 314 PTERPEATDIIEN 326 (332)
T ss_dssp GGGSCCHHHHHHS
T ss_pred CCcCCCHHHHhhc
Confidence 9999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=331.52 Aligned_cols=245 Identities=20% Similarity=0.315 Sum_probs=189.5
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccccc-C---HHHHHHHHHHHhcCCCCcceeeeeeeecCCe----eEEEEee
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV-S---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEE----KLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~-~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----~~lv~e~ 377 (608)
+.+|+|+||.||+++. .+++.||||+++.... . ...+.+|++++.+++||||+++++++..... .++||||
T Consensus 18 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~ 97 (311)
T 3ork_A 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97 (311)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred EEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEec
Confidence 5789999999999997 5789999999975322 2 3468899999999999999999999876543 4999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+++|+|.++++. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 98 ~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 98 VDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp CCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999975 356999999999999999999999987 99999999999999999999999999987653
Q ss_pred CC------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 458 KK------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 458 ~~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
.. ....||..|+||| ..++.++|||||||++|||+||+.||...... .......... .... ..
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-~~~~~~~~~~----~~~~--~~ 241 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVRED----PIPP--SA 241 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHCC----CCCH--HH
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCC----CCCc--cc
Confidence 32 2346899999999 57899999999999999999999998754332 2222222211 1111 11
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHH-HHHHHHHhhcC
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAE-VLERIEEVVNG 567 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~e-vl~~L~~~~~~ 567 (608)
.....+..+.+++.+||+.||++||++.+ +...+.++...
T Consensus 242 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 22345677899999999999999996555 55667766544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=331.49 Aligned_cols=234 Identities=21% Similarity=0.243 Sum_probs=186.3
Q ss_pred cccCCCCCceEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRL----KNSAVYAVKRLKKLQ-----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
+.+|+|+||.||+++. .+|+.||+|+++... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 23 ~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3a62_A 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEY 102 (327)
T ss_dssp EEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred EEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeC
Confidence 5689999999999987 478999999997532 2345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 103 LSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG-----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 999999999975 356899999999999999999999987 99999999999999999999999999986432
Q ss_pred C---CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 458 K---KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 458 ~---~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
. .....||+.|+||| ..++.++|||||||++|||++|+.||..... ......+..... ..+.
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~----------~~p~ 242 (327)
T 3a62_A 174 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-KKTIDKILKCKL----------NLPP 242 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTCC----------CCCT
T ss_pred CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhCCC----------CCCC
Confidence 2 23457899999999 5678999999999999999999999975432 222333222211 0122
Q ss_pred hcHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
..+..+.+++.+||+.||++|| ++.|+++.
T Consensus 243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 3456688999999999999999 77787764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.64 Aligned_cols=249 Identities=14% Similarity=0.143 Sum_probs=196.3
Q ss_pred cccCCCCCceEEEEEEcC---------CcEEEEEEecccccCHHHHHHHHHHHhcCCCCccee---------------ee
Q 042949 307 DLRSQTICSSLFMVRLKN---------SAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILP---------------LV 362 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~---------------l~ 362 (608)
+.+|+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++ ++
T Consensus 48 ~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~ 123 (352)
T 2jii_A 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCM 123 (352)
T ss_dssp EEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCC
T ss_pred EEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchh
Confidence 568999999999999764 789999998743 46889999999999999998 55
Q ss_pred eeeec-CCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC
Q 042949 363 CYNST-NEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN 441 (608)
Q Consensus 363 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~ 441 (608)
+++.. .+..++||||+ +|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 124 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 124 GFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE-----YVHGNVTAENIFVDPE 195 (352)
T ss_dssp EEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCCGGGEEEETT
T ss_pred hccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCCHHHEEEcCC
Confidence 66665 67889999999 99999999862 1357999999999999999999999987 9999999999999999
Q ss_pred C--CceEeccccccccCCCC----------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChH
Q 042949 442 E--DPLISECGYSKFLDPKK----------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLP 505 (608)
Q Consensus 442 ~--~~kl~DFGla~~~~~~~----------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~ 505 (608)
+ .+||+|||+++.+.... ....||+.|+||| ..++.++|||||||++|||++|+.||.......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 8 89999999998664321 2347899999999 468899999999999999999999997654222
Q ss_pred HHHHHHHhhh--cccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 506 KWVKAMVREE--WTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 506 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
..+....... ........ .......+..+.+++.+||+.||++|||+.++++.|+++.+...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 276 EDIMKQKQKFVDKPGPFVGP--CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HHHHHHHHHHHHSCCCEECT--TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhccCChhhhhhh--ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 2222211110 00000000 00012345678999999999999999999999999999987654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.04 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=187.4
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHH--HhcCCCCcceeeeeeee-----cCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQ--IGNLKHPNILPLVCYNS-----TNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~-----~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|+. +++.||||+++... ...+..|.++ +..++||||+++++.+. .....++||||++
T Consensus 19 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~ 95 (336)
T 3g2f_A 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP 95 (336)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCT
T ss_pred eecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCC
Confidence 5689999999999976 78999999997433 3344444444 55689999999997543 2336789999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSN----EEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
+|+|.+++.. ...++..+..++.||++||+|||+... ...+|+||||||+|||++.++.+||+|||+++.+
T Consensus 96 ~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~ 170 (336)
T 3g2f_A 96 NGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170 (336)
T ss_dssp TCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeec
Confidence 9999999975 345899999999999999999998710 0113999999999999999999999999999876
Q ss_pred CCCC-----------ccccccCccccCCC-----------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHH-------
Q 042949 456 DPKK-----------TCLFSSNGYTAPEK-----------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPK------- 506 (608)
Q Consensus 456 ~~~~-----------~~~~gt~~y~aPE~-----------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~------- 506 (608)
.... ....||..|+|||. .++.++|||||||++|||+||..|+........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~ 250 (336)
T 3g2f_A 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250 (336)
T ss_dssp SSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHH
T ss_pred ccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhc
Confidence 4321 23468999999992 234679999999999999999877643322110
Q ss_pred ---------HHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 042949 507 ---------WVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDR 573 (608)
Q Consensus 507 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 573 (608)
..............+... .......+..+.+++.+||+.||++|||+.|+++.|+++++....+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 251 EVGNHPTFEDMQVLVSREKQRPKFPEA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCTT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred ccCCCchHHHHHhhhcccccCCCCCcc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence 011111110000000000 001122445689999999999999999999999999999876554433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.80 Aligned_cols=245 Identities=18% Similarity=0.246 Sum_probs=191.6
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc------cCHHHHHHHHHHHhcCC---CCcceeeeeeeecCC-----ee
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ------VSMDEFSQTMRQIGNLK---HPNILPLVCYNSTNE-----EK 371 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~-----~~ 371 (608)
+.+|+|+||+||+|+. .+++.||||+++... .....+.+|++++++++ ||||+++++++.... ..
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~ 94 (308)
T 3g33_A 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKV 94 (308)
T ss_dssp EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeE
Confidence 5689999999999986 578999999987322 12356778888777664 999999999987654 57
Q ss_pred EEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccc
Q 042949 372 LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGY 451 (608)
Q Consensus 372 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 451 (608)
++||||+. |+|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 95 TLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLHANC-----IVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp EEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred EEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 99999996 699999875 22344999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-------ccc
Q 042949 452 SKFLDPK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-------WTG 518 (608)
Q Consensus 452 a~~~~~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~ 518 (608)
++..... .....||+.|+||| ..++.++|||||||++|||++|+.||........ ...+.... +..
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSCS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhccc
Confidence 9876543 24567899999999 5689999999999999999999999976543322 22222110 000
Q ss_pred cc----------ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 519 EV----------FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 519 ~~----------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.. ............+..+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 0001112223456778999999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=331.45 Aligned_cols=232 Identities=20% Similarity=0.193 Sum_probs=186.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||+||+|+.. +|+.||||++...... ..++..|+..+.++ +||||+++++++...+..++||||+ +|
T Consensus 63 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~ 141 (311)
T 3p1a_A 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GP 141 (311)
T ss_dssp EEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CC
T ss_pred heeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CC
Confidence 46899999999999986 7999999998753332 23445566555554 8999999999999999999999999 77
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 142 ~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 142 SLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG-----LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp BHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 999988763 456999999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 460 TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 460 ~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
....||+.|+||| ..++.++|||||||++|||++|..++..... ...+ . .....+. .....+..+
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~-~----~~~~~~~---~~~~~~~~l 281 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG----WQQL-R----QGYLPPE---FTAGLSSEL 281 (311)
T ss_dssp -CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHH-T----TTCCCHH---HHTTSCHHH
T ss_pred cccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHH-h----ccCCCcc---cccCCCHHH
Confidence 3456899999999 6789999999999999999999877653211 1111 1 1111121 123456778
Q ss_pred HHHHHHchhcCCCCCCCHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+++.+||+.||++|||+.|+++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=332.82 Aligned_cols=230 Identities=20% Similarity=0.317 Sum_probs=188.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..+|+|+||.||+++.. +++.||+|+++.... ..+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 15 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~g 94 (345)
T 3a8x_A 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 94 (345)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCC
Confidence 56899999999999986 689999999975432 234578899999987 899999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP--- 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~--- 457 (608)
|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 95 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 999999975 356999999999999999999999987 99999999999999999999999999986432
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh-------HHHHHHHHhhhcccccccHHHH
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL-------PKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
......||+.|+||| ..++.++|||||||++|||++|+.||...... .............
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------- 236 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------- 236 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---------
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---------
Confidence 234567999999999 56789999999999999999999998642211 1111111111100
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTM 554 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 554 (608)
..+...+..+.+++.+||+.||++||++
T Consensus 237 ~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1123456678899999999999999995
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=320.60 Aligned_cols=243 Identities=20% Similarity=0.266 Sum_probs=199.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|+||.||+|... ++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (277)
T 3f3z_A 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELF 94 (277)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred eEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHH
Confidence 56899999999999876 5779999999743 346788999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec---CCCCCceEeccccccccCCCC--
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL---NENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++.......
T Consensus 95 ~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 95 ERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN-----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp HHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred HHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 99875 356999999999999999999999987 9999999999999 788999999999998765433
Q ss_pred ccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 460 TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 460 ~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
....+|+.|+||| ..++.++||||||+++|||++|+.||..... ............ .... ......+..+
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~---~~~~---~~~~~~~~~~ 238 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTD-SEVMLKIREGTF---TFPE---KDWLNVSPQA 238 (277)
T ss_dssp CCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC---CCCH---HHHTTSCHHH
T ss_pred hccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhCCC---CCCc---hhhhcCCHHH
Confidence 3457899999999 5689999999999999999999999875432 222222222111 0111 1112345678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH--HHHhh
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER--IEEVV 565 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~--L~~~~ 565 (608)
.+++.+||+.||++|||+.|+++. +++..
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 899999999999999999999864 44443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=331.61 Aligned_cols=248 Identities=19% Similarity=0.274 Sum_probs=199.6
Q ss_pred cccCCCCCceEEEEEE------cCCcEEEEEEeccccc--CHHHHHHHHHHHhcC-CCCcceeeeeeeecCC-eeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL------KNSAVYAVKRLKKLQV--SMDEFSQTMRQIGNL-KHPNILPLVCYNSTNE-EKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~-~~~lv~e 376 (608)
+.+|+|+||.||+|+. .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++...+ ..++|||
T Consensus 33 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e 112 (316)
T 2xir_A 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 112 (316)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEE
T ss_pred eEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEE
Confidence 5689999999999985 3568999999975332 345688999999999 7999999999987654 5899999
Q ss_pred eccCCCHHHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCc
Q 042949 377 YQSNGSLLSLLEAYIEG------------KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~ 444 (608)
|+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dikp~Nil~~~~~~~ 187 (316)
T 2xir_A 113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVV 187 (316)
T ss_dssp CCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCE
T ss_pred cCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC-----cccccCccceEEECCCCCE
Confidence 99999999999752111 122899999999999999999999987 9999999999999999999
Q ss_pred eEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhh
Q 042949 445 LISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVRE 514 (608)
Q Consensus 445 kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 514 (608)
||+|||+++...... ....+|..|+||| ..++.++|||||||++|||+| |+.||................
T Consensus 188 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 267 (316)
T 2xir_A 188 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267 (316)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred EECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccC
Confidence 999999998765432 2345678899999 678999999999999999998 998886654333333322221
Q ss_pred hcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 515 EWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
.. . ......+..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 268 ~~-~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 268 TR-M--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CC-C--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cc-C--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11 0 012234556889999999999999999999999999998653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=328.27 Aligned_cols=249 Identities=20% Similarity=0.298 Sum_probs=190.3
Q ss_pred hcccCCCCCceEEEEEEc----CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCe-----eEE
Q 042949 306 ADLRSQTICSSLFMVRLK----NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEE-----KLL 373 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----~~l 373 (608)
.+.+|+|+||.||+|+.. ++..||+|+++.... ..+.+.+|++++++++||||+++++++...+. .++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 118 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence 356899999999999865 345899999974432 24568899999999999999999999887553 499
Q ss_pred EEeeccCCCHHHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccc
Q 042949 374 VYKYQSNGSLLSLLEAYI--EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGY 451 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 451 (608)
||||+++|+|.+++.... .....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT-----CCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEEcCCCcEEEeecCc
Confidence 999999999999996532 23467999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 452 SKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 452 a~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
++...... ....++..|+||| ..++.++||||||+++|||++ |..||..... ............ .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~-~--- 268 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYLLHGHR-L--- 268 (313)
T ss_dssp C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHHHHHHTTCC-C---
T ss_pred ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-HHHHHHHHcCCC-C---
Confidence 98764332 2345677899999 568999999999999999999 7777765432 222222222111 0
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
......+..+.+++.+||+.||++|||+.++++.|+++.+..+
T Consensus 269 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 269 -----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp -----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1123455678999999999999999999999999999986543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=332.16 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=197.0
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeee----cCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNS----TNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~----~~~~~~lv~e~~~~ 380 (608)
+.+|+|+||.||+++. .+|+.||||++... ....+.+.+|++++++++||||+++++++. .....++||||+++
T Consensus 35 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~ 114 (317)
T 2buj_A 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114 (317)
T ss_dssp EEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTT
T ss_pred EEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCC
Confidence 5789999999999997 57899999998643 234567899999999999999999999986 34578999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|+|.+++.........+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 115 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~ 189 (317)
T 2buj_A 115 GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-----YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189 (317)
T ss_dssp CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEE
T ss_pred CcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEcCCCCEEEEecCcchhcccccc
Confidence 9999999876555678999999999999999999999987 9999999999999999999999999987654211
Q ss_pred -----------ccccccCccccCCCC-------CCcchhHHHHHHHHHHHHcCCCCCcC----CCChHHHHHHHHhhhcc
Q 042949 460 -----------TCLFSSNGYTAPEKT-------VSEQGDVFSFGVILLELLTGKTVEKT----GIDLPKWVKAMVREEWT 517 (608)
Q Consensus 460 -----------~~~~gt~~y~aPE~~-------~~~ksDVwSfGvvl~elltg~~p~~~----~~~~~~~~~~~~~~~~~ 517 (608)
....||..|+|||.. ++.++|||||||++|||++|+.||.. ...... .......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~ 265 (317)
T 2buj_A 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----AVQNQLS 265 (317)
T ss_dssp SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----HHHCC--
T ss_pred cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----HhhccCC
Confidence 123468999999921 57899999999999999999999742 111111 1111000
Q ss_pred cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 518 GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
.......+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 266 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 266 --------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred --------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 01123455678999999999999999999999999999865443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.81 Aligned_cols=237 Identities=18% Similarity=0.231 Sum_probs=195.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..||+|+||.||+|+.. +++.||+|++++. ....+.+.+|+++++.++|||||++++++.+.+..++||||+++|
T Consensus 75 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 154 (410)
T 3v8s_A 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154 (410)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 46899999999999986 5899999999742 223445889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.++++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 155 ~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 155 DLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred cHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 99999874 35899999999999999999999987 9999999999999999999999999998776542
Q ss_pred --ccccccCccccCC----CC----CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 --TCLFSSNGYTAPE----KT----VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~----~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....||+.|+||| .. ++.++|||||||++|||++|+.||..... ......+......... ...
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~~~------p~~ 297 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNHKNSLTF------PDD 297 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTHHHHCCC------CTT
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-hhHHHHHHhccccccC------CCc
Confidence 3567999999999 22 67899999999999999999999975433 2333333221100000 011
Q ss_pred hhcHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 042949 530 RQWAFPLLNVALKCVSNSPDD--RPTMAEVLER 560 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 560 (608)
...+..+.+|+.+||..+|.+ ||+++|+++.
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 235667889999999999988 9999999876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.30 Aligned_cols=236 Identities=22% Similarity=0.287 Sum_probs=190.6
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHhcCCC--CcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKH--PNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||.||++...+++.||||++...... .+.+.+|++++.+++| |||+++++++...+..++|||| .+|
T Consensus 15 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~ 93 (343)
T 3dbq_A 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 93 (343)
T ss_dssp EEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSE
T ss_pred EEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCC
Confidence 568999999999999989999999999744332 3568899999999986 9999999999999999999994 588
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 94 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-----iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 94 DLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 99999986 567999999999999999999999987 99999999999997 5789999999998765432
Q ss_pred ---ccccccCccccCC---------------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 460 ---TCLFSSNGYTAPE---------------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 460 ---~~~~gt~~y~aPE---------------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
....||+.|+||| ..++.++|||||||++|||++|+.||.....................
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 241 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-- 241 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC--
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC--
Confidence 2457899999999 13678999999999999999999999765544333333322211110
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
.+...+..+.+++.+||+.||++|||+.|+++.-
T Consensus 242 ------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 242 ------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1122345588999999999999999999998763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.10 Aligned_cols=234 Identities=21% Similarity=0.306 Sum_probs=196.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|+.. +|+.||||+++.. ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 22 ~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (476)
T 2y94_A 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG 101 (476)
T ss_dssp EEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 56899999999999976 7999999999742 234567899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 102 ELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM-----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 99998863 467999999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccCccccCC----C-CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 TCLFSSNGYTAPE----K-TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~-~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....||+.|+||| . ..+.++||||+||++|||++|+.||..... ......+...... .+...+.
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~----------~p~~~s~ 241 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-PTLFKKICDGIFY----------TPQYLNP 241 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-HHHHHHHHTTCCC----------CCTTCCH
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCCcC----------CCccCCH
Confidence 4457999999999 2 247899999999999999999999975433 3333333222110 1223455
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 242 SVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 68899999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=333.89 Aligned_cols=236 Identities=22% Similarity=0.328 Sum_probs=194.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|+. .+|+.||||++..... ..+++.+|++++++++||||+++++++...+..++||||+. |
T Consensus 60 ~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g 138 (348)
T 1u5q_A 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 138 (348)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred eEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-C
Confidence 4689999999999986 5789999999974322 23568899999999999999999999999999999999996 7
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 139 ~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-~~ 209 (348)
T 1u5q_A 139 SASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NS 209 (348)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-CC
T ss_pred CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-Cc
Confidence 888888642 467999999999999999999999987 999999999999999999999999999876543 34
Q ss_pred ccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 462 LFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 462 ~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
..||+.|+||| ..++.++|||||||++|||++|+.||....... .......... ... ....++.
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~-~~~-------~~~~~~~ 280 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES-PAL-------QSGHWSE 280 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCC-CCC-------CCTTSCH
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCC-CCC-------CCCCCCH
Confidence 57899999999 357889999999999999999999987544322 2222222111 100 1223456
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
.+.+++.+||+.||++|||+.++++..
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 688999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.51 Aligned_cols=234 Identities=21% Similarity=0.256 Sum_probs=194.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..||+|+||.||+++.. +|+.||||+++.. ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 26 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 105 (353)
T 2i0e_A 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 105 (353)
T ss_dssp EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCC
Confidence 56899999999999986 4789999999743 23566788999999988 799999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP--- 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~--- 457 (608)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 106 g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 106 GDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence 999999976 356999999999999999999999987 99999999999999999999999999986432
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
......||+.|+||| ..++.++|||||||++|||++|+.||.... .......+...... .+...+
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~~----------~p~~~s 245 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHNVA----------YPKSMS 245 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC----------CCTTSC
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-HHHHHHHHHhCCCC----------CCCCCC
Confidence 234567999999999 567899999999999999999999997543 23333333322110 123455
Q ss_pred HHHHHHHHHchhcCCCCCCC-----HHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPT-----MAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs-----~~evl~~ 560 (608)
..+.+++.+||..||++||+ ++|+++.
T Consensus 246 ~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 67889999999999999995 5666653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.86 Aligned_cols=235 Identities=22% Similarity=0.289 Sum_probs=191.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccccc---CHHHHHHHHHHHhcCC--CCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLK--HPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||.||++...+++.||||++..... ..+.+.+|++++.+++ ||||+++++++...+..++||| +.++
T Consensus 62 ~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~ 140 (390)
T 2zmd_A 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 140 (390)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSE
T ss_pred EEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCC
Confidence 56899999999999988899999999974332 3467899999999996 5999999999999999999999 5689
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+....
T Consensus 141 ~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 141 DLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT-----CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 99999986 457899999999999999999999987 99999999999995 5889999999998765432
Q ss_pred ---ccccccCccccCC---C------------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 460 ---TCLFSSNGYTAPE---K------------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 460 ---~~~~gt~~y~aPE---~------------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
....||+.|+||| . .++.++|||||||++|||++|+.||.....................
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~-- 288 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-- 288 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC--
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC--
Confidence 3457999999999 2 4788999999999999999999999765554333333332211110
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 289 ------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 289 ------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 112234568899999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=324.47 Aligned_cols=244 Identities=21% Similarity=0.265 Sum_probs=200.0
Q ss_pred cccCCCCCceEEEEEEc---CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK---NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|+|+||.||+|... ++..||||+++... ...+++.+|++++++++||||+++++++. .+..++||||+++|
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEEeCCCC
Confidence 47899999999999853 67889999998532 24567899999999999999999999994 55689999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 95 ~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 95 PLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC-----EeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 99999863 2456999999999999999999999987 9999999999999999999999999998765332
Q ss_pred ----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 460 ----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 460 ----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
....+|..|+||| ..++.++||||||+++|||+| |+.||..... ........... .. ..+.
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~i~~~~-~~--------~~~~ 236 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGK-RM--------ECPP 236 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHHTTC-CC--------CCCT
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHhcCC-cC--------CCCC
Confidence 2234578899999 567899999999999999999 9999875443 22222222211 10 1123
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
..+..+.+++.+||+.||++||++.++++.|+++.....
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 456678999999999999999999999999999976443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=324.62 Aligned_cols=242 Identities=19% Similarity=0.283 Sum_probs=190.3
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecC-CeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN-EEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~ 385 (608)
+.+|+|++|.||+++. +|+.||||+++.. ...+.+.+|++++++++||||+++++++... +..++||||+++|+|.+
T Consensus 27 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~ 104 (278)
T 1byg_A 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 104 (278)
T ss_dssp EEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHH
T ss_pred eEEecCCCceEEEEEE-cCCEEEEEEecch-hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHH
Confidence 5689999999999987 5889999999753 3567899999999999999999999987654 47899999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcccccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSS 465 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt 465 (608)
++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..........++
T Consensus 105 ~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 177 (278)
T 1byg_A 105 YLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177 (278)
T ss_dssp HHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred HHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCcceEEEeCCCcEEEeeccccccccccccCCCcc
Confidence 997531 234889999999999999999999987 9999999999999999999999999998766555555678
Q ss_pred CccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHH
Q 042949 466 NGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVA 540 (608)
Q Consensus 466 ~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 540 (608)
..|+||| ..++.++||||||+++|||+| |+.||.... ........... ... ......+..+.+++
T Consensus 178 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-~~~~~~~~~~~-~~~--------~~~~~~~~~l~~li 247 (278)
T 1byg_A 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKG-YKM--------DAPDGCPPAVYEVM 247 (278)
T ss_dssp TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-GGGHHHHHTTT-CCC--------CCCTTCCHHHHHHH
T ss_pred ccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhcC-CCC--------CCcccCCHHHHHHH
Confidence 8999999 678999999999999999998 888886432 22222222111 100 11234566789999
Q ss_pred HHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 541 LKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 541 ~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
.+||+.||++|||+.|+++.|+++...
T Consensus 248 ~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 248 KNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999998753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.84 Aligned_cols=244 Identities=21% Similarity=0.313 Sum_probs=194.6
Q ss_pred cccCCCCCceEEEEEEcC-----CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLKN-----SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|.... +..||||+++... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 129 (333)
T 1mqb_A 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129 (333)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCC
Confidence 678999999999998653 2469999997432 234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 130 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 130 NGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp TEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred CCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999975 2457999999999999999999999987 9999999999999999999999999998765432
Q ss_pred ------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 ------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 ------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
....+|..|+||| ..++.++|||||||++|||++ |+.||.... .......+...... ..
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-~~~~~~~~~~~~~~---------~~ 271 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFRL---------PT 271 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTTCCC---------CC
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHCCCcC---------CC
Confidence 1223567899999 678899999999999999999 999886432 22222222221110 11
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
....+..+.+++.+||+.||++||++.++++.|+++.+..
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 2345567889999999999999999999999999998643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=339.17 Aligned_cols=239 Identities=20% Similarity=0.271 Sum_probs=195.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.||+|+||.||+|... +|+.||+|++.... .....+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 57 ~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~ 136 (387)
T 1kob_A 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136 (387)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred EEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHH
Confidence 56899999999999875 68999999997432 23457889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC--CCCceEeccccccccCCCC--c
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE--NEDPLISECGYSKFLDPKK--T 460 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~--~ 460 (608)
+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...... .
T Consensus 137 ~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 137 DRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp HHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred HHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 98863 2346999999999999999999999987 999999999999974 4679999999999776543 3
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||+.|+||| ..++.++|||||||++|||++|+.||..... ......+....+. ++. ......+..+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~~---~~~---~~~~~~s~~~ 281 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVKRCDWE---FDE---DAFSSVSPEA 281 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHHCCCC---CCS---STTTTSCHHH
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC---CCc---cccccCCHHH
Confidence 457899999999 5678999999999999999999999976433 2222222222111 000 1112345678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+||+.||++|||+.|+++.
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHhhC
Confidence 899999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=326.64 Aligned_cols=239 Identities=22% Similarity=0.281 Sum_probs=197.8
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccc-------cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-------VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
.+.+|+|+||.||+++.. +|+.||||+++... ...+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEc
Confidence 357899999999999976 68999999997432 1467899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC----CceEecccccc
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE----DPLISECGYSK 453 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~ 453 (608)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++
T Consensus 97 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~-----ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 97 VSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp CCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999974 467999999999999999999999987 99999999999999888 79999999998
Q ss_pred ccCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 454 FLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 454 ~~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
...... ....||+.|+||| ..++.++|||||||++|||++|+.||..... ........... ...+..
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~---~~~~~~--- 240 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANITSVS---YDFDEE--- 240 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHTTC---CCCCHH---
T ss_pred ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcc---cccChh---
Confidence 765432 3456899999999 5678999999999999999999999865432 22222222111 111111
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 123455668899999999999999999999873
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=359.26 Aligned_cols=240 Identities=20% Similarity=0.231 Sum_probs=196.0
Q ss_pred cccCCCCCceEEEEEEc---CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK---NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~---~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..||+|+||.||+|.+. +++.||||+++.... ..+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 36899999999999764 457899999985332 35789999999999999999999999975 457899999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~-----iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 999999975 467999999999999999999999987 9999999999999999999999999998765432
Q ss_pred -----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 -----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 -----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....+|..|+||| ..++.++|||||||++|||+| |+.||..... ......+.. .... ..+
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~~~~~i~~-~~~~--------~~p 594 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAMLEK-GERM--------GCP 594 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHT-TCCC--------CCC
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc-CCCC--------CCC
Confidence 2234567899999 678999999999999999999 9999865432 222222222 1111 112
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
..++..+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3456778999999999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.04 Aligned_cols=244 Identities=20% Similarity=0.312 Sum_probs=190.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||.||+|+.. +|+.||||++...... .+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 9 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (311)
T 4agu_A 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV 88 (311)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCch
Confidence 56899999999999985 5899999998754332 4567899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 89 l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 89 LHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN-----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp HHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred HHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 9888763 466999999999999999999999987 9999999999999999999999999998765332
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh---------------hcccc
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE---------------EWTGE 519 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~---------------~~~~~ 519 (608)
....+|..|+||| ..++.++|||||||++|||++|+.||.......... .+... .+...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhccccccccccccccccccc
Confidence 3456899999999 457899999999999999999999987654322221 11110 00000
Q ss_pred --ccc----HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 520 --VFD----KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 520 --~~~----~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+ ..........+..+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00111123456678999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=332.35 Aligned_cols=254 Identities=22% Similarity=0.282 Sum_probs=195.8
Q ss_pred cccCCCCCceEEEEEE-----cCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeee--cCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRL-----KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNS--TNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||+++. .+++.||||++.... ...+.+.+|++++++++||||+++++++. .....++||||+
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 108 (327)
T 3lxl_A 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 108 (327)
T ss_dssp EEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECC
T ss_pred hhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeec
Confidence 5689999999999985 467899999997543 23456899999999999999999999886 456789999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 109 PSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR-----CVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp TTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 999999999763 235999999999999999999999987 999999999999999999999999999876543
Q ss_pred C------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccc--ccHHH-
Q 042949 459 K------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEV--FDKEV- 525 (608)
Q Consensus 459 ~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~- 525 (608)
. ....+|..|+||| ..++.++|||||||++|||++|+.|+..... ............... .....
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA--EFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--HHHHHCC----CCHHHHHHHHHH
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc--hhhhhcccccccccHHHHHHHhh
Confidence 2 2345777899999 5678899999999999999999998753211 100000000000000 00000
Q ss_pred ----HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 526 ----AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 526 ----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
.......+..+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 011234567799999999999999999999999999999865543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.81 Aligned_cols=240 Identities=22% Similarity=0.267 Sum_probs=189.5
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
++.+|+|+||.||++.. .+++.||||+++... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 46789999999999985 478999999997543 3567899999999985 79999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC---ceEeccccccccCCC-
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED---PLISECGYSKFLDPK- 458 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~~~~- 458 (608)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 98 ILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG-----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 9999976 356999999999999999999999987 999999999999998776 899999999865421
Q ss_pred ---------CccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCCh--------------HH
Q 042949 459 ---------KTCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDL--------------PK 506 (608)
Q Consensus 459 ---------~~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~--------------~~ 506 (608)
.....||..|+|||. .++.++|||||||++|||++|+.||...... ..
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 123458999999991 3688999999999999999999998654321 11
Q ss_pred HHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 507 WVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.......... .+.. ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~i~~~~~---~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 249 LFESIQEGKY---EFPD---KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHCCC---CCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhccCc---ccCc---hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111111100 0110 1112355678999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=320.77 Aligned_cols=239 Identities=18% Similarity=0.257 Sum_probs=195.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeec----CCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNST----NEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~ 378 (608)
..+|+|+||.||+|... ++..||+|++..... ..+.+.+|++++++++||||+++++++.. ....++||||+
T Consensus 32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 111 (290)
T 1t4h_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEec
Confidence 46899999999999875 678999999975433 34568899999999999999999998764 45689999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC-CCCCceEeccccccccCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN-ENEDPLISECGYSKFLDP 457 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~ 457 (608)
++|+|.+++.. ...+++..++.++.|++.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++.....
T Consensus 112 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 112 TSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC---CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999976 356899999999999999999999875 2499999999999998 789999999999986654
Q ss_pred CC-ccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 458 KK-TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 458 ~~-~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.. ....||..|+||| ..++.++|||||||++|||++|+.||.................. .. ......+
T Consensus 185 ~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~ 256 (290)
T 1t4h_A 185 SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PA-------SFDKVAI 256 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CG-------GGGGCCC
T ss_pred cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-cc-------ccCCCCC
Confidence 43 3456899999999 56899999999999999999999999876665544443322211 10 1122334
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 568899999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.15 Aligned_cols=242 Identities=21% Similarity=0.248 Sum_probs=189.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCC------eeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNE------EKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~e 376 (608)
..+|+|+||.||+|... +|+.||||++..... ..+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e 110 (367)
T 1cm8_A 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110 (367)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEe
Confidence 56899999999999874 789999999964322 2456889999999999999999999987653 4599999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 111 FM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG-----IIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 99 8899999874 46899999999999999999999987 9999999999999999999999999999877
Q ss_pred CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc------cccccH--
Q 042949 457 PKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT------GEVFDK-- 523 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~-- 523 (608)
.......+|..|+||| ..++.++||||+||++|||++|+.||......... ..+...... ..+...
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l-~~i~~~~g~~~~~~~~~~~~~~~ 258 (367)
T 1cm8_A 180 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIMKVTGTPPAEFVQRLQSDEA 258 (367)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHTCSCHHH
T ss_pred cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCCHHHHHHhhhHHH
Confidence 6666678999999999 46899999999999999999999999765433222 222111000 000000
Q ss_pred -------------HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 524 -------------EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 524 -------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.........+..+.+|+.+||..||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0011122346678999999999999999999999884
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.27 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=198.4
Q ss_pred hcccCCCCCceEEEEEEc-CCcE--EEEEEeccc--ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAV--YAVKRLKKL--QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~--vavK~l~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.+.+|+|+||.||+|+.. ++.. +|+|+++.. ....+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 367899999999999865 5654 499998742 23455789999999999 89999999999999999999999999
Q ss_pred CCCHHHHHHHHh------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEe
Q 042949 380 NGSLLSLLEAYI------------EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLIS 447 (608)
Q Consensus 380 ~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 447 (608)
+|+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECGGGCEEEC
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCccceEEEcCCCeEEEc
Confidence 999999997521 11246999999999999999999999987 9999999999999999999999
Q ss_pred ccccccccCCC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccc
Q 042949 448 ECGYSKFLDPK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEV 520 (608)
Q Consensus 448 DFGla~~~~~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 520 (608)
|||+++..... .....++..|+||| ..++.++|||||||++|||+| |+.||.... .......... ....
T Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-~~~~~~~~~~-~~~~-- 260 (327)
T 1fvr_A 185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQ-GYRL-- 260 (327)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHGGG-TCCC--
T ss_pred ccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-HHHHHHHhhc-CCCC--
Confidence 99999854322 23345678899999 567899999999999999998 999986543 2222222211 1100
Q ss_pred ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 521 FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 521 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
......+..+.+++.+||+.||++|||+.|+++.|+++.+....
T Consensus 261 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 261 ------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 11234556789999999999999999999999999999876543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.84 Aligned_cols=239 Identities=21% Similarity=0.330 Sum_probs=195.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeec----------------CC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNST----------------NE 369 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----------------~~ 369 (608)
+.+|+|+||.||+++.. +++.||+|+++... +.+.+|++++++++||||+++++++.. ..
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (284)
T 2a19_B 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTK 93 (284)
T ss_dssp EEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEE
T ss_pred eeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcc
Confidence 56899999999999986 78999999997532 457799999999999999999998754 34
Q ss_pred eeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecc
Q 042949 370 EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC 449 (608)
Q Consensus 370 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 449 (608)
..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 94 CLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK-----LINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCC
T ss_pred eEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCHHHEEEcCCCCEEECcc
Confidence 579999999999999999763 2356999999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH
Q 042949 450 GYSKFLDPK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 450 Gla~~~~~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (608)
|+++..... .....+|..|+||| ..++.++||||||+++|||++|..|+... ....... .....
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~-~~~~~------ 236 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDL-RDGII------ 236 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHH-HTTCC------
T ss_pred hhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHh-hcccc------
Confidence 999876543 23456899999999 56789999999999999999999876421 1111111 11111
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCC
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDE 570 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 570 (608)
....+..+.+++.+||+.||++|||+.|+++.|+.+.+....
T Consensus 237 -----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 237 -----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred -----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 123445578999999999999999999999999999765443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=332.26 Aligned_cols=247 Identities=19% Similarity=0.265 Sum_probs=199.6
Q ss_pred cccCCCCCceEEEEEEcC-C-----cEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLKN-S-----AVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~-g-----~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
+.+|+|+||.||+|.... + ..||+|.++... ...+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 52 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 131 (333)
T 2i1m_A 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131 (333)
T ss_dssp EEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEec
Confidence 578999999999998742 2 489999997532 2346788999999999 899999999999999999999999
Q ss_pred ccCCCHHHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEe
Q 042949 378 QSNGSLLSLLEAYIE----------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLIS 447 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 447 (608)
+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 132 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~ 206 (333)
T 2i1m_A 132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIG 206 (333)
T ss_dssp CTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGCEEEGGGEEEBC
T ss_pred CCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC-----cccCCcccceEEECCCCeEEEC
Confidence 999999999976421 1346899999999999999999999987 9999999999999999999999
Q ss_pred ccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcc
Q 042949 448 ECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWT 517 (608)
Q Consensus 448 DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 517 (608)
|||+++...... ....+|..|+||| ..++.++|||||||++|||+| |..||......... .........
T Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~ 285 (333)
T 2i1m_A 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-YKLVKDGYQ 285 (333)
T ss_dssp CCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-HHHHHHTCC
T ss_pred ccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-HHHHhcCCC
Confidence 999998654322 2344677899999 678999999999999999999 88888654433222 222222111
Q ss_pred cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 518 GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
. ..+...+..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 286 ~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 286 M--------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp C--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C--------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1 01223456688999999999999999999999999998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=345.28 Aligned_cols=234 Identities=21% Similarity=0.290 Sum_probs=187.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||.||+++.. +|+.||||+++.. ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 154 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 233 (446)
T 4ejn_A 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 233 (446)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSC
T ss_pred EEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCC
Confidence 57899999999999874 6899999999742 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQ-KSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 458 (608)
+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 234 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g-----iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 234 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp BHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC-----CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC-----EEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 99999975 3579999999999999999999997 66 999999999999999999999999999864332
Q ss_pred -CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 459 -KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 459 -~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.....||+.|+||| ..++.++|||||||++|||++|+.||..... ............ ..+...+
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~----------~~p~~~~ 373 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI----------RFPRTLG 373 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC----------CCCTTSC
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCC----------CCCccCC
Confidence 24567999999999 6789999999999999999999999965432 223332222211 0122345
Q ss_pred HHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
..+.+++.+||+.||++|| ++.|+++.
T Consensus 374 ~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 6688999999999999999 99999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=341.90 Aligned_cols=259 Identities=18% Similarity=0.267 Sum_probs=185.2
Q ss_pred CcCHHHHHHHhhcccCCCCCceEEEEEEc---CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeee--cCC
Q 042949 295 RFKLDDLLEATADLRSQTICSSLFMVRLK---NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNS--TNE 369 (608)
Q Consensus 295 ~~~~~~l~~~~~~~~g~g~~g~vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~ 369 (608)
+..+++.++..+..||+|+||.||+|+.. +++.||||+++... ....+.+|++++++++|||||++++++. ...
T Consensus 15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 34555666555678999999999999976 57899999997543 3457889999999999999999999984 467
Q ss_pred eeEEEEeeccCCCHHHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec----CC
Q 042949 370 EKLLVYKYQSNGSLLSLLEAYIE-----GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL----NE 440 (608)
Q Consensus 370 ~~~lv~e~~~~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl----~~ 440 (608)
..++||||+. |+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECCSSTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----EeCCCcCHHHeEEecCCCC
Confidence 8999999996 689888864321 1235999999999999999999999987 9999999999999 77
Q ss_pred CCCceEeccccccccCCC------CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh-----
Q 042949 441 NEDPLISECGYSKFLDPK------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL----- 504 (608)
Q Consensus 441 ~~~~kl~DFGla~~~~~~------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~----- 504 (608)
++.+||+|||+++..... .....||+.|+||| ..++.++|||||||++|||++|+.||......
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 889999999999876532 23457899999999 34789999999999999999999998644321
Q ss_pred ---HHHHHHHHhhh-cccccccH---------------------------HHHHhchhcHHHHHHHHHHchhcCCCCCCC
Q 042949 505 ---PKWVKAMVREE-WTGEVFDK---------------------------EVAKAGRQWAFPLLNVALKCVSNSPDDRPT 553 (608)
Q Consensus 505 ---~~~~~~~~~~~-~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 553 (608)
...+..+.... ........ .........+..+.+|+.+||+.||++|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 11111111110 00000000 000001112456889999999999999999
Q ss_pred HHHHHHH
Q 042949 554 MAEVLER 560 (608)
Q Consensus 554 ~~evl~~ 560 (608)
+.|+++.
T Consensus 328 a~e~L~h 334 (405)
T 3rgf_A 328 SEQAMQD 334 (405)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.44 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=200.8
Q ss_pred hcccCCCCCceEEEEEEc--------CCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEE
Q 042949 306 ADLRSQTICSSLFMVRLK--------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLV 374 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~--------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 374 (608)
.+.+|+|+||.||+|+.. ++..||||+++... ...+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 357899999999999873 56789999997432 2345788999999999 899999999999999999999
Q ss_pred EeeccCCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC
Q 042949 375 YKYQSNGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~ 442 (608)
|||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~ 194 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENN 194 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTC
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCccceEEEcCCC
Confidence 999999999999975311 0134899999999999999999999987 99999999999999999
Q ss_pred CceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHH
Q 042949 443 DPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMV 512 (608)
Q Consensus 443 ~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 512 (608)
.+||+|||+++...... ....++..|+||| ..++.++|||||||++|||+| |+.||... ..........
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~~~ 273 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLK 273 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHH
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC-CHHHHHHHHh
Confidence 99999999998765432 2335677899999 568899999999999999999 88888643 3333332222
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
... .. ......+..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 274 ~~~-~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 274 EGH-RM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HTC-CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cCC-CC--------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 211 11 1123455678899999999999999999999999999986543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.99 Aligned_cols=245 Identities=17% Similarity=0.223 Sum_probs=200.0
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||+|+.. +++.||||++..... ....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 110 (322)
T 1p4o_A 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 110 (322)
T ss_dssp EEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeC
Confidence 56899999999999864 368899999974332 3456889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccc
Q 042949 379 SNGSLLSLLEAYIE------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452 (608)
Q Consensus 379 ~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 452 (608)
++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 111 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~NIli~~~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 111 TRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMT 185 (322)
T ss_dssp TTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred CCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCccceEEEcCCCeEEECcCccc
Confidence 99999999976421 1246799999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 453 KFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 453 ~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
+...... ....+|..|+||| ..++.++|||||||++|||+| |+.|+... ...............
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~----- 259 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGLL----- 259 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHHHHHHHHTTCCC-----
T ss_pred cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC-CHHHHHHHHHcCCcC-----
Confidence 8654332 2234678899999 678999999999999999999 77777543 333333322222110
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
......+..+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 260 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 260 ----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1123456678899999999999999999999999998865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.96 Aligned_cols=242 Identities=19% Similarity=0.271 Sum_probs=194.6
Q ss_pred cccCCCCCceEEEEEEcC----CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKN----SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.+|+|+||.||+|+..+ +..||+|+++... ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 18 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 96 (281)
T 3cc6_A 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPY 96 (281)
T ss_dssp EEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred EEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCC
Confidence 578999999999998653 2469999997532 245678999999999999999999999875 456899999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 97 GELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp CBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred CCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 9999999752 456899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ---ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 460 ---TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 460 ---~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....++..|+||| ..++.++||||||+++|||+| |+.||...... ............ .....
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~~~~~~~~~~---------~~~~~ 238 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGVLEKGDRL---------PKPDL 238 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHHHHHHHTCCC---------CCCTT
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHHHHHhcCCCC---------CCCCC
Confidence 2345677899999 678999999999999999998 99998643322 122222111110 11223
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
.+..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 456688999999999999999999999999998653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.50 Aligned_cols=241 Identities=20% Similarity=0.227 Sum_probs=195.4
Q ss_pred cccCCCCCceEEEEEEc---CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK---NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~---~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..+|+|+||.||+|... +++.||||+++.... ..+++.+|++++++++||||+++++++ ..+..++||||+++
T Consensus 23 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 101 (291)
T 1xbb_A 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL 101 (291)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred CccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence 37899999999999653 468899999975322 256789999999999999999999999 55678999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCc
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT 460 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 460 (608)
++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 102 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC-----eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 999999976 456999999999999999999999987 99999999999999999999999999987654321
Q ss_pred ------cccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 461 ------CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 461 ------~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
...++..|+||| ..++.++||||||+++|||+| |+.||..... ....... ...... ...
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~-~~~~~~--------~~~ 242 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAML-EKGERM--------GCP 242 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHH-HTTCCC--------CCC
T ss_pred cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHH-HcCCCC--------CCC
Confidence 233567899999 567889999999999999999 9999865432 2222222 111111 112
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 34566789999999999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=317.61 Aligned_cols=245 Identities=22% Similarity=0.308 Sum_probs=198.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-------cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-------VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||+++.. +|+.||+|+++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 90 (283)
T 3bhy_A 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 90 (283)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred HhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeec
Confidence 56899999999999986 68999999987432 24678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC----CceEeccccccc
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE----DPLISECGYSKF 454 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~ 454 (608)
++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++.
T Consensus 91 ~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 91 SGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999975 356999999999999999999999987 99999999999998877 799999999987
Q ss_pred cCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 455 LDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 455 ~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
..... ....++..|+||| ..++.++||||||+++|||++|+.||..... ........... ..... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~---~~~~~---~~ 234 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-QETLTNISAVN---YDFDE---EY 234 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTTC---CCCCH---HH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-HHHHHHhHhcc---cCCcc---hh
Confidence 65432 3456899999999 5678999999999999999999999875432 22222221111 11111 11
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhhcC
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVVNG 567 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~~ 567 (608)
....+..+.+++.+||..||++|||+.|+++. ++.+...
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 235 FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 23455668899999999999999999999984 6666544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.76 Aligned_cols=234 Identities=24% Similarity=0.336 Sum_probs=192.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|+|+||.||++... +++.||||++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 94 (279)
T 3fdn_A 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 94 (279)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred eEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCC
Confidence 56899999999999875 5789999998632 234567899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-Cc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-KT 460 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~ 460 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 95 ~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~-----i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 165 (279)
T 3fdn_A 95 TVYRELQK----LSKFDEQRTATYITELANALSYCHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 165 (279)
T ss_dssp EHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT-----CEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecccCChHhEEEcCCCCEEEEeccccccCCccccc
Confidence 99999976 356999999999999999999999886 999999999999999999999999998765443 24
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...|+..|+||| ..++.++||||||+++|||++|+.||..... ............ ..+...+..+
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~ 234 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QETYKRISRVEF----------TFPDFVTEGA 234 (279)
T ss_dssp --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCC----------CCCTTSCHHH
T ss_pred ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-HHHHHHHHhCCC----------CCCCcCCHHH
Confidence 567899999999 5678899999999999999999999875432 222222221111 0122345568
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 235 RDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHhccChhhCCCHHHHhhC
Confidence 899999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=327.33 Aligned_cols=241 Identities=18% Similarity=0.267 Sum_probs=190.6
Q ss_pred cccCCCCCceEEEEEEc-CCc----EEEEEEecc--cccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSA----VYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~----~vavK~l~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|+.. +++ .||+|.+.. .....+.+.+|+.++++++||||+++++++.... .++|+||++
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~ 99 (327)
T 3lzb_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 99 (327)
T ss_dssp EEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCS
T ss_pred EEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecC
Confidence 56899999999999864 444 357787753 2345678999999999999999999999998765 789999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 100 FGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp SCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC-----CcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 99999999752 456999999999999999999999987 9999999999999999999999999998764332
Q ss_pred -----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 -----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 -----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....+|..|+||| ..++.++|||||||++|||++ |+.||..... ............. ...
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-~~~~~~~~~~~~~---------~~~ 241 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERL---------PQP 241 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHHTTCCC---------CCC
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCC---------CCC
Confidence 2234577899999 678999999999999999999 9988865432 2222222111100 112
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
...+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 242 PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 3455678899999999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.11 Aligned_cols=235 Identities=20% Similarity=0.241 Sum_probs=185.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHH-HhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQ-IGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.||+|+||.||+++.. +++.||||++++... ....+.+|..+ ++.++||||+++++++.+.+..++||||+++
T Consensus 44 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 123 (373)
T 2r5t_A 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 123 (373)
T ss_dssp EEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCC
Confidence 57899999999999986 578999999975432 23456667776 5678999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP--- 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~--- 457 (608)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 124 g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 124 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 999999976 356899999999999999999999987 99999999999999999999999999986422
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
......||+.|+||| ..++.++|||||||++|||++|+.||.... .......+..... ......+
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~----------~~~~~~~ 263 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNILNKPL----------QLKPNIT 263 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-HHHHHHHHHHSCC----------CCCSSSC
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhccc----------CCCCCCC
Confidence 234567999999999 568899999999999999999999997543 2233333322211 0122345
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
..+.+++.+||+.||++||++.+.++.+
T Consensus 264 ~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 264 NSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred HHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 6688999999999999999986444333
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.36 Aligned_cols=244 Identities=20% Similarity=0.207 Sum_probs=196.5
Q ss_pred cccCCCCCceEEEEEEc-----CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeec--CCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLK-----NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNST--NEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-----~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 377 (608)
+.+|+|+||.||++.+. +++.||||+++... ...+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus 37 ~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (318)
T 3lxp_A 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116 (318)
T ss_dssp EEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECC
T ss_pred heecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEec
Confidence 56899999999998753 67899999998532 234668999999999999999999999987 4678999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 117 ~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 117 VPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp CTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred ccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999863 45999999999999999999999987 99999999999999999999999999987754
Q ss_pred CC------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChH---------HH----HHHHHhh
Q 042949 458 KK------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLP---------KW----VKAMVRE 514 (608)
Q Consensus 458 ~~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~---------~~----~~~~~~~ 514 (608)
.. ....+|..|+||| ..++.++||||||+++|||+||+.|+....... .. .......
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 32 2345677899999 567889999999999999999999876421100 00 0000000
Q ss_pred hcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 515 EWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
.. .......++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 267 ~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 267 GE--------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cc--------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 00 00112345677999999999999999999999999999997654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=332.01 Aligned_cols=228 Identities=16% Similarity=0.222 Sum_probs=191.1
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccccc---------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV---------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 376 (608)
..+|+|+||.||+|+. .+++.||||+++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 30 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 109 (335)
T 3dls_A 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME 109 (335)
T ss_dssp EECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEE
Confidence 4689999999999986 4789999999975321 23457789999999999999999999999999999999
Q ss_pred eccCC-CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 377 YQSNG-SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 377 ~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
|+.+| +|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 110 KHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp CCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99777 99999874 457999999999999999999999987 999999999999999999999999999877
Q ss_pred CCCC--ccccccCccccCC----CC-CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 456 DPKK--TCLFSSNGYTAPE----KT-VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 456 ~~~~--~~~~gt~~y~aPE----~~-~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
.... ....||+.|+||| .. .+.++|||||||++|||++|+.||...... ..... ..
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~~~~-----~~ 243 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VEAAI-----HP 243 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TTTCC-----CC
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hhhcc-----CC
Confidence 5443 3457899999999 23 378999999999999999999998642110 00000 11
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 244 PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22345668899999999999999999999885
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.16 Aligned_cols=243 Identities=18% Similarity=0.218 Sum_probs=185.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||.||+++.. +++.||||+++.... ..+.+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 40 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 118 (329)
T 3gbz_A 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-ND 118 (329)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred EEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CC
Confidence 56899999999999864 789999999974332 24567899999999999999999999999999999999997 59
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC-----CCCCceEeccccccccCC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN-----ENEDPLISECGYSKFLDP 457 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~-----~~~~~kl~DFGla~~~~~ 457 (608)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++....
T Consensus 119 L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 119 LKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR-----CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp HHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred HHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----EECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 9999976 456999999999999999999999987 99999999999994 455599999999987653
Q ss_pred C---CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccc----------
Q 042949 458 K---KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGE---------- 519 (608)
Q Consensus 458 ~---~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 519 (608)
. .....+|..|+||| ..++.++|||||||++|||++|+.||.....................
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence 2 23456799999999 34799999999999999999999999765443332222211100000
Q ss_pred --------cccHHHH-HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 520 --------VFDKEVA-KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 520 --------~~~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
....... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 111225567899999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=341.96 Aligned_cols=238 Identities=23% Similarity=0.280 Sum_probs=197.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecc---cccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKK---LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..||+|+||+||+++.. +++.||||++.. .......+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 28 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 107 (486)
T 3mwu_A 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107 (486)
T ss_dssp EEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCc
Confidence 57899999999999875 789999999963 23456789999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC---CCCCceEeccccccccCCCC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN---ENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~~ 459 (608)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++......
T Consensus 108 L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 108 LFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN-----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9998875 356999999999999999999999987 99999999999995 45679999999998765432
Q ss_pred --ccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 --TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 --~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....||+.|+||| ..++.++||||+||++|||++|+.||..... ......+......... ......+.
T Consensus 179 ~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~------~~~~~~s~ 251 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYAFDL------PQWRTISD 251 (486)
T ss_dssp ---CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCSCS------GGGGGSCH
T ss_pred ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCCC------cccCCCCH
Confidence 3457999999999 6689999999999999999999999975432 2233333222111100 11234566
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 78999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.38 Aligned_cols=244 Identities=17% Similarity=0.206 Sum_probs=175.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeec-----CCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNST-----NEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~~~lv~e~ 377 (608)
+.||+|+||+||+|+.. +|+.||||++..... ..+.+.+|++++++++|||||++++++.. ....++||||
T Consensus 59 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 138 (458)
T 3rp9_A 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI 138 (458)
T ss_dssp CC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECC
T ss_pred eEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEec
Confidence 56899999999999865 789999999975332 34568899999999999999999999843 3578999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+ +|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 139 ~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~-----iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 139 A-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG-----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp C-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred c-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 8 5799998864 567999999999999999999999987 99999999999999999999999999987642
Q ss_pred C------------------------------CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHc---------
Q 042949 458 K------------------------------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLT--------- 493 (608)
Q Consensus 458 ~------------------------------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~ellt--------- 493 (608)
. ....+||+.|+||| ..++.++|||||||++|||+|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 1 12346799999999 358899999999999999999
Q ss_pred --CCCCCcCCCChH-------------------HHHHHHHhhh------cccccccH---------------HHHHhchh
Q 042949 494 --GKTVEKTGIDLP-------------------KWVKAMVREE------WTGEVFDK---------------EVAKAGRQ 531 (608)
Q Consensus 494 --g~~p~~~~~~~~-------------------~~~~~~~~~~------~~~~~~~~---------------~~~~~~~~ 531 (608)
|+++|.+....+ .....+.... ....+... ........
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 555554322110 0000000000 00000000 00111123
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+..+.+|+.+||..||++|||++|+++.
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 46778999999999999999999999885
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.88 Aligned_cols=246 Identities=15% Similarity=0.226 Sum_probs=192.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||++... +++.||+|+++.... ..+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 2h34_A 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGV 119 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCE
T ss_pred EEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCC
Confidence 56899999999999975 789999999974322 2367889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 120 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 120 DLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG-----ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc-----CCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999976 356999999999999999999999987 9999999999999999999999999998765432
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....++..|+||| ..++.++||||||+++|||++|+.||..... ............ . ........+
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~----~--~~~~~~~~~ 262 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--SVMGAHINQAIP----R--PSTVRPGIP 262 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--HHHHHHHHSCCC----C--GGGTSTTCC
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--HHHHHHhccCCC----C--ccccCCCCC
Confidence 2456889999999 4568899999999999999999999875321 122222211110 0 111223455
Q ss_pred HHHHHHHHHchhcCCCCCC-CHHHHHHHHHHhhcCCC
Q 042949 534 FPLLNVALKCVSNSPDDRP-TMAEVLERIEEVVNGND 569 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~~~~~~ 569 (608)
..+.+++.+||+.||++|| +++++++.|+++.....
T Consensus 263 ~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 263 VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 6688999999999999999 99999999999876544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.01 Aligned_cols=240 Identities=18% Similarity=0.188 Sum_probs=194.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||+||+|+.. +++.||+|++++. ....+.+.+|+.++.+++||||++++++|.+.+..++||||+++|
T Consensus 80 ~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg 159 (437)
T 4aw2_A 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG 159 (437)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCC
Confidence 46899999999999986 4789999999742 122334889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 160 ~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 160 DLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp BHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred cHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 99999974 2457999999999999999999999987 9999999999999999999999999998765432
Q ss_pred --ccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 460 --TCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 460 --~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
....||+.|+|||. .++.++|||||||++|||++|+.||..... ......+......... ...
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~-----p~~ 305 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKERFQF-----PTQ 305 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTHHHHCCC-----CSS
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-hHHHHhhhhccccccC-----Ccc
Confidence 23579999999991 368899999999999999999999976433 2223332221100000 011
Q ss_pred chhcHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDD--RPTMAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 560 (608)
....+..+.+|+.+||..+|++ ||+++|+++.
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1235667889999999888888 9999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=321.49 Aligned_cols=246 Identities=18% Similarity=0.247 Sum_probs=194.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeee--cCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNS--TNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~lv~e~~~~ 380 (608)
+.+|+|+||.||+++.. +|+.||+|++..... ..+.+.+|++++++++||||+++++++. .....++||||+++
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 91 (279)
T 2w5a_A 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 91 (279)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTT
T ss_pred hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCC
Confidence 56899999999999875 789999999974332 3456889999999999999999999874 46788999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|+|.+++.........+++..++.++.|++.||+|||+.+....+|+||||||+||+++.++.+||+|||+++......
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~ 171 (279)
T 2w5a_A 92 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171 (279)
T ss_dssp EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH
T ss_pred CCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc
Confidence 9999999875545567999999999999999999999876333459999999999999999999999999998765443
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....++..|+||| ..++.++||||||+++|||++|+.||.... ............ .. ......+
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~i~~~~-~~--------~~~~~~~ 241 (279)
T 2w5a_A 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGK-FR--------RIPYRYS 241 (279)
T ss_dssp HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTC-CC--------CCCTTSC
T ss_pred cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-HHHHHHHHhhcc-cc--------cCCcccC
Confidence 2346899999999 567899999999999999999999986543 222222222211 11 1123456
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
..+.+++.+||+.||++|||+.|+++.+.
T Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 242 DELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 67899999999999999999999988654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.29 Aligned_cols=244 Identities=16% Similarity=0.195 Sum_probs=188.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC--HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS--MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||+|+.. +++.||||+++..... ...+.+|++++++++||||+++++++...+..++||||++ |+|
T Consensus 8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 86 (324)
T 3mtl_A 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 86 (324)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEH
T ss_pred EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCH
Confidence 46899999999999986 7899999999743221 1245679999999999999999999999999999999996 699
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---c
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---T 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---~ 460 (608)
.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 87 ~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 87 KQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK-----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp HHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence 998875 2456999999999999999999999987 9999999999999999999999999998654332 3
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------ccccccc-------
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------WTGEVFD------- 522 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~~~~~------- 522 (608)
...+|..|+||| ..++.++|||||||++|||++|+.||...... .....+.... .......
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 346799999999 35789999999999999999999998754332 2222221110 0000000
Q ss_pred -------HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 -------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 -------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..........+..+.+|+.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 01111223456678999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=332.51 Aligned_cols=242 Identities=20% Similarity=0.206 Sum_probs=190.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc------ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL------QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 32 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 111 (345)
T 3hko_A 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCH 111 (345)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCC
Confidence 56999999999999874 6889999998632 2345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcC------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 042949 380 NGSLLSLLEAYIEG------------------------------------KRDFPWKLRLSIATGIAKGLDFMYQKSNEE 423 (608)
Q Consensus 380 ~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 423 (608)
+|+|.+++...... ...+++..+..++.||+.||+|||+.+
T Consensus 112 gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--- 188 (345)
T 3hko_A 112 GGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--- 188 (345)
T ss_dssp SCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred CCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99999988421100 112357788899999999999999987
Q ss_pred CCceecCCCCCCeecCCCC--CceEeccccccccCCC-------CccccccCccccCC------CCCCcchhHHHHHHHH
Q 042949 424 KTIPHGNLKLSNILLNENE--DPLISECGYSKFLDPK-------KTCLFSSNGYTAPE------KTVSEQGDVFSFGVIL 488 (608)
Q Consensus 424 ~~ivHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~-------~~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl 488 (608)
|+||||||+|||++.++ .+||+|||+++.+... .....||+.|+||| ..++.++|||||||++
T Consensus 189 --ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 189 --ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp --EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred --ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence 99999999999998776 8999999999865321 23456899999999 3578899999999999
Q ss_pred HHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 489 LELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 489 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
|||++|+.||...... ............. .. ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 267 ~el~~g~~pf~~~~~~-~~~~~~~~~~~~~--~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 267 HLLLMGAVPFPGVNDA-DTISQVLNKKLCF--EN----PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHSSCSSCCSSHH-HHHHHHHHCCCCT--TS----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHCCCCCCCCChH-HHHHHHHhccccc--CC----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 9999999998754432 2223222221110 00 1122345678899999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.12 Aligned_cols=242 Identities=16% Similarity=0.179 Sum_probs=183.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 376 (608)
+.||+|+||+||+|... +|+.||||++.... ...+.+.+|+.++++++|||||++++++... ...++|||
T Consensus 68 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E 147 (464)
T 3ttj_A 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147 (464)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEe
Confidence 56899999999999865 68999999997532 2345688999999999999999999998654 45799999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 148 ~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~-----iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 148 LMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 9965 5666663 34999999999999999999999987 9999999999999999999999999998765
Q ss_pred CC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc-----cccc-----
Q 042949 457 PK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW-----TGEV----- 520 (608)
Q Consensus 457 ~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~----- 520 (608)
.. .....||+.|+||| ..++.++||||+||++|||++|+.||.+......+.+....-.. ....
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 43 24567999999999 57889999999999999999999999765443333222111000 0000
Q ss_pred ------------ccHHH-H--------HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 521 ------------FDKEV-A--------KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 521 ------------~~~~~-~--------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.. . ......+..+.+|+.+||..||++|||++|+++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0 0001124568999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.51 Aligned_cols=238 Identities=18% Similarity=0.245 Sum_probs=183.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHh-cCCCCcceeeeeeeec----CCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIG-NLKHPNILPLVCYNST----NEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~----~~~~~lv~e~~~~ 380 (608)
+.||+|+||+||++... +|+.||||+++. ...+.+|++++. ..+||||+++++++.. .+..++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57899999999999875 689999999964 346778888874 4589999999998865 5678999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC---CCCceEeccccccccCC
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE---NEDPLISECGYSKFLDP 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 457 (608)
|+|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 144 g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 144 GELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp EEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999974 22346999999999999999999999987 999999999999998 78899999999987654
Q ss_pred C--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChH---HHHHHHHhhhcccccccHHHHHh
Q 042949 458 K--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLP---KWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 458 ~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
. .....||..|+||| ..++.++|||||||++|||++|+.||....... ............ ... ..
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~--~~~----~~ 290 (400)
T 1nxk_A 217 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE--FPN----PE 290 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC--CCT----TT
T ss_pred CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc--CCC----cc
Confidence 3 24567899999999 567899999999999999999999986543211 111111111110 000 01
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
....+..+.+|+.+||+.||++|||+.|+++.-
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 124566789999999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.04 Aligned_cols=239 Identities=18% Similarity=0.214 Sum_probs=193.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||.||+++.. +|+.||||++++.. ...+.+.+|.+++.+++||||+++++++.+.+..++||||+++|
T Consensus 67 ~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg 146 (412)
T 2vd5_A 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG 146 (412)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCC
Confidence 46899999999999985 78999999997422 12345789999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++......
T Consensus 147 ~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 147 DLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG-----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp BHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 999999753 346999999999999999999999987 9999999999999999999999999998765432
Q ss_pred --ccccccCccccCC--C---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 460 --TCLFSSNGYTAPE--K---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 460 --~~~~gt~~y~aPE--~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
....||+.|+||| . .++.++|||||||++|||++|+.||...... .....+........ + .
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~~-~----p 292 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ETYGKIVHYKEHLS-L----P 292 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHHCC-C----C
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccCcC-C----C
Confidence 2357999999999 1 3688999999999999999999999764332 22222222110000 0 0
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCC---CCHHHHHHH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDR---PTMAEVLER 560 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~evl~~ 560 (608)
......+..+.+++.+||. +|++| |+++|+++.
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0113456678999999999 99998 589888764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.94 Aligned_cols=255 Identities=17% Similarity=0.280 Sum_probs=200.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC--eeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE--EKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|+.. +|+.||||+++.. ....+.+.+|++++++++||||+++++++...+ ..++||||+++|
T Consensus 15 ~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g 94 (396)
T 4eut_A 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94 (396)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTE
T ss_pred EEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCC
Confidence 56899999999999986 5899999999743 235677889999999999999999999988655 779999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec----CCCCCceEeccccccccCC
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL----NENEDPLISECGYSKFLDP 457 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~~~~ 457 (608)
+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 95 ~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 95 SLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp EHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred CHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 9999987532 1234999999999999999999999987 9999999999999 7778899999999987755
Q ss_pred CC--ccccccCccccCCC------------CCCcchhHHHHHHHHHHHHcCCCCCcCCC---ChHHHHHHHHhhhccccc
Q 042949 458 KK--TCLFSSNGYTAPEK------------TVSEQGDVFSFGVILLELLTGKTVEKTGI---DLPKWVKAMVREEWTGEV 520 (608)
Q Consensus 458 ~~--~~~~gt~~y~aPE~------------~~~~ksDVwSfGvvl~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~ 520 (608)
.. ....||..|+|||. .++.++|||||||++|||+||+.||.... ..................
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (396)
T 4eut_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (396)
T ss_dssp GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC
T ss_pred CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc
Confidence 43 34568999999991 34678999999999999999999986422 222333333222110000
Q ss_pred ------c------cHHH---HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 521 ------F------DKEV---AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 521 ------~------~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
. .... ..........+.+++.+||+.||++||++.|+++.++++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 0000 001133455688999999999999999999999999998764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=323.02 Aligned_cols=235 Identities=15% Similarity=0.214 Sum_probs=191.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|... +++.||||+++... ....++.+|+..+.++ +||||+++++++.+.+..++||||+++|
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 96 (289)
T 1x8b_A 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 96 (289)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred hhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCC
Confidence 56899999999999986 78999999997432 2345788999999999 8999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-------------------CC
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-------------------NE 442 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-------------------~~ 442 (608)
+|.+++.........+++..++.++.||+.||+|||+++ |+||||||+|||++. ..
T Consensus 97 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 97 SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp BHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEC--------------------CC
T ss_pred cHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 999999865433467999999999999999999999987 999999999999984 44
Q ss_pred CceEeccccccccCCCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc
Q 042949 443 DPLISECGYSKFLDPKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT 517 (608)
Q Consensus 443 ~~kl~DFGla~~~~~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 517 (608)
.+||+|||++....... ...||..|+||| ..++.++|||||||++|||++|.+++..... ....... ..
T Consensus 172 ~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~~~~~~~-~~ 245 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEIRQG-RL 245 (289)
T ss_dssp CEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----HHHHHTT-CC
T ss_pred EEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----HHHHHcC-CC
Confidence 78999999998765433 345899999999 2455799999999999999999987644311 1111111 11
Q ss_pred cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 518 GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 246 P--------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp C--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred C--------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1 1123455678899999999999999999999763
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.02 Aligned_cols=245 Identities=20% Similarity=0.214 Sum_probs=194.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcC------CCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNL------KHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l------~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.||+|+||.||+|... +++.||||+++......+++.+|++++..+ +|+||+++++++...+..++||||+.
T Consensus 103 ~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 182 (429)
T 3kvw_A 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS 182 (429)
T ss_dssp EEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC
T ss_pred EEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC
Confidence 57899999999999875 589999999986544456777888887766 57799999999999999999999995
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC--ceEeccccccccCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED--PLISECGYSKFLDP 457 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~~~ 457 (608)
++|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 183 -~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 183 -MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHKNR-----IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp -CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHHT-----EECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred -CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 799999876 23345999999999999999999999987 999999999999999887 99999999988776
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-cccc-----------cc
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-WTGE-----------VF 521 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~-----------~~ 521 (608)
......||+.|+||| ..++.++|||||||++|||+||+.||........ +..+.... .... .+
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~-l~~i~~~~~~p~~~~~~~~~~~~~~~ 333 (429)
T 3kvw_A 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ-LACMIELLGMPSQKLLDASKRAKNFV 333 (429)
T ss_dssp CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHTBTTHHHHB
T ss_pred cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHhhhhhhhcc
Confidence 666778999999999 5689999999999999999999999876543222 22111100 0000 00
Q ss_pred ---------------c---------------------HHH-HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 ---------------D---------------------KEV-AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 ---------------~---------------------~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+ ... ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 334 SSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp CTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 0 000 00011224568899999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=319.28 Aligned_cols=248 Identities=13% Similarity=0.149 Sum_probs=197.5
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeee-ecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYN-STNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|+||.||+|+. .+|+.||||++.... ..+++.+|++++.+++|++++..+.++ ...+..++||||+ +++|.
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~ 92 (296)
T 3uzp_A 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE 92 (296)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHH
Confidence 5689999999999997 578999999987433 335688999999999998877776655 5667889999999 99999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec---CCCCCceEeccccccccCCCC--
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL---NENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 93 ~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 93 DLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99974 2457999999999999999999999987 9999999999999 488999999999998765432
Q ss_pred --------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC--hHHHHHHHHhhhcccccccHHH
Q 042949 460 --------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID--LPKWVKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 460 --------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 525 (608)
....||..|+||| ..++.++|||||||++|||++|+.||..... ............... ..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~ 239 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----PI 239 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----CH
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-----ch
Confidence 3456899999999 5678999999999999999999999865321 111111111111000 01
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
.......+..+.+++.+||+.||++|||+.++++.|+++.+...
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 11123456778999999999999999999999999999987643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=317.71 Aligned_cols=238 Identities=18% Similarity=0.215 Sum_probs=195.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||.||+|... +|+.||+|++...... .+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 91 (284)
T 3kk8_A 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 91 (284)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred hhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCC
Confidence 56899999999999875 6899999999754333 3567899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC---ceEeccccccccCCCC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED---PLISECGYSKFLDPKK 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~~~~~ 459 (608)
|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++.......
T Consensus 92 l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 92 LFEDIVA----REFYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9998875 356999999999999999999999987 999999999999987655 9999999998765443
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....||..|+||| ..++.++||||||+++|||++|+.||..... ............... .......+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~ 235 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYP------SPEWDTVT 235 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCCC------TTTTTTSC
T ss_pred cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-hHHHHHHHhccccCC------chhhcccC
Confidence 3457899999999 5678999999999999999999999865432 222222222211100 01112345
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 668899999999999999999999885
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.61 Aligned_cols=242 Identities=19% Similarity=0.239 Sum_probs=182.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHhcCC-CCcceeeeeeeecCC--eeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNE--EKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~lv~e~~~ 379 (608)
..+|+|+||.||+|... +|+.||||++.... .....+.+|+.++.++. ||||+++++++...+ ..++||||++
T Consensus 15 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 94 (388)
T 3oz6_A 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME 94 (388)
T ss_dssp EC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS
T ss_pred EEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC
Confidence 56899999999999864 78999999996432 23456789999999997 999999999987544 6899999997
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 458 (608)
|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 95 -~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 95 -TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp -EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred -cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 699998874 46899999999999999999999987 999999999999999999999999999865321
Q ss_pred -----------------------CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHH
Q 042949 459 -----------------------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKA 510 (608)
Q Consensus 459 -----------------------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~ 510 (608)
.....||+.|+||| ..++.++|||||||++|||++|++||.......... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE-R 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-H
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H
Confidence 12357899999999 357899999999999999999999997654333222 2
Q ss_pred HHhhhccc--------------------------------ccccH---HHH--HhchhcHHHHHHHHHHchhcCCCCCCC
Q 042949 511 MVREEWTG--------------------------------EVFDK---EVA--KAGRQWAFPLLNVALKCVSNSPDDRPT 553 (608)
Q Consensus 511 ~~~~~~~~--------------------------------~~~~~---~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs 553 (608)
+....... ..+.. ... ......+..+.+|+.+||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 21110000 00000 000 001144667899999999999999999
Q ss_pred HHHHHHH
Q 042949 554 MAEVLER 560 (608)
Q Consensus 554 ~~evl~~ 560 (608)
++|+++.
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999876
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.88 Aligned_cols=231 Identities=11% Similarity=0.151 Sum_probs=182.8
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc----ccCHHHHHHHH---HHHhcCCCCcceeee-------eeeecCC--
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL----QVSMDEFSQTM---RQIGNLKHPNILPLV-------CYNSTNE-- 369 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~---~~l~~l~H~niv~l~-------~~~~~~~-- 369 (608)
+.+|+|+||.||+|+. .+|+.||||+++.. ....+.+.+|+ +.+++++|||||+++ +++...+
T Consensus 79 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 158 (377)
T 3byv_A 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158 (377)
T ss_dssp EEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSC
T ss_pred ceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCc
Confidence 5789999999999996 57999999999732 22346788999 556666899999998 5555443
Q ss_pred ---------------eeEEEEeeccCCCHHHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCC
Q 042949 370 ---------------EKLLVYKYQSNGSLLSLLEAYIE---GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431 (608)
Q Consensus 370 ---------------~~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDl 431 (608)
..++||||+ +|+|.+++..... ....+++..++.|+.||+.||+|||+++ |+||||
T Consensus 159 ~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDi 232 (377)
T 3byv_A 159 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYL 232 (377)
T ss_dssp SEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-----EECSCC
T ss_pred cccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-----eecCCC
Confidence 278999999 6899999986321 1123456888999999999999999987 999999
Q ss_pred CCCCeecCCCCCceEeccccccccCCCCccccccCccccCC----C-----------CCCcchhHHHHHHHHHHHHcCCC
Q 042949 432 KLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----K-----------TVSEQGDVFSFGVILLELLTGKT 496 (608)
Q Consensus 432 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE----~-----------~~~~ksDVwSfGvvl~elltg~~ 496 (608)
||+|||++.++.+||+|||+++..........| ..|+||| . .++.++|||||||++|||+||+.
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~ 311 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCC
Confidence 999999999999999999999976655556677 9999999 4 68999999999999999999999
Q ss_pred CCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 497 VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 497 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
||....... ... .........+..+.+++.+||+.||++|||+.|+++
T Consensus 312 Pf~~~~~~~----------~~~-----~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 312 PITKDAALG----------GSE-----WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp CC------C----------CSG-----GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred CCccccccc----------chh-----hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 986432100 000 011112345667899999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=320.61 Aligned_cols=238 Identities=21% Similarity=0.317 Sum_probs=193.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|+||.||+++.. +|+.||+|+++... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (304)
T 2jam_A 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF 94 (304)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred eeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHH
Confidence 56899999999999975 78999999997533 24457889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec---CCCCCceEeccccccccCCCC-c
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL---NENEDPLISECGYSKFLDPKK-T 460 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~-~ 460 (608)
+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++...... .
T Consensus 95 ~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 95 DRILE----RGVYTEKDASLVIQQVLSAVKYLHENG-----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp HHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred HHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 99875 356899999999999999999999987 9999999999999 788999999999998655432 3
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||..|+||| ..++.++|||||||++|||++|+.||..... ......+...... .. .......+..+
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~---~~---~~~~~~~~~~~ 238 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIKEGYYE---FE---SPFWDDISESA 238 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHCCCC---CC---TTTTTTSCHHH
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcCCCC---CC---ccccccCCHHH
Confidence 456899999999 4578899999999999999999999875432 2222222221110 00 01123445678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.46 Aligned_cols=238 Identities=18% Similarity=0.230 Sum_probs=183.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 376 (608)
+.+|+|+||.||+|... +++.||||++..... ....+.+|++++++++||||+++++++.. +..++|||
T Consensus 141 ~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e 219 (419)
T 3i6u_A 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLE 219 (419)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEE
T ss_pred eEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEE
Confidence 56899999999999875 679999999874321 12247899999999999999999999864 45799999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC---CCceEecccccc
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN---EDPLISECGYSK 453 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~ 453 (608)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++
T Consensus 220 ~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 220 LMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp CCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred cCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEecCCCcceEEEeecccce
Confidence 9999999887753 567999999999999999999999987 9999999999999754 459999999999
Q ss_pred ccCCCC--ccccccCccccCCC-------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHH
Q 042949 454 FLDPKK--TCLFSSNGYTAPEK-------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKE 524 (608)
Q Consensus 454 ~~~~~~--~~~~gt~~y~aPE~-------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (608)
...... ....||+.|+|||. .++.++|||||||++|||+||+.||................. .. ..
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~-~~--~~-- 365 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-YN--FI-- 365 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC-CC--CC--
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC-CC--CC--
Confidence 876443 34678999999993 356789999999999999999999975433222222222111 10 11
Q ss_pred HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 525 VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 525 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 366 -~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 366 -PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11223456678999999999999999999999873
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=326.55 Aligned_cols=251 Identities=16% Similarity=0.236 Sum_probs=194.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhc--CCCCcceeeeeeeecCC----eeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGN--LKHPNILPLVCYNSTNE----EKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~e~~~~ 380 (608)
+.+|+|+||.||+++. +|+.||||+++.. ..+.+.+|++++.. ++||||+++++++...+ ..++||||+++
T Consensus 48 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~ 124 (342)
T 1b6c_B 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 124 (342)
T ss_dssp EEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTT
T ss_pred eeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCC
Confidence 5689999999999988 6899999999743 34667888888876 78999999999998775 78999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC---CCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSN---EEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~---~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
|+|.+++.. ..+++..++.++.|++.||+|||.... +..+|+||||||+|||++.++.+||+|||+++....
T Consensus 125 g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 199 (342)
T 1b6c_B 125 GSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199 (342)
T ss_dssp CBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccc
Confidence 999999974 468999999999999999999993100 012399999999999999999999999999986654
Q ss_pred CC-------ccccccCccccCCC---C-------CCcchhHHHHHHHHHHHHcC----------CCCCcCCC----ChHH
Q 042949 458 KK-------TCLFSSNGYTAPEK---T-------VSEQGDVFSFGVILLELLTG----------KTVEKTGI----DLPK 506 (608)
Q Consensus 458 ~~-------~~~~gt~~y~aPE~---~-------~~~ksDVwSfGvvl~elltg----------~~p~~~~~----~~~~ 506 (608)
.. ....||..|+|||. . ++.++|||||||++|||+|| +.||.... ....
T Consensus 200 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 279 (342)
T 1b6c_B 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279 (342)
T ss_dssp TTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred cccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHH
Confidence 32 33468999999991 1 22689999999999999999 66765432 2222
Q ss_pred HHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 507 WVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
+............ +.... ........+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 280 ~~~~~~~~~~~~~-~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 280 MRKVVCEQKLRPN-IPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HHHHHTTSCCCCC-CCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhCCC-Ccccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 2222222111111 11110 12234566899999999999999999999999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=318.31 Aligned_cols=234 Identities=21% Similarity=0.312 Sum_probs=178.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|+. .+|+.||||++... ....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 17 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (278)
T 3cok_A 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNG 96 (278)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCC
Confidence 5689999999999987 57899999999632 223577899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 97 EMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG-----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp EHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 99999874 2467999999999999999999999987 999999999999999999999999999876532
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||..|+||| ..++.++||||||+++|||++|+.||........ ..... .... ..+...+.
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~~~~------~~~~~~~~ 237 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVV----LADY------EMPSFLSI 237 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CC----SSCC------CCCTTSCH
T ss_pred ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHh----hccc------CCccccCH
Confidence 23456899999999 4568899999999999999999999865432111 11100 0000 11223456
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 238 EAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhc
Confidence 6889999999999999999999876
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=320.72 Aligned_cols=240 Identities=19% Similarity=0.247 Sum_probs=184.1
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..+|+|+||.||+++. .+|+.||||+++..... .+.+.++...++.++||||+++++++...+..++||||++ |+
T Consensus 13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 91 (290)
T 3fme_A 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TS 91 (290)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EE
T ss_pred HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cc
Confidence 5689999999999997 47899999999743222 2234445555788899999999999999999999999996 69
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQK-SNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
|.+++.........+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++......
T Consensus 92 l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 92 LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-----VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC-----CCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred hHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 9998876555567899999999999999999999997 6 9999999999999999999999999998765432
Q ss_pred ccccccCccccCCC--------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 460 TCLFSSNGYTAPEK--------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 460 ~~~~gt~~y~aPE~--------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....||+.|+|||. .++.++|||||||++|||+||+.||.................... . ....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~-------~~~~ 238 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ-L-------PADK 238 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-C-------CTTT
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-c-------cccc
Confidence 33468999999992 367899999999999999999999976544433333333322111 0 1123
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 45668899999999999999999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=344.80 Aligned_cols=238 Identities=17% Similarity=0.235 Sum_probs=196.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..||+|+||.||+++.. +|+.||+|+++.. ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 45899999999999985 6899999999742 234567889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 271 ~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-----IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 271 DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp BHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC-----CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 999998753223457999999999999999999999987 9999999999999999999999999998765432
Q ss_pred -ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC---hHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 460 -TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID---LPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 460 -~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....||+.|+||| ..++.++|||||||++|||+||+.||..... .....+....... ..+..
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~----------~~p~~ 415 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV----------TYPDK 415 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC----------CCCTT
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc----------CCCcc
Confidence 3357999999999 5689999999999999999999999976432 2222222222110 11234
Q ss_pred cHHHHHHHHHHchhcCCCCCCCH-----HHHHH
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTM-----AEVLE 559 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 559 (608)
.+..+.+++.+||+.||++||++ .++++
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 55678899999999999999975 56654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=341.94 Aligned_cols=238 Identities=21% Similarity=0.270 Sum_probs=193.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.||+|+||+||+|+.. ++..||+|+++.. ....+.+.+|++++++++||||+++++++.+....++||||+++|+
T Consensus 43 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 122 (494)
T 3lij_A 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122 (494)
T ss_dssp EEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCc
Confidence 56899999999999975 7899999999743 2345778999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC---CCceEeccccccccCCCC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN---EDPLISECGYSKFLDPKK 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~ 459 (608)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.. +.+||+|||+++......
T Consensus 123 L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 123 LFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN-----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9998875 356999999999999999999999987 9999999999999764 459999999998765432
Q ss_pred --ccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 --TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 --~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....||+.|+||| ..++.++||||+||++|||++|..||..... ......+....... .. ......+.
T Consensus 194 ~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~--~~----~~~~~~s~ 266 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVEKGKYTF--DS----PEWKNVSE 266 (494)
T ss_dssp CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCC--CS----GGGTTSCH
T ss_pred cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCC--Cc----hhcccCCH
Confidence 4457999999999 6789999999999999999999999975432 23333332221110 00 11224556
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.+++.+||+.||++|||+.|+++.
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcC
Confidence 78899999999999999999999865
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=322.18 Aligned_cols=248 Identities=13% Similarity=0.152 Sum_probs=196.0
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeee-ecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYN-STNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|+||.||+|+. .+++.||||++.... ..+++.+|++++.+++|++++..+.++ ...+..++||||+ +|+|.
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~ 92 (296)
T 4hgt_A 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE 92 (296)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred eeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHH
Confidence 5689999999999987 578999999876432 224578899999999998887776655 5677889999999 99999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec---CCCCCceEeccccccccCCCC--
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL---NENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 93 ~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 93 DLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 999742 456999999999999999999999987 9999999999999 788999999999998765432
Q ss_pred --------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh--HHHHHHHHhhhcccccccHHH
Q 042949 460 --------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL--PKWVKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 460 --------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 525 (608)
....||..|+||| ..++.++|||||||++|||++|+.||...... .............. ..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~ 239 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----PI 239 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----CH
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-----hh
Confidence 2456899999999 56789999999999999999999998653221 11111111111000 01
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
.......+..+.+++.+||+.||++|||+.++++.|+++.+...
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 11123456679999999999999999999999999999986543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=343.61 Aligned_cols=239 Identities=22% Similarity=0.300 Sum_probs=199.5
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
...+|+|+||.||+++.. +|+.||||++... ....+.+.+|++++++++||||+++++++...+..++||||+.+
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 110 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 357899999999999976 7899999999643 34567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec---CCCCCceEeccccccccCC
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL---NENEDPLISECGYSKFLDP 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 457 (608)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 111 ~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 111 GELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK-----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 999998864 567999999999999999999999987 9999999999999 5678899999999987654
Q ss_pred CC--ccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 458 KK--TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 458 ~~--~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
.. ....||+.|+||| ..++.++||||+||++|||++|+.||..... ......+......... ......
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~------~~~~~~ 254 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANE-YDILKKVEKGKYTFEL------PQWKKV 254 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCCCCS------GGGGGS
T ss_pred ccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcCCCCCCC------cccccC
Confidence 43 3457899999999 6789999999999999999999999975432 2233333222111110 112345
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||+.||++|||+.|+++.
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 6678999999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=342.55 Aligned_cols=238 Identities=23% Similarity=0.278 Sum_probs=195.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--------------cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCee
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--------------VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEK 371 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 371 (608)
+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+....
T Consensus 42 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 121 (504)
T 3q5i_A 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121 (504)
T ss_dssp EEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 56899999999999975 57899999997432 2356789999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC---CceEec
Q 042949 372 LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE---DPLISE 448 (608)
Q Consensus 372 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~---~~kl~D 448 (608)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 122 ~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 122 YLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN-----IVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999875 356999999999999999999999987 99999999999998776 689999
Q ss_pred cccccccCCCC--ccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH
Q 042949 449 CGYSKFLDPKK--TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 449 FGla~~~~~~~--~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (608)
||+++...... ....||+.|+||| ..++.++||||+||++|||++|..||.... .......+...... ++.
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~---~~~ 268 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN-DQDIIKKVEKGKYY---FDF 268 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC---CCH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCC---CCc
Confidence 99998775432 4467999999999 668999999999999999999999997543 23333333222111 111
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
......+..+.+++.+||+.||++|||+.|+++.
T Consensus 269 ---~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 269 ---NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1123456678999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=328.30 Aligned_cols=237 Identities=22% Similarity=0.340 Sum_probs=194.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc--C-------HHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEE
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV--S-------MDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVY 375 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~--~-------~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 375 (608)
+.+|+|++|.||+|+.. +|+.||||+++.... . .+.+.+|+.++.++ +||||+++++++......++||
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 179 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence 57999999999999986 799999999874321 1 34578899999998 7999999999999999999999
Q ss_pred eeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 180 e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g-----i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 180 DLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN-----IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999975 356999999999999999999999987 999999999999999999999999999876
Q ss_pred CCCC--ccccccCccccCCC----------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH
Q 042949 456 DPKK--TCLFSSNGYTAPEK----------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 456 ~~~~--~~~~gt~~y~aPE~----------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (608)
.... ....||+.|+|||. .++.++|||||||++|||++|+.||..... ............. ...
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~---~~~ 326 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-ILMLRMIMEGQYQ---FSS 326 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCC---CCH
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhCCCC---CCC
Confidence 5432 44678999999991 378899999999999999999999875432 2222222221110 000
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 327 ---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 327 ---PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112244566889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.83 Aligned_cols=236 Identities=21% Similarity=0.245 Sum_probs=190.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|+||.||++... +|+.||||+++.... ...+|++++.++ +||||+++++++.+.+..++||||+++|+|.
T Consensus 28 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~ 104 (342)
T 2qr7_A 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL 104 (342)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHH
Confidence 56899999999999875 689999999975432 235688888887 7999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-C---CceEeccccccccCCCC-
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-E---DPLISECGYSKFLDPKK- 459 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~---~~kl~DFGla~~~~~~~- 459 (608)
+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+.++ + .+||+|||+++......
T Consensus 105 ~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g-----ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 105 DKILR----QKFFSEREASAVLFTITKTVEYLHAQG-----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp HHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred HHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 99874 467999999999999999999999987 9999999999998543 3 48999999998764432
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCC--ChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGI--DLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....||+.|+||| ..++.++|||||||++|||++|+.||.... ........+....... . ......
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~---~---~~~~~~ 249 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL---S---GGYWNS 249 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC---C---STTTTT
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc---C---cccccc
Confidence 3457899999999 347889999999999999999999997532 2233333322221110 0 001134
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+..+.+++.+||..||++|||+.|+++.
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 56678899999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.89 Aligned_cols=240 Identities=21% Similarity=0.206 Sum_probs=193.0
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
.++|+|+||.||+|.. .+++.||||.++... ...+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4789999999999987 468899999997533 34577899999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-CCCceEeccccccccCCC---Cc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-NEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~---~~ 460 (608)
+++... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++..... ..
T Consensus 108 ~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 108 ALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDNQ-----IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp HHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred HHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhCC-----EEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 999762 22345789999999999999999999987 999999999999987 899999999999876532 23
Q ss_pred cccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 461 CLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 461 ~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
...|+..|+||| ..++.++||||||+++|||++|+.||.................... ......+.
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 253 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP--------EIPESMSA 253 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC--------CCCTTSCH
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc--------cccccCCH
Confidence 456899999999 2378899999999999999999999865433222111111111000 11234556
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 78899999999999999999999763
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=347.41 Aligned_cols=237 Identities=19% Similarity=0.249 Sum_probs=196.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..||+|+||.||+++.. +|+.||||+++.. ......+.+|++++.+++|||||++++++.+.+..++||||+++|
T Consensus 190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 269 (576)
T 2acx_A 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 269 (576)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCC
Confidence 56899999999999885 7899999999642 234567889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. .+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~~g-----IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 270 DLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRER-----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp BHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred cHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence 99999874 22345999999999999999999999987 9999999999999999999999999998775443
Q ss_pred ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC---hHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 460 TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID---LPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
....||+.|+||| ..++.++|||||||++|||++|+.||..... .....+..... .. ......
T Consensus 343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---~~-------~~p~~~ 412 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---PE-------EYSERF 412 (576)
T ss_dssp ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC---CC-------CCCTTS
T ss_pred cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc---cc-------cCCccC
Confidence 3467999999999 4578999999999999999999999975432 12222211111 00 012335
Q ss_pred HHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
+..+.+|+.+||+.||++|| ++.|+++.
T Consensus 413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 56788999999999999999 78888764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=332.42 Aligned_cols=240 Identities=17% Similarity=0.178 Sum_probs=195.1
Q ss_pred cccCCCCCceEEEEE------EcCCcEEEEEEecccccCHHHHHHHHHHHhcCC---CCcceeeeeeeecCCeeEEEEee
Q 042949 307 DLRSQTICSSLFMVR------LKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~------~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
+.+|+|+||.||+|. ..+++.||||+++.. ...++.+|++++.+++ |+||+++++++...+..++||||
T Consensus 71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~ 148 (365)
T 3e7e_A 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL 148 (365)
T ss_dssp EEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECC
T ss_pred EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEec
Confidence 568999999999993 557899999999743 4667888999988887 99999999999999999999999
Q ss_pred ccCCCHHHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-----------CCCce
Q 042949 378 QSNGSLLSLLEAYIE-GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-----------NEDPL 445 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-----------~~~~k 445 (608)
+++|+|.+++..... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++. ++.+|
T Consensus 149 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~-----ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k 223 (365)
T 3e7e_A 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE-----IIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223 (365)
T ss_dssp CCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred cCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-----eecCCCCHHHEEecccccCccccccccCCEE
Confidence 999999999986433 3567999999999999999999999987 999999999999998 89999
Q ss_pred EeccccccccC---CC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc
Q 042949 446 ISECGYSKFLD---PK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW 516 (608)
Q Consensus 446 l~DFGla~~~~---~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 516 (608)
|+|||+++.+. .. .....||..|+||| ..++.++|||||||++|||+||+.||...... ...
T Consensus 224 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------~~~ 294 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG---------ECK 294 (365)
T ss_dssp ECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---------EEE
T ss_pred EeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---------cee
Confidence 99999997543 11 23457899999999 55799999999999999999999998543210 000
Q ss_pred ccccccHHHHHhchhcHHHHHHHHHHchhcCCCCC-CCHHHHHHHHHHhhcCC
Q 042949 517 TGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDR-PTMAEVLERIEEVVNGN 568 (608)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R-Ps~~evl~~L~~~~~~~ 568 (608)
....+. .......+.+++..|++.+|.+| |++.++.+.|+++.+..
T Consensus 295 ~~~~~~------~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 295 PEGLFR------RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ECSCCT------TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred echhcc------ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 000000 00123446789999999999999 68999999999987653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=331.79 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=194.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeec------------------
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNST------------------ 367 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------------------ 367 (608)
+.+|+|+||.||+|.. .+|+.||||++.... ....+|++++++++|||||++++++..
T Consensus 13 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (383)
T 3eb0_A 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKL 89 (383)
T ss_dssp EEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------------
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccc
Confidence 5689999999999987 578999999986432 223479999999999999999999843
Q ss_pred --------------------CCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCce
Q 042949 368 --------------------NEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIP 427 (608)
Q Consensus 368 --------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~iv 427 (608)
....++||||++ |+|.+.+..+......+++..+..++.||++||+|||+.+ |+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g-----i~ 163 (383)
T 3eb0_A 90 GGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG-----IC 163 (383)
T ss_dssp --------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EE
T ss_pred cccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc-----Cc
Confidence 334889999997 6999988876666778999999999999999999999887 99
Q ss_pred ecCCCCCCeecC-CCCCceEeccccccccCCC--CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCc
Q 042949 428 HGNLKLSNILLN-ENEDPLISECGYSKFLDPK--KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEK 499 (608)
Q Consensus 428 HrDlkp~NILl~-~~~~~kl~DFGla~~~~~~--~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~ 499 (608)
||||||+|||++ .++.+||+|||+++..... .....+|..|+||| ..++.++||||+||++|||++|+.||.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 999999999998 6889999999999876443 24457899999999 347999999999999999999999997
Q ss_pred CCCChHHHHHHHHhhhc-----------------ccccccHHH-HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH-
Q 042949 500 TGIDLPKWVKAMVREEW-----------------TGEVFDKEV-AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER- 560 (608)
Q Consensus 500 ~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~- 560 (608)
................. ......... .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (383)
T 3eb0_A 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP 323 (383)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence 65443333222211000 000000000 11123456678999999999999999999999864
Q ss_pred -HHHhhc
Q 042949 561 -IEEVVN 566 (608)
Q Consensus 561 -L~~~~~ 566 (608)
++++.+
T Consensus 324 ~f~~~~~ 330 (383)
T 3eb0_A 324 FFDHLRN 330 (383)
T ss_dssp GGHHHHH
T ss_pred HHHHHHh
Confidence 555443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=326.70 Aligned_cols=245 Identities=19% Similarity=0.289 Sum_probs=191.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..+|+|+||.||+++.. +|+.||||++...... .+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 110 (331)
T 4aaa_A 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI 110 (331)
T ss_dssp EEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcch
Confidence 57899999999999986 5899999998644332 3457899999999999999999999999999999999999998
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---C
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---K 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~ 459 (608)
|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .
T Consensus 111 l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 111 LDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp HHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred HHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC-----EEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence 8887653 456999999999999999999999987 999999999999999999999999999876433 2
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc--------------cc--
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW--------------TG-- 518 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--------------~~-- 518 (608)
....+|..|+||| ..++.++|||||||++|||++|+.||.................. ..
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 3456899999999 25789999999999999999999998765543332222111000 00
Q ss_pred ---ccc-cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 519 ---EVF-DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 519 ---~~~-~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
... ...........+..+.+++.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000111223456779999999999999999999998864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.14 Aligned_cols=246 Identities=19% Similarity=0.279 Sum_probs=181.9
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCC-CCcceeeeeeee--------cCCeeEEE
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLK-HPNILPLVCYNS--------TNEEKLLV 374 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~--------~~~~~~lv 374 (608)
...+|+|+||.||+++.. +++.||||++.... ...+.+.+|+.++.++. ||||+++++++. .....++|
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 357899999999999975 78999999986432 34567889999999996 999999999983 34457999
Q ss_pred EeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
|||+. |+|.+++.... ....+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 113 ~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK---PPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS---SCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred EEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 99995 89999987643 2456999999999999999999999864 3499999999999999999999999999987
Q ss_pred cCCCCc---------------cccccCccccCCC-------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHH
Q 042949 455 LDPKKT---------------CLFSSNGYTAPEK-------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMV 512 (608)
Q Consensus 455 ~~~~~~---------------~~~gt~~y~aPE~-------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~ 512 (608)
...... ...+|+.|+|||. .++.++|||||||++|||+||+.||....... ..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~ 262 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-----IV 262 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----hh
Confidence 654221 3458899999992 35779999999999999999999986532211 01
Q ss_pred hhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
...... .........+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 263 ~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 263 NGKYSI--------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ---CCC--------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred cCcccC--------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 110000 0011223347789999999999999999999999999986543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=317.32 Aligned_cols=236 Identities=18% Similarity=0.234 Sum_probs=193.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||++... +++.||||+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (276)
T 2yex_A 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92 (276)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEG
T ss_pred EEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcH
Confidence 56899999999999976 78999999997432 2356789999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-----
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK----- 458 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~----- 458 (608)
.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 93 FDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp GGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred HHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 988753 457999999999999999999999987 999999999999999999999999999865322
Q ss_pred CccccccCccccCC----CC-CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 459 KTCLFSSNGYTAPE----KT-VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~-~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.....|+..|+||| .. .+.++||||||+++|||++|+.||................... . ......+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~ 235 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---L-----NPWKKID 235 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT---S-----TTGGGSC
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc---c-----CchhhcC
Confidence 23456899999999 22 3678999999999999999999987654432222222211100 0 1123445
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 236 SAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 66889999999999999999999876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=324.22 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=196.3
Q ss_pred cccCCCCCceEEEEEE-----cCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCC--eeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRL-----KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE--EKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e~~ 378 (608)
+.+|+|+||.||+++. .+|+.||||++.... ...+.+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 126 (326)
T 2w1i_A 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 126 (326)
T ss_dssp EEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCC
T ss_pred eeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECC
Confidence 5689999999999984 368999999997533 33567899999999999999999999887654 789999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 127 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 127 PYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp TTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 999999999752 356999999999999999999999987 999999999999999999999999999877543
Q ss_pred C------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc----HH
Q 042949 459 K------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD----KE 524 (608)
Q Consensus 459 ~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 524 (608)
. ....++..|+||| ..++.++||||||+++|||+||..|+... ...+.+. ........... ..
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRM-IGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH--HHHHHHH-HCTTCCTHHHHHHHHHH
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC--HHHHHHh-hccccchhhhHHHHHHH
Confidence 2 2234667799999 56788999999999999999999886531 1111111 00000000000 00
Q ss_pred H-----HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 525 V-----AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 525 ~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+ ......++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0 011234567799999999999999999999999999998753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.22 Aligned_cols=244 Identities=18% Similarity=0.203 Sum_probs=189.0
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeec--------CCeeEEE
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNST--------NEEKLLV 374 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~~~~~lv 374 (608)
+.+|+|+||.||+|+. .+|+.||||++.... .....+.+|++++++++||||+++++++.. .+..++|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 102 (351)
T 3mi9_A 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 102 (351)
T ss_dssp EECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEE
T ss_pred EEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEE
Confidence 5689999999999998 578999999986432 234678899999999999999999999876 4468999
Q ss_pred EeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
|||++ |+|.+.+.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 103 FDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 99997 588887763 2456999999999999999999999987 99999999999999999999999999987
Q ss_pred cCCC-------CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh-h-ccccc
Q 042949 455 LDPK-------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE-E-WTGEV 520 (608)
Q Consensus 455 ~~~~-------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-~-~~~~~ 520 (608)
+... .....||+.|+||| ..++.++|||||||++|||+||+.||......... ..+... . .....
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL-ALISQLCGSITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhh
Confidence 6422 13356799999999 34789999999999999999999998765432222 111110 0 00000
Q ss_pred ccHH------------------HHH--hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 521 FDKE------------------VAK--AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 521 ~~~~------------------~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.... ... .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000 000 001124558899999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.57 Aligned_cols=234 Identities=20% Similarity=0.295 Sum_probs=195.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+++.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 20 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 99 (284)
T 2vgo_A 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRG 99 (284)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred heecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCC
Confidence 56899999999999876 5789999998632 234567899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-Cc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-KT 460 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~ 460 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 100 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (284)
T 2vgo_A 100 ELYKELQK----HGRFDEQRSATFMEELADALHYCHERK-----VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170 (284)
T ss_dssp EHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBC
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEEcCCCCEEEecccccccCcccccc
Confidence 99999976 346999999999999999999999887 999999999999999999999999999765443 34
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...|+..|+||| ..++.++||||||+++|||++|+.||..... ............ ..+...+..+
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~ 239 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-TETHRRIVNVDL----------KFPPFLSDGS 239 (284)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTTCC----------CCCTTSCHHH
T ss_pred cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-hHHHHHHhcccc----------CCCCcCCHHH
Confidence 457899999999 5678899999999999999999999865432 222222221110 0112345668
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhC
Confidence 899999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.07 Aligned_cols=234 Identities=20% Similarity=0.286 Sum_probs=187.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|+.. +|+.||||++... ....+.+.+|++.+++++||||+++++++...+..++||||++++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (276)
T 2h6d_A 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGG 96 (276)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCC
Confidence 56899999999999986 7899999999632 234568899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 97 ELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM-----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp BHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC-----SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred cHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence 99999976 356899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccCccccCC----C-CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 TCLFSSNGYTAPE----K-TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 ~~~~gt~~y~aPE----~-~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....++..|+||| . ..+.++||||||+++|||++|+.||.... ............. ..+...+.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~----------~~~~~~~~ 236 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRGGVF----------YIPEYLNR 236 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCC----------CCCTTSCH
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcCcc----------cCchhcCH
Confidence 3456889999999 2 23578999999999999999999986532 2222222221110 01223455
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 237 SVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhC
Confidence 68899999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=328.49 Aligned_cols=244 Identities=20% Similarity=0.230 Sum_probs=191.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|+|+||.||+|+.. +|+.||||+++.... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 95 (346)
T 1ua2_A 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 95 (346)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCC
Confidence 57899999999999875 689999999974221 12467899999999999999999999999999999999997
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 458 (608)
+ +|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 96 T-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW-----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp E-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred C-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 5 88888753 3456899999999999999999999987 999999999999999999999999999876433
Q ss_pred --CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-ccc-cccc-------
Q 042949 459 --KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-WTG-EVFD------- 522 (608)
Q Consensus 459 --~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~-~~~~------- 522 (608)
.....+|+.|+||| ..++.++|||||||++|||++|.+||......... ..+.... ... ....
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL-TRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCTTTSSSTTSSTT
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHcCCCChhhhhhhccCcc
Confidence 23457899999999 24788999999999999999999988765443322 2222210 000 0000
Q ss_pred ---------HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 ---------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 ---------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..........+..+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00111123455779999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=322.95 Aligned_cols=246 Identities=19% Similarity=0.288 Sum_probs=195.6
Q ss_pred cccCCCCCceEEEEEE------cCCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRL------KNSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~------~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||+|+. .++..||||++... .....++.+|+.++++++||||+++++++...+..++||||+
T Consensus 36 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (327)
T 2yfx_A 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELM 115 (327)
T ss_dssp EECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecC
Confidence 5689999999999983 35789999999743 223457889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC---CCCceEeccccc
Q 042949 379 SNGSLLSLLEAYIE---GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE---NEDPLISECGYS 452 (608)
Q Consensus 379 ~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla 452 (608)
++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++. +..+||+|||++
T Consensus 116 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp TTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred CCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-----eecCcCCHhHEEEecCCCcceEEECccccc
Confidence 99999999986321 1145899999999999999999999987 999999999999984 456999999999
Q ss_pred cccCCC-----CccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 453 KFLDPK-----KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 453 ~~~~~~-----~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
+..... .....++..|+||| ..++.++||||||+++|||+| |+.||.... ..............
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~~~~~~~~----- 264 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTSGGRM----- 264 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCCC-----
T ss_pred cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-HHHHHHHHhcCCCC-----
Confidence 754322 23456788999999 678999999999999999999 888876542 22222222221110
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
......+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 265 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 265 ----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11234556788999999999999999999999999998764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.32 Aligned_cols=236 Identities=20% Similarity=0.292 Sum_probs=192.5
Q ss_pred cccCCCCCceEEEEEE----cCCcEEEEEEeccc-----ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL----KNSAVYAVKRLKKL-----QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~----~~g~~vavK~l~~~-----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 376 (608)
+.||+|+||.||+++. .+|+.||||+++.. ....+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus 60 ~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 139 (355)
T 1vzo_A 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILD 139 (355)
T ss_dssp EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEee
Confidence 5789999999999997 47899999998742 23456678899999999 69999999999999999999999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 140 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 140 YINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred cCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999976 356999999999999999999999987 9999999999999999999999999998664
Q ss_pred CCC----ccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCCC---ChHHHHHHHHhhhcccccccH
Q 042949 457 PKK----TCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTGI---DLPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 457 ~~~----~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~ 523 (608)
... ....||..|+||| ..++.++|||||||++|||+||+.||.... ......+.......
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 283 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------- 283 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-------
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC-------
Confidence 322 3357899999999 135789999999999999999999986432 22222222221110
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCC-----CHHHHHHHH
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRP-----TMAEVLERI 561 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L 561 (608)
......+..+.+++.+||+.||++|| ++.|+++..
T Consensus 284 ---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 ---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11234456688999999999999999 999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=325.12 Aligned_cols=235 Identities=22% Similarity=0.290 Sum_probs=195.3
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
.+.+|+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 367899999999999976 57899999987432 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-- 458 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 458 (608)
++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 126 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 126 RSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR-----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999998875 356999999999999999999999987 999999999999999999999999999876432
Q ss_pred -CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 459 -KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 459 -~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.....||..|+||| ..++.++||||||+++|||++|+.||..... ............. .....+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~----------~~~~~~ 265 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-KETYLRIKKNEYS----------IPKHIN 265 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC----------CCTTSC
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-HHHHHHHhcCCCC----------CCccCC
Confidence 23456899999999 5678899999999999999999999865432 2222222211110 112344
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.+++.+||+.||++|||+.|+++.
T Consensus 266 ~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 266 PVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 568899999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=318.21 Aligned_cols=235 Identities=22% Similarity=0.286 Sum_probs=195.0
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
.+.+|+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 367899999999999986 57899999987432 2345688999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-- 458 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 458 (608)
++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 100 RSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR-----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp CBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999998875 356999999999999999999999987 999999999999999999999999999876432
Q ss_pred -CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 459 -KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 459 -~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.....||..|+||| ..++.++||||||+++|||++|+.||...... ........... ..+...+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~----------~~~~~~~ 239 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEY----------SIPKHIN 239 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCC----------CCCTTSC
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhccC----------CCccccC
Confidence 23456899999999 45788999999999999999999998654322 22222211111 0112344
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 240 PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 568899999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.67 Aligned_cols=240 Identities=20% Similarity=0.218 Sum_probs=192.4
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCC-CCcceeeeeeeec--CCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNST--NEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||.||+|+. .+++.||||+++. ...+.+.+|++++.+++ ||||+++++++.. ....++||||+++++
T Consensus 42 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~ 119 (330)
T 3nsz_A 42 RKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 119 (330)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCC
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchh
Confidence 5789999999999986 5789999999974 34678999999999997 9999999999987 567899999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-CceEeccccccccCCCC--
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-DPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~-- 459 (608)
|.+++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 120 l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 120 FKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp HHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred HHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 998874 3889999999999999999999987 99999999999999776 89999999998765432
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc----------cccccHH
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT----------GEVFDKE 524 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~ 524 (608)
....++..|+||| ..++.++|||||||++|||++|+.||............+...... ....++.
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence 4457889999999 457899999999999999999999986655443332222111000 0000110
Q ss_pred HH-----------------HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 525 VA-----------------KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 525 ~~-----------------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.. ......+..+.+++.+||+.||++|||++|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0012256779999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=321.28 Aligned_cols=247 Identities=22% Similarity=0.346 Sum_probs=180.3
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||++.. .+++.||||++... ....+++.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 100 (303)
T 2vwi_A 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 100 (303)
T ss_dssp EECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBH
T ss_pred heeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCch
Confidence 5789999999999985 47899999998743 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 384 LSLLEAYIE----GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 384 ~~~l~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp HHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred HHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 999975422 2345899999999999999999999987 9999999999999999999999999998654321
Q ss_pred --------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH-HH
Q 042949 460 --------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK-EV 525 (608)
Q Consensus 460 --------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 525 (608)
....||..|+||| ..++.++||||||+++|||++|+.||............. ... ....... ..
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~-~~~~~~~~~~ 253 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QND-PPSLETGVQD 253 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-TSS-CCCTTC----
T ss_pred CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-ccC-CCcccccccc
Confidence 2346899999999 357999999999999999999999987654433222211 111 1111000 00
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11123456678999999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.04 Aligned_cols=250 Identities=17% Similarity=0.217 Sum_probs=188.7
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecC-----CeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTN-----EEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e 376 (608)
.+.+|+|+||.||+|+.. +++.||||+++.... ..+.+.+|++++++++||||+++++++... ...++|||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 357899999999999875 678999999975322 345788999999999999999999998765 57899999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+. |+|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 111 IAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred cCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 995 699998864 467999999999999999999999987 9999999999999999999999999998764
Q ss_pred CC-------------------------CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCC--------
Q 042949 457 PK-------------------------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVE-------- 498 (608)
Q Consensus 457 ~~-------------------------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~-------- 498 (608)
.. .....||+.|+||| ..++.++||||+||++|||++|..|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 32 13457899999999 35889999999999999999854332
Q ss_pred ---cCCCCh----------------HHHHHHHHhhhc------ccccccHH---------------HHHhchhcHHHHHH
Q 042949 499 ---KTGIDL----------------PKWVKAMVREEW------TGEVFDKE---------------VAKAGRQWAFPLLN 538 (608)
Q Consensus 499 ---~~~~~~----------------~~~~~~~~~~~~------~~~~~~~~---------------~~~~~~~~~~~l~~ 538 (608)
.+.... ......+..... ...+.... ........+..+.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 221100 001111100000 00000000 01111345677899
Q ss_pred HHHHchhcCCCCCCCHHHHHHH--HHHhh
Q 042949 539 VALKCVSNSPDDRPTMAEVLER--IEEVV 565 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~~--L~~~~ 565 (608)
|+.+||+.||++|||++|+++. ++++.
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 9999999999999999999875 44443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=329.98 Aligned_cols=242 Identities=21% Similarity=0.240 Sum_probs=174.7
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 376 (608)
..+|+|+||.||+|.. .+|+.||||++..... ..+.+.+|++++++++||||+++++++... ...++|+|
T Consensus 35 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e 114 (367)
T 2fst_X 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 114 (367)
T ss_dssp EECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEec
Confidence 5689999999999986 4789999999974322 345688999999999999999999998654 56799999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 115 ~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 115 LM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 99 7899988863 56999999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------cccccccHH-
Q 042949 457 PKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------WTGEVFDKE- 524 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~- 524 (608)
.......+|..|+||| ..++.++|||||||++|||++|+.||........ +..+.... ....+....
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~~~~~~~~ 262 (367)
T 2fst_X 184 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKKISSESA 262 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHhhhHHH
Confidence 6666678999999999 3578999999999999999999999976543222 22221110 000111110
Q ss_pred --------------HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 525 --------------VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 525 --------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
........+..+.+|+.+||..||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 011112345668999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=327.46 Aligned_cols=252 Identities=20% Similarity=0.239 Sum_probs=185.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCe-------eEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEE-------KLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-------~~lv~e~~ 378 (608)
+.+|+|+||.||+|+.. +|+.||||++.........+.+|++.+.+++||||+++++++...+. .++||||+
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~ 108 (360)
T 3e3p_A 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV 108 (360)
T ss_dssp ----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecc
Confidence 46899999999999985 68999999987655455567788889999999999999999865332 78999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCCCceecCCCCCCeecCC-CCCceEecccccccc
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMY--QKSNEEKTIPHGNLKLSNILLNE-NEDPLISECGYSKFL 455 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~ 455 (608)
++ +|.+.+.........+++..+..++.|++.||+||| +.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 109 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~-----ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 109 PD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-----VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp SC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC-----CBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred cc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC-----eecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 75 677766655555678999999999999999999999 655 999999999999997 899999999999877
Q ss_pred CCCC--ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc----------
Q 042949 456 DPKK--TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG---------- 518 (608)
Q Consensus 456 ~~~~--~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 518 (608)
.... ....||..|+||| ..++.++|||||||++|||+||+.||....... ....+.......
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3e3p_A 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVLGCPSREVLRKLNP 261 (360)
T ss_dssp CTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCT
T ss_pred CCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHcCCCCHHHHHhccc
Confidence 5443 3457899999999 337899999999999999999999997654322 222222110000
Q ss_pred ccc------------cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhh
Q 042949 519 EVF------------DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVV 565 (608)
Q Consensus 519 ~~~------------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~ 565 (608)
... ...........+..+.+|+.+||+.||++|||+.|+++. ++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp TCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred chhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 000 000011112246679999999999999999999999875 44443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=323.79 Aligned_cols=237 Identities=19% Similarity=0.246 Sum_probs=188.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 376 (608)
+.+|+|+||.||+|... +++.||||++..... ....+.+|++++++++||||+++++++...+ .++|||
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e 94 (322)
T 2ycf_A 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLE 94 (322)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEE
T ss_pred eEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEe
Confidence 56899999999999875 678999999874321 1235789999999999999999999987665 899999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC---ceEecccccc
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED---PLISECGYSK 453 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~ 453 (608)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++
T Consensus 95 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 95 LMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp CCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred cCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 9999999998853 567999999999999999999999987 999999999999987664 9999999998
Q ss_pred ccCCCC--ccccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHH
Q 042949 454 FLDPKK--TCLFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKE 524 (608)
Q Consensus 454 ~~~~~~--~~~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (608)
...... ....||..|+||| ..++.++|||||||++|||++|+.||................. .. ..+
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~--~~~- 241 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-YN--FIP- 241 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC-CC--CCH-
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc-cc--cCc-
Confidence 775443 2356899999999 3468899999999999999999999875433222222221111 00 111
Q ss_pred HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 525 VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 525 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 242 --~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 242 --EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 112345667899999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=316.03 Aligned_cols=237 Identities=17% Similarity=0.276 Sum_probs=192.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+.+|+|+||.||+|... +|+.||||++... ...+++.+|++++.+++||||+++++++...+..++||||+++|+|.+
T Consensus 35 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 113 (314)
T 3com_A 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD 113 (314)
T ss_dssp EECC----CEEEEEEETTTCCEEEEEEEETT-SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHH
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEecCch-HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHH
Confidence 56899999999999876 5899999999753 345778999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTCL 462 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~~ 462 (608)
++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 114 ~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 185 (314)
T 3com_A 114 IIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR-----KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185 (314)
T ss_dssp HHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCC
T ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCcc
Confidence 98742 457999999999999999999999987 999999999999999999999999999866543 2345
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
.|+..|+||| ..++.++||||||+++|||++|+.||......... ...... ..... .....++..+.+
T Consensus 186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~-~~~~~------~~~~~~~~~l~~ 257 (314)
T 3com_A 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-FMIPTN-PPPTF------RKPELWSDNFTD 257 (314)
T ss_dssp CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHS-CCCCC------SSGGGSCHHHHH
T ss_pred CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhcC-CCccc------CCcccCCHHHHH
Confidence 6899999999 45788999999999999999999998754332211 111111 11010 012334567899
Q ss_pred HHHHchhcCCCCCCCHHHHHHH
Q 042949 539 VALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~~ 560 (608)
++.+||..||++|||+.++++.
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHccCChhhCcCHHHHHhC
Confidence 9999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.81 Aligned_cols=236 Identities=19% Similarity=0.292 Sum_probs=196.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||+|... +++.||||+++.. ....+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 107 (303)
T 3a7i_A 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 107 (303)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred hhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcH
Confidence 56899999999999864 6899999999743 33567899999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~ 460 (608)
.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 108 ~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 108 LDLLE-----PGPLDETQIATILREILKGLDYLHSEK-----KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp HHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence 99885 356999999999999999999999987 999999999999999999999999999876543 23
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||..|+||| ..++.++||||||+++|||++|+.|+..... ......... .... ......+..+
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~-~~~~--------~~~~~~~~~l 247 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-MKVLFLIPK-NNPP--------TLEGNYSKPL 247 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHH-SCCC--------CCCSSCCHHH
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-HHHHHHhhc-CCCC--------CCccccCHHH
Confidence 456899999999 5678899999999999999999999865432 222211111 1110 1122445668
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
.+++.+||+.||++|||+.|+++..-
T Consensus 248 ~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 248 KEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred HHHHHHHcCCChhhCcCHHHHhhChh
Confidence 89999999999999999999988643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=318.06 Aligned_cols=243 Identities=23% Similarity=0.265 Sum_probs=188.1
Q ss_pred cccCCCCCceEEEEEEc--CCc--EEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK--NSA--VYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~--~g~--~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||+|+.. +++ .||||+++... ...+.+.+|++++++++||||+++++++.... .++|+||+
T Consensus 24 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~ 102 (291)
T 1u46_A 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELA 102 (291)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECC
T ss_pred eeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecc
Confidence 56899999999999864 333 69999987432 23467889999999999999999999998765 88999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 103 PLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp TTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred cCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 999999999763 345899999999999999999999987 999999999999999999999999999876543
Q ss_pred C------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 459 K------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 459 ~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
. ....+|..|+||| ..++.++||||||+++|||++ |+.||.... ............... .
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~--------~ 245 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-GSQILHKIDKEGERL--------P 245 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTSCCCC--------C
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-HHHHHHHHHccCCCC--------C
Confidence 2 2235677899999 567889999999999999999 898886543 233333322221110 1
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
.....+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 246 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1234566789999999999999999999999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.94 Aligned_cols=245 Identities=18% Similarity=0.201 Sum_probs=188.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecC------CeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTN------EEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e~~~ 379 (608)
+.||+|+||.||+|+.. +|+.||||++.... +...+|++++++++|||||++++++... ...++||||++
T Consensus 60 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~ 136 (420)
T 1j1b_A 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 136 (420)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC
T ss_pred eEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc
Confidence 57899999999999985 68999999986432 2234799999999999999999987531 23679999997
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-CCceEeccccccccCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-EDPLISECGYSKFLDPK 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 458 (608)
+ +|.+.+..+......+++..++.++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 137 ~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 137 E-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp E-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred c-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 4 788877765555678999999999999999999999887 9999999999999965 56899999999876433
Q ss_pred --CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------------cccc
Q 042949 459 --KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------------WTGE 519 (608)
Q Consensus 459 --~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------------~~~~ 519 (608)
.....+|..|+||| ..++.++|||||||++|||++|+.||..........+.+..-. ...+
T Consensus 211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~ 290 (420)
T 1j1b_A 211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290 (420)
T ss_dssp CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 24467899999999 2578999999999999999999999976544333222211100 0000
Q ss_pred cccHH-----H-HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 520 VFDKE-----V-AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 520 ~~~~~-----~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
...+. . .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 291 ~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00000 0 00112345678999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=325.83 Aligned_cols=241 Identities=21% Similarity=0.258 Sum_probs=188.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCee------EEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEK------LLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~------~lv~e 376 (608)
..+|+|+||.||+|... +|+.||||+++..... .+.+.+|+.++++++||||+++++++...+.. ++|||
T Consensus 48 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 127 (371)
T 4exu_A 48 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 127 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEE
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEc
Confidence 56899999999999875 6899999999753332 45788999999999999999999999877654 99999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+. |+|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 ~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 128 FMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG-----VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 996 68877763 45999999999999999999999987 9999999999999999999999999999877
Q ss_pred CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------ccccccc---
Q 042949 457 PKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------WTGEVFD--- 522 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~~~~~--- 522 (608)
.......+|..|+||| ..++.++|||||||++|||++|+.||....... ....+.... ......+
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 274 (371)
T 4exu_A 196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQKLNDKAA 274 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHHHHhhhhhh
Confidence 6666778899999999 367899999999999999999999997654322 222221110 0000000
Q ss_pred ------------HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 ------------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 ------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00111123456779999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=329.19 Aligned_cols=243 Identities=20% Similarity=0.282 Sum_probs=191.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.+|+|+||.||+++.. +++.||+|+++... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 118 (360)
T 3eqc_A 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 118 (360)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCH
Confidence 46899999999999976 78999999997432 2346789999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCceecCCCCCCeecCCCCCceEeccccccccCC-CCcc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQK-SNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP-KKTC 461 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~-~~~~ 461 (608)
.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.... ....
T Consensus 119 ~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 189 (360)
T 3eqc_A 119 DQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189 (360)
T ss_dssp HHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC-----EEcCCccHHHEEECCCCCEEEEECCCCcccccccccC
Confidence 999976 34699999999999999999999985 5 99999999999999999999999999975432 2234
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh----------------------
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE---------------------- 515 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~---------------------- 515 (608)
..||..|+||| ..++.++|||||||++|||+||+.||...... .. .......
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK-EL-ELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH-HH-HHHHC------------------------
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH-HHHhcccccccCCCCCCCcccCCCccccc
Confidence 57899999999 56789999999999999999999998653221 11 0000000
Q ss_pred ----ccc----ccccHHHHH-----hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 516 ----WTG----EVFDKEVAK-----AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 516 ----~~~----~~~~~~~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
... +..+..... .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000 000000000 011245678999999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.81 Aligned_cols=246 Identities=18% Similarity=0.243 Sum_probs=188.8
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC------eeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE------EKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~e~~~ 379 (608)
.+.+|+|+||+||+|+..++..||+|++..... ...+|++++++++||||+++++++...+ ..++||||++
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~ 121 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence 357899999999999998777799998864321 2247999999999999999999985433 3789999997
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC-CCCCceEeccccccccCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN-ENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~ 458 (608)
+ ++.+.+.........+++..++.++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 122 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 122 E-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp E-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred c-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 6 555555544444677999999999999999999999987 99999999999999 7899999999999876433
Q ss_pred --CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh-------------hccc
Q 042949 459 --KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE-------------EWTG 518 (608)
Q Consensus 459 --~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-------------~~~~ 518 (608)
.....+|+.|+||| ..++.++|||||||++|||++|+.||...............- .+..
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 275 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME 275 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 34567899999999 257899999999999999999999997654333222211100 0000
Q ss_pred c----cccHHH-HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 519 E----VFDKEV-AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 519 ~----~~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. ...... .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 000000 01122356679999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.87 Aligned_cols=245 Identities=21% Similarity=0.245 Sum_probs=194.2
Q ss_pred cccCCCCCceEEEEEE--cCCcEEEEEEecccccCHHHHHHHHHHHhcCCCC------cceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRL--KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHP------NILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~--~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~------niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||++.. .+++.||||+++......+.+.+|++++.+++|+ +++++++++...+..++||||+
T Consensus 20 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (339)
T 1z57_A 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL 99 (339)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC
Confidence 5689999999999987 3688999999986554567788999999888665 4999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC------------------
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE------------------ 440 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~------------------ 440 (608)
+++|.+++.. .....+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 100 -~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 100 -GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHSNK-----LTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp -CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred -CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 8999999976 23346899999999999999999999987 999999999999987
Q ss_pred -CCCceEeccccccccCCCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh
Q 042949 441 -NEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE 515 (608)
Q Consensus 441 -~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 515 (608)
++.+||+|||+++..........||..|+||| ..++.++|||||||++|||++|+.||....... ....+....
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~ 250 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-HLAMMERIL 250 (339)
T ss_dssp SCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-HHHHHHHHH
T ss_pred cCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence 66899999999998776666778999999999 567999999999999999999999987543321 111111100
Q ss_pred c-cc----------cc----------ccHH---HH----------HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 516 W-TG----------EV----------FDKE---VA----------KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 516 ~-~~----------~~----------~~~~---~~----------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. .. .. .... .. ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 0 00 00 0000 00 0012235668999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=324.52 Aligned_cols=240 Identities=20% Similarity=0.220 Sum_probs=192.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||++... +|+.||+|+++.. .....++.+|+.++.+++ ||||+++++++...+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 67999999999999876 6899999999743 234678999999999995 699999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC---CCCceEeccccccccCCC
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE---NEDPLISECGYSKFLDPK 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~ 458 (608)
+|.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 115 ~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g-----ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 115 EIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN-----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred cHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99988743 22467999999999999999999999987 999999999999988 789999999999876543
Q ss_pred C--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 459 K--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 459 ~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
. ....||+.|+||| ..++.++|||||||++|||++|+.||........ ......... ... .......
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~--~~~----~~~~~~~ 260 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNISQVNV--DYS----EETFSSV 260 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCC--CCC----TTTTTTS
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhccc--ccC----chhhccc
Confidence 2 3457899999999 5678999999999999999999999876443222 222211110 000 0112345
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+..+.+++.+||+.||++|||+.|+++.
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 261 SQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 5668899999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=349.07 Aligned_cols=233 Identities=21% Similarity=0.256 Sum_probs=194.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..||+|+||.||+++.. +++.||||++++. ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 347 ~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~g 426 (674)
T 3pfq_A 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 426 (674)
T ss_dssp EESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCS
T ss_pred EEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCC
Confidence 46999999999999975 6889999999742 23456788999999988 799999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP--- 457 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~--- 457 (608)
|+|.++++. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 427 g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g-----IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 427 GDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS-----EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 999999986 356999999999999999999999987 99999999999999999999999999986432
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
......||+.|+||| ..++.++|||||||++|||++|+.||.... .......+..... ..+...+
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~----------~~p~~~s 566 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHNV----------AYPKSMS 566 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHSSCC----------CCCTTSC
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-HHHHHHHHHhCCC----------CCCccCC
Confidence 234567999999999 678999999999999999999999997543 2333333332211 1123456
Q ss_pred HHHHHHHHHchhcCCCCCCCH-----HHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTM-----AEVLE 559 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~-----~evl~ 559 (608)
..+.+|+.+||+.||++||++ +||++
T Consensus 567 ~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 678999999999999999997 66654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=333.62 Aligned_cols=246 Identities=15% Similarity=0.172 Sum_probs=196.9
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCCCC-cceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHP-NILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.||+|+||.||+|+. .+++.||||+++... ...++.+|++++..++|+ ++..+..++...+..++||||+ +++|.
T Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~ 90 (483)
T 3sv0_A 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (483)
T ss_dssp CCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHH
Confidence 5689999999999987 578999999887432 234578999999999875 5555566667788899999999 99999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec---CCCCCceEeccccccccCCCC--
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL---NENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 91 ~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g-----IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 91 DLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp HHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 999752 457999999999999999999999987 9999999999999 688999999999998765432
Q ss_pred --------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC--hHHHHHHHHhhhcccccccHHH
Q 042949 460 --------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID--LPKWVKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 460 --------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 525 (608)
....||..|+||| ..++.++|||||||++|||++|+.||..... ....+..+...... ...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-----~~~ 237 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-----TSI 237 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-----SCH
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-----ccH
Confidence 1457899999999 5688999999999999999999999975432 22222222221110 011
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
......++.++.+++.+||+.||++||++.+|++.|+++...
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 122234567799999999999999999999999999998653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=331.74 Aligned_cols=245 Identities=18% Similarity=0.238 Sum_probs=191.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCC--------CCcceeeeeeee----cCCeeEE
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK--------HPNILPLVCYNS----TNEEKLL 373 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~~~~~----~~~~~~l 373 (608)
+.+|+|+||+||+|+.. +++.||||+++......+.+.+|++++++++ |+||+++++++. .....++
T Consensus 43 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~l 122 (397)
T 1wak_A 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM 122 (397)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEE
Confidence 56899999999999864 6889999999865555677889999999885 788999999987 5668899
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCceecCCCCCCeecCCCC----------
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQK-SNEEKTIPHGNLKLSNILLNENE---------- 442 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivHrDlkp~NILl~~~~---------- 442 (608)
||||+ +|+|.+++.. .....+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 123 v~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g-----ivHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 123 VFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR-----IIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred EEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHeeEeccchhhhhhhhhh
Confidence 99999 6777777764 2235699999999999999999999997 6 99999999999998775
Q ss_pred ---------------------------------------CceEeccccccccCCCCccccccCccccCC----CCCCcch
Q 042949 443 ---------------------------------------DPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQG 479 (608)
Q Consensus 443 ---------------------------------------~~kl~DFGla~~~~~~~~~~~gt~~y~aPE----~~~~~ks 479 (608)
.+||+|||+++..........||..|+||| ..++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 274 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence 799999999998776666678999999999 5689999
Q ss_pred hHHHHHHHHHHHHcCCCCCcCCCCh-----HHHHHHHHhh------------hccccccc-----------------HHH
Q 042949 480 DVFSFGVILLELLTGKTVEKTGIDL-----PKWVKAMVRE------------EWTGEVFD-----------------KEV 525 (608)
Q Consensus 480 DVwSfGvvl~elltg~~p~~~~~~~-----~~~~~~~~~~------------~~~~~~~~-----------------~~~ 525 (608)
|||||||++|||+||+.||...... ......+... .+....+. ..+
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence 9999999999999999998643321 1111111110 00000000 000
Q ss_pred H---HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 526 A---KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 526 ~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
. ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 012234566889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.07 Aligned_cols=237 Identities=16% Similarity=0.287 Sum_probs=189.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.+|+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 104 (302)
T 2j7t_A 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD 104 (302)
T ss_dssp EEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHH
T ss_pred ceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHH
Confidence 46899999999999986 5899999998743 345678999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC---CCcc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP---KKTC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---~~~~ 461 (608)
+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..... ....
T Consensus 105 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 105 AIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR-----IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp HHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred HHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 998753 456999999999999999999999987 99999999999999999999999999764321 1234
Q ss_pred ccccCccccCC---------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 462 LFSSNGYTAPE---------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 462 ~~gt~~y~aPE---------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
..||..|+||| ..++.++||||||+++|||++|+.|+..... ............ ... .....+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~-~~~------~~~~~~ 248 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSDP-PTL------LTPSKW 248 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSCC-CCC------SSGGGS
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-HHHHHHHhccCC-ccc------CCcccc
Confidence 56899999999 2467899999999999999999999875432 222222222111 000 112345
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
+..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 567889999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=325.09 Aligned_cols=244 Identities=19% Similarity=0.187 Sum_probs=185.1
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccC------------HHHHHHHHHHHhcCCCCcceeeeeeeec-----CC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS------------MDEFSQTMRQIGNLKHPNILPLVCYNST-----NE 369 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~------------~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~ 369 (608)
..+|+|+||.||+|...+|+.||||++...... .+.+.+|++++++++||||+++++++.. ..
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 107 (362)
T 3pg1_A 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH 107 (362)
T ss_dssp EEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCC
T ss_pred EEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcc
Confidence 468999999999999888999999999632211 2678999999999999999999999843 34
Q ss_pred eeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecc
Q 042949 370 EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISEC 449 (608)
Q Consensus 370 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 449 (608)
..++||||+. |+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 108 KLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG-----VVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCT
T ss_pred eEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc-----CEecCCChHHEEEcCCCCEEEEec
Confidence 6899999997 788888863 3457999999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCC--CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc----
Q 042949 450 GYSKFLDPK--KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG---- 518 (608)
Q Consensus 450 Gla~~~~~~--~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 518 (608)
|+++..... .....+|..|+||| ..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLNKIVEVVGTPKIED 257 (362)
T ss_dssp TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHH
T ss_pred CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChHH
Confidence 999865433 24457889999999 45789999999999999999999998764332 2222221110000
Q ss_pred ------------------ccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 519 ------------------EVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 519 ------------------~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..............+..+.+++.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000001111223445668999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=320.08 Aligned_cols=238 Identities=18% Similarity=0.301 Sum_probs=189.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeec------CCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNST------NEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~------~~~~~lv~e~~ 378 (608)
+.+|+|+||.||+|+.. +|+.||||++.......+.+.+|+.++.++ +||||+++++++.. .+..++||||+
T Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~ 109 (326)
T 2x7f_A 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109 (326)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECC
T ss_pred EEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcC
Confidence 56899999999999974 789999999986666678899999999998 79999999999876 46789999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 110 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 110 GAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp TTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred CCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 999999999862 2356899999999999999999999987 999999999999999999999999999876532
Q ss_pred ---CccccccCccccCC---------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHH
Q 042949 459 ---KTCLFSSNGYTAPE---------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526 (608)
Q Consensus 459 ---~~~~~gt~~y~aPE---------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (608)
.....||..|+||| ..++.++|||||||++|||++|+.||........ ........ ....
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~~~------ 254 (326)
T 2x7f_A 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPRNP-APRL------ 254 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSC-CCCC------
T ss_pred ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhcCc-cccC------
Confidence 23456899999999 2367899999999999999999999865432221 11111111 1110
Q ss_pred HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 527 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.....+..+.+++.+||..||++|||+.++++.
T Consensus 255 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 255 -KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 122345678899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=326.01 Aligned_cols=241 Identities=17% Similarity=0.196 Sum_probs=181.2
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCC------eeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNE------EKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~e 376 (608)
..+|+|+||.||+|... +++.||||++..... ..+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 31 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e 110 (371)
T 2xrw_A 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEE
T ss_pred eeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEE
Confidence 56899999999999875 689999999975322 3456889999999999999999999987654 7899999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|++ |+|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 111 LMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC-----eecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 996 57888775 34899999999999999999999987 9999999999999999999999999998765
Q ss_pred CC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc-----ccccHHH
Q 042949 457 PK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG-----EVFDKEV 525 (608)
Q Consensus 457 ~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 525 (608)
.. .....||..|+||| ..++.++|||||||++|||++|+.||........+... ....... ..+.+..
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV-IEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HC-CCCCCHHHHTTSCHHH
T ss_pred cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHhCCCCHHHHHHhhhHH
Confidence 43 23457899999999 56789999999999999999999999765443322221 1100000 0000000
Q ss_pred ---------------------------HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 526 ---------------------------AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 526 ---------------------------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.......+..+.+|+.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00011225568999999999999999999999885
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.48 Aligned_cols=241 Identities=10% Similarity=0.009 Sum_probs=173.0
Q ss_pred hcccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHH---HHHhcCCCCcceeee-------eeeecC--
Q 042949 306 ADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTM---RQIGNLKHPNILPLV-------CYNSTN-- 368 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~---~~l~~l~H~niv~l~-------~~~~~~-- 368 (608)
.+.+|+|+||.||+|+.. +|+.||||+++.... ..+.+.+|+ +.+++ +||||++++ +++...
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTS
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCC
Confidence 357899999999999975 789999999986432 344567774 55555 799988854 333322
Q ss_pred ---------------CeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCCCce
Q 042949 369 ---------------EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLR------LSIATGIAKGLDFMYQKSNEEKTIP 427 (608)
Q Consensus 369 ---------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~~~iv 427 (608)
...++||||++ |+|.+++.... ..+++..+ ..++.||+.||+|||+++ |+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-----iv 216 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSKG-----LV 216 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-----EE
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-----Cc
Confidence 34799999998 89999998642 23455566 788899999999999987 99
Q ss_pred ecCCCCCCeecCCCCCceEeccccccccCCCCccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCC
Q 042949 428 HGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTG 501 (608)
Q Consensus 428 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~ 501 (608)
||||||+|||++.++.+||+|||+++..........+|+.|+||| ..++.++|||||||++|||+||+.||...
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999999998766554566779999999 24789999999999999999999998754
Q ss_pred CChHHHHHHHHhhhcccccccHH-HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 502 IDLPKWVKAMVREEWTGEVFDKE-VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
...... .............. ........+..+.+++.+||+.||++|||+.|+++
T Consensus 297 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 297 TPGIKG---SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CTTCTT---CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred Cccccc---chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 221000 00000000000000 00112345677899999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=321.60 Aligned_cols=242 Identities=19% Similarity=0.237 Sum_probs=191.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecC-----CeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN-----EEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~ 378 (608)
..+|+|+||.||++... +++.||||++.... ...+.+.+|++++.+++||||+++++++... ...++||||+
T Consensus 33 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~ 112 (364)
T 3qyz_A 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112 (364)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEccc
Confidence 57899999999999875 68899999997432 2346788999999999999999999998754 4689999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
. |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 113 ~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 113 E-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp S-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred C-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 6 699998874 46999999999999999999999987 999999999999999999999999999876533
Q ss_pred C------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc------ccccc
Q 042949 459 K------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW------TGEVF 521 (608)
Q Consensus 459 ~------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------~~~~~ 521 (608)
. ....||+.|+||| ..++.++|||||||++|||++|+.||........... +..... .....
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-ILGILGSPSQEDLNCII 260 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH-HHHHHCSCCHHHHHTCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH-HHHHhCCCCHHHHHHhh
Confidence 2 3347899999999 3479999999999999999999999876543322221 111000 00000
Q ss_pred cH---------------HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 DK---------------EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 ~~---------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+. .........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0011123345678999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=315.23 Aligned_cols=237 Identities=18% Similarity=0.279 Sum_probs=184.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeec-------------CCeeE
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNST-------------NEEKL 372 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-------------~~~~~ 372 (608)
..+|+|+||.||+|+.. +|+.||||+++......+.+.+|++++++++||||+++++++.. .+..+
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (303)
T 1zy4_A 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLF 91 (303)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEE
T ss_pred heeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceE
Confidence 56899999999999975 78999999997655556778999999999999999999998754 35679
Q ss_pred EEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccc
Q 042949 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYS 452 (608)
Q Consensus 373 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 452 (608)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 92 IQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG-----IIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred EEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC-----eecccCCHHhEEEcCCCCEEEeeCcch
Confidence 99999999999999975 2456888999999999999999999987 999999999999999999999999999
Q ss_pred cccCCC-----------------CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHH
Q 042949 453 KFLDPK-----------------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKA 510 (608)
Q Consensus 453 ~~~~~~-----------------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~ 510 (608)
+..... .....||..|+||| ..++.++|||||||++|||++ |+....+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~ 240 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence 876421 12346889999999 257899999999999999998 43322121222222
Q ss_pred HHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 511 MVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..... ..+.+ ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~---~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 241 LRSVS---IEFPP---DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHSTT---CCCCT---TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ccccc---cccCc---cccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 21110 00000 1122344568899999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=313.20 Aligned_cols=237 Identities=22% Similarity=0.277 Sum_probs=194.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----------cCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEE
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----------VSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLV 374 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----------~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 374 (608)
+.+|+|++|.||++... +|+.||||+++... ...+.+.+|++++.+++ ||||+++++++...+..++|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (298)
T 1phk_A 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102 (298)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred eeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEE
Confidence 56899999999999985 68999999997432 12346789999999995 99999999999999999999
Q ss_pred EeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 103 FDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999976 356999999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCC--ccccccCccccCC----------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 455 LDPKK--TCLFSSNGYTAPE----------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 455 ~~~~~--~~~~gt~~y~aPE----------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
..... ....++..|+||| ..++.++||||||+++|||++|+.||..... ...............
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~--- 249 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLMLRMIMSGNYQFG--- 249 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCCC---
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-HHHHHHHhcCCcccC---
Confidence 65432 3456899999999 1367899999999999999999999865432 222222222211100
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.......+..+.+++.+||+.||++|||+.|+++
T Consensus 250 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 250 ---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0112345667899999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.19 Aligned_cols=245 Identities=18% Similarity=0.282 Sum_probs=195.4
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccC------------------HHHHHHHHHHHhcCCCCcceeeeeeeecC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVS------------------MDEFSQTMRQIGNLKHPNILPLVCYNSTN 368 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~------------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 368 (608)
+.+|+|+||.||+++. +|+.||||++...... .+.+.+|++++++++||||+++++++.+.
T Consensus 37 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 115 (348)
T 2pml_X 37 RTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY 115 (348)
T ss_dssp EEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS
T ss_pred EEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 5689999999999999 9999999999732211 17899999999999999999999999999
Q ss_pred CeeEEEEeeccCCCHHHH------HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCceecCCCCCCeecCCC
Q 042949 369 EEKLLVYKYQSNGSLLSL------LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQ-KSNEEKTIPHGNLKLSNILLNEN 441 (608)
Q Consensus 369 ~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivHrDlkp~NILl~~~ 441 (608)
+..++||||+++|+|.++ +.. .....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.+
T Consensus 116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-----i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 116 DEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-----ICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC-----EECCCCCGGGEEECTT
T ss_pred CeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC-----EeecCCChHhEEEcCC
Confidence 999999999999999988 432 124679999999999999999999998 66 9999999999999999
Q ss_pred CCceEeccccccccCCC-CccccccCccccCCC-----CCCc-chhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh
Q 042949 442 EDPLISECGYSKFLDPK-KTCLFSSNGYTAPEK-----TVSE-QGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE 514 (608)
Q Consensus 442 ~~~kl~DFGla~~~~~~-~~~~~gt~~y~aPE~-----~~~~-ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 514 (608)
+.+||+|||+++..... .....++..|+|||. .++. ++|||||||++|||++|+.||............+...
T Consensus 189 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~ 268 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268 (348)
T ss_dssp SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred CcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 99999999999876433 344578999999992 3344 8999999999999999999998665544444433322
Q ss_pred hccccc---------ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 515 EWTGEV---------FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 515 ~~~~~~---------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
...... ............+..+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111000 000001111345677899999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=316.21 Aligned_cols=242 Identities=19% Similarity=0.229 Sum_probs=184.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeee--------------cCCe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNS--------------TNEE 370 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~--------------~~~~ 370 (608)
+.+|+|+||.||+|... +|+.||||++.... ...+++.+|++++++++||||+++++++. ....
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (320)
T 2i6l_A 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS 96 (320)
T ss_dssp EECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSE
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCc
Confidence 56899999999999986 48999999987432 34567889999999999999999998873 3467
Q ss_pred eEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC-CCCCceEecc
Q 042949 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN-ENEDPLISEC 449 (608)
Q Consensus 371 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DF 449 (608)
.++||||++ |+|.+++. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++ +++.+||+||
T Consensus 97 ~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 97 VYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN-----VLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp EEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTTEEEECCC
T ss_pred eeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCeEEEccC
Confidence 899999997 69999885 356999999999999999999999987 99999999999997 5678999999
Q ss_pred ccccccCCC------CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc
Q 042949 450 GYSKFLDPK------KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG 518 (608)
Q Consensus 450 Gla~~~~~~------~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 518 (608)
|+++..... .....+|..|+||| ..++.++|||||||++|||+||+.||....... ............
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~ 244 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILESIPVV 244 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHSCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCC
Confidence 999876432 13345788999999 467899999999999999999999997654322 222222110000
Q ss_pred ---------ccccH-----------HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 519 ---------EVFDK-----------EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 519 ---------~~~~~-----------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..... .........+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000 0011123456779999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.69 Aligned_cols=238 Identities=23% Similarity=0.278 Sum_probs=195.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|++|.||+++.. +++.||||++... ....+.+.+|++++++++||||+++++++...+..++|+||+++++
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 107 (287)
T 2wei_A 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107 (287)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCC
Confidence 56899999999999986 7899999998643 2356789999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC---CCceEeccccccccCCCC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN---EDPLISECGYSKFLDPKK 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~ 459 (608)
|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.+ ..+||+|||+++......
T Consensus 108 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 108 LFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN-----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9998875 346999999999999999999999987 9999999999999764 469999999998765432
Q ss_pred --ccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 --TCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 --~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....++..|+||| ..++.++||||||+++|||++|+.||..... ................ ......+.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~ 251 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYAFDL------PQWRTISD 251 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCCCCS------GGGTTSCH
T ss_pred ccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCc------hhhhhcCH
Confidence 3345788999999 5688999999999999999999999875432 2222222221111000 11234456
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+.+++.+||..||++|||+.|+++.
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcC
Confidence 78999999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.86 Aligned_cols=243 Identities=19% Similarity=0.239 Sum_probs=189.7
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.+.+|+|+||.||+|+..+ .+|+|+++... ...+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 3679999999999998854 49999987432 234567889999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC-----
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP----- 457 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~----- 457 (608)
|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++ ++.+||+|||+++....
T Consensus 116 L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 116 LYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG-----ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp HHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 9999863 2446999999999999999999999987 99999999999998 67999999999876532
Q ss_pred ---CCccccccCccccCC--C-----------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 458 ---KKTCLFSSNGYTAPE--K-----------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 458 ---~~~~~~gt~~y~aPE--~-----------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
......||..|+||| . .++.++|||||||++|||++|+.||..... .......... ......
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~-~~~~~~ 264 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-EAIIWQMGTG-MKPNLS 264 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-HHHHHHHHTT-CCCCCC
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhccC-CCCCCC
Confidence 112345889999999 1 257899999999999999999999865432 2222222221 111110
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
....+..+.+++.+||..||++|||+.++++.|+++.+..
T Consensus 265 -------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 265 -------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1123455889999999999999999999999999987653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=315.96 Aligned_cols=245 Identities=19% Similarity=0.290 Sum_probs=190.4
Q ss_pred cccCCCCCceEEEEEE--cCCcEEEEEEecccc---cCHHHHHHHHHHHhcC---CCCcceeeeeeee-----cCCeeEE
Q 042949 307 DLRSQTICSSLFMVRL--KNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNL---KHPNILPLVCYNS-----TNEEKLL 373 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~--~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l---~H~niv~l~~~~~-----~~~~~~l 373 (608)
+.+|+|+||.||+++. .+|+.||+|+++... .....+.+|+.+++++ +||||+++++++. .....++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 96 (326)
T 1blx_A 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96 (326)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred eeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEE
Confidence 5689999999999998 468899999987322 1233566777776655 8999999999987 5567899
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
||||+. |+|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 97 v~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~g-----i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 97 VFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEECCS-CBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEecCC-CCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 999997 799999976 23345999999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh-------hccccc
Q 042949 454 FLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE-------EWTGEV 520 (608)
Q Consensus 454 ~~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~ 520 (608)
...... ....+|..|+||| ..++.++|||||||++|||++|+.||......... ..+... .+....
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~ 247 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDWPRDV 247 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCGGGSCTTC
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHcCCCCcccCcccc
Confidence 765332 3456899999999 56789999999999999999999998765443222 222211 010000
Q ss_pred c----------cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 521 F----------DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 521 ~----------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. ...........+..+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000111223456778999999999999999999999853
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.91 Aligned_cols=242 Identities=17% Similarity=0.200 Sum_probs=190.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecC-----CeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTN-----EEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~ 378 (608)
..+|+|+||.||+|+.. +|+.||||+++... .....+.+|++++++++||||+++++++... ...++||||+
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 96 (353)
T 2b9h_A 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM 96 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCC
T ss_pred eEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEecc
Confidence 56899999999999975 68999999997432 2345678999999999999999999987654 6789999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
. |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 97 Q-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp S-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred C-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 6 699998874 46999999999999999999999987 999999999999999999999999999876532
Q ss_pred C-------------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc----
Q 042949 459 K-------------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW---- 516 (608)
Q Consensus 459 ~-------------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---- 516 (608)
. ....||..|+||| ..++.++|||||||++|||++|+.||......... ..+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~ 244 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL-LLIFGIIGTPHS 244 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCS
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCch
Confidence 1 1246789999999 45788999999999999999999998765432221 11111000
Q ss_pred ---ccccccH---------------HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 517 ---TGEVFDK---------------EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 517 ---~~~~~~~---------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
....... .........+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0111123456778999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.61 Aligned_cols=191 Identities=23% Similarity=0.235 Sum_probs=163.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCC-CC-----cceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HP-----NILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.||+|+||.||+|... +++.||||+++......+++.+|++++..++ |+ +|+++++++...+..++||||+.
T Consensus 60 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 139 (382)
T 2vx3_A 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS 139 (382)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC
Confidence 56899999999999875 6889999999865444567788888888775 55 49999999999999999999995
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC--CCCCceEeccccccccCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN--ENEDPLISECGYSKFLDP 457 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~ 457 (608)
|+|.+++... ....+++..+..++.|++.||+|||.+. .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 140 -~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 140 -YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPE---LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp -CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTT---TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred -CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCC---CCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 6999999862 2356999999999999999999999632 3499999999999995 477899999999998876
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC
Q 042949 458 KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID 503 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~ 503 (608)
......||+.|+||| ..++.++|||||||++|||+||+.||.....
T Consensus 214 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 666778999999999 5689999999999999999999999976543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.74 Aligned_cols=235 Identities=20% Similarity=0.267 Sum_probs=188.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc-----ccCHHHHHHHHHHHhcCCCCcceeeeeeee--cCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL-----QVSMDEFSQTMRQIGNLKHPNILPLVCYNS--TNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||++... +++.||+|+++.. ....+.+.+|++++++++||||+++++++. ..+..++||||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (305)
T 2wtk_C 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC 90 (305)
T ss_dssp CEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECC
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhc
Confidence 56899999999999874 6899999999743 223567899999999999999999999984 456789999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
+++ |.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~-----i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 91 VCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG-----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp SEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred cCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 876 87877652 3457999999999999999999999987 999999999999999999999999999876432
Q ss_pred C-----ccccccCccccCC--C----CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 459 K-----TCLFSSNGYTAPE--K----TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 459 ~-----~~~~gt~~y~aPE--~----~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
. ....||..|+||| . ..+.++||||||+++|||++|+.||.... ............. .
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~i~~~~~----------~ 231 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSY----------A 231 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHCCC----------C
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-HHHHHHHHhcCCC----------C
Confidence 1 2346899999999 1 23678999999999999999999987542 2222222222111 0
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 122345668899999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=343.30 Aligned_cols=242 Identities=17% Similarity=0.263 Sum_probs=195.9
Q ss_pred cccCCCCCceEEEEEEcC----CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKN----SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.+|+|+||.||+|.... +..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 396 ~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~ 474 (656)
T 2j0j_A 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTL 474 (656)
T ss_dssp EEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred eEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCC
Confidence 569999999999998742 4689999987432 23467899999999999999999999985 4568999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 475 g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 475 GELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp CBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 999999975 2456999999999999999999999987 9999999999999999999999999998765432
Q ss_pred ---ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 460 ---TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 460 ---~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....+|..|+||| ..++.++|||||||++|||++ |..||.... .......+...... ..+..
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-~~~~~~~i~~~~~~---------~~~~~ 616 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERL---------PMPPN 616 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHHTCCC---------CCCTT
T ss_pred eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCC---------CCCcc
Confidence 2234677899999 678999999999999999997 888886543 22222222221110 11234
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 566788999999999999999999999999998753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=319.50 Aligned_cols=241 Identities=21% Similarity=0.249 Sum_probs=187.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCe------eEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEE------KLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~lv~e 376 (608)
..+|+|+||.||+|... +|+.||||++...... .+.+.+|+.++++++||||+++++++...+. .++|||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 109 (353)
T 3coi_A 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 109 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEec
Confidence 56899999999999875 6899999999753322 4568899999999999999999999987654 499999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+. |+|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 110 ~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 110 FMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG-----VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 996 68877653 35999999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh------cccccccHH-
Q 042949 457 PKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE------WTGEVFDKE- 524 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~- 524 (608)
.......+|..|+||| ..++.++|||||||++|||++|+.||....... ....+.... +.....+..
T Consensus 178 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 6656677899999999 357889999999999999999999997654322 222221110 000111110
Q ss_pred --------------HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 525 --------------VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 525 --------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
........+..+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001112456779999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=313.64 Aligned_cols=236 Identities=22% Similarity=0.285 Sum_probs=189.4
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccccc---CHHHHHHHHHHHhcCC--CCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLK--HPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
..+|+|+||.||++...+++.||||++..... ..+.+.+|++++.+++ ||||+++++++...+..++||| +.++
T Consensus 34 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~ 112 (313)
T 3cek_A 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 112 (313)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred EEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCC
Confidence 56899999999999998899999999974332 3467889999999997 5999999999999999999999 5689
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++ +.+||+|||+++......
T Consensus 113 ~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 113 DLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 99999986 457999999999999999999999987 999999999999964 889999999998765432
Q ss_pred ---ccccccCccccCC---C------------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 460 ---TCLFSSNGYTAPE---K------------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 460 ---~~~~gt~~y~aPE---~------------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
....||..|+||| . .++.++|||||||++|||++|+.||.....................
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 260 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-- 260 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC--
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC--
Confidence 2346899999999 2 4678999999999999999999999765544333333322211111
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERI 561 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 561 (608)
.....+..+.+++.+||+.||++|||+.|+++.-
T Consensus 261 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 261 ------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------CcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1122345688999999999999999999998763
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=323.34 Aligned_cols=246 Identities=17% Similarity=0.263 Sum_probs=190.9
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCC-----------CCcceeeeeeeecCC----e
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-----------HPNILPLVCYNSTNE----E 370 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~~~----~ 370 (608)
+.+|+|+||.||+|+. .+++.||||+++......+.+.+|++++.+++ ||||+++++++...+ .
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 104 (373)
T 1q8y_A 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH 104 (373)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEE
T ss_pred EeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCce
Confidence 5689999999999987 47899999999865555677889999998876 899999999987643 7
Q ss_pred eEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCceecCCCCCCeecC------CCCC
Q 042949 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQK-SNEEKTIPHGNLKLSNILLN------ENED 443 (608)
Q Consensus 371 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivHrDlkp~NILl~------~~~~ 443 (608)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++ ..+.
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~-----ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 105 VVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG-----IIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECSCCSGGGEEEEEEETTTTEEE
T ss_pred EEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC-----EEecCCChHHeEEeccCCCcCcce
Confidence 89999999 89999999863 235599999999999999999999997 6 99999999999994 4447
Q ss_pred ceEeccccccccCCCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC-----hHHHHHHHHhh
Q 042949 444 PLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID-----LPKWVKAMVRE 514 (608)
Q Consensus 444 ~kl~DFGla~~~~~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~-----~~~~~~~~~~~ 514 (608)
+||+|||+++..........||..|+||| ..++.++|||||||++|||+||+.||..... .......+...
T Consensus 177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (373)
T 1q8y_A 177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256 (373)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred EEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh
Confidence 99999999998776666678999999999 5689999999999999999999999864321 11111111110
Q ss_pred h-ccc---------------------cc-----c--cHHHH---HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 515 E-WTG---------------------EV-----F--DKEVA---KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 515 ~-~~~---------------------~~-----~--~~~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
. ... .+ . ..... ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 0 000 00 0 00000 0123445678899999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=319.39 Aligned_cols=245 Identities=18% Similarity=0.240 Sum_probs=192.6
Q ss_pred cccCCCCCceEEEEEEc-CC-cEEEEEEecccccCHHHHHHHHHHHhcCCCCc------ceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NS-AVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPN------ILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.+|+|+||.||++... ++ +.||+|+++......+.+.+|++++++++|++ ++.+++++...+..++||||+
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 104 (355)
T 2eu9_A 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL 104 (355)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC
T ss_pred EEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc
Confidence 56899999999999875 44 78999999865555677889999999887665 899999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec-------------------C
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL-------------------N 439 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl-------------------~ 439 (608)
+++|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +
T Consensus 105 -~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 105 -GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHENQ-----LTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp -CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred -CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEeccccccccccccccccccc
Confidence 7788888765 23356999999999999999999999887 9999999999999 5
Q ss_pred CCCCceEeccccccccCCCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh
Q 042949 440 ENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE 515 (608)
Q Consensus 440 ~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 515 (608)
.++.+||+|||+++..........||..|+||| ..++.++|||||||++|||++|+.||.......... .+....
T Consensus 177 ~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~ 255 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV-MMEKIL 255 (355)
T ss_dssp SCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHH
T ss_pred CCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHc
Confidence 678999999999998776666778999999999 568899999999999999999999997654322111 111100
Q ss_pred -ccc----------c-------cc-----cHH-HH----------HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 516 -WTG----------E-------VF-----DKE-VA----------KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 516 -~~~----------~-------~~-----~~~-~~----------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
... . .. +.. .. ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0 00 000 00 0011234568899999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=319.81 Aligned_cols=240 Identities=15% Similarity=0.217 Sum_probs=168.5
Q ss_pred hhcccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeec----CCeeEEEEeecc
Q 042949 305 TADLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNST----NEEKLLVYKYQS 379 (608)
Q Consensus 305 ~~~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~ 379 (608)
.+.++|+|+||.||++... +|+.||||++.... ....+....+..++||||+++++++.. ....++||||++
T Consensus 33 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred cceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 3467999999999999986 68999999997532 222223334566789999999999875 445899999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC---CCCceEeccccccccC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE---NEDPLISECGYSKFLD 456 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 456 (608)
+|+|.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 110 gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-----ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 110 GGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSHN-----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp TEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999975 22357999999999999999999999987 999999999999976 4559999999998765
Q ss_pred CCC-ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHH---HHHHHhhhcccccccHHHHHh
Q 042949 457 PKK-TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKW---VKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 457 ~~~-~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 528 (608)
... ....+|+.|+||| ..++.++|||||||++|||++|+.||......... ......... . . ....
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~-~---~~~~ 256 (336)
T 3fhr_A 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY--G-F---PNPE 256 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------C-C---CTTT
T ss_pred ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc--c-c---Cchh
Confidence 432 4456899999999 34677899999999999999999998643321100 000000000 0 0 0011
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
....+..+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 13456678999999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.48 Aligned_cols=240 Identities=21% Similarity=0.269 Sum_probs=179.5
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
.+.+|+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.+.+..++||||+. |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 3678999999998877788999999998743 245678999999876 89999999999999999999999995 7999
Q ss_pred HHHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-------------CCceEec
Q 042949 385 SLLEAYIEGKRD---FPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-------------EDPLISE 448 (608)
Q Consensus 385 ~~l~~~~~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-------------~~~kl~D 448 (608)
+++......... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 999752111111 133345789999999999999987 9999999999999754 4799999
Q ss_pred cccccccCCCC-------ccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHH
Q 042949 449 CGYSKFLDPKK-------TCLFSSNGYTAPE-----------KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVK 509 (608)
Q Consensus 449 FGla~~~~~~~-------~~~~gt~~y~aPE-----------~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~ 509 (608)
||+++...... ....||+.|+||| ..++.++|||||||++|||+| |+.||....... .
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~ 248 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---S 248 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---H
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---H
Confidence 99999775432 2346899999999 246889999999999999999 888886544322 1
Q ss_pred HHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 510 AMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
............. .......+..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~i~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NIIRGIFSLDEMK---CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHTCCCCCCCT---TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhcCCCCccccc---ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111100000 0011234566889999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=316.36 Aligned_cols=228 Identities=15% Similarity=0.236 Sum_probs=188.5
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccccc-------CHHHHHHHHHHHhcCC--CCcceeeeeeeecCCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV-------SMDEFSQTMRQIGNLK--HPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e 376 (608)
+.+|+|+||.||+|.. .+++.||||+++.... ..+.+.+|+.++++++ ||||+++++++...+..++|+|
T Consensus 49 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e 128 (320)
T 3a99_A 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128 (320)
T ss_dssp EECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEE
Confidence 5789999999999986 4789999999974322 2245778999999996 5999999999999999999999
Q ss_pred eccC-CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC-CCCCceEeccccccc
Q 042949 377 YQSN-GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN-ENEDPLISECGYSKF 454 (608)
Q Consensus 377 ~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 454 (608)
|+.+ ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+++.
T Consensus 129 ~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 129 RPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG-----VLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp CCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred cCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 9976 899999976 356999999999999999999999987 99999999999999 788999999999987
Q ss_pred cCCCC-ccccccCccccCC----C-CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 455 LDPKK-TCLFSSNGYTAPE----K-TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 455 ~~~~~-~~~~gt~~y~aPE----~-~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
..... ....||..|+||| . ..+.++|||||||++|||++|+.||.... ....... ..
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~----------~~ 262 (320)
T 3a99_A 200 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV----------FF 262 (320)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC----------CC
T ss_pred cccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhcccc----------cc
Confidence 75443 3456899999999 3 34788999999999999999999986421 1111100 01
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
....+..+.+++.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12345668899999999999999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.61 Aligned_cols=243 Identities=19% Similarity=0.241 Sum_probs=174.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHH-HHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV--SMDEFSQTMR-QIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
..+|+|+||.||++... +|+.||||+++.... ...++..|+. +++.++||||+++++++...+..++||||++ |+
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 106 (327)
T 3aln_A 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TS 106 (327)
T ss_dssp CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred heeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CC
Confidence 56899999999999985 789999999975322 2345556666 6777899999999999999999999999997 58
Q ss_pred HHHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 383 LLSLLEAYI-EGKRDFPWKLRLSIATGIAKGLDFMYQK-SNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 383 L~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|.+++.... .....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++......
T Consensus 107 l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 107 FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-----IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp HHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS-----CCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred hHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC-----EeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 888876432 2356799999999999999999999997 6 9999999999999999999999999998765432
Q ss_pred -ccccccCccccCCC--------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 460 -TCLFSSNGYTAPEK--------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 460 -~~~~gt~~y~aPE~--------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
....||..|+|||. .++.++|||||||++|||++|+.||................. .... . .....
T Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~-~---~~~~~ 256 (327)
T 3aln_A 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD-PPQL-S---NSEER 256 (327)
T ss_dssp ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC-CCCC-C---CCSSC
T ss_pred cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC-CCCC-C---Ccccc
Confidence 33468999999993 267899999999999999999999865332111111000000 0000 0 00112
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+..+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 257 EFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 356678999999999999999999999774
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=307.02 Aligned_cols=238 Identities=21% Similarity=0.275 Sum_probs=175.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||.||+|+.. +|+.||||++...... .+.+.++..+++.++||||+++++++...+..++||||+ ++.
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 109 (318)
T 2dyl_A 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTC 109 (318)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEE
T ss_pred ceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCc
Confidence 56899999999999985 7899999999753322 223344455678889999999999999999999999999 556
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQK-SNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+..+.... ...+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++......
T Consensus 110 ~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 110 AEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG-----VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp HHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred HHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCC-----EEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence 65555431 45699999999999999999999985 6 9999999999999999999999999998664432
Q ss_pred ccccccCccccCCC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 460 TCLFSSNGYTAPEK---------TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 460 ~~~~gt~~y~aPE~---------~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
....+|..|+|||. .++.++|||||||++|||++|+.||................... . . ....
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~-~-----~~~~ 254 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP-L-L-----PGHM 254 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC-C-C-----CSSS
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC-C-C-----CccC
Confidence 34568999999991 36779999999999999999999997655544444333332111 0 0 0112
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+..+.+++.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 345668899999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=302.64 Aligned_cols=227 Identities=14% Similarity=0.105 Sum_probs=179.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC----HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS----MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.+|+|+||.||+|+.. +|+.||||+++..... .+.+.+|++.+.+++||||+++++++...+..++||||++++
T Consensus 37 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 116 (286)
T 3uqc_A 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGG 116 (286)
T ss_dssp EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEE
T ss_pred EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCC
Confidence 57899999999999986 4899999999854332 367899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.++++. . ....++.+++.|++.||+|||+++ |+||||||+|||++.++.+||+++|
T Consensus 117 ~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g-----ivH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 117 SLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG-----VALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred CHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC-----CccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999852 2 355678899999999999999987 9999999999999999999998543
Q ss_pred ccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHH
Q 042949 462 LFSSNGYTAPEKTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVAL 541 (608)
Q Consensus 462 ~~gt~~y~aPE~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 541 (608)
|++| ++.++|||||||++|||+||+.||........... . ........ ..........+..+.+++.
T Consensus 175 ------~~~~---~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-~-~~~~~~~~--~~~~~~~~~~~~~l~~li~ 241 (286)
T 3uqc_A 175 ------TMPD---ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-A-ERDTAGQP--IEPADIDRDIPFQISAVAA 241 (286)
T ss_dssp ------CCTT---CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-C-CBCTTSCB--CCHHHHCTTSCHHHHHHHH
T ss_pred ------ccCC---CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-H-HHHhccCC--CChhhcccCCCHHHHHHHH
Confidence 4444 68999999999999999999999875432100000 0 00000000 0111223456677899999
Q ss_pred HchhcCCCCCCCHHHHHHHHHHhhcCCC
Q 042949 542 KCVSNSPDDRPTMAEVLERIEEVVNGND 569 (608)
Q Consensus 542 ~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 569 (608)
+||+.||++| |+.|+++.|+++.....
T Consensus 242 ~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 242 RSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 9999999999 99999999999986544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.81 Aligned_cols=235 Identities=17% Similarity=0.252 Sum_probs=178.3
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
.+.+|+|+||+||.....+|+.||||++.... ...+.+|+++++++ +|||||++++++.+.+..++||||+. |+|.
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~ 105 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence 36799999999776667789999999997432 22356899999999 79999999999999999999999995 6999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-----CCCceEeccccccccCCC-
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-----NEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~~~- 458 (608)
+++.. ....+.+..++.++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 106 ~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 106 EYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSLN-----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp HHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHTT-----CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred HHHHh---cCCCccchhHHHHHHHHHHHHHHHHHCc-----CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 99874 2334555667899999999999999987 999999999999953 345789999999876532
Q ss_pred -----CccccccCccccCCC-------CCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHH
Q 042949 459 -----KTCLFSSNGYTAPEK-------TVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 459 -----~~~~~gt~~y~aPE~-------~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (608)
.....||+.|+|||. .++.++|||||||++|||+| |..||...... ......... ......
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--~~~~~~~~~-~~~~~~--- 251 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--QANILLGAC-SLDCLH--- 251 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--HHHHHTTCC-CCTTSC---
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--HHHHHhccC-CccccC---
Confidence 234568999999992 34668999999999999999 88887543321 111111111 011110
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
........+.+++.+||+.||++|||+.||++
T Consensus 252 --~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 252 --PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11123344789999999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=313.03 Aligned_cols=229 Identities=16% Similarity=0.254 Sum_probs=183.1
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEeccccc-------CHHHHHHHHHHHhcC----CCCcceeeeeeeecCCeeEE
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV-------SMDEFSQTMRQIGNL----KHPNILPLVCYNSTNEEKLL 373 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l----~H~niv~l~~~~~~~~~~~l 373 (608)
.+.+|+|+||.||+|+. .+++.||||+++.... ....+.+|+.++.++ +||||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 35789999999999986 4789999999974322 123356788888888 89999999999999999999
Q ss_pred EEee-ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC-CCCCceEecccc
Q 042949 374 VYKY-QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN-ENEDPLISECGY 451 (608)
Q Consensus 374 v~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGl 451 (608)
|+|| +.+++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++ .++.+||+|||+
T Consensus 116 v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG-----VVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp EEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT-----EECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999 789999999976 346999999999999999999999987 99999999999999 789999999999
Q ss_pred ccccCCCC-ccccccCccccCC----CC-CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHH
Q 042949 452 SKFLDPKK-TCLFSSNGYTAPE----KT-VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 452 a~~~~~~~-~~~~gt~~y~aPE----~~-~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (608)
++...... ....|+..|+||| .. .+.++|||||||++|||++|+.||.... .......
T Consensus 187 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~--------- 250 (312)
T 2iwi_A 187 GALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEAEL--------- 250 (312)
T ss_dssp CEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHTCC---------
T ss_pred hhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhhcc---------
Confidence 98765443 4456899999999 33 3558999999999999999999986421 1111100
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
......+..+.+++.+||+.||++|||+.|+++.
T Consensus 251 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 -HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0122345668899999999999999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=298.82 Aligned_cols=223 Identities=17% Similarity=0.227 Sum_probs=176.4
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHH-hcCCCCcceeeeeeeec----CCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQI-GNLKHPNILPLVCYNST----NEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~~lv~e~~~ 379 (608)
.+++|+|+||.||++.. .+++.||+|+++. ...+.+|++++ +..+||||+++++++.. ....++||||++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 35789999999999987 4789999999974 34677888887 56689999999999876 667899999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC---CCCceEeccccccccC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE---NEDPLISECGYSKFLD 456 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 456 (608)
+|+|.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 99 ~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 99 GGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp SCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred CCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999986 23356999999999999999999999987 999999999999998 7889999999997643
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccH---HHHHhchhcH
Q 042949 457 PKKTCLFSSNGYTAPEKTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK---EVAKAGRQWA 533 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 533 (608)
. ..++.++|||||||++|||+||+.||........ .......+... .........+
T Consensus 172 ~---------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 230 (299)
T 3m2w_A 172 G---------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------SPGMKTRIRMGQYEFPNPEWSEVS 230 (299)
T ss_dssp T---------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCSCCSSCTTCCSSCHHHHTTSC
T ss_pred c---------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------hHHHHHHHhhccccCCchhcccCC
Confidence 2 2367899999999999999999999865322110 00000000000 0011123456
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 231 EEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 779999999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=330.42 Aligned_cols=256 Identities=18% Similarity=0.212 Sum_probs=194.8
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeec------CCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNST------NEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~~lv~e 376 (608)
.+.+|+|+||.||++.. .+|+.||||+++... ...+.+.+|++++++++||||+++++++.. .+..++|||
T Consensus 19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmE 98 (676)
T 3qa8_A 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98 (676)
T ss_dssp CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEE
Confidence 35789999999999987 468999999987432 234668899999999999999999998765 667899999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC---ceEecccccc
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED---PLISECGYSK 453 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~ 453 (608)
|+++|+|.+++... .....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++
T Consensus 99 y~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs~g-----IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 99 YCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHENR-----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHHTT-----BCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred eCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 99999999999752 12236899999999999999999999987 999999999999997765 8999999999
Q ss_pred ccCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh----cccccccH
Q 042949 454 FLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE----WTGEVFDK 523 (608)
Q Consensus 454 ~~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 523 (608)
...... ....||..|+||| ..++.++|||||||++|||++|+.||........|........ ........
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g 252 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence 765433 3457899999999 5678899999999999999999999876543333221110000 00000000
Q ss_pred ------H---HHHhchhcHHHHHHHHHHchhcCCCCCCCHHH-----HHHHHHHhhcC
Q 042949 524 ------E---VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAE-----VLERIEEVVNG 567 (608)
Q Consensus 524 ------~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e-----vl~~L~~~~~~ 567 (608)
. ........+..+.+++.+||..||++|||+.| ..+.++++.+.
T Consensus 253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 0 00112235677999999999999999999988 55677777653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=332.69 Aligned_cols=229 Identities=15% Similarity=0.198 Sum_probs=183.7
Q ss_pred cccCCCCCceEEEEEEc--CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCe-----eEEEEee
Q 042949 307 DLRSQTICSSLFMVRLK--NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEE-----KLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----~~lv~e~ 377 (608)
..+|+|+||.||++... +|+.||||++.... ...+.+.+|++++.+++||||+++++++...+. .++||||
T Consensus 86 ~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~ 165 (681)
T 2pzi_A 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165 (681)
T ss_dssp EEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEEC
T ss_pred EEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEe
Confidence 56899999999999985 68999999986432 234568899999999999999999999987655 6999999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+++++|.+++. ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ .+||+|||+++....
T Consensus 166 ~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g-----iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 166 VGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG-----LVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp CCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred CCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 99999988764 26999999999999999999999987 9999999999999885 899999999987755
Q ss_pred CCccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 458 KKTCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
. ....||++|+||| ...+.++|||||||++|||++|.+|+..... ....... .......
T Consensus 234 ~-~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~--------------~~~~~~~---~~~~~~~ 295 (681)
T 2pzi_A 234 F-GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV--------------DGLPEDD---PVLKTYD 295 (681)
T ss_dssp C-SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC--------------SSCCTTC---HHHHHCH
T ss_pred C-CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc--------------ccccccc---cccccCH
Confidence 4 4567999999999 4458899999999999999999887653110 0000000 0011234
Q ss_pred HHHHHHHHchhcCCCCCC-CHHHHHHHHHHhh
Q 042949 535 PLLNVALKCVSNSPDDRP-TMAEVLERIEEVV 565 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~~ 565 (608)
.+.+++.+||+.||++|| +++++...|..+.
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 578999999999999999 5677777777664
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.02 Aligned_cols=231 Identities=11% Similarity=0.132 Sum_probs=174.2
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHhcCCC-Ccceeee---------ee-------
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKH-PNILPLV---------CY------- 364 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H-~niv~l~---------~~------- 364 (608)
++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++..++| +|..... ..
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence 5799999999999996 478999999997322 235779999999999987 3322111 11
Q ss_pred -----eec-----CCeeEEEEeeccCCCHHHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCC
Q 042949 365 -----NST-----NEEKLLVYKYQSNGSLLSLLEAYI---EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431 (608)
Q Consensus 365 -----~~~-----~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDl 431 (608)
+.. ....+++|+++ +++|.++++... .....+++..++.++.||++||+|||+++ |+||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----iiHrDi 237 (413)
T 3dzo_A 164 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYL 237 (413)
T ss_dssp -------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-----EECSCC
T ss_pred ccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCc
Confidence 111 12356677665 789999886431 22445788899999999999999999987 999999
Q ss_pred CCCCeecCCCCCceEeccccccccCCCCccccccCccccCCCC--------------CCcchhHHHHHHHHHHHHcCCCC
Q 042949 432 KLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKT--------------VSEQGDVFSFGVILLELLTGKTV 497 (608)
Q Consensus 432 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~~--------------~~~ksDVwSfGvvl~elltg~~p 497 (608)
||+|||++.++.+||+|||+++..........| ..|+|||.. ++.++|||||||++|||+||+.|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999877665555677 999999932 45699999999999999999999
Q ss_pred CcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 498 EKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
|...... +.... ........+..+.+++.+||+.||++|||+.|+++
T Consensus 317 f~~~~~~--------------~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 317 NTDDAAL--------------GGSEW-IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCTTGGG--------------SCSGG-GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcchh--------------hhHHH-HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 8653211 00000 01112245567899999999999999999777643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=301.93 Aligned_cols=232 Identities=12% Similarity=0.080 Sum_probs=172.8
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccc---------cCHHHHHHHHHHHhcCC---------CCcceeeee----
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ---------VSMDEFSQTMRQIGNLK---------HPNILPLVC---- 363 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~---------~~~~~~~~e~~~l~~l~---------H~niv~l~~---- 363 (608)
.+.||+|+||.||+|+. +|+.||||+++... ...+.+.+|++++++++ |||||++.+
T Consensus 25 ~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~ 103 (336)
T 2vuw_A 25 CEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCV 103 (336)
T ss_dssp CEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEE
T ss_pred eeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEe
Confidence 46799999999999988 78999999997432 23477889999988886 555555544
Q ss_pred -------------eeec-------------CCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 042949 364 -------------YNST-------------NEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMY 417 (608)
Q Consensus 364 -------------~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH 417 (608)
++.+ .+..++||||+++|++.+.+. ...+++..++.++.||+.||+|||
T Consensus 104 ~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 104 QGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp ESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH
Confidence 4443 678999999999997666553 256899999999999999999999
Q ss_pred -cCCCCCCCceecCCCCCCeecCCCC--------------------CceEeccccccccCCCCccccccCccccCC---C
Q 042949 418 -QKSNEEKTIPHGNLKLSNILLNENE--------------------DPLISECGYSKFLDPKKTCLFSSNGYTAPE---K 473 (608)
Q Consensus 418 -~~~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~gt~~y~aPE---~ 473 (608)
+.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+||| .
T Consensus 179 ~~~~-----ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 179 ASLR-----FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHC-----CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGCC
T ss_pred HhCC-----EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhcC
Confidence 776 99999999999999887 8999999999976543 457999999999 3
Q ss_pred CCCcchhHHHHHHH-HHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCC
Q 042949 474 TVSEQGDVFSFGVI-LLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRP 552 (608)
Q Consensus 474 ~~~~ksDVwSfGvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 552 (608)
..+.++||||++++ .+++++|..||......................... ......+..+.+|+.+||+.|
T Consensus 252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNT---PAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCS---HHHHHHHHHHHHHHHHGGGSS-----
T ss_pred CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccch---hhhhhcCHHHHHHHHHHhccC-----
Confidence 44889999998777 788899988874310000011111111111111111 112345667899999999976
Q ss_pred CHHHHH
Q 042949 553 TMAEVL 558 (608)
Q Consensus 553 s~~evl 558 (608)
|+.|++
T Consensus 324 sa~e~l 329 (336)
T 2vuw_A 324 SATDLL 329 (336)
T ss_dssp SHHHHH
T ss_pred CHHHHH
Confidence 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=280.52 Aligned_cols=176 Identities=13% Similarity=0.034 Sum_probs=127.7
Q ss_pred cCCCCCceEEEEE-EcCCcEEEEEEecccc-----------cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEE
Q 042949 309 RSQTICSSLFMVR-LKNSAVYAVKRLKKLQ-----------VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVY 375 (608)
Q Consensus 309 ~g~g~~g~vy~~~-~~~g~~vavK~l~~~~-----------~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 375 (608)
.+.|..|.+..++ ...|+.+|||.+.+.. ...++|.+|+++|+++ .|+||+++++++++.+..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 3456666666544 4578999999996431 1245799999999999 6999999999999999999999
Q ss_pred eeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccccc
Q 042949 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFL 455 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 455 (608)
||++||+|.++|.. ...++.. +|+.||+.||+|+|+++ ||||||||+|||+++++.+||+|||+|+..
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G-----IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG-----FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT-----CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC-----ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 99999999999975 4567664 48899999999999988 999999999999999999999999999977
Q ss_pred CCC---CccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCC
Q 042949 456 DPK---KTCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKT 496 (608)
Q Consensus 456 ~~~---~~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~ 496 (608)
... ....+||++||||| ..+..++|+||+|++++++.++..
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHH
T ss_pred CCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccc
Confidence 543 24567999999999 556778999999999888776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-25 Score=247.55 Aligned_cols=173 Identities=14% Similarity=0.132 Sum_probs=138.9
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEeccccc---------CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---------SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 376 (608)
.+.+|+|+||.||++ ...+..+|+|+...... ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRD-SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEE-ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEE-EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 568999999999999 44678899998653211 13457899999999999999977767667778899999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+++|+|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. .+||+|||+++...
T Consensus 420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g-----IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND-----VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT-----EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc-----CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999998852 5689999999999999987 999999999999998 99999999999876
Q ss_pred CCC----------ccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCC
Q 042949 457 PKK----------TCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVE 498 (608)
Q Consensus 457 ~~~----------~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~ 498 (608)
... ....||+.||||| ..|+..+|+||..+-.++.+.++.++
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 532 2457899999999 34677889999999888887766544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6e-22 Score=199.92 Aligned_cols=128 Identities=17% Similarity=0.168 Sum_probs=105.8
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccccc-------------------CHHHHHHHHHHHhcCCCCcceeeeeeeec
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV-------------------SMDEFSQTMRQIGNLKHPNILPLVCYNST 367 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~-------------------~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 367 (608)
+.+|+|+||.||+|...+|+.||||.++.... ....+.+|++++++++ | +++.+++..
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~ 172 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW 172 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence 57999999999999998899999999963221 2456889999999998 5 666665543
Q ss_pred CCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEe
Q 042949 368 NEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLIS 447 (608)
Q Consensus 368 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 447 (608)
+..++||||+++|+|.+ +. . .....++.|++.||+|||+.+ |+||||||+|||++ ++.+||+
T Consensus 173 -~~~~lvmE~~~g~~L~~-l~--------~--~~~~~i~~qi~~~l~~lH~~g-----iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 173 -EGNAVLMELIDAKELYR-VR--------V--ENPDEVLDMILEEVAKFYHRG-----IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp -ETTEEEEECCCCEEGGG-CC--------C--SCHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEEE-TTEEEEC
T ss_pred -cceEEEEEecCCCcHHH-cc--------h--hhHHHHHHHHHHHHHHHHHCC-----CEeCCCCHHHEEEE-CCcEEEE
Confidence 55699999999999887 32 1 234579999999999999987 99999999999999 9999999
Q ss_pred cccccccc
Q 042949 448 ECGYSKFL 455 (608)
Q Consensus 448 DFGla~~~ 455 (608)
|||+++..
T Consensus 235 DFG~a~~~ 242 (282)
T 1zar_A 235 DFPQSVEV 242 (282)
T ss_dssp CCTTCEET
T ss_pred ECCCCeEC
Confidence 99999743
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=178.51 Aligned_cols=138 Identities=25% Similarity=0.449 Sum_probs=122.3
Q ss_pred cChHHHHHHhHhcCCCccccccCCCCCCCCCCCCCCCCeeecCCC--CcEEEEEecCCCcee--ecChhhhcCCcCCcEE
Q 042949 31 LSESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHA--TNIVGIRLENMNLSG--IIDAETLCKLRHLRVV 106 (608)
Q Consensus 31 ~~~~~~l~~~~~~~~~~~~~~~~W~~~~~~~c~~~w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~~l~~l~~L~~L 106 (608)
..|+.||++||+++.....+ .+|+.+ .+||...|.||+|+... .+|+.|+|++|+++| .+| ..+.++++|++|
T Consensus 5 ~~~~~aL~~~k~~~~~~~~l-~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~-~~l~~l~~L~~L 81 (313)
T 1ogq_A 5 PQDKQALLQIKKDLGNPTTL-SSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP-SSLANLPYLNFL 81 (313)
T ss_dssp HHHHHHHHHHHHHTTCCGGG-TTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECC-GGGGGCTTCSEE
T ss_pred HHHHHHHHHHHHhcCCcccc-cCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccC-hhHhCCCCCCee
Confidence 46889999999999543444 589764 57895459999998543 689999999999999 887 579999999999
Q ss_pred Eccc-CcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHHH
Q 042949 107 SLAR-NLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171 (608)
Q Consensus 107 ~l~~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~~ 171 (608)
+|++ |.+.|.+|..++++++|++|+|++|+++|.+|..+..+++|++|+|++|.+++.+|..|..
T Consensus 82 ~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 147 (313)
T 1ogq_A 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhc
Confidence 9995 9999999999999999999999999999999999999999999999999999999988764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-18 Score=172.70 Aligned_cols=132 Identities=14% Similarity=0.158 Sum_probs=102.3
Q ss_pred cccCCCCCceEEEEEE-cCCcE--EEEEEecccccC-------------------------HHHHHHHHHHHhcCCCCcc
Q 042949 307 DLRSQTICSSLFMVRL-KNSAV--YAVKRLKKLQVS-------------------------MDEFSQTMRQIGNLKHPNI 358 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~--vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~H~ni 358 (608)
..+|+|+||.||+|.. .+|+. ||||+++..... ...+.+|++.+.+++|+++
T Consensus 53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 132 (258)
T 1zth_A 53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGV 132 (258)
T ss_dssp EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999998 78988 999987532111 1257899999999988864
Q ss_pred --eeeeeeeecCCeeEEEEeeccC-C----CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCCCceecC
Q 042949 359 --LPLVCYNSTNEEKLLVYKYQSN-G----SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMY-QKSNEEKTIPHGN 430 (608)
Q Consensus 359 --v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~~ivHrD 430 (608)
..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||+||| +.+ |+|||
T Consensus 133 ~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g-----ivHrD 196 (258)
T 1zth_A 133 SVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE-----LVHAD 196 (258)
T ss_dssp CCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC-----EECSS
T ss_pred CCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC-----EEeCC
Confidence 333332 356899999942 4 66665321 234567889999999999999 776 99999
Q ss_pred CCCCCeecCCCCCceEeccccccccC
Q 042949 431 LKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 431 lkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|||+|||++. .++|+|||+|....
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999988 99999999997653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-16 Score=183.52 Aligned_cols=131 Identities=17% Similarity=0.279 Sum_probs=115.2
Q ss_pred ChHHHHHHhHhcCCCccccccCCCCCC----CCC--CCCCC------------CCeeecCCCCcEEEEEecCCCceeecC
Q 042949 32 SESESFFKFISAVDSQNVLRIGWNGNL----PHP--CSYNL------------KGIKCNLHATNIVGIRLENMNLSGIID 93 (608)
Q Consensus 32 ~~~~~l~~~~~~~~~~~~~~~~W~~~~----~~~--c~~~w------------~gv~c~~~~~~v~~l~l~~~~l~g~~~ 93 (608)
.|+.||++||.+++.+ +|+.+. .+| | +| .||+|+. .++|+.|+|++++|+|.+|
T Consensus 269 ~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C--~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip 340 (876)
T 4ecn_A 269 KDYKALKAIWEALDGK-----NWRYYSGTINNTIHSL--NWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVP 340 (876)
T ss_dssp HHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCC--SCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEEC
T ss_pred HHHHHHHHHHHHcCCC-----CCCcCCCcccccCCcc--ccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCc
Confidence 5899999999998543 797654 467 6 67 9999985 4699999999999999998
Q ss_pred hhhhcCCcCCcEEEc-ccCcCCcc--------------------------------------------------------
Q 042949 94 AETLCKLRHLRVVSL-ARNLIQGR-------------------------------------------------------- 116 (608)
Q Consensus 94 ~~~l~~l~~L~~L~l-~~N~l~g~-------------------------------------------------------- 116 (608)
+.+++|+.|+.|+| ++|.++|.
T Consensus 341 -~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 341 -DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp -GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred -hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 57999999999999 88876665
Q ss_pred --------------------CcccccCCCCcceeeccCeeccc-----------------cCChhhc--CCCCCCEEeCc
Q 042949 117 --------------------IPTSISNCRRLTYLNLSSNLLSG-----------------AVPLALT--KLKHLKTLDIS 157 (608)
Q Consensus 117 --------------------~p~~~~~l~~L~~L~Ls~N~l~g-----------------~lP~~l~--~l~~L~~L~ls 157 (608)
||..+++|++|+.|+|++|+|+| .+|..++ .+++|++|+|+
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls 499 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred ccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence 88889999999999999999999 4999887 99999999999
Q ss_pred CCcCCccCChhHHH
Q 042949 158 NNHFAATSPDNFRQ 171 (608)
Q Consensus 158 ~N~l~g~~p~~~~~ 171 (608)
+|++.|.+|..|..
T Consensus 500 ~N~l~~~iP~~l~~ 513 (876)
T 4ecn_A 500 NCPNMTQLPDFLYD 513 (876)
T ss_dssp SCTTCCSCCGGGGG
T ss_pred CCCCCccChHHHhC
Confidence 99999999988764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=8.8e-17 Score=184.79 Aligned_cols=132 Identities=27% Similarity=0.459 Sum_probs=105.0
Q ss_pred cChHHHHHHhHhcCCCccccccCCCCCCCCCCCCCCCCeeecCCCCcEEEEEecCCCceee---cCh-------------
Q 042949 31 LSESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGI---IDA------------- 94 (608)
Q Consensus 31 ~~~~~~l~~~~~~~~~~~~~~~~W~~~~~~~c~~~w~gv~c~~~~~~v~~l~l~~~~l~g~---~~~------------- 94 (608)
.+|++||++||+++.++. .+.+|+.+ .+|| .|.||+|+ .++|+.|+|++++++|. +|+
T Consensus 11 ~~~~~all~~k~~~~~~~-~l~~W~~~-~~~C--~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~ 84 (768)
T 3rgz_A 11 YREIHQLISFKDVLPDKN-LLPDWSSN-KNPC--TFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFL 84 (768)
T ss_dssp HHHHHHHHHHHTTCSCTT-SSTTCCTT-SCGG--GSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEEC
T ss_pred HHHHHHHHHHHhhCCCcc-cccCCCCC-CCCc--CCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccCC
Confidence 478999999999984333 44699743 5788 68999998 46999999999999998 653
Q ss_pred ---------hhhcCCcCCcEEEcccCcCCccCcc--cccCCCCcceeeccCeeccccCChhh-cCCCCCCEEeCcCCcCC
Q 042949 95 ---------ETLCKLRHLRVVSLARNLIQGRIPT--SISNCRRLTYLNLSSNLLSGAVPLAL-TKLKHLKTLDISNNHFA 162 (608)
Q Consensus 95 ---------~~l~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~Ls~N~l~g~lP~~l-~~l~~L~~L~ls~N~l~ 162 (608)
..++++++|++|+|++|.++|.+|. .+++|++|++|||++|.++|.+|..+ ..+++|++|||++|+++
T Consensus 85 ~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~ 164 (768)
T 3rgz_A 85 SNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164 (768)
T ss_dssp TTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCE
T ss_pred cCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccC
Confidence 2466778888888888888888887 78888888888888888888777765 67788888888888888
Q ss_pred ccCChh
Q 042949 163 ATSPDN 168 (608)
Q Consensus 163 g~~p~~ 168 (608)
+.+|..
T Consensus 165 ~~~~~~ 170 (768)
T 3rgz_A 165 GANVVG 170 (768)
T ss_dssp EETHHH
T ss_pred CcCChh
Confidence 777765
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.62 E-value=5.4e-16 Score=174.36 Aligned_cols=134 Identities=18% Similarity=0.273 Sum_probs=114.4
Q ss_pred ChHHHHHHhHhcCCCccc--------cccCCCCCCCCCCCCCC---CCeeecCCCCcEEEEEecCCCceeecChhhhcCC
Q 042949 32 SESESFFKFISAVDSQNV--------LRIGWNGNLPHPCSYNL---KGIKCNLHATNIVGIRLENMNLSGIIDAETLCKL 100 (608)
Q Consensus 32 ~~~~~l~~~~~~~~~~~~--------~~~~W~~~~~~~c~~~w---~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~l~~l 100 (608)
.|.+||.+++.+++..+. ...+|+.+ .++| .| .||+|+.. ++|+.|+|++++++|.+| +.+++|
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c--~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp-~~l~~L 104 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELD--MWGAQPGVSLNSN-GRVTGLSLEGFGASGRVP-DAIGQL 104 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGG--GTTCCTTEEECTT-CCEEEEECTTSCCEEEEC-GGGGGC
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcc--cccCCCCeEEcCC-CCEEEEEecCcccCCcCC-hHHhcC
Confidence 588999999999854331 12369754 5778 57 99999754 799999999999999998 579999
Q ss_pred cCCcEEEcccCc--------------------------------------------------------------------
Q 042949 101 RHLRVVSLARNL-------------------------------------------------------------------- 112 (608)
Q Consensus 101 ~~L~~L~l~~N~-------------------------------------------------------------------- 112 (608)
++|++|+|++|.
T Consensus 105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~ 184 (636)
T 4eco_A 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184 (636)
T ss_dssp TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred ccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence 999999999884
Q ss_pred ----------CCccCcccccCCCCcceeeccCeecccc-----------------CChhhc--CCCCCCEEeCcCCcCCc
Q 042949 113 ----------IQGRIPTSISNCRRLTYLNLSSNLLSGA-----------------VPLALT--KLKHLKTLDISNNHFAA 163 (608)
Q Consensus 113 ----------l~g~~p~~~~~l~~L~~L~Ls~N~l~g~-----------------lP~~l~--~l~~L~~L~ls~N~l~g 163 (608)
++| ||..++++++|++|+|++|+|+|. +|..++ .+++|++|+|++|++.|
T Consensus 185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~ 263 (636)
T 4eco_A 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263 (636)
T ss_dssp TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS
T ss_pred hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc
Confidence 446 888999999999999999999996 999988 99999999999999999
Q ss_pred cCChhHHH
Q 042949 164 TSPDNFRQ 171 (608)
Q Consensus 164 ~~p~~~~~ 171 (608)
.+|..|.+
T Consensus 264 ~~p~~l~~ 271 (636)
T 4eco_A 264 KLPTFLKA 271 (636)
T ss_dssp SCCTTTTT
T ss_pred cChHHHhc
Confidence 99987764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-15 Score=158.82 Aligned_cols=132 Identities=12% Similarity=0.079 Sum_probs=91.6
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccccc---------------CHHHH--------HHHHHHHhcCCCCcceeeee
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV---------------SMDEF--------SQTMRQIGNLKHPNILPLVC 363 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~---------------~~~~~--------~~e~~~l~~l~H~niv~l~~ 363 (608)
..||+|++|.||+|...+|+.||||+++.... ..... .+|...|.++.+.++.-..-
T Consensus 101 ~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p 180 (397)
T 4gyi_A 101 SRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEP 180 (397)
T ss_dssp EEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCE
T ss_pred CEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCee
Confidence 46899999999999999999999998763210 11122 23445555553333221111
Q ss_pred eeecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC
Q 042949 364 YNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443 (608)
Q Consensus 364 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~ 443 (608)
+.. ...++||||+++++|.++.. . .....++.|++.+|.|||+.+ ||||||||.|||+++++.
T Consensus 181 ~~~--~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~g-----IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 181 IAQ--SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHG-----LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp EEE--ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEEEEEEC
T ss_pred eec--cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHHHEEEeCCCC
Confidence 111 12379999999888754321 1 234568899999999999987 999999999999988763
Q ss_pred ----------ceEecccccccc
Q 042949 444 ----------PLISECGYSKFL 455 (608)
Q Consensus 444 ----------~kl~DFGla~~~ 455 (608)
+.|+||+-+-..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 789999976543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.47 E-value=2e-14 Score=148.08 Aligned_cols=133 Identities=18% Similarity=0.289 Sum_probs=113.8
Q ss_pred cChHHHHHHhHhcC--CCccccccCCC---CCCCCCCCCCCCCeeec--------CCCCcEEEEEecCCCceeecChhhh
Q 042949 31 LSESESFFKFISAV--DSQNVLRIGWN---GNLPHPCSYNLKGIKCN--------LHATNIVGIRLENMNLSGIIDAETL 97 (608)
Q Consensus 31 ~~~~~~l~~~~~~~--~~~~~~~~~W~---~~~~~~c~~~w~gv~c~--------~~~~~v~~l~l~~~~l~g~~~~~~l 97 (608)
.++..||++||.++ ++.+.. .+|. ....+.| .|.|+.|. ....+|+.|+|++|+++ .+| ..+
T Consensus 26 ~~~~~aLl~~k~~~~~~~~~~~-~~w~~~~~~~~~~~--~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp-~~l 100 (328)
T 4fcg_A 26 RPYHDVLSQWQRHYNADRNRWH-SAWRQANSNNPQIE--TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFP-DQA 100 (328)
T ss_dssp CCHHHHHHHHHHHHHHCCTTHH-HHHHHHTTTCTTSC--CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCC-SCG
T ss_pred chHHHHHHHHHHhccCCchhhh-hhhccccccccccc--ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcC-hhh
Confidence 47899999999977 444444 4784 2335677 68999995 23468999999999998 676 468
Q ss_pred cCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 98 CKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 98 ~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..+..+++|++|+|++|++.+.+|..+.
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~ 171 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA 171 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSE
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHh
Confidence 89999999999999999 89999999999999999999999 8999999999999999999999999998763
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.37 E-value=6.3e-13 Score=125.71 Aligned_cols=111 Identities=22% Similarity=0.358 Sum_probs=95.6
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
..|.+.|..|.|..+ ..+++.|+|++|++++..+...+.++++|+.|+|++|.|++..|..+..+++|+.|
T Consensus 4 ~~C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 83 (192)
T 1w8a_A 4 AMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEE
Confidence 456667788888632 23789999999999887653348899999999999999999999999999999999
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+|++|+|++..|..|..+++|++|+|++|++++.+|..|.
T Consensus 84 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 123 (192)
T 1w8a_A 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE 123 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSST
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhh
Confidence 9999999988888899999999999999999999887764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=7e-13 Score=152.31 Aligned_cols=92 Identities=32% Similarity=0.513 Sum_probs=88.2
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
..++.|+|++|+++|.+| ..+++++.|+.|+|++|.++|.+|..++++++|+.|||++|+|+|.+|..+..++.|++||
T Consensus 632 ~~L~~LdLs~N~l~g~ip-~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 632 GSMMFLDMSYNMLSGYIP-KEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp BCCCEEECCSSCCBSCCC-GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred ccccEEECcCCcccccCC-HHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 468999999999999998 5799999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCcCCccCChh
Q 042949 156 ISNNHFAATSPDN 168 (608)
Q Consensus 156 ls~N~l~g~~p~~ 168 (608)
|++|+|+|.||..
T Consensus 711 ls~N~l~g~iP~~ 723 (768)
T 3rgz_A 711 LSNNNLSGPIPEM 723 (768)
T ss_dssp CCSSEEEEECCSS
T ss_pred CcCCcccccCCCc
Confidence 9999999999974
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.30 E-value=3.8e-12 Score=117.88 Aligned_cols=106 Identities=20% Similarity=0.236 Sum_probs=90.1
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
..|.+.|..|.|+.+ ...++.|+|++|++++..| ..+.++++|+.|+|++|.|++..|..+..+++|++|
T Consensus 5 ~~C~C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L 83 (170)
T 3g39_A 5 SQCSCSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEP-GVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQL 83 (170)
T ss_dssp -CCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCT-TTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CcCCcCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccCh-hhhcCcccCCEEECCCCCcCccChhhccCCCCCCEE
Confidence 456656778888532 2478999999999999765 579999999999999999997776678999999999
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCC
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSP 166 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p 166 (608)
+|++|+|++..|..+..+++|++|+|++|.|++..+
T Consensus 84 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 84 SLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999999997666679999999999999999998765
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.30 E-value=5.4e-12 Score=117.46 Aligned_cols=109 Identities=27% Similarity=0.352 Sum_probs=91.0
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
+.|.+.|.+|.|... ..+++.|+|++|++++.. +..+.++++|++|++++|.+++..+..+..+++|+.|
T Consensus 3 ~~C~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLP-HGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTIL 81 (177)
T ss_dssp TTCEEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCC-TTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCEeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeC-HHHhcCcccccEEECCCCcceEeChhHccCCCccCEE
Confidence 456667899999642 247899999999998654 4568899999999999999997666678999999999
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhH
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNF 169 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~ 169 (608)
+|++|++++..|..+..+++|+.|+|++|.+++..+..|
T Consensus 82 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 120 (177)
T 2o6r_A 82 YLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIF 120 (177)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred ECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHh
Confidence 999999997666678999999999999999986555433
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=6.8e-12 Score=121.31 Aligned_cols=111 Identities=21% Similarity=0.298 Sum_probs=94.9
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
..|.+.|..+.|+.+ ...++.|+|++|++++..+...+.++++|+.|+|++|.+++..|..+..+++|+.|
T Consensus 7 ~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 86 (220)
T 2v70_A 7 EKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI 86 (220)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence 456667788888642 13578999999999988665568899999999999999998888789999999999
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+|++|++++..|..|..+++|++|+|++|.+++..|..|.
T Consensus 87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 126 (220)
T 2v70_A 87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFI 126 (220)
T ss_dssp ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSST
T ss_pred ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcC
Confidence 9999999987777899999999999999999998887775
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.4e-11 Score=117.87 Aligned_cols=110 Identities=25% Similarity=0.322 Sum_probs=92.3
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
..|.+.|.+|.|... ..+++.|+|++|++++.. +..+.++++|++|++++|.+++..+..+..+++|++|
T Consensus 3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLP-NGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL 81 (208)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCC-TTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCC-hhhhcccccCcEEECCCCccCccChhhcCCCCCcCEE
Confidence 456668999999642 246899999999999654 4568899999999999999997666678999999999
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+|++|++++..+..+..+++|++|+|++|.+++..+..|.
T Consensus 82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 121 (208)
T 2o6s_A 82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFD 121 (208)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhc
Confidence 9999999966666689999999999999999977765554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.8e-11 Score=115.84 Aligned_cols=109 Identities=23% Similarity=0.378 Sum_probs=91.9
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
..|.+.|..|.|... ...++.|+|++|+++ .+| ..+.++++|+.|+|++|.|++..|..|..+++|+.|
T Consensus 6 ~~C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip-~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L 83 (193)
T 2wfh_A 6 TECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVP-KELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL 83 (193)
T ss_dssp TTCEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCC-GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhH-HHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEE
Confidence 345555677777532 247899999999998 576 579999999999999999998888889999999999
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+|++|+|++..|..|..+++|++|+|++|.+++..+..|.
T Consensus 84 ~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~ 123 (193)
T 2wfh_A 84 ILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFN 123 (193)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTT
T ss_pred ECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhh
Confidence 9999999987777899999999999999999976655453
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-11 Score=119.54 Aligned_cols=107 Identities=21% Similarity=0.279 Sum_probs=92.3
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
..| .|.+|.|... ..+++.|+|++|++++..| ..+.++++|+.|+|++|.|++..+..+..+++|+.|
T Consensus 17 ~~C--s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 93 (229)
T 3e6j_A 17 CSC--SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEP-GVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL 93 (229)
T ss_dssp CEE--ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CEE--eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCH-HHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEE
Confidence 667 6799999742 2478999999999999765 579999999999999999986555667999999999
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+|++|+|++..|..+..+++|+.|+|++|.|+ .+|..+.
T Consensus 94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~ 132 (229)
T 3e6j_A 94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIE 132 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGG
T ss_pred ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccc
Confidence 99999999766667899999999999999999 7887764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.7e-11 Score=118.45 Aligned_cols=111 Identities=23% Similarity=0.313 Sum_probs=95.0
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
..|.+.|..|.|... ..+++.|+|++|++++..+ ..+..+++|+.|+|++|.+++..|..+..+++|++|
T Consensus 7 ~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~-~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 85 (220)
T 2v9t_B 7 AACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPP-GAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL 85 (220)
T ss_dssp TTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECT-TSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEE
T ss_pred CCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCH-hHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEE
Confidence 557667888999642 2468999999999997554 579999999999999999999889999999999999
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHHH
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~~ 171 (608)
+|++|+|++..+..|..+++|+.|+|++|.+++..|..|..
T Consensus 86 ~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~ 126 (220)
T 2v9t_B 86 VLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQD 126 (220)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred ECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCC
Confidence 99999999544445789999999999999999988877753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.18 E-value=2.7e-11 Score=114.38 Aligned_cols=92 Identities=23% Similarity=0.332 Sum_probs=86.0
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++.+| ..+.++++|+.|+|++|.|++..|..+..+++|++|+|++|+|++.+|..+..+++|++|
T Consensus 53 l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (192)
T 1w8a_A 53 LPHLVKLELKRNQLTGIEP-NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp CTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred CCCCCEEECCCCCCCCcCH-hHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEE
Confidence 4589999999999999776 579999999999999999999988889999999999999999999999999999999999
Q ss_pred eCcCCcCCccCCh
Q 042949 155 DISNNHFAATSPD 167 (608)
Q Consensus 155 ~ls~N~l~g~~p~ 167 (608)
+|++|.|++..+-
T Consensus 132 ~L~~N~l~c~c~l 144 (192)
T 1w8a_A 132 NLASNPFNCNCHL 144 (192)
T ss_dssp ECTTCCBCCSGGG
T ss_pred EeCCCCccCcCcc
Confidence 9999999998774
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.17 E-value=5.1e-11 Score=110.64 Aligned_cols=90 Identities=20% Similarity=0.223 Sum_probs=74.4
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.+++..| ..+.++++|+.|+|++|.|++..+..+..+++|++|+|++|+|++..|..+..+++|++|+
T Consensus 33 ~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEP-GVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp TTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEEeCCCCccccCH-HHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence 468889999999988765 5788999999999999999975555578899999999999999865444588899999999
Q ss_pred CcCCcCCccCC
Q 042949 156 ISNNHFAATSP 166 (608)
Q Consensus 156 ls~N~l~g~~p 166 (608)
|++|.|....+
T Consensus 112 L~~N~~~c~~~ 122 (174)
T 2r9u_A 112 LYNNPWDCECR 122 (174)
T ss_dssp CCSSCBCTTBG
T ss_pred eCCCCcccccc
Confidence 99999886544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.17 E-value=2.3e-11 Score=124.18 Aligned_cols=96 Identities=25% Similarity=0.428 Sum_probs=89.8
Q ss_pred CCcEEEEEecC-CCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCE
Q 042949 75 ATNIVGIRLEN-MNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKT 153 (608)
Q Consensus 75 ~~~v~~l~l~~-~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~ 153 (608)
..+++.|+|++ |++.|.+| ..++++++|++|+|++|.++|.+|..+.++++|++|+|++|+++|.+|..+..+++|++
T Consensus 75 l~~L~~L~L~~~n~l~~~~p-~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 153 (313)
T 1ogq_A 75 LPYLNFLYIGGINNLVGPIP-PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp CTTCSEEEEEEETTEESCCC-GGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred CCCCCeeeCCCCCcccccCC-hhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCe
Confidence 35789999995 99999997 57999999999999999999999999999999999999999999999999999999999
Q ss_pred EeCcCCcCCccCChhHHH
Q 042949 154 LDISNNHFAATSPDNFRQ 171 (608)
Q Consensus 154 L~ls~N~l~g~~p~~~~~ 171 (608)
|+|++|.++|.+|..+..
T Consensus 154 L~L~~N~l~~~~p~~l~~ 171 (313)
T 1ogq_A 154 ITFDGNRISGAIPDSYGS 171 (313)
T ss_dssp EECCSSCCEEECCGGGGC
T ss_pred EECcCCcccCcCCHHHhh
Confidence 999999999999988764
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=8.6e-11 Score=113.51 Aligned_cols=95 Identities=16% Similarity=0.219 Sum_probs=86.6
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++..+ ..+.++++|+.|+|++|.+++..|..+..+++|++|+|++|++++..|..+..+++|++|
T Consensus 56 l~~L~~L~L~~N~i~~i~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 134 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEE-GAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred CCCCCEEECCCCcCCEECH-HHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence 4579999999999998654 579999999999999999998888889999999999999999998888899999999999
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|++++..|..|.
T Consensus 135 ~L~~N~l~~~~~~~~~ 150 (220)
T 2v70_A 135 SLYDNQITTVAPGAFD 150 (220)
T ss_dssp ECTTSCCCCBCTTTTT
T ss_pred ECCCCcCCEECHHHhc
Confidence 9999999998887765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.2e-10 Score=115.39 Aligned_cols=136 Identities=12% Similarity=0.022 Sum_probs=103.9
Q ss_pred ccCCCCCceEEEEEEcCCcEEEEEEecccc-cCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 308 LRSQTICSSLFMVRLKNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
..++|+.+.||++... +..+++|+..... .....+.+|+++++.+. |..+.++++++...+..++||||++|.+|.+
T Consensus 21 ~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 99 (263)
T 3tm0_A 21 DTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp CCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred eccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhh
Confidence 3566777899998754 6889999987421 23446889999998884 6778889999988889999999999999876
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--------------------------------------------
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSN-------------------------------------------- 421 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-------------------------------------------- 421 (608)
.+. +......++.+++++|+.||+...
T Consensus 100 ~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 100 EYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp HCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred ccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 421 112234788999999999998210
Q ss_pred ----------CCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 422 ----------EEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 422 ----------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
....++|+|++|.||+++++..+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11458999999999999876556799998775
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.10 E-value=1.8e-10 Score=119.08 Aligned_cols=100 Identities=25% Similarity=0.320 Sum_probs=73.1
Q ss_pred CCCCCCeeecCC-----------CCcEEEEEecC-CCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 63 SYNLKGIKCNLH-----------ATNIVGIRLEN-MNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 63 ~~~w~gv~c~~~-----------~~~v~~l~l~~-~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
.+.|..|.|... ..+++.|+|++ |.|++..+ ..+.+|++|+.|+|++|.|+|..|..|.+|++|++|
T Consensus 7 ~C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 85 (347)
T 2ifg_A 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLEL-RDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (347)
T ss_dssp CSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECG-GGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcCh-hHhccccCCCEEECCCCccceeCHHHhcCCcCCCEE
Confidence 446788888643 13478888886 77776543 568888888888888888888777778888888888
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCcc
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAAT 164 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~ 164 (608)
+|++|+|++..|..+..++ |+.|+|.+|.|...
T Consensus 86 ~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 86 NLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp ECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred eCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 8888888854444455554 88888888888754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.07 E-value=1.8e-10 Score=118.40 Aligned_cols=94 Identities=17% Similarity=0.244 Sum_probs=74.0
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.++ .+| ..++++++|+.|+|++|.+++ +|+.++.+++|+.|+|++|++.+.+|..+..+++|+.|
T Consensus 182 l~~L~~L~L~~n~l~-~lp-~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L 258 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLP-ASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258 (328)
T ss_dssp STTCCEEEEEEECCC-CCC-GGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEE
T ss_pred CCCCCEEECcCCCcC-cch-HhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEE
Confidence 346788888888887 666 457888888888888888884 66678888888888888888888888888888888888
Q ss_pred eCcCCcCCccCChhHHH
Q 042949 155 DISNNHFAATSPDNFRQ 171 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~~ 171 (608)
+|++|++.+.+|..+..
T Consensus 259 ~L~~n~~~~~~p~~~~~ 275 (328)
T 4fcg_A 259 ILKDCSNLLTLPLDIHR 275 (328)
T ss_dssp ECTTCTTCCBCCTTGGG
T ss_pred ECCCCCchhhcchhhhc
Confidence 88888888888877653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.06 E-value=3e-10 Score=109.68 Aligned_cols=95 Identities=21% Similarity=0.234 Sum_probs=84.9
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++..| ..+.++++|++|+|++|.|++..+..+..+++|+.|+|++|++++..|..|..+++|++|
T Consensus 55 l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 133 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAP-DAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL 133 (220)
T ss_dssp CTTCCEEECCSSCCCEECT-TTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCCcCH-HHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEE
Confidence 4589999999999998765 679999999999999999996555567899999999999999998888899999999999
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|.|++..+..|.
T Consensus 134 ~L~~N~l~~~~~~~~~ 149 (220)
T 2v9t_B 134 SLYDNKLQTIAKGTFS 149 (220)
T ss_dssp ECCSSCCSCCCTTTTT
T ss_pred ECCCCcCCEECHHHHh
Confidence 9999999988776554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=2.4e-10 Score=112.73 Aligned_cols=130 Identities=14% Similarity=0.162 Sum_probs=97.1
Q ss_pred CCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCc--ceeeeeeeecCCeeEEEEeeccCCCHHHHH
Q 042949 310 SQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPN--ILPLVCYNSTNEEKLLVYKYQSNGSLLSLL 387 (608)
Q Consensus 310 g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l 387 (608)
++|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||+++.+|. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 466679999998877888999987643 3356788999988886444 456888888777889999999998873 1
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----------------------------------------------
Q 042949 388 EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSN---------------------------------------------- 421 (608)
Q Consensus 388 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~---------------------------------------------- 421 (608)
. ..+ ...++.++++.|..||+...
T Consensus 105 ~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 105 S-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp S-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred C-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 1 111 23567778888888886430
Q ss_pred -------CCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 422 -------EEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 422 -------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
....++|+|++|.||+++++..+.|+|||.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 11239999999999999877666799999875
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.01 E-value=5.3e-10 Score=110.12 Aligned_cols=92 Identities=21% Similarity=0.258 Sum_probs=67.0
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
.++.|+|++|++++..+ ..+.++++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..+..+++|++|+|
T Consensus 36 ~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSD-ATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TCCEEECTTSCCCCCCT-TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEccCCCcCccCH-hHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 56777777777777554 45777777888888888777766666777777777888777777555556677777777777
Q ss_pred cCCcCCccCChhH
Q 042949 157 SNNHFAATSPDNF 169 (608)
Q Consensus 157 s~N~l~g~~p~~~ 169 (608)
++|.+++..|..|
T Consensus 115 ~~N~l~~~~~~~~ 127 (251)
T 3m19_A 115 GGNQLKSLPSGVF 127 (251)
T ss_dssp CSSCCCCCCTTTT
T ss_pred CCCcCCCcChhHh
Confidence 7777776555444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=3.5e-10 Score=124.39 Aligned_cols=94 Identities=21% Similarity=0.189 Sum_probs=84.3
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|++++..| ..+.++++|++|+|++|.+++..|..+.++++|++|+|++|++++..|..++.+++|++|+
T Consensus 26 ~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 104 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGH-GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104 (549)
T ss_dssp TTCCEEECCSSCCCEECS-STTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEE
T ss_pred CCccEEECcCCccCccCh-hhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEE
Confidence 479999999999998765 5799999999999999999998888999999999999999999987777799999999999
Q ss_pred CcCCcCCc-cCChhHH
Q 042949 156 ISNNHFAA-TSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g-~~p~~~~ 170 (608)
|++|.+++ .+|..+.
T Consensus 105 Ls~n~l~~~~~~~~~~ 120 (549)
T 2z81_A 105 LMGNPYQTLGVTSLFP 120 (549)
T ss_dssp CTTCCCSSSCSSCSCT
T ss_pred CCCCcccccchhhhhh
Confidence 99999987 4665554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.99 E-value=7.1e-10 Score=107.69 Aligned_cols=94 Identities=20% Similarity=0.306 Sum_probs=81.9
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|++++ +++..+..+++|+.|+|++|.|++..+..+..+++|+.|+|++|+|+ .+|..+..+++|++|
T Consensus 63 l~~L~~L~L~~N~l~~-i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 140 (229)
T 3e6j_A 63 LINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL 140 (229)
T ss_dssp CTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEE
T ss_pred ccCCcEEECCCCCCCC-cChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEE
Confidence 4579999999999965 55466889999999999999999777777899999999999999999 889999999999999
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|+|++..+..|.
T Consensus 141 ~L~~N~l~~~~~~~~~ 156 (229)
T 3e6j_A 141 ALDQNQLKSIPHGAFD 156 (229)
T ss_dssp ECCSSCCCCCCTTTTT
T ss_pred ECCCCcCCccCHHHHh
Confidence 9999999976665443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.98 E-value=3.3e-10 Score=101.95 Aligned_cols=89 Identities=29% Similarity=0.381 Sum_probs=74.6
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeecccc-CChhhcCCCCCCE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA-VPLALTKLKHLKT 153 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~-lP~~l~~l~~L~~ 153 (608)
..+++.|+|++|.+++. ..+..+++|+.|++++|.+++.+|..+..+++|++|+|++|.+++. .|..+..+++|+.
T Consensus 41 l~~L~~L~l~~n~l~~~---~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~ 117 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI---ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117 (149)
T ss_dssp CTTCCEEECTTSCCCCC---TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred cCCCcEEECcCCCCCCc---hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence 35788999999988876 3588889999999999999988888888889999999999999863 4477888999999
Q ss_pred EeCcCCcCCccCC
Q 042949 154 LDISNNHFAATSP 166 (608)
Q Consensus 154 L~ls~N~l~g~~p 166 (608)
|++++|.+++..+
T Consensus 118 L~l~~N~l~~~~~ 130 (149)
T 2je0_A 118 LDLFNCEVTNLND 130 (149)
T ss_dssp EECTTCGGGGSTT
T ss_pred EeCcCCcccchHH
Confidence 9999999887766
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.97 E-value=6.6e-10 Score=103.16 Aligned_cols=91 Identities=19% Similarity=0.264 Sum_probs=80.3
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++.. +..+..+++|+.|++++|.+++..+..+..+++|++|+|++|+|++..+..+..+++|+.|
T Consensus 51 l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 129 (177)
T 2o6r_A 51 LTQLTKLSLSQNQIQSLP-DGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKI 129 (177)
T ss_dssp CTTCSEEECCSSCCCCCC-TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred cccccEEECCCCcceEeC-hhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEE
Confidence 357999999999998654 4568999999999999999998777778999999999999999996555557889999999
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
+|++|.+++..|
T Consensus 130 ~l~~N~~~~~~~ 141 (177)
T 2o6r_A 130 WLHTNPWDCSCP 141 (177)
T ss_dssp ECCSSCBCCCHH
T ss_pred EecCCCeeccCc
Confidence 999999999877
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=6.2e-10 Score=124.22 Aligned_cols=94 Identities=18% Similarity=0.138 Sum_probs=82.5
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
..++.|+|++|+|++.. +..+.+|++|++|+|++|.|++..|..|.+|++|++|+|++|+|++..|..|.++++|++|+
T Consensus 52 ~~~~~LdLs~N~i~~l~-~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLG-SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCCEEC-TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCCCCC-HHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 46899999999999754 46799999999999999999987777899999999999999999966556789999999999
Q ss_pred CcCCcCCccCChhHH
Q 042949 156 ISNNHFAATSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g~~p~~~~ 170 (608)
|++|++++..|..|.
T Consensus 131 Ls~N~l~~l~~~~~~ 145 (635)
T 4g8a_A 131 AVETNLASLENFPIG 145 (635)
T ss_dssp CTTSCCCCSTTCCCT
T ss_pred CCCCcCCCCChhhhh
Confidence 999999987666565
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.97 E-value=7.3e-10 Score=115.36 Aligned_cols=111 Identities=23% Similarity=0.303 Sum_probs=91.5
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhc-CCcCCcEEEcccCcCCccCcccccCCCCcce
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLC-KLRHLRVVSLARNLIQGRIPTSISNCRRLTY 129 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 129 (608)
..|.+.+.-|.|... ...++.|+|++|++++..+ ..+. ++++|+.|+|++|.|++..|..+..+++|++
T Consensus 14 ~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~-~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~ 92 (361)
T 2xot_A 14 ANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRA-EWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRY 92 (361)
T ss_dssp TTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECT-TSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccCh-hhhhhcccccCEEECCCCcCCccChhhccCCCCCCE
Confidence 446556667788532 2357899999999998654 4566 8999999999999999888788999999999
Q ss_pred eeccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHHH
Q 042949 130 LNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171 (608)
Q Consensus 130 L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~~ 171 (608)
|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..
T Consensus 93 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 134 (361)
T 2xot_A 93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED 134 (361)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred EECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCC
Confidence 999999999766667899999999999999999888877753
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.96 E-value=5e-10 Score=100.80 Aligned_cols=92 Identities=18% Similarity=0.299 Sum_probs=81.3
Q ss_pred CcEEEEEecCCCce-eecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLS-GIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~-g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
.+++.|++++|.++ |.+| ..+..+++|+.|++++|.+++. ..++.+++|++|+|++|++++.+|..+..+++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLE-GLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCC-SCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHH-HHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 47999999999999 8887 4689999999999999999976 779999999999999999998899888889999999
Q ss_pred eCcCCcCCcc-CChhHH
Q 042949 155 DISNNHFAAT-SPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~-~p~~~~ 170 (608)
++++|.+++. .|..+.
T Consensus 94 ~ls~N~i~~~~~~~~~~ 110 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLK 110 (149)
T ss_dssp ECTTSCCCSHHHHGGGG
T ss_pred ECCCCcCCChHHHHHHh
Confidence 9999999873 334443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=9.3e-10 Score=121.38 Aligned_cols=86 Identities=22% Similarity=0.305 Sum_probs=48.8
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccC-ChhhcCCCCCCEEe
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAV-PLALTKLKHLKTLD 155 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~l-P~~l~~l~~L~~L~ 155 (608)
+++.|+|++|.|+ .+| ..+++|++|+.|+|++|.|++ +| .++.|++|+.|+|++|+|++.. |..+..+++|+.|+
T Consensus 464 ~L~~L~Ls~N~l~-~lp-~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 464 LVTHLDLSHNRLR-ALP-PALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp TCCEEECCSSCCC-CCC-GGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred cCcEeecCccccc-ccc-hhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 4555555555555 444 245555555566666555554 44 5555555556666555555544 55555555556666
Q ss_pred CcCCcCCccCC
Q 042949 156 ISNNHFAATSP 166 (608)
Q Consensus 156 ls~N~l~g~~p 166 (608)
|++|+|++.+|
T Consensus 540 L~~N~l~~~~~ 550 (567)
T 1dce_A 540 LQGNSLCQEEG 550 (567)
T ss_dssp CTTSGGGGSSS
T ss_pred ecCCcCCCCcc
Confidence 65555555544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.2e-09 Score=103.08 Aligned_cols=90 Identities=21% Similarity=0.266 Sum_probs=80.4
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++..+ ..+.++++|+.|+|++|.|++..|..+..+++|++|+|++|+|++..+..+..+++|+.|
T Consensus 53 l~~L~~L~Ls~N~i~~i~~-~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (193)
T 2wfh_A 53 YKHLTLIDLSNNRISTLSN-QSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHL 131 (193)
T ss_dssp CTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEE
T ss_pred ccCCCEEECCCCcCCEeCH-hHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEE
Confidence 4589999999999998654 679999999999999999998888889999999999999999996555578999999999
Q ss_pred eCcCCcCCccC
Q 042949 155 DISNNHFAATS 165 (608)
Q Consensus 155 ~ls~N~l~g~~ 165 (608)
+|++|.+...-
T Consensus 132 ~L~~N~~~C~c 142 (193)
T 2wfh_A 132 AIGANPLYCDC 142 (193)
T ss_dssp ECCSSCEECSG
T ss_pred EeCCCCeecCC
Confidence 99999998643
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.7e-09 Score=103.18 Aligned_cols=95 Identities=22% Similarity=0.275 Sum_probs=73.2
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|++++. ++..+..+++|++|+|++|.+++..+..+..+++|++|+|++|++++..|..+..+++|+.|
T Consensus 51 l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 129 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSL-PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL 129 (208)
T ss_dssp CTTCSEEECCSSCCCCC-CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cccCcEEECCCCccCcc-ChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE
Confidence 35788888888888854 44557788888888888888886666667888888888888888886655567888888888
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|.+++..+..|.
T Consensus 130 ~l~~N~l~~~~~~~~~ 145 (208)
T 2o6s_A 130 RLYQNQLKSVPDGVFD 145 (208)
T ss_dssp ECCSSCCSCCCTTTTT
T ss_pred ECCCCccceeCHHHhc
Confidence 8888888866554443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.6e-09 Score=106.56 Aligned_cols=95 Identities=20% Similarity=0.257 Sum_probs=80.6
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++..+ ..+..+++|+.|+|++|.+++..|..+..+++|++|+|++|+|++..|..+..+++|+.|
T Consensus 58 l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 136 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSA-GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL 136 (251)
T ss_dssp CTTCCEEECTTSCCCCCCT-TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cccCCEEECCCCcCCccCH-hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEE
Confidence 3579999999999998654 568899999999999999997777788999999999999999996655567889999999
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|++++..|..|.
T Consensus 137 ~Ls~N~l~~~~~~~~~ 152 (251)
T 3m19_A 137 RLNTNQLQSIPAGAFD 152 (251)
T ss_dssp ECCSSCCCCCCTTTTT
T ss_pred ECcCCcCCccCHHHcC
Confidence 9999999877775554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.4e-09 Score=116.74 Aligned_cols=106 Identities=25% Similarity=0.286 Sum_probs=90.9
Q ss_pred CCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccC
Q 042949 64 YNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSS 134 (608)
Q Consensus 64 ~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~ 134 (608)
+.|..|.|... ..+++.|+|++|++++..+ ..+.++++|+.|+|++|.+++..|..+..+++|++|+|++
T Consensus 54 ~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 54 NQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQA-DTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SSSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECH-HHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 34567888632 2478999999999998765 6799999999999999999998889999999999999999
Q ss_pred eeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 135 NLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 135 N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
|+|++..+..+..+++|+.|+|++|.+++..+..|.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 168 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTT
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHh
Confidence 999966666799999999999999999976665554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=98.92 E-value=1.6e-09 Score=100.06 Aligned_cols=89 Identities=20% Similarity=0.254 Sum_probs=77.0
Q ss_pred EEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCc
Q 042949 78 IVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDIS 157 (608)
Q Consensus 78 v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls 157 (608)
.+.+++++|+|+. +|. .+ .+.|+.|+|++|.|++..|..+..+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 11 ~~~l~~s~n~l~~-ip~-~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPT-GI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp TTEEECTTSCCSS-CCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcCc-cCc-cC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3578999999986 553 34 4899999999999999889999999999999999999997666678999999999999
Q ss_pred CCcCCccCChhHH
Q 042949 158 NNHFAATSPDNFR 170 (608)
Q Consensus 158 ~N~l~g~~p~~~~ 170 (608)
+|+|++..|..|.
T Consensus 87 ~N~l~~~~~~~~~ 99 (170)
T 3g39_A 87 DNQLKSIPRGAFD 99 (170)
T ss_dssp SSCCCCCCTTTTT
T ss_pred CCccCEeCHHHhc
Confidence 9999987776554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=7.3e-10 Score=118.85 Aligned_cols=92 Identities=13% Similarity=0.184 Sum_probs=70.0
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCc-ccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIP-TSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
.+++.|+|++|.+++..| ..+.++++|++|+|++|.+.+.+| ..+..+++|++|+|++|++++..|..+..+++|++|
T Consensus 30 ~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 108 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNE-TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVL 108 (455)
T ss_dssp TTCCEEECCSSCCCEECT-TTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEE
T ss_pred CccCEEEecCCccCcCCh-hHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEE
Confidence 467888888888877654 467888888888888888876664 457778888888888888887777778888888888
Q ss_pred eCcCCcCCccCChh
Q 042949 155 DISNNHFAATSPDN 168 (608)
Q Consensus 155 ~ls~N~l~g~~p~~ 168 (608)
+|++|++++.+|..
T Consensus 109 ~L~~n~l~~~~~~~ 122 (455)
T 3v47_A 109 TLTQCNLDGAVLSG 122 (455)
T ss_dssp ECTTSCCBTHHHHS
T ss_pred eCCCCCCCccccCc
Confidence 88888887755543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.92 E-value=8.6e-10 Score=101.39 Aligned_cols=88 Identities=32% Similarity=0.347 Sum_probs=62.3
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeecccc-CChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA-VPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~-lP~~l~~l~~L~~L 154 (608)
.+++.|+|++|.+++. ..+..+++|+.|+|++|.+++.+|..+..+++|++|+|++|++++. .+..+..+++|++|
T Consensus 49 ~~L~~L~l~~n~l~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L 125 (168)
T 2ell_A 49 VNLEFLSLINVGLISV---SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSL 125 (168)
T ss_dssp GGCCEEEEESSCCCCC---SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEE
T ss_pred CCCCEEeCcCCCCCCh---hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEE
Confidence 4677777777777765 2567777777777777777776776666677777777777777752 22567777777777
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
++++|.+++..+
T Consensus 126 ~l~~N~l~~~~~ 137 (168)
T 2ell_A 126 DLFNCEVTNLND 137 (168)
T ss_dssp ECCSSGGGTSTT
T ss_pred EeeCCcCcchHH
Confidence 777777776554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.92 E-value=1.3e-09 Score=112.53 Aligned_cols=87 Identities=18% Similarity=0.164 Sum_probs=78.2
Q ss_pred EEEecCC-CceeecChhhhcCCcCCcEEEccc-CcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCc
Q 042949 80 GIRLENM-NLSGIIDAETLCKLRHLRVVSLAR-NLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDIS 157 (608)
Q Consensus 80 ~l~l~~~-~l~g~~~~~~l~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls 157 (608)
.++++++ +|++ || . +..+++|+.|+|++ |.|++..|..|+.|++|+.|+|++|+|+|..|..|..|++|+.|||+
T Consensus 12 ~v~~~~~n~l~~-ip-~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 12 GLRCTRDGALDS-LH-H-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp CEECCSSCCCTT-TT-T-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred EEEcCCCCCCCc-cC-C-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 4588998 8886 76 4 99999999999996 99998888899999999999999999999888899999999999999
Q ss_pred CCcCCccCChhH
Q 042949 158 NNHFAATSPDNF 169 (608)
Q Consensus 158 ~N~l~g~~p~~~ 169 (608)
+|+|++..|..|
T Consensus 89 ~N~l~~~~~~~~ 100 (347)
T 2ifg_A 89 FNALESLSWKTV 100 (347)
T ss_dssp SSCCSCCCSTTT
T ss_pred CCccceeCHHHc
Confidence 999997666544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.92 E-value=6.1e-10 Score=124.95 Aligned_cols=83 Identities=14% Similarity=0.269 Sum_probs=76.8
Q ss_pred CceeecChhhhcCCcCCcEEEcccCcCCcc-----------------Cccccc--CCCCcceeeccCeeccccCChhhcC
Q 042949 87 NLSGIIDAETLCKLRHLRVVSLARNLIQGR-----------------IPTSIS--NCRRLTYLNLSSNLLSGAVPLALTK 147 (608)
Q Consensus 87 ~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~-----------------~p~~~~--~l~~L~~L~Ls~N~l~g~lP~~l~~ 147 (608)
+++| || ..++++++|++|+|++|.|+|. +|..++ ++++|++|+|++|++.|.+|..++.
T Consensus 194 ~l~~-ip-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 271 (636)
T 4eco_A 194 NITF-VS-KAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271 (636)
T ss_dssp EEEE-EC-GGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT
T ss_pred CCcc-CC-HHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc
Confidence 4556 87 4799999999999999999996 999999 9999999999999999999999999
Q ss_pred CCCCCEEeCcCCc-CCc-cCChhHHH
Q 042949 148 LKHLKTLDISNNH-FAA-TSPDNFRQ 171 (608)
Q Consensus 148 l~~L~~L~ls~N~-l~g-~~p~~~~~ 171 (608)
+++|++|+|++|+ ++| .+|..+..
T Consensus 272 l~~L~~L~Ls~n~~l~~~~lp~~~~~ 297 (636)
T 4eco_A 272 LPEMQLINVACNRGISGEQLKDDWQA 297 (636)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHH
T ss_pred CCCCCEEECcCCCCCccccchHHHHh
Confidence 9999999999998 999 99988764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.7e-09 Score=100.24 Aligned_cols=88 Identities=23% Similarity=0.289 Sum_probs=74.5
Q ss_pred EEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcC
Q 042949 79 VGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISN 158 (608)
Q Consensus 79 ~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~ 158 (608)
+.+++++|.|+ .+|. .+. ++|+.|+|++|.|++..|..+..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~-~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPA-GIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCC-CcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 56899999985 5663 343 8999999999999998899999999999999999999975445578999999999999
Q ss_pred CcCCccCChhHH
Q 042949 159 NHFAATSPDNFR 170 (608)
Q Consensus 159 N~l~g~~p~~~~ 170 (608)
|+|++..+..|.
T Consensus 91 N~l~~l~~~~~~ 102 (174)
T 2r9u_A 91 NHLKSIPRGAFD 102 (174)
T ss_dssp SCCCCCCTTTTT
T ss_pred CccceeCHHHhc
Confidence 999976665454
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.91 E-value=2.2e-09 Score=111.56 Aligned_cols=140 Identities=13% Similarity=0.172 Sum_probs=103.4
Q ss_pred ccCCCCCceEEEEEEcCCcEEEEEEec--ccc--cCHHHHHHHHHHHhcCC--CCcceeeeeeeecC---CeeEEEEeec
Q 042949 308 LRSQTICSSLFMVRLKNSAVYAVKRLK--KLQ--VSMDEFSQTMRQIGNLK--HPNILPLVCYNSTN---EEKLLVYKYQ 378 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~g~~vavK~l~--~~~--~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~e~~ 378 (608)
.+++|.++.||+....+ ..+++|+.. ... .....+.+|+++++.+. +..+.+++.++.+. +..++||||+
T Consensus 45 ~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 45 QFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp ECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 36788899999988755 578888775 322 23456888999998886 45577888888766 4589999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC------------------------------------
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNE------------------------------------ 422 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~------------------------------------ 422 (608)
++..+.+. ....++..++..++.++++.|+.||+....
T Consensus 124 ~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 124 SGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred CCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 98775431 123477888899999999999999984210
Q ss_pred -----------------CCCceecCCCCCCeecCCCCC--ceEeccccccc
Q 042949 423 -----------------EKTIPHGNLKLSNILLNENED--PLISECGYSKF 454 (608)
Q Consensus 423 -----------------~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~ 454 (608)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246899999999999987753 58999998875
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.90 E-value=5.2e-10 Score=127.22 Aligned_cols=90 Identities=20% Similarity=0.405 Sum_probs=56.4
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|+|++|.|+ .+| ..+++|++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .||..|..|++|++|+|
T Consensus 248 ~L~~L~Ls~N~l~-~lp-~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 248 FLTRLYLNGNSLT-ELP-AEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp SCSCCBCTTSCCS-CCC-GGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCEEEeeCCcCc-ccC-hhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 4555666666665 454 34666666666666666666 55666666666666666666665 56666666666666666
Q ss_pred cCCcCCccCChhHH
Q 042949 157 SNNHFAATSPDNFR 170 (608)
Q Consensus 157 s~N~l~g~~p~~~~ 170 (608)
++|.|+|.+|..+.
T Consensus 324 ~~N~l~~~~p~~~~ 337 (727)
T 4b8c_D 324 EGNPLEKQFLKILT 337 (727)
T ss_dssp TTSCCCSHHHHHHH
T ss_pred CCCccCCCChHHHh
Confidence 66666666665553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=1.5e-09 Score=119.67 Aligned_cols=89 Identities=21% Similarity=0.331 Sum_probs=82.2
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
.++.|+|++|.|++ +| . +++|++|+.|+|++|.|+ .+|..++.|++|+.|+|++|+|++ +| .++.+++|+.|+|
T Consensus 442 ~L~~L~Ls~n~l~~-lp-~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~L 515 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LC-H-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLL 515 (567)
T ss_dssp TCSEEECTTSCCSS-CC-C-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEEC
T ss_pred CceEEEecCCCCCC-Cc-C-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEEC
Confidence 47889999999998 65 3 999999999999999999 899999999999999999999997 78 8999999999999
Q ss_pred cCCcCCccC-ChhHHH
Q 042949 157 SNNHFAATS-PDNFRQ 171 (608)
Q Consensus 157 s~N~l~g~~-p~~~~~ 171 (608)
++|+|++.+ |..+..
T Consensus 516 s~N~l~~~~~p~~l~~ 531 (567)
T 1dce_A 516 CNNRLQQSAAIQPLVS 531 (567)
T ss_dssp CSSCCCSSSTTGGGGG
T ss_pred CCCCCCCCCCcHHHhc
Confidence 999999987 887764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.89 E-value=3.3e-09 Score=105.62 Aligned_cols=93 Identities=20% Similarity=0.285 Sum_probs=64.9
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
.++.|+|++|++++.. +..+.++++|++|+|++|.++...+..+..+++|++|+|++|++++..+..+..+++|++|+|
T Consensus 38 ~l~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLP-SKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCSCCC-TTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCCeeC-HHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 4677777777777543 346777778888888877777544444577777777777777777554455677777777777
Q ss_pred cCCcCCccCChhHH
Q 042949 157 SNNHFAATSPDNFR 170 (608)
Q Consensus 157 s~N~l~g~~p~~~~ 170 (608)
++|.+++..|..|.
T Consensus 117 ~~n~l~~~~~~~~~ 130 (270)
T 2o6q_A 117 DRNQLKSLPPRVFD 130 (270)
T ss_dssp CSSCCCCCCTTTTT
T ss_pred CCCccCeeCHHHhC
Confidence 77777766665543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.89 E-value=2.8e-09 Score=106.22 Aligned_cols=96 Identities=27% Similarity=0.335 Sum_probs=82.0
Q ss_pred CCCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCE
Q 042949 74 HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKT 153 (608)
Q Consensus 74 ~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~ 153 (608)
...+++.|+|++|.+++..+ ..+.++++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..+..+++|+.
T Consensus 83 ~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 161 (272)
T 3rfs_A 83 ELTNLTYLILTGNQLQSLPN-GVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE 161 (272)
T ss_dssp TCTTCCEEECTTSCCCCCCT-TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCCCEEECCCCccCccCh-hHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence 34679999999999997654 56889999999999999999877777899999999999999999766667889999999
Q ss_pred EeCcCCcCCccCChhHH
Q 042949 154 LDISNNHFAATSPDNFR 170 (608)
Q Consensus 154 L~ls~N~l~g~~p~~~~ 170 (608)
|+|++|.+++..|..|.
T Consensus 162 L~l~~n~l~~~~~~~~~ 178 (272)
T 3rfs_A 162 LDLSYNQLQSLPEGVFD 178 (272)
T ss_dssp EECCSSCCCCCCTTTTT
T ss_pred EECCCCCcCccCHHHhc
Confidence 99999999987776554
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.88 E-value=3.9e-09 Score=105.24 Aligned_cols=93 Identities=23% Similarity=0.245 Sum_probs=81.3
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++. +.+..+++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..+..+++|++|
T Consensus 62 l~~L~~L~l~~n~l~~~---~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 138 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI---SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL 138 (272)
T ss_dssp CTTCCEEECTTSCCCCC---GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCcEEECCCCCCCCc---hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEE
Confidence 35799999999999873 268999999999999999998777778999999999999999997777778999999999
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|.+++..|..|.
T Consensus 139 ~L~~n~l~~~~~~~~~ 154 (272)
T 3rfs_A 139 NLAHNQLQSLPKGVFD 154 (272)
T ss_dssp ECCSSCCCCCCTTTTT
T ss_pred ECCCCccCccCHHHhc
Confidence 9999999977776554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=2.6e-09 Score=106.56 Aligned_cols=94 Identities=18% Similarity=0.136 Sum_probs=79.3
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|++++..+ ..+.++++|++|++++|.+++..+..+.++++|++|+|++|++++..|..+..+++|+.|+
T Consensus 28 ~~l~~L~ls~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGS-YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp TTCCEEECTTCCCCEECT-TTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCccEEECCCCcccccCH-hHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 358899999999987654 5788899999999999999877777889999999999999999877777888999999999
Q ss_pred CcCCcCCccCChhHH
Q 042949 156 ISNNHFAATSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g~~p~~~~ 170 (608)
+++|.+++..+..+.
T Consensus 107 l~~n~l~~~~~~~~~ 121 (276)
T 2z62_A 107 AVETNLASLENFPIG 121 (276)
T ss_dssp CTTSCCCCSTTCCCT
T ss_pred CCCCCccccCchhcc
Confidence 999999876665443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=2.4e-09 Score=115.68 Aligned_cols=106 Identities=23% Similarity=0.283 Sum_probs=90.0
Q ss_pred CCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCe
Q 042949 65 NLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135 (608)
Q Consensus 65 ~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N 135 (608)
.|..|.|... ...++.|+|++|++++..+ ..+.++++|++|+|++|.+++..|..+.++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQ-DEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECH-hHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 4567888632 2468899999999998765 57999999999999999999988999999999999999999
Q ss_pred eccccCChhhcCCCCCCEEeCcCCcCCccCChhHHH
Q 042949 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171 (608)
Q Consensus 136 ~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~~ 171 (608)
++++..+..|..+++|++|+|++|.+++..|..|..
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~ 126 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccc
Confidence 999554456889999999999999999888877653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=2.2e-09 Score=119.51 Aligned_cols=94 Identities=17% Similarity=0.162 Sum_probs=66.3
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.+++..+ ..+.++++|++|+|++|.+++..|..+.++++|++|+|++|.+++..|..|..+++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKS-YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEeCh-hhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 457777777777776554 4577777777777777777766666777777777777777777766677777777777777
Q ss_pred CcCCcCCccCChhHH
Q 042949 156 ISNNHFAATSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g~~p~~~~ 170 (608)
|++|.+++..|..+.
T Consensus 111 L~~n~l~~~~~~~~~ 125 (606)
T 3vq2_A 111 AVETKLASLESFPIG 125 (606)
T ss_dssp CTTSCCCCSSSSCCT
T ss_pred ccCCccccccccccC
Confidence 777777665555443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.87 E-value=1.9e-09 Score=98.99 Aligned_cols=86 Identities=22% Similarity=0.329 Sum_probs=77.5
Q ss_pred CcEEEEEecCCCce-eecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLS-GIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~-g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
.+++.|+|++|+++ |.+| ..+..+++|+.|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIE-GLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCS-SCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHH-HHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 47999999999998 7887 4578999999999999999976 778999999999999999998888888889999999
Q ss_pred eCcCCcCCcc
Q 042949 155 DISNNHFAAT 164 (608)
Q Consensus 155 ~ls~N~l~g~ 164 (608)
+|++|.+++.
T Consensus 101 ~Ls~N~l~~~ 110 (168)
T 2ell_A 101 NLSGNKLKDI 110 (168)
T ss_dssp ECBSSSCCSS
T ss_pred eccCCccCcc
Confidence 9999999874
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=1.7e-09 Score=120.61 Aligned_cols=95 Identities=19% Similarity=0.299 Sum_probs=70.8
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
..++.|+|++|++.+.+.+..+..+++|+.|+|++|.+++.+|..|..|++|+.|+|++|+|++..|..+..+++|++||
T Consensus 469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 548 (635)
T 4g8a_A 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548 (635)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence 45677777777654443335677778888888888888877777788888888888888888876677777788888888
Q ss_pred CcCCcCCccCChhHH
Q 042949 156 ISNNHFAATSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g~~p~~~~ 170 (608)
|++|+|++.+|..|.
T Consensus 549 Ls~N~l~~~~~~~l~ 563 (635)
T 4g8a_A 549 YSLNHIMTSKKQELQ 563 (635)
T ss_dssp CTTSCCCBCCSSCTT
T ss_pred CCCCcCCCCCHHHHH
Confidence 888888877776654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=2.6e-09 Score=114.52 Aligned_cols=95 Identities=21% Similarity=0.268 Sum_probs=84.4
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChh--hcCCCCCC
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLA--LTKLKHLK 152 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~--l~~l~~L~ 152 (608)
..+++.|+|++|.+.+.+++..+.++++|++|+|++|.+++..|..++++++|++|+|++|++++.+|.. +..+++|+
T Consensus 53 l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~ 132 (455)
T 3v47_A 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE 132 (455)
T ss_dssp CTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCC
T ss_pred CccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCC
Confidence 4579999999999988887778999999999999999999888989999999999999999999877665 88999999
Q ss_pred EEeCcCCcCCccCChhH
Q 042949 153 TLDISNNHFAATSPDNF 169 (608)
Q Consensus 153 ~L~ls~N~l~g~~p~~~ 169 (608)
+|+|++|++++..|..+
T Consensus 133 ~L~L~~n~l~~~~~~~~ 149 (455)
T 3v47_A 133 MLVLRDNNIKKIQPASF 149 (455)
T ss_dssp EEECCSSBCCSCCCCGG
T ss_pred EEECCCCccCccCcccc
Confidence 99999999999888763
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=5.7e-09 Score=104.60 Aligned_cols=94 Identities=22% Similarity=0.279 Sum_probs=78.2
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCee-ccccCChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNL-LSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g~lP~~l~~l~~L~~L 154 (608)
.+++.|+|++|++++..+ ..+.++++|+.|++++|.+++..|..+..+++|++|+|++|. +++..|..+..+++|+.|
T Consensus 32 ~~l~~L~l~~n~i~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPA-ASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCccCH-HHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 468889999999887553 568889999999999999988878888899999999999997 665557788889999999
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|.+++..|..|.
T Consensus 111 ~l~~n~l~~~~~~~~~ 126 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFR 126 (285)
T ss_dssp ECTTSCCCCCCTTTTT
T ss_pred ECCCCcCCEECHhHhh
Confidence 9999999887776654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.3e-09 Score=125.54 Aligned_cols=79 Identities=22% Similarity=0.284 Sum_probs=73.7
Q ss_pred cChhhhcCCcCCcEEEcccCcCCc-----------------cCccccc--CCCCcceeeccCeeccccCChhhcCCCCCC
Q 042949 92 IDAETLCKLRHLRVVSLARNLIQG-----------------RIPTSIS--NCRRLTYLNLSSNLLSGAVPLALTKLKHLK 152 (608)
Q Consensus 92 ~~~~~l~~l~~L~~L~l~~N~l~g-----------------~~p~~~~--~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~ 152 (608)
|| ..+++|++|+.|+|++|.|+| .+|..++ +|++|++|+|++|++.|.+|..+..+++|+
T Consensus 440 IP-~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~ 518 (876)
T 4ecn_A 440 IS-KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518 (876)
T ss_dssp EC-GGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCC
T ss_pred hh-HHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCC
Confidence 76 469999999999999999999 4999988 999999999999999999999999999999
Q ss_pred EEeCcCCc-CCc-cCChhHHH
Q 042949 153 TLDISNNH-FAA-TSPDNFRQ 171 (608)
Q Consensus 153 ~L~ls~N~-l~g-~~p~~~~~ 171 (608)
.|+|++|+ |+| .+|..+..
T Consensus 519 ~L~Ls~N~~lsg~~iP~~i~~ 539 (876)
T 4ecn_A 519 SLNIACNRGISAAQLKADWTR 539 (876)
T ss_dssp EEECTTCTTSCHHHHHHHHHH
T ss_pred EEECcCCCCcccccchHHHHh
Confidence 99999998 999 99988764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.83 E-value=5.4e-09 Score=108.27 Aligned_cols=90 Identities=23% Similarity=0.233 Sum_probs=78.7
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|++++.. +..+.++++|+.|++++|.+++..|..+.++++|++|+|++|++++..+..+..+++|++|+
T Consensus 52 ~~L~~L~l~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 130 (353)
T 2z80_A 52 EAVKSLDLSNNRITYIS-NSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLN 130 (353)
T ss_dssp TTCCEEECTTSCCCEEC-TTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEE
T ss_pred ccCcEEECCCCcCcccC-HHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEE
Confidence 47999999999999754 45799999999999999999988888899999999999999999954444589999999999
Q ss_pred CcCCcCCccCC
Q 042949 156 ISNNHFAATSP 166 (608)
Q Consensus 156 ls~N~l~g~~p 166 (608)
|++|.+++..+
T Consensus 131 L~~n~l~~l~~ 141 (353)
T 2z80_A 131 LLGNPYKTLGE 141 (353)
T ss_dssp CTTCCCSSSCS
T ss_pred CCCCCCcccCc
Confidence 99999985433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.83 E-value=3.1e-09 Score=103.69 Aligned_cols=90 Identities=22% Similarity=0.267 Sum_probs=78.4
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCc-CCccCcccccCCCCcceeeccC-eeccccCChhhcCCCCCCE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNL-IQGRIPTSISNCRRLTYLNLSS-NLLSGAVPLALTKLKHLKT 153 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~lP~~l~~l~~L~~ 153 (608)
..++.|+|++|++++..+ ..+.++++|+.|++++|. +++..+..+..+++|++|+|++ |++++..|..|..+++|+.
T Consensus 31 ~~l~~L~l~~n~l~~i~~-~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPS-HAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCCCSEECT-TTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCcceEECH-HHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 478999999999997654 578999999999999997 8866666889999999999998 9999666668899999999
Q ss_pred EeCcCCcCCccCCh
Q 042949 154 LDISNNHFAATSPD 167 (608)
Q Consensus 154 L~ls~N~l~g~~p~ 167 (608)
|++++|.+++ +|.
T Consensus 110 L~l~~n~l~~-lp~ 122 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD 122 (239)
T ss_dssp EEEEEECCCS-CCC
T ss_pred EeCCCCCCcc-ccc
Confidence 9999999987 665
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.83 E-value=3.2e-09 Score=107.59 Aligned_cols=95 Identities=24% Similarity=0.382 Sum_probs=83.0
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCc-cCcccccCCCCcceeeccCeeccccCChhhcCCCCCCE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQG-RIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKT 153 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~ 153 (608)
..+++.|+|++|.+.+..+ ..+.++++|+.|++++|.+++ .+|..+..+++|+.|+|++|++++..|..+..+++|+.
T Consensus 125 l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 203 (306)
T 2z66_A 125 LRNLIYLDISHTHTRVAFN-GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 203 (306)
T ss_dssp CTTCCEEECTTSCCEECST-TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccCCCEEECCCCcCCccch-hhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCE
Confidence 3578999999999988775 568899999999999999987 57888999999999999999999888888999999999
Q ss_pred EeCcCCcCCccCChhHH
Q 042949 154 LDISNNHFAATSPDNFR 170 (608)
Q Consensus 154 L~ls~N~l~g~~p~~~~ 170 (608)
|+|++|.+++..+..+.
T Consensus 204 L~L~~N~l~~~~~~~~~ 220 (306)
T 2z66_A 204 LNMSHNNFFSLDTFPYK 220 (306)
T ss_dssp EECTTSCCSBCCSGGGT
T ss_pred EECCCCccCccChhhcc
Confidence 99999999987776554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.81 E-value=7.1e-09 Score=110.84 Aligned_cols=105 Identities=25% Similarity=0.276 Sum_probs=89.3
Q ss_pred CCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCe
Q 042949 65 NLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN 135 (608)
Q Consensus 65 ~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N 135 (608)
.|..|.|... ...++.|+|++|++++..+ ..+.++++|+.|+|++|.+++..|..+..+++|++|+|++|
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKV-NSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECT-TTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCH-HHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 4567888532 2468899999999998765 67999999999999999999888889999999999999999
Q ss_pred eccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 136 LLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 136 ~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+|++..+..|..+++|+.|+|++|.+++..+..|.
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 157 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFN 157 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTT
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhh
Confidence 99965556799999999999999999876665554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.81 E-value=6.2e-09 Score=108.31 Aligned_cols=92 Identities=22% Similarity=0.226 Sum_probs=79.1
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|++++..+ ..+.++++|+.|+|++|.|++..+..+..+++|+.|+|++|++++..|..|..+++|+.|
T Consensus 63 l~~L~~L~L~~N~i~~i~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISS-EAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCcCCccCh-hhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 4579999999999987654 578999999999999999997777788999999999999999998778889999999999
Q ss_pred eCcCCcCCccCCh
Q 042949 155 DISNNHFAATSPD 167 (608)
Q Consensus 155 ~ls~N~l~g~~p~ 167 (608)
+|++|.|++..+.
T Consensus 142 ~L~~N~l~~l~~~ 154 (361)
T 2xot_A 142 YLSQNQISRFPVE 154 (361)
T ss_dssp ECCSSCCCSCCGG
T ss_pred ECCCCcCCeeCHH
Confidence 9999999874443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=8.7e-09 Score=102.74 Aligned_cols=94 Identities=18% Similarity=0.285 Sum_probs=57.4
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccc-cCChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG-AVPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~lP~~l~~l~~L~~L 154 (608)
.+++.|+|++|.+++..+ ..+.++++|+.|++++|.+.+..+..++.+++|++|+|++|++++ .+|..+..+++|+.|
T Consensus 76 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L 154 (276)
T 2z62_A 76 SHLSTLILTGNPIQSLAL-GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154 (276)
T ss_dssp TTCCEEECTTCCCCEECT-TTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred cCCCEEECCCCccCccCh-hhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEE
Confidence 356666666666665443 346666666666666666665555456666666666666666654 356666666666666
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|.+++..+..+.
T Consensus 155 ~Ls~N~l~~~~~~~~~ 170 (276)
T 2z62_A 155 DLSSNKIQSIYCTDLR 170 (276)
T ss_dssp ECCSSCCCEECGGGGH
T ss_pred ECCCCCCCcCCHHHhh
Confidence 6666666665555443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.80 E-value=9.2e-09 Score=105.53 Aligned_cols=107 Identities=24% Similarity=0.365 Sum_probs=88.8
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
..|.+.|..+.|... ...++.|+|++|++++..+ ..+.++++|++|+|++|.+++..|..+.++++|++|
T Consensus 29 ~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 107 (332)
T 2ft3_A 29 FGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRK-DDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKL 107 (332)
T ss_dssp SSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEE
T ss_pred CCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCH-hHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEE
Confidence 445446788888632 2468999999999987654 579999999999999999999889999999999999
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+|++|+++ .+|..+. ++|++|++++|.+++..+..|.
T Consensus 108 ~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~ 144 (332)
T 2ft3_A 108 YISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFS 144 (332)
T ss_dssp ECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGS
T ss_pred ECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhC
Confidence 99999998 7787655 7899999999999876665554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.79 E-value=5.5e-09 Score=121.14 Aligned_cols=95 Identities=26% Similarity=0.242 Sum_probs=71.7
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChh--hcCCCCCCE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLA--LTKLKHLKT 153 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~--l~~l~~L~~ 153 (608)
.+++.|+|++|++.+.|++..+.+|++|++|+|++|.+.+..|..+.+|++|++|+|++|.+++.+|.. +..+++|++
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~ 127 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence 456777777776666776667788888888888888888777888888888888888888888766654 778888888
Q ss_pred EeCcCCcCCccCC-hhHH
Q 042949 154 LDISNNHFAATSP-DNFR 170 (608)
Q Consensus 154 L~ls~N~l~g~~p-~~~~ 170 (608)
|||++|.+++..| ..|.
T Consensus 128 L~Ls~N~l~~~~~~~~~~ 145 (844)
T 3j0a_A 128 LDLSKNQIRSLYLHPSFG 145 (844)
T ss_dssp EEEESCCCCCCCCCGGGG
T ss_pred EECCCCcccccccchhHh
Confidence 8888888877655 3444
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.78 E-value=4.6e-09 Score=119.43 Aligned_cols=90 Identities=28% Similarity=0.344 Sum_probs=72.1
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
..++.|+|++|.+. .+|. .+.+|++|+.|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..|..|++|++|+
T Consensus 224 ~~L~~L~Ls~n~l~-~l~~-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 224 QLWHALDLSNLQIF-NISA-NIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCEEECTTSCCS-CCCG-GGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCcEEECCCCCCC-CCCh-hhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 45777888888877 5653 5678888888888888888 78888888888888888888888 7788888888888888
Q ss_pred CcCCcCCccCChhHH
Q 042949 156 ISNNHFAATSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g~~p~~~~ 170 (608)
|++|.|+ .+|..|.
T Consensus 300 L~~N~l~-~lp~~~~ 313 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFG 313 (727)
T ss_dssp CCSSCCC-CCCSSTT
T ss_pred CCCCCCC-ccChhhh
Confidence 8888886 6777665
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=8.8e-09 Score=103.22 Aligned_cols=95 Identities=22% Similarity=0.251 Sum_probs=71.1
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|..-+.+++..+..+++|+.|++++|.+++..|..+..+++|++|+|++|++++..+..+..+++|+.|+
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 159 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence 46888888888733334345678888888888888888877777788888888888888888865555677888888888
Q ss_pred CcCCcCCccCChhHH
Q 042949 156 ISNNHFAATSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g~~p~~~~ 170 (608)
|++|.+++..+..|.
T Consensus 160 l~~n~l~~~~~~~~~ 174 (285)
T 1ozn_A 160 LHGNRISSVPERAFR 174 (285)
T ss_dssp CCSSCCCEECTTTTT
T ss_pred CCCCcccccCHHHhc
Confidence 888888766555454
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=1.1e-08 Score=104.79 Aligned_cols=114 Identities=23% Similarity=0.354 Sum_probs=90.5
Q ss_pred CCCCCCCCCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccC
Q 042949 53 GWNGNLPHPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISN 123 (608)
Q Consensus 53 ~W~~~~~~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~ 123 (608)
.|...-+..|...|..+.|... ...++.|+|++|++++..+ ..+.++++|++|+|++|.+++..|..+..
T Consensus 20 ~~~~~cp~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (330)
T 1xku_A 20 PMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKD-GDFKNLKNLHTLILINNKISKISPGAFAP 98 (330)
T ss_dssp --CCCCCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred cccCCCCCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeCh-hhhccCCCCCEEECCCCcCCeeCHHHhcC
Confidence 3433323456556788888631 2468899999999998654 57999999999999999999888999999
Q ss_pred CCCcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 124 CRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 124 l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+++|++|+|++|+++ .+|..+. ++|+.|++++|.+++..+..|.
T Consensus 99 l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~ 142 (330)
T 1xku_A 99 LVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFN 142 (330)
T ss_dssp CTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHT
T ss_pred CCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhc
Confidence 999999999999998 6787654 7899999999999877766554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.77 E-value=2e-09 Score=109.64 Aligned_cols=85 Identities=19% Similarity=0.211 Sum_probs=40.8
Q ss_pred cEEEEEecCCCceeecChhhh--cCCcCCcEEEcccCcCCccCcccccCC-----CCcceeeccCeeccccCChhhcCCC
Q 042949 77 NIVGIRLENMNLSGIIDAETL--CKLRHLRVVSLARNLIQGRIPTSISNC-----RRLTYLNLSSNLLSGAVPLALTKLK 149 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l--~~l~~L~~L~l~~N~l~g~~p~~~~~l-----~~L~~L~Ls~N~l~g~lP~~l~~l~ 149 (608)
+++.|+|++|.++|.+|. .+ ..+++|+.|+|++|.+++. |..++.+ ++|++|+|++|++++..|..++.++
T Consensus 96 ~L~~L~L~~n~l~~~~~~-~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPP-PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp CCCEEEEEEEBCBSCCCC-CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CccEEEccCCcccchhHH-HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 444555555555544442 22 4455555555555555544 4444443 4455555555555444444445555
Q ss_pred CCCEEeCcCCcCCc
Q 042949 150 HLKTLDISNNHFAA 163 (608)
Q Consensus 150 ~L~~L~ls~N~l~g 163 (608)
+|++|+|++|++.|
T Consensus 174 ~L~~L~Ls~N~l~~ 187 (312)
T 1wwl_A 174 ALSTLDLSDNPELG 187 (312)
T ss_dssp SCCEEECCSCTTCH
T ss_pred CCCEEECCCCCcCc
Confidence 55555555555444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.77 E-value=1.1e-08 Score=102.90 Aligned_cols=95 Identities=19% Similarity=0.160 Sum_probs=78.5
Q ss_pred CCCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCE
Q 042949 74 HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKT 153 (608)
Q Consensus 74 ~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~ 153 (608)
...+++.|+|++|.++ .+| ..+..+++|+.|+|++|.+++..|..+..+++|++|+|++|+|++..|..+..+++|+.
T Consensus 75 ~l~~L~~L~Ls~N~l~-~l~-~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 152 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQ-SLP-LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152 (290)
T ss_dssp CCTTCCEEECCSSCCS-SCC-CCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCCcCCEEECCCCcCC-cCc-hhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence 3467899999999988 455 36788999999999999999777778999999999999999999666666788999999
Q ss_pred EeCcCCcCCccCChhHH
Q 042949 154 LDISNNHFAATSPDNFR 170 (608)
Q Consensus 154 L~ls~N~l~g~~p~~~~ 170 (608)
|+|++|++++..+..|.
T Consensus 153 L~L~~N~l~~l~~~~~~ 169 (290)
T 1p9a_G 153 LSLANNNLTELPAGLLN 169 (290)
T ss_dssp EECTTSCCSCCCTTTTT
T ss_pred EECCCCcCCccCHHHhc
Confidence 99999999865544443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.77 E-value=6.1e-09 Score=98.45 Aligned_cols=88 Identities=16% Similarity=0.247 Sum_probs=76.6
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.++. . +.+..+++|+.|++++|.+++..|..++.+++|++|+|++|++++..|..+..+++|+.|+
T Consensus 66 ~~L~~L~l~~n~~~~--~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHATN--Y-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCSC--C-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCCc--c-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 479999999996553 2 3688999999999999999988888899999999999999999988888899999999999
Q ss_pred CcCCcCCccCC
Q 042949 156 ISNNHFAATSP 166 (608)
Q Consensus 156 ls~N~l~g~~p 166 (608)
|++|.+.+.+|
T Consensus 143 L~~n~~i~~~~ 153 (197)
T 4ezg_A 143 LSYNGAITDIM 153 (197)
T ss_dssp CCSCTBCCCCG
T ss_pred ccCCCCccccH
Confidence 99998556666
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.5e-08 Score=100.72 Aligned_cols=95 Identities=24% Similarity=0.327 Sum_probs=81.3
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++.. +..+.++++|+.|+|++|.+++..|..+..+++|++|+|++|++++..+..+..+++|+.|
T Consensus 84 l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 162 (270)
T 2o6q_A 84 LKNLETLWVTDNKLQALP-IGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKEL 162 (270)
T ss_dssp CTTCCEEECCSSCCCCCC-TTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCcCC-HhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCccccee
Confidence 357999999999998754 4568899999999999999998888788999999999999999996555568899999999
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|.+++..|..|.
T Consensus 163 ~L~~n~l~~~~~~~~~ 178 (270)
T 2o6q_A 163 RLYNNQLKRVPEGAFD 178 (270)
T ss_dssp ECCSSCCSCCCTTTTT
T ss_pred EecCCcCcEeChhHhc
Confidence 9999999987766554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.75 E-value=1.8e-08 Score=101.46 Aligned_cols=92 Identities=24% Similarity=0.255 Sum_probs=80.4
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++..+ ...+++|+.|+|++|.++ .+|..+..+++|++|+|++|+|++..|..|..+++|+.|
T Consensus 54 l~~L~~L~L~~n~l~~~~~---~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L 129 (290)
T 1p9a_G 54 YTRLTQLNLDRAELTKLQV---DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129 (290)
T ss_dssp CTTCCEEECTTSCCCEEEC---CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccCcccC---CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEE
Confidence 4689999999999998543 378999999999999998 788889999999999999999997666789999999999
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|++++..|..|.
T Consensus 130 ~L~~N~l~~~~~~~~~ 145 (290)
T 1p9a_G 130 YLKGNELKTLPPGLLT 145 (290)
T ss_dssp ECTTSCCCCCCTTTTT
T ss_pred ECCCCCCCccChhhcc
Confidence 9999999977665554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.75 E-value=1.1e-08 Score=96.59 Aligned_cols=89 Identities=17% Similarity=0.182 Sum_probs=61.8
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|++++|.++ .+| .+..+++|+.|++++|.+. .++.+..+++|++|+|++|++++..|..+..+++|++|+|
T Consensus 45 ~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp TCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 5677777777776 444 3677777777777777554 3346777777777777777777766777777777777777
Q ss_pred cCCcCCccCChhHH
Q 042949 157 SNNHFAATSPDNFR 170 (608)
Q Consensus 157 s~N~l~g~~p~~~~ 170 (608)
++|.+++..|..+.
T Consensus 120 s~n~i~~~~~~~l~ 133 (197)
T 4ezg_A 120 SHSAHDDSILTKIN 133 (197)
T ss_dssp CSSBCBGGGHHHHT
T ss_pred cCCccCcHhHHHHh
Confidence 77777776665554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=1.3e-08 Score=113.36 Aligned_cols=94 Identities=24% Similarity=0.315 Sum_probs=63.0
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.+++..| ..+.++++|++|+|++|.+++..|..+++|++|++|+|++|++++..|..++.+++|++|+
T Consensus 56 ~~L~~L~Ls~n~l~~i~~-~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 134 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIED-KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134 (606)
T ss_dssp TTCCEEECTTCCCCEECT-TTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred ccCcEEeCCCCcccccCH-HHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence 466777777777766544 4566777777777777777766666677777777777777777655555666677777777
Q ss_pred CcCCcCCc-cCChhHH
Q 042949 156 ISNNHFAA-TSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g-~~p~~~~ 170 (608)
|++|.+++ .+|..|.
T Consensus 135 L~~n~l~~~~lp~~~~ 150 (606)
T 3vq2_A 135 VAHNFIHSCKLPAYFS 150 (606)
T ss_dssp CCSSCCCCCCCCGGGG
T ss_pred CCCCcccceechHhHh
Confidence 77776664 5566554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.75 E-value=1e-08 Score=103.80 Aligned_cols=97 Identities=19% Similarity=0.305 Sum_probs=87.0
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccc-cCChhhcCCCCCCE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG-AVPLALTKLKHLKT 153 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~lP~~l~~l~~L~~ 153 (608)
..+++.|+|++|.+++..+...+..+++|+.|++++|.+.+.+|..+..+++|+.|+|++|.+++ .+|..+..+++|+.
T Consensus 100 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 179 (306)
T 2z66_A 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179 (306)
T ss_dssp CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE
Confidence 45799999999999986543568999999999999999999999999999999999999999997 68888999999999
Q ss_pred EeCcCCcCCccCChhHHH
Q 042949 154 LDISNNHFAATSPDNFRQ 171 (608)
Q Consensus 154 L~ls~N~l~g~~p~~~~~ 171 (608)
|+|++|.+++..|..|..
T Consensus 180 L~Ls~n~l~~~~~~~~~~ 197 (306)
T 2z66_A 180 LDLSQCQLEQLSPTAFNS 197 (306)
T ss_dssp EECTTSCCCEECTTTTTT
T ss_pred EECCCCCcCCcCHHHhcC
Confidence 999999999988877753
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.75 E-value=7.7e-09 Score=95.86 Aligned_cols=86 Identities=23% Similarity=0.179 Sum_probs=63.9
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCCh--hhcCCCCCCEE
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPL--ALTKLKHLKTL 154 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~--~l~~l~~L~~L 154 (608)
+++.|+|++|.+++. + .+..+++|+.|+|++|.+++..|..+..+++|++|+|++|+++ .+|. .+..+++|+.|
T Consensus 43 ~L~~L~Ls~N~l~~~-~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL-D--GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp CCSEEECCSSCCCEE-C--CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCEEECCCCCCCcc-c--ccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 678888888888774 2 5777888888888888888554444477888888888888885 5665 67778888888
Q ss_pred eCcCCcCCccCCh
Q 042949 155 DISNNHFAATSPD 167 (608)
Q Consensus 155 ~ls~N~l~g~~p~ 167 (608)
++++|.++. +|.
T Consensus 119 ~l~~N~i~~-~~~ 130 (176)
T 1a9n_A 119 CILRNPVTN-KKH 130 (176)
T ss_dssp ECCSSGGGG-STT
T ss_pred EecCCCCCC-cHh
Confidence 888888863 443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=9.8e-09 Score=114.29 Aligned_cols=94 Identities=21% Similarity=0.145 Sum_probs=80.9
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
..++.|+|++|.+++..| ..+.++++|++|+|++|.+.+..|..|.++++|++|+|++|++++..|..+..+++|++|+
T Consensus 33 ~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQN-TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111 (606)
T ss_dssp TTCCEEECTTCCCSEECT-TTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred CcCcEEEccCCccCcCCh-hHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence 468999999999987665 5789999999999999999988888899999999999999999988888899999999999
Q ss_pred CcCCcCCccCChhHH
Q 042949 156 ISNNHFAATSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g~~p~~~~ 170 (608)
|++|.+++..|..|.
T Consensus 112 L~~n~i~~l~~~~~~ 126 (606)
T 3t6q_A 112 FIQTGISSIDFIPLH 126 (606)
T ss_dssp CTTSCCSCGGGSCCT
T ss_pred ccccCcccCCcchhc
Confidence 999999876555453
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.73 E-value=1.1e-08 Score=118.47 Aligned_cols=96 Identities=21% Similarity=0.218 Sum_probs=73.5
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCccc--ccCCCCcceeeccCeeccccCC-hhhcCCCCC
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTS--ISNCRRLTYLNLSSNLLSGAVP-LALTKLKHL 151 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~--~~~l~~L~~L~Ls~N~l~g~lP-~~l~~l~~L 151 (608)
..+++.|+|++|.+++..| ..++++++|++|+|++|.+++.+|.. +.+|++|++|||++|.+++..| ..++.+++|
T Consensus 72 L~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L 150 (844)
T 3j0a_A 72 LPNLRILDLGSSKIYFLHP-DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSL 150 (844)
T ss_dssp CTTCCEEECTTCCCCEECT-TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSC
T ss_pred CCCCCEEECCCCcCcccCH-hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCC
Confidence 3467888888888887665 56888888888888888888766665 7788888888888888876654 467888888
Q ss_pred CEEeCcCCcCCccCChhHHH
Q 042949 152 KTLDISNNHFAATSPDNFRQ 171 (608)
Q Consensus 152 ~~L~ls~N~l~g~~p~~~~~ 171 (608)
++|+|++|.+++..|..+..
T Consensus 151 ~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 151 KSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp CEEEEESSCCCCCCSGGGHH
T ss_pred CEEECCCCcCCeeCHHHccc
Confidence 88888888888877777653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.73 E-value=1.5e-08 Score=112.66 Aligned_cols=84 Identities=14% Similarity=0.181 Sum_probs=40.0
Q ss_pred EEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCc
Q 042949 78 IVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDIS 157 (608)
Q Consensus 78 v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls 157 (608)
+..++++++.+.. +|+..+.++++|++|+|++|.+++..|..++.+++|++|+|++|.+++..|..|+.+++|++|+|+
T Consensus 53 l~~l~l~~~~l~~-lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 53 QKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CSEEEESSCEESE-ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred ceEEEeeCCCCCC-cCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 4444555444433 222334445555555555555554444444555555555555555544444444445555555555
Q ss_pred CCcCC
Q 042949 158 NNHFA 162 (608)
Q Consensus 158 ~N~l~ 162 (608)
+|.++
T Consensus 132 ~n~l~ 136 (597)
T 3oja_B 132 RNDLS 136 (597)
T ss_dssp SSCCC
T ss_pred CCCCC
Confidence 55444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.5e-08 Score=103.73 Aligned_cols=88 Identities=24% Similarity=0.312 Sum_probs=45.3
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|+|++|.+++..+ ..+.++++|+.|+|++|.+++..|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|
T Consensus 193 ~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 193 SLTELHLDGNKITKVDA-ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp TCSEEECTTSCCCEECT-GGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred cCCEEECCCCcCCccCH-HHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 34455555555554433 34555555555555555555544444555555555555555555 45555555555555555
Q ss_pred cCCcCCccCC
Q 042949 157 SNNHFAATSP 166 (608)
Q Consensus 157 s~N~l~g~~p 166 (608)
++|++++..+
T Consensus 271 ~~N~i~~~~~ 280 (330)
T 1xku_A 271 HNNNISAIGS 280 (330)
T ss_dssp CSSCCCCCCT
T ss_pred CCCcCCccCh
Confidence 5555554333
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=1e-08 Score=115.72 Aligned_cols=93 Identities=22% Similarity=0.230 Sum_probs=53.9
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|+|++|++++.. +..+.++++|++|+|++|.+++..|..+++|++|++|+|++|++++..+..|..+++|++|+|
T Consensus 26 ~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 26 NITVLNLTHNQLRRLP-AANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TCSEEECCSSCCCCCC-GGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCcEEECCCCCCCCcC-HHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 5666666666666533 234666666666666666666655555666666666666666665322224556666666666
Q ss_pred cCCcCCccCChhHH
Q 042949 157 SNNHFAATSPDNFR 170 (608)
Q Consensus 157 s~N~l~g~~p~~~~ 170 (608)
++|.+++..|..|.
T Consensus 105 ~~n~l~~~~~~~~~ 118 (680)
T 1ziw_A 105 MSNSIQKIKNNPFV 118 (680)
T ss_dssp CSSCCCCCCSCTTT
T ss_pred CCCccCccChhHcc
Confidence 66666555444443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.72 E-value=1.3e-08 Score=113.14 Aligned_cols=95 Identities=22% Similarity=0.244 Sum_probs=84.9
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.+++..+ ..++.+++|+.|+|++|.+++..|..++++++|++|+|++|.|++..|..|..+++|++|+
T Consensus 75 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDT-YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCCCCh-HHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 478999999999998765 5799999999999999999998888899999999999999999954444579999999999
Q ss_pred CcCCcCCccCChhHHH
Q 042949 156 ISNNHFAATSPDNFRQ 171 (608)
Q Consensus 156 ls~N~l~g~~p~~~~~ 171 (608)
|++|.+++..|..|..
T Consensus 154 Ls~N~l~~~~~~~~~~ 169 (597)
T 3oja_B 154 MSNNNLERIEDDTFQA 169 (597)
T ss_dssp CCSSCCCBCCTTTTTT
T ss_pred eeCCcCCCCChhhhhc
Confidence 9999999998877753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.72 E-value=9.5e-09 Score=112.18 Aligned_cols=92 Identities=25% Similarity=0.294 Sum_probs=65.8
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.+++..| ..+.++++|++|+|++|.+++..|..++++++|++|||++|+++ .+|.. .+++|++|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 21 QKTTILNISQNYISELWT-SDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD 96 (520)
T ss_dssp TTCSEEECCSSCCCCCCH-HHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred ccccEEECCCCcccccCh-hhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence 467777777777776543 46777777777777777777766777777777777777777777 56655 677777777
Q ss_pred CcCCcCCc-cCChhHHH
Q 042949 156 ISNNHFAA-TSPDNFRQ 171 (608)
Q Consensus 156 ls~N~l~g-~~p~~~~~ 171 (608)
|++|.+++ .+|..|..
T Consensus 97 L~~N~l~~~~~p~~~~~ 113 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGN 113 (520)
T ss_dssp CCSSCCSSCCCCGGGGG
T ss_pred ccCCccccccchhhhcc
Confidence 77777776 56666653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.71 E-value=8.1e-09 Score=112.72 Aligned_cols=95 Identities=20% Similarity=0.207 Sum_probs=72.9
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCc--cCcccccCCCCcceeeccCeeccccCChh-hcCCCCC
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQG--RIPTSISNCRRLTYLNLSSNLLSGAVPLA-LTKLKHL 151 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~-l~~l~~L 151 (608)
...++.|+|++|.+++.+| ..++++++|+.|++++|.+++ .+|..+..+++|++|+|++|++++.+|.. +..+++|
T Consensus 323 l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVF-ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp CCCCCEEECCSSCCCTTTT-TTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred CCcccEEEeECCccChhhh-hhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 4567888888888887665 467788888888888888886 56677788888888888888888767764 6777888
Q ss_pred CEEeCcCCcCCccCChhHH
Q 042949 152 KTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 152 ~~L~ls~N~l~g~~p~~~~ 170 (608)
+.|+|++|.+++.+|..+.
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~ 420 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP 420 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC
T ss_pred CEEECcCCCCCcchhhhhc
Confidence 8888888888777776553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.68 E-value=2.1e-08 Score=110.66 Aligned_cols=92 Identities=24% Similarity=0.306 Sum_probs=78.4
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.+++..+ ..+.++++|++|+|++|.+++..|..+..+++|++|||++|+++ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELRM-PDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCCG-GGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCcCEEECCCCCccccCh-hhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 578899999999887654 57899999999999999999888888999999999999999998 67876 789999999
Q ss_pred CcCCcCCc-cCChhHHH
Q 042949 156 ISNNHFAA-TSPDNFRQ 171 (608)
Q Consensus 156 ls~N~l~g-~~p~~~~~ 171 (608)
|++|.+++ .+|..|..
T Consensus 128 Ls~N~l~~l~~p~~~~~ 144 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGN 144 (562)
T ss_dssp CCSSCCSBCCCCGGGGG
T ss_pred CCCCCccccCchHhhcc
Confidence 99999987 56777764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.67 E-value=2e-08 Score=110.71 Aligned_cols=94 Identities=23% Similarity=0.385 Sum_probs=74.0
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCC-ccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQ-GRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
.+++.|+|++|.+.+.+| ..+.++++|+.|++++|.++ +.+|..+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 421 ~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 499 (570)
T 2z63_A 421 RNLIYLDISHTHTRVAFN-GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499 (570)
T ss_dssp TTCCEEECTTSCCEECCT-TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCEEeCcCCcccccch-hhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence 467888888888887765 46778888888888888887 5677778888888888888888887777778888888888
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|++++.+|..|.
T Consensus 500 ~l~~n~l~~~~~~~~~ 515 (570)
T 2z63_A 500 NMASNQLKSVPDGIFD 515 (570)
T ss_dssp ECCSSCCSCCCTTTTT
T ss_pred eCCCCcCCCCCHHHhh
Confidence 8888888877766554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.67 E-value=1.5e-08 Score=104.96 Aligned_cols=108 Identities=20% Similarity=0.194 Sum_probs=89.4
Q ss_pred CCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcc-cccCCCCcce-e
Q 042949 62 CSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPT-SISNCRRLTY-L 130 (608)
Q Consensus 62 c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~-L 130 (608)
|.+.+..|.|+.. ..+++.|+|++|+|+. ||+..+.+|++|+.|+|++|.+.+.+|. .+.+|++|.. +
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l 85 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSE-ECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCC-cCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence 6666788999642 1468999999999985 6656799999999999999999888876 5688988775 6
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+++.|++++..|..|..+++|++|++++|.+++..+..+.
T Consensus 86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~ 125 (350)
T 4ay9_X 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125 (350)
T ss_dssp EEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTC
T ss_pred cccCCcccccCchhhhhccccccccccccccccCCchhhc
Confidence 7778999977778899999999999999999877665543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.67 E-value=2e-08 Score=108.86 Aligned_cols=98 Identities=22% Similarity=0.260 Sum_probs=71.5
Q ss_pred CCCeeecCCCCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCccccc-CCCCcceeeccCeeccccCChh
Q 042949 66 LKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSIS-NCRRLTYLNLSSNLLSGAVPLA 144 (608)
Q Consensus 66 w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~lP~~ 144 (608)
+.++.|.. ..+++.|+|++|.+++..| ..++++++|+.|+|++|.+++.+|..+. ++++|+.|+|++|.|++. |.
T Consensus 111 l~~~~~~~-l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~- 186 (487)
T 3oja_A 111 ISRVSCSR-GQGKKNIYLANNKITMLRD-LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG- 186 (487)
T ss_dssp CCCEEECC-CSSCEEEECCSSCCCSGGG-BCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-
T ss_pred CCCCCccc-cCCCCEEECCCCCCCCCCc-hhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-
Confidence 45565643 3567888888888887664 4577788888888888888887777765 688888888888888765 32
Q ss_pred hcCCCCCCEEeCcCCcCCccCCh
Q 042949 145 LTKLKHLKTLDISNNHFAATSPD 167 (608)
Q Consensus 145 l~~l~~L~~L~ls~N~l~g~~p~ 167 (608)
+..+++|+.|+|++|.+++.+|.
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~~~~~ 209 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAFMGPE 209 (487)
T ss_dssp CCCCTTCCEEECCSSCCCEECGG
T ss_pred cccCCCCCEEECCCCCCCCCCHh
Confidence 34578888888888888875554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.66 E-value=2.8e-08 Score=92.03 Aligned_cols=86 Identities=19% Similarity=0.174 Sum_probs=72.3
Q ss_pred CcEEEEEecCCCceeecChhhhcCCc-CCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLR-HLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~-~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
.+++.|+|++|+++. ++ .+..+. +|+.|++++|.+++. ..++.+++|++|+|++|++++..|..+..+++|++|
T Consensus 19 ~~L~~L~l~~n~l~~-i~--~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IE--NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TSCEEEECTTSCCCS-CC--CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CCceEEEeeCCCCch-hH--HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 379999999999995 44 366655 999999999999975 679999999999999999996444445899999999
Q ss_pred eCcCCcCCccCCh
Q 042949 155 DISNNHFAATSPD 167 (608)
Q Consensus 155 ~ls~N~l~g~~p~ 167 (608)
+|++|.++ .+|.
T Consensus 94 ~L~~N~i~-~~~~ 105 (176)
T 1a9n_A 94 ILTNNSLV-ELGD 105 (176)
T ss_dssp ECCSCCCC-CGGG
T ss_pred ECCCCcCC-cchh
Confidence 99999995 4554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.66 E-value=2.3e-08 Score=110.29 Aligned_cols=97 Identities=19% Similarity=0.309 Sum_probs=88.9
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeecc-ccCChhhcCCCCCCE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS-GAVPLALTKLKHLKT 153 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-g~lP~~l~~l~~L~~ 153 (608)
..+++.|++++|.+.+..+...+.++++|+.|++++|.+.+.+|..+..+++|+.|+|++|.++ +.+|..+..+++|+.
T Consensus 395 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~ 474 (570)
T 2z63_A 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474 (570)
T ss_dssp CTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred cCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCE
Confidence 3578999999999998876557899999999999999999999999999999999999999998 789999999999999
Q ss_pred EeCcCCcCCccCChhHHH
Q 042949 154 LDISNNHFAATSPDNFRQ 171 (608)
Q Consensus 154 L~ls~N~l~g~~p~~~~~ 171 (608)
|+|++|++++..|..|..
T Consensus 475 L~l~~n~l~~~~~~~~~~ 492 (570)
T 2z63_A 475 LDLSQCQLEQLSPTAFNS 492 (570)
T ss_dssp EECTTSCCCEECTTTTTT
T ss_pred EECCCCccccCChhhhhc
Confidence 999999999998987753
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.65 E-value=2.9e-08 Score=107.07 Aligned_cols=95 Identities=20% Similarity=0.245 Sum_probs=79.1
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++..| ..+.++++|+.|+|++|.+++..+..+.++++|++|+|++|++++..|..+..+++|+.|
T Consensus 55 l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 133 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEP-GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133 (477)
T ss_dssp CTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccCEeCh-hhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEE
Confidence 3578899999998888765 578889999999999999886555567888999999999999988888888888899999
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|.+++..|..|.
T Consensus 134 ~l~~n~l~~~~~~~~~ 149 (477)
T 2id5_A 134 EVGDNDLVYISHRAFS 149 (477)
T ss_dssp EECCTTCCEECTTSST
T ss_pred ECCCCccceeChhhcc
Confidence 9999988887776665
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.64 E-value=1.6e-08 Score=103.82 Aligned_cols=88 Identities=24% Similarity=0.307 Sum_probs=49.6
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|++++|.+++ +|. .+. ++|+.|++++|.+++..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|
T Consensus 173 ~L~~L~l~~n~l~~-l~~-~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 248 (332)
T 2ft3_A 173 KLNYLRISEAKLTG-IPK-DLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248 (332)
T ss_dssp CCSCCBCCSSBCSS-CCS-SSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEEC
T ss_pred ccCEEECcCCCCCc-cCc-ccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEEC
Confidence 45556666666554 331 121 45666666666666555555666666666666666666554445556666666666
Q ss_pred cCCcCCccCChhH
Q 042949 157 SNNHFAATSPDNF 169 (608)
Q Consensus 157 s~N~l~g~~p~~~ 169 (608)
++|.++ .+|..+
T Consensus 249 ~~N~l~-~lp~~l 260 (332)
T 2ft3_A 249 DNNKLS-RVPAGL 260 (332)
T ss_dssp CSSCCC-BCCTTG
T ss_pred CCCcCe-ecChhh
Confidence 666665 455444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.64 E-value=1.8e-08 Score=111.18 Aligned_cols=96 Identities=15% Similarity=0.170 Sum_probs=80.5
Q ss_pred CCCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCc--cCcccccCCCCcceeeccCeeccccCChh-hcCCCC
Q 042949 74 HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQG--RIPTSISNCRRLTYLNLSSNLLSGAVPLA-LTKLKH 150 (608)
Q Consensus 74 ~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~-l~~l~~ 150 (608)
...+++.|+|++|.+++.+| ..+.++++|+.|+|++|.+++ .+|..+.++++|+.|+|++|++++.+|.. +..+++
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVF-QGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTT-TTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred CCCCceEEECCCCccccchh-hhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 34578999999999998776 578899999999999999987 44567889999999999999999877764 778899
Q ss_pred CCEEeCcCCcCCccCChhHH
Q 042949 151 LKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 151 L~~L~ls~N~l~g~~p~~~~ 170 (608)
|+.|+|++|.+++.+|..+.
T Consensus 430 L~~L~l~~n~l~~~~~~~l~ 449 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP 449 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC
T ss_pred CCEEECCCCCCCcchhhhhc
Confidence 99999999999888877654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.64 E-value=2.3e-08 Score=101.52 Aligned_cols=86 Identities=14% Similarity=0.086 Sum_probs=67.3
Q ss_pred cEEEEEecCCCceeecChhhh--cCCcCCcEEEcccCcCCccCc----ccccCCCCcceeeccCeeccccCChhhcCCCC
Q 042949 77 NIVGIRLENMNLSGIIDAETL--CKLRHLRVVSLARNLIQGRIP----TSISNCRRLTYLNLSSNLLSGAVPLALTKLKH 150 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l--~~l~~L~~L~l~~N~l~g~~p----~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~ 150 (608)
+++.|+|++|.++|.+|. .+ ..+++|+.|+|++|.+++.+| ..+..+++|++|+|++|++++..|..+..+++
T Consensus 92 ~L~~L~l~~n~l~~~~~~-~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPP-LPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp CCCEEEEESCCCBSCCCC-CSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred ceeEEEeeCCEeccchhh-hhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 488888888888887764 45 778888888888888887665 34456888888888888888777777888888
Q ss_pred CCEEeCcCCcCCc
Q 042949 151 LKTLDISNNHFAA 163 (608)
Q Consensus 151 L~~L~ls~N~l~g 163 (608)
|++|||++|++.+
T Consensus 171 L~~L~Ls~N~l~~ 183 (310)
T 4glp_A 171 LTSLDLSDNPGLG 183 (310)
T ss_dssp CCEEECCSCTTCH
T ss_pred CCEEECCCCCCcc
Confidence 8888888888765
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.64 E-value=5.1e-08 Score=102.32 Aligned_cols=90 Identities=14% Similarity=0.182 Sum_probs=70.0
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.++++++.+.. +|+..+..+++|++|+|++|.+.+..|..+..+++|++|+|++|.+++..|..+..+++|++|+
T Consensus 45 ~~l~~l~l~~~~l~~-l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEESE-ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchhh-CChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 467788888887665 4545577888888888888888877777888888888888888888877677788888888888
Q ss_pred CcCCcCCccCC
Q 042949 156 ISNNHFAATSP 166 (608)
Q Consensus 156 ls~N~l~g~~p 166 (608)
|++|.++...+
T Consensus 124 L~~n~l~~l~~ 134 (390)
T 3o6n_A 124 LERNDLSSLPR 134 (390)
T ss_dssp CCSSCCCCCCT
T ss_pred CCCCccCcCCH
Confidence 88888874333
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.64 E-value=1.7e-08 Score=102.74 Aligned_cols=90 Identities=23% Similarity=0.252 Sum_probs=77.2
Q ss_pred CCCcEEEEEecCCCcee--ecChhhhcCCcCCcEEEcccCcCCccCc-ccccCCCCcceeeccCeeccccCChhhcCCCC
Q 042949 74 HATNIVGIRLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIP-TSISNCRRLTYLNLSSNLLSGAVPLALTKLKH 150 (608)
Q Consensus 74 ~~~~v~~l~l~~~~l~g--~~~~~~l~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~ 150 (608)
...+++.|+|++|.+++ .++...+.++++|+.|+|++|.+++.+| ..+..+++|++|+|++|+|+ .+|..+. ++
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~ 275 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AK 275 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CC
Confidence 45689999999999984 4443445688999999999999999886 46778999999999999999 8898776 89
Q ss_pred CCEEeCcCCcCCccCCh
Q 042949 151 LKTLDISNNHFAATSPD 167 (608)
Q Consensus 151 L~~L~ls~N~l~g~~p~ 167 (608)
|+.|||++|++++. |.
T Consensus 276 L~~L~Ls~N~l~~~-p~ 291 (312)
T 1wwl_A 276 LSVLDLSYNRLDRN-PS 291 (312)
T ss_dssp EEEEECCSSCCCSC-CC
T ss_pred ceEEECCCCCCCCC-hh
Confidence 99999999999987 54
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.63 E-value=1.1e-08 Score=103.65 Aligned_cols=179 Identities=16% Similarity=0.151 Sum_probs=117.2
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCC-CCc--ceeeeeeeecCC---eeEEEEeeccCCC
Q 042949 309 RSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPN--ILPLVCYNSTNE---EKLLVYKYQSNGS 382 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e~~~~g~ 382 (608)
++.|....||++. ..+++|+-... .....+.+|.++++.+. +.. +.+++......+ ..|+|||+++|.+
T Consensus 28 ~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~ 102 (304)
T 3sg8_A 28 SGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVP 102 (304)
T ss_dssp EEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEE
T ss_pred cCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeE
Confidence 5678888888863 45888876532 23467889999998873 333 234444433332 3478999999988
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKS------------------------------------------ 420 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------ 420 (608)
|.+... ..++..++..++.++++.|+.||+..
T Consensus 103 l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 103 LTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 765332 24677888888999999999998621
Q ss_pred -----------CCCCCceecCCCCCCeecCC--CCCceEeccccccccCCCCcc--c------ccc-------Ccc--cc
Q 042949 421 -----------NEEKTIPHGNLKLSNILLNE--NEDPLISECGYSKFLDPKKTC--L------FSS-------NGY--TA 470 (608)
Q Consensus 421 -----------~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~--~------~gt-------~~y--~a 470 (608)
.....++|+|++|.||++++ ...+.|+||+.+..-...... . .+. ..| ..
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 01245799999999999988 455789999988754322100 0 000 012 11
Q ss_pred -CC--CCCCcchhHHHHHHHHHHHHcCCCCC
Q 042949 471 -PE--KTVSEQGDVFSFGVILLELLTGKTVE 498 (608)
Q Consensus 471 -PE--~~~~~ksDVwSfGvvl~elltg~~p~ 498 (608)
|+ .......+.|+++.+++++.+|..++
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 11122368999999999999998653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.6e-08 Score=109.36 Aligned_cols=92 Identities=22% Similarity=0.262 Sum_probs=73.5
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccc-cCChhhcCCCCCCE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG-AVPLALTKLKHLKT 153 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~lP~~l~~l~~L~~ 153 (608)
..+++.|+|++|.+++..| ..++++++|++|+|++|.+++..|..++++++|++|+|++|++++ .+|..+..+++|++
T Consensus 49 l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 127 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEG-DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127 (549)
T ss_dssp CTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCE
T ss_pred CCcccEEECCCCCcCccCh-hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccE
Confidence 3578888888888887654 568888888888888888887777778888888888888888876 46677888888888
Q ss_pred EeCcCCcCCccCCh
Q 042949 154 LDISNNHFAATSPD 167 (608)
Q Consensus 154 L~ls~N~l~g~~p~ 167 (608)
|++++|.+.+.+|.
T Consensus 128 L~L~~n~~~~~~~~ 141 (549)
T 2z81_A 128 LRIGNVETFSEIRR 141 (549)
T ss_dssp EEEEESSSCCEECT
T ss_pred EECCCCccccccCH
Confidence 88888886666653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.62 E-value=4e-08 Score=104.97 Aligned_cols=93 Identities=24% Similarity=0.335 Sum_probs=74.2
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|+..+.+++..+.++++|+.|+|++|.++ .+| .+..+++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 160 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 237 (440)
T 3zyj_A 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237 (440)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEE
Confidence 578888898877677777667888888888888888888 455 478888888888888888877777888888888888
Q ss_pred CcCCcCCccCChhHH
Q 042949 156 ISNNHFAATSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g~~p~~~~ 170 (608)
|++|.+++..|..|.
T Consensus 238 L~~n~l~~~~~~~~~ 252 (440)
T 3zyj_A 238 MIQSQIQVIERNAFD 252 (440)
T ss_dssp CTTCCCCEECTTSST
T ss_pred CCCCceeEEChhhhc
Confidence 888888877776654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.61 E-value=3.4e-08 Score=103.69 Aligned_cols=93 Identities=24% Similarity=0.312 Sum_probs=82.5
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChh-hcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLA-LTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~-l~~l~~L~~L 154 (608)
.+++.|+|++|.+++..+ ..+..+++|+.|+|++|.+++..|..++.+++|++|+|++|+++ .+|.. +..+++|++|
T Consensus 69 ~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDT-YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 146 (390)
T ss_dssp CCCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred ccCcEEECCCCcccccCh-hhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEE
Confidence 578999999999987654 57999999999999999999888888999999999999999999 56654 6899999999
Q ss_pred eCcCCcCCccCChhHH
Q 042949 155 DISNNHFAATSPDNFR 170 (608)
Q Consensus 155 ~ls~N~l~g~~p~~~~ 170 (608)
+|++|.+++..|..|.
T Consensus 147 ~L~~n~l~~~~~~~~~ 162 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQ 162 (390)
T ss_dssp ECCSSCCCBCCTTTTS
T ss_pred ECCCCccCccChhhcc
Confidence 9999999988777664
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.61 E-value=1.2e-08 Score=112.12 Aligned_cols=99 Identities=26% Similarity=0.500 Sum_probs=73.4
Q ss_pred CCCCCCCCCCCC---CCCCe-eecCCCCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcc
Q 042949 53 GWNGNLPHPCSY---NLKGI-KCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLT 128 (608)
Q Consensus 53 ~W~~~~~~~c~~---~w~gv-~c~~~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 128 (608)
+|..+ ..||.. .|.|+ .|.. ++++.|+|++|+|++ +|. .+ +++|+.|+|++|.|+ .+| ..+++|+
T Consensus 35 ~W~~~-~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~-~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 35 KWEKQ-ALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPD-NL--PPQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHTT-CCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCS-CC--CTTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHhcc-CCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCH-hH--cCCCCEEECcCCCCc-ccc---cccCCCC
Confidence 67543 478853 47888 7863 378999999999987 663 34 377888888888888 677 4577888
Q ss_pred eeeccCeeccccCChhhcCCCCCCEEeCcCCcCCccCCh
Q 042949 129 YLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPD 167 (608)
Q Consensus 129 ~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~ 167 (608)
+|+|++|+|++ +|. +.. +|+.|+|++|+|++ +|.
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~ 137 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE 137 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC
Confidence 88888888886 776 554 78888888888877 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=4.6e-08 Score=110.47 Aligned_cols=92 Identities=26% Similarity=0.293 Sum_probs=51.6
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|+|++|.+++..| ..+.++++|++|+|++|.+++..+..++++++|++|+|++|++++..|..+..+++|++|+|
T Consensus 50 ~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 50 QLTSLDVGFNTISKLEP-ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TCSEEECCSSCCCCCCT-THHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred cCcEEECCCCccCccCH-HHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 45566666666655443 34555666666666666665433334555666666666666665444445555666666666
Q ss_pred cCCcCCccCChhH
Q 042949 157 SNNHFAATSPDNF 169 (608)
Q Consensus 157 s~N~l~g~~p~~~ 169 (608)
++|.+++..|..+
T Consensus 129 s~n~l~~~~~~~~ 141 (680)
T 1ziw_A 129 SHNGLSSTKLGTQ 141 (680)
T ss_dssp CSSCCSCCCCCSS
T ss_pred CCCcccccCchhh
Confidence 6666555555443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.59 E-value=5.3e-08 Score=104.39 Aligned_cols=93 Identities=19% Similarity=0.277 Sum_probs=73.7
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|+.-+.+++..+.++++|+.|+|++|.+++ +| .+..+++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 171 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 248 (452)
T 3zyi_A 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248 (452)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEE
T ss_pred CcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEE
Confidence 4678888888776677776678888888888888888885 44 477888888888888888877777888888888888
Q ss_pred CcCCcCCccCChhHH
Q 042949 156 ISNNHFAATSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g~~p~~~~ 170 (608)
|++|++++..|..|.
T Consensus 249 L~~n~l~~~~~~~~~ 263 (452)
T 3zyi_A 249 VMNSQVSLIERNAFD 263 (452)
T ss_dssp CTTSCCCEECTTTTT
T ss_pred eCCCcCceECHHHhc
Confidence 888888877776664
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=5.2e-08 Score=108.37 Aligned_cols=92 Identities=21% Similarity=0.219 Sum_probs=71.2
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++..| ..+.++++|++|+|++|.+++..|..++.+++|++|+|++|++++..|..+..+++|++|
T Consensus 56 l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L 134 (606)
T 3t6q_A 56 LINLTFLDLTRCQIYWIHE-DTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESL 134 (606)
T ss_dssp CTTCSEEECTTCCCCEECT-TTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEE
T ss_pred CccceEEECCCCccceeCh-hhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEE
Confidence 3568888888888877654 568888888888888888887778788888888888888888886556667788888888
Q ss_pred eCcCCcCCc-cCCh
Q 042949 155 DISNNHFAA-TSPD 167 (608)
Q Consensus 155 ~ls~N~l~g-~~p~ 167 (608)
+|++|.+++ .+|.
T Consensus 135 ~L~~n~l~~~~~~~ 148 (606)
T 3t6q_A 135 YLGSNHISSIKLPK 148 (606)
T ss_dssp ECCSSCCCCCCCCT
T ss_pred ECCCCcccccCccc
Confidence 888888877 3444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.59 E-value=4.4e-08 Score=106.10 Aligned_cols=90 Identities=18% Similarity=0.158 Sum_probs=77.0
Q ss_pred CCcEEEEEecCCCceeecChhhhc-CCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLC-KLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKT 153 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~ 153 (608)
..+++.|+|++|.+++.+|. .+. .+++|+.|+|++|.|++. | .+..+++|+.|+|++|.|++ +|+.+..+++|+.
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~-~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~ 218 (487)
T 3oja_A 143 RSRVQYLDLKLNEIDTVNFA-ELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTW 218 (487)
T ss_dssp GSSEEEEECTTSCCCEEEGG-GGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSE
T ss_pred CCCCCEEECCCCCCCCcChH-HHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccE
Confidence 35899999999999998864 555 899999999999999976 3 35579999999999999997 5556999999999
Q ss_pred EeCcCCcCCccCChhH
Q 042949 154 LDISNNHFAATSPDNF 169 (608)
Q Consensus 154 L~ls~N~l~g~~p~~~ 169 (608)
|+|++|.|++ +|..+
T Consensus 219 L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 219 ISLRNNKLVL-IEKAL 233 (487)
T ss_dssp EECTTSCCCE-ECTTC
T ss_pred EEecCCcCcc-cchhh
Confidence 9999999996 56543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.57 E-value=2e-08 Score=101.97 Aligned_cols=95 Identities=16% Similarity=0.155 Sum_probs=75.5
Q ss_pred CCCcEEEEEecCCCceee--c-ChhhhcCCcCCcEEEcccCcCCccCcc----cccCCCCcceeeccCeeccccCChhhc
Q 042949 74 HATNIVGIRLENMNLSGI--I-DAETLCKLRHLRVVSLARNLIQGRIPT----SISNCRRLTYLNLSSNLLSGAVPLALT 146 (608)
Q Consensus 74 ~~~~v~~l~l~~~~l~g~--~-~~~~l~~l~~L~~L~l~~N~l~g~~p~----~~~~l~~L~~L~Ls~N~l~g~lP~~l~ 146 (608)
...+++.|+|++|.+.|. + ++..+..+++|++|+|++|.++ .+|. .+..+++|++|||++|++++.+|..+.
T Consensus 167 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~ 245 (310)
T 4glp_A 167 AFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAP 245 (310)
T ss_dssp CCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCS
T ss_pred cCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHH
Confidence 346899999999998763 2 2223468999999999999997 2333 257889999999999999988887777
Q ss_pred CC---CCCCEEeCcCCcCCccCChhHH
Q 042949 147 KL---KHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 147 ~l---~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
.+ ++|++|+|++|+|+ .+|..+.
T Consensus 246 ~~~~~~~L~~L~Ls~N~l~-~lp~~~~ 271 (310)
T 4glp_A 246 RCMWSSALNSLNLSFAGLE-QVPKGLP 271 (310)
T ss_dssp SCCCCTTCCCEECCSSCCC-SCCSCCC
T ss_pred hccCcCcCCEEECCCCCCC-chhhhhc
Confidence 66 69999999999999 6777654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.57 E-value=5.3e-08 Score=94.79 Aligned_cols=93 Identities=18% Similarity=0.263 Sum_probs=77.3
Q ss_pred CCcEEEEEecCCC-ceeecChhhhcCCcCCcEEEccc-CcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCC
Q 042949 75 ATNIVGIRLENMN-LSGIIDAETLCKLRHLRVVSLAR-NLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLK 152 (608)
Q Consensus 75 ~~~v~~l~l~~~~-l~g~~~~~~l~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~ 152 (608)
..+++.|+|++|. +++ +++..+.++++|+.|++++ |.+++..+..+..+++|++|+|++|++++ +|. +..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~-i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~ 130 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQ-LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTD 130 (239)
T ss_dssp CTTCCEEEEECCSSCCE-ECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCC
T ss_pred CCCCcEEeCCCCCCcce-eCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccc
Confidence 3579999999997 665 4445788999999999998 99997777788999999999999999986 776 88888888
Q ss_pred ---EEeCcCC-cCCccCChhHH
Q 042949 153 ---TLDISNN-HFAATSPDNFR 170 (608)
Q Consensus 153 ---~L~ls~N-~l~g~~p~~~~ 170 (608)
.|++++| .+++..+..|.
T Consensus 131 ~L~~L~l~~N~~l~~i~~~~~~ 152 (239)
T 2xwt_C 131 IFFILEITDNPYMTSIPVNAFQ 152 (239)
T ss_dssp SEEEEEEESCTTCCEECTTTTT
T ss_pred cccEEECCCCcchhhcCccccc
Confidence 9999999 88876665554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.51 E-value=3.2e-08 Score=97.61 Aligned_cols=67 Identities=27% Similarity=0.359 Sum_probs=56.1
Q ss_pred CCcCCcEEEcccCcCCc--cCcccccCCCCcceeeccCeeccccCChhhcCCC--CCCEEeCcCCcCCccCCh
Q 042949 99 KLRHLRVVSLARNLIQG--RIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLK--HLKTLDISNNHFAATSPD 167 (608)
Q Consensus 99 ~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~--~L~~L~ls~N~l~g~~p~ 167 (608)
++++|+.|+|++|.|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence 57899999999999998 5677778999999999999999864 3344444 899999999999998884
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.49 E-value=1.1e-07 Score=98.22 Aligned_cols=94 Identities=20% Similarity=0.327 Sum_probs=79.6
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCCh--hhcCCCCCC
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPL--ALTKLKHLK 152 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~--~l~~l~~L~ 152 (608)
..+++.|+|++|.+++..+ ..+.++++|++|+|++|.+++..+..+.++++|++|+|++|+++ .+|. .+..+++|+
T Consensus 75 l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEE-DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152 (353)
T ss_dssp CTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCC
T ss_pred CCCCCEEECCCCccCccCH-hhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCc
Confidence 4589999999999998665 57999999999999999999655555899999999999999999 5665 788999999
Q ss_pred EEeCcCCc-CCccCChhHH
Q 042949 153 TLDISNNH-FAATSPDNFR 170 (608)
Q Consensus 153 ~L~ls~N~-l~g~~p~~~~ 170 (608)
+|++++|+ +.+..|..|.
T Consensus 153 ~L~l~~n~~~~~~~~~~~~ 171 (353)
T 2z80_A 153 ILRVGNMDTFTKIQRKDFA 171 (353)
T ss_dssp EEEEEESSSCCEECTTTTT
T ss_pred EEECCCCccccccCHHHcc
Confidence 99999995 5555555554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.46 E-value=5.9e-09 Score=98.61 Aligned_cols=80 Identities=30% Similarity=0.430 Sum_probs=43.2
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|+|++|.+++ +| .+.++++|+.|++++|.++ .+|..+..+++|+.|+|++|++++ +| .+..+++|+.|+|
T Consensus 49 ~L~~L~ls~n~l~~-l~--~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 49 ACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TCSEEECSEEEESC-CC--CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCEEECCCCCCcc-cc--ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 45555555555555 33 3555555555555555555 445444555555555555555553 33 3555555555555
Q ss_pred cCCcCC
Q 042949 157 SNNHFA 162 (608)
Q Consensus 157 s~N~l~ 162 (608)
++|.++
T Consensus 123 ~~N~i~ 128 (198)
T 1ds9_A 123 SNNKIT 128 (198)
T ss_dssp SEEECC
T ss_pred CCCcCC
Confidence 555554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.45 E-value=2e-07 Score=94.97 Aligned_cols=92 Identities=24% Similarity=0.252 Sum_probs=76.3
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccc-cCCCCcceeeccCeeccccCChhhcCCCCCCE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI-SNCRRLTYLNLSSNLLSGAVPLALTKLKHLKT 153 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~ 153 (608)
...++.|+|++|.+++..+ ..+..+++|+.|+|++|.+++..|..+ ..+++|++|+|++|++++. |. ...+++|+.
T Consensus 119 ~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~ 195 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRD-LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKT 195 (317)
T ss_dssp CSSCEEEECCSSCCCSGGG-BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCE
T ss_pred cCCCCEEECCCCCCCCccc-hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCE
Confidence 3579999999999998654 568889999999999999998877776 4799999999999999854 43 345899999
Q ss_pred EeCcCCcCCccCChhHH
Q 042949 154 LDISNNHFAATSPDNFR 170 (608)
Q Consensus 154 L~ls~N~l~g~~p~~~~ 170 (608)
|+|++|.+++..|. +.
T Consensus 196 L~Ls~N~l~~l~~~-~~ 211 (317)
T 3o53_A 196 LDLSSNKLAFMGPE-FQ 211 (317)
T ss_dssp EECCSSCCCEECGG-GG
T ss_pred EECCCCcCCcchhh-hc
Confidence 99999999975554 54
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.45 E-value=1e-07 Score=104.85 Aligned_cols=42 Identities=12% Similarity=0.279 Sum_probs=24.7
Q ss_pred ceeeccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 128 TYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 128 ~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+.|+|++|+|+ .||..+..+++|+.|+|++|.|++.+|..+.
T Consensus 210 ~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 251 (571)
T 3cvr_A 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251 (571)
T ss_dssp EEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHH
T ss_pred eEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHH
Confidence 55555555555 4555555566666666666666666665554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.41 E-value=1.7e-07 Score=95.35 Aligned_cols=90 Identities=18% Similarity=0.150 Sum_probs=60.5
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.+++..+......+++|+.|+|++|.+++. | ....+++|+.|+|++|++++ +|..+..+++|+.|+
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~ 220 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEE
Confidence 46888888888888766532224677777777777777754 3 23347777777777777774 444566777777777
Q ss_pred CcCCcCCccCChhH
Q 042949 156 ISNNHFAATSPDNF 169 (608)
Q Consensus 156 ls~N~l~g~~p~~~ 169 (608)
|++|.+++ +|..+
T Consensus 221 L~~N~l~~-l~~~~ 233 (317)
T 3o53_A 221 LRNNKLVL-IEKAL 233 (317)
T ss_dssp CTTSCCCE-ECTTC
T ss_pred CcCCcccc-hhhHh
Confidence 77777763 45443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.40 E-value=4.1e-07 Score=91.49 Aligned_cols=85 Identities=25% Similarity=0.398 Sum_probs=71.7
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++ ++ .+..+++|+.|++++|.+++ + +.+..+++|+.|+|++|++++. ..+..+++|+.|
T Consensus 89 l~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 161 (291)
T 1h6t_A 89 LKNLGWLFLDENKVKD-LS--SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 161 (291)
T ss_dssp CTTCCEEECCSSCCCC-GG--GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred CCCCCEEECCCCcCCC-Ch--hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEE
Confidence 4578999999999887 33 48899999999999999986 3 4688899999999999999864 568889999999
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
+|++|.+++..|
T Consensus 162 ~L~~N~l~~~~~ 173 (291)
T 1h6t_A 162 SLEDNQISDIVP 173 (291)
T ss_dssp ECCSSCCCCCGG
T ss_pred EccCCccccchh
Confidence 999999987655
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.37 E-value=3.1e-07 Score=102.16 Aligned_cols=85 Identities=16% Similarity=0.269 Sum_probs=57.8
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|+|++|++++ +| ..+++|+.|+|++|.|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 222 ~L~~L~Ls~N~L~~-lp----~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 222 GLKELIVSGNRLTS-LP----VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TCCEEECCSSCCSC-CC----CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCEEEccCCccCc-CC----CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 45556666666554 33 24466677777777766 4554 5567777788888777 67777777888888888
Q ss_pred cCCcCCccCChhHHH
Q 042949 157 SNNHFAATSPDNFRQ 171 (608)
Q Consensus 157 s~N~l~g~~p~~~~~ 171 (608)
++|.|+|.+|..+..
T Consensus 292 ~~N~l~~~~~~~l~~ 306 (622)
T 3g06_A 292 EGNPLSERTLQALRE 306 (622)
T ss_dssp CSCCCCHHHHHHHHH
T ss_pred cCCCCCCcCHHHHHh
Confidence 888888777776653
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.37 E-value=3.8e-07 Score=92.46 Aligned_cols=85 Identities=26% Similarity=0.427 Sum_probs=72.1
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++. + .+..+++|+.|++++|.+++..+ +..+++|+.|+|++|++++ +|. +..+++|+.|
T Consensus 106 l~~L~~L~l~~n~l~~~-~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L 178 (308)
T 1h6u_A 106 LQSIKTLDLTSTQITDV-T--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTL 178 (308)
T ss_dssp CTTCCEEECTTSCCCCC-G--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEE
T ss_pred CCCCCEEECCCCCCCCc-h--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEE
Confidence 45799999999999874 3 38899999999999999986543 8899999999999999986 444 8899999999
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
+|++|.+++..|
T Consensus 179 ~l~~n~l~~~~~ 190 (308)
T 1h6u_A 179 KADDNKISDISP 190 (308)
T ss_dssp ECCSSCCCCCGG
T ss_pred ECCCCccCcChh
Confidence 999999987554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.37 E-value=1.1e-08 Score=96.75 Aligned_cols=84 Identities=30% Similarity=0.397 Sum_probs=63.8
Q ss_pred cEEEEEecCCCceeecCh-----hhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCC
Q 042949 77 NIVGIRLENMNLSGIIDA-----ETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHL 151 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~-----~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L 151 (608)
.++.++|+.+.++|.+|. ..+..+++|+.|+|++|.+++ +| .+..+++|+.|+|++|.++ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 455555666666666542 257788888888888888886 66 7888888888888888888 677777777888
Q ss_pred CEEeCcCCcCCc
Q 042949 152 KTLDISNNHFAA 163 (608)
Q Consensus 152 ~~L~ls~N~l~g 163 (608)
+.|+|++|.+++
T Consensus 96 ~~L~L~~N~l~~ 107 (198)
T 1ds9_A 96 EELWISYNQIAS 107 (198)
T ss_dssp SEEEEEEEECCC
T ss_pred CEEECcCCcCCc
Confidence 888888888876
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.36 E-value=4.2e-07 Score=93.47 Aligned_cols=88 Identities=23% Similarity=0.406 Sum_probs=66.4
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.+++.. .+..+++|+.|++++|.+++ + +.+..+++|+.|+|++|++++. | .+..+++|+.|+
T Consensus 221 ~~L~~L~l~~n~l~~~~---~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~ 293 (347)
T 4fmz_A 221 TRLNSLKIGNNKITDLS---PLANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-S-VLNNLSQLNSLF 293 (347)
T ss_dssp TTCCEEECCSSCCCCCG---GGTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEE
T ss_pred CcCCEEEccCCccCCCc---chhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-h-hhcCCCCCCEEE
Confidence 46888888888887643 27788888888888888875 3 3577888888888888888753 3 477788888888
Q ss_pred CcCCcCCccCChhHH
Q 042949 156 ISNNHFAATSPDNFR 170 (608)
Q Consensus 156 ls~N~l~g~~p~~~~ 170 (608)
+++|.+++..|..+.
T Consensus 294 L~~n~l~~~~~~~l~ 308 (347)
T 4fmz_A 294 LNNNQLGNEDMEVIG 308 (347)
T ss_dssp CCSSCCCGGGHHHHH
T ss_pred CcCCcCCCcChhHhh
Confidence 888888877776665
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.36 E-value=6.4e-07 Score=88.61 Aligned_cols=82 Identities=28% Similarity=0.369 Sum_probs=65.6
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++..+ +.++++|+.|+|++|.+++ +|.. .. ++|+.|+|++|++++ +| .+..+++|+.|
T Consensus 62 l~~L~~L~L~~N~i~~~~~---l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L 133 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP---LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEIL 133 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG---GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEE
T ss_pred CCCCCEEECCCCccCCChh---hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEE
Confidence 3578899999999887532 8889999999999999986 4543 33 889999999999886 44 58888999999
Q ss_pred eCcCCcCCcc
Q 042949 155 DISNNHFAAT 164 (608)
Q Consensus 155 ~ls~N~l~g~ 164 (608)
+|++|++++.
T Consensus 134 ~Ls~N~i~~~ 143 (263)
T 1xeu_A 134 SIRNNKLKSI 143 (263)
T ss_dssp ECTTSCCCBC
T ss_pred ECCCCcCCCC
Confidence 9999988874
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.35 E-value=6.2e-07 Score=90.13 Aligned_cols=83 Identities=25% Similarity=0.394 Sum_probs=73.3
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++..+ +.++++|+.|++++|.+++ +| .+..+++|++|+|++|++++ + ..+..+++|+.|
T Consensus 67 l~~L~~L~L~~n~l~~~~~---l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L 139 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP---LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESL 139 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEE
T ss_pred CCCCCEEEccCCccCCCcc---cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEE
Confidence 3579999999999998542 8999999999999999986 44 49999999999999999996 4 468899999999
Q ss_pred eCcCCcCCcc
Q 042949 155 DISNNHFAAT 164 (608)
Q Consensus 155 ~ls~N~l~g~ 164 (608)
++++|.+++.
T Consensus 140 ~l~~n~l~~~ 149 (291)
T 1h6t_A 140 YLGNNKITDI 149 (291)
T ss_dssp ECCSSCCCCC
T ss_pred EccCCcCCcc
Confidence 9999999875
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.35 E-value=2.7e-07 Score=94.96 Aligned_cols=87 Identities=23% Similarity=0.336 Sum_probs=78.9
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++. +.+..+++|+.|++++|.+++. +.+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 242 l~~L~~L~l~~n~l~~~---~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 242 LSQLTWLEIGTNQISDI---NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp CTTCCEEECCSSCCCCC---GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred CCCCCEEECCCCccCCC---hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 46899999999999874 3589999999999999999974 468999999999999999999888899999999999
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
+|++|.+++..|
T Consensus 317 ~L~~n~l~~~~~ 328 (347)
T 4fmz_A 317 FLSQNHITDIRP 328 (347)
T ss_dssp ECCSSSCCCCGG
T ss_pred EccCCccccccC
Confidence 999999998877
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.35 E-value=7.2e-07 Score=98.95 Aligned_cols=85 Identities=25% Similarity=0.402 Sum_probs=60.4
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.|++ ++ .+..|++|+.|+|++|.+++ + +.+..|++|+.|+|++|+|++. ..+..+++|+.|
T Consensus 86 l~~L~~L~Ls~N~l~~-l~--~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 158 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKD-LS--SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 158 (605)
T ss_dssp CTTCCEEECCSSCCCC-CT--TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEE
T ss_pred CCCCCEEECcCCCCCC-Ch--hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEE
Confidence 3467778888887776 22 47777777777777777775 3 3477777777777777777754 456777777777
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
+|++|.|++..|
T Consensus 159 ~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 159 SLEDNQISDIVP 170 (605)
T ss_dssp ECCSSCCCCCGG
T ss_pred ECcCCcCCCchh
Confidence 777777776655
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.34 E-value=4.2e-07 Score=89.94 Aligned_cols=82 Identities=21% Similarity=0.305 Sum_probs=69.3
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++ ++ .+.. ++|+.|+|++|.+++ +| .+..+++|+.|+|++|++++ +| .+..+++|+.|
T Consensus 84 l~~L~~L~L~~N~l~~-l~--~~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L 155 (263)
T 1xeu_A 84 LTKLEELSVNRNRLKN-LN--GIPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVL 155 (263)
T ss_dssp CSSCCEEECCSSCCSC-CT--TCCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEE
T ss_pred CCCCCEEECCCCccCC-cC--cccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEE
Confidence 4579999999999987 33 2444 899999999999996 44 58999999999999999986 44 68889999999
Q ss_pred eCcCCcCCcc
Q 042949 155 DISNNHFAAT 164 (608)
Q Consensus 155 ~ls~N~l~g~ 164 (608)
+|++|.+++.
T Consensus 156 ~L~~N~i~~~ 165 (263)
T 1xeu_A 156 DLHGNEITNT 165 (263)
T ss_dssp ECTTSCCCBC
T ss_pred ECCCCcCcch
Confidence 9999999886
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=6.2e-07 Score=90.89 Aligned_cols=86 Identities=22% Similarity=0.405 Sum_probs=74.7
Q ss_pred CCCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCE
Q 042949 74 HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKT 153 (608)
Q Consensus 74 ~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~ 153 (608)
...+++.|+|++|.+++. + .+..+++|+.|++++|.+++ +|. +..+++|+.|+|++|++++..| +..+++|+.
T Consensus 83 ~l~~L~~L~L~~n~l~~~-~--~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~ 155 (308)
T 1h6u_A 83 NLTKITELELSGNPLKNV-S--AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQY 155 (308)
T ss_dssp TCCSCCEEECCSCCCSCC-G--GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred cCCCCCEEEccCCcCCCc-h--hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccE
Confidence 346899999999999874 3 59999999999999999996 454 9999999999999999996433 889999999
Q ss_pred EeCcCCcCCccCC
Q 042949 154 LDISNNHFAATSP 166 (608)
Q Consensus 154 L~ls~N~l~g~~p 166 (608)
|+|++|.+++..+
T Consensus 156 L~l~~n~l~~~~~ 168 (308)
T 1h6u_A 156 LSIGNAQVSDLTP 168 (308)
T ss_dssp EECCSSCCCCCGG
T ss_pred EEccCCcCCCChh
Confidence 9999999987544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.30 E-value=1.2e-07 Score=99.29 Aligned_cols=95 Identities=22% Similarity=0.269 Sum_probs=79.6
Q ss_pred CcEEEEEecCCCce--ee--cChhhhcCCcCCcEEEcccCcCC----ccCcccccCCCCcceeeccCeecccc----CCh
Q 042949 76 TNIVGIRLENMNLS--GI--IDAETLCKLRHLRVVSLARNLIQ----GRIPTSISNCRRLTYLNLSSNLLSGA----VPL 143 (608)
Q Consensus 76 ~~v~~l~l~~~~l~--g~--~~~~~l~~l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~L~Ls~N~l~g~----lP~ 143 (608)
.+++.|+|++|.++ |. +.+..+..+++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++. +|.
T Consensus 187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 266 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266 (386)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHH
Confidence 47999999999998 41 22236889999999999999997 67888999999999999999999876 677
Q ss_pred hhc--CCCCCCEEeCcCCcCCc----cCChhHH
Q 042949 144 ALT--KLKHLKTLDISNNHFAA----TSPDNFR 170 (608)
Q Consensus 144 ~l~--~l~~L~~L~ls~N~l~g----~~p~~~~ 170 (608)
.+. .+++|+.|+|++|.+++ .+|..+.
T Consensus 267 ~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~ 299 (386)
T 2ca6_A 267 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299 (386)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHH
T ss_pred HHhhccCCCeEEEECcCCcCCHHHHHHHHHHHH
Confidence 774 48999999999999998 5777663
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.29 E-value=2e-07 Score=95.44 Aligned_cols=86 Identities=19% Similarity=0.275 Sum_probs=65.3
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCcc-CcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGR-IPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
.+++.+++++|.+.+.++ .+.++++|+.|++++|.+++. +|..+..+++|++|+|++|.+++..|..++.+++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~--~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLA--EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCC--SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccch--hhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 467777787777777664 366778888888888887765 77777778888888888888877777777778888888
Q ss_pred eCcCC-cCCc
Q 042949 155 DISNN-HFAA 163 (608)
Q Consensus 155 ~ls~N-~l~g 163 (608)
+|++| .+++
T Consensus 148 ~L~~~~~l~~ 157 (336)
T 2ast_B 148 NLSGCSGFSE 157 (336)
T ss_dssp ECTTCBSCCH
T ss_pred ECCCCCCCCH
Confidence 88887 5665
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.29 E-value=3.3e-07 Score=98.22 Aligned_cols=62 Identities=26% Similarity=0.330 Sum_probs=50.9
Q ss_pred cCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCCc--cCChhHH
Q 042949 101 RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAA--TSPDNFR 170 (608)
Q Consensus 101 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g--~~p~~~~ 170 (608)
++|+.|++++|.+++ +|.. +++|+.|+|++|+++ .+|. .+++|++|++++|++++ .+|.++.
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~ 380 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVE 380 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHH
Confidence 588899999999986 6654 578899999999998 5776 47889999999999998 7887764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.29 E-value=9.4e-07 Score=94.78 Aligned_cols=78 Identities=21% Similarity=0.319 Sum_probs=48.5
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|++++. | ++.+++|++|++++|.+++. | ++++++|++|+|++|++++ +| +..+++|++|+
T Consensus 64 ~~L~~L~Ls~n~l~~~-~---~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~ 133 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D---LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLN 133 (457)
T ss_dssp TTCSEEECCSSCCSCC-C---CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCeE-c---cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEE
Confidence 3566666666666652 2 55666666666666666653 3 6666666666666666664 33 56666666666
Q ss_pred CcCCcCCc
Q 042949 156 ISNNHFAA 163 (608)
Q Consensus 156 ls~N~l~g 163 (608)
+++|++++
T Consensus 134 l~~N~l~~ 141 (457)
T 3bz5_A 134 CARNTLTE 141 (457)
T ss_dssp CTTSCCSC
T ss_pred CCCCccce
Confidence 66666665
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.29 E-value=9.6e-07 Score=94.71 Aligned_cols=78 Identities=19% Similarity=0.214 Sum_probs=38.9
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|++++|...|.++ +..+++|+.|++++|.+++ +| ++.+++|+.|+|++|++++. .+..+++|+.|++
T Consensus 149 ~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~L 219 (457)
T 3bz5_A 149 QLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDC 219 (457)
T ss_dssp TCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEEC
T ss_pred cCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEEC
Confidence 45555555555444442 4455555555555555554 33 44455555555555555432 2444445555555
Q ss_pred cCCcCCc
Q 042949 157 SNNHFAA 163 (608)
Q Consensus 157 s~N~l~g 163 (608)
++|++++
T Consensus 220 s~N~l~~ 226 (457)
T 3bz5_A 220 SSNKLTE 226 (457)
T ss_dssp CSSCCSC
T ss_pred cCCcccc
Confidence 5555544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.28 E-value=6.8e-07 Score=99.12 Aligned_cols=83 Identities=31% Similarity=0.437 Sum_probs=73.6
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|.+++. +.+..|++|+.|+|++|.+++. ..+..|++|+.|+|++|+|++..| +..+++|+.|
T Consensus 108 l~~L~~L~Ls~N~l~~l---~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 180 (605)
T 1m9s_A 108 LKKLKSLSLEHNGISDI---NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 180 (605)
T ss_dssp CTTCCEEECTTSCCCCC---GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred CCCCCEEEecCCCCCCC---ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEE
Confidence 45799999999999973 2589999999999999999975 578999999999999999997666 8899999999
Q ss_pred eCcCCcCCcc
Q 042949 155 DISNNHFAAT 164 (608)
Q Consensus 155 ~ls~N~l~g~ 164 (608)
+|++|+|++.
T Consensus 181 ~Ls~N~i~~l 190 (605)
T 1m9s_A 181 YLSKNHISDL 190 (605)
T ss_dssp ECCSSCCCBC
T ss_pred ECcCCCCCCC
Confidence 9999999874
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.27 E-value=8.3e-07 Score=95.42 Aligned_cols=82 Identities=32% Similarity=0.431 Sum_probs=58.4
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.+++..+ +..+++|+.|++++|.+.+..| +..+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 265 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 337 (466)
T 1o6v_A 265 TKLTELKLGANQISNISP---LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 337 (466)
T ss_dssp TTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEE
T ss_pred CCCCEEECCCCccCcccc---ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeE
Confidence 467778888887776432 6777777777777777776433 6777777777777777776554 56677777777
Q ss_pred CcCCcCCcc
Q 042949 156 ISNNHFAAT 164 (608)
Q Consensus 156 ls~N~l~g~ 164 (608)
+++|.+++.
T Consensus 338 l~~n~l~~~ 346 (466)
T 1o6v_A 338 FYNNKVSDV 346 (466)
T ss_dssp CCSSCCCCC
T ss_pred CCCCccCCc
Confidence 777777664
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.26 E-value=1.7e-07 Score=98.09 Aligned_cols=89 Identities=24% Similarity=0.395 Sum_probs=77.6
Q ss_pred CcEEEEEecCCCce-eecCh--hhhcCCcCCcEEEcccCcCC--c---cCcccccCCCCcceeeccCeecc----ccCCh
Q 042949 76 TNIVGIRLENMNLS-GIIDA--ETLCKLRHLRVVSLARNLIQ--G---RIPTSISNCRRLTYLNLSSNLLS----GAVPL 143 (608)
Q Consensus 76 ~~v~~l~l~~~~l~-g~~~~--~~l~~l~~L~~L~l~~N~l~--g---~~p~~~~~l~~L~~L~Ls~N~l~----g~lP~ 143 (608)
.+++.|+|++|.++ +.++. ..+..+++|+.|+|++|.++ | .+|..+..+++|+.|+|++|.++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 58999999999998 44431 35778999999999999998 4 45558899999999999999997 77899
Q ss_pred hhcCCCCCCEEeCcCCcCCcc
Q 042949 144 ALTKLKHLKTLDISNNHFAAT 164 (608)
Q Consensus 144 ~l~~l~~L~~L~ls~N~l~g~ 164 (608)
.+..+++|+.|+|++|.+++.
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHH
T ss_pred HHccCCCcCEEECCCCCCchh
Confidence 999999999999999999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=2.1e-06 Score=86.91 Aligned_cols=135 Identities=16% Similarity=0.114 Sum_probs=92.0
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCC---cceeeeeeee-cCCeeEEEEeeccCCCHH
Q 042949 309 RSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHP---NILPLVCYNS-TNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~~g~L~ 384 (608)
++.|....||+. |..+++|+-.. ......+.+|.++|..+.+. .+.+++.++. ..+..++||||++|..+.
T Consensus 27 l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~ 101 (306)
T 3tdw_A 27 LGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILG 101 (306)
T ss_dssp EEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECH
T ss_pred cCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECc
Confidence 456777788887 56688887532 22346788999999988753 2445566654 445678999999998876
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-------------------------------------------
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSN------------------------------------------- 421 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~------------------------------------------- 421 (608)
+..- ..++..++..++.++++.|+.||+...
T Consensus 102 ~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 102 EDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp HHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred hhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 6321 224555556666666666666665321
Q ss_pred ------------CCCCceecCCCCCCeecCC---CCCc-eEeccccccc
Q 042949 422 ------------EEKTIPHGNLKLSNILLNE---NEDP-LISECGYSKF 454 (608)
Q Consensus 422 ------------~~~~ivHrDlkp~NILl~~---~~~~-kl~DFGla~~ 454 (608)
....++|+|++|.||+++. ++.+ .|.||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 4554 7999998764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.25 E-value=1.2e-06 Score=93.81 Aligned_cols=76 Identities=20% Similarity=0.357 Sum_probs=41.4
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|++++|.+++ ++. + .++|++|++++|.+++ +| .++++++|++|+|++|++++ +|..+ .+|++|++
T Consensus 112 ~L~~L~l~~n~l~~-l~~--~--~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L 180 (454)
T 1jl5_A 112 SLKSLLVDNNNLKA-LSD--L--PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAA 180 (454)
T ss_dssp TCCEEECCSSCCSC-CCS--C--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEEC
T ss_pred CCcEEECCCCccCc-ccC--C--CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEEC
Confidence 45555555555443 110 0 1456666666666664 55 46666666666666666664 44322 35666666
Q ss_pred cCCcCCc
Q 042949 157 SNNHFAA 163 (608)
Q Consensus 157 s~N~l~g 163 (608)
++|.+++
T Consensus 181 ~~n~l~~ 187 (454)
T 1jl5_A 181 GNNQLEE 187 (454)
T ss_dssp CSSCCSS
T ss_pred cCCcCCc
Confidence 6666655
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.24 E-value=1.8e-07 Score=95.74 Aligned_cols=93 Identities=19% Similarity=0.192 Sum_probs=79.7
Q ss_pred CcEEEEEecCCCceee-cChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCe-ecccc-CChhhcCCCCCC
Q 042949 76 TNIVGIRLENMNLSGI-IDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSN-LLSGA-VPLALTKLKHLK 152 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~-~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~g~-lP~~l~~l~~L~ 152 (608)
.+++.|+|++|.+++. ++ ..+..+++|+.|+|++|.+++.+|..++.+++|++|+|++| .+++. +|..+..+++|+
T Consensus 93 ~~L~~L~L~~~~l~~~~~~-~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLH-GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp BCCCEEECTTCEECHHHHH-HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCEEEccCCCcCHHHHH-HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 5799999999998876 64 56889999999999999999989999999999999999999 78863 777788899999
Q ss_pred EEeCcCC-cCCcc-CChhH
Q 042949 153 TLDISNN-HFAAT-SPDNF 169 (608)
Q Consensus 153 ~L~ls~N-~l~g~-~p~~~ 169 (608)
.|+|++| .+++. +|..+
T Consensus 172 ~L~l~~~~~l~~~~~~~~~ 190 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAV 190 (336)
T ss_dssp EEECCCCTTCCHHHHHHHH
T ss_pred EEcCCCCCCcChHHHHHHH
Confidence 9999999 88864 45444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.22 E-value=4.3e-07 Score=94.28 Aligned_cols=92 Identities=23% Similarity=0.300 Sum_probs=44.6
Q ss_pred EEEEEecCCCceeecCh---hhhcCCc-CCcEEEcccCcCCccCcccccCC-----CCcceeeccCeeccccCChhhc--
Q 042949 78 IVGIRLENMNLSGIIDA---ETLCKLR-HLRVVSLARNLIQGRIPTSISNC-----RRLTYLNLSSNLLSGAVPLALT-- 146 (608)
Q Consensus 78 v~~l~l~~~~l~g~~~~---~~l~~l~-~L~~L~l~~N~l~g~~p~~~~~l-----~~L~~L~Ls~N~l~g~lP~~l~-- 146 (608)
++.|+|++|.+++..+. ..+.+++ +|+.|+|++|.+++..+..+..+ ++|+.|+|++|++++..+..+.
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 55555555555443210 2344454 55555555555555444444443 5555555555555544443222
Q ss_pred --CC-CCCCEEeCcCCcCCccCChhH
Q 042949 147 --KL-KHLKTLDISNNHFAATSPDNF 169 (608)
Q Consensus 147 --~l-~~L~~L~ls~N~l~g~~p~~~ 169 (608)
.+ ++|+.|+|++|.+++..+..+
T Consensus 104 l~~~~~~L~~L~Ls~N~l~~~~~~~l 129 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFSSKSSSEF 129 (362)
T ss_dssp HHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred HHhCCCCccEEECcCCcCCcHHHHHH
Confidence 22 455555555555554444433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.21 E-value=5.4e-07 Score=93.49 Aligned_cols=92 Identities=21% Similarity=0.208 Sum_probs=79.1
Q ss_pred EEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCc----ccccCCC-CcceeeccCeeccccCChhhcCC-----C
Q 042949 80 GIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIP----TSISNCR-RLTYLNLSSNLLSGAVPLALTKL-----K 149 (608)
Q Consensus 80 ~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p----~~~~~l~-~L~~L~Ls~N~l~g~lP~~l~~l-----~ 149 (608)
..+|+.|+++|.+| ..+...++|+.|+|++|.+++..+ ..+..++ +|+.|+|++|.+++..+..+..+ +
T Consensus 2 ~~~ls~n~~~~~~~-~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVE-EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHH-HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHH-HHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 46789999999986 456667779999999999998777 6778888 89999999999998877777665 9
Q ss_pred CCCEEeCcCCcCCccCChhHHHh
Q 042949 150 HLKTLDISNNHFAATSPDNFRQE 172 (608)
Q Consensus 150 ~L~~L~ls~N~l~g~~p~~~~~~ 172 (608)
+|+.|+|++|.+++..+..+...
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHH
T ss_pred CccEEECcCCcCChHHHHHHHHH
Confidence 99999999999999888877653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.20 E-value=1.4e-06 Score=93.58 Aligned_cols=84 Identities=35% Similarity=0.497 Sum_probs=49.8
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.+.+. +.+..+++|+.|++++|.+++..| +..+++|+.|+|++|.+++..| +..+++|+.|+
T Consensus 221 ~~L~~L~l~~n~l~~~---~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI---GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293 (466)
T ss_dssp TTCCEEECCSSCCCCC---GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred CCCCEEECCCCCcccc---hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEE
Confidence 3566666666666652 245666666666666666665433 5666666666666666664322 55566666666
Q ss_pred CcCCcCCccCC
Q 042949 156 ISNNHFAATSP 166 (608)
Q Consensus 156 ls~N~l~g~~p 166 (608)
|++|.+++..|
T Consensus 294 L~~n~l~~~~~ 304 (466)
T 1o6v_A 294 LNENQLEDISP 304 (466)
T ss_dssp CCSSCCSCCGG
T ss_pred cCCCcccCchh
Confidence 66666655433
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=9.8e-06 Score=80.06 Aligned_cols=129 Identities=16% Similarity=0.204 Sum_probs=92.1
Q ss_pred ceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCCCHHHHHHHHhc
Q 042949 315 SSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIE 392 (608)
Q Consensus 315 g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 392 (608)
..||+.... ++..+++|+-... ...++.+|...|+.+. +--+.++++++.+.+..++|||++++.++.+.....
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-- 114 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-- 114 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--
T ss_pred CeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC--
Confidence 468987764 4567888976532 3456888999888774 323567788888888999999999998887765421
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------------------
Q 042949 393 GKRDFPWKLRLSIATGIAKGLDFMYQKS---------------------------------------------------- 420 (608)
Q Consensus 393 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------------- 420 (608)
......+..+++..|.-||...
T Consensus 115 ------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 188 (272)
T 4gkh_A 115 ------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLP 188 (272)
T ss_dssp ------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCC
T ss_pred ------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccc
Confidence 1223455666777777777532
Q ss_pred -CCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 421 -NEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 421 -~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
.....++|+|+.+.|||+++++.+-|.||+.+.
T Consensus 189 ~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 189 FSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 012247899999999999887767799999875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.08 E-value=2e-06 Score=84.81 Aligned_cols=78 Identities=19% Similarity=0.273 Sum_probs=65.3
Q ss_pred CcEEEEEecCCCcee--ecChhhhcCCcCCcEEEcccCcCCccCcccccCCC--CcceeeccCeeccccCCh-------h
Q 042949 76 TNIVGIRLENMNLSG--IIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCR--RLTYLNLSSNLLSGAVPL-------A 144 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g--~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~--~L~~L~Ls~N~l~g~lP~-------~ 144 (608)
.+++.|+|++|.|++ .++ ..+..+++|+.|+|++|.|++. ..+..++ +|+.|+|++|.+++.+|. .
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~-~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i 246 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMS-SIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI 246 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGT-THHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred CCCCEEECCCCCCCCCccch-hHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence 579999999999998 555 4577899999999999999976 3455555 999999999999998873 3
Q ss_pred hcCCCCCCEEeC
Q 042949 145 LTKLKHLKTLDI 156 (608)
Q Consensus 145 l~~l~~L~~L~l 156 (608)
+..+++|+.||=
T Consensus 247 l~~~P~L~~LDg 258 (267)
T 3rw6_A 247 RERFPKLLRLDG 258 (267)
T ss_dssp HHHCTTCCEESS
T ss_pred HHHCcccCeECC
Confidence 677899998873
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=97.92 E-value=1.2e-05 Score=89.26 Aligned_cols=61 Identities=21% Similarity=0.336 Sum_probs=34.0
Q ss_pred cCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 101 RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 101 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
++|+.|+|++|.|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~ 281 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLI 281 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGG
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHh
Confidence 445555555555553 44 33455666666666665 3444 4456666666666666 5555544
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.90 E-value=1.7e-06 Score=92.50 Aligned_cols=94 Identities=16% Similarity=0.143 Sum_probs=68.1
Q ss_pred CcEEEEEecCCCceeecChhhhc-----CCcCCcEEEcccCcCCcc----CcccccCCCCcceeeccCeeccccCChhhc
Q 042949 76 TNIVGIRLENMNLSGIIDAETLC-----KLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLSGAVPLALT 146 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~-----~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~ 146 (608)
.+++.|+|++|.+++..+ ..+. ..++|+.|++++|.+++. +|..+..+++|+.|+|++|.+++..+..+.
T Consensus 284 ~~L~~L~Ls~n~i~~~~~-~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 362 (461)
T 1z7x_W 284 ESLKELSLAGNELGDEGA-RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362 (461)
T ss_dssp TTCCEEECTTCCCHHHHH-HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred CCcceEECCCCCCchHHH-HHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHH
Confidence 478889999988875422 2232 236888888988888866 566677788888888888888766554443
Q ss_pred C-----CCCCCEEeCcCCcCCc----cCChhHH
Q 042949 147 K-----LKHLKTLDISNNHFAA----TSPDNFR 170 (608)
Q Consensus 147 ~-----l~~L~~L~ls~N~l~g----~~p~~~~ 170 (608)
. .++|+.|+|++|.+++ .+|..+.
T Consensus 363 ~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~ 395 (461)
T 1z7x_W 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL 395 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred HHHcCCCCceEEEECCCCCCChhhHHHHHHHHH
Confidence 2 6788888888888876 6666554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=7.4e-06 Score=84.58 Aligned_cols=76 Identities=7% Similarity=0.027 Sum_probs=52.0
Q ss_pred cc-CCCCCceEEEEEEc-------CCcEEEEEEecccc----cCHHHHHHHHHHHhcCC-C--CcceeeeeeeecC---C
Q 042949 308 LR-SQTICSSLFMVRLK-------NSAVYAVKRLKKLQ----VSMDEFSQTMRQIGNLK-H--PNILPLVCYNSTN---E 369 (608)
Q Consensus 308 ~~-g~g~~g~vy~~~~~-------~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~---~ 369 (608)
.+ +.|....+|+.... ++..+++|+-.... .....+.+|+++++.+. + -.+.+++.++.+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 45 67888899998765 26778888765322 12345778888887774 3 2456677777654 3
Q ss_pred eeEEEEeeccCCCH
Q 042949 370 EKLLVYKYQSNGSL 383 (608)
Q Consensus 370 ~~~lv~e~~~~g~L 383 (608)
..++||||+++..+
T Consensus 107 ~~~~v~e~l~G~~l 120 (357)
T 3ats_A 107 TPFFLMDYVEGVVP 120 (357)
T ss_dssp SCEEEEECCCCBCC
T ss_pred CceEEEEecCCCCh
Confidence 56899999987654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.79 E-value=2.2e-05 Score=80.91 Aligned_cols=92 Identities=18% Similarity=0.155 Sum_probs=74.2
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcE-EEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRV-VSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKT 153 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~-L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~ 153 (608)
..+++.|+|++|.+.+.+|+..+.+|+.|.. +.+++|++.+..|..+..+++|++|++++|++++..+..+....++..
T Consensus 53 l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~ 132 (350)
T 4ay9_X 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 132 (350)
T ss_dssp CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEE
T ss_pred CCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhh
Confidence 4589999999999999998777889998775 667789999888888999999999999999999665556666777888
Q ss_pred EeCcCCcCCccCC
Q 042949 154 LDISNNHFAATSP 166 (608)
Q Consensus 154 L~ls~N~l~g~~p 166 (608)
|++.+|+--..+|
T Consensus 133 l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 133 LDIQDNINIHTIE 145 (350)
T ss_dssp EEEESCTTCCEEC
T ss_pred hhhcccccccccc
Confidence 8887644333333
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00018 Score=73.25 Aligned_cols=141 Identities=16% Similarity=0.165 Sum_probs=79.2
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCC-----CCcceeee-e--eeecCCeeEEEEeeccC
Q 042949 309 RSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-----HPNILPLV-C--YNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~-~--~~~~~~~~~lv~e~~~~ 380 (608)
+++|....||++...+|. +++|+... ..+++..|.+++..+. .|.++.-. | +....+..+++|||++|
T Consensus 40 l~gG~~n~~~~v~~~~~~-~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 40 IQGNQMALVWKVHTDSGA-VCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp CC----CEEEEEEETTEE-EEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred ccccccCcEEEEEeCCCC-EEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 455678899999886654 88998875 2344445555554442 34444311 1 12245678899999988
Q ss_pred CCHH--------------HHHHHHhcCC--C--------CCCHHHH-------------------------------HHH
Q 042949 381 GSLL--------------SLLEAYIEGK--R--------DFPWKLR-------------------------------LSI 405 (608)
Q Consensus 381 g~L~--------------~~l~~~~~~~--~--------~l~~~~~-------------------------------~~i 405 (608)
..+. ..+|...... . .-.|... ..+
T Consensus 116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (346)
T 2q83_A 116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF 195 (346)
T ss_dssp BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence 6431 1223221111 0 0123211 011
Q ss_pred HHHHHHHHHHHhcC-------C-CCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 406 ATGIAKGLDFMYQK-------S-NEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 406 ~~~ia~gL~yLH~~-------~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
...+.+++++|++. . .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 12244466777630 0 012459999999999999888889999999775
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.73 E-value=6.3e-06 Score=85.75 Aligned_cols=92 Identities=15% Similarity=0.176 Sum_probs=66.0
Q ss_pred cEEEEEecCCCceeecChhhh-----cCCcCCcEEEcccCcCCcc----CcccccCCCCcceeeccCeecccc----CCh
Q 042949 77 NIVGIRLENMNLSGIIDAETL-----CKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLSGA----VPL 143 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l-----~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----lP~ 143 (608)
+++.|+|++|.++..-. ..+ ...+.|+.|+|++|.|+.. ++..+..++.|++|||++|.++.. ++.
T Consensus 127 ~L~~L~Ls~n~l~~~~~-~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 127 RARKLGLQLNSLGPEAC-KDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp TEEEEECCSSCCCHHHH-HHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHH-HHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 68889999998875321 222 2467889999999988652 445567788899999999988742 355
Q ss_pred hhcCCCCCCEEeCcCCcCCccCChhH
Q 042949 144 ALTKLKHLKTLDISNNHFAATSPDNF 169 (608)
Q Consensus 144 ~l~~l~~L~~L~ls~N~l~g~~p~~~ 169 (608)
.+...++|+.|||++|.++..-...+
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 66777889999999998875433333
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.65 E-value=1.2e-05 Score=85.92 Aligned_cols=36 Identities=28% Similarity=0.435 Sum_probs=16.5
Q ss_pred CcEEEcccCcCCc----cCcccccCCCCcceeeccCeecc
Q 042949 103 LRVVSLARNLIQG----RIPTSISNCRRLTYLNLSSNLLS 138 (608)
Q Consensus 103 L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~ 138 (608)
|++|+|++|.++. .+|..+..+++|++|+|++|.++
T Consensus 87 L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 126 (461)
T 1z7x_W 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126 (461)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred eeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCc
Confidence 4444444444442 23444444444444444444444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.53 E-value=1.3e-05 Score=83.44 Aligned_cols=88 Identities=16% Similarity=0.128 Sum_probs=59.2
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccc-----cCCCCcceeeccCeeccc----cCChhhc
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSI-----SNCRRLTYLNLSSNLLSG----AVPLALT 146 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~-----~~l~~L~~L~Ls~N~l~g----~lP~~l~ 146 (608)
.+++.|+|++|.++..-...-...+.+|+.|+|++|.++......+ ...+.|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 4688888888887643211122345678888888888875433333 246778888888888864 2445567
Q ss_pred CCCCCCEEeCcCCcCCc
Q 042949 147 KLKHLKTLDISNNHFAA 163 (608)
Q Consensus 147 ~l~~L~~L~ls~N~l~g 163 (608)
.+++|++|||++|.++.
T Consensus 181 ~~~~L~~L~Ls~N~l~~ 197 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGD 197 (372)
T ss_dssp TCSSCCEEECTTSSCHH
T ss_pred cCCCcCEEeCCCCCCCc
Confidence 77888888888888764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00025 Score=74.17 Aligned_cols=72 Identities=10% Similarity=0.070 Sum_probs=47.1
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccc--------ccCHHHHHHHHHHHhcCCC--Ccce-eeeeeeecCCeeEEEE
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKL--------QVSMDEFSQTMRQIGNLKH--PNIL-PLVCYNSTNEEKLLVY 375 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~--------~~~~~~~~~e~~~l~~l~H--~niv-~l~~~~~~~~~~~lv~ 375 (608)
.+|.|..+.||+++.. ++..++||..... ....+.+..|.+++..+.. +..+ +++.+ +.+..++||
T Consensus 37 ~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvm 114 (397)
T 2olc_A 37 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 114 (397)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred ECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEE
Confidence 4788999999999754 5688999986421 1233456788888877632 3433 45544 344568999
Q ss_pred eeccCC
Q 042949 376 KYQSNG 381 (608)
Q Consensus 376 e~~~~g 381 (608)
||+++.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.46 E-value=3.2e-05 Score=85.35 Aligned_cols=87 Identities=14% Similarity=0.144 Sum_probs=42.8
Q ss_pred cEEEEEec----CCCceee-----cChhhhcCCcCCcEEEccc--CcCCccCcccccC-CCCcceeeccCeeccc-cCCh
Q 042949 77 NIVGIRLE----NMNLSGI-----IDAETLCKLRHLRVVSLAR--NLIQGRIPTSISN-CRRLTYLNLSSNLLSG-AVPL 143 (608)
Q Consensus 77 ~v~~l~l~----~~~l~g~-----~~~~~l~~l~~L~~L~l~~--N~l~g~~p~~~~~-l~~L~~L~Ls~N~l~g-~lP~ 143 (608)
+++.|+|+ .|.+++. ++ ..+.++++|+.|++++ |.+++..+..++. +++|+.|+|++|++++ .+|.
T Consensus 404 ~L~~L~l~~~~~~n~l~~~p~~~~~~-~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 482 (592)
T 3ogk_B 404 NLCDFRLVLLDREERITDLPLDNGVR-SLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482 (592)
T ss_dssp SCCEEEEEECSCCSCCSSCCCHHHHH-HHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHH
T ss_pred CCcEEEEeecCCCccccCchHHHHHH-HHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHH
Confidence 46666664 4445542 21 1244455566666542 2344444433332 5555555555555554 2333
Q ss_pred hhcCCCCCCEEeCcCCcCCcc
Q 042949 144 ALTKLKHLKTLDISNNHFAAT 164 (608)
Q Consensus 144 ~l~~l~~L~~L~ls~N~l~g~ 164 (608)
.+..+++|+.|+|++|.|++.
T Consensus 483 ~~~~~~~L~~L~l~~n~l~~~ 503 (592)
T 3ogk_B 483 FSRGCPNLQKLEMRGCCFSER 503 (592)
T ss_dssp HHTCCTTCCEEEEESCCCBHH
T ss_pred HHhcCcccCeeeccCCCCcHH
Confidence 345555555555555555443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.35 E-value=6.6e-05 Score=69.75 Aligned_cols=88 Identities=20% Similarity=0.255 Sum_probs=63.4
Q ss_pred CcEEEEEecCC-Cceee----cChhhhcCCcCCcEEEcccCcCCcc----CcccccCCCCcceeeccCeecccc----CC
Q 042949 76 TNIVGIRLENM-NLSGI----IDAETLCKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLSGA----VP 142 (608)
Q Consensus 76 ~~v~~l~l~~~-~l~g~----~~~~~l~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----lP 142 (608)
..++.|+|++| .+... +. ..+...++|++|+|++|.+... +...+...+.|++|+|++|.++.. +.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~-~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACA-EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHH-HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHH-HHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 46888888888 77632 22 3466778888888888888643 334455667888888888888743 44
Q ss_pred hhhcCCCCCCEEeC--cCCcCCcc
Q 042949 143 LALTKLKHLKTLDI--SNNHFAAT 164 (608)
Q Consensus 143 ~~l~~l~~L~~L~l--s~N~l~g~ 164 (608)
..+...++|+.|+| ++|.++..
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHH
Confidence 56677788888888 77888654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00066 Score=68.49 Aligned_cols=137 Identities=14% Similarity=0.137 Sum_probs=88.3
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCC---CCcceeeeeeeecCCeeEEEEeeccCCCHH-
Q 042949 309 RSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK---HPNILPLVCYNSTNEEKLLVYKYQSNGSLL- 384 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~g~L~- 384 (608)
++.|....+|+... ++..+++|+-... ....+..|.+.|+.+. ...+.++++++...+..++||||+++..+.
T Consensus 44 l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~ 120 (312)
T 3jr1_A 44 LYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQ 120 (312)
T ss_dssp ECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCT
T ss_pred eCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCc
Confidence 57888899999876 5667888976532 3567888988888774 356778888888778899999999987541
Q ss_pred -------H---HHHHHhc-CCC-----------------CCCHHHHH---HHHH----------------HHHHH-HHHH
Q 042949 385 -------S---LLEAYIE-GKR-----------------DFPWKLRL---SIAT----------------GIAKG-LDFM 416 (608)
Q Consensus 385 -------~---~l~~~~~-~~~-----------------~l~~~~~~---~i~~----------------~ia~g-L~yL 416 (608)
. .||.... ... .-+|.... ++.. .+... .+.|
T Consensus 121 ~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L 200 (312)
T 3jr1_A 121 SSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTL 200 (312)
T ss_dssp THHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHh
Confidence 1 2332111 000 01454321 1111 11111 2344
Q ss_pred hcCCCCCCCceecCCCCCCeecCCCCCceEeccc
Q 042949 417 YQKSNEEKTIPHGNLKLSNILLNENEDPLISECG 450 (608)
Q Consensus 417 H~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 450 (608)
.... ..+.++|+|+.+.||+++.++ +.|.|+.
T Consensus 201 ~~~~-~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 201 SKHN-PKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp TTCC-CCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred ccCC-CCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3221 346799999999999999887 8888874
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.23 E-value=7.1e-05 Score=69.56 Aligned_cols=87 Identities=16% Similarity=0.185 Sum_probs=69.9
Q ss_pred CCcEEEEEecCCCceee----cChhhhcCCcCCcEEEcccCcCCcc----CcccccCCCCcceeec--cCeecccc----
Q 042949 75 ATNIVGIRLENMNLSGI----IDAETLCKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNL--SSNLLSGA---- 140 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~----~~~~~l~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~L--s~N~l~g~---- 140 (608)
...++.|+|++|.+... +. ..+...+.|++|+|++|.|... +...+...+.|+.|+| ++|.++..
T Consensus 64 ~~~L~~L~Ls~n~i~~~g~~~l~-~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~ 142 (185)
T 1io0_A 64 NTYVKKFSIVGTRSNDPVAFALA-EMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 142 (185)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHH-HHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred CCCcCEEECcCCCCChHHHHHHH-HHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHH
Confidence 35799999999998742 32 3466778999999999999864 5567788899999999 88999754
Q ss_pred CChhhcCCCCCCEEeCcCCcCC
Q 042949 141 VPLALTKLKHLKTLDISNNHFA 162 (608)
Q Consensus 141 lP~~l~~l~~L~~L~ls~N~l~ 162 (608)
+...+...++|+.|+|++|.+.
T Consensus 143 l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 143 IANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCCCcCEEeccCCCCC
Confidence 3345666789999999999885
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00064 Score=67.70 Aligned_cols=70 Identities=14% Similarity=0.174 Sum_probs=49.7
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCC---cceeeeeeeecCCeeEEEEeeccCCC
Q 042949 309 RSQTICSSLFMVRLKNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHP---NILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~---niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+|.|..+.||+.+..||+.|.+|+-.... .....|..|.+.|+.+.-. -+.+++++. ..++||||++.+.
T Consensus 23 ~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 23 RGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred cCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 57788999999999999999999865322 2345678899888877421 233444432 3478999987764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0012 Score=69.63 Aligned_cols=71 Identities=8% Similarity=0.138 Sum_probs=44.2
Q ss_pred CCceecCCCCCCeecCCCCCceEeccccccccCCCCc--cccc--cCccccCC-------CCCCcchhHHHHHHHHHHHH
Q 042949 424 KTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKT--CLFS--SNGYTAPE-------KTVSEQGDVFSFGVILLELL 492 (608)
Q Consensus 424 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--~~~g--t~~y~aPE-------~~~~~ksDVwSfGvvl~ell 492 (608)
..++|+|++|.|||++.++ ++|.||+.+..-..... .... ...|.+|+ .......++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4599999999999998776 99999998875432110 0000 11244433 11122355567788888877
Q ss_pred cCC
Q 042949 493 TGK 495 (608)
Q Consensus 493 tg~ 495 (608)
++.
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00043 Score=70.40 Aligned_cols=90 Identities=20% Similarity=0.273 Sum_probs=58.2
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcc-eeeccCeeccccCChhhcCCCCCCEEe
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLT-YLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~-~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
+++.|+|++|+++ .|+...+.++++|+.|+|++| +...-+..|.+|++|+ .++|++ +++-.-+..|.++++|+.|+
T Consensus 227 ~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 227 NLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 5777777777665 355556777777777777776 5533444567777777 777776 55522234677777777777
Q ss_pred CcCCcCCccCChhH
Q 042949 156 ISNNHFAATSPDNF 169 (608)
Q Consensus 156 ls~N~l~g~~p~~~ 169 (608)
++.|+++.--+..|
T Consensus 304 l~~n~i~~I~~~aF 317 (329)
T 3sb4_A 304 ATGDKITTLGDELF 317 (329)
T ss_dssp ECSSCCCEECTTTT
T ss_pred eCCCccCccchhhh
Confidence 77777764444444
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00011 Score=81.13 Aligned_cols=86 Identities=16% Similarity=0.265 Sum_probs=41.6
Q ss_pred CcEEEEEecCCCceeecChhhhcC-Cc-CCcEEEcccCc-CCc-cCcccccCCCCcceeeccCeecccc----CChhhcC
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCK-LR-HLRVVSLARNL-IQG-RIPTSISNCRRLTYLNLSSNLLSGA----VPLALTK 147 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~-l~-~L~~L~l~~N~-l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~----lP~~l~~ 147 (608)
.+++.|+|+++.+++..+ ..+.. ++ +|++|+|++|. ++. .++....+|++|++|+|++|.+++. ++..+..
T Consensus 112 ~~L~~L~L~~~~i~~~~~-~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~ 190 (592)
T 3ogk_B 112 RQLKSVHFRRMIVSDLDL-DRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQH 190 (592)
T ss_dssp TTCCEEEEESCBCCHHHH-HHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHH
T ss_pred CCCCeEEeeccEecHHHH-HHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhc
Confidence 357777777776665432 23333 22 25555555544 110 1222223455555555555555443 3333344
Q ss_pred CCCCCEEeCcCCcCC
Q 042949 148 LKHLKTLDISNNHFA 162 (608)
Q Consensus 148 l~~L~~L~ls~N~l~ 162 (608)
+++|+.|+|++|.++
T Consensus 191 ~~~L~~L~L~~n~~~ 205 (592)
T 3ogk_B 191 NTSLEVLNFYMTEFA 205 (592)
T ss_dssp CCCCCEEECTTCCCS
T ss_pred CCCccEEEeeccCCC
Confidence 555555555555554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0011 Score=66.36 Aligned_cols=31 Identities=23% Similarity=0.222 Sum_probs=25.7
Q ss_pred CCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 423 EKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 423 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
...++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 5667789999988764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.004 Score=62.90 Aligned_cols=141 Identities=9% Similarity=0.072 Sum_probs=80.0
Q ss_pred CCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCC--cceeeeee-----eecCCeeEEEEeeccCCCHH
Q 042949 312 TICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHP--NILPLVCY-----NSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 312 g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~-----~~~~~~~~lv~e~~~~g~L~ 384 (608)
|....||++...+|+.+++|.......+.+.+..|..++..+... .+.+++.. ....+..+++|+|+++..+.
T Consensus 36 g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~ 115 (328)
T 1zyl_A 36 SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 115 (328)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCCC
Confidence 566789998877787899999874334567777888887766421 23444432 12245567899999874321
Q ss_pred -----H------H---HHHHhcC-----CCCCCHHHH----HHH---------------HHHHHHHHHHHhcCC--CCCC
Q 042949 385 -----S------L---LEAYIEG-----KRDFPWKLR----LSI---------------ATGIAKGLDFMYQKS--NEEK 424 (608)
Q Consensus 385 -----~------~---l~~~~~~-----~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~~--~~~~ 424 (608)
. . +|..... ...+++... ..+ ...+...++.+.... ....
T Consensus 116 ~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 195 (328)
T 1zyl_A 116 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 195 (328)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCe
Confidence 1 1 2221111 011222211 001 111112233332211 1234
Q ss_pred CceecCCCCCCeecCCCCCceEeccccccc
Q 042949 425 TIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 425 ~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
.++|+|+++.|||++ + .+.|+||+.+..
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 589999999999998 4 889999987753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0065 Score=61.59 Aligned_cols=32 Identities=13% Similarity=0.167 Sum_probs=27.0
Q ss_pred CCCceecCCCCCCeecCCC----CCceEeccccccc
Q 042949 423 EKTIPHGNLKLSNILLNEN----EDPLISECGYSKF 454 (608)
Q Consensus 423 ~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 454 (608)
...++|+|+.+.||+++.+ ..+.|.||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3469999999999999874 6789999998764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.00016 Score=79.74 Aligned_cols=88 Identities=18% Similarity=0.217 Sum_probs=51.0
Q ss_pred CcEEEEEec--C----CCcee-----ecChhhhcCCcCCcEEEcccCcCCccCcccccC-CCCcceeeccCeeccccCCh
Q 042949 76 TNIVGIRLE--N----MNLSG-----IIDAETLCKLRHLRVVSLARNLIQGRIPTSISN-CRRLTYLNLSSNLLSGAVPL 143 (608)
Q Consensus 76 ~~v~~l~l~--~----~~l~g-----~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~-l~~L~~L~Ls~N~l~g~lP~ 143 (608)
.+++.|+|+ + +++++ .++ ..+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+.
T Consensus 397 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~~-~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~ 474 (594)
T 2p1m_B 397 PNMTRFRLCIIEPKAPDYLTLEPLDIGFG-AIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH 474 (594)
T ss_dssp TTCCEEEEEESSTTCCCTTTCCCTHHHHH-HHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHH
T ss_pred CCcceeEeecccCCCcccccCCchhhHHH-HHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHH
Confidence 457777777 3 34442 111 1245566777777755 555554445544 66677777777776654444
Q ss_pred hh-cCCCCCCEEeCcCCcCCccC
Q 042949 144 AL-TKLKHLKTLDISNNHFAATS 165 (608)
Q Consensus 144 ~l-~~l~~L~~L~ls~N~l~g~~ 165 (608)
.+ ..+++|+.|+|++|.+++..
T Consensus 475 ~l~~~~~~L~~L~L~~n~~~~~~ 497 (594)
T 2p1m_B 475 HVLSGCDSLRKLEIRDCPFGDKA 497 (594)
T ss_dssp HHHHHCTTCCEEEEESCSCCHHH
T ss_pred HHHhcCCCcCEEECcCCCCcHHH
Confidence 43 45667777777777764433
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0037 Score=64.74 Aligned_cols=140 Identities=12% Similarity=0.100 Sum_probs=81.0
Q ss_pred cCCCCCceEEEEEEcC--------CcEEEEEEecccccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeecc
Q 042949 309 RSQTICSSLFMVRLKN--------SAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|-...+|++...+ +..+++|+-.........+.+|.++++.+. +.-..++++++.+ .+||||++
T Consensus 58 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~ 133 (379)
T 3feg_A 58 VSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIP 133 (379)
T ss_dssp C-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCS
T ss_pred cCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEec
Confidence 4456667788887653 478888886432234667778999887774 3223566666653 28999998
Q ss_pred CCCHH--------------HHHHHHhcC----CCCCC--HHHHHHHHHHHHH-------------------HHHHH----
Q 042949 380 NGSLL--------------SLLEAYIEG----KRDFP--WKLRLSIATGIAK-------------------GLDFM---- 416 (608)
Q Consensus 380 ~g~L~--------------~~l~~~~~~----~~~l~--~~~~~~i~~~ia~-------------------gL~yL---- 416 (608)
+..|. +.|.+.-.- ..... |.++.++..++.. .++.|
T Consensus 134 G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L 213 (379)
T 3feg_A 134 SRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLL 213 (379)
T ss_dssp EEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHH
T ss_pred CccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHH
Confidence 75432 112111111 11122 4455555444322 23333
Q ss_pred hcCCCCCCCceecCCCCCCeecCCC----CCceEecccccc
Q 042949 417 YQKSNEEKTIPHGNLKLSNILLNEN----EDPLISECGYSK 453 (608)
Q Consensus 417 H~~~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~ 453 (608)
.... ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 214 ~~~~-~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 214 ESTP-SPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HTSC-CCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhcC-CCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2222 34568999999999999876 688999998875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.00078 Score=74.10 Aligned_cols=84 Identities=21% Similarity=0.268 Sum_probs=61.1
Q ss_pred CcEEEEEecCCCceeecChhhhc-CCcCCcEEEcccC-cCCcc-CcccccCCCCcceeeccCeeccccCChhhc----CC
Q 042949 76 TNIVGIRLENMNLSGIIDAETLC-KLRHLRVVSLARN-LIQGR-IPTSISNCRRLTYLNLSSNLLSGAVPLALT----KL 148 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~-~l~~L~~L~l~~N-~l~g~-~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~----~l 148 (608)
.+++.|+|+++.+++..+ ..+. .+++|+.|+|++| .++.. ++..+.+|++|++|+|++|.+++..+..+. .+
T Consensus 105 ~~L~~L~L~~~~~~~~~~-~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCL-ELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp TTCCEEEEESCBCCHHHH-HHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCeEEeeCcEEcHHHH-HHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 468888998888877654 3454 6888888988888 55433 444455788889999988888765544443 56
Q ss_pred CCCCEEeCcCCc
Q 042949 149 KHLKTLDISNNH 160 (608)
Q Consensus 149 ~~L~~L~ls~N~ 160 (608)
++|+.|++++|.
T Consensus 184 ~~L~~L~l~~~~ 195 (594)
T 2p1m_B 184 TSLVSLNISCLA 195 (594)
T ss_dssp CCCCEEECTTCC
T ss_pred CcCcEEEecccC
Confidence 688888888886
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.55 E-value=0.029 Score=52.68 Aligned_cols=99 Identities=13% Similarity=0.071 Sum_probs=64.4
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFM-YQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
-+|.++|..+ ..++++.+++.++.|.+++|.-+ +... + ..+=+-|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~----~~~i~~~~~i~l~~dG~V~f~~-~~s~------ 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ-P----RHRVRSAAQIRVWRDGAVTLAP-AADD------ 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C----CCCCCSGGGEEEETTSCEEECC-C---------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc-C----CceecCCcceEEecCCceeccc-cccc------
Confidence 4799999865 67899999999999999998765 2111 0 1223346889999998887664 1111
Q ss_pred ccccccCccccCCC---CCCcchhHHHHHHHHHHHHcCCCC
Q 042949 460 TCLFSSNGYTAPEK---TVSEQGDVFSFGVILLELLTGKTV 497 (608)
Q Consensus 460 ~~~~gt~~y~aPE~---~~~~ksDVwSfGvvl~elltg~~p 497 (608)
.....+.+||. ..+.+.=|||+|+++|.-+-=..+
T Consensus 98 ---~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC
Confidence 11224667884 347889999999999998764433
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0032 Score=54.61 Aligned_cols=37 Identities=30% Similarity=0.316 Sum_probs=26.0
Q ss_pred CcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCC
Q 042949 126 RLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFA 162 (608)
Q Consensus 126 ~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~ 162 (608)
+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4677777777777333335677788888888888764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0013 Score=60.12 Aligned_cols=84 Identities=17% Similarity=0.166 Sum_probs=63.5
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCc-CCccCcccccCC----CCcceeeccCee-ccccCChhhcCCC
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNL-IQGRIPTSISNC----RRLTYLNLSSNL-LSGAVPLALTKLK 149 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~L~Ls~N~-l~g~lP~~l~~l~ 149 (608)
-+++.|+|+++.++..- -..+.++++|+.|+|+++. ++..-=..++.+ ++|++|+|+++. +|..==..+..++
T Consensus 61 ~~L~~LDLs~~~Itd~G-L~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIG-FDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCEEEEEEESCCCCGGG-GGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred ceEeEEeCcCCCccHHH-HHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 37999999999977431 1357899999999999984 775433456654 479999999964 7632223578899
Q ss_pred CCCEEeCcCCc
Q 042949 150 HLKTLDISNNH 160 (608)
Q Consensus 150 ~L~~L~ls~N~ 160 (608)
+|+.|+|+++.
T Consensus 140 ~L~~L~L~~c~ 150 (176)
T 3e4g_A 140 NLKYLFLSDLP 150 (176)
T ss_dssp TCCEEEEESCT
T ss_pred CCCEEECCCCC
Confidence 99999999975
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0043 Score=62.52 Aligned_cols=143 Identities=11% Similarity=0.139 Sum_probs=77.2
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCc--ceeeeee------eecCCeeEEEEeeccC
Q 042949 309 RSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPN--ILPLVCY------NSTNEEKLLVYKYQSN 380 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~------~~~~~~~~lv~e~~~~ 380 (608)
+++|....+|+....+| .+++|+.... ...+++..|+.++..+.... +.+++.. ....+..+++++|++|
T Consensus 30 i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G 107 (322)
T 2ppq_A 30 IAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG 107 (322)
T ss_dssp ECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred cCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCC
Confidence 45566778999887666 5788987642 22345566777766553212 2233321 1223567899999987
Q ss_pred CCHH-----------H---HHHHHhcC--CC---CC---CHHHHHH------------HHHHHHHHHHHHhcCC--CCCC
Q 042949 381 GSLL-----------S---LLEAYIEG--KR---DF---PWKLRLS------------IATGIAKGLDFMYQKS--NEEK 424 (608)
Q Consensus 381 g~L~-----------~---~l~~~~~~--~~---~l---~~~~~~~------------i~~~ia~gL~yLH~~~--~~~~ 424 (608)
..+. + .+|..... .. .. .|..... +...+.+.++++++.. ....
T Consensus 108 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~ 187 (322)
T 2ppq_A 108 MWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPA 187 (322)
T ss_dssp BCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCE
T ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCc
Confidence 5421 1 12221111 00 01 1322110 0112444556665321 1234
Q ss_pred CceecCCCCCCeecCCCCCceEecccccc
Q 042949 425 TIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 425 ~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 68999999999999877556799998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.24 E-value=0.016 Score=61.19 Aligned_cols=67 Identities=12% Similarity=0.050 Sum_probs=45.6
Q ss_pred cCCCCCceEEEEEEcC--------CcEEEEEEecccccCHHHHHHHHHHHhcCCCCcc-eeeeeeeecCCeeEEEEeecc
Q 042949 309 RSQTICSSLFMVRLKN--------SAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNI-LPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~ 379 (608)
+++|....+|++...+ +..+++|+.... ...+.+.+|..++..+...++ .++++.+.+ .+|+||++
T Consensus 81 l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~ 155 (429)
T 1nw1_A 81 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIP 155 (429)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCC
T ss_pred eCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeC
Confidence 4677778899998763 478889987432 122566689888887753333 566666542 38999997
Q ss_pred C
Q 042949 380 N 380 (608)
Q Consensus 380 ~ 380 (608)
+
T Consensus 156 G 156 (429)
T 1nw1_A 156 S 156 (429)
T ss_dssp E
T ss_pred C
Confidence 5
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.00084 Score=69.23 Aligned_cols=92 Identities=16% Similarity=0.149 Sum_probs=58.7
Q ss_pred CcEEEEEecCCCceeecChhhhc--CCcCCcEEEccc--CcCCcc-----Ccccc--cCCCCcceeeccCeeccccCChh
Q 042949 76 TNIVGIRLENMNLSGIIDAETLC--KLRHLRVVSLAR--NLIQGR-----IPTSI--SNCRRLTYLNLSSNLLSGAVPLA 144 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~--~l~~L~~L~l~~--N~l~g~-----~p~~~--~~l~~L~~L~Ls~N~l~g~lP~~ 144 (608)
.+++.|+|..++++...- ..++ .+++|+.|+|+. |...|. +...+ ..+++|++|+|++|.+++..+..
T Consensus 193 ~~L~~L~L~~~~l~~~~l-~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 193 PNLKSLEIISGGLPDSVV-EDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp TTCSEEEEECSBCCHHHH-HHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCcEEEEecCCCChHHH-HHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 356666666655543221 2343 789999999863 332222 11222 35789999999999987655444
Q ss_pred hc---CCCCCCEEeCcCCcCCccCChh
Q 042949 145 LT---KLKHLKTLDISNNHFAATSPDN 168 (608)
Q Consensus 145 l~---~l~~L~~L~ls~N~l~g~~p~~ 168 (608)
+. .+++|++|||+.|.+++.-+..
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~G~~~ 298 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDEGARL 298 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHHHHHH
T ss_pred HHhCccCCCCCEEECCCCCCChHHHHH
Confidence 43 4788999999999998754333
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.86 E-value=0.047 Score=55.49 Aligned_cols=32 Identities=16% Similarity=0.300 Sum_probs=27.7
Q ss_pred CCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 423 EKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 423 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
...++|+|+.+.||+++.++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34689999999999999888899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.78 E-value=0.0052 Score=63.39 Aligned_cols=70 Identities=11% Similarity=0.013 Sum_probs=39.9
Q ss_pred cCCCCCceEEEEEEcC---------CcEEEEEEecccccCHHHHHHHHHHHhcCCCCc-ceeeeeeeecCCeeEEEEeec
Q 042949 309 RSQTICSSLFMVRLKN---------SAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPN-ILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~~ 378 (608)
+++|....+|++...+ +..+++|+.........+...|.+++..+...+ ..++++.. . -++||||+
T Consensus 41 l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e~i 116 (369)
T 3c5i_A 41 ILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEEWL 116 (369)
T ss_dssp C----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECC
T ss_pred eCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEEEe
Confidence 4567777899988754 267888876532211112356777777664223 33566544 2 36899999
Q ss_pred cCCC
Q 042949 379 SNGS 382 (608)
Q Consensus 379 ~~g~ 382 (608)
++..
T Consensus 117 ~G~~ 120 (369)
T 3c5i_A 117 YGDP 120 (369)
T ss_dssp CSEE
T ss_pred cCCc
Confidence 8743
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.61 E-value=0.0054 Score=63.16 Aligned_cols=90 Identities=14% Similarity=0.142 Sum_probs=61.2
Q ss_pred CCcEEEEEecCCC-ceeecChhhhcCCcCCcEEEcccCcCCccCccccc--CCCCcceeeccC--eecccc--C---Chh
Q 042949 75 ATNIVGIRLENMN-LSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSIS--NCRRLTYLNLSS--NLLSGA--V---PLA 144 (608)
Q Consensus 75 ~~~v~~l~l~~~~-l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~--~l~~L~~L~Ls~--N~l~g~--l---P~~ 144 (608)
..+++.|+|+++. + .+++ + .+++|+.|+|..+.++...-..+. .+++|+.|+|+. |...|. + -..
T Consensus 171 ~P~L~~L~L~g~~~l--~l~~--~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~ 245 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNL--SIGK--K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL 245 (362)
T ss_dssp CTTCCEEEEECCBTC--BCCS--C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGG
T ss_pred CCCCcEEEEeCCCCc--eecc--c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHH
Confidence 3579999999873 2 2332 3 388999999998888754444444 789999999864 332222 1 112
Q ss_pred h--cCCCCCCEEeCcCCcCCccCChhH
Q 042949 145 L--TKLKHLKTLDISNNHFAATSPDNF 169 (608)
Q Consensus 145 l--~~l~~L~~L~ls~N~l~g~~p~~~ 169 (608)
+ ..+++|++|+|.+|.+.+..+..+
T Consensus 246 l~~~~~p~Lr~L~L~~~~i~~~~~~~l 272 (362)
T 2ra8_A 246 FSKDRFPNLKWLGIVDAEEQNVVVEMF 272 (362)
T ss_dssp SCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred HhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence 2 357899999999999986554443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.017 Score=58.46 Aligned_cols=78 Identities=13% Similarity=0.134 Sum_probs=65.4
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCc-EEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLR-VVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
.+++.|+|++| +. .|+...+.+|.+|+ .|++.+ .+...-+..|..|++|+.|+|+.|+++..-+..|.++++|+.+
T Consensus 250 ~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 250 KYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp TTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred CCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 47999999997 44 46777899999999 999998 7775556789999999999999999994444589999999988
Q ss_pred eC
Q 042949 155 DI 156 (608)
Q Consensus 155 ~l 156 (608)
..
T Consensus 327 y~ 328 (329)
T 3sb4_A 327 YK 328 (329)
T ss_dssp EC
T ss_pred cc
Confidence 64
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.44 E-value=0.08 Score=56.14 Aligned_cols=71 Identities=11% Similarity=0.064 Sum_probs=43.9
Q ss_pred ccCCCCCceEEEEEEcC-CcEEEEEEecccccCHHHHHHHHHHHhcCCCCcc-eeeeeeeecCCeeEEEEeeccCCC
Q 042949 308 LRSQTICSSLFMVRLKN-SAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNI-LPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~~-g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
.+++|....+|++...+ +..+++|+........-+..+|..++..+...++ .++++.+. + .+||||+++.+
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 35677788899998865 4778888764321111112578888887764444 46677663 2 35999998643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=94.77 E-value=0.032 Score=48.15 Aligned_cols=56 Identities=13% Similarity=0.082 Sum_probs=43.4
Q ss_pred EEEecCCCce-eecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeecc
Q 042949 80 GIRLENMNLS-GIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS 138 (608)
Q Consensus 80 ~l~l~~~~l~-g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 138 (608)
.++.++++|+ ..+|. .+ -.+|+.|+|++|.|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~-~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPT-AF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCS-CC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCC-CC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5677778886 34542 12 237999999999999655567889999999999999885
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.51 E-value=0.018 Score=53.49 Aligned_cols=84 Identities=23% Similarity=0.347 Sum_probs=60.9
Q ss_pred CCcEEEEEecCC-Ccee----ecChhhhcCCcCCcEEEcccCcCCcc----CcccccCCCCcceeeccCeecccc----C
Q 042949 75 ATNIVGIRLENM-NLSG----IIDAETLCKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLSGA----V 141 (608)
Q Consensus 75 ~~~v~~l~l~~~-~l~g----~~~~~~l~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----l 141 (608)
...++.|+|+++ .+.. .+ ...|..-+.|+.|+|++|.|... |-..+..-+.|+.|+|++|+++.. |
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~l-a~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSL-IEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHH-HHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHH-HHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 357899999986 6652 13 24577788999999999999743 233444567899999999999743 2
Q ss_pred ChhhcCCCCCCEEeCcCC
Q 042949 142 PLALTKLKHLKTLDISNN 159 (608)
Q Consensus 142 P~~l~~l~~L~~L~ls~N 159 (608)
-..+..-+.|+.|+|++|
T Consensus 119 a~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHTTTTCCCSEEECCCC
T ss_pred HHHHhhCCceeEEECCCC
Confidence 234555677999999865
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.26 E-value=0.11 Score=54.31 Aligned_cols=140 Identities=11% Similarity=0.078 Sum_probs=79.4
Q ss_pred cCCCCCceEEEEEEcC--------CcEEEEEEecccccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeecc
Q 042949 309 RSQTICSSLFMVRLKN--------SAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.+|-...+|+....+ +..+++|+-.......-+..+|.++++.+. +.-..++++.+. -++|+||++
T Consensus 78 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~efI~ 153 (424)
T 3mes_A 78 IFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEFID 153 (424)
T ss_dssp ECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEECCC
T ss_pred cCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEEeC
Confidence 4567777889988763 578888886432211122356777777664 222345555432 378999998
Q ss_pred CCCHH--------------HHH---HHHhc---------CCCCCCHHHHHHHHHHH-------------------HHHHH
Q 042949 380 NGSLL--------------SLL---EAYIE---------GKRDFPWKLRLSIATGI-------------------AKGLD 414 (608)
Q Consensus 380 ~g~L~--------------~~l---~~~~~---------~~~~l~~~~~~~i~~~i-------------------a~gL~ 414 (608)
+..|. +.| |.... ...+.-|.++.++..++ ...++
T Consensus 154 G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e~~ 233 (424)
T 3mes_A 154 GEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEEID 233 (424)
T ss_dssp SEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHHHH
T ss_pred CccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHHHH
Confidence 75531 111 11111 11111244443333222 22334
Q ss_pred HHhcC-------------------CCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 415 FMYQK-------------------SNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 415 yLH~~-------------------~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
+|.+. ......++|+|+.+.||+ +.++.+.++||..+.
T Consensus 234 ~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 234 QLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 43311 112346899999999999 778889999998875
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=94.07 E-value=0.073 Score=55.46 Aligned_cols=82 Identities=16% Similarity=0.255 Sum_probs=61.1
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCC-----ccCcccccCCCCcceeeccCeeccccCCh-hhcCCC
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQ-----GRIPTSISNCRRLTYLNLSSNLLSGAVPL-ALTKLK 149 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~-----g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~-~l~~l~ 149 (608)
..++.+.|.+ ++. .|+...+.++++|+.+++.+|.+. -.-+..|..|++|+.++|++ .++ .|+. .|.+++
T Consensus 248 ~~L~~i~lp~-~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~ 323 (401)
T 4fdw_A 248 SGITTVKLPN-GVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNR 323 (401)
T ss_dssp CCCSEEEEET-TCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCC
T ss_pred CCccEEEeCC-Ccc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCC
Confidence 4688888854 344 355567889999999999988775 22345688899999999994 466 4554 688899
Q ss_pred CCCEEeCcCCcCC
Q 042949 150 HLKTLDISNNHFA 162 (608)
Q Consensus 150 ~L~~L~ls~N~l~ 162 (608)
+|+.++|..| ++
T Consensus 324 ~L~~l~lp~~-l~ 335 (401)
T 4fdw_A 324 KVTQLTIPAN-VT 335 (401)
T ss_dssp SCCEEEECTT-CC
T ss_pred CccEEEECcc-cc
Confidence 9999999655 44
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=92.31 E-value=0.043 Score=49.95 Aligned_cols=62 Identities=10% Similarity=0.114 Sum_probs=47.4
Q ss_pred cCCcEEEcccCcCCccCcccccCCCCcceeeccCee-ccccCChhhcCC----CCCCEEeCcCCc-CC
Q 042949 101 RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNL-LSGAVPLALTKL----KHLKTLDISNNH-FA 162 (608)
Q Consensus 101 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g~lP~~l~~l----~~L~~L~ls~N~-l~ 162 (608)
..|+.||++++.++..--..+..|++|+.|+|+++. ++..-=..++.+ ++|+.|||++|. +|
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 479999999999876544567899999999999985 664322345554 379999999974 65
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=90.82 E-value=0.086 Score=48.89 Aligned_cols=69 Identities=12% Similarity=0.203 Sum_probs=51.7
Q ss_pred hhcCCcCCcEEEcccC-cCCcc----CcccccCCCCcceeeccCeecccc----CChhhcCCCCCCEEeCcCCcCCcc
Q 042949 96 TLCKLRHLRVVSLARN-LIQGR----IPTSISNCRRLTYLNLSSNLLSGA----VPLALTKLKHLKTLDISNNHFAAT 164 (608)
Q Consensus 96 ~l~~l~~L~~L~l~~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----lP~~l~~l~~L~~L~ls~N~l~g~ 164 (608)
.+.+-+.|+.|+|++| .+... +-..+..-+.|+.|+|++|++... |-..|..-+.|+.|+|++|++...
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~ 113 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPE 113 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHH
Confidence 3556789999999986 77532 334566678899999999999732 223454568899999999999753
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=90.32 E-value=0.36 Score=50.10 Aligned_cols=90 Identities=13% Similarity=0.204 Sum_probs=64.2
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeecc----ccCC-hhhcCCCC
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLS----GAVP-LALTKLKH 150 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~----g~lP-~~l~~l~~ 150 (608)
.+++.|+|..+ +. .|+...+.+ ..|+.+.+ .|.+...-+..|.+|++|+.++|++|.+. ..|+ ..|..+++
T Consensus 226 ~~L~~l~l~~~-l~-~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~ 301 (401)
T 4fdw_A 226 SQLKTIEIPEN-VS-TIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPK 301 (401)
T ss_dssp TTCCCEECCTT-CC-EECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTT
T ss_pred CCCCEEecCCC-cc-Ccccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCcc
Confidence 46888888864 43 355556666 78999999 45566444567899999999999998875 1244 47899999
Q ss_pred CCEEeCcCCcCCccCChhHH
Q 042949 151 LKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 151 L~~L~ls~N~l~g~~p~~~~ 170 (608)
|+.++|.+ +++---...|.
T Consensus 302 L~~l~l~~-~i~~I~~~aF~ 320 (401)
T 4fdw_A 302 LARFEIPE-SIRILGQGLLG 320 (401)
T ss_dssp CCEECCCT-TCCEECTTTTT
T ss_pred CCeEEeCC-ceEEEhhhhhc
Confidence 99999984 45433333443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=84.51 E-value=1.3 Score=45.58 Aligned_cols=62 Identities=13% Similarity=0.186 Sum_probs=34.7
Q ss_pred hhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCC-hhhcCCCCCCEEeCcCC
Q 042949 95 ETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVP-LALTKLKHLKTLDISNN 159 (608)
Q Consensus 95 ~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP-~~l~~l~~L~~L~ls~N 159 (608)
..+..+..|+.+.+..| +.-.-...+.+|++|+.++|+.+ ++ .|+ ..|.++.+|+.+++..|
T Consensus 291 ~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 291 KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT
T ss_pred ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc
Confidence 34556666666666544 33222334666666666666543 44 333 35666666666666554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=82.40 E-value=1.7 Score=44.25 Aligned_cols=80 Identities=11% Similarity=0.170 Sum_probs=55.3
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCC-hhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVP-LALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP-~~l~~l~~L~~L 154 (608)
..+..+.+..+ ++ .|....+.++..|+.+.+..+ +.-.-...+..|++|+.+++.+|.++ .|+ ..|.++.+|+.+
T Consensus 240 ~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i 315 (379)
T 4h09_A 240 KALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSV 315 (379)
T ss_dssp SSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEE
T ss_pred ccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCCCCCEE
Confidence 45777777664 33 344456777888888888654 44233346778888998888888777 444 467888888888
Q ss_pred eCcCC
Q 042949 155 DISNN 159 (608)
Q Consensus 155 ~ls~N 159 (608)
+|..|
T Consensus 316 ~lp~~ 320 (379)
T 4h09_A 316 TLPTA 320 (379)
T ss_dssp ECCTT
T ss_pred EcCcc
Confidence 88654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.20 E-value=2.2 Score=39.85 Aligned_cols=114 Identities=15% Similarity=0.136 Sum_probs=75.8
Q ss_pred CCCcceeeeeeeecCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCCCceecCCC
Q 042949 354 KHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLD-FMYQKSNEEKTIPHGNLK 432 (608)
Q Consensus 354 ~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~~~ivHrDlk 432 (608)
.||++ -...-.+.+...+.|+.-+++.=...++ .++...+++++..|+.-.+ +++. -+|--+.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-------r~tf~l~ 111 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-------RLIFIVC 111 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-------SEECCCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-------ceeEEEe
Confidence 57887 3444466777777777654443233333 3778889999888877665 4432 6788999
Q ss_pred CCCeecCCCCCceEeccccccccCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 042949 433 LSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTVSEQGDVFSFGVILLELLTGKTVE 498 (608)
Q Consensus 433 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~~~~~ksDVwSfGvvl~elltg~~p~ 498 (608)
|+||++|.++.+++.-.|+-..+ +|.. .+..-=.-.+=+++..++.++..|
T Consensus 112 P~NL~f~~~~~p~i~hRGi~~~l--------------pP~e-~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 112 PENLMFNRALEPFFLHVGVKESL--------------PPDE-WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp GGGEEECTTCCEEESCCEETTTB--------------SSCS-CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred CceEEEeCCCcEEEEEcCCcccC--------------CCCC-CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999999999999888875433 3322 222222335777888888877654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=80.32 E-value=2.9 Score=42.88 Aligned_cols=79 Identities=10% Similarity=0.256 Sum_probs=45.6
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCC-hhhcCCCCCCEE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVP-LALTKLKHLKTL 154 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP-~~l~~l~~L~~L 154 (608)
..++.+.+..+-. .|....+.++..|+.+.+. +.+.-.-...|..|.+|+.++|+.| ++ .|. ..|.++.+|+.+
T Consensus 265 ~~L~~i~lp~~~~--~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i 339 (394)
T 4gt6_A 265 AYLASVKMPDSVV--SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERI 339 (394)
T ss_dssp SSCCEEECCTTCC--EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEE
T ss_pred ccccEEecccccc--eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEE
Confidence 3566677765433 2334456667777777775 3344222335666777777777654 43 333 356677777777
Q ss_pred eCcCC
Q 042949 155 DISNN 159 (608)
Q Consensus 155 ~ls~N 159 (608)
.|..+
T Consensus 340 ~ip~s 344 (394)
T 4gt6_A 340 AIPSS 344 (394)
T ss_dssp EECTT
T ss_pred EECcc
Confidence 77543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 608 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-38 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-36 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-31 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-30 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-30 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-29 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-29 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-29 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-27 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-27 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-26 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-25 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-24 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-24 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-23 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-22 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-22 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-21 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-20 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-20 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-19 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-19 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-19 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-18 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-18 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-17 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-16 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-15 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-15 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-14 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-04 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 2e-39
Identities = 58/262 (22%), Positives = 105/262 (40%), Gaps = 31/262 (11%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLLV 374
+ + AVK L + + ++ +H NIL + Y ST + +V
Sbjct: 25 YKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIV 81
Query: 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
++ SL L + F + IA A+G+D+++ KS I H +LK +
Sbjct: 82 TQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS-----IIHRDLKSN 133
Query: 435 NILLNENEDPLISECGYSKFLDPKKTCLFSSN-----GYTAPE-------KTVSEQGDVF 482
NI L+E+ I + G + + APE S Q DV+
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 483 SFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALK 542
+FG++L EL+TG+ + I+ + MV + +++K + + +
Sbjct: 194 AFGIVLYELMTGQLPY-SNINNRDQIIFMVGRGY----LSPDLSKVRSNCPKAMKRLMAE 248
Query: 543 CVSNSPDDRPTMAEVLERIEEV 564
C+ D+RP ++L IE +
Sbjct: 249 CLKKKRDERPLFPQILASIELL 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-38
Identities = 47/256 (18%), Positives = 102/256 (39%), Gaps = 25/256 (9%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377
+ N A+K +++ +S ++F + + L HP ++ L LV+++
Sbjct: 22 HLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+G L + F + L + + +G+ ++ E + H +L N L
Sbjct: 82 MEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLE-----EACVIHRDLAARNCL 133
Query: 438 LNENEDPLISECGYSKFLDPKKT----CLFSSNGYTAPE----KTVSEQGDVFSFGVILL 489
+ EN+ +S+ G ++F+ + + +PE S + DV+SFGV++
Sbjct: 134 VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMW 193
Query: 490 ELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPD 549
E+ + + + V+ + G K R + + + C P+
Sbjct: 194 EVFSEGKIPYENRSNSEVVEDIST----GFRLYKP-----RLASTHVYQIMNHCWKERPE 244
Query: 550 DRPTMAEVLERIEEVV 565
DRP + +L ++ E+
Sbjct: 245 DRPAFSRLLRQLAEIA 260
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-38
Identities = 58/254 (22%), Positives = 109/254 (42%), Gaps = 25/254 (9%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377
+M AVK LK+ +S D F + L+H ++ L T E ++ +Y
Sbjct: 30 WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEY 88
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
NGSL+ L L +A IA+G+ F+ +++ H +L+ +NIL
Sbjct: 89 MENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----YIHRDLRAANIL 141
Query: 438 LNENEDPLISECGYSKFLDPKKTCLFSSN----GYTAPE----KTVSEQGDVFSFGVILL 489
+++ I++ G ++ ++ + +TAPE T + + DV+SFG++L
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLT 201
Query: 490 ELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPD 549
E++T + G+ P+ ++ + R V + L + C P+
Sbjct: 202 EIVTHGRIPYPGMTNPEVIQNLERGYR--MVRPDNCPEE-------LYQLMRLCWKERPE 252
Query: 550 DRPTMAEVLERIEE 563
DRPT + +E+
Sbjct: 253 DRPTFDYLRSVLED 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 5e-38
Identities = 48/252 (19%), Positives = 110/252 (43%), Gaps = 22/252 (8%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPL--VCYNSTNEEKLLV 374
R + + K L ++ E + ++ LKHPNI+ + TN +V
Sbjct: 24 RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83
Query: 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
+Y G L S++ + ++ + L + T + L +++S+ T+ H +LK +
Sbjct: 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143
Query: 435 NILLNENEDPLISECGYSKFLDPKKTCLFS---SNGYTAPE----KTVSEQGDVFSFGVI 487
N+ L+ ++ + + G ++ L+ + + + Y +PE + +E+ D++S G +
Sbjct: 144 NVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 203
Query: 488 LLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNS 547
L EL A ++E G++ + + + +++ L + + ++
Sbjct: 204 LYELCALMP----------PFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLK 253
Query: 548 PDDRPTMAEVLE 559
RP++ E+LE
Sbjct: 254 DYHRPSVEEILE 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-38
Identities = 52/252 (20%), Positives = 103/252 (40%), Gaps = 23/252 (9%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKL-LVYK 376
+ + + V AVK +K + F + L+H N++ L+ + L +V +
Sbjct: 24 MLGDYRGNKV-AVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
Y + GSL+ L + G+ L + + + ++++ + H +L N+
Sbjct: 82 YMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNV 134
Query: 437 LLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELL 492
L++E+ +S+ G +K + +TAPE K S + DV+SFG++L E+
Sbjct: 135 LVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 194
Query: 493 TGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRP 552
+ V I K V V + + + D + V C RP
Sbjct: 195 SFGRVPYPRIP-LKDVVPRVEKGYKMDAPDG--------CPPAVYEVMKNCWHLDAAMRP 245
Query: 553 TMAEVLERIEEV 564
+ ++ E++E +
Sbjct: 246 SFLQLREQLEHI 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-37
Identities = 45/255 (17%), Positives = 101/255 (39%), Gaps = 25/255 (9%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377
+ + A+K +K+ +S DEF + + + NL H ++ L + ++ +Y
Sbjct: 21 KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+NG LL+ L E + F + L + + + ++++ K H +L N L
Sbjct: 81 MANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCL 132
Query: 438 LNENEDPLISECGYSKFLDP----KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILL 489
+N+ +S+ G S+++ ++ PE S + D+++FGV++
Sbjct: 133 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMW 192
Query: 490 ELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPD 549
E+ + + + + + + ++ + + C D
Sbjct: 193 EIYSLGKMPYERFTNSETAEHIAQ--GLRLYRPHLASEK-------VYTIMYSCWHEKAD 243
Query: 550 DRPTMAEVLERIEEV 564
+RPT +L I +V
Sbjct: 244 ERPTFKILLSNILDV 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-36
Identities = 54/272 (19%), Positives = 107/272 (39%), Gaps = 31/272 (11%)
Query: 327 VYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEK-LLVYKYQSNGSL 383
AVK L ++ + +F + + HPN+L L+ +E L+V Y +G L
Sbjct: 57 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116
Query: 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443
+ + K + +AKG+ F+ K H +L N +L+E
Sbjct: 117 RNF---IRNETHNPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFT 168
Query: 444 PLISECGYSKFLDPKKTCLFSSN-------GYTAPE----KTVSEQGDVFSFGVILLELL 492
+++ G ++ + K+ + + A E + + + DV+SFGV+L EL+
Sbjct: 169 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 228
Query: 493 TGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRP 552
T ++ +++ PL V LKC + RP
Sbjct: 229 TRGAPPYPDVNTFDITVYLLQGRRL---------LQPEYCPDPLYEVMLKCWHPKAEMRP 279
Query: 553 TMAEVLERIEEVVNGNDERDRDHSNSSFSSME 584
+ +E++ RI + + H N+++ +++
Sbjct: 280 SFSELVSRISAIFSTFIGEHYVHVNATYVNVK 311
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-36
Identities = 57/268 (21%), Positives = 111/268 (41%), Gaps = 25/268 (9%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377
+M + A+K LK +S + F Q + + L+H ++ L + E +V +Y
Sbjct: 34 WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEY 92
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
S GSLL E + + +A IA G+ ++ + + H +L+ +NIL
Sbjct: 93 MSKGSLLDF--LKGETGKYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANIL 145
Query: 438 LNENEDPLISECGYSKFLDPKKTCLFSSN----GYTAPE----KTVSEQGDVFSFGVILL 489
+ EN +++ G ++ ++ + +TAPE + + DV+SFG++L
Sbjct: 146 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 205
Query: 490 ELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPD 549
EL T V G+ + V V + + L ++ +C P+
Sbjct: 206 ELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPE--------CPESLHDLMCQCWRKEPE 256
Query: 550 DRPTMAEVLERIEEVVNGNDERDRDHSN 577
+RPT + +E+ + + + N
Sbjct: 257 ERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 7e-36
Identities = 50/282 (17%), Positives = 98/282 (34%), Gaps = 41/282 (14%)
Query: 318 FMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCY----NSTNEEKLL 373
+ + + V AVK + + Q L+H NIL + N T + L
Sbjct: 20 WRGKWRGEEV-AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78
Query: 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQ---KSNEEKTIPHGN 430
V Y +GSL L + + + +A A GL ++ + + I H +
Sbjct: 79 VSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133
Query: 431 LKLSNILLNENEDPLISECGYSKFLDP-------KKTCLFSSNGYTAPE----------K 473
LK NIL+ +N I++ G + D + Y APE
Sbjct: 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 193
Query: 474 TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533
++ D+++ G++ E+ ++ D +V + + E K V + +
Sbjct: 194 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN 253
Query: 534 FP-----------LLNVALKCVSNSPDDRPTMAEVLERIEEV 564
P + + +C + R T + + + ++
Sbjct: 254 IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (334), Expect = 2e-35
Identities = 57/264 (21%), Positives = 116/264 (43%), Gaps = 25/264 (9%)
Query: 318 FMVRLKNSA-VYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376
+ K + AVK LK+ + ++EF + + +KHPN++ L+ + ++ +
Sbjct: 34 YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
+ + G+LL L +++ + L +AT I+ ++++ +K+ H +L N
Sbjct: 94 FMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNC 146
Query: 437 LLNENEDPLISECGYSKFLDPKKTCLFSSN----GYTAP----EKTVSEQGDVFSFGVIL 488
L+ EN +++ G S+ + + +TAP S + DV++FGV+L
Sbjct: 147 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 206
Query: 489 LELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
E+ T GID V ++ +++ E + K + + C +P
Sbjct: 207 WEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK--------VYELMRACWQWNP 257
Query: 549 DDRPTMAEVLERIEEVVNGNDERD 572
DRP+ AE+ + E + + D
Sbjct: 258 SDRPSFAEIHQAFETMFQESSISD 281
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 4e-34
Identities = 52/280 (18%), Positives = 107/280 (38%), Gaps = 41/280 (14%)
Query: 314 CSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNSTNE 369
++ +++ + AVK LK + E M ++ L H NI+ L+ +
Sbjct: 42 ATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100
Query: 370 EKLLVYKYQSNGSLLSLLEAY--------------IEGKRDFPWKLRLSIATGIAKGLDF 415
L++ +Y G LL+ L + + + LS + +AKG+ F
Sbjct: 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160
Query: 416 MYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE--- 472
+ K+ H +L NILL I + G ++ + + N +
Sbjct: 161 LASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA 215
Query: 473 ------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVA 526
+ + DV+S+G+ L EL + + G+ + M++E + + A
Sbjct: 216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPA 275
Query: 527 KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566
+ + ++ C P RPT ++++ IE+ ++
Sbjct: 276 E--------MYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 2e-33
Identities = 54/304 (17%), Positives = 117/304 (38%), Gaps = 49/304 (16%)
Query: 294 ERFKLDDLLEATADLRSQTICSSLFMVRL------------------KNSAVYAVKRLKK 335
+ F +D EA + + S + + ++ K A+K LK
Sbjct: 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS 64
Query: 336 --LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLEAYIEG 393
+ +F +G HPN++ L + + +++ ++ NGSL S +
Sbjct: 65 GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---LRQN 121
Query: 394 KRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453
F + + GIA G+ ++ + H +L NIL+N N +S+ G S+
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMN-----YVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 454 FLDPKKTCLFSSN--------GYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTG 501
FL+ + ++ +TAPE + + DV+S+G+++ E+++
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 502 IDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERI 561
+ + A+ ++ D L + L C + RP +++ +
Sbjct: 237 MTNQDVINAIEQDYRLPPPMD---------CPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 562 EEVV 565
++++
Sbjct: 288 DKMI 291
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 8e-33
Identities = 61/293 (20%), Positives = 116/293 (39%), Gaps = 44/293 (15%)
Query: 318 FMVRLKNSA---VYAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNSTNEE 370
R+K A+KR+K+ S D+ ++ L HPNI+ L+
Sbjct: 27 LKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85
Query: 371 KLLVYKYQSNGSLLSLLEAYIEGKRD------------FPWKLRLSIATGIAKGLDFMYQ 418
L +Y +G+LL L + D + L A +A+G+D++ Q
Sbjct: 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 145
Query: 419 KSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP--KKTCLFSSNGYTAPE---- 472
K H +L NIL+ EN I++ G S+ + KKT + A E
Sbjct: 146 KQ-----FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY 200
Query: 473 KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532
+ DV+S+GV+L E+++ G+ + + + + G +K
Sbjct: 201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----GYRLEKP-----LNC 251
Query: 533 AFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERDRDHSNSSFSSMES 585
+ ++ +C P +RP+ A++L + ++ E + + N++ +
Sbjct: 252 DDEVYDLMRQCWREKPYERPSFAQILVSLNRML----EERKTYVNTTLYEKFT 300
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-32
Identities = 52/260 (20%), Positives = 103/260 (39%), Gaps = 29/260 (11%)
Query: 323 KNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380
K A+K LK + +F +G H NI+ L S + +++ +Y N
Sbjct: 34 KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN 93
Query: 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440
G+L E +F + + GIA G+ ++ H +L NIL+N
Sbjct: 94 GALDKF---LREKDGEFSVLQLVGMLRGIAAGMKYLA-----NMNYVHRDLAARNILVNS 145
Query: 441 NEDPLISECGYSKFLDPKKTCLFSSNG------YTAPE----KTVSEQGDVFSFGVILLE 490
N +S+ G S+ L+ ++++G +TAPE + + DV+SFG+++ E
Sbjct: 146 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205
Query: 491 LLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDD 550
++T + + E + D + + ++C
Sbjct: 206 VMTYG---------ERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERAR 256
Query: 551 RPTMAEVLERIEEVVNGNDE 570
RP A+++ +++++ D
Sbjct: 257 RPKFADIVSILDKLIRAPDS 276
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (306), Expect = 1e-31
Identities = 52/276 (18%), Positives = 99/276 (35%), Gaps = 45/276 (16%)
Query: 319 MVRLKNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376
++ + + AVK LK+ +F + + +PNI+ L+ + + L+++
Sbjct: 37 LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96
Query: 377 YQSNGSLLSLLEAY--------------------IEGKRDFPWKLRLSIATGIAKGLDFM 416
Y + G L L + G +L IA +A G+ ++
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 417 YQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSN-----GYTAP 471
++ H +L N L+ EN I++ G S+ + N + P
Sbjct: 157 SERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211
Query: 472 E----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527
E + + DV+++GV+L E+ + + M EE V D +
Sbjct: 212 ESIFYNRYTTESDVWAYGVVLWEIFSYGL---------QPYYGMAHEEVIYYVRDGNILA 262
Query: 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEE 563
L N+ C S P DRP+ + ++
Sbjct: 263 CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-31
Identities = 52/256 (20%), Positives = 99/256 (38%), Gaps = 36/256 (14%)
Query: 323 KNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380
K A+K LK+ + +E + + + L +P I+ L+ E +LV +
Sbjct: 34 KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGG 92
Query: 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440
G L L + + + P + ++ G+ ++ +K+ H +L N+LL
Sbjct: 93 GPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVN 144
Query: 441 NEDPLISECGYSKFLDPKKTCLFSSN------GYTAPE----KTVSEQGDVFSFGVILLE 490
IS+ G SK L + + + + APE + S + DV+S+GV + E
Sbjct: 145 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 204
Query: 491 LLTGKTV---EKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNS 547
L+ + G ++ +++ R E E + L + C
Sbjct: 205 ALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE------------LYALMSDCWIYK 252
Query: 548 PDDRPTMAEVLERIEE 563
+DRP V +R+
Sbjct: 253 WEDRPDFLTVEQRMRA 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-31
Identities = 52/254 (20%), Positives = 91/254 (35%), Gaps = 32/254 (12%)
Query: 323 KNSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379
K AVK LK DE + L +P I+ ++ E +LV +
Sbjct: 32 KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAE 90
Query: 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
G L Y++ R K + + ++ G+ ++ + + H +L N+LL
Sbjct: 91 LGPLNK----YLQQNRHVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLV 141
Query: 440 ENEDPLISECGYSKFLDPKKTCLFSSN------GYTAPE----KTVSEQGDVFSFGVILL 489
IS+ G SK L + + + APE S + DV+SFGV++
Sbjct: 142 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 201
Query: 490 ELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPD 549
E + G+ V AM+ + + ++ C + +
Sbjct: 202 EAFSYGQKPYRGMK-GSEVTAMLEKGERMGCPAG--------CPREMYDLMNLCWTYDVE 252
Query: 550 DRPTMAEVLERIEE 563
+RP A V R+
Sbjct: 253 NRPGFAAVELRLRN 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (301), Expect = 1e-30
Identities = 48/251 (19%), Positives = 92/251 (36%), Gaps = 30/251 (11%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQ----IGNLKHPNILPLVCYNSTNEEKLLVY 375
++NS V A+K++ +E Q + + + L+HPN + LV
Sbjct: 35 RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
+Y + + K+ ++ G +GL +++ + + H ++K N
Sbjct: 95 EYCLGSAS----DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGN 145
Query: 436 ILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE-------KTVSEQGDVFSFGVIL 488
ILL+E + + G + + P + + + + APE + DV+S G+
Sbjct: 146 ILLSEPGLVKLGDFGSASIMAPANSFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 489 LELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
+EL K P ++ A W+ N C+ P
Sbjct: 205 IELAERK---------PPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255
Query: 549 DDRPTMAEVLE 559
DRPT +L+
Sbjct: 256 QDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-30
Identities = 60/252 (23%), Positives = 106/252 (42%), Gaps = 30/252 (11%)
Query: 318 FMVRLKNS-AVYAVKRLKKLQVSMDEFSQTMRQ----IGNLKHPNILPLVCYNSTNEEKL 372
++ R K S + A+K L K Q+ +R+ +L+HPNIL L Y
Sbjct: 23 YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
L+ +Y G++ L+ F + + T +A L + + K + H ++K
Sbjct: 83 LILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKR-----VIHRDIK 133
Query: 433 LSNILLNENEDPLISECGYSKFLDPKKTCLF-SSNGYTAPE----KTVSEQGDVFSFGVI 487
N+LL + I++ G+S + + Y PE + E+ D++S GV+
Sbjct: 134 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 193
Query: 488 LLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNS 547
E L GK + + K + R E+T F V + R ++ + + ++
Sbjct: 194 CYEFLVGKPPFE-ANTYQETYKRISRVEFT---FPDFVTEGAR-------DLISRLLKHN 242
Query: 548 PDDRPTMAEVLE 559
P RP + EVLE
Sbjct: 243 PSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 2e-30
Identities = 40/253 (15%), Positives = 96/253 (37%), Gaps = 29/253 (11%)
Query: 320 VRLKNSAVYAVKRLKKLQVS-MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378
+ S + A K + ++++ + + + HPNI+ L+ ++ ++
Sbjct: 32 QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
+ G++ +++ +E +R + L++++ I H +LK NIL
Sbjct: 92 AGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDNK-----IIHRDLKAGNILF 143
Query: 439 NENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE---------KTVSEQGDVFSFGV 486
+ D +++ G S S G + APE + + DV+S G+
Sbjct: 144 TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 203
Query: 487 ILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSN 546
L+E+ + ++ + + + + E + + KC+
Sbjct: 204 TLIEMAEIEPPHH-ELNPMRVLLKIAKSEPPTLAQPSRWSSN-------FKDFLKKCLEK 255
Query: 547 SPDDRPTMAEVLE 559
+ D R T +++L+
Sbjct: 256 NVDARWTTSQLLQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 4e-30
Identities = 53/283 (18%), Positives = 111/283 (39%), Gaps = 31/283 (10%)
Query: 328 YAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385
A+K L++ + E + ++ +P++ L+ T+ +L+
Sbjct: 41 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFG----C 96
Query: 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPL 445
LL+ E K + + L+ IAKG++++ + + H +L N+L+ +
Sbjct: 97 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVK 151
Query: 446 ISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDVFSFGVILLELLTGKT 496
I++ G +K L ++ + G + A E + + Q DV+S+GV + EL+T +
Sbjct: 152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211
Query: 497 VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAE 556
GI + + + GE + + + +KC D RP E
Sbjct: 212 KPYDGIPASEISSILEK----GERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRE 262
Query: 557 VLERIEEVVNGNDERDRDHSNSSFSSMESIPHDSCLLHTVIQE 599
++ ++ + +R + S P DS ++ E
Sbjct: 263 LIIEFSKMAR-DPQRYLVIQGDERMHLPS-PTDSNFYRALMDE 303
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 6e-30
Identities = 48/274 (17%), Positives = 100/274 (36%), Gaps = 46/274 (16%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNSTNEEKLLVYK 376
+ S AVK LK+ + E M ++ + H NI+ L+ + + L+++
Sbjct: 63 KTGVSIQVAVKMLKE-KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121
Query: 377 YQSNGSLLSLLE-------------------AYIEGKRDFPWKLRLSIATGIAKGLDFMY 417
Y G LL+ L E ++ L A +AKG++F+
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL- 180
Query: 418 QKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSN-----GYTAPE 472
E K+ H +L N+L+ + I + G ++ + + N + APE
Sbjct: 181 ----EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236
Query: 473 ----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528
+ + DV+S+G++L E+ + GI + +++ + + +
Sbjct: 237 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD-QPFYATEE 295
Query: 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562
+ + C + RP+ + +
Sbjct: 296 -------IYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 8e-30
Identities = 55/256 (21%), Positives = 98/256 (38%), Gaps = 31/256 (12%)
Query: 323 KNSAVYAVKRLKKLQVS----MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378
+ AVK LK +S MD+F + + + +L H N++ L T K+ V +
Sbjct: 34 GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELA 92
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
GSLL + + F A +A+G+ ++ K H +L N+LL
Sbjct: 93 PLGSLLDR---LRKHQGHFLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLL 144
Query: 439 NENEDPLISECGYSKFLDPKKTCLFSSN------GYTAP----EKTVSEQGDVFSFGVIL 488
+ I + G + L + AP +T S D + FGV L
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204
Query: 489 LELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
E+ T G++ + + + +E + + NV ++C ++ P
Sbjct: 205 WEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED--------CPQDIYNVMVQCWAHKP 256
Query: 549 DDRPTMAEVLERIEEV 564
+DRPT + + + E
Sbjct: 257 EDRPTFVALRDFLLEA 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-29
Identities = 47/252 (18%), Positives = 97/252 (38%), Gaps = 27/252 (10%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCY----NSTNEEKL 372
+ + + A L+ +++ E + + L+HPNI+ + +
Sbjct: 29 LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
LV + ++G+L + Y++ + K+ S I KGL F++ ++ I H +LK
Sbjct: 89 LVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLK 141
Query: 433 LSNILLN-ENEDPLISECGYSKFLDPKKTCLFS-SNGYTAPE---KTVSEQGDVFSFGVI 487
NI + I + G + + + APE + E DV++FG+
Sbjct: 142 CDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMC 201
Query: 488 LLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNS 547
+LE+ T + + + V FDK + + C+ +
Sbjct: 202 MLEMATSEYP-YSECQNAAQIYRRVTSGVKPASFDKVAIPE-------VKEIIEGCIRQN 253
Query: 548 PDDRPTMAEVLE 559
D+R ++ ++L
Sbjct: 254 KDERYSIKDLLN 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 45/280 (16%), Positives = 99/280 (35%), Gaps = 48/280 (17%)
Query: 320 VRLKNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377
+ V A K + ++ + ++ + P I+ ++ E + ++
Sbjct: 26 SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
GS L+ ++ P ++ ++ + KGL ++ +K I H ++K SNIL
Sbjct: 86 MDGGS----LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK----IMHRDVKPSNIL 137
Query: 438 LNENEDPLISECGYSKFLDPKKTCLFS-SNGYTAPE----KTVSEQGDVFSFGVILLELL 492
+N + + + G S L F + Y +PE S Q D++S G+ L+E+
Sbjct: 138 VNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197
Query: 493 TGKT-----------------VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ---- 531
G+ VE + P + R + + +
Sbjct: 198 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYI 257
Query: 532 ------------WAFPLLNVALKCVSNSPDDRPTMAEVLE 559
++ + KC+ +P +R + +++
Sbjct: 258 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-29
Identities = 52/270 (19%), Positives = 107/270 (39%), Gaps = 40/270 (14%)
Query: 321 RLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK----HPNILPLVCYNSTNEEKLLVYK 376
+ AVK LK + + S + ++ +K H NI+ L+ + + ++ +
Sbjct: 41 KPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 99
Query: 377 YQSNGSLLSLLEAY------------IEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEK 424
Y S G+L L+A + K +S A +A+G++++ K
Sbjct: 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---- 155
Query: 425 TIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE---------KTV 475
H +L N+L+ E+ I++ G ++ + ++NG + +
Sbjct: 156 -CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 214
Query: 476 SEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535
+ Q DV+SFGV+L E+ T G+ + + +++E +
Sbjct: 215 THQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSN--------CTNE 265
Query: 536 LLNVALKCVSNSPDDRPTMAEVLERIEEVV 565
L + C P RPT +++E ++ +V
Sbjct: 266 LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-29
Identities = 38/248 (15%), Positives = 100/248 (40%), Gaps = 26/248 (10%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDE-FSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378
+ + A++++ Q E + + K+PNI+ + +E +V +Y
Sbjct: 40 MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
+ GSL ++ + ++ + L+F++ + H ++K NILL
Sbjct: 100 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILL 149
Query: 439 NENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSFGVILLEL 491
+ +++ G+ + P+++ + G + APE K + D++S G++ +E+
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
Query: 492 LTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDR 551
+ G+ + + + + ++++ R + +C+ + R
Sbjct: 210 IEGEPPYL-NENPLRALYLIATNGTPELQNPEKLSAIFR-------DFLNRCLDMDVEKR 261
Query: 552 PTMAEVLE 559
+ E+L+
Sbjct: 262 GSAKELLQ 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 7e-29
Identities = 47/262 (17%), Positives = 95/262 (36%), Gaps = 31/262 (11%)
Query: 319 MVRLKNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYK 376
+V+ + A+K + + EF + +++ L+ S + L++ +
Sbjct: 44 VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103
Query: 377 YQSNGSLLSLL------EAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
+ G L S L A + +A IA G+ ++ H +
Sbjct: 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN-----ANKFVHRD 158
Query: 431 LKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNG-----YTAPE----KTVSEQGDV 481
L N ++ E+ I + G ++ + G + +PE + DV
Sbjct: 159 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 218
Query: 482 FSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVAL 541
+SFGV+L E+ T G+ + ++ ++ G + DK L +
Sbjct: 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVME----GGLLDKP-----DNCPDMLFELMR 269
Query: 542 KCVSNSPDDRPTMAEVLERIEE 563
C +P RP+ E++ I+E
Sbjct: 270 MCWQYNPKMRPSFLEIISSIKE 291
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 1e-28
Identities = 45/252 (17%), Positives = 86/252 (34%), Gaps = 29/252 (11%)
Query: 320 VRLKNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377
V AVK + + + + L H N++ + + L +Y
Sbjct: 25 VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
S G L IE P + G+ +++ I H ++K N+L
Sbjct: 85 CSGGELFD----RIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLL 135
Query: 438 LNENEDPLISECGYSKFLDPKKTCLFSSN-----GYTAPE-----KTVSEQGDVFSFGVI 487
L+E ++ IS+ G + + Y APE + +E DV+S G++
Sbjct: 136 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 195
Query: 488 LLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNS 547
L +L G+ D + ++ + K L + K + +
Sbjct: 196 LTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK--------IDSAPLALLHKILVEN 247
Query: 548 PDDRPTMAEVLE 559
P R T+ ++ +
Sbjct: 248 PSARITIPDIKK 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-27
Identities = 44/273 (16%), Positives = 97/273 (35%), Gaps = 38/273 (13%)
Query: 321 RLKNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLV--CYNSTNEEKLLVYK 376
+ AVK LK+ ++ + ++ H + + +++ +
Sbjct: 39 KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 98
Query: 377 YQSNGSLLSLLEAY------------IEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEK 424
+ G+L + L + K + + + +AKG++F+ +
Sbjct: 99 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---- 154
Query: 425 TIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE---------KTV 475
H +L NILL+E I + G ++ + + + + +
Sbjct: 155 -CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213
Query: 476 SEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFP 535
+ Q DV+SFGV+L E+ + G+ + + ++E D +
Sbjct: 214 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE-------- 265
Query: 536 LLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568
+ L C P RPT +E++E + ++ N
Sbjct: 266 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-27
Identities = 43/253 (16%), Positives = 90/253 (35%), Gaps = 28/253 (11%)
Query: 323 KNSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380
+ A+K K ++F Q + HP+I+ L+ T ++ + +
Sbjct: 33 NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTL 91
Query: 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440
G L S K + A ++ L ++ K H ++ N+L++
Sbjct: 92 GELRSF---LQVRKYSLDLASLILYAYQLSTALAYLE-----SKRFVHRDIAARNVLVSS 143
Query: 441 NEDPLISECGYSKFLDP----KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELL 492
N+ + + G S++++ K + + APE + + DV+ FGV + E+L
Sbjct: 144 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203
Query: 493 TGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRP 552
G+ + + E L ++ KC + P RP
Sbjct: 204 MHGVKPFQGVKNNDVIGRIENGERL--PMPPNCPPT-------LYSLMTKCWAYDPSRRP 254
Query: 553 TMAEVLERIEEVV 565
E+ ++ ++
Sbjct: 255 RFTELKAQLSTIL 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 109 bits (274), Expect = 8e-27
Identities = 46/249 (18%), Positives = 96/249 (38%), Gaps = 24/249 (9%)
Query: 320 VRLKNSAVYAVKRLKK-LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378
+A K + + + + ++ + L+HP ++ L + E +++Y++
Sbjct: 46 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
S G L + + + + KGL M++ + H +LK NI+
Sbjct: 106 SGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMF 157
Query: 439 NENEDPLISEC--GYSKFLDPKKTCLFSSN--GYTAPE----KTVSEQGDVFSFGVILLE 490
+ G + LDPK++ ++ + APE K V D++S GV+
Sbjct: 158 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 217
Query: 491 LLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDD 550
LL+G + G + + ++ + +W D + + K + P+
Sbjct: 218 LLSGLSPFG-GENDDETLRNVKSCDWN---MDDSAFS---GISEDGKDFIRKLLLADPNT 270
Query: 551 RPTMAEVLE 559
R T+ + LE
Sbjct: 271 RMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 107 bits (267), Expect = 7e-26
Identities = 46/249 (18%), Positives = 93/249 (37%), Gaps = 24/249 (9%)
Query: 320 VRLKNSAVYAVKRLKK-LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378
V V+ K + + + + L HP ++ L E +L+ ++
Sbjct: 49 VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
S G L + ++ +GL M++ S I H ++K NI+
Sbjct: 109 SGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMC 160
Query: 439 NENEDPLISEC--GYSKFLDPKKTCLFS--SNGYTAPE----KTVSEQGDVFSFGVILLE 490
+ + G + L+P + + + + APE + V D+++ GV+
Sbjct: 161 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 220
Query: 491 LLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDD 550
LL+G + G D + ++ + R +W FD++ + A + + P
Sbjct: 221 LLSGLSP-FAGEDDLETLQNVKRCDWE---FDEDAFSSVSPEAKDFIK---NLLQKEPRK 273
Query: 551 RPTMAEVLE 559
R T+ + LE
Sbjct: 274 RLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 4e-25
Identities = 48/248 (19%), Positives = 99/248 (39%), Gaps = 23/248 (9%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379
V + Y K +K + + + +H NIL L + EE ++++++ S
Sbjct: 25 VETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84
Query: 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
+ + + + +S + + L F++ + I H +++ NI+
Sbjct: 85 GLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQ 136
Query: 440 ENEDPL--ISECGYSKFLDPKKTC--LFSSNGYTAPE----KTVSEQGDVFSFGVILLEL 491
I E G ++ L P LF++ Y APE VS D++S G ++ L
Sbjct: 137 TRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVL 196
Query: 492 LTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDR 551
L+G + ++ ++ E+T FD+E K + + ++ + + R
Sbjct: 197 LSGINPFL-AETNQQIIENIMNAEYT---FDEEAFK---EISIEAMDFVDRLLVKERKSR 249
Query: 552 PTMAEVLE 559
T +E L+
Sbjct: 250 MTASEALQ 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 53/252 (21%), Positives = 98/252 (38%), Gaps = 33/252 (13%)
Query: 320 VRLKNSAVYAVKRLKKLQVS----MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVY 375
L S YA+K L+K + + ++ + L HP + L +E+
Sbjct: 28 RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
Y NG LL YI F I L++++ K I H +LK N
Sbjct: 88 SYAKNGELLK----YIRKIGSFDETCTRFYTAEIVSALEYLH-----GKGIIHRDLKPEN 138
Query: 436 ILLNENEDPLISECGYSKFLDPKKTCLFSSN-----GYTAPE----KTVSEQGDVFSFGV 486
ILLNE+ I++ G +K L P+ +++ Y +PE K+ + D+++ G
Sbjct: 139 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 198
Query: 487 ILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSN 546
I+ +L+ G + + + +++ E+ F ++ R ++ K +
Sbjct: 199 IIYQLVAGLPPFR-AGNEYLIFQKIIKLEYD---FPEKFFPKAR-------DLVEKLLVL 247
Query: 547 SPDDRPTMAEVL 558
R E+
Sbjct: 248 DATKRLGCEEME 259
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 100 bits (251), Expect = 2e-24
Identities = 55/267 (20%), Positives = 99/267 (37%), Gaps = 35/267 (13%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQ----IGNLKHPNILPLVCYNSTNEEKL--- 372
L+ AVK L+ F R+ L HP I+ +
Sbjct: 27 RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86
Query: 373 -LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
+V +Y +L + + K + + + L+F +Q I H ++
Sbjct: 87 YIVMEYVDGVTLRD----IVHTEGPMTPKRAIEVIADACQALNFSHQNG-----IIHRDV 137
Query: 432 KLSNILLNENEDPLISECGYSKFLDPKKTCLFSSN------GYTAPE----KTVSEQGDV 481
K +NI+++ + + G ++ + + + Y +PE +V + DV
Sbjct: 138 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 197
Query: 482 FSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVAL 541
+S G +L E+LTG+ TG VRE+ E + L V L
Sbjct: 198 YSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPSARHE------GLSADLDAVVL 250
Query: 542 KCVSNSPDDRP-TMAEVLERIEEVVNG 567
K ++ +P++R T AE+ + V NG
Sbjct: 251 KALAKNPENRYQTAAEMRADLVRVHNG 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 5e-24
Identities = 45/255 (17%), Positives = 93/255 (36%), Gaps = 30/255 (11%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL--VCYNSTNEEK--LLVY 375
+ +A+K L+ + E R + P+I+ + V N K L+V
Sbjct: 32 FNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDVYENLYAGRKCLLIVM 88
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
+ G L S ++ G + F + I I + + +++ + I H ++K N
Sbjct: 89 ECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPEN 141
Query: 436 ILLNENEDPL---ISECGYSKFLDPKKTC--LFSSNGYTAPE----KTVSEQGDVFSFGV 486
+L +++ G++K + + Y APE + + D++S GV
Sbjct: 142 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 201
Query: 487 ILLELLTGKT--VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCV 544
I+ LL G G+ + +K +R + + + + + +
Sbjct: 202 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-----YEFPNPEWSEVSEEVKMLIRNLL 256
Query: 545 SNSPDDRPTMAEVLE 559
P R T+ E +
Sbjct: 257 KTEPTQRMTITEFMN 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (249), Expect = 7e-24
Identities = 50/248 (20%), Positives = 92/248 (37%), Gaps = 21/248 (8%)
Query: 320 VRLKNSAVYAVKRLKK--LQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377
+ + A+K + K L+ + + +KHPNI+ L + L+ +
Sbjct: 29 EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
S G L I K + + + + + +++ + + N L
Sbjct: 89 VSGGELFD----RIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPEN--LLYYS 142
Query: 438 LNENEDPLISECGYSKFLDP--KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLEL 491
L+E+ +IS+ G SK DP + + GY APE K S+ D +S GVI L
Sbjct: 143 LDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYIL 202
Query: 492 LTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDR 551
L G + K + +++ E+ FD + + + P+ R
Sbjct: 203 LCGYPP-FYDENDAKLFEQILKAEYE---FDSPYWD---DISDSAKDFIRHLMEKDPEKR 255
Query: 552 PTMAEVLE 559
T + L+
Sbjct: 256 FTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 97.4 bits (242), Expect = 3e-23
Identities = 52/263 (19%), Positives = 100/263 (38%), Gaps = 39/263 (14%)
Query: 320 VRLKNSAVYAVKRLKKLQVSM-------DEFSQTMRQIGNLK----HPNILPLVCYNSTN 368
+ YAVK + + T++++ L+ HPNI+ L TN
Sbjct: 23 IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82
Query: 369 EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPH 428
LV+ G L Y+ K K I + + + +++ + I H
Sbjct: 83 TFFFLVFDLMKKGELFD----YLTEKVTLSEKETRKIMRALLEVICALHKLN-----IVH 133
Query: 429 GNLKLSNILLNENEDPLISECGYSKFLDP--KKTCLFSSNGYTAPE----------KTVS 476
+LK NILL+++ + +++ G+S LDP K + + Y APE
Sbjct: 134 RDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYG 193
Query: 477 EQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536
++ D++S GVI+ LL G ++ ++ + + + ++ +
Sbjct: 194 KEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNY------QFGSPEWDDYSDTV 246
Query: 537 LNVALKCVSNSPDDRPTMAEVLE 559
++ + + P R T E L
Sbjct: 247 KDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 8e-23
Identities = 60/251 (23%), Positives = 104/251 (41%), Gaps = 32/251 (12%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMD-EFSQTMRQI----GNLKHPNILPLVCYNSTNEEKLLV 374
K + +A+K LKK V MD + TM + +HP + + C T E V
Sbjct: 22 EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81
Query: 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLS 434
+Y + G L+ +I+ F A I GL F++ K I + +LKL
Sbjct: 82 MEYLNGGDLMY----HIQSCHKFDLSRATFYAAEIILGLQFLHSKG-----IVYRDLKLD 132
Query: 435 NILLNENEDPLISECGYSKFL---DPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVI 487
NILL+++ I++ G K D K + Y APE + + D +SFGV+
Sbjct: 133 NILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVL 192
Query: 488 LLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNS 547
L E+L G++ G D + ++ + + + + K + ++ +K
Sbjct: 193 LYEMLIGQSPFH-GQDEEELFHSIRMDNPF---YPRWLEKEAK-------DLLVKLFVRE 241
Query: 548 PDDRPTMAEVL 558
P+ R + +
Sbjct: 242 PEKRLGVRGDI 252
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 1e-22
Identities = 53/295 (17%), Positives = 107/295 (36%), Gaps = 35/295 (11%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLLVYK 376
V + A A+K+L + S + R++ +++H N++ L+ + +E
Sbjct: 38 VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
+ + + + + KGL +++ I H +LK N+
Sbjct: 98 FYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH-----AAGIIHRDLKPGNL 152
Query: 437 LLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPEKTVSEQG-----DVFSFGVILLEL 491
+NE+ + I + G ++ D + T + Y APE ++ D++S G I+ E+
Sbjct: 153 AVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212
Query: 492 LTGKT-------------VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538
+TGKT + K P ++ + + +A L N
Sbjct: 213 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 272
Query: 539 VA-------LKCVSNSPDDRPTMAEVLER--IEEVVNGNDERDRDHSNSSFSSME 584
+ K + + R T E L E + + DE + SF ++
Sbjct: 273 ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVD 327
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 2e-22
Identities = 45/269 (16%), Positives = 88/269 (32%), Gaps = 37/269 (13%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLLVYK 376
V A+K+++ + S +R+I L HPNI+ L+ T + LV++
Sbjct: 22 RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
+ + P L S + +GL F + + H +LK N+
Sbjct: 82 FLHQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCH-----SHRVLHRDLKPQNL 133
Query: 437 LLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE-----KTVSEQGDVFSFGVIL 488
L+N +++ G ++ Y APE K S D++S G I
Sbjct: 134 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193
Query: 489 LELLTGKT------------------VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530
E++T + + P + + ++ +K
Sbjct: 194 AEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVP 253
Query: 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLE 559
++ + + P+ R + L
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.2 bits (231), Expect = 8e-22
Identities = 38/256 (14%), Positives = 93/256 (36%), Gaps = 41/256 (16%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIG---------NLKHPNILPLVCYNSTNEE 370
+R+ ++ A+K ++K ++S ++ + ++ L+ + +
Sbjct: 24 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83
Query: 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
+L+ + L +I + +L S + + + + + H +
Sbjct: 84 FVLILERPEPVQDLF---DFITERGALQEELARSFFWQVLEAVRHCHNCG-----VLHRD 135
Query: 431 LKLSNILLNENEDPL-ISECGYSKFLDPKKTCLFS-SNGYTAPE-----KTVSEQGDVFS 483
+K NIL++ N L + + G L F + Y+ PE + V+S
Sbjct: 136 IKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 195
Query: 484 FGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKC 543
G++L +++ G + ++ + + R+ + E ++ C
Sbjct: 196 LGILLYDMVCGDIPFEHDEEIIRG-QVFFRQRVSSE----------------CQHLIRWC 238
Query: 544 VSNSPDDRPTMAEVLE 559
++ P DRPT E+
Sbjct: 239 LALRPSDRPTFEEIQN 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.8 bits (232), Expect = 1e-21
Identities = 35/262 (13%), Positives = 79/262 (30%), Gaps = 29/262 (11%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379
+ A+K + + + ++ +P + + + ++
Sbjct: 27 TDIAAGEEVAIKLECV-KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85
Query: 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
SL L + R F K L +A + +++++ K+ H ++K N L+
Sbjct: 86 GPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMG 137
Query: 440 ENEDPLI---SECGYSKFLDPKKTCLFSSN----------GYTAPE----KTVSEQGDVF 482
+ + + G +K +T Y + S + D+
Sbjct: 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLE 197
Query: 483 SFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALK 542
S G +L+ G + K K E + + K +
Sbjct: 198 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK---GYPSEFATYLNF 254
Query: 543 CVSNSPDDRPTMAEVLERIEEV 564
C S DD+P + + + +
Sbjct: 255 CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.3 bits (226), Expect = 1e-20
Identities = 49/253 (19%), Positives = 92/253 (36%), Gaps = 31/253 (12%)
Query: 318 FMVRLKNS-AVYAVKRLKKLQVSMDEFSQT-------MRQIGNLKHPNILPLVCYNSTNE 369
+ R ++ +YA+K L K ++ M + + + P I+ + T +
Sbjct: 21 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80
Query: 370 EKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHG 429
+ + + G L ++ F A I GL+ M+ + + +
Sbjct: 81 KLSFILDLMNGGDLHY----HLSQHGVFSEADMRFYAAEIILGLEHMHNRF-----VVYR 131
Query: 430 NLKLSNILLNENEDPLISECGYSKFLDPKKT-CLFSSNGYTAPE-----KTVSEQGDVFS 483
+LK +NILL+E+ IS+ G + KK ++GY APE D FS
Sbjct: 132 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 191
Query: 484 FGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKC 543
G +L +LL G + + K + R T V + ++ L ++
Sbjct: 192 LGCMLFKLLRGHSPFRQ--HKTKDKHEIDRMTLTMAVELPD------SFSPELRSLLEGL 243
Query: 544 VSNSPDDRPTMAE 556
+ + R
Sbjct: 244 LQRDVNRRLGCLG 256
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 2e-20
Identities = 47/257 (18%), Positives = 94/257 (36%), Gaps = 33/257 (12%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI-------GNLKHPNILPLVCYNSTNEEKL 372
YA K +KK + + I ++HPN++ L + +
Sbjct: 30 REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89
Query: 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLK 432
L+ + + G L ++ K + I G+ +++ I H +LK
Sbjct: 90 LILELVAGGELFD----FLAEKESLTEEEATEFLKQILNGVYYLH-----SLQIAHFDLK 140
Query: 433 LSNILLNENEDPL----ISECGYSKFLDP--KKTCLFSSNGYTAPE----KTVSEQGDVF 482
NI+L + P I + G + +D + +F + + APE + + + D++
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 200
Query: 483 SFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALK 542
S GVI LL+G + G + + + + F+ E A + +
Sbjct: 201 SIGVITYILLSGASPFL-GDTKQETLANVSAVNYE---FEDEYFSNTSALAKDFIR---R 253
Query: 543 CVSNSPDDRPTMAEVLE 559
+ P R T+ + L+
Sbjct: 254 LLVKDPKKRMTIQDSLQ 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 2e-20
Identities = 49/274 (17%), Positives = 98/274 (35%), Gaps = 41/274 (14%)
Query: 318 FMVRLKNS-AVYAVKRLKKLQVSMDE------FSQTMRQIGNLKHPNILPLVCYNSTNEE 370
+ R KN+ + A+K++K S + + ++ + L HPNI+ L+
Sbjct: 15 YKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 74
Query: 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
LV+ + + + + + +GL++++ + I H +
Sbjct: 75 ISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLH-----QHWILHRD 125
Query: 431 LKLSNILLNENEDPLISECGYSKFLDP---KKTCLFSSNGYTAPE-----KTVSEQGDVF 482
LK +N+LL+EN +++ G +K T + Y APE + D++
Sbjct: 126 LKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMW 185
Query: 483 SFGVILLELLTGK------TVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536
+ G IL ELL + + + + E+W + PL
Sbjct: 186 AVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 245
Query: 537 -----------LNVALKCVSNSPDDRPTMAEVLE 559
L++ +P R T + L+
Sbjct: 246 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 2e-20
Identities = 50/303 (16%), Positives = 106/303 (34%), Gaps = 41/303 (13%)
Query: 320 VRLKNSAVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377
N A+K++ Q + ++ + +H NI+ + + + Y
Sbjct: 28 YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87
Query: 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437
+ + L ++ + I +GL +++ + + H +LK SN+L
Sbjct: 88 LVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSAN-----VLHRDLKPSNLL 141
Query: 438 LNENEDPLISECGYSKFLDPKK------TCLFSSNGYTAPE-----KTVSEQGDVFSFGV 486
LN D I + G ++ DP T ++ Y APE K ++ D++S G
Sbjct: 142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201
Query: 487 ILLELLTGKTV---------------EKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531
IL E+L+ + + + + + K
Sbjct: 202 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN 261
Query: 532 WAFP-----LLNVALKCVSNSPDDRPTMAEVLER--IEEVVNGNDERDRDHSNSSFSSME 584
FP L++ K ++ +P R + + L +E+ + +DE + ++
Sbjct: 262 RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELD 321
Query: 585 SIP 587
+P
Sbjct: 322 DLP 324
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 86.4 bits (213), Expect = 3e-19
Identities = 39/264 (14%), Positives = 74/264 (28%), Gaps = 31/264 (11%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379
L N+ A+K + + R L +P V Y ++
Sbjct: 25 TNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83
Query: 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN 439
SL LL+ R F K A + + +++KS + + ++K N L+
Sbjct: 84 GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS-----LVYRDIKPDNFLIG 135
Query: 440 ENEDPL-----ISECGYSKFLDPKKTCLFSSN----------GYTAPE----KTVSEQGD 480
+ + G KF T Y + + S + D
Sbjct: 136 RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDD 195
Query: 481 VFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVA 540
+ + G + + L G G+ + R + AG +
Sbjct: 196 LEALGHVFMYFLRGSL-PWQGLKAATNKQKYERIGEKKQSTPLRELCAG--FPEEFYKYM 252
Query: 541 LKCVSNSPDDRPTMAEVLERIEEV 564
+ + D P + +V
Sbjct: 253 HYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 4e-19
Identities = 43/263 (16%), Positives = 89/263 (33%), Gaps = 35/263 (13%)
Query: 327 VYAVKRLKKLQVSMDEFSQT------MRQIGNLKHPNILPL--VCYNSTNEEKLLVYKYQ 378
A+KR++ T +R + +HPN++ L VC S + + +
Sbjct: 35 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 94
Query: 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438
+ + P + + + +GLDF++ + H +LK NIL+
Sbjct: 95 EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILV 149
Query: 439 NENEDPLISECGYSKFLDP--KKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELL 492
+ +++ G ++ T + + Y APE + + D++S G I E+
Sbjct: 150 TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 209
Query: 493 TGK----------------TVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536
K V + + + + + K
Sbjct: 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269
Query: 537 LNVALKCVSNSPDDRPTMAEVLE 559
++ LKC++ +P R + L
Sbjct: 270 KDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 85.3 bits (210), Expect = 6e-19
Identities = 44/274 (16%), Positives = 92/274 (33%), Gaps = 38/274 (13%)
Query: 315 SSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEK 371
++ + +A+K+++ + S T+R+I LKH NI+ L T +
Sbjct: 16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75
Query: 372 LLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
+LV+++ L + + S + G+ + + + + H +L
Sbjct: 76 VLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR-----VLHRDL 126
Query: 432 KLSNILLNENEDPLISECGYSKFLDPKKTCLFSSN---GYTAPE-----KTVSEQGDVFS 483
K N+L+N + I++ G ++ Y AP+ K S D++S
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 484 FGVILLELLTGKT------------------VEKTGIDLPKWVKAMVREEWTGEVFDKEV 525
G I E++ G + P + +
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246
Query: 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559
+ +++ K + P+ R T + LE
Sbjct: 247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.1 bits (210), Expect = 1e-18
Identities = 50/253 (19%), Positives = 99/253 (39%), Gaps = 33/253 (13%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQ----IGNLKHPNILPLVCYNSTNEEKLLVY 375
N YA+K LKK V + + + + HP I+ + ++ ++
Sbjct: 24 RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
Y G L S + + FP + A + L++++ K I + +LK N
Sbjct: 84 DYIEGGELFS----LLRKSQRFPNPVAKFYAAEVCLALEYLH-----SKDIIYRDLKPEN 134
Query: 436 ILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLEL 491
ILL++N I++ G++K++ L + Y APE K ++ D +SFG+++ E+
Sbjct: 135 ILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM 194
Query: 492 LTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDR 551
L G T + K + ++ E F + + ++ + ++ R
Sbjct: 195 LAGYTP-FYDSNTMKTYEKILNAELR---FPPFFNED-------VKDLLSRLITRDLSQR 243
Query: 552 -----PTMAEVLE 559
+V
Sbjct: 244 LGNLQNGTEDVKN 256
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.6 bits (211), Expect = 1e-18
Identities = 52/274 (18%), Positives = 100/274 (36%), Gaps = 40/274 (14%)
Query: 318 FMVRLKNS-AVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLV-CYNSTNEEKLLVY 375
+ +L +S + A+K++ + + + Q MR+ L H NI+ L + S+ E+K VY
Sbjct: 37 YQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK---LDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 376 KY----QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNL 431
++ + Y K+ P + + L +++ I H ++
Sbjct: 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-----ICHRDI 148
Query: 432 KLSNILLN-ENEDPLISECGYSKFLDPKKTC--LFSSNGYTAP-----EKTVSEQGDVFS 483
K N+LL+ + + + G +K L + S Y AP + DV+S
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWS 208
Query: 484 FGVILLELLTGKT-------------VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530
G +L ELL G+ + K + + +T F + A
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT 268
Query: 531 QWAFP-----LLNVALKCVSNSPDDRPTMAEVLE 559
+ P + + + + +P R T E
Sbjct: 269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.4 bits (197), Expect = 3e-17
Identities = 45/270 (16%), Positives = 91/270 (33%), Gaps = 39/270 (14%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLLVYK 376
+ + A+KR++ S +R+I LKH NI+ L ++++ LV++
Sbjct: 22 KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
+ + D ++ S + KGL F + ++ + H +LK N+
Sbjct: 82 FCDQDLKKY----FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNL 132
Query: 437 LLNENEDPLISECGYSKFLDPKK---TCLFSSNGYTAPE-----KTVSEQGDVFSFGVIL 488
L+N N + ++ G ++ + + Y P+ K S D++S G I
Sbjct: 133 LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 192
Query: 489 LELLTGKT-------------------VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529
EL T P K + + +
Sbjct: 193 AELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVV 252
Query: 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559
+ ++ + +P R + E L+
Sbjct: 253 PKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.2 bits (197), Expect = 5e-17
Identities = 44/248 (17%), Positives = 97/248 (39%), Gaps = 31/248 (12%)
Query: 320 VRLKNSAVYAVKRLKK-LQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLLVY 375
YA+K L+K + ++ DE + T+ + N +HP + L T++ V
Sbjct: 25 REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
+Y + G L ++ +R F + I L++++ + + + ++KL N
Sbjct: 85 EYANGGELFF----HLSRERVFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLEN 135
Query: 436 ILLNENEDPLISECGYSKFLDPKKTCLFSSNG---YTAPE----KTVSEQGDVFSFGVIL 488
++L+++ I++ G K + + G Y APE D + GV++
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 489 LELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSP 548
E++ G+ D + + ++ EE F + ++ + ++ + P
Sbjct: 196 YEMMCGRLPFY-NQDHERLFELILMEEIR---FPRTLSPEAK-------SLLAGLLKKDP 244
Query: 549 DDRPTMAE 556
R
Sbjct: 245 KQRLGGGP 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 79.1 bits (194), Expect = 1e-16
Identities = 32/184 (17%), Positives = 74/184 (40%), Gaps = 17/184 (9%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQ----IGNLKHPNILPLVCYNSTNEEKLLVY 375
++ YA+K L K +V + + + + P ++ L N +V
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 376 KYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSN 435
+Y + G + S ++ F A I ++++ + + +LK N
Sbjct: 121 EYVAGGEMFS----HLRRIGRFSEPHARFYAAQIVLTFEYLHSLD-----LIYRDLKPEN 171
Query: 436 ILLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLEL 491
+L+++ +++ G++K + + L + APE K ++ D ++ GV++ E+
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 492 LTGK 495
G
Sbjct: 232 AAGY 235
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 1e-15
Identities = 43/287 (14%), Positives = 87/287 (30%), Gaps = 59/287 (20%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVC--------YNSTN 368
K A+K++ +R+I LKH N++ L+ YN
Sbjct: 30 RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89
Query: 369 EEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPH 428
LV+ + + L F + + GL +++ I H
Sbjct: 90 GSIYLVFDFCEHD----LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-----RNKILH 140
Query: 429 GNLKLSNILLNENEDPLISECGYSKFLDPKK------------TCLFSSNGYTAPEKTVS 476
++K +N+L+ + +++ G ++ K T + E+
Sbjct: 141 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG 200
Query: 477 EQGDVFSFGVILLELLTGKT------------------------VEKTGIDLPKWVKAMV 512
D++ G I+ E+ T V + + K +
Sbjct: 201 PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL 260
Query: 513 REEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559
+ +V D+ A +A L++ K + P R + L
Sbjct: 261 VKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDSDDALN 304
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 2e-15
Identities = 56/295 (18%), Positives = 105/295 (35%), Gaps = 35/295 (11%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTNEEKLLVYK 376
K AVK+L + S+ +T R++ ++KH N++ L+ +
Sbjct: 38 FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
L+ I + + I +GL +++ H +LK SN+
Sbjct: 98 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI-----IHRDLKPSNL 152
Query: 437 LLNENEDPLISECGYSKFLDPKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLEL 491
+NE+ + I + G ++ D + T ++ Y APE ++ D++S G I+ EL
Sbjct: 153 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 492 LTGKT-------------VEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538
LTG+T + + + + E +A +
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 272
Query: 539 VA-------LKCVSNSPDDRPTMAEVLER--IEEVVNGNDERDRDHSNSSFSSME 584
K + D R T A+ L + + +DE D + SF S +
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRD 327
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 75.8 bits (185), Expect = 2e-15
Identities = 34/198 (17%), Positives = 73/198 (36%), Gaps = 26/198 (13%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379
+ N+ A+K ++ +V + ++ + + + + + KLL +
Sbjct: 33 KDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92
Query: 380 NGSLL------------SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIP 427
+ + L R P I+ + GLD+M+++ I
Sbjct: 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG----II 148
Query: 428 HGNLKLSNILLNENEDPL------ISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSE 477
H ++K N+L+ + P I++ G + + D T + Y +PE
Sbjct: 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGC 208
Query: 478 QGDVFSFGVILLELLTGK 495
D++S ++ EL+TG
Sbjct: 209 GADIWSTACLIFELITGD 226
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 72.2 bits (176), Expect = 2e-14
Identities = 47/278 (16%), Positives = 98/278 (35%), Gaps = 52/278 (18%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPL--VCYNSTNEEKLLVYK 376
+ + N+ VK LK V + + ++ + NL+ PNI+ L + + + LV++
Sbjct: 55 INITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112
Query: 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNI 436
+ +N L + I K LD+ + I H ++K N+
Sbjct: 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM-----GIMHRDVKPHNV 160
Query: 437 LL-NENEDPLISECGYSKFLDPKKTCLFS--SNGYTAPE-----KTVSEQGDVFSFGVIL 488
++ +E+ + + G ++F P + S + PE + D++S G +L
Sbjct: 161 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220
Query: 489 LELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDK---------------EVAKAGRQWA 533
++ K G D + + + T +++D + ++W
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280
Query: 534 FPLLNVALKCVSNS------------PDDRPTMAEVLE 559
+ + VS R T E +E
Sbjct: 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 2e-12
Identities = 46/246 (18%), Positives = 92/246 (37%), Gaps = 32/246 (13%)
Query: 327 VYAVKRLKKLQVSMDE--FSQTMRQIGNLK----HPNILPLVCYNSTNEEKLLVYKYQSN 380
+YA+K LKK + T + L+ P ++ L T + L+ Y +
Sbjct: 54 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 113
Query: 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE 440
G L + ++ + F I L+ +++ I + ++KL NILL+
Sbjct: 114 GELFT----HLSQRERFTEHEVQIYVGEIVLALEHLHKLG-----IIYRDIKLENILLDS 164
Query: 441 NEDPLISECGYSKFLDPKKT----CLFSSNGYTAPE------KTVSEQGDVFSFGVILLE 490
N ++++ G SK +T + Y AP+ + D +S GV++ E
Sbjct: 165 NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224
Query: 491 LLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDD 550
LLTG + + + R + + +E++ + ++ + + P
Sbjct: 225 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK-------DLIQRLLMKDPKK 277
Query: 551 RPTMAE 556
R
Sbjct: 278 RLGCGP 283
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.5 bits (153), Expect = 2e-11
Identities = 20/79 (25%), Positives = 36/79 (45%), Gaps = 7/79 (8%)
Query: 81 IRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGA 140
+ L N+S I +L KL+ L A N + +S++N + +L+ N +S
Sbjct: 312 LTLYFNNISDISPVSSLTKLQRL---FFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366
Query: 141 VPLALTKLKHLKTLDISNN 159
PLA L + L +++
Sbjct: 367 TPLA--NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 4e-08
Identities = 24/139 (17%), Positives = 48/139 (34%), Gaps = 28/139 (20%)
Query: 52 IGWNGNLPHPCSY-----NLKGIKCNLHATNIVGIRLENMNLSGIIDAETL--------- 97
IG +L + + + T + ++L +S I L
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELN 293
Query: 98 ----------CKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTK 147
L++L ++L N I P +S+ +L L ++N +S +L
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 148 LKHLKTLDISNNHFAATSP 166
L ++ L +N + +P
Sbjct: 350 LTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 1e-04
Identities = 19/79 (24%), Positives = 32/79 (40%), Gaps = 7/79 (8%)
Query: 83 LENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVP 142
L N++ + L ++ L+ L I G + LT +N S+N L+ P
Sbjct: 29 LGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP 83
Query: 143 LALTKLKHLKTLDISNNHF 161
L L L + ++NN
Sbjct: 84 LK--NLTKLVDILMNNNQI 100
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 3e-10
Identities = 19/69 (27%), Positives = 30/69 (43%), Gaps = 1/69 (1%)
Query: 98 CKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDIS 157
++L + L N I G +P ++ + L LN+S N L G +P L+ +
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYA 299
Query: 158 NNHFAATSP 166
NN SP
Sbjct: 300 NNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 48.6 bits (114), Expect = 1e-06
Identities = 17/90 (18%), Positives = 36/90 (40%), Gaps = 2/90 (2%)
Query: 54 WNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLI 113
+ + + + N+ G+ L N + G + + L +L+ L ++++ N +
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL-PQGLTQLKFLHSLNVSFNNL 280
Query: 114 QGRIPTSISNCRRLTYLNLSSNLLSGAVPL 143
G IP N +R ++N PL
Sbjct: 281 CGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.8 bits (99), Expect = 7e-05
Identities = 23/133 (17%), Positives = 45/133 (33%), Gaps = 28/133 (21%)
Query: 32 SESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNL--HATNIVGIRLENMNLS 89
+ ++ + + + L W C+ G+ C+ + + L +NL
Sbjct: 6 QDKQALLQIKKDLGNPTTLS-SWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 90 GIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNL-LSGAVPLALTKL 148
IP+S++N L +L + L G +P A+ KL
Sbjct: 64 KPYP-----------------------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100
Query: 149 KHLKTLDISNNHF 161
L L I++ +
Sbjct: 101 TQLHYLYITHTNV 113
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 15/45 (33%), Positives = 25/45 (55%)
Query: 123 NCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPD 167
+ L L+L +N + G +P LT+LK L +L++S N+ P
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (135), Expect = 3e-09
Identities = 43/286 (15%), Positives = 95/286 (33%), Gaps = 58/286 (20%)
Query: 320 VRLKNSAVYAVKRLKKLQVSMDEFSQTMRQI---GNLKHPNILPLVCYNSTN------EE 370
A+K+L + + + R++ + H NI+ L+ + ++
Sbjct: 37 YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96
Query: 371 KLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGN 430
LV + + + + + + + G+ ++ H +
Sbjct: 97 VYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHSAGII-----HRD 144
Query: 431 LKLSNILLNENEDPLISECGYSKFLDP--KKTCLFSSNGYTAPE----KTVSEQGDVFSF 484
LK SNI++ + I + G ++ T + Y APE E D++S
Sbjct: 145 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 485 GVILLELLTGKT--------------VEKTGIDLPKWVKAMV---------REEWTGEVF 521
G I+ E++ K +E+ G P+++K + R ++ G F
Sbjct: 205 GCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 264
Query: 522 DKEVAKAGRQWAFP--------LLNVALKCVSNSPDDRPTMAEVLE 559
K + ++ K + P R ++ + L+
Sbjct: 265 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 2e-07
Identities = 23/157 (14%), Positives = 46/157 (29%), Gaps = 9/157 (5%)
Query: 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNL 132
+I + ++ LS AE L L+ +VV L + I +++ L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 133 SSNLLSGAVPLALTKL-----KHLKTLDISNNHFAATSPDNFRQEIKYFDKYVVETSSSE 187
SN L + + ++ L + N ++ S
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 188 INRASTVEARGLEDTQPPSVHNKSEHGEKRHWFRNWM 224
+ + ++ P K + +
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 159
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 18/82 (21%), Positives = 35/82 (42%), Gaps = 9/82 (10%)
Query: 102 HLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLSGAVPLALTK-LKH----LK 152
LRV+ LA + + ++ L L+LS+N L A L L + ++ L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 153 TLDISNNHFAATSPDNFRQEIK 174
L + + +++ D + K
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 7e-04
Identities = 11/44 (25%), Positives = 17/44 (38%), Gaps = 4/44 (9%)
Query: 122 SNCRRLTYLNLSSNLLSG----AVPLALTKLKHLKTLDISNNHF 161
L L L+ +S ++ L L+ LD+SNN
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 16/61 (26%), Positives = 23/61 (37%)
Query: 101 RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNH 160
++ L N I N + L L L +N +S P A L L+ L +S N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 161 F 161
Sbjct: 91 L 91
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 14/56 (25%), Positives = 24/56 (42%), Gaps = 2/56 (3%)
Query: 116 RIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
++P + L+L +N ++ LK+L TL + NN + SP F
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP 77
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 5e-06
Identities = 18/105 (17%), Positives = 39/105 (37%), Gaps = 4/105 (3%)
Query: 54 WNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLI 113
+ +L I + ++ ++ + + D L L L + N I
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185
Query: 114 QGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISN 158
P +++ L ++L +N +S PLA +L + ++N
Sbjct: 186 SDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTN 226
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 7e-05
Identities = 17/108 (15%), Positives = 32/108 (29%), Gaps = 8/108 (7%)
Query: 54 WNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLI 113
+ L + + + L +N S L ++++ N +
Sbjct: 237 TDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL 296
Query: 114 QGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+P L L S N L+ L ++LK L + N
Sbjct: 297 I-ELPALPPR---LERLIASFNHLAEVPEL----PQNLKQLHVEYNPL 336
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 22/146 (15%), Positives = 41/146 (28%), Gaps = 7/146 (4%)
Query: 54 WNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLI 113
L + L + N + L L +SLA N +
Sbjct: 101 ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160
Query: 114 QGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEI 173
++ L L L N L +P L + N + EI
Sbjct: 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN------CEI 213
Query: 174 KYFDKYVVETSSSEINRASTVEARGL 199
YF +++ + + + V+ + +
Sbjct: 214 LYFRRWLQDNAENVYVWKQGVDVKAM 239
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.001
Identities = 11/45 (24%), Positives = 17/45 (37%), Gaps = 2/45 (4%)
Query: 117 IPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHF 161
+P + + T L+LS NLL L L L++
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 2e-04
Identities = 18/114 (15%), Positives = 38/114 (33%), Gaps = 29/114 (25%)
Query: 83 LENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRL--------------- 127
L + +L+ + L +L + + L+ N ++ P +++ R L
Sbjct: 5 LAHKDLTVL---CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDG 60
Query: 128 -------TYLNLSSNLL-SGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQEI 173
L L +N L A L L L++ N + ++ +
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL--CQEEGIQERL 112
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.001
Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 3/74 (4%)
Query: 104 RVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAA 163
RV+ LA + + + +T+L+LS N L P AL L+ L+ L S+N
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 164 TSPDNFRQEIKYFD 177
++
Sbjct: 58 VDGVANLPRLQELL 71
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 3e-04
Identities = 7/43 (16%), Positives = 11/43 (25%)
Query: 117 IPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159
L++S + L LK L+ N
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 9/82 (10%), Positives = 27/82 (32%)
Query: 54 WNGNLPHPCSYNLKGIKCNLHATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLI 113
+ L + + C + T + + L + N + + ++ ++R I
Sbjct: 154 ESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 213
Query: 114 QGRIPTSISNCRRLTYLNLSSN 135
+ N ++L + +
Sbjct: 214 HSLPSYGLENLKKLRARSTYNL 235
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 6e-04
Identities = 12/92 (13%), Positives = 34/92 (36%), Gaps = 4/92 (4%)
Query: 81 IRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG- 139
+ L NL D + + R+ + + S R + +++LS++++
Sbjct: 5 LDLTGKNLHP--DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 140 AVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171
+ L++ L+ L + + + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK 93
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.002
Identities = 16/71 (22%), Positives = 29/71 (40%), Gaps = 4/71 (5%)
Query: 97 LCKLRHLRVVSLAR-NLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155
+L +L+ +SL+R I + L L + + G + L L HL+
Sbjct: 196 FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ--- 252
Query: 156 ISNNHFAATSP 166
I+ +HF +
Sbjct: 253 INCSHFTTIAR 263
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 7e-04
Identities = 7/65 (10%), Positives = 23/65 (35%), Gaps = 5/65 (7%)
Query: 101 RHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSG----AVPLALTKLKHLKTLDI 156
+ L++ ++ + + + + + LS N + + + K L+ +
Sbjct: 8 KSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 157 SNNHF 161
S+
Sbjct: 67 SDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.002
Identities = 13/65 (20%), Positives = 22/65 (33%), Gaps = 11/65 (16%)
Query: 108 LARNLIQGRIPTSISNC------RRLTYLNLSSNLLSGAVPLAL-----TKLKHLKTLDI 156
L L+ R ++ + L L L N + L K+ L L++
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 157 SNNHF 161
+ N F
Sbjct: 310 NGNRF 314
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 4/61 (6%)
Query: 98 CKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDIS 157
+L L +SL N I +P ++ +L L LS N +S AL LK+L L++
Sbjct: 153 SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
Query: 158 N 158
+
Sbjct: 209 S 209
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.002
Identities = 18/79 (22%), Positives = 30/79 (37%), Gaps = 4/79 (5%)
Query: 99 KLRHLRVVSLARNLIQGR--IPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156
+ L ++L+ N + + + + L LNLS N L L K L+ L +
Sbjct: 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122
Query: 157 SNNHFAATSPD--NFRQEI 173
N + T D + I
Sbjct: 123 DGNSLSDTFRDQSTYISAI 141
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 608 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.81 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.32 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.02 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.97 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.92 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.88 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.83 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.65 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.62 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.54 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.53 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.53 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.47 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.46 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.38 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.32 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.26 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.08 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.04 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.04 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.02 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.01 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.0 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 97.98 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.92 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.91 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.74 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.55 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.43 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.34 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.26 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.19 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.15 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.12 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.12 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.98 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.96 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.87 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.47 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.24 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.79 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.29 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 94.35 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 91.87 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 88.55 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=405.28 Aligned_cols=243 Identities=19% Similarity=0.316 Sum_probs=200.1
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.||+|+||+||+|++.+++.||||+++......++|.+|++++++++|||||+++|+|..++..++||||+++|+|.++
T Consensus 11 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~ 90 (263)
T d1sm2a_ 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 90 (263)
T ss_dssp EEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred EEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHH
Confidence 45899999999999999999999999987777788999999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
+.. ....+++..++.++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 91 l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~-----iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 91 LRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp HHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred hhc---cccCCCHHHHHHHHHHHHHHHHhhhccc-----eeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 874 3467899999999999999999999987 9999999999999999999999999998765432 235
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
.||..|+||| ..++.++|||||||++|||+|+..|+................... ..+..++.++.+
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---------~~p~~~~~~l~~ 233 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------YKPRLASTHVYQ 233 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC---------CCCTTSCHHHHH
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC---------CCccccCHHHHH
Confidence 6889999999 678999999999999999999766655555554444443332110 112345567899
Q ss_pred HHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 539 VALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
++.+||+.||++||||+||++.|+++.+
T Consensus 234 li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 234 IMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-50 Score=403.94 Aligned_cols=245 Identities=23% Similarity=0.353 Sum_probs=210.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+.||+|+||+||+|... +|+.||||+++......++|.+|++++++++|||||+++++|.+.+..++|||||++|+|.+
T Consensus 23 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~ 102 (287)
T d1opja_ 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 102 (287)
T ss_dssp EETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred eEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHH
Confidence 56899999999999986 58899999998777778899999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----cc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TC 461 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~ 461 (608)
++.. .....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 103 ~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 175 (287)
T d1opja_ 103 YLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175 (287)
T ss_dssp HHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETT
T ss_pred Hhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCC-----cccCccccCeEEECCCCcEEEccccceeecCCCCceeecc
Confidence 9975 34567999999999999999999999987 9999999999999999999999999999876543 22
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..|+..|+||| ..++.++|||||||++|||++|..|+....+.....+.+.. .... ..+..++..+.
T Consensus 176 ~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-~~~~--------~~~~~~~~~l~ 246 (287)
T d1opja_ 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRM--------ERPEGCPEKVY 246 (287)
T ss_dssp EEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-TCCC--------CCCTTCCHHHH
T ss_pred ccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-CCCC--------CCCccchHHHH
Confidence 35788899999 78899999999999999999988887766665544433322 2111 11234567789
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+|+.+||+.||++|||++||++.|+.+.+.
T Consensus 247 ~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999988654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=403.14 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=199.3
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.||+|+||+||+|+.++ .||||+++... ...+.|.+|++++++++|||||++++++.. +..++|||||++|+|
T Consensus 14 ~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L 90 (276)
T d1uwha_ 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSL 90 (276)
T ss_dssp SEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEH
T ss_pred EEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCH
Confidence 568999999999997643 59999997432 335679999999999999999999998764 568999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---- 459 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---- 459 (608)
.++++. ....+++..++.++.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 91 ~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~-----ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 91 YHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS-----IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp HHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred HHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC-----EeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999974 2456999999999999999999999987 9999999999999999999999999998765322
Q ss_pred -ccccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 460 -TCLFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 460 -~~~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....||+.||||| ..++.++|||||||++|||+||+.||............. ..... .+........
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~-~~~~~----~p~~~~~~~~ 237 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV-GRGYL----SPDLSKVRSN 237 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-HHTSC----CCCGGGSCTT
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH-hcCCC----CCcchhcccc
Confidence 3457899999999 247889999999999999999999997655443332222 22211 1122223445
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
++..+.+|+.+||+.||++||||+||++.|+.+.+..
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 6778999999999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=403.04 Aligned_cols=243 Identities=23% Similarity=0.360 Sum_probs=205.1
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.||+|+||+||+|++++++.||||+++......++|.+|++++++++|||||+++|++.+ +..++||||+++|+|.++
T Consensus 19 ~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~ 97 (272)
T d1qpca_ 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97 (272)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHH
T ss_pred EEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHH
Confidence 5689999999999999988999999998777778899999999999999999999998764 567999999999999997
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
+... ....+++..+++|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.... ...
T Consensus 98 ~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~-----ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (272)
T d1qpca_ 98 LKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN-----YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (272)
T ss_dssp TTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred Hhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence 7532 1245999999999999999999999987 9999999999999999999999999999876443 345
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLN 538 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 538 (608)
.||+.|+||| ..++.++|||||||++|||+||..|+............+..... . ..+...+.++.+
T Consensus 171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~-~--------~~p~~~~~~l~~ 241 (272)
T d1qpca_ 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-M--------VRPDNCPEELYQ 241 (272)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-C--------CCCTTCCHHHHH
T ss_pred CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-C--------CCcccChHHHHH
Confidence 6888999999 67899999999999999999987776655555444443332211 1 112345667899
Q ss_pred HHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 539 VALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 539 li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
|+.+||+.||++||||+||++.|+++..
T Consensus 242 li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 242 LMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-49 Score=401.18 Aligned_cols=242 Identities=21% Similarity=0.348 Sum_probs=191.5
Q ss_pred cccCCCCCceEEEEEEc-CC---cEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NS---AVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g---~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.||+|+||+||+|+.. ++ ..||||++.... ...++|.+|+++|++++|||||+++|++..++..++|||||++
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~ 111 (299)
T d1jpaa_ 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN 111 (299)
T ss_dssp EEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCC
Confidence 46899999999999875 23 368999987432 2346799999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|+|.+++.. ....+++.+++.++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 112 g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 112 GSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred Ccceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC-----CccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 999998874 2456999999999999999999999987 9999999999999999999999999999775432
Q ss_pred -------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 460 -------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 460 -------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
....+|+.||||| ..++.++|||||||++|||+| |+.||.... .......+...... .
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-~~~~~~~i~~~~~~---------~ 253 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-NQDVINAIEQDYRL---------P 253 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTTCCC---------C
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC---------C
Confidence 1235688999999 678999999999999999998 788886543 23333333222111 1
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
.+..++..+.+|+.+||+.||++||||.||++.|+++++
T Consensus 254 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 233466778999999999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=392.27 Aligned_cols=243 Identities=18% Similarity=0.267 Sum_probs=188.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeec--CCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNST--NEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~~ 380 (608)
+.||+|+||+||+|+.. +|+.||||+++....+ .+.+.+|++++++++|||||++++++.+ .+..++|||||++
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~ 89 (269)
T d2java1 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 89 (269)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence 56899999999999874 7899999999754433 3568899999999999999999998865 4568999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|+|.+++.........+++..++.++.||+.||+|||+.+....+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 90 g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 169 (269)
T d2java1 90 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 169 (269)
T ss_dssp EEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----
T ss_pred CcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC
Confidence 9999999765444678999999999999999999999865334569999999999999999999999999999875432
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
....||+.||||| ..++.++|||||||++|||+||+.||... +..+....+..... . ..+...+
T Consensus 170 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-~~~~~~~~i~~~~~-~--------~~~~~~s 239 (269)
T d2java1 170 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREGKF-R--------RIPYRYS 239 (269)
T ss_dssp ------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHTCC-C--------CCCTTSC
T ss_pred ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCC-C--------CCCcccC
Confidence 3467999999999 56899999999999999999999998653 33333333322211 1 1123456
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.++.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 240 DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 67899999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=392.08 Aligned_cols=245 Identities=21% Similarity=0.307 Sum_probs=198.9
Q ss_pred hcccCCCCCceEEEEEEcCC-----cEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 306 ADLRSQTICSSLFMVRLKNS-----AVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g-----~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
.++||+|+||+||+|.+++. ..||||+++... ....+|.+|++++++++|||||+++|++.+.+..++||||+
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 36799999999999987643 479999997432 23457899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
.+|++.+++.. ....+++.++++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 92 ~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 92 ENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp TTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc-----cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999998765 3467999999999999999999999987 999999999999999999999999999976543
Q ss_pred C------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 459 K------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 459 ~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
. ....||..||||| ..++.++|||||||++|||+||..|+..........+.+.... .. ..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~--------~~ 234 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RL--------PT 234 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CC--------CC
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-CC--------CC
Confidence 2 2245788999999 6789999999999999999998777766665555444333221 11 12
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
+..++..+.+|+.+||+.||++||||.||++.|+++++.
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 235 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 234567789999999999999999999999999998864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=386.92 Aligned_cols=233 Identities=24% Similarity=0.348 Sum_probs=198.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||+||+|+.. +|+.||+|++... ....+.+.+|++++++++|||||++++++.+++..++|||||++|
T Consensus 12 ~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g 91 (263)
T d2j4za1 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 91 (263)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 56899999999999985 6899999998632 335677899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-Cc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-KT 460 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~ 460 (608)
+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 92 ~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~-----ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 92 TVYRELQK----LSKFDEQRTATYITELANALSYCHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred cHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 99999976 356999999999999999999999987 999999999999999999999999999877544 34
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||+.||||| ..++.++|||||||++|||+||+.||.... .............. .+...+.++
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~----------~p~~~s~~~ 231 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRISRVEFT----------FPDFVTEGA 231 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTTCCC----------CCTTSCHHH
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCC----------CCccCCHHH
Confidence 567999999999 568999999999999999999999996543 33333333222110 122355678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+|+.+||+.||++|||++|+++
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCCHhHCcCHHHHHc
Confidence 89999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=392.17 Aligned_cols=246 Identities=23% Similarity=0.331 Sum_probs=203.7
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
.+.||+|+||.||+|+.++++.||||+++......+.|.+|+.++++++|||||+++|++.+ +..++||||+++|+|..
T Consensus 22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~ 100 (285)
T d1fmka3 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 100 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHH
T ss_pred eeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhh
Confidence 35689999999999999988899999998777778899999999999999999999999854 56899999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----cc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TC 461 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~ 461 (608)
++.... ...++|.+++.++.||++||+|||+++ |+||||||+|||+|+++.+||+|||+++...... ..
T Consensus 101 ~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~-----ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 173 (285)
T d1fmka3 101 FLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173 (285)
T ss_dssp HHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred hhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhh-----eecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence 886532 346999999999999999999999987 9999999999999999999999999998765432 33
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..||+.|+||| ..++.++|||||||++|||+||..|+............+.... .. .....++.++.
T Consensus 174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-~~--------~~~~~~~~~l~ 244 (285)
T d1fmka3 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RM--------PCPPECPESLH 244 (285)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CC--------CCCTTSCHHHH
T ss_pred ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CC--------CCCcccCHHHH
Confidence 56889999999 7889999999999999999998877766666555544433221 11 11234566789
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
+++.+||+.||++||||++|+++|++.....
T Consensus 245 ~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999999999999999999877543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=394.28 Aligned_cols=236 Identities=18% Similarity=0.225 Sum_probs=194.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 90 (271)
T d1nvra_ 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 90 (271)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEG
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcH
Confidence 56899999999999875 78999999997432 2345789999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-----
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK----- 458 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~----- 458 (608)
.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 91 ~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~-----IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 91 FDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp GGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC-----CccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 998853 567999999999999999999999987 999999999999999999999999999976432
Q ss_pred CccccccCccccCC----CC-CCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 459 KTCLFSSNGYTAPE----KT-VSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~-~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.....||+.||||| .. ++.++||||+||++|||+||+.||....+............... ......+
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~s 233 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--------NPWKKID 233 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS--------TTGGGSC
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------CccccCC
Confidence 24467999999999 33 46789999999999999999999976554333333322221110 1123345
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 234 SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 66889999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=389.86 Aligned_cols=236 Identities=16% Similarity=0.279 Sum_probs=198.3
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|++++++++|||||++++++.+.+..++|||||++|+|.
T Consensus 26 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~ 105 (293)
T d1yhwa1 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (293)
T ss_dssp EECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred EEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHH
Confidence 4589999999999986 57999999999743 345678999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Ccc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~ 461 (608)
+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+... ...
T Consensus 106 ~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~-----iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 106 DVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp HHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred HHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 98764 46999999999999999999999987 999999999999999999999999999977543 245
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..||+.|+||| ..++.++||||+||++|||+||+.||....... ........... .. ..+...+..+.
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~-~~------~~~~~~s~~~~ 247 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP-EL------QNPEKLSAIFR 247 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC-CC------SSGGGSCHHHH
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCC-CC------CCcccCCHHHH
Confidence 67999999999 568999999999999999999999997654332 22222222111 11 11234566789
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+|+.+||+.||++|||+.|+++.
T Consensus 248 ~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 248 DFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=384.45 Aligned_cols=240 Identities=19% Similarity=0.301 Sum_probs=204.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLSL 386 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 386 (608)
+.||+|+||+||+|+.++++.||||+++......++|.+|++++++++|||||+++|+|.+.+..++||||+++|+|.++
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~ 89 (258)
T d1k2pa_ 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 89 (258)
T ss_dssp CCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHH
T ss_pred EEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHh
Confidence 46899999999999999899999999997777889999999999999999999999999999999999999999999998
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----ccc
Q 042949 387 LEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK----TCL 462 (608)
Q Consensus 387 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~ 462 (608)
+.. ....+++..+.+++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+.... ...
T Consensus 90 ~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 90 LRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp HHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT-----BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred hhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC-----cccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 764 2456899999999999999999999987 9999999999999999999999999998765432 235
Q ss_pred cccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 463 FSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 463 ~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
.+|..|+||| ..++.++|||||||++|||+| |+.||... ...+....+... ... ..+...+.++.
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~~~-~~~--------~~p~~~~~~l~ 231 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQG-LRL--------YRPHLASEKVY 231 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTT-CCC--------CCCTTCCHHHH
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-CHHHHHHHHHhC-CCC--------CCcccccHHHH
Confidence 6788999999 678999999999999999998 78887644 333333333221 111 11234556789
Q ss_pred HHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 538 NVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
+|+.+||+.||++|||++|+++.|.++
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 999999999999999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=386.38 Aligned_cols=237 Identities=18% Similarity=0.273 Sum_probs=196.2
Q ss_pred ccCCCCCceEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeec----CCeeEEEEeecc
Q 042949 308 LRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNST----NEEKLLVYKYQS 379 (608)
Q Consensus 308 ~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~ 379 (608)
.||+|+||+||+|... +++.||+|+++.... ..+.+.+|++++++++|||||++++++.+ ....++||||++
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~ 95 (270)
T d1t4ha_ 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 95 (270)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCC
Confidence 4899999999999875 688999999975432 34568899999999999999999999864 356799999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC-CCCCceEeccccccccCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN-ENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~ 458 (608)
+|+|.+++.. ...+++..++.++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++.....
T Consensus 96 ~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~---~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 96 SGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC---CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 9999999976 357999999999999999999999875 3599999999999996 4789999999999876544
Q ss_pred -CccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 -KTCLFSSNGYTAPE---KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 -~~~~~gt~~y~aPE---~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
.....||+.||||| ..++.++|||||||++|||+||+.||....+.....+.+.... ... ......+.
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~-~~~-------~~~~~~~~ 240 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPA-------SFDKVAIP 240 (270)
T ss_dssp SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CCG-------GGGGCCCH
T ss_pred ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC-CCc-------ccCccCCH
Confidence 34568999999999 6789999999999999999999999976655544444332221 111 11223455
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhC
Confidence 6889999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=391.24 Aligned_cols=239 Identities=21% Similarity=0.278 Sum_probs=198.1
Q ss_pred cCCCCCceEEEEEEc---CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 309 RSQTICSSLFMVRLK---NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
||+|+||+||+|... ++..||||+++... ...++|.+|+++|++++|||||+++|++.+ +..++|||||++|+|
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L 95 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL 95 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcH
Confidence 899999999999764 45689999997432 235679999999999999999999999975 457999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC----
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK---- 459 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---- 459 (608)
.+++.. ....+++..++.++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 96 ~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~-----iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 96 HKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp HHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred HHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 998753 3467999999999999999999999987 9999999999999999999999999999775432
Q ss_pred --ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 460 --TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 460 --~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
....||+.|+||| ..++.++|||||||++|||+| |+.||..... .+....+.. .... ..+..+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~~~~i~~-~~~~--------~~p~~~ 237 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQ-GKRM--------ECPPEC 237 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHHT-TCCC--------CCCTTC
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHc-CCCC--------CCCCcC
Confidence 2345788999999 678999999999999999998 8999875433 333332222 1111 123456
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
+.++.+|+.+||+.||++||||.+|++.|+.+..
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 6778999999999999999999999999997753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=389.93 Aligned_cols=237 Identities=16% Similarity=0.272 Sum_probs=197.5
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc-ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++|||||++++++.+++..++|||||++|+|.
T Consensus 18 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~ 97 (288)
T d2jfla1 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHH
Confidence 45899999999999875 7899999999743 344577899999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Ccc
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KTC 461 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~~ 461 (608)
+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 98 ~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~-----ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 98 AVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK-----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp HHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 998652 456999999999999999999999987 999999999999999999999999999865432 235
Q ss_pred ccccCccccCC---------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 462 LFSSNGYTAPE---------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 462 ~~gt~~y~aPE---------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
..||+.|+||| ..++.++|||||||++|||+||+.||......... ........ ... ..+...
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~-~~i~~~~~-~~~------~~~~~~ 241 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL-LKIAKSEP-PTL------AQPSRW 241 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-HHHHHSCC-CCC------SSGGGS
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH-HHHHcCCC-CCC------CccccC
Confidence 67999999999 23688999999999999999999999765443322 22222211 011 112345
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
+.++.+|+.+||+.||++|||++|+++
T Consensus 242 s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 667899999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=384.15 Aligned_cols=239 Identities=20% Similarity=0.224 Sum_probs=195.2
Q ss_pred cccCCCCCceEEEEEEcC---CcEEEEEEeccccc---CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKN---SAVYAVKRLKKLQV---SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~---g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
..||+|+||+||+|.+.+ ++.||||+++.... ..++|.+|++++++++|||||+++++|.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 358999999999998753 46899999974322 246799999999999999999999999754 57899999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|+|.++++. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~-----iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC-----cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999999976 567999999999999999999999987 9999999999999999999999999999765432
Q ss_pred -----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 -----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 -----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....||+.|+||| ..++.++|||||||++|||+| |+.||.... ..+....+.. .... ..+
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-~~~~~~~i~~-~~~~--------~~p 232 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAMLEK-GERM--------GCP 232 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHT-TCCC--------CCC
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-HHHHHHHHHc-CCCC--------CCC
Confidence 2346889999999 668999999999999999998 888887543 2232222222 1111 122
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhh
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVV 565 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 565 (608)
..++.++.+|+.+||+.||++|||+++|++.|+...
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 346677899999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=386.81 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=202.2
Q ss_pred hcccCCCCCceEEEEEEcCC----cEEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeec-CCeeEEEEeec
Q 042949 306 ADLRSQTICSSLFMVRLKNS----AVYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNST-NEEKLLVYKYQ 378 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g----~~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 378 (608)
+++||+|+||+||+|++.++ ..||||+++.. ....++|.+|++++++++|||||+++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999997542 36999999742 2234679999999999999999999999865 56889999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++|+|.++++. ....+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~-----iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC-----cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999998873 3556889999999999999999999987 999999999999999999999999999976543
Q ss_pred C-------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 459 K-------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 459 ~-------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
. ....||..|+||| ..++.++|||||||++|||+||+.||....+.......+...... .
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~---------~ 254 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---------L 254 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC---------C
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---------C
Confidence 2 2346788999999 788999999999999999999888877655444333333322111 1
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGNDERD 572 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 572 (608)
.+..++.++.+|+.+||+.||++||||.||++.|+++.+......
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 123456678999999999999999999999999999987654433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=381.33 Aligned_cols=241 Identities=20% Similarity=0.316 Sum_probs=190.9
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeec-CCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNST-NEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~ 385 (608)
+.||+|+||.||+|+. .|+.||||+++.. ...++|.+|++++++++|||||+++|+|.+ .+..++||||+++|+|.+
T Consensus 13 ~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~ 90 (262)
T d1byga_ 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 90 (262)
T ss_dssp EEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHH
T ss_pred EEEecCCCeEEEEEEE-CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHH
Confidence 5689999999999998 5788999999753 356789999999999999999999999865 456899999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcccccc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTCLFSS 465 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt 465 (608)
+|... ....+++..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..........++
T Consensus 91 ~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~-----ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~ 163 (262)
T d1byga_ 91 YLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 163 (262)
T ss_dssp HHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred HHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc-----eeccccchHhheecCCCCEeecccccceecCCCCcccccc
Confidence 99753 1235899999999999999999999986 9999999999999999999999999999877666667789
Q ss_pred CccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHHHHH
Q 042949 466 NGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVA 540 (608)
Q Consensus 466 ~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 540 (608)
..|+||| ..++.++|||||||++|||+| |+.|+.. ....+....... .... ..+...+..+.+|+
T Consensus 164 ~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~-~~~~--------~~~~~~~~~~~~li 233 (262)
T d1byga_ 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEK-GYKM--------DAPDGCPPAVYEVM 233 (262)
T ss_dssp TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTT-TCCC--------CCCTTCCHHHHHHH
T ss_pred ccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHc-CCCC--------CCCccCCHHHHHHH
Confidence 9999999 788999999999999999999 5666543 343333333322 1111 12334556789999
Q ss_pred HHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 541 LKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 541 ~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
.+||+.||++||||.|++++|++++.
T Consensus 234 ~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 234 KNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=393.11 Aligned_cols=249 Identities=19% Similarity=0.256 Sum_probs=196.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.||+|+||+||+|+.. +|+.||+|+++... ...+.+.+|+++|++++|||||+++++|.+++..++||||+++|+|
T Consensus 12 ~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L 91 (322)
T d1s9ja_ 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 91 (322)
T ss_dssp EEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEH
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcH
Confidence 46899999999999974 78999999997432 2356789999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-Ccc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQK-SNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-KTC 461 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~~ 461 (608)
.+++.. ...+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 92 ~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~-----IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 162 (322)
T d1s9ja_ 92 DQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162 (322)
T ss_dssp HHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC-----EEccccCHHHeeECCCCCEEEeeCCCccccCCCcccc
Confidence 999976 35699999999999999999999974 5 999999999999999999999999999976433 345
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHH-HH-Hhhh--------------------
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVK-AM-VREE-------------------- 515 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~-~~-~~~~-------------------- 515 (608)
.+||+.|+||| ..++.++||||+||++|||+||+.||........... .. ....
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 68999999999 6799999999999999999999999975433211100 00 0000
Q ss_pred -cccccccHHHHH----------hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHh
Q 042949 516 -WTGEVFDKEVAK----------AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEV 564 (608)
Q Consensus 516 -~~~~~~~~~~~~----------~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~ 564 (608)
............ .....+.++.+++.+||+.||++|||++|+++. +++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 000000000000 001245678999999999999999999999884 5443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-47 Score=387.83 Aligned_cols=234 Identities=21% Similarity=0.299 Sum_probs=194.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|++++++++|||||++++++.+.+..++|||||++|
T Consensus 21 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g 100 (309)
T d1u5ra_ 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 100 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCC
Confidence 34899999999999864 789999999975432 2346889999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 101 ~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~-----iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~ 170 (309)
T d1u5ra_ 101 ASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NS 170 (309)
T ss_dssp HHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-CC
T ss_pred chHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCCCcceEEECCCCCEEEeecccccccCCC-Cc
Confidence 98776654 467999999999999999999999987 999999999999999999999999999876543 45
Q ss_pred ccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 462 LFSSNGYTAPE-------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 462 ~~gt~~y~aPE-------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
..||+.||||| ..++.++|||||||++|||++|+.||........ ......... ... ....++.
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i~~~~~-~~~-------~~~~~s~ 241 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNES-PAL-------QSGHWSE 241 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCC-CCC-------SCTTSCH
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCC-CCC-------CCCCCCH
Confidence 67999999999 2478899999999999999999999876543322 222222111 111 1223566
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
.+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 242 YFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHHh
Confidence 7899999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=390.07 Aligned_cols=243 Identities=19% Similarity=0.254 Sum_probs=196.6
Q ss_pred hcccCCCCCceEEEEEEcC-C-----cEEEEEEeccc--ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLKN-S-----AVYAVKRLKKL--QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~-g-----~~vavK~l~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 376 (608)
.+.||+|+||+||+|+... + ..||||++... ......+.+|+.++.++ +|||||++++++.+.+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (325)
T d1rjba_ 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121 (325)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence 4679999999999998753 2 36999998643 23456789999999998 89999999999999999999999
Q ss_pred eccCCCHHHHHHHHhc-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCee
Q 042949 377 YQSNGSLLSLLEAYIE-------------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNIL 437 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NIL 437 (608)
||++|+|.++|+.... ....+++..++.++.||++||+|||+++ ||||||||+|||
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-----IiHRDlKp~Nil 196 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVL 196 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-----EEETTCSGGGEE
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCchhccc
Confidence 9999999999975211 1235899999999999999999999987 999999999999
Q ss_pred cCCCCCceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHH
Q 042949 438 LNENEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKW 507 (608)
Q Consensus 438 l~~~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~ 507 (608)
++.++.+||+|||+|+...... ....||+.||||| ..++.++|||||||++|||+| |+.||.........
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~ 276 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998765432 2345789999999 788999999999999999998 89898754443332
Q ss_pred HHHHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 042949 508 VKAMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIE 562 (608)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 562 (608)
.......... ..+..++..+.+|+.+||+.||++|||++||+++|.
T Consensus 277 -~~~~~~~~~~--------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 277 -YKLIQNGFKM--------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -HHHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHhcCCCC--------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2233222111 123345677899999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=384.52 Aligned_cols=234 Identities=22% Similarity=0.324 Sum_probs=196.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++|||||++++++.+.+..++||||+++|
T Consensus 14 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg 93 (288)
T d1uu3a_ 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG 93 (288)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCC
Confidence 57899999999999974 7899999999732 335677999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC--
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 459 (608)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 94 ~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~-----iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 94 ELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc-----EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999876 457999999999999999999999987 9999999999999999999999999999775332
Q ss_pred ---ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 460 ---TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 460 ---~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
....||+.|+||| ..++.++||||+||++|||+||+.||..... ......+..... ..+...
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~~~~----------~~p~~~ 233 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKIIKLEY----------DFPEKF 233 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHTTCC----------CCCTTC
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-HHHHHHHHcCCC----------CCCccC
Confidence 3457999999999 6789999999999999999999999976432 222333322211 012345
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+.++.+|+.+||+.||++|||++|+++.
T Consensus 234 s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 234 FPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 5678899999999999999999997553
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-47 Score=386.03 Aligned_cols=238 Identities=23% Similarity=0.304 Sum_probs=182.8
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.||+|+||+||+|+.. +|+.||||++.... .....+.+|++++++++|||||++++++.+++..++|||||++|+|
T Consensus 15 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L 94 (307)
T d1a06a_ 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 94 (307)
T ss_dssp EESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 57899999999999875 68999999997432 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC---CCCCceEeccccccccCCCC-
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN---ENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~~- 459 (608)
.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+++......
T Consensus 95 ~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~-----iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 95 FDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG-----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp HHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred HHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce-----eeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 999974 567999999999999999999999987 99999999999994 57889999999999775432
Q ss_pred -ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 460 -TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 460 -~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....||+.||||| ..++.++|||||||++|||+||+.||.+... .............. . .......+.
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~~~~~~---~---~~~~~~~s~ 238 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-AKLFEQILKAEYEF---D---SPYWDDISD 238 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHTTCCCC---C---TTTTTTSCH
T ss_pred eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHhccCCCC---C---CccccCCCH
Confidence 4567999999999 5689999999999999999999999976433 22222222221110 0 011234566
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
++.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 78999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-47 Score=385.05 Aligned_cols=246 Identities=20% Similarity=0.310 Sum_probs=201.6
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.||+|+||+||+|+.. +++.||||+++.... ..++|.+|++++++++||||++++++|...+..+++|||+
T Consensus 19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~ 98 (301)
T d1lufa_ 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 98 (301)
T ss_dssp EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEec
Confidence 45899999999999874 357899999974332 3467999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHh--------------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeec
Q 042949 379 SNGSLLSLLEAYI--------------------EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILL 438 (608)
Q Consensus 379 ~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl 438 (608)
++|+|.+++.... .....+++..++.|+.|++.||+|||+++ ||||||||+|||+
T Consensus 99 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~-----ivHrDlKp~NILl 173 (301)
T d1lufa_ 99 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLV 173 (301)
T ss_dssp TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEE
T ss_pred CCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-----eEeeEEcccceEE
Confidence 9999999997521 11235899999999999999999999987 9999999999999
Q ss_pred CCCCCceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHH
Q 042949 439 NENEDPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVK 509 (608)
Q Consensus 439 ~~~~~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~ 509 (608)
|.++.+||+|||+++...... ....+|+.|+||| ..++.++|||||||++|||++|..|+....+..+...
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~ 253 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 253 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHH
Confidence 999999999999998664332 2346788999999 6899999999999999999999765444445444444
Q ss_pred HHHhhhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 510 AMVREEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
.+.... .. ..+...+..+.+|+.+||+.||++||||.||+++|+++.+
T Consensus 254 ~v~~~~-~~--------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 254 YVRDGN-IL--------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHTTC-CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHcCC-CC--------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 433322 11 1233456678999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=377.80 Aligned_cols=237 Identities=19% Similarity=0.289 Sum_probs=197.5
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc-------cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ-------VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 16 ~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (293)
T d1jksa_ 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 95 (293)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5689999999999997 478999999986321 24678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC----CceEeccccccc
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE----DPLISECGYSKF 454 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~ 454 (608)
++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+|++|||+++.
T Consensus 96 ~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~-----ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 96 AGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred CCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc-----eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999976 357999999999999999999999987 99999999999998776 489999999987
Q ss_pred cCCC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 455 LDPK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 455 ~~~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
.... .....||+.|+||| ..++.++|||||||++|||+||+.||..... ......+..... .... ..
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~~~~---~~~~---~~ 239 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANVSAVNY---EFED---EY 239 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHTTCC---CCCH---HH
T ss_pred cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-HHHHHHHHhcCC---CCCc---hh
Confidence 7543 34567899999999 5689999999999999999999999975432 222222222111 1111 11
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
....+..+.+|+.+||+.||++|||++|+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2345667899999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=382.66 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=201.4
Q ss_pred hcccCCCCCceEEEEEEc-CCc--EEEEEEeccc--ccCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRLK-NSA--VYAVKRLKKL--QVSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~-~g~--~vavK~l~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
.+.||+|+||+||+|++. +|. .||||+++.. ....++|.+|+++|+++ +|||||+++++|.+++..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 467999999999999875 444 5788888632 23456799999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHHH------------hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEe
Q 042949 380 NGSLLSLLEAY------------IEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLIS 447 (608)
Q Consensus 380 ~g~L~~~l~~~------------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 447 (608)
+|+|.++|+.. ......+++.++++++.|||+||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~-----iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECGGGCEEEC
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-----ccccccccceEEEcCCCceEEc
Confidence 99999999742 112467999999999999999999999987 9999999999999999999999
Q ss_pred ccccccccCCCC--ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 448 ECGYSKFLDPKK--TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 448 DFGla~~~~~~~--~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
|||+++...... ....||..|+||| ..++.++|||||||++|||++|..|+....+.......+... ...
T Consensus 170 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-~~~--- 245 (309)
T d1fvra_ 170 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRL--- 245 (309)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCC---
T ss_pred cccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CCC---
Confidence 999998765432 3456899999999 678999999999999999999876554455544444433221 111
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
..+...+..+.+|+.+||+.||++||||.||++.|+++++..
T Consensus 246 -----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 246 -----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 122345677999999999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=373.20 Aligned_cols=242 Identities=17% Similarity=0.267 Sum_probs=189.7
Q ss_pred cccCCCCCceEEEEEEcC----CcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLKN----SAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.||+|+||.||+|+... +..||||+++... ...+.|.+|++++++++|||||++++++. .+..++||||+++
T Consensus 13 ~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~ 91 (273)
T d1mp8a_ 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTL 91 (273)
T ss_dssp EEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred EEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccC
Confidence 578999999999998743 3579999987432 23467999999999999999999999986 4678999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC-
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK- 459 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 459 (608)
|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 92 g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~-----iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 92 GELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp EEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred CcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC-----eeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 999998765 3457999999999999999999999987 9999999999999999999999999998765332
Q ss_pred ---ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchh
Q 042949 460 ---TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQ 531 (608)
Q Consensus 460 ---~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (608)
....||+.|+||| ..++.++|||||||++|||+| |.+|+..... ......+..... . ..+..
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-~~~~~~i~~~~~-~--------~~~~~ 233 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGER-L--------PMPPN 233 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHHTTCC-C--------CCCTT
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCC-C--------CCCCC
Confidence 3456788999999 688999999999999999998 7777765432 222332222211 1 12335
Q ss_pred cHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 532 WAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 532 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
++.++.+|+.+||+.||++|||+.||++.|+++++.
T Consensus 234 ~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 667799999999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=377.67 Aligned_cols=247 Identities=19% Similarity=0.232 Sum_probs=189.6
Q ss_pred cccCCCCCceEEEEEEc------CCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecC-CeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTN-EEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lv~e 376 (608)
+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|+..+.++ +|+|||.+++++... +..++|||
T Consensus 19 ~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E 98 (299)
T d1ywna1 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 98 (299)
T ss_dssp EEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEE
T ss_pred eEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEE
Confidence 56899999999999864 34689999997432 2345677888888776 689999999987654 56899999
Q ss_pred eccCCCHHHHHHHHhc------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCc
Q 042949 377 YQSNGSLLSLLEAYIE------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDP 444 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~ 444 (608)
||++|+|.++++.... ....+++.+++.++.||++||+|||+++ ||||||||+|||+++++.+
T Consensus 99 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~-----ivHrDlKp~NILl~~~~~~ 173 (299)
T d1ywna1 99 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVV 173 (299)
T ss_dssp CCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECGGGCE
T ss_pred ecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC-----CcCCcCCccceeECCCCcE
Confidence 9999999999976321 1245899999999999999999999987 9999999999999999999
Q ss_pred eEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCC-CCcCCCChHHHHHHHHhh
Q 042949 445 LISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKT-VEKTGIDLPKWVKAMVRE 514 (608)
Q Consensus 445 kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~-p~~~~~~~~~~~~~~~~~ 514 (608)
||+|||+|+...... ....||+.|+||| ..++.++|||||||++|||+||.. ||..... ...+......
T Consensus 174 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~~~~~~~~~~ 252 (299)
T d1ywna1 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKE 252 (299)
T ss_dssp EECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SHHHHHHHHH
T ss_pred EEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhc
Confidence 999999998764332 3457899999999 778999999999999999999865 5544333 3333333333
Q ss_pred hcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 515 EWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
..... .+...+..+.+++.+||+.||++|||+.|++++|+++++.
T Consensus 253 ~~~~~--------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 253 GTRMR--------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp TCCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC--------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 22211 1234556789999999999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.9e-46 Score=385.06 Aligned_cols=239 Identities=19% Similarity=0.287 Sum_probs=199.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|++++++++|||||++++++.+.+..++|||||++|+|.
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~ 111 (350)
T d1koaa2 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 111 (350)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHH
Confidence 56899999999999874 78999999997533 34567899999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC--CCCceEeccccccccCCCC--c
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE--NEDPLISECGYSKFLDPKK--T 460 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~--~ 460 (608)
+++.. ....+++..+..|+.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+++.+.... .
T Consensus 112 ~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~-----iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 112 EKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp HHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred HHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC-----CeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 98853 2456999999999999999999999987 999999999999964 5789999999999876543 3
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||+.||||| ..++.++||||+||++|||+||+.||... +.......+....+... . ......+..+
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~---~---~~~~~~s~~~ 256 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWNMD---D---SAFSGISEDG 256 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCSC---C---GGGGGCCHHH
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCC---c---ccccCCCHHH
Confidence 467999999999 56889999999999999999999999754 33333443333221110 0 1123455678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+|+.+||+.||++|||++|+++.
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-45 Score=375.99 Aligned_cols=234 Identities=22% Similarity=0.322 Sum_probs=200.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||+||+|+.. +|+.||||++++. ....+.+.+|+.++++++|||||++++++.+.+..++|||||++|
T Consensus 10 ~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 89 (316)
T d1fota_ 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 89 (316)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCc
Confidence 56899999999999974 6999999999732 335678999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+........
T Consensus 90 ~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~-----iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~ 160 (316)
T d1fota_ 90 ELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 160 (316)
T ss_dssp BHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred cccccccc----cccccccHHHHHHHHHHHhhhhhccCc-----EEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence 99998876 567899999999999999999999987 999999999999999999999999999998877777
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..||+.||||| ..++.++||||+||++|||+||+.||.... ............. ..+...+.++.
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~~----------~~p~~~s~~~~ 229 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKILNAEL----------RFPPFFNEDVK 229 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHCCC----------CCCTTSCHHHH
T ss_pred ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-HHHHHHHHHcCCC----------CCCCCCCHHHH
Confidence 88999999999 568999999999999999999999997543 2233333322211 01223456688
Q ss_pred HHHHHchhcCCCCCC-----CHHHHHHH
Q 042949 538 NVALKCVSNSPDDRP-----TMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RP-----s~~evl~~ 560 (608)
+++.+||+.||.+|| |++|+++.
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 999999999999996 89999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=376.74 Aligned_cols=241 Identities=18% Similarity=0.276 Sum_probs=194.0
Q ss_pred cccCCCCCceEEEEEEc-CCc----EEEEEEeccc--ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSA----VYAVKRLKKL--QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~----~vavK~l~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+.||+|+||+||+|+.. +|+ .||+|+++.. ....++|.+|++++++++|||||+++|+|.++ ..++++||+.
T Consensus 15 ~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~ 93 (317)
T d1xkka_ 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 93 (317)
T ss_dssp EEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEecc
Confidence 57899999999999864 443 6899988742 34567899999999999999999999999875 5678889999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
+|+|.+++.. ....+++..+++++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~-----iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 94 FGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp TCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred CCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC-----cccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 9999998875 3567999999999999999999999987 9999999999999999999999999999775432
Q ss_pred -----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhc
Q 042949 460 -----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAG 529 (608)
Q Consensus 460 -----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (608)
....||+.|+||| ..++.++|||||||++|||+| |++||... +.......+...... ..+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~-~~~~~~~~i~~~~~~---------~~p 235 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERL---------PQP 235 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CGGGHHHHHHHTCCC---------CCC
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC---------CCC
Confidence 2345789999999 778999999999999999999 56666543 322222222221110 123
Q ss_pred hhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 530 RQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 530 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
..++..+.+|+.+||+.||++|||+.|+++.|+.+.+
T Consensus 236 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 4566778999999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=375.17 Aligned_cols=234 Identities=20% Similarity=0.286 Sum_probs=198.3
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||.||+|+. .+|+.||||++++. ....+.+.+|+.+|++++|||||++++++.+.+..++|||||++|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg 90 (337)
T d1o6la_ 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90 (337)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCC
Confidence 5689999999999987 47999999999742 235677899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK--- 458 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 458 (608)
+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 91 ~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~-----iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 91 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp BHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred chhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC-----ccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 99999986 467999999999999999999999987 999999999999999999999999999976432
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHH
Q 042949 459 KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAF 534 (608)
Q Consensus 459 ~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (608)
....+||+.|+||| ..++.++||||+||++|||++|+.||.... .....+....... ..+...+.
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-~~~~~~~i~~~~~----------~~p~~~s~ 230 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEI----------RFPRTLSP 230 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCC----------CCCTTSCH
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-HHHHHHHHhcCCC----------CCCccCCH
Confidence 24567999999999 568999999999999999999999987543 2333333322211 11234566
Q ss_pred HHHHHHHHchhcCCCCCCC-----HHHHHHH
Q 042949 535 PLLNVALKCVSNSPDDRPT-----MAEVLER 560 (608)
Q Consensus 535 ~l~~li~~Cl~~dP~~RPs-----~~evl~~ 560 (608)
++.+|+.+||+.||++||+ +.|+++.
T Consensus 231 ~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 7889999999999999995 7888763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=376.25 Aligned_cols=249 Identities=20% Similarity=0.295 Sum_probs=203.2
Q ss_pred hcccCCCCCceEEEEEEc------CCcEEEEEEecccc--cCHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEEe
Q 042949 306 ADLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 376 (608)
.+.||+|+||.||+|++. +++.||||+++... ....+|.+|+.+++++ +|||||+++++|.+.+..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 357999999999999863 45799999997433 2345788999999999 69999999999999999999999
Q ss_pred eccCCCHHHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC
Q 042949 377 YQSNGSLLSLLEAYIE--------------GKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE 442 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~ 442 (608)
||++|+|.++++.... ....+++..++.++.||++||+|||+++ ||||||||+|||++.++
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-----ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGR 182 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEETTT
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccccccccccccC
Confidence 9999999999986321 2336899999999999999999999987 99999999999999999
Q ss_pred CceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHh
Q 042949 443 DPLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVR 513 (608)
Q Consensus 443 ~~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 513 (608)
.+|++|||+++...... ....||+.|+||| ..++.++|||||||++|||+|+..|+.........+.....
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~ 262 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999999775432 2356789999999 77899999999999999999965554444333333333333
Q ss_pred hhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 514 EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
...... .+...+..+.+|+.+||+.||++||||.||+++|++++..
T Consensus 263 ~~~~~~--------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 263 EGFRML--------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HTCCCC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCC--------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 322111 1234566789999999999999999999999999988754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-45 Score=382.96 Aligned_cols=239 Identities=19% Similarity=0.251 Sum_probs=197.8
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ-VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..++|||||++|+|.
T Consensus 35 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~ 114 (352)
T d1koba_ 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 114 (352)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHH
Confidence 5689999999999987 479999999997533 34557889999999999999999999999999999999999999998
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC--CCCCceEeccccccccCCCC--c
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN--ENEDPLISECGYSKFLDPKK--T 460 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~--~ 460 (608)
+++.. ....+++.+++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.+.... .
T Consensus 115 ~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~-----iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 115 DRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp HHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 87653 2456999999999999999999999987 99999999999998 56899999999999876543 3
Q ss_pred cccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHH
Q 042949 461 CLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPL 536 (608)
Q Consensus 461 ~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 536 (608)
...||+.|+||| ..++.++||||+||++|||+||+.||.+... ......+....... .. ......+.++
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~~~---~~---~~~~~~s~~~ 259 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVKRCDWEF---DE---DAFSSVSPEA 259 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHHCCCCC---CS---STTTTSCHHH
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCC---Cc---ccccCCCHHH
Confidence 467899999999 5689999999999999999999999975433 22333332221110 00 1123455678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 042949 537 LNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 537 ~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=375.64 Aligned_cols=251 Identities=18% Similarity=0.230 Sum_probs=191.0
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCC----eeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE----EKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~e~~~~g~ 382 (608)
+.||+|+||.||+|++ +|+.||||+++........++.|+..+.+++|||||++++++...+ ..++|||||++|+
T Consensus 9 ~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~ 87 (303)
T d1vjya_ 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS 87 (303)
T ss_dssp EEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCB
T ss_pred EEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCC
Confidence 4589999999999986 7899999999754322223344555667889999999999987643 5799999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC---CCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSN---EEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~---~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
|.++|+. ..++|.++++++.|+|.||+|||+... +.++|+||||||+|||++.++.+||+|||+++......
T Consensus 88 L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 88 LFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp HHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 9999985 469999999999999999999997421 23469999999999999999999999999998764322
Q ss_pred -------ccccccCccccCC---C-------CCCcchhHHHHHHHHHHHHcCCCCCcCCCC-------------hHHHHH
Q 042949 460 -------TCLFSSNGYTAPE---K-------TVSEQGDVFSFGVILLELLTGKTVEKTGID-------------LPKWVK 509 (608)
Q Consensus 460 -------~~~~gt~~y~aPE---~-------~~~~ksDVwSfGvvl~elltg~~p~~~~~~-------------~~~~~~ 509 (608)
....||+.|+||| . .++.++|||||||++|||+||..|+..... ......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHH
Confidence 3457899999999 1 146789999999999999999877532110 111122
Q ss_pred HHHhhhcccccccHHHHHh--chhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 510 AMVREEWTGEVFDKEVAKA--GRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
....... ..+.+... .......+.+|+.+||+.||++|||+.||+++|+++.+.
T Consensus 243 ~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 243 KVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 2211111 11111111 122345588999999999999999999999999998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=373.74 Aligned_cols=248 Identities=17% Similarity=0.230 Sum_probs=205.0
Q ss_pred hcccCCCCCceEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEee
Q 042949 306 ADLRSQTICSSLFMVRLK------NSAVYAVKRLKKLQV--SMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKY 377 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 377 (608)
.+.||+|+||+||+|.+. +++.||||+++.... ....|.+|++++++++|||||++++++...+..++||||
T Consensus 25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 104 (308)
T d1p4oa_ 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 104 (308)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEee
Confidence 366999999999999863 357899999974332 234689999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccc
Q 042949 378 QSNGSLLSLLEAYI------EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGY 451 (608)
Q Consensus 378 ~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 451 (608)
+++|+|.+++.... .....+++..+.+++.|+|+||+|||+++ |+||||||+|||+++++++||+|||+
T Consensus 105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-----ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeeceEcCCceeecCCceEEEeeccc
Confidence 99999999987532 12345799999999999999999999986 99999999999999999999999999
Q ss_pred ccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccccccc
Q 042949 452 SKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFD 522 (608)
Q Consensus 452 a~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (608)
++.+.... ....+|+.|+||| ..++.++|||||||++|||+||..++..+.+.......+.+....
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~----- 254 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL----- 254 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC-----
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC-----
Confidence 98765432 2346789999999 678999999999999999999976555555655555544432211
Q ss_pred HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcC
Q 042949 523 KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNG 567 (608)
Q Consensus 523 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 567 (608)
..+..++..+.+++.+||+.||++||||.||+++|++.++.
T Consensus 255 ----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 255 ----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 12234566799999999999999999999999999888653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.3e-45 Score=367.94 Aligned_cols=239 Identities=21% Similarity=0.270 Sum_probs=197.7
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEeccccc---C-------HHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEE
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV---S-------MDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLL 373 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~---~-------~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 373 (608)
.+.||+|+||+||+|+. .+|+.||||+++.... . .+.+.+|+.++++++ |||||++++++.+++..++
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 36789999999999987 4789999999974321 1 235789999999997 9999999999999999999
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
|||||++|+|.++++. ...+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 88 vmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 88 VFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999975 357999999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCC--CccccccCccccCC----------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc
Q 042949 454 FLDPK--KTCLFSSNGYTAPE----------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF 521 (608)
Q Consensus 454 ~~~~~--~~~~~gt~~y~aPE----------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 521 (608)
.+... .....||..|+||| ..++.++||||+||++|||+||+.||..... ....+........ ..
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-~~~~~~i~~~~~~--~~ 235 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLMLRMIMSGNYQ--FG 235 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCC--CC
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-HHHHHHHHhCCCC--CC
Confidence 87653 34567999999999 2468899999999999999999999976543 2222223322111 00
Q ss_pred cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.......+.++.+++.+||+.||++|||++|+++.
T Consensus 236 ----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 236 ----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01123456679999999999999999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-45 Score=370.48 Aligned_cols=244 Identities=21% Similarity=0.295 Sum_probs=194.5
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHhcCCCCcceeeeeeeecCC----eeEEEEee
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQV----SMDEFSQTMRQIGNLKHPNILPLVCYNSTNE----EKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~e~ 377 (608)
+.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|++++++++|||||++++++...+ ..++||||
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~ 92 (277)
T d1o6ya_ 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 92 (277)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEEC
Confidence 5789999999999987 4799999999974322 2346889999999999999999999987643 37899999
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+++|+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++..+++|||.++....
T Consensus 93 ~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~-----iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 93 VDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp CCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred CCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCccccCcccccCccccceeehhhhhhhhcc
Confidence 999999998875 457999999999999999999999987 99999999999999999999999999876543
Q ss_pred C------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 458 K------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 458 ~------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
. .....||+.|+||| ..++.++|||||||++|||+||+.||...... ............. + ..
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~~~~~~~~~----~--~~ 236 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVREDPIP----P--SA 236 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHCCCCC----G--GG
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-HHHHHHHhcCCCC----C--ch
Confidence 2 23457899999999 56899999999999999999999999754332 2222222221110 0 01
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHhhc
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRP-TMAEVLERIEEVVN 566 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~~~ 566 (608)
.....+..+.+++.+||+.||++|| |+++++..|.++.+
T Consensus 237 ~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 1234567789999999999999999 89999999998864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-44 Score=372.92 Aligned_cols=233 Identities=16% Similarity=0.212 Sum_probs=200.0
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 381 (608)
+.||+|+||.||+|+.. +|+.||||+++.. ....+.+.+|+++|++++|||||++++++...+..++||||+.+|
T Consensus 47 ~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g 126 (350)
T d1rdqe_ 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccccc
Confidence 46899999999999875 7999999999632 234677899999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCCcc
Q 042949 382 SLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKKTC 461 (608)
Q Consensus 382 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 461 (608)
+|.+++.. ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+......
T Consensus 127 ~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~-----iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~ 197 (350)
T d1rdqe_ 127 EMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp BHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred chhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCcCCHHHcccCCCCCEEeeeceeeeeccccccc
Confidence 99999976 357999999999999999999999987 999999999999999999999999999988777777
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..||+.||||| ..++.++|||||||++|||+||+.||.... .......+..... ..+...+.++.
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~~----------~~p~~~s~~~~ 266 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKV----------RFPSHFSSDLK 266 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCC----------CCCTTCCHHHH
T ss_pred ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-HHHHHHHHhcCCC----------CCCccCCHHHH
Confidence 88999999999 568999999999999999999999997543 3333333322211 11234566788
Q ss_pred HHHHHchhcCCCCCC-----CHHHHHH
Q 042949 538 NVALKCVSNSPDDRP-----TMAEVLE 559 (608)
Q Consensus 538 ~li~~Cl~~dP~~RP-----s~~evl~ 559 (608)
+++.+||+.||.+|+ |++|+++
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHhhhCHHhccccccccHHHHHc
Confidence 999999999999994 8999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=369.20 Aligned_cols=240 Identities=23% Similarity=0.281 Sum_probs=188.4
Q ss_pred cccCCCCCceEEEEEEc--CC--cEEEEEEecccc----cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK--NS--AVYAVKRLKKLQ----VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~--~g--~~vavK~l~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.||+|+||.||+|+.. ++ ..||||+++... ...++|.+|++++++++|||||+++|++.++ ..++||||+
T Consensus 14 ~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~ 92 (273)
T d1u46a_ 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELA 92 (273)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECC
T ss_pred EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeee
Confidence 45899999999999864 22 478999987432 2346799999999999999999999999764 678999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++|++.+++... ...+++..++.++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 93 ~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~-----iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 93 PLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp TTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred cCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC-----EeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 999999988753 346999999999999999999999987 999999999999999999999999999987543
Q ss_pred C------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHhhhcccccccHHHHH
Q 042949 459 K------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAK 527 (608)
Q Consensus 459 ~------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (608)
. ....++..|+||| ..++.++|||||||++|||+| |+.||... +.......+.......+
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-~~~~~~~~i~~~~~~~~-------- 235 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLP-------- 235 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTSCCCCC--------
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-CHHHHHHHHHhCCCCCC--------
Confidence 2 2345678899999 678899999999999999998 78888643 44444444433322111
Q ss_pred hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHh
Q 042949 528 AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEV 564 (608)
Q Consensus 528 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 564 (608)
.....+..+.+|+.+||+.||++||||.||++.|++.
T Consensus 236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1234556789999999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=374.90 Aligned_cols=244 Identities=21% Similarity=0.227 Sum_probs=191.6
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC------HHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS------MDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
++||+|+||+||+|+.. +|+.||||+++..... .+.+.+|++++++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 57999999999999874 6899999999743221 2468899999999999999999999999999999999998
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK 459 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 459 (608)
++++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~-----iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW-----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhccc-----eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 876665443 3567999999999999999999999987 9999999999999999999999999998765432
Q ss_pred ---ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc--cc----------
Q 042949 460 ---TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT--GE---------- 519 (608)
Q Consensus 460 ---~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~---------- 519 (608)
....||+.|+||| ..++.++|||||||++|||+||++||....+... ...+...... .+
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCChhhccchhccch
Confidence 3457899999999 3578999999999999999999999876543322 2222211000 00
Q ss_pred ------cccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 520 ------VFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 520 ------~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
.............+..+.+|+.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00001111223456679999999999999999999999763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=372.66 Aligned_cols=239 Identities=19% Similarity=0.284 Sum_probs=198.9
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCHHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSLLS 385 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 385 (608)
+.||+|+||+||+|... +|+.||||+++........+.+|+++|++++|||||++++++.+++..|+|||||++|+|.+
T Consensus 11 ~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~ 90 (321)
T d1tkia_ 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHH
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHH
Confidence 56899999999999875 68899999998665556678899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC--CCceEeccccccccCCCC--cc
Q 042949 386 LLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN--EDPLISECGYSKFLDPKK--TC 461 (608)
Q Consensus 386 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~--~~ 461 (608)
++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+++...... ..
T Consensus 91 ~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~-----iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~ 162 (321)
T d1tkia_ 91 RINT---SAFELNEREIVSYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp HHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence 9863 2346999999999999999999999987 9999999999999854 478999999999776543 44
Q ss_pred ccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcHHHHH
Q 042949 462 LFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWAFPLL 537 (608)
Q Consensus 462 ~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 537 (608)
..+|+.|+||| ..++.++||||+||++|||++|+.||..... ......+..... .++.. .....+.++.
T Consensus 163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-~~~~~~i~~~~~---~~~~~---~~~~~s~~~~ 235 (321)
T d1tkia_ 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEY---TFDEE---AFKEISIEAM 235 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCC---CCCHH---HHTTSCHHHH
T ss_pred cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC---CCChh---hccCCCHHHH
Confidence 57899999999 5678999999999999999999999976533 233333333211 11111 1224566789
Q ss_pred HHHHHchhcCCCCCCCHHHHHHH
Q 042949 538 NVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 538 ~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
+|+.+||..||++|||+.|+++.
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=369.15 Aligned_cols=245 Identities=23% Similarity=0.340 Sum_probs=194.8
Q ss_pred cccCCCCCceEEEEEEcC--------CcEEEEEEeccccc--CHHHHHHHHHHHhcC-CCCcceeeeeeeecCCeeEEEE
Q 042949 307 DLRSQTICSSLFMVRLKN--------SAVYAVKRLKKLQV--SMDEFSQTMRQIGNL-KHPNILPLVCYNSTNEEKLLVY 375 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~--------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 375 (608)
+.||+|+||.||+|+... +..||||+++.... ...++.+|+..+.++ +|||||+++++|.+++..++||
T Consensus 19 ~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~ 98 (299)
T d1fgka_ 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 98 (299)
T ss_dssp EECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEE
Confidence 568999999999998632 35799999975332 346788899999888 7999999999999999999999
Q ss_pred eeccCCCHHHHHHHHh------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCC
Q 042949 376 KYQSNGSLLSLLEAYI------------EGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENED 443 (608)
Q Consensus 376 e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~ 443 (608)
||+++|+|.++|.... .....+++.+++.++.||+.||+|||+.+ ||||||||+|||++.++.
T Consensus 99 e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-----ivHrDiKp~NiLl~~~~~ 173 (299)
T d1fgka_ 99 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNV 173 (299)
T ss_dssp CCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCC
T ss_pred EccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-----EEeeeecccceeecCCCC
Confidence 9999999999997421 11346899999999999999999999987 999999999999999999
Q ss_pred ceEeccccccccCCCC-----ccccccCccccCC----CCCCcchhHHHHHHHHHHHHc-CCCCCcCCCChHHHHHHHHh
Q 042949 444 PLISECGYSKFLDPKK-----TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLT-GKTVEKTGIDLPKWVKAMVR 513 (608)
Q Consensus 444 ~kl~DFGla~~~~~~~-----~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 513 (608)
+||+|||+++...... ....+|+.|+||| ..++.++|||||||++|||+| |.+||. +.......+.+.
T Consensus 174 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~-~~~~~~~~~~i~- 251 (299)
T d1fgka_ 174 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-GVPVEELFKLLK- 251 (299)
T ss_dssp EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHH-
T ss_pred eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC-CCCHHHHHHHHH-
Confidence 9999999999764332 3356888999999 789999999999999999999 566664 344333333222
Q ss_pred hhcccccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 514 EEWTGEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
..... ..+...+..+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 252 ~~~~~--------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 252 EGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TTCCC--------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCC--------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 22111 1123456678999999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=373.61 Aligned_cols=241 Identities=18% Similarity=0.238 Sum_probs=189.9
Q ss_pred hcccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcC-CCCcceeeeeeeec----CCeeEEEEeecc
Q 042949 306 ADLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNL-KHPNILPLVCYNST----NEEKLLVYKYQS 379 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~~~lv~e~~~ 379 (608)
+++||+|+||+||+|+. .+|+.||||+++. ...+.+|++++.++ +|||||++++++.+ ....|+|||||+
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 45789999999999987 5789999999974 35678899987654 89999999998865 466899999999
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC---CCCceEeccccccccC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE---NEDPLISECGYSKFLD 456 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 456 (608)
+|+|.++|.. .+...+++.++..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 93 gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~-----iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 93 GGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp SEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHcC-----Cccccccccccccccccccccccccccceeeecc
Confidence 9999999974 23457999999999999999999999987 999999999999986 4569999999999765
Q ss_pred CC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhch
Q 042949 457 PK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGR 530 (608)
Q Consensus 457 ~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (608)
.. .....||+.||||| ..++.++|||||||++|||+||+.||.+....... ..+...........+ .....
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-~~~~~~i~~~~~~~~--~~~~~ 242 (335)
T d2ozaa1 166 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRMGQYEFP--NPEWS 242 (335)
T ss_dssp CCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCSSSCC--TTHHH
T ss_pred CCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-HHHHHHHhcCCCCCC--Ccccc
Confidence 43 34567999999999 45889999999999999999999999754332111 111111000110000 01122
Q ss_pred hcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 531 QWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 531 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..+.++.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 456678999999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-44 Score=373.76 Aligned_cols=237 Identities=22% Similarity=0.222 Sum_probs=191.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccc----cCHHHHHH---HHHHHhcCCCCcceeeeeeeecCCeeEEEEeec
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQ----VSMDEFSQ---TMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQ 378 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~---e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 378 (608)
+.||+|+||.||+|+.. +|+.||||++.... .....+.+ |+++++.++|||||++++++.+.+..++|||||
T Consensus 10 ~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~ 89 (364)
T d1omwa3 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 89 (364)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEec
Confidence 57899999999999975 68999999986321 22333444 467778889999999999999999999999999
Q ss_pred cCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC
Q 042949 379 SNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK 458 (608)
Q Consensus 379 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 458 (608)
++|+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 90 ~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~-----iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 90 NGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp CSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred CCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC-----ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999976 456899999999999999999999987 999999999999999999999999999977554
Q ss_pred -CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhc
Q 042949 459 -KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQW 532 (608)
Q Consensus 459 -~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (608)
.....||+.|+||| ..++.++|||||||++|||+||+.||......... ........... ..+...
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~~~~------~~~~~~ 232 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTMAV------ELPDSF 232 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHSSSCCC------CCCSSS
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcccCCC------CCCCCC
Confidence 34567999999999 35789999999999999999999999754321111 01111100000 112345
Q ss_pred HHHHHHHHHHchhcCCCCCCC-----HHHHHHH
Q 042949 533 AFPLLNVALKCVSNSPDDRPT-----MAEVLER 560 (608)
Q Consensus 533 ~~~l~~li~~Cl~~dP~~RPs-----~~evl~~ 560 (608)
+..+.+|+.+||+.||++||| ++|+++.
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 667899999999999999999 6888753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=362.72 Aligned_cols=246 Identities=19% Similarity=0.260 Sum_probs=194.4
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.+|+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..++||||+.+ +
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~ 86 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-D 86 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-c
Confidence 4689999999999987 579999999997432 2356789999999999999999999999999999999999965 5
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
+.+++.. .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 87 ~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~-----IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 87 LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC-----EEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 5555543 23567999999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccc-------------
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVF------------- 521 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------- 521 (608)
....||+.|+||| ..++.++||||+||++|||++|+.||..........+.........+..
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 3457899999999 3468899999999999999999999976544333322221111001000
Q ss_pred -----cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 -----DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 -----~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
...........+.++.+|+.+||..||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 011111223456778999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=366.95 Aligned_cols=233 Identities=22% Similarity=0.322 Sum_probs=194.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHh-cCCCCcceeeeeeeecCCeeEEEEeeccC
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKL----QVSMDEFSQTMRQIG-NLKHPNILPLVCYNSTNEEKLLVYKYQSN 380 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 380 (608)
+.||+|+||+||+|+.. +|+.||||++++. ....+.+..|..++. .++|||||++++++.+++..++||||+++
T Consensus 8 ~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~ 87 (320)
T d1xjda_ 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 87 (320)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCC
Confidence 56899999999999875 7899999999742 334567778887765 68999999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC--
Q 042949 381 GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK-- 458 (608)
Q Consensus 381 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 458 (608)
|+|.++++. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 88 g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~-----iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 88 GDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG-----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999986 456899999999999999999999987 999999999999999999999999999865432
Q ss_pred -CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHhchhcH
Q 042949 459 -KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKAGRQWA 533 (608)
Q Consensus 459 -~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (608)
.....||+.|+||| ..++.++|||||||++|||+||+.||.+.. ............. . .+...+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~~---~-------~p~~~s 227 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDNP---F-------YPRWLE 227 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCC---C-------CCTTSC
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCC---C-------CCccCC
Confidence 24467999999999 678999999999999999999999997543 2222322222111 0 122345
Q ss_pred HHHHHHHHHchhcCCCCCCCHH-HHHH
Q 042949 534 FPLLNVALKCVSNSPDDRPTMA-EVLE 559 (608)
Q Consensus 534 ~~l~~li~~Cl~~dP~~RPs~~-evl~ 559 (608)
.++.+|+.+||+.||++|||+. |+++
T Consensus 228 ~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 228 KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 6689999999999999999995 6754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.6e-44 Score=358.78 Aligned_cols=243 Identities=17% Similarity=0.183 Sum_probs=191.7
Q ss_pred cccCCCCCceEEEEEEcCCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 307 DLRSQTICSSLFMVRLKNSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
+.||+|+||+||+|+.++|+.||||+++.. ....+.+.+|+.+|++++|||||++++++...+..++++||+.++.+
T Consensus 8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~ 87 (286)
T d1ob3a_ 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87 (286)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence 458999999999999999999999999743 23357899999999999999999999999999999999999987766
Q ss_pred HHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC---Cc
Q 042949 384 LSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK---KT 460 (608)
Q Consensus 384 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~---~~ 460 (608)
..+.. ....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+|++|||.+...... ..
T Consensus 88 ~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 88 KLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR-----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp HHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred HHHHh----hcCCcchhhhHHHHHHHHHHHHHhccCc-----EEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 55543 3567999999999999999999999987 999999999999999999999999999876543 23
Q ss_pred cccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhh-hcccccccHH----------
Q 042949 461 CLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVRE-EWTGEVFDKE---------- 524 (608)
Q Consensus 461 ~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~---------- 524 (608)
...+++.|+||| ..++.++||||+||++|||++|+.||.+....... ..+... ........+.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL-MRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH-HHHHHhhCCCChhhccchhhhhhcccc
Confidence 456889999999 45789999999999999999999999765433222 222111 0000000000
Q ss_pred --------HHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 525 --------VAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 525 --------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
........+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112334567899999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=358.44 Aligned_cols=228 Identities=15% Similarity=0.233 Sum_probs=188.3
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEeccccc-------CHHHHHHHHHHHhcCC--CCcceeeeeeeecCCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQV-------SMDEFSQTMRQIGNLK--HPNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e 376 (608)
+.||+|+||+||+|+.. +|+.||||+++.... ...++.+|+.++++++ |||||++++++.+.+..++|||
T Consensus 10 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e 89 (273)
T d1xwsa_ 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 89 (273)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEE
Confidence 57899999999999874 789999999974321 1234678999999986 8999999999999999999999
Q ss_pred eccC-CCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCC-CCceEeccccccc
Q 042949 377 YQSN-GSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNEN-EDPLISECGYSKF 454 (608)
Q Consensus 377 ~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~ 454 (608)
|+.+ +++.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 90 ~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~-----iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 90 RPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG-----VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp CCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccccCcccceEEecCCCeEEECcccccee
Confidence 9975 688888875 457999999999999999999999987 9999999999999854 7899999999987
Q ss_pred cCCCC-ccccccCccccCC----C-CCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccccccHHHHHh
Q 042949 455 LDPKK-TCLFSSNGYTAPE----K-TVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGEVFDKEVAKA 528 (608)
Q Consensus 455 ~~~~~-~~~~gt~~y~aPE----~-~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (608)
..... ....||+.|+||| . .++.++||||+||++|||+||+.||.... ....... ..
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~----------~~ 223 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV----------FF 223 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC----------CC
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhccc----------CC
Confidence 65443 4567999999999 3 34678999999999999999999986421 1111110 01
Q ss_pred chhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 529 GRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 529 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
....+.++.+|+.+||+.||++|||++|+++.
T Consensus 224 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 224 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 22355678999999999999999999999763
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=358.02 Aligned_cols=248 Identities=22% Similarity=0.245 Sum_probs=191.7
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecCC------eeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTNE------EKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~e 376 (608)
+.||+|+||+||+|... +|+.||||+++....+ .+.+.+|+++|++++|||||+++++|...+ ..++|||
T Consensus 24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 103 (346)
T d1cm8a_ 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 103 (346)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEe
Confidence 46899999999999874 6999999999754333 456889999999999999999999987654 5699999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+ +++|..+++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++...
T Consensus 104 ~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~-----IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 104 FM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG-----IIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC-----CcccccCcchhhcccccccccccccceeccC
Confidence 99 6688887753 56999999999999999999999987 9999999999999999999999999999888
Q ss_pred CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcc--------------
Q 042949 457 PKKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWT-------------- 517 (608)
Q Consensus 457 ~~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------- 517 (608)
.......||+.|+||| ..++.++||||+||++|||++|+.||...................
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 7777888999999999 356899999999999999999999997654332221111100000
Q ss_pred ------cccccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhh
Q 042949 518 ------GEVFDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVV 565 (608)
Q Consensus 518 ------~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~ 565 (608)
.+.............+..+.+|+.+||..||++|||+.|+++. ++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000011112345678899999999999999999999986 55554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=357.69 Aligned_cols=250 Identities=18% Similarity=0.225 Sum_probs=191.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceeeeeeeec------CCeeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPLVCYNST------NEEKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~~lv~e~~~ 379 (608)
++||+|+||+||+|+.. +|+.||||+++.... ...+|+++|++++|||||++++++.. ..+.++|||||+
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~ 102 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 102 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCS
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccC
Confidence 46999999999999975 689999999975332 23479999999999999999998853 335789999997
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-CceEeccccccccCCC
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-DPLISECGYSKFLDPK 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 458 (608)
+| +.+.+.........+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 103 ~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~-----IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 103 ET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred Cc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 65 55555444445678999999999999999999999887 99999999999999775 8999999999876543
Q ss_pred --CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh--------------cc
Q 042949 459 --KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE--------------WT 517 (608)
Q Consensus 459 --~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------------~~ 517 (608)
.....||..|+||| ..++.++||||+||++|||++|+.||......... ..+.... ..
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l-~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL-VEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHHHCC---
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH-HHHHHHhCCChHHhhhhhccchh
Confidence 34467899999999 45799999999999999999999999765432222 1111100 00
Q ss_pred ccccc-----HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHhhc
Q 042949 518 GEVFD-----KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IEEVVN 566 (608)
Q Consensus 518 ~~~~~-----~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~ 566 (608)
...+. +.........+..+.+|+.+||+.||++|||+.|+++. ++++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00000 00001112345678999999999999999999999874 666544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=353.10 Aligned_cols=245 Identities=19% Similarity=0.265 Sum_probs=186.7
Q ss_pred cccCCCCCceEEEEEEc-C-CcEEEEEEecccc---cCHHHHHHHHHHHhcC---CCCcceeeeeeeec-----CCeeEE
Q 042949 307 DLRSQTICSSLFMVRLK-N-SAVYAVKRLKKLQ---VSMDEFSQTMRQIGNL---KHPNILPLVCYNST-----NEEKLL 373 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~-g~~vavK~l~~~~---~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~~~~l 373 (608)
+.||+|+||+||+|+.. + ++.||||+++... .....+.+|+.+++.+ +|||||+++++|.. ....++
T Consensus 13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~ 92 (305)
T d1blxa_ 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92 (305)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence 45899999999999873 4 5789999986322 2233466777776655 89999999998853 346799
Q ss_pred EEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 374 VYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 374 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
+|||+.+|++..... .....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~-----ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 93 VFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 999998876654433 34567999999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh-------ccccc
Q 042949 454 FLDPK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE-------WTGEV 520 (608)
Q Consensus 454 ~~~~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~ 520 (608)
..... .....||+.|+||| ..++.++||||+||++|||+||+.||........ ...+.... +....
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGGSCTTC
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCchhcccccc
Confidence 76543 24567999999999 6789999999999999999999999976543322 22222110 00000
Q ss_pred ----------ccHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 521 ----------FDKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 521 ----------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000111123456678999999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=351.86 Aligned_cols=244 Identities=18% Similarity=0.217 Sum_probs=186.6
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc--cCHHHHHHHHHHHhcCCCCcceeeeeeeecCC----eeEEEEeecc
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ--VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNE----EKLLVYKYQS 379 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~e~~~ 379 (608)
..||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.... ..+++++|+.
T Consensus 14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~ 93 (345)
T d1pmea_ 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 93 (345)
T ss_dssp EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeec
Confidence 5689999999999986 589999999997433 23457889999999999999999999987543 2345556777
Q ss_pred CCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCC-
Q 042949 380 NGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 380 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 458 (608)
+|+|.+++.. ..+++..++.++.|+++||+|||+++ ||||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~-----iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 94 GADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred CCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 9999999974 46999999999999999999999987 999999999999999999999999999876432
Q ss_pred -----CccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc-----cccc-
Q 042949 459 -----KTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG-----EVFD- 522 (608)
Q Consensus 459 -----~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~- 522 (608)
.....||+.|+||| ..++.++||||+||++|||++|+.||.................... ....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 23456899999999 4568899999999999999999999976543222211111000000 0000
Q ss_pred --------------HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 --------------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 --------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011122344568999999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=342.34 Aligned_cols=245 Identities=18% Similarity=0.215 Sum_probs=198.3
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHhcCCCCcceeeeeeeecCCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQ---VSMDEFSQTMRQIGNLKHPNILPLVCYNSTNEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 382 (608)
+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++|||||++++++.+.+..++|+||+.+++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 4689999999999997 478999999997432 235678999999999999999999999999999999999999998
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCCCC---
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDPKK--- 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 459 (608)
|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 88 l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~-----IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 88 KKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred ccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC-----EeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 8887753 567899999999999999999999987 9999999999999999999999999999775433
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhcccc--ccc----------
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTGE--VFD---------- 522 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~---------- 522 (608)
....++..|+||| ..++.++||||+||++|||++|+.||..+.+.......+........ ...
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 2345677888998 34689999999999999999999998777776665554433211100 000
Q ss_pred -------HHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 523 -------KEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 523 -------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
..........+..+.+|+.+||+.||.+|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011123345678899999999999999999998763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-41 Score=343.91 Aligned_cols=244 Identities=18% Similarity=0.182 Sum_probs=185.1
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEeccc---ccCHHHHHHHHHHHhcCCCCcceeeeeeeec--------CCeeEEE
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKL---QVSMDEFSQTMRQIGNLKHPNILPLVCYNST--------NEEKLLV 374 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~~~~~lv 374 (608)
+.||+|+||+||+|+. .+|+.||||++... ....+++.+|+++|++++||||+++++++.. .+..++|
T Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv 95 (318)
T d3blha1 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 95 (318)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEE
Confidence 4589999999999997 47999999998633 2345678899999999999999999998755 3467999
Q ss_pred EeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccc
Q 042949 375 YKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKF 454 (608)
Q Consensus 375 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 454 (608)
|||+.++.+..+. .....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~-----ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 96 FDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp EECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCC-----EEecCcCchheeecCCCcEEeeecceeee
Confidence 9999877655433 23567899999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCC-------ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc--ccc-
Q 042949 455 LDPKK-------TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW--TGE- 519 (608)
Q Consensus 455 ~~~~~-------~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~- 519 (608)
+.... ....||+.|+||| ..++.++||||+||++|||++|+.||....+... ...+..... ..+
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH-HHHHHHhcCCCChhh
Confidence 65321 3356899999999 3578999999999999999999999875443222 221111100 000
Q ss_pred ---ccc----HH----------HH--HhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 520 ---VFD----KE----------VA--KAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 520 ---~~~----~~----------~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
... .. .. .........+.+|+.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 00 00 0011234457899999999999999999999854
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-40 Score=333.69 Aligned_cols=247 Identities=15% Similarity=0.123 Sum_probs=198.1
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHhcCCC-CcceeeeeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKH-PNILPLVCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|++++.+++| +|++.+++++......++||||+ +|+|.
T Consensus 11 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~ 88 (293)
T d1csna_ 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE 88 (293)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHH
Confidence 56899999999999975 78999999886432 33457789999999975 89999999999999999999999 78999
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCC-----CCCceEeccccccccCCC-
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNE-----NEDPLISECGYSKFLDPK- 458 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~~~- 458 (608)
+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.....
T Consensus 89 ~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g-----iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 89 DLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS-----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp HHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC-----ceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 98875 2456999999999999999999999987 999999999999975 567999999999876432
Q ss_pred ---------CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCC--hHHHHHHHHhhhcccccccH
Q 042949 459 ---------KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGID--LPKWVKAMVREEWTGEVFDK 523 (608)
Q Consensus 459 ---------~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 523 (608)
.....||+.||||| ..++.++|||||||++|||+||+.||..... ...............
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~----- 235 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST----- 235 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-----
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-----
Confidence 13457999999999 5689999999999999999999999975432 222222221111100
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhcCC
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVNGN 568 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 568 (608)
.........+.++.+++..|+..+|++||+++.+.+.|+++++..
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 011122345667899999999999999999999999999987643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-40 Score=335.75 Aligned_cols=245 Identities=14% Similarity=0.151 Sum_probs=189.8
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcceee-eeeeecCCeeEEEEeeccCCCHH
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNILPL-VCYNSTNEEKLLVYKYQSNGSLL 384 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~niv~l-~~~~~~~~~~~lv~e~~~~g~L~ 384 (608)
+.||+|+||+||+|+. .+|+.||||++.... ..+++.+|++++++++|+|+|.. .+++...+..++||||+ +|++.
T Consensus 13 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~ 90 (299)
T d1ckia_ 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE 90 (299)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchh
Confidence 5689999999999987 468999999987532 23457899999999987776655 45556778889999999 56777
Q ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecC---CCCCceEeccccccccCCCC--
Q 042949 385 SLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLN---ENEDPLISECGYSKFLDPKK-- 459 (608)
Q Consensus 385 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~~-- 459 (608)
+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+....
T Consensus 91 ~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 91 DLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp HHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred hhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 76654 3567999999999999999999999987 99999999999875 45679999999999764322
Q ss_pred --------ccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHH--HHHHHhhhcccccccHHH
Q 042949 460 --------TCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKW--VKAMVREEWTGEVFDKEV 525 (608)
Q Consensus 460 --------~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 525 (608)
....||+.||||| ..++.++|||||||++|||+||+.||......... .......... ...
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-----~~~ 237 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-----TPI 237 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-----SCH
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-----CCh
Confidence 3457999999999 46899999999999999999999998654322111 1111110000 001
Q ss_pred HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHhhc
Q 042949 526 AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLERIEEVVN 566 (608)
Q Consensus 526 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 566 (608)
......++.++.+++.+||+.+|++||++.++.+.|+.+..
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 11233566779999999999999999999999999998864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=344.82 Aligned_cols=234 Identities=21% Similarity=0.289 Sum_probs=190.1
Q ss_pred cccCCCCCceEEEEEEc----CCcEEEEEEeccc-----ccCHHHHHHHHHHHhcCCC-CcceeeeeeeecCCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK----NSAVYAVKRLKKL-----QVSMDEFSQTMRQIGNLKH-PNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~----~g~~vavK~l~~~-----~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e 376 (608)
+.||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++| |||+++++++.+....+++||
T Consensus 30 ~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e 109 (322)
T d1vzoa_ 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILD 109 (322)
T ss_dssp EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeee
Confidence 56899999999999862 5789999998632 2345678899999999976 899999999999999999999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 110 ~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~-----ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 110 YINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred cccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC-----EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999976 356788999999999999999999987 9999999999999999999999999998765
Q ss_pred CCC----ccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh--HHH-HHHHHhhhcccccccH
Q 042949 457 PKK----TCLFSSNGYTAPE------KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL--PKW-VKAMVREEWTGEVFDK 523 (608)
Q Consensus 457 ~~~----~~~~gt~~y~aPE------~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~--~~~-~~~~~~~~~~~~~~~~ 523 (608)
... ....|++.|+||| ..++.++||||+||+||||+||+.||...... ... .+...... .
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--~----- 253 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--P----- 253 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--C-----
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--C-----
Confidence 432 3456889999999 24678999999999999999999999654321 111 11111110 0
Q ss_pred HHHHhchhcHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 042949 524 EVAKAGRQWAFPLLNVALKCVSNSPDDRPT-----MAEVLE 559 (608)
Q Consensus 524 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 559 (608)
..+...+..+.+++.+||+.||++||| ++|+++
T Consensus 254 ---~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 112345677899999999999999994 788875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=346.11 Aligned_cols=243 Identities=21% Similarity=0.222 Sum_probs=189.7
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeecC-----CeeEEEEee
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNSTN-----EEKLLVYKY 377 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~ 377 (608)
+.||+|+||+||+|+. .+|+.||||+++....+ .+.+.+|+++|++++|||||++++++... ...+++++|
T Consensus 24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~ 103 (348)
T d2gfsa1 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 103 (348)
T ss_dssp EECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEe
Confidence 4689999999999986 57999999999854333 34688999999999999999999998643 334667788
Q ss_pred ccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccCC
Q 042949 378 QSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLDP 457 (608)
Q Consensus 378 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 457 (608)
+.+|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.....
T Consensus 104 ~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~g-----iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 104 LMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred ecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCC-----CcccccCCccccccccccccccccchhcccCc
Confidence 88999999885 356999999999999999999999987 99999999999999999999999999988776
Q ss_pred CCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhccc------ccc-----
Q 042949 458 KKTCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEWTG------EVF----- 521 (608)
Q Consensus 458 ~~~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~----- 521 (608)
......||..|+||| ..++.++||||+||++|||++|+.||......... ..+....... ...
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCChHHhhhccchhhh
Confidence 667778999999999 34688999999999999999999999765432222 2221111000 000
Q ss_pred ----------cHHHHHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 522 ----------DKEVAKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 522 ----------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
...........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000111122355678999999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-40 Score=340.14 Aligned_cols=239 Identities=19% Similarity=0.204 Sum_probs=188.6
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCC-CCcceeeeeeeec--CCeeEEEEeeccCCC
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNST--NEEKLLVYKYQSNGS 382 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lv~e~~~~g~ 382 (608)
+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++||||+.+|+
T Consensus 41 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~ 118 (328)
T d3bqca1 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 118 (328)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCB
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCc
Confidence 5689999999999987 57899999999743 4678899999999995 9999999999874 456899999999999
Q ss_pred HHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCC-CceEeccccccccCCC--C
Q 042949 383 LLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENE-DPLISECGYSKFLDPK--K 459 (608)
Q Consensus 383 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~--~ 459 (608)
|..+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 119 L~~~-------~~~l~e~~i~~i~~qil~aL~~LH~~g-----IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 119 FKQL-------YQTLTDYDIRFYMYEILKALDYCHSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp GGGT-------TTSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred HHHH-------hcCCCHHHHHHHHHHHHHHHHHHhhcc-----cccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 8654 246999999999999999999999987 99999999999998765 5899999999877643 3
Q ss_pred ccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhh----------cccccccHH
Q 042949 460 TCLFSSNGYTAPE-----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREE----------WTGEVFDKE 524 (608)
Q Consensus 460 ~~~~gt~~y~aPE-----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~~~ 524 (608)
....+|+.|+||| ..++.++||||+||++|||++|+.||....+.......+.... .........
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 4567899999999 3478999999999999999999999876654332211111100 000000000
Q ss_pred H-----------------HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 042949 525 V-----------------AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLE 559 (608)
Q Consensus 525 ~-----------------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 559 (608)
. .......+.++.+|+.+||..||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011234567899999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=336.54 Aligned_cols=241 Identities=16% Similarity=0.178 Sum_probs=178.4
Q ss_pred cccCCCCCceEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHhcCCCCcceeeeeeeec------CCeeEEEEe
Q 042949 307 DLRSQTICSSLFMVRLK-NSAVYAVKRLKKLQVS---MDEFSQTMRQIGNLKHPNILPLVCYNST------NEEKLLVYK 376 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~~lv~e 376 (608)
+.||+|+||+||+|+.. +|+.||||+++....+ ..++.+|+.++++++|||||++++++.. ....|+|||
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E 102 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence 46899999999999875 6999999999754333 3468899999999999999999999864 367899999
Q ss_pred eccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceEeccccccccC
Q 042949 377 YQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLISECGYSKFLD 456 (608)
Q Consensus 377 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 456 (608)
|+.++ +.+.+ ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++...
T Consensus 103 y~~~~-l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~g-----iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 103 LMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCSEE-HHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred ccchH-HHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcc-----cccccCCccccccccccceeeechhhhhccc
Confidence 99654 54444 246899999999999999999999987 9999999999999999999999999988765
Q ss_pred CC--CccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCChHHHHHHHHhhhc--------------
Q 042949 457 PK--KTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDLPKWVKAMVREEW-------------- 516 (608)
Q Consensus 457 ~~--~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-------------- 516 (608)
.. .....+|+.|+||| ..++.++||||+||+++||++|+.||......... ..+.....
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHTTSCHHH
T ss_pred cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH-HHHHHhccCCCHHHHHHhhhhH
Confidence 43 24457899999999 56889999999999999999999998754332221 11111000
Q ss_pred ---------ccccccHHH---------HHhchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 042949 517 ---------TGEVFDKEV---------AKAGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER 560 (608)
Q Consensus 517 ---------~~~~~~~~~---------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 560 (608)
......+.. .......+.++.+|+.+||..||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 00112245568999999999999999999999866
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-35 Score=306.89 Aligned_cols=252 Identities=16% Similarity=0.234 Sum_probs=184.8
Q ss_pred cccCCCCCceEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHhcCC-----------CCcceeeeeeeec--CCeeE
Q 042949 307 DLRSQTICSSLFMVRL-KNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLK-----------HPNILPLVCYNST--NEEKL 372 (608)
Q Consensus 307 ~~~g~g~~g~vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~--~~~~~ 372 (608)
..||+|+||+||+|+. .+|+.||||+++......+.+.+|++++++++ |+|||++++++.. ....+
T Consensus 19 ~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 98 (362)
T d1q8ya_ 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH 98 (362)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccccee
Confidence 5689999999999997 57999999999865555567888998888775 5789999988754 45667
Q ss_pred EEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCceecCCCCCCeecCCCCC------ce
Q 042949 373 LVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQ-KSNEEKTIPHGNLKLSNILLNENED------PL 445 (608)
Q Consensus 373 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~ivHrDlkp~NILl~~~~~------~k 445 (608)
++++++..+........ ......+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++. ++
T Consensus 99 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~-----IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 99 VVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG-----IIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp EEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred eeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhcC-----cccccCChhHeeeeccCcccccceee
Confidence 77777665544333322 2345678999999999999999999997 44 999999999999987654 89
Q ss_pred EeccccccccCCCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCcCCCCh-----HHHHHHHHhh--
Q 042949 446 ISECGYSKFLDPKKTCLFSSNGYTAPE----KTVSEQGDVFSFGVILLELLTGKTVEKTGIDL-----PKWVKAMVRE-- 514 (608)
Q Consensus 446 l~DFGla~~~~~~~~~~~gt~~y~aPE----~~~~~ksDVwSfGvvl~elltg~~p~~~~~~~-----~~~~~~~~~~-- 514 (608)
++|||.+...........||+.|+||| ..++.++||||+||+++||++|+.||...... ..........
T Consensus 173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg 252 (362)
T d1q8ya_ 173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252 (362)
T ss_dssp ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence 999999987776667778999999999 66889999999999999999999998643211 1111110000
Q ss_pred ----------h-----c--------cccc----ccHHHHH---hchhcHHHHHHHHHHchhcCCCCCCCHHHHHHH--HH
Q 042949 515 ----------E-----W--------TGEV----FDKEVAK---AGRQWAFPLLNVALKCVSNSPDDRPTMAEVLER--IE 562 (608)
Q Consensus 515 ----------~-----~--------~~~~----~~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~ 562 (608)
. . .... ....... .....+..+.+|+.+||+.||.+|||++|+++. ++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332 (362)
T ss_dssp SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccC
Confidence 0 0 0000 0000000 112345678999999999999999999999875 54
Q ss_pred Hh
Q 042949 563 EV 564 (608)
Q Consensus 563 ~~ 564 (608)
+.
T Consensus 333 ~~ 334 (362)
T d1q8ya_ 333 DT 334 (362)
T ss_dssp TC
T ss_pred CC
Confidence 44
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=1.7e-22 Score=189.61 Aligned_cols=160 Identities=15% Similarity=0.121 Sum_probs=117.0
Q ss_pred hcccCCCCCceEEEEEEcCCcEEEEEEeccccc-------------------CHHHHHHHHHHHhcCCCCcceeeeeeee
Q 042949 306 ADLRSQTICSSLFMVRLKNSAVYAVKRLKKLQV-------------------SMDEFSQTMRQIGNLKHPNILPLVCYNS 366 (608)
Q Consensus 306 ~~~~g~g~~g~vy~~~~~~g~~vavK~l~~~~~-------------------~~~~~~~e~~~l~~l~H~niv~l~~~~~ 366 (608)
++.||+|+||+||+|+..+|+.||||+++.... ......+|...+.++.|.+++..+++..
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~ 84 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG 84 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC
Confidence 567999999999999999999999998752110 0123456888899999999998876642
Q ss_pred cCCeeEEEEeeccCCCHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCceecCCCCCCeecCCCCCceE
Q 042949 367 TNEEKLLVYKYQSNGSLLSLLEAYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSNEEKTIPHGNLKLSNILLNENEDPLI 446 (608)
Q Consensus 367 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~ivHrDlkp~NILl~~~~~~kl 446 (608)
.+++|||++++.+. .++......++.|++++|+|||+++ |+||||||+|||++++ .++|
T Consensus 85 ----~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~g-----iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 85 ----NAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHRG-----IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp ----TEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEEETT-EEEE
T ss_pred ----CEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhCC-----EEEccCChhheeeeCC-CEEE
Confidence 37999999876532 2444556789999999999999987 9999999999999865 5899
Q ss_pred eccccccccCCCCccc-cc-----cCccccCCCCCCcchhHHHHHHHH
Q 042949 447 SECGYSKFLDPKKTCL-FS-----SNGYTAPEKTVSEQGDVFSFGVIL 488 (608)
Q Consensus 447 ~DFGla~~~~~~~~~~-~g-----t~~y~aPE~~~~~ksDVwSfGvvl 488 (608)
+|||.|.......... .. ...|. .+.++.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILERDVRNIITYF--SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHHHHHHHHHHH--HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHHHHHHHHHHH--cCCCCCcccHHHHHHHH
Confidence 9999998765332110 00 00010 03467788999975433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.81 E-value=3.1e-20 Score=187.89 Aligned_cols=138 Identities=25% Similarity=0.449 Sum_probs=122.1
Q ss_pred cChHHHHHHhHhcCCCccccccCCCCCCCCCCCCCCCCeeecCC--CCcEEEEEecCCCcee--ecChhhhcCCcCCcEE
Q 042949 31 LSESESFFKFISAVDSQNVLRIGWNGNLPHPCSYNLKGIKCNLH--ATNIVGIRLENMNLSG--IIDAETLCKLRHLRVV 106 (608)
Q Consensus 31 ~~~~~~l~~~~~~~~~~~~~~~~W~~~~~~~c~~~w~gv~c~~~--~~~v~~l~l~~~~l~g--~~~~~~l~~l~~L~~L 106 (608)
.+|++||++||+++..+..+ .+|..+ .+||...|.||+|+.. ..+|+.|+|++++++| .|| ..+++|++|++|
T Consensus 5 ~~e~~aLl~~k~~~~~~~~l-~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp-~~l~~L~~L~~L 81 (313)
T d1ogqa_ 5 PQDKQALLQIKKDLGNPTTL-SSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP-SSLANLPYLNFL 81 (313)
T ss_dssp HHHHHHHHHHHHHTTCCGGG-TTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECC-GGGGGCTTCSEE
T ss_pred HHHHHHHHHHHHHCCCCCcC-CCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCC-hHHhcCcccccc
Confidence 47899999999999555554 589754 5899756999999853 3489999999999998 466 579999999999
Q ss_pred Eccc-CcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHHH
Q 042949 107 SLAR-NLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFRQ 171 (608)
Q Consensus 107 ~l~~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~~ 171 (608)
+|++ |+++|.+|..|++|++|++|+|++|+|.|..|..+..+..|++++++.|.+.+.+|..+..
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~ 147 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhcc
Confidence 9996 8999999999999999999999999999999988999999999999999999999988764
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.32 E-value=8.6e-13 Score=122.54 Aligned_cols=111 Identities=22% Similarity=0.358 Sum_probs=97.0
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
..|.+.|.-|.|+.. ...++.|+|++|.+++.++...+.++++|+.|+|++|.+.+..+..+..+++|+.|
T Consensus 4 ~~C~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L 83 (192)
T d1w8aa_ 4 AMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCEEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccccee
Confidence 346556788889642 24789999999999988877778999999999999999999999999999999999
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCChhHH
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPDNFR 170 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~~~~ 170 (608)
+|++|+|++..|..|.++++|++|+|++|+|++..|..|.
T Consensus 84 ~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~ 123 (192)
T d1w8aa_ 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE 123 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSST
T ss_pred eeccccccccCHHHHhCCCcccccccCCccccccCHHHhc
Confidence 9999999977677899999999999999999988887664
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.02 E-value=1.1e-10 Score=116.54 Aligned_cols=96 Identities=25% Similarity=0.428 Sum_probs=90.1
Q ss_pred CCcEEEEEecC-CCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCE
Q 042949 75 ATNIVGIRLEN-MNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKT 153 (608)
Q Consensus 75 ~~~v~~l~l~~-~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~ 153 (608)
...++.|+|++ |+++|.|| ..+++|++|++|+|++|.+.|..|..+..+..|+.++++.|++.+.+|..+..++.|+.
T Consensus 75 L~~L~~L~Ls~~N~l~g~iP-~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~ 153 (313)
T d1ogqa_ 75 LPYLNFLYIGGINNLVGPIP-PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp CTTCSEEEEEEETTEESCCC-GGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred Cccccccccccccccccccc-cccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccce
Confidence 35799999997 89999998 47999999999999999999999999999999999999999999999999999999999
Q ss_pred EeCcCCcCCccCChhHHH
Q 042949 154 LDISNNHFAATSPDNFRQ 171 (608)
Q Consensus 154 L~ls~N~l~g~~p~~~~~ 171 (608)
+++++|.++|.+|..+..
T Consensus 154 l~l~~n~l~~~ip~~~~~ 171 (313)
T d1ogqa_ 154 ITFDGNRISGAIPDSYGS 171 (313)
T ss_dssp EECCSSCCEEECCGGGGC
T ss_pred eecccccccccccccccc
Confidence 999999999999987753
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.97 E-value=9.5e-10 Score=97.83 Aligned_cols=96 Identities=25% Similarity=0.348 Sum_probs=78.1
Q ss_pred CCCCeeecC-----------CCCcEEEEEecCCC-ceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeec
Q 042949 65 NLKGIKCNL-----------HATNIVGIRLENMN-LSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNL 132 (608)
Q Consensus 65 ~w~gv~c~~-----------~~~~v~~l~l~~~~-l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~L 132 (608)
.+.+|+|.. ...+++.|++++|+ ++ .|++..+.++++|+.|+|++|.|+...|..|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCccCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 356788853 12478999998776 55 466677999999999999999999777788999999999999
Q ss_pred cCeeccccCChhhcCCCCCCEEeCcCCcCC
Q 042949 133 SSNLLSGAVPLALTKLKHLKTLDISNNHFA 162 (608)
Q Consensus 133 s~N~l~g~lP~~l~~l~~L~~L~ls~N~l~ 162 (608)
++|+|+ .+|........|+.|+|++|.|.
T Consensus 88 s~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 88 SFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cCCCCc-ccChhhhccccccccccCCCccc
Confidence 999999 67765545557999999999885
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.92 E-value=6.9e-10 Score=102.40 Aligned_cols=92 Identities=23% Similarity=0.332 Sum_probs=83.4
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|++.+..+ ..+..++.|+.|+|++|.|.+..|..|.++++|++|+|++|+|++..|..|..+++|++|
T Consensus 53 l~~L~~L~L~~N~i~~~~~-~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l 131 (192)
T d1w8aa_ 53 LPHLVKLELKRNQLTGIEP-NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp CTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred CceEeeeeccccccccccc-cccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccc
Confidence 4589999999999998765 679999999999999999998888889999999999999999998777789999999999
Q ss_pred eCcCCcCCccCCh
Q 042949 155 DISNNHFAATSPD 167 (608)
Q Consensus 155 ~ls~N~l~g~~p~ 167 (608)
+|++|.+.+..+.
T Consensus 132 ~L~~N~~~~~~~~ 144 (192)
T d1w8aa_ 132 NLASNPFNCNCHL 144 (192)
T ss_dssp ECTTCCBCCSGGG
T ss_pred cccccccccccch
Confidence 9999999876553
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.88 E-value=1.3e-09 Score=92.88 Aligned_cols=82 Identities=23% Similarity=0.332 Sum_probs=39.3
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccC-ChhhcCCCCCCEEe
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAV-PLALTKLKHLKTLD 155 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~l-P~~l~~l~~L~~L~ 155 (608)
.++.|+|++|.++. +| +.++.+++|+.|++++|.|++ +| .+..+++|+.|++++|+++..- +..+..+++|++|+
T Consensus 21 ~L~~L~ls~N~l~~-lp-~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~ 96 (124)
T d1dcea3 21 LVTHLDLSHNRLRA-LP-PALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 96 (124)
T ss_dssp TCCEEECCSSCCCC-CC-GGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred CCCEEECCCCccCc-ch-hhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEE
Confidence 45555555555542 33 234555555555555555552 23 2455555555555555554211 12344555555555
Q ss_pred CcCCcCC
Q 042949 156 ISNNHFA 162 (608)
Q Consensus 156 ls~N~l~ 162 (608)
+++|.++
T Consensus 97 l~~N~i~ 103 (124)
T d1dcea3 97 LQGNSLC 103 (124)
T ss_dssp CTTSGGG
T ss_pred CCCCcCC
Confidence 5555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.83 E-value=3.3e-09 Score=90.32 Aligned_cols=80 Identities=24% Similarity=0.361 Sum_probs=71.0
Q ss_pred EEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcCC
Q 042949 80 GIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNN 159 (608)
Q Consensus 80 ~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N 159 (608)
.|+|++|+++. ++ .+..++.|++|++++|.|+ .+|+.++.+++|+.|++++|++++ +| .+..+++|+.|++++|
T Consensus 2 ~L~Ls~n~l~~-l~--~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLTV-LC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCSS-CC--CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCCC-Cc--ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 58999999983 44 4899999999999999998 688889999999999999999994 55 5899999999999999
Q ss_pred cCCccC
Q 042949 160 HFAATS 165 (608)
Q Consensus 160 ~l~g~~ 165 (608)
.++...
T Consensus 76 ~i~~~~ 81 (124)
T d1dcea3 76 RLQQSA 81 (124)
T ss_dssp CCCSSS
T ss_pred ccCCCC
Confidence 998543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.65 E-value=1.6e-08 Score=98.96 Aligned_cols=92 Identities=22% Similarity=0.245 Sum_probs=44.0
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
.+..+++++|++++. ++..+..++.|+.|++++|.+++..|..+..+++|+.+++++|++++..|..|..+++|+.||+
T Consensus 130 ~L~~l~l~~N~l~~i-~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 130 ALQYLYLQDNALQAL-PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp TCCEEECCSSCCCCC-CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccchhhhcccccccc-ChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence 344445555544432 2233444445555555555554444444445555555555555555444444555555555555
Q ss_pred cCCcCCccCChhH
Q 042949 157 SNNHFAATSPDNF 169 (608)
Q Consensus 157 s~N~l~g~~p~~~ 169 (608)
++|.+++..|..|
T Consensus 209 ~~N~i~~~~~~~~ 221 (284)
T d1ozna_ 209 FANNLSALPTEAL 221 (284)
T ss_dssp CSSCCSCCCHHHH
T ss_pred ccccccccccccc
Confidence 5555544444333
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=1.9e-08 Score=98.35 Aligned_cols=91 Identities=23% Similarity=0.282 Sum_probs=83.2
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|++++..+ ..+.++++|+.+++++|.+++..|..|..+++|++||+++|.+++..|..|..+++|+.|
T Consensus 152 ~~~L~~L~l~~N~l~~l~~-~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L 230 (284)
T d1ozna_ 152 LGNLTHLFLHGNRISSVPE-RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230 (284)
T ss_dssp CTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred ccchhhcccccCcccccch-hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEE
Confidence 3578999999999987654 678999999999999999999999999999999999999999998888889999999999
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
+|++|.+.+.-+
T Consensus 231 ~l~~N~l~C~C~ 242 (284)
T d1ozna_ 231 RLNDNPWVCDCR 242 (284)
T ss_dssp ECCSSCEECSGG
T ss_pred EecCCCCCCCcc
Confidence 999999987654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=3e-08 Score=88.41 Aligned_cols=82 Identities=18% Similarity=0.216 Sum_probs=44.4
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
++..|+|++|+++.. + .....+++|+.|+|++|.++ .++ .+..+++|+.|+|++|+++...+..+..+++|+.|++
T Consensus 19 ~lr~L~L~~n~I~~i-~-~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 19 RDRELDLRGYKIPVI-E-NLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp SCEEEECTTSCCCSC-C-CGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred cCcEEECCCCCCCcc-C-ccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 455566666665542 2 22345566666666666665 332 3555666666666666665322223345566666666
Q ss_pred cCCcCC
Q 042949 157 SNNHFA 162 (608)
Q Consensus 157 s~N~l~ 162 (608)
++|+++
T Consensus 95 ~~N~i~ 100 (162)
T d1a9na_ 95 TNNSLV 100 (162)
T ss_dssp CSCCCC
T ss_pred cccccc
Confidence 666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=4.6e-08 Score=87.16 Aligned_cols=85 Identities=24% Similarity=0.182 Sum_probs=69.9
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCC--hhhcCCCCCCE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVP--LALTKLKHLKT 153 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP--~~l~~l~~L~~ 153 (608)
..++.|+|++|.++. ++ .+..+++|+.|++++|.++...+..+..+++|+.|+|++|+++ .++ ..+..+++|++
T Consensus 41 ~~L~~L~Ls~N~i~~-l~--~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~ 116 (162)
T d1a9na_ 41 DQFDAIDFSDNEIRK-LD--GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY 116 (162)
T ss_dssp TCCSEEECCSSCCCE-EC--CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred ccCCEEECCCCCCCc-cC--CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccch
Confidence 479999999999884 44 4888999999999999998655555678999999999999997 344 36788999999
Q ss_pred EeCcCCcCCcc
Q 042949 154 LDISNNHFAAT 164 (608)
Q Consensus 154 L~ls~N~l~g~ 164 (608)
|++++|.++..
T Consensus 117 L~l~~N~i~~~ 127 (162)
T d1a9na_ 117 LCILRNPVTNK 127 (162)
T ss_dssp EECCSSGGGGS
T ss_pred hhcCCCccccc
Confidence 99999988643
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=6.4e-08 Score=93.63 Aligned_cols=92 Identities=23% Similarity=0.254 Sum_probs=50.1
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.++..|+++++.+.+..+ ..+..+.+|+.|++++|.+.+..+..+..++.|+.|++++|+|++..|..+..+++|+.||
T Consensus 100 ~~L~~L~l~~~~~~~~~~-~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~ 178 (266)
T d1p9ag_ 100 PALTVLDVSFNRLTSLPL-GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (266)
T ss_dssp TTCCEEECCSSCCCCCCS-STTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccccccccccccceeec-cccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceee
Confidence 345566666655554332 3445555556666666655544444445555566666666666544444555555666666
Q ss_pred CcCCcCCccCChhH
Q 042949 156 ISNNHFAATSPDNF 169 (608)
Q Consensus 156 ls~N~l~g~~p~~~ 169 (608)
|++|+|+ .+|.++
T Consensus 179 Ls~N~L~-~lp~~~ 191 (266)
T d1p9ag_ 179 LQENSLY-TIPKGF 191 (266)
T ss_dssp CCSSCCC-CCCTTT
T ss_pred cccCCCc-ccChhH
Confidence 6666555 455443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.53 E-value=6.3e-08 Score=95.49 Aligned_cols=86 Identities=24% Similarity=0.319 Sum_probs=70.8
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|++++|..++.++ ..+.+++.+++|++++|.+.+..|..+..+++|+.|+|++|.|+ .+|.++..+++|++|+
T Consensus 171 ~~L~~L~l~~n~~~~~~~-~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 171 PSLTELHLDGNKITKVDA-ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp TTCSEEECTTSCCCEECT-GGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CccCEEECCCCcCCCCCh-hHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 467788888888887765 56888888888888888888877778888888888888888887 6788888888888888
Q ss_pred CcCCcCCc
Q 042949 156 ISNNHFAA 163 (608)
Q Consensus 156 ls~N~l~g 163 (608)
|++|+++.
T Consensus 249 Ls~N~i~~ 256 (305)
T d1xkua_ 249 LHNNNISA 256 (305)
T ss_dssp CCSSCCCC
T ss_pred CCCCccCc
Confidence 88888874
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=1.3e-07 Score=83.49 Aligned_cols=87 Identities=16% Similarity=0.085 Sum_probs=72.5
Q ss_pred EEEEecCCCceeecChhhhcCCcCCcEEEcccC-cCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCc
Q 042949 79 VGIRLENMNLSGIIDAETLCKLRHLRVVSLARN-LIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDIS 157 (608)
Q Consensus 79 ~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls 157 (608)
..++.+++++... | ..+..+++|+.|++++| .++..-+..|..+++|+.|+|++|+|+..-|..|..+++|++|+|+
T Consensus 11 ~~l~c~~~~~~~~-p-~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 11 SGLRCTRDGALDS-L-HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SCEECCSSCCCTT-T-TTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CeEEecCCCCccC-c-ccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 3478888887754 3 46888999999999866 4886666779999999999999999997667789999999999999
Q ss_pred CCcCCccCChh
Q 042949 158 NNHFAATSPDN 168 (608)
Q Consensus 158 ~N~l~g~~p~~ 168 (608)
+|+|+. +|..
T Consensus 89 ~N~l~~-l~~~ 98 (156)
T d2ifga3 89 FNALES-LSWK 98 (156)
T ss_dssp SSCCSC-CCST
T ss_pred CCCCcc-cChh
Confidence 999984 4443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=1.5e-07 Score=91.00 Aligned_cols=95 Identities=19% Similarity=0.161 Sum_probs=78.9
Q ss_pred CCCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCE
Q 042949 74 HATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKT 153 (608)
Q Consensus 74 ~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~ 153 (608)
....++.|+|++|.+++.. ..+..++.|+.|++++|.+.+..+..+..+.+|+.|++++|.+++..|..+..+++|+.
T Consensus 75 ~l~~L~~L~Ls~N~l~~~~--~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~ 152 (266)
T d1p9ag_ 75 TLPVLGTLDLSHNQLQSLP--LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152 (266)
T ss_dssp CCTTCCEEECCSSCCSSCC--CCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchh
Confidence 3457889999999988754 35788999999999999998877778888999999999999998655566788899999
Q ss_pred EeCcCCcCCccCChhHH
Q 042949 154 LDISNNHFAATSPDNFR 170 (608)
Q Consensus 154 L~ls~N~l~g~~p~~~~ 170 (608)
|++++|++++..|..|.
T Consensus 153 l~l~~N~l~~~~~~~~~ 169 (266)
T d1p9ag_ 153 LSLANNNLTELPAGLLN 169 (266)
T ss_dssp EECTTSCCSCCCTTTTT
T ss_pred cccccccccccCccccc
Confidence 99999999987776664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.38 E-value=2.6e-07 Score=90.89 Aligned_cols=103 Identities=22% Similarity=0.358 Sum_probs=66.1
Q ss_pred CCCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCccee
Q 042949 60 HPCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYL 130 (608)
Q Consensus 60 ~~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 130 (608)
..|.+.|.+|.|+.. ...++.|+|++|+++.. |+..+.++++|+.|++++|.+....|..|.+++.|+.|
T Consensus 6 ~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l-~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L 84 (305)
T d1xkua_ 6 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEI-KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 84 (305)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCB-CTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCc-ChhHhhccccccccccccccccccchhhhhCCCccCEe
Confidence 456667889999642 13466677777766643 33456677777777777777775556667777777777
Q ss_pred eccCeeccccCChhhcCCCCCCEEeCcCCcCCccCC
Q 042949 131 NLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSP 166 (608)
Q Consensus 131 ~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p 166 (608)
+|++|+++ .+|..+ ...|..|+++.|.+.+..+
T Consensus 85 ~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~ 117 (305)
T d1xkua_ 85 YLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRK 117 (305)
T ss_dssp ECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCH
T ss_pred cccCCccC-cCccch--hhhhhhhhccccchhhhhh
Confidence 77777776 455432 3456677777776665444
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.32 E-value=2.2e-07 Score=94.17 Aligned_cols=85 Identities=24% Similarity=0.377 Sum_probs=66.7
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
...+..+.+..|.+.+. ..+..++.++.|++++|++++. + .+..+++|+.|+|++|+|++ +| .+..+++|+.|
T Consensus 284 ~~~l~~l~~~~n~l~~~---~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L 356 (384)
T d2omza2 284 LTALTNLELNENQLEDI---SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWL 356 (384)
T ss_dssp CTTCSEEECCSSCCSCC---GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEE
T ss_pred ccccccccccccccccc---cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEE
Confidence 34567788888888763 2477888888899999988864 3 37888889999999998884 44 58888889999
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
++++|++++.+|
T Consensus 357 ~l~~N~l~~l~~ 368 (384)
T d2omza2 357 SAGHNQISDLTP 368 (384)
T ss_dssp ECCSSCCCBCGG
T ss_pred ECCCCcCCCChh
Confidence 999998887655
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.26 E-value=4.2e-07 Score=86.07 Aligned_cols=105 Identities=21% Similarity=0.255 Sum_probs=84.6
Q ss_pred CCCCCCCCeeecCC---------CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcc-cccCCCCccee
Q 042949 61 PCSYNLKGIKCNLH---------ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPT-SISNCRRLTYL 130 (608)
Q Consensus 61 ~c~~~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L 130 (608)
+|.+....|.|... ...++.|+|++|.++. +|+..+.++++|++|++++|.+...+|. .+..++.++.+
T Consensus 5 ~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~-l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l 83 (242)
T d1xwdc1 5 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 83 (242)
T ss_dssp SEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCE-ECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEE
T ss_pred cCCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCc-cChhHhhccchhhhhhhccccccceeeccccccccccccc
Confidence 36555667888531 1368999999999975 5556789999999999999999876654 57889999999
Q ss_pred eccC-eeccccCChhhcCCCCCCEEeCcCCcCCccCC
Q 042949 131 NLSS-NLLSGAVPLALTKLKHLKTLDISNNHFAATSP 166 (608)
Q Consensus 131 ~Ls~-N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p 166 (608)
++.. |++....|..|..+++|++|++++|.+....+
T Consensus 84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~ 120 (242)
T d1xwdc1 84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120 (242)
T ss_dssp EEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCC
T ss_pred cccccccccccccccccccccccccccchhhhccccc
Confidence 9864 78887777789999999999999999975444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.08 E-value=2.6e-06 Score=78.12 Aligned_cols=80 Identities=29% Similarity=0.393 Sum_probs=49.4
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|+|++|.+++.. .++++++|+.|++++|.+. .+| .+.+++.|+.|++++|.+... ..+..+++|+.|+
T Consensus 62 ~nL~~L~Ls~N~l~~~~---~l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~ 134 (199)
T d2omxa2 62 NNLTQINFSNNQLTDIT---PLKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLE 134 (199)
T ss_dssp TTCCEEECCSSCCCCCG---GGTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred CCcCcCccccccccCcc---cccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhh
Confidence 35666677766666532 2666666777777766665 233 366666677777766666532 2355666677777
Q ss_pred CcCCcCC
Q 042949 156 ISNNHFA 162 (608)
Q Consensus 156 ls~N~l~ 162 (608)
+++|.+.
T Consensus 135 l~~n~l~ 141 (199)
T d2omxa2 135 LSSNTIS 141 (199)
T ss_dssp CCSSCCC
T ss_pred hhhhhhc
Confidence 7766664
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.04 E-value=3.1e-06 Score=78.25 Aligned_cols=79 Identities=27% Similarity=0.433 Sum_probs=35.0
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|+|++|.+++.. .++.+++|+.|++++|.+++ +| .+..+++|+.|++++|.+. .++ .+..++.|+.+++
T Consensus 69 ~L~~L~L~~n~i~~l~---~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 69 NVTKLFLNGNKLTDIK---PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp TCCEEECCSSCCCCCG---GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCEEeCCCccccCcc---ccccCccccccccccccccc-cc-ccccccccccccccccccc-ccc-ccccccccccccc
Confidence 3444444444444421 13444444445554444442 22 2444444444554444443 121 3444444445554
Q ss_pred cCCcCC
Q 042949 157 SNNHFA 162 (608)
Q Consensus 157 s~N~l~ 162 (608)
++|.++
T Consensus 142 ~~n~l~ 147 (210)
T d1h6ta2 142 GNNKIT 147 (210)
T ss_dssp CSSCCC
T ss_pred cccccc
Confidence 444444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.04 E-value=5.3e-06 Score=79.20 Aligned_cols=133 Identities=12% Similarity=0.040 Sum_probs=89.5
Q ss_pred CCCCceEEEEEEcCCcEEEEEEeccc-ccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeeccCCCHHHHHH
Q 042949 311 QTICSSLFMVRLKNSAVYAVKRLKKL-QVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQSNGSLLSLLE 388 (608)
Q Consensus 311 ~g~~g~vy~~~~~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 388 (608)
++....||+... +++.+++|+.... ......+.+|...+..+. +--+.+++.+....+..++||+++++.++.+...
T Consensus 24 G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 24 GMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp CCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence 444568998864 5566778887632 223445677888776653 3335567777788888999999999988765331
Q ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-----------------------------------------------
Q 042949 389 AYIEGKRDFPWKLRLSIATGIAKGLDFMYQKSN----------------------------------------------- 421 (608)
Q Consensus 389 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----------------------------------------------- 421 (608)
+......++.++++.++.||+...
T Consensus 103 ---------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 103 ---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp ---------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred ---------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 111223455666666777775321
Q ss_pred -------CCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 422 -------EEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 422 -------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
....++|+|+.|.|||++++..+-|.||+.+.
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 12237899999999999877666799999875
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.02 E-value=2.2e-06 Score=80.21 Aligned_cols=84 Identities=24% Similarity=0.390 Sum_probs=67.4
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
..+..+.++++.+.... .+.+.++|+.|++++|.+.+.. .++++++|+.|+|++|++++ +| .+..+++|+.|+
T Consensus 129 ~~~~~l~~~~~~~~~~~---~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~ 201 (227)
T d1h6ua2 129 SNLQVLYLDLNQITNIS---PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVH 201 (227)
T ss_dssp TTCCEEECCSSCCCCCG---GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEE
T ss_pred cchhhhhchhhhhchhh---hhccccccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEE
Confidence 46777888888877643 3678889999999999987543 38889999999999999985 44 378899999999
Q ss_pred CcCCcCCccCC
Q 042949 156 ISNNHFAATSP 166 (608)
Q Consensus 156 ls~N~l~g~~p 166 (608)
|++|++++..|
T Consensus 202 Ls~N~lt~i~~ 212 (227)
T d1h6ua2 202 LKNNQISDVSP 212 (227)
T ss_dssp CTTSCCCBCGG
T ss_pred CcCCcCCCCcc
Confidence 99999986433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.01 E-value=3.2e-06 Score=85.28 Aligned_cols=85 Identities=19% Similarity=0.372 Sum_probs=72.9
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|++++++++. +. .+..|++|++|+|++|.|++ +|+ +++|++|++|+|++|++++. + .++.+++|+.|+
T Consensus 44 ~~l~~L~l~~~~I~~-l~--gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~ 116 (384)
T d2omza2 44 DQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 116 (384)
T ss_dssp TTCCEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCC-cc--ccccCCCCCEEeCcCCcCCC-Ccc-ccCCcccccccccccccccc-c-cccccccccccc
Confidence 479999999999875 43 58899999999999999996 443 99999999999999999864 3 388999999999
Q ss_pred CcCCcCCccCCh
Q 042949 156 ISNNHFAATSPD 167 (608)
Q Consensus 156 ls~N~l~g~~p~ 167 (608)
+++|.+++..+.
T Consensus 117 ~~~~~~~~~~~~ 128 (384)
T d2omza2 117 LFNNQITDIDPL 128 (384)
T ss_dssp CCSSCCCCCGGG
T ss_pred cccccccccccc
Confidence 999999876554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.00 E-value=1.3e-07 Score=87.22 Aligned_cols=83 Identities=29% Similarity=0.409 Sum_probs=60.9
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.|+|++|+++. ++ .+.+|++|+.|+|++|.++ .+|.....++.|+.|++++|+++. ++ .+..+++|++|
T Consensus 47 L~~L~~L~Ls~n~I~~-i~--~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L 120 (198)
T d1m9la_ 47 LKACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVL 120 (198)
T ss_dssp TTTCCEEECSEEEESC-CC--CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEE
T ss_pred ccccceeECcccCCCC-cc--cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccccccccc
Confidence 3467888888888773 43 3777888888888888887 566555556678888888888874 33 46677788888
Q ss_pred eCcCCcCCc
Q 042949 155 DISNNHFAA 163 (608)
Q Consensus 155 ~ls~N~l~g 163 (608)
+|++|+++.
T Consensus 121 ~L~~N~i~~ 129 (198)
T d1m9la_ 121 YMSNNKITN 129 (198)
T ss_dssp EESEEECCC
T ss_pred ccccchhcc
Confidence 888888764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=97.98 E-value=5.6e-06 Score=77.35 Aligned_cols=82 Identities=23% Similarity=0.372 Sum_probs=54.4
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..+++.++++++...+.. .+...+.+..+.++++.+.+.. .+..+++|+.|++++|.+++.. .+..+++|+.|
T Consensus 106 l~~L~~l~l~~~~~~~~~---~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L 178 (227)
T d1h6ua2 106 LQSIKTLDLTSTQITDVT---PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTL 178 (227)
T ss_dssp CTTCCEEECTTSCCCCCG---GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred cccccccccccccccccc---hhccccchhhhhchhhhhchhh--hhccccccccccccccccccch--hhcccccceec
Confidence 346677777777666532 3556677777777777776433 3566777777777777776432 36677777777
Q ss_pred eCcCCcCCc
Q 042949 155 DISNNHFAA 163 (608)
Q Consensus 155 ~ls~N~l~g 163 (608)
||++|.+++
T Consensus 179 ~Ls~n~l~~ 187 (227)
T d1h6ua2 179 KADDNKISD 187 (227)
T ss_dssp ECCSSCCCC
T ss_pred ccCCCccCC
Confidence 777777765
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.92 E-value=5e-06 Score=76.84 Aligned_cols=84 Identities=29% Similarity=0.391 Sum_probs=70.9
Q ss_pred CCcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEE
Q 042949 75 ATNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTL 154 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L 154 (608)
..++..++++++.+.. + ..+..++.|+.+++++|.+++ +..+..+++|+.+++++|++++ ++ .+..+++|+.|
T Consensus 111 l~~L~~L~l~~~~~~~-~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L 183 (210)
T d1h6ta2 111 LKKLKSLSLEHNGISD-I--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNL 183 (210)
T ss_dssp CTTCCEEECTTSCCCC-C--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEE
T ss_pred cccccccccccccccc-c--ccccccccccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEE
Confidence 4578999999998764 3 358899999999999999985 3457889999999999999996 44 38899999999
Q ss_pred eCcCCcCCccCC
Q 042949 155 DISNNHFAATSP 166 (608)
Q Consensus 155 ~ls~N~l~g~~p 166 (608)
+|++|+++. +|
T Consensus 184 ~Ls~N~i~~-l~ 194 (210)
T d1h6ta2 184 YLSKNHISD-LR 194 (210)
T ss_dssp ECCSSCCCB-CG
T ss_pred ECCCCCCCC-Ch
Confidence 999999974 55
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.91 E-value=9.3e-06 Score=74.24 Aligned_cols=83 Identities=18% Similarity=0.382 Sum_probs=68.4
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEe
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLD 155 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ 155 (608)
.+++.|++++++++. ++ .+..+++|++|++++|.+++..| ++++++|++|++++|.+. .+| .+..++.|+.|+
T Consensus 40 ~~l~~L~l~~~~i~~-l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLT 112 (199)
T ss_dssp TTCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred cCCCEEECCCCCCCC-cc--ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccc
Confidence 368889999998874 43 47889999999999999986433 889999999999999987 455 488899999999
Q ss_pred CcCCcCCccC
Q 042949 156 ISNNHFAATS 165 (608)
Q Consensus 156 ls~N~l~g~~ 165 (608)
+++|.+....
T Consensus 113 l~~~~~~~~~ 122 (199)
T d2omxa2 113 LFNNQITDID 122 (199)
T ss_dssp CCSSCCCCCG
T ss_pred cccccccccc
Confidence 9999887643
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.74 E-value=1.6e-06 Score=79.63 Aligned_cols=66 Identities=30% Similarity=0.373 Sum_probs=58.0
Q ss_pred hhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCCc
Q 042949 95 ETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAA 163 (608)
Q Consensus 95 ~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g 163 (608)
..+..|++|+.|+|++|.++ .++ .+..|++|+.|+|++|+++ .+|.....+++|+.|++++|+++.
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~ 107 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS 107 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC
T ss_pred hHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc
Confidence 46889999999999999998 565 5899999999999999998 677655666789999999999985
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.58 E-value=5.5e-05 Score=74.61 Aligned_cols=76 Identities=21% Similarity=0.331 Sum_probs=38.2
Q ss_pred cEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeC
Q 042949 77 NIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDI 156 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~l 156 (608)
+++.|+|++|+|+ .+|. .+.+|+.|++++|.++ .++. + .+.|++|+|++|.++ .+|. ++.+++|+.|++
T Consensus 59 ~L~~L~Ls~N~l~-~lp~----~~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 59 HLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp TCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCEEECCCCCCc-cccc----chhhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeecc
Confidence 4555555555555 3331 1334555555555554 2221 1 123556666666655 3443 345566666666
Q ss_pred cCCcCCc
Q 042949 157 SNNHFAA 163 (608)
Q Consensus 157 s~N~l~g 163 (608)
++|.+..
T Consensus 128 ~~~~~~~ 134 (353)
T d1jl5a_ 128 DNNSLKK 134 (353)
T ss_dssp CSSCCSC
T ss_pred ccccccc
Confidence 6665543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.55 E-value=0.00012 Score=69.03 Aligned_cols=68 Identities=12% Similarity=0.089 Sum_probs=49.0
Q ss_pred CceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCC--CcceeeeeeeecCCeeEEEEeeccCCCH
Q 042949 314 CSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKH--PNILPLVCYNSTNEEKLLVYKYQSNGSL 383 (608)
Q Consensus 314 ~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g~L 383 (608)
...||+....++..+++|.-.... ...+..|.+.++.+.. -.+.+++++..+.+..++||+|+++.++
T Consensus 24 ~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 24 DAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 467899988888888999765332 2346677777766532 2355677777888889999999987654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.43 E-value=1.8e-05 Score=69.82 Aligned_cols=70 Identities=23% Similarity=0.201 Sum_probs=56.2
Q ss_pred hcCCcCCcEEEcccCcCCcc--CcccccCCCCcceeeccCeeccccCCh-hhcCCCCCCEEeCcCCcCCccCCh
Q 042949 97 LCKLRHLRVVSLARNLIQGR--IPTSISNCRRLTYLNLSSNLLSGAVPL-ALTKLKHLKTLDISNNHFAATSPD 167 (608)
Q Consensus 97 l~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~L~Ls~N~l~g~lP~-~l~~l~~L~~L~ls~N~l~g~~p~ 167 (608)
...+++|++|+|++|.++.. ++..+..|++|+.|||++|.++. +++ .......|+.|++++|.++.....
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~ 133 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRD 133 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCccc
Confidence 45789999999999999854 34557789999999999999984 443 334456799999999999877654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.34 E-value=1.9e-05 Score=69.59 Aligned_cols=80 Identities=21% Similarity=0.248 Sum_probs=61.5
Q ss_pred CcEEEEEecCCCceeecC-hhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCCh-------hhcC
Q 042949 76 TNIVGIRLENMNLSGIID-AETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPL-------ALTK 147 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~-~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~-------~l~~ 147 (608)
..++.|+|++|.++..-+ +..+..+++|+.|+|++|.++..-+-.......|+.|+|++|.++..... -+..
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~ 144 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTT
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHH
Confidence 479999999999986421 13467899999999999999954332334455799999999999876553 2567
Q ss_pred CCCCCEEe
Q 042949 148 LKHLKTLD 155 (608)
Q Consensus 148 l~~L~~L~ 155 (608)
+++|+.||
T Consensus 145 ~P~L~~LD 152 (162)
T d1koha1 145 FPKLLRLD 152 (162)
T ss_dssp STTCCEET
T ss_pred CCCCCEEC
Confidence 89999987
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.26 E-value=0.00012 Score=68.37 Aligned_cols=87 Identities=15% Similarity=0.207 Sum_probs=68.8
Q ss_pred EEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCCh-hhcCCCCCCEEeCcC
Q 042949 80 GIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPL-ALTKLKHLKTLDISN 158 (608)
Q Consensus 80 ~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~-~l~~l~~L~~L~ls~ 158 (608)
.++.++.+|+ .+|+ .+. +++++|+|++|.++...+..|.++++|++|+|++|.+...+|. .+..++.++.|++..
T Consensus 12 ~i~c~~~~l~-~iP~-~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 12 VFLCQESKVT-EIPS-DLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp EEEEESCSCS-SCCS-CSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred EEEEeCCCCC-CcCC-CCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 5777888887 5663 332 5899999999999865555789999999999999999877765 688899999999865
Q ss_pred -CcCCccCChhHH
Q 042949 159 -NHFAATSPDNFR 170 (608)
Q Consensus 159 -N~l~g~~p~~~~ 170 (608)
|++....|..|.
T Consensus 88 ~n~l~~~~~~~~~ 100 (242)
T d1xwdc1 88 ANNLLYINPEAFQ 100 (242)
T ss_dssp CTTCCEECTTSEE
T ss_pred ccccccccccccc
Confidence 677766665553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.19 E-value=0.00055 Score=69.00 Aligned_cols=72 Identities=10% Similarity=0.027 Sum_probs=45.2
Q ss_pred cCCCCCceEEEEEEcC-CcEEEEEEecc--------cccCHHHHHHHHHHHhcCC-C--CcceeeeeeeecCCeeEEEEe
Q 042949 309 RSQTICSSLFMVRLKN-SAVYAVKRLKK--------LQVSMDEFSQTMRQIGNLK-H--PNILPLVCYNSTNEEKLLVYK 376 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~-g~~vavK~l~~--------~~~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~~~~~lv~e 376 (608)
+|.|....||++...+ ++.++||.-.. ...+.++...|.+.|..+. + ..+.+++.+ +++..++|||
T Consensus 34 ig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE 111 (392)
T d2pula1 34 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVME 111 (392)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEEC
T ss_pred eCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEe
Confidence 5788889999998654 67899997431 1123445566887776552 2 334455554 3455689999
Q ss_pred eccCCC
Q 042949 377 YQSNGS 382 (608)
Q Consensus 377 ~~~~g~ 382 (608)
++++..
T Consensus 112 ~L~~~~ 117 (392)
T d2pula1 112 DLSHLK 117 (392)
T ss_dssp CCTTSE
T ss_pred ccCCcc
Confidence 997643
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.15 E-value=0.00036 Score=68.42 Aligned_cols=59 Identities=29% Similarity=0.343 Sum_probs=48.4
Q ss_pred CcCCcEEEcccCcCCccCcccccCCCCcceeeccCeeccccCChhhcCCCCCCEEeCcCCcCCccCCh
Q 042949 100 LRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSSNLLSGAVPLALTKLKHLKTLDISNNHFAATSPD 167 (608)
Q Consensus 100 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~lP~~l~~l~~L~~L~ls~N~l~g~~p~ 167 (608)
+++|++|+|++|.|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+++ .+|.
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 578999999999998 67754 567889999999998 67753 568999999999987 4553
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.12 E-value=4.8e-05 Score=73.50 Aligned_cols=87 Identities=21% Similarity=0.198 Sum_probs=68.8
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCccCcccccCCCCcceeeccC-eecccc-CChhhcCCCCCCE
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQGRIPTSISNCRRLTYLNLSS-NLLSGA-VPLALTKLKHLKT 153 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~-lP~~l~~l~~L~~ 153 (608)
.+++.|+|+++.++.......+..+++|++|+|+++.+++..+..++.+++|++|+|++ +.++.. +..-+..+++|+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 47899999998887643234577899999999999999988888999999999999998 566632 2223456899999
Q ss_pred EeCcCC-cCC
Q 042949 154 LDISNN-HFA 162 (608)
Q Consensus 154 L~ls~N-~l~ 162 (608)
|+++++ .++
T Consensus 126 L~ls~c~~~~ 135 (284)
T d2astb2 126 LNLSWCFDFT 135 (284)
T ss_dssp EECCCCTTCC
T ss_pred cccccccccc
Confidence 999985 444
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.12 E-value=0.0015 Score=63.79 Aligned_cols=158 Identities=9% Similarity=0.103 Sum_probs=89.2
Q ss_pred cCcCHHHHHHHhhccc--CCC------C-CceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCCcc--eeee
Q 042949 294 ERFKLDDLLEATADLR--SQT------I-CSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHPNI--LPLV 362 (608)
Q Consensus 294 ~~~~~~~l~~~~~~~~--g~g------~-~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~ni--v~l~ 362 (608)
..++.+-+..+.+.+. ..+ + --.||+++..+|+.|++|+.+....+.+++..|...+..|....+ +..+
T Consensus 6 ~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~ 85 (325)
T d1zyla1 6 QTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPV 85 (325)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred cccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCce
Confidence 3456666666665432 111 1 137999999999999999987655577888889888876642222 1111
Q ss_pred -----eeeecCCeeEEEEeeccCCCH-----H---------HHHHHHhcC-----CCCCCH-------------------
Q 042949 363 -----CYNSTNEEKLLVYKYQSNGSL-----L---------SLLEAYIEG-----KRDFPW------------------- 399 (608)
Q Consensus 363 -----~~~~~~~~~~lv~e~~~~g~L-----~---------~~l~~~~~~-----~~~l~~------------------- 399 (608)
..+...+..+.++++++|..+ . ..+|..... ...+++
T Consensus 86 ~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~ 165 (325)
T d1zyla1 86 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 165 (325)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCH
Confidence 123345677889999875321 1 112221110 111111
Q ss_pred HHHHHHHHHHHHHHHHHhcCC--CCCCCceecCCCCCCeecCCCCCceEecccccc
Q 042949 400 KLRLSIATGIAKGLDFMYQKS--NEEKTIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 400 ~~~~~i~~~ia~gL~yLH~~~--~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
..+..+...+.+.++.+.... .....+||+|+.+.|||++++ ..+.||+.+.
T Consensus 166 ~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 166 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 111112222233333332211 123468999999999999753 5689999876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.98 E-value=8.9e-05 Score=75.75 Aligned_cols=86 Identities=22% Similarity=0.294 Sum_probs=45.4
Q ss_pred cEEEEEecCCCcee----ecChhhhcCCcCCcEEEcccCcCCcc----Cccccc-CCCCcceeeccCeecccc----CCh
Q 042949 77 NIVGIRLENMNLSG----IIDAETLCKLRHLRVVSLARNLIQGR----IPTSIS-NCRRLTYLNLSSNLLSGA----VPL 143 (608)
Q Consensus 77 ~v~~l~l~~~~l~g----~~~~~~l~~l~~L~~L~l~~N~l~g~----~p~~~~-~l~~L~~L~Ls~N~l~g~----lP~ 143 (608)
+++.|+|++|+++- .|. ..+..+++|+.|+|++|.|+.. +...+. ...+|+.|+|++|+++.. ++.
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~-~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~ 106 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDIS-SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 106 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHH-HHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHH-HHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccc
Confidence 34556666665541 121 2345566666666666666421 111221 223566666666666532 344
Q ss_pred hhcCCCCCCEEeCcCCcCCc
Q 042949 144 ALTKLKHLKTLDISNNHFAA 163 (608)
Q Consensus 144 ~l~~l~~L~~L~ls~N~l~g 163 (608)
.+..+++|+.|+|++|.++.
T Consensus 107 ~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 107 TLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp HTTSCTTCCEEECCSSBCHH
T ss_pred hhhccccccccccccccchh
Confidence 55566666666666666653
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.96 E-value=6.8e-05 Score=76.68 Aligned_cols=89 Identities=25% Similarity=0.235 Sum_probs=67.6
Q ss_pred CcEEEEEecCCCceeecChhhhcCCcCCcEEEcccCcCCc----cCcccccCCCCcceeeccCeecccc----CChhhc-
Q 042949 76 TNIVGIRLENMNLSGIIDAETLCKLRHLRVVSLARNLIQG----RIPTSISNCRRLTYLNLSSNLLSGA----VPLALT- 146 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~----lP~~l~- 146 (608)
.+|+.|+++.+++++..=...+..+++|++|+|++|.++- .++..+..+++|+.|||++|.++.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3689999999999974212346678999999999999873 3455678899999999999998631 222332
Q ss_pred CCCCCCEEeCcCCcCCcc
Q 042949 147 KLKHLKTLDISNNHFAAT 164 (608)
Q Consensus 147 ~l~~L~~L~ls~N~l~g~ 164 (608)
...+|+.|+|++|+++..
T Consensus 82 ~~~~L~~L~L~~n~it~~ 99 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGA 99 (460)
T ss_dssp TTCCCCEEECTTSCCBGG
T ss_pred CCCCCCEEECCCCCcccc
Confidence 235799999999999754
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.87 E-value=0.00032 Score=67.46 Aligned_cols=60 Identities=20% Similarity=0.180 Sum_probs=27.1
Q ss_pred CcCCcEEEcccC-cCCccCcccccCCCCcceeeccC-eeccccCChhhcCCCCCCEEeCcCC
Q 042949 100 LRHLRVVSLARN-LIQGRIPTSISNCRRLTYLNLSS-NLLSGAVPLALTKLKHLKTLDISNN 159 (608)
Q Consensus 100 l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~lP~~l~~l~~L~~L~ls~N 159 (608)
+++|+.|++++| .+++.....+.++++|++|+|++ +.+++.-...++.+++|+.|+++++
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 444455555442 34444444444444555555544 3344333334444444555554443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.47 E-value=0.00047 Score=68.05 Aligned_cols=87 Identities=21% Similarity=0.308 Sum_probs=48.0
Q ss_pred cEEEEEecCCCceee----cChhhhcCCcCCcEEEcccCcCCcc-----CcccccCCCCcceeeccCeecccc----CCh
Q 042949 77 NIVGIRLENMNLSGI----IDAETLCKLRHLRVVSLARNLIQGR-----IPTSISNCRRLTYLNLSSNLLSGA----VPL 143 (608)
Q Consensus 77 ~v~~l~l~~~~l~g~----~~~~~l~~l~~L~~L~l~~N~l~g~-----~p~~~~~l~~L~~L~Ls~N~l~g~----lP~ 143 (608)
.+..+.+++|.++-. +. ..+..+..|+.|+|++|.++.. +...+..++.|+.|+|++|.++.. +..
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~-~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWA-KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHH-HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred ccceeeccccccccccccccc-chhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 456666666655421 11 2344556666666666666532 223355566666666666666422 333
Q ss_pred hhcCCCCCCEEeCcCCcCCcc
Q 042949 144 ALTKLKHLKTLDISNNHFAAT 164 (608)
Q Consensus 144 ~l~~l~~L~~L~ls~N~l~g~ 164 (608)
.+..+++|+.|+|++|.+++.
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCHH
T ss_pred cccccccchhhhhhcCccCch
Confidence 455566666666666666543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.24 E-value=0.00063 Score=67.04 Aligned_cols=89 Identities=21% Similarity=0.257 Sum_probs=59.7
Q ss_pred CcEEEEEecCCCce--e--ecC--------hhhhcCCcCCcEEEcccCcCCcc----CcccccCCCCcceeeccCeeccc
Q 042949 76 TNIVGIRLENMNLS--G--IID--------AETLCKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLSG 139 (608)
Q Consensus 76 ~~v~~l~l~~~~l~--g--~~~--------~~~l~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g 139 (608)
.+++.|+|++|.++ | .+. .......+.|+.|++++|.++.. +...+..++.|+.|+|++|+++.
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 200 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence 46888888888753 1 110 01124567888888888887632 33445667888899998888863
Q ss_pred c-----CChhhcCCCCCCEEeCcCCcCCcc
Q 042949 140 A-----VPLALTKLKHLKTLDISNNHFAAT 164 (608)
Q Consensus 140 ~-----lP~~l~~l~~L~~L~ls~N~l~g~ 164 (608)
. +...+..+++|+.|+|++|.|+..
T Consensus 201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 230 (344)
T d2ca6a1 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHL 230 (344)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHH
T ss_pred cccccchhhhhcchhhhccccccccccccc
Confidence 2 233466778889999988887543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.01 E-value=0.0017 Score=56.82 Aligned_cols=86 Identities=22% Similarity=0.333 Sum_probs=62.6
Q ss_pred CcEEEEEecCC-Cceee----cChhhhcCCcCCcEEEcccCcCCcc----CcccccCCCCcceeeccCeecccc----CC
Q 042949 76 TNIVGIRLENM-NLSGI----IDAETLCKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLSGA----VP 142 (608)
Q Consensus 76 ~~v~~l~l~~~-~l~g~----~~~~~l~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----lP 142 (608)
..++.|+|+++ .++.. + ...+...+.|+.|+|++|.+... +...+...+.|+.|+|++|.++.. +-
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l-~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSL-IEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHH-HHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHH-HHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 47899999874 45421 2 13567788999999999998743 223455678899999999999743 22
Q ss_pred hhhcCCCCCCEEeCcCCcCC
Q 042949 143 LALTKLKHLKTLDISNNHFA 162 (608)
Q Consensus 143 ~~l~~l~~L~~L~ls~N~l~ 162 (608)
..+...++|+.|+|++|.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSC
T ss_pred HHHHhCCcCCEEECCCCcCC
Confidence 35667788999999998765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.79 E-value=0.013 Score=58.43 Aligned_cols=69 Identities=12% Similarity=-0.024 Sum_probs=45.4
Q ss_pred cCCCCCceEEEEEEcCC--------cEEEEEEecccccCHHHHHHHHHHHhcCC-CCcceeeeeeeecCCeeEEEEeecc
Q 042949 309 RSQTICSSLFMVRLKNS--------AVYAVKRLKKLQVSMDEFSQTMRQIGNLK-HPNILPLVCYNSTNEEKLLVYKYQS 379 (608)
Q Consensus 309 ~g~g~~g~vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 379 (608)
+++|-.-.+|++...++ +.|.+++.- .........+|.++++.+. +.-..++++++.+ .+|+||++
T Consensus 50 l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~ 124 (395)
T d1nw1a_ 50 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIP 124 (395)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCC
T ss_pred cCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEec
Confidence 56677778999987653 456666554 2334455678888888774 4333467777653 68999997
Q ss_pred CCC
Q 042949 380 NGS 382 (608)
Q Consensus 380 ~g~ 382 (608)
+..
T Consensus 125 g~~ 127 (395)
T d1nw1a_ 125 SRP 127 (395)
T ss_dssp EEE
T ss_pred ccc
Confidence 643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.29 E-value=0.018 Score=55.30 Aligned_cols=141 Identities=13% Similarity=0.068 Sum_probs=71.9
Q ss_pred CCCCCceEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHhcCCCC-----cceeee-e--eeecCCeeEEEEeeccCC
Q 042949 310 SQTICSSLFMVRLKNSAVYAVKRLKKLQVSMDEFSQTMRQIGNLKHP-----NILPLV-C--YNSTNEEKLLVYKYQSNG 381 (608)
Q Consensus 310 g~g~~g~vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~H~-----niv~l~-~--~~~~~~~~~lv~e~~~~g 381 (608)
..|.--+.|+.+..+|+ +++|+.... .+.+++..|++.+..+... ..+... | +.........++.+..+.
T Consensus 27 ~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~ 104 (316)
T d2ppqa1 27 AEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGM 104 (316)
T ss_dssp CC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCB
T ss_pred CCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecccc
Confidence 34555678998887765 889988642 2344555666666655322 222211 1 112234556666666543
Q ss_pred CH--------------HHHHHHHhcC---C---CCC-----------------CHHHHHHHHHHHHHHHHHHhcCCCCCC
Q 042949 382 SL--------------LSLLEAYIEG---K---RDF-----------------PWKLRLSIATGIAKGLDFMYQKSNEEK 424 (608)
Q Consensus 382 ~L--------------~~~l~~~~~~---~---~~l-----------------~~~~~~~i~~~ia~gL~yLH~~~~~~~ 424 (608)
.. ...++..... . ... ........+..+...+.-.+... -..
T Consensus 105 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-L~~ 183 (316)
T d2ppqa1 105 WLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD-LPA 183 (316)
T ss_dssp CCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS-SCE
T ss_pred cccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccc-ccc
Confidence 22 1111111000 0 000 00111222333333444443332 345
Q ss_pred CceecCCCCCCeecCCCCCceEecccccc
Q 042949 425 TIPHGNLKLSNILLNENEDPLISECGYSK 453 (608)
Q Consensus 425 ~ivHrDlkp~NILl~~~~~~kl~DFGla~ 453 (608)
++||+|+.+.||+++.+...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 79999999999999988777899999875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=94.35 E-value=0.0081 Score=52.22 Aligned_cols=86 Identities=17% Similarity=0.169 Sum_probs=63.6
Q ss_pred CcEEEEEecCCCceee--cC-hhhhcCCcCCcEEEcccCcCCcc----CcccccCCCCcceeeccCeecccc-------C
Q 042949 76 TNIVGIRLENMNLSGI--ID-AETLCKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLSGA-------V 141 (608)
Q Consensus 76 ~~v~~l~l~~~~l~g~--~~-~~~l~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~-------l 141 (608)
..++.|+|++|.+... .. ...+...+.|+.|+|++|.++.. +-..+...+.|+.|+|++|.+... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 4799999999998732 11 13466778999999999999854 223577788999999999876521 3
Q ss_pred ChhhcCCCCCCEEeCcCCcC
Q 042949 142 PLALTKLKHLKTLDISNNHF 161 (608)
Q Consensus 142 P~~l~~l~~L~~L~ls~N~l 161 (608)
-..+..-++|+.|+++.+..
T Consensus 124 ~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCCccEeeCcCCCc
Confidence 34455678999999987754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.87 E-value=0.032 Score=47.98 Aligned_cols=86 Identities=22% Similarity=0.271 Sum_probs=53.8
Q ss_pred CcEEEEEecCC-Cceee----cChhhhcCCcCCcEEEcccCcCCcc----CcccccCCCCcceeeccCeecccc----CC
Q 042949 76 TNIVGIRLENM-NLSGI----IDAETLCKLRHLRVVSLARNLIQGR----IPTSISNCRRLTYLNLSSNLLSGA----VP 142 (608)
Q Consensus 76 ~~v~~l~l~~~-~l~g~----~~~~~l~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----lP 142 (608)
..++.|+|+++ .++.. + ...+...++|+.|+|++|.++.. +-..+...+.|+.+++++|.++.. +-
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l-~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKAC-AEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHH-HHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHH-HHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 46777888763 45421 2 13456778888888888887644 222345667888888888887633 22
Q ss_pred hhhcCCCCCCEEeC--cCCcCC
Q 042949 143 LALTKLKHLKTLDI--SNNHFA 162 (608)
Q Consensus 143 ~~l~~l~~L~~L~l--s~N~l~ 162 (608)
..+...++|+.++| ++|.+.
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHhCccccEEeeccCCCcCc
Confidence 35566777876555 445553
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=88.55 E-value=0.06 Score=46.17 Aligned_cols=86 Identities=16% Similarity=0.177 Sum_probs=63.9
Q ss_pred CCcEEEEEecCCCceee----cChhhhcCCcCCcEEEcccCcCCcc----CcccccCCCCcce--eeccCeeccc----c
Q 042949 75 ATNIVGIRLENMNLSGI----IDAETLCKLRHLRVVSLARNLIQGR----IPTSISNCRRLTY--LNLSSNLLSG----A 140 (608)
Q Consensus 75 ~~~v~~l~l~~~~l~g~----~~~~~l~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~--L~Ls~N~l~g----~ 140 (608)
...++.|+|++|.++.. + ...+...+.|+.|++++|.+... +-..+...+.|+. |+++.|.+.. .
T Consensus 45 n~~L~~L~Ls~n~l~~~~~~~L-~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 45 NTYVKKFSIVGTRSNDPVAFAL-AEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp CCSCCEEECTTSCCCHHHHHHH-HHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred CCccCeeeccCCcccHHHHHHH-HHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 35799999999998743 2 13466789999999999999754 3345677888886 5556788853 2
Q ss_pred CChhhcCCCCCCEEeCcCCcC
Q 042949 141 VPLALTKLKHLKTLDISNNHF 161 (608)
Q Consensus 141 lP~~l~~l~~L~~L~ls~N~l 161 (608)
+-..+...++|+.|+++.|+.
T Consensus 124 La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCCCcCEEeCcCCCC
Confidence 445667789999999988765
|